PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Chang, XF; Wang, SP; Cui, SJ; Zhu, XX; Luo, CY; Zhang, ZH; Wilkes, A				Chang, Xiaofeng; Wang, Shiping; Cui, Shujuan; Zhu, Xiaoxue; Luo, Caiyun; Zhang, Zhenhua; Wilkes, Andreas			Alpine Grassland Soil Organic Carbon Stock and Its Uncertainty in the Three Rivers Source Region of the Tibetan Plateau	PLOS ONE			English	Article							SPATIAL VARIABILITY; ASSESSMENTS; PATTERNS; DENSITY; POOL	Alpine grassland of the Tibetan Plateau is an important component of global soil organic carbon (SOC) stocks, but insufficient field observations and large spatial heterogeneity leads to great uncertainty in their estimation. In the Three Rivers Source Region (TRSR), alpine grasslands account for more than 75% of the total area. However, the regional carbon (C) stock estimate and their uncertainty have seldom been tested. Here we quantified the regional SOC stock and its uncertainty using 298 soil profiles surveyed from 35 sites across the TRSR during 2006-2008. We showed that the upper soil (0-30 cm depth) in alpine grasslands of the TRSR stores 2.03 Pg C, with a 95% confidence interval ranging from 1.25 to 2.81 Pg C. Alpine meadow soils comprised 73% (i.e. 1.48 Pg C) of the regional SOC estimate, but had the greatest uncertainty at 51%. The statistical power to detect a deviation of 10% uncertainty in grassland C stock was less than 0.50. The required sample size to detect this deviation at a power of 90% was about 6-7 times more than the number of sample sites surveyed. Comparison of our observed SOC density with the corresponding values from the dataset of Yang et al. indicates that these two datasets are comparable. The combined dataset did not reduce the uncertainty in the estimate of the regional grassland soil C stock. This result could be mainly explained by the underrepresentation of sampling sites in large areas with poor accessibility. Further research to improve the regional SOC stock estimate should optimize sampling strategy by considering the number of samples and their spatial distribution.	[Chang, Xiaofeng] Northwest A&F Univ, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Peoples R China; [Chang, Xiaofeng; Cui, Shujuan; Zhu, Xiaoxue; Luo, Caiyun; Zhang, Zhenhua] Chinese Acad Sci, Northwest Inst Plateau Biol, Key Lab Adaptat & Evolut Plateau Biota, Xining, Peoples R China; [Wang, Shiping] Chinese Acad Sci, Inst Tibetan Plateau Res, Lab Alpine Ecol & Biodivers, Beijing, Peoples R China; [Cui, Shujuan; Zhu, Xiaoxue] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wilkes, Andreas] World Agroforestry Ctr East Asia Programme, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Tibetan Plateau Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, SP (corresponding author), Chinese Acad Sci, Inst Tibetan Plateau Res, Lab Alpine Ecol & Biodivers, Beijing, Peoples R China.	wangsp@itpcas.ac.cn			National Basic Research Program [2013CB956000]; Strategic Priority Research Program (B) of the Chinese Academy of Sciences [XDB03030403]; Special Program of Carbon Sequestration of the Chinese Academy of Sciences [XDA05070205]; National Science Foundation for Young Scientists [41303062]; West Light Foundation of the Chinese Academy of Science	National Basic Research Program(National Basic Research Program of China); Strategic Priority Research Program (B) of the Chinese Academy of Sciences(Chinese Academy of Sciences); Special Program of Carbon Sequestration of the Chinese Academy of Sciences; National Science Foundation for Young Scientists; West Light Foundation of the Chinese Academy of Science(Chinese Academy of Sciences)	This work was supported by the National Basic Research Program (2013CB956000), Strategic Priority Research Program (B) of the Chinese Academy of Sciences (XDB03030403), Special Program of Carbon Sequestration of the Chinese Academy of Sciences (XDA05070205), the National Science Foundation for Young Scientists (41303062), the West Light Foundation of the Chinese Academy of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akumu CE, 2013, GEODERMA, V209, P161, DOI 10.1016/j.geoderma.2013.06.021; Allen DE, 2010, RANGELAND J, V32, P227, DOI 10.1071/RJ09043; Boucneau G., 1998, PEDOLOGIE THEMATA, V5, P67; Cambule AH, 2013, GEODERMA, V192, P341, DOI 10.1016/j.geoderma.2012.08.020; Conant RT, 2002, ENVIRON POLLUT, V116, pS127, DOI 10.1016/S0269-7491(01)00265-2; De Vos B, 2005, SOIL SCI SOC AM J, V69, P500, DOI 10.2136/sssaj2005.0500; Goidts E, 2009, EUR J SOIL SCI, V60, P723, DOI 10.1111/j.1365-2389.2009.01157.x; [郭小伟 GUO Xiaowei], 2011, [草地学报, Acta Agrestia Sinica], V19, P740; Johnston CA, 2004, FRONT ECOL ENVIRON, V2, P522, DOI 10.1890/1540-9295(2004)002[0522:CCIS]2.0.CO;2; Kravchenko AN, 2011, SOIL SCI SOC AM J, V75, P235, DOI 10.2136/sssaj2010.0076; Liu YuHong, 2009, Journal of Agro-Environment Science, V28, P2559; Muukkonen P, 2009, ENVIRON MONIT ASSESS, V158, P67, DOI 10.1007/s10661-008-0565-2; Pringle MJ, 2011, GEODERMA, V167-68, P261, DOI 10.1016/j.geoderma.2011.09.001; Shi Y, 2012, BIOGEOSCIENCES, V9, P2287, DOI 10.5194/bg-9-2287-2012; Sierra CA, 2007, FOREST ECOL MANAG, V243, P299, DOI 10.1016/j.foreco.2007.03.026; Vanguelova EI, 2013, SOIL USE MANAGE, V29, P169, DOI 10.1111/sum.12025; Wang GX, 2008, GEODERMA, V143, P143, DOI 10.1016/j.geoderma.2007.10.023; Wang GX, 2007, CATENA, V70, P506, DOI 10.1016/j.catena.2007.01.001; Wang GX, 2002, SCI TOTAL ENVIRON, V291, P207, DOI 10.1016/S0048-9697(01)01100-7; Yang YH, 2008, GLOBAL CHANGE BIOL, V14, P1592, DOI 10.1111/j.1365-2486.2008.01591.x; Yang YH, 2009, GLOBAL CHANGE BIOL, V15, P2723, DOI 10.1111/j.1365-2486.2009.01924.x; Yi XS, 2012, J GEOGR SCI, V22, P451, DOI 10.1007/s11442-012-0939-9; Yu DS, 2011, PEDOSPHERE, V21, P207, DOI 10.1016/S1002-0160(11)60119-7; Yuan ZQ, 2013, GEODERMA, V195, P48, DOI 10.1016/j.geoderma.2012.11.008; Zhang WT, 2011, SOIL SCI, V176, P367, DOI 10.1097/SS.0b013e31821eb7d2; Zhang ZQ, 2010, SOIL TILL RES, V110, P2, DOI 10.1016/j.still.2010.05.007; Zhao X.Q., 2009, ALPINE MEADOW ECOSYS; [钟聪 Zhong Cong], 2012, [现代地质, Geoscience], V26, P896; Zhou X. M, 1987, VEGETATION QINGHAI P; Zhou X.M., 2001, CHINESE KOBRESIA PYG	30	14	16	5	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97140	10.1371/journal.pone.0097140	http://dx.doi.org/10.1371/journal.pone.0097140			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819054	gold, Green Published, Green Submitted			2022-12-27	WOS:000336653300082
J	Muench, MO; Beyer, AI; Fomin, ME; Thakker, R; Mulvaney, US; Nakamura, M; Suemizu, H; Barcena, A				Muench, Marcus O.; Beyer, Ashley I.; Fomin, Marina E.; Thakker, Rahul; Mulvaney, Usha S.; Nakamura, Masato; Suemizu, Hiroshi; Barcena, Alicia			The Adult Livers of Immunodeficient Mice Support Human Hematopoiesis: Evidence for a Hepatic Mast Cell Population that Develops Early in Human Ontogeny	PLOS ONE			English	Article							HUMAN FETAL LIVER; HUMAN-BONE-MARROW; STEM-CELLS; IN-VITRO; T-CELLS; C-KIT; DIFFERENTIATION; EXPRESSION; TRANSPLANTATION; RECONSTITUTION	The liver plays a vital role in hematopoiesis during mammalian prenatal development but its hematopoietic output declines during the perinatal period. Nonetheless, hepatic hematopoiesis is believed to persist into adulthood. We sought to model human adult-liver hematopoiesis by transplantation of fetal and neonatal hematopoietic stem cells (HSCs) into adult immunodeficient mice. Livers were found to be engrafted with human cells consisting primarily of monocytes and B-cells with lesser contributions by erythrocytes, T-cells, NK-cells and mast-cells. A resident population of CD117(++)CD203c(+) mast cells was also documented in human midgestation liver, indicating that these cells comprise part of the liver's resident immune cell repertoire throughout human ontogeny. The murine liver was shown to support human multilineage hematopoiesis up to 321 days after transplant. Evidence of murine hepatic hematopoiesis was also found in common mouse strains as old as 2 years. Human HSC engraftment of the murine liver was demonstrated by detection of high proliferative-potential colony-forming cells in clonal cultures, observation of CD38(-)CD34(++) and CD133(+)CD34(++) cells by flow cytometry, and hematopoietic reconstitution of secondary transplant recipients of chimeric liver cells. Additionally, chimeric mice with both hematopoietic and endothelial reconstitution were generated by intrasplenic injection of immunodeficient mice with liver specific expression of the urokinase-type plasminogen activator (uPA) transgene. In conclusion, the murine liver is shown to be a hematopoietic organ throughout adult life that can also support human hematopoiesis in severely immunodeficient strains. Further humanization of the murine liver can be achieved in mice harboring an uPA transgene, which support engraftment of non-hematopoietic cells types. Thus, offering a model system to study the interaction of diverse human liver cell types that regulate hematopoiesis and immune function in the liver.	[Muench, Marcus O.; Beyer, Ashley I.; Fomin, Marina E.; Thakker, Rahul; Mulvaney, Usha S.; Barcena, Alicia] Blood Syst Res Inst, San Francisco, CA 94118 USA; [Muench, Marcus O.; Fomin, Marina E.] Univ Calif San Francisco, Lab Med, San Francisco, CA 94143 USA; [Muench, Marcus O.] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA; [Nakamura, Masato; Suemizu, Hiroshi] Cent Inst Expt Animals, Biomed Res Dept, Kawasaki, Kanagawa, Japan; [Barcena, Alicia] Univ Calif San Francisco, Inst Regenerat Med, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA	Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Muench, MO (corresponding author), Blood Syst Res Inst, San Francisco, CA 94118 USA.	mmuench@bloodsystems.org	Muench, Marcus O./C-5025-2009	Muench, Marcus O./0000-0001-8946-6605; Suemizu, Hiroshi/0000-0002-3706-2454	Blood Systems Inc.; National Institutes of Health [R21 HD055328, P01 DK088760, P30 DK026743]; California Institute of Regenerative Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD055328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK088760, P30DK026743] Funding Source: NIH RePORTER	Blood Systems Inc.; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Blood Systems Inc. and the National Institutes of Health: grant numbers R21 HD055328, P01 DK088760 and P30 DK026743 (to the University of California San Francisco Liver Center) The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. USM was supported by a Bridges to Stem Cell Training grant from the California Institute of Regenerative Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo T, 2000, IMMUNOL REV, V174, P135, DOI 10.1034/j.1600-0528.2002.017415.x; Barcena A, 1999, EXP HEMATOL, V27, P1428, DOI 10.1016/S0301-472X(99)00080-6; BARCENA A, 1993, BLOOD, V82, P3401; BERNSTEIN A, 1990, CIBA F SYMP, V148, P158; BUHRING HJ, 1989, EUR J HAEMATOL, V42, P143; Charbord P, 1996, BLOOD, V87, P4109, DOI 10.1182/blood.V87.10.4109.bloodjournal87104109; Chen QF, 2009, P NATL ACAD SCI USA, V106, P21783, DOI 10.1073/pnas.0912274106; Choi B, 2011, CLIN IMMUNOL, V139, P321, DOI 10.1016/j.clim.2011.02.019; COLLINS RH, 1993, NEW ENGL J MED, V328, P762, DOI 10.1056/NEJM199303183281104; Crosbie OM, 1999, HEPATOLOGY, V29, P1193, DOI 10.1002/hep.510290402; Divoky V, 2002, BLOOD, V99, P3873, DOI 10.1182/blood-2002-01-0301; Fomin ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077255; Fomin ME, 2011, STEM CELLS DEV, V20, P1247, DOI 10.1089/scd.2010.0218; Francis H, 2010, DIGEST LIVER DIS, V42, P529, DOI 10.1016/j.dld.2010.02.016; Fujio K, 1996, EXP CELL RES, V224, P243, DOI 10.1006/excr.1996.0134; Ghannadan M, 2002, INT ARCH ALLERGY IMM, V127, P299, DOI 10.1159/000057747; Golden-Mason L, 2002, IMMUNOL CELL BIOL, V80, P45, DOI 10.1046/j.1440-1711.2002.01066.x; Golfier F, 2000, BRIT J HAEMATOL, V109, P173, DOI 10.1046/j.1365-2141.2000.02009.x; Golfier F, 1999, BONE MARROW TRANSPL, V24, P451, DOI 10.1038/sj.bmt.1701940; IRANI AMA, 1992, BLOOD, V80, P3009; Katoh M, 2008, TOXICOLOGY, V246, P9, DOI 10.1016/j.tox.2007.11.012; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kinoshita T, 1999, P NATL ACAD SCI USA, V96, P7265, DOI 10.1073/pnas.96.13.7265; KOLLMANN TR, 1994, P NATL ACAD SCI USA, V91, P8032, DOI 10.1073/pnas.91.17.8032; Kotton DN, 2005, BLOOD, V106, P1574, DOI 10.1182/blood-2005-03-1017; KYOIZUMI S, 1992, BLOOD, V79, P1704; LOKEN MR, 1987, BLOOD, V70, P1316; Macchiarini Francesca, 2005, J Exp Med, V202, P1307, DOI 10.1084/jem.20051547; MIGLIACCIO G, 1986, J CLIN INVEST, V78, P51, DOI 10.1172/JCI112572; Muench Marcus O., 2002, Biological Procedures Online, V4, P10, DOI 10.1251/bpo29; Muench MO, 1997, BLOOD, V89, P1364, DOI 10.1182/blood.V89.4.1364; MUENCH MO, 1992, EXP HEMATOL, V20, P339; MUENCH MO, 1994, BLOOD, V83, P3170; Muench MO, 2001, BLOOD CELL MOL DIS, V27, P377, DOI 10.1006/bcmd.2001.0393; Namikawa R, 1999, EXP HEMATOL, V27, P1029, DOI 10.1016/S0301-472X(99)00034-X; Nicolini FE, 1999, BLOOD, V94, P2686, DOI 10.1182/blood.V94.8.2686.420k15_2686_2695; Nierhoff D, 2000, BLOOD, V96, P763; NILSSON G, 1993, IMMUNOLOGY, V79, P325; OHTEKI T, 1990, J EXP MED, V172, P7, DOI 10.1084/jem.172.1.7; OHTEKI T, 1991, EUR J IMMUNOL, V21, P1733, DOI 10.1002/eji.1830210722; OKADA S, 1992, BLOOD, V80, P3044; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Ren XD, 2003, J CLIN INVEST, V112, P1407, DOI 10.1172/JCI200317391; ROWLEY PT, 1978, P NATL ACAD SCI USA, V75, P984, DOI 10.1073/pnas.75.2.984; SHIMIZU Y, 1995, BLOOD, V86, P930; Simpson-Abelson MR, 2008, J IMMUNOL, V180, P7009, DOI 10.4049/jimmunol.180.10.7009; Smith KA, 2001, CURR PROTOC IMMUNOL, V6; Suemizu H, 2008, BIOCHEM BIOPH RES CO, V377, P248, DOI 10.1016/j.bbrc.2008.09.124; Taniguchi H, 1996, NAT MED, V2, P198, DOI 10.1038/nm0296-198; TERSTAPPEN LWMM, 1990, ANAL CELL PATHOL, V2, P229; TERSTAPPEN LWMM, 1990, LEUKEMIA, V4, P657; TERSTAPPEN LWMM, 1991, BLOOD, V77, P1218; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Ueda M, 1997, CLIN TRANSPLANT, V11, P193; Varga N. L., 2010, STEM CELL STUD, V1, pe5, DOI DOI 10.4081/SCS.2010.E5; Wang XQ, 2012, HEPATOLOGY, V56, P1557, DOI 10.1002/hep.25820; Watanabe H, 1996, J EXP MED, V184, P687, DOI 10.1084/jem.184.2.687; Wulf-Goldenberg A, 2012, TISSUE CELL, V44, P80, DOI 10.1016/j.tice.2011.11.004; Xiao M, 2000, LEUKEMIA LYMPHOMA, V38, P489, DOI 10.3109/10428190009059267; Yamamoto S, 1999, HEPATOLOGY, V30, P705, DOI 10.1002/hep.510300331; Yu XB, 2001, BLOOD, V98, P475, DOI 10.1182/blood.V98.2.475	61	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97312	10.1371/journal.pone.0097312	http://dx.doi.org/10.1371/journal.pone.0097312			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819392	Green Published, Green Submitted, gold			2022-12-27	WOS:000336653300106
J	Ng, PK; Lim, PE; Phang, SM				Ng, Poh-Kheng; Lim, Phaik-Eem; Phang, Siew-Moi			Radiation of the Red Algal Parasite Congracilaria babae onto a Secondary Host Species, Hydropuntia sp (Gracilariaceae, Rhodophyta)	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; EVOLUTION; DNA; CHOREOCOLACACEAE; ADELPHOPARASITES; SYSTEMATICS; GENERA	Congracilaria babae was first reported as a red alga parasitic on the thallus of Gracilaria salicornia based on Japanese materials. It was circumscribed to have deep spermatangial cavities, coloration similar to its host and the absence of rhizoids. We observed a parasitic red alga with morphological and anatomical features suggestive of C. babae on a Hydropuntia species collected from Sabah, East Malaysia. We addressed the taxonomic affinities of the parasite growing on Hydropuntia sp. based on the DNA sequence of molecular markers from the nuclear, mitochondrial and plastid genomes (nuclear ITS region, mitochondrial cox1 gene and plastid rbcL gene). Phylogenetic analyses based on all genetic markers also implied the monophyly of the parasite from Hydropuntia sp. and C. babae, suggesting their conspecificity. The parasite from Hydropuntia sp. has a DNA signature characteristic to C. babae in having plastid rbcL gene sequence identical to G. salicornia. C. babae is likely to have evolved directly from G. salicornia and subsequently radiated onto a secondary host Hydropuntia sp. We also recommend the transfer of C. babae to the genus Gracilaria and propose a new combination, G. babae, based on the anatomical observations and molecular data.	[Ng, Poh-Kheng; Lim, Phaik-Eem; Phang, Siew-Moi] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia; [Ng, Poh-Kheng; Lim, Phaik-Eem; Phang, Siew-Moi] Univ Malaya, Inst Ocean & Earth Sci, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Lim, PE (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia.	phaikeem@um.edu.my	LIM, Phaik Eem/B-5331-2010; Ng, Poh-Kheng/AAH-1976-2020; Phang, Siew Moi/A-7653-2008	LIM, Phaik Eem/0000-0001-9186-1487; 	Postgraduate Research Fund from University of Malaya [PV082/2011B]; Fundamental Research Grant Scheme [FP0332012A]; Ministry of Higher Education (MOHE), Malaysia [H-50001-00-A000025]	Postgraduate Research Fund from University of Malaya; Fundamental Research Grant Scheme; Ministry of Higher Education (MOHE), Malaysia	This project is funded by the Postgraduate Research Fund from University of Malaya (PV082/2011B), the Fundamental Research Grant Scheme (FP0332012A) and MoHE-HIR grant (H-50001-00-A000025) from the Ministry of Higher Education (MOHE), Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrios G.N., 2005, PLANT PATHOL, V5th; APT KE, 1984, J PHYCOL, V20, P148, DOI 10.1111/j.0022-3646.1984.00148.x; Bellorin AM, 2002, J PHYCOL, V38, P551, DOI 10.1046/j.1529-8817.2002.t01-1-01152.x; Blouin NA, 2012, BIOESSAYS, V34, P226, DOI 10.1002/bies.201100139; FRESHWATER DW, 1994, PHYCOLOGIA, V33, P187, DOI 10.2216/i0031-8884-33-3-187.1; Gavio B, 2002, EUR J PHYCOL, V37, P349, DOI 10.1017/S0967026202003839; Geraldino Paul John L., 2006, Algae, V21, P417; Gerung GS, 1999, TAXONOMY EC SEAWEEDS, VVII, P131; Gerung GS, 2002, TAXONOMY EC SEAWEEDS, VVIII, P209; GOFF L.J., 1982, PROGR PHYCOLOGICAL R, P289; GOFF LJ, 1987, ANN NY ACAD SCI, V503, P402, DOI 10.1111/j.1749-6632.1987.tb40626.x; Goff LJ, 1997, EVOLUTION, V51, P1068, DOI 10.1111/j.1558-5646.1997.tb03954.x; Goff LJ, 1996, J PHYCOL, V32, P297, DOI 10.1111/j.0022-3646.1996.00297.x; GOFF LJ, 1995, PLANT CELL, V7, P1899; GOFF LJ, 1994, J PHYCOL, V30, P695, DOI 10.1111/j.0022-3646.1994.00695.x; GOFF LJ, 1994, J PHYCOL, V30, P521, DOI 10.1111/j.0022-3646.1994.00521.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gurgel CFD, 2004, J PHYCOL, V40, P138, DOI 10.1111/j.0022-3646.2003.02-129.x; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hancock L, 2010, GENOME BIOL EVOL, V2, P897, DOI 10.1093/gbe/evq075; Hu ZM, 2009, HYDROBIOLOGIA, V635, P279, DOI 10.1007/s10750-009-9920-8; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kurihara A, 2010, J PHYCOL, V46, P580, DOI 10.1111/j.1529-8817.2010.00834.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Morgenstern B, 2004, NUCLEIC ACIDS RES, V32, pW33, DOI 10.1093/nar/gkh373; Ng PK, 2014, J APPL PHYCOL, V26, P1287, DOI 10.1007/s10811-013-0166-5; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Schneider CW, 2007, BOT MAR, V50, P197, DOI 10.1515/BOT.2007.025; Sherwood AR, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-258; Sturch HH, 1926, ANN BOT-LONDON, V40, P585, DOI 10.1093/oxfordjournals.aob.a090039; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Terada R, 1999, TAXONOMY EC SEAWEEDS, VVII, P121; Weber-van BosseA., 1928, SIBOGA EXPED MONOG D, P393; Wilson H.L., 1910, U CALIFORNIA PUBLICA, V4, P75; Withell Anne F., 1994, Australian Systematic Botany, V7, P281, DOI 10.1071/SB9940281; YAMAMOTO H, 1991, Japanese Journal of Phycology, V39, P381; YAMAMOTO H, 1986, Bulletin of the Faculty of Fisheries Hokkaido University, V37, P281; Yamamoto H, 1997, TAXONOMY EC SEAWEEDS, VVI, P91; Zuccarello GC, 2006, PHYCOLOGIA, V45, P24, DOI 10.2216/05-07.1; ZUCCARELLO GC, 1994, PHYCOLOGIA, V33, P213, DOI 10.2216/i0031-8884-33-3-213.1; Zuccarello GC, 2004, J PHYCOL, V40, P937, DOI 10.1111/j.1529-8817.2004.04029.x	41	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97450	10.1371/journal.pone.0097450	http://dx.doi.org/10.1371/journal.pone.0097450			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24820330	Green Published, gold, Green Submitted			2022-12-27	WOS:000336653300114
J	Hung, JH; Hu, LY; Tsai, SJ; Yang, AC; Huang, MW; Chen, PM; Wang, SL; Lu, T; Shen, CC				Hung, Jeng-Hsiu; Hu, Li-Yu; Tsai, Shih-Jen; Yang, Albert C.; Huang, Min-Wei; Chen, Pan-Ming; Wang, Shu-Li; Lu, Ti; Shen, Cheng-Che			Risk of Psychiatric Disorders following Polycystic Ovary Syndrome: A Nationwide Population-Based Cohort Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; INSULIN-RESISTANCE; BIPOLAR DISORDER; ANXIETY DISORDER; MENTAL-HEALTH; WOMEN; DEPRESSION; OBESITY; ASSOCIATION; PCOS	Background: Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders among women of reproductive age. A higher prevalence of psychiatric comorbidities, including depressive disorder, anxiety disorder, and bipolar disorder has been proved in patients with PCOS. However, a clear temporal causal relationship between PCOS and psychiatric disorders has not been well established. Objective: We explored the relationship between PCOS and the subsequent development of psychiatric disorders including schizophrenia, bipolar disorder, depressive disorder, anxiety disorder, and sleep disorder. Methods: We identified patients who were diagnosed with PCOS by an obstetrician-gynecologist in the Taiwan National Health Insurance Research Database. A comparison cohort was constructed of patients without PCOS who were matched according to age and sex. The occurrence of subsequent new-onset psychiatric disorders was evaluated in both cohorts based on diagnoses made by psychiatrists. Results: The PCOS cohort consisted of 5431 patients, and the comparison cohort consisted of 21,724 matched control patients without PCOS. The incidence of depressive disorder (hazard ratio [HR] 1.296, 95% confidence interval [CI] 1.084-.550), anxiety disorder (HR 1.392, 95% CI 1.121-1.729), and sleep disorder (HR 1.495, 95% CI 1.176-1.899) were higher among the PCOS patients than among the patients in the comparison cohort. In addition, a higher incidence of newly diagnosed depressive disorder, anxiety disorder, and sleep disorder remained significantly increased in all of the stratified follow-up durations (0-1, 1-5, >= 5 y). Conclusions: PCOS might increase the risk of subsequent newly diagnosed depressive disorder, anxiety disorder, and sleep disorder. The risk of newly diagnosed bipolar disorder, which has often been reported in the literature to be comorbid with PCOS, was not significantly elevated.	[Hung, Jeng-Hsiu] Taipei Tzu Chi Hosp, Dept Obstet & Gynecol, Buddhist Tzu Chi Med Fdn, Taipei, Taiwan; [Hung, Jeng-Hsiu] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Hu, Li-Yu; Lu, Ti] Kaohsiung Vet Gen Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Tsai, Shih-Jen; Yang, Albert C.] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Yang, Albert C.] Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Chungli 32054, Taiwan; [Huang, Min-Wei; Shen, Cheng-Che] Taichung Vet Gen Hosp, Dept Psychiat, Chiayi Branch, Chiayi, Taiwan; [Chen, Pan-Ming] Taipei Vet Gen Hosp, Yuanshan Branch, Dept Psychiat, Yilan, Taiwan; [Wang, Shu-Li] Entral Taiwan Univ Sci & Technol, Dept Dent Lab Technol, Taichung, Taiwan; [Shen, Cheng-Che] Natl Chung Cheng Univ, Dept Informat Magagement, Chiayi, Taiwan; [Hu, Li-Yu] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Hu, Li-Yu; Tsai, Shih-Jen; Yang, Albert C.; Shen, Cheng-Che] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan	Tzu Chi University; Kaohsiung Veterans General Hospital; Taipei Veterans General Hospital; National Central University; Taichung Veterans General Hospital; Taipei Veterans General Hospital; National Chung Cheng University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Shen, CC (corresponding author), Taichung Vet Gen Hosp, Dept Psychiat, Chiayi Branch, Chiayi, Taiwan.	pures1000@yahoo.com.tw	Tsai, Shih-Jen/AAK-7944-2020	Tsai, Shih-Jen/0000-0002-9987-022X; Shen, Cheng-Che/0000-0003-1587-5590; Yang, Albert Chih-Chieh/0000-0003-2794-9649				Acmaz G, 2013, SCI WORLD J, DOI 10.1155/2013/851815; Anderson SE, 2007, PSYCHOSOM MED, V69, P740, DOI 10.1097/PSY.0b013e31815580b4; Annagur BB, 2013, J PSYCHOSOM RES, V74, P244, DOI 10.1016/j.jpsychores.2013.01.002; Azziz R, 2009, FERTIL STERIL, V91, P456, DOI 10.1016/j.fertnstert.2008.06.035; Bazarganipour F, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-141; Bentley-Lewis R, 2011, ENDOCRIN METAB CLIN, V40, P433, DOI 10.1016/j.ecl.2011.01.009; Bilo L, 2008, GYNECOL ENDOCRINOL, V24, P562, DOI 10.1080/09513590802288259; Cinar N, 2011, HUM REPROD, V26, P3339, DOI 10.1093/humrep/der338; Cirillo PC, 2012, REV BRAS PSIQUIATR, V34, P467, DOI 10.1016/j.rbp.2012.04.010; Cwikel J, 2004, EUR J OBSTET GYN R B, V117, P126, DOI 10.1016/j.ejogrb.2004.05.004; de Sousa G, 2012, SLEEP BREATH, V16, P169, DOI 10.1007/s11325-010-0469-6; DUNAIF A, 1989, DIABETES, V38, P1165, DOI 10.2337/diabetes.38.9.1165; FRANKS S, 1995, NEW ENGL J MED, V333, P853, DOI 10.1056/NEJM199509283331307; Gateva A, 2013, Akush Ginekol (Sofiia), V52, P63; Haut ER, 2011, JAMA-J AM MED ASSOC, V305, P2462, DOI 10.1001/jama.2011.822; Himelein MJ, 2006, OBSTET GYNECOL SURV, V61, P723, DOI 10.1097/01.ogx.0000243772.33357.84; Hollinrake E, 2007, FERTIL STERIL, V87, P1369, DOI 10.1016/j.fertnstert.2006.11.039; Kerchner A, 2009, FERTIL STERIL, V91, P207, DOI 10.1016/j.fertnstert.2007.11.022; Klipstein KG, 2006, J AFFECT DISORDERS, V91, P205, DOI 10.1016/j.jad.2006.01.011; Legro RS, 2005, J CLIN ENDOCR METAB, V90, P3236, DOI 10.1210/jc.2004-1843; Legro RS, 1999, FERTIL STERIL, V72, P990, DOI 10.1016/S0015-0282(99)00401-X; Mallon E, 1999, BRIT J DERMATOL, V140, P672; Mansson M, 2008, PSYCHONEUROENDOCRINO, V33, P1132, DOI 10.1016/j.psyneuen.2008.06.003; Nandalike K, 2012, SLEEP MED, V13, P1307, DOI 10.1016/j.sleep.2012.07.002; Oulis P, 2013, INT J PSYCHIAT CLIN, V28, P28; Pan A, 2008, J AFFECT DISORDERS, V109, P75, DOI 10.1016/j.jad.2007.11.002; Rasgon NL, 2003, J AFFECT DISORDERS, V74, P299, DOI 10.1016/S0165-0327(02)00117-9; Rassi A, 2010, COMPR PSYCHIAT, V51, P599, DOI 10.1016/j.comppsych.2010.02.009; Roberts RE, 2003, INT J OBESITY, V27, P514, DOI 10.1038/sj.ijo.0802204; Sahingoz M, 2013, GEN HOSP PSYCHIAT, V35, P508, DOI 10.1016/j.genhosppsych.2013.04.003; Shreeve N, 2013, HUM REPROD, V28, P1348, DOI 10.1093/humrep/det013; Simon GE, 2006, ARCH GEN PSYCHIAT, V63, P824, DOI 10.1001/archpsyc.63.7.824; Sirmans SM, 2014, CLIN EPIDEMIOL, V6, P1, DOI 10.2147/CLEP.S37559; SONINO N, 1993, POSTGRAD MED J, V69, P186, DOI 10.1136/pgmj.69.809.186; Weiner CL, 2004, PSYCHOSOM MED, V66, P356, DOI 10.1097/01.psy.0000127871.46309.fe; Wild RA, 2011, FERTIL STERIL, V95, P1073, DOI 10.1016/j.fertnstert.2010.12.027; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Wu YC, 2013, NEUROSCIENCE, V239, P67, DOI 10.1016/j.neuroscience.2012.10.024	38	75	80	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97041	10.1371/journal.pone.0097041	http://dx.doi.org/10.1371/journal.pone.0097041			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4LX	24816764	Green Published, gold, Green Submitted			2022-12-27	WOS:000336838000098
J	Oono, Y; Yazawa, T; Kawahara, Y; Kanamori, H; Kobayashi, F; Sasaki, H; Mori, S; Wu, JZ; Handa, H; Itoh, T; Matsumoto, T				Oono, Youko; Yazawa, Takayuki; Kawahara, Yoshihiro; Kanamori, Hiroyuki; Kobayashi, Fuminori; Sasaki, Harumi; Mori, Satomi; Wu, Jianzhong; Handa, Hirokazu; Itoh, Takeshi; Matsumoto, Takashi			Genome-Wide Transcriptome Analysis Reveals that Cadmium Stress Signaling Controls the Expression of Genes in Drought Stress Signal Pathways in Rice	PLOS ONE			English	Article							RNA-SEQ REVEALS; ABSCISIC-ACID; ARABIDOPSIS-THALIANA; FUNCTIONAL-ANALYSIS; ENHANCES DROUGHT; OVER-EXPRESSION; 9-CIS-EPOXYCAROTENOID DIOXYGENASE; TRANSGENIC TOBACCO; ALPHA-DIOXYGENASE; ABIOTIC STRESS	Plant growth is severely affected by toxic concentrations of the non-essential heavy metal cadmium (Cd). Comprehensive transcriptome analysis by RNA-Seq following cadmium exposure is required to further understand plant responses to Cd and facilitate future systems-based analyses of the underlying regulatory networks. In this study, rice plants were hydroponically treated with 50 mu M Cd for 24 hours and similar to 60,000 expressed transcripts, including transcripts that could not be characterized by microarray-based approaches, were evaluated. Upregulation of various ROS-scavenging enzymes, chelators and metal transporters demonstrated the appropriate expression profiles to Cd exposure. Gene Ontology enrichment analysis of the responsive transcripts indicated the upregulation of many drought stress-related genes under Cd exposure. Further investigation into the expression of drought stress marker genes such as DREB suggested that expression of genes in several drought stress signal pathways was activated under Cd exposure. Furthermore, qRT-PCR analyses of randomly selected Cd-responsive metal transporter transcripts under various metal ion stresses suggested that the expression of Cd-responsive transcripts might be easily affected by other ions. Our transcriptome analysis demonstrated a new transcriptional network linking Cd and drought stresses in rice. Considering our data and that Cd is a non-essential metal, the network underlying Cd stress responses and tolerance, which plants have developed to adapt to other stresses, could help to acclimate to Cd exposure. Our examination of this transcriptional network provides useful information for further studies of the molecular mechanisms of plant adaptation to Cd exposure and the improvement of tolerance in crop species.	[Oono, Youko; Yazawa, Takayuki; Kawahara, Yoshihiro; Kanamori, Hiroyuki; Kobayashi, Fuminori; Sasaki, Harumi; Mori, Satomi; Wu, Jianzhong; Handa, Hirokazu; Itoh, Takeshi; Matsumoto, Takashi] Natl Inst Agrobiol Sci, Agrogen Res Ctr, Tsukuba, Ibaraki, Japan; [Yazawa, Takayuki] Hitachi Govt & Public Corp Syst Engn Ltd, New Project Dev Div, Koto Ku, Tokyo, Japan	National Institute of Agrobiological Sciences - Japan	Oono, Y (corresponding author), Natl Inst Agrobiol Sci, Agrogen Res Ctr, Tsukuba, Ibaraki, Japan.	yoono@nias.affrc.go.jp	HANDA, Hirokazu/C-9781-2009; Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	HANDA, Hirokazu/0000-0003-2985-2883; Wu, Jian/0000-0001-9933-7364; Itoh, Takeshi/0000-0002-6291-4233; Wu, Jian/0000-0002-3394-1507	Ministry of Agriculture, Forestry and Fisheries of Japan [RTR-0001]	Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This work was supported by a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation, RTR-0001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn P, 2005, PHYTOPATHOLOGY, V95, P1248, DOI 10.1094/PHYTO-95-1248; Chen JQ, 2008, BIOTECHNOL LETT, V30, P2191, DOI 10.1007/s10529-008-9811-5; CHEN SL, 1995, PLANT GROWTH REGUL, V17, P67; Clemens S, 2002, TRENDS PLANT SCI, V7, P309, DOI 10.1016/S1360-1385(02)02295-1; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; Considine MJ, 2002, PLANT PHYSIOL, V129, P949, DOI 10.1104/pp.004150; Cosio C, 2009, J EXP BOT, V60, P391, DOI 10.1093/jxb/ern318; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Frova C, 2003, PHYSIOL PLANTARUM, V119, P469, DOI 10.1046/j.1399-3054.2003.00183.x; Gautam N, 2012, FUNCT INTEGR GENOMIC, V12, P635, DOI 10.1007/s10142-012-0297-9; GRILL E, 1989, P NATL ACAD SCI USA, V86, P6838, DOI 10.1073/pnas.86.18.6838; Grossoehme NE, 2006, INORG CHEM, V45, P8500, DOI 10.1021/ic0606431; Ha SB, 1999, PLANT CELL, V11, P1153, DOI 10.1105/tpc.11.6.1153; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; Hiraga S, 2001, PLANT CELL PHYSIOL, V42, P462, DOI 10.1093/pcp/pce061; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Huang TL, 2012, PLANT MOL BIOL, V80, P587, DOI 10.1007/s11103-012-9969-z; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; Ito Y, 2006, PLANT CELL PHYSIOL, V47, P141, DOI 10.1093/pcp/pci230; Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x; Jang IC, 2003, PLANT PHYSIOL, V131, P516, DOI 10.1104/pp.007237; Koeduka T, 2005, J PLANT PHYSIOL, V162, P912, DOI 10.1016/j.jplph.2004.11.003; Koeduka T, 2002, J BIOL CHEM, V277, P22648, DOI 10.1074/jbc.M110420200; Korshunova YO, 1999, PLANT MOL BIOL, V40, P37, DOI 10.1023/A:1026438615520; Kramer U, 2007, FEBS LETT, V581, P2263, DOI 10.1016/j.febslet.2007.04.010; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee KO, 2000, FEBS LETT, V486, P103, DOI 10.1016/S0014-5793(00)02230-4; Lee K, 2010, J PLANT PHYSIOL, V167, P161, DOI 10.1016/j.jplph.2009.09.006; Lee S, 2009, PLANT CELL ENVIRON, V32, P408, DOI 10.1111/j.1365-3040.2009.01935.x; Lefebvre V, 2006, PLANT J, V45, P309, DOI 10.1111/j.1365-313X.2005.02622.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li LG, 2002, J BIOL CHEM, V277, P5360, DOI 10.1074/jbc.M108777200; Liu XM, 2010, PLANT PHYSIOL, V152, P985, DOI 10.1104/pp.109.150656; Lu TT, 2010, GENOME RES, V20, P1238, DOI 10.1101/gr.106120.110; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Mizuno T, 2005, PLANT PHYSIOL BIOCH, V43, P793, DOI 10.1016/j.plaphy.2005.07.006; Moons A, 2003, FEBS LETT, V553, P370, DOI 10.1016/S0014-5793(03)01060-3; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MUNDY J, 1988, EMBO J, V7, P2279, DOI 10.1002/j.1460-2075.1988.tb03070.x; Nuruzzaman M, 2008, MOL GENET GENOMICS, V280, P139, DOI 10.1007/s00438-008-0351-4; Obara K, 2002, PLANT CELL PHYSIOL, V43, P697, DOI 10.1093/pcp/pcf103; Ogawa I, 2009, PLANT SOIL, V325, P97, DOI 10.1007/s11104-009-0116-9; Oh SJ, 2009, PLANT PHYSIOL, V150, P1368, DOI 10.1104/pp.109.137554; Oh SJ, 2005, PLANT PHYSIOL, V138, P341, DOI 10.1104/pp.104.059147; Oono Y, 2011, RICE, V4, P50, DOI 10.1007/s12284-011-9064-0; Palmiter RD, 1998, P NATL ACAD SCI USA, V95, P8428, DOI 10.1073/pnas.95.15.8428; PARCY F, 1994, PLANT CELL, V6, P1567, DOI 10.1105/tpc.6.11.1567; Park MR, 2010, PLANT CELL ENVIRON, V33, P2209, DOI 10.1111/j.1365-3040.2010.02221.x; Passardi F, 2004, PHYTOCHEMISTRY, V65, P1879, DOI 10.1016/j.phytochem.2004.06.023; Passardi F, 2004, TRENDS PLANT SCI, V9, P534, DOI 10.1016/j.tplants.2004.09.002; Pedas P, 2008, PLANT PHYSIOL, V148, P455, DOI 10.1104/pp.108.118851; Perfus-Barbeoch L, 2002, PLANT J, V32, P539, DOI 10.1046/j.1365-313X.2002.01442.x; Qin XQ, 2002, PLANT PHYSIOL, V128, P544, DOI 10.1104/pp.010663; Roth U, 2006, J EXP BOT, V57, P4003, DOI 10.1093/jxb/erl170; Rouhier N, 2006, J EXP BOT, V57, P1685, DOI 10.1093/jxb/erl001; Roxas VP, 2000, PLANT CELL PHYSIOL, V41, P1229, DOI 10.1093/pcp/pcd051; Sasaki A, 2012, PLANT CELL, V24, P2155, DOI 10.1105/tpc.112.096925; Satoh-Nagasawa N, 2012, PLANT CELL PHYSIOL, V53, P213, DOI 10.1093/pcp/pcr166; Shah K, 1998, BIOL PLANTARUM, V40, P121, DOI 10.1023/A:1000956803911; Shah K, 2001, PLANT SCI, V161, P1135, DOI 10.1016/S0168-9452(01)00517-9; Song SY, 2011, PLANTA, V234, P331, DOI 10.1007/s00425-011-1403-2; Soranzo N, 2004, MOL GENET GENOMICS, V271, P511, DOI 10.1007/s00438-004-1006-8; Sperotto RA, 2009, PLANTA, V230, P985, DOI 10.1007/s00425-009-1000-9; Sun XM, 2010, CHEMOSPHERE, V78, P840, DOI 10.1016/j.chemosphere.2009.11.045; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; Takasaki H, 2010, MOL GENET GENOMICS, V284, P173, DOI 10.1007/s00438-010-0557-0; Tan BC, 2003, PLANT J, V35, P44, DOI 10.1046/j.1365-313X.2003.01786.x; Tirajoh A, 2005, J EXP BOT, V56, P713, DOI 10.1093/jxb/eri038; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Ueno D, 2010, P NATL ACAD SCI USA, V107, P16500, DOI 10.1073/pnas.1005396107; Uraguchi S, 2011, P NATL ACAD SCI USA, V108, P20959, DOI 10.1073/pnas.1116531109; Valerio L, 2004, PHYTOCHEMISTRY, V65, P1331, DOI 10.1016/j.phytochem.2004.04.017; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095; Xiang Y, 2008, PLANT PHYSIOL, V148, P1938, DOI 10.1104/pp.108.128199; Xiao BZ, 2007, THEOR APPL GENET, V115, P35, DOI 10.1007/s00122-007-0538-9; Xu DQ, 2008, FEBS LETT, V582, P1037, DOI 10.1016/j.febslet.2008.02.052; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; YAMAGUCHISHINOZAKI K, 1990, PLANT MOL BIOL, V14, P29, DOI 10.1007/BF00015652; Ye HY, 2009, PLANT MOL BIOL, V71, P291, DOI 10.1007/s11103-009-9524-8; Yoshida S., 1976, LAB MANUAL PHYSL STU; Zhang M, 2012, PLANT PHYSIOL BIOCH, V50, P79, DOI 10.1016/j.plaphy.2011.07.015; Zhou GK, 2006, J BIOCHEM MOL BIOL, V39, P595; Zou MJ, 2008, PLANT MOL BIOL, V66, P675, DOI 10.1007/s11103-008-9298-4	90	78	82	3	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96946	10.1371/journal.pone.0096946	http://dx.doi.org/10.1371/journal.pone.0096946			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816929	Green Submitted, Green Published, gold			2022-12-27	WOS:000336838000085
J	Shao, JB; Li, Y; Zhao, PW; Yue, X; Jiang, J; Liang, XH; He, XL				Shao, Jianbo; Li, Ying; Zhao, Peiwei; Yue, Xin; Jiang, Jun; Liang, Xiaohui; He, Xuelian			Association of mTOR Polymorphisms with Cancer Risk and Clinical Outcomes: A Meta-Analysis	PLOS ONE			English	Article							ACTIVATED MAMMALIAN TARGET; SQUAMOUS-CELL CARCINOMA; PI3K/PTEN/AKT/MTOR PATHWAY; GENETIC-VARIATIONS; SIGNALING PATHWAY; PI3K-AKT-MTOR PATHWAY; CISPLATIN RESISTANCE; RAPAMYCIN; VARIANTS; EXPRESSION	Genetic polymorphisms in mTOR gene may be associated with cancer risk and clinical outcomes of cancer patients by affecting mTOR gene expression or its activation. However, inconsistent results have been reported. The aim of this study is to systematically evaluate the association between mTOR polymorphisms (rs2295080, rs2536 and rs11121704) and cancer risk as well as clinical outcome by a meta-analysis. We identified 10 eligible studies and extracted data by two investigators. Based on dominant and recessive models, odds ratio (ORs) and 95% confidence intervals (CIs) were calculated by using Stata, version 11 to evaluate the association strength. Our meta-analysis results showed that the wild genotype TT of rs2295080 polymorphism was associated with increased cancer risk under dominant model (OR = 1.24, 95% CI: 1.12-1.36, p < 0.0005) in Chinese but not with clinical outcome parameters, while the TT genotype of rs11121704 was associated with poor clinical outcome parameters (OR = 1.53, 95% CI: 1.01-2.32, p = 0.044), such as death, metastasis and resistance to chemotherapy. However, rs2536 may not influence cancer susceptibility. In conclusion, this meta-analysis indicated the common polymorphisms in mTOR gene might be genetic risk factors for the carcinogenesis and clinical outcomes of cancer patients. However, further investigation on large population and different ethnicities are warranted.	[Shao, Jianbo] Wuhan Childrens Hosp, Dept CT MRI, Wuhan, Hubei, Peoples R China; [Li, Ying] Wuhan Childrens Hosp, Dept Radiol, Wuhan, Hubei, Peoples R China; [Zhao, Peiwei; Yue, Xin; He, Xuelian] Wuhan Childrens Hosp, Cent Lab, Wuhan, Hubei, Peoples R China; [Jiang, Jun] Wuhan Childrens Hosp, Dept Electrophysiol, Wuhan, Hubei, Peoples R China; [Liang, Xiaohui] Wuhan Univ, Sch Publ Hlth, Wuhan, Hubei, Peoples R China	Wuhan University	Liang, XH (corresponding author), Wuhan Univ, Sch Publ Hlth, Wuhan, Hubei, Peoples R China.	xhliang@whu.edu.cn; hexuelian2013@hotmail.com			Ministry of Human Resource of China	Ministry of Human Resource of China	This study was funded by the support program of the Ministry of Human Resource of China Overseas Returned scholars. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050302; Chen JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040817; Chen M, 2009, CARCINOGENESIS, V30, P2047, DOI 10.1093/carcin/bgp258; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Faried LS, 2008, MOL CARCINOGEN, V47, P446, DOI 10.1002/mc.20402; Faried LS, 2006, ONCOL REP, V16, P57; He J, 2013, MOL CARCINOGEN, V52, P70, DOI 10.1002/mc.22013; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hildebrandt MAT, 2012, CLIN CANCER RES, V18, P3705, DOI 10.1158/1078-0432.CCR-11-3271; Hildebrandt MAT, 2009, J CLIN ONCOL, V27, P857, DOI 10.1200/JCO.2008.17.6297; Hou GQ, 2007, CANCER LETT, V253, P236, DOI 10.1016/j.canlet.2007.01.026; Huang LZ, 2012, LEUKEMIA LYMPHOMA, V53, P947, DOI 10.3109/10428194.2011.628062; Kim JG, 2010, ONCOLOGY-BASEL, V79, P278, DOI 10.1159/000320761; Kremer CL, 2006, PROSTATE, V66, P1203, DOI 10.1002/pros.20410; Lee S, 2005, GYNECOL ONCOL, V97, P26, DOI 10.1016/j.ygyno.2004.11.051; Li QX, 2013, CLIN CANCER RES, V19, P6252, DOI 10.1158/1078-0432.CCR-13-1093; Li QX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071968; Lin J, 2010, CANCER PREV RES, V3, P505, DOI 10.1158/1940-6207.CAPR-09-0263; Liu LZ, 2007, CANCER RES, V67, P6325, DOI 10.1158/0008-5472.CAN-06-4261; MANTEL N, 1959, J NATL CANCER I, V22, P719; Pu X, 2011, LUNG CANCER, V71, P82, DOI 10.1016/j.lungcan.2010.04.008; Rosner M, 2008, MUTAT RES-REV MUTAT, V659, P284, DOI 10.1016/j.mrrev.2008.06.001; Sato T, 2010, ONCOGENE, V29, P2746, DOI 10.1038/onc.2010.28; Slattery ML, 2011, NUTR CANCER, V63, P1226, DOI 10.1080/01635581.2011.607545; Slattery ML, 2010, CARCINOGENESIS, V31, P1604, DOI 10.1093/carcin/bgq142; Strimpakos AS, 2009, CANCER TREAT REV, V35, P148, DOI 10.1016/j.ctrv.2008.09.006; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang LE, 2012, J CANCER RES CLIN, V138, P377, DOI 10.1007/s00432-011-1103-0; Xu JL, 2012, ASIAN PAC J CANCER P, V13, P2157, DOI 10.7314/APJCP.2012.13.5.2157; Xu M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060080; Zhu ML, 2013, J THORAC ONCOL, V8, P788, DOI 10.1097/JTO.0b013e31828916c6	35	16	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97085	10.1371/journal.pone.0097085	http://dx.doi.org/10.1371/journal.pone.0097085			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816861	gold, Green Submitted, Green Published			2022-12-27	WOS:000336838000102
J	Tomaru, A; Kawachi, M; Demura, M; Fukuyo, Y				Tomaru, Akiko; Kawachi, Masanobu; Demura, Mikihide; Fukuyo, Yasuwo			Changes in Microbial Communities, Including both Uncultured and Culturable Bacteria, with Mid-Ocean Ballast-Water Exchange during a Voyage from Japan to Australia	PLOS ONE			English	Article							MARINE VIRUSES; SHIPS; TRANSPORT; PHYTOPLANKTON; POPULATIONS; DISPERSAL; INVASION	We assessed changes in the microbial communities in ballast water during a trans-Pacific voyage from Japan to Australia that included a mid-ocean ballast-water exchange. Uncultured (i.e., total) and culturable bacteria were counted and were characterized by using denaturing gradient gel electrophoresis (DGGE). There was a clear decrease over time in numbers of uncultured microorganisms, except for heterotrophic nanoflagellates, whereas the abundance of culturable bacteria initially decreased after the ballast-water exchange but then increased. The increase, however, was only up to 5.34% of the total number of uncultured bacteria. Cluster analysis showed that the DGGE profiles of uncultured bacteria clearly changed after the exchange. In contrast, there was no clear change in the DGGE profiles of culturable bacteria after the exchange. Multidimensional scaling analysis showed changes in microbial communities over the course of the voyage. Although indicator microbes as defined by the International Convention for the Control and Management of Ships' Ballast Water and Sediments were occasionally detected, no coliform bacteria were detected after the exchange.	[Tomaru, Akiko; Fukuyo, Yasuwo] Univ Tokyo, Asian Nat Environm Sci Ctr, Tokyo, Japan; [Kawachi, Masanobu; Demura, Mikihide] Natl Inst Environm Studies, Div Environm Biol, Ibaraki, Japan	University of Tokyo; National Institute for Environmental Studies - Japan	Tomaru, A (corresponding author), Natl Inst Hlth Sci, Div Microbiol, Setagaya Ku, Tokyo 1588501, Japan.	akotoma@gmail.com			Global Environment Research Funds	Global Environment Research Funds	Support was provided by the Global Environment Research Funds (http://www.env.go.jp/policy/kenkyu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; ANDERSON C, 1991, NATURE, V354, P255; [Anonymous], 2006, BROCK BIOL MICROORGA; Aridgides LJ, 2004, MAR POLLUT BULL, V48, P1096, DOI 10.1016/j.marpolbul.2003.12.017; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; BISHOP RF, 1973, LANCET, V2, P1281, DOI 10.1016/s0140-6736(73)92867-5; Burkholder JM, 2007, HARMFUL ALGAE, V6, P486, DOI 10.1016/j.hal.2006.11.006; Byrd JJ, 2000, NONCULTURABLE MICROORGANISMS IN THE ENVIRONMENT, P7; CARLTON JT, 1993, SCIENCE, V261, P78, DOI 10.1126/science.261.5117.78; CARLTON JT, 1985, OCEANOGR MAR BIOL, V23, P313; Centers for Disease Control (CDC), 1991, MMWR Morb Mortal Wkly Rep, V40, P108; Cohen AN, 1998, SCIENCE, V279, P555, DOI 10.1126/science.279.5350.555; Cohen AN, 1998, SHIPS BALLAST WATER; Coleman W, 2003, CHOLERA, P36; Cotton AD, 1908, B MISC INF ROYAL GAR, V2, P73, DOI [10.2307/4111835, DOI 10.2307/4111835, 10.1016/j.biortech.2009.07.021, DOI 10.1016/j.biortech.2009.07.021]; Dickman M, 1999, MAR ECOL PROG SER, V176, P253, DOI 10.3354/meps176253; Dobbs F.C., 2005, ENVIRON SCI TECHNOL, V78, P259; Drake LA, 2002, MAR ECOL PROG SER, V233, P13, DOI 10.3354/meps233013; Elton CS, 1958, ECOLOGY INVASION ANI, P94; Fabre-Domergue M, 1906, CR HEBD ACAD SCI, V142, P1223; Finlay BJ, 2004, PROTIST, V155, P237, DOI 10.1078/143446104774199619; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Galil BS, 1997, EUR J PROTISTOL, V33, P244, DOI 10.1016/S0932-4739(97)80002-8; HALLEGRAEFF GM, 1990, TOXIC MARINE PHYTOPLANKTON, P475; Hallegraeff GM, 1998, MAR ECOL PROG SER, V168, P297, DOI 10.3354/meps168297; Hansell DA., 2002, BIOGEOCHEMISTRY MARI, V1; Heinemann S, 2006, MAR POLLUT BULL, V52, P1310, DOI 10.1016/j.marpolbul.2006.02.023; Husmann N, 2001, MAR POLLUT B, V42, P1082; IMCO, 1973, INT CONV PREV POLL S; IMO, 2010, 61WP8 IMO MEPC; IMO, 2003, 2 INT M MEPC BALL WA; IMO, 1999, MAR ENV PROT COMM IT; IMO, 2005, INT CONV CONTR MAN S, P134; IMO, 2003, MEPC4922 IMO; International Maritime Consultative Organization (IMCO), 1973, MPCONFDR1 IMCO, P10; International Maritime Organization (IMO), 1998, FOC IMO INT, P161; International Maritime Organization (IMO), 2001, MAR ENV PROT COMM IT; Japanese Industrial Standards Committee (JIS), 2002, K03503010 JIS JAP ST; KAPIKIAN AZ, 1972, J VIROL, V10, P1075, DOI 10.1128/JVI.10.5.1075-1081.1972; LALLI CAROL M., 1997, BIOL OCEANOGRAPHY IN, P112; Lee J. J., 2000, ILLUSTRATED GUIDE PR, VI; Lee SKY, 2002, MAR POLLUT BULL, V44, P412, DOI 10.1016/S0025-326X(01)00256-9; Marine Environment Protection Committee (MEPC), 2004, 5227 MEPC; MCCARTHY SA, 1994, APPL ENVIRON MICROB, V60, P2597, DOI 10.1128/AEM.60.7.2597-2601.1994; McCollin T, 2007, HARMFUL ALGAE, V6, P531, DOI 10.1016/j.hal.2006.04.015; Medcov J. C, 1975, P NATL SHELLFISH ASS, V65, P54; Mimura H, 2005, MAR POLLUT BULL, V50, P751, DOI 10.1016/j.marpolbul.2005.02.006; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Noble RT, 1998, AQUAT MICROB ECOL, V14, P113, DOI 10.3354/ame014113; Ostenfeld C.H., 1908, MEDD KOMM HAVUNDER P, V1, P1; POMEROY LR, 1988, HYDROBIOLOGIA, V159, P7, DOI 10.1007/BF00007363; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; RIGBY G, 1994, J MAR ENV ENG, V1, P91; Rosenthal H, 1976, FAO TECHN C AQ; Ruiz GM, 2000, ANNU REV ECOL SYST, V31, P481, DOI 10.1146/annurev.ecolsys.31.1.481; Ruiz GM, 2000, NATURE, V408, P49, DOI 10.1038/35040695; Ruiz GM, 1997, AM ZOOL, V37, P621; SHERR B, 1983, ESTUAR COAST SHELF S, V16, P1, DOI 10.1016/0272-7714(83)90089-6; SHERR EB, 1983, APPL ENVIRON MICROB, V46, P1388, DOI 10.1128/AEM.46.6.1388-1393.1983; The Ship Equipment Inspection Society of Japan Nippon hakuyohin kentei kyokai HK, 2007, BAR SUI KAINM SHIS N, P32; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; Tomaru A, 2010, MAR POLLUT BULL, V60, P299, DOI 10.1016/j.marpolbul.2009.11.019; Ueno K, 1980, HUNE NO SEKAISI JOU, P302; United Nations Conference on Environment and Development (UNCED), 1992, AGENDA, V21; van Hannen EJ, 1999, APPL ENVIRON MICROB, V65, P2478; VANES FB, 1982, ADV MICROB ECOL, V6, P111; WILMOTTE A, 1993, FEBS LETT, V317, P96, DOI 10.1016/0014-5793(93)81499-P; ZAR JH, 1999, BIOSTAT ANAL, P273; Zhang FZ, 1999, MAR ECOL PROG SER, V176, P243, DOI 10.3354/meps176243; [No title captured]	71	16	18	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96274	10.1371/journal.pone.0096274	http://dx.doi.org/10.1371/journal.pone.0096274			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24817212	Green Published, gold, Green Submitted			2022-12-27	WOS:000336838000030
J	von Merten, S; Hoier, S; Pfeifle, C; Tautz, D				von Merten, Sophie; Hoier, Svenja; Pfeifle, Christine; Tautz, Diethard			A Role for Ultrasonic Vocalisation in Social Communication and Divergence of Natural Populations of the House Mouse (Mus musculus domesticus)	PLOS ONE			English	Article							FEMALE MICE; VOCAL COMMUNICATION; SELECTIVE SWEEPS; BEHAVIOR; COMPLEXITY; EVOLUTION; SIGNALS; REVEAL; SPEECH; SYSTEM	It has long been known that rodents emit signals in the ultrasonic range, but their role in social communication and mating is still under active exploration. While inbred strains of house mice have emerged as a favourite model to study ultrasonic vocalisation (USV) patterns, studies in wild animals and natural situations are still rare. We focus here on two wild derived mouse populations. We recorded them in dyadic encounters for extended periods of time to assess possible roles of USVs and their divergence between allopatric populations. We have analysed song frequency and duration, as well as spectral features of songs and syllables. We show that the populations have indeed diverged in several of these aspects and that USV patterns emitted in a mating context differ from those emitted in same sex encounters. We find that females vocalize not less, in encounters with another female even more than males. This implies that the current focus of USVs being emitted mainly by males within the mating context needs to be reconsidered. Using a statistical syntax analysis we find complex temporal sequencing patterns that could suggest that the syntax conveys meaningful information to the receivers. We conclude that wild mice use USV for complex social interactions and that USV patterns can diverge fast between populations.	[von Merten, Sophie; Hoier, Svenja; Pfeifle, Christine; Tautz, Diethard] Max Planck Inst Evolutionary Biol, Dept Evolutionary Genet, Plon, Germany	Max Planck Society	von Merten, S (corresponding author), Max Planck Inst Evolutionary Biol, Dept Evolutionary Genet, Plon, Germany.	sophievonmerten@gmail.com	Tautz, Diethard/H-8436-2014; von Merten, Sophie/U-6470-2018; Branchi, Igor/N-9897-2017	Tautz, Diethard/0000-0002-0460-5344; von Merten, Sophie/0000-0001-6010-1127; Branchi, Igor/0000-0003-4484-3598	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	This study was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim MCP, 2013, FUNCT ECOL, V27, P289, DOI 10.1111/1365-2435.12032; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Arriaga G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046610; Arriaga G, 2013, BRAIN LANG, V124, P96, DOI 10.1016/j.bandl.2012.10.002; Asaba A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087186; Ayub Q, 2013, AM J HUM GENET, V92, P696, DOI 10.1016/j.ajhg.2013.03.019; Bee MA, 2001, ETHOLOGY, V107, P65, DOI 10.1046/j.1439-0310.2001.00640.x; Branchi I, 1998, DEV PSYCHOBIOL, V33, P249, DOI 10.1002/(SICI)1098-2302(199811)33:3<249::AID-DEV5>3.0.CO;2-R; Branchi I, 2009, NEUROSCI BIOBEHAV R, V33, P551, DOI 10.1016/j.neubiorev.2008.03.011; Collins Sarah, 2004, P39, DOI 10.1016/B978-012473070-0/50005-0; D'Amato FR, 2001, BEHAV NEUROSCI, V115, P834, DOI 10.1037//0735-7044.115.4.834; DIZINNO G, 1978, BEHAV BIOL, V22, P104, DOI 10.1016/S0091-6773(78)92094-1; Draganoiu TI, 2002, P ROY SOC B-BIOL SCI, V269, P2525, DOI 10.1098/rspb.2002.2192; Durbin R., 1998, BIOL SEQUENCE ANAL P; Freeberg TM, 2012, PHILOS T R SOC B, V367, P1785, DOI 10.1098/rstb.2011.0213; Garamszegi LZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002647; Giorgino T, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i07; Gourbal BEF, 2004, NATURWISSENSCHAFTEN, V91, P381, DOI 10.1007/s00114-004-0543-7; Hammerschmidt K, 2009, BIOL LETTERS, V5, P589, DOI 10.1098/rsbl.2009.0317; Hammerschmidt K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041133; Hammerschmidt K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-40; Hanson JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040782; Hoffmann F, 2012, J ETHOL, V30, P173, DOI 10.1007/s10164-011-0312-y; Hoffmann F, 2012, PHYSIOL BEHAV, V105, P766, DOI 10.1016/j.physbeh.2011.10.011; Hoffmann F, 2009, PHYSIOL BEHAV, V96, P602, DOI 10.1016/j.physbeh.2008.12.014; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; Hurst JL, 2009, BEHAV BRAIN RES, V200, P295, DOI 10.1016/j.bbr.2008.12.020; Ihle S, 2006, MOL BIOL EVOL, V23, P790, DOI 10.1093/molbev/msj096; Kalcounis-Rueppell MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009705; KALKO EKV, 1995, ANIM BEHAV, V50, P861, DOI 10.1016/0003-3472(95)80090-5; Kikusui T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017721; KONIG B, 1994, ANIM BEHAV, V48, P1449, DOI 10.1006/anbe.1994.1381; LAWRENCE BD, 1982, J ACOUST SOC AM, V71, P585, DOI 10.1121/1.387529; LEVIN D. A., 2009, MARKOV CHAINS MIXING; Maciej P, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-58; MAGGIO JC, 1985, J COMP PSYCHOL, V99, P420, DOI 10.1037/0735-7036.99.4.420; MARKL H, 1973, Zeitschrift fuer Tierpsychologie, V33, P274; Moles A, 2000, ANIM BEHAV, V60, P689, DOI 10.1006/anbe.2000.1504; Moles A, 2007, BEHAV BRAIN RES, V182, P223, DOI 10.1016/j.bbr.2007.01.020; Montero I, 2013, MOL ECOL, V22, P2549, DOI 10.1111/mec.12271; Musolf K, 2010, ANIM BEHAV, V79, P757, DOI 10.1016/j.anbehav.2009.12.034; Nomura T, 1996, GENET SEL EVOL, V28, P141, DOI 10.1051/gse:19960202; NYBY J, 1983, BEHAV NEURAL BIOL, V39, P128, DOI 10.1016/S0163-1047(83)90722-7; Panksepp JB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000351; Panksepp JB, 2011, NEUROSCI BIOBEHAV R, V35, P1864, DOI 10.1016/j.neubiorev.2011.05.013; Pasch B, 2011, ANIM BEHAV, V82, P177, DOI 10.1016/j.anbehav.2011.04.018; Podos J, 1997, EVOLUTION, V51, P537, DOI 10.1111/j.1558-5646.1997.tb02441.x; Pollard KA, 2012, PHILOS T R SOC B, V367, P1869, DOI 10.1098/rstb.2011.0221; POMERANTZ SM, 1983, PHYSIOL BEHAV, V31, P91, DOI 10.1016/0031-9384(83)90101-4; Portfors CV, 2007, J AM ASSOC LAB ANIM, V46, P28; Price T, 1998, PHILOS T R SOC B, V353, P251, DOI 10.1098/rstb.1998.0207; R Core Team, 2021, R LANGUAGE ENV STAT; RABINER LR, 1978, IEEE T ACOUST SPEECH, V26, P575, DOI 10.1109/TASSP.1978.1163164; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; RAPP KG, 1972, Z VERSUCHSTIERKD, V14, P133; Ratanamahatana C.A., 2004, 3 WORKSH MIN TEMP SE, P22, DOI DOI 10.1097/01.CCM.0000279204.24648.44; Roullet FI, 2011, BEHAV BRAIN RES, V216, P19, DOI 10.1016/j.bbr.2010.06.004; Ryan M.J., 1990, Oxford Surveys in Evolutionary Biology, V7, P157; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; Scharff C, 2011, PHILOS T R SOC B, V366, P2124, DOI 10.1098/rstb.2011.0001; Semple S, 2000, P ROY SOC B-BIOL SCI, V267, P707, DOI 10.1098/rspb.2000.1060; Seyfarth RM, 2010, BRAIN LANG, V115, P92, DOI 10.1016/j.bandl.2009.10.003; Staubach F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002891; Teschke M, 2008, GENETICS, V180, P1537, DOI 10.1534/genetics.108.090811; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828	65	49	49	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97244	10.1371/journal.pone.0097244	http://dx.doi.org/10.1371/journal.pone.0097244			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816836	Green Published, gold			2022-12-27	WOS:000336838000121
J	Zhou, XC; Hu, Y; Dai, L; Wang, YF; Zhou, JH; Wang, WW; Di, W; Qiu, LH				Zhou, Xingchen; Hu, Yuan; Dai, Lan; Wang, Yunfei; Zhou, Jinhua; Wang, WenWen; Di, Wen; Qiu, Lihua			MicroRNA-7 Inhibits Tumor Metastasis and Reverses Epithelial-Mesenchymal Transition through AKT/ERK1/2 Inactivation by Targeting EGFR in Epithelial Ovarian Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; E-CADHERIN EXPRESSION; CELL-MIGRATION; PROSTATE-CANCER; PATHWAY; SURVIVAL; INVASION; GENE; ACTIVATION; PACLITAXEL	Epidermal growth factor receptor (EGFR) overexpression and activation result in increased proliferation and migration of solid tumors including ovarian cancer. In recent years, mounting evidence indicates that EGFR is a direct and functional target of miR-7. In this study, we found that miR-7 expression was significantly downregulated in highly metastatic epithelial ovarian cancer (EOC) cell lines and metastatic tissues, whereas the expression of, EGFR correlated positively with metastasis in both EOC patients and cell lines. Overexpression of miR-7 markedly suppressed the capacities of cell invasion and migration and resulted in morphological changes from a mesenchymal phenotype to an epithelial-like phenotype in EOC. In addition, overexpression of miR-7 upregulated CK-18 and beta-catenin expression and downregulated Vimentin expression, accompanied with EGFR inhibition and AKT/ERK1/2 inactivation. Similar to miR-7 transfection, silencing of EGFR with this siRNA in EOC cells also upregulated CK-18 and beta-catenin expression and downregulated Vimentin expression, and decreased phosphorylation of both Akt and ERK1/2, confirming that EGFR is a target of miR-7 in reversing EMT. The pharmacological inhibition of PI3K-AKT and ERK1/2 both significantly enhanced CK-18 and beta-catenin expression and suppressed vimentin expression, indicating that AKT and ERK1/2 pathways are required for miR-7 mediating EMT. Finally, the expression of miR-7 and EGFR in primary EOC with matched metastasis tissues was explored. It was showed that miR-7 is inversely correlated with EGFR. Taken together, our results suggested that miR-7 inhibited tumor metastasis and reversed EMT through AKT and ERK1/2 pathway inactivation by reducing EGFR expression in EOC cell lines. Thus, miR-7 might be a potential prognostic marker and therapeutic target for ovarian cancer metastasis intervention.	[Zhou, Xingchen; Hu, Yuan; Dai, Lan; Wang, Yunfei; Zhou, Jinhua; Wang, WenWen; Di, Wen; Qiu, Lihua] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Gynecol & Obstet, Shanghai 200030, Peoples R China; [Zhou, Xingchen; Hu, Yuan; Dai, Lan; Wang, Yunfei; Zhou, Jinhua; Wang, WenWen; Di, Wen; Qiu, Lihua] Shanghai Key Lab Gynecol Oncol, Shanghai, Peoples R China	Shanghai Jiao Tong University	Qiu, LH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Gynecol & Obstet, Shanghai 200030, Peoples R China.	lilyqiulh@126.com			National Natural Science Foundation of China [81072138]; Medical-engineering cross project of Shanghai Jiao Tong University [YG2010MS24]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical-engineering cross project of Shanghai Jiao Tong University	This work was supported by grants from National Natural Science Foundation of China (Grant No. 81072138), Medical-engineering cross project of Shanghai Jiao Tong University (YG2010MS24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang ZG, 2012, DIGEST DIS SCI, V57, P1181, DOI 10.1007/s10620-012-2036-4; Cheng JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034071; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Gan Y, 2010, ONCOGENE, V29, P4947, DOI 10.1038/onc.2010.240; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gebeshuber CA, 2009, EMBO REP, V10, P400, DOI 10.1038/embor.2009.9; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Grossmann TN, 2012, P NATL ACAD SCI US; Han M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032383; Hassan MQ, 2012, J BIOL CHEM; Ivanova L, 2008, AM J PHYSIOL-RENAL, V294, pF1238, DOI 10.1152/ajprenal.00326.2007; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ji C, 2008, CANCER CHEMOTH PHARM, V62, P857, DOI 10.1007/s00280-007-0674-6; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Kong XB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041523, 10.1371/journal.pone.0033381]; Konishi H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-462; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li YW, 2010, CANCER RES, V70, P1486, DOI 10.1158/0008-5472.CAN-09-2792; Liang SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018409; Liu WG, 2009, CHINESE MED J; Loganathan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043577; Maihle N J, 2002, Cancer Treat Res, V107, P247; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Qiu LH, 2005, INT J ONCOL, V27, P1441; Qiu LH, 2006, INT J ONCOL, V29, P1003; Saegusa M, 2009, AM J PATHOL, V174, P2107, DOI 10.2353/ajpath.2009.081018; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Saydam O, 2011, CANCER RES, V71, P852, DOI 10.1158/0008-5472.CAN-10-1219; Shenhua X, 1999, J EXP CLIN CANC RES, V18, P233; Shi L, 2008, BRAIN RES, V1236, P185, DOI 10.1016/j.brainres.2008.07.085; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Wang Y, 2012, ONCOGENE, V31, P2512, DOI 10.1038/onc.2011.435; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; Wittinger M, 2011, CLIN CANCER RES, V17, P7816, DOI 10.1158/1078-0432.CCR-11-0408; Wu ZS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-542; Yang K, 2009, INT J CLIN EXP PATHO, V2, P361; Zhang S, 2006, INT J GYNECOL CANCER, V16, P522, DOI 10.1111/j.1525-1438.2006.00547.x; Zhao XD, 2012, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2012-240; Zhou CL, 2006, INT J ONCOL, V29, P269; Zou W, 2007, CANCER LETT, V248, P211, DOI 10.1016/j.canlet.2006.07.005	45	52	60	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96718	10.1371/journal.pone.0096718	http://dx.doi.org/10.1371/journal.pone.0096718			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816687	Green Published, Green Submitted, gold			2022-12-27	WOS:000336838000056
J	Hilmi, D; Parcina, M; Stollewerk, D; Ostrop, J; Josten, M; Meilaender, A; Zaehringer, U; Wichelhaus, TA; Bierbaum, G; Heeg, K; Wolz, C; Bekeredjian-Ding, I				Hilmi, Dina; Parcina, Marijo; Stollewerk, Daniel; Ostrop, Jenny; Josten, Michaele; Meilaender, Alina; Zaehringer, Ulrich; Wichelhaus, Thomas A.; Bierbaum, Gabriele; Heeg, Klaus; Wolz, Christiane; Bekeredjian-Ding, Isabelle			Heterogeneity of Host TLR2 Stimulation by Staphylocoocus aureus Isolates	PLOS ONE			English	Article							SMALL-COLONY VARIANTS; CAPSULAR POLYSACCHARIDE; INTRACELLULAR PERSISTENCE; B-CELLS; LIPOPROTEINS; EXPRESSION; AGR; DIFFERENTIATION; KERATINOCYTES; INFLAMMATION	High lipoprotein expression and potent activation of host Toll-like receptor-2 (TLR2) are characteristic features of the staphylococcal species. Expression of TLR2 in the host is important for clearance of Staphylococcus aureus infection and host survival. Thus, we hypothesized that bacterial regulation of its intrinsic TLR2-stimulatory capacity could represent a means for immune evasion or host adaptation. We, therefore, compared clinical S. aureus isolates in regards to their TLR2 activation potential and assessed the bacterial factors that modulate TLR2-mediated recognition. S. aureus isolates displayed considerable variability in TLR2-activity with low to absent TLR2-activity in 64% of the isolates tested (68/106). Notably, strain-specific TLR2-activity was independent of the strain origin, e. g. no differences were found between strains isolated from respiratory specimen from cystic fibrosis patients or those isolated from invasive disease specimen. TLR2-activity correlated with protein A expression but not with the agr status. Capsule expression and small colony variant formation had a negative impact on TLR2-activity but any disruption of cell wall integrity enhanced TLR2 activation. Altogether, heterogeneity in host TLR2-activity reflects differences in metabolic activity and cell wall synthesis and/or remodeling.	[Hilmi, Dina; Parcina, Marijo; Ostrop, Jenny; Heeg, Klaus; Bekeredjian-Ding, Isabelle] Univ Heidelberg Hosp, Dept Infect Dis Med Microbiol & Hyg, Heidelberg, Germany; [Hilmi, Dina; Parcina, Marijo; Stollewerk, Daniel; Josten, Michaele; Meilaender, Alina; Bierbaum, Gabriele; Bekeredjian-Ding, Isabelle] Univ Hosp Bonn, Inst Med Microbiol Immunol & Parasitol, Bonn, Germany; [Zaehringer, Ulrich] LG Immunchem, Res Ctr Borstel, Borstel, Germany; [Wichelhaus, Thomas A.] Hosp Goethe Univ, Inst Med Microbiol & Infect Control, Frankfurt, Germany; [Wolz, Christiane] Univ Klinikum Tuebingen, IMIT Interfak Inst Mikrobiol & Infekt Med, Tubingen, Germany	Ruprecht Karls University Heidelberg; University of Bonn; Forschungszentrum Borstel; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Bekeredjian-Ding, I (corresponding author), Univ Heidelberg Hosp, Dept Infect Dis Med Microbiol & Hyg, Heidelberg, Germany.	bekeredjian-ding@uni-bonn.de	Ostrop, Jenny/AAE-5774-2021; Parcina, Marijo/ABG-4659-2020; Bekeredjian-Ding, Isabelle/I-6197-2013	Bekeredjian-Ding, Isabelle/0000-0001-6646-5888; Ostrop, Jenny/0000-0003-2752-8377; Wolz, Christiane/0000-0003-3909-5281	University of Damaskus, Syria; German Research Association (DFG) Priority program "IMMUNOBONE'' grant [RI-707/8-1]; ARGUS Stiftung; Medical faculty of the University of Heidelberg, Germany (Olympia Morata program); Medical faculty of the University Hospital Bonn (BONFOR program	University of Damaskus, Syria; German Research Association (DFG) Priority program "IMMUNOBONE'' grant; ARGUS Stiftung; Medical faculty of the University of Heidelberg, Germany (Olympia Morata program); Medical faculty of the University Hospital Bonn (BONFOR program	DH received a grant from the University of Damaskus, Syria. IBD received funding from the German Research Association (DFG) Priority program "IMMUNOBONE'' grant RI-707/8-1, the ARGUS Stiftung, the Medical faculty of the University of Heidelberg, Germany (Olympia Morata program) and the Medical faculty of the University Hospital Bonn (BONFOR program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Bekeredjian-Ding I, 2007, J IMMUNOL, V178, P2803, DOI 10.4049/jimmunol.178.5.2803; Besier S, 2007, INT J MED MICROBIOL, V297, P217, DOI 10.1016/j.ijmm.2007.02.003; Buzzola FR, 2007, INFECT IMMUN, V75, P886, DOI 10.1128/IAI.01215-06; Gagnaire J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040660; Hashimoto M, 2006, J IMMUNOL, V177, P3162, DOI 10.4049/jimmunol.177.5.3162; Hilmi D, 2013, INT J MED MICROBIOL, V303, P61, DOI 10.1016/j.ijmm.2012.12.008; HOCHKEPPEL HK, 1987, J CLIN MICROBIOL, V25, P526, DOI 10.1128/JCM.25.3.526-530.1987; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Jansen A, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-65; JANZON L, 1989, MOL GEN GENET, V219, P480, DOI 10.1007/BF00259623; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Josten M, 2013, J CLIN MICROBIOL, V51, P1809, DOI 10.1128/JCM.00518-13; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Lattar SM, 2009, INFECT IMMUN, V77, P1968, DOI 10.1128/IAI.01214-08; Lee CC, 2012, NAT REV IMMUNOL, V12, P168, DOI 10.1038/nri3151; Moore LJ, 2003, J INFECT DIS, V188, P1040, DOI 10.1086/378238; Muller P, 2010, INFECT IMMUN, V78, P4243, DOI 10.1128/IAI.00538-10; Navarre WW, 1996, J BACTERIOL, V178, P441, DOI 10.1128/jb.178.2.441-446.1996; O'Riordan K, 2004, CLIN MICROBIOL REV, V17, P218, DOI 10.1128/CMR.17.1.218-234.2004; Parcina M, 2013, J IMMUNOL, V190, P1591, DOI 10.4049/jimmunol.1201222; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; Schmaler M, 2009, J IMMUNOL, V182, P7110, DOI 10.4049/jimmunol.0804292; Stoll H, 2005, INFECT IMMUN, V73, P2411, DOI 10.1128/IAI.73.4.2411-2423.2005; Sun Y, 2006, INFECT IMMUN, V74, P5325, DOI 10.1128/IAI.00645-06; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Traber KE, 2008, MICROBIOL-SGM, V154, P2265, DOI 10.1099/mic.0.2007/011874-0; Tsuru T, 2008, MOL BIOL EVOL, V25, P2457, DOI 10.1093/molbev/msn192; Tuchscherr L, 2010, FUTURE MICROBIOL, V5, P1823, DOI 10.2217/FMB.10.147; Tuchscherr L, 2010, J INFECT DIS, V202, P1031, DOI 10.1086/656047; von Eiff C, 2001, CLIN INFECT DIS, V32, P1643, DOI 10.1086/320519; Zahringer U, 2008, IMMUNOBIOLOGY, V213, P205, DOI 10.1016/j.imbio.2008.02.005; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012	33	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96416	10.1371/journal.pone.0096416	http://dx.doi.org/10.1371/journal.pone.0096416			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810614	Green Submitted, gold, Green Published			2022-12-27	WOS:000338213300034
J	Ishii, T; Hashimoto, E; Ukai, W; Kakutani, Y; Sasaki, R; Saito, T				Ishii, Takao; Hashimoto, Eri; Ukai, Wataru; Kakutani, Yohei; Sasaki, Ryuji; Saito, Toshikazu			Characteristics of Attempted Suicide by Patients with Schizophrenia Compared with Those with Mood Disorders: A Case-Controlled Study in Northern Japan	PLOS ONE			English	Article							TOWER-OF-BABEL; RISK-FACTORS; REVISED NOMENCLATURE; DEPRESSION; BEHAVIOR; ALCOHOL; ASSOCIATION; PREDICTORS; PSYCHOSES; RATES	Recent reports suggest a lifetime suicide risk for schizophrenia patients of approximately 5%. This figure is significantly higher than the general population suicide risk consequently, detection of those at risk is clinically important. This study was undertaken to define the characteristics of suicide attempts by schizophrenia patients compared with attempts by patients with mood disorders. All patients were diagnosed using the ICD-10 criteria. The study population comprised 65 patients with F2 disorders (schizophrenia, schizotypal and delusional disorders), i.e., "the F2 group'', and 94 patients with F3 disorders (mood disorders), i.e., "the F3 group'', who presented in the clinical setting of consultation-liaison psychiatry. The F2 group had a significantly younger mean age and significantly higher ratios of 'past/present psychiatric treatment' and 'more than 3 months interruption of psychiatric treatment'. In contrast, the ratios of 'physical disorder comorbidity', 'alcohol intake at suicide attempt' and 'suicide note left behind' were significantly higher in the F3 group. The F2 group attempted suicide by significantly more serious methods. Furthermore, 'hallucination-delusion' was the most prevalent motive in the F2 group and was the only factor that showed a significant association with the seriousness of the method of suicide attempt (OR = 3.36, 95% CI: 1.05-11.33).	[Ishii, Takao; Hashimoto, Eri; Ukai, Wataru; Kakutani, Yohei; Sasaki, Ryuji; Saito, Toshikazu] Sapporo Med Univ, Sch Med, Dept Neuropsychiat, Sapporo, Hokkaido, Japan	Sapporo Medical University	Ukai, W (corresponding author), Sapporo Med Univ, Sch Med, Dept Neuropsychiat, Sapporo, Hokkaido, Japan.	ukai@sapmed.ac.jp			Grants-in-Aid for Scientific Research [25461737] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		ASUKAI N, 1995, PSYCHIAT CLIN NEUROS, V49, pS91, DOI 10.1111/j.1440-1819.1995.tb01926.x; Barth J, 2004, PSYCHOSOM MED, V66, P802, DOI 10.1097/01.psy.0000146332.53619.b2; Bhatia T, 2006, SCHIZOPHR RES, V86, P208, DOI 10.1016/j.schres.2006.04.015; Brady J, 2006, ALCOHOL ALCOHOLISM, V41, P473, DOI 10.1093/alcalc/agl060; CALDWELL CB, 1990, SCHIZOPHRENIA BULL, V16, P571, DOI 10.1093/schbul/16.4.571; Chochinov HM, 2001, LANCET ONCOL, V2, P499, DOI 10.1016/S1470-2045(01)00456-9; Conwell Y, 2001, SUICIDE LIFE-THREAT, V31, P32, DOI 10.1521/suli.31.1.5.32.24221; De Hert M, 2001, SCHIZOPHR RES, V47, P127, DOI 10.1016/S0920-9964(00)00003-7; Dvorak RD, 2013, J AFFECT DISORDERS, V149, P326, DOI 10.1016/j.jad.2013.01.046; GOLDNEY RD, 1985, AUST NZ J PSYCHIAT, V19, P177, DOI 10.1080/00048678509161316; Harkavy-Friedman JM, 1999, AM J PSYCHIAT, V156, P1276; Hawton K, 2005, BRIT J PSYCHIAT, V187, P9, DOI 10.1192/bjp.187.1.9; Hor K, 2010, J PSYCHOPHARMACOL, V24, P81, DOI 10.1177/1359786810385490; Hufford MR, 2001, CLIN PSYCHOL REV, V21, P797, DOI 10.1016/S0272-7358(00)00070-2; Hunt IM, 2006, BRIT J PSYCHIAT, V188, P135, DOI 10.1192/bjp.188.2.135; Jackson D, 2013, INT J METH PSYCH RES, V22, P36, DOI 10.1002/mpr.1376; Kawakami Norito, 2007, Nihon Rinsho, V65, P1578; Koeda A, 2012, SCHIZOPHR RES, V142, P31, DOI 10.1016/j.schres.2012.08.029; Kroon JS, 2013, BIPOLAR DISORD, V15, P306, DOI 10.1111/bdi.12058; Meltzer HY, 2001, ANN NY ACAD SCI, V932, P44, DOI 10.1111/j.1749-6632.2001.tb05797.x; MILES CP, 1977, J NERV MENT DIS, V164, P231, DOI 10.1097/00005053-197704000-00002; Musselman DL, 2003, BIOL PSYCHIAT, V54, P317, DOI 10.1016/S0006-3223(03)00569-9; Oladeji BD, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0390-3; Palmer BA, 2005, ARCH GEN PSYCHIAT, V62, P247, DOI 10.1001/archpsyc.62.3.247; Passik SD, 1998, J CLIN ONCOL, V16, P1594, DOI 10.1200/JCO.1998.16.4.1594; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Pompili M, 2011, SCHIZOPHR RES, V129, P1, DOI 10.1016/j.schres.2011.03.008; Pycha R, 2009, EUR PSYCHIAT, V24, P47, DOI 10.1016/j.eurpsy.2008.08.005; Sadock BJ, 2015, CLIN PSYCHIATR, V11, P1118; Sanchez-Gistau V, 2013, J CLIN PSYCHIAT, V74, P61, DOI 10.4088/JCP.12m07632; Silverman MM, 2007, SUICIDE LIFE-THREAT, V37, P248, DOI 10.1521/suli.2007.37.3.248; Silverman MM, 2007, SUICIDE LIFE-THREAT, V37, P264, DOI 10.1521/suli.2007.37.3.264; Steblaj A, 1999, ACTA PSYCHIAT SCAND, V100, P383	33	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96272	10.1371/journal.pone.0096272	http://dx.doi.org/10.1371/journal.pone.0096272			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK1XT	24809694	Green Published, gold			2022-12-27	WOS:000338213300026
J	Li, CF; Yang, J; Park, K; Wu, HL; Hu, S; Zhang, W; Bu, JJ; Xu, CS; Qiu, BS; Zhang, XC				Li, Chuanfu; Yang, Jun; Park, Kyungmo; Wu, Hongli; Hu, Sheng; Zhang, Wei; Bu, Junjie; Xu, Chunsheng; Qiu, Bensheng; Zhang, Xiaochu			Prolonged Repeated Acupuncture Stimulation Induces Habituation Effects in Pain-Related Brain Areas: An fMRI Study	PLOS ONE			English	Article							ACUPOINT SPECIFICITY; NEEDLING SENSATION; SHAM ACUPUNCTURE; FUNCTIONAL MRI; LIMBIC SYSTEM; DEFAULT MODE; ACTIVATION; ANALGESIA; NETWORK; CORTEX	Most previous studies of brain responses to acupuncture were designed to investigate the acupuncture instant effect while the cumulative effect that should be more important in clinical practice has seldom been discussed. In this study, the neural basis of the acupuncture cumulative effect was analyzed. For this experiment, forty healthy volunteers were recruited, in which more than 40 minutes of repeated acupuncture stimulation was implemented at acupoint Zhusanli (ST36). Three runs of acupuncture fMRI datasets were acquired, with each run consisting of two blocks of acupuncture stimulation. Besides general linear model (GLM) analysis, the cumulative effects of acupuncture were analyzed with analysis of covariance (ANCOVA) to find the association between the brain response and the cumulative duration of acupuncture stimulation in each stimulation block. The experimental results showed that the brain response in the initial stage was the strongest although the brain response to acupuncture was time-variant. In particular, the brain areas that were activated in the first block and the brain areas that demonstrated cumulative effects in the course of repeated acupuncture stimulation overlapped in the pain-related areas, including the bilateral middle cingulate cortex, the bilateral paracentral lobule, the SII, and the right thalamus. Furthermore, the cumulative effects demonstrated bimodal characteristics, i.e. the brain response was positive at the beginning, and became negative at the end. It was suggested that the cumulative effect of repeated acupuncture stimulation was consistent with the characteristic of habituation effects. This finding may explain the neurophysiologic mechanism underlying acupuncture analgesia.	[Li, Chuanfu; Zhang, Wei; Xu, Chunsheng] Anhui Univ Chinese Med, Affiliated Hosp 1, Med Imaging Ctr, Lab Digital Med Imaging, Hefei, Anhui, Peoples R China; [Yang, Jun] Anhui Univ Chinese Med, Affiliated Hosp 1, Dept Acupuncture & Moxibust, Hefei, Anhui, Peoples R China; [Park, Kyungmo] Kyung Hee Univ, Dept Biomed Engn, Yongin, South Korea; [Wu, Hongli] Anhui Univ Chinese Med, Coll Med Informat Engn, Hefei, Anhui, Peoples R China; [Hu, Sheng; Qiu, Bensheng] Univ Sci & Technol China, Sch Informat Sci & Technol, Hefei 230026, Anhui, Peoples R China; [Bu, Junjie; Zhang, Xiaochu] Univ Sci & Technol China, CAS Key Lab Brain Funct & Dis, Hefei 230026, Anhui, Peoples R China; [Bu, Junjie; Zhang, Xiaochu] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China	Anhui University of Chinese Medicine; Anhui University of Chinese Medicine; Kyung Hee University; Anhui University of Chinese Medicine; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Yang, J (corresponding author), Anhui Univ Chinese Med, Affiliated Hosp 1, Dept Acupuncture & Moxibust, Hefei, Anhui, Peoples R China.	yangzyun@aliyun.com; zxcustc@ustc.edu.cn	Zhang, Xiaochu/O-9592-2014; Zhang, Xiaochu/AAG-8768-2022; Zhang, Xiaochu/AEW-0582-2022	Zhang, Xiaochu/0000-0002-7541-0130; park, kyungmo/0000-0002-7689-8967	Anhui Provincial Natural Science Foundation [1208085MH147]; Major Scientific Projects of Anhui Provincial Education Commission [KJ2011ZD05]; National Natural Science Foundation of China [81202768, 31171083, 31230032]; National Key Basic Research and Development Program (973) [2010CB530500]	Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province); Major Scientific Projects of Anhui Provincial Education Commission; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research and Development Program (973)(National Basic Research Program of China)	This study was supported by grants from Anhui Provincial Natural Science Foundation under Grant No. 1208085MH147 (http://220.178.98.52/ zrkxjj/), Major Scientific Projects of Anhui Provincial Education Commission under Grant No. KJ2011ZD05 (http://www.ahsr.edu.cn/ srmis/), the National Natural Science Foundation of China under Grant No. 81202768, 31171083, 31230032 (http://www.nsfc.gov.cn/ Portal0/ default152.htm), and the National Key Basic Research and Development Program (973) under Grant No. 2010CB530500 (http://www.973.gov.cn/ Default_3.aspx).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Asghar AU, 2010, BRAIN RES, V1315, P111, DOI 10.1016/j.brainres.2009.12.019; Bai LJ, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-73; Bai LJ, 2010, J MAGN RESON IMAGING, V31, P71, DOI 10.1002/jmri.22006; Bai LJ, 2009, HUM BRAIN MAPP, V30, P3445, DOI 10.1002/hbm.20769; Beissner F, 2011, EVID-BASED COMPL ALT, V2011, P607; Bingel U, 2007, PAIN, V131, P21, DOI 10.1016/j.pain.2006.12.005; Boensch S, 2011, ANAEST INTENS CARE M, V12, P28, DOI 10.1016/j.mpaic.2010.10.003; Brown CA, 2008, CLIN NEUROPHYSIOL, V119, P2370, DOI 10.1016/j.clinph.2008.06.014; Chae Y, 2013, J PAIN, V14, P215, DOI 10.1016/j.jpain.2012.11.011; Chae Y, 2009, MOVEMENT DISORD, V24, P1794, DOI 10.1002/mds.22673; Chae Y, 2009, NEUROSCI LETT, V450, P80, DOI 10.1016/j.neulet.2008.11.048; Chen TL, 2008, NEUROIMAGE, V40, P1765, DOI 10.1016/j.neuroimage.2008.01.020; Cho SY, 2010, J ALTERN COMPLEM MED, V16, P489, DOI 10.1089/acm.2009.0395; Claunch JD, 2012, AM J CHINESE MED, V40, P695, DOI 10.1142/S0192415X12500528; Connell C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032442; Dong MH, 2012, BRAIN RES, V1436, P34, DOI 10.1016/j.brainres.2011.11.050; Dougherty DD, 2008, BEHAV BRAIN RES, V193, P63, DOI 10.1016/j.bbr.2008.04.020; Fang JL, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/515893; Fang JL, 2009, HUM BRAIN MAPP, V30, P1196, DOI 10.1002/hbm.20583; Fang JL, 2004, NEURORADIOLOGY, V46, P359, DOI 10.1007/s00234-003-1125-7; Feng YY, 2011, J MAGN RESON IMAGING, V34, P31, DOI 10.1002/jmri.22585; Han JS, 2011, PAIN, V152, pS41, DOI 10.1016/j.pain.2010.10.012; Ho TJ, 2008, AM J CHINESE MED, V36, P55, DOI 10.1142/S0192415X08005588; Ho TJ, 2007, J ALTERN COMPLEM MED, V13, P13, DOI 10.1089/acm.2006.6217; Hsieh CW, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/951258; Hui KKS, 2010, AUTON NEUROSCI-BASIC, V157, P81, DOI 10.1016/j.autneu.2010.03.022; Hui KKS, 2009, BRAIN RES, V1287, P84, DOI 10.1016/j.brainres.2009.06.061; Hui KKS, 2005, NEUROIMAGE, V27, P479, DOI 10.1016/j.neuroimage.2005.04.037; Hui KKS, 2000, HUM BRAIN MAPP, V9, P13, DOI 10.1002/(SICI)1097-0193(2000)9:1<13::AID-HBM2>3.0.CO;2-F; Jiang Y, 2012, BRAIN RES, V1457, P13, DOI 10.1016/j.brainres.2012.03.063; Kong J, 2006, J NEUROSCI, V26, P381, DOI 10.1523/JNEUROSCI.3556-05.2006; Kong J, 2007, NEUROIMAGE, V34, P1171, DOI 10.1016/j.neuroimage.2006.10.019; Kong J, 2009, NEUROIMAGE, V47, P1066, DOI 10.1016/j.neuroimage.2009.05.087; Kong J, 2009, NEUROIMAGE, V45, P940, DOI 10.1016/j.neuroimage.2008.12.025; Leung L, 2012, J ACUPUNCT MERIDIAN, V5, P261, DOI 10.1016/j.jams.2012.07.017; Li CL, 2013, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2013-28; Li G, 2006, J MAGN RESON IMAGING, V24, P1018, DOI 10.1002/jmri.20702; Li L, 2008, J ALTERN COMPLEM MED, V14, P671, DOI 10.1089/acm.2008.0036; Li LL, 2010, MAGN RESON IMAGING, V28, P380, DOI 10.1016/j.mri.2009.11.009; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/jour-nal.pone.0037919; Liu H, 2012, PLOS ONE, V7; Liu JX, 2011, J MAGN RESON IMAGING, V33, P33, DOI 10.1002/jmri.22393; Liu P, 2011, MAGN RESON IMAGING, V29, P1059, DOI 10.1016/j.mri.2011.06.002; Liu P, 2010, NEUROSCI LETT, V479, P267, DOI 10.1016/j.neulet.2010.05.077; Liu P, 2009, NEUROSCI LETT, V462, P183, DOI 10.1016/j.neulet.2009.07.015; Liu S, 2007, NEUROSCI LETT, V421, P203, DOI 10.1016/j.neulet.2007.04.078; MacPherson H, 2012, J ACUPUNCT MERIDIAN, V5, P141, DOI 10.1016/j.jams.2012.05.001; Moffet Howard H, 2006, BMC Complement Altern Med, V6, P25, DOI 10.1186/1472-6882-6-25; Moffet HH, 2009, J ALTERN COMPLEM MED, V15, P213, DOI 10.1089/acm.2008.0356; Na BJ, 2009, NEUROSCI LETT, V464, P1, DOI 10.1016/j.neulet.2009.08.009; Napadow V, 2007, PAIN, V130, P254, DOI 10.1016/j.pain.2006.12.003; Napadow V, 2009, NEUROIMAGE, V47, P1055, DOI 10.1016/j.neuroimage.2009.05.079; Napadow V, 2009, NEUROIMAGE, V47, P289, DOI 10.1016/j.neuroimage.2009.03.060; Noback CR., 2005, HUMAN NERVOUS SYSTEM; Pandolfi M, 2012, EUR J INTERN MED, V23, P31, DOI 10.1016/j.ejim.2011.07.017; Park SU, 2009, J ALTERN COMPLEM MED, V15, P1193, DOI 10.1089/acm.2008.0602; Qin W, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-19; Quah-Smith I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012619; Rankin CH, 2009, NEUROBIOL LEARN MEM, V92, P135, DOI 10.1016/j.nlm.2008.09.012; Robinson NG, 2009, J EQUINE VET SCI, V29, P642, DOI 10.1016/j.jevs.2009.07.009; Schaechter JD, 2007, J ALTERN COMPLEM MED, V13, P527, DOI 10.1089/acm.2007.6316; Shi GX, 2012, TRIALS, V13; Shukla S, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-45; Sun JB, 2012, EVIDENCE BASED COMPL; Sun JB, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/297839; Sun JB, 2010, J MAGN RESON IMAGING, V32, P298, DOI 10.1002/jmri.22238; THOMPSON RF, 1966, PSYCHOL REV, V73, P16, DOI 10.1037/h0022681; Thompson RF, 2009, NEUROBIOL LEARN MEM, V92, P127, DOI 10.1016/j.nlm.2008.07.011; Wu Y, 2008, J CHILD NEUROL, V23, P1267, DOI 10.1177/0883073808318049; Wu Y, 2010, J CHILD NEUROL, V25, P849, DOI 10.1177/0883073809351314; Yen Chen-Tung, 2013, Acta Anaesthesiol Taiwan, V51, P73, DOI 10.1016/j.aat.2013.06.011; Yeo S, 2012, CNS NEUROSCI THER, V18, P781, DOI 10.1111/j.1755-5949.2012.00363.x; Yeo S, 2010, J ALTERN COMPLEM MED, V16, P481, DOI 10.1089/acm.2009.0606; Zheng Z, 2010, EUR J PAIN, V14, P725, DOI 10.1016/j.ejpain.2009.11.006	75	22	24	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97502	10.1371/journal.pone.0097502	http://dx.doi.org/10.1371/journal.pone.0097502			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24821143	Green Published, Green Submitted, gold			2022-12-27	WOS:000336653300118
J	Yang, Z; Zhao, TZ; Zou, YJ; Zhang, JH; Feng, H				Yang, Zhao; Zhao, Tian-zhi; Zou, Yong-jie; Zhang, John H.; Feng, Hua			Hypoxia Induces Autophagic Cell Death through Hypoxia-Inducible Factor 1 alpha in Microglia	PLOS ONE			English	Article							IN-VIVO; CEREBRAL-ISCHEMIA; STROKE; ACTIVATION; INJURY; BRAIN; METABOLISM; EXPRESSION; TARGET; GROWTH	As phagocytic cells of central nervous system, excessive activation or cell death of microglia is involved in a lot of nervous system injury and degenerative disease, such as stroke, epilepsy, Parkinson's disease, Alzheimer's disease. Accumulating evidence indicates that hypoxia upregulates HIF-1 alpha expression leading to cell death of microglia. However, the exact mechanism of cell death induced by hypoxia in microglia is not clear. In the current study, we showed that hypoxia induced cell death and autophagy in microglia. The suppression of autophagy using either pharmacologic inhibitors (3-methyladenine, bafilomycin A1) or RNA interference in essential autophagy genes (BECN1 and ATG5) decreased the cell death induced by hypoxia in microglia cells. Moreover, the suppression of HIF-1 alpha using either pharmacologic inhibitors 3-MA, Baf A1) or RNA interference decreased the microglia death and autophagy in vitro. Taken together, these data indicate that hypoxia contributes to autophagic cell death of microglia through HIF-1 alpha, and provide novel therapeutic interventions for cerebral hypoxic diseases associated with microglia activation.	[Yang, Zhao; Zou, Yong-jie; Zhang, John H.; Feng, Hua] Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing, Peoples R China; [Zhao, Tian-zhi] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian, Shaanxi Provinc, Peoples R China	Army Medical University; Air Force Military Medical University	Feng, H (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing, Peoples R China.	fenghua8888@vip.163.com	Feng, Hua/AAX-4121-2021	Feng, Hua/0000-0003-4489-9217	National Natural Science Foundation of China [81200908]; National Basic Research Program of China (973Program) [2014CB541600]; Major International (Regional) Joint Research Project of China [81220108009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973Program)(National Basic Research Program of China); Major International (Regional) Joint Research Project of China	This study was supported by a grant from National Natural Science Foundation of China (No. 81200908), National Basic Research Program of China (973Program) (No. 2014CB541600) and Major International (Regional) Joint Research Project of China (No. 81220108009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand PK, 2011, J BIOL CHEM, V286, P42981, DOI 10.1074/jbc.M111.310599; Band M, 2009, FASEB J, V23, P2327, DOI 10.1096/fj.08-122978; Bergeron M, 2000, ANN NEUROL, V48, P285, DOI 10.1002/1531-8249(200009)48:3<285::AID-ANA2>3.0.CO;2-8; Bergmann A, 2007, CELL, V131, P1032, DOI 10.1016/j.cell.2007.11.027; Birse-Archbold JLA, 2005, J CEREBR BLOOD F MET, V25, P1356, DOI 10.1038/sj.jcbfm.9600133; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Chen D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000486; Chen WQ, 2008, ACTA NEUROCHIR SUPPL, V102, P395, DOI 10.1007/978-3-211-85578-2_77; Dalby KN, 2010, AUTOPHAGY, V6, P322, DOI 10.4161/auto.6.3.11625; Esteban MA, 2006, CANCER RES, V66, P3567, DOI 10.1158/0008-5472.CAN-05-2670; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Graumann U, 2003, BRAIN PATHOL, V13, P554, DOI 10.1111/j.1750-3639.2003.tb00485.x; Han ZB, 2008, CARCINOGENESIS, V29, P1853, DOI 10.1093/carcin/bgn066; Jiang M, 2010, AM J PATHOL, V176, P1181, DOI 10.2353/ajpath.2010.090594; Li ZL, 2012, AUTOPHAGY, V8, P992, DOI 10.4161/auto.20285; Lin Baowan, 2013, Central Nervous System Agents in Medicinal Chemistry, V13, P57; Lv M, 2011, NEUROSCIENCE, V176, P162, DOI 10.1016/j.neuroscience.2010.11.066; Matrone C, 2004, J NEUROCHEM, V90, P368, DOI 10.1111/j.1471-4159.2004.02483.x; Mayo L, 2011, GLIA, V59, P397, DOI 10.1002/glia.21109; Ricker JL, 2004, CLIN CANCER RES, V10, P8665, DOI 10.1158/1078-0432.CCR-04-1393; Ryter SW, 2012, ANNU REV PHYSIOL, V74, P377, DOI 10.1146/annurev-physiol-020911-153348; Salminen A, 2013, PROG NEUROBIOL, V106, P33, DOI 10.1016/j.pneurobio.2013.06.002; Schmid T, 2004, J CELL MOL MED, V8, P423, DOI 10.1111/j.1582-4934.2004.tb00467.x; Scott GB, 2010, BIOCHEM J, V431, P423, DOI 10.1042/BJ20091073; Shahnazari S, 2011, AUTOPHAGY, V7, P957, DOI 10.4161/auto.7.9.16435; Sheldon RA, 2009, DEV NEUROSCI-BASEL, V31, P452, DOI 10.1159/000232563; Shi HL, 2009, CURR MED CHEM, V16, P4593, DOI 10.2174/092986709789760779; Shi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051076; Stead LG, 2005, NEUROLOGY, V65, P1179, DOI 10.1212/01.wnl.0000180939.24845.22; Wei ZL, 2011, STROKE, V42, P2589, DOI 10.1161/STROKEAHA.111.614834; Weimar C, 2006, ARCH NEUROL-CHICAGO, V63, P1287, DOI 10.1001/archneur.63.9.1287; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301; Wong KS, 2003, STROKE, V34, P2361, DOI 10.1161/01.STR.0000089017.90037.7A; Yao LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078439; Yeo EJ, 2003, J NATL CANCER I, V95, P516, DOI 10.1093/jnci/95.7.516; Yokoyama T, 2008, GENE THER, V15, P1233, DOI 10.1038/gt.2008.98	36	58	66	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96509	10.1371/journal.pone.0096509	http://dx.doi.org/10.1371/journal.pone.0096509			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24818601	Green Published, gold, Green Submitted			2022-12-27	WOS:000336653300019
J	Akula, S; Mohammadamin, S; Hellman, L				Akula, Srinivas; Mohammadamin, Sayran; Hellman, Lars			Fc Receptors for Immunoglobulins and Their Appearance during Vertebrate Evolution	PLOS ONE			English	Article							ORNITHORHYNCHUS-ANATINUS PLATYPUS; HEAVY-CHAIN; TACHYGLOSSUS-ACULEATUS; MAMMALIAN EVOLUTION; PAIRED RECEPTORS; GAMMA RECEPTORS; GENE-FAMILY; CLONING; CHICKEN; IDENTIFICATION	Receptors interacting with the constant domain of immunoglobulins (Igs) have a number of important functions in vertebrates. They facilitate phagocytosis by opsonization, are key components in antibody-dependent cellular cytotoxicity as well as activating cells to release granules. In mammals, four major types of classical Fc receptors (FcRs) for IgG have been identified, one high-affinity receptor for IgE, one for both IgM and IgA, one for IgM and one for IgA. All of these receptors are related in structure and all of them, except the IgA receptor, are found in primates on chromosome 1, indicating that they originate from a common ancestor by successive gene duplications. The number of Ig isotypes has increased gradually during vertebrate evolution and this increase has likely been accompanied by a similar increase in isotype-specific receptors. To test this hypothesis we have performed a detailed bioinformatics analysis of a panel of vertebrate genomes. The first components to appear are the poly-Ig receptors (PIGRs), receptors similar to the classic FcRs in mammals, so called FcRL receptors, and the FcR gamma chain. These molecules are not found in cartilagous fish and may first appear within bony fishes, indicating a major step in Fc receptor evolution at the appearance of bony fish. In contrast, the receptor for IgA is only found in placental mammals, indicating a relatively late appearance. The IgM and IgA/M receptors are first observed in the monotremes, exemplified by the platypus, indicating an appearance during early mammalian evolution. Clearly identifiable classical receptors for IgG and IgE are found only in marsupials and placental mammals, but closely related receptors are found in the platypus, indicating a second major step in Fc receptor evolution during early mammalian evolution, involving the appearance of classical IgG and IgE receptors from FcRL molecules and IgM and IgA/M receptors from PIGR.	[Akula, Srinivas; Mohammadamin, Sayran; Hellman, Lars] Uppsala Univ, Dept Cell & Mol Biol, Biomed Ctr, Uppsala, Sweden	Uppsala University	Hellman, L (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Biomed Ctr, Uppsala, Sweden.	Lars.Hellman@icm.uu.se	Akula, Srinivas/GYJ-1463-2022		Swedish Technical Natural Sciences Research Council (VR-NT)	Swedish Technical Natural Sciences Research Council (VR-NT)	This work was made possible by grants from the Swedish Technical Natural Sciences Research Council (VR-NT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano Masatake, 2011, J Oral Sci, V53, P147; Aveskogh M, 1999, DEV COMP IMMUNOL, V23, P597, DOI 10.1016/S0145-305X(99)00050-6; Aveskogh M, 1998, EUR J IMMUNOL, V28, P2738, DOI 10.1002/(SICI)1521-4141(199809)28:09<2738::AID-IMMU2738>3.0.CO;2-I; Bakema JE, 2011, MUCOSAL IMMUNOL, V4, P612, DOI 10.1038/mi.2011.36; Barrow AD, 2008, IMMUNOL REV, V224, P98, DOI 10.1111/j.1600-065X.2008.00653.x; Belov K, 2003, COMP BIOCHEM PHYS A, V136, P811, DOI 10.1016/S1095-6433(03)00165-X; BLANK U, 1989, NATURE, V337, P187, DOI 10.1038/337187a0; Brown D, 2004, TISSUE ANTIGENS, V64, P215, DOI 10.1111/j.0001-2815.2004.00290.x; Danilova N, 2005, NAT IMMUNOL, V6, P295, DOI 10.1038/ni1166; Davis RS, 2007, ANNU REV IMMUNOL, V25, P525, DOI 10.1146/annurev.immunol.25.022106.141541; Davis RS, 2005, EUR J IMMUNOL, V35, P674, DOI 10.1002/eji.200425886; Ding Y, 2003, J BIOL CHEM, V278, P27966, DOI 10.1074/jbc.C300223200; Dooley H, 2006, DEV COMP IMMUNOL, V30, P43, DOI 10.1016/j.dci.2005.06.022; Ehrhardt GRA, 2011, CURR TOP MICROBIOL, V350, P89, DOI 10.1007/82_2010_88; Espeli M, 2010, CURR OPIN IMMUNOL, V22, P715, DOI 10.1016/j.coi.2010.10.003; Fayngerts SA, 2007, IMMUNOGENETICS, V59, P493, DOI 10.1007/s00251-007-0208-8; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Feng LN, 2009, COMP BIOCHEM PHYS B, V154, P282, DOI 10.1016/j.cbpb.2009.07.003; Franco A, 2013, J IMMUNOL, V190, P5739, DOI 10.4049/jimmunol.1202860; Fugmann SD, 2010, SEMIN IMMUNOL, V22, P10, DOI 10.1016/j.smim.2009.11.004; Guselnikov SV, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-148; Hamuro K, 2007, J IMMUNOL, V178, P5682, DOI 10.4049/jimmunol.178.9.5682; Hansen JD, 2005, P NATL ACAD SCI USA, V102, P6919, DOI 10.1073/pnas.0500027102; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Klimovich VB, 2011, BIOCHEMISTRY-MOSCOW+, V76, P534, DOI 10.1134/S0006297911050038; Kubagawa H, 2009, J EXP MED, V206, P2779, DOI 10.1084/jem.20091107; Kuroki K, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00429; Lanier LL, 2009, IMMUNOL REV, V227, P150, DOI 10.1111/j.1600-065X.2008.00720.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liang YH, 2001, GENOMICS, V72, P119, DOI 10.1006/geno.2000.6472; Nikolaidis N, 2005, IMMUNOGENETICS, V57, P151, DOI 10.1007/s00251-004-0764-0; Norderhaug IN, 1999, EUR J IMMUNOL, V29, P3401, DOI 10.1002/(SICI)1521-4141(199910)29:10<3401::AID-IMMU3401>3.0.CO;2-G; Parham P, 2010, J MED PRIMATOL, V39, P194, DOI 10.1111/j.1600-0684.2010.00432.x; Purzel J, 2009, J IMMUNOL, V183, P4554, DOI 10.4049/jimmunol.0901699; Rajalingam Raja, 2011, Korean J Hematol, V46, P216, DOI 10.5045/kjh.2011.46.4.216; Rivera J, 2008, ADV IMMUNOL, V98, P85, DOI 10.1016/S0065-2776(08)00403-3; RODEWALD HR, 1991, J BIOL CHEM, V266, P15974; Rombout JHWM, 2008, FISH SHELLFISH IMMUN, V24, P620, DOI 10.1016/j.fsi.2008.01.016; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schaerlinger B, 2008, MOL IMMUNOL, V45, P776, DOI 10.1016/j.molimm.2007.06.356; Schreeder DM, 2010, J IMMUNOL, V185, P23, DOI 10.4049/jimmunol.1000832; Shimizu Y, 2001, IMMUNOGENETICS, V53, P709, DOI 10.1007/s00251-001-0375-y; Stafford JL, 2007, IMMUNOGENETICS, V59, P77, DOI 10.1007/s00251-006-0169-3; Stafford JL, 2006, J IMMUNOL, V177, P2505, DOI 10.4049/jimmunol.177.4.2505; Sundstrom G, 2008, GEN COMP ENDOCR, V155, P705, DOI 10.1016/j.ygcen.2007.08.016; Tacchi L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070650; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsubata Takeshi, 2012, Infectious Disorders - Drug Targets, V12, P181; van der Poel CE, 2011, J IMMUNOL, V186, P2699, DOI 10.4049/jimmunol.1003526; Vernersson M, 2004, DEV COMP IMMUNOL, V28, P61, DOI 10.1016/S0145-305X(03)00084-3; Vernersson M, 2002, EUR J IMMUNOL, V32, P2145, DOI 10.1002/1521-4141(200208)32:8<2145::AID-IMMU2145>3.0.CO;2-I; Vernersson M, 2010, MOL IMMUNOL, V47, P785, DOI 10.1016/j.molimm.2009.10.007; Viertboeck BC, 2009, J IMMUNOL, V182, P1533, DOI 10.4049/jimmunol.182.3.1533; Viertlboeck BC, 2011, VET IMMUNOL IMMUNOP, V144, P1, DOI 10.1016/j.vetimm.2011.07.001; Viertlboeck BC, 2009, J IMMUNOL, V182, P6985, DOI 10.4049/jimmunol.0803060; Wang XX, 2009, IMMUNOGENETICS, V61, P581, DOI 10.1007/s00251-009-0385-8; WARR GW, 1995, IMMUNOL TODAY, V16, P392, DOI 10.1016/0167-5699(95)80008-5; WEISSMAN AM, 1988, P NATL ACAD SCI USA, V85, P9709, DOI 10.1073/pnas.85.24.9709; Wieland WH, 2004, BIOCHEM J, V380, P669, DOI [10.1042/BJ20040200, 10.1042/bj20040200]; Wilson TJ, 2012, J IMMUNOL, V188, P4741, DOI 10.4049/jimmunol.1102651; Yamashita T, 2008, J BIOL CHEM, V283, P28584, DOI 10.1074/jbc.M802679200; Zhang C, 2013, J IMMUNOL, V191, P3410, DOI 10.4049/jimmunol.1301257; Zhang YA, 2010, NAT IMMUNOL, V11, P827, DOI 10.1038/ni.1913; Zhao YF, 2006, P NATL ACAD SCI USA, V103, P12087, DOI 10.1073/pnas.0600291103; Zhao YF, 2009, J IMMUNOL, V183, P3285, DOI 10.4049/jimmunol.0900469; Zucchetti I, 2009, IMMUNOGENETICS, V61, P463, DOI 10.1007/s00251-009-0373-z	68	74	79	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96903	10.1371/journal.pone.0096903	http://dx.doi.org/10.1371/journal.pone.0096903			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816777	Green Published, Green Submitted, gold			2022-12-27	WOS:000336838000078
J	He, L; Zhao, J; Wang, MH; Siu, KKY; Gan, YX; Chen, L; Zee, BCY; Yang, L; Kung, HF; Yang, ZR; He, ML				He, Lai; Zhao, Jin; Wang, Maggie Haitian; Siu, Kenny K. Y.; Gan, Yong-Xia; Chen, Lin; Zee, Benny C. Y.; Yang, Li; Kung, Hsiang-Fu; Yang, Zheng-Rong; He, Ming-Liang			Interleukin-27 Is Differentially Associated with HIV Viral Load and CD4(+) T Cell Counts in Therapy-Naive HIV-Mono-Infected and HIV/HCV-Co-Infected Chinese	PLOS ONE			English	Article							VIRUS-INFECTION; CYTOKINE; IL-27; REPLICATION; INDUCTION; RISK; SEX; MEN	Human Immunodeficiency Virus (HIV) infection and the resultant Acquired Immunodeficiency Syndrome (AIDS) epidemic are major global health challenges; hepatitis C virus (HCV) co-infection has made the HIV/AIDS epidemic even worse. Interleukin-27 (IL-27), a cytokine which inhibits HIV and HCV replication in vitro, associates with HIV infection and HIV/HCV co-infection in clinical settings. However, the impact of HIV and HCV viral loads on plasma IL-27 expression levels has not been well characterized. In this study, 155 antiretroviral therapy-naive Chinese were recruited. Among them 80 were HIV- and HCV-negative healthy controls, 45 were HIV-mono-infected and 30 were HIV/HCV-co-infected. Plasma level HIV, HCV, IL-27 and CD4+ number were counted and their correlation, regression relationships were explored. We show that: plasma IL-27 level was significantly upregulated in HIV-mono-infected and HIV/HCV-co-infected Chinese; HIV viral load was negatively correlated with IL-27 titer in HIV-mono-infected subjects whereas the relationship was opposite in HIV/HCV-co-infected subjects; and the relationships between HIV viral loads, IL-27 titers and CD4(+) T cell counts in the HIV mono-infection and HIV/HCV co-infection groups were dramatically different. Overall, our results suggest that IL-27 differs in treatment-naive groups with HIV mono-infections and HIV/HCV co-infections, thereby providing critical information to be considered when caring and treating those with HIV mono-infection and HIV/HCV co-infection.	[He, Lai; Zhao, Jin; Kung, Hsiang-Fu; He, Ming-Liang] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Zhao, Jin; Gan, Yong-Xia; Chen, Lin; Yang, Zheng-Rong] Shenzhen Ctr Dis Control & Prevent, Shenzhen, Peoples R China; [Wang, Maggie Haitian; Zee, Benny C. Y.] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Div Biostat, Hong Kong, Hong Kong, Peoples R China; [Siu, Kenny K. Y.] UCL, Fac Life Sci, Div Biosci, London, England; [Yang, Li] Sichuan Univ, West China Hosp, Div Digest Dis, Chengdu 610064, Peoples R China; [Kung, Hsiang-Fu; He, Ming-Liang] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Shenzhen Center for Disease Control & Prevention (SZCDC); Chinese University of Hong Kong; University of London; University College London; Sichuan University; Chinese University of Hong Kong	Yang, ZR (corresponding author), Shenzhen Ctr Dis Control & Prevent, Shenzhen, Peoples R China.	zryang2012@gmail.com; mlhe7788@gmail.com	Zee, Benny Chung Ying/G-5606-2017; HE, Ming-Liang/AAG-3397-2022; HE, Ming-Liang/AFK-4738-2022; Wang, Maggie Haitian/F-5954-2017	Zee, Benny Chung Ying/0000-0002-7238-845X; Wang, Maggie Haitian/0000-0003-1223-4595; HE, Mingliang/0000-0002-9942-9151; Yang, Zheng-Rong/0000-0001-9284-5593	Natural Basic Science Development Program of China [2013CB911302]; RGC-GRF grant [464512, 476013]; Bureau of Innovative Science and Technology of Shenzhen [JCYJ20130401172046448, JCYJ20120615085419420]; CUHK direct grant [4054077]	Natural Basic Science Development Program of China; RGC-GRF grant; Bureau of Innovative Science and Technology of Shenzhen; CUHK direct grant(Chinese University of Hong Kong)	This study is partially supported by the Natural Basic Science Development Program (2013CB911302) of China, a RGC-GRF grant (464512) and Bureau of Innovative Science and Technology of Shenzhen (JCYJ20130401172046448, JCYJ20120615085419420) (to MLH); and by a CUHK direct grant (4054077) and a RGC-GRF grant (476013) (to MHW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, LEPROSY REV, V67, P248; Anthony DD, 2012, J INFECT DIS, V206, P969, DOI 10.1093/infdis/jis434; Barre-Sinoussi F, 2004, REV INVEST CLIN, V56, P126; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Beijer U, 2012, LANCET INFECT DIS, V12, P859, DOI 10.1016/S1473-3099(12)70177-9; Bender H, 2009, HEPATOLOGY, V50, P585, DOI 10.1002/hep.22988; Chen Q., 2013, PLOS ONE, V8; de Groot R, 2012, IMMUNOLOGY, V137, P348; Fakruddin JM, 2007, BLOOD, V109, P1841, DOI 10.1182/blood-2006-02-001578; Frank AC, 2010, J INTERF CYTOK RES, V30, P427, DOI 10.1089/jir.2009.0093; GALLO RC, 1983, SCIENCE, V220, P865, DOI 10.1126/science.6601823; GOTTLIEB MS, 1981, NEW ENGL J MED, V305, P1425, DOI 10.1056/NEJM198112103052401; Greenwell-Wild T, 2009, BLOOD, V114, P1864, DOI 10.1182/blood-2009-03-211540; Guzzo C, 2010, AIDS, V24, P1371, DOI 10.1097/QAD.0b013e3283391d2b; Hunter CA, 2012, IMMUNITY, V37, P960, DOI 10.1016/j.immuni.2012.11.003; Imamichi T, 2008, AIDS, V22, P39, DOI 10.1097/QAD.0b013e3282f3356c; Kondo Y, 2009, J INFECT DIS, V199, P726, DOI 10.1086/596739; Lai He JZ, 2011, J AIDS HIV RES, V3; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; Monforte AD, 2009, CLIN INFECT DIS, V49, P612, DOI 10.1086/603557; Monga HK, 2001, CLIN INFECT DIS, V33, P240, DOI 10.1086/321819; Muessig KE, 2013, CLIN INFECT DIS, V57, P310, DOI 10.1093/cid/cit213; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Rockstroh JK, 2005, J INFECT DIS, V192, P992, DOI 10.1086/432762; Saag MS, 1996, NAT MED, V2, P625, DOI 10.1038/nm0696-625; Schoenherr C, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-19; Siebler J, 2008, J IMMUNOL, V180, P30, DOI 10.4049/jimmunol.180.1.30; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Stebbing J, 2005, CLIN INFECT DIS, V41, P906, DOI 10.1086/432885; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Tan Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003608; Wojno EDT, 2012, TRENDS IMMUNOL, V33, P91, DOI 10.1016/j.it.2011.11.003; Yang HM, 2005, SEX TRANSM DIS, V32, P270, DOI 10.1097/01.olq.0000162360.11910.5a; Yi LN, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-27; Youssef SS, 2013, J INTERF CYTOK RES, V33, P415, DOI 10.1089/jir.2012.0161; Zhao J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045200	36	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96792	10.1371/journal.pone.0096792	http://dx.doi.org/10.1371/journal.pone.0096792			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816922	Green Published, gold, Green Submitted			2022-12-27	WOS:000336838000066
J	Jin, G; Sun, J; Qin, MX; Wang, C; Guo, WY; Yan, QG; Peng, B; Pan, WC				Jin, Gui; Sun, Jian; Qin, Mingxin; Wang, Chao; Guo, Wanyou; Yan, Qingguang; Peng, Bin; Pan, Wencai			A Special Phase Detector for Magnetic Inductive Measurement of Cerebral Hemorrhage	PLOS ONE			English	Article							SHIFT SPECTROSCOPY; TOMOGRAPHY; SYSTEM; BRAIN; SIMULATION; HARDWARE; MIT	Cerebral hemorrhage is an important clinical problem that is often monitored and studied with expensive techniques, such as computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET). These devices are not readily available in economically underdeveloped regions of the world and in emergency departments and emergency zones. The magnetic inductive method is an emerging technology that may become a new tool to detect cerebral hemorrhage. In this study, a special phase detector (PD) was developed and used for cerebral hemorrhage detection with the magnetic inductive method. The performance indicated that the PD can achieve phase noise as low as 6 m degrees and a 4-hour phase drift as low as 30 m degrees at 21.4 MHz. The noise and drift decreased as the frequency decreased. The performance at 10.7 MHz was slightly better than that of other recently developed phase detection systems. To test the practicality of the system, the PD was used to detect the volume change in a self-made physical model of the brain. The measured phase shift was approximately proportional to the volume change of physiological saline inside the model. The change of the phase shift increased as the volume change and frequency increased. The results are in agreement with those from previous reports. To verify the feasibility of in vivo detection, an autologous blood injection model was established in rabbit brain. The results from the injection group showed a similar trend of increasing phase shift change with increasing injection volume. The average phase shift change induced by a 3-ml injection of blood was 0.502 degrees +/- 0.119 degrees, which was much larger than that of the control group. The measurement system can distinguish a minimal cerebral hemorrhage volume of approximately 0.5 ml. All of the results demonstrated that the PD used with this method can detect cerebral hemorrhage.	[Jin, Gui; Sun, Jian; Qin, Mingxin; Yan, Qingguang; Peng, Bin; Pan, Wencai] Third Mil Med Univ, Coll Biomed Engn, Chongqing, Peoples R China; [Wang, Chao; Guo, Wanyou] Xidian Univ, Coll Elect Engn, Xian, Peoples R China	Army Medical University; Xidian University	Qin, MX (corresponding author), Third Mil Med Univ, Coll Biomed Engn, Chongqing, Peoples R China.	jellyhuang415@163.com	SUN, Jian/HGV-0337-2022		Foundation of the Third Military Medical University; National Natural Science Foundation of China [61372065]	Foundation of the Third Military Medical University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Foundation of the Third Military Medical University and the National Natural Science Foundation of China (61372065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Flores O, 2008, IEEE ENG MED BIO, P678, DOI 10.1109/IEMBS.2008.4649243; Gonzalez CA, 2007, P ANN INT IEEE EMBS, P2346, DOI 10.1109/IEMBS.2007.4352797; Griffiths H, 2001, MEAS SCI TECHNOL, V12, P1126, DOI 10.1088/0957-0233/12/8/319; Griffiths H, 2009, ANN NY ACAD SCI, V873, P335; Helsinki F, 1996, BRIT MED J, V313, P1448; Kidwell CS, 2004, JAMA-J AM MED ASSOC, V292, P1823, DOI 10.1001/jama.292.15.1823; Liang YW, 2010, DESIGN FPGA BASED DI, P363; Liang YW, 2009, IST P, P239; Patz R., 2010, Journal of Physics: Conference Series, V224, DOI 10.1088/1742-6596/224/1/012017; Polk C., 1996, HDB BIOL EFFECTS ELE; Riedel CH, 2004, PHYSIOL MEAS, V25, P403, DOI 10.1088/0967-3334/25/1/043; Roger VL, 2010, CIRCULATION, V121, P863, DOI 10.1161/CIRCULATIONAHA.109.897249; Rojas R, 2008, PHYSIOL MEAS, V29, pS255, DOI 10.1088/0967-3334/29/6/S22; Scharfetter H, 2008, PHYSIOL MEAS, V29, pS431, DOI 10.1088/0967-3334/29/6/S36; Scharfetter H, 2007, IFMBE PROC, V17, P452; Trakic A, 2012, MEAS SCI TECHNOL, V23, DOI 10.1088/0957-0233/23/2/025402; Watson S, 2004, PHYSIOL MEAS, V25, P271, DOI 10.1088/0967-3334/25/1/031; Watson S, 2001, P ANN INT IEEE EMBS, V23, P3182, DOI 10.1109/IEMBS.2001.1019498; Watson S, 2008, MEAS SCI TECHNOL, V19, DOI 10.1088/0957-0233/19/4/045501; Wee H. C., 2008, IFMBE P 4 EUR C ANTW, P744; Wei HY, 2012, PHYSIOL MEAS, V33, P863, DOI 10.1088/0967-3334/33/5/863; Xu Z, 2009, PHYSIOL MEAS, V30, pS175, DOI 10.1088/0967-3334/30/6/S12; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	23	17	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97179	10.1371/journal.pone.0097179	http://dx.doi.org/10.1371/journal.pone.0097179			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816470	Green Submitted, gold, Green Published			2022-12-27	WOS:000336838000112
J	Nielsen, SCA; Bruhn, CAW; Samaniego, JA; Wadsworth, J; Knowles, NJ; Gilbert, MTP				Nielsen, Sandra C. Abel; Bruhn, Christian A. W.; Samaniego, Jose Alfredo; Wadsworth, Jemma; Knowles, Nick J.; Gilbert, M. Thomas P.			Near-Complete Genome Sequencing of Swine Vesicular Disease Virus Using the Roche GS FLX Sequencing Platform	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; FOOT; PIGS	Swine vesicular disease virus (SVDV) is an enterovirus that is both genetically and antigenically closely related to human coxsackievirus B5 within the Picornaviridae family. SVDV is the causative agent of a highly contagious (though rarely fatal) vesicular disease in pigs. We report a rapid method that is suitable for sequencing the complete protein-encoding sequences of SVDV isolates in which the RNA is relatively intact. The approach couples a single PCR amplification reaction, using only a single PCR primer set to amplify the near-complete SVDV genome, with deep-sequencing using a small fraction of the capacity of a Roche GS FLX sequencing platform. Sequences were initially verified through one of two criteria; either a match between a de novo assembly and a reference mapping, or a match between all of five different reference mappings performed against a fixed set of starting reference genomes with significant genetic distances within the same species of viruses. All reference mappings used an iterative method to avoid bias. Further verification was achieved through phylogenetic analysis against published SVDV genomes and additional Enterovirus B sequences. This approach allows high confidence in the obtained consensus sequences, as well as provides sufficiently high and evenly dispersed sequence coverage to allow future studies of intra-host variation.	[Nielsen, Sandra C. Abel; Bruhn, Christian A. W.; Samaniego, Jose Alfredo; Gilbert, M. Thomas P.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark; [Wadsworth, Jemma; Knowles, Nick J.] Pirbright Inst, Vesicular Dis Reference Lab Grp, Pirbright, Surrey, England	University of Copenhagen; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Knowles, NJ (corresponding author), Pirbright Inst, Vesicular Dis Reference Lab Grp, Pirbright, Surrey, England.	nick.knowles@pirbright.ac.uk; mtpgilbert@gmail.com	Samaniego Castruita, José Alfredo/B-9033-2015; Gilbert, Marcus/A-8936-2013	Samaniego Castruita, José Alfredo/0000-0001-5904-1198; Gilbert, Marcus/0000-0002-5805-7195	Danish National Research Foundation [DNRF94]; Lundbeck Foundation [R52-A5062]; European Reference Laboratory for Swine Vesicular Disease; Livestock Viral Diseases Programme by the Biotechnology and Biological Sciences Research Council; Department for Environment, Food and Rural Affairs, UK [SE2940]; BBSRC [BBS/E/I/00001713] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001713] Funding Source: researchfish	Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden); European Reference Laboratory for Swine Vesicular Disease; Livestock Viral Diseases Programme by the Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for Environment, Food and Rural Affairs, UK(Department for Environment, Food & Rural Affairs (DEFRA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by Danish National Research Foundation grant DNRF94 and Lundbeck Foundation grant R52-A5062. Furthermore, The Pirbright Institute was funded by the European Reference Laboratory for Swine Vesicular Disease (NJK), core funding under the Livestock Viral Diseases Programme provided by the Biotechnology and Biological Sciences Research Council (NJK) and a Department for Environment, Food and Rural Affairs, UK, project SE2940 (NJK & JW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; BROWN F, 1973, NATURE, V245, P315, DOI 10.1038/245315a0; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DAWE PS, 1973, NATURE, V241, P540, DOI 10.1038/241540a0; De Castro MP, 1964, ARQ I BIOL-SAO PAULO, P63; GRAVES JH, 1973, NATURE, V245, P314, DOI 10.1038/245314a0; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; INOUE T, 1989, J GEN VIROL, V70, P919, DOI 10.1099/0022-1317-70-4-919; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; MOWAT GN, 1972, VET REC, V90, P618, DOI 10.1136/vr.90.22.618; NARDELLI L, 1968, NATURE, V219, P1275, DOI 10.1038/2191275a0; Nielsen SCA, 2012, EMERG INFECT DIS, V18, P1163, DOI 10.3201/eid1807.111689; SEECHURN P, 1990, VIRUS RES, V16, P255, DOI 10.1016/0168-1702(90)90052-D; Zhang G, 1999, J GEN VIROL, V80, P639, DOI 10.1099/0022-1317-80-3-639; ZHANG G, 1993, J GEN VIROL, V74, P845, DOI 10.1099/0022-1317-74-5-845	18	2	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97180	10.1371/journal.pone.0097180	http://dx.doi.org/10.1371/journal.pone.0097180			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816564	gold, Green Published, Green Submitted			2022-12-27	WOS:000336838000113
J	Nudelman, KNH; Wang, Y; McDonald, BC; Conroy, SK; Smith, DJ; West, JD; O'Neill, DP; Schneider, BP; Saykin, AJ				Nudelman, Kelly N. H.; Wang, Yang; McDonald, Brenna C.; Conroy, Susan K.; Smith, Dori J.; West, John D.; O'Neill, Darren P.; Schneider, Bryan P.; Saykin, Andrew J.			Altered Cerebral Blood Flow One Month after Systemic Chemotherapy for Breast Cancer: A Prospective Study Using Pulsed Arterial Spin Labeling MRI Perfusion	PLOS ONE			English	Article							ADJUVANT CHEMOTHERAPY; COGNITIVE FUNCTION; BRAIN ACTIVATION; WORKING-MEMORY; SURVIVORS; PACLITAXEL; WOMEN; CARCINOMA; THERAPY; IMPACT	Cerebral structural and functional alterations have been reported after chemotherapy for non-CNS cancers, yet the causative mechanism behind these changes remains unclear. This study employed a novel, non-invasive, MRI-based neuroimaging measure to provide the first direct longitudinal measurement of resting cerebral perfusion in breast cancer patients, which was tested for association with changes in cognitive function and gray matter density. Perfusion was measured using pulsed arterial spin labeling MRI in women with breast cancer treated with (N = 27) or without (N = 26) chemotherapy and matched healthy controls (N = 26) after surgery before other treatments (baseline), and one month after chemotherapy completion or yoked intervals. Voxel-based analysis was employed to assess perfusion in gray matter; changes were examined in relation to overall neuropsychological test performance and frontal gray matter density changes measured by structural MRI. Baseline perfusion was not significantly different across groups. Unlike control groups, chemotherapy-treated patients demonstrated significantly increased perfusion post-treatment relative to baseline, which was statistically significant relative to controls in the right precentral gyrus. This perfusion increase was negatively correlated with baseline overall neuropsychological performance, but was not associated with frontal gray matter density reduction. However, decreased frontal gray matter density was associated with decreased perfusion in bilateral frontal and parietal lobes in the chemotherapy-treated group. These findings indicate that chemotherapy is associated with alterations in cerebral perfusion which are both related to and independent of gray matter changes. This pattern of results suggests the involvement of multiple mechanisms of chemotherapy-induced cognitive dysfunction. Additionally, lower baseline cognitive function may be a risk factor for treatment-associated perfusion dysregulation. Future research is needed to clarify these mechanisms, identify individual differences in susceptibility to treatment-associated changes, and further examine perfusion change over time in survivors.	[Nudelman, Kelly N. H.; Schneider, Bryan P.; Saykin, Andrew J.] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Nudelman, Kelly N. H.] Indiana Univ Sch Med, Training Res Behav Oncol & Canc Control Program, Indianapolis, IN 46202 USA; [Nudelman, Kelly N. H.; Wang, Yang; McDonald, Brenna C.; Conroy, Susan K.; Smith, Dori J.; West, John D.; O'Neill, Darren P.; Saykin, Andrew J.] Indiana Univ Sch Med, Ctr Neuroimaging, Dept Radiol & Imaging Sci, Indianapolis, IN 46202 USA; [Wang, Yang; McDonald, Brenna C.; West, John D.; O'Neill, Darren P.; Saykin, Andrew J.] Indiana Univ Sch Med, Indiana Alzheimer Dis Ctr, Indianapolis, IN 46202 USA; [McDonald, Brenna C.; Schneider, Bryan P.; Saykin, Andrew J.] Indiana Univ Sch Med, Indiana Univ Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46202 USA; [Schneider, Bryan P.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Saykin, AJ (corresponding author), Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA.	asaykin@iupui.edu	Nudelman, Kelly/AFM-1022-2022; Saykin, Andrew/A-1318-2007	Saykin, Andrew/0000-0002-1376-8532; Conroy, Susan/0000-0002-0573-4420; Nudelman, Kelly/0000-0003-4040-1717	National Cancer Institute [R01 CA101318, R01 CA087845, P30 CA082709, R25 CA117865]; National Institute on Aging [R01 AG19771, P30 AG10133]; Indiana CTSI [U54 RR025761, RR027710-01, RR020128]; Indiana Economic Development Corporation [87884]; Siemens Medical Solutions; NATIONAL CANCER INSTITUTE [R01CA087845, R25CA117865, R01CA101318, P30CA082709] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001108, UL1TR002529] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027710, UL1RR025761, C06RR020128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019771, P30AG010133] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Indiana CTSI; Indiana Economic Development Corporation; Siemens Medical Solutions(Siemens AG); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was partially supported by the National Cancer Institute (R01 CA101318, R01 CA087845, P30 CA082709, and R25 CA117865), National Institute on Aging (R01 AG19771, P30 AG10133), and the Indiana CTSI (U54 RR025761, RR027710-01, RR020128), as well as the Indiana Economic Development Corporation (#87884) and an Investigator-Initiated Grant from Siemens Medical Solutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal K, 2010, MATURITAS, V67, P209, DOI 10.1016/j.maturitas.2010.07.004; Ahles TA, 2002, J CLIN ONCOL, V20, P485, DOI 10.1200/JCO.2002.20.2.485; Ahles TA, 2008, BREAST CANCER RES TR, V110, P143, DOI 10.1007/s10549-007-9686-5; Ahles TA, 2007, NAT REV CANCER, V7, P192, DOI 10.1038/nrc2073; Ahles TA, 2012, J CLIN ONCOL, V30, P3675, DOI 10.1200/JCO.2012.43.0116; Ahles TA, 2010, J CLIN ONCOL, V28, P4434, DOI 10.1200/JCO.2009.27.0827; Bar-Joseph H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023492; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Bender CM, 2006, PSYCHO-ONCOLOGY, V15, P422, DOI 10.1002/pon.964; Brett M AJ, 2002, 8 INT C FUNCT MAPP H; Cimprich B, 2010, J CLIN EXP NEUROPSYC, V32, P324, DOI 10.1080/13803390903032537; Collins B, 2009, PSYCHO-ONCOLOGY, V18, P134, DOI 10.1002/pon.1379; Conroy SK, 2013, BRAIN IMAGING BEHAV, V7, P491, DOI 10.1007/s11682-013-9240-5; Conroy SK, 2013, BREAST CANCER RES TR, V137, P493, DOI 10.1007/s10549-012-2385-x; Dashjamts T, 2011, ACAD RADIOL, V18, P1492, DOI 10.1016/j.acra.2011.07.015; de Ruiter MB, 2011, HUM BRAIN MAPP, V32, P1206, DOI 10.1002/hbm.21102; Detre JA, 2009, CURR OPIN NEUROL, V22, P348, DOI 10.1097/WCO.0b013e32832d9505; Dietrich Joerg, 2006, J Biol, V5, P22, DOI 10.1186/jbiol50; Falleti MG, 2005, BRAIN COGNITION, V59, P60, DOI 10.1016/j.bandc.2005.05.001; Fan HGM, 2005, J CLIN ONCOL, V23, P8025, DOI 10.1200/JCO.2005.01.6550; Gangloff A, 2005, J NUCL MED, V46, P1866; GINOS JZ, 1987, J NUCL MED, V28, P1844; Holohan Kelly N, 2013, Semin Oncol Nurs, V29, P280, DOI 10.1016/j.soncn.2013.08.008; Howlader N, 2012, SEER CANC STAT REV 1; Inagaki M, 2007, CANCER, V109, P146, DOI 10.1002/cncr.22368; Jim HSL, 2009, CANCER-AM CANCER SOC, V115, P1776, DOI 10.1002/cncr.24192; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McDonald BC, 2013, BRAIN BEHAV IMMUN, V30, pS117, DOI 10.1016/j.bbi.2012.05.007; McDonald BC, 2012, J CLIN ONCOL, V30, P2500, DOI 10.1200/JCO.2011.38.5674; McDonald BC, 2010, BREAST CANCER RES TR, V123, P819, DOI 10.1007/s10549-010-1088-4; Pachnicki Jan Pawel Andrade, 2012, Rev. Col. Bras. Cir., V39, P86; Quesnel C, 2009, BREAST CANCER RES TR, V116, P113, DOI 10.1007/s10549-008-0114-2; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Saykin Andrew J, 2003, Semin Clin Neuropsychiatry, V8, P201; Scherling C, 2012, J CLIN EXP NEUROPSYC, V34, P543, DOI 10.1080/13803395.2012.666227; Scherling C, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00122; Schilder CM, 2009, ACTA ONCOL, V48, P76, DOI 10.1080/02841860802314738; Silverman DHS, 2007, BREAST CANCER RES TR, V103, P303, DOI 10.1007/s10549-006-9380-z; Spielberger C. D., 1983, MIND GARDEN; Troy L, 2000, PSYCHO-ONCOL, V9, P29, DOI 10.1002/(SICI)1099-1611(200001/02)9:1<29::AID-PON428>3.0.CO;2-Z; Vacca A, 2002, J HEMATOTH STEM CELL, V11, P103, DOI 10.1089/152581602753448577; Verstappen CCP, 2003, DRUGS, V63, P1549, DOI 10.2165/00003495-200363150-00003; Walker CH, 2012, CANCER INVEST, V30, P135, DOI 10.3109/07357907.2011.636116; Wang DJJ, 2011, J PHARMACOL EXP THER, V337, P359, DOI 10.1124/jpet.110.172577; Wang JY, 2003, ANTI-CANCER DRUG, V14, P13, DOI 10.1097/00001813-200301000-00003; Wang Y, 2011, NEUROIMAGE, V54, P1188, DOI 10.1016/j.neuroimage.2010.08.043; Wefel JS, 2004, CANCER-AM CANCER SOC, V101, P466, DOI 10.1002/cncr.20393; Wefel JS, 2004, CANCER-AM CANCER SOC, V100, P2292, DOI 10.1002/cncr.20272; Wierenga CE, 2013, J ALZHEIMERS DIS, V34, P921, DOI 10.3233/JAD-121897	49	36	37	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96713	10.1371/journal.pone.0096713	http://dx.doi.org/10.1371/journal.pone.0096713			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816641	Green Published, gold, Green Submitted			2022-12-27	WOS:000336838000055
J	Yu, ZG; Yu, WH; Fan, XH; Wang, X				Yu, Zhonggen; Yu, Wei Hua; Fan, Xiaohui; Wang, Xiao			An Exploration of Computer Game-Based Instruction in the "World History'' Class in Secondary Education: A Comparative Study in China	PLOS ONE			English	Article							INFORMATION-TECHNOLOGY; VIDEO GAMES; PLAY; SCIENCE; DESIGN; IMPACT; YOUTH	So far, many studies on educational games have been carried out in America and Europe. Very few related empirical studies, however, have been conducted in China. This study, combining both quantitative with qualitative research methods, possibly compensated for this regret. The study compared data collected from two randomly selected classes (out of 13 classes) under computer game-based instruction (CGBI) and non-computer game-based instruction (NCGBI), respectively, in a senior high school located in Nanjing, Capital of Jiangsu Province, in China. The participants were 103 students, composed of 52 boys and 51 girls (aged 17-18 years old). The following conclusion was reached: (1) participants under CGBI obtained significantly greater learning achievement than those under NCGBI; (2) participants were significantly more motivated by CGBI compared with NCGBI; (3) there were no significant differences in learning achievement between boys and girls; although (4) boys were significantly more motivated by CGBI than girls. Both disadvantages and advantages were discussed, together with directions for future research.	[Yu, Zhonggen; Fan, Xiaohui; Wang, Xiao] Hohai Univ, Sch Foreign Languages, Nanjing, Jiangsu, Peoples R China; [Yu, Wei Hua] Zhejiang Yuexiu Univ Foreign Languages, Sch English, Shaoxing, Peoples R China	Hohai University; Zhejiang Yuexiu University	Yu, ZG (corresponding author), Hohai Univ, Sch Foreign Languages, Nanjing, Jiangsu, Peoples R China.	zhonggenyu@gmail.com	Yu, Wei/GZL-3831-2022; Zhonggen, Yu/AAE-5514-2020; Yu, Zhonggen/AAJ-3063-2020	Zhonggen, Yu/0000-0002-3873-980X; 	National Social Science Fund [11BYY001]; Youth Fund of Humanities and Social Sciences of Ministry of Education of China, "The Regression and Threshold Hypotheses of English Negative Sentences Attrition among English Learners in China" [11YJC740138]; Teaching Innovation Project of Tongda College of Nanjing University of Posts & Telecommunications, "The Regression and Threshold Hypotheses of Foreign Languages and Teaching Innovation of College English in Civil Colleges" [TD02011JG02]; Second Batch of Post-doctoral Research Fund of Jiangsu Province in, "The Regression and Threshold Hypotheses of English Language Attrition among Students in China" [1202112C]; Philosophy and Social Science Guidance Research Project of Education Bureau of Jiangsu Province [2013SJD740005]; Special Fundamental Research Fund for the Central Universities [2013B33914]; Shaoxing Important Research Project of Higher Education Reform; Research Project of Zhejiang Yuexiu University of Foreign Languages [N2014013]	National Social Science Fund; Youth Fund of Humanities and Social Sciences of Ministry of Education of China, "The Regression and Threshold Hypotheses of English Negative Sentences Attrition among English Learners in China"; Teaching Innovation Project of Tongda College of Nanjing University of Posts & Telecommunications, "The Regression and Threshold Hypotheses of Foreign Languages and Teaching Innovation of College English in Civil Colleges"; Second Batch of Post-doctoral Research Fund of Jiangsu Province in, "The Regression and Threshold Hypotheses of English Language Attrition among Students in China"; Philosophy and Social Science Guidance Research Project of Education Bureau of Jiangsu Province; Special Fundamental Research Fund for the Central Universities; Shaoxing Important Research Project of Higher Education Reform; Research Project of Zhejiang Yuexiu University of Foreign Languages	The authors wish to thank the people who helped this study and the projects which financially supported this study: 2011 National Social Science Fund (Project No. 11BYY001); 2011 Youth Fund of Humanities and Social Sciences of Ministry of Education of China, "The Regression and Threshold Hypotheses of English Negative Sentences Attrition among English Learners in China" (Project No. 11YJC740138); 2011 Teaching Innovation Project of Tongda College of Nanjing University of Posts & Telecommunications, "The Regression and Threshold Hypotheses of Foreign Languages and Teaching Innovation of College English in Civil Colleges" (Project No. TD02011JG02); The Second Batch of Post-doctoral Research Fund of Jiangsu Province in 2012, "The Regression and Threshold Hypotheses of English Language Attrition among Students in China" (Project No. 1202112C); 2013 Philosophy and Social Science Guidance Research Project of Education Bureau of Jiangsu Province (Project No. 2013SJD740005) and Special Fundamental Research Fund for the Central Universities (Project No. 2013B33914); 2013 Shaoxing Important Research Project of Higher Education Reform; and 2014 Research Project of Zhejiang Yuexiu University of Foreign Languages (Project No. N2014013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annetta LA, 2009, COMPUT EDUC, V53, P74, DOI 10.1016/j.compedu.2008.12.020; Bavelier D, 2012, ANNU REV NEUROSCI, V35, P391, DOI 10.1146/annurev-neuro-060909-152832; Best JR, 2013, Z PSYCHOL, V221, P72, DOI 10.1027/2151-2604/a000137; Carr D, 2005, SIMULAT GAMING, V36, P464, DOI 10.1177/1046878105282160; Cassell Justine., 1998, BARBIE MORTAL KOMBAT; Connolly TM, 2012, COMPUT EDUC, V59, P661, DOI 10.1016/j.compedu.2012.03.004; Lopez JMC, 2010, COMPUT EDUC, V55, P1336, DOI 10.1016/j.compedu.2010.05.028; De Jean J, 1999, GENDER ED, V11, P207, DOI DOI 10.1080/09540259920708; Dede C, 2000, J CURRICULUM STUD, V32, P281, DOI 10.1080/002202700182763; Dovis S, 2012, J ABNORM CHILD PSYCH, V40, P669, DOI 10.1007/s10802-011-9601-8; Downes T., 1999, Education and Information Technologies, V4, P65, DOI 10.1023/A:1009607432286; Durkin K, 2002, J APPL DEV PSYCHOL, V23, P373, DOI 10.1016/S0193-3973(02)00124-7; Evans MA, 2013, Z PSYCHOL, V221, P98, DOI 10.1027/2151-2604/a000135; Facer K., 2003, COMPUTER GAMES LEARN; Gee JP, 2003, WHAT VIDEO GAMES HAVE TO TEACH US ABOUT LEARNING AND LITERACY, P1; Girard C, 2013, J COMPUT ASSIST LEAR, V29, P207, DOI 10.1111/j.1365-2729.2012.00489.x; Hamlen KR, 2013, Z PSYCHOL, V221, P107, DOI 10.1027/2151-2604/a000136; Harris S, 1999, BRIT J EDUC TECHNOL, V30, P331, DOI 10.1111/1467-8535.00123; Jenkins Henry, 2008, BARBIE MORTAL KOMBAT, P5; Jenson J, 2010, SIMULAT GAMING, V41, P51, DOI 10.1177/1046878109353473; Kafai Y., 2001, ED POTENTIAL ELECT G; Ke FF, 2008, COMPUT EDUC, V51, P1609, DOI 10.1016/j.compedu.2008.03.003; Ke FF, 2007, BRIT J EDUC TECHNOL, V38, P249, DOI 10.1111/j.1467-8535.2006.00593.x; Klawe MM, 1999, PROC GRAPH INTERF, P36; Kriz WC, 2006, SIMULAT GAMING, V37, P268, DOI 10.1177/1046878106287950; LEPPER MR, 1985, AM PSYCHOL, V40, P1, DOI 10.1037/0003-066X.40.1.1; Malone T.W., 1980, P 3 ACM SIGSMALL S 1, P162, DOI [10.1145/800088.802839, DOI 10.1145/800088.802839]; Mayer I, 2013, EUR J ENG EDUC, V38, P85, DOI 10.1080/03043797.2012.742872; McFarlane A., 2002, REPORT ED USE GAMES; Mumtaz S, 2001, COMPUT EDUC, V36, P347, DOI 10.1016/S0360-1315(01)00023-9; National Research Council, 2011, LEARNING SCI COMPUTE; Oblinger D., 2006, EDUCAUSE Q, V3, P5; Oblinger D., 2004, EDUCATION-CANADA, V8, P1, DOI DOI 10.5334/2004-8-OBLINGER; Papastergiou M, 2008, COMPUT EDUC, V51, P594, DOI 10.1016/j.compedu.2007.06.009; Papastergiou M, 2009, COMPUT EDUC, V52, P1, DOI 10.1016/j.compedu.2008.06.004; Plass JL, 2013, J EDUC PSYCHOL, V105, P1050, DOI 10.1037/a0032688; Prensky M., 2003, COMPUTER ENTERTAINME, V1, P21, DOI DOI 10.1145/950566.950596; Prins PJM, 2011, CYBERPSYCH BEH SOC N, V14, P115, DOI 10.1089/cyber.2009.0206; Rieber LP, 1996, ETR&D-EDUC TECH RES, V44, P43, DOI 10.1007/BF02300540; Rosas R, 2003, COMPUT EDUC, V40, P71, DOI 10.1016/S0360-1315(02)00099-4; Shaffer D. W., 2006, COMPUTER GAMES HELP; Sherry JL, 2013, Z PSYCHOL, V221, P90, DOI 10.1027/2151-2604/a000134; Sitzmann T, 2011, PERS PSYCHOL, V64, P489, DOI 10.1111/j.1744-6570.2011.01190.x; Squire K.R, 2011, VIDEO GAMES LEARNING; Staiano AE, 2012, DEV PSYCHOL, V48, P337, DOI 10.1037/a0026938; Staiano AE, 2011, CHILD DEV PERSPECT, V5, P93, DOI 10.1111/j.1750-8606.2011.00162.x; Watson W, 2007, THESIS INDIANA U; Young J., 1999, Education and Information Technologies, V4, P391, DOI 10.1023/A:1009600528811; Young MF, 2012, REV EDUC RES, V82, P61, DOI 10.3102/0034654312436980	49	1	1	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96865	10.1371/journal.pone.0096865	http://dx.doi.org/10.1371/journal.pone.0096865			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4LX	24816635	Green Published, Green Submitted, gold			2022-12-27	WOS:000336838000074
J	Zellander, A; Zhao, CL; Kotecha, M; Gemeinhart, R; Wardlow, M; Abiade, J; Cho, M				Zellander, Amelia; Zhao, Chenlin; Kotecha, Mrignayani; Gemeinhart, Richard; Wardlow, Melissa; Abiade, Jeremiah; Cho, Michael			Characterization of Pore Structure in Biologically Functional Poly(2-Hydroxyethyl Methacrylate) - Poly(Ethylene Glycol) Diacrylate (PHEMA-PEGDA)	PLOS ONE			English	Article							CELL; HYDROGEL; ALCOHOL; HEMA; SIZE	A copolymer composed of poly(2-hydroxyethyl methacrylate) (PHEMA) and poly(ethylene glycol) diacrylate (PEGDA) (PHEMA-PEGDA) is structurally versatile. Its structure can be adjusted using the following porogens: water, sucrose, and benzyl alcohol. Using phase separation technique, a variety of surface architectures and pore morphologies were developed by adjusting porogen volume and type. The water and sucrose porogens were effective in creating porous and cytocompatible PHEMA-PEGDA scaffolds. When coated with collagen, the PHEMA-PEGDA scaffolds accommodated cell migration. The PHEMA-PEGDA scaffolds are easy to produce, non-toxic, and mechanically stable enough to resist fracture during routine handling. The PHEMA-PEGDA structures presented in this study may expedite the current research effort to engineer tissue scaffolds that provide both structural stability and biological activity.	[Zellander, Amelia; Kotecha, Mrignayani; Wardlow, Melissa; Cho, Michael] Univ Illinois, Dept Bioengn, Chicago, IL 60612 USA; [Zhao, Chenlin; Abiade, Jeremiah] Univ Illinois, Dept Mech & Ind Engn, Chicago, IL USA; [Gemeinhart, Richard] Univ Illinois, Dept Biopharmaceut Sci, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Cho, M (corresponding author), Univ Illinois, Dept Bioengn, Chicago, IL 60612 USA.	mcho@uic.edu	Zhao, Chenlin/ABF-2989-2020; Gemeinhart, Richard A/B-8017-2008	Gemeinhart, Richard A/0000-0002-1580-7304; Cho, Myoung Rae/0000-0002-8191-8045	Office of Navy Research [N00014-06-1-0100]	Office of Navy Research(Office of Naval Research)	This work was supported by the grant from the Office of Navy Research (N00014-06-1-0100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abend AM, 2004, J PHARMACEUT BIOMED, V34, P957, DOI 10.1016/j.jpba.2003.11.007; Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7; Baker MV, 2009, POLYMER, V50, P5918, DOI 10.1016/j.polymer.2009.10.047; Belsito D, 2012, FOOD CHEM TOXICOL, V50, pS269, DOI 10.1016/j.fct.2012.02.091; Cowie JMG, 2008, POLYM CHEM PHYS MODE, V3; Curtis MW, 2011, PFLUG ARCH EUR J PHY, V462, P105, DOI 10.1007/s00424-011-0931-8; Dziubla TD, 2004, J BIOMED MATER RES A, V68A, P603, DOI 10.1002/jbm.a.20023; Ghosh K, 2007, BIOMATERIALS, V28, P671, DOI 10.1016/j.biomaterials.2006.09.038; Gulsen D, 2006, J MEMBRANE SCI, V269, P35, DOI 10.1016/j.memsci.2005.06.024; Horak D, 2004, BIOMATERIALS, V25, P5249, DOI 10.1016/j.biomaterials.2003.12.031; Jacobsen NE, 2007, NMR SPECTROSCOPY EXPLAINED: SIMPLIFIED THEORY, APPLICATIONS AND EXAMPLES FOR ORGANIC CHEMISTRY AND STRUCTURAL BIOLOGY, P1, DOI 10.1002/9780470173350; Lawrence BD, 2012, ACTA BIOMATER, V8, P3732, DOI 10.1016/j.actbio.2012.06.009; Litvinov VM, 2001, MACROMOLECULES, V34, P4051, DOI 10.1021/ma010066u; Nishiyama N, 2002, J DENT RES, V81, P469, DOI 10.1177/154405910208100707; Park S, 2012, J APPL POLYM SCI, V123, P637, DOI 10.1002/app.34532; Patel AA, 2010, BIOMED MICRODEVICES, V12, P287, DOI 10.1007/s10544-009-9384-7; Rapier R, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-24; Reynolds PM, 2012, SMALL, V8, P2541, DOI 10.1002/smll.201200235; Scognamiglio J, 2012, FOOD CHEM TOXICOL, V50, pS140, DOI 10.1016/j.fct.2011.10.013; Son YK, 2006, MACROMOL RES, V14, P394, DOI 10.1007/BF03219100; Ventre M, 2012, J R SOC INTERFACE, V9, P2017, DOI 10.1098/rsif.2012.0308; Yamane S, 2007, J BIOMED MATER RES A, V81A, P586, DOI 10.1002/jbm.a.31095; Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183; Zink C, 2012, BIOMATERIALS, V33, P8055, DOI 10.1016/j.biomaterials.2012.07.037	24	17	19	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96709	10.1371/journal.pone.0096709	http://dx.doi.org/10.1371/journal.pone.0096709			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816589	Green Published, gold			2022-12-27	WOS:000336838000054
J	Barteselli, G; Chhablani, J; Gomez, ML; Doede, AL; Dustin, L; Kozak, I; Bartsch, DU; Azen, SP; Letendre, SL; Freeman, WR				Barteselli, Giulio; Chhablani, Jay; Gomez, Maria Laura; Doede, Aubrey L.; Dustin, Laurie; Kozak, Igor; Bartsch, Dirk-Uwe; Azen, Stanley P.; Letendre, Scott L.; Freeman, William R.			Visual Function Assessment in Simulated Real-Life Situations in HIV-Infected Subjects	PLOS ONE			English	Article							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; FIBER LAYER THICKNESS; CONTRAST SENSITIVITY; POSITIVE PATIENTS; MACULAR DEGENERATION; VIRUS-INFECTION; COLOR-VISION; RETINITIS; INDIVIDUALS; AIDS	Visual function abnormalities are common in people living with HIV disease (PLWH) without retinitis, even after improvement in immune status. Abnormalities such as reduced contrast sensitivity, altered color vision, peripheral visual field loss, and electrophysiological changes are related to a combination of retinal dysfunctions, involving inner and outer retinal structures. The standard protocol for testing vision performance in clinical practice is the Early Treatment Diabetic Retinopathy Study (ETDRS) chart. However, this method poorly correlates with activities of daily living that require patients to assess visual stimuli in multiple light/contrast conditions, and with limited time. We utilized a novel interactive computer program (Central Vision Analyzer) to analyze vision performance in PLWH under a variety of light/contrast conditions that simulate stressful and real-world environments. The program tests vision in a time-dependent way that we believe better correlates with daily living activities than the non-timed ETDRS chart. We also aimed to correlate visual scores with retinal neuro-fiber layer thickness on optical coherence tomography. Here we show that visual acuity is more affected in PLWH in comparison to HIV-seronegative controls in varying contrast and luminance, especially if the nadir CD4+ T-cell count was lower than 100 cells/mm(3). Visual impairment reflects the loss of retinal nerve fiber layer thickness especially of the temporal-inferior sector. In PLWH the ETDRS chart test led to better visual acuity compared to the Central Vision Analyzer equivalent test, likely because patients had indefinite time to guess the letters. This study confirms and strengthens the finding that visual function is affected in PLWH even in absence of retinitis, since we found that the HIV serostatus is the best predictor of visual loss. The Central Vision Analyzer may be useful in the diagnosis of subclinical HIV-associated visual loss in multiple light/contrast conditions, and may offer better understanding of this entity called "neuroretinal disorder".	[Barteselli, Giulio; Chhablani, Jay; Gomez, Maria Laura; Doede, Aubrey L.; Kozak, Igor; Bartsch, Dirk-Uwe; Freeman, William R.] Univ Calif San Diego, Dept Ophthalmol, Jacobs Retina Ctr, Shiley Eye Ctr, La Jolla, CA 92093 USA; [Barteselli, Giulio] Univ Milan, Osped Maggiore Policlin, Ca Granda Fdn, Ophthalmol Unit,Dept Clin Sci & Community Hlth, Milan, Italy; [Chhablani, Jay] LV Prasad Eye Inst, Srimati Kanuri Santhamma Vitreoretina Serv, Hyderabad, Andhra Pradesh, India; [Dustin, Laurie; Azen, Stanley P.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Kozak, Igor] King Khalid Eye Specialist Hosp, Riyadh, Saudi Arabia; [Letendre, Scott L.] Univ Calif San Diego, HIV Neurobehav Res Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; L. V. Prasad Eye Institute; University of Southern California; King Khaled Eye Specialist Hospital; University of California System; University of California San Diego	Freeman, WR (corresponding author), Univ Calif San Diego, Dept Ophthalmol, Jacobs Retina Ctr, Shiley Eye Ctr, La Jolla, CA 92093 USA.	freeman@eyecenter.ucsd.edu	Doede, Aubrey L/N-9859-2016; Letendre, Scott L./GLU-6874-2022; Kozak, Igor/AAC-4645-2019	Doede, Aubrey L/0000-0002-9977-2806; Barteselli, Giulio/0000-0003-0533-1135	National Institutes of Health (NIH) [R01EY007366, R01EY018589, R01EY016323]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY007366, R01EY018589, R01EY016323, P30EY022589] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062512, K24MH097673] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported in part by National Institutes of Health (NIH) grants R01EY007366 and R01EY018589 (WRF), R01EY016323 (DUB), and an unrestricted fund from Research to Prevent Blindness to the Department of Ophthalmology, University of California San Diego. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng S, 2011, GRAEF ARCH CLIN EXP, V249, P1643, DOI 10.1007/s00417-011-1735-4; El-Emam S, 2013, RETINA-J RET VIT DIS, V33, P1249, DOI 10.1097/IAE.0b013e31827b6439; Falkenstein I, 2006, RETINA-J RET VIT DIS, V26, P928, DOI 10.1097/01.iae.0000250009.60908.35; Falkenstein IA, 2008, AM J OPHTHALMOL, V146, P579, DOI 10.1016/j.ajo.2007.12.021; Freeman WR, 2008, AM J OPHTHALMOL, V145, P453, DOI 10.1016/j.ajo.2007.10.013; GEIER SA, 1994, INVEST OPHTH VIS SCI, V35, P3011; Goldbaum Michael H, 2008, Trans Am Ophthalmol Soc, V106, P196; Gomez ML, 2014, CURR OPIN OPHTHALMOL, V25, P3, DOI 10.1097/ICU.0000000000000011; Gomez ML, 2009, OPHTHALMOLOGY, V116, P2407, DOI 10.1016/j.ophtha.2009.05.012; Gutstein W, 2010, OPTOMETRY, V81, P94, DOI 10.1016/j.optm.2009.09.017; Holland GN, 2010, AM J OPHTHALMOL, V149, P807, DOI 10.1016/j.ajo.2009.12.019; Kalyani PS, 2012, AM J OPHTHALMOL, V153, P734, DOI 10.1016/j.ajo.2011.09.019; Kozak I, 2005, AM J OPHTHALMOL, V139, P295, DOI 10.1016/j.ajo.2004.09.039; Kozak Igor, 2007, Trans Am Ophthalmol Soc, V105, P111; Kozak I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074712; Letendre S, 2008, ARCH NEUROL-CHICAGO, V65, P65, DOI 10.1001/archneurol.2007.31; Lim LA, 2010, EYE, V24, P673, DOI 10.1038/eye.2009.147; Manly JJ, 2011, J CLIN EXP NEUROPSYC, V33, P853, DOI 10.1080/13803395.2010.547662; Mueller AJ, 1997, AM J OPHTHALMOL, V124, P158, DOI 10.1016/S0002-9394(14)70780-9; MUTLUKAN E, 1992, EYE, V6, P39, DOI 10.1038/eye.1992.6; Nguyen NX, 2009, ACTA OPHTHALMOL, V87, P849, DOI 10.1111/j.1755-3768.2008.01423.x; Pesudovs K, 2004, BRIT J OPHTHALMOL, V88, P11, DOI 10.1136/bjo.88.1.11; QUICENO JI, 1992, AM J OPHTHALMOL, V113, P8, DOI 10.1016/S0002-9394(14)75745-9; Sample PA, 1999, ARCH OPHTHALMOL-CHIC, V117, P755; Shah KH, 2006, AM J OPHTHALMOL, V142, P284, DOI 10.1016/j.ajo.2006.03.046; Sommerhalder J, 1998, VISION RES, V38, P3441, DOI 10.1016/S0042-6989(98)00011-X; TENHULA WN, 1992, AM J OPHTHALMOL, V113, P14, DOI 10.1016/S0002-9394(14)75746-0; Yavuz GA, 2009, EYE, V23, P2082, DOI 10.1038/eye.2009.177	28	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e97023	10.1371/journal.pone.0097023	http://dx.doi.org/10.1371/journal.pone.0097023			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809827	Green Published, gold, Green Submitted			2022-12-27	WOS:000338213300107
J	Koohy, H; Down, TA; Spivakov, M; Hubbard, T				Koohy, Hashem; Down, Thomas A.; Spivakov, Mikhail; Hubbard, Tim			A Comparison of Peak Callers Used for DNase-Seq Data	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; CHIP-SEQ; OPEN CHROMATIN; MAP	Genome-wide profiling of open chromatin regions using DNase I and high-throughput sequencing (DNase-seq) is an increasingly popular approach for finding and studying regulatory elements. A variety of algorithms have been developed to identify regions of open chromatin from raw sequence-tag data, which has motivated us to assess and compare their performance. In this study, four published, publicly available peak calling algorithms used for DNase-seq data analysis (F-seq, Hotspot, MACS and ZINBA) are assessed at a range of signal thresholds on two published DNase-seq datasets for three cell types. The results were benchmarked against an independent dataset of regulatory regions derived from ENCODE in vivo transcription factor binding data for each particular cell type. The level of overlap between peak regions reported by each algorithm and this ENCODE-derived reference set was used to assess sensitivity and specificity of the algorithms. Our study suggests that F-seq has a slightly higher sensitivity than the next best algorithms. Hotspot and the ChIP-seq oriented method, MACS, both perform competitively when used with their default parameters. However the generic peak finder ZINBA appears to be less sensitive than the other three. We also assess accuracy of each algorithm over a range of signal thresholds. In particular, we show that the accuracy of F-Seq can be considerably improved by using a threshold setting that is different from the default value.	[Koohy, Hashem; Down, Thomas A.; Hubbard, Tim] Babraham Inst, Cambridge, England; [Koohy, Hashem; Spivakov, Mikhail] Wellcome Trust Sanger Inst, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Wellcome Trust Sanger Institute	Koohy, H (corresponding author), Babraham Inst, Babraham Res Campus, Cambridge, England.	hashem.koohy@babraham.ac.uk; th@sanger.ac.uk	Hubbard, Tim J.P./AAT-4571-2020; Hubbard, Tim J/C-2567-2008	Hubbard, Tim J.P./0000-0002-1767-9318; Hubbard, Tim J/0000-0002-1767-9318; Spivakov, Mikhail/0000-0002-0383-3943; Koohy, Hashem/0000-0002-3640-7043	Wellcome Trust [098051]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Wellcome Trust grant [098051]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek S, 2011, METHOD MOL BIOL, V833, P433; Boyle AP, 2008, BIOINFORMATICS, V24, P2537, DOI 10.1093/bioinformatics/btn480; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Down TA, 2011, BIOINFORMATICS, V27, P889, DOI 10.1093/bioinformatics/btr020; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Johnson S.G, 2011, NOTES FFT BASES DIFF, P1; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kim Hyunmin, 2011, Human Genomics, V5, P117; Kim TH, 2006, ANNU REV GENOM HUM G, V7, P81, DOI 10.1146/annurev.genom.7.080505.115634; Koohy H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069853; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Madrigal Pedro, 2012, Frontiers in Genetics, V3, P230, DOI 10.3389/fgene.2012.00230; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; Rashid NU, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r67; Rye MB, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1187; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Song L., 2010, COLD SPRING HARBOR P; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Szalkowski AM, 2011, BRIEF BIOINFORM, V12, P626, DOI 10.1093/bib/bbq068; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tong YG, 2009, METHODS MOL BIOL, V590, P235, DOI 10.1007/978-1-60327-378-7_15; Wang YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042414; Zeng WH, 2012, NAT IMMUNOL, V13, P802, DOI 10.1038/ni.2407; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	29	44	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96303	10.1371/journal.pone.0096303	http://dx.doi.org/10.1371/journal.pone.0096303			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810143	gold, Green Published, Green Submitted			2022-12-27	WOS:000338213300029
J	Bridges, JP; Schehr, A; Wang, YH; Huo, LY; Besnard, V; Ikegami, M; Whitsett, JA; Xu, Y				Bridges, James P.; Schehr, Angelica; Wang, Yanhua; Huo, Liya; Besnard, Valerie; Ikegami, Machiko; Whitsett, Jeffrey A.; Xu, Yan			Epithelial SCAP/INSIG/SREBP Signaling Regulates Multiple Biological Processes during Perinatal Lung Maturation	PLOS ONE			English	Article							CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; IDIOPATHIC PULMONARY-FIBROSIS; ACTIVATED RECEPTOR-GAMMA; ELEMENT-BINDING PROTEINS; FATTY-ACID-METABOLISM; GENE-EXPRESSION; ADIPOCYTE DIFFERENTIATION; GLUCOCORTICOID-RECEPTOR; C/EBP-ALPHA; LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE	Pulmonary surfactant is required for lung function at birth and throughout postnatal life. Defects in the surfactant system are associated with common pulmonary disorders including neonatal respiratory distress syndrome and acute respiratory distress syndrome in children and adults. Lipogenesis is essential for the synthesis of pulmonary surfactant by type II epithelial cells lining the alveoli. This study sought to identify the role of pulmonary epithelial SREBP, a transcriptional regulator of cellular lipid homeostasis, during a critical time period of perinatal lung maturation in the mouse. Genome wide mRNA expression profiling of lung tissue from transgenic mice with epithelial-specific deletions of Scap (Scap(Delta/Delta), resulting in inactivation of SREBP signaling) or Insig1 and Insig2 (Insig1/2(Delta/Delta), resulting in activation of SREBP signaling) was assessed. Differentially expressed genes responding to SREBP perturbations were identified and subjected to functional enrichment analysis, pathway mapping and literature mining to predict upstream regulators and transcriptional networks regulating surfactant lipid homeostasis. Through comprehensive data analysis and integration, time dependent effects of epithelial SCAP/INSIG/SREBP deletion and defined SCAP/INSIG/SREBP-associated genes, bioprocesses and downstream pathways were identified. SREBP signaling influences epithelial development, cell death and cell proliferation at E17.5, while primarily influencing surfactant physiology, lipid/sterol synthesis, and phospholipid transport after birth. SREBP signaling integrated with the Wnt/beta-catenin and glucocorticoid receptor signaling pathways during perinatal lung maturation. SREBP regulates perinatal lung lipogenesis and maturation through multiple mechanisms by interactions with distinct sets of regulatory partners.	[Bridges, James P.; Schehr, Angelica; Wang, Yanhua; Huo, Liya; Ikegami, Machiko; Whitsett, Jeffrey A.; Xu, Yan] Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Perinatal Inst, Cincinnati, OH 45229 USA; [Besnard, Valerie] INSERM, U700, Paris, France	Cincinnati Children's Hospital Medical Center; Institut National de la Sante et de la Recherche Medicale (Inserm)	Xu, Y (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Perinatal Inst, Cincinnati, OH 45229 USA.	Yan.Xu@cchmc.org		Bridges, James P./0000-0002-4815-117X; Besnard, Valerie/0000-0002-2614-629X; , Yan/0000-0003-2025-027X	NIH/NHLBI [R01 HL105433]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105433, U01HL110964] Funding Source: NIH RePORTER	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by R01 HL105433 NIH/NHLBI (to YX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aumiller V, 2013, AM J RESP CELL MOL, V49, P96, DOI 10.1165/rcmb.2012-0524OC; Besnard V, 2007, AM J PHYSIOL-LUNG C, V293, pL1395, DOI 10.1152/ajplung.00275.2007; Besnard V, 2009, J BIOL CHEM, V284, P4018, DOI 10.1074/jbc.M805388200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bostrom H, 1996, CELL, V85, P863, DOI 10.1016/S0092-8674(00)81270-2; Bridges JP, 2013, AM J RESP CELL MOL, V49, P348, DOI 10.1165/rcmb.2012-0439OC; Bridges JP, 2010, J CLIN INVEST, V120, P1736, DOI 10.1172/JCI38061; Chen T, 2011, FEBS LETT, V585, P657, DOI 10.1016/j.febslet.2011.01.027; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Cornett B, 2013, DEV BIOL, V379, P38, DOI 10.1016/j.ydbio.2013.03.010; Cushing L, 2011, AM J RESP CELL MOL, V45, P287, DOI 10.1165/rcmb.2010-0323OC; Davalos A, 2011, P NATL ACAD SCI USA, V108, P9232, DOI 10.1073/pnas.1102281108; Engelking LJ, 2005, J CLIN INVEST, V115, P2489, DOI 10.1172/JCI25614; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; GAVIN BJ, 1990, GENE DEV, V4, P2319, DOI 10.1101/gad.4.12b.2319; Granjon A, 2009, DIABETES, V58, P2555, DOI 10.2337/db09-0165; He AB, 2007, MOL ENDOCRINOL, V21, P2785, DOI 10.1210/me.2007-0167; Heijink IH, 2013, THORAX, V68, P709, DOI 10.1136/thoraxjnl-2012-201667; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hulsmans M, 2011, FASEB J, V25, P2515, DOI 10.1096/fj.11-181149; Kast HR, 2001, J LIPID RES, V42, P1266; Kim JB, 1998, P NATL ACAD SCI USA, V95, P4333, DOI 10.1073/pnas.95.8.4333; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Kneidinger N, 2011, AM J RESP CRIT CARE, V183, P723, DOI 10.1164/rccm.200910-1560OC; Kousteni S, 2012, BONE, V50, P437, DOI 10.1016/j.bone.2011.06.034; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kukreti H, 2013, J BIOL CHEM, V288, P6663, DOI 10.1074/jbc.M112.390369; Kuriyama H, 2005, CELL METAB, V1, P41, DOI 10.1016/j.cmet.2004.11.004; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Li ZQ, 2012, J BIOL CHEM, V287, P20122, DOI 10.1074/jbc.M111.334664; Lu NZ, 2007, MOL CELL BIOL, V27, P7143, DOI 10.1128/MCB.00253-07; Mallampalli RK, 2002, BIOCHEM J, V362, P81, DOI 10.1042/0264-6021:3620081; Marquart TJ, 2010, P NATL ACAD SCI USA, V107, P12228, DOI 10.1073/pnas.1005191107; MASON RJ, 1976, J LIPID RES, V17, P281; Mayanil CSK, 2001, J BIOL CHEM, V276, P49299, DOI 10.1074/jbc.M107933200; Meuten T, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-62; Michalik L, 2004, NAT REV CANCER, V4, P61, DOI 10.1038/nrc1254; Miller MF, 2012, P NATL ACAD SCI USA, V109, P15348, DOI 10.1073/pnas.1201583109; Mucenski ML, 2003, J BIOL CHEM, V278, P40231, DOI 10.1074/jbc.M305892200; Nakanishi N, 2009, BIOCHEM BIOPH RES CO, V385, P492, DOI 10.1016/j.bbrc.2009.05.058; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Ortega FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009022; Payne VA, 2010, BIOCHEM J, V425, P215, DOI 10.1042/BJ20091112; Pelaia G, 2003, LIFE SCI, V72, P1549, DOI 10.1016/S0024-3205(02)02446-3; Perl AKT, 2002, TRANSGENIC RES, V11, P21, DOI 10.1023/A:1013986627504; Plantier L, 2012, J BIOL CHEM, V287, P10099, DOI 10.1074/jbc.M111.303669; Ponugoti B, 2007, MOL ENDOCRINOL, V21, P2698, DOI 10.1210/me.2007-0196; Rajagopal J, 2008, DEVELOPMENT, V135, P1625, DOI 10.1242/dev.015495; Rawson RB, 2003, NAT REV MOL CELL BIO, V4, P631, DOI 10.1038/nrm1174; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Rebello CM, 1996, AM J RESP CRIT CARE, V154, P625, DOI 10.1164/ajrccm.154.3.8810596; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; Ryan AJ, 2000, J LIPID RES, V41, P1268; Schaaf MJM, 2002, J STEROID BIOCHEM, V83, P37, DOI 10.1016/S0960-0760(02)00263-7; Sekine K, 2007, EMBO J, V26, P3607, DOI 10.1038/sj.emboj.7601784; She HY, 2005, J BIOL CHEM, V280, P4959, DOI 10.1074/jbc.M410078200; Shu WG, 2005, DEV BIOL, V283, P226, DOI 10.1016/j.ydbio.2005.04.014; Shu WG, 2002, DEVELOPMENT, V129, P4831; Song CZ, 1999, P NATL ACAD SCI USA, V96, P11776, DOI 10.1073/pnas.96.21.11776; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Takada I, 2009, NAT REV RHEUMATOL, V5, P442, DOI 10.1038/nrrheum.2009.137; Tavor S, 2003, J BIOL CHEM, V278, P52651, DOI 10.1074/jbc.M307077200; Tian Y, 2007, MOL CELL BIOL, V27, P975, DOI 10.1128/MCB.01512-06; Tsai WC, 2012, J CLIN INVEST, V122, P2884, DOI 10.1172/JCI63455; Usui H, 2004, BIOCHEM BIOPH RES CO, V322, P887, DOI 10.1016/j.bbrc.2004.07.198; Waite KJ, 2001, J BIOL CHEM, V276, P7062, DOI 10.1074/jbc.M007894200; Wang HY, 2003, J BIOL CHEM, V278, P16622, DOI 10.1074/jbc.M212488200; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Weber LW, 2004, WORLD J GASTROENTERO, V10, P3081, DOI 10.3748/wjg.v10.i21.3081; Whitsett JA, 2002, NEW ENGL J MED, V347, P2141, DOI 10.1056/NEJMra022387; Whitsett JA, 2004, HUM MOL GENET, V13, pR207, DOI 10.1093/hmg/ddh252; Whitsett JA, 2006, PEDIATR CLIN N AM, V53, P873, DOI 10.1016/j.pcl.2006.08.009; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; Wu Y, 2013, BIOCHEM BIOPH RES CO, V438, P575, DOI 10.1016/j.bbrc.2013.08.016; Xu Y, 2006, J BIOL CHEM, V281, P11279, DOI 10.1074/jbc.M512072200; Xu Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-455; Xu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037046; Xu Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-451; Yamamoto T, 2004, J BIOL CHEM, V279, P12027, DOI 10.1074/jbc.M310333200; Zhang FJ, 2004, AM J RESP CELL MOL, V30, P174, DOI 10.1165/rcmb.2003-0235OC; Zhang MZ, 1999, P NATL ACAD SCI USA, V96, P15280, DOI 10.1073/pnas.96.26.15280; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200; Zhao Y, 2008, J BIOL CHEM, V283, P8258, DOI 10.1074/jbc.M710422200	84	12	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e91376	10.1371/journal.pone.0091376	http://dx.doi.org/10.1371/journal.pone.0091376			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806461	Green Published, Green Submitted, gold			2022-12-27	WOS:000335728900002
J	DeWitte, SN				DeWitte, Sharon N.			Mortality Risk and Survival in the Aftermath of the Medieval Black Death	PLOS ONE			English	Article							YERSINIA-PESTIS DNA; AGE; ENGLAND; POPULATION; DYNAMICS; HISTORY; FRAILTY; SAMPLE	The medieval Black Death (c. 1347-1351) was one of the most devastating epidemics in human history. It killed tens of millions of Europeans, and recent analyses have shown that the disease targeted elderly adults and individuals who had been previously exposed to physiological stressors. Following the epidemic, there were improvements in standards of living, particularly in dietary quality for all socioeconomic strata. This study investigates whether the combination of the selective mortality of the Black Death and post-epidemic improvements in standards of living had detectable effects on survival and mortality in London. Samples are drawn from several pre-and post-Black Death London cemeteries. The pre-Black Death sample comes from the Guildhall Yard (n = 75) and St. Nicholas Shambles (n = 246) cemeteries, which date to the 11(th) - 12(th) centuries, and from two phases within the St. Mary Spital cemetery, which date to between 1120-1300 (n = 143). The St. Mary Graces cemetery (n = 133) was in use from 1350-1538 and thus represents post-epidemic demographic conditions. By applying Kaplan-Meier analysis and the Gompertz hazard model to transition analysis age estimates, and controlling for changes in birth rates, this study examines differences in survivorship and mortality risk between the pre-and post-Black Death populations of London. The results indicate that there are significant differences in survival and mortality risk, but not birth rates, between the two time periods, which suggest improvements in health following the Black Death, despite repeated outbreaks of plague in the centuries after the Black Death.	Univ S Carolina, Dept Anthropol, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	DeWitte, SN (corresponding author), Univ S Carolina, Dept Anthropol, Columbia, SC 29208 USA.	dewittes@mailbox.sc.edu		DeWitte, Sharon/0000-0003-0754-8485	NSF [BCS-1261682]; Wenner-Gren Foundation [8247]; American Association of Physical Anthropologist; School for Advanced Research; Ethel-Jane Westfeldt Bunting Foundation	NSF(National Science Foundation (NSF)); Wenner-Gren Foundation; American Association of Physical Anthropologist; School for Advanced Research; Ethel-Jane Westfeldt Bunting Foundation	Data collection was supported by funding from NSF (www.nsf.gov; BCS-1261682), the Wenner-Gren Foundation (wwww.wennergren.org; grant #8247), and the American Association of Physical Anthropologists (www.physanth.org). Preliminary analyses were conducted during a summer fellowship at the School for Advanced Research, sponsored by the Ethel-Jane Westfeldt Bunting Foundation (www.sarweb.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre JB, 2005, EVOLUTION, V59, P1406, DOI 10.1111/j.0014-3820.2005.tb01791.x; Bailey M, 1996, ECON HIST REV, V49, P1; Bailey M, 1998, ECON HIST REV, V51, P223, DOI 10.1111/1468-0289.00089; Benedictow O.J., 2004, BLACK DEATH 1346 135; BOCQUETAPPEL JP, 1982, J HUM EVOL, V11, P321, DOI 10.1016/S0047-2484(82)80023-7; Boldsen JL, 2002, PALEODEMOGRAPHY AGE, P73, DOI [10.1017/CBO9780511542428.005, DOI 10.1017/CBO9780511542428.005]; Bos KI, 2011, NATURE, V478, P506, DOI 10.1038/nature10549; BRIDBURY AR, 1973, ECON HIST REV, V26, P577; Buikstra J.E., 1994, STANDARDS DATA COLLE; BUIKSTRA JE, 1986, AM ANTIQUITY, V51, P528, DOI 10.2307/281750; Casadevall A, 2001, J INFECT DIS, V184, P337, DOI 10.1086/322044; Cohn Samuel K., 2002, BLACK DEATH TRANSFOR; Cohn Samuel K Jr, 2008, Med Hist Suppl, P74; Connell B., 2012, BIOARCHAEOLOGICAL ST; DeWitte S, 2013, J INTERDISCIPL HIST, V44, P37, DOI 10.1162/JINH_a_00500; DeWitte SN, 2008, P NATL ACAD SCI USA, V105, P1436, DOI 10.1073/pnas.0705460105; DeWitte SN, 2012, J ARCHAEOL SCI, V39, P1412, DOI 10.1016/j.jas.2012.01.019; DeWitte SN, 2010, J ARCHAEOL SCI, V37, P3394, DOI 10.1016/j.jas.2010.08.006; Drancourt M, 1998, P NATL ACAD SCI USA, V95, P12637, DOI 10.1073/pnas.95.21.12637; Dyer C., 2005, AGE TRANSITION EC SO; Dyer C, 2002, MAKING LIVING MIDDLE, DOI DOI 10.1371/journal.pone.0214461; El-Sherpieny EA, 2013, INT J BASIC APPL SCI, V2; GAGE TB, 1989, YEARB PHYS ANTHROPOL, V32, P185; GAGE TB, 1988, AM J PHYS ANTHROPOL, V76, P429, DOI 10.1002/ajpa.1330760403; Grainger I., 1988, LONDON ARCHAEOLOGIST, V5, P429; Grainger I., 2011, MOLA MONOGRAPH SERIE, V44; Grainger I., 2008, MUSEUM LONDON ARCHAE, V43; GUSTAFSON G, 1974, ODONTOL REVY, V25, P297; Harvey B, 2001, ECON HIST REV, V54, P215, DOI 10.1111/1468-0289.00190; Hinde Andrew, 2003, ENGLANDS POPULATION; Holman D. J., 2005, MLE PROGRAMMING LANG; Horrox R, 2006, SOCIAL HISTORY OF ENGLAND, 1200-1500, P260; Kacki S, 2011, J ARCHAEOL SCI, V38, P581, DOI 10.1016/j.jas.2010.10.012; KOWALESKI M, 1988, J MEDIEVAL HIST, V14, P47, DOI 10.1016/0304-4181(88)90016-4; Milner GR, 2012, AM J PHYS ANTHROPOL, V148, P98, DOI 10.1002/ajpa.22047; MILNER GR, 1989, AM J PHYS ANTHROPOL, V80, P49, DOI 10.1002/ajpa.1330800107; Miner G.R., 2008, BIOL ANTHR HUMAN SKE, P561, DOI DOI 10.1002/9780470245842.CH18; MOORREES CF, 1969, AMER J ORTHODONTICS, V55, P600, DOI 10.1016/0002-9416(69)90037-2; Mueller LD, 1995, EXP GERONTOL, V30, P553, DOI 10.1016/0531-5565(95)00029-1; Munro JH, 2004, 24 U TENN, P335; Nightingale P, 2005, PAST PRESENT, P33, DOI 10.1093/pastj/gti009; O'Connor KA., 1995, THESIS U ALBANY ALBA; PAINE RR, 1989, AM J PHYS ANTHROPOL, V79, P51, DOI 10.1002/ajpa.1330790106; Paine RR, 2000, AM J PHYS ANTHROPOL, V112, P181, DOI 10.1002/(SICI)1096-8644(2000)112:2<181::AID-AJPA5>3.0.CO;2-9; Perry MA, 2007, J ANTHROPOL ARCHAEOL, V26, P486, DOI 10.1016/j.jaa.2007.02.002; Poos LR, 1991, RURAL SOC BLACK DEAT, P1350; Postan M, 1950, ECON HIST REV, V2, P221; Raoult D, 2000, P NATL ACAD SCI USA, V97, P12800, DOI 10.1073/pnas.220225197; Rappaport S., 1989, WORLDS WORLDS STRUCT; Rohrkasten J., 2001, NOTTINGHAM MEDIEVAL, VXLV, P172; RUSSELL JC, 1966, COMP STUD SOC HIST, V8, P464, DOI 10.1017/S0010417500004230; SATTENSPIEL L, 1983, AM ANTIQUITY, V48, P489, DOI 10.2307/280557; SCHEUER JL, 1980, ANN HUM BIOL, V7, P257, DOI 10.1080/03014468000004301; Scheuer L., 2000, DEV JUVENILE OSTEOLO; SCHOENINGER MJ, 1984, GEOCHIM COSMOCHIM AC, V48, P625, DOI 10.1016/0016-7037(84)90091-7; Schofield J., 1997, T LONDON MIDDLESEX A, V48, P77; Schuenemann VJ, 2011, P NATL ACAD SCI USA, V108, pE746, DOI 10.1073/pnas.1105107108; Scrimshaw NS, 2003, J NUTR, V133, p316S, DOI 10.1093/jn/133.1.316S; SHOUMAN R, 1995, J GERONTOL A-BIOL, V50, pB177, DOI 10.1093/gerona/50A.3.B177; SMITH BH, 1991, ADVANCES IN DENTAL ANTHROPOLOGY, P143; Stone D. J., 2006, FOOD MEDIEVAL ENGLAN, P11; Tran TNN, 2011, EMERG INFECT DIS, V17, P955, DOI 10.3201/eid1705.101777; Twigg G., 1984, BLACK DEATH BIOL REA; Usher B.M ., 2000, THESIS PENNSYLVANIA; VAUPEL JW, 1979, DEMOGRAPHY, V16, P439, DOI 10.2307/2061224; WEISS KM, 1975, AM ANTIQUITY, V40, P46; White W. J., 1988, SKELETAL REMAINS CEM; Wood J.W., 2002, PALEODEMOGRAPHY AGE, P129, DOI DOI 10.1017/CBO9780511542428.007; Wood JW, 2003, HUM BIOL, V75, P427, DOI 10.1353/hub.2003.0067	70	68	70	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96513	10.1371/journal.pone.0096513	http://dx.doi.org/10.1371/journal.pone.0096513			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AG9HB	24806459	Green Submitted, gold, Green Published			2022-12-27	WOS:000335728900066
J	Liu, HS; Marubashi, W				Liu, Hongshuo; Marubashi, Wataru			Species Origin of Genomic Factors in Nicotiana nudicaulis Watson Controlling Hybrid Lethality in Interspecific Hybrids between N-nudicaulis Watson and N-tabacum L	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; Q-CHROMOSOME; PLANT DNA; SOLANACEAE; SUAVEOLENS; INVITRO; VITRIFICATION; CULTURE; CROSSES; DIPLOIDIZATION	Hybrid lethality is expressed at 28 degrees C in the cross Nicotiana nudicaulis x N. tabacum. The S subgenome of N. tabacum has been identified as controlling this hybrid lethality. To clarify the responsible genomic factor(s) of N. nudicaulis, we crossed N. trigonophylla (paternal progenitor of N. nudicaulis) with N. tabacum, because hybrids between N. sylvestris (maternal progenitor of N. nudicaulis) and N. tabacum are viable when grown in a greenhouse. In the cross N. trigonophylla x N. tabacum, approximately 50% of hybrids were vitrified, 20% were viable, and 20% were nonviable at 28 degrees C. To reveal which subgenome of N. tabacum was responsible for these phenotypes, we crossed N. trigonophylla with two progenitors of N. tabacum, N. sylvestris (S) and N. tomentosiformis (TT). In the cross N. sylvestris x N. trigonophylla, we confirmed that over half of hybrids of N. sylvestris x N. trigonophylla were vitrified, and none of the hybrids of N. trigonophylla x N. tomentosiformis were. The results imply that the S subgenome, encoding a gene or genes inducing hybrid lethality in the cross between N. nudicaulis and N. tabacum, has one or more genomic factors that induce vitrification. Furthermore, in vitrified hybrids of N. trigonophylla x N. tabacum and N. sylvestris x N. trigonophylla, we found that nuclear fragmentation, which progresses during expression of hybrid lethality, was accompanied by vitrification. This observation suggests that vitrification has a relationship to hybrid lethality. Based on these results, we speculate that when N. nudicaulis was formed approximately 5 million years ago, several causative genomic factors determining phenotypes of hybrid seedlings were inherited from N. trigonophylla. Subsequently, genome downsizing and various recombination-based processes took place. Some of the causative genomic factors were lost and some became genomic factor(s) controlling hybrid lethality in extant N. nudicaulis.	[Liu, Hongshuo; Marubashi, Wataru] Meiji Univ, Grad Sch Agr, Tokyo, Kanagawa 101, Japan	Meiji University	Marubashi, W (corresponding author), Meiji Univ, Grad Sch Agr, Tokyo, Kanagawa 101, Japan.	marubasi@isc.meiji.ac.jp						Bindler G, 2011, THEOR APPL GENET, V123, P219, DOI 10.1007/s00122-011-1578-8; Bomblies K, 2007, PLOS BIOL, V5, P1962, DOI 10.1371/journal.pbio.0050236; Bomblies K, 2007, NAT REV GENET, V8, P382, DOI 10.1038/nrg2082; Chase MW, 2003, ANN BOT-LONDON, V92, P107, DOI 10.1093/aob/mcg087; Chung SC, 1988, JPN J BREED, V38, P319; Clarkson JJ, 2010, MOL PHYLOGENET EVOL, V55, P99, DOI 10.1016/j.ympev.2009.10.003; Clarkson JJ, 2004, MOL PHYLOGENET EVOL, V33, P75, DOI 10.1016/j.ympev.2004.05.002; Clarkson JJ, 2005, NEW PHYTOL, V168, P241, DOI 10.1111/j.1469-8137.2005.01480.x; Clausen RE, 1944, GENETICS, V29, P447; COHEN JJ, 1993, IMMUNOL TODAY, V14, P126, DOI 10.1016/0167-5699(93)90214-6; DEBERGH P, 1981, PHYSIOL PLANTARUM, V53, P181, DOI 10.1111/j.1399-3054.1981.tb04130.x; DEBERGH PC, 1983, PHYSIOL PLANTARUM, V59, P270, DOI 10.1111/j.1399-3054.1983.tb00770.x; DEVERNA JW, 1987, THEOR APPL GENET, V73, P665, DOI 10.1007/BF00260773; GRAY JC, 1974, NATURE, V252, P226, DOI 10.1038/252226a0; HAKKAART FA, 1983, NETH J PLANT PATHOL, V89, P47, DOI 10.1007/BF01974443; Iizuka T, 2012, EUPHYTICA, V186, P321, DOI 10.1007/s10681-011-0570-3; INOUE E, 1994, BREEDING SCI, V44, P333; Inoue E, 1996, THEOR APPL GENET, V93, P341, DOI 10.1007/BF00223174; Jeuken MJW, 2009, PLANT CELL, V21, P3368, DOI 10.1105/tpc.109.070334; KENTON A, 1993, MOL GEN GENET, V240, P159, DOI 10.1007/BF00277053; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Knapp S, 2004, TAXON, V53, P73, DOI 10.2307/4135490; Kobori S, 2004, BREEDING SCI, V54, P347, DOI 10.1270/jsbbs.54.347; Kruger J, 2002, SCIENCE, V296, P744, DOI 10.1126/science.1069288; Laskowska D, 2012, EUPHYTICA, V183, P75, DOI 10.1007/s10681-011-0500-4; Leitch IJ, 2008, ANN BOT-LONDON, V101, P805, DOI 10.1093/aob/mcm326; Leitch IJ, 2004, BIOL J LINN SOC, V82, P651, DOI 10.1111/j.1095-8312.2004.00349.x; Lim KY, 2000, CHROMOSOMA, V109, P245, DOI 10.1007/s004120000074; Liu HS, 2013, PLANT BIOTECHNOL-NAR, V30, P347, DOI 10.5511/plantbiotechnology.13.0414a; Liu HS, 2013, PLANT BIOTECHNOL-NAR, V30, P179, DOI 10.5511/plantbiotechnology.13.0312a; MARUBASHI W, 1985, JPN J BREED, V35, P429; Marubashi W, 2002, BREEDING SCI, V52, P137, DOI 10.1270/jsbbs.52.137; Marubashi W., 2002, PLANT BIOTEC, V19, P267, DOI [10.5511/plantbiotechnology.19.267, DOI 10.5511/PLANTBIOTECHNOLOGY.19.267]; Matsuo C, 2011, BREED RES S1, V13, P90; MICHAELSON MJ, 1991, AM J BOT, V78, P183, DOI 10.2307/2445241; Murad L, 2004, HEREDITY, V92, P352, DOI 10.1038/sj.hdy.6800431; Murad L, 2002, AM J BOT, V89, P921, DOI 10.3732/ajb.89.6.921; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Olmo HP, 1935, GENETICS, V20, P0286; Parisod C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050352; PASQUALETTO PL, 1986, J AM SOC HORTIC SCI, V111, P976; REED SM, 1978, J HERED, V69, P311, DOI 10.1093/oxfordjournals.jhered.a108956; Renny-Byfield S, 2013, PLANT J, V74, P829, DOI 10.1111/tpj.12168; SHEEN SJ, 1972, EVOLUTION, V26, P143, DOI 10.1111/j.1558-5646.1972.tb00181.x; STEBBINS GL, 1966, PROCESSES ORGANIC EV, P85; Tezuka T., 2006, SABRAO Journal of Breeding and Genetics, V38, P69; Tezuka T, 2006, THEOR APPL GENET, V112, P1172, DOI 10.1007/s00122-006-0219-0; Tezuka T, 2012, BOTANY, P191; Tezuka T, 2007, PLANTA, V226, P753, DOI 10.1007/s00425-007-0522-2; Tezuka T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037822; Tezuka T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036204; Tezuka T, 2010, ANN BOT-LONDON, V106, P267, DOI 10.1093/aob/mcq114; Wylie AH, 1984, J PATHOL, V142, P67; Yamada T, 1999, BREEDING SCI, V49, P203, DOI 10.1270/jsbbs.49.203; ZIMMERMAN TW, 1989, PLANT CELL REP, V8, P358, DOI 10.1007/BF00716673; ZIV M, 1991, In Vitro Cellular and Developmental Biology Plant, V27P, P64; ZIV M, 1983, PLANT CELL TISS ORG, V2, P55, DOI 10.1007/BF00033553	58	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e97004	10.1371/journal.pone.0097004	http://dx.doi.org/10.1371/journal.pone.0097004			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806486	Green Published, gold, Green Submitted			2022-12-27	WOS:000335728900125
J	Rickard, DJ; Sehon, CA; Kasparcova, V; Kallal, LA; Haile, PA; Zeng, X; Montoute, MN; Poore, DD; Li, H; Wu, ZN; Eidam, PM; Emery, JG; Marquis, RW; Gough, PJ; Bertin, J				Rickard, David J.; Sehon, Clark A.; Kasparcova, Viera; Kallal, Lorena A.; Haile, Pamela A.; Zeng, Xin; Montoute, Monica N.; Poore, Derek D.; Li, Hu; Wu, Zining; Eidam, Patrick M.; Emery, John G.; Marquis, Robert W.; Gough, Peter J.; Bertin, John			Identification of Selective Small Molecule Inhibitors of the Nucleotide-Binding Oligomerization Domain 1 (NOD1) Signaling Pathway	PLOS ONE			English	Article							INNATE IMMUNE RECOGNITION; KAPPA-B ACTIVATION; BACTERIAL PEPTIDOGLYCAN; DIAMINOPIMELIC ACID; ADAPTIVE IMMUNITY; ASSOCIATION	NOD1 is an intracellular pattern recognition receptor that recognizes diaminopimelic acid (DAP), a peptidoglycan component in gram negative bacteria. Upon ligand binding, NOD1 assembles with receptor-interacting protein (RIP)-2 kinase and initiates a signaling cascade leading to the production of pro-inflammatory cytokines. Increased NOD1 signaling has been associated with a variety of inflammatory disorders suggesting that small-molecule inhibitors of this signaling complex may have therapeutic utility. We utilized a cell-based screening approach with extensive selectivity profiling to search for small molecule inhibitors of the NOD1 signaling pathway. Via this process we identified three distinct chemical series, xanthines (SB711), quinazolininones (GSK223) and aminobenzothiazoles (GSK966) that selectively inhibited iE-DAP-stimulated IL-8 release via the NOD1 signaling pathway. All three of the newly identified compound series failed to block IL-8 secretion in cells following stimulation with ligands for TNF receptor, TLR2 or NOD2 and, in addition, none of the compound series directly inhibited RIP2 kinase activity. Our initial exploration of the structure-activity relationship and physicochemical properties of the three series directed our focus to the quinazolininone biarylsulfonamides (GSK223). Further investigation allowed for the identification of significantly more potent analogs with the largest boost in activity achieved by fluoro to chloro replacement on the central aryl ring. These results indicate that the NOD1 signaling pathway, similarly to activation of NOD2, is amenable to modulation by small molecules that do not target RIP2 kinase. These compounds should prove useful tools to investigate the importance of NOD1 activation in various inflammatory processes and have potential clinical utility in diseases driven by hyperactive NOD1 signaling.	[Rickard, David J.; Sehon, Clark A.; Kasparcova, Viera; Haile, Pamela A.; Eidam, Patrick M.; Emery, John G.; Marquis, Robert W.; Gough, Peter J.; Bertin, John] GlaxoSmithKline, Immunoinflammat Therapeut Area, Pattern Recognit Receptor Discovery Performance U, Collegeville, PA USA; [Kallal, Lorena A.; Poore, Derek D.; Li, Hu] GlaxoSmithKline, Biol Reagents & Assay Dev, Platform Technol Sci, Collegeville, PA USA; [Zeng, Xin; Montoute, Monica N.; Wu, Zining] GlaxoSmithKline, Platform Technol Sci, Screening & Compound Profiling, Collegeville, PA USA	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Rickard, DJ (corresponding author), GlaxoSmithKline, Platform Technol Sci, Target & Pathway Validat, Res Triangle Pk, NC 27709 USA.	David.J.Rickard@gsk.com			GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	Funding support for this research was provided entirely by GlaxoSmithKline. Only the authors, who are full-time employees of GSK, were involved in the study design, data analysis, decision to publish and manuscript preparation. No individuals employed or contracted by the funder, other than the named authors, were involved in these tasks. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askari N, 2012, J BIOTECHNOL, V157, P75, DOI 10.1016/j.jbiotec.2011.10.007; Bryant C, 2009, TRENDS CELL BIOL, V19, P455, DOI 10.1016/j.tcb.2009.06.002; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Correa RG, 2011, CHEM BIOL, V18, P825, DOI 10.1016/j.chembiol.2011.06.009; Dharancy S, 2010, GASTROENTEROLOGY, V138, P1546, DOI 10.1053/j.gastro.2009.12.008; Fritz JH, 2008, TRENDS IMMUNOL, V29, P41, DOI 10.1016/j.it.2007.10.002; Fritz JH, 2007, IMMUNITY, V26, P445, DOI 10.1016/j.immuni.2007.03.009; Gatheral T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042386; Girardin SE, 2005, J BIOL CHEM, V280, P38648, DOI 10.1074/jbc.M509537200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Hysi P, 2005, HUM MOL GENET, V14, P935, DOI 10.1093/hmg/ddi087; Inohara N, 2000, J BIOL CHEM, V275, P27823; Khan PM, 2011, ACS MED CHEM LETT, V2, P780, DOI 10.1021/ml200158b; Laroui H, 2011, J BIOL CHEM, V286, P31003, DOI 10.1074/jbc.M111.257501; Magalhaes JG, 2005, EMBO REP, V6, P1201, DOI 10.1038/sj.embor.7400552; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; McGovern DPB, 2005, HUM MOL GENET, V14, P1245, DOI 10.1093/hmg/ddi135; Mo JY, 2012, J BIOL CHEM, V287, P23057, DOI 10.1074/jbc.M112.344283; Nishio H, 2011, ARTERIOSCL THROM VAS, V31, P1093, DOI 10.1161/ATVBAHA.110.216325; Opitz B, 2005, CIRC RES, V96, P319, DOI 10.1161/01.RES.0000155721.83594.2c; Rickard DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069619; Schertzer JD, 2011, DIABETES, V60, P2206, DOI 10.2337/db11-0004; Shigeoka AA, 2010, J IMMUNOL, V184, P2297, DOI 10.4049/jimmunol.0903065; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Watanabe T, 2010, J CLIN INVEST, V120, P1645, DOI 10.1172/JCI39481; Weidinger S, 2005, J ALLERGY CLIN IMMUN, V116, P177, DOI 10.1016/j.jaci.2005.02.034	26	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96737	10.1371/journal.pone.0096737	http://dx.doi.org/10.1371/journal.pone.0096737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806487	Green Published, Green Submitted, gold			2022-12-27	WOS:000335728900088
J	Rodriguez, E; Barbeitos, MS; Brugler, MR; Crowley, LM; Grajales, A; Gusmao, L; Haussermann, V; Reft, A; Daly, M				Rodriguez, Estefania; Barbeitos, Marcos S.; Brugler, Mercer R.; Crowley, Louise M.; Grajales, Alejandro; Gusmao, Luciana; Haeussermann, Verena; Reft, Abigail; Daly, Marymegan			Hidden among Sea Anemones: The First Comprehensive Phylogenetic Reconstruction of the Order Actiniaria (Cnidaria, Anthozoa, Hexacorallia) Reveals a Novel Group of Hexacorals	PLOS ONE			English	Article							PHYLUM CNIDARIA; EDWARDSIIDAE CNIDARIA; CLASSIFICATION; FORMS; EVOLUTION; RDNA; NEMATOCYSTS; SELECTION; NOV	Sea anemones (order Actiniaria) are among the most diverse and successful members of the anthozoan subclass Hexacorallia, occupying benthic marine habitats across all depths and latitudes. Actiniaria comprises approximately 1,200 species of solitary and skeleton-less polyps and lacks any anatomical synapomorphy. Although monophyly is anticipated based on higher-level molecular phylogenies of Cnidaria, to date, monophyly has not been explicitly tested and at least some hypotheses on the diversification of Hexacorallia have suggested that actiniarians are para- or poly-phyletic. Published phylogenies have demonstrated the inadequacy of existing morphological-based classifications within Actiniaria. Superfamilial groups and most families and genera that have been rigorously studied are not monophyletic, indicating conflict with the current hierarchical classification. We test the monophyly of Actiniaria using two nuclear and three mitochondrial genes with multiple analytical methods. These analyses are the first to include representatives of all three currently-recognized suborders within Actiniaria. We do not recover Actiniaria as a monophyletic clade: the deep-sea anemone Boloceroides daphneae, previously included within the infraorder Boloceroidaria, is resolved outside of Actiniaria in several of the analyses. We erect a new genus and family for B. daphneae, and rank this taxon incerti ordinis. Based on our comprehensive phylogeny, we propose a new formal higher-level classification for Actiniaria composed of only two suborders, Anenthemonae and Enthemonae. Suborder Anenthemonae includes actiniarians with a unique arrangement of mesenteries (members of Edwardsiidae and former suborder Endocoelantheae). Suborder Enthemonae includes actiniarians with the typical arrangement of mesenteries for actiniarians (members of former suborders Protantheae, Ptychodacteae, and Nynantheae and subgroups therein). We also erect subgroups within these two newly-erected suborders. Although some relationships among these newly-defined groups are still ambiguous, morphological and molecular results are consistent enough to proceed with a new higher-level classification and to discuss the putative functional and evolutionary significance of several morphological attributes within Actiniaria.	[Rodriguez, Estefania; Brugler, Mercer R.; Crowley, Louise M.; Grajales, Alejandro] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA; [Barbeitos, Marcos S.; Brugler, Mercer R.] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Barbeitos, Marcos S.] Univ Fed Parana, Dept Zool, BR-80060000 Curitiba, Parana, Brazil; [Brugler, Mercer R.; Grajales, Alejandro] Amer Museum Nat Hist, Richard Gilder Grad Sch, New York, NY 10024 USA; [Gusmao, Luciana] Univ Sao Paulo, Dept Zool, Sao Paulo, Brazil; [Haeussermann, Verena] Pontificia Univ Catolica Valparaiso, Escuela Ciencias Mar, Valparaiso, Chile; [Reft, Abigail] Heidelberg Univ, Dept Mol Evolut & Genom, Heidelberg, Germany; [Daly, Marymegan] Ohio State Univ, Dept Ecol Evolut & Organismal Biol, Columbus, OH 43210 USA	American Museum of Natural History (AMNH); American Museum of Natural History (AMNH); Universidade Federal do Parana; American Museum of Natural History (AMNH); Universidade de Sao Paulo; Pontificia Universidad Catolica de Valparaiso; Ruprecht Karls University Heidelberg; University System of Ohio; Ohio State University	Rodriguez, E (corresponding author), Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA.	erodriguez@amnh.org	Brugler, Mercer R./AAV-3202-2021; Daly, Marymegan/F-9178-2011; Barbeitos, Marcos/L-3516-2016; Rodríguez, Estefanía/AAK-4634-2021	Brugler, Mercer R./0000-0003-3676-1226; Rodríguez, Estefanía/0000-0002-5590-6606; Barbeitos, Marcos/0000-0001-6488-8254	U.S. National Science Foundation [NSF EF-0531763]; Lerner Gray Fund for Marine Research (AMNH); Chilean Fondecyt project [1131039]; Gerstner Family Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); Lerner Gray Fund for Marine Research (AMNH); Chilean Fondecyt project(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Gerstner Family Foundation	Partial support was provided by U.S. National Science Foundation (NSF EF-0531763) to M Daly, the Lerner Gray Fund for Marine Research (AMNH) to E Rodriguez, the Chilean Fondecyt project 1131039 to V Haussermann and the Gerstner Family Foundation to MR Brugler. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do no necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Andres A, 1880, MITTEILUNGEN ZOOLOGI, V2, P305; Andres A, 1883, ATTINIE BIBLIO INTRO; Appellof A, 1893, BERGENS MUSEUM AARBO, V4, P3; Ardelean A, 2003, THESIS U KANSAS; Balinski A, 2012, NATURWISSENSCHAFTEN, V99, P645, DOI 10.1007/s00114-012-0947-8; Berntson EA, 1999, MOL PHYLOGENET EVOL, V13, P417, DOI 10.1006/mpev.1999.0649; Bourne G. C., 1916, Journal of the Linnean Society London Zoology, V32; BRIDGE D, 1995, MOL BIOL EVOL, V12, P679; Brugler MR, 2007, MOL PHYLOGENET EVOL, V42, P776, DOI 10.1016/j.ympev.2006.08.016; Brugler MR, 2013, ZOOL J LINN SOC-LOND, V169, P312, DOI 10.1111/zoj.12060; Cappola VA, 2000, AM ZOOL, V40, P961; Carlgren, 1918, KUNGLIGA FYSIOGRAFIS, V29, P1; Carlgren, 1925, ARK ZOOL, V17, P1; Carlgren O., 1925, Zoologischer Anzeiger Leipzig, V65, P87; Carlgren O., 1924, Videnskabelige Meddelelser fra Dansk Naturhistorisk Forening i Kjobenhavn, V77, P179; Carlgren O., 1900, MITT NAT MUS HAMB, V17, P1; Carlgren O, 1893, KUNGLIGA SVENSKA VET, V25, P1; Carlgren O, 1921, DAN INGOLF EXPED, V5, P1; Carlgren O, 1938, KUNGLIGA SVENSKA VET, V17, P1; Carlgren O., 1924, ARK ZOOL, V17, P1; Carlgren O, 1932, ZUSAMMENSTELLUNG ARK, P255; CARLGREN OSKAR, 1940, ZOOLOGICA [NEW YORK], V25, P211; CARLGREN OSKAR, 1934, ARKIV ZOOL, V26 A, P1; CARLGREN OSKAR, 1949, K SVENSKA VETENSKAPSAKAD HANDL, V1, P1; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Crowther AL, 2011, ZOOKEYS, P33, DOI 10.3897/zookeys.89.825; Daly M, 2008, MOL PHYLOGENET EVOL, V48, P292, DOI 10.1016/j.ympev.2008.02.022; Daly M, 2006, MAR BIOL, V148, P1241, DOI 10.1007/s00227-005-0170-7; Daly M, 2003, ZOOL J LINN SOC-LOND, V139, P419, DOI 10.1046/j.1096-3642.2003.00084.x; Daly M, 2002, INVERTEBR BIOL, V121, P212; Daly M, 2002, EVOLUTION, V56, P502; Daly M, 2010, INTEGR COMP BIOL, P1; Daly M, 2008, ZOOTAXA, P1; Danielssen DC, 1890, NORSKE NORDHAVS EXPE, P1; Duerden J.E., 1895, ANN MAGAZINE NATURAL, V15, P213, DOI DOI 10.1080/00222939508677871; ENGLAND K W, 1984, Annals of the South African Museum, V94, P305; England K.W., 1987, B BR MUS NAT HIS Z, V53, P205; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Fautin D.G., 2013, HEXACORALLIANS WORLD; Fautin D. G., 1988, WASMANN J BIOL, V45, P26; Fautin DG, 2007, ZOOTAXA, P183; Fowler G.H., 1894, Q J MICROSC SCI, V35, P461; France SC, 1996, MOL MAR BIOL BIOTECH, V5, P15; Goloboff P, 2008, CLADISTICS, V24, P91; Gontcharov AA, 2004, MOL BIOL EVOL, V21, P612, DOI 10.1093/molbev.msh052; Gosse P.H., 1858, ANN MAG NAT HIST, V2, P192, DOI [10.1080/00222935808697006, DOI 10.1080/00222935808697006]; Gosse P. H., 1860, HIST BRIT SEA ANEMON; Grebelnyj S.D., 1982, P101; Gusmao LC, 2010, MOL PHYLOGENET EVOL, V56, P868, DOI 10.1016/j.ympev.2010.05.001; Haddon A. C., 1898, Transactions Royal Dublin Society, Vvi, P393; Haime J., 1857, HIST NATURELLE CORAL; Hand C., 1955, Wasmann Journal of Biology, V13, P189; HAND CADET, 1966, SYMP ZOOL SOC LONDON, V16, P135; HART CE, 1977, T AM MICROSC SOC, V96, P28, DOI 10.2307/3225960; Hertwig R., 1882, ACTINIEN CHALLENGER; Hertwig R., 1879, ACTINIEN ANATOMISCH; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Kayal E, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-5; Kweitniewski C. R., 1898, Semon's Zoologische Forschungsreisen in Australien, Vv, P385; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lauretta D, 2014, ORG DIVERS EVOL, V14, P31, DOI 10.1007/s13127-013-0149-z; Linnaeus C., 1761, FAUNA SVECICA; MADDISON WP, 2004, MESQUITE MODULAR SYS; McMurrich J. Playfair, 1913, Proceedings of the United States National Museum Smithsonian Institution Washington, V44; Miller M.A., 2010, P GAT COMP ENV WORKS; Milne-Edwards H, 1851, MONOGRAPHIE POLYPIER; Rafinesque C. S., 1815, ANAL NATURE TABLEAU, DOI 10.5962/bhl.title.106607; Reft A., 2012, THESIS OHIO STATE U; Reft AJ, 2012, J MORPHOL, V273, P121, DOI 10.1002/jmor.11014; Reitzel AM, 2009, J PARASITOL, V95, P100, DOI 10.1645/GE-1623.1; Riemann-Zurneck K, 2000, POLAR BIOL, V23, P604, DOI 10.1007/s003000000127; Riemann-Zurneck K., 1991, Senckenbergiana Maritima, V21, P191; Riemann-Zurneck K, 1998, MAR ECOL-P S Z N I, V19, P247, DOI 10.1111/j.1439-0485.1998.tb00466.x; RiemannZurneck K, 1997, J MAR BIOL ASSOC UK, V77, P361, DOI 10.1017/S0025315400071721; RiemannZurneck K, 1997, J MAR BIOL ASSOC UK, V77, P1011, DOI 10.1017/S0025315400038595; Rodriguez E, 2013, MAR BIOL, V160, P67, DOI 10.1007/s00227-012-2063-x; Rodriguez E., 2012, CLADISTICS, V1, P1; Rodriguez E., 2007, ZOOTAXA, V1668, P131; Rodriguez E, 2008, INVERTEBR SYST, V22, P439, DOI 10.1071/IS07053; Rodriguez E, 2013, J MAR BIOL ASSOC UK, V93, P2089, DOI 10.1017/S0025315413000775; Rodriguez E, 2012, HELGOLAND MAR RES, V66, P211, DOI 10.1007/s10152-011-0263-2; Rodriguez E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010958; Rodriguez E, 2009, POLAR BIOL, V32, P703, DOI 10.1007/s00300-008-0575-0; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanamyan N.P., 2012, Zoologiya Bespozvonochnykh, V9, P127; Schmidt H., 1974, Proceedings int Coral Reef Symp, V2, P533; SCHMIDT H, 1969, HELGOLAND WISS MEER, V19, P284, DOI 10.1007/BF01625610; Shearer TL, 2002, MOL ECOL, V11, P2475, DOI 10.1046/j.1365-294X.2002.01652.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stephenson T.A, 1928, BRIT SEA ANEMONES; Stephenson TA, 1922, Q J MICROSC SCI, V66, P247; Stephenson TA, 1921, Q J MICROSC SCI, V65, P493; Stephenson TA, 1920, Q J MICROSC SCI, V64, P425; Stephenson TA, 1935, BRIT SEA ANEMONES, VII; Stolarski J, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-316; Varon A, 2010, CLADISTICS, V26, P72, DOI 10.1111/j.1096-0031.2009.00282.x; Verrill A. E., 1899, American Journal of Science, Vvii, P41; Verrill A. E., 1869, T CONN ACAD ARTS SCI, V1, P377; Verrill AE, 1864, MEMOIRS BOSTON SOC N, V1, P1, DOI DOI 10.5962/BHL.TITLE.78052; Verrill AE, 1868, COMMUNICATIONS ESSEX, V5, P315; Won JH, 2001, CORAL REEFS, V20, P39	105	92	103	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96998	10.1371/journal.pone.0096998	http://dx.doi.org/10.1371/journal.pone.0096998			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806477	Green Submitted, gold, Green Published			2022-12-27	WOS:000335728900124
J	Villaverde, AF; Ross, J; Moran, F; Banga, JR				Villaverde, Alejandro F.; Ross, John; Moran, Federico; Banga, Julio R.			MIDER: Network Inference with Mutual Information Distance and Entropy Reduction	PLOS ONE			English	Article							GENE REGULATORY NETWORKS; TIME-SERIES; REACTION MECHANISMS; REACTION PATHWAYS; PROTEIN; RECONSTRUCTION; DEPENDENCIES; CONSTRUCTION; RELEVANCE; SYSTEMS	The prediction of links among variables from a given dataset is a task referred to as network inference or reverse engineering. It is an open problem in bioinformatics and systems biology, as well as in other areas of science. Information theory, which uses concepts such as mutual information, provides a rigorous framework for addressing it. While a number of information-theoretic methods are already available, most of them focus on a particular type of problem, introducing assumptions that limit their generality. Furthermore, many of these methods lack a publicly available implementation. Here we present MIDER, a method for inferring network structures with information theoretic concepts. It consists of two steps: first, it provides a representation of the network in which the distance among nodes indicates their statistical closeness. Second, it refines the prediction of the existing links to distinguish between direct and indirect interactions and to assign directionality. The method accepts as input time-series data related to some quantitative features of the network nodes (such as e. g. concentrations, if the nodes are chemical species). It takes into account time delays between variables, and allows choosing among several definitions and normalizations of mutual information. It is general purpose: it may be applied to any type of network, cellular or otherwise. A Matlab implementation including source code and data is freely available (http://www.iim.csic.es/similar to gingproc/mider.html). The performance of MIDER has been evaluated on seven different benchmark problems that cover the main types of cellular networks, including metabolic, gene regulatory, and signaling. Comparisons with state of the art information-theoretic methods have demonstrated the competitive performance of MIDER, as well as its versatility. Its use does not demand any a priori knowledge from the user; the default settings and the adaptive nature of the method provide good results for a wide range of problems without requiring tuning.	[Villaverde, Alejandro F.; Banga, Julio R.] IIM CSIC, Bioproc Engn Grp, Vigo, Spain; [Ross, John] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Moran, Federico] Univ Complutense, Dept Biochem & Mol Biol, E-28040 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); Stanford University; Complutense University of Madrid	Villaverde, AF (corresponding author), IIM CSIC, Bioproc Engn Grp, Vigo, Spain.	afvillaverde@iim.csic.es	Banga, Julio R./ABD-8629-2020; Moran, Federico/L-1297-2014; Villaverde, Alejandro F./B-8936-2015; Banga, Julio R./A-8388-2008	Banga, Julio R./0000-0002-4245-0320; Moran, Federico/0000-0003-3992-8829; Villaverde, Alejandro F./0000-0001-7401-7380; Banga, Julio R./0000-0002-4245-0320	EU project "BioPreDyn'' (European Commission) [FP7-KBBE-2011-5/289434]; Spanish Ministerio de Economia y Competitividad (MINECO) [DPI2011-28112-C04-03, BFU2009-12895-C02-02, BFU2012-39816-C02-02]; CSIC intramural project "BioREDES'' [PIE201170E018]; National Science Foundation [CHE 0847073]; Spanish Ministry of Economy and Competitiveness (MINECO) [BFU2012-39816-C02-02]; Spanish MICINN [CSD2007-00002]	EU project "BioPreDyn'' (European Commission); Spanish Ministerio de Economia y Competitividad (MINECO)(Spanish Government); CSIC intramural project "BioREDES''; National Science Foundation(National Science Foundation (NSF)); Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the EU project "BioPreDyn'' (European Commission grant FP7-KBBE-2011-5/289434); the Spanish Ministerio de Economia y Competitividad (MINECO) projects DPI2011-28112-C04-03, BFU2009-12895-C02-02, and BFU2012-39816-C02-02; the CSIC intramural project "BioREDES'' (PIE201170E018); and the National Science Foundation grant CHE 0847073. Work in UCM is supported by grant BFU2012-39816-C02-02 from Spanish Ministry of Economy and Competitiveness (MINECO) and Consolider/Ingenio2010 CSD2007-00002 from Spanish MICINN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alipanahi B, 2013, NAT BIOTECHNOL, V31, P714, DOI 10.1038/nbt.2657; Altay G, 2010, BIOINFORMATICS, V26, P1738, DOI 10.1093/bioinformatics/btq259; Amblard PO, 2013, ENTROPY-SWITZ, V15, P113, DOI 10.3390/e15010113; Arkin A, 1997, SCIENCE, V277, P1275, DOI 10.1126/science.277.5330.1275; ARKIN A, 1995, J PHYS CHEM-US, V99, P970, DOI 10.1021/j100003a020; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Barzel B, 2013, NAT BIOTECHNOL, V31, P720, DOI 10.1038/nbt.2601; Bell DA, 2000, MACH LEARN, V41, P175, DOI 10.1023/A:1007612503587; Borland L, 1998, J MATH PHYS, V39, P6490, DOI 10.1063/1.532660; Butte A J, 2000, Pac Symp Biocomput, P418; Cantone I, 2009, CELL, V137, P172, DOI 10.1016/j.cell.2009.01.055; Cellucci CJ, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.066208; Cover T. M., 1991, ELEMENTS INFORM THEO; Crampin EJ, 2004, PROG BIOPHYS MOL BIO, V86, P77, DOI 10.1016/j.pbiomolbio.2004.04.002; Davis J., 2006, P 23 INT C MACH LEAR, P233, DOI [10.1145/1143844.1143874, DOI 10.1145/1143844.1143874]; De Smet R, 2010, NAT REV MICROBIOL, V8, P717, DOI 10.1038/nrmicro2419; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; FARBER R, 1992, J MOL BIOL, V226, P471, DOI 10.1016/0022-2836(92)90961-I; Feizi S, 2013, NAT BIOTECHNOL, V31, P726, DOI 10.1038/nbt.2635; FRASER AM, 1986, PHYS REV A, V33, P1134, DOI 10.1103/PhysRevA.33.1134; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Hurley D, 2012, NUCLEIC ACIDS RES, V40, P2377, DOI 10.1093/nar/gkr902; Jang IS, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2013.0011; KORBER BTM, 1993, P NATL ACAD SCI USA, V90, P7176, DOI 10.1073/pnas.90.15.7176; Lecca P, 2013, DRUG DISCOV TODAY, V18, P256, DOI 10.1016/j.drudis.2012.11.001; Lecca P, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-51; Liang S, 1998, Pac Symp Biocomput, P18; Linfoot EH, 1957, INFORM CONTR, V1, P85, DOI DOI 10.1016/S0019-9958(57)90116-X; Lopes FM, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-61; Lopez-Kleine L, 2013, BRIEF FUNCT GENOMICS; Luo WJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-467; Maathuis MH, 2010, NAT METHODS, V7, P247, DOI 10.1038/nmeth0410-247; Maetschke SR, 2013, BRIEF BIOINFORM; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Margolin AA, 2006, NAT PROTOC, V1, P663, DOI 10.1038/nprot.2006.106; Markowetz F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S5; Meyer PE, 2007, EURASIP J BIOINFORM, DOI 10.1155/2007/79879; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Michaels G S, 1998, Pac Symp Biocomput, P42; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Prill RJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002212; Ross J, 2008, J PHYS CHEM A, V112, P2134, DOI 10.1021/jp711313e; Samoilov M, 2001, CHAOS, V11, P108, DOI 10.1063/1.1336499; Samoilov M, 1997, THESIS STANFORD U; Schaffter T, 2011, BIOINFORMATICS, V27, P2263, DOI 10.1093/bioinformatics/btr373; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Schulz MH, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-104; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Snijder B, 2013, NAT METHODS, V10, P1089, DOI [10.1038/NMETH.2655, 10.1038/nmeth.2655]; Steuer R, 2002, BIOINFORMATICS, V18, pS231, DOI 10.1093/bioinformatics/18.suppl_2.S231; Studholme C, 1999, PATTERN RECOGN, V32, P71, DOI 10.1016/S0031-3203(98)00091-0; Tsallis C, 2005, P NATL ACAD SCI USA, V102, P15377, DOI 10.1073/pnas.0503807102; TSALLIS C, 1988, J STAT PHYS, V52, P479, DOI 10.1007/BF01016429; Tsallis C, 1998, PHYS REV E, V58, P1442, DOI 10.1103/PhysRevE.58.1442; Villaverde Alejandro F, 2013, Cells, V2, P306, DOI 10.3390/cells2020306; Villaverde AF, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0505; Wang LM, 2013, BIOINFORMATICS, V29, P338, DOI 10.1093/bioinformatics/bts634; Zoppoli P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-154	62	76	76	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96732	10.1371/journal.pone.0096732	http://dx.doi.org/10.1371/journal.pone.0096732			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806471	Green Published, Green Submitted, gold			2022-12-27	WOS:000335728900087
J	Wei, Y; Wang, HT; Zhai, Y; Russell, P; Du, LL				Wei, Yi; Wang, Hai-Tao; Zhai, Yonggong; Russell, Paul; Du, Li-Lin			Mdb1, a Fission Yeast Homolog of Human MDC1, Modulates DNA Damage Response and Mitotic Spindle Function	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; HISTONE H2A; CHROMATIN MODIFICATIONS; GENOME INTEGRITY; CHECKPOINT; REPAIR; CRB2; PHOSPHORYLATION; RECRUITMENT; PROTEINS	During eukaryotic DNA damage response (DDR), one of the earliest events is the phosphorylation of the C-terminal SQ motif of histone H2AX (H2A in yeasts). In human cells, phosphorylated H2AX (gamma H2AX) is recognized by MDC1, which serves as a binding platform for the accumulation of a myriad of DDR factors on chromatin regions surrounding DNA lesions. Despite its important role in DDR, no homolog of MDC1 outside of metazoans has been described. Here, we report the characterization of Mdb1, a protein from the fission yeast Schizosaccharomyces pombe, which shares significant sequence homology with human MDC1 in their C-terminal tandem BRCT (tBRCT) domains. We show that in vitro, recombinant Mdb1 protein binds a phosphorylated H2A (gamma H2A) peptide, and the phospho-specific binding requires two conserved phosphobinding residues in the tBRCT domain of Mdb1. In vivo, Mdb1 forms nuclear foci at DNA double strand breaks (DSBs) induced by the HO endonuclease and ionizing radiation (IR). IR-induced Mdb1 focus formation depends on cH2A and the phospho-binding residues of Mdb1. Deleting the mdb1 gene does not overtly affect DNA damage sensitivity in a wild type background, but alters the DNA damage sensitivity of cells lacking another gamma H2A binder Crb2. Overexpression of Mdb1 causes severe DNA damage sensitivity in a manner that requires the interaction between Mdb1 and gamma H2A. During mitosis, Mdb1 localizes to spindles and concentrates at spindle midzones at late mitosis. The spindle midzone localization of Mdb1 requires its phospho-binding residues, but is independent of gamma H2A. Loss of Mdb1 or mutating its phospho-binding residues makes cells more resistant to the microtubule depolymerizing drug thiabendazole. We propose that Mdb1 performs dual roles in DDR and mitotic spindle regulation.	[Wei, Yi; Zhai, Yonggong] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Wei, Yi; Wang, Hai-Tao; Du, Li-Lin] Natl Inst Biol Sci, Beijing, Peoples R China; [Russell, Paul] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA	Beijing Normal University; National Institute of Biological Sciences, Beijing; Scripps Research Institute	Russell, P (corresponding author), Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA.	prussell@scripps.edu; dulilin@nibs.ac.cn		Du, Li-Lin/0000-0002-1028-7397	National Institutes of Health [GM059447, CA077325, CA117638]; Chinese Ministry of Science and Technology; Beijing Municipal Government; NATIONAL CANCER INSTITUTE [R01CA077325, R01CA117638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059447] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Beijing Municipal Government; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants GM059447, CA077325, and CA117638 awarded to Paul Russell, and grants from the Chinese Ministry of Science and Technology and the Beijing Municipal Government to Li-Lin Du. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Altmeyer M, 2013, CURR OPIN GENET DEV, V23, P156, DOI 10.1016/j.gde.2012.11.001; Bicho CC, 2010, MOL CELL PROTEOMICS, V9, P1567, DOI 10.1074/mcp.M110.000208; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Bratman SV, 2007, DEV CELL, V13, P812, DOI 10.1016/j.devcel.2007.10.015; Coster G, 2007, J BIOL CHEM, V282, P32053, DOI 10.1074/jbc.M705890200; Coster G, 2012, J BIOL CHEM, V287, P36488, DOI 10.1074/jbc.M112.402487; Coster G, 2010, NUCLEUS-PHILA, V1, P166, DOI 10.4161/nucl.1.2.11176; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Dronamraju R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000473; Du LL, 2006, GENE DEV, V20, P1583, DOI 10.1101/gad.1422606; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; Garcia MA, 2002, CURR BIOL, V12, P610, DOI 10.1016/S0960-9822(02)00761-3; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Griffiths K, 2008, BIOCHEM BIOPH RES CO, V368, P670, DOI 10.1016/j.bbrc.2008.01.156; Janson ME, 2007, CELL, V128, P357, DOI 10.1016/j.cell.2006.12.030; Jungmichel S, 2010, CHROMOSOMA, V119, P337, DOI 10.1007/s00412-010-0266-9; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Khmelinskii A, 2007, J CELL BIOL, V177, P981, DOI 10.1083/jcb.200702145; Kilkenny ML, 2008, GENE DEV, V22, P2034, DOI 10.1101/gad.472808; Koch A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001588; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; Lee S, 2013, CAN THEATRE REV, V155, P33, DOI 10.3138/CTR.155.008; Li J, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1358; Loiodice I, 2005, MOL BIOL CELL, V16, P1756, DOI 10.1091/mbc.E04-10-0899; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Matsuyama A, 2004, YEAST, V21, P1289, DOI 10.1002/yea.1181; Nakamura TM, 2004, MOL CELL BIOL, V24, P6215, DOI 10.1128/MCB.24.14.6215-6230.2004; Panier S, 2013, NAT REV MOL CELL BIO, V14, P661, DOI 10.1038/nrm3659; Papamichos-Chronakis M, 2013, NAT REV GENET, V14, P62, DOI 10.1038/nrg3345; Qu M, 2013, MOL CELL, V51, P723, DOI 10.1016/j.molcel.2013.08.030; Redon C, 2003, EMBO REP, V4, P678, DOI 10.1038/sj.embor.embor871; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rozenzhak S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001032; Sanchez-Perez I, 2005, EMBO J, V24, P2931, DOI 10.1038/sj.emboj.7600761; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Smeenk G, 2013, ANNU REV BIOCHEM, V82, P55, DOI 10.1146/annurev-biochem-061809-174504; Sofueva S, 2010, MOL CELL BIOL, V30, P4732, DOI 10.1128/MCB.00413-10; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Tsabar M, 2013, CURR OPIN GENET DEV, V23, P166, DOI 10.1016/j.gde.2012.11.015; West RR, 2001, MOL BIOL CELL, V12, P3919, DOI 10.1091/mbc.12.12.3919; Williams JS, 2010, EMBO J, V29, P1136, DOI 10.1038/emboj.2009.413; Yamashita A, 2005, MOL BIOL CELL, V16, P1378, DOI 10.1091/mbc.e04-10-0859; Yu Y, 2013, DNA REPAIR, V12, P433, DOI 10.1016/j.dnarep.2013.04.001; Yuan JS, 2010, FEBS LETT, V584, P3717, DOI 10.1016/j.febslet.2010.05.021	46	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e97028	10.1371/journal.pone.0097028	http://dx.doi.org/10.1371/journal.pone.0097028			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806815	Green Published, Green Submitted, gold			2022-12-27	WOS:000335728900128
J	Ahn, SB; Mohamedali, A; Chan, C; Fletcher, J; Kwun, SY; Clarke, C; Dent, OF; Chapuis, PH; Nice, E; Baker, MS				Ahn, Seong Beom; Mohamedali, Abidali; Chan, Charles; Fletcher, Julie; Kwun, Sun Young; Clarke, Candice; Dent, Owen F.; Chapuis, Pierre H.; Nice, Edouard; Baker, Mark S.			Correlations between Integrin alpha nu beta 6 Expression and Clinico-Pathological Features in Stage B and Stage C Rectal Cancer	PLOS ONE			English	Article							ALPHA-V-BETA-6 INTEGRIN; IN-VIVO; MATRIX-METALLOPROTEINASE; PROGNOSTIC INDICATOR; COLORECTAL-CARCINOMA; OVEREXPRESSION; SURVIVAL; TERMINOLOGY; PROGRESSION; RECURRENCE	Integrin alpha nu beta 6 is highly expressed in a range of human cancers and frequently correlates with patient survival. This study examines correlations between alpha nu beta 6 expression and patient clinico-pathological features in Stage B and Stage C rectal cancer, including overall survival. Expression of alpha nu beta 6 was measured in 362 Stage B or C rectal cancer tissue samples at the tumour central region, invasive tumour front and adjacent non-neoplastic mucosa using immunohistochemistry. Distribution of alpha nu beta 6 was found to be significantly higher at the invasive front compared to central regions of the tumour (p<0.001) or adjacent non-neoplastic mucosa (p<0.001) suggesting alpha nu beta 6 plays a role in tumour cell invasion. However, integrin alpha nu beta 6 expression was not associated with clinico-pathological features or overall survival indicating it is not an independent prognostic marker differentiating Stage B or C rectal cancer. Previous alpha nu beta 6 studies have suggested the expression of alpha nu beta 6 is involved in the earlier stages (i.e. Stages A/B) of tumour progression rather than the later stages (i.e. Stages C/D). However, our study has revealed that in rectal cancer alpha nu beta 6 expression does not increase between Stages B and C, but may occur earlier, namely before or during Stage B cancer.	[Ahn, Seong Beom; Mohamedali, Abidali; Baker, Mark S.] Macquarie Univ, Australian Sch Adv Med, N Ryde, NSW, Australia; [Ahn, Seong Beom; Mohamedali, Abidali; Baker, Mark S.] Macquarie Univ, Dept Chem & Biomol Sci, N Ryde, NSW, Australia; [Chan, Charles; Fletcher, Julie; Kwun, Sun Young; Clarke, Candice] Univ Sydney, Concord Hosp, Dept Anat Pathol, Sydney, NSW 2006, Australia; [Dent, Owen F.; Chapuis, Pierre H.] Univ Sydney, Concord Hosp, Dept Colorectal Surg, Sydney, NSW 2006, Australia; [Nice, Edouard] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia	Macquarie University; Macquarie University; Concord Repatriation General Hospital; University of Sydney; Concord Repatriation General Hospital; University of Sydney; Monash University	Baker, MS (corresponding author), Macquarie Univ, Australian Sch Adv Med, N Ryde, NSW, Australia.	mark.baker@mq.edu.au	Mohamedali, Abidali/AGZ-8179-2022	Mohamedali, Abidali/0000-0001-5627-4105; Baker, Mark/0000-0001-5858-4035; Ahn, Seong Beom/0000-0001-5907-3544	Biofocus Research Centre; Macquarie University; NHMRC [1010303]; Cancer Council NSW	Biofocus Research Centre; Macquarie University; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council NSW(Cancer Council New South Wales)	This work was supported by the Biofocus Research Centre, Macquarie University and grants from NHMRC (1010303) and Cancer Council NSW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2002, ONCOGENE, V21, P1370, DOI 10.1038/sj.onc.1205286; Ahmed N, 2002, J HISTOCHEM CYTOCHEM, V50, P1371, DOI 10.1177/002215540205001010; Bandyopadhyay A, 2009, CURR DRUG TARGETS, V10, P645, DOI 10.2174/138945009788680374; Bates RC, 2005, J CLIN INVEST, V115, P339, DOI 10.1172/JCI200523183; Bokey EL, 1999, BRIT J SURG, V86, P1164, DOI 10.1046/j.1365-2168.1999.01216.x; BREUSS JM, 1995, J CELL SCI, V108, P2241; Darakhshan A, 2008, ANN SURG, V247, P650, DOI 10.1097/SLA.0b013e318163d264; DAVIS NC, 1983, AUST NZ J SURG, V53, P211, DOI 10.1111/j.1445-2197.1983.tb02430.x; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; FIELDING LP, 1991, J GASTROEN HEPATOL, V6, P325, DOI 10.1111/j.1440-1746.1991.tb00867.x; Gu X, 2002, BRIT J CANCER, V87, P348, DOI 10.1038/sj.bjc.6600480; Hazelbag S, 2007, J PATHOL, V212, P316, DOI 10.1002/path.2168; Hecht JL, 2008, APPL IMMUNOHISTO M M, V16, P543, DOI 10.1097/PAI.0b013e31816bc5ee; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jones J, 1997, J ORAL PATHOL MED, V26, P63, DOI 10.1111/j.1600-0714.1997.tb00023.x; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Keshava A, 2007, COLORECTAL DIS, V9, P609, DOI 10.1111/j.1463-1318.2006.01136.x; Kho PSS, 2012, INT J COLORECTAL DIS, V27, P1409, DOI 10.1007/s00384-012-1469-8; Liu S, 2013, PHYTOCHEM LETT, V6, P5, DOI 10.1016/j.phytol.2012.10.003; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Mekkawy AH, 2009, FUTURE ONCOL, V5, P1487, DOI 10.2217/FON.09.108; Morgan MR, 2004, J BIOL CHEM, V279, P26533, DOI 10.1074/jbc.M401736200; NEWLAND RC, 1981, CANCER, V47, P1424, DOI 10.1002/1097-0142(19810315)47:6<1424::AID-CNCR2820470630>3.0.CO;2-O; NEWLAND RC, 1987, CANCER, V60, P852, DOI 10.1002/1097-0142(19870815)60:4<852::AID-CNCR2820600422>3.0.CO;2-5; Patsenker E, 2010, J HEPATOL, V52, P362, DOI 10.1016/j.jhep.2009.12.006; Pepper MS, 2001, ARTERIOSCL THROM VAS, V21, P1104, DOI 10.1161/hq0701.093685; Saha A, 2010, J PATHOL, V222, P52, DOI 10.1002/path.2745; Sipos B, 2004, HISTOPATHOLOGY, V45, P226, DOI 10.1111/j.1365-2559.2004.01919.x; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Trujillo KA, 2011, INT J CANCER, V129, P1310, DOI 10.1002/ijc.25788; Van Aarsen LAK, 2008, CANCER RES, V68, P561, DOI 10.1158/0008-5472.CAN-07-2307; Weinreb PH, 2004, J BIOL CHEM, V279, P17875, DOI 10.1074/jbc.M312103200; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Zhang ZY, 2008, CLIN ONCOL-UK, V20, P61, DOI 10.1016/j.clon.2007.09.008; Zhuang ZN, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0580-1	36	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97248	10.1371/journal.pone.0097248	http://dx.doi.org/10.1371/journal.pone.0097248			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24821188	Green Submitted, Green Published, gold			2022-12-27	WOS:000336653300098
J	Jeong, S; Than, V; Lim, I; Kim, W				Jeong, Sunyoung; Van Thai Than; Lim, Inseok; Kim, Wonyong			Whole-Genome Analysis of a Rare Human Korean G3P[9] Rotavirus Strain Suggests a Complex Evolutionary Origin Potentially Involving Reassortment Events between Feline and Bovine Rotaviruses	PLOS ONE			English	Article							ACUTE GASTROENTERITIS; PHYLOGENETIC ANALYSIS; VACCINATION PROGRAMS; NUCLEOTIDE-SEQUENCE; GLOBAL SPREAD; G3 ROTAVIRUS; CHILDREN; GENE; CLASSIFICATION; DIVERSITY	A rare human rotavirus, G3P[9] strain RVA/Human-tc/KOR/CAU12-2-51/2013/G3P[9], was isolated from the stool of a 9-year-old female hospitalized with acute watery diarrhea in August 2012 in South Korea using a cell culture system, and its genome was analyzed. The complete genomic constellation of the CAU12-2-51 strain revealed a novel genotype constellation for human rotavirus, G3-P[9]-I2-R2-C2-M2-A3-N2-T3-E3-H3. Phylogenetic analysis revealed that the CAU12-2-51 strain originated from feline-and bovine-like reassortment strains. The genes encoding VP4, VP7, NSP1, NSP3, NSP4, and NSP5 were related to human/feline-like and feline rotavirus strains, whereas the remaining five genes encoding VP1, VP2, VP3, VP6, and NSP2 were related to the human/bovine-like and bovine rotavirus strains. This novel strain was identified for the first time, providing evidence of feline/bovine-to-human transmission of rotavirus. The data presented herein provide information regarding rotavirus diversity and evolution.	[Jeong, Sunyoung; Van Thai Than; Kim, Wonyong] Chung Ang Univ, Coll Med, Dept Microbiol, Seoul 156756, South Korea; [Lim, Inseok] Chung Ang Univ, Coll Med, Dept Pediat, Seoul 156756, South Korea	Chung Ang University; Chung Ang University Hospital; Chung Ang University; Chung Ang University Hospital	Kim, W (corresponding author), Chung Ang Univ, Coll Med, Dept Microbiol, Seoul 156756, South Korea.	kimwy@cau.ac.kr	Than, Van Thai/AAX-2106-2021; Than, Van-Thai/GPX-9664-2022		Basic Science Research Program through the National Research Foundation of Korea (NRF) [2013R1A1A2A10012148]; Brain Korea 21 PLUS Program - Ministry of Education	Basic Science Research Program through the National Research Foundation of Korea (NRF); Brain Korea 21 PLUS Program - Ministry of Education	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) (2013R1A1A2A10012148) and the Brain Korea 21 PLUS Program funded by the Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banyai K, 2009, J MED VIROL, V81, P362, DOI 10.1002/jmv.21375; Banyai K, 2012, VACCINE, V30, pA122, DOI 10.1016/j.vaccine.2011.09.111; BIRCH CJ, 1985, J GEN VIROL, V66, P2731, DOI 10.1099/0022-1317-66-12-2731; COHEN J, 1984, VIROLOGY, V138, P178, DOI 10.1016/0042-6822(84)90159-4; De Grazia S, 2010, EMERG INFECT DIS, V16, P859, DOI 10.3201/eid1605.091826; Donato CM, 2012, VACCINE, V30, pA152, DOI 10.1016/j.vaccine.2011.07.119; Felsenstein J., 1993, PHYLIP PHYLOGENETIC; Gascuel O, 2006, MOL BIOL EVOL, V23, P1997, DOI 10.1093/molbev/msl072; Gentsch JR, 2005, J INFECT DIS, V192, pS146, DOI 10.1086/431499; Ghosh S, 2012, J GEN VIROL, V93, P1700, DOI 10.1099/vir.0.043026-0; Grant L, 2011, J MED VIROL, V83, P1288, DOI 10.1002/jmv.22076; Heatona PM, 2007, CLIN INFECT DIS, V45, P1618, DOI 10.1086/522997; Horie Y, 1997, J GEN VIROL, V78, P2341, DOI 10.1099/0022-1317-78-9-2341; Hoshino Y, 2000, J HEALTH POPUL NUTR, V18, P5; Hu LY, 2012, CURR OPIN VIROL, V2, P380, DOI 10.1016/j.coviro.2012.06.003; Huh JW, 2009, ARCH VIROL, V154, P167, DOI 10.1007/s00705-008-0275-7; JUKES T H, 1969, P21; Kapikian AZ, 2007, FIELDS VIROLOGY, P1787; Khamrin P, 2007, J MED VIROL, V79, P843, DOI 10.1002/jmv.20840; Maestri RP, 2012, J MED VIROL, V84, P1993, DOI 10.1002/jmv.23364; MARSHALL JA, 1987, AUST VET J, V64, P100, DOI 10.1111/j.1751-0813.1987.tb09638.x; Martella V, 2011, J GEN VIROL, V92, P1214, DOI 10.1099/vir.0.027425-0; Matthijnssens J, 2008, J GEN VIROL, V89, P2630, DOI 10.1099/vir.0.2008/003780-0; Matthijnssens J, 2008, ARCH VIROL, V153, P1621, DOI 10.1007/s00705-008-0155-1; Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07; Matthijnssens J, 2012, ARCH VIROL, V157, P1177, DOI 10.1007/s00705-012-1273-3; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; Matthijnssens J, 2010, MOL BIOL EVOL, V27, P2431, DOI 10.1093/molbev/msq137; Matthijnssens J, 2009, J VIROL, V83, P2917, DOI 10.1128/JVI.02246-08; Mitui MT, 2011, J CLIN VIROL, V50, P325, DOI 10.1016/j.jcv.2011.01.008; Mochizuki M, 1997, J CLIN MICROBIOL, V35, P1272, DOI 10.1128/JCM.35.5.1272-1275.1997; NAKAGOMI O, 1989, MOL CELL PROBE, V3, P251, DOI 10.1016/0890-8508(89)90006-6; Ndze VN, 2013, J MED VIROL, V85, P1485, DOI 10.1002/jmv.23603; Ngo TC, 2009, VACCINE, V27, pF75, DOI 10.1016/j.vaccine.2009.08.074; Rahman M, 2007, J VIROL, V81, P2382, DOI 10.1128/JVI.01622-06; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Seah Oh,, 2013, Journal of Bacteriology and Virology, V43, P307, DOI 10.4167/jbv.2013.43.4.307; Seo JK, 2000, PEDIATR INT, V42, P406, DOI 10.1046/j.1442-200x.2000.01250.x; TANIGUCHI K, 1989, J VIROL, V63, P4101, DOI 10.1128/JVI.63.9.4101-4106.1989; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Than Van Thai, 2013, Korean J Pediatr, V56, P465, DOI 10.3345/kjp.2013.56.11.465; Theamboonlers A, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-569; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thongprachum A, 2013, INFECT GENET EVOL, V13, P168, DOI 10.1016/j.meegid.2012.09.010; Trojnar E, 2013, J GEN VIROL, V94, P136, DOI 10.1099/vir.0.047381-0; Tsugawa T, 2008, VIROLOGY, V380, P344, DOI 10.1016/j.virol.2008.07.041; Than VT, 2013, ARCH VIROL, V158, P2385, DOI 10.1007/s00705-013-1720-9; Wang YH, 2013, INFECT GENET EVOL, V16, P103, DOI 10.1016/j.meegid.2013.01.016; Wang YH, 2009, J MED VIROL, V81, P382, DOI 10.1002/jmv.21387; Ward RL, 2009, CLIN INFECT DIS, V48, P222, DOI 10.1086/595702; Yamamoto D, 2011, VIRUS GENES, V43, P215, DOI 10.1007/s11262-011-0624-6	52	14	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97127	10.1371/journal.pone.0097127	http://dx.doi.org/10.1371/journal.pone.0097127			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24818762	Green Published, gold			2022-12-27	WOS:000336653300080
J	Pliatsikas, C; Johnstone, T; Marinis, T				Pliatsikas, Christos; Johnstone, Tom; Marinis, Theodoros			fMRI Evidence for the Involvement of the Procedural Memory System in Morphological Processing of a Second Language	PLOS ONE			English	Article							PAST TENSE; MOTION CORRECTION; COMPLEX WORDS; BRAIN IMAGES; LANGUAGE; ROBUST; CEREBELLUM; DECOMPOSITION; COMPREHENSION; OPTIMIZATION	Behavioural evidence suggests that English regular past tense forms are automatically decomposed into their stem and affix (played = play+ed) based on an implicit linguistic rule, which does not apply to the idiosyncratically formed irregular forms (kept). Additionally, regular, but not irregular inflections, are thought to be processed through the procedural memory system (left inferior frontal gyrus, basal ganglia, cerebellum). It has been suggested that this distinction does not to apply to second language (L2) learners of English; however, this has not been tested at the brain level. This fMRI study used a masked-priming task with regular and irregular prime-target pairs (played-play/kept-keep) to investigate morphological processing in native and highly proficient late L2 English speakers. No between-groups differences were revealed. Compared to irregular pairs, regular pairs activated the pars opercularis, bilateral caudate nucleus and the right cerebellum, which are part of the procedural memory network and have been connected with the processing of morphologically complex forms. Our study is the first to provide evidence for native-like involvement of the procedural memory system in processing of regular past tense by late L2 learners of English.	[Pliatsikas, Christos; Johnstone, Tom] Univ Reading, Ctr Integrat Neurosci & Neurodynam, Reading, Berks, England; [Pliatsikas, Christos; Marinis, Theodoros] Univ Reading, Sch Psychol & Clin Language Sci, Dept Clin Language Sci, Reading, Berks, England; [Johnstone, Tom] Univ Reading, Sch Psychol & Clin Language Sci, Dept Psychol, Reading, Berks, England	University of Reading; University of Reading; University of Reading	Pliatsikas, C (corresponding author), Univ Reading, Ctr Integrat Neurosci & Neurodynam, Reading, Berks, England.	c.pliatsikas@kent.ac.uk	Pliatsikas, Christos/B-8671-2008; Marinis, Theodoros/K-6446-2019; Johnstone, Tom/C-5909-2011	Pliatsikas, Christos/0000-0001-7093-1773; Marinis, Theodoros/0000-0002-4120-3141; Johnstone, Tom/0000-0001-8635-8158	Economic and Social Research Council (ESRC), UK [PTA-030-2006-00359]; Onassis Fellowship	Economic and Social Research Council (ESRC), UK(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Onassis Fellowship	This research was funded by the Economic and Social Research Council (ESRC), UK (PTA-030-2006-00359). During the write up of this manuscript, Theo Marinis was supported by an Onassis Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillieux H, 2008, CLIN NEUROL NEUROSUR, V110, P763, DOI 10.1016/j.clineuro.2008.05.013; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Bozic M, 2007, J COGNITIVE NEUROSCI, V19, P1464, DOI 10.1162/jocn.2007.19.9.1464; Bozic M, 2010, LANG LINGUIST COMPAS, V4, P1063, DOI 10.1111/j.1749-818x.2010.00254.x; De Smet HJ, 2013, BRAIN LANG, V127, P334, DOI 10.1016/j.bandl.2012.11.001; Devlin JT, 2004, P NATL ACAD SCI USA, V101, P14984, DOI 10.1073/pnas.0403766101; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Gold BT, 2007, J COGNITIVE NEUROSCI, V19, P1983, DOI 10.1162/jocn.2007.19.12.1983; Hahne A, 2006, J COGNITIVE NEUROSCI, V18, P121, DOI 10.1162/089892906775250067; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2003, MAGNET RESON MED, V49, P193, DOI 10.1002/mrm.10354; Jenkinson M, 2004, INT C HUM BRAIN MAPP; Johnstone T, 2006, HUM BRAIN MAPP, V27, P779, DOI 10.1002/hbm.20219; Lehtonen M, 2009, J NEUROLINGUIST, V22, P495, DOI 10.1016/j.jneuroling.2009.05.001; Longworth CE, 2005, J COGNITIVE NEUROSCI, V17, P1087, DOI 10.1162/0898929054475109; Marangolo P, 2006, CORTEX, V42, P1093, DOI 10.1016/S0010-9452(08)70221-1; Marien P, 2000, J NEUROLINGUIST, V13, P145, DOI 10.1016/S0911-6044(00)00009-9; Marslen-Wilson WD, 2007, PHILOS T R SOC B, V362, P823, DOI 10.1098/rstb.2007.2091; MarslenWilson WD, 1997, NATURE, V387, P592, DOI 10.1038/42456; Osterhout L, 1997, BRAIN LANG, V59, P494, DOI 10.1006/brln.1997.1793; Penke M, 1997, COGNITIVE BRAIN RES, V6, P37, DOI 10.1016/S0926-6410(97)00012-8; Pinker S, 2002, TRENDS COGN SCI, V6, P456, DOI 10.1016/S1364-6613(02)01990-3; Pliatsikas C, 2013, LANG STUDY WORK PAP, V5, P3; Pliatsikas C, 2014, CEREBELLUM, V13, P55, DOI 10.1007/s12311-013-0515-6; Pliatsikas C, 2013, APPL PSYCHOLINGUIST, V34, P943, DOI 10.1017/S0142716412000082; Pliatsikas C, 2013, BILING-LANG COGN, V16, P167, DOI 10.1017/S136672891200017X; Schneider W., 2002, E PRIME VERSION 20 C; Schneider W., 2002, E PRIME USERS GUIDE; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stoodley CJ, 2012, CEREBELLUM, V11, P352, DOI 10.1007/s12311-011-0260-7; Stoodley CJ, 2010, CORTEX, V46, P831, DOI 10.1016/j.cortex.2009.11.008; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Tyler LK, 2005, BRAIN LANG, V95, P172, DOI 10.1016/j.bandl.2005.07.093; Tyler LK, 2005, NEUROPSYCHOLOGIA, V43, P1963, DOI 10.1016/j.neuropsychologia.2005.03.008; UCLES, 2001, QUICK PLAC TEST 250; Ullman MT, 2004, COGNITION, V92, P231, DOI 10.1016/j.cognition.2003.10.008; Vannest J, 2005, COGN AFFECT BEHAV NE, V5, P67, DOI 10.3758/CABN.5.1.67; Woolrich M, 2008, NEUROIMAGE, V41, P286, DOI 10.1016/j.neuroimage.2008.02.042; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Worsley K.J., 2001, FUNCTIONAL MRI AN IN, P251, DOI [10.1093/acprof:oso/ 9780192630711.003.0014, DOI 10.1093/ACPROF:OSO/9780192630711.003.0014]	44	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97298	10.1371/journal.pone.0097298	http://dx.doi.org/10.1371/journal.pone.0097298			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819196	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000336653300104
J	Svennerholm, K; Bergh, N; Larsson, P; Jern, S; Johansson, G; Biber, B; Haney, M				Svennerholm, Kristina; Bergh, Niklas; Larsson, Pia; Jern, Sverker; Johansson, Goran; Biber, Bjorn; Haney, Michael			Histone Deacetylase Inhibitor Treatment Increases Coronary t-PA Release in a Porcine Ischemia Model	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; HUMAN ENDOTHELIAL-CELLS; MYOCARDIAL-ISCHEMIA; IMPAIRED CAPACITY; VALPROIC ACID; FIBRINOLYSIS; HYPERTENSION; DISEASE; POLYMORPHISM; STIMULATION	Background: The expression of the tissue plasminogen activator gene can be affected by histone deacetylation inhibition and thus appears to be under epigenetic control. Objectives: The study aimed to test if in vivo pharmacological intervention by valproic acid treatment would lead to increase in tissue plasminogen activator release capacity. Methods: In an anaesthetized pig model, a controlled transient coronary occlusion was used to stimulate coronary tissue plasminogen activator release in a valproic acid treated (one week) and a non-treated group. Coronary venous blood samples from the ischemic region were collected, great cardiac vein thermodilution flow measurements were performed, and trans-coronary tissue plasminogen activator fluxes were calculated. Plasminogen activator inhibitor-1 was also measured. Results: Adequate sampling from the affected area after the 10 minute ischemic period was confirmed by lactate measurements. Fluxes for tissue plasminogen activator at minutes 1, 3, 5, 7 and 10 were measured and then used to present cumulative net tissue plasminogen activator release for the whole measurement period for both groups. Area under the curve was higher for the valproic acid treated group at 10 minutes; 932 +/- 173 nanograms (n = 12) compared to the non-treated group, 451 +/- 78 nanograms (n = 10, p = 0.023). There was no difference in levels of plasminogen activator inhibitor-1 between groups. Conclusions: These findings support a proof of concept for histone deacetylation inhibition positive effect on tissue plasminogen activator expression in an in vivo setting. Further studies are needed to find an optimal way to implement histone deacetylation inhibition to achieve desired clinical changes in tissue plasminogen activator expression.	[Svennerholm, Kristina; Biber, Bjorn] Gothenburg Univ, Sahlgrenska Acad, Inst Clin Sci, Gothenburg, Sweden; [Bergh, Niklas; Larsson, Pia; Jern, Sverker] Gothenburg Univ, Sahlgrenska Acad, Inst Med, Wallenberg Lab Cardiovasc Res, Gothenburg, Sweden; [Johansson, Goran; Haney, Michael] Umea Univ, Inst Surg & Perioperat Sci, Umea, Sweden	University of Gothenburg; University of Gothenburg; Umea University	Svennerholm, K (corresponding author), Gothenburg Univ, Sahlgrenska Acad, Inst Clin Sci, Gothenburg, Sweden.	kristina.svennerholm@vgregion.se	Haney, Michael/N-5707-2015	Haney, Michael/0000-0002-4049-8910; Larsson, Pia/0000-0001-9115-4213; Bergh, Niklas/0000-0002-7440-2366	Swedish Research Council [521-2012-2392]; Swedish Heart-Lung Foundation [HLF-20120369, HLR-20110321, HLF-20100617]; Umea University; University Hospital of Umea (ALF-LUA); Gothenburg University; Sahlgrenska University Hospital (ALF-LUA), Gothenburg, Sweden	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Umea University; University Hospital of Umea (ALF-LUA); Gothenburg University; Sahlgrenska University Hospital (ALF-LUA), Gothenburg, Sweden	This work was supported by grants from the Swedish Research Council: 521-2012-2392 (www.vr.se), Swedish Heart-Lung Foundation (www.hjartlungfonden.se) [HLF-20120369, HLR-20110321, and HLF-20100617], and support from Umea University and the University Hospital of Umea (ALF-LUA) as well as Gothenburg University, and the Sahlgrenska University Hospital (ALF-LUA), Gothenburg, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTS J, 1995, BIOCHEM J, V310, P171, DOI 10.1042/bj3100171; Aspelin T, 2005, J THROMB HAEMOST, V3, P1947, DOI 10.1111/j.1538-7836.2005.01514.x; Aspelin T, 2012, BLOOD COAGUL FIBRIN, V23, P714, DOI 10.1097/MBC.0b013e328357d388; BROMMER EJP, 1984, THROMB RES, V34, P109, DOI 10.1016/0049-3848(84)90067-7; Collen D, 2009, ARTERIOSCL THROM VAS, V29, P1151, DOI 10.1161/ATVBAHA.108.179655; Dunoyer-Geindre S, 2011, CARDIOVASC RES, V90, P457, DOI 10.1093/cvr/cvr028; EMEIS JJ, 1992, ANN NY ACAD SCI, V667, P249, DOI 10.1111/j.1749-6632.1992.tb51622.x; FOX KAA, 1985, CIRCULATION, V72, P1346, DOI 10.1161/01.CIR.72.6.1346; GILES AR, 1990, THROMB HAEMOSTASIS, V63, P476; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; HAGGMARK S, 1982, SCAND J CLIN LAB INV, V42, P315; Hrafnkelsdottir T, 1998, LANCET, V352, P1597, DOI 10.1016/S0140-6736(05)61044-6; Hrafnkelsdottir T, 2004, HYPERTENSION, V44, P300, DOI 10.1161/01.HYP.0000137380.91476.fb; Jern C, 1999, ARTERIOSCL THROM VAS, V19, P454, DOI 10.1161/01.ATV.19.2.454; Karen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024954; Kathiresan S, 2006, ARTERIOSCL THROM VAS, V26, P1405, DOI 10.1161/01.ATV.0000222011.13026.25; Ladenvall P, 2002, THROMB HAEMOSTASIS, V87, P105; Larsson P, 2013, J THROMB THROMBOLYS, V35, P185, DOI 10.1007/s11239-012-0831-6; Larsson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031573; Newby DE, 2001, CIRCULATION, V103, P1936; Olesen JB, 2011, PHARMACOEPIDEM DR S, V20, P146, DOI 10.1002/pds.2073; Oliver JJ, 2005, ARTERIOSCL THROM VAS, V25, P2470, DOI 10.1161/01.ATV.0000189309.05924.88; Osterlund B, 2008, ACTA ANAESTH SCAND, V52, P1375, DOI 10.1111/j.1399-6576.2008.01741.x; Osterlund B, 2000, ACTA ANAESTH SCAND, V44, P1226, DOI 10.1034/j.1399-6576.2000.441007.x; Osterlund B, 2002, ACTA ANAESTH SCAND, V46, P271, DOI 10.1034/j.1399-6576.2002.t01-1-460308.x; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Ridderstrale W, 2006, HYPERTENSION, V47, P686, DOI 10.1161/01.HYP.0000210540.35296.62; SCHNEIDERMAN J, 1991, THROMB RES, V62, P401, DOI 10.1016/0049-3848(91)90013-M; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Van Guilder GP, 2005, AM J PHYSIOL-ENDOC M, V289, pE807, DOI 10.1152/ajpendo.00072.2005; Weil BR, 2011, AM J CARDIOL, V108, P1675, DOI 10.1016/j.amjcard.2011.07.026; Winnerkvist A, 1996, THROMB RES, V82, P533, DOI 10.1016/0049-3848(96)00103-X	33	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97260	10.1371/journal.pone.0097260	http://dx.doi.org/10.1371/journal.pone.0097260			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24818610	Green Submitted, Green Published, gold			2022-12-27	WOS:000336653300099
J	Lee, DH; Dane, MJC; van den Berg, BM; Boels, MGS; van Teeffelen, JW; de Mutsert, R; den Heijer, M; Rosendaal, FR; van der Vlag, J; van Zonneveld, AJ; Vink, H; Rabelink, TJ				Lee, Dae Hyun; Dane, Martijn J. C.; van den Berg, Bernard M.; Boels, Margien G. S.; van Teeffelen, Jurgen W.; de Mutsert, Renee; den Heijer, Martin; Rosendaal, Frits R.; van der Vlag, Johan; van Zonneveld, Anton Jan; Vink, Hans; Rabelink, Ton J.		NEO Study Grp	Deeper Penetration of Erythrocytes into the Endothelial Glycocalyx Is Associated with Impaired Microvascular Perfusion	PLOS ONE			English	Article							CELL GLYCOCALYX; MICROCIRCULATION; DYSFUNCTION; DIMENSIONS; LEUKOCYTES; BARRIER; DAMAGE; FLOW	Changes in endothelial glycocalyx are one of the earliest changes in development of cardiovascular disease. The endothelial glycocalyx is both an important biological modifier of interactions between flowing blood and the vessel wall, and a determinant of organ perfusion. We hypothesize that deeper penetration of erythrocytes into the glycocalyx is associated with reduced microvascular perfusion. The population-based prospective cohort study (the Netherlands Epidemiology of Obesity [NEO] study) includes 6,673 middle-aged individuals (oversampling of overweight and obese individuals). Within this cohort, we have imaged the sublingual microvasculature of 915 participants using sidestream darkfield (SDF) imaging together with a recently developed automated acquisition and analysis approach. Presence of RBC (as a marker of microvascular perfusion) and perfused boundary region (PBR), a marker for endothelial glycocalyx barrier properties for RBC accessibility, were assessed in vessels between 5 and 25 mm RBC column width. A wide range of variability in PBR measurements, with a mean PBR of 2.14 mm (range: 1.43-2.86 mm), was observed. Linear regression analysis showed a marked association between PBR and microvascular perfusion, reflected by RBC filling percentage (regression coefficient beta: -0.034; 95% confidence interval: -0.037 to -0.031). We conclude that microvascular beds with a thick ("healthy'') glycocalyx (low PBR), reflects efficient perfusion of the microvascular bed. In contrast, a thin ("risk'') glycocalyx (high PBR) is associated with a less efficient and defective microvascular perfusion.	[Lee, Dae Hyun; Dane, Martijn J. C.; van den Berg, Bernard M.; Boels, Margien G. S.; van Zonneveld, Anton Jan; Rabelink, Ton J.] Leiden Univ Med Ctr, Dept Nephrol, Leiden, Netherlands; [Lee, Dae Hyun; Dane, Martijn J. C.; van den Berg, Bernard M.; Boels, Margien G. S.; van Zonneveld, Anton Jan; Rabelink, Ton J.] Leiden Univ Med Ctr, Einthoven Lab Vasc Med, Leiden, Netherlands; [de Mutsert, Renee; den Heijer, Martin; Rosendaal, Frits R.] Leiden Univ Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [van Teeffelen, Jurgen W.; Vink, Hans] Maastricht Univ Med Ctr, Dept Physiol & Glycocheck, Maastricht, Netherlands; [van der Vlag, Johan] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Nephrol, NL-6525 ED Nijmegen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Radboud University Nijmegen	Rabelink, TJ (corresponding author), Leiden Univ Med Ctr, Dept Nephrol, Leiden, Netherlands.	A.J.Rabelink@lumc.nl	Van der Vlag, Johan/E-4636-2010; Rosendaal, Frits/Q-3842-2017; Lee, Dae Hyun/AAZ-6007-2021; van Zonneveld, Anton Jan/D-8060-2018; van den berg, bernard m/D-8444-2014; den Heijer, Martin/J-8036-2015; Rabelink, Ton J./A-5316-2008; Lee, Dae Hyun/T-9838-2019; de Vries, Aiko P.J./J-5397-2015; Pijl, Hanno/W-8719-2018; Willems van Dijk, Ko/A-1798-2008	Van der Vlag, Johan/0000-0001-7843-5918; Rosendaal, Frits/0000-0003-2558-7496; van Zonneveld, Anton Jan/0000-0002-1676-7738; den Heijer, Martin/0000-0003-3620-5617; Rabelink, Ton J./0000-0001-6780-5186; de Vries, Aiko P.J./0000-0002-9284-3595; Pijl, Hanno/0000-0002-3076-1551; Willems van Dijk, Ko/0000-0002-2172-7394; Lee, Dae Hyun/0000-0001-8141-0404; le Cessie, Saskia/0000-0003-2154-4923; van den Berg, Bernard/0000-0002-5726-5777	Dutch Kidney Foundation [C08.2265, CP09.03]; Division and the Board of Directors of the Leiden University Medical Center; Leiden University, Research Profile Area 'Vascular and Regenerative Medicine'	Dutch Kidney Foundation; Division and the Board of Directors of the Leiden University Medical Center; Leiden University, Research Profile Area 'Vascular and Regenerative Medicine'	This work was supported by the Dutch Kidney Foundation [grant number C08.2265 and CP09.03]. The NEO study is supported by participating departments, the Division and the Board of Directors of the Leiden University Medical Center, and by the Leiden University, Research Profile Area 'Vascular and Regenerative Medicine'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boels MG, 2013, EUR J INTERN MED; Brands J, 2010, AM J PHYSIOL-HEART C, V298, pH515, DOI 10.1152/ajpheart.01306.2008; Broekhuizen LN, 2010, DIABETOLOGIA, V53, P2646, DOI 10.1007/s00125-010-1910-x; Cabrales P, 2007, J APPL PHYSIOL, V102, P2251, DOI 10.1152/japplphysiol.01155.2006; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Constantinescu AA, 2003, ARTERIOSCL THROM VAS, V23, P1541, DOI 10.1161/01.ATV.0000085630.24353.3D; Creteur J, 2006, INTENS CARE MED, V32, P516, DOI 10.1007/s00134-006-0070-4; Dane MJC, 2014, CLIN J AM SOC NEPHRO, V9, P698, DOI 10.2215/CJN.08160813; Dane MJC, 2013, AM J PATHOL, V182, P1532, DOI 10.1016/j.ajpath.2013.01.049; De Backer D, 2007, CRIT CARE, V11, DOI 10.1186/cc6118; de Mutsert R, 2013, EUR J EPIDEMIOL, V28, P513, DOI 10.1007/s10654-013-9801-3; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; DESJARDINS C, 1990, AM J PHYSIOL, V258, pH647, DOI 10.1152/ajpheart.1990.258.3.H647; Donati A, 2013, MICROVASC RES, V90, P86, DOI 10.1016/j.mvr.2013.08.007; Eskens BJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055399; Goedhart PT, 2007, OPT EXPRESS, V15, P15101, DOI 10.1364/OE.15.015101; Edul VSK, 2012, CRIT CARE MED, V40, P1443, DOI 10.1097/CCM.0b013e31823dae59; Klijn E, 2008, CLIN CHEST MED, V29, P643, DOI 10.1016/j.ccm.2008.06.008; KORN EL, 1991, AM J PUBLIC HEALTH, V81, P1166, DOI 10.2105/AJPH.81.9.1166; Martens RJH, 2013, CEREBROVASC DIS, V35, P451, DOI 10.1159/000348854; Meuwese MC, 2009, J LIPID RES, V50, P148, DOI 10.1194/jlr.P800025-JLR200; Mochizuki S, 2003, AM J PHYSIOL-HEART C, V285, pH722, DOI 10.1152/ajpheart.00691.2002; Mulders TA, 2013, INT J CARDIOL, V168, P5026, DOI 10.1016/j.ijcard.2013.07.166; Nieuwdorp M, 2006, DIABETES, V55, P1127, DOI 10.2337/diabetes.55.04.06.db05-1619; Nieuwdorp M, 2008, J APPL PHYSIOL, V104, P845, DOI 10.1152/japplphysiol.00440.2007; Piagnerelli M, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/867176; Pranskunas A, 2012, CRIT CARE, V16, DOI 10.1186/cc11341; Rabelink TJ, 2010, NAT REV NEPHROL, V6, P404, DOI 10.1038/nrneph.2010.65; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Reitsma S, 2011, THROMB HAEMOSTASIS, V106, P939, DOI 10.1160/TH11-02-0133; Sallisalmi M, 2012, ACTA ANAESTH SCAND, V56, P298, DOI 10.1111/j.1399-6576.2011.02569.x; Schmidt EP, 2012, NAT MED, V18, P1217, DOI 10.1038/nm.2843; van den Berg BM, 2003, CIRC RES, V92, P592, DOI 10.1161/01.RES.0000065917.53950.75; VanTeeffelen JWGE, 2010, CARDIOVASC RES, V87, P311, DOI 10.1093/cvr/cvq114; VanTeeffelen JWGE, 2005, AM J PHYSIOL-HEART C, V289, pH2508, DOI 10.1152/ajpheart.00446.2005; Verdant CL, 2009, CRIT CARE MED, V37, P2875, DOI 10.1097/CCM.0b013e3181b029c1; Vink H, 2000, AM J PHYSIOL-HEART C, V278, pH285, DOI 10.1152/ajpheart.2000.278.1.H285; Vink H, 1996, CIRC RES, V79, P581, DOI 10.1161/01.RES.79.3.581; Vlahu CA, 2012, J AM SOC NEPHROL, V23, P1900, DOI 10.1681/ASN.2011121181; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959	40	107	110	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96477	10.1371/journal.pone.0096477	http://dx.doi.org/10.1371/journal.pone.0096477			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816787	Green Published, Green Submitted, gold			2022-12-27	WOS:000336838000039
J	Zhu, HY; Li, C; Bai, WD; Su, LL; Liu, JQ; Li, Y; Shi, JH; Cai, WX; Bai, XZ; Jia, YH; Zhao, B; Wu, X; Li, J; Hu, DH				Zhu, Hua-Yu; Li, Chao; Bai, Wen-Dong; Su, Lin-Lin; Liu, Jia-Qi; Li, Yan; Shi, Ji-Hong; Cai, Wei-Xia; Bai, Xiao-Zhi; Jia, Yan-Hui; Zhao, Bin; Wu, Xue; Li, Jun; Hu, Da-Hai			MicroRNA-21 Regulates hTERT via PTEN in Hypertrophic Scar Fibroblasts	PLOS ONE			English	Article							BLADDER-CANCER; EXPRESSION; CELLS; APOPTOSIS; FIBROSIS; INJURY; INACTIVATION; PROGRESSION; INHIBITION; CONTRIBUTE	Background: As an important oncogenic miRNA, microRNA-21 (miR-21) is associated with various malignant diseases. However, the precise biological function of miR-21 and its molecular mechanism in hypertrophic scar fibroblast cells has not been fully elucidated. Methodology/Principal Findings: Quantitative Real-Time PCR (qRT-PCR) analysis revealed significant upregulation of miR-21 in hypertrophic scar fibroblast cells compared with that in normal skin fibroblast cells. The effects of miR-21 were then assessed in MTT and apoptosis assays through in vitro transfection with a miR-21 mimic or inhibitor. Next, PTEN (phosphatase and tensin homologue deleted on chromosome ten) was identified as a target gene of miR-21 in hypertrophic scar fibroblast cells. Furthermore, Western-blot and qRT-PCR analyses revealed that miR-21 increased the expression of human telomerase reverse transcriptase (hTERT) via the PTEN/PI3K/AKT pathway. Introduction of PTEN cDNA led to a remarkable depletion of hTERT and PI3K/AKT at the protein level as well as inhibition of miR-21-induced proliferation. In addition, Western-blot and qRT-PCR analyses confirmed that hTERT was the downstream target of PTEN. Finally, miR-21 and PTEN RNA expression levels in hypertrophic scar tissue samples were examined. Immunohistochemistry assays revealed an inverse correlation between PTEN and hTERT levels in high miR-21 RNA expressing-hypertrophic scar tissues. Conclusions/Significance: These data indicate that miR-21 regulates hTERT expression via the PTEN/PI3K/AKT signaling pathway by directly targeting PTEN, therefore controlling hypertrophic scar fibroblast cell growth. MiR-21 may be a potential novel molecular target for the treatment of hypertrophic scarring.	[Zhu, Hua-Yu; Li, Chao; Su, Lin-Lin; Liu, Jia-Qi; Li, Yan; Shi, Ji-Hong; Cai, Wei-Xia; Bai, Xiao-Zhi; Jia, Yan-Hui; Zhao, Bin; Wu, Xue; Li, Jun; Hu, Da-Hai] Fourth Mil Med Univ, Xijing Hosp, Dept Burns & Cutaneous Surg, Xian 710032, Shaanxi, Peoples R China; [Bai, Wen-Dong] Fourth Mil Med Univ, Dept Immunol, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Li, J (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Burns & Cutaneous Surg, Xian 710032, Shaanxi, Peoples R China.	lijunfmmu@163.com.cn; zzhuhy@aliyun.com		zhu, huayu/0000-0002-8480-7615; Zhu, Huayu/0000-0002-3038-6624; Bai, Wen-Dong/0000-0003-1873-7900; /0000-0002-3640-6729; Li, Yan/0000-0003-0096-0813	National Natural Scientific Foundation of China [81171811, 81000062, 81102006]; China Postdoctoral Science Foundation [2013M542501]; Natural Science Foundation of Shaanxi Province [2012JQ4008]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province)	This work was supported by grants from the National Natural Scientific Foundation of China (Nos. 81171811, 81000062 and 81102006), the funding of China Postdoctoral Science Foundation (No. 2013M542501) and the Natural Science Foundation of Shaanxi Province (No. 2012JQ4008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarabi S, 2007, PLOS MED, V4, P1464, DOI 10.1371/journal.pmed.0040234; Aldaz B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077098; Antoniou KM, 2013, ONCOL REP, V30, P2617, DOI 10.3892/or.2013.2753; Bhalala OG, 2012, J NEUROSCI, V32, P17935, DOI 10.1523/JNEUROSCI.3860-12.2012; Bovell LC, 2013, CLIN CANCER RES, V19, P3955, DOI 10.1158/1078-0432.CCR-12-3302; Chakrabarti M, 2013, EXP CELL RES, V319, P1575, DOI 10.1016/j.yexcr.2013.02.025; Chen HP, 2009, MOL BIOTECHNOL, V41, P194, DOI 10.1007/s12033-008-9117-9; Chen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054213; Chen YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082751; Cordes I, 2013, HISTOPATHOLOGY, V63, P670, DOI 10.1111/his.12209; Dellago H, 2013, AGING CELL, V12, P446, DOI 10.1111/acel.12069; Dey N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037366; Giunco S, 2013, CLIN CANCER RES, V19, P2036, DOI 10.1158/1078-0432.CCR-12-2537; Gont A, 2013, ONCOTARGET, V4, P1266, DOI 10.18632/oncotarget.1164; Guo L, 2012, MOL CELL BIOCHEM, V361, P161, DOI 10.1007/s11010-011-1100-2; Kadera BE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071978; Kashiyama K, 2012, J INVEST DERMATOL, V132, P1597, DOI 10.1038/jid.2012.22; Kitagishi Y, 2013, ALZHEIMERS RES THER, V5, DOI [10.1186/1758-9193-5-42, 10.1186/alzrt208]; Kwak MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053476; Lo TF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075628; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Miyoshi K, 2013, AM J RESP CRIT CARE, V187, P262, DOI 10.1164/rccm.201205-0851OC; Moreira FC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092300; Nouraee N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073009; Pan JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091580; Parapuram SK, 2011, J INVEST DERMATOL, V131, P1996, DOI 10.1038/jid.2011.156; Paul P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072570; Pericacho M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054687; Pi WF, 2013, INT J MOL MED, V32, P1101, DOI 10.3892/ijmm.2013.1487; Saad R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064463; Sanchez-Diaz PC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061622; Satzger I, 2012, EXP DERMATOL, V21, P509, DOI 10.1111/j.1600-0625.2012.01510.x; Schee K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066165; Seront E, 2013, BRIT J CANCER, V109, P1586, DOI 10.1038/bjc.2013.505; Seton-Rogers S, 2013, NAT REV CANCER, V13, P606; Shen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057652; Song JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047657; Tesio M, 2013, J EXP MED, V210, P2337, DOI 10.1084/jem.20122768; Tyack Z, 2012, BURNS, V38, P6, DOI 10.1016/j.burns.2011.09.021; Vang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058226; Waite KA, 2002, AM J HUM GENET, V70, P829, DOI 10.1086/340026; Wang JL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078393, 10.1371/journal.pone.0073683, 10.1371/journal.pone.0063924, 10.1371/journal.pone.0066563, 10.1371/journal.pone.0070587]; Xia XC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080426; Yang GD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078355; Zhang J, 2013, BURNS, V4179; Zhang JG, 2010, CLIN CHIM ACTA, V411, P846, DOI 10.1016/j.cca.2010.02.074; Zhang Y, 2013, CANCER BIOMARK, V13, P299, DOI 10.3233/CBM-130352; Zhao GY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053906; Zhi F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060034; Zhou C, 2006, GYNECOL ONCOL, V101, P305, DOI 10.1016/j.ygyno.2005.10.038; Zhu GY, 2013, BIOCHEM BIOPH RES CO, V433, P526, DOI 10.1016/j.bbrc.2013.03.018; Zhu ZS, 2013, J CELL COMMUN SIGNAL, V7, P239, DOI 10.1007/s12079-013-0195-5	52	61	65	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97114	10.1371/journal.pone.0097114	http://dx.doi.org/10.1371/journal.pone.0097114			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24817011	Green Submitted, Green Published, gold			2022-12-27	WOS:000336838000105
J	Aloni, MN; Ngiyulu, RM; Gini-Ehungu, JL; Nsibu, CN; Ekila, MB; Lepira, FB; Nseka, NM				Aloni, Michel Ntetani; Ngiyulu, Rene Makwala; Gini-Ehungu, Jean-Lambert; Nsibu, Celestin Ndosimao; Ekila, Mathilde Bothale; Lepira, Francois Bompeka; Nseka, Nazaire Mangani			Renal Function in Children Suffering from Sickle Cell Disease: Challenge of Early Detection in Highly Resource-Scarce Settings	PLOS ONE			English	Article							GLOMERULAR-FILTRATION RATE; NEPHROTIC SYNDROME; NIGERIAN CHILDREN; NATURAL-HISTORY; BLOOD-PRESSURE; PREVALENCE; HYPERURICEMIA; MICROALBUMINURIA; HYPERTENSION; PREVENTION	Background: The prevalence of Sickle cell disease is extremely high in Democratic Republic of Congo. Despite this high prevalence of the disease, data on renal abnormalities in children are rare. Method: The study proposed to assess blood pressure, glomerular function, urea and uric acid levels in 65 steady state Congolese children with homozygous sickle cell disease and 67 normal controls. Results: In Hb-SS group, blood pressure level tended to be lower than Hb-AA groups but there was no statistically significant difference (p>0.05) between the two groups. The absolute values for GFR corrected for BSA were significantly higher in Hb-SS group compared to Hb-AA group (130.5 +/- 34.1 ml/min/1.73 m(2) vs 113.7 +/- 24.5 ml/min/1.73 m(2); p = 0.004). Children with Hb-SS were more likely to hyperfiltrate (30.8% of subjects) than children with Hb-AA (6.1% of subjects). Proteinuria was found in 4 (6.2%) children with Hb-SS. Uric acid level was significantly increased in children with Hb-SS compared to corresponding values in control group (4.4 +/- 1.3 mg/dl vs 3.5 +/- 1.1 mg/dl; p<0.001). Urea level was significantly decreased compared to corresponding values in Hb-AA group (15.3 +/- 8.3 mg/dl vs 22.9 +/- 10.1 mg/dl; p<0.001). Conclusion: Hyperfiltration, low creatinine, lower urea and high uric acid are more common in children with sickle cell disease than in normal controls.	[Aloni, Michel Ntetani; Ngiyulu, Rene Makwala; Gini-Ehungu, Jean-Lambert] Univ Kinshasa, Sch Med, Univ Hosp Kinshasa, Div Hematooncol & Nephrol,Dept Pediat, Kinshasa, DEM REP CONGO; [Nsibu, Celestin Ndosimao] Univ Kinshasa, Sch Med, Univ Hosp Kinshasa, Intens Care Div,Dept Pediat, Kinshasa, DEM REP CONGO; [Ekila, Mathilde Bothale] Univ Kinshasa, Sch Med, Univ Hosp Kinshasa, Dept Internal Med, Kinshasa, DEM REP CONGO; [Lepira, Francois Bompeka; Nseka, Nazaire Mangani] Univ Kinshasa, Sch Med, Univ Hosp Kinshasa, Div Nephrol & Dialysis,Dept Internal Med, Kinshasa, DEM REP CONGO	Universite de Kinshasa; Universite de Kinshasa; Universite de Kinshasa; Universite de Kinshasa	Aloni, MN (corresponding author), Univ Kinshasa, Sch Med, Univ Hosp Kinshasa, Div Hematooncol & Nephrol,Dept Pediat, Kinshasa, DEM REP CONGO.	michelaloni2003@yahoo.fr		Aloni, Michel/0000-0002-7479-1170				Adedoyin O T, 2012, Niger Postgrad Med J, V19, P119; al-Naama L M, 2000, J Pak Med Assoc, V50, P98; ALALI AK, 1995, ACTA HAEMATOL-BASEL, V94, P114; Aleem Aamer, 2008, Saudi J Kidney Dis Transpl, V19, P194; Aloni MN, 2012, ACTA PAEDIATR, V101, pe514, DOI 10.1111/j.1651-2227.2012.02827.x; Arlet JB, 2012, REV MED INTERNE, V33, P13, DOI 10.1016/j.revmed.2011.07.002; Aygun B, 2011, PEDIATR NEPHROL, V26, P1285, DOI 10.1007/s00467-011-1857-2; Bank N, 1996, KIDNEY INT, V50, P184, DOI 10.1038/ki.1996.301; Bayazit AK, 2002, CLIN NEPHROL, V57, P127; Cochat P, 2009, Med Trop (Mars), V69, P543; DeBaun MR, 2012, BLOOD, V119, P3684, DOI 10.1182/blood-2011-05-349621; Dharnidharka VR, 1998, PEDIATR NEPHROL, V12, P475, DOI 10.1007/s004670050491; DIAMOND HS, 1979, ANN INTERN MED, V90, P752, DOI 10.7326/0003-4819-90-5-752; Foucan L, 1999, REV EPIDEMIOL SANTE, V47, P329; HOMI J, 1993, ARCH INTERN MED, V153, P1233, DOI 10.1001/archinte.153.10.1233; ISICHEI UP, 1984, TROP GEOGR MED, V36, P351; Jordan LC, 2012, BRIT J HAEMATOL, V157, P14, DOI 10.1111/j.1365-2141.2011.09005.x; McKie KT, 2007, J PEDIAT HEMATOL ONC, V29, P140, DOI 10.1097/MPH.0b013e3180335081; Okoro BA, 1997, E AFR MED J, V74, P819; OKORO BA, 1991, ANN TROP PAEDIATR, V11, P47, DOI 10.1080/02724936.1991.11747477; Olowu W A, 2002, Niger J Med, V11, P23; Osei-Yeboah C T, 2011, Ghana Med J, V45, P155; Pakasa NM, 2006, NEW ENGL J MED, V354, P1085, DOI 10.1056/NEJMc052696; Pegelow CH, 1997, AM J MED, V102, P171; Piel FB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001484; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; POWARS DR, 1991, ANN INTERN MED, V115, P614, DOI 10.7326/0003-4819-115-8-614; REYNOLDS MD, 1983, SEMIN ARTHRITIS RHEU, V12, P404, DOI 10.1016/0049-0172(83)90020-3; SCHWARTZ GJ, 1976, PEDIATRICS, V58, P259; Sharpe CC, 2011, BRIT J HAEMATOL, V155, P287, DOI 10.1111/j.1365-2141.2011.08853.x; Shatat IF, 2013, PEDIATR NEPHROL, V28, P115, DOI 10.1007/s00467-012-2275-9; SKLAR AH, 1990, INT J ARTIF ORGANS, V13, P231, DOI 10.1177/039139889001300408; Stallworth JR, 2011, SOUTH MED J, V104, P752, DOI 10.1097/SMJ.0b013e318232d9ab; Thompson A, 1982, COMP CLIN ASPECTS SI; Tshilolo L, 2009, J CLIN PATHOL, V62, P35, DOI 10.1136/jcp.2008.058958; Wigfall DR, 2000, J PEDIATR-US, V136, P749, DOI 10.1016/S0022-3476(00)48828-1	36	33	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96561	10.1371/journal.pone.0096561	http://dx.doi.org/10.1371/journal.pone.0096561			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810610	Green Submitted, Green Published, gold			2022-12-27	WOS:000338213300054
J	Campen, MJ; Paffett, ML; Colombo, ES; Lucas, SN; Anderson, T; Nysus, M; Norenberg, JP; Gershman, B; Hesterman, J; Hoppin, J; Willis, M				Campen, Matthew J.; Paffett, Michael L.; Colombo, E. Sage; Lucas, Selita N.; Anderson, Tamara; Nysus, Monique; Norenberg, Jeffrey P.; Gershman, Ben; Hesterman, Jacob; Hoppin, Jack; Willis, Monte			Muscle RING Finger-1 Promotes a Maladaptive Phenotype in Chronic Hypoxia-Induced Right Ventricular Remodeling	PLOS ONE			English	Article							UBIQUITIN-LIGASE; FAILURE; DISEASE; ATROGIN-1; EXPRESSION; INCREASE; MURF-1; DEATH; MASS	Exposure to chronic hypoxia (CH) induces elevated pulmonary artery pressure/resistance, leading to an eventual maladaptive right ventricular hypertrophy (RVH). Muscle RING finger-1 (MuRF1) is a muscle-specific ubiquitin ligase that mediates myocyte atrophy and has been shown to play a role in left ventricular hypertrophy and altered cardiac bioenergetics in pressure overloaded hearts. However, little is known about the contribution of MuRF1 impacting RVH in the setting of CH. Therefore, we hypothesized that MuRF1 deletion would enhance RVH compared to their wild-type littermates, while cardiac-specific overexpression would reduce hypertrophy following CH-induced pulmonary hypertension. We assessed right ventricular systolic pressure (RVSP), right ventricle to left ventricle plus septal weight ratio (RV/LV+S) and hematocrit (Hct) following a 3-wk isobaric CH exposure. Additionally, we conducted dual-isotope SPECT/CT imaging with cardiac function agent Tl-201-chloride and cell death agent Tc-99m-annexin V. Predictably, CH induced pulmonary hypertension, measured by increased RVSP, RV/LV+S and Hct in WT mice compared to normoxic WT mice. Normoxic WT and MuRF1-null mice exhibited no significant differences in RVSP, RV/LV+S or Hct. CH-induced increases in RVSP were also similar between WT and MuRF1-null mice; however, RV/LV+S and Hct were significantly elevated in CH-exposed MuRF1-null mice compared to WT. In cardiac-specific MuRF1 overexpressing mice, RV/LV+S increased significantly due to CH exposure, even greater than in WT mice. This remodeling appeared eccentric, maladaptive and led to reduced systemic perfusion. In conclusion, these results are consistent with an atrophic role for MuRF1 regulating the magnitude of right ventricular hypertrophy following CH-induction of pulmonary hypertension.	[Campen, Matthew J.; Paffett, Michael L.; Colombo, E. Sage; Lucas, Selita N.] Univ New Mexico, Coll Pharm, Hlth Sci Ctr, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA; [Anderson, Tamara; Nysus, Monique; Norenberg, Jeffrey P.] Univ New Mexico, Coll Pharm, Hlth Sci Ctr, Radiopharmaceut Sci Program, Albuquerque, NM 87131 USA; [Gershman, Ben; Hesterman, Jacob; Hoppin, Jack] inviCRO LLC, Boston, MA USA; [Willis, Monte] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC USA; [Willis, Monte] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Campen, MJ (corresponding author), Univ New Mexico, Coll Pharm, Hlth Sci Ctr, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA.	mcampen@salud.unm.edu	Willis, Monte S/J-9994-2015; Norenberg, Jeffrey/AAL-1725-2021	Willis, Monte S/0000-0002-0769-5816; 	National Institutes of Health (NIH) [ES014639, R01HL104129]; University of New Mexico Cancer Center (NIH) [P30 CA118100-06]; W.M. KECK Foundation; Leducq Foundation; inviCRO, LLC; NATIONAL CANCER INSTITUTE [P30CA118100] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R56ES014639, R01ES014639] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of New Mexico Cancer Center (NIH); W.M. KECK Foundation(W.M. Keck Foundation); Leducq Foundation(Leducq Foundation); inviCRO, LLC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work is supported by the National Institutes of Health (NIH ES014639 to MJC and R01HL104129 to MW), the University of New Mexico Cancer Center (NIH P30 CA118100-06), the W.M. KECK Foundation, and the Leducq Foundation (MW). inviCRO, LLC provided support in the form of salaries for authors JH, JH, and BG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Baskin KK, 2011, CIRC RES; Bdolah Y, 2007, AM J PHYSIOL-REG I, V292, pR971, DOI 10.1152/ajpregu.00617.2006; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Campen MJ, 2005, J APPL PHYSIOL, V99, P2028, DOI 10.1152/japplphysiol.00411.2005; Fielitz J, 2007, J CLIN INVEST, V117, P2486, DOI 10.1172/JCI32827; Forfia PR, 2013, PULM CIRC, V3, P5, DOI 10.4103/2045-8932.109910; Hayot M, 2011, MOL CELL ENDOCRINOL, V332, P38, DOI 10.1016/j.mce.2010.09.008; Hepple RT, 2008, AM J PHYSL REGUL INT; Kedar V, 2004, P NATL ACAD SCI USA, V101, P18135, DOI 10.1073/pnas.0404341102; Li HH, 2011, AM J PATHOL, V178, P1043, DOI 10.1016/j.ajpath.2010.11.049; Mille-Hamard L, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-29; Miller MS, 2010, J PHYSIOL-LONDON, V588, P4039, DOI 10.1113/jphysiol.2010.191957; Minai OA, 2010, CHEST, V137, p39S, DOI 10.1378/chest.10-0087; Noordegraaf AV, 2011, EUR RESPIR REV, V20, P243, DOI 10.1183/09059180.00006511; Norese MF, 2002, HIGH ALT MED BIOL, V3, P49, DOI 10.1089/152702902753639540; Paffett ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040910; Paffett ML, 2012, CARDIOVASC TOXICOL, V12, P226, DOI 10.1007/s12012-012-9158-y; Paffett ML, 2012, VASC PHARMACOL, V56, P64, DOI 10.1016/j.vph.2011.11.002; Paffett ML, 2011, VASCUL PHARM; Patel ARC, 2011, EXPERT REV RESP MED, V5, P647, DOI [10.1586/ERS.11.62, 10.1586/ers.11.62]; Rajagopalan V, 2013, AM J PHYSL HEART CIR; Tonelli AR, 2013, AM J RESP CRIT CARE, V188, P365, DOI 10.1164/rccm.201209-1640OC; Toth MJ, 2012, J APPL PHYSIOL, V112, P1864, DOI 10.1152/japplphysiol.01591.2011; Toth MJ, 2011, J APPL PHYSIOL, V110, P892, DOI 10.1152/japplphysiol.00545.2010; Tverskaya MS, 2011, B EXP BIOL MED+, V151, P634; Tyndall AJ, 2010, ANN RHEUM DIS, V69, P1809, DOI 10.1136/ard.2009.114264; van Wolferen SA, 2007, EUR HEART J, V28, P1250, DOI 10.1093/eurheartj/ehl477; Willis MS, 2008, FUTUR CARDIOL, V4, P65, DOI 10.2217/14796678.4.1.65; Willis MS, 2007, CIRC RES, V100, P456, DOI 10.1161/01.RES.0000259559.48597.32; Willis MS, 2009, CIRC RES, V105, P80, DOI 10.1161/CIRCRESAHA.109.194928; Willis MS, 2009, AM J PHYSIOL-HEART C, V296, pH997, DOI 10.1152/ajpheart.00660.2008; Witt CC, 2008, EMBO J, V27, P350, DOI 10.1038/sj.emboj.7601952; Witt SH, 2005, J MOL BIOL, V350, P713, DOI 10.1016/j.jmb.2005.05.021	33	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e97084	10.1371/journal.pone.0097084	http://dx.doi.org/10.1371/journal.pone.0097084			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24811453	Green Published, gold, Green Submitted			2022-12-27	WOS:000338213300120
J	Dey, T; Gogoi, K; Unni, BG; Kalita, M; Bharadwaz, M; Bhattacharjee, M; Boruah, PK; Bora, T; Ozah, D; Kalita, M				Dey, Tapan; Gogoi, Kabita; Unni, Bala Gopalan; Kalita, Munmi; Bharadwaz, Moonmee; Bhattacharjee, Minakshi; Boruah, Pranab Kumar; Bora, Thaneswar; Ozah, Dibyajyoti; Kalita, Manoj			Role of Glutathione S Transferase Polymorphism in COPD with Special Reference to Peoples Living in the Vicinity of the Open Cast Coal Mine of Assam	PLOS ONE			English	Article							MICROSOMAL EPOXIDE HYDROLASE; OBSTRUCTIVE PULMONARY-DISEASE; AIR-POLLUTION; CARDIOVASCULAR-DISEASE; GENE POLYMORPHISMS; LUNG-FUNCTION; SUSCEPTIBILITY; ASSOCIATION; HEALTH; DECLINE	Background: COPD may develop due to variation in the functioning of antioxidants along with smoking and environmental factors in genetically susceptible individuals. Since there are different views about the antioxidants responsible for detoxifying xenobiotic compound in the human body whose functional variation may lead to obstructive disease, this associative study has been taken up between GST gene polymorphism and COPD in populations exposed to coal dusts. Methods: Genotypes of the 70 COPD patients and 85 non COPD patients were determined by PCR based methods followed by multiplex PCR of GSTT1 and GSTM1 genes taking albumin gene as a control. Suspended particulate analyses were determined through the Respirable Dust sampler along with the FTIR analysis of the dust samples from the glass microfiber filters. Results: Dust sampling analysis reveals higher level of respirable suspended particulate matter, non respirable particulate matter, SO2 and NO2 present in air of the study site. FTIR analysis also suggests a higher concentration of organic silicone and aliphatic C-F compounds present in air of the study site and when spirometry was done, low lung function was observed among most of the subjects. GSTM1 null type was significantly associated with low lung function in smoker groups and the presence of at least one active allele (either GSTM1/GSTT1) seemed to have a protective role in the development of COPD. Conclusions: GSTM1 (null genotype) appeared to be a risk factor for lower lung function in smokers living in the vicinity of coal mines. Apart from polluted environment and genetic susceptibility, mixed coal dust exposure rich in organic silicone and aliphatic C-F compounds also appears to be a factor for the low lung function.	[Dey, Tapan; Gogoi, Kabita; Unni, Bala Gopalan; Kalita, Munmi; Bharadwaz, Moonmee; Boruah, Pranab Kumar; Bora, Thaneswar; Ozah, Dibyajyoti; Kalita, Manoj] North East Inst Sci & Technol, CSIR, Div Biotechnol, Jorhat, Assam, India; [Bhattacharjee, Minakshi] Univ Sci & Technol Meghalaya, Dept Biotechnol, Shillong, Meghalaya, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - North East Institute of Science & Technology (NEIST)	Unni, BG (corresponding author), North East Inst Sci & Technol, CSIR, Div Biotechnol, Jorhat, Assam, India.	bgunni@yahoo.com	Dey, Tapan/M-7856-2019	Dey, Tapan/0000-0003-3497-8624	Council of Scientific and Industrial Research, Govt. of India	Council of Scientific and Industrial Research, Govt. of India(Council of Scientific & Industrial Research (CSIR) - India)	The project was entirely funded by Council of Scientific and Industrial Research, Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Baranova H, 1997, HUM GENET, V99, P822, DOI 10.1007/s004390050455; Barnes PJ, 1999, THORAX, V54, P245, DOI 10.1136/thx.54.3.245; Barnes PJ, 2004, NEW ENGL J MED, V350, P2635, DOI 10.1056/NEJMp048102; Bhattacharjee M., 2011, International Journal for Biotechnology and Molecular Biology Research, V2, P195, DOI 10.5897/IJBMBR11.051; Bhattacharjee M, 2012, AFR J BIOTECHNOL, V111, P207; BHOPAL RS, 1994, J EPIDEMIOL COMMUN H, V48, P237, DOI 10.1136/jech.48.3.237; BRABIN B, 1994, ARCH DIS CHILD, V70, P305, DOI 10.1136/adc.70.4.305; Braun FC, 1992, AM REV RESPIR DIS, V14, P542; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Cahkoglu M, 2006, BIOCH GENET, V447/8, P307; Cheng SL, 2004, EUR RESPIR J, V23, P818, DOI 10.1183/09031936.04.00104904; Coates J., 2000, ENCY ANAL CHEM, DOI DOI 10.1002/9780470027318.A5606; Dockery D W, 1993, N Engl J Med, V329, P1753, DOI 10.1056/NEJM199312093292401; Hayes JD, 2000, PHARMACOLOGY, V61, P154, DOI 10.1159/000028396; He JQ, 2002, AM J RESP CRIT CARE, V166, P323, DOI 10.1164/rccm.2111059; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Jindal SK, 2006, INDIAN J MED RES, V124, P619; Koyama H, 1998, THORAX S2, V2, P10; Laden F, 2006, AM J RESP CRIT CARE, V173, P667, DOI 10.1164/rccm.200503-443OC; Lakhdar R, 2010, BIOCHEM GENET, V48, P647, DOI 10.1007/s10528-010-9346-z; LEIGH J, 1994, OCCUP ENVIRON MED, V51, P400, DOI 10.1136/oem.51.6.400; Love RG, 1997, OCCUP ENVIRON MED, V54, P416, DOI 10.1136/oem.54.6.416; Lu B, 2002, ZHONGHUA NEI KE ZA Z, V4, P678; [卢冰冰 Lu Bingbing], 2002, [中华内科杂志, Chinese Journal of Internal Medicine], V41, P678; Piqueras CMG, 2001, EUR RES J S34, V18, P41; Pope A, 2006, J AIR WASTE MANAGE, V56, P209; Repine JE, 1997, AM J RESP CRIT CARE, V156, P341, DOI 10.1164/ajrccm.156.2.9611013; Sandford AJ, 2000, CLIN CHEST MED, V21, P633, DOI 10.1016/S0272-5231(05)70173-8; Schikowski T, 2013, ENVIRON HEALTH PERSP, V121, P1034, DOI 10.1289/ehp.1206145; Schwartz J, 1997, EPIDEMIOLOGY, V8, P371, DOI 10.1097/00001648-199707000-00004; Smith CAD, 1997, LANCET, V350, P630, DOI 10.1016/S0140-6736(96)08061-0; Yim JJ, 2002, LUNG, V180, P119, DOI 10.1007/s004080000086; Yim JJ, 2000, THORAX, V55, P121, DOI 10.1136/thorax.55.2.121; Zidzik J, 2008, CROAT MED J, V49, P182, DOI 10.3325/cmj.2008.2.182	34	11	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96739	10.1371/journal.pone.0096739	http://dx.doi.org/10.1371/journal.pone.0096739			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809844	Green Published, gold, Green Submitted			2022-12-27	WOS:000338213300067
J	Dolz-Marco, R; Gallego-Pinazo, R; Pinazo-Duran, MD; Pons-Vazquez, S; Domingo-Pedro, JC; Diaz-Llopis, M				Dolz-Marco, Rosa; Gallego-Pinazo, Roberto; Dolores Pinazo-Duran, M.; Pons-Vazquez, Sheila; Carles Domingo-Pedro, Joan; Diaz-Llopis, Manuel			Intravitreal Docosahexaenoic Acid in a Rabbit Model: Preclinical Safety Assessment	PLOS ONE			English	Article							MACULAR DEGENERATION; SUPPLEMENTATION; DISEASE; RETINA	Purpose: The purpose of the present study was to evaluate the retinal toxicity of a single dose of intravitreal docosahexaenoic acid (DHA) in rabbit eyes over a short-term period. Methods: Sixteen New Zealand albino rabbits were selected for this pre-clinical study. Six concentrations of DHA (Brudy Laboratories, Barcelona, Spain) were prepared: 10 mg/50 mu l, 5 mg/50 mu l, 2'5 mg/50 mu l, 50 mu g/50 mu l, 25 mu g/50 mu l, and 5 mu g/50 ml. Each concentration was injected intravitreally in the right eye of two rabbits. As a control, the vehicle solution was injected in one eye of four animals. Retinal safety was studied by slit-lamp examination, and electroretinography. All the rabbits were euthanized one week after the intravitreal injection of DHA and the eyeballs were processed to morphologic and morphometric histological examination by light microscopy. At the same time aqueous and vitreous humor samples were taken to quantify the concentration of omega-3 acids by gas chromatography. Statistical analysis was performed by SPSS 21.0. Results: Slit-lamp examination revealed an important inflammatory reaction on the anterior chamber of the rabbits injected with the higher concentrations of DHA (10 mg/50 mu l, 5 mg/50 mu l, 2'5 mg/50 mu) Lower concentrations showed no inflammation. Electroretinography and histological studies showed no significant difference between control and DHA-injected groups except for the group injected with 50 mg/50 ml. Conclusions: Our results indicate that administration of intravitreal DHA is safe in the albino rabbit model up to the maximum tolerated dose of 25 mu g/50 mu l. Further studies should be performed in order to evaluate the effect of intravitreal injection of DHA as a treatment, alone or in combination, of different retinal diseases.	[Dolz-Marco, Rosa; Gallego-Pinazo, Roberto] Univ & Polytech Hosp La Fe, Dept Ophthalmol, Valencia, Spain; [Dolores Pinazo-Duran, M.; Pons-Vazquez, Sheila] Ophthalmol Res Unit Santiago Grisolia, Valencia, Spain; [Dolores Pinazo-Duran, M.; Diaz-Llopis, Manuel] Univ Valencia, Fac Med, Dept Surg, Valencia, Spain; [Carles Domingo-Pedro, Joan] Univ Barcelona, Fac Biol, Biochem & Mol Biol Dept, Barcelona, Spain	University of Valencia; University of Barcelona	Dolz-Marco, R (corresponding author), Univ & Polytech Hosp La Fe, Dept Ophthalmol, Valencia, Spain.	rosadolzmarco@gmail.com	Pedrol, Joan Carles C Domingo/A-4856-2019	Pedrol, Joan Carles C Domingo/0000-0002-6356-0836; Dolz-Marco, Rosa/0000-0002-2963-2541; Pinazo-Duran, Maria Dolores/0000-0002-0118-7837				Acar N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035102; Acar N, 2009, EXP EYE RES, V89, P840, DOI 10.1016/j.exer.2009.07.008; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Aydin E, 2006, RETINA-J RET VIT DIS, V26, P187, DOI 10.1097/00006982-200602000-00011; Bazan NG, 2011, ANNU REV NUTR, V31, P321, DOI 10.1146/annurev.nutr.012809.104635; Bazan NG, 2009, PROSTAG LEUKOTR ESS, V81, P205, DOI 10.1016/j.plefa.2009.05.024; Berson EL, 2004, ARCH OPHTHALMOL-CHIC, V122, P1306, DOI 10.1001/archopht.122.9.1306; Birch David G, 2005, Retina, V25, pS52, DOI 10.1097/00006982-200512001-00023; Bressler NM, 2003, ARCH OPHTHALMOL-CHIC, V121, P1621; Casaroli-Marano R, 2011, BRIT J OPHTHALMOL, V95, P931, DOI 10.1136/bjo.2010.187773; Galbis-Estrada C, 2012, FREE RADICAL RES, V46, P77, DOI 10.3109/10715762.2011.640324; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; Hoffman DR, 1998, WORLD REV NUTR DIET, V83, P52; Lee TKM, 2010, CAN J OPHTHALMOL, V45, P514, DOI 10.3129/i10-028; Lukiw WJ, 2008, J NUTR, V138, P2510, DOI 10.3945/jn.108.096016; Pinazo-Durán M.D., 2008, Arch Soc Esp Oftalmol, V83, P401; Querques G, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/748361; Querques G, 2010, CLIN OPHTHALMOL, V4, P575; Rotstein NP, 2003, INVEST OPHTH VIS SCI, V44, P2252, DOI 10.1167/iovs.02-0901; SanGiovanni JP, 2007, ARCH OPHTHALMOL-CHIC, V125, P671, DOI 10.1001/archopht.125.5.671	20	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96872	10.1371/journal.pone.0096872	http://dx.doi.org/10.1371/journal.pone.0096872			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809445	Green Published, gold			2022-12-27	WOS:000338213300082
J	Kim, SH; Hwang, SY; Yoon, JT				Kim, Sang Hwan; Hwang, Sue Yun; Yoon, Jong Taek			Microarray-Based Analysis of the Differential Expression of Melanin Synthesis Genes in Dark and Light-Muzzle Korean Cattle	PLOS ONE			English	Article							MELANOGENESIS-RELATED GENES; COAT COLOR; TRANSCRIPTION FACTOR; SIGNALING PATHWAY; MSH RECEPTOR; P38 MAPK; PIGMENTATION; POLYMORPHISM; SEQUENCE; MC1R	The coat color of mammals is determined by the melanogenesis pathway, which is responsible for maintaining the balance between black-brown eumelanin and yellow-reddish pheomelanin. It is also believed that the color of the bovine muzzle is regulated in a similar manner; however, the molecular mechanism underlying pigment deposition in the dark-muzzle has yet to be elucidated. The aim of the present study was to identify melanogenesis-associated genes that are differentially expressed in the dark vs. light muzzle of native Korean cows. Using microarray clustering and real-time polymerase chain reaction techniques, we observed that the expression of genes involved in the mitogen-activated protein kinase (MAPK) and Wnt signaling pathways is distinctively regulated in the dark and light muzzle tissues. Differential expression of tyrosinase was also noticed, although the difference was not as distinct as those of MAPK and Wnt. We hypothesize that emphasis on the MAPK pathway in the dark-muzzle induces eumelanin synthesis through the activation of cAMP response element-binding protein and tyrosinase, while activation of Wnt signaling counteracts this process and raises the amount of pheomelanin in the light-muzzle. We also found 2 novel genes (GenBank No. NM-001076026 and XM-588439) with increase expression in the black nose, which may provide additional information about the mechanism of nose pigmentation. Regarding the increasing interest in the genetic diversity of cattle stocks, genes we identified for differential expression in the dark vs. light muzzle may serve as novel markers for genetic diversity among cows based on the muzzle color phenotype.	[Kim, Sang Hwan; Yoon, Jong Taek] Hankyong Natl Univ, Inst Genet Engn, Ansung, Kyeonggido, South Korea; [Hwang, Sue Yun] Hankyong Natl Univ, Dept Chem Engn, Ansung, Kyeonggi Do, South Korea; [Yoon, Jong Taek] Hankyong Natl Univ, Dept Anim Life Sci, Ansung, Kyeonggido, South Korea	Hankyong National University; Hankyong National University; Hankyong National University	Yoon, JT (corresponding author), Hankyong Natl Univ, Inst Genet Engn, Ansung, Kyeonggido, South Korea.	jtyoon@hknu.ac.kr		Kim, SangHwan/0000-0003-0996-6912	Rural Development Administration, Republic of Korea [PJ907087, PJ008028]	Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by a grant from the Agenda Program (No. PJ907087) and Next-Generation BioGreen 21 Program (No. PJ008028), Rural Development Administration, Republic of Korea. URL: http://atis.rda.go.kr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett DC, 2003, PIGM CELL RES, V16, P333, DOI 10.1034/j.1600-0749.2003.00067.x; Berryere TG, 2003, ANIM GENET, V34, P169, DOI 10.1046/j.1365-2052.2003.00985.x; Busca R, 2000, PIGM CELL RES, V13, P60, DOI 10.1034/j.1600-0749.2000.130203.x; Cheli Y, 2010, PIGM CELL MELANOMA R, V23, P27, DOI 10.1111/j.1755-148X.2009.00653.x; Deng WD, 2008, MOL BIOL REP, V35, P379, DOI 10.1007/s11033-007-9097-z; Deng WD, 2009, GENOME, V52, P1001, DOI 10.1139/G09-078; Ducrest AL, 2008, TRENDS ECOL EVOL, V23, P502, DOI 10.1016/j.tree.2008.06.001; Girardot M, 2005, PIGM CELL RES, V18, P34, DOI 10.1111/j.1600-0749.2004.00195.x; Girardot M, 2006, PIGM CELL RES, V19, P346, DOI 10.1111/j.1600-0749.2006.00312.x; Gudjonsson JE, 2010, J INVEST DERMATOL, V130, P1849, DOI 10.1038/jid.2010.67; JACKSON IJ, 1993, NATURE, V362, P587, DOI 10.1038/362587a0; Joerg H, 1996, MAMM GENOME, V7, P317, DOI 10.1007/s003359900090; Kang HY, 2011, J INVEST DERMATOL, V131, P1692, DOI 10.1038/jid.2011.109; 이호준, 2011, [DEVELOPMENT & REPRODUCTION, 발생과 생식], V15, P325; Kim SangHwan, 2013, Journal of Animal and Veterinary Advances, V12, P1101; KLUNGLAND H, 1995, MAMM GENOME, V6, P636, DOI 10.1007/BF00352371; Park HY, 1999, CELL MOL BIOL, V45, P919; Park Jae-Hee, 2012, Journal of Animal Science and Technology, V54, P255, DOI 10.5187/JAST.2012.54.4.255; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; Rouzaud F, 2000, GENET SEL EVOL, V32, P511, DOI 10.1051/gse:2000102; Royo LJ, 2005, J ANIM BREED GENET, V122, P357, DOI 10.1111/j.1439-0388.2005.00541.x; Saito H, 2003, PIGM CELL RES, V16, P261, DOI 10.1034/j.1600-0749.2003.00039.x; Selz Y, 2007, GENE, V401, P114, DOI 10.1016/j.gene.2007.07.005; Shen T, 2012, CHEM-BIOL INTERACT, V199, P106, DOI 10.1016/j.cbi.2012.06.004; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Vachtenheim J, 2010, EXP DERMATOL, V19, P617, DOI 10.1111/j.1600-0625.2009.01053.x; Zhang JQ, 2010, MOL BIOL REP, V37, P165, DOI 10.1007/s11033-009-9567-6; Zhou J, 2012, J ETHNOPHARMACOL, V143, P639, DOI 10.1016/j.jep.2012.07.030; 이성수, 2002, [Journal of Animal Science and Technology, 한국축산학회지], V44, P23	29	3	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96453	10.1371/journal.pone.0096453	http://dx.doi.org/10.1371/journal.pone.0096453			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24811126	gold, Green Submitted, Green Published			2022-12-27	WOS:000338213300039
J	Levi-Meyrueis, C; Monteil, V; Sismeiro, O; Dillies, MA; Monot, M; Jagla, B; Coppee, JY; Dupuy, B; Norel, F				Levi-Meyrueis, Corinne; Monteil, Veronique; Sismeiro, Odile; Dillies, Marie-Agnes; Monot, Marc; Jagla, Bernd; Coppee, Jean-Yves; Dupuy, Bruno; Norel, Francoise			Expanding the RpoS/sigma(S)-Network by RNA Sequencing and Identification of sigma(S)-Controlled Small RNAs in Salmonella	PLOS ONE			English	Article							GENERAL STRESS-RESPONSE; ESCHERICHIA-COLI; STATIONARY-PHASE; OXIDATIVE STRESS; SIGMA(S)-DEPENDENT GENES; DI-GMP; RPOS; EXPRESSION; SIGMA(S); VIRULENCE	The RpoS/sigma(S) sigma subunit of RNA polymerase (RNAP) controls a global adaptive response that allows many Gram-negative bacteria to survive starvation and various stresses. sigma(S) also contributes to biofilm formation and virulence of the food-borne pathogen Salmonella enterica serovar Typhimurium (S. Typhimurium). In this study, we used directional RNA-sequencing and complementary assays to explore the sigma(S)-dependent transcriptome of S. Typhimurium during late stationary phase in rich medium. This study confirms the large regulatory scope of sigma(S) and provides insights into the physiological functions of sigma(S) in Salmonella. Extensive regulation by sigma(S) of genes involved in metabolism and membrane composition, and down-regulation of the respiratory chain functions, were important features of the sigma(S) effects on gene transcription that might confer fitness advantages to bacterial cells and/or populations under starving conditions. As an example, we show that arginine catabolism confers a competitive fitness advantage in stationary phase. This study also provides a firm basis for future studies to address molecular mechanisms of indirect regulation of gene expression by sigma(S). Importantly, the sigma(S)-controlled downstream network includes small RNAs that might endow sigma(S) with post-transcriptional regulatory functions. Of these, four (RyhB-1/RyhB-2, SdsR, SraL) were known to be controlled by sigma(S) and deletion of the sdsR locus had a competitive fitness cost in stationary phase. The sigma(S)-dependent control of seven additional sRNAs was confirmed in Northern experiments. These findings will inspire future studies to investigate molecular mechanisms and the physiological impact of post-transcriptional regulation by sigma(S).	[Levi-Meyrueis, Corinne; Monteil, Veronique; Norel, Francoise] Inst Pasteur, Mol Genet Unit, Dept Microbiol, Paris, France; [Levi-Meyrueis, Corinne; Monteil, Veronique; Norel, Francoise] CNRS, ERL3526, Paris, France; [Levi-Meyrueis, Corinne] Univ Paris 11, Orsay, France; [Sismeiro, Odile; Dillies, Marie-Agnes; Jagla, Bernd; Coppee, Jean-Yves] Inst Pasteur, Dept Genome & Genet, Paris, France; [Monot, Marc; Dupuy, Bruno] Inst Pasteur, Dept Microbiol, Lab Pathogenese Bacteries Anaerobies, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Norel, F (corresponding author), Inst Pasteur, Mol Genet Unit, Dept Microbiol, Paris, France.	francoise.norel@pasteur.fr	Monot, Marc/F-3058-2015	Monot, Marc/0000-0003-0738-7335	French National Research Agency [ANR- 11-BSV3-009]; Institut Pasteur; Centre National de la Recherche Scientifique	French National Research Agency(French National Research Agency (ANR)); Institut Pasteur(European Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the French National Research Agency (ANR- 11-BSV3-009 to FN) and by grants from the Institut Pasteur and the Centre National de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andrews SC, 2011, MOL MICROBIOL, V80, P286, DOI 10.1111/j.1365-2958.2011.07594.x; AVIV M, 1994, MOL MICROBIOL, V14, P1021, DOI 10.1111/j.1365-2958.1994.tb01336.x; Bang IS, 2005, MOL MICROBIOL, V56, P811, DOI 10.1111/j.1365-2958.2005.04580.x; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOCHNER BR, 1980, J BACTERIOL, V143, P926, DOI 10.1128/JB.143.2.926-933.1980; Charoenwong D, 2011, APPL ENVIRON MICROB, V77, P5220, DOI 10.1128/AEM.00648-11; Chiang SM, 2012, ARCH BIOCHEM BIOPHYS, V525, P161, DOI 10.1016/j.abb.2012.02.007; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dong T, 2010, INFECT IMMUN, V78, P887, DOI 10.1128/IAI.00882-09; Dong T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-349; Dukan S, 1999, J BIOL CHEM, V274, P26027, DOI 10.1074/jbc.274.37.26027; Ezraty B, 2013, SCIENCE, V340, P1583, DOI 10.1126/science.1238328; Farewell A, 1998, MOL MICROBIOL, V29, P1039, DOI 10.1046/j.1365-2958.1998.00990.x; Ferenci T, 2005, MOL MICROBIOL, V57, P1, DOI 10.1111/j.1365-2958.2005.04649.x; Fernandez L, 2012, CLIN MICROBIOL REV, V25, P661, DOI 10.1128/CMR.00043-12; Frohlich KS, 2012, NUCLEIC ACIDS RES, V40, P3623, DOI 10.1093/nar/gkr1156; Frohlich KS, 2013, EMBO J, V32, P2963, DOI 10.1038/emboj.2013.222; Gerlach RG, 2009, APPL ENVIRON MICROB, V75, P1575, DOI 10.1128/AEM.02509-08; Gil-Cruz C, 2009, P NATL ACAD SCI USA, V106, P9803, DOI 10.1073/pnas.0812431106; Gogol EB, 2011, P NATL ACAD SCI USA, V108, P12875, DOI 10.1073/pnas.1109379108; Gottesman S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003798; Gutierrez A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2607; Hebrard M, 2012, RNA BIOL, V9, P437, DOI 10.4161/rna.20480; Hebrard M, 2009, J BACTERIOL, V191, P4605, DOI 10.1128/JB.00144-09; Hengge R, 2011, BACTERIAL STRESS RESPONSES, 2ND EDITION, P251; Husain M, 2008, J BIOL CHEM, V283, P7682, DOI 10.1074/jbc.M708845200; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Ibanez-Ruiz M, 2000, J BACTERIOL, V182, P5749, DOI 10.1128/JB.182.20.5749-5756.2000; Jonas K, 2010, ENVIRON MICROBIOL, V12, P524, DOI 10.1111/j.1462-2920.2009.02097.x; Kim JN, 2013, MICROBIOL RES, V168, P41, DOI 10.1016/j.micres.2012.06.007; Klupakis AK, 2002, J BACTERIOL, V184, P2940; Kroger C, 2012, P NATL ACAD SCI USA, V109, pE1277, DOI 10.1073/pnas.1201061109; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lacour S, 2004, J BACTERIOL, V186, P7186, DOI 10.1128/JB.186.21.7186-7195.2004; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee EJ, 2013, CELL, V154, P146, DOI 10.1016/j.cell.2013.06.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu CD, 1999, J BACTERIOL, V181, P1934, DOI 10.1128/JB.181.6.1934-1938.1999; Maciag A, 2011, NUCLEIC ACIDS RES, V39, P5338, DOI 10.1093/nar/gkr129; Martinez LC, 2014, J BACTERIOL, V196, P325, DOI 10.1128/JB.00806-13; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; Mika F, 2013, INT J MOL SCI, V14, P4560, DOI 10.3390/ijms14034560; Monot M, 2014, OMICS, V18, P184, DOI 10.1089/omi.2013.0119; Monteil V, 2010, J BACTERIOL, V192, P6401, DOI 10.1128/JB.00801-10; Monteiro C, 2012, RNA BIOL, V9, P489, DOI 10.4161/rna.19682; Notley-McRobb L, 2002, J BACTERIOL, V184, P806, DOI 10.1128/JB.184.3.806-811.2002; Nystrom T, 2004, MOL MICROBIOL, V54, P855, DOI 10.1111/j.1365-2958.2004.04342.x; Osterberg S, 2011, ANNU REV MICROBIOL, V65, P37, DOI 10.1146/annurev.micro.112408.134219; Padalon-Brauch G, 2008, NUCLEIC ACIDS RES, V36, P1913, DOI 10.1093/nar/gkn050; Patten CL, 2004, MOL GENET GENOMICS, V272, P580, DOI 10.1007/s00438-004-1089-2; R Development Core Team, 2012, R LANG ENV STAT COMP; Ramachandran VK, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-25; Robbe-Saule V, 2003, APPL ENVIRON MICROB, V69, P4352, DOI 10.1128/AEM.69.8.4352-4358.2003; Robbe-Saule V, 2001, MOL MICROBIOL, V39, P1533, DOI 10.1046/j.1365-2958.2001.02340.x; Robbe-Saule V, 2007, J BACTERIOL, V189, P2976, DOI 10.1128/JB.01919-06; Robbe-Saule V, 2006, J BACTERIOL, V188, P3983, DOI 10.1128/JB.00033-06; Roche B, 2013, BBA-BIOENERGETICS, V1827, P455, DOI 10.1016/j.bbabio.2012.12.010; Romeo T, 2013, ENVIRON MICROBIOL, V15, P313, DOI 10.1111/j.1462-2920.2012.02794.x; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Sezonov G, 2007, J BACTERIOL, V189, P8746, DOI 10.1128/JB.01368-07; Silva IJ, 2013, RNA, V19, P1253, DOI 10.1261/rna.039537.113; STERNBERG NL, 1991, METHOD ENZYMOL, V204, P18; Timmermans J, 2010, CELL MOL LIFE SCI, V67, P2897, DOI 10.1007/s00018-010-0381-z; Vallenet D, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap021; Varghese S, 2003, J BACTERIOL, V185, P221, DOI 10.1128/JB.185.1.221-230.2003; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Yakhnin H, 2011, MOL MICROBIOL, V81, P689, DOI 10.1111/j.1365-2958.2011.07723.x; YAMASHINO T, 1994, MOL MICROBIOL, V13, P475, DOI 10.1111/j.1365-2958.1994.tb00442.x; ZAMBRANO MM, 1993, SCIENCE, V259, P1757, DOI 10.1126/science.7681219	73	33	35	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96918	10.1371/journal.pone.0096918	http://dx.doi.org/10.1371/journal.pone.0096918			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810289	Green Published, Green Submitted, gold			2022-12-27	WOS:000338213300090
J	Oh, J; Kim, SH; Kim, YJ; Lee, H; Cho, JH; Cho, YH; Kim, CK; Lee, TJ; Lee, S; Park, KH; Yu, HG; Lee, HJ; Jun, SC; Kim, JH				Oh, Juyeong; Kim, Seok Hwan; Kim, Yu Jeong; Lee, Hyunho; Cho, Joon Hyong; Cho, Young Ho; Kim, Chul-Ki; Lee, Taik Jin; Lee, Seok; Park, Ki Ho; Yu, Hyeong Gon; Lee, Hyuk-jae; Jun, Seong Chan; Kim, Jae Hun			Detection of Retinitis Pigmentosa by Differential Interference Contrast Microscopy	PLOS ONE			English	Article							BETA-SUBUNIT; MUTATION; MOUSE; CELL; RD; SUPPLEMENTATION; TRIAL	Differential interference contrast microscopy is designed to image unstained and transparent specimens by enhancing the contrast resulting from the Nomarski prism-effected optical path difference. Retinitis pigmentosa, one of the most common inherited retinal diseases, is characterized by progressive loss of photoreceptors. In this study, Differential interference contrast microscopy was evaluated as a new and simple application for observation of the retinal photoreceptor layer and retinitis pigmentosa diagnostics and monitoring. Retinal tissues of Royal College of Surgeons rats and retinal-degeneration mice, both well-established animal models for the disease, were prepared as flatmounts and histological sections representing different elapsed times since the occurrence of the disease. Under the microscopy, the retinal flatmounts showed that the mosaic pattern of the photoreceptor layer was irregular and partly collapsed at the early stage of retinitis pigmentosa, and, by the advanced stage, amorphous. The histological sections, similarly, showed thinning of the photoreceptor layer at the early stage and loss of the outer nuclear layer by the advanced stage. To count and compare the number of photoreceptors in the normal and early-retinitis pigmentosa-stage tissues, an automated cell-counting program designed with MATLAB, a numerical computing language, using a morphological reconstruction method, was applied to the differential interference contrast microscopic images. The number of cells significantly decreased, on average, from 282 to 143 cells for the Royal College of Surgeons rats and from 255 to 170 for the retinal-degeneration mouse. We successfully demonstrated the potential of the differential interference contrast microscopy technique's application to the diagnosis and monitoring of RP.	[Oh, Juyeong; Lee, Hyunho; Cho, Joon Hyong; Cho, Young Ho; Kim, Chul-Ki; Lee, Taik Jin; Lee, Seok; Kim, Jae Hun] KIST, Sensor Syst Res Ctr, Seoul, South Korea; [Oh, Juyeong; Jun, Seong Chan] Yonsei Univ, Sch Mech Engn, Seoul 120749, South Korea; [Kim, Seok Hwan] Seoul Natl Univ, Boramae Hosp, Dept Ophthalmol, Seoul, South Korea; [Kim, Seok Hwan; Park, Ki Ho; Yu, Hyeong Gon] Seoul Natl Univ Hosp, Dept Ophthalmol, Seoul 110744, South Korea; [Lee, Hyuk-jae] Kookmin Univ, Dept Nano & Elect Phys, Seoul, South Korea	Korea Institute of Science & Technology (KIST); Yonsei University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Kookmin University	Jun, SC (corresponding author), Yonsei Univ, Sch Mech Engn, Seoul 120749, South Korea.	scj@yonsei.ac.kr; jaekim@kist.re.kr	Cho, Joon Hyong/S-4029-2018	Yu, Hyeong Gon/0000-0002-1795-202X	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2012M3A7B4049804, 2010-0020796, 2010-0019457]; National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology (MEST) of the Korean government [2012-8-1663]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology (MEST) of the Korean government	This work was partially supported by the public welfare & safety research program (2010-0020796), Nano Material Technology Development Program (2012M3A7B4049804), and the Pioneer Research Center Program (2010-0019457) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning. The Priority Research Centers Program (2012-8-1663) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST) of the Korean government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang PK, 2011, NANO LETT, V11, P5240, DOI 10.1021/nl202579k; Audo I, 2010, ARCH OPHTHALMOL-CHIC, V128, P1036, DOI 10.1001/archophthalmol.2010.162; BERSON EL, 1993, ARCH OPHTHALMOL-CHIC, V111, P761, DOI 10.1001/archopht.1993.01090060049022; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; BUNKER CH, 1984, AM J OPHTHALMOL, V97, P357, DOI 10.1016/0002-9394(84)90636-6; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; CASPER JT, 1976, BLOOD, V47, P183; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; Cheng HY, 2006, P NATL ACAD SCI USA, V103, P17525, DOI 10.1073/pnas.0605790103; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; DEKORTE PAJ, 1979, APPL OPTICS, V18, P236, DOI 10.1364/AO.18.000236; Fariss RN, 2000, AM J OPHTHALMOL, V129, P215, DOI 10.1016/S0002-9394(99)00401-8; Godara P, 2010, OPTOMETRY VISION SCI, V87, P930, DOI 10.1097/OPX.0b013e3181ff9a8b; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hoffman DR, 2004, AM J OPHTHALMOL, V137, P704, DOI 10.1016/j.ajo.2003.10.045; Ishiwata H, 2006, OPT COMMUN, V260, P117, DOI 10.1016/j.optcom.2005.10.079; Kothari S, 2009, I S BIOMED IMAGING, P795, DOI 10.1109/ISBI.2009.5193169; Li Y, 2011, J COMPUTATIONAL INFO, V7, P4724; MCLAUGHLIN ME, 1995, P NATL ACAD SCI USA, V92, P3249, DOI 10.1073/pnas.92.8.3249; Milam AH, 1996, INVEST OPHTH VIS SCI, V37, P753; Salembier P, 1992, SIGNAL PROCESS, V29, P231; Sandberg MA, 2005, INVEST OPHTH VIS SCI, V46, P3349, DOI 10.1167/iovs.04-1383; Strettoi E, 2000, P NATL ACAD SCI USA, V97, P11020, DOI 10.1073/pnas.190291097; Sun W, 2008, ANAL BIOANAL CHEM, V391, P2119, DOI 10.1007/s00216-008-2162-1; Wilhein T, 2001, APPL PHYS LETT, V78, P2082, DOI 10.1063/1.1360776; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392; Zarubiieva I, 2013, AEROSOL AIR QUAL RES, V13, P1145, DOI 10.4209/aaqr.2012.04.0094	28	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e97170	10.1371/journal.pone.0097170	http://dx.doi.org/10.1371/journal.pone.0097170			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810005	Green Submitted, Green Published, gold			2022-12-27	WOS:000338213300128
J	Ottermanns, R; Szonn, K; Preuss, TG; Ross-Nickoll, M				Ottermanns, Richard; Szonn, Kerstin; Preuss, Thomas G.; Ross-Nickoll, Martina			Non-Linear Analysis Indicates Chaotic Dynamics and Reduced Resilience in Model-Based Daphnia Populations Exposed to Environmental Stress	PLOS ONE			English	Article							DENSITY-DEPENDENCE; RECURRENCE PLOTS; CHRONIC TOXICITY; RISK-ASSESSMENT; AGE CLASSES; RECOVERY; STABILITY; COMPETITION; MAGNA; 3,4-DICHLOROANILINE	In this study we present evidence that anthropogenic stressors can reduce the resilience of age-structured populations. Enhancement of disturbance in a model-based Daphnia population lead to a repression of chaotic population dynamics at the same time increasing the degree of synchrony between the population's age classes. Based on the theory of chaos-mediated survival an increased risk of extinction was revealed for this population exposed to high concentrations of a chemical stressor. The Lyapunov coefficient was supposed to be a useful indicator to detect disturbance thresholds leading to alterations in population dynamics. One possible explanation could be a discrete change in attractor orientation due to external disturbance. The statistical analysis of Lyapunov coefficient distribution is proposed as a methodology to test for significant non-linear effects of general disturbance on populations. Although many new questions arose, this study forms a theoretical basis for a dynamical definition of population recovery.	[Ottermanns, Richard; Szonn, Kerstin; Preuss, Thomas G.; Ross-Nickoll, Martina] Rhein Westfal TH Aachen, Inst Environm Res, Aachen, Germany	RWTH Aachen University	Ottermanns, R (corresponding author), Rhein Westfal TH Aachen, Inst Environm Res, Aachen, Germany.	ottermanns@bio5.rwth-aachen.de	RoÃ-NIckoll, Martina/HGE-9656-2022; Ottermanns, Richard/C-8466-2013; Preuss, Thomas G./A-7926-2009	Ottermanns, Richard/0000-0002-2168-9455; Preuss, Thomas G./0000-0001-6249-6003				ABARBANEL HDI, 1994, PHYS REV E, V49, P1840, DOI 10.1103/PhysRevE.49.1840; ADEMA DMM, 1978, HYDROBIOLOGIA, V59, P125, DOI 10.1007/BF00020773; ADEMA DMM, 1981, CHEMOSPHERE, V10, P533, DOI 10.1016/0045-6535(81)90255-1; AIELLO WG, 1990, MATH BIOSCI, V101, P139, DOI 10.1016/0025-5564(90)90019-U; ALLEN JC, 1993, NATURE, V364, P229, DOI 10.1038/364229a0; ALLEN JC, 1990, ECOL MODEL, V51, P281, DOI 10.1016/0304-3800(90)90072-O; [Anonymous], CREATING FORESTRY 21; Argyris JH., 1994, EXPLORATION CHAOS; BAIRD DJ, 1991, ECOTOX ENVIRON SAFE, V21, P257, DOI 10.1016/0147-6513(91)90064-V; Barnthouse LW, 2004, ENVIRON TOXICOL CHEM, V23, P500, DOI 10.1897/02-521; Baudo R., 1987, MEM I ITAL IDROBIOL, V45, P461; Becks L, 2005, NATURE, V435, P1226, DOI 10.1038/nature03627; BELLOWS TS, 1982, J ANIM ECOL, V51, P263, DOI 10.2307/4324; BENDER EA, 1984, ECOLOGY, V65, P1, DOI 10.2307/1939452; Beninca E, 2008, NATURE, V451, P822, DOI 10.1038/nature06512; BERGH MO, 1988, J MATH BIOL, V26, P551, DOI 10.1007/BF00276060; Bjornstad ON, 2004, J ANIM ECOL, V73, P1157, DOI 10.1111/j.0021-8790.2004.00888.x; Box GE, 1976, TIME SERIES ANAL FOR, V2nd; Caswell H, 1989, MATRIX POPULATION MO; Chazdon RL, 2003, PERSPECT PLANT ECOL, V6, P51, DOI 10.1078/1433-8319-00042; COSTANTINO RF, 1995, NATURE, V375, P227, DOI 10.1038/375227a0; Costantino RF, 1997, SCIENCE, V275, P389, DOI 10.1126/science.275.5298.389; Cushing J.M., 1987, Developments in Environmental Modelling, V11, P153; Cushing JM, 1998, J THEOR BIOL, V194, P1, DOI 10.1006/jtbi.1998.0736; CUSHING JM, 1989, B MATH BIOL, V51, P687, DOI 10.1007/BF02459656; CUSHING JM, 1992, B MATH BIOL, V54, P503, DOI 10.1007/BF02459632; CUSHING JM, 1984, J MATH BIOL, V20, P259, DOI 10.1007/BF00275988; Dennis B, 2001, ECOL MONOGR, V71, P277, DOI 10.1890/0012-9615(2001)071[0277:ECACDI]2.0.CO;2; Dennis B, 2003, OIKOS, V102, P329, DOI 10.1034/j.1600-0706.2003.12387.x; DODSON SI, 1995, ENVIRON HEALTH PERSP, V103, P7, DOI 10.2307/3432405; EBENMAN B, 1987, J THEOR BIOL, V124, P25, DOI 10.1016/S0022-5193(87)80249-7; EBENMAN B, 1988, J THEOR BIOL, V131, P389, DOI 10.1016/S0022-5193(88)80036-5; Ebenman B., 1988, SIZE STRUCTURED POPU; ECKMANN JP, 1985, REV MOD PHYS, V57, P617, DOI 10.1103/RevModPhys.57.617; ECKMANN JP, 1987, EUROPHYS LETT, V4, P973, DOI 10.1209/0295-5075/4/9/004; ELENDT BP, 1990, WATER RES, V24, P1169, DOI 10.1016/0043-1354(90)90181-5; ELLNER S, 1995, AM NAT, V145, P343, DOI 10.1086/285744; European Commission (EU), 2006, 3 4 DICHLOROANILINE; Gabsi F, 2014, ECOL MODEL, V280, P18, DOI 10.1016/j.ecolmodel.2013.06.018; Gao JB, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.066204; Gao JB, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016117; Gergs A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02036; Golestani A, 2010, CHAOS, V20, DOI 10.1063/1.3514011; Grimm V, 1997, OECOLOGIA, V109, P323, DOI 10.1007/s004420050090; GUCKENHEIMER J, 1977, J MATH BIOL, V4, P101, DOI 10.1007/BF00275980; Gunderson LH, 2000, ANNU REV ECOL SYST, V31, P425, DOI 10.1146/annurev.ecolsys.31.1.425; GURTIN ME, 1974, ARCH RATION MECH AN, V54, P280; HASSELL MP, 1975, J ANIM ECOL, V44, P283, DOI 10.2307/3863; HASTINGS A, 1983, THEOR POPUL BIOL, V23, P347, DOI 10.1016/0040-5809(83)90023-0; HASTINGS A, 1992, THEOR POPUL BIOL, V41, P388, DOI 10.1016/0040-5809(92)90036-S; HASTINGS A, 1984, J MATH BIOL, V21, P35, DOI 10.1007/BF00275221; Hegger R, 1999, CHAOS, V9, P413, DOI 10.1063/1.166424; Higgins K, 1997, AM NAT, V149, P247, DOI 10.1086/285989; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Hopp PW, 2010, INSECT CONSERV DIVER, V3, P103, DOI 10.1111/j.1752-4598.2010.00078.x; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUSTON M, 1988, BIOSCIENCE, V38, P682, DOI 10.2307/1310870; Jorgensen SE., 2004, THERMODYNAMIC THEORY, V1; KANTZ H, 1994, PHYS LETT A, V185, P77, DOI 10.1016/0375-9601(94)90991-1; Kantz H., 2004, NONLINEAR TIME SERIE; Kareiva P., 1989, P68; Kluttgen B, 1996, CHEMOSPHERE, V32, P2015, DOI 10.1016/0045-6535(96)00081-1; KOSTELICH EJ, 1990, PHYSICA D, V41, P183, DOI 10.1016/0167-2789(90)90121-5; Lampert W, 2006, POL J ECOL, V54, P607; Levin S. A., 1981, Renewable Resource Management. Proceedings of a Workshop on Control Theory, P21; LEVIN SA, 1980, J MATH BIOL, V9, P245, DOI 10.1007/BF00276028; Liess M, 2006, ENVIRON TOXICOL CHEM, V25, P1326, DOI 10.1897/05-466R.1; Ling SD, 2009, P NATL ACAD SCI USA, V106, P22341, DOI 10.1073/pnas.0907529106; LIU LF, 1987, J MATH BIOL, V25, P73, DOI 10.1007/BF00275889; Lopes C, 2005, ECOL MODEL, V188, P30, DOI 10.1016/j.ecolmodel.2005.05.004; Ma~ne R., 1981, LECT NOTES MATH, P230, DOI DOI 10.1007/BFB0091916; Marwan N, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.026702; Marwan N, 2007, PHYS REP, V438, P237, DOI 10.1016/j.physrep.2006.11.001; MAY RM, 1975, J THEOR BIOL, V51, P511, DOI 10.1016/0022-5193(75)90078-8; May RM, 1974, J ANIM ECOL, V47, P249; MEA, 2005, EC HUM WELL BEING SY, DOI DOI 10.1119/1.2344558; Metz J. A. J., 1986, LECT NOTES BIOMATHEM, V68; Naito W, 2002, WATER RES, V36, P1, DOI 10.1016/S0043-1354(01)00200-7; NEWMAN MC, 2008, ECOTOXICOLOGY COMPRE; Newman MC., 2013, QUANTITATIVE ECOTOXI; NEWTON I, 1992, J APPL ECOL, V29, P476, DOI 10.2307/2404515; NISBET RM, 1994, J MATH BIOL, V32, P329, DOI 10.1007/BF00160164; NYCHKA D, 1992, J ROY STAT SOC B MET, V54, P399; Ott E, 2002, CHAOS DYNAMICAL SYST; Ottermanns R, 2011, ECOL COMPLEX, V8, P299, DOI 10.1016/j.ecocom.2011.06.001; Peters R.H., 1987, DAPHNIA; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; Poincare H, 1892, METHODS NOUVELLES ME; Preuss TG, 2010, J ENVIRON MONITOR, V12, P2070, DOI 10.1039/c0em00096e; Preuss TG, 2009, ECOL MODEL, V220, P310, DOI 10.1016/j.ecolmodel.2008.09.018; R Core Team, 2021, R LANGUAGE ENV STAT; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; ROSENSTEIN MT, 1993, PHYSICA D, V65, P117, DOI 10.1016/0167-2789(93)90009-P; SAUER T, 1991, J STAT PHYS, V65, P579, DOI 10.1007/BF01053745; Stenseth NC, 1996, P ROY SOC B-BIOL SCI, V263, P1117, DOI 10.1098/rspb.1996.0164; Summers D, 2000, CHAOS SOLITON FRACT, V11, P2331, DOI 10.1016/S0960-0779(99)00154-X; Takens F, 1981, DYNAMICAL SYSTEMS TU, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; Tang SY, 2003, B MATH BIOL, V65, P479, DOI 10.1016/S0092-8240(03)00005-3; Tang SY, 2002, J MATH BIOL, V44, P185, DOI 10.1007/s002850100121; TENBERGE WF, 1978, HYDROBIOLOGIA, V59, P121, DOI 10.1007/BF00020772; TSCHUMY WO, 1982, THEOR POPUL BIOL, V21, P255, DOI 10.1016/0040-5809(82)90017-X; Turchin P, 2000, ECOLOGY, V81, P3099, DOI 10.1890/0012-9658(2000)081[3099:LOTEOC]2.0.CO;2; Van den Brink PJ, 2007, ENVIRON TOXICOL CHEM, V26, P2226, DOI 10.1897/07-022R.1; Van den Brink PJ, 2006, ECOL MODEL, V191, P106, DOI 10.1016/j.ecolmodel.2005.08.015; VANDERHOEVEN N, 1990, ECOTOX ENVIRON SAFE, V20, P53, DOI 10.1016/0147-6513(90)90046-8; Vandermeer J, 2001, CHAOS SOLITON FRACT, V12, P265, DOI 10.1016/S0960-0779(00)00111-9; WALLACE JB, 1990, ENVIRON MANAGE, V14, P605, DOI 10.1007/BF02394712; Webb CT, 2007, BIOSCIENCE, V57, P470, DOI 10.1641/B570602; Webb G., 1985, THEORY NONLINEAR AGE; White P.S., 1985, ECOLOGY NATURAL DIST; Wikan A, 1996, J MATH BIOL, V35, P195; Wogram J, 2001, B ENVIRON CONTAM TOX, V67, P360; WOLF A, 1985, PHYSICA D, V16, P285, DOI 10.1016/0167-2789(85)90011-9; Zunino L, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.046210	114	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96270	10.1371/journal.pone.0096270	http://dx.doi.org/10.1371/journal.pone.0096270			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809537	Green Published, gold			2022-12-27	WOS:000338213300025
J	Srivastava, AK; Rai, S; Srivastava, MK; Lohani, M; Mudiam, MKR; Srivastava, LP				Srivastava, Ashutosh K.; Rai, Satyajeet; Srivastava, M. K.; Lohani, M.; Mudiam, M. K. R.; Srivastava, L. P.			Determination of 17 Organophosphate Pesticide Residues in Mango by Modified QuEChERS Extraction Method Using GC-NPD/GC-MS and Hazard Index Estimation in Lucknow, India	PLOS ONE			English	Article							SOLID-PHASE EXTRACTION; LIQUID-CHROMATOGRAPHY; MULTIRESIDUE METHOD; VEGETABLES; FRUITS; VALIDATION	A total of 162 samples of different varieties of mango: Deshehari, Langra, Safeda in three growing stages (Pre-mature, Unripe and Ripe) were collected from Lucknow, India, and analyzed for the presence of seventeen organophosphate pesticide residues. The QuEChERS (Quick, Easy, Cheap, Effective, Rugged and Safe) method of extraction coupled with gas chromatography was validated for pesticides and qualitatively confirmed by gas chromatography-mass spectrometry. The method was validated with different concentrations of mixture of seventeen organophosphate pesticides (0.05, 0.10, 0.50 mg kg(-1)) in mango. The average recovery varied from 70.20% to 95.25% with less than 10% relative standard deviation. The limit of quantification of different pesticides ranged from 0.007 to 0.033 mg kg(-1). Out of seventeen organophosphate pesticides only malathion and chlorpyriphos were detected. Approximately 20% of the mango samples have shown the presence of these two pesticides. The malathion residues ranged from ND-1.407 mg kg(-1) and chlorpyriphos ND-0.313 mg kg(-1) which is well below the maximum residues limit (PFA-1954). In three varieties of mango at different stages from unpeeled to peeled sample reduction of malathion and chlorpyriphos ranged from 35.48%-100% and 46.66%-100% respectively. The estimated daily intake of malathion ranged from 0.032 to 0.121 mg kg(-1) and chlorpyriphos ranged from zero to 0.022 mg kg(-1) body weight from three different stages of mango. The hazard indices ranged from 0.0015 to 0.0060 for malathion and zero to 0.0022 for chlorpyriphos. It is therefore indicated that seasonal consumption of these three varieties of mango may not pose any health hazards for the population of Lucknow, city, India because the hazard indices for malathion and chlorpyriphos residues were below to one.	[Srivastava, Ashutosh K.; Rai, Satyajeet; Srivastava, M. K.; Mudiam, M. K. R.; Srivastava, L. P.] Govt India, Council Sci & Ind Res, CSIR Indian Inst Toxicol Res, Pesticide Toxicol Lab, Lucknow, Uttar Pradesh, India; [Lohani, M.] Integral Univ, Dept Biotechnol, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Integral University	Srivastava, LP (corresponding author), Govt India, Council Sci & Ind Res, CSIR Indian Inst Toxicol Res, Pesticide Toxicol Lab, Mahatma Gandhi Marg, Lucknow, Uttar Pradesh, India.	laxmanprasad13@gmail.com	Lohani, Mohtashim/AAR-3394-2021; Mudiam, Mohana Krishna Reddy/O-6824-2014	Mudiam, Mohana Krishna Reddy/0000-0002-0771-8053	MPRNL (Monitoring of Pesticide Residues at National Level) Government of India [GAP-168]; CSIR-SRF Contingency	MPRNL (Monitoring of Pesticide Residues at National Level) Government of India; CSIR-SRF Contingency	The financial assistance for the publication of manuscript is provided by GAP-168 MPRNL (Monitoring of Pesticide Residues at National Level) Government of India, as well as the CSIR-SRF Contingency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassiades M, 2003, J AOAC INT, V86, P412; Aysal P, 2007, J ENVIRON SCI HEAL B, V42, P481, DOI 10.1080/19312450701392490; Banerjee K, 2009, J AGR FOOD CHEM, V57, P4068, DOI 10.1021/jf900358r; Barakat AA, 2007, J FOOD AGRIC ENVIRON, V5, P97; Bhanti M, 2007, CHEMOSPHERE, V69, P63, DOI 10.1016/j.chemosphere.2007.04.071; Biswas B, 2011, FERTILIZER MARKETING, P1; Darko G, 2008, FOOD CHEM TOXICOL, V46, P3703, DOI 10.1016/j.fct.2008.09.049; European Commission, 2007, SANCO20073131 EUR CO; Filho AM, 2011, J SEP SCI, V34, P2960, DOI 10.1002/jssc.201100341; Food and Agriculture Organization, 2002, SUBM EV PEST RES EST; Lehotay SJ, 2007, J AOAC INT, V90, P485; Mohapatra S, 2011, B ENVIRON CONTAM TOX, V86, P101, DOI 10.1007/s00128-010-0154-2; Mukherjee I, 2007, B ENVIRON CONTAM TOX, V78, P380, DOI 10.1007/s00128-007-9203-x; National Nutrition Monitoring Bureau (NNMB), 1979, SANCO20073131 EUR CO; Osman KA, 2011, FOOD CONTROL, V22, P947, DOI 10.1016/j.foodcont.2010.11.031; Pathak MK, 2013, ENVIRON SCI POLLUT R, V20, P7296, DOI 10.1007/s11356-013-1743-5; Pathak MK, 2011, TOXICOL ENVIRON CHEM, V93, P188, DOI 10.1080/02772248.2010.496587; Paya P, 2007, ANAL BIOANAL CHEM, V389, P1697, DOI 10.1007/s00216-007-1610-7; Perret D, 2002, J AOAC INT, V85, P724; PRATI P, 2008, BIO ENG, V2, P37; Raju MB, 2011, J APP BIO PHARM TECH, V2, P279; Saadati N, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-63; Sharma D, 2010, TALANTA, V82, P1077, DOI 10.1016/j.talanta.2010.06.043; Sharma KK, 2007, PESTICIDE RESIDUES A; Srivastava AK, 2011, ENVIRON MONIT ASSESS, V176, P465, DOI 10.1007/s10661-010-1597-y; Taylor JK, 1987, QUALITY ASSURANCE CH; Wang LG, 2008, B ENVIRON CONTAM TOX, V81, P377, DOI 10.1007/s00128-008-9498-2; World Health Organization: WHO, 1997, CHEM CENTRAL J; Furlani RPZ, 2011, FOOD CHEM, V126, P1283, DOI 10.1016/j.foodchem.2010.11.074	29	13	14	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96493	10.1371/journal.pone.0096493	http://dx.doi.org/10.1371/journal.pone.0096493			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809911	Green Submitted, gold, Green Published			2022-12-27	WOS:000338213300047
J	Sunguya, BF; Hinthong, W; Jimba, M; Yasuoka, J				Sunguya, Bruno F.; Hinthong, Woranich; Jimba, Masamine; Yasuoka, Junko			Interprofessional Education for Whom? - Challenges and Lessons Learned from Its Implementation in Developed Countries and Their Application to Developing Countries: A Systematic Review	PLOS ONE			English	Article							MEDICAL-EDUCATION; ACCREDITATION STANDARDS; HEALTH-PROFESSIONS; MENTAL-HEALTH; US COLLEGES; STUDENTS; COMPETENCES; TEAMWORK; PERCEPTIONS; LEADERSHIP	Background: Evidence is available on the potential efficacy of interprofessional education (IPE) to foster interprofessional cooperation, improve professional satisfaction, and improve patient care. While the intention of the World Health Organization (WHO) is to implement IPE in all countries, evidence comes from developed countries about its efficiency, challenges, and barriers to planning and implementing IPE. We therefore conducted this review to examine challenges of implementing IPE to suggest possible pathways to overcome the anticipated challenges in developing countries. Methods: We searched for literatures on IPE in PubMed/MEDLINE, CINAHL, PsycINFO, and ERIC databases. We examined challenges or barriers and initiatives to overcome them so as to suggest methods to solve the anticipated challenges in developing countries. We could not conduct a meta-analysis because of the qualitative nature of the research question and the data; instead we conducted a meta-narrative of evidence. Results: A total of 40 out of 2,146 articles were eligible for analyses in the current review. Only two articles were available from developing countries. Despite the known benefits of IPE, a total of ten challenges or barriers were common based on the retrieved evidence. They included curriculum, leadership, resources, stereotypes and attitudes, variety of students, IPE concept, teaching, enthusiasm, professional jargons, and accreditation. Out of ten, three had already been reported in developing countries: IPE curriculum, resource limitations, and stereotypes. Conclusion: This study found ten important challenges on implementing IPE. They are curriculum, leadership, resources, stereotypes, students' diversity, IPE concept, teaching, enthusiasm, professional jargons, and accreditation. Although only three of them are already experienced in developing countries, the remaining seven are potentially important for developing countries, too. By knowing these challenges and barriers in advance, those who implement IPE programs in developing countries will be much more prepared, and can enhance the program's potential success.	[Sunguya, Bruno F.; Jimba, Masamine; Yasuoka, Junko] Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Tokyo, Japan; [Hinthong, Woranich] Mahidol Univ, Fac Trop Med, Dept Social & Environm Med, Bangkok, Thailand	University of Tokyo; Mahidol University	Yasuoka, J (corresponding author), Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Tokyo, Japan.	jyasuoka@post.harvard.edu	Yasuoka, Junko/GVT-8950-2022; Jimba, Masamine/AAF-5630-2020	Sunguya, Bruno/0000-0003-3625-0725; Hinthong, Woranich/0000-0002-4466-9246	Directorate of Research and Publication of the Muhimbili University of Health and Allied Sciences [MU/01/1022/0130/21]; Ministry of Health, Labor and Welfare of Japan [H24-Chikyukibo-Ippan-008]	Directorate of Research and Publication of the Muhimbili University of Health and Allied Sciences; Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study is funded by a grant from the Directorate of Research and Publication of the Muhimbili University of Health and Allied Sciences (Ref. No: MU/01/1022/0130/21), and the Ministry of Health, Labor and Welfare of Japan (Research Grant No: H24-Chikyukibo-Ippan-008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aase I, 2013, J INTERPROF CARE, V27, P238, DOI 10.3109/13561820.2012.745489; Anderson ES, 2009, J INTERPROF CARE, V23, P81, DOI 10.1080/13561820802565106; Anderson ES, 2009, J INTERPROF CARE, V23, P557, DOI 10.3109/13561820903051451; Aston SJ, 2012, ACAD MED, V87, P949, DOI 10.1097/ACM.0b013e3182583374; Ateah CA, 2011, NURS EDUC TODAY, V31, P208, DOI 10.1016/j.nedt.2010.06.004; Barker Keegan K, 2005, J Interprof Care, V19, P207, DOI 10.1080/13561820500138693; Barr Hugh, 2006, J Interprof Care, V20, P75; Beaglehole R, 2011, LANCET, V378, P449, DOI 10.1016/S0140-6736(11)60879-9; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Blue AV, 2010, J INTERPROF CARE, V24, P204, DOI 10.3109/13561820903442887; Brashers V, 2012, J INTERPROF CARE, V26, P73, DOI 10.3109/13561820.2011.636846; Brennan CW, 2013, J INTERPROF CARE; Brett J, 2013, EXPLORE-NY, V9, P314, DOI 10.1016/j.explore.2013.06.001; Brigley S, 2009, MED TEACH, V31, pE169, DOI 10.1080/01421590802590546; Buring SM, 2009, AM J PHARM EDUC, V73, DOI 10.5688/aj730460; Cameron Andrea, 2009, J Allied Health, V38, P220; Cameron A, 2009, AM J PHARM EDUC, V73, DOI 10.5688/aj730462; Carlisle C, 2004, MED TEACH, V26, P545, DOI 10.1080/61421590410001711616; Chen C, 2012, HUM RESOUR HEALTH, V10, DOI 10.1186/1478-4491-10-4; Church EA, 2010, HEALTH SOC CARE COMM, V18, P433, DOI 10.1111/j.1365-2524.2010.00938.x; Clark PG, 2011, J INTERPROF CARE, V25, P26, DOI 10.3109/13561820.2010.497751; Courtenay M, 2013, J INTERPROF CARE, V27, P93, DOI 10.3109/13561820.2012.724126; Curran V, 2012, ACAD PSYCHIATR, V36, P91, DOI 10.1176/appi.ap.10030045; Djukic M, 2012, NURS CLIN N AM, V47, P333, DOI 10.1016/j.cnur.2012.05.003; Fook J, 2013, J INTERPROF CARE, V27, P286, DOI 10.3109/13561820.2012.759911; Forte A, 2009, J INTERPROF CARE, V23, P58, DOI 10.1080/13561820802551874; Furber C, 2004, MIDWIFERY, V20, P358, DOI 10.1016/j.midw.2004.04.001; Gilbert John H V, 2005, J Interprof Care, V19 Suppl 1, P87, DOI 10.1080/13561820500067132; Ginsburg Liane, 2005, J Interprof Care, V19 Suppl 1, P177, DOI 10.1080/13561820500083105; Hammick M, 2007, MED TEACH, V29, P735, DOI 10.1080/01421590701682576; Hammick Marilyn, 2002, J Interprof Care, V16, P80; Headrick LA, 2012, HEALTH AFFAIR, V31, P2669, DOI 10.1377/hlthaff.2011.0121; Henderson LN, 2008, HUM RESOUR HEALTH, V6, DOI 10.1186/1478-4491-6-18; Ho K, 2008, ACAD MED, V83, P934, DOI 10.1097/ACM.0b013e3181850a75; Hoffman SJ, 2008, MED EDUC, V42, P654, DOI 10.1111/j.1365-2923.2008.03042.x; Hosny S, 2013, MED TEACH, V35, pS68, DOI 10.3109/0142159X.2013.765550; Jacobs JL, 2013, MED TEACH, V35, P343, DOI 10.3109/0142159X.2013.775414; Jones KM, 2012, AM J PHARM EDUC, V76, DOI 10.5688/ajpe76580; Juntunen Anitta, 2004, J Interprof Care, V18, P269, DOI 10.1080/13561820410001731313; Kobor K, 2009, J INTERPROF CARE, V23, P523, DOI 10.1080/13561820902921951; Lapkin S, 2012, J INTERPROF CARE, V26, P390, DOI 10.3109/13561820.2012.690009; Leasure EL, 2013, ACAD MED, V88, P585, DOI 10.1097/ACM.0b013e31828b0289; Lee B, 2012, J INTERPROF CARE, V26, P479, DOI 10.3109/13561820.2012.706336; Leon BK, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-3; Lindqvist SM, 2007, MED TEACH, V29, P403, DOI 10.1080/01421590701509662; Liston BW, 2011, ACAD MED, V86, P872, DOI 10.1097/ACM.0b013e31821d699b; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; McKimm J, 2010, NEW ZEAL MED J, V123, P96; Meffe F, 2012, J INTERPROF CARE, V26, P183, DOI 10.3109/13561820.2011.645089; Mitchell PH, 2006, ACAD MED, V81, P891, DOI 10.1097/01.ACM.0000238078.93713.a6; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Mullan F, 2012, HEALTH AFFAIR, V31, P1561, DOI 10.1377/hlthaff.2012.0219; Nango Eishu, 2010, Journal of Medical and Dental Sciences, V57, P109; Ndetei DM, 2010, MED TEACH, V32, P812, DOI 10.3109/0142159X.2010.496011; Olenick M, 2010, ADV MED EDUC PRACT, V1, P75, DOI 10.2147/AMEP.S13207; Oman KM, 2009, QUAL HEALTH RES, V19, P1246, DOI 10.1177/1049732309344116; Oman KM, 2009, HUMAN RESOURCES HLTH, V7, P10; Organization WH, 2016, GLOBAL STATUS REPORT; Pecukonis E, 2013, SOC WORK HEALTH CARE, V52, P625, DOI 10.1080/00981389.2013.792913; Pecukonis E, 2008, J INTERPROF CARE, V22, P417, DOI 10.1080/13561820802190442; Priest HM, 2008, J NURS MANAGE, V16, P474, DOI 10.1111/j.1365-2834.2008.00867.x; Rafter Mary E, 2006, J Dent Educ, V70, P417; Reeves S, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002213.pub2; Reeves Scott, 2006, Nurse Educ Pract, V6, P246, DOI 10.1016/j.nepr.2006.02.001; Russell Lynn, 2006, J Interprof Care, V20, P29, DOI 10.1080/13561820500476473; Salfi J, 2012, J NURS EDUC, V51, P106, DOI 10.3928/01484834-20111230-05; Smith KM, 2009, AM J PHARM EDUC, V73, DOI 10.5688/aj730461; Steinert Yvonne, 2005, J Interprof Care, V19 Suppl 1, P60, DOI 10.1080/13561820500081778; Stew Graham, 2005, J Interprof Care, V19, P223, DOI 10.1080/13561820500138685; Thistlethwaite J, 2010, J INTERPROF CARE, V24, P503, DOI 10.3109/13561820.2010.483366; Tullmann DF, 2013, J INTERPROF CARE, V27, P426, DOI 10.3109/13561820.2013.790880; Wessels Q, 2013, J INTERPROF CARE, V27, P69, DOI 10.3109/13561820.2013.804043; World Health Organization, 2010, FRAM ACT INT ED COLL; World Health Organization (WHO), 2006, WORLD HLTH REP 2006; Zorek J, 2013, J INTERPROF CARE, V27, P123, DOI 10.3109/13561820.2012.718295	75	74	78	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96724	10.1371/journal.pone.0096724	http://dx.doi.org/10.1371/journal.pone.0096724			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK1XT	24809509	Green Published, Green Submitted, gold			2022-12-27	WOS:000338213300064
J	Tsairidou, S; Woolliams, JA; Allen, AR; Skuce, RA; McBride, SH; Wright, DM; Bermingham, ML; Pong-Wong, R; Matika, O; McDowell, SWJ; Glass, EJ; Bishop, SC				Tsairidou, Smaragda; Woolliams, John A.; Allen, Adrian R.; Skuce, Robin A.; McBride, Stewart H.; Wright, David M.; Bermingham, Mairead L.; Pong-Wong, Ricardo; Matika, Oswald; McDowell, Stanley W. J.; Glass, Elizabeth J.; Bishop, Stephen C.			Genomic Prediction for Tuberculosis Resistance in Dairy Cattle	PLOS ONE			English	Article							BOVINE TUBERCULOSIS; MYCOBACTERIUM-BOVIS; GENETIC-RESISTANCE; INBREEDING TRENDS; INFECTION; SELECTION; DISEASE; IMPACT; ACCURACY; RISK	Background: The increasing prevalence of bovine tuberculosis (bTB) in the UK and the limitations of the currently available diagnostic and control methods require the development of complementary approaches to assist in the sustainable control of the disease. One potential approach is the identification of animals that are genetically more resistant to bTB, to enable breeding of animals with enhanced resistance. This paper focuses on prediction of resistance to bTB. We explore estimation of direct genomic estimated breeding values (DGVs) for bTB resistance in UK dairy cattle, using dense SNP chip data, and test these genomic predictions for situations when disease phenotypes are not available on selection candidates. Methodology/Principal Findings: We estimated DGVs using genomic best linear unbiased prediction methodology, and assessed their predictive accuracies with a cross validation procedure and receiver operator characteristic (ROC) curves. Furthermore, these results were compared with theoretical expectations for prediction accuracy and area-under-the-ROC-curve (AUC). The dataset comprised 1151 Holstein-Friesian cows (bTB cases or controls). All individuals (592 cases and 559 controls) were genotyped for 727,252 loci (Illumina Bead Chip). The estimated observed heritability of bTB resistance was 0.23 +/- 0.06 (0.34 on the liability scale) and five-fold cross validation, replicated six times, provided a prediction accuracy of 0.33 (95% C.I.: 0.26, 0.40). ROC curves, and the resulting AUC, gave a probability of 0.58, averaged across six replicates, of correctly classifying cows as diseased or as healthy based on SNP chip genotype alone using these data. Conclusions/Significance: These results provide a first step in the investigation of the potential feasibility of genomic selection for bTB resistance using SNP data. Specifically, they demonstrate that genomic selection is possible, even in populations with no pedigree data and on animals lacking bTB phenotypes. However, a larger training population will be required to improve prediction accuracies.	[Tsairidou, Smaragda; Woolliams, John A.; Bermingham, Mairead L.; Pong-Wong, Ricardo; Matika, Oswald; Glass, Elizabeth J.; Bishop, Stephen C.] Univ Edinburgh, Roslin Inst, Edinburgh EH8 9YL, Midlothian, Scotland; [Tsairidou, Smaragda; Woolliams, John A.; Bermingham, Mairead L.; Pong-Wong, Ricardo; Matika, Oswald; Glass, Elizabeth J.; Bishop, Stephen C.] Univ Edinburgh, RDVS, Edinburgh EH8 9YL, Midlothian, Scotland; [Allen, Adrian R.; Skuce, Robin A.; McBride, Stewart H.; McDowell, Stanley W. J.] Agrifood & Biosci Inst, Belfast, Antrim, North Ireland; [Wright, David M.] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Agri-Food & Biosciences Institute; Queens University Belfast	Tsairidou, S (corresponding author), Univ Edinburgh, Roslin Inst, Edinburgh EH8 9YL, Midlothian, Scotland.	Smaragda.Tsairidou@roslin.ed.ac.uk	Bermingham, Mairead L./A-3372-2015; Allen, Adrian R/C-6242-2009; Glass, Elizabeth J/L-4612-2016; Matika, Oswald/C-9913-2013	Bermingham, Mairead L./0000-0002-0931-0051; Glass, Elizabeth J/0000-0002-6183-0185; Pong-Wong, Ricardo/0000-0001-9808-2742; McDowell, Stanley/0000-0002-9081-1469; Wright, David/0000-0001-8948-3691; Matika, Oswald/0000-0002-4213-3907	Roslin Institute; University of Edinburgh through the Principal's Career Development PhD; Greek State Scholarship Foundation; Biotechnology and Biological Sciences Research Council, through CEDFAS initiative [BB/E018335/1, BB/E018335/2]; Roslin Institute Strategic Programme Grant; Biotechnology and Biological Sciences Research Council [BB/E018335/2, BB/E018386/1, BBS/E/D/20211554, BBS/E/D/20231760, BB/E018335/1] Funding Source: researchfish; BBSRC [BB/E018335/2, BB/E018335/1, BBS/E/D/20211554, BB/E018386/1, BBS/E/D/20231760] Funding Source: UKRI	Roslin Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Edinburgh through the Principal's Career Development PhD; Greek State Scholarship Foundation(Greek Ministry of Development-GSRT); Biotechnology and Biological Sciences Research Council, through CEDFAS initiative; Roslin Institute Strategic Programme Grant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Smaragda Tsairidou gratefully acknowledges financial support from the Roslin Institute and the University of Edinburgh through the Principal's Career Development PhD, as well as the Greek State Scholarship Foundation. The authors also acknowledge the financial support of the Biotechnology and Biological Sciences Research Council, through CEDFAS initiative grants BB/E018335/1 & 2, and the Roslin Institute Strategic Programme Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy DA, 2006, VET MICROBIOL, V112, P231, DOI 10.1016/j.vetmic.2005.11.023; Allen AR, 2010, P ROY SOC B-BIOL SCI, V277, P2737, DOI 10.1098/rspb.2010.0830; Bermingham ML, 2009, J DAIRY SCI, V92, P3447, DOI 10.3168/jds.2008-1848; Bermingham ML, 2014, HEREDITY; Bishop Stephen C., 2012, Frontiers in Genetics, V3, P114, DOI [10.3389/fgene.2012.00114, 10.3389/fgene.2012.00266]; Bishop SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008940; Brotherstone S, 2010, J DAIRY SCI, V93, P1234, DOI 10.3168/jds.2009-2609; Buddle BM, 2003, INT J PARASITOL, V33, P555, DOI 10.1016/S0020-7519(03)00060-2; Cox DR, 2005, P NATL ACAD SCI USA, V102, P17588, DOI 10.1073/pnas.0509003102; Daetwyler HD, 2013, GENETICS, V193, P347, DOI 10.1534/genetics.112.147983; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; Daetwyler HD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003395; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; de los Campos G, 2012, GENETICS; Donnelly CA, 2007, INT J INFECT DIS, V11, P300, DOI 10.1016/j.ijid.2007.04.001; Falconer D.S., 1997, INTRO QUANTITATIVE G, VFourth; Ferguson NM, 2001, NATURE, V413, P542, DOI 10.1038/35097116; Gilmour AR, 2009, ASREML USER GUIDE RE; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; Hastie T., 2003, ELEMENTS STAT LEARNI; Hayes BJ, 2009, GENET RES, V91, P47, DOI 10.1017/S0016672308009981; Janssens ACJW, 2006, GENET MED, V8, P395, DOI 10.1097/01.gim.0000229689.18263.f4; Kearney JF, 2004, J DAIRY SCI, V87, P3503, DOI 10.3168/jds.S0022-0302(04)73485-2; Legarra A, 2008, GENETICS, V180, P611, DOI 10.1534/genetics.108.088575; Luan T, 2009, GENETICS, V183, P1119, DOI 10.1534/genetics.109.107391; Mackintosh CG, 2000, INFECT IMMUN, V68, P1620, DOI 10.1128/IAI.68.3.1620-1625.2000; Mc Parland S, 2007, J ANIM SCI, V85, P322, DOI 10.2527/jas.2006-367; Meuwissen THE, 2001, GENETICS, V157, P1819; Pollock JM, 2002, VET J, V163, P115, DOI 10.1053/tvjl.2001.0655; Quilez J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035349; Uemoto Yoshinobu, 2013, Frontiers in Genetics, V4, P232, DOI 10.3389/fgene.2013.00232; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407; Wray NR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000864	33	34	35	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96728	10.1371/journal.pone.0096728	http://dx.doi.org/10.1371/journal.pone.0096728			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809715	Green Published, gold, Green Submitted			2022-12-27	WOS:000338213300066
J	Marshall, MR; Walker, RC; Polkinghorne, KR; Lynn, KL				Marshall, Mark R.; Walker, Rachael C.; Polkinghorne, Kevan R.; Lynn, Kelvin L.			Survival on Home Dialysis in New Zealand	PLOS ONE			English	Article							STAGE RENAL-DISEASE; PERITONEAL-DIALYSIS; ESRD PATIENTS; COMPARING MORTALITY; PATIENT SURVIVAL; RISK-FACTORS; HEMODIALYSIS; MODALITY; OUTCOMES; STATES	Background: New Zealand (NZ) has a high prevalence of both peritoneal dialysis (PD) and home haemodialysis (HD) relative to other countries, and probably less selection bias. We aimed to determine if home dialysis associates with better survival than facility HD by simultaneous comparisons of the three modalities. Methods: We analysed survival by time-varying dialysis modality in New Zealanders over a 15-year period to 31-Dec-2011, adjusting for patient co-morbidity by Cox proportional hazards multivariate regression. Results: We modelled 6,419 patients with 3,254 deaths over 20,042 patient-years of follow-up. Patients treated with PD and facility HD are similar; those on home HD are younger and healthier. Compared to facility HD, home dialysis (as a unified category) associates with an overall 13% lower mortality risk. Home HD associates with a 52% lower mortality risk. PD associates with a 20% lower mortality risk in the early period (< 3 years) that is offset by a 33% greater mortality risk in the late period (> 3 years), with no overall net effect. There was effect modification and less observable benefit associated with PD in those with diabetes mellitus, co-morbidity, and in NZ Maori and Pacific People. There was no effect modification by age or by era. Conclusion: Our study supports the culture of home dialysis in NZ, and suggests that the extent and duration of survival benefit associated with early PD may be greater than appreciated. We are planning further analyses to exclude residual confounding from unmeasured co-morbidity and other sociodemographic factors using database linkage to NZ government datasets. Finally, our results suggest further research into the practice of PD in NZ Maori and Pacific People, as well as definitive study to determine the best timing for switching from PD in the late phase.	[Marshall, Mark R.] Univ Auckland, Fac Med & Hlth Sci, Auckland 1, New Zealand; [Marshall, Mark R.] Counties Manukau Dist Hlth Board, Dept Renal Med, Auckland, New Zealand; [Marshall, Mark R.; Polkinghorne, Kevan R.] Royal Adelaide Hosp, Australia & New Zealand Dialysis & Transplant Reg, Adelaide, SA 5000, Australia; [Walker, Rachael C.] Hawkes Bay Dist Hlth Board, Renal Dept, Hastings, New Zealand; [Walker, Rachael C.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Polkinghorne, Kevan R.] Monash Med Ctr, Dept Nephrol, Clayton, Vic 3168, Australia; [Polkinghorne, Kevan R.] Monash Univ, Dept Med, Clayton, Vic, Australia; [Polkinghorne, Kevan R.] Monash Univ, Dept Epidemiol & Prevent Med, Clayton, Vic, Australia; [Lynn, Kelvin L.] Kidney Hlth New Zealand, Christchurch, New Zealand	University of Auckland; Royal Adelaide Hospital; University of Sydney; Monash University; Monash University; Monash University	Marshall, MR (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Auckland 1, New Zealand.	mrmarshall@middlemore.co.nz	Marshall, Mark/Y-6745-2018; Marshall, Mark Roger/K-5751-2019	Marshall, Mark/0000-0003-0499-4527; Marshall, Mark Roger/0000-0003-0499-4527; Polkinghorne, Kevan/0000-0002-9851-002X; Walker, Rachael/0000-0001-5163-4351	Royal Australasian College of Physicians Foundation	Royal Australasian College of Physicians Foundation	The Royal Australasian College of Physicians Foundation funded this study through a Jacquot Research Establishment Award to M. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KC, 2004, KIDNEY INT, V65, P597, DOI 10.1111/j.1523-1755.2004.00385.x; Blagg CR, 2005, NEPHROLOGY, V10, P206, DOI 10.1111/j.1440-1797.2005.00383.x; Boissinot L, 2013, PERITON DIALYSIS INT, V33, P391, DOI 10.3747/pdi.2011.00134; Chan CT, 2009, ADV CHRONIC KIDNEY D, V16, P158, DOI 10.1053/j.ackd.2009.02.010; CHRISTENSEN AJ, 1990, HEALTH PSYCHOL, V9, P225, DOI 10.1037/0278-6133.9.2.225; CHRISTENSEN AJ, 1992, J BEHAV MED, V15, P313, DOI 10.1007/BF00844725; Churchill DN, 1997, J AM SOC NEPHROL, V8, P965; Collins AJ, 1999, AM J KIDNEY DIS, V34, P1065, DOI 10.1016/S0272-6386(99)70012-0; Dale PL, 2008, CURR MED RES OPIN, V24, P193, DOI 10.1185/030079908X253410; Ganesh SK, 2003, J AM SOC NEPHROL, V14, P415, DOI 10.1097/01.ASN.0000043140.23422.4F; Golper TA, 2011, PERITON DIALYSIS INT, V31, P12, DOI 10.3747/pdi.2010.00143; GRANT AC, 1992, PERITON DIALYSIS INT, V12, P365; Heaf JG, 2002, NEPHROL DIAL TRANSPL, V17, P112, DOI 10.1093/ndt/17.1.112; Inrig JK, 2006, CLIN J AM SOC NEPHRO, V1, P774, DOI 10.2215/CJN.00580705; Jaar BG, 2005, ANN INTERN MED, V143, P174, DOI 10.7326/0003-4819-143-3-200508020-00003; Kraus Michael, 2007, Hemodial Int, V11, P468, DOI 10.1111/j.1542-4758.2007.00229.x; Lameire N, 2000, PERITON DIALYSIS INT, V20, pS134; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lynn KL, 2005, NEPHROLOGY, V10, P231, DOI 10.1111/j.1440-1797.2005.00399.x; Mailloux L U, 1996, Adv Ren Replace Ther, V3, P112; MAILLOUX LU, 1994, CLIN NEPHROL, V42, P127; MAILLOUX LU, 1988, AM J MED, V84, P855, DOI 10.1016/0002-9343(88)90063-0; Marshall MR, 2011, AM J KIDNEY DIS, V58, P782, DOI 10.1053/j.ajkd.2011.04.027; McDonald SP, 2009, J AM SOC NEPHROL, V20, P155, DOI 10.1681/ASN.2007111188; McGregor D, 2000, NEW ZEAL MED J, V113, P27; McGregor DO, 2001, BLOOD PURIFICAT, V19, P293, DOI 10.1159/000046957; Mowatt G, 2003, Health Technol Assess, V7, P1; Mowatt G, 2004, INT J TECHNOL ASSESS, V20, P258, DOI 10.1017/S0266462304001060; National Institutes of Health NIoDaDaKD, 2012, US REN DAT SYST USRD; Nitsch D, 2011, NEPHROL DIAL TRANSPL, V26, P1670, DOI 10.1093/ndt/gfq561; Polaschek N, 2007, J REN CARE, V33, P20, DOI 10.1111/j.1755-6686.2007.tb00032.x; PROWANT B, 1983, AM J KIDNEY DIS, V3, P27, DOI 10.1016/S0272-6386(83)80006-7; Rodriguez RA, 2012, CLIN J AM SOC NEPHRO, V7, P1055, DOI 10.2215/CJN.05410512; RUBIN J, 1989, AM J MED SCI, V297, P80, DOI 10.1097/00000441-198902000-00004; RUBIN J, 1983, KIDNEY INT, V23, P51, DOI 10.1038/ki.1983.10; Rubin J, 1985, ASAIO J, V8, P22; Sanabria M, 2008, KIDNEY INT, V73, pS165, DOI 10.1038/sj.ki.5002619; Saner E, 2005, NEPHROL DIAL TRANSPL, V20, P604, DOI 10.1093/ndt/gfh674; Schaubel DE, 1998, PERITON DIALYSIS INT, V18, P478; Snyder JJ, 2003, KIDNEY INT, V64, P1838, DOI 10.1046/j.1523-1755.2003.00287.x; Snyder WL, 1977, ABSTR HOSP MAN STUD, V14, P18102; Stack AG, 2004, KIDNEY INT, V65, P2398, DOI 10.1111/j.1523-1755.2004.00654.x; Stack AG, 2003, KIDNEY INT, V64, P1071, DOI 10.1046/j.1523-1755.2003.00165.x; Termorshuizen F, 2003, J AM SOC NEPHROL, V14, P2851, DOI 10.1097/01.ASN.0000091585.45723.9E; Thodis ED, 2011, J NEPHROL, V24, P398, DOI 10.5301/JN.2011.8374; Tonelli M, 2007, KIDNEY INT, V72, P1023, DOI 10.1038/sj.ki.5002443; Van Biesen W, 2000, J AM SOC NEPHROL, V11, P116, DOI 10.1681/ASN.V111116; Vonesh EF, 2006, KIDNEY INT, V70, pS3, DOI 10.1038/sj.ki.5001910; Vonesh EF, 2004, KIDNEY INT, V66, P2389, DOI 10.1111/j.1523-1755.2004.66028.x; Vonesh EF, 1999, J AM SOC NEPHROL, V10, P354; Vonesh EF, 2000, KIDNEY INT, V57, pS19, DOI 10.1046/j.1523-1755.2000.07405.x; WELLER JM, 1982, KIDNEY INT, V21, P78, DOI 10.1038/ki.1982.11; WILLIAMS GW, 1983, KIDNEY INT, V24, P691, DOI 10.1038/ki.1983.212; Winkelmayer WC, 2002, J AM SOC NEPHROL, V13, P2353, DOI 10.1097/01.ASN.0000025785.41314.76; Woods JD, 1996, KIDNEY INT, V49, P1464, DOI 10.1038/ki.1996.206; Wyld M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001307; Xu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050766	57	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96847	10.1371/journal.pone.0096847	http://dx.doi.org/10.1371/journal.pone.0096847			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806458	Green Submitted, gold, Green Published			2022-12-27	WOS:000335728900106
J	Wan, Q; Zhang, H; Ye, WX; Wu, HT; Zhang, TZ				Wan, Qun; Zhang, Hua; Ye, Wenxue; Wu, Huaitong; Zhang, Tianzhen			Genome-Wide Transcriptome Profiling Revealed Cotton Fuzz Fiber Development Having a Similar Molecular Model as Arabidopsis Trichome	PLOS ONE			English	Article							GENE-EXPRESSION; UPLAND COTTON; ANTHOCYANIN BIOSYNTHESIS; ENCODES; PROTEIN; GL3; DIFFERENTIATION; IDENTIFICATION; INHERITANCE; INITIATION	The cotton fiber, as a single-celled trichome, is a biological model system for studying cell differentiation and elongation. However, the complexity of gene expression and regulation in the fiber complicates genetic research. In this study, we investigated the genome-wide transcriptome profiling in Texas Marker-1 (TM-1) and five naked seed or fuzzless mutants (three dominant and two recessive) during the fuzz initial development stage. More than three million clean tags were generated from each sample representing the expression data for 27,325 genes, which account for 72.8% of the annotated Gossypium raimondii primary transcript genes. Thousands of differentially expressed genes (DEGs) were identified between TM-1 and the mutants. Based on functional enrichment analysis, the DEGs downregulated in the mutants were enriched in protein synthesis-related genes and transcription factors, while DEGs upregulated in the mutants were enriched in DNA/chromatin structure-related genes and transcription factors. Pathway analysis showed that ATP synthesis, and sugar and lipid metabolism-related pathways play important roles in fuzz initial development. Also, we identified a large number of transcription factors such as MYB, bHLH, HB, WRKY, AP2/EREBP, bZIP and C2H2 zinc finger families that were differently expressed between TM-1 and the mutants, and were also related to trichome development in Arabidopsis.	[Wan, Qun; Zhang, Hua; Ye, Wenxue; Wu, Huaitong; Zhang, Tianzhen] Nanjing Agr Univ, Cotton Res Inst, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Nanjing Agricultural University	Zhang, TZ (corresponding author), Nanjing Agr Univ, Cotton Res Inst, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.	cotton@njau.edu.cn			State Basic Research Development Program of China (973 Program) [2011CB109300]; National High Technology Research and Development Program of China (863 Program) [2011AA10A102]; Priority Academic Program Development of Jiangsu Higher Education Institutions	State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Priority Academic Program Development of Jiangsu Higher Education Institutions	The State Basic Research Development Program of China (973 Program, 2011CB109300), the National High Technology Research and Development Program of China (863 Program) (2011AA10A102), and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, ANN STAT, V29, P1165; Bernhardt C, 2003, DEVELOPMENT, V130, P6431, DOI 10.1242/dev.00880; Du SJ, 2013, J PROTEOMICS, V82, P113, DOI 10.1016/j.jprot.2013.02.020; Du XM, 2001, PLANT BREEDING, V120, P519, DOI 10.1046/j.1439-0523.2001.00643.x; Guan XY, 2008, PHYSIOL PLANTARUM, V134, P174, DOI 10.1111/j.1399-3054.2008.01115.x; Guan XY, 2007, CHINESE SCI BULL, V52, P1734, DOI 10.1007/s11434-007-0273-2; Guan XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021301; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Hovav R, 2008, PLANTA, V227, P319, DOI 10.1007/s00425-007-0619-7; Huang YQ, 2013, PLANT PHYSIOL BIOCH, V73, P16, DOI 10.1016/j.plaphy.2013.08.004; Humphries JA, 2005, PLANT MOL BIOL, V57, P67, DOI 10.1007/s11103-004-6768-1; JENSEN WA, 1968, PLANTA, V79, P346, DOI 10.1007/BF00386917; [蒋建雄 Jiang Jianxiong], 2003, [棉花学报, Cotton Science], V15, P166; Johnson CS, 2002, PLANT CELL, V14, P1359, DOI 10.1105/tpc.001404; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kearney TH, 1927, J AGRIC RES, V35, P0193; KOHEL RJ, 1973, J HERED, V64, P291, DOI 10.1093/oxfordjournals.jhered.a108415; LARKIN JC, 1994, PLANT CELL, V6, P1065, DOI 10.1105/tpc.6.8.1065; LARKIN JC, 1993, PLANT CELL, V5, P1739, DOI 10.1105/tpc.5.12.1739; Lee JJ, 2007, ANN BOT-LONDON, V100, P1391, DOI 10.1093/aob/mcm232; Lee JJ, 2006, PLANTA, V223, P418, DOI 10.1007/s00425-005-0098-7; Lee MM, 2001, DEVELOPMENT, V128, P1539; Loguercio LL, 1999, MOL GEN GENET, V261, P660; Machado A, 2009, PLANT J, V59, P52, DOI 10.1111/j.1365-313X.2009.03847.x; Mandaokar A, 2003, PLANT MOL BIOL, V52, P775, DOI 10.1023/A:1025045217859; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Nesi N, 2000, PLANT CELL, V12, P1863, DOI 10.1105/tpc.12.10.1863; NODA K, 1994, NATURE, V369, P661, DOI 10.1038/369661a0; Payne CT, 2000, GENETICS, V156, P1349; Perez-Rodriguez M, 2005, DEVELOPMENT, V132, P359, DOI 10.1242/dev.01584; Ramsay NA, 2005, TRENDS PLANT SCI, V10, P63, DOI 10.1016/j.tplants.2004.12.011; Ramsay NA, 2003, PLANT MOL BIOL, V52, P679, DOI 10.1023/A:1024852021124; Schaller A, 2004, PLANTA, V220, P183, DOI 10.1007/s00425-004-1407-2; Schellmann S, 2002, EMBO J, V21, P5036, DOI 10.1093/emboj/cdf524; Shangguan XX, 2008, J EXP BOT, V59, P3533, DOI 10.1093/jxb/ern204; STEWART JM, 1975, AM J BOT, V62, P723, DOI 10.2307/2442061; Suo JF, 2003, BBA-GENE STRUCT EXPR, V1630, P25, DOI 10.1016/j.bbaexp.2003.08.009; Szymanski DB, 1998, DEVELOPMENT, V125, P1161; Taliercio EW, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-22; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Turley RB, 2002, J HERED, V93, P359, DOI 10.1093/jhered/93.5.359; Turley RB, 2002, CROP SCI, V42, P994, DOI 10.2135/cropsci2002.994a; Turley RB, 2008, EUPHYTICA, V164, P123, DOI 10.1007/s10681-008-9670-0; Wada T, 1997, SCIENCE, V277, P1113, DOI 10.1126/science.277.5329.1113; Walford SA, 2011, PLANT J, V65, P785, DOI 10.1111/j.1365-313X.2010.04464.x; Walker AR, 1999, PLANT CELL, V11, P1337, DOI 10.1105/tpc.11.7.1337; Wang QQ, 2010, GENOMICS, V96, P369, DOI 10.1016/j.ygeno.2010.08.009; Wang S, 2004, PLANT CELL, V16, P2323, DOI 10.1105/tpc.104.024844; WARE JO, 1947, J HERED, V38, P313; Wu Y, 2007, PLANTA, V226, P1475, DOI 10.1007/s00425-007-0580-5; Wu YR, 2006, PLANT CELL PHYSIOL, V47, P107, DOI 10.1093/pcp/pci228; Zhang DY, 2007, J INTEGR PLANT BIO, V49, P975; Zhang F, 2003, DEVELOPMENT, V130, P4859, DOI 10.1242/dev.00681; Zhang TZ, 1991, JIANGSU J AGR SCI, V7, P13	57	37	40	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97313	10.1371/journal.pone.0097313	http://dx.doi.org/10.1371/journal.pone.0097313			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24823367	Green Published, Green Submitted, gold			2022-12-27	WOS:000336369200093
J	Alawadhi, F; Du, HL; Cakmak, H; Taylor, HS				Alawadhi, Feryal; Du, Hongling; Cakmak, Hakan; Taylor, Hugh S.			Bone Marrow-Derived Stem Cell (BMDSC) Transplantation Improves Fertility in a Murine Model of Asherman's Syndrome	PLOS ONE			English	Article							UTERINE SYNECHIAE; ENDOMETRIUM; MANAGEMENT	Asherman's Syndrome is characterized by intrauterine adhesions or fibrosis resulting as a consequence of damage to the basal layer of endometrium and is associated with infertility due to loss of normal endometrium. We have previously shown that bone marrow derived stem cells (BMDSCs) engraft the endometrium in mice and humans and Ischemia/reperfusion injury of uterus promoted BMDSCs migration to the endometrium; however, the role of BMDSCs in Asherman's syndrome has not been characterized. Here a murine model of Asherman's syndrome was created by traumatizing the uterus. We evaluate stem cell recruitment and pregnancy after BMDSCs transplantation in a model of Asherman's syndrome. In the Asheman's syndrome model, after BMDSC transplant, the Y chromosome bearing CD45-cells represented less than 0.1% of total endometrial cells. Twice the number of Y+CD45-cells was identified in the damaged uterus compared to the uninjured controls. There was no significant difference between the damaged and undamaged uterine horns in mice that received injury to a single horn. In the BMDSC transplant group, 9 of the 10 mice conceived, while only 3 of 10 in the non-transplanted group conceived (Chi-Square p = 0.0225); all mice in an uninjured control group conceived. The time to conception and mean litter size were not different between groups. Taken together, BMDSCs are recruited to endometrium in response to injury. Fertility improves after BMDSC transplant in Asherman's Syndrome mice, demonstrating a functional role for these cells in uterine repair. BMDSC transplantation is a potential novel treatment for Asherman's Syndrome and may also be useful to prevent Asherman's syndrome after uterine injury.	[Alawadhi, Feryal; Du, Hongling; Cakmak, Hakan; Taylor, Hugh S.] Yale Univ, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA; [Taylor, Hugh S.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA	Yale University; Yale University	Taylor, HS (corresponding author), Yale Univ, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA.	hugh.taylor@yale.edu			NIH [U54 HD052668]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD052668] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by NIH U54 HD052668. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akram KM, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-9; BUTTRAM VC, 1977, INT J FERTIL, V22, P98; Capella-Allouc S, 1999, HUM REPROD, V14, P1230, DOI 10.1093/humrep/14.5.1230; Cervello I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030260; Chan RWS, 2006, STEM CELLS, V24, P1529, DOI 10.1634/stemcells.2005-0411; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; COWELL TP, 1969, J REPROD FERTIL, V19, P239, DOI 10.1530/jrf.0.0190239; Curley GF, 2012, THORAX, V67, P496, DOI 10.1136/thoraxjnl-2011-201059; Du HL, 2007, STEM CELLS, V25, P2082, DOI 10.1634/stemcells.2006-0828; Du HL, 2012, STEM CELLS DEV, V21, P3324, DOI 10.1089/scd.2011.0193; Gargett CE, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.05.004; Kennedy DJ, 2006, HYPERTENSION, V47, P488, DOI 10.1161/01.HYP.0000202594.82271.92; KLEIN SM, 1973, FERTIL STERIL, V24, P722; Lee HJ, 2007, J CLIN ONCOL, V25, P3198, DOI 10.1200/JCO.2006.10.3028; March CM, 2011, REPROD BIOMED ONLINE, V23, P63, DOI 10.1016/j.rbmo.2010.11.018; Myers EM, 2012, FERTIL STERIL, V97, P160, DOI 10.1016/j.fertnstert.2011.10.036; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Takasaki A, 2010, FERTIL STERIL, V93, P1851, DOI 10.1016/j.fertnstert.2008.12.062; Taylor HS, 2004, JAMA-J AM MED ASSOC, V292, P81, DOI 10.1001/jama.292.1.81; Tuuli MG, 2012, OBSTET GYNECOL, V119, P810, DOI 10.1097/AOG.0b013e31824be28a; Wang N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043768; Yu D, 2008, FERTIL STERIL, V89, P759, DOI 10.1016/j.fertnstert.2008.02.096; PLOS ONE	23	141	157	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96662	10.1371/journal.pone.0096662	http://dx.doi.org/10.1371/journal.pone.0096662			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819371	Green Published, gold			2022-12-27	WOS:000336653300025
J	de Araujo, AA; Varela, H; Brito, GADC; de Medeiros, CACX; Araujo, LDS; do Nascimento, JHO; de Araujo, RF				de Araujo, Aurigena Antunes; Varela, Hugo; de Castro Brito, Gerly Anne; Carvalho Xavier de Medeiros, Caroline Addison; Araujo, Lorena De Souza; Oliveira do Nascimento, Jose Heriberto; De Araujo Junior, Raimundo Fernandes			Azilsartan Increases Levels of IL-10, Down-Regulates MMP-2, MMP-9, RANKL/RANK, Cathepsin K and Up-Regulates OPG in an Experimental Periodontitis Model	PLOS ONE			English	Article							TNF-ALPHA; PORPHYROMONAS-GINGIVALIS; BONE-RESORPTION; RATS; INTERLEUKIN-10; TELMISARTAN; INHIBITION; EXPRESSION; MOUSE; INFLAMMATION	Aims: The aim of this study was to evaluate the effects of azilsartan (AZT) on bone loss, inflammation, and the expression of matrix metallo proteinases (MMPs), receptor activator of nuclear factor kappa B ligand (RANKL), receptor activator of nuclear factor kappa B (RANK), osteoprotegerin (OPG), cyclooxygenase-2 (COX-2), and cathepsin K in periodontal tissue in a rat model of ligature-induced periodontitis. Materials and Methods: Male Wistar albino rats were randomly divided into 5 groups of 10 rats each: (1) nonligated, water; (2) ligated, water; (3) ligated, 1 mg/kg AZT; (4) ligated, 5 mg/kg AZT; and (5) ligated, 10 mg/kg AZT. All groups were treated with saline or AZT for 10 days. Periodontal tissues were analyzed by histopathology and immunohistochemical detection of MMP-2, MMP-9, COX-2, RANKL, RANK, OPG, and cathepsin K. Levels of IL-1 beta, IL-10, TNF-alpha, myeloperoxidase (MPO), and glutathione (GSH) were determined by ELISA. Results: Treatment with 5 mg/kg AZT resulted in reduced MPO (p<0.05) and IL-1 beta (p<0.05), increased levels of IL-10 (p<0.05), and reduced expression of MMP-2, MMP-9, COX-2, RANK, RANKL, cathepsin K, and increased expression of OPG. Conclusions: These findings reveal that AZT increases anti-inflammatory cytokines and GSH and decreases bone loss in ligature-induced periodontitis in rats.	[de Araujo, Aurigena Antunes] Univ Fed Rio Grande do Norte, Dept Biophys & Pharmacol, Post Graduat Program Pharmaceut Sci, Post Graduat Program Publ Health, Natal, RN, Brazil; [Varela, Hugo] Univ Fed Rio Grande do Norte, Dept Dent, Post Graduat Program Publ Hlth, Natal, RN, Brazil; [de Castro Brito, Gerly Anne] Univ Fed Ceara, Dept Morphol, Post Graduat Program Pharmacology, Fortaleza, Ceara, Brazil; [Carvalho Xavier de Medeiros, Caroline Addison] UERN, Post Graduat Program Hlth & Soc, UFRN, Dept Biophys & Pharmacol, Natal, RN, Brazil; [Araujo, Lorena De Souza] Univ Fed Rio Grande do Norte, Dept Dent, Natal, RN, Brazil; [Oliveira do Nascimento, Jose Heriberto] Univ Fed Rio Grande do Norte, Dept Textile Engn, Natal, RN, Brazil; [De Araujo Junior, Raimundo Fernandes] Univ Fed Rio Grande do Norte, Dept Morphol, Post Graduat Program Hlth Sci, Post Graduat Program Funct & Struct Biol, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Ceara; Universidade do Estado do Rio Grande do Norte (UERN); Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte	de Araujo, AA (corresponding author), Univ Fed Rio Grande do Norte, Dept Biophys & Pharmacol, Post Graduat Program Pharmaceut Sci, Post Graduat Program Publ Health, Natal, RN, Brazil.	aurigena@ufrnet.br	Brito, Gerly/AHB-3965-2022; nascimento, jose heriberto oliveira/AAG-7423-2020; de Araujo, Aurigena/ABI-8455-2020; de Castro Brito, Gerly Anne/C-8597-2013	Brito, Gerly/0000-0002-8214-4379; nascimento, jose heriberto oliveira/0000-0001-6804-2854; de Castro Brito, Gerly Anne/0000-0002-8214-4379; Araujo, Aurigena/0000-0001-9264-4695				Araujo AA, 2013, J CLIN PERIODONTOL, V40, P1104, DOI 10.1111/jcpe.12160; Araujo AA, 2013, N-S ARCH PHARMACOL, V386, P875, DOI 10.1007/s00210-013-0886-8; Bostanci N, 2011, J CLIN PERIODONTOL, V38, P428, DOI 10.1111/j.1600-051X.2011.01701.x; Carvalho RD, 2013, ARCH ORAL BIOL, V58, P50, DOI 10.1016/j.archoralbio.2012.04.020; Carvalho RS, 2010, J NEGAT RESULTS BIOM, V9, DOI 10.1186/1477-5751-9-3; Curtale G, 2013, P NATL ACAD SCI USA, V110, P11499, DOI 10.1073/pnas.1219852110; de Araujo RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075322; de Araujo RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066391; Elavarasu S, 2012, J PHARM BIOALLIED SC, V4, pS256, DOI 10.4103/0975-7406.100244; Evans KE, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-4; Gaddis DE, 2013, J LEUKOCYTE BIOL, V93, P21, DOI 10.1189/jlb.0512220; Garlet GP, 2006, ORAL MICROBIOL IMMUN, V21, P12, DOI 10.1111/j.1399-302X.2005.00245.x; Graves DT, 2011, J DENT RES, V90, P143, DOI 10.1177/0022034510385236; Graves D, 2008, J PERIODONTOL, V79, P1585, DOI 10.1902/jop.2008.080183; KENDALL C, 1983, J IMMUNOL METHODS, V56, P329, DOI 10.1016/S0022-1759(83)80022-2; Kusano K, 1998, ENDOCRINOLOGY, V139, P1338, DOI 10.1210/en.139.3.1338; Leitao RFC, 2005, J PERIODONTOL, V76, P956, DOI 10.1902/jop.2005.76.6.956; Liu DW, 2006, EUR J ORAL SCI, V114, P42, DOI 10.1111/j.1600-0722.2006.00283.x; Lovibond AC, 2003, BIOCHEM BIOPH RES CO, V309, P762, DOI 10.1016/j.bbrc.2003.08.068; Mohamed SGK, 2007, BONE, V41, P592, DOI 10.1016/j.bone.2007.05.016; Nakano A, 2009, HYPERTENS RES, V32, P765, DOI 10.1038/hr.2009.95; SAFIEHGARABEDIAN B, 1995, BRIT J PHARMACOL, V115, P1265, DOI 10.1111/j.1476-5381.1995.tb15035.x; Salvi GE, 2005, J CLIN PERIODONTOL, V32, P108, DOI 10.1111/j.1600-051X.2005.00785.x; Sanz M, 2011, J CLIN PERIODONTOL, V38, P3, DOI 10.1111/j.1600-051X.2010.01681.x; Sasaki H, 2004, J PERIODONTAL RES, V39, P432, DOI 10.1111/j.1600-0765.2004.00760.x; Soung DY, 2013, BONE, V55, P248, DOI 10.1016/j.bone.2013.02.010; Souza MHLP, 2003, BRAZ J MED BIOL RES, V36, P1383, DOI 10.1590/S0100-879X2003001000015; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Wienen W, 2001, J RENIN-ANGIO-ALDO S, V2, P31, DOI 10.3317/jraas.2001.005; WIENEN W, 1993, BRIT J PHARMACOL, V110, P245, DOI 10.1111/j.1476-5381.1993.tb13800.x; Yamaguchi M, 2005, ARCH IMMUNOL THER EX, V53, P388; Zaiken K, 2011, CLIN THER, V33, P1577, DOI 10.1016/j.clinthera.2011.10.007	32	14	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96750	10.1371/journal.pone.0096750	http://dx.doi.org/10.1371/journal.pone.0096750			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819928	Green Published, gold, Green Submitted			2022-12-27	WOS:000336653300029
J	Fourcade, Y; Engler, JO; Rodder, D; Secondi, J				Fourcade, Yoan; Engler, Jan O.; Roedder, Dennis; Secondi, Jean			Mapping Species Distributions with MAXENT Using a Geographically Biased Sample of Presence Data: A Performance Assessment of Methods for Correcting Sampling Bias	PLOS ONE			English	Article							DISTRIBUTION MODELS; EXTINCTION RISK; CONSERVATION PRIORITIES; BIODIVERSITY HOTSPOTS; SELECTION BIAS; CLIMATE-CHANGE; PREDICTION; ACCURACY; RANGE; IMPROVE	MAXENT is now a common species distribution modeling (SDM) tool used by conservation practitioners for predicting the distribution of a species from a set of records and environmental predictors. However, datasets of species occurrence used to train the model are often biased in the geographical space because of unequal sampling effort across the study area. This bias may be a source of strong inaccuracy in the resulting model and could lead to incorrect predictions. Although a number of sampling bias correction methods have been proposed, there is no consensual guideline to account for it. We compared here the performance of five methods of bias correction on three datasets of species occurrence: one "virtual'' derived from a land cover map, and two actual datasets for a turtle (Chrysemys picta) and a salamander (Plethodon cylindraceus). We subjected these datasets to four types of sampling biases corresponding to potential types of empirical biases. We applied five correction methods to the biased samples and compared the outputs of distribution models to unbiased datasets to assess the overall correction performance of each method. The results revealed that the ability of methods to correct the initial sampling bias varied greatly depending on bias type, bias intensity and species. However, the simple systematic sampling of records consistently ranked among the best performing across the range of conditions tested, whereas other methods performed more poorly in most cases. The strong effect of initial conditions on correction performance highlights the need for further research to develop a step-by-step guideline to account for sampling bias. However, this method seems to be the most efficient in correcting sampling bias and should be advised in most cases.	[Fourcade, Yoan; Secondi, Jean] Univ Angers, LUNAM, GECCO Grp Ecol & Conservat Vertebres, Angers, France; [Engler, Jan O.] Univ Gottingen, Dept Wildlife Ecol, D-37073 Gottingen, Germany; [Engler, Jan O.; Roedder, Dennis] Zool Res Museum Alexander Koenig, Bonn, Germany	Universite d'Angers; University of Gottingen; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK)	Fourcade, Y (corresponding author), Univ Angers, LUNAM, GECCO Grp Ecol & Conservat Vertebres, Angers, France.	yoanfourcade@gmail.com	Engler, Jan O/C-3432-2009; Rödder, Dennis/AAT-8644-2021; Fourcade, Yoan/H-7253-2012	Rödder, Dennis/0000-0002-6108-1639; Fourcade, Yoan/0000-0003-3820-946X; Secondi, Jean/0000-0001-8130-1195	Plan Loire Grandeur Nature and European Regional Development Fund (ERDF); German Federal Environmental Foundation	Plan Loire Grandeur Nature and European Regional Development Fund (ERDF); German Federal Environmental Foundation	This study was supported by a grant to YF and JS from Plan Loire Grandeur Nature and European Regional Development Fund (ERDF). JOE was kindly supported within the German Federal Environmental Foundation fellowship program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo P, 2012, J BIOGEOGR, V39, P1383, DOI 10.1111/j.1365-2699.2012.02713.x; Adams WM, 2004, SCIENCE, V306, P1146, DOI 10.1126/science.1097920; [Anonymous], BIODIVERSITY INFORM, DOI DOI 10.1111/jbi.12227; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Arino O, 2008, ESA BULL-EUR SPACE, P24; Austin MP, 2006, ECOL MODEL, V199, P197, DOI 10.1016/j.ecolmodel.2006.05.023; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Beck J, 2014, ECOL INFORM, V19, P10, DOI 10.1016/j.ecoinf.2013.11.002; Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012; Boyce MS, 1999, TRENDS ECOL EVOL, V14, P268, DOI 10.1016/S0169-5347(99)01593-1; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Breiman L., 2017, CLASSIFICATION REGRE; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Bystriakova N, 2012, SYST BIODIVERS, V10, P305, DOI 10.1080/14772000.2012.705357; Chefaoui RM, 2008, ECOL MODEL, V210, P478, DOI 10.1016/j.ecolmodel.2007.08.010; Costa GC, 2010, BIODIVERS CONSERV, V19, P883, DOI 10.1007/s10531-009-9746-8; Dennis RLH, 2000, J INSECT CONSERV, V4, P73, DOI 10.1023/A:1009690919835; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Dudik M., 2005, NIPS 05 P 18 INT C N, V18, P323; Edwards TC, 2006, ECOL MODEL, V199, P132, DOI 10.1016/j.ecolmodel.2006.05.016; Elith J, 2002, PREDICTING SPECIES OCCURRENCES: ISSUES OF ACCURACY AND SCALE, P303; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2006, SPATIAL CONSERVATION; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Ferrier S, 1984, THESIS U NEW ENGLAND; Fourcade Y, 2013, BIOL CONSERV, V167, P161, DOI 10.1016/j.biocon.2013.08.009; Franklin J, 2009, MAPPING SPECIES DIST; Freeman EA, 2008, J STAT SOFTW, V23, P1; Gonzalez Sergio C., 2011, BMC Ecology, V11, P20, DOI 10.1186/1472-6785-11-20; Harris G, 2008, CONSERV BIOL, V22, P163, DOI 10.1111/j.1523-1739.2007.00798.x; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2012, SPECIES DISTRIBUTION; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Ihlow F, 2012, GLOBAL CHANGE BIOL, V18, P1520, DOI 10.1111/j.1365-2486.2011.02623.x; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; Jeschke JM, 2008, ANN NY ACAD SCI, V1134, P1, DOI 10.1196/annals.1439.002; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Jimenez-Valverde A, 2014, BIODIVERS CONSERV, V23, P369, DOI 10.1007/s10531-013-0606-1; Jimenez-Valverde A, 2013, GLOBAL ECOL BIOGEOGR, V22, P508, DOI 10.1111/geb.12007; Kadmon R, 2004, ECOL APPL, V14, P401, DOI 10.1890/02-5364; Kozak KH, 2008, TRENDS ECOL EVOL, V23, P141, DOI 10.1016/j.tree.2008.02.001; Kramer-Schadt S, 2013, DIVERS DISTRIB, V19, P1366, DOI 10.1111/ddi.12096; Leitao PJ, 2011, INT J GEOGR INF SCI, V25, P439, DOI 10.1080/13658816.2010.531020; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Loiselle BA, 2008, J BIOGEOGR, V35, P105, DOI 10.1111/j.1365-2699.2007.01779.x; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Maisongrande P, 2004, INT J REMOTE SENS, V25, P9, DOI 10.1080/0143116031000115265; Manly B., 1993, RESOURCE SELECTION A; Mccarthy KP, 2012, CONSERV BIOL, V26, P68, DOI 10.1111/j.1523-1739.2011.01754.x; McCullagh P, 1989, MONOGRAPHS STAT APPL, V37, P1, DOI DOI 10.1007/978-1-4899-3242-6; Mittermeier RA, 1998, CONSERV BIOL, V12, P516, DOI 10.1046/j.1523-1739.1998.012003516.x; Moilanen A, 2005, P ROY SOC B-BIOL SCI, V272, P1885, DOI 10.1098/rspb.2005.3164; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nelson A., 2008, TRAVEL TIME MAJOR CI; Osborne PE, 2002, ECOL MODEL, V157, P249, DOI 10.1016/S0304-3800(02)00198-9; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P272, DOI 10.1111/j.0906-7590.2008.5378.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Reddy S, 2003, J BIOGEOGR, V30, P1719, DOI 10.1046/j.1365-2699.2003.00946.x; Reid WV, 1998, TRENDS ECOL EVOL, V13, P275, DOI 10.1016/S0169-5347(98)01363-9; Ripley B. D., 1996, PATTERN RECOGNITION; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Rodder D, 2011, GLOBAL ECOL BIOGEOGR, V20, P915, DOI 10.1111/j.1466-8238.2011.00659.x; Roedder Dennis, 2009, Diversity, V1, P52; Rodder D, 2009, GLOBAL ECOL BIOGEOGR, V18, P674, DOI 10.1111/j.1466-8238.2009.00477.x; Sagarin RD, 2002, ECOL LETT, V5, P137, DOI 10.1046/j.1461-0248.2002.00297.x; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; Sinclair SJ, 2010, ECOL SOC, V15, DOI 10.5751/ES-03089-150108; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Stiels D, 2011, J ORNITHOL, V152, P769, DOI 10.1007/s10336-011-0662-9; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158; Thorn JS, 2009, DIVERS DISTRIB, V15, P289, DOI 10.1111/j.1472-4642.2008.00535.x; Thuiller W, 2004, ECOGRAPHY, V27, P165, DOI 10.1111/j.0906-7590.2004.03673.x; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Varela S, 2014, ECOGRAPHY, V37, P1084, DOI 10.1111/j.1600-0587.2013.00441.x; Veloz SD, 2009, J BIOGEOGR, V36, P2290, DOI 10.1111/j.1365-2699.2009.02174.x; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x	87	595	624	16	244	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97122	10.1371/journal.pone.0097122	http://dx.doi.org/10.1371/journal.pone.0097122			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24818607	gold, Green Published, Green Submitted			2022-12-27	WOS:000336653300079
J	Jongjitwimol, J; Feng, M; Zhou, LH; Wilkinson, O; Small, L; Baldock, R; Taylor, DL; Smith, D; Bowler, LD; Morley, SJ; Watts, FZ				Jongjitwimol, Jirapas; Feng, Min; Zhou, Lihong; Wilkinson, Oliver; Small, Lauren; Baldock, Robert; Taylor, Deborah L.; Smith, Duncan; Bowler, Lucas D.; Morley, Simon J.; Watts, Felicity Z.			The S-pombe Translation Initiation Factor eIF4G Is Sumoylated and Associates with the SUMO Protease Ulp2	PLOS ONE			English	Article							MESSENGER-RNA TRANSLATION; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; FISSION YEAST; DNA-DAMAGE; CHROMOSOME SEGREGATION; SUBSTRATE PROTEINS; GENE ENCODES; UBIQUITIN; NUCLEAR	SUMO is a small post-translational modifier, that is attached to lysine residues in target proteins. It acts by altering protein-protein interactions, protein localisation and protein activity. SUMO chains can also act as substrates for ubiquitination, resulting in proteasome-mediated degradation of the target protein. SUMO is removed from target proteins by one of a number of specific proteases. The processes of sumoylation and desumoylation have well documented roles in DNA metabolism and in the maintenance of chromatin structure. To further analyse the role of this modification, we have purified protein complexes containing the S. pombe SUMO protease, Ulp2. These complexes contain proteins required for ribosome biogenesis, RNA stability and protein synthesis. Here we have focussed on two translation initiation factors that we identified as co-purifying with Ulp2, eIF4G and eIF3h. We demonstrate that eIF4G, but not eIF3h, is sumoylated. This modification is increased under conditions that produce cytoplasmic stress granules. Consistent with this we observe partial co-localisation of eIF4G and SUMO in stressed cells. Using HeLa cells, we demonstrate that human eIF4GI is also sumoylated; in vitro studies indicate that human eIF4GI is modified on K1368 and K1588, that are located in the C-terminal eIF4A- and Mnk-binding sites respectively.	[Jongjitwimol, Jirapas; Feng, Min; Zhou, Lihong; Wilkinson, Oliver; Small, Lauren; Baldock, Robert; Taylor, Deborah L.; Bowler, Lucas D.; Watts, Felicity Z.] Univ Sussex, Sch Life Sci, Genome Damage & Stabil Ctr, Brighton, E Sussex, England; [Smith, Duncan] Univ Manchester, Paterson Inst Canc Res, Manchester, Lancs, England; [Morley, Simon J.] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England	University of Sussex; Paterson Institute for Cancer Research; University of Manchester; University of Sussex	Watts, FZ (corresponding author), Univ Sussex, Sch Life Sci, Genome Damage & Stabil Ctr, Brighton, E Sussex, England.	f.z.watts@sussex.ac.uk	Baldock, Robert/K-3810-2019	Baldock, Robert/0000-0002-4649-2966; Bowler, Lucas/0000-0002-7004-8021; Jongjitwimol, Jirapas/0000-0003-0854-3475	CRUK [C1206/A5451, C1206/A1845, C1206/A11978]; BBSRC Special Studentship [G/03524]; University of Sussex; Royal Thai Government scholarship; Biotechnology and Biological Sciences Research Council [BB/L018209/1] Funding Source: researchfish; Cancer Research UK [11978] Funding Source: researchfish; Medical Research Council [G0500308] Funding Source: researchfish; BBSRC [BB/L018209/1] Funding Source: UKRI; MRC [G0500308] Funding Source: UKRI	CRUK(Cancer Research UK); BBSRC Special Studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Sussex; Royal Thai Government scholarship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	MF, LZ and OW were funded by CRUK grant nos C1206/A5451, C1206/A1845 and C1206/A11978. DLT was funded by a BBSRC Special Studentship no (G/03524), LS and RB were funded by the University of Sussex, and JJ was funded by a Royal Thai Government scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKHODAIRY F, 1995, J CELL SCI, V108, P475; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Becker J, 2013, NAT STRUCT MOL BIOL, V20, P525, DOI 10.1038/nsmb.2526; Blomster HA, 2009, MOL CELL PROTEOMICS, V8, P1382, DOI 10.1074/mcp.M800551-MCP200; Brengues M, 2007, MOL BIOL CELL, V18, P2592, DOI 10.1091/mbc.E06-12-1149; Bruderer R, 2011, EMBO REP, V12, P142, DOI 10.1038/embor.2010.206; Bylebyl GR, 2003, J BIOL CHEM, V278, P44113, DOI 10.1074/jbc.M308357200; Cha JH., 2018, MOL CELL, V71; Chicooree N, 2013, RAPID COMMUN MASS SP, V27, P127, DOI 10.1002/rcm.6425; Coldwell MJ, 2012, BIOCHEM J, V448, P1, DOI 10.1042/BJ20111765; Coldwell MJ, 2004, J CELL SCI, V117, P2545, DOI 10.1242/jcs.01106; Denison C, 2005, MOL CELL PROTEOMICS, V4, P246, DOI 10.1074/mcp.M400154-MCP200; Finkbeiner E, 2011, NUCLEUS-PHILA, V2, P527, DOI 10.4161/nucl.2.6.17604; Finkbeiner E, 2011, EMBO J, V30, P1067, DOI 10.1038/emboj.2011.33; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Haindl M, 2008, EMBO REP, V9, P273, DOI 10.1038/embor.2008.3; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hardeland U, 2002, EMBO J, V21, P1456, DOI 10.1093/emboj/21.6.1456; Hashemzadeh-Bonehi L, 2003, GENES CELLS, V8, P163, DOI 10.1046/j.1365-2443.2003.00623.x; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Ho JCY, 2001, NUCLEIC ACIDS RES, V29, P4179, DOI 10.1093/nar/29.20.4179; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Jian Ouyang, 2009, V497, P141, DOI 10.1007/978-1-59745-566-4_9; Joseph J, 2002, J CELL BIOL, V156, P595, DOI 10.1083/jcb.200110109; Kafasla P, 2009, RNA BIOL, V6, P563, DOI 10.4161/rna.6.5.9861; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kolli N, 2010, BIOCHEM J, V430, P335, DOI 10.1042/BJ20100504; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; Li SJ, 2003, J CELL BIOL, V160, P1069, DOI 10.1083/jcb.200212052; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; Matafora V, 2009, MOL CELL PROTEOMICS, V8, P2243, DOI 10.1074/mcp.M900079-MCP200; McKendrick L, 2001, MOL CELL BIOL, V21, P3632, DOI 10.1128/MCB.21.11.3632-3641.2001; Miller MJ, 2010, P NATL ACAD SCI USA, V107, P16512, DOI 10.1073/pnas.1004181107; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morley SJ, 2005, CELL DEATH DIFFER, V12, P571, DOI 10.1038/sj.cdd.4401591; MURRAY JM, 1991, NUCLEIC ACIDS RES, V19, P3525, DOI 10.1093/nar/19.13.3525; Nie MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005905; Nilsson D, 2011, RNA, V17, P120, DOI 10.1261/rna.2268111; Panse VG, 2004, J BIOL CHEM, V279, P41346, DOI 10.1074/jbc.M407950200; Panse VG, 2003, NAT CELL BIOL, V5, P21, DOI 10.1038/ncb893; Panse VG, 2006, TRAFFIC, V7, P1311, DOI 10.1111/j.1600-0854.2006.00471.x; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Seraphin B, 2003, ADV PROTEIN CHEM, V61, P99; Shayeghi M, 1997, NUCLEIC ACIDS RES, V25, P1162, DOI 10.1093/nar/25.6.1162; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Srikumar T, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.23; Takahashi Y, 2000, J BIOCHEM-TOKYO, V128, P723, DOI 10.1093/oxfordjournals.jbchem.a022807; Tanaka K, 1999, MOL CELL BIOL, V19, P8660; Taylor DL, 2002, J CELL SCI, V115, P1113; Topisirovic I, 2004, CANCER RES, V64, P8639, DOI 10.1158/0008-5472.CAN-04-2677; Vertegaal ACO, 2004, J BIOL CHEM, V279, P33791, DOI 10.1074/jbc.M404201200; Wan J, 2012, CURR PROTEIN PEPT SC, V13, P467, DOI 10.2174/138920312802430563; Wang CY, 2012, RNA, V18, P694, DOI 10.1261/rna.030270.111; Watts F, 2004, SUMOYLATION: MOLECULAR BIOLOGY AND BIOCHEMISTRY, P113; Watts FZ, 2011, BIOESSAYS, V33, P529, DOI 10.1002/bies.201100002; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Xhemalce B, 2004, EMBO J, V23, P3844, DOI 10.1038/sj.emboj.7600394; Xu XA, 2010, J BIOL CHEM, V285, P18139, DOI 10.1074/jbc.C110.131599; Xu X, 2010, EMBO REP, V11, P299, DOI 10.1038/embor.2010.18; Yang W, 2012, J PROTEOME RES, V11, P1108, DOI 10.1021/pr200834f; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Zhao YM, 2004, J BIOL CHEM, V279, P20999, DOI 10.1074/jbc.M401541200	72	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e94182	10.1371/journal.pone.0094182	http://dx.doi.org/10.1371/journal.pone.0094182			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24818994	Green Accepted, Green Published, gold			2022-12-27	WOS:000336653300002
J	Fernandez-Perez, L; Santana-Farre, R; de Mirecki-Garrido, M; Garcia, I; Guerra, B; Mateo-Diaz, C; Iglesias-Gato, D; Diaz-Chico, JC; Flores-Morales, A; Diaz, M				Fernandez-Perez, Leandro; Santana-Farre, Ruyman; de Mirecki-Garrido, Mercedes; Garcia, Irma; Guerra, Borja; Mateo-Diaz, Carlos; Iglesias-Gato, Diego; Carlos Diaz-Chico, Juan; Flores-Morales, Amilcar; Diaz, Mario			Lipid Profiling and Transcriptomic Analysis Reveals a Functional Interplay between Estradiol and Growth Hormone in Liver	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; GENE-EXPRESSION; RAT-LIVER; SIGNAL TRANSDUCER; MICROARRAY DATA; BETA-OXIDATION; UREA SYNTHESIS; METABOLISM; SEX; MICE	17 beta-estradiol (E2) may interfere with endocrine, metabolic, and gender-differentiated functions in liver in both females and males. Indirect mechanisms play a crucial role because of the E2 influence on the pituitary GH secretion and the GHR-JAK2-STAT5 signaling pathway in the target tissues. E2, through its interaction with the estrogen receptor, exerts direct effects on liver. Hypothyroidism also affects endocrine and metabolic functions of the liver, rendering a metabolic phenotype with features that mimic deficiencies in E2 or GH. In this work, we combined the lipid and transcriptomic analysis to obtain comprehensive information on the molecular mechanisms of E2 effects, alone and in combination with GH, to regulate liver functions in males. We used the adult hypothyroid-orchidectomized rat model to minimize the influence of internal hormones on E2 treatment and to explore its role in male-differentiated functions. E2 influenced genes involved in metabolism of lipids and endo-xenobiotics, and the GH-regulated endocrine, metabolic, immune, and male-specific responses. E2 induced a female-pattern of gene expression and inhibited GH-regulated STAT5b targeted genes. E2 did not prevent the inhibitory effects of GH on urea and amino acid metabolism-related genes. The combination of E2 and GH decreased transcriptional immune responses. E2 decreased the hepatic content of saturated fatty acids and induced a transcriptional program that seems to be mediated by the activation of PPAR alpha. In contrast, GH inhibited fatty acid oxidation. Both E2 and GH replacements reduced hepatic CHO levels and increased the formation of cholesterol esters and triacylglycerols. Notably, the hepatic lipid profiles were endowed with singular fingerprints that may be used to segregate the effects of different hormonal replacements. In summary, we provide in vivo evidence that E2 has a significant impact on lipid content and transcriptome in male liver and that E2 exerts a marked influence on GH physiology, with implications in human therapy.	[Fernandez-Perez, Leandro; Santana-Farre, Ruyman; de Mirecki-Garrido, Mercedes; Guerra, Borja; Mateo-Diaz, Carlos; Carlos Diaz-Chico, Juan] Univ Las Palmas Gran Canaria, Biomed & Hlth Res Inst IUIBS, Mol & Translat Endocrinol Grp, Dept Clin Sci, Las Palmas Gran Canaria, Spain; [Fernandez-Perez, Leandro; Garcia, Irma; Guerra, Borja; Mateo-Diaz, Carlos; Carlos Diaz-Chico, Juan; Diaz, Mario] Canc Res Inst Canary Isl ICIC, Las Palmas Gran Canaria, Canary Islands, Spain; [Garcia, Irma; Diaz, Mario] Univ La Laguna, Lab Membrane Physiol & Biophys, Dept Anim Biol, E-38207 San Cristobal la Laguna, Spain; [Iglesias-Gato, Diego; Flores-Morales, Amilcar] Univ Copenhagen, Mol Endocrinol Grp, Novo Nordisk Ctr Prot Res, Copenhagen, Denmark	Universidad de Las Palmas de Gran Canaria; Universidad de la Laguna; University of Copenhagen	Fernandez-Perez, L (corresponding author), Univ Las Palmas Gran Canaria, Biomed & Hlth Res Inst IUIBS, Mol & Translat Endocrinol Grp, Dept Clin Sci, Las Palmas Gran Canaria, Spain.	lfernandez@dcc.ulpgc.es	Iglesias-Gato, Diego/R-1794-2016; Guerra, Borja/ABE-1138-2021; Guerra, Borja/G-9739-2015; Diaz, Mario/C-1916-2014; Fernandez-Perez, Leandro/H-1493-2015; Diaz-Chico, Juan/H-1527-2015; Mirecki-Garrido, Mercedes/H-6075-2015	Iglesias-Gato, Diego/0000-0002-8982-9936; Guerra, Borja/0000-0003-4355-5682; Guerra, Borja/0000-0003-4355-5682; Diaz, Mario/0000-0001-5692-8906; Fernandez-Perez, Leandro/0000-0001-7802-465X; Diaz-Chico, Juan/0000-0002-0944-990X; Mirecki-Garrido, Mercedes/0000-0003-0488-6307	Spanish Ministry of Science and Innovation [SAF2003-02117, SAF2006-07824, SAF2010- 22114-C02-01]; ACIISI [PI2007/033, PI2010/0110]; Alfredo Martin-Reyes Foundation (Arehucas)-FICIC; Danish Council for Independent Research; Novo Nordisk Foundation; MCYT [SAF2003-02117]; ULPGC-ACIISI [ULPAPD-08/01-4]; ACIIS-IFSE [SE -10/13]; ULPGC-MEC [AP2001-3499]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ACIISI; Alfredo Martin-Reyes Foundation (Arehucas)-FICIC; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); MCYT(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ULPGC-ACIISI; ACIIS-IFSE; ULPGC-MEC	The Spanish Ministry of Science and Innovation with the funding of European Regional Development Fund-European Social Fund supported this research by grants-in-aid to LF-P (SAF2003-02117; SAF2006-07824) and MD (SAF2010- 22114-C02-01). LF-P was also supported by grants-in-aid from ACIISI (PI2007/033; PI2010/0110) and Alfredo Martin-Reyes Foundation (Arehucas)-FICIC. D.I-G and A.F-M are supported by the Danish Council for Independent Research and the Novo Nordisk Foundation. R.S-F was recipient of a predoctoral fellowship from the MCYT (SAF2003-02117), ULPGC-ACIISI (ULPAPD-08/01-4), and ACIIS-IFSE (SE -10/13). M.M-G is a recipient of predoctoral fellowship from ULPGC-MEC (AP2001-3499). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almansa E, 2003, J COMP PHYSIOL B, V173, P231, DOI 10.1007/s00360-003-0327-y; Alonso A, 2006, STEROIDS, V71, P1052, DOI 10.1016/j.steroids.2006.09.004; Anderson CM, 2013, MOL ASPECTS MED, V34, P516, DOI 10.1016/j.mam.2012.07.010; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Barclay JL, 2011, ENDOCRINOLOGY, V152, P181, DOI 10.1210/en.2010-0537; Barros RPA, 2011, CELL METAB, V14, P289, DOI 10.1016/j.cmet.2011.08.005; Borski RJ, 1996, ENDOCRINOLOGY, V137, P3253, DOI 10.1210/en.137.8.3253; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cummings DE, 2003, ANNU REV MED, V54, P513, DOI 10.1146/annurev.med.54.101601.152147; DEBEER LJ, 1983, DIABETES METAB, V9, P134; Della Torre S, 2011, CELL METAB, V13, P205, DOI 10.1016/j.cmet.2011.01.002; Devries MC, 2005, J CLIN ENDOCR METAB, V90, P6218, DOI 10.1210/jc.2005-0926; Diaz M, 2004, EUR J PHARMACOL, V501, P161, DOI 10.1016/j.ejphar.2004.08.020; Diaz ML, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00454; Djouadi F, 1998, J CLIN INVEST, V102, P1083, DOI 10.1172/JCI3949; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fabelo N, 2012, J NEUROENDOCRINOL, V24, P292, DOI 10.1111/j.1365-2826.2011.02242.x; Fabelo N, 2012, J NEUROPATH EXP NEUR, V71, P868, DOI 10.1097/NEN.0b013e31826be03c; Falany CN, 2002, J LIPID RES, V43, P2062, DOI 10.1194/jlr.M200260-JLR200; Fan Y, 2009, J BIOL CHEM, V284, P19937, DOI 10.1074/jbc.M109.014308; Faulds MH, 2012, J ENDOCRINOL, V212, P3, DOI 10.1530/JOE-11-0044; Fitts JM, 2001, ENDOCRINOLOGY, V142, P4223, DOI 10.1210/en.142.10.4223; Fitts JM, 1998, J PHARMACOL EXP THER, V286, P392; Flores-Morales A, 2001, ENDOCRINOLOGY, V142, P3163, DOI 10.1210/en.142.7.3163; Gao H, 2006, MOL ENDOCRINOL, V20, P1287, DOI 10.1210/me.2006-0012; Geng XC, 2012, J APPL TOXICOL, V32, P850, DOI 10.1002/jat.2773; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Grofte T, 1997, HEPATOLOGY, V25, P964, DOI 10.1002/hep.510250429; Hamadeh MJ, 2005, J CLIN ENDOCR METAB, V90, P3592, DOI 10.1210/jc.2004-1743; HAYASE K, 1991, J NUTR, V121, P970, DOI 10.1093/jn/121.7.970; Henriquez-Hernandez LA, 2007, J PHARMACOL EXP THER, V320, P695, DOI 10.1124/jpet.106.113209; Hodgin JB, 2002, ENDOCRINOLOGY, V143, P4495, DOI 10.1210/en.2002-220844; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Hosui A, 2008, PHYSIOL GENOMICS, V34, P135, DOI 10.1152/physiolgenomics.00048.2008; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inagaki T, 2008, CELL METAB, V8, P77, DOI 10.1016/j.cmet.2008.05.006; Ishimoto K, 2009, J BIOL CHEM, V284, P22195, DOI 10.1074/jbc.M109.028753; Jogl G, 2004, ANN NY ACAD SCI, V1033, P17, DOI 10.1196/annals.1320.002; Leung KC, 2004, ENDOCR REV, V25, P693, DOI 10.1210/er.2003-0035; Lopez-Guerra A, 1997, J STEROID BIOCHEM, V63, P219, DOI 10.1016/S0960-0760(97)00123-4; Loria P, 2009, NAT REV GASTRO HEPAT, V6, P236, DOI 10.1038/nrgastro.2009.33; Maher AC, 2010, PHYSIOL GENOMICS, V42, P342, DOI 10.1152/physiolgenomics.00016.2010; Marcoulides, 2008, INTRO APPL MULTIVARI; Mode A, 2006, DRUG METAB REV, V38, P197, DOI 10.1080/03602530600570057; Munzer T, 2006, AM J PHYSIOL-ENDOC M, V290, pE1006, DOI 10.1152/ajpendo.00166.2005; NANTOSALONEN K, 1993, ENDOCRINOLOGY, V132, P781, DOI 10.1210/en.132.2.781; OSCARSSON J, 1989, ENDOCRINOLOGY, V125, P1638, DOI 10.1210/endo-125-3-1638; Pedram A, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004013; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Rico-Bautista E, 2006, CYTOKINE GROWTH F R, V17, P431, DOI 10.1016/j.cytogfr.2006.09.008; Rochira V, 2002, J CLIN ENDOCR METAB, V87, P2857, DOI 10.1210/jc.87.6.2857; Rochira V, 2001, MOL CELL ENDOCRINOL, V178, P215, DOI 10.1016/S0303-7207(01)00446-4; Rochira V, 2010, J CLIN ENDOCR METAB, V95, P1626, DOI 10.1210/jc.2009-1743; Rozen S, 2000, Methods Mol Biol, V132, P365; SAP J, 1990, EMBO J, V9, P887, DOI 10.1002/j.1460-2075.1990.tb08186.x; Simpson ER, 2005, CELL METAB, V2, P346, DOI 10.1016/j.cmet.2005.11.010; Sjoberg A, 1996, J LIPID RES, V37, P275; SMITH EP, 1994, NEW ENGL J MED, V331, P1056, DOI 10.1056/NEJM199410203311604; Sos BC, 2011, J CLIN INVEST, V121, P1412, DOI 10.1172/JCI42894; Su X, 2009, TRENDS ENDOCRIN MET, V20, P72, DOI 10.1016/j.tem.2008.11.001; Takashima K, 2006, LIFE SCI, V78, P2787, DOI 10.1016/j.lfs.2005.11.010; Tollet-Egnell P, 2001, MOL ENDOCRINOL, V15, P308, DOI 10.1210/me.15.2.308; Tollet-Egnell P, 2004, PHYSIOL GENOMICS, V16, P261, DOI 10.1152/physiolgenomics.00093.2002; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vidal OM, 2007, MOL ENDOCRINOL, V21, P293, DOI 10.1210/me.2006-0096; Vijayakumar A, 2010, GROWTH HORM IGF RES, V20, P1, DOI 10.1016/j.ghir.2009.09.002; Villa A, 2012, P NATL ACAD SCI USA, V109, P11806, DOI 10.1073/pnas.1205797109; WAXMAN DJ, 1991, P NATL ACAD SCI USA, V88, P6868, DOI 10.1073/pnas.88.15.6868; Wolthers T, 2001, AM J PHYSIOL-ENDOC M, V281, pE1191, DOI 10.1152/ajpendo.2001.281.6.E1191; Yamazaki T, 2012, BIOL PHARM BULL, V35, P116, DOI 10.1248/bpb.35.116; Zadjali F, 2012, FASEB J, V26, P3282, DOI 10.1096/fj.12-205583; Zhu L, 2013, DIABETES, V62, P424, DOI 10.2337/db11-1718	74	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96305	10.1371/journal.pone.0096305	http://dx.doi.org/10.1371/journal.pone.0096305			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816529	gold, Green Submitted, Green Published			2022-12-27	WOS:000336838000033
J	Hidding, JT; Beurskens, CHG; van der Wees, PJ; van Laarhoven, HWM; Nijhuis-van der Sanden, MWG				Hidding, Janine T.; Beurskens, Carien H. G.; van der Wees, Philip J.; van Laarhoven, Hanneke W. M.; Nijhuis-van der Sanden, Maria W. G.			Treatment Related Impairments in Arm and Shoulder in Patients with Breast Cancer: A Systematic Review	PLOS ONE			English	Review							LYMPH-NODE DISSECTION; QUALITY-OF-LIFE; AXILLARY DISSECTION; RISK-FACTORS; FOLLOW-UP; PROSPECTIVE SURVEILLANCE; ARM/SHOULDER PROBLEMS; ADJUVANT BREAST; SURGERY; SURVIVORS	Background: Breast cancer is the most common type of cancer in women in the developed world. As a result of breast cancer treatment, many patients suffer from serious complaints in their arm and shoulder, leading to limitations in activities of daily living and participation. In this systematic literature review we present an overview of the adverse effects of the integrated breast cancer treatment related to impairment in functions and structures in the upper extremity and upper body and limitations in daily activities. Patients at highest risk were defined. Methods and Findings: We conducted a systematic literature search using the databases of PubMed, Embase, CINAHL and Cochrane from 2000 to October 2012, according to the PRISMA guidelines. Included were studies with patients with stage I-III breast cancer, treated with surgery and additional treatments (radiotherapy, chemotherapy and hormonal therapy). The following health outcomes were extracted: reduced joint mobility, reduced muscle strength, pain, lymphedema and limitations in daily activities. Outcomes were divided in within the first 12 months and >12 months post-operatively. Patients treated with ALND are at the highest risk of developing impairments of the arm and shoulder. Reduced ROM and muscle strength, pain, lymphedema and decreased degree of activities in daily living were reported most frequently in relation to ALND. Lumpectomy was related to a decline in the level of activities of daily living. Radiotherapy and hormonal therapy were the main risk factors for pain. Conclusions: Patients treated with ALND require special attention to detect and consequently address impairments in the arm and shoulder. Patients with pain should be monitored carefully, because pain limits the degree of daily activities. Future research has to describe a complete overview of the medical treatment and analyze outcome in relation to the treatment. Utilization of uniform validated measurement instruments has to be encouraged.	[Hidding, Janine T.; Beurskens, Carien H. G.] Radboud Univ Nijmegen Med Ctr, Dept Orthoped, Sect Phys Therapy, Nijmegen, Netherlands; [Hidding, Janine T.; van der Wees, Philip J.; Nijhuis-van der Sanden, Maria W. G.] Radboud Univ Nijmegen Med Ctr, Sci Inst Qual Healthcare, Nijmegen, Netherlands; [van Laarhoven, Hanneke W. M.] Univ Amsterdam, Acad Med Ctr, Dept Med Oncol, NL-1105 AZ Amsterdam, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam	Hidding, JT (corresponding author), Radboud Univ Nijmegen Med Ctr, Dept Orthoped, Sect Phys Therapy, Nijmegen, Netherlands.	Janine.Hidding@radboudumc.nl	der Sanden, Maria WG Nijhuis-van/B-3463-2012; van Laarhoven, Hanneke/AAW-3464-2021; Beurskens, C.H.G./L-4197-2015; van der Wees, Philip Jan/L-4748-2015	der Sanden, Maria WG Nijhuis-van/0000-0003-2637-6877; van Laarhoven, H.W.M./0000-0003-1274-5643	Dutch Society for Lymphology, part of the Royal Dutch Society for Physical Therapy	Dutch Society for Lymphology, part of the Royal Dutch Society for Physical Therapy	The Dutch Society for Lymphology, part of the Royal Dutch Society for Physical Therapy, has funded submission of this manuscript in PLOS ONE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen KG, 2012, ACTA ONCOL, V51, P1036, DOI 10.3109/0284186X.2012.692884; Ashikaga T, 2010, J SURG ONCOL, V102, P111, DOI 10.1002/jso.21535; Avraham T, 2010, ANN SURG ONCOL, V17, P2926, DOI 10.1245/s10434-010-1112-2; Beurskens CHG, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-166; Bevilacqua JLB, 2012, ANN SURG ONCOL, V19, P2580, DOI 10.1245/s10434-012-2290-x; Chang DW, 2010, PLAST RECONSTR SURG, V125, P19, DOI 10.1097/PRS.0b013e3181c49477; Cheville AL, 2007, J SURG ONCOL, V95, P409, DOI 10.1002/jso.20782; Dahl AA, 2011, SLEEP MED, V12, P584, DOI 10.1016/j.sleep.2011.01.011; Devoogdt N, 2010, BREAST CANCER RES TR, V123, P417, DOI 10.1007/s10549-010-0997-6; Hayes SC, 2011, BREAST CANCER RES TR, V130, P227, DOI 10.1007/s10549-011-1547-6; Hickey BE, 2013, COCHRANE DB SYST REV, V4, DOI [10.1002/14651858.CD005212, DOI 10.1002/14651858.CD005212]; Johnsson A, 2010, EUR J CANCER CARE, V19, P317, DOI 10.1111/j.1365-2354.2008.01043.x; Kanematsu M, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-436; Khan AJ, 2012, ANN SURG ONCOL, V19, P1477, DOI 10.1245/s10434-011-2133-1; Kwan ML, 2010, ARCH SURG-CHICAGO, V145, P1055, DOI 10.1001/archsurg.2010.231; Land SR, 2010, J CLIN ONCOL, V28, P3929, DOI 10.1200/JCO.2010.28.2491; Lee TS, 2008, BREAST CANCER RES TR, V110, P19, DOI 10.1007/s10549-007-9710-9; Levangie PK, 2009, BREAST CANCER RES TR, V116, P1, DOI 10.1007/s10549-008-0246-4; Levy EW, 2012, BREAST CANCER RES TR, V134, P315, DOI 10.1007/s10549-012-2061-1; Liu CQ, 2009, EUR J CANCER, V45, P1560, DOI 10.1016/j.ejca.2009.02.012; Lundstedt D, 2012, RADIOTHER ONCOL, V103, P155, DOI 10.1016/j.radonc.2011.12.017; Mak SS, 2008, NURS RES, V57, P418, DOI 10.1097/NNR.0b013e31818c3de2; McNeely ML, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005211.pub2; Mieog JSD, 2012, LANCET ONCOL, V13, P420, DOI 10.1016/S1470-2045(11)70328-X; Miller CL, 2012, BREAST CANCER RES TR, V135, P781, DOI 10.1007/s10549-012-2231-1; Moja L, 2012, COCHRANE DATABASE SY; Nesvold IL, 2011, J CANCER SURVIV, V5, P62, DOI 10.1007/s11764-010-0156-4; Norman SA, 2010, CANCER EPIDEM BIOMAR, V19, P2734, DOI 10.1158/1055-9965.EPI-09-1245; Ozcinar B, 2012, BREAST, V21, P361, DOI 10.1016/j.breast.2012.03.002; Park JH, 2008, J CLIN NURS, V17, P1450, DOI 10.1111/j.1365-2702.2007.02187.x; Paskett ED, 2007, CANCER EPIDEM BIOMAR, V16, P775, DOI 10.1158/1055-9965.EPI-06-0168; Ridner SH, 2011, SUPPORT CARE CANCER, V19, P853, DOI 10.1007/s00520-011-1089-9; Rief W, 2011, BREAST CANCER RES TR, V130, P579, DOI 10.1007/s10549-011-1614-z; Rietman JS, 2006, EJSO-EUR J SURG ONC, V32, P148, DOI 10.1016/j.ejso.2005.11.008; Sagen A, 2009, ACTA ONCOL, V48, P1111, DOI 10.3109/02841860903061691; Schmitz KH, 2012, CANCER-AM CANCER SOC, V118, P2270, DOI 10.1002/cncr.27462; Shamley D, 2009, BREAST CANCER RES TR, V118, P315, DOI 10.1007/s10549-008-0240-x; Sheridan D, 2012, J PAIN SYMPTOM MANAG, V44, P608, DOI 10.1016/j.jpainsymman.2011.10.021; Stout NL, 2012, PHYS THER, V92, P152, DOI 10.2522/ptj.20100167; Taira N, 2011, BREAST CANCER RES TR, V128, P735, DOI 10.1007/s10549-011-1631-y; Tsai RJ, 2009, ANN SURG ONCOL, V16, P1959, DOI 10.1245/s10434-009-0452-2; Ververs JMMA, 2001, EUR J CANCER, V37, P991, DOI 10.1016/S0959-8049(01)00067-3; Wernicke AG, 2011, BREAST CANCER RES TR, V125, P893, DOI 10.1007/s10549-010-1167-6; Yang EJ, 2010, J SURG ONCOL, V101, P84, DOI 10.1002/jso.21435; Yen TWF, 2009, ANN SURG ONCOL, V16, P979, DOI 10.1245/s10434-009-0347-2; Zhou WB, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-72	46	161	166	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96748	10.1371/journal.pone.0096748	http://dx.doi.org/10.1371/journal.pone.0096748			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816774	Green Submitted, Green Published, gold			2022-12-27	WOS:000336838000059
J	Dhawan, A; Kohandel, M; Hill, R; Sivaloganathan, S				Dhawan, Andrew; Kohandel, Mohammad; Hill, Richard; Sivaloganathan, Sivabal			Tumour Control Probability in Cancer Stem Cells Hypothesis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; IDENTIFICATION; RADIOTHERAPY	The tumour control probability (TCP) is a formalism derived to compare various treatment regimens of radiation therapy, defined as the probability that given a prescribed dose of radiation, a tumour has been eradicated or controlled. In the traditional view of cancer, all cells share the ability to divide without limit and thus have the potential to generate a malignant tumour. However, an emerging notion is that only a sub-population of cells, the so-called cancer stem cells (CSCs), are responsible for the initiation and maintenance of the tumour. A key implication of the CSC hypothesis is that these cells must be eradicated to achieve cures, thus we define TCPS as the probability of eradicating CSCs for a given dose of radiation. A cell surface protein expression profile, such as CD44high/CD24low for breast cancer or CD133 for glioma, is often used as a biomarker to monitor CSCs enrichment. However, it is increasingly recognized that not all cells bearing this expression profile are necessarily CSCs, and in particular early generations of progenitor cells may share the same phenotype. Thus, due to the lack of a perfect biomarker for CSCs, we also define a novel measurable TCPCD+, that is the probability of eliminating or controlling biomarker positive cells. Based on these definitions, we use stochastic methods and numerical simulations parameterized for the case of gliomas, to compare the theoretical TCPS and the measurable TCPCD+. We also use the measurable TCP to compare the effect of various radiation protocols.	[Dhawan, Andrew; Kohandel, Mohammad; Sivaloganathan, Sivabal] Univ Waterloo, Dept Appl Math, Waterloo, ON N2L 3G1, Canada; [Dhawan, Andrew] Queens Univ, Sch Med, Kingston, ON, Canada; [Kohandel, Mohammad; Sivaloganathan, Sivabal] Fields Inst Res Math Sci, Ctr Math Med, Toronto, ON, Canada; [Hill, Richard] Univ Toronto, Ontario Canc Inst, Dept Med Biophys, Princess Margaret Hosp, Toronto, ON M5S 1A1, Canada	University of Waterloo; Queens University - Canada; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Kohandel, M (corresponding author), Univ Waterloo, Dept Appl Math, Waterloo, ON N2L 3G1, Canada.	kohandel@math.uwaterloo.ca	Dhawan, Andrew/AAN-5014-2020	Dhawan, Andrew/0000-0002-5027-1277; Hill, Richard Peter/0000-0001-5331-8045	NSERC/CIHR Collaborative Health Research grant	NSERC/CIHR Collaborative Health Research grant(Canadian Institutes of Health Research (CIHR))	This work was financially supported by NSERC/CIHR Collaborative Health Research grant (SS and MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; Baumann M, 2009, INT J RADIAT BIOL, V85, P391, DOI 10.1080/09553000902836404; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Dasu A, 2005, ACTA ONCOL, V44, P563, DOI 10.1080/02841860500244435; Dhawan A, 2013, ARXIV13127556QBIOQM; Gao XF, 2013, CANCER RES, V73, P1481, DOI 10.1158/0008-5472.CAN-12-3429; Maler A, 2010, MATH MED BIOL, V27, P313, DOI 10.1093/imammb/dqp024; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marjanovic ND, 2013, CLIN CHEM, V59, P168, DOI 10.1373/clinchem.2012.184655; McCord AM, 2009, CLIN CANCER RES, V15, P5145, DOI 10.1158/1078-0432.CCR-09-0263; MUNRO TR, 1961, BRIT J RADIOL, V34, P246, DOI 10.1259/0007-1285-34-400-246; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; Powathil G, 2007, PHYS MED BIOL, V52, P3291, DOI 10.1088/0031-9155/52/11/023; Powathil G, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/410602; Rockne Russell, 2008, P207, DOI 10.1007/978-0-8176-4713-1_8; Sachs RK, 1996, MATH BIOSCI, V138, P131, DOI 10.1016/S0025-5564(96)00128-9; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Turner C, 2010, J THEOR BIOL, V265, P329, DOI 10.1016/j.jtbi.2010.05.024; Turner C, 2009, CELL PROLIFERAT, V42, P529, DOI 10.1111/j.1365-2184.2009.00619.x; Turner C, 2010, SEMINARS CANC BIOL, V22, P374; Wouters BG, 1997, RADIAT RES, V147, P541, DOI 10.2307/3579620; Zaider M, 2000, PHYS MED BIOL, V45, P279, DOI 10.1088/0031-9155/45/2/303; Zaider M, 2011, MED PHYS, V38, P574, DOI 10.1118/1.3521406	27	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96093	10.1371/journal.pone.0096093	http://dx.doi.org/10.1371/journal.pone.0096093			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24811314	gold, Green Submitted, Green Published			2022-12-27	WOS:000338213300020
J	Gurtner, G; Vitali, S; Cipolla, M; Lillo, F; Mantegna, RN; Micciche, S; Pozzi, S				Gurtner, Gerald; Vitali, Stefania; Cipolla, Marco; Lillo, Fabrizio; Mantegna, Rosario Nunzio; Micciche, Salvatore; Pozzi, Simone			Multi-Scale Analysis of the European Airspace Using Network Community Detection	PLOS ONE			English	Article							AIR TRANSPORTATION NETWORK; COMPLEX NETWORKS; AIRPORT NETWORK; CENTRALITY	We show that the European airspace can be represented as a multi-scale traffic network whose nodes are airports, sectors, or navigation points and links are defined and weighted according to the traffic of flights between the nodes. By using a unique database of the air traffic in the European airspace, we investigate the architecture of these networks with a special emphasis on their community structure. We propose that unsupervised network community detection algorithms can be used to monitor the current use of the airspace and improve it by guiding the design of new ones. Specifically, we compare the performance of several community detection algorithms, both with fixed and variable resolution, and also by using a null model which takes into account the spatial distance between nodes, and we discuss their ability to find communities that could be used to define new control units of the airspace.	[Gurtner, Gerald; Lillo, Fabrizio] Scuola Normale Super Pisa, Pisa, Italy; [Vitali, Stefania; Cipolla, Marco; Lillo, Fabrizio; Mantegna, Rosario Nunzio; Micciche, Salvatore] Univ Palermo, Dipartimento Chim Fis, I-90123 Palermo, Italy; [Lillo, Fabrizio] Santa Fe Inst, Santa Fe, NM 87501 USA; [Mantegna, Rosario Nunzio] Cent European Univ, Ctr Network Sci, Budapest, Hungary; [Mantegna, Rosario Nunzio] Cent European Univ, Dept Econ, Budapest, Hungary; [Pozzi, Simone] Deep Blue Srl, Rome, Italy	Scuola Normale Superiore di Pisa; University of Palermo; The Santa Fe Institute; Central European University; Central European University	Lillo, F (corresponding author), Scuola Normale Super Pisa, Pisa, Italy.	fabrizio.lillo@sns.it	Miccichè, Salvatore/B-6575-2008; Mantegna, Rosario N/H-3652-2014	Miccichè, Salvatore/0000-0003-3779-592X; Mantegna, Rosario N/0000-0003-4177-171X	SESAR-JU (Single European Sky ATM Research joint undertaking) through the research project ELSA [10-220719-C18]	SESAR-JU (Single European Sky ATM Research joint undertaking) through the research project ELSA	The research is funded by SESAR-JU (Single European Sky ATM Research joint undertaking) (http://www.sesarju.eu) through the research project ELSA "Empirically grounded agent based models for the future ATM scenario'', Contract Number 10-220719-C18. SESAR-JU is a a legal entity founded by the European Union and EUROCONTROL (European Organisation for the Safety of Air Navigation), to coordinate and concentrate all relevant research in the technological and operational dimension of the Single European Sky (SES). Data collection has been performed by EUROCONTROL. The paper reflects only the authors' views. EUROCONTROL is not liable for any use that may be made of the information contained. The funders had no role in study design and analysis, decision to publish, or preparation of the manuscript.	Bagler G, 2008, PHYSICA A, V387, P2972, DOI 10.1016/j.physa.2008.01.077; Barrat A, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/05/P05003; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Cai KQ, 2012, CHINESE PHYS B, V21, DOI 10.1088/1674-1056/21/2/028903; Chi LP, 2003, CHINESE PHYS LETT, V20, P1393, DOI 10.1088/0256-307X/20/8/362; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; De Montis A, 2011, J GEOGR SYST, V13, P49, DOI 10.1007/s10109-010-0130-8; Esquivel AV, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.021025; EUROCONTROL, 2005, FIN REP EUR COMM MAN; EUROCONTROL, 2010, DDR REF MAN 1 5 8; Expert P, 2011, P NATL ACAD SCI USA, V108, P7663, DOI 10.1073/pnas.1018962108; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gfeller D, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056135; Guida M, 2007, CHAOS SOLITON FRACT, V31, P527, DOI 10.1016/j.chaos.2006.02.007; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Lambiotte Renaud, 2010, 2010 8th International Symposium on Modeling and Optimization in Mobile, Ad Hoc and Wireless Networks (WiOpt), P546; Lancichinetti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018961; Li W, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.046106; Lillo F., 2011, P SESAR INN DAYS EUR; Miller R.G., 1981, SIMULTANEOUS STAT IN, Ved 2nd, DOI DOI 10.1007/s11263-015-0816-y; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Popovic M, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.208701; Quartieri J., 2008, INT J MATH MODELS ME, V2, P312; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Reichardt J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.218701; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rosvall M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008694; Schaub MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032210; SESAR, 2007, DEF FUT ATM TARG CON; Tumminello M, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/01/P01019; Wang JE, 2011, J TRANSP GEOGR, V19, P712, DOI 10.1016/j.jtrangeo.2010.08.012; Xu XL, 2011, EPL-EUROPHYS LETT, V93, DOI 10.1209/0295-5075/93/68002; Xu ZW, 2008, GEOJOURNAL, V73, P87, DOI 10.1007/s10708-008-9173-5; Zanin M, 2013, EUR PHYS J-SPEC TOP, V215, P5, DOI 10.1140/epjst/e2013-01711-9; Zanin M, 2008, CHAOS, V18, DOI 10.1063/1.2901916	37	30	32	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e94414	10.1371/journal.pone.0094414	http://dx.doi.org/10.1371/journal.pone.0094414			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809991	Green Submitted, Green Published, gold			2022-12-27	WOS:000338213300008
J	He, Y; Tang, JS; Li, ZC; Li, H; Liao, YH; Tang, YQ; Tan, LW; Chen, JD; Xia, K; Chen, XG				He, Ying; Tang, Jinsong; Li, Zongchang; Li, Hong; Liao, Yanhui; Tang, Yanqing; Tan, Liwen; Chen, Jindong; Xia, Kun; Chen, Xiaogang			Leukocyte Mitochondrial DNA Copy Number in Blood Is Not Associated with Major Depressive Disorder in Young Adults	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; POLYMERASE CHAIN-REACTION; BASAL GANGLIA; MUTATION; DISEASE; SCHIZOPHRENIA; INHERITANCE; EXPRESSION; DEPLETION; POINT	Background: Major depressive disorder (MDD) is the leading cause of disability worldwide, and has significant genetic predisposition. Mitochondria may have a role in MDD and so mitochondrial DNA (mtDNA) has been suggested as a possible biomarker for this disease. We aimed to test whether the mtDNA copy number of peripheral blood leukocytes is related to MDD in young adults. Methods: A case-control study was conducted with 210 MDD patients and 217 healthy controls (HC). The mtDNA copy number was measured by quantitative polymerase chain reaction (qPCR) method. Depression severity was assessed by the Hamilton-17 Depression Rating Scale (HDRS-17). Results: We found no significant differences in mtDNA copy number between MDD patients and HC, though the power analysis showed that our sample size has enough power to detect the difference. There were also no significant correlations between mtDNA copy number and the clinical characteristics (such as age, age of onset, episodes, Hamilton Depression Rating Scale (HDRS) score and Global Assessment of Function Scale (GAF) score) in MDD patients. Conclusion: Our study suggests that leukocyte mtDNA copy number is unlikely to contribute to MDD, but it doesn't mean that we can exclude the possibility of involvement of mitochondria in the disease. Further studies are required to elucidate whether mtDNA can be a biomarker of MDD.	[He, Ying; Tang, Jinsong; Li, Hong; Liao, Yanhui; Tan, Liwen; Chen, Jindong; Chen, Xiaogang] Cent S Univ, Xiangya Hosp 2, Inst Mental Hlth, Changsha, Hunan, Peoples R China; [Li, Zongchang] Wenzhou Med Univ, Inst Genom Med, Wenzhou, Zhejiang, Peoples R China; [Tang, Yanqing] China Med Univ, Affiliated Hosp 1, Dept Psychiat, Shenyang, Liaoning, Peoples R China; [Xia, Kun; Chen, Xiaogang] Cent S Univ, State Key Lab Med Genet, Changsha, Hunan, Peoples R China; [Chen, Xiaogang] Cent S Univ, Key Lab Psychiat & Mental Hlth Hunan Prov, Changsha, Hunan, Peoples R China; [Chen, Xiaogang] Cent S Univ, State Key Lab Med Genet, Changsha, Hunan, Peoples R China	Central South University; Wenzhou Medical University; China Medical University; Central South University; Central South University; Central South University	Tang, JS (corresponding author), Cent S Univ, Xiangya Hosp 2, Inst Mental Hlth, Changsha, Hunan, Peoples R China.	tangjinsonghn@gmail.com; chenxghn@gmail.com	XIA, KUN/AAO-3525-2020; Liao, Yanhui/L-1590-2016	Liao, Yanhui/0000-0003-4735-3252	National Natural Science Foundation of China [30900486, 81371480, 81271484, 81100996, 81071099, 81271499]; National Key Basic Research and Development Program (973) [2012CB517904]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research and Development Program (973)(National Basic Research Program of China)	The study was supported by the National Natural Science Foundation of China (Grant Nos. 30900486 and 81371480 to J.T., 81271484 to X. C., 81100996 to Y.L., 81071099 and 81271499 to Y.T.), and the National Key Basic Research and Development Program (973) (Grant No. 2012CB517904 to X. C.). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Association AP DSM-IV APA on, 2000, DIAGN STAT MAN MENT; Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8; Ben-Shachar D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003676; Bergernann ER, 2010, PSYCHIAT GENET, V20, P31, DOI 10.1097/YPG.0b013e3283351153; Bi R, 2010, HUM MUTAT, V31, P538, DOI 10.1002/humu.21220; Blokhin A, 2008, J MOL NEUROSCI, V35, P283, DOI 10.1007/s12031-008-9115-1; BUCHSBAUM MS, 1986, J AFFECT DISORDERS, V10, P137, DOI 10.1016/0165-0327(86)90036-4; Burnett BB, 2005, J AFFECT DISORDERS, V88, P109, DOI 10.1016/j.jad.2005.05.009; Choi YS, 2001, DIABETES RES CLIN PR, V54, pS3, DOI 10.1016/S0168-8227(01)00330-8; Curran JE, 2007, HUM MOL GENET, V16, P1504, DOI 10.1093/hmg/ddm101; de Sousa RT, 2014, PROG NEURO-PSYCHOPH, V48, P32, DOI 10.1016/j.pnpbp.2013.09.002; Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549; Gardner A, 2003, J AFFECT DISORDERS, V76, P55, DOI 10.1016/S0165-0327(02)00067-8; Gardner A, 2005, CURR PSYCHIATRY REV, V1, P255, DOI 10.2174/157340005774575064; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Jeng JY, 2008, J CELL BIOCHEM, V103, P347, DOI 10.1002/jcb.21625; Kato M, 2011, NEUROSCI RES, V69, P331, DOI 10.1016/j.neures.2010.12.013; Kim MY, 2011, ARCH GERONTOL GERIAT, V53, pE218, DOI 10.1016/j.archger.2010.11.019; Koene S, 2009, J AFFECT DISORDERS, V114, P327, DOI 10.1016/j.jad.2008.06.023; Kupfer DJ, 2012, LANCET, V379, P1045, DOI 10.1016/S0140-6736(11)60602-8; Laderman KA, 1996, J BIOL CHEM, V271, P15891, DOI 10.1074/jbc.271.27.15891; Lohoff FW, 2010, CURR PSYCHIAT REP, V12, P539, DOI 10.1007/s11920-010-0150-6; Malik AN, 2013, MITOCHONDRION, V13, P481, DOI 10.1016/j.mito.2012.10.011; Molnar MJ, 2009, J NEUROL, V256, P264, DOI 10.1007/s00415-009-0841-2; Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5; Moore CM, 1997, AM J PSYCHIAT, V154, P116; Morava E, 2010, MITOCHONDRION, V10, P528, DOI 10.1016/j.mito.2010.05.011; Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740; Onishi H, 1997, BIOL PSYCHIAT, V41, P1137, DOI 10.1016/S0006-3223(97)00005-X; Rezin GT, 2008, NEUROCHEM INT, V53, P395, DOI 10.1016/j.neuint.2008.09.012; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; SHANSKE AL, 1993, NEUROMUSCULAR DISORD, V3, P191, DOI 10.1016/0960-8966(93)90058-R; SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856; Volz HP, 1998, EUR ARCH PSY CLIN N, V248, P289, DOI 10.1007/s004060050052; Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586; Wang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038848; Whatley SA, 1996, NEUROCHEM RES, V21, P995, DOI 10.1007/BF02532409; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213; Yu M, 2007, IUBMB LIFE, V59, P450, DOI 10.1080/15216540701509955	40	34	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96869	10.1371/journal.pone.0096869	http://dx.doi.org/10.1371/journal.pone.0096869			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809340	Green Published, gold, Green Submitted			2022-12-27	WOS:000338213300081
J	Niegowski, D; Kleinschmidt, T; Ahmad, S; Qureshi, AA; Marback, M; Rinaldo-Matthis, A; Haeggstrom, JZ				Niegowski, Damian; Kleinschmidt, Thea; Ahmad, Shabbir; Qureshi, Abdul Aziz; Marback, Michaela; Rinaldo-Matthis, Agnes; Haeggstrom, Jesper Z.			Structure and Inhibition of Mouse Leukotriene C-4 Synthase	PLOS ONE			English	Article							MEMBRANE-ASSOCIATED PROTEINS; CRYSTAL-STRUCTURE; MAPEG; IDENTIFICATION; EXPRESSION; MODIFIERS; ASTHMA; MODEL	Leukotriene (LT) C-4 synthase (LTC4S) is an integral membrane protein that catalyzes the conjugation reaction between the fatty acid LTA(4) and GSH to form the pro-inflammatory LTC4, an important mediator of asthma. Mouse models of inflammatory disorders such as asthma are key to improve our understanding of pathogenesis and potential therapeutic targets. Here, we solved the crystal structure of mouse LTC4S in complex with GSH and a product analog, S-hexyl-GSH. Furthermore, we synthesized a nM inhibitor and compared its efficiency and binding mode against the purified mouse and human isoenzymes, along with the enzymes' steady-state kinetics. Although structural differences near the active site and along the C-terminal a-helix V suggest that the mouse and human LTC4S may function differently in vivo, our data indicate that mouse LTC4S will be a useful tool in future pharmacological research and drug development.	[Niegowski, Damian; Kleinschmidt, Thea; Ahmad, Shabbir; Qureshi, Abdul Aziz; Marback, Michaela; Rinaldo-Matthis, Agnes; Haeggstrom, Jesper Z.] Karolinska Inst, Dept Med Biochem & Biophys, Div Chem 2, Stockholm, Sweden	Karolinska Institutet	Rinaldo-Matthis, A (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Chem 2, Stockholm, Sweden.	Agnes.Rinaldo-Matthis@ki.se		Ahmad, Shabbir/0000-0003-2374-1197	Swedish Research Council [621-2011-5003, 10350, 20854]; Swedish Research Council (CERIC Linneus Grant); Stockholm County Council (Cardiovascular Program, Thematic Center Inflammation); FP7 [201668]; Hans Kroner Graduierten Kolleg; Torsten Soderberg foundation; Distinguished Professor Award from Karolinska Institutet	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council (CERIC Linneus Grant)(Swedish Research Council); Stockholm County Council (Cardiovascular Program, Thematic Center Inflammation)(Stockholm County Council); FP7; Hans Kroner Graduierten Kolleg; Torsten Soderberg foundation; Distinguished Professor Award from Karolinska Institutet	Funding for this work was provided primarily by The Swedish Research Council (621-2011-5003, 10350, 20854, and CERIC Linneus Grant), Stockholm County Council (Cardiovascular Program, Thematic Center Inflammation), FP7 (201668), Hans Kroner Graduierten Kolleg, and Torsten Soderberg foundation. JZH is the recipient of a Distinguished Professor Award from Karolinska Institutet. The funders had no other role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ago H, 2007, NATURE, V448, P609, DOI 10.1038/nature05936; Ago H, 2013, J BIOCHEM, V153, P421, DOI 10.1093/jb/mvt007; Ahmad S, 2013, BIOCHEMISTRY-US, V52, P1755, DOI 10.1021/bi3014104; Bisgaard H, 2001, PEDIATRICS, V107, P381, DOI 10.1542/peds.107.2.381; Bresell A, 2005, FEBS J, V272, P1688, DOI 10.1111/j.1742-4658.2005.04596.x; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Di Gennaro A, 2010, P NATL ACAD SCI USA, V107, P21093, DOI 10.1073/pnas.1015166107; Drazen JM, 1999, NEW ENGL J MED, V340, P197, DOI 10.1056/NEJM199901213400306; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferguson AD, 2007, SCIENCE, V317, P510, DOI 10.1126/science.1144346; Funk CD, 2005, NAT REV DRUG DISCOV, V4, P664, DOI 10.1038/nrd1796; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Haeggstrom JZ, 2010, BIOCHEM BIOPH RES CO, V396, P135, DOI 10.1016/j.bbrc.2010.03.140; Heise CE, 2000, J BIOL CHEM, V275, P30531, DOI 10.1074/jbc.M003490200; Jakobsson PJ, 2000, AM J RESP CRIT CARE, V161, pS20, DOI 10.1164/ajrccm.161.supplement_1.ltta-5; Jakobsson PJ, 1999, PROTEIN SCI, V8, P689, DOI 10.1110/ps.8.3.689; Jegerschold C, 2008, P NATL ACAD SCI USA, V105, P11110, DOI 10.1073/pnas.0802894105; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Lam BK, 1996, EUR J BIOCHEM, V238, P606, DOI 10.1111/j.1432-1033.1996.0606w.x; Lynch KR, 1999, NATURE, V399, P789; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Molina DM, 2007, NATURE, V448, P613, DOI 10.1038/nature06009; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niegowski D, 2014, J BIOL CHEM, V289, P5199, DOI 10.1074/jbc.M113.534628; Nilsson P, 2013, Internat Publication Nr, Patent No. [WO/2011/110824, 2011110824]; Pawelzik SC, 2010, J BIOL CHEM, V285, P29254, DOI 10.1074/jbc.M110.114454; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Rinaldo-Matthis A, 2012, BIOCHEMISTRY-US, V51, P848, DOI 10.1021/bi201402s; Rinaldo-Matthis A, 2010, J BIOL CHEM, V285, P40771, DOI 10.1074/jbc.M110.105940; Saino H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.150177; Samuelsson B, 2012, J BIOL CHEM, V287, P10070, DOI 10.1074/jbc.X112.351437; Svartz J, 2003, BBA-MOL CELL BIOL L, V1633, P90, DOI 10.1016/S1388-1981(03)00091-X; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	36	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96763	10.1371/journal.pone.0096763	http://dx.doi.org/10.1371/journal.pone.0096763			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810165	Green Published, Green Submitted, gold			2022-12-27	WOS:000338213300069
J	Mathews, JA; Williams, AS; Brand, JD; Wurmbrand, AP; Chen, L; Ninin, FMC; Si, HQ; Kasahara, DI; Shore, SA				Mathews, Joel A.; Williams, Alison S.; Brand, Jeffrey D.; Wurmbrand, Allison P.; Chen, Lucas; Ninin, Fernanda M. C.; Si, Huiqing; Kasahara, David I.; Shore, Stephanie A.			gamma delta T Cells Are Required for Pulmonary IL-17A Expression after Ozone Exposure in Mice: Role of TNF alpha	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; INDUCED LUNG INFLAMMATION; COLONY-STIMULATING FACTOR; INDUCED OBESE MICE; DEFICIENT MICE; AIR-POLLUTION; EPITHELIAL-CELLS; INFLUENZA-VIRUS; SUBACUTE OZONE; RESPONSES	Ozone is an air pollutant that causes pulmonary symptoms. In mice, ozone exposure causes pulmonary injury and increases bronchoalveolar lavage macrophages and neutrophils. We have shown that IL-17A is important in the recruitment of neutrophils after subacute ozone exposure (0.3 ppm for 24-72 h). We hypothesized that gamma delta T cells are the main producers of IL-17A after subacute ozone. To explore this hypothesis we exposed wildtype mice and mice deficient in gamma delta T cells (TCR delta(-/-)) to ozone or room air. Ozone-induced increases in BAL macrophages and neutrophils were attenuated in TCR delta(-/-) mice. Ozone increased the number of gamma delta T cells in the lungs and increased pulmonary Il17a mRNA expression and the number of IL-17A(+) CD45(+) cells in the lungs and these effects were abolished in TCR delta(-/-) mice. Ozone-induced increases in factors downstream of IL-17A signaling, including G-CSF, IL-6, IP-10 and KC were also decreased in TCR delta(-/-) versus wildtype mice. Neutralization of IL-17A during ozone exposure in wildtype mice mimicked the effects of gamma delta T cell deficiency. TNFR2 deficiency and etanercept, a TNF alpha antagonist, also reduced ozone-induced increases in Il17a mRNA, IL-17A(+) CD45(+) cells and BAL G-CSF as well as BAL neutrophils. TNFR2 deficient mice also had decreased ozone-induced increases in Ccl20, a chemoattractant for IL-17A(+) gamma delta T cells. Il17a mRNA and IL-17A(+) gamma delta T cells were also lower in obese Cpe(fat) versus lean WT mice exposed to subacute ozone, consistent with the reduced neutrophil recruitment observed in the obese mice. Taken together, our data indicate that pulmonary inflammation induced by subacute ozone requires gamma delta T cells and TNF alpha-dependent recruitment of IL-17A(+) gamma delta T cells to the lung.	[Mathews, Joel A.; Williams, Alison S.; Brand, Jeffrey D.; Wurmbrand, Allison P.; Chen, Lucas; Ninin, Fernanda M. C.; Si, Huiqing; Kasahara, David I.; Shore, Stephanie A.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Mol & Integrat Physiol Sci Program, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Mathews, JA (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Mol & Integrat Physiol Sci Program, Boston, MA 02115 USA.	jmathews@hsph.harvard.edu		Chen, Lucas/0000-0002-9228-1959	 [F32ES02256];  [NIH-HL007118];  [NIEHS: ES-013307];  [ES-000002]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002, R01ES013307, F32ES022556] Funding Source: NIH RePORTER	; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by: F32ES02256, NIH-HL007118, NIEHS: ES-013307 and ES-000002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antiga E, 2012, J CLIN IMMUNOL, V32, P1221, DOI 10.1007/s10875-012-9716-x; Backus GS, 2010, ENVIRON HEALTH PERSP, V118, P1721, DOI 10.1289/ehp.1002182; Bauer AK, 2010, EUR RESPIR J, V36, P428, DOI 10.1183/09031936.00145309; Bell ML, 2005, EPIDEMIOLOGY, V16, P436, DOI 10.1097/01.ede.0000165817.40152.85; Bhalla DK, 1999, J TOXICOL ENV HEAL B, V2, P31, DOI 10.1080/109374099281232; Boutin-Forzano S, 2005, Eur Ann Allergy Clin Immunol, V37, P11; Braun RK, 2008, INFLAMMATION, V31, P167, DOI 10.1007/s10753-008-9062-6; Brunner PM, 2013, J ALLERGY CLIN IMMUN, V132, P1184, DOI 10.1016/j.jaci.2013.05.036; Cai XY, 1998, IMMUNOL LETT, V62, P51, DOI 10.1016/S0165-2478(98)00027-3; Cazzola M, 2013, RESP MED, V107, P107, DOI 10.1016/j.rmed.2012.09.022; Charpin D, 1999, CLIN EXP ALLERGY, V29, P1474; Cheng P, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-38; Chiu HF, 2009, INHAL TOXICOL, V21, P32, DOI 10.1080/08958370802441198 ; Cho HY, 2001, AM J PHYSIOL-LUNG C, V280, pL537, DOI 10.1152/ajplung.2001.280.3.L537; Churg A, 2002, AM J RESP CRIT CARE, V166, P849, DOI 10.1164/rccm.200202-097OC; COLEMAN DL, 1990, J HERED, V81, P424, DOI 10.1093/oxfordjournals.jhered.a111019; COX G, 1992, AM J RESP CELL MOL, V7, P507, DOI 10.1165/ajrcmb/7.5.507; DEVLIN RB, 1991, AM J RESP CELL MOL, V4, P72, DOI 10.1165/ajrcmb/4.1.72; Ehrlich SF, 2010, DIABETES CARE, V33, P55, DOI 10.2337/dc09-0880; Grounds MD, 2005, CELL TISSUE RES, V320, P509, DOI 10.1007/s00441-005-1102-z; Hirai Y, 2012, AM J PHYSIOL-RENAL, V302, pF244, DOI 10.1152/ajprenal.00113.2011; Johnston RA, 2006, AM J PHYSIOL-REG I, V290, pR126, DOI 10.1152/ajpregu.00306.2005; Johnston RA, 2005, AM J PHYSIOL-LUNG C, V288, pL390, DOI 10.1152/ajplung.00007.2004; Johnston RA, 2008, J APPL PHYSIOL, V104, P1727, DOI 10.1152/japplphysiol.00075.2008; Jones CE, 2002, AM J RESP CELL MOL, V26, P748, DOI 10.1165/ajrcmb.26.6.4757; Kasahara DI, 2012, J IMMUNOL, V188, P4558, DOI 10.4049/jimmunol.1102363; Kim Chang H., 2009, Inflammation & Allergy Drug Targets, V8, P221; King DP, 1999, J IMMUNOL, V162, P5033; Kleeberger SR, 1997, NAT GENET, V17, P475, DOI 10.1038/ng1297-475; Koohsari H, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-21; Kordonowy LL, 2012, AM J RESP CELL MOL, V47, P120, DOI 10.1165/rcmb.2011-0334OC; Korn T, 2012, ANN NY ACAD SCI, V1247, P34, DOI 10.1111/j.1749-6632.2011.06355.x; Laan M, 1999, J IMMUNOL, V162, P2347; Lahn M, 1998, J IMMUNOL, V160, P5221; Levy JI, 2005, EPIDEMIOLOGY, V16, P458, DOI 10.1097/01.ede.0000165820.08301.b3; Li WJ, 2012, J VIROL, V86, P12304, DOI 10.1128/JVI.01269-12; Li ZJ, 2011, FASEB J, V25, P2659, DOI 10.1096/fj.11-184804; Lo Re S, 2010, J IMMUNOL, V184, P6367, DOI 10.4049/jimmunol.0900459; Lu FL, 2006, AM J PHYSIOL-LUNG C, V290, pL856, DOI 10.1152/ajplung.00386.2005; Mabuchi T, 2013, J INVEST DERMATOL, V133, P164, DOI 10.1038/jid.2012.260; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; Mancuso P, 2002, J IMMUNOL, V168, P4018, DOI 10.4049/jimmunol.168.8.4018; Mancuso P, 2010, J APPL PHYSIOL, V108, P722, DOI 10.1152/japplphysiol.00781.2009; Matsubara S, 2009, AM J RESP CELL MOL, V40, P454, DOI 10.1165/rcmb.2008-0346OC; MCMENAMIN C, 1994, SCIENCE, V265, P1869, DOI 10.1126/science.7916481; Michalec L, 2002, J IMMUNOL, V168, P846, DOI 10.4049/jimmunol.168.2.846; Milner JJ, 2013, J IMMUNOL, V191, P2474, DOI 10.4049/jimmunol.1202429; Morgan OW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009694; Peden DB, 1996, OTOLARYNG HEAD NECK, V114, P242, DOI 10.1016/S0194-5998(96)70175-4; POBER JS, 1987, CIBA F SYMP, V131, P170; Pociask DA, 2011, AM J PATHOL, V178, P1167, DOI 10.1016/j.ajpath.2010.11.055; Pons J, 2005, EUR RESPIR J, V25, P441, DOI 10.1183/09031936.05.00069304; Sergejeva S, 2005, AM J RESP CELL MOL, V33, P248, DOI 10.1165/rcmb.2004-0213OC; Shimizu M, 2009, SHOCK, V32, P535, DOI 10.1097/SHK.0b013e3181a2adb7; Shore SA, 2003, J APPL PHYSIOL, V95, P938, DOI 10.1152/japplphysiol.00336.2003; Shore SA, 2009, J APPL PHYSIOL, V107, P1445, DOI 10.1152/japplphysiol.00456.2009; SKEEN MJ, 1993, J EXP MED, V178, P971, DOI 10.1084/jem.178.3.971; Skerry C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039680; Smith AG, 2007, J NUTR, V137, P1236, DOI 10.1093/jn/137.5.1236; Sugita S, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3824; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Taylor KR, 2011, J INVEST DERMATOL, V131, P2409, DOI 10.1038/jid.2011.241; Taylor KR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011422; Triche EW, 2006, ENVIRON HEALTH PERSP, V114, P911, DOI 10.1289/ehp.8559; Ueta C, 1996, EUR J IMMUNOL, V26, P3066, DOI 10.1002/eji.1830261237; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; VASSALLI P, 1992, ANNU REV IMMUNOL, V10, P411, DOI 10.1146/annurev.iy.10.040192.002211; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wands JM, 2005, J LEUKOCYTE BIOL, V78, P1086, DOI 10.1189/jlb.0505244; Wieland CW, 2005, INT IMMUNOL, V17, P1399, DOI 10.1093/intimm/dxh317; Williams AS, 2013, ENVIRON HEALTH PERSP, V121, P551, DOI 10.1289/ehp.1205880; Wozniak KL, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-65; YONEMARU M, 1989, J LAB CLIN MED, V114, P674; Zhao QY, 1998, AM J PHYSIOL-LUNG C, V274, pL39, DOI 10.1152/ajplung.1998.274.1.L39	74	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97707	10.1371/journal.pone.0097707	http://dx.doi.org/10.1371/journal.pone.0097707			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24823369	Green Published, gold, Green Submitted			2022-12-27	WOS:000336369200133
J	Bollmann, A; Bullerjahn, GS; Mckay, RM				Bollmann, Annette; Bullerjahn, George S.; Mckay, Robert Michael			Abundance and Diversity of Ammonia-Oxidizing Archaea and Bacteria in Sediments of Trophic End Members of the Laurentian Great Lakes, Erie and Superior	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVITY; VERTICAL-DISTRIBUTION; AMOA GENES; NICHE; NITRIFICATION; COMMUNITY; CRENARCHAEOTA; OXIDATION; SEGREGATION; CULTIVATION	Ammonia oxidation is the first step of nitrification carried out by ammonia-oxidizing Archaea (AOA) and Bacteria (AOB). Lake Superior and Erie are part of the Great Lakes system differing in trophic status with Lake Superior being oligotrophic and Lake Erie meso-to eutrophic. Sediment samples were collected from both lakes and used to characterize abundance and diversity of AOA and AOB based on the ammonia monooxygenase (amoA) gene. Diversity was accessed by a pyro-sequencing approach and the obtained sequences were used to determine the phylogeny and alpha and beta diversity of the AOA and AOB populations. In Lake Erie copy numbers of bacterial amoA genes were in the same order of magnitude or even higher than the copy numbers of the archaeal amoA genes, while in Lake Superior up to 4 orders of magnitude more archaeal than bacterial amoA copies were detected. The AOB detected in the samples from Lake Erie belonged to AOB that are frequently detected in freshwater. Differences were detected between the phylogenetic affiliations of the AOA from the two lakes. Most sequences detected in Lake Erie clustered in the Nitrososphaera cluster (Thaumarchaeal soil group I. 1b) where as most of the sequences in Lake Superior were found in the Nitrosopumilus cluster (Thaumarchaeal marine group I.1a) and the Nitrosotalea cluster. Pearson correlations and canonical correspondence analysis (CCA) showed that the differences in abundance and diversity of AOA are very likely related to the sampling location and thereby to the different trophic states of the lakes.	[Bollmann, Annette] Miami Univ, Dept Microbiol, Oxford, OH 45056 USA; [Bullerjahn, George S.; Mckay, Robert Michael] Bowling Green State Univ, Dept Biol Sci, Bowling Green, OH 43403 USA	University System of Ohio; Miami University; University System of Ohio; Bowling Green State University	Bollmann, A (corresponding author), Miami Univ, Dept Microbiol, Oxford, OH 45056 USA.	bollmaa@miamioh.edu	Bullerjahn, George S/F-4428-2010; McKay, Robert Michael/P-3759-2017	McKay, Robert Michael/0000-0003-2723-5371; Bullerjahn, George/0000-0001-5319-7896	National Science Foundation (NSF) Department of Environmental Biology (DEB) [1120443]; Department of Ocean Sciences (OCE) [0927277]	National Science Foundation (NSF) Department of Environmental Biology (DEB)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Department of Ocean Sciences (OCE)	The work was funded by the National Science Foundation (NSF) Department of Environmental Biology (DEB) Grant No: 1120443 to AB and Department of Ocean Sciences (OCE) Grant No: 0927277 to RMM and GSB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arp DJ, 2002, ARCH MICROBIOL, V178, P250, DOI 10.1007/s00203-002-0452-0; Auguet JC, 2013, FEMS MICROBIOL ECOL, V84, P154, DOI 10.1111/1574-6941.12047; Auguet JC, 2012, ISME J, V6, P1786, DOI 10.1038/ismej.2012.33; Auguet JC, 2011, APPL ENVIRON MICROB, V77, P1937, DOI 10.1128/AEM.01213-10; Baker DB, 2002, J ENVIRON QUAL, V31, P96, DOI 10.2134/jeq2002.0096; BEETON ALFRED M., 1965, LIMNOL OCEANOGR, V10, P240; Beman JM, 2008, ISME J, V2, P429, DOI 10.1038/ismej.2007.118; Bernhard AE, 2010, APPL ENVIRON MICROB, V76, P1285, DOI 10.1128/AEM.02018-09; Berry D, 2011, APPL ENVIRON MICROB, V77, P7846, DOI 10.1128/AEM.05220-11; Bollmann A, 2001, FEMS MICROBIOL ECOL, V37, P211, DOI 10.1016/S0168-6496(01)00163-5; Bollmann A, 2011, METHOD ENZYMOL, V486, P55, DOI [10.1016/S0076-6879(11)86003-9, 10.1016/B978-0-12-381294-0.00003-1]; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chapra SC, 2012, J GREAT LAKES RES, V38, P550, DOI 10.1016/j.jglr.2012.06.010; Chen GY, 2009, RES MICROBIOL, V160, P173, DOI 10.1016/j.resmic.2009.01.003; Coci M, 2008, APPL ENVIRON MICROB, V74, P1963, DOI 10.1128/AEM.00694-07; Coolen MJL, 2007, ENVIRON MICROBIOL, V9, P1001, DOI 10.1111/j.1462-2920.2006.01227.x; de Bie MJM, 2001, AQUAT MICROB ECOL, V23, P225, DOI 10.3354/ame023225; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; French E, 2012, APPL ENVIRON MICROB, V78, P5773, DOI 10.1128/AEM.00432-12; Gubry-Rangin C, 2011, P NATL ACAD SCI USA, V108, P21206, DOI 10.1073/pnas.1109000108; Gubry-Rangin C, 2010, FEMS MICROBIOL ECOL, V74, P566, DOI 10.1111/j.1574-6941.2010.00971.x; Hatzenpichler R, 2012, APPL ENVIRON MICROB, V78, P7501, DOI 10.1128/AEM.01960-12; Herfort L, 2009, AQUAT MICROB ECOL, V55, P189, DOI 10.3354/ame01294; Herrmann M, 2008, APPL ENVIRON MICROB, V74, P3279, DOI 10.1128/AEM.02802-07; Herrmann M, 2012, ENVIRON MICROBIOL, V14, P3013, DOI 10.1111/j.1462-2920.2012.02882.x; Herrmann M, 2011, APPL ENVIRON MICROB, V77, P1896, DOI 10.1128/AEM.02879-10; Herrmann M, 2009, APPL ENVIRON MICROB, V75, P3127, DOI 10.1128/AEM.02806-08; Hu AY, 2010, FRESHWATER BIOL, V55, P2375, DOI 10.1111/j.1365-2427.2010.02454.x; Jung MY, 2011, APPL ENVIRON MICROB, V77, P8635, DOI 10.1128/AEM.05787-11; KANDELER E, 1988, BIOL FERT SOILS, V6, P68, DOI 10.1007/BF00257924; Keeney D. R., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P643; Kim JG, 2012, ENVIRON MICROBIOL, V14, P1528, DOI 10.1111/j.1462-2920.2012.02740.x; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Koops HP, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P778, DOI 10.1007/0-387-30745-1_36; Koops HP, 2001, FEMS MICROBIOL ECOL, V37, P1, DOI 10.1111/j.1574-6941.2001.tb00847.x; Kowalchuk GA, 2001, ANNU REV MICROBIOL, V55, P485, DOI 10.1146/annurev.micro.55.1.485; Kowalchuk GA, 1997, APPL ENVIRON MICROB, V63, P1489, DOI 10.1128/AEM.63.4.1489-1497.1997; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lavrentyev PJ, 1997, AQUAT MICROB ECOL, V13, P161, DOI 10.3354/ame013161; Lebedeva EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080835; Lehtovirta-Morley LE, 2011, P NATL ACAD SCI USA, V108, P15892, DOI 10.1073/pnas.1107196108; Liu S, 2013, APPL ENVIRON MICROB, V79, P4065, DOI 10.1128/AEM.00543-13; Lliros M, 2010, APPL ENVIRON MICROB, V76, P6853, DOI 10.1128/AEM.02864-09; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Luke C, 2011, APPL ENVIRON MICROB, V77, P6305, DOI 10.1128/AEM.05355-11; Magalhaes CM, 2009, AQUAT MICROB ECOL, V56, P13, DOI 10.3354/ame01313; Mao YJ, 2013, ENVIRON MICROBIOL, V15, P928, DOI 10.1111/j.1462-2920.2012.02844.x; Mao YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024750; Martens-Habbena W, 2009, NATURE, V461, P976, DOI 10.1038/nature08465; Merbt SN, 2011, LIMNOL OCEANOGR, V56, P1054, DOI 10.4319/lo.2011.56.3.1054; Mincer TJ, 2007, ENVIRON MICROBIOL, V9, P1162, DOI 10.1111/j.1462-2920.2007.01239.x; Mosier AC, 2008, ENVIRON MICROBIOL, V10, P3002, DOI 10.1111/j.1462-2920.2008.01764.x; Mosier AC, 2012, MICROB ECOL, V64, P955, DOI 10.1007/s00248-012-0075-1; Mussmann M, 2011, P NATL ACAD SCI USA, V108, P16771, DOI 10.1073/pnas.1106427108; Nicol GW, 2008, ENVIRON MICROBIOL, V10, P2966, DOI 10.1111/j.1462-2920.2008.01701.x; Park BJ, 2010, APPL ENVIRON MICROB, V76, P7575, DOI 10.1128/AEM.01478-10; Pester M, 2012, ENVIRON MICROBIOL, V14, P525, DOI 10.1111/j.1462-2920.2011.02666.x; Pester M, 2011, CURR OPIN MICROBIOL, V14, P300, DOI 10.1016/j.mib.2011.04.007; Pratscher J, 2011, P NATL ACAD SCI USA, V108, P4170, DOI 10.1073/pnas.1010981108; Reed DW, 2010, APPL ENVIRON MICROB, V76, P2517, DOI 10.1128/AEM.02436-09; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Sauder LA, 2012, ENVIRON MICROBIOL, V14, P2589, DOI 10.1111/j.1462-2920.2012.02786.x; Sauder LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023281; Shand CA, 2008, TALANTA, V74, P648, DOI 10.1016/j.talanta.2007.06.039; Small GE, 2013, LIMNOL OCEANOGR, V58, P276, DOI 10.4319/lo.2013.58.1.0276; Spang A, 2010, TRENDS MICROBIOL, V18, P331, DOI 10.1016/j.tim.2010.06.003; Speksnijder AGCL, 1998, SYST APPL MICROBIOL, V21, P321, DOI 10.1016/S0723-2020(98)80040-4; Stahl DA, 2012, ANNU REV MICROBIOL, V66, P83, DOI 10.1146/annurev-micro-092611-150128; STEHR G, 1995, MICROB ECOL, V30, P115, DOI 10.1007/BF00172568; Sterner RW, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028861; Tourna M, 2008, ENVIRON MICROBIOL, V10, P1357, DOI 10.1111/j.1462-2920.2007.01563.x; Tourna M, 2011, P NATL ACAD SCI USA, V108, P8420, DOI 10.1073/pnas.1013488108; van der Wielen PWJJ, 2009, APPL ENVIRON MICROB, V75, P4687, DOI 10.1128/AEM.00387-09; Verhamme DT, 2011, ISME J, V5, P1067, DOI 10.1038/ismej.2010.191; Vissers EW, 2013, ARCHAEA, V2013, DOI 10.1155/2013/289478; Vissers EW, 2013, FEMS MICROBIOL ECOL, V83, P515, DOI 10.1111/1574-6941.12013; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103; Ye WJ, 2009, FEMS MICROBIOL ECOL, V70, P263, DOI 10.1111/j.1574-6941.2009.00761.x	81	55	61	2	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97068	10.1371/journal.pone.0097068	http://dx.doi.org/10.1371/journal.pone.0097068			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819357	Green Published, Green Submitted, gold			2022-12-27	WOS:000336653300066
J	Gao, XJ; Kong, LY; Lu, XH; Zhang, GL; Chi, LF; Jiang, Y; Wu, YH; Yan, CL; Duerksen-Hughes, P; Zhu, XQ; Yang, J				Gao, Xiangjing; Kong, Liya; Lu, Xianghong; Zhang, Guanglin; Chi, Linfeng; Jiang, Ying; Wu, Yihua; Yan, Chunlan; Duerksen-Hughes, Penelope; Zhu, Xinqiang; Yang, Jun			Paraspeckle Protein 1 (PSPC1) Is Involved in the Cisplatin Induced DNA Damage Response-Role in G1/S	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; GAMMA-H2AX FOCI FORMATION; GENOMIC INSTABILITY; HISTONE H2AX; MITOTIC CATASTROPHE; IONIZING-RADIATION; DEPENDENT MANNER; MAMMALIAN-CELLS; SPLICING-FACTOR; NUCLEAR FOCI	Paraspeckle protein 1 (PSPC1) was first identified as a structural protein of the subnuclear structure termed paraspeckle. However, the exact physiological functions of PSPC1 are still largely unknown. Previously, using a proteomic approach, we have shown that exposure to cisplatin can induce PSPC1 expression in HeLa cells, indicating the possible involvement for PSPC1 in the DNA damage response (DDR). In the current study, the role of PSPC1 in DDR was examined. First, it was found that cisplatin treatment could indeed induce the expression of PSPC1 protein. Abolishing PSPC1 expression by siRNA significantly inhibited cell growth, caused spontaneous cell death, and increased DNA damage. However, PSPC1 did not colocalize with gamma H2AX, 53BP1, or Rad51, indicating no direct involvement in DNA repair pathways mediated by these molecules. Interestingly, knockdown of PSPC1 disrupted the normal cell cycle distribution, with more cells entering the G2/M phase. Furthermore, while cisplatin induced G1/S arrest in HeLa cells, knockdown of PSPC1 caused cells to escape the G1/S checkpoint and enter mitosis, and resulted in more cell death. Taken together, these observations indicate a new role for PSPC1 in maintaining genome integrity during the DDR, particularly in the G1/S checkpoint.	[Gao, Xiangjing; Zhang, Guanglin; Chi, Linfeng; Wu, Yihua; Yan, Chunlan; Yang, Jun] Zhejiang Univ, Affiliated Hosp 1, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China; [Gao, Xiangjing; Zhang, Guanglin; Chi, Linfeng; Wu, Yihua; Yan, Chunlan; Zhu, Xinqiang] Zhejiang Univ, Sch Publ Hlth, Dept Toxicol, Hangzhou 310003, Zhejiang, Peoples R China; [Kong, Liya] Zhejiang Chinese Med Univ, Dept Prevent Med, Hangzhou, Peoples R China; [Lu, Xianghong] Lishui Peoples Hosp, Lishui, Zhejiang, Peoples R China; [Jiang, Ying] Ctr Testing Int Corp, Shenzhen, Guangdong, Peoples R China; [Duerksen-Hughes, Penelope] Loma Linda Univ, Sch Med, Dept Basic Sci, Loma Linda, CA USA; [Yang, Jun] Hangzhou Normal Univ, Sch Publ Hlth, Dept Toxicol, Hangzhou, Zhejiang, Peoples R China; [Yang, Jun] Zhejiang Agr & Forestry Univ, Coll Biotechnol, Dept Biomed, Hangzhou, Zhejiang, Peoples R China	Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Zhejiang University; Zhejiang Chinese Medical University; Loma Linda University; Hangzhou Normal University; Zhejiang A&F University	Yang, J (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China.	zhuxq@zju.edu.cn; gastate@zju.edu.cn		Duerksen-Hughes, Penelope/0000-0002-0998-2157	National Natural Science Foundation of China [81172692, 81302398, 81202241]; Postdoctoral Science Foundation of China [2011M501020, 2012M511378, 2013M530286]; Zhejiang Provincial Natural Science Foundation [LY12H2600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	National Natural Science Foundation of China (Nos. 81172692, 81302398 and 81202241; http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list); Postdoctoral Science Foundation of China (Nos. 2011M501020, 2012M511378, and 2013M530286; http://jj.chinapostdoctor.org.cn/V1/Program1/Info_Show.aspx?InfoID=9e750e10-db65-4ef5-96a0-55285269580d); Zhejiang Provincial Natural Science Foundation (No. LY12H2600; http://www.zjnsf.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amelio AL, 2007, P NATL ACAD SCI USA, V104, P20314, DOI 10.1073/pnas.0707999105; Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Anderson L, 2001, MOL CELL BIOL, V21, P1719, DOI 10.1128/MCB.21.5.1719-1729.2001; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; Bladen CL, 2005, J BIOL CHEM, V280, P5205, DOI 10.1074/jbc.M412758200; Bond CS, 2009, J CELL BIOL, V186, P637, DOI 10.1083/jcb.200906113; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Fox AH, 2005, MOL BIOL CELL, V16, P5304, DOI 10.1091/mbc.E05-06-0587; Fox AH, 2002, CURR BIOL, V12, P13, DOI 10.1016/S0960-9822(01)00632-7; Gartel AL, 2002, MOL CANCER THER, V1, P639; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Ha K, 2011, DNA REPAIR, V10, P252, DOI 10.1016/j.dnarep.2010.11.009; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Huang BH, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.180; Huen MSY, 2010, TRENDS BIOCHEM SCI, V35, P101, DOI 10.1016/j.tibs.2009.09.001; Juan G, 1998, CYTOMETRY, V32, P71, DOI 10.1002/(SICI)1097-0320(19980601)32:2<71::AID-CYTO1>3.0.CO;2-H; Krietsch J, 2012, NUCLEIC ACIDS RES, V40, P10287, DOI 10.1093/nar/gks798; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Kuwahara S, 2006, BIOL REPROD, V75, P352, DOI 10.1095/biolreprod.106.051136; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Li SY, 2009, NUCLEIC ACIDS RES, V37, P6746, DOI 10.1093/nar/gkp741; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Morozumi Y, 2009, NUCLEIC ACIDS RES, V37, P4296, DOI 10.1093/nar/gkp298; Murga M, 2007, CLIN TRANSL ONCOL, V9, P216, DOI 10.1007/s12094-007-0042-3; Myojin R, 2004, BIOL REPROD, V71, P926, DOI 10.1095/biolreprod.104.028159; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Rajesh C, 2011, NUCLEIC ACIDS RES, V39, P132, DOI 10.1093/nar/gkq738; Rao VA, 2007, CANCER RES, V67, P9971, DOI 10.1158/0008-5472.CAN-07-0804; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Redon CE, 2009, ADV SPACE RES, V43, P1171, DOI 10.1016/j.asr.2008.10.011; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Salton M, 2010, CELL CYCLE, V9, P1568, DOI 10.4161/cc.9.8.11298; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Tarsounas M, 2004, PHILOS T R SOC B, V359, P87, DOI 10.1098/rstb.2003.1368; Tsukahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058749; Van Dyck E, 1999, NATURE, V398, P728, DOI 10.1038/43942; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Wagner JM, 2009, MOL PHARMACOL, V76, P208, DOI 10.1124/mol.109.055178; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Wu W, 2010, MUTAT RES-FUND MOL M, V691, P1, DOI 10.1016/j.mrfmmm.2010.06.002; Yu YK, 2006, TOXICOL IN VITRO, V20, P959, DOI 10.1016/j.tiv.2006.01.004; Zhang B, 2011, TOXICOL APPL PHARM, V252, P307, DOI 10.1016/j.taap.2011.03.003; Zhou CX, 2006, MUTAT RES-GEN TOX EN, V604, P8, DOI 10.1016/j.mrgentox.2005.12.004	55	11	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97174	10.1371/journal.pone.0097174	http://dx.doi.org/10.1371/journal.pone.0097174			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819514	gold, Green Submitted, Green Published			2022-12-27	WOS:000336653300087
J	Masaoka, T; Vanuytsel, T; Vanormelingen, C; Kindt, S; Rasoel, SS; Boesmans, W; De Hertogh, G; Farre, R; Vanden Berghe, P; Tack, J				Masaoka, Tatsuhiro; Vanuytsel, Tim; Vanormelingen, Christophe; Kindt, Sebastien; Rasoel, Shadea Salim; Boesmans, Werend; De Hertogh, Gert; Farre, Ricard; Vanden Berghe, Pieter; Tack, Jan			A Spontaneous Animal Model of Intestinal Dysmotility Evoked by Inflammatory Nitrergic Dysfunction	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; GLYCATION END-PRODUCTS; DIABETES-MELLITUS; GENE-EXPRESSION; BB-RAT; NEUROPATHY; EXCITABILITY; ACTIVATION; PREVENTION; DISORDERS	Background and Aims: Recent reports indicate the presence of low grade inflammation in functional gastrointestinal disorders (FGID), in these cases often called "post-inflammatory" FGIDs. However, suitable animal models to study these disorders are not available. The Biobreeding (BB) rat consists of a diabetes-resistant (BBDR) and a diabetes-prone (BBDP) strain. In the diabetes-prone strain, 40-60% of the animals develop diabetes and concomitant nitrergic dysfunction. Our aim was to investigate the occurrence of intestinal inflammation, nitrergic dysfunction and intestinal dysmotility in non-diabetic animals. Methods: Jejunal inflammation (MPO assay, Hematoxylin&Eosin staining and inducible nitric oxide synthase (iNOS) mRNA expression), in vitro jejunal motility (video analysis) and myenteric neuronal numbers (immunohistochemistry) were assessed in control, normoglycaemic BBDP and diabetic BBDP rats. To study the impact of iNOS inhibition on these parameters, normoglycaemic BBDP rats were treated with aminoguanidine. Results: Compared to control, significant polymorphonuclear (PMN) cell infiltration, enhanced MPO activity, increased iNOS mRNA expression and a decreased ratio of nNOS to Hu-C/D positive neurons were observed in both normoglycaemic and diabetic BBDP rats. Aminoguanidine treatment decreased PMN infiltration, iNOS mRNA expression and MPO activity. Moreover, it restored the ratio of nNOS to Hu-C/D positive nerves in the myenteric plexus and decreased the abnormal jejunal elongation and dilation observed in normoglycaemic BBDP rats. Conclusions: Aminoguanidine treatment counteracts the inflammation-induced nitrergic dysfunction and prevents dysmotility, both of which are independent of hyperglycaemia in BB rats. Nitrergic dysfunction may contribute to the pathophysiology of "low-grade inflammatory" FGIDs. Normoglycaemic BBDP rats may be considered a suitable animal model to study the pathogenesis of FGIDs.	[Masaoka, Tatsuhiro; Vanuytsel, Tim; Vanormelingen, Christophe; Kindt, Sebastien; Rasoel, Shadea Salim; Boesmans, Werend; Farre, Ricard; Vanden Berghe, Pieter; Tack, Jan] Univ Louvain, Translat Res Ctr Gastrointestinal Disorders, Louvain, Belgium; [De Hertogh, Gert] Univ Louvain, Dept Pathol, Louvain, Belgium		Tack, J (corresponding author), Univ Louvain, Translat Res Ctr Gastrointestinal Disorders, Louvain, Belgium.	Jan.Tack@med.kuleuven.be	Farre, Ricard/O-4549-2016; Farre, Ricard/M-9275-2013; Vanuytsel, Tim/O-9972-2016	Farre, Ricard/0000-0001-7158-171X; Farre, Ricard/0000-0001-7158-171X; Boesmans, Werend/0000-0002-2426-0451; Vanuytsel, Tim/0000-0001-8728-0903; Vanden Berghe, Pieter/0000-0002-0009-2094; Tack, Jan/0000-0002-3206-6704	Leuven University	Leuven University(KU Leuven)	The research was funded by a Methusalem grant from Leuven University to Prof. Tack. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTHO L, 1994, EUR J PHARMACOL, V259, P101, DOI 10.1016/0014-2999(94)90166-X; Bornstein JC, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00030; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Camilleri M, 2001, NEUROGASTROENT MOTIL, V13, P277, DOI 10.1046/j.1365-2982.2001.00277.x; Cellek S, 2004, CURR PHARM DESIGN, V10, P3683, DOI 10.2174/1381612043382792; Cellek S, 2004, DIABETOLOGIA, V47, P331, DOI 10.1007/s00125-003-1298-y; Chandrasekharan B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003304; De Alba J, 1999, J NEUROCHEM, V72, P248, DOI 10.1046/j.1471-4159.1999.0720248.x; De Giorgio R, 2004, NEUROGASTROENT MOTIL, V16, P515, DOI 10.1111/j.1365-2982.2004.00538.x; Demedts I, 2006, NEUROGASTROENT MOTIL, V18, P1102, DOI 10.1111/j.1365-2982.2006.00857.x; Demedts I, 2013, J NEUROGASTROENTEROL, V19, P161, DOI 10.5056/jnm.2013.19.2.161; Depoortere I, 2010, BRIT J PHARMACOL, V159, P384, DOI 10.1111/j.1476-5381.2009.00537.x; Depreter M, 2002, J ENDOCRINOL, V175, P779, DOI 10.1677/joe.0.1750779; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; Dunlop SP, 2006, AM J GASTROENTEROL, V101, P1288, DOI 10.1111/j.1572-0241.2006.00672.x; Futagami S, 2010, AM J GASTROENTEROL, V105, P1835, DOI 10.1038/ajg.2010.151; Giardino I, 1998, DIABETES, V47, P1114, DOI 10.2337/diabetes.47.7.1114; Grundy D, 2006, GASTROENTEROLOGY, V130, P1391, DOI 10.1053/j.gastro.2005.11.060; Harberson J, 2010, DIGEST DIS SCI, V55, P359, DOI 10.1007/s10620-009-1071-2; Hardin JA, 2002, CAN J PHYSIOL PHARM, V80, P1064, DOI 10.1139/Y02-138; Huber A, 1998, AM J PHYSIOL-GASTR L, V275, pG1146, DOI 10.1152/ajpgi.1998.275.5.G1146; JENKINS RL, 1988, DIABETES, V37, P629, DOI 10.2337/diabetes.37.5.629; Jeyabal PVS, 2008, NEUROGASTROENT MOTIL, V20, P253, DOI 10.1111/j.1365-2982.2007.01018.x; Kindt S, 2009, NEUROGASTROENT MOTIL, V21, P832, DOI 10.1111/j.1365-2982.2009.01299.x; Kindt S, 2009, GASTROENTEROLOGY, V136, pA145; KRAWISZ JE, 1984, GASTROENTEROLOGY, V87, P1344; Kristjansson G, 2004, GUT, V53, P1806, DOI 10.1136/gut.2003.036418; LIKE AA, 1986, J EXP MED, V164, P1145, DOI 10.1084/jem.164.4.1145; LIKE AA, 1979, SCIENCE, V206, P1421, DOI 10.1126/science.388619; Linden DR, 2003, J PHYSIOL-LONDON, V547, P589, DOI 10.1113/jphysiol.2002.035147; Mizuta Y, 2000, GASTROENTEROLOGY, V118, P714, DOI 10.1016/S0016-5085(00)70141-7; Roberts RR, 2007, AM J PHYSIOL-GASTR L, V292, pG930, DOI 10.1152/ajpgi.00444.2006; Roosen L, 2012, J PHYSIOL-LONDON, V590, P4321, DOI 10.1113/jphysiol.2012.231134; ROSSINI AA, 1995, CLIN IMMUNOL IMMUNOP, V74, P2, DOI 10.1006/clin.1995.1002; Saur D, 2002, AM J PHYSIOL-GASTR L, V282, pG349, DOI 10.1152/ajpgi.00226.2001; Southan GJ, 1996, BIOCHEM PHARMACOL, V51, P383, DOI 10.1016/0006-2952(95)02099-3; Tack J, 2002, GASTROENTEROLOGY, V122, P1738, DOI 10.1053/gast.2002.33663; Tornblom H, 2002, GASTROENTEROLOGY, V123, P1972, DOI 10.1053/gast.2002.37059; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vanheel H, 2014, GUT, V63, P262, DOI 10.1136/gutjnl-2012-303857; Vanormelingen C, 2013, GASTROENTEROLOGY, V144, pS542; Wallis RH, 2009, DIABETES, V58, P1007, DOI 10.2337/db08-1215; Wimalawansa SJ, 2008, EXPERT OPIN PHARMACO, V9, P1935, DOI 10.1517/14656566.9.11.1935 ; Zandecki M, 2008, NEUROGASTROENT MOTIL, V20, P818, DOI 10.1111/j.1365-2982.2008.01091.x; Zandecki M, 2006, NEUROGASTROENT MOTIL, V18, P307, DOI 10.1111/j.1365-2982.2005.00755.x; Zinck T, 2006, CEPHALALGIA, V26, P14, DOI 10.1111/j.1468-2982.2005.00978.x	46	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e95879	10.1371/journal.pone.0095879	http://dx.doi.org/10.1371/journal.pone.0095879			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819503	Green Submitted, gold, Green Published			2022-12-27	WOS:000336653300007
J	Schlosser, TPC; van der Heijden, GJMG; Versteeg, AL; Castelein, RM				Schlosser, Tom P. C.; van der Heijden, Geert J. M. G.; Versteeg, Anne L.; Castelein, Rene M.			How 'Idiopathic' Is Adolescent Idiopathic Scoliosis ? A Systematic Review on Associated Abnormalities	PLOS ONE			English	Review							BONE-MINERAL DENSITY; DYNAMIC BALANCE; PATHOGENESIS; OSTEOPENIA; ASYMMETRY	Background: Despite more than a century of dedicated research, the etiology and pathogenesis of adolescent idiopathic scoliosis (AIS) remain unclear. By definition, 'idiopathic' implies an unknown cause. Nevertheless, many abnormalities concomitant to AIS have been described, often with the suggestion that these abnormalities are related to etiopathogenesis. Insight in the concomitant abnormalities may assist in improving the understanding of the etiological pathways of AIS. We aimed to systematically review and synthesize available studies on abnormalities concomitant to AIS. Methods: Original studies comparing untreated AIS patients with healthy adolescents on abnormalities other than the deformity of the spine were retrieved from PubMed and Embase. We followed PRISMA guidelines and to quantify the relationship between each abnormality and AIS we used a best-evidence-syntheses for relating risk-of-bias to consistency of effect sizes. Results: We identified 88 relevant citations, forty-seven carried high risk-of-bias and twenty studies did not report quantitative data in a sufficient manner. The remaining twenty-one publications failed to report data from before initiation of the deformity and blind assessments. These cross-sectional studies provided data on fourteen abnormalities concomitant to AIS. With our best-evidence-syntheses we were unable to find both strong evidence and a consistent pattern of occurrence for AIS and any of these abnormalities. From moderate risk-of-bias studies a relatively consistent pattern of occurrence for AIS and impaired gait control (4 studies; 155 subjects; Cohen's d = 1.00) and decreased bone mineral density (2 studies; 954 subjects; Cohen's d = 20.83) was found. For nine abnormalities a consistent pattern of occurrence with AIS was found, but the evidence for these was weak. Conclusions: Based on the available literature, strong evidence is lacking for a consistent pattern of occurrence of AIS and any abnormality. The relevance for understanding the multifactorial etiology of AIS is very limited.	[Schlosser, Tom P. C.; Versteeg, Anne L.; Castelein, Rene M.] Univ Med Ctr Utrecht, Dept Orthopaed Surg, Utrecht, Netherlands; [van der Heijden, Geert J. M. G.] Univ Med Ctr Utrecht, Dept Epidemiol, Utrecht, Netherlands; [van der Heijden, Geert J. M. G.] VU Amsterdam Univ, Acad Ctr Dent Amsterdam, Dept Social Dent, Amsterdam, Netherlands; [van der Heijden, Geert J. M. G.] Univ Amsterdam, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam	Castelein, RM (corresponding author), Univ Med Ctr Utrecht, Dept Orthopaed Surg, Utrecht, Netherlands.	R.M.Castelein@umcutrecht.nl	van der Heijden, Geert/M-3733-2013; Versteeg, Anne/AAN-2167-2021; Schloesser, Tom/H-9625-2019	van der Heijden, Geert/0000-0003-4979-2099; Schloesser, Tom/0000-0003-1517-5914	Alexandre Suerman MD/PhD programme; Medtronic Research Grant	Alexandre Suerman MD/PhD programme; Medtronic Research Grant	This study was supported by the Alexandre Suerman MD/PhD programme and by a Medtronic Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acaroglu E, 2012, EUR SPINE J, V21, P1033, DOI 10.1007/s00586-012-2245-8; Altaf F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2508; Barrios C, 2011, SPINE, V36, P1470, DOI 10.1097/BRS.0b013e3181f55083; Berven S, 2002, SEMIN NEUROL, V22, P167, DOI 10.1055/s-2002-36540; BJURE J, 1968, SCAND J CLIN LAB INV, V21, P190, DOI 10.3109/00365516809084283; Bruyneel AV, 2008, NEUROSCI LETT, V447, P158, DOI 10.1016/j.neulet.2008.10.007; Castelein RM, 2005, MED HYPOTHESES, V65, P501, DOI 10.1016/j.mehy.2005.03.025; Chen ZJ, 2014, SPINE J, V14, P1095, DOI 10.1016/j.spinee.2013.07.465; Cheng JCY, 2000, J BONE MINER RES, V15, P1587, DOI 10.1359/jbmr.2000.15.8.1587; Cheng JCY, 1997, SPINE, V22, P1716, DOI 10.1097/00007632-199708010-00006; Cheung CSK, 2003, SPINE, V28, P2152, DOI 10.1097/01.BRS.0000084265.15201.D5; Colonna PC, 1941, J BONE JOINT SURG, V23, P335; Gorman KF, 2012, EUR SPINE J, V21, P1905, DOI 10.1007/s00586-012-2389-6; Gruber AH, 2011, GAIT POSTURE, V34, P13, DOI 10.1016/j.gaitpost.2011.02.015; Guo X, 2006, SPINE, V31, pE437, DOI 10.1097/01.brs.0000222048.47010.bf; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hojat M, 2004, ADV HEALTH SCI EDUC, V9, P241, DOI 10.1023/B:AHSE.0000038173.00909.f6; JAMES JIP, 1956, J BONE JOINT SURG BR, V38, P660, DOI 10.1302/0301-620X.38B3.660; Janssen MMA, 2011, SPINE J, V11, P347, DOI 10.1016/j.spinee.2011.03.010; Kesling KL, 1997, SPINE, V22, P2009, DOI 10.1097/00007632-199709010-00014; Kotani T, 2004, SPINE, V29, P298, DOI 10.1097/01.BRS.0000106490.82936.89; Kouwenhoven JWM, 2008, SPINE, V33, P2898, DOI 10.1097/BRS.0b013e3181891751; Kuo FC, 2010, SPINE, V35, P2084, DOI 10.1097/BRS.0b013e3181cc8108; Labelle H, 2004, SPINE, V29, P2049, DOI 10.1097/01.brs.0000138279.53439.cc; Lam TP, 2011, SPINE, V36, P1211, DOI 10.1097/BRS.0b013e3181ebab39; Lambert FM, 2009, J NEUROSCI, V29, P12477, DOI 10.1523/JNEUROSCI.2583-09.2009; Lao MLM, 2008, J PEDIATR ORTHOPED, V28, P846, DOI 10.1097/BPO.0b013e31818e1bc9; Lee WTK, 2005, OSTEOPOROSIS INT, V16, P1924, DOI 10.1007/s00198-005-1964-7; Liu Z, 2012, SPINE, V37, P599, DOI 10.1097/BRS.0b013e318227dd0c; LONSTEIN JE, 1994, LANCET, V344, P1407; Lowe TG, 2000, J BONE JOINT SURG AM, V82A, P1157, DOI 10.2106/00004623-200008000-00014; MACHIDA M, 1995, J BONE JOINT SURG BR, V77B, P134, DOI 10.1302/0301-620X.77B1.7822371; McIntire KL, 2007, SCOLIOSIS SPINAL DIS, V2, DOI 10.1186/1748-7161-2-9; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Nicoladoni C, 1904, ANATOMIE MECHANISMUS; NORMELLI H, 1986, SPINE, V11, P405, DOI 10.1097/00007632-198606000-00001; Ouellet J, 2013, EUR SPINE J, V22, pS81, DOI 10.1007/s00586-012-2396-7; Parent Stefan, 2005, Instr Course Lect, V54, P529; Park WW, 2009, EUR SPINE J, V18, P1920, DOI 10.1007/s00586-009-1129-z; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, P5; Shi L, 2013, SPINE J, V13, P1904, DOI 10.1016/j.spinee.2013.06.045; Shi L, 2011, NEUROIMAGE, V54, pS180, DOI 10.1016/j.neuroimage.2010.04.002; SLAVIN RE, 1995, J CLIN EPIDEMIOL, V48, P9, DOI 10.1016/0895-4356(94)00097-A; Stedman T.L, 1982, STEDMANS MED DICT; Sun X, 2008, J PEDIATR ORTHOPED, V28, P669, DOI 10.1097/BPO.0b013e3181834afa; Wang DF, 2012, NEUROIMAGE, V59, P935, DOI 10.1016/j.neuroimage.2011.07.097; Weinstein SL, 2013, NEW ENGL J MED, V369, P1512, DOI 10.1056/NEJMoa1307337; Yang JH, 2013, EUR SPINE J, V22, P2407, DOI 10.1007/s00586-013-2845-y; Yu WS, 2013, SPINE J, V13, P1493, DOI 10.1016/j.spinee.2013.05.018	49	35	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97461	10.1371/journal.pone.0097461	http://dx.doi.org/10.1371/journal.pone.0097461			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24820478	Green Published, gold			2022-12-27	WOS:000336653300115
J	Schwedhelm, E; Wallaschofski, H; Atzler, D; Dorr, M; Nauck, M; Volker, U; Kroemer, HK; Volzke, H; Boger, RH; Friedrich, N				Schwedhelm, Edzard; Wallaschofski, Henri; Atzler, Dorothee; Doerr, Marcus; Nauck, Matthias; Voelker, Uwe; Kroemer, Heyo K.; Voelzke, Henry; Boeger, Rainer H.; Friedrich, Nele			Incidence of All-Cause and Cardiovascular Mortality Predicted by Symmetric Dimethylarginine in the Population-Based Study of Health in Pomerania	PLOS ONE			English	Article							PLASMA ASYMMETRIC DIMETHYLARGININE; MASS-SPECTROMETRIC DETERMINATION; NITRIC-OXIDE; L-ARGININE; RISK MARKER; DISEASE; ADMA; SDMA	Background: L-Arginine and its dimethylated derivatives asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) have been associated with cardiovascular (CV) and all-cause mortality in populations at risk. The present study aimed to investigate the prognostic value of L-arginine and its derivatives in the general population. Methods and Results: We evaluated 3,952 individuals (1,936 men and 2,016 women) aged 20-81 (median (IQR) 51 (37; 64) years) from the population-based Study of Health in Pomerania (SHIP). Associations of continuous [per standard deviation (SD) increase] and categorized (age- and sex-specific tertiles) serum L-arginine, ADMA, and SDMA concentrations with all-cause and cause-specific mortality were analysed. During a median (IQR) follow-up period of 10.1 (9.3; 10.8) years (38,476 person-years), 426 deaths (10.8%) were observed, including 139 CV deaths (3.5%), and 150 cancer deaths (3.8%). After multivariable adjustment, we revealed a positive association of SDMA with all-cause [hazard ratio (HR) per SD increase: 1.16, 95% confidence interval (CI): 1.07-1.25] and CV mortality [HR: 1.19, 95% CI: 1.05-1.35]. In contrast, we did not observe any association of SDMA with cancer mortality. Neither L-arginine nor ADMA were associated with all-cause or CV mortality. Conclusion: SDMA, but not ADMA, is an independent predictor of all-cause and CV mortality in a large population-based cohort of European ancestry.	[Schwedhelm, Edzard; Atzler, Dorothee; Boeger, Rainer H.] Univ Med Ctr Hamburg Eppendorf, Inst Clin Pharmacol & Toxicol, Hamburg, Germany; [Schwedhelm, Edzard; Atzler, Dorothee; Boeger, Rainer H.] Univ Med Ctr Hamburg Eppendorf, Cardiovasc Res Ctr, Hamburg, Germany; [Schwedhelm, Edzard; Atzler, Dorothee; Boeger, Rainer H.] DZHK, German Ctr Cardiovasc Res, Partner Site Hamburg Lubeck Kiel, Hamburg, Germany; [Wallaschofski, Henri; Nauck, Matthias; Friedrich, Nele] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Wallaschofski, Henri; Doerr, Marcus; Nauck, Matthias; Voelker, Uwe; Friedrich, Nele] DZHK, German Ctr Cardiovasc Res, Partner Site, Greifswald, Germany; [Doerr, Marcus] Univ Med Greifswald, Dept Internal Med Cardiol B, Greifswald, Germany; [Voelker, Uwe] Univ Med Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Kroemer, Heyo K.] DZHK, German Ctr Cardiovasc Res, Partner Site Gottingen, Gottingen, Germany; [Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Dept SHIP Clin Epidemiol, Greifswald, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; German Centre for Cardiovascular Research; Greifswald Medical School; German Centre for Cardiovascular Research; Greifswald Medical School; Greifswald Medical School; German Centre for Cardiovascular Research; Greifswald Medical School	Schwedhelm, E (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Clin Pharmacol & Toxicol, Hamburg, Germany.	schwedhelm@uke.de; nele.friedrich@uni-greifswald.de	Stefanadis, Christodoulos/ABH-2232-2020; Dörr, Marcus/F-1919-2010	Stefanadis, Christodoulos/0000-0001-5974-6454; Dörr, Marcus/0000-0001-7471-475X; Volker, Uwe/0000-0002-5689-3448; Atzler, Dorothee/0000-0002-6551-1544	German Federal Ministry of Education and Research (BMBF) [01ZZ96030, 01ZZ0701]; Ministry for Education, Research, and Cultural Affairs; Ministry for Social Affairs of the Federal State of Mecklenburg-West Pomerania; DZHK (German Centre for Cardiovascular Research); BMBF (German Ministry of Education and Research)	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Ministry for Education, Research, and Cultural Affairs; Ministry for Social Affairs of the Federal State of Mecklenburg-West Pomerania; DZHK (German Centre for Cardiovascular Research); BMBF (German Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF))	SHIP is part of the Community Medicine Net (http://www.medizin.uni-greifswald.de/icm) of the University of Greifswald, which is funded by grants from the German Federal Ministry of Education and Research (BMBF, grant 01ZZ96030, 01ZZ0701); the Ministry for Education, Research, and Cultural Affairs; and the Ministry for Social Affairs of the Federal State of Mecklenburg-West Pomerania as well by the DZHK (German Centre for Cardiovascular Research) and by the BMBF (German Ministry of Education and Research). This work is also part of the research project Greifswald Approach to Individualized Medicine (GANI_MED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atzler D, 2011, J CHROMATOGR B, V879, P2294, DOI 10.1016/j.jchromb.2011.06.016; Boger RH, 2007, J NUTR, V137, p1650S, DOI 10.1093/jn/137.6.1650S; Boger RH, 2009, CIRCULATION, V119, P1592, DOI 10.1161/CIRCULATIONAHA.108.838268; Boger RH, 2006, ANN MED, V38, P126, DOI 10.1080/07853890500472151; Caplin B, 2012, ARTERIOSCL THROM VAS, V32, P1343, DOI 10.1161/ATVBAHA.112.247726; Closs EI, 1997, NITRIC OXIDE-BIOL CH, V1, P65, DOI 10.1006/niox.1996.0106; Gore MO, 2013, ARTERIOSCL THROM VAS, V33, P2682, DOI 10.1161/ATVBAHA.113.301219; John U, 2001, SOZ PRAVENTIV MED, V46, P186, DOI 10.1007/BF01324255; KEIL U, 1988, ACTA MED SCAND, P119; Kiechl S, 2009, ATHEROSCLEROSIS, V205, P261, DOI 10.1016/j.atherosclerosis.2008.10.040; Kielstein JT, 2006, NEPHROL DIAL TRANSPL, V21, P2446, DOI 10.1093/ndt/gfl292; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Meinitzer A, 2011, CLIN CHEM, V57, P112, DOI 10.1373/clinchem.2010.150854; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Ronden RA, 2012, AM J PHYSIOL-RENAL, V303, pF149, DOI 10.1152/ajprenal.00045.2012; Schepers E, 2009, NEPHROL DIAL TRANSPL, V24, P1429, DOI 10.1093/ndt/gfn670; Schwedhelm E, 2008, BRIT J CLIN PHARMACO, V65, P51, DOI 10.1111/j.1365-2125.2007.02990.x; Schwedhelm E, 2007, J CHROMATOGR B, V851, P211, DOI 10.1016/j.jchromb.2006.11.052; Schwedhelm E, 2011, NAT REV NEPHROL, V7, P275, DOI 10.1038/nrneph.2011.31; Seppala I, 2014, EUR HEART J, V35, P524, DOI 10.1093/eurheartj/eht447; Servillo L, 2013, NITRIC OXIDE-BIOL CH, V30, P43, DOI 10.1016/j.niox.2013.02.080; Siegerink B, 2013, CLIN RES CARDIOL, V102, P193, DOI 10.1007/s00392-012-0515-4; STONE C, 1985, ADDITIVE SPLINES STA; Strobel J, 2012, J MOL CELL CARDIOL, V53, P392, DOI 10.1016/j.yjmcc.2012.06.002; Tousoulis D, 2012, CURR VASC PHARMACOL, V10, P4, DOI 10.2174/157016112798829760; VALLANCE P, 1992, LANCET, V339, P572; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394	28	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96875	10.1371/journal.pone.0096875	http://dx.doi.org/10.1371/journal.pone.0096875			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819070	Green Published, gold, Green Submitted			2022-12-27	WOS:000336653300042
J	Xiao, Y; Wen, J; Bai, YX; Duan, N; Jing, GX				Xiao, Ying; Wen, Jian; Bai, Yanxia; Duan, Na; Jing, G. X.			Different Effects of Propofol and Isoflurane on Cochlear Blood Flow and Hearing Function in Guinea Pigs	PLOS ONE			English	Article							PRODUCT OTOACOUSTIC EMISSIONS; MIDDLE-EAR SURGERY; CONTROLLED HYPOTENSION; CEREBRAL AUTOREGULATION; ANESTHESIA; DEXMEDETOMIDINE; REMIFENTANIL; DESFLURANE; TRIAL; NOISE	Objectives: To investigate the effects of isoflurane and propofol on mean arterial pressure (MAP), cochlear blood flow (CoBF), distortion-product otoacoustic emission (DPOAE), and the ultrastructure of outer hair cells (OHCs) in guinea pig cochleae. Methods: Forty-eight male guinea pigs were randomly assigned to one of six treatment groups. Groups 1 to 3 were infused (i.v.) with a loading dose of propofol (5 mg/kg) for 5 min and three maintenance doses (10, 20, or 40 mg kg(-1)center dot h(-1), respectively) for 115 min. Groups 4 to 6 were inhaled with isoflurane at concentrations of 1.15 vol%, 2.30 vol% or 3.45 vol% respectively for 120 min. CoBF and MAP were recorded prior to and at 5 min intervals during drug administration. DPOAE was measured before, immediately after, and 1 h after administration. Following the final DPOAE test, cochleae were examined using scanning electron microscopy. Results: Propofol treatment reduced MAP in a dose-dependent manner. CoBF and DPOAE showed increases at propofol maintenance doses of 10 and 20 mg kg(-1)center dot h(-1). Inhalation of isoflurane at concentrations of 2.30 vol% and 3.45 vol% reduced MAP and CoBF. DPOAE amplitude increased following inhalation of 1.15 vol% isoflurane, but decreased following inhalations of 2.30 vol% and 3.45 vol%. Cochlear structure was changed following inhalation of either 2.30 vol% or 3.45 vol% isoflurane. Conclusions: Propofol could decrease MAP and increase both CoBF and DPOAE without affecting OHC structure. Inhalation of isoflurane at concentrations >2.30 vol% decreased CoBF and DPOAE, and produced injury to OHCs.	[Xiao, Ying; Wen, Jian; Duan, Na; Jing, G. X.] Xi An Jiao Tong Univ, Affiliated Hosp 1, Coll Med, Dept Anesthesiol, Xian 710049, Peoples R China; [Bai, Yanxia] Xi An Jiao Tong Univ, Affiliated Hosp 1, Coll Med, Dept Otolaryngol, Xian 710049, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Jing, GX (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Coll Med, Dept Anesthesiol, Xian 710049, Peoples R China.	jgx1899123@163.com			First Affiliated Hospital of Medical College of Xi'an Jiaotong University	First Affiliated Hospital of Medical College of Xi'an Jiaotong University	The present research was funded by The First Affiliated Hospital of Medical College of Xi'an Jiaotong University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attanasio G, 2001, ACTA OTO-LARYNGOL, V121, P465, DOI 10.1080/00016480120524; Boyev KP, 2002, JARO, V3, P362, DOI 10.1007/s101620020044; BROWN JN, 1994, AM J PHYSIOL, V266, pH458, DOI 10.1152/ajpheart.1994.266.2.H458; Buki B, 2000, BRAIN RES, V852, P140, DOI 10.1016/S0006-8993(99)02227-1; Degoute CS, 2003, CAN J ANAESTH, V50, P270, DOI 10.1007/BF03017797; Di Girolamo S, 2007, ACTA NEUROCHIR SUPPL, V97, P419; Firat Y, 2007, OTOLARYNG HEAD NECK, V137, P218, DOI 10.1016/j.otohns.2007.03.005; Hamed SA, 2010, AM J OTOLARYNG, V31, P154, DOI 10.1016/j.amjoto.2008.12.002; Harel N, 1997, HEARING RES, V110, P25, DOI 10.1016/S0378-5955(97)00061-0; Hatzopoulos S, 2002, HEARING RES, V170, P12, DOI 10.1016/S0378-5955(02)00448-3; Janssen T, 2006, ORL-J OTO-RHIN-LARYN, V68, P334, DOI 10.1159/000095275; KAWAKAMI M, 1991, EUR ARCH OTO-RHINO-L, V248, P471, DOI 10.1007/BF00627636; Kol IO, 2009, CURR THER RES CLIN E, V70, P197, DOI 10.1016/j.curtheres.2009.06.001; Lawton BK, 2012, BRIT J ANAESTH, V108, P929, DOI 10.1093/bja/aes069; LeBourgeois 3rd HW, 2000, ENT-EAR NOSE THROAT, V79, P618; LeBourgeois 3rd HW, 2000, ENT-EAR NOSE THROAT, V79, P614; LeBourgeois H W 3rd, 2000, Ear Nose Throat J, V79, P610; Morawski K, 2003, LARYNGOSCOPE, V113, P1615, DOI 10.1097/00005537-200309000-00039; Ogawa Y, 2010, ANESTH ANALG, V111, P1279, DOI 10.1213/ANE.0b013e3181f42fc0; Powell JT, 2014, BRIT J SURG, V101, P216, DOI 10.1002/bjs.9410; Preckel MP, 1998, ANESTH ANALG, V87, P1002, DOI 10.1097/00000539-199811000-00004; Ryu JH, 2009, BRIT J ANAESTH, V103, P490, DOI 10.1093/bja/aep229; Shi XR, 2011, HEARING RES, V282, P10, DOI 10.1016/j.heares.2011.08.006; STREBEL S, 1995, ANESTHESIOLOGY, V83, P66, DOI 10.1097/00000542-199507000-00008	24	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96861	10.1371/journal.pone.0096861	http://dx.doi.org/10.1371/journal.pone.0096861			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24818751	gold, Green Published, Green Submitted			2022-12-27	WOS:000336653300040
J	Emig-Agius, D; Olivieri, K; Pache, L; Shih, HL; Pustovalova, O; Bessarabova, M; Young, JAT; Chanda, SK; Ideker, T				Emig-Agius, Dorothea; Olivieri, Kevin; Pache, Lars; Shih, Hsin Ling; Pustovalova, Olga; Bessarabova, Marina; Young, John A. T.; Chanda, Sumit K.; Ideker, Trey			An Integrated Map of HIV-Human Protein Complexes that Facilitate Viral Infection	PLOS ONE			English	Article							COMPREHENSIVE RESOURCE; SWI/SNF; KINASE; MECP1; CORUM	Recent proteomic and genetic studies have aimed to identify a complete network of interactions between HIV and human proteins and genes. This HIV-human interaction network provides invaluable information as to how HIV exploits the host machinery and can be used as a starting point for further functional analyses. We integrated this network with complementary datasets of protein function and interaction to nominate human protein complexes with likely roles in viral infection. Based on our approach we identified a global map of 40 HIV-human protein complexes with putative roles in HIV infection, some of which are involved in DNA replication and repair, transcription, translation, and cytoskeletal regulation. Targeted RNAi screens were used to validate several proteins and complexes for functional impact on viral infection. Thus, our HIV-human protein complex map provides a significant resource of potential HIV-host interactions for further study.	[Emig-Agius, Dorothea; Ideker, Trey] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Emig-Agius, Dorothea; Ideker, Trey] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Emig-Agius, Dorothea; Pustovalova, Olga; Bessarabova, Marina] Thomson Reuters Sci Inc, IP&Sci, Carlsbad, CA USA; [Olivieri, Kevin; Pache, Lars; Shih, Hsin Ling; Chanda, Sumit K.] Sanford Burnham Med Res Inst, La Jolla, CA USA; [Young, John A. T.] Salk Inst Biol Studies, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Clarivate; Sanford Burnham Prebys Medical Discovery Institute; Salk Institute	Emig-Agius, D (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	dorothea.emig@gmail.com; tideker@ucsd.edu		Young, John/0000-0003-1824-2561; Ideker, Trey/0000-0002-1708-8454	National Institute of Mental Health [P30 MH062261]; NIH [5 P01 AI090935-03]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI090935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062261] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by funds from the National Institute of Mental Health grant P30 MH062261 and NIH grant 5 P01 AI090935-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baekelandt V, 2000, J VIROL, V74, P11278, DOI 10.1128/JVI.74.23.11278-11285.2000; Bhattacharya S, 2009, J INFECTION, V59, P377, DOI 10.1016/j.jinf.2009.09.014; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Daniel R, 1999, SCIENCE, V284, P644, DOI 10.1126/science.284.5414.644; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1; Huang L, 2011, MOL CELL BIOL, V31, P3472, DOI 10.1128/MCB.05587-11; Ishizaka A, 2012, J BIOL CHEM, V287, P11924, DOI 10.1074/jbc.M111.322792; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Kadin I, 2007, J IMMUNOL, V178, P6404, DOI 10.4049/jimmunol.178.10.6404; Knijnenburg TA, 2009, BIOINFORMATICS, V25, pI161, DOI 10.1093/bioinformatics/btp211; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Magadan JG, 2012, J VIROL, V86, P757, DOI 10.1128/JVI.05933-11; Mahajan MC, 2005, P NATL ACAD SCI USA, V102, P15012, DOI 10.1073/pnas.0507596102; Murali TM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002164; Pache L, 2011, METHODS, V53, P3, DOI 10.1016/j.ymeth.2010.07.009; Ruepp A, 2008, NUCLEIC ACIDS RES, V36, pD646, DOI 10.1093/nar/gkm936; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Ting NSY, 1998, J BIOL CHEM, V273, P2136, DOI 10.1074/jbc.273.4.2136; Van Duyne R, 2011, J MOL BIOL, V411, P581, DOI 10.1016/j.jmb.2011.06.001; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Wuchty S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011796; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	26	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96687	10.1371/journal.pone.0096687	http://dx.doi.org/10.1371/journal.pone.0096687			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24817247	Green Published, gold, Green Submitted			2022-12-27	WOS:000336838000050
J	Wang, F; Dai, WQ; Wang, YG; Shen, M; Chen, K; Cheng, P; Zhang, Y; Wang, CF; Li, JJ; Zheng, YY; Lu, J; Yang, J; Zhu, R; Zhang, HW; Zhou, YQ; Xu, L; Guo, CY				Wang, Fan; Dai, Weiqi; Wang, Yugang; Shen, Miao; Chen, Kan; Cheng, Ping; Zhang, Yan; Wang, Chengfen; Li, Jingjing; Zheng, Yuanyuan; Lu, Jie; Yang, Jing; Zhu, Rong; Zhang, Huawei; Zhou, Yingqun; Xu, Ling; Guo, Chuanyong			The Synergistic In Vitro and In Vivo Antitumor Effect of Combination Therapy with Salinomycin and 5-Fluorouracil against Hepatocellular Carcinoma	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CANCER STEM-CELLS; BREAST-CANCER; CATENIN; RESISTANCE; ACTIVATION; GROWTH; LINES; CHEMORESISTANCE; CHEMOTHERAPY	Hepatocellular carcinoma (HCC) is one of the few cancers in which a continuous increase in incidence has been observed over several years. Drug resistance is a major problem in the treatment of HCC. In the present study, we used salinomycin (Sal) and 5-fluorouracil (5-FU) combination therapy on HCC cell lines Huh7, LM3 and SMMC-7721 and nude mice subcutaneously tumor model to study whether Sal could increase the sensitivity of hepatoma cells to the traditional chemotherapeutic agent such as 5-FU. The combination of Sal and 5-FU resulted in a synergistic antitumor effect against liver tumors both in vitro and in vivo. Sal reversed the 5-FU-induced increase in CD133(+) EPCAM(+) cells, epithelial-mesenchymal transition and activation of the Wnt/beta-catenin signaling pathway. The combination of Sal and 5-FU may provide us with a new approach to reverse drug resistant for the treatment of patients with HCC.	[Wang, Fan; Dai, Weiqi; Shen, Miao; Chen, Kan; Cheng, Ping; Zhang, Yan; Wang, Chengfen; Li, Jingjing; Zheng, Yuanyuan; Lu, Jie; Yang, Jing; Zhou, Yingqun; Guo, Chuanyong] Tongji Univ Med, Shanghai Peoples Hosp 10, Dept Gastroenterol, Shanghai, Peoples R China; [Wang, Yugang; Xu, Ling] Jiaotong Univ Med, Shanghai Tongren Hosp, Dept Gastroenterol, Shanghai, Peoples R China; [Zhu, Rong] Nanjing Med Univ, Clin Med Shanghai Peoples Hosp 10, Dept Gastroenterol, Shanghai, Peoples R China; [Zhang, Huawei] Suzhou Univ, Hosp 1, Dept Gastroenterol, Suzhou 215006, Peoples R China	Tongji University; Shanghai Jiao Tong University; Nanjing Medical University; Soochow University - China	Xu, L (corresponding author), Jiaotong Univ Med, Shanghai Tongren Hosp, Dept Gastroenterol, Shanghai, Peoples R China.	xuling606@sina.com; guochuanyong@hotmail.com		Guo, Chuanyong/0000-0002-6527-4673	National Nature Science Foundation of China [81302788]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by National Nature Science Foundation of China (No. 81302788). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Y, 2012, INT J BIOL SCI, V8, P992, DOI 10.7150/ijbs.4454; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Collura A, 2013, CELL MOL LIFE SCI, V70, P729, DOI 10.1007/s00018-012-1160-9; Dang HE, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-396; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Haraguchi N, 2010, J CLIN INVEST, V120, P3326, DOI 10.1172/JCI42550; He L, 2013, PANCREATOLOGY, V13, P72, DOI 10.1016/j.pan.2012.11.314; Huntly BJP, 2005, NATURE, V435, P1169, DOI 10.1038/4351169a; Ikeda M, 2008, JPN J CLIN ONCOL, V38, P675, DOI 10.1093/jjco/hyn087; Jin J, 2002, WORLD J GASTROENTERO, V8, P1029, DOI 10.3748/wjg.v8.i6.1029; Kelland LR, 2004, EUR J CANCER, V40, P827, DOI 10.1016/j.ejca.2003.11.028; Kusunoki S, 2013, GYNECOL ONCOL, V129, P598, DOI 10.1016/j.ygyno.2013.03.005; Lan X, 2013, INT J MOL MED, V31, P315, DOI 10.3892/ijmm.2012.1208; Li XF, 2013, CANCER LETT, V336, P379, DOI 10.1016/j.canlet.2013.03.027; Lin DY, 1997, J GASTROEN HEPATOL, V12, pS319, DOI 10.1111/j.1440-1746.1997.tb00516.x; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Macdonald JS, 2001, SEMIN ONCOL, V28, P30, DOI 10.1053/sonc.2001.20750; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martin M, 2005, NEW ENGL J MED, V352, P2302, DOI 10.1056/NEJMoa043681; Miyake M, 2012, ONCOL LETT, V3, P1195, DOI 10.3892/ol.2012.662; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Na DC, 2011, EXP MOL PATHOL, V90, P66, DOI 10.1016/j.yexmp.2010.10.003; Noda T, 2009, BRIT J CANCER, V100, P1647, DOI 10.1038/sj.bjc.6605064; Santisteban M, 2009, CANCER RES, V69, P2887, DOI 10.1158/0008-5472.CAN-08-3343; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sun YF, 2013, HEPATOLOGY, V57, P1458, DOI 10.1002/hep.26151; Tanahashi T, 2013, INT J ONCOL, V42, P556, DOI 10.3892/ijo.2012.1726; Tang QL, 2011, CANCER LETT, V311, P113, DOI 10.1016/j.canlet.2011.07.016; Terpstra W, 1996, BLOOD, V88, P1944, DOI 10.1182/blood.V88.6.1944.bloodjournal8861944; Uchibori K, 2012, INT J ONCOL, V40, P1005, DOI 10.3892/ijo.2011.1300; Voskoglou-Nomikos T, 2003, CLIN CANCER RES, V9, P4227; Wagner RT, 2010, STEM CELLS, V28, P1794, DOI 10.1002/stem.502; Wang F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050638; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Yang LQ, 2006, CELL, V127, P139, DOI 10.1016/j.cell.2006.08.036; Yang W, 2008, CANCER RES, V68, P4287, DOI 10.1158/0008-5472.CAN-07-6691; Yoo BK, 2009, P NATL ACAD SCI USA, V106, P12938, DOI 10.1073/pnas.0901451106; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Zhang WJ, 2012, BIOCHEM BIOPH RES CO, V417, P679, DOI 10.1016/j.bbrc.2011.11.142; Zhang Y, 2012, CANCER LETT, V322, P70, DOI 10.1016/j.canlet.2012.02.010	42	48	50	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97414	10.1371/journal.pone.0097414	http://dx.doi.org/10.1371/journal.pone.0097414			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816638	gold, Green Published, Green Submitted			2022-12-27	WOS:000336838000134
J	Yang, P; Li, XL; Chua, HN; Kwoh, CK; Ng, SK				Yang, Peng; Li, Xiaoli; Chua, Hon-Nian; Kwoh, Chee-Keong; Ng, See-Kiong			Ensemble Positive Unlabeled Learning for Disease Gene Identification	PLOS ONE			English	Article							SEMANTIC SIMILARITY; PRIORITIZATION; ASSOCIATIONS; PREDICTION; OBESITY	An increasing number of genes have been experimentally confirmed in recent years as causative genes to various human diseases. The newly available knowledge can be exploited by machine learning methods to discover additional unknown genes that are likely to be associated with diseases. In particular, positive unlabeled learning (PU learning) methods, which require only a positive training set P (confirmed disease genes) and an unlabeled set U (the unknown candidate genes) instead of a negative training set N-1 have been shown to be effective in uncovering new disease genes in the current scenario. Using only a single source of data for prediction can be susceptible to bias due to incompleteness and noise in the genomic data and a single machine learning predictor prone to bias caused by inherent limitations of individual methods. In this paper, we propose an effective PU learning framework that integrates multiple biological data sources and an ensemble of powerful machine learning classifiers for disease gene identification. Our proposed method integrates data from multiple biological sources for training PU learning classifiers. A novel ensemble-based PU learning method EPU is then used to integrate multiple PU learning classifiers to achieve accurate and robust disease gene predictions. Our evaluation experiments across six disease groups showed that EPU achieved significantly better results compared with various state-of-the-art prediction methods as well as ensemble learning classifiers. Through integrating multiple biological data sources for training and the outputs of an ensemble of PU learning classifiers for prediction, we are able to minimize the potential bias and errors in individual data sources and machine learning algorithms to achieve more accurate and robust disease gene predictions. In the future, our EPU method provides an effective framework to integrate the additional biological and computational resources for better disease gene predictions.	[Yang, Peng; Li, Xiaoli; Chua, Hon-Nian; Ng, See-Kiong] ASTAR, Data Analyt Dept, Inst Infocomm Res I2R, Singapore, Singapore; [Kwoh, Chee-Keong] Nanyang Technol Univ, Bioinformat Res Ctr, Sch Comp Engn, Singapore 639798, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute for Infocomm Research (I2R); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Yang, P (corresponding author), ASTAR, Data Analyt Dept, Inst Infocomm Res I2R, Singapore, Singapore.	yangp@i2r.a-star.edu.sg; xlli@i2r.a-star.edu.sg	Li, Xiaoli/GYQ-7384-2022; Li, Xiaoli/C-9739-2012	Li, Xiaoli/0000-0002-0762-6562				Adie EA, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-55; Ala U, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000043; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Brunner HG, 2004, NAT REV GENET, V5, P545, DOI 10.1038/nrg1383; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Deza M. M., 2009, ENCY DISTANCES; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Kuncheva L., 2014, COMBINING PATTERN CL; Linghu B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r91; Liu T, 2011, AAAI; Lopez-Bigas N, 2004, NUCLEIC ACIDS RES, V32, P3108, DOI 10.1093/nar/gkh605; Lovasz L, 1993, BOLYAI MATH STUD, V1, P9; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Mei JP, 2013, BIOINFORMATICS, V29, P238, DOI 10.1093/bioinformatics/bts670; Mei JP, 2012, P 11 INT WORKSH DAT, P8; Mitchell T.M., 1997, MACH LEARN, V45, P81, DOI DOI 10.1145/242224.242229; Mordelet F, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-389; Palaniappan S, 2008, I C COMP SYST APPLIC, P108, DOI 10.1109/AICCSA.2008.4493524; Perez-Iratxeta C, 2002, NAT GENET, V31, P316, DOI 10.1038/ng895; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Radivojac P, 2008, PROTEINS, V72, P1030, DOI 10.1002/prot.21989; Schlicker A, 2010, BIOINFORMATICS, V26, pi561, DOI 10.1093/bioinformatics/btq384; Sciarretta S, 2012, CIRCULATION, V125, P1134, DOI 10.1161/CIRCULATIONAHA.111.078212; Smalter A, 2007, BIBM; Tabassum R, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-35; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Vapnik V., 1998, STAT LEARNING THEORY, V3, DOI DOI 10.1007/978-1-4419-1428-6_5864; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Xu JZ, 2006, BIOINFORMATICS, V22, P2800, DOI 10.1093/bioinformatics/btl467; Yang P, 2012, BIOINFORMATICS, V28, P2640, DOI 10.1093/bioinformatics/bts504; Yang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021502	36	54	54	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97079	10.1371/journal.pone.0097079	http://dx.doi.org/10.1371/journal.pone.0097079			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816822	Green Published, gold			2022-12-27	WOS:000336838000101
J	Calvao, AM; Brigatti, E				Calvao, Angelo M.; Brigatti, Edgardo			The Role of Neighbours Selection on Cohesion and Order of Swarms	PLOS ONE			English	Article							SELFISH HERD BEHAVIOR; COLLECTIVE BEHAVIOR; MOVEMENT RULES; ANIMAL GROUPS; COORDINATION; INFORMATION; DISTANCE; MOTION; MODELS	We introduce a multi-agent model for exploring how selection of neighbours determines some aspects of order and cohesion in swarms. The model algorithm states that every agents' motion seeks for an optimal distance from the nearest topological neighbour encompassed in a limited attention field. Despite the great simplicity of the implementation, varying the amplitude of the attention landscape, swarms pass from cohesive and regular structures towards fragmented and irregular configurations. Interestingly, this movement rule is an ideal candidate for implementing the selfish herd hypothesis which explains aggregation of alarmed group of social animals.	[Calvao, Angelo M.] Univ Fed Fluminense, Inst Fis, BR-24020 Niteroi, RJ, Brazil; [Brigatti, Edgardo] Univ Fed Rio de Janeiro, Inst Fis, Rio De Janeiro, RJ, Brazil	Universidade Federal Fluminense; Universidade Federal do Rio de Janeiro	Brigatti, E (corresponding author), Univ Fed Rio de Janeiro, Inst Fis, Rio De Janeiro, RJ, Brazil.	edgardo@if.ufrj.br	Brigatti, Edgardo/ABD-4541-2021; Brigatti, Edgardo/AAT-6945-2020	Brigatti, Edgardo/0000-0002-2981-3270	CNPq	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	A. M. Calvao acknowledges partial financial support from a CNPq fellowship (http://www.cnpq.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional funding was received for this study.	Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; BARLOW GW, 1974, ANIM BEHAV, V22, P876, DOI 10.1016/0003-3472(74)90010-4; Basken M, 2013, CGAL USER REFERENCE; Burger J., 1991, COMMON TERN ITS BREE; Camperi M, 2012, INTERFACE FOCUS, V2, P715, DOI 10.1098/rsfs.2012.0026; Cavagna A, 2010, P NATL ACAD SCI USA, V107, P11865, DOI 10.1073/pnas.1005766107; Cortes J, 2005, SIAM J CONTROL OPTIM, V44, P1543, DOI 10.1137/S0363012903428652; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; De Vos A, 2013, BEHAV ECOL, V24, P190, DOI 10.1093/beheco/ars153; Dukas R, 1998, COGNITIVE ECOLOGY EV; Gallup AC, 2012, P NATL ACAD SCI USA, V109, P7245, DOI 10.1073/pnas.1116141109; Gautrais J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002678; Ginelli F, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.184502; Goldstein E.Bruce., 2013, SENSATION PERCEPTION; Gregoire G, 2003, PHYSICA D, V181, P157, DOI 10.1016/S0167-2789(03)00102-7; Gueron S, 1996, J THEOR BIOL, V182, P85, DOI 10.1006/jtbi.1996.0144; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Herbert-Read JE, 2011, P NATL ACAD SCI USA, V108, P18726, DOI 10.1073/pnas.1109355108; Hildenbrandt H, 2010, BEHAV ECOL, V21, P1349, DOI 10.1093/beheco/arq149; Lemasson BH, 2009, J THEOR BIOL, V261, P501, DOI 10.1016/j.jtbi.2009.08.013; Li YJ, 2011, EPL-EUROPHYS LETT, V93, DOI 10.1209/0295-5075/93/68003; Lukeman R, 2010, P NATL ACAD SCI USA, V107, P12576, DOI 10.1073/pnas.1001763107; Martinez S, 2007, IEEE CONTR SYST MAG, V27, P75, DOI 10.1109/MCS.2007.384124; MORTON TL, 1994, J THEOR BIOL, V167, P73, DOI 10.1006/jtbi.1994.1051; NELSON DR, 1979, PHYS REV B, V19, P2457, DOI 10.1103/PhysRevB.19.2457; Okubo A., 1986, Advances in Biophysics, V22, P1, DOI 10.1016/0065-227X(86)90003-1; Reluga TC, 2005, J THEOR BIOL, V234, P213, DOI 10.1016/j.jtbi.2004.11.035; Reynolds C., 1987, ACM SIGGRAPH COMPUTE, V21, P25, DOI DOI 10.1145/37402.37406; Speakman JR, 1998, IBIS, V140, P280, DOI 10.1111/j.1474-919X.1998.tb04390.x; Sperati V, 2011, SWARM INTELL-US, V5, P97, DOI 10.1007/s11721-011-0055-y; STRANDBURG KJ, 1988, REV MOD PHYS, V60, P161, DOI 10.1103/RevModPhys.60.161; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Vicsek T, 2012, PHYS REP, V517, P71, DOI 10.1016/j.physrep.2012.03.004; Viscido SV, 2002, J THEOR BIOL, V217, P183, DOI 10.1006/jtbi.2002.3025; Viscido SV, 2002, ANIM BEHAV, V63, P735, DOI 10.1006/anbe.2001.1935; WARBURTON K, 1991, J THEOR BIOL, V150, P473, DOI 10.1016/S0022-5193(05)80441-2	36	7	7	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e94221	10.1371/journal.pone.0094221	http://dx.doi.org/10.1371/journal.pone.0094221			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809718	Green Published, gold, Green Submitted			2022-12-27	WOS:000338213300006
J	Zila, V; Difato, F; Klimova, L; Huerfano, S; Forstova, J				Zila, Vojtech; Difato, Francesco; Klimova, Lucie; Huerfano, Sandra; Forstova, Jitka			Involvement of Microtubular Network and Its Motors in Productive Endocytic Trafficking of Mouse Polyomavirus	PLOS ONE			English	Article							VESICULAR-TRANSPORT; CYTOPLASMIC DYNEIN; MEMBRANE DOMAINS; BK-VIRUS; INFECTION; ENDOSOMES; CAVEOLAE; PATHWAY; CELLS; MOVEMENT	Infection of non-enveloped polyomaviruses depends on an intact microtubular network. Here we focus on mouse polyomavirus (MPyV). We show that the dynamics of MPyV cytoplasmic transport reflects the characteristics of microtubular motor-driven transport with bi-directional saltatory movements. In cells treated with microtubule-disrupting agents, localization of MPyV was significantly perturbed, the virus was retained at the cell periphery, mostly within membrane structures resembling multicaveolar complexes, and at later times post-infection, only a fraction of the virus was found in Rab7-positive endosomes and multivesicular bodies. Inhibition of cytoplasmic dynein-based motility by overexpression of dynamitin affected perinuclear translocation of the virus, delivery of virions to the ER and substantially reduced the numbers of infected cells, while overexpression of dominant-negative form of kinesin-1 or kinesin-2 had no significant impact on virus localization and infectivity. We also found that transport along microtubules was important for MPyV-containing endosome sequential acquisition of Rab5, Rab7 and Rab11 GTPases. However, in contrast to dominant-negative mutant of Rab7 (T22N), overexpression of dominant-negative mutant Rab11 (S25N) did not affect the virus infectivity. Altogether, our study revealed that MPyV cytoplasmic trafficking leading to productive infection bypasses recycling endosomes, does not require the function of kinesin-1 and kinesin-2, but depends on functional dynein-mediated transport along microtubules for translocation of the virions from peripheral, often caveolin-positive compartments to late endosomes and ER - a prerequisite for efficient delivery of the viral genome to the nucleus.	[Zila, Vojtech; Difato, Francesco; Klimova, Lucie; Huerfano, Sandra; Forstova, Jitka] Charles Univ Prague, Fac Sci, Dept Genet & Microbiol, Prague, Czech Republic	Charles University Prague	Forstova, J (corresponding author), Charles Univ Prague, Fac Sci, Dept Genet & Microbiol, Prague, Czech Republic.	jitkaf@natur.cuni.cz	Meneses, Sandra Huerfano-/AAZ-2287-2020; Huerfano, Sandra/G-8469-2013; Forstová, Jitka/L-7328-2017	Meneses, Sandra Huerfano-/0000-0001-5221-3014; Huerfano, Sandra/0000-0001-5221-3014; Forstová, Jitka/0000-0003-0219-506X; Zila, Vojtech/0000-0003-2032-3600; difato, francesco/0000-0001-6404-588X	Grant Agency of the Czech Republic [P302/13-26115S]; Ministry of Education, Youth and Sports of the Czech Republic [SVV-2014-260081]; Charles University in Prague [UNCE 204013]; project BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences; Charles University [CZ.1.05/1.1.00/02.0109]; European Regional Development Fund	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Charles University in Prague; project BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences; Charles University; European Regional Development Fund(European Commission)	This study was supported by the Grant Agency of the Czech Republic (Project P302/13-26115S), by the Ministry of Education, Youth and Sports of the Czech Republic (Project SVV-2014-260081), by the Charles University in Prague (Project UNCE 204013) and by the project BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University (CZ.1.05/1.1.00/02.0109), from the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; Ashok A, 2003, J VIROL, V77, P1347, DOI 10.1128/JVI.77.2.1347-1356.2003; Baravalle G, 2005, CELL TISSUE RES, V320, P99, DOI 10.1007/s00441-004-1060-x; Bayer N, 1998, J VIROL, V72, P9645, DOI 10.1128/JVI.72.12.9645-9655.1998; Benesch S, 2002, J BIOL CHEM, V277, P37771, DOI 10.1074/jbc.M204145200; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; Botos E, 2008, J CELL MOL MED, V12, P1632, DOI 10.1111/j.1582-4934.2007.00167.x; Brankatschk B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021771; Brown CL, 2005, TRAFFIC, V6, P1114, DOI 10.1111/j.1600-0854.2005.00347.x; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Coy DL, 1999, NAT CELL BIOL, V1, P288, DOI 10.1038/13001; Dodding MP, 2011, EMBO J, V30, P3527, DOI 10.1038/emboj.2011.283; Dohner K, 2002, MOL BIOL CELL, V13, P2795, DOI 10.1091/mbc.01-07-0348; Driskell OJ, 2007, NAT CELL BIOL, V9, P113, DOI 10.1038/ncb1525; Eash S, 2005, J VIROL, V79, P11734, DOI 10.1128/JVI.79.18.11734-11741.2005; Echarri A, 2012, J CELL SCI, V125, P3097, DOI 10.1242/jcs.090134; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Engel S, 2011, J VIROL, V85, P4198, DOI 10.1128/JVI.02179-10; Ewers H, 2005, P NATL ACAD SCI USA, V102, P15110, DOI 10.1073/pnas.0504407102; Gilbert J, 2004, J VIROL, V78, P12259, DOI 10.1128/JVI.78.22.12259-12267.2004; Gilbert JM, 2003, J VIROL, V77, P2615, DOI 10.1128/JVI.77.4.2615-2622.2003; Gilbert JM, 2000, J VIROL, V74, P8582, DOI 10.1128/JVI.74.18.8582-8588.2000; Gilbert J, 2006, J VIROL, V80, P10868, DOI 10.1128/JVI.01117-06; Ginkel LM, 2000, MOL BIOL CELL, V11, P4143, DOI 10.1091/mbc.11.12.4143; Hayer A, 2010, J CELL BIOL, V191, P615, DOI 10.1083/jcb.201003086; Holtta-Vuori M, 2002, MOL BIOL CELL, V13, P3107, DOI 10.1091/mbc.E02-01-0025; Horgan CP, 2010, J CELL SCI, V123, P181, DOI 10.1242/jcs.052670; Hunt SD, 2011, BIOCHEM SOC T, V39, P1179, DOI 10.1042/BST0391179; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Jiang MX, 2009, J VIROL, V83, P1350, DOI 10.1128/JVI.02169-08; Kiss AL, 2012, ADV EXP MED BIOL, V729, P14, DOI 10.1007/978-1-4614-1222-9_2; Kiss AL, 2009, PATHOL ONCOL RES, V15, P479, DOI 10.1007/s12253-008-9139-4; Kobiler O, 2012, NUCLEUS-PHILA, V3, P526, DOI 10.4161/nucl.21979; Krauzewicz N, 2000, GENE THER, V7, P2122, DOI 10.1038/sj.gt.3301322; LI GP, 1993, J BIOL CHEM, V268, P24475; Liebl D, 2006, J VIROL, V80, P4610, DOI 10.1128/JVI.80.9.4610-4622.2006; Loubery S, 2008, TRAFFIC, V9, P492, DOI 10.1111/j.1600-0854.2008.00704.x; MACKAY RL, 1976, J VIROL, V19, P620, DOI 10.1128/JVI.19.2.620-636.1976; Magnuson B, 2005, MOL CELL, V20, P289, DOI 10.1016/j.molcel.2005.08.034; Mannova P, 2003, J VIROL, V77, P1672, DOI 10.1128/JVI.77.3.1672-1681.2003; Moriyama T, 2008, VIROLOGY, V371, P336, DOI 10.1016/j.virol.2007.09.030; Mundy DI, 2012, MOL BIOL CELL, V23, P864, DOI 10.1091/mbc.E11-07-0598; Muriel O, 2011, J CELL SCI, V124, P2763, DOI 10.1242/jcs.080804; Orth JD, 2002, P NATL ACAD SCI USA, V99, P167, DOI 10.1073/pnas.012607899; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Presley JF, 1998, MOL BIOL CELL, V9, P1617, DOI 10.1091/mbc.9.7.1617; Qian MD, 2010, J VIROL, V84, P9840, DOI 10.1128/JVI.01093-10; Qian MD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000465; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; Richterova Z, 2001, J VIROL, V75, P10880, DOI 10.1128/JVI.75.22.10880-10891.2001; Sanjuan N, 2003, VIROLOGY, V313, P105, DOI 10.1016/S0042-6822(03)00309-X; Schelhaas M, 2007, CELL, V131, P516, DOI 10.1016/j.cell.2007.09.038; SHIMURA H, 1987, VIROLOGY, V158, P34, DOI 10.1016/0042-6822(87)90235-2; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Tsai B, 2003, EMBO J, V22, P4346, DOI 10.1093/emboj/cdg439; Turler H, 1985, VIROLOGY PRACTICAL A, P169; Walczak CP, 2011, J VIROL, V85, P2386, DOI 10.1128/JVI.01855-10; Welsch T, 2005, AM J PHYSIOL-RENAL, V289, pF1134, DOI 10.1152/ajprenal.00178.2005; Wozniak MJ, 2006, EMBO J, V25, P5457, DOI 10.1038/sj.emboj.7601427; Wozniak MJ, 2009, J CELL SCI, V122, P1979, DOI 10.1242/jcs.041962; Zhou AY, 2011, J VIROL, V85, P3046, DOI 10.1128/JVI.02209-10	66	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96922	10.1371/journal.pone.0096922	http://dx.doi.org/10.1371/journal.pone.0096922			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810588	Green Submitted, Green Published, gold			2022-12-27	WOS:000338213300092
J	Diederich, AK; Wobser, D; Spiess, M; Sava, IG; Huebner, J; Sakinc, T				Diederich, Ann-Kristin; Wobser, Dominique; Spiess, Meike; Sava, Irina G.; Huebner, Johannes; Sakinc, Tuerkan			Role of Glycolipids in the Pathogenesis of Enterococcus faecalis Urinary Tract Infection	PLOS ONE			English	Article							LIPOTEICHOIC ACID; UROLOGIC DISEASES; ESCHERICHIA-COLI; COLLAGEN ADHESIN; AMERICA PROJECT; TEICHOIC-ACIDS; RESOURCE USE; ADHERENCE; MSCRAMMS; BINDING	Background: After uropathogenic Escherichia coli (UPEC), Enterococcus faecalis is the second most common pathogen causing urinary tract infections. Monoglucosyl-diacylglycerol (MGlcDAG) and diglucosyl-diacylglycerol (DGlcDAG) are the main glycolipids of the E. faecalis cell membrane. Examination of two mutants in genes bgsB and bgsA (both glycosyltransferases) showed that these genes are involved in cell membrane glycolipid biosynthesis, and that their inactivation leads to loss of glycolipids DGlcDAG (bgsA) or both MGlcDAG and DGlcDAG (bgsB). Here we investigate the function of bgsB and bgsA regarding their role in the pathogenesis in a mouse model of urinary tract infection and in bacterial adhesion to T24 bladder epithelial cells. Results: In a mouse model of urinary tract infection, we showed that E. faecalis 12030 Delta bgsB and E. faecalis 12030 Delta bgsA mutants, colonize uroepithelial surfaces more efficiently than wild-type bacteria. We also demonstrated that these mutants showed a more than three-fold increased binding to human bladder carcinoma cells line T24 compared to the wild-type strain. Bacterial binding could be specifically inhibited by purified glycolipids. Lipoteichoic acid (LTA), wall-teichoic acid (WTA), and glycosaminoglycans (GAGs) were not significantly involved in binding of E. faecalis to the bladder epithelial cell line. Conclusions: Our data show that the deletion of bgsB and bgsA and the absence of the major glycolipid diglucosyldiacylglycerol increases colonization and binding to uroepithelial cells. We hypothesize that secreted diglucosyldiacylglycerol blocks host binding sites, thereby preventing bacterial adhesion. Further experiments will be needed to clarify the exact mechanism underlying the adhesion through glycolipids and their cognate receptors.	[Diederich, Ann-Kristin; Wobser, Dominique; Spiess, Meike; Huebner, Johannes; Sakinc, Tuerkan] Univ Hosp Freiburg, Div Infect Dis, Freiburg, Germany; [Sava, Irina G.] Tech Univ Munich, Res Ctr Nutr & Food Sci, D-80290 Munich, Germany; [Huebner, Johannes] Univ Munich, Div Pediat Infect Dis, Dr Von Hauner Childrens Hosp, Munich, Germany	University of Freiburg; Technical University of Munich; University of Munich	Huebner, J (corresponding author), Univ Hosp Freiburg, Div Infect Dis, Freiburg, Germany.	johannes.huebner@med.uni-muenchen.de		Huebner, Johannes/0000-0003-1232-4646	German Ministry of Science and Education [BMBF: UroGenOmics0315833C]; Albert Ludwigs University Freiburg	German Ministry of Science and Education; Albert Ludwigs University Freiburg	This work was supported by grants from the German Ministry of Science and Education (BMBF: UroGenOmics0315833C). The article processing charge was funded by the open access publication fund of the Albert Ludwigs University Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abachin E, 2002, MOL MICROBIOL, V43, P1, DOI 10.1046/j.1365-2958.2002.02723.x; Baldassarri L, 2005, J INFECT DIS, V191, P1253, DOI 10.1086/428778; BEACHEY EH, 1981, J INFECT DIS, V143, P325, DOI 10.1093/infdis/143.3.325; Dobrindt U, 2001, INFECT IMMUN, V69, P4248, DOI 10.1128/IAI.69.7.4248-4256.2001; Fabretti F, 2005, INT J ARTIF ORGANS, V28, P1079, DOI 10.1177/039139880502801105; Fleckenstein JM, 2002, INFECT IMMUN, V70, P1530, DOI 10.1128/IAI.70.3.1530-1537.2002; Griebling TL, 2005, J UROLOGY, V173, P1288, DOI 10.1097/01.ju.0000155595.98120.8e; Griebling TL, 2005, J UROLOGY, V173, P1281, DOI 10.1097/01.ju.0000155596.98780.82; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Hooton TM, 2012, NEW ENGL J MED, V366, P1028, DOI 10.1056/NEJMcp1104429; Hooton TM, 1997, INFECT DIS CLIN N AM, V11, P551, DOI 10.1016/S0891-5520(05)70373-1; Huebner J, 1999, INFECT IMMUN, V67, P1213, DOI 10.1128/IAI.67.3.1213-1219.1999; Hunstad DA, 2005, INFECT IMMUN, V73, P3999, DOI 10.1128/IAI.73.7.3999-4006.2005; Huycke MM, 1998, EMERG INFECT DIS, V4, P239, DOI 10.3201/eid0402.980211; JOHNSON JR, 1991, CLIN MICROBIOL REV, V4, P80, DOI 10.1128/CMR.4.1.80-128.1991; Kau AL, 2005, INFECT IMMUN, V73, P2461, DOI 10.1128/IAI.73.4.2461-2468.2005; KUNIN CM, 1994, CLIN INFECT DIS, V18, P1, DOI 10.1093/clinids/18.1.1; McCormick NE, 2011, MICROBIOL-SGM, V157, P2248, DOI 10.1099/mic.0.048140-0; Minagawa S, 2005, J UROLOGY, V173, P2171, DOI 10.1097/01.ju.0000158122.16046.68; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; Nallapareddy SR, 2011, INFECT IMMUN, V79, P2901, DOI 10.1128/IAI.00038-11; Ronald A, 2003, DM-DIS MON, V49, P71, DOI 10.1067/mda.2003.8; Ross CL, 2012, J BIOL CHEM, V287, P34856, DOI 10.1074/jbc.M112.371054; Rostand KS, 1997, INFECT IMMUN, V65, P1; Sava IG, 2010, CLIN MICROBIOL INFEC, V16, P533, DOI 10.1111/j.1469-0691.2010.03213.x; Sava IG, 2009, J BIOL CHEM, V284, P18194, DOI 10.1074/jbc.M901460200; Schappert Susan M, 2011, Vital Health Stat 13, P1; Sillanpaa J, 2004, MICROBIOL-SGM, V150, P2069, DOI 10.1099/mic.0.27074-0; Sillanpaa J, 2009, MICROBIOL-SGM, V155, P2390, DOI 10.1099/mic.0.027821-0; Sillapaa J, 2008, MICROBIOL-SGM, V154, P3199, DOI 10.1099/mic.0.2008/017319-0; Singh KV, 2009, J INFECT DIS, V200, P417, DOI 10.1086/600124; Svenborg-Eden C, 1993, PROG ALLERGY, V33, P175; Tendolkar PM, 2003, CELL MOL LIFE SCI, V60, P2622, DOI 10.1007/s00018-003-3138-0; Teng F, 2009, INFECT IMMUN, V77, P3759, DOI 10.1128/IAI.00149-09; Theilacker C, 2006, INFECT IMMUN, V74, P5703, DOI 10.1128/IAI.00570-06; Theilacker C, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-67; Theilacker C, 2009, MOL MICROBIOL, V71, P1055, DOI [10.1111/j.1365-2958.2008.06587.x, 10.1111/j.1365-2958.2009.06587.x]; Wang A, 2007, JAMA-J AM MED ASSOC, V297, P1354, DOI 10.1001/jama.297.12.1354; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Xu Y, 1998, INFECT IMMUN, V66, P4313	42	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96295	10.1371/journal.pone.0096295	http://dx.doi.org/10.1371/journal.pone.0096295			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806450	Green Published, Green Submitted, gold			2022-12-27	WOS:000335728900044
J	Almagrami, AA; Alshawsh, MA; Saif-Ali, R; Shwter, A; Salem, SD; Abdulla, MA				Almagrami, Amel A.; Alshawsh, Mohammed A.; Saif-Ali, Riyadh; Shwter, Abdrabuh; Salem, Sameer D.; Abdulla, Mahmood A.			Evaluation of Chemopreventive Effects of Acanthus ilicifolius against Azoxymethane-Induced Aberrant Crypt Foci in the Rat Colon	PLOS ONE			English	Article							CELL-PROLIFERATION; COLORECTAL-CANCER; OXIDATIVE STRESS; IN-VIVO; APOPTOSIS; ANTIOXIDANT; INDUCTION; CARCINOGENESIS; BAX; PATHOGENESIS	Background: Acanthus ilicifolius, a mangrove medicinal plant, is traditionally used to treat a variety of diseases. The aim of this research is to assess the chemoprotective outcomes of A. ilicifolius ethanolic extract against azoxymethane (AOM) induced colonic aberrant crypt foci (ACF) in rats. Methodology/Principal Findings: In our study, rats were arranged in to five groups. Rats in the normal control group were given subcutaneous injections of normal saline once weekly for 2 weeks. The AOM control, reference and treatment groups were given subcutaneous injection of AOM, 15 mg/kg body weight, once weekly for 2 weeks each. The reference group was treated with 35 mg/kg 5-Fluorouracil via intraperitoneal injection once weekly for 8 weeks, and the treatment groups were administered by gavage with 250 and 500 mg/kg A. ilicifolius extract daily for 8 weeks. Both normal and AOM control groups received the vehicle; 10% Tween-20 only. Rats treated with 250 mg/kg and 500 mg/kg of A. ilicifolius extracts showed a decrease in the mean number of ACF by 65% and 53%, respectively. Those fed with A. ilicifolius showed significantly decreased multiplicity of ACF formations when compared with the results from the AOM control group. The 250 mg/kg A. ilicifolius treatment group showed significant decreases in lipid peroxidation MDA levels when compared with the AOM control group. In immunohistochemistry staining, the proliferating nuclear cell antigen (PCNA)-positive cells were significantly higher in the AOM control group than in the A. ilicifolius-treated groups. RT-PCR showed that A. ilicifolius caused a change in the regulation of apoptosis-related genes expression. Conclusion/Significance: The results of the current study show that AOM-treated rats receiving oral exposure to A. ilicifolius demonstrated a significant decrease in the number of ACF in the colon when compared to AOM-treated rats receiving vehicle only. A ilicifolius may be an effective herbal approach for the prevention of AOM-induced ACF in the rat colon.	[Almagrami, Amel A.; Shwter, Abdrabuh; Abdulla, Mahmood A.] Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur, Malaysia; [Alshawsh, Mohammed A.] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia; [Saif-Ali, Riyadh; Salem, Sameer D.] Fac Med, Dept Biochem, Sanaa, Yemen	Universiti Malaya; Universiti Malaya	Almagrami, AA (corresponding author), Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur, Malaysia.	amel_almagrami@yahoo.com; ammeen@um.edu.my	Alshawsh, Mohammed Abdullah/B-2887-2010	Alshawsh, Mohammed Abdullah/0000-0001-8342-5183; Saif-Ali, Riyadh/0000-0002-0246-3856	University of Malaya [PV042/2011A]; High Impact Research Grant from the Ministry of Higher Education Malaysia [UM-MOHE UM.C/625/1/HIR/MOHE/SC/09]	University of Malaya(Universiti Malaya); High Impact Research Grant from the Ministry of Higher Education Malaysia	This research is supported by University of Malaya grants; PV042/2011A, and High Impact Research Grant UM-MOHE UM.C/625/1/HIR/MOHE/SC/09 from the Ministry of Higher Education Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Numair KS, 2011, EXP BIOL MED, V236, P1005, DOI 10.1258/ebm.2011.011010; [Anonymous], 2001, GUID 423 AC OR TOX A; AOAC, 1995, OFF METH AN ASS AN C; Babu BH, 2002, J ETHNOPHARMACOL, V79, P27, DOI 10.1016/S0378-8741(01)00347-6; Babu BH, 2001, FITOTERAPIA, V72, P272, DOI 10.1016/S0367-326X(00)00300-2; Bejar LM, 2012, GAC SANIT, V26, P69, DOI 10.1016/j.gaceta.2011.04.016; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; BIRD RP, 1987, CANCER LETT, V37, P147, DOI 10.1016/0304-3835(87)90157-1; Bird RP, 2000, TOXICOL LETT, V112, P395, DOI 10.1016/S0378-4274(99)00261-1; BIRD RP, 1995, CANCER LETT, V93, P55, DOI 10.1016/0304-3835(95)03788-X; Boonstra J, 2004, GENE, V337, P1, DOI 10.1016/j.gene.2004.04.032; Bousserouel S, 2011, PATHOL INT, V61, P80, DOI 10.1111/j.1440-1827.2010.02621.x; Bousserouel S, 2010, ONCOL REP, V23, P511, DOI 10.3892/or_00000663; Cheng L, 2003, WORLD J GASTROENTERO, V9, P2642; Corpet DE, 2002, NUTR CANCER, V43, P1, DOI 10.1207/S15327914NC431_1; Di Carlo G, 1999, LIFE SCI, V65, P337, DOI 10.1016/S0024-3205(99)00120-4; DIPPLE A, 1995, CARCINOGENESIS, V16, P437, DOI 10.1093/carcin/16.3.437; Dobrovolskaia MA, 2005, CURR CANCER DRUG TAR, V5, P325, DOI 10.2174/1568009054629645; DOWD LE, 1959, ANAL CHEM, V31, P1184, DOI 10.1021/ac60151a033; Eastwood GL, 1995, J CLIN GASTROENTEROL, V21, pS1; Gupta SC, 2010, CANCER METAST REV, V29, P405, DOI 10.1007/s10555-010-9235-2; Hirose Y, 1996, JPN J CANCER RES, V87, P575, DOI 10.1111/j.1349-7006.1996.tb00262.x; JACOBS LR, 1986, CANCER RES, V46, P1727; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; Kanchanapoom T, 2001, PHYTOCHEMISTRY, V56, P369, DOI 10.1016/S0031-9422(00)00362-9; Kapiszewska M, 2006, VEGETABLE MEAT CONSU; Kim ND, 2006, CURR CANCER DRUG TAR, V6, P681; Kohno H, 2006, INT J CANCER, V118, P2936, DOI 10.1002/ijc.21719; Kundu T, 2005, CANCER LETT, V230, P111, DOI 10.1016/j.canlet.2004.12.035; Lee WR, 2002, BIOCHEM PHARMACOL, V63, P225, DOI 10.1016/S0006-2952(01)00876-0; LIPKIN M, 1983, CANCER RES, V43, P1899; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Natarajan V, 2003, Indian J Med Microbiol, V21, P98; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; OSAWA T, 1990, BASIC LIFE SCI, V52, P139; Patel BB, 2009, AM J PHYSIOL-GASTR L, V296, pG955, DOI 10.1152/ajpgi.90726.2008; PONDER BAJ, 1986, J NATL CANCER I, V77, P967; Raju J, 2004, CANCER EPIDEM BIOMAR, V13, P1392; RAO CV, 1993, CARCINOGENESIS, V14, P2219, DOI 10.1093/carcin/14.11.2219; RAO CV, 1993, CANCER RES, V53, P4182; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; Rodriguez-Ramiro I, 2011, MOL NUTR FOOD RES, V55, P1895, DOI 10.1002/mnfr.201100363; ROJA G, 1994, PHYTOCHEMISTRY, V36, P65, DOI 10.1016/S0031-9422(00)97013-4; SELVAKUMARAN M, 1994, ONCOGENE, V9, P1791; Shahidi F, 2010, PHYTOCHEM REV, V9, P147, DOI 10.1007/s11101-009-9142-8; Singh Amrita, 2001, Indian Journal of Experimental Biology, V39, P263; Siu IM, 1999, CANCER RES, V59, P63; Srimuangwong K, 2012, WORLD J GASTROENTERO, V18, P6951, DOI 10.3748/wjg.v18.i47.6951; Takayama T, 1998, NEW ENGL J MED, V339, P1277, DOI 10.1056/NEJM199810293391803; Tanaka T, 1997, CARCINOGENESIS, V18, P957, DOI 10.1093/carcin/18.5.957; Waly MI, 2012, ASIAN PAC J CANCER P, V13, P4051, DOI 10.7314/APJCP.2012.13.8.4051; Woestmann Ralf, 2008, Senckenbergiana Maritima, V38, P31; Wu J, 2003, PHARMAZIE, V58, P363; Wu WS, 2006, CANCER METAST REV, V25, P695, DOI 10.1007/s10555-006-9037-8; Yang HL, 2006, CANCER LETT, V231, P215, DOI 10.1016/j.canlet.2005.02.004; Yusoff HM, 2012, ASIAN PAC J CANCER P, V13, P3983, DOI 10.7314/APJCP.2012.13.8.3983; ZHAN QM, 1994, ONCOGENE, V9, P3743	57	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96004	10.1371/journal.pone.0096004	http://dx.doi.org/10.1371/journal.pone.0096004			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819728	Green Published, gold			2022-12-27	WOS:000336653300010
J	Fox, SE; Geniza, M; Hanumappa, M; Naithani, S; Sullivan, C; Preece, J; Tiwari, VK; Elser, J; Leonard, JM; Sage, A; Gresham, C; Kerhornou, A; Bolser, D; McCarthy, F; Kersey, P; Lazo, GR; Jaiswal, P				Fox, Samuel E.; Geniza, Matthew; Hanumappa, Mamatha; Naithani, Sushma; Sullivan, Chris; Preece, Justin; Tiwari, Vijay K.; Elser, Justin; Leonard, Jeffrey M.; Sage, Abigail; Gresham, Cathy; Kerhornou, Arnaud; Bolser, Dan; McCarthy, Fiona; Kersey, Paul; Lazo, Gerard R.; Jaiswal, Pankaj			De Novo Transcriptome Assembly and Analyses of Gene Expression during Photomorphogenesis in Diploid Wheat Triticum monococcum	PLOS ONE			English	Article							TERMINATION FACTOR MTERF; AEGILOPS-TAUSCHII; DRAFT GENOME; PROTEIN; ANNOTATION; LIGHT; MAP; DNA; IDENTIFICATION; DOMESTICATION	Background: Triticum monococcum (2n) is a close ancestor of T. urartu, the A-genome progenitor of cultivated hexaploid wheat, and is therefore a useful model for the study of components regulating photomorphogenesis in diploid wheat. In order to develop genetic and genomic resources for such a study, we constructed genome-wide transcriptomes of two Triticum monococcum subspecies, the wild winter wheat T. monococcum ssp. aegilopoides (accession G3116) and the domesticated spring wheat T. monococcum ssp. monococcum (accession DV92) by generating de novo assemblies of RNA-Seq data derived from both etiolated and green seedlings. Principal Findings: The de novo transcriptome assemblies of DV92 and G3116 represent 120,911 and 117,969 transcripts, respectively. We successfully mapped similar to 90% of these transcripts from each accession to barley and similar to 95% of the transcripts to T. urartu genomes. However, only similar to 77% transcripts mapped to the annotated barley genes and similar to 85% transcripts mapped to the annotated T. urartu genes. Differential gene expression analyses revealed 22% more light up-regulated and 35% more light down-regulated transcripts in the G3116 transcriptome compared to DV92. The DV92 and G3116 mRNA sequence reads aligned against the reference barley genome led to the identification of similar to 500,000 single nucleotide polymorphism (SNP) and similar to 22,000 simple sequence repeat (SSR) sites. Conclusions: De novo transcriptome assemblies of two accessions of the diploid wheat T. monococcum provide new empirical transcriptome references for improving Triticeae genome annotations, and insights into transcriptional programming during photomorphogenesis. The SNP and SSR sites identified in our analysis provide additional resources for the development of molecular markers.	[Fox, Samuel E.; Geniza, Matthew; Hanumappa, Mamatha; Naithani, Sushma; Sullivan, Chris; Preece, Justin; Elser, Justin; Sage, Abigail; Jaiswal, Pankaj] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Geniza, Matthew] Oregon State Univ, Mol & Cellular Biol Grad Program, Corvallis, OR 97331 USA; [Naithani, Sushma; Sullivan, Chris] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA; [Tiwari, Vijay K.; Leonard, Jeffrey M.; Jaiswal, Pankaj] Oregon State Univ, Dept Crop & Soil Sci, Corvallis, OR 97331 USA; [Gresham, Cathy] Mississippi State Univ, Inst Gen Biocomp & Biotechnol, Mississippi State, MS 39762 USA; [Kerhornou, Arnaud; Bolser, Dan; Kersey, Paul] European Bioinformat Inst, Cambridge, England; [McCarthy, Fiona] Univ Arizona, Sch Anim & Comparat Biomed Sci, Tucson, AZ USA; [Lazo, Gerard R.] USDA ARS, Western Reg Res Ctr, Albany, CA 94710 USA	Oregon State University; Oregon State University; Oregon State University; Oregon State University; Mississippi State University; European Molecular Biology Laboratory (EMBL); University of Arizona; United States Department of Agriculture (USDA)	Jaiswal, P (corresponding author), Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA.	jaiswalp@science.oregonstate.edu	Lazo, Gerard/A-8900-2009; Tiwari, Vijay/AAD-7197-2021; Jaiswal, Pankaj/H-7599-2016; Bolser, Dan/AAE-3087-2019; Jaiswal, Pankaj/R-4214-2019; Naithani, Sushma/AAU-1450-2021	Lazo, Gerard/0000-0002-9160-2052; Jaiswal, Pankaj/0000-0002-1005-8383; Bolser, Dan/0000-0002-3991-0859; Jaiswal, Pankaj/0000-0002-1005-8383; Naithani, Sushma/0000-0001-7819-4552; Geniza, Matthew/0000-0003-4828-7891; Kerhornou, Arnaud/0000-0002-2890-295X; Kersey, Paul/0000-0002-7054-800X	European Commission [283496]; Triticeae Genomics for Sustainable Agriculture project (BBSRC) [BB/J003743/1]; Biotechnology and Biological Sciences Research Council [BB/J00328X/1, BB/J003743/1] Funding Source: researchfish; BBSRC [BB/J00328X/1, BB/J003743/1] Funding Source: UKRI	European Commission(European CommissionEuropean Commission Joint Research Centre); Triticeae Genomics for Sustainable Agriculture project (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the laboratory startup funds provided by the Department of Botany and Plant Pathology and College of Agricultural Sciences at Oregon State University to PJ and SN. Research funds were also provided by the Department of Crop and Soil Science, Agricultural Sciences at Oregon State University to JL. MG received Anita S. Summers travel award from the Department of Botany and Plant Pathology at Oregon State University and to present this work at the Plant and Animal Genome Conference. Contributions from International collaborators, PK, DB and AK were supported by the 'transPLANT' project funded by the European Commission within its 7th Framework Programme, under the thematic area 'Infrastructures' (contract #283496) and the Triticeae Genomics for Sustainable Agriculture project (BBSRC: #BB/J003743/1). The funders had no role in the study design, data analysis, or preparation of the manuscript.	Arsovski Andrej A, 2012, Arabidopsis Book, V10, pe0147, DOI 10.1199/tab.0147; Babiychuk E, 2011, P NATL ACAD SCI USA, V108, P6674, DOI 10.1073/pnas.1103442108; Banerjee J, 2010, BIOCHEM BIOPH RES CO, V394, P178, DOI 10.1016/j.bbrc.2010.02.142; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; BENNETT MD, 1995, ANN BOT-LONDON, V76, P113, DOI 10.1006/anbo.1995.1085; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cumbie JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025279; Dharmawardhana P, 2013, RICE, V6, DOI 10.1186/1939-8433-6-15; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Dubcovsky J, 1996, GENETICS, V143, P983; FernandezSilva P, 1997, EMBO J, V16, P1066, DOI 10.1093/emboj/16.5.1066; Feuillet C, 2003, P NATL ACAD SCI USA, V100, P15253, DOI 10.1073/pnas.2435133100; Filichkin SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016907; Fox S, 2009, METHODS MOL BIOL, V553, P79, DOI 10.1007/978-1-60327-563-7_5; Fox SE, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200011; Fox SE, 2014, OREGON STATE U LIB D, DOI [10.7267/N92Z13FV, DOI 10.7267/N92Z13FV]; Fu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057686; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Guerriero ML, 2012, J R SOC INTERFACE, V9, P744, DOI 10.1098/rsif.2011.0378; Hanumappa M, 2013, RICE, V6, DOI 10.1186/1939-8433-6-14; Harberd NP, 2003, SCIENCE, V299, P1853, DOI 10.1126/science.1083217; HARLAN JR, 1966, SCIENCE, V153, P1074, DOI 10.1126/science.153.3740.1074; Heun M, 1997, SCIENCE, V278, P1312, DOI 10.1126/science.278.5341.1312; Hunter S, 2012, NUCLEIC ACIDS RES, V40, P4725, DOI 10.1093/nar/gks456; Hyvarinen AK, 2007, NUCLEIC ACIDS RES, V35, P6458, DOI 10.1093/nar/gkm676; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Jing HC, 2007, J EXP BOT, V58, P3749, DOI 10.1093/jxb/erm225; Kim M, 2012, PLANT CELL, V24, P3349, DOI 10.1105/tpc.112.101006; Li JG, 2012, PROTEIN CELL, V3, P106, DOI 10.1007/s13238-012-2016-7; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Liu AH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056536, 10.1371/journal.pone.0057359, 10.1371/journal.pone.0056570, 10.1371/journal.pone.0054001]; Luo MC, 2013, P NATL ACAD SCI USA, V110, P7940, DOI 10.1073/pnas.1219082110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW677, DOI 10.1093/nar/gki394; Mount David W, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.top17; Munns R, 2012, NAT BIOTECHNOL, V30, P360, DOI 10.1038/nbt.2120; Oyama T, 1997, GENE DEV, V11, P2983, DOI 10.1101/gad.11.22.2983; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Poolman MG, 2013, PLANT PHYSIOL, V162, P1060, DOI 10.1104/pp.113.216762; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Robles P, 2012, MOL PLANT, V5, P294, DOI 10.1093/mp/sss016; Saintenac C, 2013, SCIENCE, V341, P783, DOI 10.1126/science.1239022; Salamini F, 2002, NAT REV GENET, V3, P429, DOI 10.1038/nrg817; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Seo HS, 2003, NATURE, V423, P995, DOI 10.1038/nature01696; Shi F, 1997, GENES GENET SYST, V72, P243, DOI 10.1266/ggs.72.243; Singla B, 2006, J EXP BOT, V57, P4059, DOI 10.1093/jxb/erl182; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; The International Barley Genome Sequencing Consortium, 2012, Nature (London), V491, P711; Wang YX, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034225, 10.1371/journal.pone.0039525, 10.1371/journal.pone.0037152]; Xiong LM, 2003, PLANT PHYSIOL, V133, P29, DOI 10.1104/pp.103.025395; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang FT, 2013, RICE, V6, DOI 10.1186/1939-8433-6-7; Zoccatelli G, 2012, FOOD CHEM, V135, P2643, DOI 10.1016/j.foodchem.2012.06.123	63	43	45	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96855	10.1371/journal.pone.0096855	http://dx.doi.org/10.1371/journal.pone.0096855			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24821410	gold, Green Published, Green Submitted			2022-12-27	WOS:000336653300038
J	Leng, XY; Scalzo, F; Ip, HL; Johnson, M; Fong, AK; Fan, FSY; Chen, XY; Soo, YOY; Miao, ZR; Liu, LP; Feldmann, E; Leung, TWH; Liebeskind, DS; Wong, KS				Leng, Xinyi; Scalzo, Fabien; Ip, Hing Lung; Johnson, Mark; Fong, Albert K.; Fan, Florence S. Y.; Chen, Xiangyan; Soo, Yannie O. Y.; Miao, Zhongrong; Liu, Liping; Feldmann, Edward; Leung, Thomas W. H.; Liebeskind, David S.; Wong, Ka Sing			Computational Fluid Dynamics Modeling of Symptomatic Intracranial Atherosclerosis May Predict Risk of Stroke Recurrence	PLOS ONE			English	Article							FRACTIONAL FLOW RESERVE; ENDOTHELIAL SHEAR-STRESS; AGGREGATION; HEMODYNAMICS; TERRITORY	Background: Patients with symptomatic intracranial atherosclerosis (ICAS) of >= 70% luminal stenosis are at high risk of stroke recurrence. We aimed to evaluate the relationships between hemodynamics of ICAS revealed by computational fluid dynamics (CFD) models and risk of stroke recurrence in this patient subset. Methods: Patients with a symptomatic ICAS lesion of 70-99% luminal stenosis were screened and enrolled in this study. CFD models were reconstructed based on baseline computed tomographic angiography (CTA) source images, to reveal hemodynamics of the qualifying symptomatic ICAS lesions. Change of pressures across a lesion was represented by the ratio of post-and pre-stenotic pressures. Change of shear strain rates (SSR) across a lesion was represented by the ratio of SSRs at the stenotic throat and proximal normal vessel segment, similar for the change of flow velocities. Patients were followed up for 1 year. Results: Overall, 32 patients (median age 65; 59.4% males) were recruited. The median pressure, SSR and velocity ratios for the ICAS lesions were 0.40 (-22.46-0.79), 4.5 (2.2-20.6), and 7.4 (5.2-12.5), respectively. SSR ratio (hazard ratio [HR] 1.027; 95% confidence interval [CI], 1.004-1.051; P = 0.023) and velocity ratio (HR 1.029; 95% CI, 1.002-1.056; P = 0.035) were significantly related to recurrent territorial ischemic stroke within 1 year by univariate Cox regression, respectively with the c-statistics of 0.776 (95% CI, 0.594-0.903; P = 0.014) and 0.776 (95% CI, 0.594-0.903; P = 0.002) in receiver operating characteristic analysis. Conclusions: Hemodynamics of ICAS on CFD models reconstructed from routinely obtained CTA images may predict subsequent stroke recurrence in patients with a symptomatic ICAS lesion of 70-99% luminal stenosis.	[Leng, Xinyi; Ip, Hing Lung; Fan, Florence S. Y.; Chen, Xiangyan; Soo, Yannie O. Y.; Leung, Thomas W. H.; Wong, Ka Sing] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Scalzo, Fabien; Johnson, Mark; Fong, Albert K.; Liebeskind, David S.] Univ Calif Los Angeles, Stroke Ctr, Los Angeles, CA USA; [Miao, Zhongrong; Liu, Liping] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Feldmann, Edward] Tufts Univ, Dept Neurol, Boston, MA 02111 USA	Chinese University of Hong Kong; Prince of Wales Hospital; University of California System; University of California Los Angeles; Capital Medical University; Tufts University	Wong, KS (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.	ks-wong@cuhk.edu.hk	Leung, Thomas W/AAU-6475-2021; liu, li/HGC-0900-2022; Chen, Xiang Yan/O-8602-2015; Scalzo, Fabien/AAM-6328-2020; LENG, Xinyi/N-4082-2015; Wong, Ka Sing Lawrence/N-3434-2015; Leung, Thomas W. H./O-8567-2015	Leung, Thomas W/0000-0001-8193-0709; Scalzo, Fabien/0000-0001-9755-8104; LENG, Xinyi/0000-0001-7300-6647; Wong, Ka Sing Lawrence/0000-0002-2031-9866; 	Chinese University of Hong Kong; Institute of Innovative Medicine, Chinese University of Hong Kong; NIH-National Institute of Neurological Disorders; Stroke Awards NIH/NINDS [K24NS072272]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K24NS072272] Funding Source: NIH RePORTER	Chinese University of Hong Kong(Chinese University of Hong Kong); Institute of Innovative Medicine, Chinese University of Hong Kong; NIH-National Institute of Neurological Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Stroke Awards NIH/NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Chinese University of Hong Kong (Focused Investment Scheme B) and the Institute of Innovative Medicine, Chinese University of Hong Kong, and NIH-National Institute of Neurological Disorders and Stroke Awards NIH/NINDS K24NS072272. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antiga L, 2008, MED BIOL ENG COMPUT, V46, P1097, DOI 10.1007/s11517-008-0420-1; Bodle JD, 2013, STROKE, V44, P287, DOI 10.1161/STROKEAHA.112.664680; Chatzizisis YS, 2007, CURR OPIN CARDIOL, V22, P552, DOI 10.1097/HCO.0b013e3282f07548; Chimowitz MI, 2011, NEW ENGL J MED, V365, P993, DOI 10.1056/NEJMoa1105335; Chimowitz MI, 2005, NEW ENGL J MED, V352, P1305, DOI 10.1056/NEJMoa043033; Clemens MS, 2007, NEUROSURGERY, V61, P842, DOI [10.1227/01.NEU.0000280081.68618.22, 10.1227/01.NEU.0000280054.23770.3E]; De Bruyne B, 2008, HEART, V94, P949, DOI 10.1136/hrt.2007.122838; Derdeyn CP, 2014, LANCET, V383, P333, DOI 10.1016/S0140-6736(13)62038-3; Donahue MJ, 2012, STROKE, V43, P903, DOI 10.1161/STROKEAHA.111.635995; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Jung JM, 2012, STROKE, V43, P2785, DOI 10.1161/STROKEAHA.112.659185; Kasner SE, 2006, CIRCULATION, V113, P555, DOI 10.1161/CIRCULATIONAHA.105.578229; Kwon SU, 2011, STROKE, V42, P2883, DOI 10.1161/STROKEAHA.110.609370; Leng X, 2013, CEREBROVASC DIS, V36, pP48; Leng XY, 2014, STROKE, V45, P645, DOI 10.1161/STROKEAHA.113.002491; Liebeskind DS, 2012, INTERV NEUROL, V1, P87, DOI 10.1159/000346803; Liebeskind DS, 2011, ANN NEUROL, V69, P963, DOI 10.1002/ana.22354; Maxwell MJ, 2007, BLOOD, V109, P566, DOI 10.1182/blood-2006-07-028282; Nesbitt WS, 2009, NAT MED, V15, P665, DOI 10.1038/nm.1955; Ruggeri ZM, 2006, BLOOD, V108, P1903, DOI 10.1182/blood-2006-04-011551; Scalzo F, 2010, LECT NOTES COMPUT SC, V6455, P359; Sorimachi T, 2011, J NEUROINTERV SURG, V3, P43, DOI 10.1136/jnis.2010.003061; Suh Dae Chul, 2011, Neurointervention, V6, P13, DOI 10.5469/neuroint.2011.6.1.13; Taylor CA, 2013, J AM COLL CARDIOL, V61, P2233, DOI 10.1016/j.jacc.2012.11.083; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; van Laar PJ, 2008, RADIOLOGY, V246, P354, DOI 10.1148/radiol.2462061775; Wentzel JJ, 2012, CARDIOVASC RES, V96, P234, DOI 10.1093/cvr/cvs217	28	39	42	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97531	10.1371/journal.pone.0097531	http://dx.doi.org/10.1371/journal.pone.0097531			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24818753	Green Submitted, Green Published, gold			2022-12-27	WOS:000336653300120
J	Li, IC; Chen, YC; Wang, YY; Tzeng, BW; Ou, CW; Lau, YY; Wu, KM; Chan, TM; Lin, WH; Hwang, SPL; Chow, WY				Li, I-Chen; Chen, Yu-Chia; Wang, Yi-Yun; Tzeng, Bo-Wei; Ou, Chun-Wen; Lau, Yi-Yan; Wu, Kan-Mai; Chan, Tzu-Min; Lin, Wei-Hsiang; Hwang, Sheng-Ping L.; Chow, Wei-Yuan			Zebrafish Adar2 Edits the Q/R Site of AMPA Receptor Subunit gria2 alpha Transcript to Ensure Normal Development of Nervous System and Cranial Neural Crest Cells	PLOS ONE			English	Article							ADENOSINE DEAMINASES; UNEDITED GLUR2; MOTOR-NEURONS; ION FLOW; RNA; GENES; DIFFERENTIATION; EXPRESSION; DEFICIENT; DEATH	Background: Adar2 deaminates selective adenosines to inosines (A-to-I RNA editing) in the double-stranded region of nuclear transcripts. Although the functions of mouse Adar2 and its biologically most important substrate gria2, encoding the GluA2 subunit of AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptor, have been extensively studied, the substrates and functions of zebrafish Adar2 remain elusive. Methods/Principal Findings: Expression of Adar2 was perturbed in the adar2 morphant (adar2MO), generated by antisense morpholio oligonucleotides. The Q/R editing of gria2 alpha was reduced in the adar2MO and was enhanced by overexpression of Adar2, demonstrating an evolutionarily conserved activity between zebrafish and mammalian Adar2 in editing the Q/R site of gria2. To delineate the role of Q/R editing of gria2 alpha in the developmental defects observed in the adar2MO, the Q/R editing of gria2 alpha was specifically perturbed in the gria2 alpha QRMO, generated by a morpholio oligonucleotide complementary to the exon complementary sequence (ECS) required for the Q/R editing. Analogous to the adar2-deficient and Q/R-editing deficient mice displaying identical neurological defects, the gria2 alpha QRMO and adar2MO displayed identical developmental defects in the nervous system and cranial cartilages. Knockdown p53 abolished apoptosis and partially suppressed the loss of spinal cord motor neurons in these morphants. However, reducing p53 activity neither replenished the brain neuronal populations nor rescued the developmental defects. The expressions of crestin and sox9b in the neural crest cells were reduced in the adar2MO and gria2 alpha QRMO. Overexpressing the edited GluA2 alpha(R) in the adar2MO restored normal expressions of cresting and sox9b. Moreover, overexpressing the unedited GluA2 alpha(Q) in the wild type embryos resulted in reduction of crestin and sox9b expressions. These results argue that an elevated GluA2 alpha(Q) level is sufficient for generating the cranial neural crest defects observed in the adar2MO. Our results present a link between dysfunction of AMPA receptors and defective development of the nervous system and cranial neural crest in the zebrafish.	[Li, I-Chen; Chen, Yu-Chia; Tzeng, Bo-Wei; Ou, Chun-Wen; Lau, Yi-Yan; Wu, Kan-Mai; Chan, Tzu-Min; Lin, Wei-Hsiang; Chow, Wei-Yuan] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan; [Wang, Yi-Yun; Chow, Wei-Yuan] Natl Tsing Hua Univ, Inst Syst Neurosci, Hsinchu, Taiwan; [Hwang, Sheng-Ping L.] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan	National Tsing Hua University; National Tsing Hua University; Academia Sinica - Taiwan	Hwang, SPL (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan.	zoslh@gate.sinica.edu.tw; wychow@life.nthu.edu.tw	Hwang, Sheng-Ping/F-2882-2014	Chan, Tzu-Min/0000-0002-0140-5240	Nation Science Consel of Taiwan [NSC 98-2313-B-007-002-MY3, NSC 101-2313-B-001-006-MY3]	Nation Science Consel of Taiwan	Funding provided by Nation Science Consel of Taiwan NSC 98-2313-B-007-002-MY3 to WYC and NSC 101-2313-B-001-006-MY3 to SPLH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre D, 1999, P NATL ACAD SCI USA, V96, P7558, DOI 10.1073/pnas.96.13.7558; Barrallo-Gimeno A, 2004, DEVELOPMENT, V131, P1463, DOI 10.1242/dev.01033; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; Cenci C, 2008, J BIOL CHEM, V283, P7251, DOI 10.1074/jbc.M708316200; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; Chen YH, 2009, DEV DYNAM, V238, P1021, DOI 10.1002/dvdy.21908; Chen YC, 2008, ANAL BIOCHEM, V375, P46, DOI 10.1016/j.ab.2007.12.037; Cole LK, 2001, DEV BIOL, V240, P123, DOI 10.1006/dbio.2001.0432; Danilova N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015938; Dominissini D, 2011, CARCINOGENESIS, V32, P1569, DOI 10.1093/carcin/bgr124; Gill SS, 2001, TOXICOL PATHOL, V29, P208, DOI 10.1080/019262301317052486; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Heale BSE, 2009, EMBO J, V28, P3145, DOI 10.1038/emboj.2009.244; Hideyama T, 2010, J NEUROSCI, V30, P11917, DOI 10.1523/JNEUROSCI.2021-10.2010; Higashijima S, 2000, J NEUROSCI, V20, P206, DOI 10.1523/JNEUROSCI.20-01-00206.2000; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Hoppmann V, 2008, DEV DYNAM, V237, P788, DOI 10.1002/dvdy.21447; Horsch M, J BIOL CHEM, V286, P18614; Jin YF, 2009, IUBMB LIFE, V61, P572, DOI 10.1002/iub.207; Keegan LP, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-209; Keegan LP, 2001, NAT REV GENET, V2, P869, DOI 10.1038/35098584; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kung SS, 2001, FEBS LETT, V509, P277, DOI 10.1016/S0014-5793(01)03183-0; Kwak S, 2005, J MOL MED, V83, P110, DOI 10.1007/s00109-004-0599-z; Lam HM, 1998, NATURE, V396, P125, DOI 10.1038/24066; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Lin WH, 2006, BRAIN RES, V1110, P46, DOI 10.1016/j.brainres.2006.06.054; Minoux M, 2010, DEVELOPMENT, V137, P2605, DOI 10.1242/dev.040048; Morrison RS, 1996, J NEUROSCI, V16, P1337; Nechiporuk A, 2008, SCIENCE, V320, P1774, DOI 10.1126/science.1156547; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Sato T, 2006, GENESIS, V44, P136, DOI 10.1002/gene.20196; Seeburg PH, 2001, BRAIN RES, V907, P233, DOI 10.1016/S0006-8993(01)02445-3; Slavov D, 2002, GENE, V299, P83, DOI 10.1016/S0378-1119(02)01016-8; Slavov D, 2000, GENE, V250, P53, DOI 10.1016/S0378-1119(00)00175-X; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tu CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032899; Wahlstedt H, 2009, GENOME RES, V19, P978, DOI 10.1101/gr.089409.108; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200; Whitney NP, 2008, FASEB J, V22, P2888, DOI 10.1096/fj.07-104661; Wienholds E, 2003, NAT GENET, V35, P217, DOI 10.1038/ng1251; Xiang H, 1996, J NEUROSCI, V16, P6753; Yan YL, 2005, DEVELOPMENT, V132, P1069, DOI 10.1242/dev.01674; Ying SY, 2005, BIOCHEM BIOPH RES CO, V335, P1, DOI 10.1016/j.bbrc.2005.06.130	49	8	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97133	10.1371/journal.pone.0097133	http://dx.doi.org/10.1371/journal.pone.0097133			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24818983	Green Submitted, gold, Green Published			2022-12-27	WOS:000336653300081
J	Pikora, TJ; Bourke, J; Bathgate, K; Foley, KR; Lennox, N; Leonard, H				Pikora, Terri J.; Bourke, Jenny; Bathgate, Katherine; Foley, Kitty-Rose; Lennox, Nicholas; Leonard, Helen			Health Conditions and Their Impact among Adolescents and Young Adults with Down Syndrome	PLOS ONE			English	Article							MENTALLY-HANDICAPPED ADULTS; SCHOOL-AGED CHILDREN; INTELLECTUAL DISABILITY; CARE; PREVALENCE; SURVIVAL; INFANTS; DISEASE; GUIDELINES; PROFILE	Objective: To examine the prevalence of medical conditions and use of health services among young adults with Down syndrome and describe the impact of these conditions upon their lives. Methods: Using questionnaire data collected in 2011 from parents of young adults with Down syndrome we investigated the medical conditions experienced by their children in the previous 12 months. Univariate, linear and logistic regression analyses were performed. Results: We found that in addition to the conditions commonly experienced by children with Down syndrome, including eye and vision problems (affecting 73%), ear and hearing problems (affecting 45%), cardiac (affecting 25%) and respiratory problems (affecting 36%), conditions also found to be prevalent within our young adult cohort included musculoskeletal conditions (affecting 61%), body weight (affecting 57%), skin (affecting 56%) and mental health (affecting 32%) conditions and among young women menstrual conditions (affecting 58%). Few parents reported that these conditions had no impact, with common impacts related to restrictions in opportunities to participate in employment and community leisure activities for the young people, as well as safety concerns. Conclusion: There is the need to monitor, screen and provide appropriate strategies such as through the promotion of healthy lifestyles to prevent the development of comorbidities in young people with Down syndrome and, where present, to reduce their impact.	[Pikora, Terri J.; Bourke, Jenny; Bathgate, Katherine; Foley, Kitty-Rose; Leonard, Helen] Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia; [Bathgate, Katherine] Curtin Univ, Sch Publ Hlth, Bentley, WA, Australia; [Lennox, Nicholas] Univ Queensland, Queeensland Ctr Intellectual & Dev Disabil, South Brisbane, WA, Australia	Telethon Kids Institute; University of Western Australia; Curtin University; University of Queensland	Leonard, H (corresponding author), Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia.	hleonard@ichr.uwa.edu.au	Leonard, Helen/A-1010-2013; Lennox, Nicholas G/F-4113-2010; Foley, Kitty-Rose/D-1368-2017; Pikora, Terri/AAB-1759-2019; Foley, Kitty-Rose/C-8800-2018	Leonard, Helen/0000-0001-6405-5834; Pikora, Terri/0000-0002-9099-1607; Foley, Kitty-Rose/0000-0002-1956-4995	Australian Research Council Linkage Project [LP0989847]	Australian Research Council Linkage Project(Australian Research Council)	The study was funded by an Australian Research Council Linkage Project LP0989847. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Bureau of Statistics, 2013, 4364 0 55 003 AUSTR; Australian Bureau of Statistics, 2013, 4364 0 55 002 AUSTR; Bergholdt R, 2006, DIABETOLOGIA, V49, P1179, DOI 10.1007/s00125-006-0231-6; Bittles AH, 2007, EUR J PUBLIC HEALTH, V17, P221, DOI 10.1093/eurpub/ckl103; Bower C, 2011, W AUSTR REGISTER DEV; Cleves MA, 2007, BIRTH DEFECTS RES A, V79, P657, DOI 10.1002/bdra.20393; Cohen W. I., 1999, DOWN SYNDROME Q, V4, P1, DOI DOI 10.1002/0471227579.CH17; COLLACOTT RA, 1992, BRIT J PSYCHIAT, V161, P671, DOI 10.1192/bjp.161.5.671; Coppus AMW, 2008, J AM GERIATR SOC, V56, P2311, DOI 10.1111/j.1532-5415.2008.01999.x; Costa AC, 2012, NAT REV NEUROL, V8, P182, DOI 10.1038/nrneurol.2012.40; Curtin C, 2013, J PEDIATR-US, V163, P1402, DOI 10.1016/j.jpeds.2013.06.081; Faulks D, 2006, NURS OUTLOOK, V54, P345, DOI 10.1016/j.outlook.2006.09.004; Fitzgerald P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070401; Frid C, 2002, J INTELL DISABIL RES, V46, P310, DOI 10.1046/j.1365-2788.2002.00392.x; Fujiura GT, 1997, RES DEV DISABIL, V18, P261, DOI 10.1016/S0891-4222(97)00008-5; Gibson PA, 2005, ARCH DIS CHILD, V90, P574, DOI 10.1136/adc.2004.049536; Goldacre MJ, 2004, ARCH DIS CHILD, V89, P1014, DOI 10.1136/adc.2003.046219; Grondhuis S, 2013, J INTELLECT DISABIL; Hodapp RM, 2010, INT REV RES MENT RET, V39, P37, DOI 10.1016/S0074-7750(10)39002-1; Honey A, 2011, SOC PSYCH PSYCH EPID, V46, P1, DOI 10.1007/s00127-009-0161-y; HRESKO MT, 1993, J BONE JOINT SURG BR, V75, P604, DOI 10.1302/0301-620X.75B4.8331117; Irving CA, 2012, ARCH DIS CHILD, V97, P326, DOI 10.1136/adc.2010.210534; Jensen KM, 2013, J INTELL DISABIL RES, V57, P947, DOI 10.1111/j.1365-2788.2012.01589.x; Kyrkou M, 2005, J INTELL DISABIL RES, V49, P770, DOI 10.1111/j.1365-2788.2005.00749.x; LantmandeValk HMJV, 1996, J INTELL DISABIL RES, V40, P385, DOI 10.1111/j.1365-2788.1996.tb00646.x; Lennox N, 2007, INT J EPIDEMIOL, V36, P139, DOI 10.1093/ije/dyl254; Lennox N, 2010, J APPL RES INTELLECT, V23, P303, DOI 10.1111/j.1468-3148.2009.00533.x; Leonard H, 2013, INT REV RES DEV DISA, V45, P281, DOI 10.1016/B978-0-12-407760-7.00008-6; Leonard S, 1999, DEV MED CHILD NEUROL, V41, P683, DOI 10.1017/S0012162299001401; Leonard S, 2000, PAEDIATR PERINAT EP, V14, P163; Maatta T, 2011, J INTELLECT DEV DIS, V36, P118, DOI 10.1080/13668250.2011.570253; Maatta Tuomo, 2006, Downs Syndr Res Pract, V11, P78, DOI 10.3104/reports.317; Mahy J, 2010, J INTELL DISABIL RES, V54, P795, DOI 10.1111/j.1365-2788.2010.01308.x; Mantry D, 2008, J INTELL DISABIL RES, V52, P141, DOI 10.1111/j.1365-2788.2007.00985.x; MCCONKEY R, 1982, J MENT DEFIC RES, V26, P47; McConkey R., 2001, J LEARN DISABIL, V5, P309, DOI DOI 10.1177/146900470100500403; McGrath RJ, 2011, J PEDIATR-US, V159, P535, DOI 10.1016/j.jpeds.2011.04.019; Oates A, 2011, DISABIL REHABIL, V33, P1880, DOI 10.3109/09638288.2011.553701; Prasher V P, 1999, Downs Syndr Res Pract, V6, P25, DOI 10.3104/reviews.95; Puri BK, 2001, INT J CLIN PRACT, V55, P442; Rodgers J, 2006, J APPL RES INTELLECT, V19, P364, DOI 10.1111/j.1468-3148.2006.00298.x; Schieve LA, 2009, PEDIATRICS, V123, pE253, DOI 10.1542/peds.2008-1440; Spendelow JS, 2011, BRIT J LEARN DISABIL, V39, P306, DOI 10.1111/j.1468-3156.2010.00670.x; Sullivan SG, 2007, J INTELL DISABIL RES, V51, P228, DOI 10.1111/j.1365-2788.2006.00862.x; Tenenbaum A, 2012, RES DEV DISABIL, V33, P435, DOI 10.1016/j.ridd.2011.09.026; Thomas K, 2011, J PEDIATR-US, V158, P194, DOI 10.1016/j.jpeds.2010.08.045; Thomas K, 2010, INT REV RES MENT RET, V39, P67, DOI 10.1016/S0074-7750(10)39003-3; Tuysuz B, 2001, ACTA PAEDIATR, V90, P1389; Van Allen MI, 1999, AM J MED GENET, V89, P100, DOI 10.1002/(SICI)1096-8628(19990625)89:2<100::AID-AJMG8>3.3.CO;2-E; VanGoor JC, 1997, ARCH DIS CHILD, V77, P186; Yang QH, 2002, LANCET, V359, P1019, DOI 10.1016/S0140-6736(02)08092-3	51	47	49	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96868	10.1371/journal.pone.0096868	http://dx.doi.org/10.1371/journal.pone.0096868			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI1ZC	24818963	Green Published, gold			2022-12-27	WOS:000336653300041
J	Winglee, K; Eloe-Fadrosh, E; Gupta, S; Guo, HD; Fraser, C; Bishai, W				Winglee, Kathryn; Eloe-Fadrosh, Emiley; Gupta, Shashank; Guo, Haidan; Fraser, Claire; Bishai, William			Aerosol Mycobacterium tuberculosis Infection Causes Rapid Loss of Diversity in Gut Microbiota	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; IMMUNE-SYSTEM; DISEASES	Mycobacterium tuberculosis is an important human pathogen, and yet diagnosis remains challenging. Little research has focused on the impact of M. tuberculosis on the gut microbiota, despite the significant immunological and homeostatic functions of the gastrointestinal tract. To determine the effect of M. tuberculosis infection on the gut microbiota, we followed mice from M. tuberculosis aerosol infection until death, using 16S rRNA sequencing. We saw a rapid change in the gut microbiota in response to infection, with all mice showing a loss and then recovery of microbial community diversity, and found that pre-infection samples clustered separately from post-infection samples, using ecological beta-diversity measures. The effect on the fecal microbiota was observed as rapidly as six days following lung infection. Analysis of additional mice infected by a different M. tuberculosis strain corroborated these results, together demonstrating that the mouse gut microbiota significantly changes with M. tuberculosis infection.	[Winglee, Kathryn; Gupta, Shashank; Guo, Haidan; Bishai, William] Johns Hopkins Univ, Dept Med, Baltimore, MD 21218 USA; [Eloe-Fadrosh, Emiley; Fraser, Claire] Univ Maryland, Inst Genome Sci, Baltimore, MD 21201 USA; [Bishai, William] Howard Hughes Med Inst, Chevy Chase, MD USA	Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; Howard Hughes Medical Institute	Bishai, W (corresponding author), Johns Hopkins Univ, Dept Med, Baltimore, MD 21218 USA.	wbishai1@jhmi.edu	Gupta, Shashank/E-7382-2016; Eloe-Fadrosh, Emiley/AAP-8019-2021	Gupta, Shashank/0000-0003-0445-5195; Fraser, Claire/0000-0003-1462-2428; Eloe-Fadrosh, Emiley/0000-0002-8162-1276; Winglee, Kathryn/0000-0002-3623-0700	Howard Hughes Medical Institute; National Institutes of Health [AI097138, AI037856, AI036973]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097138, R01AI037856, R29AI036973, R01AI036973] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors gratefully acknowledge the financial support of Howard Hughes Medical Institute and National Institutes of Health grants AI097138, AI037856, and AI036973. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chackerian AA, 2002, INFECT IMMUN, V70, P4501, DOI 10.1128/IAI.70.8.4501-4509.2002; Cheung MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054574; Costa MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041484; Cui ZL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-276; Dubourg G, 2013, EUR J CLIN MICROBIOL; Flynn JL, 2001, INFECT IMMUN, V69, P4195, DOI 10.1128/IAI.69.7.4195-4201.2001; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gill N, 2010, NAT IMMUNOL, V11, P558, DOI 10.1038/ni0710-558; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Jarchum I, 2011, CURR OPIN IMMUNOL, V23, P353, DOI 10.1016/j.coi.2011.03.001; Kamada N, 2012, SCIENCE, V336, P1325, DOI 10.1126/science.1222195; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Nishio J, 2012, CELL MOL LIFE SCI, V69, P3635, DOI 10.1007/s00018-012-0993-6; Nuermberger E, 2008, SEMIN RESP CRIT CARE, V29, P542, DOI 10.1055/s-0028-1085705; Oksanen J., 2016, R PACKAG; Penders J, 2007, ALLERGY, V62, P1223, DOI 10.1111/j.1398-9995.2007.01462.x; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Russell SL, 2012, EMBO REP, V13, P440, DOI 10.1038/embor.2012.32; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sekirov I, 2009, J PHYSIOL-LONDON, V587, P4159, DOI 10.1113/jphysiol.2009.172742; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wilks J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002681; World Health Organization, 2012, TUBERCULOSIS EDINB; Yeoh N, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-012-0314-y	33	83	91	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97048	10.1371/journal.pone.0097048	http://dx.doi.org/10.1371/journal.pone.0097048			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819223	gold, Green Submitted, Green Published			2022-12-27	WOS:000336653300065
J	deCastro, BR				deCastro, B. Rey			Acrolein and Asthma Attack Prevalence in a Representative Sample of the United States Adult Population 2000-2009	PLOS ONE			English	Article							HAZARDOUS AIR-POLLUTANTS; AUTISM SPECTRUM DISORDERS; HEALTH INTERVIEW SURVEY; TOXICS CONCENTRATIONS; OXIDATIVE STRESS; INHALED ACROLEIN; RISK-ASSESSMENT; LUNG-FUNCTION; MAIN ROAD; POLLUTION	Background: Acrolein is an air toxic and highly potent respiratory irritant. There is little epidemiology available, but US EPA estimates that outdoor acrolein is responsible for about 75 percent of non-cancer respiratory health effects attributable to air toxics in the United States, based on the Agency's 2005 NATA (National-Scale Air Toxics Assessment) and acrolein's comparatively potent inhalation reference concentration of 0.02 mu g/m(3). Objectives: Assess the association between estimated outdoor acrolein exposure and asthma attack reported by a representative cross-sectional sample of the adult United States population. Methods: NATA 2005 chronic outdoor acrolein exposure estimates at the census tract were linked with residences oif adults (>= 18 years old) in the NHIS (National Health Interview Survey) 2000 - 2009 (n = 271,348 subjects). A sample-weighted logistic regression model characterized the association between the prevalence of reporting at least one asthma attack in the 12 months prior to survey interview and quintiles of exposure to outdoor acrolein, controlling for potential confounders. Results: In the highest quintile of outdoor acrolein exposure (0.05 - 0.46 mu g/m(3)), there was a marginally significant increase in the asthma attack pOR (prevalence-odds ratio [95% CI] = 1.08 [0.98: 1.19]) relative to the lowest quintile. The highest quintile was also associated with a marginally significant increase in prevalence-odds (1.13 [0.98: 1.29]) in a model limited to never smokers (n = 153,820). Conclusions: Chronic exposure to outdoor acrolein of 0.05 - 0.46 mg/m(3) appears to increase the prevalence-odds of having at least one asthma attack in the previous year by 8 percent in a representative cross-sectional sample of the adult United States population.	Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Div Sci Lab, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	deCastro, BR (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Div Sci Lab, Atlanta, GA 30333 USA.	rdecastro@cdc.gov	deCastro, Rey/G-2874-2011	deCastro, Rey/0000-0002-1610-5849				Abraham K, 2011, MOL NUTR FOOD RES, V55, P1277, DOI 10.1002/mnfr.201100481; Akinbami LJ, 2010, ENVIRON RES, V110, P294, DOI 10.1016/j.envres.2010.01.001; Alarie Y, 1973, CRC Crit Rev Toxicol, V2, P299, DOI 10.3109/10408447309082020; Alwis KU, 2012, ANAL CHIM A IN PRESS; [Anonymous], 2010, HLTH US 2010; [Anonymous], TOX PROF ACR; ATKINSON R, 1986, CHEM REV, V86, P69, DOI 10.1021/cr00071a004; Baumann LM, 2011, J ALLERGY CLIN IMMUN, V127, P875, DOI 10.1016/j.jaci.2010.11.031; Bein K, 2011, MOL NUTR FOOD RES, V55, P1342, DOI 10.1002/mnfr.201100279; BESWICK FW, 1983, HUM TOXICOL, V2, P247, DOI 10.1177/096032718300200213; BINDER DA, 1983, INT STAT REV, V51, P279, DOI 10.2307/1402588; Biswal S, 2003, CARCINOGENESIS, V24, P1401, DOI 10.1093/carcin/bgg061; Brauer M, 2002, AM J RESP CRIT CARE, V166, P1092, DOI 10.1164/rccm.200108-007OC; CA Office of Environmental Health Hazard Assessment, 2008, AIR TOX HOT SPOTS RI; Cahill Thomas M, 2010, Res Rep Health Eff Inst, P3; CDC, 2009, VAR EST OTH AN ISS 1; CDC, 2011, US SURV WEIGHTS LINK; CDC, 2010, NHI SURV DESCR; CDC, 2000, NAT HLTH INT SURV; CDC, 2011, VAR EST OTH AN ISS N; CDC, 2010, MULT IMP FAM INC PER; Cowell EM, 1939, BRIT MED J, V2, P736, DOI 10.1136/bmj.2.4109.736; Dorman DC, 2008, INHAL TOXICOL, V20, P205, DOI 10.1080/08958370701864151 ; Eastern Research Group, 2010, RES 2005 NATA MOD TO; EDNEY EO, 1986, INT J CHEM KINET, V18, P1355, DOI 10.1002/kin.550181207; Faroon O, 2008, TOXICOL IND HEALTH, V24, P447, DOI 10.1177/0748233708094188; Faroon O, 2008, TOXICOL IND HEALTH, V24, P543, DOI 10.1177/0748233708098124; Feng ZH, 2006, P NATL ACAD SCI USA, V103, P15404, DOI 10.1073/pnas.0607031103; Folsom RE, 2009, P JOINT STAT M 2000, P598; GDCh Advisory Committee on Existing Chemicals of Environmental Relevance (BUA), 1994, 157 BUA GDCH ADV COM; GRAFSTROM RC, 1988, CANCER RES, V48, P1717; Haag WR, 1988, ESTIMATION PHOTOLYSI; Health Effects Institute Air Toxics Review Panel, 2007, MOB SOURC AIR TOX CR; Hecht SS, 2006, P NATL ACAD SCI USA, V103, P15725, DOI 10.1073/pnas.0607811103; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hilmas C. J., 2008, MED ASPECTS CHEM WAR, P9; Holguin F, 2007, AM J RESP CRIT CARE, V176, P1236, DOI 10.1164/rccm.200611-1616OC; Howard P. H., 1989, HDB ENV FATE EXPOSUR; International Agency for Research on Cancer, 1985, DRY CLEAN SOM CHL SO; Jomova K, 2010, MOL CELL BIOCHEM, V345, P91, DOI 10.1007/s11010-010-0563-x; Kalkbrenner AE, 2010, EPIDEMIOLOGY, V21, P631, DOI 10.1097/EDE.0b013e3181e65d76; Kan HD, 2007, THORAX, V62, P873, DOI 10.1136/thx.2006.073015; Kehrer JP, 2000, TOXICOL SCI, V57, P6, DOI 10.1093/toxsci/57.1.6; Kelly FJ, 2011, CLIN EXP ALLERGY, V41, P1059, DOI 10.1111/j.1365-2222.2011.03776.x; Kim JJ, 2008, ENVIRON HEALTH PERSP, V116, P1274, DOI 10.1289/ehp.10735; Leikauf GD, 2002, ENVIRON HEALTH PERSP, V110, P505, DOI 10.1289/ehp.02110s4505; Leung G, 2011, NEUROSCIENCE, V173, P150, DOI 10.1016/j.neuroscience.2010.11.018; Linder SH, 2008, ENVIRON SCI TECHNOL, V42, P4312, DOI 10.1021/es072042u; Logue JM, 2011, INDOOR AIR, V21, P92, DOI 10.1111/j.1600-0668.2010.00683.x; Logue JM, 2010, J AIR WASTE MANAGE, V60, P271, DOI 10.3155/1047-3289.60.3.271; LoPachin RM, 2008, NEUROTOXICOLOGY, V29, P871, DOI 10.1016/j.neuro.2008.04.016; MacKay D, 1995, ILLUSTRATED HDB PHYS; Mason JB, 2011, ENVIRON SCI TECHNOL, V45, P2243, DOI 10.1021/es102500v; McCarthy MC, 2009, ENVIRON HEALTH PERSP, V117, P790, DOI 10.1289/ehp.11861; Monteil C, 1999, TOXICOLOGY, V133, P129, DOI 10.1016/S0300-483X(99)00015-3; Morgenstern V, 2008, AM J RESP CRIT CARE, V177, P1331, DOI 10.1164/rccm.200701-036OC; Moriarity CL, 2000, DESIGN ESTIMATION NA; *NAT HEART LUNG BL, 2007, GUID DIAGN MAN ASTHM; *NAT HEART LUNG BL, 1995, GLOB IN ASTHM; National Heart Lung and Blood Institute NIH, 2012, WHAT IS ASTHM; Nazaroff WW, 2004, J EXPO ANAL ENV EPID, V14, pS71, DOI 10.1038/sj.jea.7500361; Parker JD, 2008, ENVIRON RES, V106, P384, DOI 10.1016/j.envres.2007.11.001; Parker JD, 2009, ENVIRON HEALTH PERSP, V117, P140, DOI 10.1289/ehp.11497; Payne-Sturges DC, 2004, ENVIRON HEALTH PERSP, V112, P589, DOI 10.1289/ehp.6496; Pujades-Rodriguez M, 2009, OCCUP ENVIRON MED, V66, P679, DOI 10.1136/oem.2008.043885; Research Triangle Institute, 2008, SAS CALL SUDAAN; Rosenbaum AS, 1999, J AIR WASTE MANAGE, V49, P1138, DOI 10.1080/10473289.1999.10463919; Rubin D. B., 2004, MULTIPLE IMPUTATION; Saeed S., 2002, P 1 ANN GTI NATURAL; Salam MT, 2008, CURR OPIN PULM MED, V14, P3, DOI 10.1097/MCP.0b013e3282f1987a; Schenker N, 2006, J AM STAT ASSOC, V101, P924, DOI 10.1198/016214505000001375; Schroeter JD, 2008, INHAL TOXICOL, V20, P227, DOI 10.1080/08958370701864235 ; Seaman VY, 2007, ENVIRON SCI TECHNOL, V41, P6940, DOI 10.1021/es0707299; Shi RY, 2011, MOL NUTR FOOD RES, V55, P1320, DOI 10.1002/mnfr.201100217; Shorter JH, 2012, ACROLEIN MONITOR USI; Singh M, 2010, J ALZHEIMERS DIS, V21, P741, DOI 10.3233/JAD-2010-100405; Stone V, 2000, AM J RESP CRIT CARE, V162, pS44, DOI 10.1164/ajrccm.162.supplement_1.maic-12; Stoner AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075176; Struve MF, 2008, INHAL TOXICOL, V20, P217, DOI [10.1080/08958370701864219, 10.1080/08958370701864219 ]; Swift JL, 2006, 22 ANN NAT ENV MON C; Tanuma N, 2008, BRAIN DEV-JPN, V30, P402, DOI 10.1016/j.braindev.2007.12.001; Tourinsky S. D., 2008, MED ASPECTS CHEM WAR, P339; U.S. Environmental Protection Agency (EPA), 2005, 2005 NAT SCAL AIR TO; U.S. Environmental Protection Agency (EPA), 2003, TOX REV ACR; U.S. EPA, 2003, INT RISK INF SYST IR; US Census Bureau, 2012, CENS TRACTS BLOCK NU; US EPA, 2010, TOX REL INV; US EPA, 2010, 2005 NAT EM INV DAT; US EPA, 2010, EPA SCH MON IN FACT; US EPA, 2010, CLEAN AIR ACT AM 199; US EPA O, 2015, 2011 NAT AIR TOX ASS; Venn AJ, 2001, AM J RESP CRIT CARE, V164, P2177, DOI 10.1164/ajrccm.164.12.2106126; Voulgaridou GP, 2011, MUTAT RES-FUND MOL M, V711, P13, DOI 10.1016/j.mrfmmm.2011.03.006; Windham GC, 2006, ENVIRON HEALTH PERSP, V114, P1438, DOI 10.1289/ehp.9120; Woodruff TJ, 1998, ENVIRON HEALTH PERSP, V106, P245, DOI 10.2307/3434011; Woodruff TJ, 2007, ENVIRON HEALTH PERSP, V115, P410, DOI 10.1289/ehp.9467	96	12	12	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96926	10.1371/journal.pone.0096926	http://dx.doi.org/10.1371/journal.pone.0096926			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816802	Green Published, gold			2022-12-27	WOS:000336838000080
J	Lange, M; Habekost, M; Eisenhauer, N; Roscher, C; Bessler, H; Engels, C; Oelmann, Y; Scheu, S; Wilcke, W; Schulze, ED; Gleixner, G				Lange, Markus; Habekost, Maike; Eisenhauer, Nico; Roscher, Christiane; Bessler, Holger; Engels, Christof; Oelmann, Yvonne; Scheu, Stefan; Wilcke, Wolfgang; Schulze, Ernst-Detlef; Gleixner, Gerd			Biotic and Abiotic Properties Mediating Plant Diversity Effects on Soil Microbial Communities in an Experimental Grassland	PLOS ONE			English	Article							CARBON STORAGE; FATTY-ACIDS; BIODIVERSITY; PATTERNS; DRIVERS; IMPACT; SCALE; ECOSYSTEMS; EXTRACTION; RATIOS	Plant diversity drives changes in the soil microbial community which may result in alterations in ecosystem functions. However, the governing factors between the composition of soil microbial communities and plant diversity are not well understood. We investigated the impact of plant diversity (plant species richness and functional group richness) and plant functional group identity on soil microbial biomass and soil microbial community structure in experimental grassland ecosystems. Total microbial biomass and community structure were determined by phospholipid fatty acid (PLFA) analysis. The diversity gradient covered 1, 2, 4, 8, 16 and 60 plant species and 1, 2, 3 and 4 plant functional groups (grasses, legumes, small herbs and tall herbs). In May 2007, soil samples were taken from experimental plots and from nearby fields and meadows. Beside soil texture, plant species richness was the main driver of soil microbial biomass. Structural equation modeling revealed that the positive plant diversity effect was mainly mediated by higher leaf area index resulting in higher soil moisture in the top soil layer. The fungal-to-bacterial biomass ratio was positively affected by plant functional group richness and negatively by the presence of legumes. Bacteria were more closely related to abiotic differences caused by plant diversity, while fungi were more affected by plant-derived organic matter inputs. We found diverse plant communities promoted faster transition of soil microbial communities typical for arable land towards grassland communities. Although some mechanisms underlying the plant diversity effect on soil microorganisms could be identified, future studies have to determine plant traits shaping soil microbial community structure. We suspect differences in root traits among different plant communities, such as root turnover rates and chemical composition of root exudates, to structure soil microbial communities.	[Lange, Markus; Habekost, Maike; Schulze, Ernst-Detlef; Gleixner, Gerd] Max Planck Inst Biogeochem, D-07745 Jena, Germany; [Eisenhauer, Nico] Univ Jena, Inst Ecol, Jena, Germany; [Roscher, Christiane] UFZ, Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany; [Bessler, Holger; Engels, Christof] Humboldt Univ, Fac Agr & Hort, Dept Plant Nutr, D-10099 Berlin, Germany; [Oelmann, Yvonne] Univ Tubingen, Tubingen, Germany; [Scheu, Stefan] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany; [Wilcke, Wolfgang] Univ Bern, Inst Geog, Soil Sci Grp, Bern, Switzerland	Max Planck Society; Friedrich Schiller University of Jena; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Humboldt University of Berlin; Eberhard Karls University of Tubingen; University of Gottingen; University of Bern	Gleixner, G (corresponding author), Max Planck Inst Biogeochem, D-07745 Jena, Germany.	ggleix@bgc-jena.mpg.de	Gleixner, Gerd/M-8519-2017; Schulze, Ernst-Detlef/K-9627-2014; Wilcke, Wolfgang/P-4620-2016; Gleixner, Gerd/O-4215-2019; Eisenhauer, Nico/I-3191-2019; Oelmann, Yvonne/J-8730-2016; Scheu, Stefan/H-7049-2015; Eisenhauer, Nico/I-5932-2012	Gleixner, Gerd/0000-0002-4616-0953; Wilcke, Wolfgang/0000-0002-6031-4613; Gleixner, Gerd/0000-0002-4616-0953; Eisenhauer, Nico/0000-0002-0371-6720; Oelmann, Yvonne/0000-0003-3513-6568; Eisenhauer, Nico/0000-0002-0371-6720	Deutsche Forschungsgemeinschaft [GL 262, FOR 456]; Friedrich Schiller University Jena; Max Planck Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich Schiller University Jena; Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work (GL 262) was funded by the Deutsche Forschungsgemeinschaft within the scope of the biodiversity research group (FOR 456) with support from the Friedrich Schiller University Jena and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058179; Angers DA, 1998, BIOGEOCHEMISTRY, V42, P55, DOI 10.1023/A:1005944025343; Arbuckle JL, 2009, AMOS 18 USERS GUIDE; Baath E, 2003, SOIL BIOL BIOCHEM, V35, P955, DOI 10.1016/S0038-0717(03)00154-8; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Balser TC, 2005, BIOGEOCHEMISTRY, V73, P395, DOI 10.1007/s10533-004-0372-y; Bardgett RD, 1996, BIOL FERT SOILS, V22, P261, DOI 10.1007/BF00382522; Baudoin E, 2003, SOIL BIOL BIOCHEM, V35, P1183, DOI 10.1016/S0038-0717(03)00179-2; Bessler H, 2012, PLANT SOIL, V358, P301, DOI 10.1007/s11104-012-1181-z; Bezemer TM, 2006, J ECOL, V94, P893, DOI 10.1111/j.1365-2745.2006.01158.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOWEN RM, 1990, SOIL BIOL BIOCHEM, V22, P393, DOI 10.1016/0038-0717(90)90118-J; Breulmann M, 2012, PLANT SOIL, V352, P253, DOI 10.1007/s11104-011-0993-6; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Cookson WR, 2008, SOIL BIOL BIOCHEM, V40, P763, DOI 10.1016/j.soilbio.2007.10.011; De Deyn GB, 2009, J ECOL, V97, P864, DOI 10.1111/j.1365-2745.2009.01536.x; de Vries FT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051201; de Vries FT, 2012, ECOL LETT, V15, P1230, DOI 10.1111/j.1461-0248.2012.01844.x; Eisenhauer N, 2010, ECOLOGY, V91, P485, DOI 10.1890/08-2338.1; Ellenberg H., 1988, VEGETATION ECOLOGY C; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; FROSTEGARD A, 1993, SOIL BIOL BIOCHEM, V25, P723, DOI 10.1016/0038-0717(93)90113-P; Gleixner G, 2005, ECOL STUD-ANAL SYNTH, V176, P165; Goebel M, 2011, ECOL MONOGR, V81, P89, DOI 10.1890/09-2390.1; Grace JB., 2015, STRUCTURAL EQUATION; Griffiths BS, 1999, PEDOBIOLOGIA, V43, P297; Griffiths RI, 2011, ENVIRON MICROBIOL, V13, P1642, DOI 10.1111/j.1462-2920.2011.02480.x; Habekost M, 2008, SOIL BIOL BIOCHEM, V40, P2588, DOI 10.1016/j.soilbio.2008.06.019; Hamelinck CN, 2006, ENERG POLICY, V34, P3268, DOI 10.1016/j.enpol.2005.06.012; Hooper DU, 2000, BIOSCIENCE, V50, P1049, DOI 10.1641/0006-3568(2000)050[1049:IBAABB]2.0.CO;2; Kramer C, 2006, SOIL BIOL BIOCHEM, V38, P3267, DOI 10.1016/j.soilbio.2006.04.006; Kreutziger Y, 2006, THESIS FRIEDRICH SCH; Lamb EG, 2011, PLANT SOIL, V338, P483, DOI 10.1007/s11104-010-0560-6; Latz E, 2012, J ECOL, V100, P597, DOI 10.1111/j.1365-2745.2011.01940.x; Leigh MB, 2002, ENVIRON SCI TECHNOL, V36, P1579, DOI 10.1021/es015702i; O'Donnell AG, 2001, PLANT SOIL, V232, P135, DOI 10.1023/A:1010394221729; Oksanen J., 2010, COMMUNITY ECOLOGY PA; Papatheodorou EM, 2004, APPL SOIL ECOL, V25, P37, DOI 10.1016/S0929-1393(03)00100-8; Porazinska DL, 2003, ECOL MONOGR, V73, P377, DOI 10.1890/0012-9615(2003)073[0377:RATAIP]2.0.CO;2; Potthoff M, 2006, SOIL BIOL BIOCHEM, V38, P1851, DOI 10.1016/j.soilbio.2005.12.009; R DevelopmentCoreTeam, 2012, R LANG ENV STAT COMP; Ravit B, 2006, SOIL BIOL BIOCHEM, V38, P2359, DOI 10.1016/j.soilbio.2006.02.012; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Rosenkranz S, 2012, SOIL BIOL BIOCHEM, V48, P78, DOI 10.1016/j.soilbio.2012.01.008; Ruess L, 2010, SOIL BIOL BIOCHEM, V42, P1898, DOI 10.1016/j.soilbio.2010.07.020; Seifert AG, 2011, GEOCHIM COSMOCHIM AC, V75, P2557, DOI 10.1016/j.gca.2011.02.037; Steenwerth KL, 2008, SOIL BIOL BIOCHEM, V40, P1330, DOI 10.1016/j.soilbio.2007.04.031; Steinbeiss S, 2008, GLOBAL CHANGE BIOL, V14, P2937, DOI 10.1111/j.1365-2486.2008.01697.x; Thoms C, 2010, SOIL BIOL BIOCHEM, V42, P1558, DOI 10.1016/j.soilbio.2010.05.030; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Vogel A, 2013, GLOBAL CHANGE BIOL, V19, P2795, DOI 10.1111/gcb.12225; Wardle DA, 2004, SCIENCE, V305, P509, DOI 10.1126/science.1098778; Weigelt A., 2010, ECOLOGY, V91, P930, DOI DOI 10.1890/09-0863.1; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433; ZELLES L, 1993, SOIL BIOL BIOCHEM, V25, P495, DOI 10.1016/0038-0717(93)90075-M; Zelles L, 1999, BIOL FERT SOILS, V29, P111, DOI 10.1007/s003740050533; Zhang CB, 2011, ECOL ENG, V37, P1360, DOI 10.1016/j.ecoleng.2011.03.018	57	134	145	20	239	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96182	10.1371/journal.pone.0096182	http://dx.doi.org/10.1371/journal.pone.0096182			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816860	Green Published, Green Submitted, gold			2022-12-27	WOS:000336838000025
J	Miranda, KC; Bond, DT; Levin, JZ; Adiconis, X; Sivachenko, A; Russ, C; Brown, D; Nusbaum, C; Russo, LM				Miranda, Kevin C.; Bond, Daniel T.; Levin, Joshua Z.; Adiconis, Xian; Sivachenko, Andrey; Russ, Carsten; Brown, Dennis; Nusbaum, Chad; Russo, Leileata M.			Massively Parallel Sequencing of Human Urinary Exosome/Microvesicle RNA Reveals a Predominance of Non-Coding RNA	PLOS ONE			English	Article							PROSTATE-CANCER; GENE; EXOSOMES; ASSIGNMENT; CLONING; CELLS; TRANSCRIPTOMES; EXPRESSION; BIOMARKERS; MICRORNAS	Intact RNA from exosomes/microvesicles (collectively referred to as microvesicles) has sparked much interest as potential biomarkers for the non-invasive analysis of disease. Here we use the Illumina Genome Analyzer to determine the comprehensive array of nucleic acid reads present in urinary microvesicles. Extraneous nucleic acids were digested using RNase and DNase treatment and the microvesicle inner nucleic acid cargo was analyzed with and without DNase digestion to examine both DNA and RNA sequences contained in microvesicles. Results revealed that a substantial proportion (similar to 87%) of reads aligned to ribosomal RNA. Of the non-ribosomal RNA sequences, similar to 60% aligned to non-coding RNA and repeat sequences including LINE, SINE, satellite repeats, and RNA repeats (tRNA, snRNA, scRNA and srpRNA). The remaining similar to 40% of non-ribosomal RNA reads aligned to protein coding genes and splice sites encompassing approximately 13,500 of the known 21,892 protein coding genes of the human genome. Analysis of protein coding genes specific to the renal and genitourinary tract revealed that complete segments of the renal nephron and collecting duct as well as genes indicative of the bladder and prostate could be identified. This study reveals that the entire genitourinary system may be mapped using microvesicle transcript analysis and that the majority of non-ribosomal RNA sequences contained in microvesicles is potentially functional non-coding RNA, which play an emerging role in cell regulation.	[Miranda, Kevin C.; Bond, Daniel T.; Brown, Dennis; Russo, Leileata M.] Massachusetts Gen Hosp, Div Nephrol, Program Membrane Biol, Boston, MA 02114 USA; [Miranda, Kevin C.; Bond, Daniel T.; Brown, Dennis; Russo, Leileata M.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Miranda, Kevin C.; Bond, Daniel T.; Brown, Dennis; Russo, Leileata M.] Harvard Univ, Sch Med, Boston, MA USA; [Levin, Joshua Z.; Adiconis, Xian; Sivachenko, Andrey; Russ, Carsten; Nusbaum, Chad] MIT, Broad Inst, Cambridge, MA 02139 USA; [Levin, Joshua Z.; Adiconis, Xian; Sivachenko, Andrey; Russ, Carsten; Nusbaum, Chad] Harvard Univ, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Russo, LM (corresponding author), Massachusetts Gen Hosp, Div Nephrol, Program Membrane Biol, Boston, MA 02114 USA.	Lrusso@mgh.harvard.edu		Levin, Joshua/0000-0002-0170-3598	Juvenile Diabetes Research Foundation [5-2008-722, 10-2006-75]; National Kidney Foundation	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Kidney Foundation	This research was supported by the Juvenile Diabetes Research Foundation International Innovation Award (LMR, KCM) 5-2008-722. LMR Received a Juvenile Diabetes Research Foundation International Transition Award (10-2006-75). KCM received a National Kidney Foundation Postdoctoral Fellowship Award. This work was presented in part at the American Society of Nephrology Annual Meeting. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellingham SA, 2012, NUCLEIC ACIDS RES, V40, P10937, DOI 10.1093/nar/gks832; Bussemakers MJG, 1999, CANCER RES, V59, P5975; Calin GA, 2007, CANCER CELL, V12, P215, DOI 10.1016/j.ccr.2007.07.027; Chung SY, 2011, CANCER SCI, V102, P245, DOI 10.1111/j.1349-7006.2010.01737.x; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Dubbink HJ, 1996, BIOCHEM J, V315, P901, DOI 10.1042/bj3150901; FUSHIMI K, 1993, NATURE, V361, P549, DOI 10.1038/361549a0; Gasparini P, 1997, ANN GENET-PARIS, V40, P227; Gonzales PA, 2009, J AM SOC NEPHROL, V20, P363, DOI 10.1681/ASN.2008040406; GRANGE T, 1987, NUCLEIC ACIDS RES, V15, P4771, DOI 10.1093/nar/15.12.4771; Guduric-Fuchs J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-357; Guescini M, 2010, J NEURAL TRANSM, V117, P1, DOI 10.1007/s00702-009-0288-8; He WW, 1997, GENOMICS, V43, P69, DOI 10.1006/geno.1997.4715; KANEDA Y, 1984, P NATL ACAD SCI-BIOL, V81, P3158, DOI 10.1073/pnas.81.10.3158; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Koide Y, 2009, BBA-GEN SUBJECTS, V1790, P326, DOI 10.1016/j.bbagen.2009.01.012; Lespagnol A, 2008, CELL DEATH DIFFER, V15, P1723, DOI 10.1038/cdd.2008.104; Miranda KC, 2010, KIDNEY INT, V78, P191, DOI 10.1038/ki.2010.106; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ogawa Y, 2013, BIOL PHARM BULL, V36, P66, DOI 10.1248/bpb.b12-00607; PAN BT, 1985, J CELL BIOL, V101, P942, DOI 10.1083/jcb.101.3.942; Pang KC, 2005, NUCLEIC ACIDS RES, V33, pD125, DOI 10.1093/nar/gri089; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Roselli S, 2002, AM J PATHOL, V160, P131, DOI 10.1016/S0002-9440(10)64357-X; SAITO A, 1994, P NATL ACAD SCI USA, V91, P9725, DOI 10.1073/pnas.91.21.9725; Sanchez JC, 1997, ELECTROPHORESIS, V18, P150, DOI 10.1002/elps.1150180127; Sasaki T, 1996, CYTOGENET CELL GENET, V72, P177, DOI 10.1159/000134180; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; TREMBLAY J, 1987, PROSTATE, V10, P235, DOI 10.1002/pros.2990100306; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; WU XR, 1993, J CELL SCI, V106, P31; Yassour M, 2009, P NATL ACAD SCI USA, V106, P3264, DOI 10.1073/pnas.0812841106; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158	35	89	91	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96094	10.1371/journal.pone.0096094	http://dx.doi.org/10.1371/journal.pone.0096094			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816817	Green Submitted, Green Published, gold			2022-12-27	WOS:000336838000023
J	Garrels, W; Holler, S; Taylor, U; Herrmann, D; Niemann, H; Ivics, Z; Kues, WA				Garrels, Wiebke; Holler, Stephanie; Taylor, Ulrike; Herrmann, Doris; Niemann, Heiner; Ivics, Zoltan; Kues, Wilfried A.			Assessment of Fetal Cell Chimerism in Transgenic Pig Lines Generated by Sleeping Beauty Transposition	PLOS ONE			English	Article							MICROCHIMERISM; PREGNANCY; MOUSE; WOMEN; IMPACT; CANCER	Human cells migrate between mother and fetus during pregnancy and persist in the respective host for long-term after birth. Fetal microchimerism occurs also in twins sharing a common placenta or chorion. Whether microchimerism occurs in multiparous mammals such as the domestic pig, where fetuses have separate placentas and chorions, is not well understood. Here, we assessed cell chimerism in litters of wild-type sows inseminated with semen of transposon transgenic boars. Segregation of three independent monomeric transposons ensured an excess of transgenic over non-transgenic offspring in every litter. Transgenic siblings (n = 35) showed robust ubiquitous expression of the reporter transposon encoding a fluorescent protein, and provided an unique resource to assess a potential cell trafficking to non-transgenic littermates (n = 7) or mothers (n = 4). Sensitive flow cytometry, fluorescence microscopy, and real-time PCR provided no evidence for microchimerism in porcine littermates, or piglets and their mothers in both blood and solid organs. These data indicate that the epitheliochorial structure of the porcine placenta effectively prevents cellular exchange during gestation.	[Garrels, Wiebke; Holler, Stephanie; Taylor, Ulrike; Herrmann, Doris; Niemann, Heiner; Kues, Wilfried A.] Friedrich Loeffler Inst, Inst Nutztiergenet, Mariensee, Germany; [Ivics, Zoltan] Paul Ehrlich Inst, Langen, Germany	Friedrich Loeffler Institute; Paul Ehrlich Institute	Kues, WA (corresponding author), Friedrich Loeffler Inst, Inst Nutztiergenet, Mariensee, Germany.	wilfried.kues@fli.bund.de	Kues, Wilfried/AAX-2466-2020; Kues, Wilfried/D-9232-2011	Kues, Wilfried/0000-0002-0850-8103	Deutsche Forschungsgemeinschaft (DFG) [KU-1586/2-1, SPP1313]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Financial support was provided by the Deutsche Forschungsgemeinschaft (DFG) via KU-1586/2-1 and SPP1313 is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner B, 2010, J MOL MED, V88, P653, DOI 10.1007/s00109-010-0610-9; ANDERSON D, 1951, HEREDITY, V5, P379, DOI 10.1038/hdy.1951.38; Axiak-Bechtel SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068114; Bakkour S, 2014, CHIMERISM; Beschorner WE, 2003, ANN SURG, V237, P265, DOI 10.1097/00000658-200302000-00016; BILLINGHAM RE, 1952, HEREDITY, V6, P200, DOI 10.1038/hdy.1952.20; Bogdanova N, 2010, HUM REPROD, V25, P1339, DOI 10.1093/humrep/deq048; BONDURANT RH, 1980, J AM VET MED ASSOC, V177, P1024; Carter AM, 2013, ANNU REV ANIM BIOSCI, V1, P443, DOI 10.1146/annurev-animal-031412-103653; Cirello V, 2008, CANCER RES, V68, P8482, DOI 10.1158/0008-5472.CAN-08-0672; Clifton VL, 2012, PLACENTA, V33, pS37, DOI 10.1016/j.placenta.2011.11.005; Engelhardt H, 1996, NAT IMMUN, V15, P53; Entrican G, 2002, J COMP PATHOL, V126, P79, DOI 10.1053/jcpa.2001.0539; Fujiki Y, 2008, CYTOM PART A, V73A, P111, DOI 10.1002/cyto.a.20533; Fujiki Y, 2009, BIOL REPROD, V81, P26, DOI 10.1095/biolreprod.108.074468; Gadi VK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001706; Gadi VK, 2007, CANCER RES, V67, P9035, DOI 10.1158/0008-5472.CAN-06-4209; Garrels Wiebke, 2012, Biotechniques, V52, DOI 10.2144/000113874; Garrels W, 2012, GENES-BASEL, V3, P615, DOI 10.3390/genes3040615; Garrels W, 2012, TRENDS BIOTECHNOL, V30, P386, DOI 10.1016/j.tibtech.2012.03.008; Garrels W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027563; Garrels W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023573; Ivics Z, 2014, NAT PROTOC, V9, P810, DOI 10.1038/nprot.2014.010; Kallenbach LR, 2011, CANCER RES, V71, P8, DOI 10.1158/0008-5472.CAN-10-0618; Kues WA, 2004, TRENDS BIOTECHNOL, V22, P286, DOI 10.1016/j.tibtech.2004.04.003; Kues WA, 2011, PREV VET MED, V102, P146, DOI 10.1016/j.prevetmed.2011.04.009; Lapaire O, 2007, J MATERN-FETAL NEO M, V20, P1, DOI 10.1080/14767050601144834; Lee ESM, 2010, MOL HUM REPROD, V16, P869, DOI 10.1093/molehr/gaq067; Matsubara K, 2009, TOHOKU J EXP MED, V218, P107, DOI 10.1620/tjem.218.107; McConico A, 2011, REPROD FERT DEVELOP, V23, P297, DOI 10.1071/RD10165; Mold JE, 2012, ADV IMMUNOL, V115, P73, DOI 10.1016/B978-0-12-394299-9.00003-5; Niku M., 2007, BMC VET RES, V3, P29, DOI [DOI 10.1186/1746-6148-3-29, 10.1186/1746-6148-3-29]; Ostensen M, 2012, AUTOIMMUN REV, V11, pA437, DOI 10.1016/j.autrev.2011.11.013; REYNOLDS AG, 1955, OBSTET GYNECOL, V6, P205; Rubin JP, 2001, J SURG RES, V95, P188, DOI 10.1006/jsre.2000.6044; SCHRODER J, 1972, BLOOD-J HEMATOL, V39, P153, DOI 10.1182/blood.V39.2.153.153; Srivatsa B, 2001, LANCET, V358, P2034, DOI 10.1016/S0140-6736(01)07099-4; Steinkraus HB, 2012, J ANIM SCI, V90, P481, DOI 10.2527/jas.2011-4034; Sunami R, 2010, J REPROD IMMUNOL, V84, P117, DOI 10.1016/j.jri.2009.11.006; Tang MX, 2013, THERIOGENOLOGY, V79, P667, DOI 10.1016/j.theriogenology.2012.11.022; Turin Lauretta, 2007, Biotechnology Journal, V2, P486, DOI 10.1002/biot.200600218; Pereira FTV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064399; Vernochet C, 2007, PLACENTA, V28, P639, DOI 10.1016/j.placenta.2006.10.006; Whyte JJ, 2011, MOL REPROD DEV, V78, P879, DOI 10.1002/mrd.21333; Yan Z, 2006, ARTHRITIS RHEUM, V54, P2069, DOI 10.1002/art.21966	45	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96673	10.1371/journal.pone.0096673	http://dx.doi.org/10.1371/journal.pone.0096673			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24811124	Green Published, gold, Green Submitted			2022-12-27	WOS:000338213300059
J	Godoy, PL; Montefeltro, FC; Norell, MA; Langer, MC				Godoy, Pedro L.; Montefeltro, Felipe C.; Norell, Mark A.; Langer, Max C.			An Additional Baurusuchid from the Cretaceous of Brazil with Evidence of Interspecific Predation among Crocodyliformes	PLOS ONE			English	Article							BAURU-BASIN; CROCODYLOMORPHA; MESOEUCROCODYLIA; THEROPODA	A new Baurusuchidae (Crocodyliformes, Mesoeucrocodylia), Aplestosuchus sordidus, is described based on a nearly complete skeleton collected in deposits of the Adamantina Formation (Bauru Group, Late Cretaceous) of Brazil. The nesting of the new taxon within Baurusuchidae can be ensured based on several exclusive skull features of this clade, such as the quadrate depression, medial approximation of the prefrontals, rostral extension of palatines (not reaching the level of the rostral margin of suborbital fenestrae), cylindrical dorsal portion of palatine bar, ridge on the ectopterygoid-jugal articulation, and supraoccipital with restricted thin transversal exposure in the caudalmost part of the skull roof. A newly proposed phylogeny of Baurusuchidae encompasses A. sordidus and recently described forms, suggesting its sixter-taxon relationship to Baurusuchus albertoi, within Baurusuchinae. Additionally, the remains of a sphagesaurid crocodyliform were preserved in the abdominal cavity of the new baurusuchid. Direct fossil evidence of behavioral interaction among fossil crocodyliforms is rare and mostly restricted to bite marks resulting from predation, as well as possible conspecific male-to-male aggression. This is the first time that a direct and unmistaken evidence of predation between different taxa of this group is recorded as fossils. This discovery confirms that baurusuchids were top predators of their time, with sphagesaurids occupying a lower trophic position, possibly with a more generalist diet.	[Godoy, Pedro L.; Langer, Max C.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Biol, Sao Paulo, Brazil; [Godoy, Pedro L.; Norell, Mark A.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Montefeltro, Felipe C.] Univ Estadual Paulista UNESP, Dept Zool, Sao Paulo, Brazil	Universidade de Sao Paulo; American Museum of Natural History (AMNH); Universidade Estadual Paulista	Godoy, PL (corresponding author), Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Biol, Sao Paulo, Brazil.	pedrolorenagodoy@gmail.com	Montefeltro, Felipe Chinaglia/AAQ-4003-2020; Langer, Max C/F-7483-2012; Langer, Max/Y-1753-2019; Montefeltro, Felipe C/L-5780-2015; Godoy, Pedro/E-9526-2014	Montefeltro, Felipe Chinaglia/0000-0001-6519-8546; Langer, Max C/0000-0003-1009-4605; Godoy, Pedro/0000-0003-4519-5094	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/16007-9, 2013/06811-0]; Programa de Pos-Graduacao em Biologia Comparada, FFCLRP-USP; FAPESP [2013/11358-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); FAPESP; Division of Paleontology, American Museum of Natural History	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Programa de Pos-Graduacao em Biologia Comparada, FFCLRP-USP; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Division of Paleontology, American Museum of Natural History	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - grant numbers: 2011/16007-9 and 2013/06811-0), and Programa de Pos-Graduacao em Biologia Comparada, FFCLRP-USP to PLG. FAPESP (grant number: 2013/11358-3) to FCM and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) and FAPESP to MCL. Additional support was provided by the Division of Paleontology, American Museum of Natural History. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avilla LS, 2004, J VERTEBR PALEONTOL, V24, P971, DOI 10.1671/0272-4634(2004)024[0971:BMOACF]2.0.CO;2; Batezelli A., 2010, REV BRAS GEOCIENCIAS, V40, P265; Benton M.J., 1988, Systematics Association Special Volume Series, P295; Boyd CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057605; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Brochu CA, 2003, ANNU REV EARTH PL SC, V31, P357, DOI 10.1146/annurev.earth.31.100901.141308; BUFFETAUT E, 1983, Palaeontologische Zeitschrift, V57, P143; Campos DA, 2011, AN ACAD BRAS CIENC, V83, P317, DOI 10.1590/S0001-37652011000100020; Campos Diogenes de Almeida, 2001, Boletim do Museu Nacional Nova Serie Geologia, V57, P1; Candeiro CRA, 2012, CRETACEOUS RES, V37, P223, DOI 10.1016/j.cretres.2012.04.001; Candeiro CRA, 2010, J S AM EARTH SCI, V29, P346, DOI 10.1016/j.jsames.2009.08.001; Carvalho ID, 2005, GONDWANA RES, V8, P11, DOI 10.1016/S1342-937X(05)70259-8; Carvalho ID, 2011, ZOOTAXA, P19; de Andrade MB, 2008, HIST BIOL, V20, P101, DOI 10.1080/08912960701642949; Farmer CG, 2008, PHYSIOL BIOCHEM ZOOL, V81, P125, DOI 10.1086/524150; de Azevedo RPF, 2013, CRETACEOUS RES, V40, P131, DOI 10.1016/j.cretres.2012.06.004; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Iori FV, 2011, J VERTEBR PALEONTOL, V31, P1255, DOI 10.1080/02724634.2011.602777; Iori Fabiano Vidoi, 2012, Revista Brasileira de Geociencias, V42, P397; Katsura Yoshihiro, 2004, Historical Biology, V16, P93, DOI 10.1080/08912963400015041; Kellner AWA, 2011, ZOOL J LINN SOC-LOND, V163, pS57, DOI 10.1111/j.1096-3642.2011.00712.x; LANGSTON W, 1978, J PALEONTOL, V52, P122; Leanza HA, 2004, CRETACEOUS RES, V25, P61, DOI 10.1016/j.cretres.2003.10.005; Mackness B, 2000, ALCHERINGA, V24, P55, DOI 10.1080/03115510008619523; Marinho TD, 2013, CRETACEOUS RES, V44, P104, DOI 10.1016/j.cretres.2013.03.010; Marinho TS, 2009, J S AM EARTH SCI, V27, P36, DOI 10.1016/j.jsames.2008.11.005; Martin JE, 2013, PALAIOS, V28, P6, DOI 10.2110/palo.2012.p12-068r; Martinelli AG, 2008, CR PALEVOL, V7, P371, DOI 10.1016/j.crpv.2008.05.002; Mendez AH, 2012, CR PALEVOL, V11, P251, DOI 10.1016/j.crpv.2011.12.007; Montefeltro FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021916; Nascimento Paulo Miranda, 2010, Pap. Avulsos Zool. (São Paulo), V50, P323, DOI 10.1590/S0031-10492010002100001; Nesbitt SJ, 2006, BIOL LETT-UK, V2, P611, DOI 10.1098/rsbl.2006.0524; Noto CR, 2012, PALAIOS, V27, P105, DOI 10.2110/palo.2011.p11-052r; Novas F. E., 2009, AGE DINOSAURS S AM; Novas FE, 2009, J VERTEBR PALEONTOL, V29, P1316, DOI 10.1671/039.029.0409; O'Connor PM, 2010, NATURE, V466, P748, DOI 10.1038/nature09061; Osi A, 2014, HIST BIOL, V26, P279, DOI 10.1080/08912963.2013.777533; Pol D, 2003, J VERTEBR PALEONTOL, V23, P817, DOI 10.1671/A1015-7; Prasad Guntupalli V.R., 2002, Annales de Paleontologie, V88, P19, DOI 10.1016/S0753-3969(02)01036-4; Price L.I., 1945, NOTAS PRELIMINARES E, V25, P1; Riff D, 2011, ZOOL J LINN SOC-LOND, V163, pS37, DOI 10.1111/j.1096-3642.2011.00713.x; Santucci RM, 2011, ZOOTAXA, P1; Saunders JC, 2000, SPR HDB AUD, V13, P13; Schwimmer DR., 2002, KING CROCODYLIANS PA; Sellwood BW, 2006, SEDIMENT GEOL, V190, P269, DOI 10.1016/j.sedgeo.2006.05.013; Sereno PC, 2009, ZOOKEYS, P1, DOI 10.3897/zookeys.28.325; SHUTE C. C. D., 1955, PROC ZOOL SOC LONDON, V124, P741; Vasconcellos FM., 2010, B NEW MEXICO MUSEUM, V51, P227; Weaver E G, 1978, REPTILE EAR ITS STRU; WEBB GJW, 1982, AUST J ZOOL, V30, P877, DOI 10.1071/ZO9820877; Whetstone K.N., 1983, OCCASIONAL PAPERS MU, V106, P1, DOI DOI 10.1017/CBO9781107415324.004; WU XC, 1995, NATURE, V376, P678, DOI 10.1038/376678a0; Xing LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044012; Zaher H, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3512[1:ROTCMO]2.0.CO;2	54	46	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e97138	10.1371/journal.pone.0097138	http://dx.doi.org/10.1371/journal.pone.0097138			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809508	Green Published, Green Submitted, gold			2022-12-27	WOS:000338213300124
J	Jiang, DJ; Hong, QX; Shen, YS; Xu, Y; Zhu, HK; Li, YR; Xu, CJ; Ouyang, GF; Duan, SW				Jiang, Danjie; Hong, Qingxiao; Shen, Yusheng; Xu, Yan; Zhu, Huangkai; Li, Yirun; Xu, Chunjing; Ouyang, Guifang; Duan, Shiwei			The Diagnostic Value of DNA Methylation in Leukemia: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; PROMOTER METHYLATION; MYELODYSPLASTIC SYNDROMES; ABERRANT METHYLATION; TUMOR-SUPPRESSOR; B-CELL; HMLH1 PROMOTER; CPG ISLAND; GENE	Background: Accumulating evidence supports a role of DNA methylation in the pathogenesis of leukemia. The aim of our study was to evaluate the potential genes with aberrant DNA methylation in the prediction of leukemia risk by a comprehensive meta-analysis of the published data. Methods: A series of meta-analyses were done among the eligible studies that were harvested after a careful filtration of the searching results from PubMed literature database. Mantel-Haenszel odds ratios and 95% confidence intervals were computed for each methylation event assuming the appropriate model. Results: A total of 535 publications were initially retrieved from PubMed literature database. After a three-step filtration, we harvested 41 case-control articles that studied the role of gene methylation in the prediction of leukemia risk. Among the involving 30 genes, 20 genes were shown to be aberrantly methylated in the leukemia patients. A further subgroup meta-analysis by subtype of leukemia showed that CDKN2A, CDKN2B, ID4 genes were significantly hypermethylated in acute myeloid leukemia. Conclusions: Our meta-analyses identified strong associations between a number of genes with aberrant DNA methylation and leukemia. Further studies should be required to confirm the results in the future.	[Jiang, Danjie; Hong, Qingxiao; Shen, Yusheng; Xu, Yan; Zhu, Huangkai; Li, Yirun; Xu, Chunjing; Duan, Shiwei] Ningbo Univ, Sch Med, Zhejiang Prov Key Lab Pathophysiol, Ningbo 315211, Zhejiang, Peoples R China; [Ouyang, Guifang] Ningbo First Hosp, Dept Hematol, Ningbo, Zhejiang, Peoples R China	Ningbo University	Ouyang, GF (corresponding author), Ningbo First Hosp, Dept Hematol, Ningbo, Zhejiang, Peoples R China.	ouyangguifang2000@aliyun.com; duanshiwei@nbu.edu.cn	Duan, Shiwei/AAA-4782-2022	Duan, Shiwei/0000-0001-7682-2877; Zhu, Huangkai/0000-0002-6809-0837	National Natural Science Foundation of China [31100919, 81371469]; Natural Science Foundation of Zhejiang Province [LR13H020003]; K. C. Wong Magna Fund in Ningbo University; Ningbo Social Development Research Projects [2010C50019, 2012C50032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); K. C. Wong Magna Fund in Ningbo University; Ningbo Social Development Research Projects	The research was supported by the grants from National Natural Science Foundation of China (31100919 and 81371469), Natural Science Foundation of Zhejiang Province (LR13H020003), K. C. Wong Magna Fund in Ningbo University, and Ningbo Social Development Research Projects (2010C50019 and 2012C50032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirre X, 2003, ONCOGENE, V22, P1070, DOI 10.1038/sj.onc.1206236; Agrawal-Singh S, 2012, BLOOD, V119, P2346, DOI 10.1182/blood-2011-06-358705; Balmain A, 2003, NAT GENET, V33, P238, DOI 10.1038/ng1107; Bax L, 2009, AM J EPIDEMIOL, V169, P249, DOI 10.1093/aje/kwn340; Benetatos L, 2011, ANN HEMATOL, V90, P1037, DOI 10.1007/s00277-011-1193-4; Benetatos L, 2010, LEUKEMIA RES, V34, P148, DOI 10.1016/j.leukres.2009.06.019; Capalbo G, 2013, ONCOL REP, V30, P2254, DOI 10.3892/or.2013.2716; Cechova H, 2012, NEOPLASMA, V59, P168, DOI 10.4149/neo_2012_022; Chen C, 2013, GENE DEV, V27, P1974, DOI 10.1101/gad.226613.113; Chen SS, 2011, BLOOD, V117, P862, DOI 10.1182/blood-2010-05-284638; Chim CS, 2005, LEUKEMIA, V19, P2241, DOI 10.1038/sj.leu.2403937; Chim CS, 2004, ANN HEMATOL, V83, P527, DOI 10.1007/s00277-004-0843-1; Christiansen DH, 2003, LEUKEMIA, V17, P1813, DOI 10.1038/sj.leu.2403054; Claus R, 2012, INT J CANCER, V131, pE138, DOI 10.1002/ijc.26429; Deligezer U, 2006, ANN HEMATOL, V85, P102, DOI 10.1007/s00277-005-0041-9; Dellorto MC, 2007, ONCOL REP, V18, P417; Deng G, 2011, ONCOL REP, V25, P367, DOI 10.3892/or.2010.1108; DerSimonian R, 1996, STAT MED, V15, P1237, DOI 10.1002/(SICI)1097-0258(19960630)15:12<1237::AID-SIM301>3.0.CO;2-N; Dou Li-Ping, 2009, Zhonghua Xue Ye Xue Za Zhi, V30, P473; FLODIN U, 1986, ARCH ENVIRON HEALTH, V41, P77, DOI 10.1080/00039896.1986.9937413; Gao Feng, 2006, Zhonghua Xue Ye Xue Za Zhi, V27, P25; Gauffin F, 2009, PEDIATR HEMAT ONCOL, V26, P48, DOI 10.1080/08880010802625530; Hatirnaz M, 2007, AM J HEMATOL, V82, P729, DOI 10.1002/ajh.20886; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hsiao PC, 2008, CHINESE J PHYSIOL, V51, P27; Issa JPJ, 1997, LEUKEMIA, V11, pS7; Iwai M, 2005, LEUKEMIA, V19, P1367, DOI 10.1038/sj.leu.2403805; Jiang DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059752; Jost E, 2009, LEUKEMIA RES, V33, P443, DOI 10.1016/j.leukres.2008.07.027; Kanno S, 2012, INT J ONCOL, V41, P862, DOI 10.3892/ijo.2012.1507; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Li YH, 2002, BLOOD, V100, P2572, DOI 10.1182/blood-2001-11-0026; Liang Ting, 2009, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V34, P388; Lin Dong-Jun, 2008, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V16, P263; Lupo PJ, 2012, CANCER CAUSE CONTROL, V23, P1797, DOI 10.1007/s10552-012-0058-z; Martel V, 1997, BRIT J HAEMATOL, V99, P320, DOI 10.1046/j.1365-2141.1997.3953209.x; Matsushita M, 2005, ONCOL REP, V14, P191; Nakatsuka S, 2003, CANCER SCI, V94, P87, DOI 10.1111/j.1349-7006.2003.tb01357.x; Oka T, 2002, CANCER RES, V62, P6390; Olme CH, 2013, LEUKEMIA RES, V37, P1374, DOI 10.1016/j.leukres.2013.05.019; Otto N, 2011, LEUKEMIA, V25, P1202, DOI 10.1038/leu.2011.61; Pehlivan M, 2009, LEUKEMIA RES, V33, P1062, DOI 10.1016/j.leukres.2008.11.013; Qian Jun, 2010, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V18, P1390; Qian J, 2011, LEUKEMIA RES, V35, P783, DOI 10.1016/j.leukres.2010.10.013; Qian J, 2009, EUR J HAEMATOL, V82, P119, DOI 10.1111/j.1600-0609.2008.01178.x; Rushton L, 2014, BRIT J CANCER, V110, P783, DOI 10.1038/bjc.2013.780; Scott S, 2003, LEUKEMIA RES, V27, P23, DOI 10.1016/S0145-2126(02)00078-4; Seedhouse CH, 2003, LEUKEMIA, V17, P83, DOI 10.1038/sj.leu.2402747; Shanmugam R, 2012, CLIN CANCER RES, V18, P360, DOI 10.1158/1078-0432.CCR-10-3022; Song JJ, 2012, INT J MOL MED, V30, P179, DOI 10.3892/ijmm.2012.970; Wang Xiao-Juan, 2009, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V17, P1405; Wang Xin-Rong, 2010, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V18, P1402; [王焱 Wang Yan], 2011, [中华医学杂志, National Medical Journal of China], V91, P2858; Wang Ye-kai, 2011, Zhonghua Xue Ye Xue Za Zhi, V32, P317; Xiao YH, 2011, J CANCER RES CLIN, V137, P1831, DOI 10.1007/s00432-011-1065-2; Xu Rui-Rong, 2011, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V19, P582; Yalcin A, 2009, INT J LAB HEMATOL, V31, P407, DOI 10.1111/j.1751-553X.2008.01052.x; Yao DM, 2011, LEUKEMIA RES, V35, P957, DOI 10.1016/j.leukres.2010.10.031; Zhang L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052384, 10.1371/journal.pone.0066569]; Zhao Yu, 2008, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V16, P476; Zhao Yu, 2007, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V15, P1156	61	36	44	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96822	10.1371/journal.pone.0096822	http://dx.doi.org/10.1371/journal.pone.0096822			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810788	Green Submitted, Green Published, gold			2022-12-27	WOS:000338213300076
J	Yi, LL; Cheng, D; Shi, HM; Huo, XR; Zhang, K; Zhen, GH				Yi, Lingling; Cheng, Dan; Shi, Huimin; Huo, Xiaorong; Zhang, Kan; Zhen, Guohua			A Meta-Analysis of P2X7 Gene-762T/C Polymorphism and Pulmonary Tuberculosis Susceptibility	PLOS ONE			English	Article							GENE POLYMORPHISMS; EXTRAPULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; P2X(7) GENE; ASSOCIATION; RISK; POPULATION; ACTIVATION; RECEPTOR	Aim: We performed a comprehensive meta-analysis to determine the association between P2X7 -762T/C polymorphism and pulmonary tuberculosis susceptibility. Methodology: Based on comprehensive searches of the PubMed, SCI, Elsevier, China National Knowledge Infrastructure (CNKI) and Wanfang Database, we identified eligible studies about the association between P2X7 -762T/C polymorphism and pulmonary tuberculosis risk. Pooled odds ratio (ORs) and 95% confidence intervals (95% CIs) were calculated in random-effects model. Results: A total of 2207 tuberculosis cases and 2220 controls in 8 case-control studies were included in this meta-analysis. Allele model (C vs. T: p = 0.15; OR = 0.83, 95% CI = 0.65-1.07), homozygous model (CC vs. TT: p = 0.23; OR = 0.73, 95% CI = 0.44 to 1.22), and heterozygous model (CT vs. TT: p = 0.57; OR = 0.92, 95% CI = 0.68 to 1.24) did not show increased risk of developing pulmonary tuberculosis. Similarly, dominant model (CC+CT vs. TT: p = 0.32; OR = 0.84, 95% CI = 0.59 to 1.19) and recessive model (CC vs. CT+TT: p = 0.08; OR = 0.77, 95% CI = 0.57 to 1.04) failed to show increased risk of developing pulmonary tuberculosis. Subgroup analysis by ethnicity did not detect any significant association between P2X7-762T/C polymorphism and pulmonary tuberculosis susceptibility. Conclusions: P2X7 -762T/C gene polymorphism is not associated with pulmonary tuberculosis susceptibility.	[Zhen, Guohua] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Resp & Crit Care Med, Wuhan 430074, Hubei, Peoples R China; Minist Hlth, Key Lab Resp Dis, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology	Zhen, GH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Resp & Crit Care Med, Wuhan 430074, Hubei, Peoples R China.	ghzhen@tjh.tjmu.edu.cn	Zhen, Guohua/HHC-2805-2022		National Natural Science Foundation of China [81170022]; National Key Technology R&D Program of the 12th Five-year Development Plan [2012BAI05B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program of the 12th Five-year Development Plan(National Key Technology R&D Program)	This study was supported by National Natural Science Foundation of China Grant 81170022, and National Key Technology R&D Program of the 12th Five-year Development Plan 2012BAI05B01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azad AK, 2012, INFECT IMMUN, V80, P3343, DOI 10.1128/IAI.00443-12; Bahari G, 2013, GENET MOL RES, V12, P160, DOI 10.4238/2013.January.24.8; Bellamy R, 2003, GENES IMMUN, V4, P4, DOI 10.1038/sj.gene.6363915; Ben-Selma W, 2011, FEMS IMMUNOL MED MIC, V63, P65, DOI 10.1111/j.1574-695X.2011.00824.x; Cohn LD, 2003, PSYCHOL METHODS, V8, P243, DOI 10.1037/1082-989X.8.3.243; Coutinho-Silva R, 2003, IMMUNITY, V19, P403, DOI 10.1016/S1074-7613(03)00235-8; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gong T, 2013, INFECT GENET EVOL, V20, P1, DOI [10.1016/j.meegid.2013.08.001, 10.1016/j.meeg]; Humphreys BD, 2000, J BIOL CHEM, V275, P26792; Kusner DJ, 2001, J IMMUNOL, V167, P3308, DOI 10.4049/jimmunol.167.6.3308; Li CM, 2002, J INFECT DIS, V186, P1458, DOI 10.1086/344351; Li XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015831; Meilang Q, 2012, INT J TUBERC LUNG D, V16, P437, DOI 10.5588/ijtld.10.0743; Mokrousov I, 2008, J MED MICROBIOL, V57, P581, DOI 10.1099/jmm.0.47455-0; Nino-Moreno P, 2007, CLIN EXP IMMUNOL, V148, P469, DOI 10.1111/j.1365-2249.2007.03359.x; Sambasivan V, 2010, DIS MARKERS, V28, P43, DOI [10.3233/DMA-2010-0682, 10.1155/2010/843729]; Singla N, 2012, INT J TUBERC LUNG D, V16, P224, DOI 10.5588/ijtld.11.0076; Sluyter Ronald, 2011, Recent Pat DNA Gene Seq, V5, P41; Songane M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041618; Tekin D, 2010, PEDIATR INFECT DIS J, V29, P779, DOI 10.1097/INF.0b013e3181d9932e; Wu RL, 1999, BIOMETRICS, V55, P355; Wu YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066944; Xiao J, 2010, FEMS IMMUNOL MED MIC, V60, P165, DOI 10.1111/j.1574-695X.2010.00735.x; Xiao J, 2009, FEMS IMMUNOL MED MIC, V55, P107, DOI 10.1111/j.1574-695X.2008.00508.x; Zaman K, 2010, J HEALTH POPUL NUTR, V28, P111; Zhang YG, 2011, ALLERGY, V66, P197, DOI 10.1111/j.1398-9995.2010.02438.x; Zhu H, 2012, GENE, V509, P206, DOI 10.1016/j.gene.2012.08.027; Zumla A, 2013, LANCET, V382, P1765, DOI 10.1016/S0140-6736(13)62078-4	28	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96359	10.1371/journal.pone.0096359	http://dx.doi.org/10.1371/journal.pone.0096359			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810548	Green Published, Green Submitted, gold			2022-12-27	WOS:000338213300032
J	Bartley, CM; O'Keefe, RA; Bordey, A				Bartley, Christopher M.; O'Keefe, Rachel A.; Bordey, Angelique			FMRP S499 Is Phosphorylated Independent of mTORC1-S6K1 Activity	PLOS ONE			English	Article							MENTAL-RETARDATION PROTEIN; FRAGILE-X-SYNDROME; TUBEROUS SCLEROSIS COMPLEX; METABOTROPIC GLUTAMATE RECEPTORS; LONG-TERM DEPRESSION; MESSENGER-RNAS; S6 KINASE; MAMMALIAN TARGET; CELL-SIZE; TRANSLATION	Hyperactive mammalian target of rapamycin (mTOR) is associated with cognitive deficits in several neurological disorders including tuberous sclerosis complex (TSC). The phosphorylation of the mRNA-binding protein FMRP reportedly depends on mTOR complex 1 (mTORC1) activity via p70 S6 kinase 1 (S6K1). Because this phosphorylation is thought to regulate the translation of messages important for synaptic plasticity, we explored whether FMRP phosphorylation of the S6K1-dependent residue (S499) is altered in TSC and states of dysregulated TSC-mTORC1 signaling. Surprisingly, we found that FMRP S499 phosphorylation was unchanged in heterozygous and conditional Tsc1 knockout mice despite significantly elevated mTORC1-S6K1 activity. Neither up- nor down-regulation of the mTORC1-S6K1 axis in vivo or in vitro had any effect on phospho-FMRP S499 levels. In addition, FMRP S499 phosphorylation was unaltered in S6K1-knockout mice. Collectively, these data strongly suggest that FMRP S499 phosphorylation is independent of mTORC1-S6K1 activity and is not altered in TSC.	[Bartley, Christopher M.; O'Keefe, Rachel A.; Bordey, Angelique] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA; [Bartley, Christopher M.; O'Keefe, Rachel A.; Bordey, Angelique] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Bartley, Christopher M.] Yale Univ, Sch Med, Med Scientist Training Program, New Haven, CT USA; [Bartley, Christopher M.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University	Bordey, A (corresponding author), Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA.	angelique.bordey@yale.edu	Bartley, Christopher/HGD-1058-2022	Bartley, Christopher/0000-0002-1391-4130	McKnight Disorder award; NIH [MSTP TG T32GM07205]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS086329] Funding Source: NIH RePORTER	McKnight Disorder award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a McKnight Disorder award (A.B.) and NIH MSTP TG T32GM07205 (C.M.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bernard PB, 2013, NEUROBIOL DIS, V59, P1, DOI 10.1016/j.nbd.2013.06.013; Brackett DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058296; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Ceman S, 2003, HUM MOL GENET, V12, P3295, DOI 10.1093/hmg/ddg350; Cheever A, 2009, RNA, V15, P362, DOI 10.1261/rna.1500809; Chevere-Torres I, 2012, NEUROBIOL DIS, V45, P1101, DOI 10.1016/j.nbd.2011.12.028; Coffee RL, 2012, HUM MOL GENET, V21, P900, DOI 10.1093/hmg/ddr527; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Eberhart DE, 1996, COLD SPRING HARB SYM, V61, P679; Ebert DH, 2013, NATURE, V493, P327, DOI 10.1038/nature11860; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Evans TL, 2010, PROTEIN EXPRES PURIF, V74, P242, DOI 10.1016/j.pep.2010.06.002; Feliciano DM, 2013, INT J DEV NEUROSCI, V31, P667, DOI 10.1016/j.ijdevneu.2013.02.008; Feliciano DM, 2011, J CLIN INVEST, V121, P1596, DOI 10.1172/JCI44909; Goorden SMI, 2007, ANN NEUROL, V62, P648, DOI 10.1002/ana.21317; Hallett Penelope J, 2008, Curr Protoc Neurosci, VChapter 1, DOI 10.1002/0471142301.ns0116s42; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Iliff AJ, 2013, HUM MOL GENET, V22, P1180, DOI 10.1093/hmg/dds525; Joinson C, 2003, PSYCHOL MED, V33, P335, DOI 10.1017/S0033291702007092; Kang A, 2008, NEUR M WASH DC SOC N; Maehama T, 2008, J BIOL CHEM, V283, P35053, DOI 10.1074/jbc.M805822200; Marmy-Conus N, 2002, FEBS LETT, V519, P135, DOI 10.1016/S0014-5793(02)02738-2; Mazroui R, 2003, HUM MOL GENET, V12, P3087, DOI 10.1093/hmg/ddg335; Meyuhas O, 2009, PROG MOL BIOL TRANSL, V90, P109, DOI 10.1016/S1877-1173(09)90003-5; Nalavadi VC, 2012, J NEUROSCI, V32, P2582, DOI 10.1523/JNEUROSCI.5057-11.2012; Narayanan U, 2008, J BIOL CHEM, V283, P18478, DOI 10.1074/jbc.C800055200; Narayanan U, 2007, J NEUROSCI, V27, P14349, DOI 10.1523/JNEUROSCI.2969-07.2007; O'Callaghan FJK, 2004, ARCH DIS CHILD, V89, P530, DOI 10.1136/adc.2003.026815; Pasumarthi KBS, 2000, CIRC RES, V86, P1069, DOI 10.1161/01.RES.86.10.1069; Pearce LR, 2010, BIOCHEM J, V431, P245, DOI 10.1042/BJ20101024; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Potter WB, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001627; Prasad S, 2008, NEUROCHEM RES, V33, P1028, DOI 10.1007/s11064-007-9545-0; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Sharma A, 2010, J NEUROSCI, V30, P694, DOI 10.1523/JNEUROSCI.3696-09.2010; SIMEONE A, 1992, EMBO J, V11, P2541, DOI 10.1002/j.1460-2075.1992.tb05319.x; Singh K, 2008, MOL BIOL REP, V35, P677, DOI 10.1007/s11033-007-9140-0; Siomi MC, 2002, MOL CELL BIOL, V22, P8438, DOI 10.1128/MCB.22.24.8438-8447.2002; Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104; Villasana LE, 2006, J NEUROSCI METH, V158, P30, DOI 10.1016/j.jneumeth.2006.05.008; Wang HS, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00028; Wang H, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-27; Westmark CJ, 2007, PLOS BIOL, V5, P629, DOI 10.1371/journal.pbio.0050052; ZHANG Y, 1995, EMBO J, V14, P5358, DOI 10.1002/j.1460-2075.1995.tb00220.x; Zhao WF, 2011, J NEUROSCI, V31, P725, DOI 10.1523/JNEUROSCI.2915-10.2011	50	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96956	10.1371/journal.pone.0096956	http://dx.doi.org/10.1371/journal.pone.0096956			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806451	Green Published, Green Submitted, gold			2022-12-27	WOS:000335728900121
J	Valiakos, G; Papaspyropoulos, K; Giannakopoulos, A; Birtsas, P; Tsiodras, S; Hutchings, MR; Spyrou, V; Pervanidou, D; Athanasiou, LV; Papadopoulos, N; Tsokana, C; Baka, A; Manolakou, K; Chatzopoulos, D; Artois, M; Yon, L; Hannant, D; Petrovska, L; Hadjichristodoulou, C; Billinis, C				Valiakos, George; Papaspyropoulos, Konstantinos; Giannakopoulos, Alexios; Birtsas, Periklis; Tsiodras, Sotirios; Hutchings, Michael R.; Spyrou, Vassiliki; Pervanidou, Danai; Athanasiou, Labrini V.; Papadopoulos, Nikolaos; Tsokana, Constantina; Baka, Agoritsa; Manolakou, Katerina; Chatzopoulos, Dimitrios; Artois, Marc; Yon, Lisa; Hannant, Duncan; Petrovska, Liljana; Hadjichristodoulou, Christos; Billinis, Charalambos			Use of Wild Bird Surveillance, Human Case Data and GIS Spatial Analysis for Predicting Spatial Distributions of West Nile Virus in Greece	PLOS ONE			English	Article							NEUTRALIZING ANTIBODIES; EXPERIMENTAL-INFECTION; NEW-YORK; INDIANAPOLIS; ASSOCIATION; PREVALENCE; COUNTY	West Nile Virus (WNV) is the causative agent of a vector-borne, zoonotic disease with a worldwide distribution. Recent expansion and introduction of WNV into new areas, including southern Europe, has been associated with severe disease in humans and equids, and has increased concerns regarding the need to prevent and control future WNV outbreaks. Since 2010, 524 confirmed human cases of the disease have been reported in Greece with greater than 10% mortality. Infected mosquitoes, wild birds, equids, and chickens have been detected and associated with human disease. The aim of our study was to establish a monitoring system with wild birds and reported human cases data using Geographical Information System (GIS). Potential distribution of WNV was modelled by combining wild bird serological surveillance data with environmental factors (e. g. elevation, slope, land use, vegetation density, temperature, precipitation indices, and population density). Local factors including areas of low altitude and proximity to water were important predictors of appearance of both human and wild bird cases (Odds Ratio = 1,001 95% CI = 0,723-1,386). Using GIS analysis, the identified risk factors were applied across Greece identifying the northern part of Greece (Macedonia, Thrace) western Greece and a number of Greek islands as being at highest risk of future outbreaks. The results of the analysis were evaluated and confirmed using the 161 reported human cases of the 2012 outbreak predicting correctly (Odds = 130/31 = 4,194 95% CI = 2,841-6,189) and more areas were identified for potential dispersion in the following years. Our approach verified that WNV risk can be modelled in a fast cost-effective way indicating high risk areas where prevention measures should be implemented in order to reduce the disease incidence.	[Valiakos, George; Papaspyropoulos, Konstantinos; Giannakopoulos, Alexios; Athanasiou, Labrini V.; Tsokana, Constantina; Manolakou, Katerina; Chatzopoulos, Dimitrios; Billinis, Charalambos] Univ Thessaly, Fac Vet Med, Kardhitsa, Greece; [Valiakos, George; Billinis, Charalambos] Inst Res & Technol Thessaly, Dept Biomed, Ctr Res & Technol Hellas, Larisa, Greece; [Papaspyropoulos, Konstantinos] Hunting Federat Macedonia & Thrace, Div Res, Thessaloniki, Greece; [Birtsas, Periklis; Spyrou, Vassiliki] Technol Educ Inst Thessaly, Larisa, Greece; [Tsiodras, Sotirios; Pervanidou, Danai] Minist Hlth, Hellen Ctr Dis Control & Prevent, Athens, Greece; [Tsiodras, Sotirios] Univ Athens, Fac Med, Athens 11528, Greece; [Hutchings, Michael R.] SRUC, Edinburgh, Midlothian, Scotland; [Papadopoulos, Nikolaos] Univ Thessaly, Dept Agr Crop Prod & Rural Environm, Volos, Greece; [Artois, Marc] Univ Lyon, VetAgro Sup, Lyon, France; [Yon, Lisa; Hannant, Duncan] Univ Nottingham, Sch Vet Med & Sci, Nottingham NG7 2RD, England; [Petrovska, Liljana] Anim Hlth & Vet Labs Agcy Weybridge, Addlestone, Surrey, England; [Hadjichristodoulou, Christos] Univ Thessaly, Fac Med, Larisa, Greece	University of Thessaly; Centre for Research & Technology Hellas; National & Kapodistrian University of Athens; University of Thessaly; VetAgro Sup; University of Nottingham; Veterinary Laboratories Agency; University of Thessaly	Billinis, C (corresponding author), Univ Thessaly, Fac Vet Med, Kardhitsa, Greece.	billinis@vet.uth.gr	Chatzopoulos, Dimitrios/AAN-2180-2021; Chatzopoulos, Dimitrios/AAH-1204-2019; Petrovska, Liljana/D-7319-2011; Papadopoulos, Nikos/AAJ-1721-2020; Papaspyropoulos, Konstantinos/CAF-7819-2022; TSIODRAS, SOTIRIOS/AAD-8273-2019; Hutchings, Mike/P-6836-2019; Tsokana, Constantina/AAY-5551-2020; ATHANASIOU, LABRINI/H-7463-2019; Yon, Lisa K/G-4453-2011; Valiakos, George/C-5328-2011; Hannant, Duncan/G-4185-2011; N.G., Papadopoulos/L-8670-2013; Athanasiou, Labrini V/AAI-2744-2020	Chatzopoulos, Dimitrios/0000-0003-1400-7599; Papadopoulos, Nikos/0000-0003-2480-8189; Papaspyropoulos, Konstantinos/0000-0002-9661-7827; TSIODRAS, SOTIRIOS/0000-0002-0463-4321; Tsokana, Constantina/0000-0003-4180-6310; Yon, Lisa K/0000-0002-9765-3192; Valiakos, George/0000-0002-3869-5026; Hannant, Duncan/0000-0003-0792-7418; N.G., Papadopoulos/0000-0002-4448-3468; Athanasiou, Labrini V/0000-0001-8723-2629; Hadjichristodoulou, Christos/0000-0002-4769-8376; Hutchings, Mike/0000-0003-3338-471X	European Union [222633]; Integrated Surveillance and control programme for West Nile Virus and malaria in Greece - NSRF (National Strategic Reference Framework)	European Union(European Commission); Integrated Surveillance and control programme for West Nile Virus and malaria in Greece - NSRF (National Strategic Reference Framework)	The research leading to these results received partial funding from the European Union Seventh Framework Programme (2007-2013) under grant agreement no. 222633 (WildTech). This project was also co-funded by the Integrated Surveillance and control programme for West Nile Virus and malaria in Greece funded by NSRF (National Strategic Reference Framework) 2007-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bian L, 2006, GISCI REMOTE SENS, V43, P128, DOI 10.2747/1548-1603.43.2.128; Bowman C, 2005, B MATH BIOL, V67, P1107, DOI 10.1016/j.bulm.2005.01.002; Brownstein JS, 2002, VECTOR-BORNE ZOONOT, V2, P157, DOI 10.1089/15303660260613729; Bunning ML, 2002, EMERG INFECT DIS, V8, P380; Cooke William H 3rd, 2006, Int J Health Geogr, V5, P36, DOI 10.1186/1476-072X-5-36; Crowder DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055006; Cruz-Pacheco G, 2005, B MATH BIOL, V67, P1157, DOI 10.1016/j.bulm.2004.11.008; Gibbs SEJ, 2006, VECTOR-BORNE ZOONOT, V6, P73, DOI 10.1089/vbz.2006.6.73; Hair J.F., 2010, MULTIVARIANT DATA AN, V7th; Handrinos G., 1997, THE BIRDS OF GREECE; Hellenic Centre for Disease Control and Prevention - HCDCP, 2013, W NIL VIR EP GREEC; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jourdain E, 2008, J WILDLIFE DIS, V44, P766, DOI 10.7589/0090-3558-44.3.766; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; Konrad SK, 2009, VECTOR-BORNE ZOONOT, V9, P267, DOI 10.1089/vbz.2008.0084; Lelli R, 2012, TRANSBOUND EMERG DIS, V59, P421, DOI 10.1111/j.1865-1682.2011.01287.x; Liu H, 2008, ENVIRON MONIT ASSESS, V144, P199, DOI 10.1007/s10661-007-9979-5; Liu H, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-66; Lopez G, 2008, VECTOR-BORNE ZOONOT, V8, P615, DOI 10.1089/vbz.2007.0200; Malkinson M, 2002, EMERG INFECT DIS, V8, P392, DOI 10.3201/eid0804.010217; Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0; Norusis M, 2011, SPSS 19 0 BASE; Ozdenerol E, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-12; Patnaik JL, 2007, EMERG INFECT DIS, V13, P1788, DOI 10.3201/eid1311.070506; Rappole JH, 2000, EMERG INFECT DIS, V6, P319, DOI 10.3201/eid0604.000401; Rochlin I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023280; Rodriguez-Prieto V, 2012, EPIDEMIOL INFECT, V140, P1617, DOI 10.1017/S0950268811002366; Ruiz MO, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-10; Ruiz Marilyn O, 2004, Int J Health Geogr, V3, P8, DOI 10.1186/1476-072X-3-8; Tachiiri Kaoru, 2006, Int J Health Geogr, V5, P21; Valiakos G, 2011, EURO SURVEILL, V16; Valiakos G, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-266; Valiakos G, 2012, EUR J WILDLIFE RES, V58, P749, DOI 10.1007/s10344-011-0603-1; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Warton DI, 2010, ANN APPL STAT, V4, P1383, DOI 10.1214/10-AOAS331	37	31	32	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96935	10.1371/journal.pone.0096935	http://dx.doi.org/10.1371/journal.pone.0096935			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806216	Green Submitted, Green Published, gold			2022-12-27	WOS:000335728900119
J	Basquin, D; Spierer, A; Begeot, F; Koryakov, DE; Todeschini, AL; Ronsseray, S; Vieira, C; Spierer, P; Delattre, M				Basquin, Denis; Spierer, Anne; Begeot, Flora; Koryakov, Dmitry E.; Todeschini, Anne-Laure; Ronsseray, Stephane; Vieira, Cristina; Spierer, Pierre; Delattre, Marion			The Drosophila Su(var)3-7 Gene Is Required for Oogenesis and Female Fertility, Genetically Interacts with piwi and aubergine, but Impacts Only Weakly Transposon Silencing	PLOS ONE			English	Article							POSITION-EFFECT VARIEGATION; PRIMARY PIRNA BIOGENESIS; TUDOR-DOMAIN PROTEIN; WIDE RNAI SCREEN; DROSOPHILA-MELANOGASTER; HYBRID DYSGENESIS; P-ELEMENTS; HETEROCHROMATIN FORMATION; POLYTENE CHROMOSOMES; CHROMATIN	Heterochromatin is made of repetitive sequences, mainly transposable elements (TEs), the regulation of which is critical for genome stability. We have analyzed the role of the heterochromatin-associated Su(var) 3-7 protein in Drosophila ovaries. We present evidences that Su(var) 3-7 is required for correct oogenesis and female fertility. It accumulates in heterochromatic domains of ovarian germline and somatic cells nuclei, where it co-localizes with HP1. Homozygous mutant females display ovaries with frequent degenerating egg-chambers. Absence of Su(var) 3-7 in embryos leads to defects in meiosis and first mitotic divisions due to chromatin fragmentation or chromosome loss, showing that Su(var) 3-7 is required for genome integrity. Females homozygous for Su(var) 3-7 mutations strongly impair repression of P-transposable element induced gonadal dysgenesis but have minor effects on other TEs. Su(var) 3-7 mutations reduce piRNA cluster transcription and slightly impact ovarian piRNA production. However, this modest piRNA reduction does not correlate with transposon de-silencing, suggesting that the moderate effect of Su(var) 3-7 on some TE repression is not linked to piRNA production. Strikingly, Su(var) 3-7 genetically interacts with the piwi and aubergine genes, key components of the piRNA pathway, by strongly impacting female fertility without impairing transposon silencing. These results lead us to propose that the interaction between Su(var) 3-7 and piwi or aubergine controls important developmental processes independently of transposon silencing.	[Basquin, Denis; Spierer, Anne; Begeot, Flora; Spierer, Pierre; Delattre, Marion] Univ Geneva, Dept Genet & Evolut, Geneva, Switzerland; [Koryakov, Dmitry E.] SB RAS, Inst Mol & Cellular Biol, Novosibirsk, Russia; [Todeschini, Anne-Laure; Ronsseray, Stephane] Univ Paris 06, CNRS, Lab Biol Dev, UMR7622, Paris, France; [Vieira, Cristina] Univ Lyon 1, Lab Biometr & Biol Evolut, UMR5558, F-69622 Villeurbanne, France; [Vieira, Cristina] Inst Univ France, Paris, France	University of Geneva; Russian Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Institut Universitaire de France	Spierer, P (corresponding author), Univ Geneva, Dept Genet & Evolut, Geneva, Switzerland.	Pierre.spierer@unige.ch	Koryakov, Dmitry E/N-4934-2015; Ronsseray, Stephane/AAD-6378-2021; Vieira, Cristina/Q-3137-2017	Vieira, Cristina/0000-0003-3414-3993; Koryakov, Dmitry/0000-0001-7365-5583	Swiss National Science Foundation; State of Geneva; Program of presidium RAS Molecular and Cellular Biology [6.3]; ANR Genemobile; CNRS;  [RFBR-12-0400160]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); State of Geneva; Program of presidium RAS Molecular and Cellular Biology; ANR Genemobile(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); 	DB, AS, FB, PS and MD were supported by the Swiss National Science Foundation and the State of Geneva. DK was supported by grant RFBR-12-0400160, and grant 6.3 of the Program of presidium RAS Molecular and Cellular Biology. CV was supported by the ANR Genemobile and by the CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand A, 2012, EMBO J, V31, P870, DOI 10.1038/emboj.2011.449; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; BUCHETON A, 1984, CELL, V38, P153, DOI 10.1016/0092-8674(84)90536-1; Chen Y, 2007, CURR BIOL, V17, P637, DOI 10.1016/j.cub.2007.02.027; CLEARD F, 1995, NUCLEIC ACIDS RES, V23, P796, DOI 10.1093/nar/23.5.796; Cleard F, 2001, EMBO REP, V2, P1095, DOI 10.1093/embo-reports/kve243; Cleard F, 1997, EMBO J, V16, P5280, DOI 10.1093/emboj/16.17.5280; Cox DN, 2000, DEVELOPMENT, V127, P503; Czech B, 2013, MOL CELL, V50, P749, DOI 10.1016/j.molcel.2013.04.007; Delattre M, 2000, J CELL SCI, V113, P4253; Eissenberg JC, 2009, INT REV CEL MOL BIO, V273, P1, DOI 10.1016/S1937-6448(08)01801-7; Findley SD, 2003, DEVELOPMENT, V130, P859, DOI 10.1242/dev.00310; Handler D, 2013, MOL CELL, V50, P762, DOI 10.1016/j.molcel.2013.04.031; HEARN MG, 1991, GENETICS, V128, P785; Huang XA, 2013, DEV CELL, V24, P502, DOI 10.1016/j.devcel.2013.01.023; Johansson AM, 2007, EMBO J, V26, P2307, DOI 10.1038/sj.emboj.7601604; Juliano C, 2011, ANNU REV GENET, V45, P447, DOI 10.1146/annurev-genet-110410-132541; Khurana JS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001246; KIDWELL MG, 1977, GENETICS, V86, P813; KING RC, 1981, SCIENCE, V212, P441, DOI 10.1126/science.6782674; Klattenhoff C, 2009, CELL, V138, P1137, DOI 10.1016/j.cell.2009.07.014; Klenov MS, 2007, NUCLEIC ACIDS RES, V35, P5430, DOI 10.1093/nar/gkm576; Koryakov DE, 2003, DROSOPHILA CYTOGENET, P139; Koryakov DE, 2006, CHROMOSOMA, V115, P296, DOI 10.1007/s00412-005-0044-2; Le Thomas A, 2013, GENE DEV, V27, P390, DOI 10.1101/gad.209841.112; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Lim AK, 2007, P NATL ACAD SCI USA, V104, P6714, DOI 10.1073/pnas.0701920104; Liu L, 2011, DEVELOPMENT, V138, P1863, DOI 10.1242/dev.059287; Loppin B, 2001, DEV BIOL, V231, P383, DOI 10.1006/dbio.2000.0152; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Mani SR, 2013, MOL REPROD DEV, V80, P632, DOI 10.1002/mrd.22195; Mani SR, 2013, DEV BIOL; Marin L, 2000, GENETICS, V155, P1841; Mathe E, 2003, DROSOPHILA CYTOGENET, P89; Moshkovich N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000880; Muerdter F, 2013, MOL CELL, V50, P736, DOI 10.1016/j.molcel.2013.04.006; Niemi JB, 2004, GENETICS, V166, P255, DOI 10.1534/genetics.166.1.255; Olivieri D, 2010, EMBO J, V29, P3301, DOI 10.1038/emboj.2010.212; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; Pane A, 2011, EMBO J, V30, P4601, DOI 10.1038/emboj.2011.334; Patil VS, 2010, CURR BIOL, V20, P724, DOI 10.1016/j.cub.2010.02.046; Rangan P, 2011, CURR BIOL, V21, P1373, DOI 10.1016/j.cub.2011.06.057; Ronsseray S, 1996, GENETICS, V143, P1663; RONSSERAY S, 1991, GENETICS, V129, P501; Rouget C, 2010, NATURE, V467, P1128, DOI 10.1038/nature09465; Rozhkov NV, 2013, GENE DEV, V27, P400, DOI 10.1101/gad.209767.112; SCHAEFER RE, 1979, GENETICS, V92, P1141; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; SCHUPBACH T, 1991, GENETICS, V129, P1119; Seum C, 2002, GENETICS, V161, P1125; Sienski G, 2012, CELL, V151, P964, DOI 10.1016/j.cell.2012.10.040; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Spierer A, 2005, J CELL SCI, V118, P5047, DOI 10.1242/jcs.02623; Todeschini AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011032; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang SH, 2011, P NATL ACAD SCI USA, V108, P21164, DOI 10.1073/pnas.1107892109	59	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96802	10.1371/journal.pone.0096802	http://dx.doi.org/10.1371/journal.pone.0096802			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24820312	Green Published, gold			2022-12-27	WOS:000336653300032
J	Yin, ZG; Li, L; Cui, M; Zhou, SM; Yu, MM; Zhou, HD				Yin, Ze-Gang; Li, Ling; Cui, Min; Zhou, Shi-Ming; Yu, Ming-Ming; Zhou, Hua-Dong			Inverse Relationship between Apolipoprotein A-I and Cerebral White Matter Lesions: A Cross-Sectional Study in Middle-Aged and Elderly Subjects	PLOS ONE			English	Article							SMALL-VESSEL DISEASE; DENSITY-LIPOPROTEIN-CHOLESTEROL; VASCULAR RISK-FACTORS; METABOLIC SYNDROME; STROKE; BRAIN; HYPERINTENSITIES; MRI; ATHEROSCLEROSIS; LEUKOARAIOSIS	Background: Apolipoprotein A-I (apoA-I), the major protein for high density lipoprotein, is essential for reverse cholesterol transport. Decreased serum levels of apoA-I have been reported to correlate with subcortical infarction and dementia, both of which are highly related to white matter lesions (WMLs). However, the association between apoA-I and WMLs has never been investigated. In this study, we sought to investigate the association between apoA-I and the presence of WMLs in middle-aged and elderly subjects. Methods: Consecutive patients aged 50 years and older of our department were prospectively enrolled in this study (n = 1282, 606 men and 676 women, 65.96 +/- 9.4 years). All participants underwent MRI scans to assess the presence and severity of WMLs. Multivariate logistic regression analyses were performed to examine the association of apoA-I with WMLs. Results: Patients with WMLs were older and showed significantly higher proportion of male sex, hypertension, diabetes mellitus, previous stroke, and coronary heart disease whereas levels of total cholesterol, high density lipoprotein cholesterol, and apoA-I were lower. After adjustment for potential confounders, the lowest apoA-I quartile was independently associated with an increased risk of WMLs (odds ratio: 1.87, 95% confidence interval: 1.29-2.72). In sex-specific analyses, this relationship was observed only in women. Conclusions: Our findings demonstrated that apoA-I was inversely associated with the presence of WMLs in middle-aged and elderly subjects. This results suggest that therapies which increase apoA-I concentration may be beneficial to reduce the risk of WMLs, dementia and stroke.	[Yin, Ze-Gang; Li, Ling; Zhou, Shi-Ming; Yu, Ming-Ming; Zhou, Hua-Dong] Third Mil Med Univ, Daping Hosp & Inst Field Surg, Dept Neurol, Chongqing, Peoples R China; [Cui, Min] Wuhan Gen Hosp PLA, Dept Neurol, Wuhan, Hunan, Peoples R China	Army Medical University	Zhou, HD (corresponding author), Third Mil Med Univ, Daping Hosp & Inst Field Surg, Dept Neurol, Chongqing, Peoples R China.	zhouhuad@163.com		Yin, Ze-Gang/0000-0001-7578-0732	National Natural Science Foundation of China [30870860]; Chongqing Science and Technology Commission (CSTC) [2010AB5106]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Science and Technology Commission (CSTC)(Natural Science Foundation Project of CQ CSTC)	This study was supported by grants from the National Natural Science Foundation of China (No. 30870860) and Chongqing Science and Technology Commission (CSTC, 2010AB5106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Sabin J, 2007, STROKE, V38, P1076, DOI 10.1161/01.STR.0000258075.58283.8f; Amarenco P, 2008, ATHEROSCLEROSIS, V196, P489, DOI 10.1016/j.atherosclerosis.2007.07.033; Amarenco P, 2009, LANCET NEUROL, V8, P453, DOI 10.1016/S1474-4422(09)70058-4; BRETELER MMB, 1994, NEUROLOGY, V44, P1246, DOI 10.1212/WNL.44.7.1246; Brisset M, 2013, NEUROLOGY, V80, P662, DOI 10.1212/WNL.0b013e318281ccc2; Chao LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065175; Choi HS, 2009, CLIN ENDOCRINOL, V71, P184, DOI 10.1111/j.1365-2265.2008.03444.x; Crisby M, 2010, CURR ALZHEIMER RES, V7, P534, DOI 10.2174/156720510792231694; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; Farrall AJ, 2009, NEUROBIOL AGING, V30, P337, DOI 10.1016/j.neurobiolaging.2007.07.015; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Fornage M, 2008, STROKE, V39, P1952, DOI 10.1161/STROKEAHA.107.508135; Gouw AA, 2011, J NEUROL NEUROSUR PS, V82, P126, DOI 10.1136/jnnp.2009.204685; Gurol ME, 2013, ANN NEUROL, V73, P529, DOI 10.1002/ana.23830; Holme I, 2009, J INTERN MED, V265, P275, DOI 10.1111/j.1365-2796.2008.02016.x; Jalal FY, 2012, STROKE, V43, P1115, DOI 10.1161/STROKEAHA.111.643080; Jickling G, 2009, STROKE, V40, P3191, DOI 10.1161/STROKEAHA.109.554527; Jimenez-Conde J, 2010, STROKE, V41, P437, DOI 10.1161/STROKEAHA.109.563502; Kuo HK, 2010, INT J CARDIOL, V143, P184, DOI 10.1016/j.ijcard.2009.02.005; Lefterov I, 2010, J BIOL CHEM, V285, P36945, DOI 10.1074/jbc.M110.127738; Marcovina S, 2006, J INTERN MED, V259, P437, DOI 10.1111/j.1365-2796.2006.01648.x; Markus HS, 2005, STROKE, V36, P1410, DOI 10.1161/01.STR.0000169924.60783.d4; Merched A, 2000, NEUROBIOL AGING, V21, P27, DOI 10.1016/S0197-4580(99)00103-7; Murray AD, 2005, RADIOLOGY, V237, P251, DOI 10.1148/radiol.2371041496; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Pantoni L, 2005, NEUROEPIDEMIOLOGY, V24, P51, DOI 10.1159/000081050; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Park JH, 2013, EUR J NEUROL, V20, P671, DOI 10.1111/ene.12021; Park K, 2007, NEUROLOGY, V69, P974, DOI 10.1212/01.wnl.0000266562.54684.bf; Paula-Lima AC, 2009, INT J BIOCHEM CELL B, V41, P1361, DOI 10.1016/j.biocel.2008.12.003; Poggesi A, 2011, CEREBROVASC DIS, V32, P577, DOI 10.1159/000334498; Reynolds CA, 2010, J AM GERIATR SOC, V58, P501, DOI 10.1111/j.1532-5415.2010.02739.x; Romero JR, 2009, STROKE, V40, P1590, DOI 10.1161/STROKEAHA.108.535245; Saczynski JS, 2007, AM J EPIDEMIOL, V165, P985, DOI 10.1093/aje/kwm027; Schmidt R, 1997, J NEUROL SCI, V152, P15, DOI 10.1016/S0022-510X(97)00137-8; Sniderman AD, 2003, LANCET, V361, P777, DOI 10.1016/S0140-6736(03)12663-3; Tang CR, 2009, J BIOL CHEM, V284, P32336, DOI 10.1074/jbc.M109.047472; Tirschwell DL, 2004, NEUROLOGY, V63, P1868, DOI 10.1212/01.WNL.0000144282.42222.DA; van Dijk EJ, 2005, CIRCULATION, V112, P900, DOI 10.1161/CIRCULATIONAHA.104.506337; Zhu XW, 2012, ANNU REV NUTR, V32, P161, DOI 10.1146/annurev-nutr-071811-150709	40	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97113	10.1371/journal.pone.0097113	http://dx.doi.org/10.1371/journal.pone.0097113			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24820970	Green Submitted, Green Published, gold			2022-12-27	WOS:000336653300077
J	Bouleftour, W; Boudiffa, M; Wade-Gueye, NM; Bouet, G; Cardelli, M; Laroche, N; Vanden-Bossche, A; Thomas, M; Bonnelye, E; Aubin, JE; Vico, L; Lafage-Proust, MH; Malaval, L				Bouleftour, Wafa; Boudiffa, Maya; Wade-Gueye, Ndeye Marieme; Bouet, Guenaelle; Cardelli, Marco; Laroche, Norbert; Vanden-Bossche, Arnaud; Thomas, Mireille; Bonnelye, Edith; Aubin, Jane E.; Vico, Laurence; Lafage-Proust, Marie Helene; Malaval, Luc			Skeletal Development of Mice Lacking Bone Sialoprotein (BSP) - Impairment of Long Bone Growth and Progressive Establishment of High Trabecular Bone Mass	PLOS ONE			English	Article							OSTEOPONTIN; PLATE; OSTEOCLASTOGENESIS; CHONDROCYTES; ARCHITECTURE; DEFECTS	Adult Ibsp-knockout mice (BSP-/-) display shorter stature, lower bone turnover and higher trabecular bone mass than wild type, the latter resulting from impaired bone resorption. Unexpectedly, BSP knockout also affects reproductive behavior, as female mice do not construct a proper "nest" for their offsprings. Multiple crossing experiments nonetheless indicated that the shorter stature and lower weight of BSP-/- mice, since birth and throughout life, as well as their shorter femur and tibia bones are independent of the genotype of the mothers, and thus reflect genetic inheritance. In BSP-/- newborns, mu CT analysis revealed a delay in membranous primary ossification, with wider cranial sutures, as well as thinner femoral cortical bone and lower tissue mineral density, reflected in lower expression of bone formation markers. However, trabecular bone volume and osteoclast parameters of long bones do not differ between genotypes. Three weeks after birth, osteoclast number and surface drop in the mutants, concomitant with trabecular bone accumulation. The growth plates present a thinner hypertrophic zone in newborns with lower whole bone expression of IGF-1 and higher IHH in 6 days old BSP-/- mice. At 3 weeks the proliferating zone is thinner and the hypertrophic zone thicker in BSP-/- than in BSP+/+ mice of either sex, maybe reflecting a combination of lower chondrocyte proliferation and impaired cartilage resorption. Six days old BSP-/- mice display lower osteoblast marker expression but higher MEPE and higher osteopontin(Opn)/Runx2 ratio. Serum Opn is higher in mutants at day 6 and in adults. Thus, lack of BSP alters long bone growth and membranous/cortical primary bone formation and mineralization. Endochondral development is however normal in mutant mice and the accumulation of trabecular bone observed in adults develops progressively in the weeks following birth. Compensatory high Opn may allow normal endochondral development in BSP-/- mice, while impairing primary mineralization.	[Bouleftour, Wafa; Boudiffa, Maya; Wade-Gueye, Ndeye Marieme; Bouet, Guenaelle; Laroche, Norbert; Vanden-Bossche, Arnaud; Thomas, Mireille; Vico, Laurence; Lafage-Proust, Marie Helene; Malaval, Luc] Univ St Etienne, Lab Biol Tissu Osseux, St Etienne, France; [Bouleftour, Wafa; Boudiffa, Maya; Wade-Gueye, Ndeye Marieme; Bouet, Guenaelle; Laroche, Norbert; Vanden-Bossche, Arnaud; Thomas, Mireille; Vico, Laurence; Lafage-Proust, Marie Helene; Malaval, Luc] Univ St Etienne, Univ Lyon, Inst Natl Sante & Rech Med, U1059, St Etienne, France; [Cardelli, Marco; Aubin, Jane E.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Bonnelye, Edith] Univ Lyon 1, Inst Natl Sante & Rech Med, U1033, F-69365 Lyon, France	Universite Jean Monnet; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; University of Toronto; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Malaval, L (corresponding author), Univ St Etienne, Lab Biol Tissu Osseux, St Etienne, France.	luc.malaval@univ-st-etienne.fr	Malaval, Luc/K-3060-2019; Malaval, Luc/D-2206-2011; Vico, Laurence/O-1927-2018; Vico, Laurence/ABG-7239-2020; Bonnelye, Edith/AAT-9134-2021	Malaval, Luc/0000-0002-8640-2646; Malaval, Luc/0000-0002-8640-2646; Vico, Laurence/0000-0002-2110-287X; Vico, Laurence/0000-0002-2110-287X; Aubin, Jane E./0000-0002-7268-5235; Boudiffa, Maya/0000-0001-8346-6874; Lafage-Proust, Marie-Helene/0000-0002-2091-3961; Bouleftour, Wafa/0000-0002-8485-9386	Canadian Institutes of Health Research [FRN83704]; French "Institut National de la Sante et de la Recherche Medicale" (INSERM); french Ministry of Research; Rhone-Alpes Region; Societe Francaise de Rhumatologie	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); French "Institut National de la Sante et de la Recherche Medicale" (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); french Ministry of Research(Ministry of Research, FranceEuropean Commission); Rhone-Alpes Region(Region Auvergne-Rhone-Alpes); Societe Francaise de Rhumatologie	This work was funded by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca,FRN83704toJEA) and by the French "Institut National de la Sante et de la Recherche Medicale" (INSERM, http://www.inserm.fr). The authors gratefully acknowledge support from the french Ministry of Research (http://www. enseignementsup-recherche.gouv.fr,scholarshipsforMB,NMWG,GB), the Rhone-Alpes Region (http://www.rhonealpes.fr,including scholarshipforWBandtravelgrantforMB) and the "Societe Francaise de Rhumatologie" (http://sfr.larhumatologie.fr,including scholarshipforNMWG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellahcene A, 2000, CIRC RES, V86, P885, DOI 10.1161/01.RES.86.8.885; Boskey AL, 2002, CALCIFIED TISSUE INT, V71, P145, DOI 10.1007/s00223-001-1121-z; Boudiffa M, 2010, J BONE MINER RES, V25, P2393, DOI 10.1002/jbmr.245; CHEN JK, 1992, J BONE MINER RES, V7, P987; David V, 2003, J BONE MINER RES, V18, P1622, DOI 10.1359/jbmr.2003.18.9.1622; Fisher LW, 2003, CONNECT TISSUE RES, V44, P33, DOI 10.1080/03008200390152061; Ganss B, 1999, CRIT REV ORAL BIOL M, V10, P79, DOI 10.1177/10454411990100010401; Gorski JP, 2004, J BIOL CHEM, V279, P25455, DOI 10.1074/jbc.M312408200; Harmey D, 2006, J BONE MINER RES, V21, P1377, DOI 10.1359/JBMR.060619; Hess SE, 2008, J AM ASSOC LAB ANIM, V47, P25; HUNTER GK, 1994, BIOCHEM J, V302, P175, DOI 10.1042/bj3020175; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lazic SE, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-37; Long FX, 2006, DEV BIOL, V298, P327, DOI 10.1016/j.ydbio.2006.06.042; Lv K, 2010, INT J BIOL SCI, V6, P537; Malaval L, 2008, J EXP MED, V205, P1145, DOI 10.1084/jem.20071294; Malaval L, 2009, BONE, V45, P853, DOI 10.1016/j.bone.2009.06.005; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Rowe PSN, 2012, CELL BIOCHEM FUNCT, V30, P355, DOI 10.1002/cbf.2841; Sauce Bruno, 2012, Frontiers in Genetics, V3, P90, DOI 10.3389/fgene.2012.00090; Sawae Y, 2002, J ELECTRON MICROSC, V51, P413, DOI 10.1093/jmicro/51.6.413; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Staines KA, 2012, BONE, V51, P418, DOI 10.1016/j.bone.2012.06.022; Wade-Gueye NM, 2010, ENDOCRINOLOGY, V151, P5103, DOI 10.1210/en.2010-0091; Weizmann S, 2005, MATRIX BIOL, V24, P520, DOI 10.1016/j.matbio.2005.07.003; Yakar S, 2002, J CLIN INVEST, V110, P771, DOI 10.1172/JCI200215463; Yakar S, 2010, J BONE MINER RES, V25, P2267, DOI 10.1002/jbmr.234	28	29	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e95144	10.1371/journal.pone.0095144	http://dx.doi.org/10.1371/journal.pone.0095144			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816232	Green Published, gold, Green Submitted			2022-12-27	WOS:000336838000012
J	Nicol, JTJ; Liais, E; Potier, R; Mazzoni, E; Tognon, M; Coursaget, P; Touze, A				Nicol, Jerome T. J.; Liais, Etienne; Potier, Romain; Mazzoni, Elisa; Tognon, Mauro; Coursaget, Pierre; Touze, Antoine			Serological Cross-Reactivity between Merkel Cell Polyomavirus and Two Closely Related Chimpanzee Polyomaviruses	PLOS ONE			English	Article							LYMPHOTROPIC POLYOMAVIRUS; SEROPREVALENCE; IDENTIFICATION; ANTIBODIES; INFECTION; CARCINOMA; SV40	Phylogenetic analyses based on the major capsid protein sequence indicate that Merkel cell polyomavirus (MCPyV) and chimpanzee polyomaviruses (PtvPyV1, PtvPyV2), and similarly Trichodysplasia spinulosa-associated polyomavirus (TSPyV) and the orangutan polyomavirus (OraPyV1) are closely related. The existence of cross-reactivity between these polyomaviruses was therefore investigated. The findings indicated serological identity between the two chimpanzee polyomaviruses investigated and a high level of cross-reactivity with Merkel cell polyomavirus. In contrast, cross-reactivity was not observed between TSPyV and OraPyV1. Furthermore, specific antibodies to chimpanzee polyomaviruses were detected in chimpanzee sera by pre-incubation of sera with the different antigens, but not in human sera.	[Nicol, Jerome T. J.; Liais, Etienne; Coursaget, Pierre; Touze, Antoine] Univ Tours, Tours, France; [Nicol, Jerome T. J.; Liais, Etienne; Touze, Antoine] INRA, UMR 1282, Tours, France; [Potier, Romain] Assoc Beauval Nat Conservat & Rech, St Aignan Sur Cher, France; [Mazzoni, Elisa; Tognon, Mauro] Univ Ferrara, Dept Morphol Surg & Expt Med, Sch Med, I-44100 Ferrara, Italy	Universite de Tours; INRAE; University of Ferrara	Touze, A (corresponding author), Univ Tours, Tours, France.	antoine.touze@univ-tours.fr	Mazzoni, Elisa/K-6313-2016	Mazzoni, Elisa/0000-0001-6829-8569; Touze, antoine/0000-0002-9856-9945	Ligue Contre le Cancer	Ligue Contre le Cancer(Ligue nationale contre le cancer)	This study was funded by grants to Antoine Touze from the "Ligue Contre le Cancer". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07; BRADE L, 1980, J MED VIROL, V6, P301, DOI 10.1002/jmv.1890060405; Carter JJ, 2003, JNCI-J NATL CANCER I, V95, P1522, DOI 10.1093/jnci/djg074; Carter JJ, 2009, JNCI-J NATL CANCER I, V101, P1510, DOI 10.1093/jnci/djp332; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; Groenewoud MJ, 2010, J GEN VIROL, V91, P653, DOI 10.1099/vir.0.017673-0; Kean JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000363; Kjaerheim K, 2007, INT J CANCER, V120, P2459, DOI 10.1002/ijc.22592; Korup S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058021; Leendertz FH, 2011, J VIROL, V85, P916, DOI 10.1128/JVI.01585-10; Lim ES, 2013, VIROLOGY, V436, P295, DOI 10.1016/j.virol.2012.12.005; Moens U, 2013, REV MED VIROL, V23, P250, DOI 10.1002/rmv.1747; Nicol JTJ, 2013, CLIN VACCINE IMMUNOL, V20, P363, DOI 10.1128/CVI.00438-12; Nicol JTJ, 2012, EMERG INFECT DIS, V18, P1329, DOI 10.3201/eid1808.111625; Nicol JTJ, 2011, FUTURE VIROL, V6, P1187, DOI 10.2217/FVL.11.96; Pastrana DV, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000578; Rollison DE, 2005, CANCER EPIDEM BIOMAR, V14, P1448, DOI 10.1158/1055-9965.EPI-04-0674; Sauvage V, 2011, EMERG INFECT DIS, V17, P1364, DOI 10.3201/eid1708.110278; Schowalter RM, 2010, CELL HOST MICROBE, V7, P509, DOI 10.1016/j.chom.2010.05.006; Scuda N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003429; Scuda N, 2011, J VIROL, V85, P4586, DOI 10.1128/JVI.02602-10; Siebrasse EA, 2012, J VIROL, V86, P10321, DOI 10.1128/JVI.01210-12; Touze A, 2010, J CLIN MICROBIOL, V48, P1767, DOI 10.1128/JCM.01691-09; Trusch F, 2012, J GEN VIROL, V93, P698, DOI 10.1099/vir.0.039156-0; van der Meijden E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081078; van der Meijden E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001024; Viscidi RP, 2011, CLIN VACCINE IMMUNOL, V18, P1737, DOI 10.1128/CVI.05175-11; Viscidi RP, 2006, ADV EXP MED BIOL, V577, P73; Zielonka A, 2011, VIRUS RES, V155, P514, DOI 10.1016/j.virusres.2010.12.009	30	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97030	10.1371/journal.pone.0097030	http://dx.doi.org/10.1371/journal.pone.0097030			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816721	Green Published, Green Submitted, gold			2022-12-27	WOS:000336838000096
J	Steegen, K; Levin, L; Ketseoglou, I; Bronze, M; Papathanasopoulos, MA; Carmona, S; Stevens, W				Steegen, Kim; Levin, Leon; Ketseoglou, Irene; Bronze, Michelle; Papathanasopoulos, Maria A.; Carmona, Sergio; Stevens, Wendy			High-Level Cross-Resistance to Didanosine Observed in South African Children Failing an Abacavir- or Stavudine-Based 1st-Line Regimen	PLOS ONE			English	Article							DRUG-RESISTANCE; ANTIRETROVIRAL TREATMENT; HIV-1; SUBTYPE; MUTATIONS; THERAPY	Background: The knowledge-base of emerging drug resistance profiles in children exposed to abacavir-based antiretroviral regimens in South Africa is very limited. This study investigated the suitability of didanosine-based 2nd-line regimens for children in the context of antiretroviral drug resistance patterns emerging after 1st-line virologic failure. Methods: A retrospective dataset of 354 antiretroviral drug resistant genotypes from children failing either abacavir (n = 81) or stavudine (n = 273) based 1st-line regimens, was analysed. Samples were sent to the HIV genotyping laboratory at Charlotte Maxeke Johannesburg Academic Hospital, for routine testing. Pol sequences were submitted to the Stanford HIV drug resistance database for genotypic predictions. Results: Children were exposed to abacavir or stavudine-based 1st-line regimens for an average of 21 and 36 months, respectively. The frequency of reduced susceptibility to didanosine was substantial in the abacavir-exposed group (69.1%). This reduced susceptibility was commonly attributed to L74V/I (n = 44) and to a lesser extent K65R (n = 10) mutations. Didanosine resistance was observed in 43.2% of patients exposed to stavudine-based regimens. In contrast, most children remained susceptible to stavudine regardless of exposure to abacavir (77.8%) or stavudine (74.7%). At least 80% of children remained susceptible to zidovudine irrespective of stavudine or abacavir-exposure. The presence of the K65R mutation was more common after abacavir pressure (12.3% vs 1.8%). Conclusion: Analysis revealed that didanosine-based 2nd-line regimens have limitations for South African children, given the high frequency of mutations that confer cross-resistance to didanosine; especially after abacavir-exposure. This data has influenced South African paediatric treatment guidelines, which now recommend zidovudine-based 2nd-line regimens.	[Steegen, Kim; Ketseoglou, Irene; Bronze, Michelle; Papathanasopoulos, Maria A.; Carmona, Sergio; Stevens, Wendy] Univ Witwatersrand, Dept Haematol & Mol Med, Johannesburg, South Africa; [Steegen, Kim; Ketseoglou, Irene; Bronze, Michelle; Carmona, Sergio; Stevens, Wendy] Natl Hlth Lab Serv, Johannesburg, South Africa; [Levin, Leon] Right Care, Johannesburg, South Africa	University of Witwatersrand; National Health Laboratory Service	Steegen, K (corresponding author), Univ Witwatersrand, Dept Haematol & Mol Med, Johannesburg, South Africa.	kim.steegen@nhls.ac.za	Steegen, Kim/ABH-4471-2020; Steegen, K/AAF-6512-2020	Steegen, Kim/0000-0003-3226-7685; Carmona, Sergio/0000-0002-6792-4748	NIH Fogarty International Center [5 U2R TW007373, TW007370]; FOGARTY INTERNATIONAL CENTER [U2RTW007373, U2RTW007370] Funding Source: NIH RePORTER	NIH Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported in part by the NIH Fogarty International Center awards 5 U2R TW007373 and TW007370. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Khaled M, 2002, AIDS, V16, P1686, DOI 10.1097/00002030-200208160-00017; [Anonymous], 2013, S AFR ANT TREAT GUID; Back NKT, 1996, EMBO J, V15, P4040, DOI 10.1002/j.1460-2075.1996.tb00777.x; Barth RE, 2011, PEDIATR INFECT DIS J, V30, P52, DOI 10.1097/INF.0b013e3181ed2af3; Bronze M, 2012, 1 INT C AF SOC LAB M; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Dlamini NR, 2012, CIRCULAR MINUTE 2 20; Johnson LF, 2012, S AFR J HIV MED, P22; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Lukhwareni A, 2012, PATHPOINT CONFERENCE; NDoH, 2010, S AFR GUID MAN HIV C; Orrell C, 2013, PEDIATR INFECT DIS J, V32, P644, DOI 10.1097/INF.0b013e3182829092; Rhee SY, 2006, AIDS, V20, P643, DOI 10.1097/01.aids.0000216363.36786.2b; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor BS, 2011, AIDS RES HUM RETROV, V27, P945, DOI 10.1089/aid.2010.0205; UNAIDS, 2012, FACT SHEET S AFR; Van Zyl GU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067188; van Zyl GU, 2009, PEDIATR INFECT DIS J, V28, P1125, DOI 10.1097/INF.0b013e3181af829d; Venter WD, 2012, SO AFRICAN J HIV MED, V13; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Wallis CL, 2010, J VIROL METHODS, V163, P505, DOI 10.1016/j.jviromet.2009.11.011; Wallis CL, 2009, PEDIATR INFECT DIS J, V28, P1123, DOI 10.1097/INF.0b013e3181af5a00; WHO, 2009, STAV D4T PHAS OUT MA	23	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97067	10.1371/journal.pone.0097067	http://dx.doi.org/10.1371/journal.pone.0097067			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816790	Green Published, Green Submitted, gold			2022-12-27	WOS:000336838000099
J	Vivodtzev, I; Rivard, B; Gagnon, P; Mainguy, V; Dube, A; Belanger, M; Jean, B; Maltais, F				Vivodtzev, Isabelle; Rivard, Benoit; Gagnon, Philippe; Mainguy, Vincent; Dube, Annie; Belanger, Marthe; Jean, Brigitte; Maltais, Francois			Tolerance and Physiological Correlates of Neuromuscular Electrical Stimulation in COPD: A Pilot Study	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; MUSCLE STRENGTH; QUADRICEPS; EXERCISE; CONTRACTIONS; VOLUNTARY; RESPONSES; ENDURANCE; CAPACITY; FATIGUE	Rationale: Neuromuscular electrical stimulation (NMES) of the lower limbs is an emerging training strategy in patients with COPD. The efficacy of this technique is related to the intensity of the stimulation that is applied during the training sessions. However, little is known about tolerance to stimulation current intensity and physiological factors that could determine it. Our goal was to find potential physiological predictors of the tolerance to increasing NMES stimulation intensity in patients with mild to severe COPD. Methods: 20 patients with COPD (FEV1 = 54+/-14% pred.) completed 2 supervised NMES sessions followed by 5 self-directed sessions at home and one final supervised session. NMES was applied simultaneously to both quadriceps for 45 minutes, at a stimulation frequency of 50 Hz. Spirometry, body composition, muscle function and aerobic capacity were assessed at baseline. Cardiorespiratory responses, leg discomfort, muscle fatigue and markers of systemic inflammation were assessed during or after the last NMES session. Tolerance to NMES was quantified as the increase in current intensity from the initial to the final NMES session (Delta Int). Results: Mean Delta Int was 12+/-10 mA. FEV1, fat-free-mass, quadriceps strength, aerobic capacity and leg discomfort during the last NMES session positively correlated with Delta Int (r = 0.42 to 0.64, all p <= 0.06) while post/pre NMES IL-6 ratio negatively correlated with Delta Int (r = -0.57, p = 0.001). FEV1, leg discomfort during last NMES session and post/pre IL-6 ratio to NMES were independent factors of variance in Delta Int (r(2) = 0.72, p = 0.001). Conclusion: Lower tolerance to NMES was associated with increasing airflow obstruction, low tolerance to leg discomfort during NMES and the magnitude of the IL-6 response after NMES.	[Vivodtzev, Isabelle; Gagnon, Philippe; Mainguy, Vincent; Dube, Annie; Belanger, Marthe; Jean, Brigitte; Maltais, Francois] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Quebec City, PQ, Canada; [Vivodtzev, Isabelle] Univ Grenoble Alpes, Hypoxia Resp & Cardiovasc Physiopathol HP2, Grenoble, France; [Vivodtzev, Isabelle] INSERM, Hypoxia Resp & Cardiovasc Physiopathol HP2, Grenoble, France; [Vivodtzev, Isabelle] Ctr Hosp Grenoble, Grenoble, France; [Rivard, Benoit] CHA Hop Enfant Jesus, Dept Physiotherapie, Quebec City, PQ, Canada	Laval University; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Laval University	Vivodtzev, I (corresponding author), Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Quebec City, PQ, Canada.	IVivodtzev@chu-grenoble.fr	Vivodtzev, Isabelle/M-7368-2014	Vivodtzev, Isabelle/0000-0002-5201-8603	CIHR [MOP-84091]	CIHR(Canadian Institutes of Health Research (CIHR))	The sutdy was supported by CIHR grant MOP-84091. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdellaoui A, 2011, EUR RESPIR J, V38, P781, DOI 10.1183/09031936.00167110; Allaire J, 2004, THORAX, V59, P673, DOI 10.1136/thx.2003.020636; Botter A, 2011, EUR J APPL PHYSIOL, V111, P2461, DOI 10.1007/s00421-011-2093-y; Bourjeily-Habr G, 2002, THORAX, V57, P1045, DOI 10.1136/thorax.57.12.1045; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Debigare R, 2003, CHEST, V124, P83, DOI 10.1378/chest.124.1.83; DELITTO A, 1992, PHYS THER, V72, P410, DOI 10.1093/ptj/72.6.410; Gagnon P, 2009, J APPL PHYSIOL, V107, P832, DOI 10.1152/japplphysiol.91546.2008; Giavedoni S, 2012, RESP MED, V106, P1429, DOI 10.1016/j.rmed.2012.05.005; Gleeson M, 2000, IMMUNOL CELL BIOL, V78, P554, DOI 10.1046/j.1440-1711.2000.00953.x; HAMILTON AL, 1995, AM J RESP CRIT CARE, V152, P2021, DOI 10.1164/ajrccm.152.6.8520771; HEYMSFIELD SB, 1994, JPEN-PARENTER ENTER, V18, P91, DOI 10.1177/014860719401800291; Jonsdottir IH, 2000, J PHYSIOL-LONDON, V528, P157, DOI 10.1111/j.1469-7793.2000.00157.x; Maffiuletti NA, 2010, EUR J APPL PHYSIOL, V110, P223, DOI 10.1007/s00421-010-1502-y; McCarthy JJ, 2010, CURR OPIN CLIN NUTR, V13, P230, DOI 10.1097/MCO.0b013e32833781b5; Neder JA, 2002, THORAX, V57, P333, DOI 10.1136/thorax.57.4.333; Pepin V, 2005, AM J RESP CRIT CARE, V172, P1517, DOI 10.1164/rccm.200507-1037OC; Petrofsky J, 2008, EUR J APPL PHYSIOL, V103, P265, DOI 10.1007/s00421-008-0700-3; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Ratkevicius A, 1998, EUR J APPL PHYSIOL O, V77, P462, DOI 10.1007/s004210050361; Revill SM, 1999, THORAX, V54, P213, DOI 10.1136/thx.54.3.213; Sillen MJH, 2008, RESP MED, V102, P786, DOI 10.1016/j.rmed.2008.01.013; Sillen MJH, 2009, CHEST, V136, P44, DOI 10.1378/chest.08-2481; Theurel J, 2007, RESP PHYSIOL NEUROBI, V157, P341, DOI 10.1016/j.resp.2006.12.002; Van Helvoort HAC, 2006, MED SCI SPORT EXER, V38, P1543, DOI 10.1249/01.mss.0000228331.13123.53; Vivodtzev I, 2008, J CARDIOPULM REHABIL, V28, P79, DOI 10.1097/01.HCR.0000314201.02053.a3; Vivodtzev I, 2006, CHEST, V129, P1540, DOI 10.1378/chest.129.6.1540; Vivodtzev I, 2012, CHEST, V141, P716, DOI 10.1378/chest.11-0839; Vivodtzev I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017007; Zanotti E, 2003, CHEST, V124, P292, DOI 10.1378/chest.124.1.292	30	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e94850	10.1371/journal.pone.0094850	http://dx.doi.org/10.1371/journal.pone.0094850			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24817528	gold, Green Submitted, Green Published			2022-12-27	WOS:000336838000009
J	Behjati, S; Maschietto, M; Williams, RD; Side, L; Hubank, M; West, R; Pearson, K; Sebire, N; Tarpey, P; Futreal, A; Brooks, T; Stratton, MR; Anderson, J				Behjati, Sam; Maschietto, Mariana; Williams, Richard D.; Side, Lucy; Hubank, Mike; West, Rebecca; Pearson, Katie; Sebire, Neil; Tarpey, Patrick; Futreal, Andrew; Brooks, Tony; Stratton, Michael R.; Anderson, John			A Pathogenic Mosaic TP53 Mutation in Two Germ Layers Detected by Next Generation Sequencing	PLOS ONE			English	Article							LI-FRAUMENI-SYNDROME; HUMAN BRAIN; CANCER; GENE; FAMILIES; CARRIERS; RETROTRANSPOSITION; NUMBER; AGE	Background: Li-Fraumeni syndrome is caused by germline TP53 mutations and is clinically characterized by a predisposition to a range of cancers, most commonly sarcoma, brain tumours and leukemia. Pathogenic mosaic TP53 mutations have only rarely been described. Methods and Findings: We describe a 2 years old child presenting with three separate cancers over a 6 month period; two soft tissue mesenchymal tumors and an aggressive metastatic neuroblastoma. As conventional testing of blood DNA by Sanger sequencing for mutations in TP53, ALK, and SDH was negative, whole exome sequencing of the blood DNA of the patient and both parents was performed to screen more widely for cancer predisposing mutations. In the patient's but not the parents' DNA we found a c.743 G>A, p.Arg248Gln (CCDS11118.1) TP53 mutation in 3-20% of sequencing reads, a level that would not generally be detectable by Sanger sequencing. Homozygosity for this mutation was detected in all tumor samples analyzed, and germline mosaicism was demonstrated by analysis of the child's newborn blood spot DNA. The occurrence of separate tumors derived from different germ layers suggests that this de novo mutation occurred early in embryogenesis, prior to gastrulation. Conclusion: The case demonstrates pathogenic mosaicim, detected by next generation deep sequencing, that arose in the early stages of embryogenesis.	[Behjati, Sam; Stratton, Michael R.] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, Cambs, England; [Behjati, Sam; Tarpey, Patrick; Futreal, Andrew] Univ Cambridge, Dept Paediat, Cambridge, England; [Maschietto, Mariana; Williams, Richard D.; Hubank, Mike; West, Rebecca; Pearson, Katie; Brooks, Tony; Anderson, John] UCL Inst Child Hlth, Unit Mol Haematol & Canc Biol, London, England; [Side, Lucy] Great Ormond St Hosp Sick Children, Dept Clin Genet, London WC1N 3JH, England; [Sebire, Neil] Great Ormond St Hosp Sick Children, Dept Histopathol, London WC1N 3JH, England	Wellcome Trust Sanger Institute; University of Cambridge; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Anderson, J (corresponding author), UCL Inst Child Hlth, Unit Mol Haematol & Canc Biol, London, England.	J.anderson@ucl.ac.uk	Hubank, Michael JF/C-1837-2008; Maschietto, Mariana/G-4999-2010	Hubank, Michael JF/0000-0002-2901-0742; Maschietto, Mariana/0000-0003-2589-3186; Behjati, Sam/0000-0002-6600-7665; Sebire, Neil/0000-0001-5348-9063; Anderson, William/0000-0001-7509-3203	Wellcome Trust; Great Ormond Street Hospital Charity Leadership Award; Great Ormond Street Hospital Biomedical Research Centre	Wellcome Trust(Wellcome TrustEuropean Commission); Great Ormond Street Hospital Charity Leadership Award; Great Ormond Street Hospital Biomedical Research Centre	SB is funded through the Wellcome Trust PhD Programme for Clinicians. JA holds a Great Ormond Street Hospital Charity Leadership Award and receives support from the Great Ormond Street Hospital Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aretz S, 2007, HUM MUTAT, V28, P985, DOI 10.1002/humu.20549; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; BIRCH JM, 1994, CANCER RES, V54, P1298; Birch JM, 2001, ONCOGENE, V20, P4621, DOI 10.1038/sj.onc.1204621; Chompret A, 2001, J MED GENET, V38, P43, DOI 10.1136/jmg.38.1.43; Consoli C, 2005, J INVEST DERMATOL, V125, P463, DOI 10.1111/j.0022-202X.2005.23834.x; Eeles RA, 1995, CANCER SURV, V25, P101; Evrony GD, 2012, CELL, V151, P483, DOI 10.1016/j.cell.2012.09.035; Hes FJ, 2008, GUT, V57, P71, DOI 10.1136/gut.2006.117796; Kluwe L, 1998, HUM MOL GENET, V7, P2051, DOI 10.1093/hmg/7.13.2051; LI FP, 1969, J NATL CANCER I, V43, P1365; Lupski JR, 2013, SCIENCE, V341, P358, DOI 10.1126/science.1239503; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Malkin D., 2011, GENES CANC, V2, P475, DOI DOI 10.1177/1947601911413466; Marcel V, 2009, J MED GENET, V46, P766, DOI 10.1136/jmg.2009.066704; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Poduri A, 2013, SCIENCE, V341, P43, DOI 10.1126/science.1237758; Prochazkova K, 2009, AM J MED GENET A, V149A, P206, DOI 10.1002/ajmg.a.32574; Rushlow D, 2009, HUM MUTAT, V30, P842, DOI 10.1002/humu.20940; Shlien A, 2008, P NATL ACAD SCI USA, V105, P11264, DOI 10.1073/pnas.0802970105; Silva AG, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-101; Tarpey PS, 2013, NAT GENET, V45, P923, DOI 10.1038/ng.2668; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trkova M, 2002, J HUM GENET, V47, P381, DOI 10.1007/s100380200055; Trkova M, 2007, CANCER, V110, P694, DOI 10.1002/cncr.22834; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Villani A, 2011, LANCET ONCOL, V12, P559, DOI 10.1016/S1470-2045(11)70119-X	27	23	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96531	10.1371/journal.pone.0096531	http://dx.doi.org/10.1371/journal.pone.0096531			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810334	gold, Green Published, Green Submitted			2022-12-27	WOS:000338213300050
J	Berhanu, WM; Hansmann, UHE				Berhanu, Workalemahu M.; Hansmann, Ulrich H. E.			Inter-Species Cross-Seeding: Stability and Assembly of Rat - Human Amylin Aggregates	PLOS ONE			English	Article							ISLET AMYLOID POLYPEPTIDE; PARTICLE MESH EWALD; MOLECULAR-DYNAMICS; FIBRIL FORMATION; BETA SPINE; A-BETA; PROTEIN; IAPP; MECHANISMS; MUTATIONS	Diseases such as type 2 diabetes, Alzheimer's and Parkinson's share as common feature the accumulation of mis-folded disease-specific protein aggregates into fibrillar structures, or plaques. These fibrils may either be toxic by themselves, or act as reservoirs for smaller cytotoxic oligomers. This suggests to investigate molecules as potential therapeutics that either reduce fibril formation or increase fibril stability. One example is rat amylin, which can inhibit aggregation of human amylin, a hallmark of type 2 diabetes. In the present paper, we use molecular dynamics to compare the stability of various preformed aggregates, built out of either human amylin, rat amylin, or mixtures of both. We considered two types of fibril-like oligomers: a single-layer in-register conformation, and a double-layer conformation in which the first U-shaped layer consists of rat amylin and the second layer of human amylin. Our results explain the weak amyloid-inhibiting properties of rat amylin and suggest that membrane leakage due to pore formation is responsible for the toxicity of rat amylin observed in a recent experiment. Together, our results put in question the use of rat amylin or the similar FDA approved drug pramlintide as an inhibitor of human amylin aggregation. They also point to mixed human-rat amylin fibril-like oligomers as possible model-systems for studies of amyloid formation that involve cross-species transmission.	[Berhanu, Workalemahu M.; Hansmann, Ulrich H. E.] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Hansmann, UHE (corresponding author), Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA.	uhansmann@ou.edu	Hansmann, Ulrich/L-4597-2017	Hansmann, Ulrich/0000-0002-0700-4835	National Institutes of Health [GM62838]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062838] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health, R01 grant GM62838. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedini A, 2013, FEBS LETT, V587, P1119, DOI 10.1016/j.febslet.2013.01.017; Apostol MI, 2011, BIOCHEMISTRY-US, V50, P2456, DOI 10.1021/bi101803k; Bedrood S, 2012, J BIOL CHEM, V287, P5235, DOI 10.1074/jbc.M111.327817; Berhanu WM, 2013, J BIOMOLECULAR STRUC; Berhanu WM, 2013, PROTEINS STRUCTURE F, V81; Berhanu WM, 2013, ACS CHEM NEUROSCI, V4, P1488, DOI 10.1021/cn400141x; Berhanu WM, 2012, BIOPOLYMERS, V98, P131, DOI 10.1002/bip.21731; Berhanu WM, 2011, BIOPOLYMERS, V95, P573, DOI 10.1002/bip.21611; Berhanu WM, 2012, J MOL MODEL, V18, P1129, DOI 10.1007/s00894-011-1123-3; Bernhardt NA, 2013, J PHYS CHEM B, V117, P16076, DOI 10.1021/jp409777p; Blancas-Mejia LM, 2013, ANNU REV BIOCHEM, V82, P745, DOI 10.1146/annurev-biochem-072611-130030; Brender JR, 2012, ACCOUNTS CHEM RES, V45, P454, DOI 10.1021/ar200189b; Buchanan LE, 2013, P NATL ACAD SCI USA, V110, P19285, DOI 10.1073/pnas.1314481110; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Bussi G, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3073889; Cao P, 2013, FEBS LETT, V587, P1106, DOI 10.1016/j.febslet.2013.01.046; Caoa PAA, 2013, P NATL ACAD SCI US; Chiu CC, 2013, BIOPHYS J, V105, P1227, DOI 10.1016/j.bpj.2013.07.029; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Despa S, 2012, CIRC RES, V110, P598, DOI [10.1161/CIRCRESAHA.111.258285, 10.1161/circresaha.111.258285]; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fowler DM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001459; Fox A, 2010, BIOCHEMISTRY-US, V49, P7783, DOI 10.1021/bi100337p; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Gong W, 2007, KIDNEY INT, V72, P213, DOI 10.1038/sj.ki.5002305; Green J, 2003, J MOL BIOL, V326, P1147, DOI 10.1016/S0022-2836(02)01377-3; Hard T, 2014, J PHYS CHEM LETT, V5, P607, DOI 10.1021/jz4027612; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jackson K, 2013, ANN NEUROL, V74, P517, DOI 10.1002/ana.23956; Jaikaran ETAS, 2001, BBA-MOL BASIS DIS, V1537, P179, DOI 10.1016/S0925-4439(01)00078-3; Jang H, 2013, J CHEM THEORY COMPUT, V9, P822, DOI 10.1021/ct300916f; Jiang L, 2013, ELIFE, V2, DOI 10.7554/eLife.00857; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kahler A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070521; Kajava AV, 2005, J MOL BIOL, V348, P247, DOI 10.1016/j.jmb.2005.02.029; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kutzner C, 2011, BIOPHYS J, V101, P809, DOI 10.1016/j.bpj.2011.06.010; Last NB, 2013, P NATL ACAD SCI USA, V110, P6382, DOI 10.1073/pnas.1219059110; Li YY, 2012, J CHEM INF MODEL, V52, P2983, DOI 10.1021/ci300300e; Li YF, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4817680; Liang GZ, 2013, BIOCHEMISTRY-US, V52, P1089, DOI 10.1021/bi301525e; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q; Lutz TA, 2012, CELL MOL LIFE SCI, V69, P1947, DOI 10.1007/s00018-011-0905-1; Ma BY, 2012, J MOL BIOL, V421, P172, DOI 10.1016/j.jmb.2011.11.023; Meyer V, 2014, ANGEW CHEM INT EDIT, V53, P1590, DOI 10.1002/anie.201308473; Middleton CT, 2012, NAT CHEM, V4, P355, DOI [10.1038/nchem.1293, 10.1038/NCHEM.1293]; Miller Y, 2011, BIOCHEMISTRY-US, V50, P5172, DOI 10.1021/bi200400u; Milton NGN, 2013, MICRON, V44, P246, DOI 10.1016/j.micron.2012.07.001; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Morales R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003537; Nanga RPR, 2011, BBA-BIOMEMBRANES, V1808, P2337, DOI 10.1016/j.bbamem.2011.06.012; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Nonoyama A, 2008, J PHARM SCI-US, V97, P2552, DOI 10.1002/jps.21197; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Poojari C, 2013, BIOPHYS J, V105, P2323, DOI 10.1016/j.bpj.2013.09.045; Poojari C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078399; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Raz Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073303; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Seuring C, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001451; Sievers SA, 2011, NATURE, V475, P96, DOI 10.1038/nature10154; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Smaoui MR, 2013, BIOPHYS J, V104, P683, DOI 10.1016/j.bpj.2012.12.037; Spiliotopoulos D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046902; Tsemekhman K, 2007, PROTEIN SCI, V16, P761, DOI 10.1110/ps.062609607; Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009; Wiltzius JJW, 2008, PROTEIN SCI, V17, P1467, DOI 10.1110/ps.036509.108; Wiltzius JJW, 2009, NAT STRUCT MOL BIOL, V16, P973, DOI 10.1038/nsmb.1643; Wu C, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003211; Xu WX, 2012, J PHYS CHEM B, V116, P13991, DOI 10.1021/jp308708h; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809; Zachariae U, 2012, STRUCTURE, V20, P1540, DOI 10.1016/j.str.2012.06.015; Zhao J, 2011, BIOMACROMOLECULES, V12, P210, DOI 10.1021/bm101159p; Zheng J, 2007, BIOPHYS J, V93, P3046, DOI 10.1529/biophysj.107.110700	82	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e97051	10.1371/journal.pone.0097051	http://dx.doi.org/10.1371/journal.pone.0097051			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810618	Green Submitted, Green Published, gold			2022-12-27	WOS:000338213300114
J	Wang, H; Sun, W; Zhang, WZ; Ge, CY; Zhang, JT; Liu, ZY; Fan, YZ				Wang, Hui; Sun, Wei; Zhang, Wen-Zhong; Ge, Chun-Yan; Zhang, Jing-Tao; Liu, Zhong-Yan; Fan, Yue-Zu			Inhibition of Tumor Vasculogenic Mimicry and Prolongation of Host Survival in Highly Aggressive Gallbladder Cancers by Norcantharidin via Blocking the Ephrin Type a Receptor 2/Focal Adhesion Kinase/Paxillin Signaling Pathway	PLOS ONE			English	Article							HUMAN-MELANOMA CELLS; GBC-SD CELLS; IN-VITRO; HEPG2 CELLS; NUDE-MICE; GROWTH; APOPTOSIS; KINASE; CARCINOMA; VIVO	Vasculogenic mimicry (VM) is a newly-defined tumor microcirculation pattern in highly aggressive malignant tumors. We recently reported tumor growth and VM formation of gallbladder cancers through the contribution of the ephrin type a receptor 2 (EphA2)/focal adhesion kinase (FAK)/Paxillin signaling pathways. In this study, we further investigated the anti-VM activity of norcantharidin (NCTD) as a VM inhibitor for gallbladder cancers and the underlying mechanisms. In vivo and in vitro experiments to determine the effects of NCTD on tumor growth, host survival, VM formation of GBC-SD nude mouse xenografts, and vasculogenic-like networks, malignant phenotypes i.e., proliferation, apoptosis, invasion and migration of GBC-SD cells. Expression of VM signaling-related markers EphA2, FAK and Paxillin in vivo and in vitro were examined by immunofluorescence, western blotting and real-time polymerase chain reaction (RT-PCR), respectively. The results showed that after treatment with NCTD, GBC-SD cells were unable to form VM structures when injecting into nude mouse, growth of the xenograft was inhibited and these observations were confirmed by facts that VM formation by three-dimensional (3-D) matrix, proliferation, apoptosis, invasion, migration of GBC-SD cells were affected; and survival time of the xenograft mice was prolonged. Furthermore, expression of EphA2, FAK and Paxillin proteins/mRNAs of the xenografts was downregulated. Thus, we concluded that NCTD has potential anti-VM activity against human gallbladder cancers; one of the underlying mechanisms may be via blocking the EphA2/FAK/Paxillin signaling pathway.	[Wang, Hui; Zhang, Jing-Tao; Liu, Zhong-Yan; Fan, Yue-Zu] Tongji Univ, Sch Med, Dept Surg, Tongji Hosp, Shanghai 200092, Peoples R China; [Sun, Wei] Tongji Univ, Sch Med, Dept Surg, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China; [Zhang, Wen-Zhong] Shanghai Pudong New Area Peoples Hosp, Dept Surg, Shanghai, Peoples R China; [Ge, Chun-Yan] Shanghai Yangpu Geriatr Hosp, Dept Oncol, Shanghai, Peoples R China	Tongji University; Tongji University	Fan, YZ (corresponding author), Tongji Univ, Sch Med, Dept Surg, Tongji Hosp, Shanghai 200092, Peoples R China.	fanyuezu@hotmail.com	Zhang, Jing/GWZ-7332-2022		National Nature Science Foundation of China [30672073, 81372614]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Nature Science Foundation of China (30672073, 81372614). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An W, 2004, J KOREAN MED SCI, V19, P560, DOI 10.3346/jkms.2004.19.4.560; Baeten CIM, 2009, DIS COLON RECTUM, V52, P2028, DOI 10.1007/DCR.0b013e3181beb4ff; Brantley DM, 2002, ONCOGENE, V21, P7011, DOI 10.1038/sj.onc.1205679; Chakravarty KD, 2009, DIGESTION, V79, P151, DOI 10.1159/000210131; Chang C, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-145; Chen LX, 2011, CANCER BIOL THER, V11, P229, DOI 10.4161/cbt.11.2.13842; Chen YN, 2002, INT J CANCER, V100, P158, DOI 10.1002/ijc.10479; Chen YN, 2003, BRIT J PHARMACOL, V140, P461, DOI 10.1038/sj.bjp.0705461; Chen YJ, 2009, LIFE SCI, V85, P642, DOI 10.1016/j.lfs.2009.09.003; Cheng N, 2002, MOL CANCER RES, V1, P2; Cong RH, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-124; Emmett MS, 2011, AM J CANCER RES, V1, P852; Fan YZ, 2007, HEPATOB PANCREAT DIS, V6, P72; Fan YZ, 2005, WORLD J GASTROENTERO, V11, P2431, DOI 10.3748/wjg.v11.i16.2431; Fan YZ, 2010, WORLD J GASTRO SURG, V2, P117, DOI 10.4240/wjgs.v2.i4.117; Fan YZ, 2010, HEPATOB PANCREAT DIS, V9, P414; Fan Yue-zu, 2006, Zhonghua Yi Xue Za Zhi, V86, P693; Fan Yue-zu, 2007, Zhonghua Yi Xue Za Zhi, V87, P145; Fan YZ, 2012, SURG RES NEW TECH, V1, P13; Folberg R, 2004, APMIS, V112, P508, DOI 10.1111/j.1600-0463.2004.apm11207-0810.x; Fu DH, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-146; Gourgiotis S, 2008, AM J SURG, V196, P252, DOI 10.1016/j.amjsurg.2007.11.011; Hart ME, 2004, BIOORG MED CHEM LETT, V14, P1969, DOI 10.1016/j.bmcl.2004.01.093; Hendrix MJC, 2003, ONCOGENE, V22, P3070, DOI 10.1038/sj.onc.1206447; Hess AR, 2006, CELL CYCLE, V5, P478, DOI 10.4161/cc.5.5.2518; Hess AR, 2005, CANCER RES, V65, P9851, DOI 10.1158/0008-5472.CAN-05-2172; Hess AR, 2001, CANCER RES, V61, P3250; Higa GM, 2009, EXPERT REV ANTICANC, V9, P999, DOI 10.1586/ERA.09.68; Ho YP, 2001, J MED CHEM, V44, P2065, DOI 10.1021/jm000476t; Hong CY, 2000, BIOCHEM BIOPH RES CO, V276, P278, DOI 10.1006/bbrc.2000.3341; Hsing AW, 1998, INT J CANCER, V75, P368, DOI 10.1002/(SICI)1097-0215(19980130)75:3&lt;368::AID-IJC7&gt;3.0.CO;2-0; Ishii H, 2004, ONCOLOGY-BASEL, V66, P138, DOI 10.1159/000077440; Itzhaki O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057160; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Konstantinidis IT, 2009, ARCH SURG-CHICAGO, V144, P441, DOI 10.1001/archsurg.2009.46; Lazcano-Ponce EC, 2001, CA-CANCER J CLIN, V51, P349, DOI 10.3322/canjclin.51.6.349; Li JL, 2006, ANTI-CANCER DRUG, V17, P307, DOI 10.1097/00001813-200603000-00009; Li M, 2010, PATHOL ONCOL RES, V16, P259, DOI 10.1007/s12253-009-9220-7; Liao HF, 2011, TOXICOL IN VITRO, V25, P206, DOI 10.1016/j.tiv.2010.11.001; Liu Jian, 2003, Zhong Yao Cai, V26, P453; LIU XH, 1995, EUR J CANCER, V31A, P953, DOI 10.1016/0959-8049(95)00050-X; Lu XS, 2013, INT J ONCOL, V42, P2103, DOI 10.3892/ijo.2013.1897; Mahantshetty Umesh M, 2006, J Cancer Res Ther, V2, P52; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; McNamara MG, 2013, CURR OPIN ONCOL, V25, P425, DOI 10.1097/CCO.0b013e3283620fd8; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Reddy SK, 2009, SURG ONCOL CLIN N AM, V18, P307, DOI 10.1016/j.soc.2008.12.004; Rybak SM, 2003, CANCER RES, V63, P2812; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Seftor REB, 2001, CANCER RES, V61, P6322; Shirakawa K, 2002, INT J CANCER, V99, P821, DOI 10.1002/ijc.10423; Shukla PJ, 2009, ANN SURG ONCOL, V16, P2084, DOI 10.1245/s10434-009-0541-2; Sood AK, 2004, AM J OBSTET GYNECOL, V190, P899, DOI 10.1016/j.ajog.2004.02.011; Sun BC, 2006, ONCOL REP, V16, P693; Sun W, 2012, ONCOL REP, V27, P1990, DOI 10.3892/or.2012.1746; Sun W, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-46; Thies A, 2001, J PATHOL, V195, P537, DOI 10.1002/path.988; van der Schaft DWJ, 2004, JNCI-J NATL CANCER I, V96, P1473, DOI 10.1093/jnci/djh267; WANG GS, 1989, J ETHNOPHARMACOL, V26, P147, DOI 10.1016/0378-8741(89)90062-7; Warso MA, 2001, CLIN CANCER RES, V7, P473; Yang EB, 1997, CANCER LETT, V117, P93, DOI 10.1016/S0304-3835(97)00206-1; YI SN, 1991, LEUKEMIA RES, V15, P883, DOI 10.1016/0145-2126(91)90163-N; Zhang JT, 2012, INT J ONCOL, V40, P1501, DOI 10.3892/ijo.2011.1314; Zhang SW, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-60	64	19	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96982	10.1371/journal.pone.0096982	http://dx.doi.org/10.1371/journal.pone.0096982			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24811250	gold, Green Submitted, Green Published			2022-12-27	WOS:000338213300100
J	Ian, E; Malko, DB; Sekurova, ON; Bredholt, H; Ruckert, C; Borisova, ME; Albersmeier, A; Kalinowski, J; Gelfand, MS; Zotchev, SB				Ian, Elena; Malko, Dmitry B.; Sekurova, Olga N.; Bredholt, Harald; Rueckert, Christian; Borisova, Marina E.; Albersmeier, Andreas; Kalinowski, Joern; Gelfand, Mikhail S.; Zotchev, Sergey B.			Genomics of Sponge-Associated Streptomyces spp. Closely Related to Streptomyces albus J1074: Insights into Marine Adaptation and Secondary Metabolite Biosynthesis Potential	PLOS ONE			English	Article							TERMINAL INVERTED REPEATS; TRONDHEIM FJORD; GENE-CLUSTER; SEQUENCE; IDENTIFICATION; REVEALS; ANTIBIOTICS; ENTEROCIN; CLONING; SYSTEM	A total of 74 actinomycete isolates were cultivated from two marine sponges, Geodia barretti and Phakellia ventilabrum collected at the same spot at the bottom of the Trondheim fjord (Norway). Phylogenetic analyses of sponge-associated actinomycetes based on the 16S rRNA gene sequences demonstrated the presence of species belonging to the genera Streptomyces, Nocardiopsis, Rhodococcus, Pseudonocardia and Micromonospora. Most isolates required sea water for growth, suggesting them being adapted to the marine environment. Phylogenetic analysis of Streptomyces spp. revealed two isolates that originated from different sponges and had 99.7% identity in their 16S rRNA gene sequences, indicating that they represent very closely related strains. Sequencing, annotation, and analyses of the genomes of these Streptomyces isolates demonstrated that they are sister organisms closely related to terrestrial Streptomyces albus J1074. Unlike S. albus J1074, the two sponge streptomycetes grew and differentiated faster on the medium containing sea water. Comparative genomics revealed several genes presumably responsible for partial marine adaptation of these isolates. Genome mining targeted to secondary metabolite biosynthesis gene clusters identified several of those, which were not present in S. albus J1074, and likely to have been retained from a common ancestor, or acquired from other actinomycetes. Certain genes and gene clusters were shown to be differentially acquired or lost, supporting the hypothesis of divergent evolution of the two Streptomyces species in different sponge hosts.	[Ian, Elena; Sekurova, Olga N.; Bredholt, Harald; Zotchev, Sergey B.] Norwegian Univ Sci & Technol, Dept Biotechnol, N-7034 Trondheim, Norway; [Malko, Dmitry B.] Russian Acad Sci, Dept Computat Biol, NI Vavilov Inst Gen Genet, Moscow, Russia; [Rueckert, Christian; Albersmeier, Andreas; Kalinowski, Joern] Univ Bielefeld, Centrum Biotechnol CeBiTec, D-33615 Bielefeld, Germany; [Borisova, Marina E.; Gelfand, Mikhail S.] Russian Acad Sci, AA Kharkevich Inst Informat Transmiss Problems, Moscow, Russia; [Gelfand, Mikhail S.] Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow, Russia	Norwegian University of Science & Technology (NTNU); Russian Academy of Sciences; Vavilov Institute of General Genetics; University of Bielefeld; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Lomonosov Moscow State University	Zotchev, SB (corresponding author), Norwegian Univ Sci & Technol, Dept Biotechnol, N-7034 Trondheim, Norway.	sergey.zotchev@ntnu.no	Malko, Dmitry/B-9285-2016; Gelfand, Mikhail S/F-3425-2012	Malko, Dmitry/0000-0002-3278-3930; Sekurova, Olga/0000-0001-5034-2015; Gelfand, Mikhail/0000-0003-4181-0846; Ruckert-Reed, Christian/0000-0002-9722-4435; Zotchev, Sergey/0000-0002-9324-245X	Research Council of Norway; Russian state [8049]; RFBR [12-04-01105]; RAS program "Molecular and Cellular Biology''; German Federal Ministry for Education and Research [0316017A]	Research Council of Norway(Research Council of Norway); Russian state; RFBR(Russian Foundation for Basic Research (RFBR)); RAS program "Molecular and Cellular Biology''; German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the Research Council of Norway. DBM, MEB and MSG were partially supported by Russian state contract 8049, RFBR grant 12-04-01105 and RAS program "Molecular and Cellular Biology''. CR acknowledges a grant by the German Federal Ministry for Education and Research (0316017A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angiuoli SV, 2008, OMICS, V12, P137, DOI 10.1089/omi.2008.0017; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Bredholdt H, 2007, ENVIRON MICROBIOL, V9, P2756, DOI 10.1111/j.1462-2920.2007.01387.x; Bucarey SA, 2012, APPL ENVIRON MICROB, V78, P4175, DOI 10.1128/AEM.00577-12; Bull AT, 2007, TRENDS MICROBIOL, V15, P491, DOI 10.1016/j.tim.2007.10.004; Choulet F, 2006, J BACTERIOL, V188, P6599, DOI 10.1128/JB.00734-06; Cruz-Morales P, 2013, GENOME BIOL EVOL, V5, P1165, DOI 10.1093/gbe/evt082; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Dettman JR, 2012, MOL ECOL, V21, P2058, DOI 10.1111/j.1365-294X.2012.05484.x; Freel KC, 2011, APPL ENVIRON MICROB, V77, P7261, DOI 10.1128/AEM.05943-11; GOODFELLOW M, 1983, ANNU REV MICROBIOL, V37, P189, DOI 10.1146/annurev.mi.37.100183.001201; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gordon D., 2003, CURR PROTOC BIOINFOR, V11, P1, DOI DOI 10.1002/0471250953.BI1102S02; Hakvag S, 2008, MAR DRUGS, V6, P620, DOI 10.3390/md6040620; Izumikawa M, 2010, J NAT PROD, V73, P208, DOI 10.1021/np900747t; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Khan ST, 2011, ENVIRON MICROBIOL, V13, P391, DOI 10.1111/j.1462-2920.2010.02337.x; Kinashi H, 2011, J ANTIBIOT, V64, P19, DOI 10.1038/ja.2010.146; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Medema MH, 2010, GENOME BIOL EVOL, V2, P212, DOI 10.1093/gbe/evq013; Mesak LR, 2008, ANTIMICROB AGENTS CH, V52, P3394, DOI 10.1128/AAC.01599-07; MIYAIRI N, 1976, J ANTIBIOT, V29, P227, DOI 10.7164/antibiotics.29.227; NAKAMURA T, 1994, BBA-GENE STRUCT EXPR, V1219, P701, DOI 10.1016/0167-4781(94)90231-3; Olano C, 2014, MICROB BIOTECHNOL, V7, P242, DOI 10.1111/1751-7915.12116; Pang XH, 2004, ANTIMICROB AGENTS CH, V48, P575, DOI 10.1128/AAC.48.2.575-588.2004; Penn K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-86; Penn K, 2009, ISME J, V3, P1193, DOI 10.1038/ismej.2009.58; Piel J, 2000, CHEM BIOL, V7, P943, DOI 10.1016/S1074-5521(00)00044-2; RODICIO MR, 1988, GENE, V74, P39, DOI 10.1016/0378-1119(88)90246-6; SCHLOSSER A, 1993, MOL MICROBIOL, V9, P533, DOI 10.1111/j.1365-2958.1993.tb01714.x; Schneemann I, 2010, APPL ENVIRON MICROB, V76, P3702, DOI 10.1128/AEM.00780-10; Schwientek P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-112; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wolf YI, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-46; Xiong ZQ, 2012, J BACTERIOL, V194, P5474, DOI 10.1128/JB.01247-12; Yim G, 2007, PHILOS T R SOC B, V362, P1195, DOI 10.1098/rstb.2007.2044; Zaburannyi N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-97	39	31	31	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96719	10.1371/journal.pone.0096719	http://dx.doi.org/10.1371/journal.pone.0096719			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819608	Green Published, Green Submitted, gold			2022-12-27	WOS:000336653300027
J	Hertz, JT; Reardon, JM; Rodrigues, CG; de Andrade, L; Limkakeng, AT; Bloomfield, GS; Lynch, CA				Hertz, Julian T.; Reardon, Joseph M.; Rodrigues, Clarissa G.; de Andrade, Luciano; Limkakeng, Alexander T.; Bloomfield, Gerald S.; Lynch, Catherine A.			Acute Myocardial Infarction in Sub-Saharan Africa: The Need for Data	PLOS ONE			English	Article							ISCHEMIC-HEART-DISEASE; STROKE	Background: Trends in the prevalence of acute myocardial infarction in sub-Saharan Africa have not been well described, despite growing recognition of the increasing burden of cardiovascular disease in low- and middle-income countries. The aim of this systematic review was to describe the prevalence of acute myocardial infarction in sub-Saharan Africa. Methods: We searched PubMed, EMBASE, Global Health Archive, CINAHL, and Web of Science, and conducted reference and citation analyses. Inclusion criteria were: observational studies, studies that reported incidence or prevalence of acute myocardial infarction, studies conducted in sub-Saharan Africa, and studies that defined acute myocardial infarction by EKG changes or elevation of cardiac biomarkers. Studies conducted prior to 1992 were excluded. Two independent reviewers analyzed titles and abstracts, full-texts, and references and citations. These reviewers also performed quality assessment and data extraction. Quality assessment was conducted with a validated scale for observational studies. Findings: Of 2292 records retrieved, seven studies met all inclusion criteria. These studies included a total of 92,378 participants from highly heterogeneous study populations in five different countries. Methodological quality assessment demonstrated scores ranging from 3 to 7 points (on an 8-point scale). Prevalence of acute myocardial infarction ranged from 0.1 to 10.4% among the included studies. Interpretation: There is insufficient population-based data describing the prevalence of acute myocardial infarction in sub-Saharan Africa. Well-designed registries and surveillance studies that capture the broad and diverse population with acute myocardial infarction in sub-Saharan Africa using common diagnostic criteria are critical in order to guide prevention and treatment strategies. Registration: Registered in International Prospective Register of Systematic Reviews (PROSPERO) Database #CRD42012003161.	[Hertz, Julian T.] Vanderbilt Univ, Dept Emergency Med, Nashville, TN 37235 USA; [Reardon, Joseph M.; Limkakeng, Alexander T.; Lynch, Catherine A.] Duke Univ, Div Emergency Med, Durham, NC 27708 USA; [Bloomfield, Gerald S.] Duke Univ, Div Cardiol, Durham, NC USA; [Bloomfield, Gerald S.] Duke Univ, Duke Clin Res Inst, Durham, NC USA; [Bloomfield, Gerald S.; Lynch, Catherine A.] Duke Univ, Global Hlth Inst, Durham, NC USA; [Rodrigues, Clarissa G.; de Andrade, Luciano] Duke Univ, Dept Surg, Durham, NC USA; [Rodrigues, Clarissa G.] Fundacao Univ Cardiol, Inst Cardiol RS, Porto Alegre, RS, Brazil; [de Andrade, Luciano] Univ Estadual Oeste Parana UNIOESTE, Foz Do Iguacu, PR, Brazil	Vanderbilt University; Duke University; Duke University; Duke University; Duke University; Duke University; Fundacao Universitaria de Cardiologia; Universidade Estadual do Oeste do Parana	Lynch, CA (corresponding author), Duke Univ, Div Emergency Med, Durham, NC 27708 USA.	Catherine.Lynch@duke.edu	Limkakeng, Alexander T./AAH-7733-2020; Reardon, Joseph/I-4419-2012	Limkakeng, Alexander T./0000-0002-9822-5595; Hertz, Julian/0000-0002-7396-4789; Reardon, Joseph/0000-0002-1093-5518; Bloomfield, Gerald/0000-0002-7176-1611; Staton, Catherine/0000-0002-6468-2894	Duke Department of Surgery	Duke Department of Surgery	There were no external funding sources. Funding to obtain included articles was provided by Duke Department of Surgery. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo J, 2007, HYPERTENSION, V50, P1012, DOI 10.1161/HYPERTENSIONAHA.107.093336; Ahmed AM, 2000, PRACTICAL DIABETES I, V17, P41; Ansa V, 2008, E AFR MED J, V84, P318, DOI DOI 10.4314/eamj.v84i7.9586; BOGOUSSLAVSKY J, 1988, STROKE, V19, P1083, DOI 10.1161/01.STR.19.9.1083; Booth A, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-2; Bule V, 2010, NATL HOP DISCHARGE S; Gaziano TA, 2010, CURR PROB CARDIOLOGY, V35, P72, DOI 10.1016/j.cpcardiol.2009.10.002; Greer S, 2010, ATLAS HEART DIS HOSP; GROEGER JS, 1993, CRIT CARE MED, V21, P279, DOI 10.1097/00003246-199302000-00022; Joubert J, 2000, STROKE, V31, P1294, DOI 10.1161/01.STR.31.6.1294; Kaduka LU, 2012, DIABETES CARE, V35, P887, DOI 10.2337/dc11-0537; Kolo P M, 2013, Niger Postgrad Med J, V20, P5; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Loney PL, 2000, CHRONIC DIS CAN, V9; Mbewu A, 2006, DISEASE AND MORTALITY IN SUB-SAHARAN AFRICA, 2ND EDITION, P305; Mensah GA, 2008, HEART, V94, P836, DOI 10.1136/hrt.2007.136523; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Moran AE, 2012, GLOB HEART, V7, P315, DOI 10.1016/j.gheart.2012.10.004; Nguchu H K, 2009, East Afr Med J, V86, P463; Quantum GIS Development Team, 2011, DEV TEAM 2012 QUANT; R Development Core Team, 2005, R LANG ENV STAT COMP; Robertson C, 2010, EMERG INFECT DIS, V16, P1524, DOI 10.3201/eid1610.100249; Sani M, 2013, COMMUNICATION; Sani M U, 2006, Niger J Med, V15, P128; Seck M, 2007, Med Trop (Mars), V67, P569; Shavadia J, 2012, CARDIOVASC J AFR, V23, P318, DOI 10.5830/CVJA-2012-002; Sonderegger-Iseli K, 2000, LANCET, V355, P2027, DOI 10.1016/S0140-6736(00)02349-7; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Tibazarwa K, 2009, INT J CARDIOL, V132, P233, DOI 10.1016/j.ijcard.2007.11.067; Walker ARP, 2004, J R SOC PROMO HEALTH, V124, P40, DOI 10.1177/146642400312400112; WHO, 2002, RED RISKS PROM HLTH	31	37	37	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96688	10.1371/journal.pone.0096688	http://dx.doi.org/10.1371/journal.pone.0096688			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816222	gold, Green Submitted, Green Published			2022-12-27	WOS:000336838000051
J	Hu, H; Duan, ZH; Long, XR; Hertzanu, Y; Shi, HB; Liu, S; Yang, ZQ				Hu, Hao; Duan, Zhenhua; Long, Xiaoran; Hertzanu, Yancu; Shi, Haibin; Liu, Sheng; Yang, Zhengqiang			Sorafenib Combined with Transarterial Chemoembolization versus Transarterial Chemoembolization Alone for Advanced-Stage Hepatocellular Carcinoma: A Propensity Score Matching Study	PLOS ONE			English	Article							MAIN PORTAL-VEIN; PHASE-II; PROGNOSIS; EFFICACY; SAFETY	Aims: The purpose of the present study was to compare the efficacies of transarterial chemoembolization (TACE) combined with sorafenib versus TACE monotherapy for treating patients with advanced hepatocellular carcinoma (HCC). Methods: We enrolled 321 patients and selected 280 with advanced HCC (Barcelona Clinic Liver Cancer stage C) who underwent TACE therapy between February 2009 and February 2013. TACE alone (monotherapy group) was administered to 198 patients (70.7%), and the remaining 82 (29.3%) underwent repeat combined TACE and sorafenib therapy (combined group). To minimize selection bias, these latter 82 patients were matched using propensity-score matching at a 1:2 ratio with 164 patients who received TACE monotherapy. The primary endpoints were overall survival (OS) and related subgroup analysis. The secondary endpoints were time to progression (TTP) and treatment-related adverse events. Results: Of the respective patients in the combined and monotherapy groups, 64.6% and 49.2% had vascular invasion, 87.8% and 91.1% had extrahepatic metastasis, and 54.3% and 47.1% had both. In the propensity-score-matched cohort, the OS survival of the combined group was significantly higher compared with the monotherapy group (7.0 months vs. 4.9 months, respectively, P = 0.003). The TTP was significantly longer in the combined group (2.6 months vs. 1.9 months, respectively, P = 0.001). Subgroup analysis showed that the outcomes of patients with advanced HCC without main portal vein invasion who were treated with combined therapy were significantly better compared with those who received monotherapy (P<0.05). Univariate and subsequent multivariate analyses revealed that the addition of sorafenib was an independent predictor of favorable OS and TTP (adjusted hazard ratios, 0.63 and 0.62, respectively; P<0.05 for both). Conclusion: Sorafenib plus TACE was more effective than TACE monotherapy for treating patients with advanced HCC without main portal vein invasion. Future trials with larger samples are required to validate these preliminary findings.	[Hu, Hao; Shi, Haibin; Liu, Sheng; Yang, Zhengqiang] Nanjing Med Univ, Affiliated Hosp 1, Dept Intervent Radiol, Nanjing, Jiangsu, Peoples R China; [Duan, Zhenhua] Chengdu Ctr Dis Control & Prevent, Chengdu, Peoples R China; [Long, Xiaoran] Anhui Med Univ, Sch Pharm, Hefei, Peoples R China; [Hertzanu, Yancu] Ben Gurion Univ Negev, Fac Hlth Sci, IL-84105 Beer Sheva, Israel	Nanjing Medical University; Anhui Medical University; Ben Gurion University	Yang, ZQ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Intervent Radiol, Nanjing, Jiangsu, Peoples R China.	olivialong@sina.cn	Duan, Zhenhua/GRJ-2294-2022					Bai W, 2013, J DIGEST DIS; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Chung GE, 2011, RADIOLOGY, V258, P627, DOI 10.1148/radiol.10101058; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Georgiades CS, 2005, J VASC INTERV RADIOL, V16, P1653, DOI 10.1097/01.RVI.0000182185.47500.7A; Kim JE, 2012, ONCOLOGY-BASEL, V82, P119, DOI 10.1159/000336082; Kim KM, 2009, J GASTROEN HEPATOL, V24, P806, DOI 10.1111/j.1440-1746.2008.05728.x; Kim Sung Eun, 2011, Korean J Hepatol, V17, P113, DOI 10.3350/kjhep.2011.17.2.113; Kudo M, 2011, EUR J CANCER, V47, P2117, DOI 10.1016/j.ejca.2011.05.007; Kurth T, 2006, AM J EPIDEMIOL, V163, P262, DOI 10.1093/aje/kwj047; Lee HS, 1997, CANCER-AM CANCER SOC, V79, P2087, DOI 10.1002/(SICI)1097-0142(19970601)79:11<2087::AID-CNCR5>3.0.CO;2-M; Lee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077240; Leuven Edwin., 2003, PSMATCH2 STATA MODUL; Liao MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068453; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Luo J, 2011, ANN SURG ONCOL, V18, P413, DOI 10.1245/s10434-010-1321-8; Muhammad A, 2013, WORLD J HEPATOL, V5, P364, DOI 10.4254/wjh.v5.i7.364; Okusaka T, 1997, HEPATO-GASTROENTEROL, V44, P251; Park JW, 2012, J HEPATOL, V56, P1336, DOI 10.1016/j.jhep.2012.01.006; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Pawlik TM, 2011, J CLIN ONCOL, V29, P3960, DOI 10.1200/JCO.2011.37.1021; Pinter M, 2012, RADIOLOGY, V263, P590, DOI 10.1148/radiol.12111550; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Takayasu K, 2006, GASTROENTEROLOGY, V131, P461, DOI 10.1053/j.gastro.2006.05.021; Takayasu K, 2010, AM J ROENTGENOL, V194, P830, DOI 10.2214/AJR.09.3308; Uka K, 2007, WORLD J GASTROENTERO, V13, P414, DOI 10.3748/wjg.v13.i3.414	28	46	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96620	10.1371/journal.pone.0096620	http://dx.doi.org/10.1371/journal.pone.0096620			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24817002	gold, Green Submitted, Green Published			2022-12-27	WOS:000336838000047
J	Joshi, SR; Anjana, RM; Deepa, M; Pradeepa, R; Bhansali, A; Dhandania, VK; Joshi, PP; Unnikrishnan, R; Nirmal, E; Subashini, R; Madhu, V; Rao, PV; Das, AK; Kaur, T; Shukla, DK; Mohan, V				Joshi, Shashank R.; Anjana, Ranjit Mohan; Deepa, Mohan; Pradeepa, Rajendra; Bhansali, Anil; Dhandania, Vinay K.; Joshi, Prashant P.; Unnikrishnan, Ranjit; Nirmal, Elangovan; Subashini, Radhakrishnan; Madhu, Venkata; Rao, Paturi Vishnupriya; Das, Ashok Kumar; Kaur, Tanvir; Shukla, Deepak Kumar; Mohan, Viswanathan		ICMR-INDIAB Collaborative Study	Prevalence of Dyslipidemia in Urban and Rural India: The ICMR-INDIAB Study	PLOS ONE			English	Article							CORONARY-ARTERY DISEASE; RISK-FACTORS; EPIDEMIOLOGIC TRANSITION; CARDIOVASCULAR-DISEASES; POPULATION; OBESITY	Aim: To study the pattern and prevalence of dyslipidemia in a large representative sample of four selected regions in India. Methods: Phase I of the Indian Council of Medical Research-India Diabetes (ICMR-INDIAB) study was conducted in a representative population of three states of India [Tamil Nadu, Maharashtra and Jharkhand] and one Union Territory [ Chandigarh], and covered a population of 213 million people using stratified multistage sampling design to recruit individuals >= 20 years of age. All the study subjects (n = 16,607) underwent anthropometric measurements and oral glucose tolerance tests were done using capillary blood (except in self-reported diabetes). In addition, in every 5th subject (n = 2042), a fasting venous sample was collected and assayed for lipids. Dyslipidemia was diagnosed using National Cholesterol Education Programme (NCEP) guidelines. Results: Of the subjects studied, 13.9% had hypercholesterolemia, 29.5% had hypertriglyceridemia, 72.3% had low HDL-C, 11.8% had high LDL-C levels and 79% had abnormalities in one of the lipid parameters. Regional disparity exists with the highest rates of hypercholesterolemia observed in Tamilnadu (18.3%), highest rates of hypertriglyceridemia in Chandigarh (38.6%), highest rates of low HDL-C in Jharkhand (76.8%) and highest rates of high LDL-C in Tamilnadu (15.8%). Except for low HDL-C and in the state of Maharashtra, in all other states, urban residents had the highest prevalence of lipid abnormalities compared to rural residents. Low HDL-C was the most common lipid abnormality (72.3%) in all the four regions studied; in 44.9% of subjects, it was present as an isolated abnormality. Common significant risk factors for dyslipidemia included obesity, diabetes, and dysglycemia. Conclusion: The prevalence of dyslipidemia is very high in India, which calls for urgent lifestyle intervention strategies to prevent and manage this important cardiovascular risk factor.	[Joshi, Shashank R.] Lilavati Hosp, Mumbai, Maharashtra, India; [Anjana, Ranjit Mohan; Deepa, Mohan; Pradeepa, Rajendra; Unnikrishnan, Ranjit; Nirmal, Elangovan; Subashini, Radhakrishnan; Mohan, Viswanathan] Madras Diabet Res Fdn, Chennai, Tamil Nadu, India; [Anjana, Ranjit Mohan; Deepa, Mohan; Pradeepa, Rajendra; Unnikrishnan, Ranjit; Nirmal, Elangovan; Subashini, Radhakrishnan; Mohan, Viswanathan] WHO Collaborating Ctr Noncommunicable Dis Prevent, Dr Mohans Diabet Special Ctr, Chennai, Tamil Nadu, India; [Anjana, Ranjit Mohan; Deepa, Mohan; Pradeepa, Rajendra; Unnikrishnan, Ranjit; Nirmal, Elangovan; Subashini, Radhakrishnan; Mohan, Viswanathan] IDF Ctr Educ, Chennai, Tamil Nadu, India; [Bhansali, Anil] Postgrad Inst Med Educ & Res, Chandigarh 160012, India; [Dhandania, Vinay K.] Diabet Care Ctr, Ranchi, Bihar, India; [Joshi, Prashant P.] Indira Gandhi Govt Med Coll, Nagpur, Maharashtra, India; [Madhu, Venkata] Univ Coll Med Sci, Delhi 110095, India; [Madhu, Venkata] GTB Hosp, Delhi, India; [Rao, Paturi Vishnupriya] Nizams Inst Med Sci, Hyderabad, Andhra Pradesh, India; [Das, Ashok Kumar] Jawaharlal Inst Postgrad Med Educ & Res, Dept Med, Pondicherry, India; [Kaur, Tanvir; Shukla, Deepak Kumar] Indian Council Med Res, New Delhi, India	Madras Diabetes Research Foundation; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; University of Delhi; University College of Medical Sciences; University of Delhi; University College of Medical Sciences; Nizam's Institute of Medical Sciences; Jawaharlal Institute of Postgraduate Medical Education & Research; Indian Council of Medical Research (ICMR)	Mohan, V (corresponding author), Madras Diabet Res Fdn, Chennai, Tamil Nadu, India.	drmohans@diabetes.ind.in	Madhu, S/AAH-7431-2019; Das, Ashok Kumar Umar/K-7202-2017	Madhu, S/0000-0003-0018-5984; Pradeepa, Rajendra/0000-0002-4909-3733	Indian Council of Medical Research, New Delhi [55/1/TF/Diab./07-NCD-II]; Indian Council of Medical Research	Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR)); Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This study was funded by the Indian Council of Medical Research, New Delhi (No. 55/1/TF/Diab./07-NCD-II). The funders, Indian Council of Medical Research, provided expertise in designing the study and revising the manuscript critically for important intellectual content.	Anjana RM, 2011, DIABETOLOGIA, V54, P3022, DOI 10.1007/s00125-011-2291-5; Anjana Ranjit Mohan, 2011, J Diabetes Sci Technol, V5, P906; Bull FC, 2009, J PHYS ACT HEALTH, V6, P790, DOI 10.1123/jpah.6.6.790; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Costa J, 2006, BMJ-BRIT MED J, V332, P1115, DOI 10.1136/bmj.38793.468449.AE; Deepa R, 2006, TYPE 2 DIABETES S AS, P138; ENAS EA, 1992, AM J CARDIOL, V70, P945, DOI 10.1016/0002-9149(92)90744-J; Erem C, 2008, ENDOCRINE, V34, P36, DOI 10.1007/s12020-008-9100-z; Fuster, 2010, PROMOTING CARDIOVASC; Grundy SM, 1997, CIRCULATION, V95, P1, DOI 10.1161/01.CIR.95.1.1; Gupta R, 1997, J Assoc Physicians India, V45, P275; Haffner SM, 1999, AM J CARDIOL, V83, p17F; Joshi Rajnish, 2013, J Cardiovasc Dis Res, V4, P140, DOI 10.1016/j.jcdr.2013.03.002; Khader YS, 2010, J CLIN LIPIDOL, V4, P53, DOI 10.1016/j.jacl.2009.12.004; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; Misra A, 2004, J Assoc Physicians India, V52, P137; Misra A, 2001, INT J OBESITY, V25, P1722, DOI 10.1038/sj.ijo.0801748; Misra R, 2010, J DIABETES COMPLICAT, V24, P145, DOI 10.1016/j.jdiacomp.2009.01.003; Mohan V, 2001, J AM COLL CARDIOL, V38, P682, DOI 10.1016/S0735-1097(01)01415-2; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Parikh RM, 2010, DIABETES METAB SYND, V4, P10, DOI 10.1016/j.dsx.2009.04.005; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Reddy KS, 2006, B WORLD HEALTH ORGAN, V84, P461, DOI 10.2471/BLT.05.027037; Rose GA, 1982, CARDIOVASCULAR SURVE, P124; Sample Registration System, 2007, MILL DEATH STUD PREL; Sharma U, 2013, J CLIN LIPIDOL, V7, P653, DOI 10.1016/j.jacl.2013.06.003; World Health Organization, 2006, DEF DIAGN DIAB MELL, P39; World Health Organization, 2000, ASI PAC PERSP RED OB; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488; Zahid N, 2008, DIABETES METAB SYND, V2, P13, DOI 10.1016/j.dsx.2007.11.001	31	160	163	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96808	10.1371/journal.pone.0096808	http://dx.doi.org/10.1371/journal.pone.0096808			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24817067	Green Submitted, Green Published, gold			2022-12-27	WOS:000336838000068
J	Huang, CB; Li, XD				Huang, Chaobin; Li, Xiangdong			Maternal Cypermethrin Exposure during the Perinatal Period Impairs Testicular Development in C57BL Male Offspring	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; ENDOCRINE-DISRUPTING CHEMICALS; ANDROGEN RECEPTOR; URINARY CONCENTRATIONS; RETINOIC ACID; MALE-MOUSE; MALE-MICE; PYRETHROID INSECTICIDES; REPRODUCTIVE-ORGANS; OXIDATIVE STRESS	Numerous studies have demonstrated that endocrine-disrupting compounds (EDC) are a possible cause of male reproductive organ malfunction and malformation. Cypermethrin (CYP) is a widely used synthetic pyrethroid and a potential EDC. This study aimed to examine the effects of perinatal exposure to low-dose CYP on the development and function of the offspring testes. Pregnant mice were intragastrically administered 0.12 to 12 mg/kg/day CYP from embryonic day 0.5 (E0.5) to weaning (PD21.5, postnatal day 21.5). Maternal exposure to 0.12, 1.2, and 12 mg/kg/day CYP affected the body and organ weight of the offspring. Exposure of CYP led to a dose-dependent decrease in the male-to-female sex ratio. A histopathological analysis revealed a thinner seminiferous epithelium layer at PD21.5, interstitial hyperplasia at PD45.5, and germ cell vacuolization at PD90.5 in the 12 mg/kg/day CYP group. The TUNEL assay results revealed increased germ cell apoptosis in the 12 mg/kg/day CYP group. The serum testosterone (T) level decreased, whereas the estradiol level increased with age in the 1.2 and 12 mg/kg/day CYP groups. The RT-PCR analysis demonstrated decreased expression of T production-related, mitosis-related, and meiosis-related genes in the 1.2 and 12 mg/kg/day CYP groups. The in vitro experimental results demonstrated reduced expression of steroidogenesis genes and decreased T levels. It is concluded that perinatal exposure to low-dose CYP affects testes development and function in adults.	[Huang, Chaobin; Li, Xiangdong] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China	China Agricultural University	Li, XD (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	xiangdongli@cau.edu.cn		Li, Xiangdong/0000-0003-2261-2393	China 973 Project [2011CB504703, 2010CB945404]	China 973 Project(National Basic Research Program of China)	This work was supported by the China 973 Project (Grant No. 2011CB504703 and 2010CB945404, http://www.most.gov.cn/) to XL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2009, EXP TOXICOL PATHOL, V61, P339, DOI 10.1016/j.etp.2008.10.002; Al-Hamdani NMH, 2010, ECOTOX ENVIRON SAFE, V73, P1092, DOI 10.1016/j.ecoenv.2010.04.009; Andersen HR, 2008, ENVIRON HEALTH PERSP, V116, P566, DOI 10.1289/ehp.10790; Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI [10.1073/pnas.0807297105, 10.1038/s41598-019-45839-z]; Barr DB, 2010, ENVIRON HEALTH PERSP, V118, P742, DOI 10.1289/ehp.0901275; Becker K, 2006, INT J HYG ENVIR HEAL, V209, P221, DOI 10.1016/j.ijheh.2005.12.002; Bedi JS, 2013, SCI TOTAL ENVIRON, V463, P720, DOI 10.1016/j.scitotenv.2013.06.066; BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; Berteau Peter E, 1988, INSECTICIDE ABSORPTI, P315; BHUNYA SP, 1988, TOXICOL LETT, V41, P223, DOI 10.1016/0378-4274(88)90058-6; Bigsby R, 1999, ENVIRON HEALTH PERSP, V107, P613, DOI 10.2307/3434553; Blanco-Rodriguez J, 1998, INT J ANDROL, V21, P109; Carbone P, 2007, INT J ANDROL, V30, P3, DOI 10.1111/j.1365-2605.2006.00703.x; Caserta D, 2008, HUM REPROD UPDATE, V14, P59, DOI 10.1093/humupd/dmm025; Centers for Disease Control (CDC), 1989, MMWR Morb Mortal Wkly Rep, V38, P345; Cheek AO, 1998, ENVIRON HEALTH PERSP, V106, P5, DOI 10.2307/3433910; Choi H, 2006, ARCH ENVIRON CON TOX, V50, P437, DOI 10.1007/s00244-005-1050-3; COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890; Dohle GR, 2003, WORLD J UROL, V21, P341, DOI 10.1007/s00345-003-0365-9; El-Gohary M, 1999, TOXICOLOGY, V132, P1, DOI 10.1016/S0300-483X(98)00114-0; Elbetieha A, 2001, ARCH ENVIRON CON TOX, V41, P522, DOI 10.1007/s002440010280; Fisher JS, 1997, J ENDOCRINOL, V153, P485, DOI 10.1677/joe.0.1530485; GRECO TL, 1992, ENDOCRINOLOGY, V130, P421, DOI 10.1210/en.130.1.421; Hannas BR, 2012, TOXICOL SCI, V125, P544, DOI 10.1093/toxsci/kfr315; HIKIM APS, 1995, ENDOCRINOLOGY, V136, P2770, DOI 10.1210/en.136.6.2770; Holdcraft RW, 2004, INT J ANDROL, V27, P335, DOI 10.1111/j.1365-2605.2004.00502.x; Hu JX, 2013, J APPL TOXICOL, V33, P576, DOI 10.1002/jat.1769; Hu JX, 2012, TOXICOLOGY, V292, P99, DOI 10.1016/j.tox.2011.11.019; Jaensson A, 2007, AQUAT TOXICOL, V81, P1, DOI 10.1016/j.aquatox.2006.10.011; James WH, 2006, ENVIRON RES, V100, P77, DOI 10.1016/j.envres.2005.03.001; James WH, 2008, J ENDOCRINOL, V198, P3, DOI 10.1677/JOE-07-0446; Jin YX, 2011, CHEMOSPHERE, V84, P124, DOI 10.1016/j.chemosphere.2011.02.034; Khan DA, 2010, ENVIRON MONIT ASSESS, V168, P231, DOI 10.1007/s10661-009-1107-2; Kjeldsen LS, 2013, TOXICOL APPL PHARM, V272, P453, DOI 10.1016/j.taap.2013.06.028; Kjeldsen LS, 2013, TOXICOL APPL PHARM; Komarek M, 2010, ENVIRON INT, V36, P138, DOI 10.1016/j.envint.2009.10.005; KRISHNAN AV, 1993, ENDOCRINOLOGY, V132, P2279, DOI 10.1210/en.132.6.2279; Kristensen F, 1997, EPIDEMIOLOGY, V8, P537, DOI 10.1097/00001648-199709000-00011; Kumari B, 2008, ENVIRON MONIT ASSESS, V136, P239, DOI 10.1007/s10661-007-9679-1; Laabs V, 2002, J ENVIRON QUAL, V31, P1636, DOI 10.2134/jeq2002.1636; LeBlanc LA, 2008, HYDROBIOLOGIA, V604, P151, DOI 10.1007/s10750-008-9316-1; Li XD, 2001, ENDOCRINOLOGY, V142, P2435, DOI 10.1210/en.142.6.2435; Li XD, 2008, GEN COMP ENDOCR, V159, P1, DOI 10.1016/j.ygcen.2008.07.025; Lin W, 2011, AM J PATHOL, V178, P1233, DOI 10.1016/j.ajpath.2010.11.056; Liu D, 1998, NAT GENET, V20, P377, DOI 10.1038/3855; Lolicato F, 2008, DEV BIOL, V313, P725, DOI 10.1016/j.ydbio.2007.11.011; Lu DS, 2013, ENVIRON INT, V60, P137, DOI 10.1016/j.envint.2013.08.004; Ma A, 2008, REPROD TOXICOL, V25, P367, DOI 10.1016/j.reprotox.2007.12.007; Mendis-Handagama SMLC, 2001, BIOL REPROD, V65, P660, DOI 10.1095/biolreprod65.3.660; Merlet J, 2007, CELL CYCLE, V6, P2258, DOI 10.4161/cc.6.18.4654; Mocarelli P, 2000, LANCET, V355, P1858, DOI 10.1016/S0140-6736(00)02290-X; Nielsen M, 2000, J REPROD FERTIL, V118, P195, DOI 10.1530/reprod/118.1.195; O'Donnell L, 2001, ENDOCR REV, V22, P289, DOI 10.1210/er.22.3.289; OuladAbdelghani M, 1996, J CELL BIOL, V135, P469, DOI 10.1083/jcb.135.2.469; Pelletier G, 2000, J ENDOCRINOL, V165, P359, DOI 10.1677/joe.0.1650359; Rey RA, 2009, MICROSC RES TECHNIQ, V72, P787, DOI 10.1002/jemt.20754; Rodriguez H, 2009, ECOTOX ENVIRON SAFE, V72, P658, DOI 10.1016/j.ecoenv.2008.03.015; Roy AK, 1999, VITAM HORM, V55, P309; RUSSELL HH, 1987, WESTERN J MED, V147, P615; Schrader M, 2002, HUM REPROD, V17, P2338, DOI 10.1093/humrep/17.9.2338; Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972; Song L, 2008, J TOXICOL ENV HEAL A, V71, P325, DOI 10.1080/15287390701738517; Stephan H, 1996, HISTOCHEM CELL BIOL, V106, P383; Sun H, 2007, CHEMOSPHERE, V66, P474, DOI 10.1016/j.chemosphere.2006.05.059; Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100; Symonds DA, 2005, TOXICOL SCI, V83, P355, DOI 10.1093/toxsci/kfi024; Ueyama J, 2009, ENVIRON RES, V109, P175, DOI 10.1016/j.envres.2008.09.006; Wallis MC, 2008, CELL MOL LIFE SCI, V65, P3182, DOI 10.1007/s00018-008-8109-z; Wang H, 2011, ENVIRON TOXICOL, V26, P382, DOI 10.1002/tox.20566; Weidner IS, 1998, ENVIRON HEALTH PERSP, V106, P793, DOI 10.2307/3434122; Wielgomas B, 2013, INT J HYG ENVIR HEAL, V216, P295, DOI 10.1016/j.ijheh.2012.09.001; Wohlfahrt-Veje C, 2011, ENV HLTH, V10, P10; Wu Wei, 2008, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V26, P193; Zhang GL, 2013, REPROD FERT DEVELOP, V25, P847, DOI 10.1071/RD12159; Zhou Q, 2008, BIOL REPROD, V79, P35, DOI 10.1095/biolreprod.107.066795; ZOBER A, 1995, OCCUP ENVIRON MED, V52, P233, DOI 10.1136/oem.52.4.233	76	22	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96781	10.1371/journal.pone.0096781	http://dx.doi.org/10.1371/journal.pone.0096781			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810582	Green Published, gold, Green Submitted			2022-12-27	WOS:000338213300072
J	Hutchinson, SG; Kuijlaars, JS; Mesters, I; Muris, JWM; van Schayck, CP; Dompeling, E; Feron, FJM				Hutchinson, Sasha G.; Kuijlaars, Jennifer S.; Mesters, Ilse; Muris, Jean W. M.; van Schayck, Constant P.; Dompeling, Edward; Feron, Frans J. M.			Addressing Passive Smoking in Children	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; FAMILY-PHYSICIANS; PARENTAL SMOKING; 2ND-HAND SMOKE; YOUNG-CHILDREN; PEDIATRICIANS; EXPOSURE; INTERVENTION; ASTHMA; PREVENTION	Background: A significant number of parents are unaware or unconvinced of the health consequences of passive smoking (PS) in children. Physicians could increase parental awareness by giving personal advice. Aim: To evaluate the current practices of three Dutch health professions (paediatricians, youth health care physicians, and family physicians) regarding parental counselling for passive smoking (PS) in children. Methods: All physicians (n = 720) representing the three health professions in Limburg, the Netherlands, received an invitation to complete a self-administered electronic questionnaire including questions on their: sex, work experience, personal smoking habits, counselling practices and education regarding PS in children. Results: The response rate was 34%. One tenth (11%) of the responding physicians always addressed PS in children, 32% often, 54% occasionally and 4% reported to never attend to it. The three health professions appeared comparable regarding their frequency of parental counselling for PS in children. Addressing PS was more likely when children had respiratory problems. Lack of time was the most frequently mentioned barrier, being very and somewhat applicable for respectively 14% and 43% of the physicians. One fourth of the responders had received postgraduate education about PS. Additionally, 49% of the responders who did not have any education about PS were interested in receiving it. Conclusions: Physicians working in the paediatric field in Limburg, the Netherlands, could more frequently address PS in children with parents. Lack of time appeared to be the most mentioned barrier and physicians were more likely to counsel parents for PS in children with respiratory complaints/diseases. Finally, a need for more education on parental counselling for PS was expressed.	[Hutchinson, Sasha G.; Kuijlaars, Jennifer S.; Dompeling, Edward] Maastricht Univ Med Ctr, Dept Paediat Pulmonol, CAPHRI Sch Publ Hlth & Primary Care, Maastricht, Netherlands; [Mesters, Ilse] Maastricht Univ Med Ctr, CAPHRI Sch Publ Hlth & Primary Care, Dept Epidemiol, Maastricht, Netherlands; [Muris, Jean W. M.; van Schayck, Constant P.] Maastricht Univ Med Ctr, CAPHRI Sch Publ Hlth & Primary Care, Dept Family Med, Maastricht, Netherlands; [Feron, Frans J. M.] Maastricht Univ Med Ctr, CAPHRI Sch Publ Hlth & Primary Care, Dept Social Med, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC)	Hutchinson, SG (corresponding author), Maastricht Univ Med Ctr, Dept Paediat Pulmonol, CAPHRI Sch Publ Hlth & Primary Care, Maastricht, Netherlands.	sasha.hutchinson@maastrichtuniversity.nl	mesters, Ilse/AAN-2824-2021; Feron, Frans J.M./B-1748-2014	mesters, Ilse/0000-0003-0605-6286; Muris, Jean/0000-0002-8780-476X; Mesters, Ilse/0000-0001-8940-5271	Dutch Asthma Foundation [3.4.08.047]; Netherlands Organization for Health Research and Development (ZonMw) [VEMI 08-82305-97-12022]	Dutch Asthma Foundation; Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This research is part of the PREPASE study funded by the Dutch Asthma Foundation (grant 3.4.08.047) and the Netherlands Organization for Health Research and Development (ZonMw) (grant VEMI 08-82305-97-12022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, MONITOR ARBEIDSMARKT; Binns HJ, 2009, PATIENT EDUC COUNS, V74, P272, DOI 10.1016/j.pec.2008.09.001; Boldo E, 2010, PUBLIC HEALTH REP, V125, P478, DOI 10.1177/003335491012500317; Breuning-Boers Jacqueline M, 2012, Ned Tijdschr Geneeskd, V156, pA5204; Browning KK, 2008, NICOTINE TOB RES, V10, P55, DOI 10.1080/14622200701704905; Cheraghi M, 2009, EUR J PEDIATR, V168, P897, DOI 10.1007/s00431-009-0967-3; Collins BN, 2007, J PEDIATR-US, V150, P547, DOI 10.1016/j.jpeds.2007.01.006; Crone Matty R, 2010, Ned Tijdschr Geneeskd, V154, pA1658; Crone MR, 2006, HEALTH EDUC BEHAV, V33, P178, DOI 10.1177/1090198105276296; Crone MR, 2003, EUR J PUBLIC HEALTH, V13, P269, DOI 10.1093/eurpub/13.3.269; Crone MR, 1995, TIJDSCHR JEUGDGEZOND, V27, P59; Dodge RAB, 2008, CLIN PEDIATR, V47, P237, DOI 10.1177/0009922807308182; Fishbein M., 2010, PREDICTING CHANGING, DOI 10.4324/9780203838020; FRANKOWSKI BL, 1993, PEDIATRICS, V91, P296; Garg A, 2007, CLIN PEDIATR, V46, P252, DOI 10.1177/0009922806290694; Gartner CE, 2013, TOB CONTROL, V22, P344, DOI 10.1136/tobaccocontrol-2011-050297; Groner JA, 2000, PEDIATRICS, V105, P267; Hutchinson SG, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-177; Hymowitz N, 2006, J NATL MED ASSOC, V98, P190; Hymowitz N, 2006, J NATL MED ASSOC, V98, P1489; International Tobacco Control Policy Evaluation Project, 2011, ITC NETH SURV REP SM; Kuiper S, 2005, PEDIAT ALLERG IMM-UK, V16, P321, DOI 10.1111/j.1399-3038.2005.00278.x; Kuiper S, 2007, J ALLERGY CLIN IMMUN, V120, P388, DOI 10.1016/j.jaci.2007.03.038; Lannero E, 2008, THORAX, V63, P172, DOI 10.1136/thx.2007.079053; Ministerie van Volksgezondheid Welzijn en Sport (Ministry of Health Welfare and Sport), 2012, BASISTAKENPAKKET JEU; Moss D, 2006, NICOTINE TOB RES, V8, P67, DOI 10.1080/14622200500431809; Norman G, 2010, ADV HEALTH SCI EDUC, V15, P625, DOI 10.1007/s10459-010-9222-y; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; Perez-Stable EJ, 2001, ARCH PEDIAT ADOL MED, V155, P25, DOI 10.1001/archpedi.155.1.25; Pisinger C, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-65; van de Kant KDG, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-210; Victor JC, 2010, CAN FAM PHYSICIAN, V56, P157; Vork KL, 2007, ENVIRON HEALTH PERSP, V115, P1394, DOI 10.1289/ehp.10155; Winickoff JP, 2008, PEDIATRICS, V122, pE363, DOI 10.1542/peds.2008-0478; Winickoff JP, 2003, PEDIATRICS, V112, P1146, DOI 10.1542/peds.112.5.1146; Zapka JC, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.5.e65	36	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e93220	10.1371/journal.pone.0093220	http://dx.doi.org/10.1371/journal.pone.0093220			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809443	Green Published, gold, Green Submitted			2022-12-27	WOS:000338213300002
J	Komarov, I; Dashti, A; D'Souza, RM				Komarov, Ivan; Dashti, Ali; D'Souza, Roshan M.			Fast k-NNG Construction with GPU-Based Quick Multi-Select	PLOS ONE			English	Article							NEAREST-NEIGHBOR GRAPHS	In this paper, we describe a new brute force algorithm for building the k-Nearest Neighbor Graph (k-NNG). The k-NNG algorithm has many applications in areas such as machine learning, bio-informatics, and clustering analysis. While there are very efficient algorithms for data of low dimensions, for high dimensional data the brute force search is the best algorithm. There are two main parts to the algorithm: the first part is finding the distances between the input vectors, which may be formulated as a matrix multiplication problem; the second is the selection of the k-NNs for each of the query vectors. For the second part, we describe a novel graphics processing unit (GPU)-based multi-select algorithm based on quick sort. Our optimization makes clever use of warp voting functions available on the latest GPUs along with user-controlled cache. Benchmarks show significant improvement over state-of-the-art implementations of the k-NN search on GPUs.	[Komarov, Ivan; Dashti, Ali; D'Souza, Roshan M.] Univ Wisconsin, Dept Mech Engn, Complex Syst Simulat Lab, Milwaukee, WI 53201 USA	University of Wisconsin System; University of Wisconsin Milwaukee	D'Souza, RM (corresponding author), Univ Wisconsin, Dept Mech Engn, Complex Syst Simulat Lab, Milwaukee, WI 53201 USA.	dsouza@uwm.edu	Valiyaveettill, Suresh/D-4848-2009	Valiyaveettill, Suresh/0000-0001-6990-660X	National Science Foundation [CCF 1013278, CNS 1013278]	National Science Foundation(National Science Foundation (NSF))	This work was partially supported by grants CCF 1013278 and CNS 1013278 by the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabi T., 2012, J EXP ALGORITHMICS, V17; Arefin AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044000; ARYA S, 1994, PROCEEDINGS OF THE FIFTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P573; Barrientos RJ, 2011, LECT NOTES COMPUT SC, V6852, P380, DOI 10.1007/978-3-642-23400-2_35; Baxter S, 2011, MGPU SELECT; BENTLEY JL, 1980, COMMUN ACM, V23, P214, DOI 10.1145/358841.358850; Cederman D., 2010, J EXP ALGORITHMICS, V14; Chan TM, 1998, DISCRETE COMPUT GEOM, V20, P359, DOI 10.1007/PL00009390; Chen J, 2009, J MACH LEARN RES, V10, P1989; Clarkson K., 1983, S FDN COMP SCI, P26, DOI DOI 10.1109/SFCS.1983.16; Connor M, 2010, IEEE T VIS COMPUT GR, V16, P599, DOI 10.1109/TVCG.2010.9; Dasgupta S, 2008, ACM S THEORY COMPUT, P537; Datar M., 2004, P 20 ANN S COMP GEOM, P253; Dong W., 2011, P 20 INT C WORLD WID, P577, DOI DOI 10.1145/1963405.1963487; Duda R.O., 2006, PATTERN CLASSIFICATI; Franti P, 2006, IEEE T PATTERN ANAL, V28, P1875, DOI 10.1109/TPAMI.2006.227; Garcia V, 2010, IEEE IMAGE PROC, P3757, DOI 10.1109/ICIP.2010.5654017; Ho Ching-Tien, 2000, LECT NOTES COMPUTER, V1759; Indyk P., 2004, HDB DISCRETE COMPUTA; Jones PW, 2011, P NATL ACAD SCI USA, V108, P15679, DOI 10.1073/pnas.1107769108; Kato K, 2009, CORR; Kuang QS, 2009, PROCEEDINGS OF INTERNATIONAL SYMPOSIUM ON COMPUTER SCIENCE AND COMPUTATIONAL TECHNOLOGY (ISCSCT 2009), P151; Liu W., 2010, P 27 INT C MACH LEAR, P679; Maier M, 2009, THEOR COMPUT SCI, V410, P1749, DOI 10.1016/j.tcs.2009.01.009; Monroe Laura, 2011, P ACM SIGGRAPH S HIG, P89, DOI [DOI 10.1145/2018323.2018338, 10.1145/2018323.2018338]; Owens JD, 2007, COMPUT GRAPH FORUM, V26, P80, DOI 10.1111/j.1467-8659.2007.01012.x; Paredes R, 2006, LECT NOTES COMPUT SC, V4007, P85; Roberts A, 2007, BIOINFORMATICS, V23, pI401, DOI 10.1093/bioinformatics/btm220; Sanders J., 2010, CUDA EXAMPLE INTRO G; Sismanis N., 2012, HIGH PERF EXTR COMP, P1, DOI [DOI 10.1109/HPEC.2012.6408667, 10.1109/HPEC.2012.6408667]; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; VAIDYA PM, 1989, DISCRETE COMPUT GEOM, V4, P101, DOI 10.1007/BF02187718; Volkov V., 2008, P 2008 ACM IEEE C SU; Wang J, 2012, PROC CVPR IEEE, P1106, DOI 10.1109/CVPR.2012.6247790; Weston J, 2004, P NATL ACAD SCI USA, V101, P6559, DOI 10.1073/pnas.0308067101	35	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e92409	10.1371/journal.pone.0092409	http://dx.doi.org/10.1371/journal.pone.0092409			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809341	Green Submitted, gold, Green Published			2022-12-27	WOS:000338213300001
J	Krohn, J; Speed, D; Palme, R; Touma, C; Mott, R; Flint, J				Krohn, Jon; Speed, Doug; Palme, Rupert; Touma, Chadi; Mott, Richard; Flint, Jonathan			Genetic Interactions with Sex Make a Relatively Small Contribution to the Heritability of Complex Traits in Mice	PLOS ONE			English	Article							QUANTITATIVE TRAITS; BODY-WEIGHT; LOCI; SUSCEPTIBILITY; ARCHITECTURE; ASSOCIATION; CANCER; QTLS	The extent to which sex-specific genetic effects contribute to phenotypic variation is largely unknown. We applied a novel Bayesian method, sparse partitioning, to detect gene by sex (GxS) and gene by gene (GxG) quantitative loci (QTLs) in 1,900 outbred heterogeneous stock mice. In an analysis of 55 phenotypes, we detected 16 GxS and 6 GxG QTLs. The increase in the amount of phenotypic variance explained by models including GxS was small, ranging from 0.14% to 4.30%. We conclude that GxS rarely make a large overall contribution to the heritability of phenotypes, however there are cases where these will be individually important.	[Krohn, Jon; Mott, Richard; Flint, Jonathan] Wellcome Trust Ctr Human Genet, Oxford, England; [Speed, Doug] UCL, UCL Genet Inst, London, England; [Palme, Rupert] Univ Vet Med, Dept Biomed Sci Med Biochem, Vienna, Austria; [Touma, Chadi] Max Planck Inst Psychiat, D-80804 Munich, Germany	University of Oxford; Wellcome Centre for Human Genetics; University of London; University College London; University of Veterinary Medicine Vienna; Max Planck Society	Flint, J (corresponding author), Wellcome Trust Ctr Human Genet, Oxford, England.	jf@well.ox.ac.uk	Speed, Doug/AAM-1032-2021; Palme, Rupert/A-3499-2008; Touma, Chadi/G-4677-2011	Palme, Rupert/0000-0001-9466-3662; Speed, Doug/0000-0002-0096-9765; Mott, Richard/0000-0002-1022-9330; Flint, Jonathan/0000-0002-9427-4429	Wellcome Trust; Medical Research Council [G0901388] Funding Source: researchfish; MRC [G0901388] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the Wellcome Trust. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astle W, 2009, STAT SCI, V24, P451, DOI 10.1214/09-STS307; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Brockmann GA, 2004, MAMM GENOME, V15, P593, DOI 10.1007/s00335-004-3026-4; Brockmann GA, 1998, GENETICS, V150, P369; CORBEIL RR, 1976, TECHNOMETRICS, V18, P31, DOI 10.2307/1267913; Demarest K, 1999, J NEUROSCI, V19, P549; Fijneman RJA, 1996, NAT GENET, V14, P465, DOI 10.1038/ng1296-465; Kendler KS, 2001, PSYCHOL MED, V31, P605, DOI 10.1017/S0033291701003907; Kendler KS, 2006, AM J PSYCHIAT, V163, P115, DOI 10.1176/appi.ajp.163.1.115; Mackay TFC, 2004, CURR OPIN GENET DEV, V14, P253, DOI 10.1016/j.gde.2004.04.003; Mattson DL, 2007, AM J PHYSIOL-RENAL, V293, pF1905, DOI 10.1152/ajprenal.00012.2007; Mott R, 2000, P NATL ACAD SCI USA, V97, P12649, DOI 10.1073/pnas.230304397; Patsopoulos NA, 2007, JAMA-J AM MED ASSOC, V298, P880, DOI 10.1001/jama.298.8.880; Peirce JL, 1998, MAMM GENOME, V9, P942, DOI 10.1007/s003359900904; Speed D, 2012, AM J HUM GENET, V91, P1011, DOI 10.1016/j.ajhg.2012.10.010; Speed D, 2011, ANN APPL STAT, V5, P873, DOI 10.1214/10-AOAS411; Taylor BA, 1999, MAMM GENOME, V10, P963, DOI 10.1007/s003359901141; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; van Wezel T, 1999, CANCER RES, V59, P4216; Wandstrat A, 2001, NAT IMMUNOL, V2, P802, DOI 10.1038/ni0901-802; Weiss LA, 2006, NAT GENET, V38, P218, DOI 10.1038/ng1726; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	22	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96450	10.1371/journal.pone.0096450	http://dx.doi.org/10.1371/journal.pone.0096450			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24811081	Green Published, Green Submitted, gold			2022-12-27	WOS:000338213300038
J	Minato, Y; Fassio, SR; Kirkwood, JS; Halang, P; Quinn, MJ; Faulkner, WJ; Aagesen, AM; Steuber, J; Stevens, JF; Hase, CC				Minato, Yusuke; Fassio, Sara R.; Kirkwood, Jay S.; Halang, Petra; Quinn, Matthew J.; Faulkner, Wyatt J.; Aagesen, Alisha M.; Steuber, Julia; Stevens, Jan F.; Haese, Claudia C.			Roles of the Sodium-Translocating NADH:Quinone Oxidoreductase (Na+-NQR) on Vibrio cholerae Metabolism, Motility and Osmotic Stress Resistance	PLOS ONE			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; ACID TOLERANCE; GROWTH; EXPRESSION; PROTEINS; MARINE; SIAPQM; GENES; PH	The Na+ translocating NADH: quinone oxidoreductase (Na+-NQR) is a unique respiratory enzyme catalyzing the electron transfer from NADH to quinone coupled with the translocation of sodium ions across the membrane. Typically, Vibrio spp., including Vibrio cholerae, have this enzyme but lack the proton-pumping NADH: ubiquinone oxidoreductase (Complex I). Thus, Na+-NQR should significantly contribute to multiple aspects of V. cholerae physiology; however, no detailed characterization of this aspect has been reported so far. In this study, we broadly investigated the effects of loss of Na+-NQR on V. cholerae physiology by using Phenotype Microarray (Biolog), transcriptome and metabolomics analyses. We found that the V. cholerae Delta nqrA-F mutant showed multiple defects in metabolism detected by Phenotype Microarray. Transcriptome analysis revealed that the V. cholerae Delta nqrA-F mutant up-regulates 31 genes and down-regulates 55 genes in both early and mid-growth phases. The most up-regulated genes included the cadA and cadB genes, encoding a lysine decarboxylase and a lysine/cadaverine antiporter, respectively. Increased CadAB activity was further suggested by the metabolomics analysis. The down-regulated genes include sialic acid catabolism genes. Metabolomic analysis also suggested increased reductive pathway of TCA cycle and decreased purine metabolism in the V. cholerae Delta nqrA-F mutant. Lack of Na+-NQR did not affect any of the Na+ pumping-related phenotypes of V. cholerae suggesting that other secondary Na+ pump(s) can compensate for Na+ pumping activity of Na+-NQR. Overall, our study provides important insights into the contribution of Na+-NQR to V. cholerae physiology.	[Minato, Yusuke; Haese, Claudia C.] Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA; [Fassio, Sara R.; Quinn, Matthew J.; Faulkner, Wyatt J.; Aagesen, Alisha M.; Haese, Claudia C.] Oregon State Univ, Dept Microbiol, Coll Sci, Corvallis, OR 97331 USA; [Kirkwood, Jay S.; Stevens, Jan F.] Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA; [Kirkwood, Jay S.; Stevens, Jan F.] Oregon State Univ, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Halang, Petra; Steuber, Julia] Univ Hohenheim, Inst Microbiol, Stuttgart, Germany	Oregon State University; Oregon State University; Oregon State University; Oregon State University; University Hohenheim	Hase, CC (corresponding author), Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA.	hasec@science.oregonstate.edu	Minato, Yusuke/B-9510-2018	Minato, Yusuke/0000-0002-0888-8564; Stevens, Jan Frederik/0000-0002-6348-9347	National Institutes of Health [AI-063121-02, S10RR027878, P30ES000210]; Deutsche Forschungsgemeinschaft [FR1321/3-1]; OSU Undergraduate Research, Innovation, Scholarship & Creativity (URISC) fund; OSU Howard Hughes Medical Institute Summer Undergraduate Research Program; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); OSU Undergraduate Research, Innovation, Scholarship & Creativity (URISC) fund; OSU Howard Hughes Medical Institute Summer Undergraduate Research Program; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by grants from the National Institutes of Health to C. C. H. [AI-063121-02] and to J.F.S [S10RR027878 and P30ES000210] and the Deutsche Forschungsgemeinschaft (FR1321/3-1) to J.S. S. R. F was partially supported by the OSU Undergraduate Research, Innovation, Scholarship & Creativity (URISC) fund and the OSU Howard Hughes Medical Institute Summer Undergraduate Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro-Moreno S, 2009, INFECT IMMUN, V77, P3807, DOI 10.1128/IAI.00279-09; American Society for Microbiology, 2002, ECOSAL ESCHERICHIA C; Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; Chowdhury N, 2012, MICROBIOL-SGM, V158, P2158, DOI 10.1099/mic.0.059659-0; Dimroth P, 1997, BBA-BIOENERGETICS, V1318, P11, DOI 10.1016/S0005-2728(96)00127-2; Gosink KK, 2000, J BACTERIOL, V182, P4234, DOI 10.1128/JB.182.15.4234-4240.2000; Halang P, 2013, J BACTERIOL, V195, P4888, DOI 10.1128/JB.00353-13; Hase CC, 1999, P NATL ACAD SCI USA, V96, P3183, DOI 10.1073/pnas.96.6.3183; Hase CC, 2001, MICROBIOL MOL BIOL R, V65, P353, DOI 10.1128/MMBR.65.3.353-370.2001; Kerscher Stefan, 2008, V45, P185, DOI 10.1007/400_2007_028; Kirkwood JS, 2013, J BIOL CHEM, V288, P19000, DOI 10.1074/jbc.M112.445452; Kogure K, 1998, CURR OPIN BIOTECH, V9, P278, DOI 10.1016/S0958-1669(98)80059-1; Kovacikova G, 2010, J BACTERIOL, V192, P4181, DOI 10.1128/JB.00193-10; Melo AMP, 2004, MICROBIOL MOL BIOL R, V68, P603, DOI 10.1128/MMBR.68.4.603-616.2004; Merrell DS, 2000, J BACTERIOL, V182, P5342, DOI 10.1128/JB.182.19.5342-5350.2000; Merrell DS, 2002, MOL MICROBIOL, V43, P1471, DOI 10.1046/j.1365-2958.2002.02857.x; Minato Y, 2014, MICROB PATHOGENESIS, V66, P36, DOI 10.1016/j.micpath.2013.12.002; Minato Y, 2013, MICROBIOL-SGM, V159, P792, DOI 10.1099/mic.0.064865-0; Mulligan C, 2012, J BIOL CHEM, V287, P3598, DOI 10.1074/jbc.M111.281030; PRUSS BM, 1994, J BACTERIOL, V176, P2143; Quinn MJ, 2012, MICROBIOL-SGM, V158, P1094, DOI 10.1099/mic.0.056119-0; Rohmer L, 2011, TRENDS MICROBIOL, V19, P341, DOI 10.1016/j.tim.2011.04.003; UNEMOTO T, 1993, J BIOENERG BIOMEMBR, V25, P385, DOI 10.1007/BF00762464; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Yanes O, 2011, ANAL CHEM, V83, P2152, DOI 10.1021/ac102981k	25	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e97083	10.1371/journal.pone.0097083	http://dx.doi.org/10.1371/journal.pone.0097083			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24811312	Green Published, Green Submitted, gold			2022-12-27	WOS:000338213300119
J	Pikala, M; Bryla, M; Bryla, P; Maniecka-Bryla, I				Pikala, Malgorzata; Bryla, Marek; Bryla, Pawel; Maniecka-Bryla, Irena			Years of Life Lost Due to External Causes of Death in the Lodz Province, Poland	PLOS ONE			English	Article							SELF-RATED HEALTH; SUICIDE MORTALITY; JOINPOINT REGRESSION; PREMATURE DEATH; RISK-FACTORS; TRENDS; DEPRESSION; DETERMINANTS; INEQUALITIES; COUNTRIES	Background: The aim of the study is the analysis of years of life lost due to external causes of death, particularly due to traffic accidents and suicides. Materials and Methods: The study material includes a database containing information gathered from 376,281 death certificates of inhabitants of the Lodz province who died between 1999 and 2010. The Lodz province is characterized by the highest mortality rates in Poland. The SEYLLp (Standard Expected Years of Life Lost per living person) and the SEYLLd (per death) indices were used to determine years of life lost. Joinpoint models were used to analyze time trends. Results: In 2010, deaths due to external causes constituted 6.0% of the total number of deaths. The standardized death rate (SDR) due to external causes was 110.0 per 100,000 males and was five times higher than for females (22.0 per 100,000 females). In 2010, the SEYLLp due to external causes was 3746 per 100,000 males and 721 per 100,000 females. Among males, suicides and traffic accidents were the most common causes of death (the values of the SEYLLp were: 1098 years and 887 years per 100,000 people, respectively). Among females, the SEYLLp values were 183 years due to traffic accidents and 143 years due to suicides (per 100,000 people). Conclusions: A decrease in the number of years of life lost due to external causes is much higher among females. The authors observe that a growing number of suicides contribute to an increase in the value of the SEYLLp index. This directly contributes to over-mortality of males due to external causes. The analysis of the years of life lost focuses on the social and economic aspects of premature mortality due to external causes.	[Pikala, Malgorzata; Maniecka-Bryla, Irena] Med Univ Lodz, Chair Social & Prevent Med, Dept Epidemiol & Biostat, Lodz, Poland; [Bryla, Marek] Med Univ Lodz, Chair Social & Prevent Med, Dept Social Med, Lodz, Poland; [Bryla, Pawel] Univ Lodz, Dept Int Mkt & Retailing, PL-90131 Lodz, Poland	Medical University Lodz; Medical University Lodz; University of Lodz	Maniecka-Bryla, I (corresponding author), Med Univ Lodz, Chair Social & Prevent Med, Dept Epidemiol & Biostat, Lodz, Poland.	irena.maniecka-bryla@umed.lodz.pl	Bryła, Paweł/B-8262-2013; Pikala, Malgorzata/S-9898-2016; Maniecka-Bryla, Irena/AAW-5779-2021; Bryla, Marek/AAW-5787-2021	Bryła, Paweł/0000-0003-1535-5659; Pikala, Malgorzata/0000-0003-4426-4908; Maniecka-Bryla, Irena/0000-0002-6671-7456; Bryla, Marek/0000-0001-6757-9211	Medical University of Lodz [503/6-029-07/503-01]	Medical University of Lodz	The study was conducted on the basis of the Medical University of Lodz project no. 503/6-029-07/503-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, HLTH STAT ATLAS MORT; Bertolote J.M., 2002, SUICIDOLOGI, V7, P6, DOI [DOI 10.5617/SUICIDOLOGI.2330, 10.5617/suicidologi.2330]; Bryla M, 2013, MED PR, V64, P307; Bryla M, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-181; Chishti P, 2003, EUR J PUBLIC HEALTH, V13, P108, DOI 10.1093/eurpub/13.2.108; Flavio M, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13759; Goniewicz M, 2010, BEZPIECZENSTWO PRACY, V9, P14; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Hofer P, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-644; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Kolves K, 2013, SOCIOL HEALTH ILL, V35, P956, DOI 10.1111/1467-9566.12011; Kulaga Z, 2009, PROBL HIG EPIDEMIOL, V90, P332; Kuypers KPC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043496; Maki NE, 2007, SCAND J PUBLIC HEALT, V35, P387; Makinen IH, 2006, SOC SCI MED, V63, P307, DOI 10.1016/j.socscimed.2006.01.002; Maniecka-Bryla I, 2013, INT J OCCUP MED ENV, V26, P724, DOI 10.2478/s13382-013-0154-7; Maniecka-Bryla I, 2013, ANN AGR ENV MED, V20, P794; Maniecka-Bryla I, 2013, KARDIOL POL, V71, P1065, DOI 10.5603/KP.2013.0262; Maniecka-Bryla I, 2013, ARCH GERONTOL GERIAT, V57, P156, DOI 10.1016/j.archger.2013.03.006; Maniecka-Bryla I, 2012, ANN AGR ENV MED, V19, P723; Maniecka-Bryla I, 2011, MED LAV, V102, P523; Maniecka-Bryla I, 2011, POL J ENVIRON STUD, V20, P691; Marshall R., 2009, HDB DIS BURDENS QUAL, P3421; Marshall RJ, 2004, AUST NZ J PUBL HEAL, V28, P452, DOI 10.1111/j.1467-842X.2004.tb00027.x; Martin LA, 2013, JAMA PSYCHIAT, V70, P1100, DOI 10.1001/jamapsychiatry.2013.1985; Martinez-Beneito MA, 2011, ANN APPL STAT, V5, P2150, DOI 10.1214/11-AOAS471; Mazur Joanna, 2007, Przegl Epidemiol, V61, P777; Mladovsky P., 2009, HLTH EUROPEAN UNION; Moller-Leimkuhler AM, 2003, EUR ARCH PSY CLIN N, V253, P1, DOI 10.1007/s00406-003-0397-6; Moniruzzaman S, 2004, PUBLIC HEALTH, V118, P346, DOI 10.1016/j.puhe.2003.10.004; Murray CJL, 1999, B WORLD HEALTH ORGAN, V77, P537; Murray CJL, 2000, GLOBAL BURDEN DIS, V1; Nordentoft M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055176; Oquendo MA, 2007, AM J PSYCHIAT, V164, P134, DOI 10.1176/appi.ajp.164.1.134; Pikala M, 2014, ARCH MED SCI, V10, P999, DOI 10.5114/aoms.2013.36237; Pikala M, 2011, CENT EUR J PUBL HEAL, V19, P183, DOI 10.21101/cejph.a3675; Razvodovsky Y, 2009, PUBLIC HEALTH, V123, P27, DOI 10.1016/j.puhe.2008.10.003; Rockett IRH, 2011, SUICIDOL ONLINE-SOL, V2, P48; Salmeron D, 2013, J PUBLIC HEALTH-UK, V35, P237, DOI 10.1093/pubmed/fds103; Skog OJ, 2001, ADDICTION, V96, pS49; Titelman D, 2013, NORD J PSYCHIAT, V67, P414, DOI 10.3109/08039488.2012.752036; Twisk DAM, 2007, J SAFETY RES, V38, P245, DOI 10.1016/j.jsr.2007.03.006; Vlajinac H, 2008, PUBLIC HEALTH, V122, P277, DOI 10.1016/j.puhe.2007.06.010; Walinder J, 2001, INT CLIN PSYCHOPHARM, V16, pS21; Wojtyniak B, 2012, HLTH SITUATION POLIS	45	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96830	10.1371/journal.pone.0096830	http://dx.doi.org/10.1371/journal.pone.0096830			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK1XT	24810942	gold, Green Published			2022-12-27	WOS:000338213300077
J	Torok, P; Valko, O; Deak, B; Kelemen, A; Tothmeresz, B				Toeroek, Peter; Valko, Orsolya; Deak, Balazs; Kelemen, Andras; Tothmeresz, Bela			Traditional Cattle Grazing in a Mosaic Alkali Landscape: Effects on Grassland Biodiversity along a Moisture Gradient	PLOS ONE			English	Article							PLANT-SPECIES COMPOSITION; VEGETATION; DIVERSITY; RESTORATION; MANAGEMENT; PASTURES; HORSES; FORBS	Extensively managed pastures are of crucial importance in sustaining biodiversity both in local-and landscape-level. Thus, re-introduction of traditional grazing management is a crucial issue in grassland conservation actions worldwide. Traditional grazing with robust cattle breeds in low stocking rates is considered to be especially useful to mimic natural grazing regimes, but well documented case-studies are surprisingly rare on this topic. Our goal was to evaluate the effectiveness of traditional Hungarian Grey cattle grazing as a conservation action in a mosaic alkali landscape. We asked the following questions: (i) How does cattle grazing affect species composition and diversity of the grasslands? (ii) What are the effects of grazing on short-lived and perennial noxious species? (iii) Are there distinct effects of grazing in dry-, mesophilous-and wet grassland types? Vegetation of fenced and grazed plots in a 200-ha sized habitat complex (secondary dry grasslands and pristine mesophilous-and wet alkali grasslands) was sampled from 2006-2009 in East-Hungary. We found higher diversity scores in grazed plots compared to fenced ones in mesophilous-and wet grasslands. Higher cover of noxious species was typical in fenced plots compared to their grazed counterparts in the last year in every studied grassland type. We found an increasing effect of grazing from the dry-towards the wet grassland types. The year-to-year differences also followed similar pattern: the site-dependent effects were the lowest in the dry grassland and an increasing effect was detected along the moisture gradient. We found that extensive Hungarian Grey cattle grazing is an effective tool to suppress noxious species and to create a mosaic vegetation structure, which enables to maintain high species richness in the landscape. Hungarian Grey cattle can feed in open habitats along long moisture gradient, thus in highly mosaic landscapes this breed can be the most suitable livestock type.	[Toeroek, Peter; Deak, Balazs; Kelemen, Andras] MTA DE Biodivers & Ecosyst Serv Res Grp, Debrecen, Hungary; [Valko, Orsolya; Tothmeresz, Bela] Univ Debrecen, Dept Ecol, H-4012 Debrecen, Hungary	MTA-DE Biodiversity & Ecosystem Services Research Group; University of Debrecen	Deak, B (corresponding author), MTA DE Biodivers & Ecosyst Serv Res Grp, Debrecen, Hungary.	debalazs@gmail.com	Deák, Balázs/Q-1069-2016; Valkó, Orsolya/Q-1061-2016; Peter, Torok/C-5514-2008; Valkó, Orsolya/H-4553-2019	Deák, Balázs/0000-0001-6938-1997; Valkó, Orsolya/0000-0001-7919-6293; Peter, Torok/0000-0002-4428-3327; Valkó, Orsolya/0000-0001-7919-6293; Tothmeresz, Bela/0000-0002-4766-7668	European Union; State of Hungary - European Social Fund [TAMOP-4.2.4.A/2-11/1-2012-0001]; University of Debrecen; OTKA [PD 100 192]; European Social Fund; European Regional Development Fund;  [TAMOP 4.2.1./B-09/1/KONV-2010-0007];  [TAMOP-4.2.2_B-10_1-2010-0024];  [TAMOP-4.2.2.C-11/1/KONV-2012-0010]	European Union(European Commission); State of Hungary - European Social Fund; University of Debrecen; OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Social Fund(European Social Fund (ESF)); European Regional Development Fund(European Commission); ; ; 	This research was supported by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP-4.2.4.A/2-11/1-2012-0001 "National Excellence Program" (PT, OV, BD, AK, BT). The consumables and miscellaneous costs were covered by the Internal Research Grant of the University of Debrecen (OV), by the OTKA research grant (PD 100 192, PT), by the TAMOP 4.2.1./B-09/1/KONV-2010-0007, by the TAMOP-4.2.2_B-10_1-2010-0024, and by the TAMOP-4.2.2.C-11/1/KONV-2012-0010 projects. The TAMOP projects are implemented through the New Hungary Development Plan, co-financed by the European Social Fund and the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2001, OECOLOGIA, V128, P465, DOI 10.1007/s004420100737; Ausden M, 2005, BIOL CONSERV, V122, P317, DOI 10.1016/j.biocon.2004.07.021; Bakker J.P., 1989, NATURE MANAGEMENT GR; Baldi A, 2013, AGR ECOSYST ENVIRON, V166, P28, DOI 10.1016/j.agee.2012.03.005; Bartosiewicz L., 1997, Animal Genetic Resources Information, P49; Bokdam J, 2000, J APPL ECOL, V37, P415, DOI 10.1046/j.1365-2664.2000.00507.x; Borhidi A., 1995, Acta Botanica Hungarica, V39, P97; Borhidi A., 2012, PLANT COMMUNITIEHU; Conant RT, 2001, ECOL APPL, V11, P343, DOI 10.1890/1051-0761(2001)011[0343:GMACIG]2.0.CO;2; Cousins SAO, 2008, BIOL CONSERV, V141, P233, DOI 10.1016/j.biocon.2007.09.016; De Bruijn SL, 2006, BIOL CONTROL, V36, P305, DOI 10.1016/j.biocontrol.2005.10.007; Deak, 2011, GRASSLANDS TYPES BIO, P109; Dengler J, 2014, AGR ECOSYST ENVIRON, V182, P1, DOI 10.1016/j.agee.2013.12.015; Donath TW, 2010, PLANT ECOL, V207, P257, DOI 10.1007/s11258-009-9670-8; Ellenberg H., 1992, SCRIPTA GEOBOT, V18, P1, DOI DOI 10.1002/FEDR.19931040323; Enyedi ZM, 2008, APPL VEG SCI, V11, P55, DOI 10.1111/j.1654-109X.2008.tb00204.x; Gilhaus K, 2014, PLANT ECOL, V215, P169, DOI 10.1007/s11258-013-0287-6; Golodets C, 2010, PLANT SOIL, V329, P365, DOI 10.1007/s11104-009-0164-1; Hayes GF, 2003, CONSERV BIOL, V17, P1694, DOI 10.1111/j.1523-1739.2003.00281.x; Hazi J, 2012, APPL ECOL ENV RES, V10, P223, DOI 10.15666/aeer/1003_223231; Isselstein J., 2005, Agronomy Research, V3, P139; Jutila H, 1999, PLANT ECOL, V140, P77, DOI 10.1023/A:1009744117329; Kiraly G, 2009, UJ MAGYAR FUVESZKONY; Kleijn D, 2006, ECOL LETT, V9, P243, DOI 10.1111/j.1461-0248.2005.00869.x; Lengyel S, 2012, APPL VEG SCI, V15, P264, DOI 10.1111/j.1654-109X.2011.01179.x; Leps J, 2003, MULTIVARIATE ANAL EC; Loucougaray G, 2004, BIOL CONSERV, V116, P59, DOI 10.1016/S0006-3207(03)00177-0; Metera E, 2010, ANIM SCI PAP REP, V28, P315; Molnar Z, 2003, PHYTOCOENOLOGIA, V33, P377, DOI 10.1127/0340-269X/2003/0033-0377; Pykala J, 2003, BIODIVERS CONSERV, V12, P2211, DOI 10.1023/A:1024558617080; Pykala J, 2000, CONSERV BIOL, V14, P705, DOI 10.1046/j.1523-1739.2000.99119.x; Ren HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052180; Rook AJ, 2004, BIOL CONSERV, V119, P137, DOI 10.1016/j.biocon.2003.11.010; SefferovuY StanovuY V., 2008, MANAGEMENT NATURA 20; Sykora KV, 2009, PHYTOCOENOLOGIA, V39, P265, DOI 10.1127/0340-269X/2009/0039-0265; Torok P, 2012, J NAT CONSERV, V20, P41, DOI 10.1016/j.jnc.2011.07.006; Torok P, 2011, BIODIVERS CONSERV, V20, P2311, DOI 10.1007/s10531-011-9992-4; Torok P, 2010, BIOL CONSERV, V143, P806, DOI 10.1016/j.biocon.2009.12.024; Valko O, 2012, FLORA, V207, P303, DOI 10.1016/j.flora.2012.02.003; Vulink JT, 2000, APPL VEG SCI, V3, P73, DOI 10.2307/1478920; WallisDeVries MF, 2002, BIOL CONSERV, V104, P265, DOI 10.1016/S0006-3207(01)00191-4; Wrbka T, 2008, COMMUNITY ECOL, V9, P217, DOI 10.1556/ComEc.9.2008.2.11	42	44	49	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e97095	10.1371/journal.pone.0097095	http://dx.doi.org/10.1371/journal.pone.0097095			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809348	Green Submitted, Green Published, gold			2022-12-27	WOS:000338213300121
J	Chen, ZB; Liew, D; Kwan, P				Chen, Zhibin; Liew, Danny; Kwan, Patrick			Real-World Efficiency of Pharmacogenetic Screening for Carbamazepine-Induced Severe Cutaneous Adverse Reactions	PLOS ONE			English	Article							STEVENS-JOHNSON-SYNDROME; TOXIC EPIDERMAL NECROLYSIS; HLA-B-ASTERISK-1502 ALLELE; ANTIEPILEPTIC DRUGS; COST-EFFECTIVENESS; HAN CHINESE; BREAST; CANCER; ASSOCIATION; INFORMATION	Objectives: We evaluated the cost and efficiency of routine HLA-B*15:02 screening to prevent carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis (CBZ-SJS/TEN) in Hong Kong. Methods: Data were extracted from patients who commenced CBZ as the first-ever AED treatment or tested for HLA-B*15: 02 allele in three years before policy implementation (pre-policy: 16 September 2005 to 15 September 2008) and three years after (post-policy: 16 September 2008 to 15 September 2011). Using published unit costs, we estimated the cost of screening by comparing the costs to prevent and treat CBZ-SJS/TEN. We compared the number of person-tests needed and the cost to prevent resultant death with cancer screening programs. Results: The number of screening tests needed to prevent one case of CBZ-SJS/TEN was 442, and to prevent one resultant death was 1,474 to 8,840. The screening cost was $332 per person, of which 42% was attributed to an additional consultation to review result and prescribe appropriate medication. HLA-B*15:02 screening expended $146,749 to prevent a case of CBZ-SJS/TEN, and $489,386-$2,934,986 to prevent a resultant death. The corresponding numbers of tests and costs for mammography and Pap smear to prevent death due to breast and cervical cancers were 7,150 and 7,000, and $614,900 and $273,000, respectively. Comparing to the SJS/TEN treatment cost, HLA-B*15:02 screening would become cost saving if a point-of-care test of less than $37 was available. Conclusions: HLA-B*15:02 screening is as efficient as mammography and Pap smear in preventing death. Development of point-of-care testing will vastly improve efficiency.	[Chen, Zhibin; Liew, Danny; Kwan, Patrick] Univ Melbourne, Dept Med, Parkville, Vic 3052, Australia; [Chen, Zhibin; Liew, Danny] Royal Melbourne Hosp, Melbourne Brain Ctr, Parkville, Vic 3050, Australia; [Liew, Danny] Royal Melbourne Hosp, Melbourne EpiCtr, Parkville, Vic 3050, Australia; [Kwan, Patrick] Royal Melbourne Hosp, Dept Neurol, Parkville, Vic 3050, Australia; [Kwan, Patrick] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China	University of Melbourne; Royal Melbourne Hospital; Royal Melbourne Hospital; Royal Melbourne Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Kwan, P (corresponding author), Univ Melbourne, Dept Med, Parkville, Vic 3052, Australia.	patrick.kwan@unimelb.edu.au	Chen, Zhibin/T-1567-2017	Chen, Zhibin/0000-0002-1888-6917; Kwan, Patrick/0000-0001-7310-276X; Liew, Danny/0000-0002-0131-623X				Census and Statistics Department HKSAR, 2012, 2011 POP CENS THEM R; Chang CC, 2011, INT J DERMATOL, V50, P221, DOI 10.1111/j.1365-4632.2010.04745.x; Chen P, 2011, NEW ENGL J MED, V364, P1126, DOI 10.1056/NEJMoa1009717; Cheung NT, 2004, STUD HEALTH TECHNOL, V107, P1183; Cheung NT, 2001, ST HEAL T, V84, P609; Cheung YK, 2013, EPILEPSIA, V54, P1307, DOI 10.1111/epi.12217; Chung WH, 2004, NATURE, V428, P486, DOI 10.1038/428486a; Dong D, 2012, NEUROLOGY, V79, P1259, DOI 10.1212/WNL.0b013e31826aac73; Dowling EC, 2010, J MED SCREEN, V17, P139, DOI 10.1258/jms.2010.010033; Franciotta D, 2009, CURR OPIN NEUROL, V22, P144, DOI 10.1097/WCO.0b013e328328f276; Glauser T, 2013, EPILEPSIA, V54, P551, DOI 10.1111/epi.12074; Hansen R C, 1984, Pediatr Dermatol, V1, P298, DOI 10.1111/j.1525-1470.1984.tb01133.x; Harr T, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-39; Hung SL, 2006, PHARMACOGENET GENOM, V16, P297, DOI 10.1097/01.fpc.0000199500.46842.4a; Karnon J, 2004, HEALTH TECHNOL ASSES, V8, P1; Leckband SG, 2013, CLIN PHARM THER; Locharernkul C, 2011, J CLIN NEUROSCI, V18, P1289, DOI 10.1016/j.jocn.2010.12.054; Man CBL, 2007, EPILEPSIA, V48, P1015, DOI 10.1111/j.1528-1167.2007.01022.x; Ng M, RE GENETIC TESTING P; Plevritis SK, 2006, JAMA-J AM MED ASSOC, V295, P2374, DOI 10.1001/jama.295.20.2374; Raffle AE, 2003, BRIT MED J, V326, P901, DOI 10.1136/bmj.326.7395.901; Rattanavipapong W, 2013, EPILEPSIA; Roberts JD, 2012, LANCET, V379, P1705, DOI 10.1016/S0140-6736(12)60161-5; ROUJEAU JC, 1994, NEW ENGL J MED, V331, P1272, DOI 10.1056/NEJM199411103311906; ROUJEAU JC, 1995, NEW ENGL J MED, V333, P1600, DOI 10.1056/NEJM199512143332404; Tangamornsuksan W, 2013, JAMA DERMATOL; Tennis P, 1997, NEUROLOGY, V49, P542, DOI 10.1212/WNL.49.2.542; Tiamkao S, 2013, INT J CLIN PHARM-NET, V35, P608, DOI 10.1007/s11096-013-9777-9; U. S. Food and Drug Administration, 2007, INF HEALTHC PROF DAN; UK Medicines and Healthcare products Regulatory Agency, 2008, CARB EP GEN TEST REC; Wallack T, 2013, FAMILY AWARDED 63 MI; Warner E, 2011, NEW ENGL J MED, V365, P1025, DOI 10.1056/NEJMcp1101540	32	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96990	10.1371/journal.pone.0096990	http://dx.doi.org/10.1371/journal.pone.0096990			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806465	Green Published, gold			2022-12-27	WOS:000335728900123
J	Gangal, K; Sarson, GR; Shukurov, A				Gangal, Kavita; Sarson, Graeme R.; Shukurov, Anvar			The Near-Eastern Roots of the Neolithic in South Asia	PLOS ONE			English	Article							EUROPE; SPREAD; DIFFUSION; AGRICULTURE; TRANSITION	The Fertile Crescent in the Near East is one of the independent origins of the Neolithic, the source from which farming and pottery-making spread across Europe from 9,000 to 6,000 years ago at an average rate of about 1 km/yr. There is also strong evidence for causal connections between the Near-Eastern Neolithic and that further east, up to the Indus Valley. The Neolithic in South Asia has been far less explored than its European counterpart, especially in terms of absolute (14 degrees C) dating; hence, there were no previous attempts to assess quantitatively its spread in Asia. We combine the available 14 degrees C data with the archaeological evidence for early Neolithic sites in South Asia to analyze the spatio-temporal continuity of the Neolithic dispersal from the Near East through the Middle East and to the Indian subcontinent. We reveal an approximately linear dependence between the age and the geodesic distance from the Near East, suggesting a systematic (but not necessarily uniform) spread at an average speed of about 0.65 km/yr.	[Gangal, Kavita; Sarson, Graeme R.; Shukurov, Anvar] Newcastle Univ, Sch Math & Stat, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Gangal, K (corresponding author), Newcastle Univ, Sch Math & Stat, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	k.gangal@newcastle.ac.uk	Shukurov, Anvar/F-9605-2014	Shukurov, Anvar/0000-0001-6200-4304	School of Mathematics and Statistics of the University of Newcastle upon Tyne; Leverhulme Trust [F/00 125/AD]	School of Mathematics and Statistics of the University of Newcastle upon Tyne; Leverhulme Trust(Leverhulme Trust)	This work was funded by: 1. School of Mathematics and Statistics of the University of Newcastle upon Tyne, 2. The Leverhulme Trust ( Research Grant F/00 125/AD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackland GJ, 2007, P NATL ACAD SCI USA, V104, P8714, DOI 10.1073/pnas.0702469104; Alizadeh A, 2003, TECHNICAL REPORT; Ammerman A.J., 1973, EXPLANATION CULTURE, P343; [Anonymous], 2002, IRAN ANTIQ, DOI DOI 10.2143/IA.37.0.120; Baggaley AW, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.016105; Bellwood Peter S, 2005, 1 FARMERS ORIGINS AG; Bocquet-Appel JP, 2009, J ARCHAEOL SCI, V36, P807, DOI 10.1016/j.jas.2008.11.004; CLARK JGD, 1965, ANTIQUITY, V39, P45, DOI 10.1017/S0003598X00031392; Costantini L., 2008, PRAGDHARA, V18, P167; Davison K, 2006, J ARCHAEOL SCI, V33, P641, DOI 10.1016/j.jas.2005.09.017; Davison K, 2009, QUATERN INT, V203, P10, DOI 10.1016/j.quaint.2008.04.013; DOLUKHANOV P, 1994, ENV ETHNICITY ANCIEN; Drechsler P, 2009, BRIT ARCHAEOLOGICA S, VS1969; Ex Oriente, 2013, PPND PLATF NEOL RAD; Feugier FG, 2009, BRIT ARCHAEOLOGICA S, VS1964, P217; Fort J., 2009, BRIT ARCHAEOLOGICAL, V1964, P211; Fort J, 2012, P NATL ACAD SCI USA, V109, P18669, DOI 10.1073/pnas.1200662109; Fort J, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/8/086001; FRALEY C, 2006, 504 U WASH DEP STAT; Fuller DQ, 2006, J WORLD PREHIST, V20, P1, DOI 10.1007/s10963-006-9006-8; Gangal K, 2010, CURR SCI INDIA, V98, P846; Ghilde VG, 1925, DAWN EUROPEAN CIVILI, P11; Gkiasta M, 2003, ANTIQUITY, V77, P45, DOI 10.1017/S0003598X00061330; Goring-Morris AN, 2011, CURR ANTHROPOL, V52, pS195, DOI 10.1086/658860; Harris D., 2010, ORIGINS AGR W CENTRA; Jarrige C., 2008, PRAGDHARA, V18, P155; Jarrige JF, 2008, PRAGDHARA, V18, P136; Kuzmina EE, 2008, ENCOUNTERS ASIA, P1; Lubbock John, 1913, PREHISTORIC TIMES IL; Marshall J., 2012, THESIS; Patterson MA, 2010, J ARCHAEOL SCI, V37, P2929, DOI 10.1016/j.jas.2010.07.003; Petrie CA, 2012, ANTIQUITY, V86, P1055, DOI 10.1017/S0003598X00048249; Pinhasi R, 2005, PLOS BIOL, V3, P2220, DOI 10.1371/journal.pbio.0030410; Possehl GL, 1999, INDUS AGE BEGINNINGS; Price TD, 2000, EUROPES 1 FARMERS; Quintana-Murci L, 2004, AM J HUM GENET, V74, P827, DOI 10.1086/383236; Quintana-Murci L, 2001, AM J HUM GENET, V68, P537, DOI 10.1086/318200; Rowley-Conwy P, 2011, CURR ANTHROPOL, V52, pS431, DOI 10.1086/658368; Scott EM, 2007, RADIOCARBON, V49, P427, DOI 10.1017/S0033822200042351; Weeks L.R., 2006, IRAN, V44, P1, DOI DOI 10.1080/05786967.2006.11834679; Zilhao J, 2001, P NATL ACAD SCI USA, V98, P14180, DOI 10.1073/pnas.241522898	41	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e95714	10.1371/journal.pone.0095714	http://dx.doi.org/10.1371/journal.pone.0095714			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AG9HB	24806472	Green Published, gold, Green Submitted			2022-12-27	WOS:000335728900024
J	Kang, YU; Kim, HY; Choi, JS; Kim, CS; Bae, EH; Ma, SK; Kim, SW				Kang, Yong Un; Kim, Ha Yeon; Choi, Joon Seok; Kim, Chang Seong; Bae, Eun Hui; Ma, Seong Kwon; Kim, Soo Wan			Metabolic Syndrome and Chronic Kidney Disease in an Adult Korean Population: Results from the Korean National Health Screening	PLOS ONE			English	Article							RENAL-FUNCTION; RISK; ASSOCIATION; HYPERTENSION; DYSLIPIDEMIA; PREVALENCE; DIAGNOSIS; OBESITY; CKD	Background: This study was aimed to examine the prevalence of metabolic syndrome (MS) and chronic kidney disease (CKD), and the association between MS and its components with CKD in Korea. Methods: We excluded diabetes to appreciate the real impact of MS and performed a cross-sectional study using the general health screening data of 10,253,085 (48.86 +/- 613.83 years, men 56.18%) participants (age, >= 20 years) from the Korean National Health Screening 2011. CKD was defined as dipstick proteinuria >= 1 or an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73 m(2). Results: The prevalence of CKD was 6.15% (men, 5.37%; women, 7.15%). Further, 22.25% study population had MS (abdominal obesity, 27.98%; hypertriglyceridemia, 30.09%; low high-density cholesterol levels, 19.74%; high blood pressure, 43.45%; and high fasting glucose levels, 30.44%). Multivariate-adjusted analysis indicated that proteinuria risk increased in participants with MS (odds ratio [OR] 1.884, 95% confidence interval [CI] 1.867-1.902, P<0.001). The presence of MS was associated with eGFR, 60 mL/min/1.73 m(2) (OR 1.364, 95% CI 1.355-1.373, P<0.001). MS individual components were also associated with an increased CKD risk. The strength of association between MS and the development of CKD increase as the number of components increased from 1 to 5. In sub-analysis by men and women, MS and its each components were a significant determinant for CKD. Conclusions: MS and its individual components can predict the risk of prevalent CKD for men and women.	[Kang, Yong Un; Kim, Ha Yeon; Choi, Joon Seok; Kim, Chang Seong; Bae, Eun Hui; Ma, Seong Kwon; Kim, Soo Wan] Chonnam Natl Univ, Dept Internal Med, Sch Med, Kwangju, South Korea	Chonnam National University	Kim, SW (corresponding author), Chonnam Natl Univ, Dept Internal Med, Sch Med, Kwangju, South Korea.	skimw@chonnam.ac.kr			Korea Centers for Disease Control and Prevention [2012-E33024-00]; National Research Foundation of Korea (NRF) [2011-0030132]; Korea government (MSIP); Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Science, ICT and future Planning [2013R1A2A2A01067611]	Korea Centers for Disease Control and Prevention; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MSIP); Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Science, ICT and future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)	This research was supported by a fund under the Korea Centers for Disease Control and Prevention (2012-E33024-00), by the National Research Foundation of Korea (NRF) grant (MRC for Gene Regulation, 2011-0030132) funded by the Korea government (MSIP), and by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning (2013R1A2A2A01067611). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Athyros VG, 2011, CURR MED RES OPIN, V27, P1659, DOI 10.1185/03007995.2011.595782; Bagby SP, 2004, J AM SOC NEPHROL, V15, P2775, DOI 10.1097/01.ASN.0000141965.28037.EE; Banach M, 2010, EXPERT OPIN PHARMACO, V11, P2575, DOI 10.1517/14656566.2010.522569; Cases A, 2005, KIDNEY INT, V68, P87; Chang IH, 2009, NEPHROLOGY, V14, P321, DOI 10.1111/j.1440-1797.2009.01091.x; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; Deedwania P, 2011, J CLIN HYPERTENS, V13, P52, DOI 10.1111/j.1751-7176.2010.00386.x; Eckel RH, 2010, LANCET, V375, P181, DOI 10.1016/S0140-6736(09)61794-3; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Ford ES, 2004, DIABETES CARE, V27, P2444, DOI 10.2337/diacare.27.10.2444; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Gluba A, 2010, EXPERT OPIN PHARMACO, V11, P2665, DOI 10.1517/14656566.2010.512419; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Joles JA, 2000, J AM SOC NEPHROL, V11, P669, DOI 10.1681/ASN.V114669; Kitiyakara C, 2007, KIDNEY INT, V71, P693, DOI 10.1038/sj.ki.5002128; Kopple JD, 2011, J RENAL NUTR, V21, P66, DOI 10.1053/j.jrn.2010.10.009; Kurella M, 2005, J AM SOC NEPHROL, V16, P2134, DOI 10.1681/ASN.2005010106; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lucove J, 2008, AM J KIDNEY DIS, V51, P21, DOI 10.1053/j.ajkd.2007.09.014; Luk AOY, 2008, DIABETES CARE, V31, P2357, DOI 10.2337/dc08-0971; Mancia G, 2007, HYPERTENSION, V49, P40, DOI 10.1161/01.HYP.0000251933.22091.24; Muntner P, 2000, KIDNEY INT, V58, P293, DOI 10.1046/j.1523-1755.2000.00165.x; Nestel P, 2007, ASIA PAC J CLIN NUTR, V16, P362; Palaniappan L, 2003, AM J HYPERTENS, V16, P952, DOI 10.1016/S0895-7061(03)01009-4; Park HS, 2004, INT J EPIDEMIOL, V33, P328, DOI 10.1093/ije/dyh032; Pinto-Sietsma SJ, 2003, AM J KIDNEY DIS, V41, P733, DOI 10.1016/S0272-6386(03)00020-9; Rashidi A, 2007, CLIN J AM SOC NEPHRO, V2, P976, DOI 10.2215/CJN.01020207; Ryu S, 2009, AM J KIDNEY DIS, V53, P59, DOI 10.1053/j.ajkd.2008.07.027; Schelling JR, 2004, J AM SOC NEPHROL, V15, P2773, DOI 10.1097/01.ASN.0000141964.68839.BB; Sun F, 2010, NEPHROLOGY, V15, P84, DOI 10.1111/j.1440-1797.2009.01150.x; Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X; Thomas G, 2011, CLIN J AM SOC NEPHRO, V6, P2364, DOI 10.2215/CJN.02180311; Tomaszewski M, 2007, KIDNEY INT, V71, P816, DOI 10.1038/sj.ki.5002160; Tozawa M, 2002, KIDNEY INT, V62, P1743, DOI 10.1046/j.1523-1755.2002.00626.x; Watanabe H, 2010, DIABETES-METAB RES, V26, P26, DOI 10.1002/dmrr.1058; Wisse BE, 2004, J AM SOC NEPHROL, V15, P2792, DOI 10.1097/01.ASN.0000141966.69934.21	38	14	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e93795	10.1371/journal.pone.0093795	http://dx.doi.org/10.1371/journal.pone.0093795			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24807226	Green Published, gold, Green Submitted			2022-12-27	WOS:000335728900008
J	Cheng, DQ; Li, Y; Huang, JF				Cheng, Dong-Qiang; Li, Ying; Huang, Jing-Fei			Molecular Evolution of the Primate alpha-/theta-Defensin Multigene Family	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; THETA-DEFENSINS; FUNCTIONAL DIVERGENCE; BETA-DEFENSINS; PANETH CELLS; GENE FAMILY; INFECTION; VIRUS; DIMER; DISCOVERY	The primate alpha-/theta-defensin multigene family encodes versatile endogenous cationic and amphipathic peptides that have broad-spectrum antibacterial, antifungal and antiviral activity. Although previous studies have reported that alpha-/theta-defensin (DEFA/DEFT) genes are under birth-and-death evolution with frequent duplication and rapid evolution, the phylogenetic relationships of the primate DEFA/DEFT genes; the genetic bases for the existence of similar antimicrobial spectra among closely related species; and the evolutionary processes involved in the emergence of cyclic theta-defensins in Old World monkeys and their subsequent loss of function in humans, chimpanzees and gorillas require further investigation. In this study, the DEFA/DEFT gene repertoires from primate and treeshrew were collected, followed by detailed phylogenetic, sequence and structure, selection pressure and comparative genomics analyses. All treeshrew, prosimian and simian DEFA/DEFT genes are grouped into two major clades, which are tissue-specific for enteric and myeloid defensins in simians. The simian enteric and myeloid alpha-defensins are classified into six functional gene clusters with diverged sequences, variable structures, altered functional constraints and different selection pressures, which likely reflect the antimicrobial spectra among closely related species. Species-specific duplication or pseudogenization within each simian cluster implies that the antimicrobial spectrum is ever-shifting, most likely challenged by the ever-changing pathogen environment. The DEFT evolved from the myeloid DEFA8. The prosegment of theta-defensin is detected with adaptive changes coevolving with the new protein fold of mature peptide, coincident with the importance of the prosegment for the correct folding of the mature peptide. Lastly, a less-is-hitchhiking hypothesis was proposed as a possible explanation for the expansion of pseudogene DEFTP and the loss of functional DEFT, where the gain or loss of the hitchhiker is determined by its adjacent driver gene during the birth-and-death evolutionary process.	[Cheng, Dong-Qiang; Li, Ying; Huang, Jing-Fei] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Cheng, Dong-Qiang] Univ Chinese Acad Sci, Kunming Coll Life Sci, Beijing, Peoples R China; [Li, Ying] Sichuan Agr Univ, Coll Anim Sci & Technol, Inst Anim Genet & Breeding, Yaan, Peoples R China; [Huang, Jing-Fei] Chinese Univ Hongkong, Joint Res Ctr Bioresources & Human Dis Mech, Kunming Inst Zool, Kunming, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Sichuan Agricultural University; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese University of Hong Kong	Huang, JF (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.	huangjf@mail.kiz.ac.cn		Cheng, Dong-Qiang/0000-0002-5314-9568	National Natural Science Foundation of China [31123005, 30600066]; Chinese Academy of Sciences [2007211311091]; ''100-Talent Program in Sichuan''	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); ''100-Talent Program in Sichuan''	This work was supported by the National Natural Science Foundation of China (Grant No. 31123005) and Chinese Academy of Sciences (Grant No. 2007211311091) for JFH, and the ''100-Talent Program'' in Sichuan and National Natural Science Foundation of China (Grant No. 30600066) for YL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldred PMR, 2005, HUM MOL GENET, V14, P2045, DOI 10.1093/hmg/ddi209; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Belov K, 2007, GENOME RES, V17, P982, DOI 10.1101/gr.6121807; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; Bruhn O, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-631; Buck CB, 2006, P NATL ACAD SCI USA, V103, P1516, DOI 10.1073/pnas.0508033103; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cole AM, 2002, P NATL ACAD SCI USA, V99, P1813, DOI 10.1073/pnas.052706399; Conibear AC, 2013, J BIOL CHEM, V288, P10830, DOI 10.1074/jbc.M113.451047; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dalla Valle L, 2012, DEV COMP IMMUNOL, V36, P222, DOI 10.1016/j.dci.2011.05.004; Das S, 2010, MOL BIOL EVOL, V27, P2333, DOI 10.1093/molbev/msq118; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Dugan AS, 2008, J BIOL CHEM, V283, P31125, DOI 10.1074/jbc.M805902200; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Garcia AE, 2008, INFECT IMMUN, V76, P5883, DOI 10.1128/IAI.01100-08; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; Glenthoj A, 2013, EUR J CLIN INVEST, V43, P836, DOI 10.1111/eci.12114; Gu X, 1999, MOL BIOL EVOL, V16, P1664, DOI 10.1093/oxfordjournals.molbev.a026080; Gu X, 2001, MOL BIOL EVOL, V18, P453, DOI 10.1093/oxfordjournals.molbev.a003824; Gu X, 2013, MOL BIOL EVOL, V30, P1713, DOI 10.1093/molbev/mst069; Henriques ST, 2010, DRUG DISCOV TODAY, V15, P57, DOI 10.1016/j.drudis.2009.10.007; HILL CP, 1991, SCIENCE, V251, P1481, DOI 10.1126/science.2006422; Hollox EJ, 2008, GENOME RES, V18, P1686, DOI 10.1101/gr.080945.108; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jarczak J, 2013, HUM IMMUNOL, V74, P1069, DOI 10.1016/j.humimm.2013.05.008; JONES DE, 1993, FEBS LETT, V315, P187, DOI 10.1016/0014-5793(93)81160-2; Kamdar K, 2008, J BIOL CHEM, V283, P32361, DOI 10.1074/jbc.M805296200; Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860; Lang GI, 2013, NATURE, V500, P571, DOI 10.1038/nature12344; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; Lehrer RI, 2012, J BIOL CHEM, V287, P27014, DOI 10.1074/jbc.R112.346098; Lehrer RI, 2012, IMMUNOL REV, V245, P84, DOI 10.1111/j.1600-065X.2011.01082.x; Leikina E, 2005, NAT IMMUNOL, V6, P995, DOI 10.1038/ni1248; Leonova L, 2001, J LEUKOCYTE BIOL, V70, P461; Li D, 2014, MOL BIOL REP; Linzmeier R, 1999, GENE, V233, P205, DOI 10.1016/S0378-1119(99)00136-5; Linzmeier RM, 2005, GENOMICS, V86, P423, DOI 10.1016/j.ygeno.2005.06.003; Lynn DJ, 2007, DEV COMP IMMUNOL, V31, P963, DOI 10.1016/j.dci.2007.01.007; Lynn DJ, 2004, MOL BIOL EVOL, V21, P819, DOI 10.1093/molbev/msh084; Mars WM, 1995, J BIOL CHEM, V270, P30371, DOI 10.1074/jbc.270.51.30371; Maxwell AI, 2003, MOL IMMUNOL, V40, P413, DOI 10.1016/S0161-5890(03)00160-3; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Nguyen TX, 2003, PEPTIDES, V24, P1647, DOI 10.1016/j.peptides.2003.07.023; Patil A, 2004, PHYSIOL GENOMICS, V20, P1, DOI 10.1152/physiolgenomics.00150.2004; Pazgier M, 2012, J BIOL CHEM, V287, P8944, DOI 10.1074/jbc.M111.332205; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Porter EM, 1997, INFECT IMMUN, V65, P2389, DOI 10.1128/IAI.65.6.2389-2395.1997; Presgraves DC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001498; Quintana-Murci L, 2012, SCIENCE, V335, P806, DOI 10.1126/science.1219299; Rajabi M, 2012, J BIOL CHEM, V287, P21615, DOI 10.1074/jbc.M112.367995; Rehaume LM, 2008, CRIT REV IMMUNOL, V28, P185, DOI 10.1615/CritRevImmunol.v28.i3.10; Salvatore M, 2007, J INFECT DIS, V196, P835, DOI 10.1086/521027; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Seidel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009737; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Smith JG, 2008, CELL HOST MICROBE, V3, P11, DOI 10.1016/j.chom.2007.12.001; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Sugiarto H, 2004, BIOCHEM BIOPH RES CO, V323, P721, DOI 10.1016/j.bbrc.2004.08.162; Szyk A, 2006, PROTEIN SCI, V15, P2749, DOI 10.1110/ps.062336606; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang YQ, 1999, INFECT IMMUN, V67, P6139, DOI 10.1128/IAI.67.11.6139-6144.1999; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Tongaonkar P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032469; Valore EV, 1996, J CLIN INVEST, V97, P1624, DOI 10.1172/JCI118588; Wang YF, 2001, GENETICS, V158, P1311; Wei G, 2009, J BIOL CHEM, V284, P29180, DOI 10.1074/jbc.M109.018085; Wohlford-Lenane CL, 2009, J VIROL, V83, P11385, DOI 10.1128/JVI.01363-09; Wood MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055478; Wright KM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001497; Wu ZB, 2007, J MOL BIOL, V368, P537, DOI 10.1016/j.jmb.2007.02.040; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; Yang D, 2009, TRENDS IMMUNOL, V30, P531, DOI 10.1016/j.it.2009.07.004; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yasin B, 2004, J VIROL, V78, P5147, DOI 10.1128/JVI.78.10.5147-5156.2004; Zhang LQ, 2002, SCIENCE, V298, P995, DOI 10.1126/science.1076185; Zhang YA, 2010, BIOCHEMISTRY-US, V49, P9770, DOI 10.1021/bi101512j; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2; Zou J, 2007, MOL IMMUNOL, V44, P638, DOI 10.1016/j.molimm.2006.01.012	83	8	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97425	10.1371/journal.pone.0097425	http://dx.doi.org/10.1371/journal.pone.0097425			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819937	gold, Green Submitted, Green Published			2022-12-27	WOS:000336653300111
J	Duarte, S; Kato, H; Kuriyama, N; Suko, K; Ishikawa, TO; Busuttil, RW; Herschman, HR; Coito, AJ				Duarte, Sergio; Kato, Hiroyuki; Kuriyama, Naohisa; Suko, Kathryn; Ishikawa, Tomo-o; Busuttil, Ronald W.; Herschman, Harvey R.; Coito, Ana J.			Hepatic Ischemia and Reperfusion Injury in the Absence of Myeloid Cell-Derived COX-2 in Mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CYCLOOXYGENASE-2 INHIBITOR; ENDOTHELIAL-CELLS; LIVER; MACROPHAGES; REJECTION; (COX)-2; GAMMA	Cyclooxygenase-2 (COX-2) is a mediator of hepatic ischemia and reperfusion injury (IRI). While both global COX-2 deletion and pharmacologic COX-2 inhibition ameliorate liver IRI, the clinical use of COX-2 inhibitors has been linked to increased risks of heart attack and stroke. Therefore, a better understanding of the role of COX-2 in different cell types may lead to improved therapeutic strategies for hepatic IRI. Macrophages of myeloid origin are currently considered to be important sources of the COX-2 in damaged livers. Here, we used a Cox-2(flox) conditional knockout mouse (COX-2(-M/-M)) to examine the function of COX-2 expression in myeloid cells during liver IRI. COX-2(-M/-M) mice and their WT control littermates were subjected to partial liver ischemia followed by reperfusion. COX-2(-M/-M) macrophages did not express COX-2 upon lipopolysaccharide stimulation and COX-2(-M/-M) livers showed reduced levels of COX-2 protein post-IRI. Nevertheless, selective deletion of myeloid cell-derived COX-2 failed to ameliorate liver IRI; serum transaminases and histology were comparable in both COX-2(-M/-M) and WT mice. COX-2(-M/-M) livers, like WT livers, developed extensive necrosis, vascular congestion, leukocyte infiltration and matrix metalloproteinase-9 (MMP-9) expression post-reperfusion. In addition, myeloid COX-2 deletion led to a transient increase in IL-6 levels after hepatic reperfusion, when compared to controls. Administration of celecoxib, a selective COX-2 inhibitor, resulted in significantly improved liver function and histology in both COX-2(-M/-M) and WT mice post-reperfusion, providing evidence that COX-2-mediated liver IRI is caused by COX-2 derived from a source(s) other than myeloid cells. In conclusion, these results support the view that myeloid COX-2, including myeloid-macrophage COX-2, is not responsible for the hepatic IRI phenotype.	[Duarte, Sergio; Kato, Hiroyuki; Suko, Kathryn; Busuttil, Ronald W.; Coito, Ana J.] Univ Calif Los Angeles, David Geffen Sch Med, Dumont UCLA Transplant Ctr, Dept Surg, Los Angeles, CA 90095 USA; [Herschman, Harvey R.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Coito, AJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dumont UCLA Transplant Ctr, Dept Surg, Los Angeles, CA 90095 USA.	acoito@mednet.ucla.edu	Duarte, Sergio/AAH-2142-2021		National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID) [R01AI057832]; Pfleger Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057832] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Pfleger Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) R01AI057832 and the Pfleger Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braet F, 1996, J MICROSC-OXFORD, V181, P10, DOI 10.1046/j.1365-2818.1996.72348.x; Busuttil RW, 2003, LIVER TRANSPLANT, V9, P651, DOI 10.1053/jlts.2003.50105; Cannon CP, 2012, SCIENCE, V336, P1386, DOI 10.1126/science.1224398; Coito AJ, 2011, CURR OPIN ORGAN TRAN, V16, P34, DOI 10.1097/MOT.0b013e328342542e; Duarte S, 2012, AM J TRANSPLANT, V12, P2689, DOI 10.1111/j.1600-6143.2012.04161.x; Duarte S, 2012, HEPATOLOGY, V56, P1074, DOI 10.1002/hep.25710; Giroux M, 2000, J IMMUNOL, V165, P3985, DOI 10.4049/jimmunol.165.7.3985; Hamada T, 2008, J IMMUNOL, V180, P1843, DOI 10.4049/jimmunol.180.3.1843; Hamada T, 2009, AM J PATHOL, V174, P2265, DOI 10.2353/ajpath.2009.080872; Henderson JM, 1999, HEPATO-GASTROENTEROL, V46, P1482; Herschman Harvey R, 2003, Mol Imaging Biol, V5, P286; HOWARD TK, 1990, TRANSPLANTATION, V49, P103, DOI 10.1097/00007890-199001000-00023; Ishikawa T, 2006, GENESIS, V44, P143, DOI 10.1002/gene.20192; Ishikawa TO, 2011, CARCINOGENESIS, V32, P417, DOI 10.1093/carcin/bgq268; Kim SF, 2005, SCIENCE, V310, P1966, DOI 10.1126/science.1119407; Kirkby NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069524; Kobayashi M, 2007, HEPATO-GASTROENTEROL, V54, P522; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; Moore C, 2005, TRANSPL P, V37, P1682, DOI 10.1016/j.transproceed.2005.03.146; Narasimha AJ, 2010, ARTERIOSCL THROM VAS, V30, P260, DOI 10.1161/ATVBAHA.109.198762; Ni J, 2007, J NEUROIMMUNOL, V186, P94, DOI 10.1016/j.jneuroim.2007.03.012; Oshima K, 2009, J INVEST SURG, V22, P239, DOI 10.1080/08941930903040080; Ozturk H, 2006, HEPATOL RES, V34, P76, DOI 10.1016/j.hepres.2005.11.003; Ray WA, 2002, LANCET, V360, P1071, DOI 10.1016/S0140-6736(02)11131-7; Salinas G, 2007, J CARDIOVASC PHARM T, V12, P98, DOI 10.1177/1074248407301172; Schwarz NT, 2001, GASTROENTEROLOGY, V121, P1354, DOI 10.1053/gast.2001.29605; Stoffels B, 2011, EUR SURG RES, V47, P109, DOI 10.1159/000329414; Suzuki JI, 2006, J MOL CELL CARDIOL, V40, P688, DOI 10.1016/j.yjmcc.2006.01.006; Takeyoshi I, 2001, J SURG RES, V100, P25, DOI 10.1006/jsre.2001.6211; Wojcik M, 2012, HISTOCHEM CELL BIOL, V137, P217, DOI 10.1007/s00418-011-0889-9; Wustefeld T, 2000, HEPATOLOGY, V32, P514, DOI 10.1053/jhep.2000.16604; Yu Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003787; Zhang YQ, 2004, GENE DEV, V18, P157, DOI 10.1101/gad.1138104	33	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96913	10.1371/journal.pone.0096913	http://dx.doi.org/10.1371/journal.pone.0096913			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819536	gold, Green Published, Green Submitted			2022-12-27	WOS:000336653300047
J	He, ZM; Li, J; Hwa, YL; Brost, B; Fang, Q; Jiang, SW				He, Zhi-ming; Li, Jinping; Hwa, Yi Lisa; Brost, Brian; Fang, Qun; Jiang, Shi-Wen			Transition of LINE-1 DNA Methylation Status and Altered Expression in First and Third Trimester Placentas	PLOS ONE			English	Article							CELL-PROLIFERATION; GENE-EXPRESSION; 5-METHYLCYTOSINE CONTENT; ENDOMETRIAL CANCERS; L1 RETROTRANSPOSONS; ELEMENTS; HYPOMETHYLATION; PREGNANCY; TISSUES; HYPERMETHYLATION	DNA methylation plays a critical role in the regulation of gene expression, genomic DNA stability, cell proliferation, and malignant transformation. Common cellular features including fast tissue expansion, invasive growth, and active angiogenesis, have been noticed between placental development and tumorigenesis by many investigators. While the DNA hypomethylation and transcriptional activation of LINE-1 has been found to be a feature of tumorigenesis, it is not clear if similar changes could be involved in placental development. In this study, we assessed LINE-1 methylation in human placentas from different gestational ages and observed a significant decrease of LINE-1 methylation levels in third trimester placentas compared to first trimester placentas. Accompanying with this change is the significantly increased LINE-1 mRNA levels in third trimester placentas. Since no global DNA methylation change was detected between first and third trimesters, LINE-1 methylation changes appeared to be a specific epigenetic entity contributing to placental development. Indeed, further analyses showed that LINE-1 upregulation was correlated with higher levels of PCNA, suggesting a link between LINE-1 activation and fast proliferation of certain cellular components in third trimester placentas. Measurement of the DNMT1, DNMT3A, and DNMT3B expression found a significant reduction of DNMT3B between third and first trimesters, pointing to the possible involvement of this enzyme in the regulation of LINE-1 methylation. Taken together these results provided evidence for a dynamic temporal regulation of LINE-1 methylation and activation during placental development. These studies have laid a foundation for future investigation on the function of LINE-1 expression in human placenta under different patho-physiological conditions.	[He, Zhi-ming; Fang, Qun] Sun Yat Sen Univ, Affiliated Hosp 1, Fetal Med Ctr, Dept Obstet & Gynecol, Guangzhou 510275, Guangdong, Peoples R China; [He, Zhi-ming; Li, Jinping; Jiang, Shi-Wen] Mercer Univ, Sch Med, Dept Biol Sci, Savannah, GA USA; [Li, Jinping; Brost, Brian; Jiang, Shi-Wen] Mayo Clin, Dept Obstet & Gynecol, Rochester, MN USA; [Li, Jinping; Hwa, Yi Lisa; Brost, Brian; Jiang, Shi-Wen] Mayo Coll Med, Rochester, MN USA; [Li, Jinping; Jiang, Shi-Wen] Mem Hlth Univ, Med Ctr, Dept Obstet & Gynecol, Savannah, GA USA; [Hwa, Yi Lisa] Mayo Clin, Dept Med, Rochester, MN USA	Sun Yat Sen University; Mercer University; Mayo Clinic; Mayo Clinic; Mayo Clinic	Fang, Q (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Fetal Med Ctr, Dept Obstet & Gynecol, Guangzhou 510275, Guangdong, Peoples R China.	fang_qun@163.com; jiang_s@mercer.edu		Brost, Brian/0000-0002-4903-4186	NIH [HD41577]; Distinguished Cancer Scholarship of Georgia Research Alliance; Research Supplement from Mercer University School of Medicine; Mercer University Seed Fund; Mayo Foundation Clinical Research Program; Mayo Clinic Department of Obstetrics and Gynecology Chair Discretionary Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD041577] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Distinguished Cancer Scholarship of Georgia Research Alliance; Research Supplement from Mercer University School of Medicine; Mercer University Seed Fund; Mayo Foundation Clinical Research Program; Mayo Clinic Department of Obstetrics and Gynecology Chair Discretionary Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported from the following funding sources: The NIH R01 grant HD41577 (Shi-Wen Jiang); The Distinguished Cancer Scholarship (Shi-Wen Jiang) of Georgia Research Alliance; The Research Supplement from Mercer University School of Medicine (Jinping Li, Shi-Wen Jiang); Mercer University Seed Fund (Shi-Wen Jiang, Jinping Li); Mayo Foundation Clinical Research Program (Brian Brost, Shi-Wen Jiang); Mayo Clinic Department of Obstetrics and Gynecology Chair Discretionary Fund (Shi-Wen Jiang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babushok DV, 2007, HUM MUTAT, V28, P527, DOI 10.1002/humu.20486; Baylin SB, 2001, HUM MOL GENET, V10, P687, DOI 10.1093/hmg/10.7.687; Belgnaoui SM, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-13; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Chavan-Gautam P, 2011, MOL REPROD DEV, V78, P150, DOI 10.1002/mrd.21296; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709; Ergun S, 2004, J BIOL CHEM, V279, P27753, DOI 10.1074/jbc.M312985200; Esteller M, 2002, J PATHOL, V196, P1, DOI 10.1002/path.1024; Ferretti C, 2007, HUM REPROD UPDATE, V13, P121, DOI 10.1093/humupd/dml048; Fuke C, 2004, ANN HUM GENET, V68, P196, DOI 10.1046/j.1529-8817.2004.00081.x; GAMASOSA MA, 1983, NUCLEIC ACIDS RES, V11, P3087, DOI 10.1093/nar/11.10.3087; Garcia-Perez JL, 2007, HUM MOL GENET, V16, P1569, DOI 10.1093/hmg/ddm105; Grazul-Bilska AT, 2011, REPRODUCTION, V141, P529, DOI 10.1530/REP-10-0505; Hoffmann MJ, 2005, BIOCHEM CELL BIOL, V83, P296, DOI 10.1139/o05-036; Holtan SG, 2009, MAYO CLIN PROC, V84, P985, DOI 10.1016/S0025-6196(11)60669-1; Huang Q, 2013, CELL SIGNAL, V25, P1027, DOI 10.1016/j.cellsig.2013.01.008; Jin F, 2005, GYNECOL ONCOL, V96, P531, DOI 10.1016/j.ygyno.2004.10.039; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Kano H, 2009, GENE DEV, V23, P1303, DOI 10.1101/gad.1803909; Kaufmann P, 2004, PLACENTA, V25, P114, DOI 10.1016/j.placenta.2003.10.009; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kimura F, 2003, INT J CANCER, V104, P568, DOI 10.1002/ijc.10988; Kuo KW, 1998, BIOCHEM BIOPH RES CO, V253, P566, DOI 10.1006/bbrc.1998.9811; Landriscina M, 2005, J CLIN ENDOCR METAB, V90, P5663, DOI 10.1210/jc.2005-0367; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maruo T, 2001, Early Pregnancy, V5, P28; Oricchio E, 2007, ONCOGENE, V26, P4226, DOI 10.1038/sj.onc.1210214; Ostertag EM, 2003, AM J HUM GENET, V73, P1444, DOI 10.1086/380207; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Penzkofer T, 2005, NUCLEIC ACIDS RES, V33, pD498, DOI 10.1093/nar/gki044; Perrin D, 2007, ONCOGENE, V26, P2518, DOI 10.1038/sj.onc.1210039; Rangwala SH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r100; RAZIN A, 1991, MICROBIOL REV, V55, P451, DOI 10.1128/MMBR.55.3.451-458.1991; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Ren J, 2011, CELL SIGNAL, V23, P1082, DOI 10.1016/j.cellsig.2011.02.003; Roman-Gomez J, 2005, ONCOGENE, V24, P7213, DOI 10.1038/sj.onc.1208866; Schulz WA, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/83672; Sciamanna E, 2005, ONCOGENE, V24, P3923, DOI 10.1038/sj.onc.1208562; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Soundararajan Rama, 2004, Reprod Biol Endocrinol, V2, P15, DOI 10.1186/1477-7827-2-15; Steinhoff C, 2004, MOL GENET GENOMICS, V270, P394, DOI 10.1007/s00438-003-0931-2; STRICKLAND S, 1992, CELL, V71, P355, DOI 10.1016/0092-8674(92)90503-5; The UniProt Consortium, 2022, NUCL ACIDS RES, DOI [10.1093/nar/28.1.27, 10.1093/nar/gkac1052]; Wilhelm-Benartzi CS, 2012, ENVIRON HEALTH PERSP, V120, P296, DOI 10.1289/ehp.1103927; Wilson AS, 2007, BBA-REV CANCER, V1775, P138, DOI 10.1016/j.bbcan.2006.08.007; Xiong YN, 2005, GYNECOL ONCOL, V96, P601, DOI 10.1016/j.ygyno.2004.11.047; Xiong YN, 2005, CANCER RES, V65, P2684, DOI 10.1158/0008-5472.CAN-04-2843; Yu F, 2001, NUCLEIC ACIDS RES, V29, P4493, DOI 10.1093/nar/29.21.4493	51	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96994	10.1371/journal.pone.0096994	http://dx.doi.org/10.1371/journal.pone.0096994			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24821186	Green Submitted, Green Published, gold			2022-12-27	WOS:000336653300058
J	Panczak, R; Zwahlen, M; Woitek, U; Ruhli, FJ; Staub, K				Panczak, Radoslaw; Zwahlen, Marcel; Woitek, Ulrich; Ruehli, Frank J.; Staub, Kaspar			Socioeconomic, Temporal and Regional Variation in Body Mass Index among 188,537 Swiss Male Conscripts Born between 1986 and 1992	PLOS ONE			English	Article							OBESITY EPIDEMIC; RISK-FACTORS; OVERWEIGHT; SWITZERLAND; PREVALENCE; CHILDREN; POSITION; TRENDS; ADOLESCENTS; MORTALITY	Background: Rising levels of overweight and obesity are important public-health concerns worldwide. The purpose of this study is to elucidate their prevalence and trends in Switzerland by analyzing variations in Body Mass Index (BMI) of Swiss conscripts. Methods: The conscription records were provided by the Swiss Army. This study focussed on conscripts 18.5-20.5 years of age from the seven one-year birth cohorts spanning the period 1986-1992. BMI across professional status, area-based socioeconomic position (abSEP), urbanicity and regions was analyzed. Two piecewise quantile regression models with linear splines for three birth-cohort groups were used to examine the association of median BMI with explanatory variables and to determine the extent to which BMI has varied over time. Results: The study population consisted of 188,537 individuals. Median BMI was 22.51 kg/m(2) (22.45-22.57 95% confidence interval (CI)). BMI was lower among conscripts of high professional status (-0.46 kg/m(2); 95% CI: -0.50, -0.42, compared with low), living in areas of high abSEP (-0.11 kg/m(2); 95% CI: -0.16, -0.07 compared to medium) and from urban communities (-0.07 kg/m(2); 95% CI: -0.11, -0.03, compared with peri-urban). Comparing with Midland, median BMI was highest in the North-West (0.25 kg/m(2); 95% CI: 0.19-0.30) and Central regions (0.11 kg/m(2); 95% CI: 0.05-0.16) and lowest in the East (-0.19 kg/m(2); 95% CI: -0.24, -0.14) and Lake Geneva regions (-0.15 kg/m(2); 95% CI: -0.20, -0.09). Trajectories of regional BMI growth varied across birth cohorts, with median BMI remaining high in the Central and North-West regions, whereas stabilization and in some cases a decline were observed elsewhere. Conclusions: BMI of Swiss conscripts is associated with individual and abSEP and urbanicity. Results show regional variation in the levels and temporal trajectories of BMI growth and signal their possible slowdown among recent birth cohorts.	[Panczak, Radoslaw; Ruehli, Frank J.; Staub, Kaspar] Univ Zurich, Inst Anat, Ctr Evolutionary Med, Zurich, Switzerland; [Panczak, Radoslaw; Zwahlen, Marcel] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Woitek, Ulrich] Univ Zurich, Dept Econ, Zurich, Switzerland	University of Zurich; University of Bern; University of Zurich	Staub, K (corresponding author), Univ Zurich, Inst Anat, Ctr Evolutionary Med, Zurich, Switzerland.	kaspar.staub@anatom.uzh.ch	Panczak, Radoslaw/E-7384-2018; Zwahlen, Marcel/AFF-8559-2022	Panczak, Radoslaw/0000-0001-5141-683X; Zwahlen, Marcel/0000-0002-6772-6346; Staub, Kaspar/0000-0002-3951-1807	Federal Office of Public Health [12.005283]; Maxi Foundation	Federal Office of Public Health; Maxi Foundation	KS (PI), FJR and UW received grant from Federal Office of Public Health (Project-No: 12.005283). RP was funded by grant from Federal Office of Public Health (Project- No: 12.005283). KS and FJR were funded by Maxi Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel T, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13901; Aeberli I, 2010, SWISS MED WKLY, V140, DOI 10.4414/smw.2010.13046; [Anonymous], [No title captured]; Bingham CML, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-91; Bottai M, 2014, OBESITY, V22, pE149, DOI 10.1002/oby.20618; Burkhauser RV, 2008, J HEALTH ECON, V27, P519, DOI 10.1016/j.jhealeco.2007.05.005; Chappuis A., 2011, SWISS SURVEY SALT IN; Chiolero A, 2007, OBES REV, V8, P373, DOI 10.1111/j.1467-789X.2007.00375.x; Davin C, 2012, NUTR METAB CARDIOVAS, V22, P952, DOI 10.1016/j.numecd.2011.01.004; Engeland A, 2003, AM J EPIDEMIOL, V157, P517, DOI 10.1093/aje/kwf219; Engeland A, 2003, EPIDEMIOLOGY, V14, P293, DOI 10.1097/00001648-200305000-00008; Faeh D, 2011, OBES REV, V12, P151, DOI 10.1111/j.1467-789X.2010.00793.x; Faeh D, 2012, SECHSTER SCHWEIZERIS, P128; Faeh D, 2013, EPIDEMIOLOGIE UBERGE, P1; Faeh D, 2008, SWISS MED WKLY, V138, P204, DOI 2008/13/smw-12065; Faeh D, 2010, OBESITY, V18, P644, DOI 10.1038/oby.2009.310; Faeh D, 2009, SWISS MED WKLY, V139, P752, DOI smw-12863; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Fuchs VR, 2004, J HEALTH ECON, V23, P653, DOI 10.1016/j.jhealeco.2004.04.004; Galobardes B, 2003, AM J PUBLIC HEALTH, V93, P1302, DOI 10.2105/AJPH.93.8.1302; Henneberg M., 2005, J HUM ECOL, P85; International Labour Organization, 2014, INT STAND CLASS OCC; James P T, 2001, Obes Res, V9 Suppl 4, p228S, DOI 10.1038/oby.2001.123; Kakinami L, 2014, J EPIDEMIOL COMMUN H, V68, P239, DOI 10.1136/jech-2012-201881; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; KEYS A, 1972, J CHRON DIS, V25, P329, DOI 10.1016/0021-9681(72)90027-6; Koenker R., 2010, ECONOMETRIC SOC MONO, V2005, P295; Leahey TM, 2011, OBESITY, V19, P1157, DOI 10.1038/oby.2010.301; Ledergerber M, 2011, GESUNDHEITSWESEN, V73, P46, DOI 10.1055/s-0030-1268447; Logistikbasis der Armee LBA San, 2014, MIL DIENST; Malatesta D, 2013, GULTIGKEIT RELEVANZ; Marques-Vidal P, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-87; Morabia A, 2005, AM J PUBLIC HEALTH, V95, P632, DOI 10.2105/2004.047877; Murer SB, 2014, EUR J NUTR, V53, P865, DOI 10.1007/s00394-013-0590-y; Ogna A, 2014, EUR J NUTR, V53, P1281, DOI 10.1007/s00394-013-0643-2; Olds T, 2011, INT J PEDIATR OBES, V6, P342, DOI 10.3109/17477166.2011.605895; Oliver LN, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-16; Panczak R, 2012, J EPIDEMIOL COMMUN H, V66, P1129, DOI 10.1136/jech-2011-200699; Poglitsch M, 2011, EUR SURG, V43, P181, DOI 10.1007/s10353-011-0009-z; Rami B, 2004, J PEDIATR ENDOCR MET, V17, P67, DOI 10.1515/JPEM.2004.17.1.67; Ruhli F, 2008, AM J PHYS ANTHROPOL, V137, P457, DOI 10.1002/ajpa.20889; Saely CH, 2009, SWISS MED WKLY, V139, P518; Schneider H, 2009, OVERWEIGHT OBESITY S; Schneider HJ, 2010, J CLIN ENDOCR METAB, V95, P1777, DOI 10.1210/jc.2009-1584; Schneider H, 2010, INT J ENV RES PUB HE, V7, P460, DOI 10.3390/ijerph7020460; Schutz Y, 2002, INT J OBESITY, V26, pS3, DOI 10.1038/sj.ijo.0802122; Sebo P, 2008, PREV MED, V47, P389, DOI 10.1016/j.ypmed.2008.06.012; Smith GD, 1997, BMJ-BRIT MED J, V314, P547, DOI 10.1136/bmj.314.7080.547; Stamm H, 2013, VERGLEICHENDES MONIT; Stamm HP, 2011, INDIKA TORENBERICHT; Staub K, 2010, EUR J CLIN NUTR, V64, P335, DOI 10.1038/ejcn.2010.7; Staub K, 2010, THESIS U BERN; Staub K., 2013, AUXOLOGY, P148; Staub K, 2013, SWISS REV MIL DISAST, V1, P41; Stronski-Huwiler S, 2013, UBERGEWICHT ADIPOSIT, P9; Swiss Federal Statistical Office, 2013, SCHWEIZ GES 2012; Swiss Federal Statistical Office, 2014, NOM RAUML GLIED; Swiss Federal Statistical Office, 2014, BEV STRUKT IND; Toschke AM, 2005, INT J OBESITY, V29, P875, DOI 10.1038/sj.ijo.0802989; Tschumper A, 2006, INT J PEDIATR OBES, V1, P153, DOI 10.1080/17477160600881767; Wolff H, 2006, OBESITY, V14, P2080, DOI 10.1038/oby.2006.243; World Health Organization, 2014, BMI CLASS; Zimmerman MB, 2004, SWISS MED WKLY, V134, P523	63	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96721	10.1371/journal.pone.0096721	http://dx.doi.org/10.1371/journal.pone.0096721			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI1ZC	24819730	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000336653300028
J	Park, M; Sun, Q; Liu, F; DeLisa, MP; Chen, W				Park, Miso; Sun, Qing; Liu, Fang; DeLisa, Matthew P.; Chen, Wilfred			Positional Assembly of Enzymes on Bacterial Outer Membrane Vesicles for Cascade Reactions	PLOS ONE			English	Article							CELL-SURFACE; IN-VITRO; CELLULOSOMES; METABOLON	The systematic organization of enzymes is a key feature for the efficient operation of cascade reactions in nature. Here, we demonstrate a facile method to create nanoscale enzyme cascades by using engineered bacterial outer membrane vesicles (OMVs) that are spheroid nanoparticles (roughly 50 nm in diameter) produced by Gram-negative bacteria during all phases of growth. By taking advantage of the fact that OMVs naturally contain proteins found in the outer cell membrane, we displayed a trivalent protein scaffold containing three divergent cohesin domains for the position-specific presentation of a three-enzyme cascade on OMVs through a truncated ice nucleation protein anchoring motif (INP). The positional assembly of three enzymes for cellulose hydrolysis was demonstrated. The enzyme-decorated OMVs provided synergistic cellulose hydrolysis resulting in 23-fold enhancement in glucose production than free enzymes.	[Park, Miso; Sun, Qing; Liu, Fang; Chen, Wilfred] Univ Delaware, Dept Chem & Biomol Engn, Newark, DE 19716 USA; [DeLisa, Matthew P.] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY USA	University of Delaware; Cornell University	Chen, W (corresponding author), Univ Delaware, Dept Chem & Biomol Engn, Newark, DE 19716 USA.	wilfred@udel.edu	Liu, Fang/D-7999-2015; DeLisa, Matthew/AAE-7361-2019	DeLisa, Matthew/0000-0003-3226-1566	National Science Foundation [CBET1263774]; Directorate For Engineering [1264701] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	The authors would like to acknowledge the funding support from National Science Foundation (CBET1263774). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapakis CM, 2012, NAT CHEM BIOL, V8, P527, DOI [10.1038/NCHEMBIO.975, 10.1038/nchembio.975]; Bae W, 2002, J INORG BIOCHEM, V88, P223, DOI 10.1016/S0162-0134(01)00392-0; Bayer EA, 1998, J STRUCT BIOL, V124, P221, DOI 10.1006/jsbi.1998.4065; Ben-Haim N, 2008, NANO LETT, V8, P1368, DOI 10.1021/nl080105g; Bernadac A, 1998, J BACTERIOL, V180, P4872, DOI 10.1128/JB.180.18.4872-4878.1998; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; Chandrawati R, 2012, LANGMUIR, V28, P13798, DOI 10.1021/la301958v; Chen DJ, 2010, P NATL ACAD SCI USA, V107, P3099, DOI 10.1073/pnas.0805532107; Conrado RJ, 2008, CURR OPIN BIOTECH, V19, P492, DOI 10.1016/j.copbio.2008.07.006; Fischer A, 2002, CHEMBIOCHEM, V3, P409, DOI 10.1002/1439-7633(20020503)3:5<409::AID-CBIC409>3.0.CO;2-P; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; Jorgensen K, 2005, CURR OPIN PLANT BIOL, V8, P280, DOI 10.1016/j.pbi.2005.03.014; Kim JY, 2008, J MOL BIOL, V380, P51, DOI 10.1016/j.jmb.2008.03.076; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Liu F, 2013, CHEM COMMUN, V49, P3766, DOI 10.1039/c3cc40454d; Murdock RC, 2008, TOXICOL SCI, V101, P239, DOI 10.1093/toxsci/kfm240; Schoffelen S, 2012, SOFT MATTER, V8, P1736, DOI 10.1039/c1sm06452e; Tsai SL, 2009, APPL ENVIRON MICROB, V75, P6087, DOI 10.1128/AEM.01538-09; van Dongen SFM, 2009, CHEM-EUR J, V15, P1107, DOI 10.1002/chem.200802114; Velot C, 1997, BIOCHEMISTRY-US, V36, P14271, DOI 10.1021/bi972011j; Vriezema DM, 2007, ANGEW CHEM INT EDIT, V46, P7378, DOI 10.1002/anie.200701125	22	40	45	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97103	10.1371/journal.pone.0097103	http://dx.doi.org/10.1371/journal.pone.0097103			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24820175	Green Published, Green Submitted, gold			2022-12-27	WOS:000336653300073
J	Stroebe, M; Stroebe, W; van de Schoot, R; Schut, H; Abakoumkin, G; Li, J				Stroebe, Margaret; Stroebe, Wolfgang; van de Schoot, Rens; Schut, Henk; Abakoumkin, Georgios; Li, Jie			Guilt in Bereavement: The Role of Self-Blame and Regret in Coping with Loss	PLOS ONE			English	Article							DEATH; ADJUSTMENT; DEPRESSION; RECOVERY; EVENT; GRIEF	Despite the apparent centrality of guilt in complicating reactions following bereavement, scientific investigation has been limited. Establishing the impact of specific components associated with guilt could enhance understanding. The aim of this study was to examine the relationships between two guilt-related manifestations, namely self-blame and regret, with grief and depression. A longitudinal investigation was conducted 4-7 months, 14 months and 2 years post-loss. Participants were bereaved spouses (30 widows; 30 widowers); their mean age was 53.05 years. Results showed that self-blame was associated with grief at the initial time-point and with its decline over time. Such associations were not found for depression. Initial levels of regret were neither associated with initial levels of grief and depression, nor were they related to the decline over time in either outcome variable. These results demonstrate the importance of examining guilt-related manifestations independently, over time, and with respect to both generic and grief-specific outcome variables. A main conclusion is that self-blame (but not regret) is a powerful determinant of grief-specific difficulties following the loss of a loved one. Implications for intervention are considered.	[Stroebe, Margaret; Stroebe, Wolfgang; Schut, Henk] Univ Utrecht, Dept Psychol, Utrecht, Netherlands; [Stroebe, Margaret; Stroebe, Wolfgang] Univ Groningen, Dept Psychol, NL-9712 TS Groningen, Netherlands; [van de Schoot, Rens] Univ Utrecht, Dept Methods & Stat, Utrecht, Netherlands; [van de Schoot, Rens] North West Univ, Fac Humanities, Optentia Res Program, Mahikeng, South Africa; [Abakoumkin, Georgios] Univ Thessaly, Dept Early Childhood Educ, Volos, Greece; [Li, Jie] Renmin Univ China, Dept Psychol, Beijing, Peoples R China	Utrecht University; University of Groningen; Utrecht University; North West University - South Africa; University of Thessaly; Renmin University of China	Stroebe, M (corresponding author), Univ Utrecht, Dept Psychol, Utrecht, Netherlands.	M.S.Stroebe@UU.NL	Abakoumkin, Georgios/AAD-7902-2021; Schut, Henk/E-7487-2013	Abakoumkin, Georgios/0000-0002-1671-3561; Stroebe, Margaret/0000-0002-8468-3317	Deutsche Forschungs Gemeinschaft (DFG); German Research Association (DFG) [186/4-3]	Deutsche Forschungs Gemeinschaft (DFG)(German Research Foundation (DFG)); German Research Association (DFG)(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungs Gemeinschaft (DFG); the German Research Association (DFG), project number: 186/4-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama A, 2010, ARCH GERONTOL GERIAT, V50, P175, DOI 10.1016/j.archger.2009.03.006; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; Boelen PA, 2005, J PSYCHOPATHOL BEHAV, V27, P291, DOI 10.1007/s10862-005-2409-5; Boelen PA, 2003, BEHAV RES THER, V41, P1123, DOI 10.1016/S0005-7967(02)00259-0; Bonanno GA, 2004, PSYCHOL AGING, V19, P260, DOI 10.1037/0882-7974.19.2.260; Bryant RA, 2013, CURR OPIN PSYCHIATR, V26, P41, DOI 10.1097/YCO.0b013e32835b2ca2; Davis CG, 1996, PERS SOC PSYCHOL B, V22, P557, DOI 10.1177/0146167296226002; DOWNEY G, 1990, J PERS SOC PSYCHOL, V59, P925, DOI 10.1037/0022-3514.59.5.925; Field NP, 2001, AM BEHAV SCI, V44, P764, DOI 10.1177/00027640121956485; Field NP, 2000, COGNITIVE THER RES, V24, P551, DOI 10.1023/A:1005514128798; Garnefski N., 2009, INDIVIDUAL DIFFERENC, V7, P168; Gelman A., 2004, BAYESIAN DATA ANAL; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Golden AMJ, 2012, J CONSULT CLIN PSYCH, V80, P512, DOI 10.1037/a0027338; HAZZARD A, 1992, J DEV BEHAV PEDIATR, V13, P24; Holland JM, 2013, J GERONTOL IN PRESS; HOROWITZ MJ, 1984, J NERV MENT DIS, V172, P383, DOI 10.1097/00005053-198407000-00002; Hox J, 2012, SURV RES METHODS-GER, V6, P87; Hox JJ, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00078; Hox JJ, 2010, STAT NEERL, V64, P157, DOI 10.1111/j.1467-9574.2009.00445.x; Jalland P., 2013, FAM SCI, V4, P4, DOI DOI 10.1080/19424620.2013.819224; JANOFFBULMAN R, 1979, J PERS SOC PSYCHOL, V37, P1798, DOI 10.1037/0022-3514.37.10.1798; Kammer D., 1983, DIAGNOSTICA, V29, P48; Kaplan D., 2012, HDB STRUCTURAL EQUAT, P650; Kruschke J. K., 2011, DOING BAYESIAN DATA; Lee S.-Y., 2007, STRUCTURAL EQUATION; Lee SY, 2004, MULTIVAR BEHAV RES, V39, P653, DOI 10.1207/s15327906mbr3904_4; Li J, 2014, DEATH STUD, V38, P165, DOI 10.1080/07481187.2012.738770; Lynch SM, 2007, STAT SOC BEHAV SC, P1, DOI 10.1007/978-0-387-71265-9; Maas C.J.M., 2005, METHODOLOGY, V1, P86, DOI [10.1027/1614-2241.1.3.86, DOI 10.1027/1614-2241.1.3.86]; Meuleman B., 2009, SURV RES METHODS-GER, V3, P45, DOI [10.18148/srm/2009.v3i1.666, DOI 10.18148/SRM/2009.V3I1.666]; Mizota Y, 2006, SOC SCI MED, V62, P2397, DOI 10.1016/j.socscimed.2005.10.032; Muthen B.O., 2012, MPLUS USERS GUIDE, V7th; Parkes CM, 1996, BEREAVEMENT STUDIES; Preacher K.J., 2008, LATENT GROWTH CURVE; Prigerson H.G., 2001, HDB BEREAVEMENT RES, P613, DOI DOI 10.1037/10436-026; Prigerson HG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000121; Robinson P., 2001, HDB BEREAVEMENT RES, P647; Roese NJ, 2009, J SOC CLIN PSYCHOL, V28, P671, DOI 10.1521/jscp.2009.28.6.671; Sanders CM, 1985, MANUAL GRIEF EXPERIE; Stroebe M, 2005, AM J PSYCHIAT, V162, P2178, DOI 10.1176/appi.ajp.162.11.2178; Stroebe M, 2007, LANCET, V370, P1960, DOI 10.1016/S0140-6736(07)61816-9; Stroebe MS, 2012, PERS RELATIONSHIP, V19, P255, DOI 10.1111/j.1475-6811.2011.01352.x; STROEBE MS, 1989, OMEGA-J DEATH DYING, V20, P1, DOI 10.2190/C3JE-C9L1-5R91-DWDU; Stroebe W, 2010, OMEGA, V61, P87; Stroebe Wolfgang, 1993, P208, DOI 10.1017/CBO9780511664076.015; Stroebe Wolfgang., 1987, BEREAVEMENT HLTH PSY; TANGNEY JP, 1992, J ABNORM PSYCHOL, V101, P469, DOI 10.1037/0021-843X.101.3.469; Tangney JP, 2007, ANNU REV PSYCHOL, V58, P345, DOI 10.1146/annurev.psych.56.091103.070145; Torges CM, 2008, PSYCHOL AGING, V23, P169, DOI 10.1037/0882-7974.23.1.169; van de Schoot R, 2014, CHILD DEV, V85, P842, DOI 10.1111/cdev.12169; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P779, DOI 10.3758/BF03194105; WEINBERG N, 1995, HEALTH SOC WORK, V20, P294, DOI 10.1093/hsw/20.4.294; WEINBERG N, 1994, DEATH STUD, V18, P583, DOI 10.1080/07481189408252702	54	38	39	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96606	10.1371/journal.pone.0096606	http://dx.doi.org/10.1371/journal.pone.0096606			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI1ZC	24819238	Green Published, Green Submitted, gold			2022-12-27	WOS:000336653300024
J	Carel, C; Nukdee, K; Cantaloube, S; Bonne, M; Diagne, CT; Laval, F; Daffe, M; Zerbib, D				Carel, Clement; Nukdee, Kanjana; Cantaloube, Sylvain; Bonne, Melanie; Diagne, Cheikh T.; Laval, Francoise; Daffe, Mamadou; Zerbib, Didier			Mycobacterium tuberculosis Proteins Involved in Mycolic Acid Synthesis and Transport Localize Dynamically to the Old Growing Pole and Septum	PLOS ONE			English	Article							CELL-DIVISION; ESCHERICHIA-COLI; INTRACELLULAR-SURVIVAL; MEMBRANE-PROTEIN; OUTER-MEMBRANE; GROWTH; BIOSYNTHESIS; PHOSPHORYLATION; DIVIVA; SYNTHASE	Understanding the mechanism that controls space-time coordination of elongation and division of Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), is critical for fighting the tubercle bacillus. Most of the numerous enzymes involved in the synthesis of Mycolic acid -Arabinogalactan-Peptidoglycan complex (MAPc) in the cell wall are essential in vivo. Using a dynamic approach, we localized Mtb enzymes belonging to the fatty acid synthase-II (FAS-II) complexes and involved in mycolic acid (MA) biosynthesis in a mycobacterial model of Mtb: M. smegmatis. Results also showed that the MA transporter MmpL3 was present in the mycobacterial envelope and was specifically and dynamically accumulated at the poles and septa during bacterial growth. This localization was due to its C-terminal domain. Moreover, the FAS-II enzymes were co-localized at the poles and septum with Wag31, the protein responsible for the polar localization of mycobacterial peptidoglycan biosynthesis. The dynamic localization of FAS-II and of the MA transporter with Wag31, at the old-growing poles and at the septum suggests that the main components of the mycomembrane may potentially be synthesized at these precise foci. This finding highlights a major difference between mycobacteria and other rod-shaped bacteria studied to date. Based on the already known polar activities of envelope biosynthesis in mycobacteria, we propose the existence of complex polar machinery devoted to the biogenesis of the entire envelope. As a result, the mycobacterial pole would represent the Achilles' heel of the bacillus at all its growing stages.	[Carel, Clement; Nukdee, Kanjana; Cantaloube, Sylvain; Bonne, Melanie; Diagne, Cheikh T.; Laval, Francoise; Daffe, Mamadou; Zerbib, Didier] Ctr Natl Rech Sci, Inst Pharmacol & Biol Struct, Toulouse, France; [Carel, Clement; Nukdee, Kanjana; Cantaloube, Sylvain; Bonne, Melanie; Diagne, Cheikh T.; Laval, Francoise; Daffe, Mamadou; Zerbib, Didier] Univ Toulouse 3, Univ Toulouse, F-31062 Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Zerbib, D (corresponding author), Ctr Natl Rech Sci, Inst Pharmacol & Biol Struct, Toulouse, France.	Didier.Zerbib@ipbs.fr	LAUZERAL-VIZCAINO, Françoise/W-8898-2019	LAUZERAL-VIZCAINO, Françoise/0000-0002-9741-3252; Zerbib, Didier/0000-0001-7175-502X; Diagne, Cheikh Tidiane/0000-0003-2119-9349; ARIYACHAOKUN, Kanchiyaphat/0000-0001-5772-4307	Centre National de la Recherche Scientifique (CNRS); French ministry of research; Thailand government	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); French ministry of research(Ministry of Research, FranceEuropean Commission); Thailand government	This work was supported by the Centre National de la Recherche Scientifique (CNRS). CC was supported by the French ministry of research; KN was supported by a fellowship from the Thailand government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge BB, 2012, SCIENCE, V335, P100, DOI 10.1126/science.1216166; Asselineau C, 2002, PROG LIPID RES, V41, P501, DOI 10.1016/S0163-7827(02)00008-5; Backus KM, 2011, NAT CHEM BIOL, V7, P228, DOI 10.1038/NCHEMBIO.539; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Bardou F, 1996, ANTIMICROB AGENTS CH, V40, P2459, DOI 10.1128/AAC.40.11.2459; Bhatt A, 2005, J BACTERIOL, V187, P7596, DOI 10.1128/JB.187.22.7596-7606.2005; Bhatt A, 2007, P NATL ACAD SCI USA, V104, P5157, DOI 10.1073/pnas.0608654104; Blair JMA, 2009, CURR OPIN MICROBIOL, V12, P512, DOI 10.1016/j.mib.2009.07.003; BOEHRINGER D, 2013, J MOL BIOL, V0825; Cantaloube S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029564; Carlsson F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000285; Cha JH, 1997, J BACTERIOL, V179, P1671, DOI 10.1128/jb.179.5.1671-1683.1997; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Corrales RM, 2012, J BIOL CHEM, V287, P26187, DOI 10.1074/jbc.M112.373209; Crick DC, 2001, GLYCOBIOLOGY, V11, p107R, DOI 10.1093/glycob/11.9.107R; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; den Blaauwen T, 2008, FEMS MICROBIOL REV, V32, P321, DOI 10.1111/j.1574-6976.2007.00090.x; Domenech P, 2005, INFECT IMMUN, V73, P3492, DOI 10.1128/IAI.73.6.3492-3501.2005; DROCOURT D, 1990, NUCLEIC ACIDS RES, V18, P4009, DOI 10.1093/nar/18.13.4009; Edwards DH, 2000, EMBO J, V19, P2719, DOI 10.1093/emboj/19.11.2719; Ernst JD, 2012, NAT REV IMMUNOL, V12, P581, DOI 10.1038/nri3259; Feilmeier BJ, 2000, J BACTERIOL, V182, P4068, DOI 10.1128/JB.182.14.4068-4076.2000; Flardh K, 2003, MOL MICROBIOL, V49, P1523, DOI 10.1046/j.1365-2958.2003.03660.x; Flardh K, 2010, CURR OPIN MICROBIOL, V13, P758, DOI 10.1016/j.mib.2010.10.002; Gago G, 2011, FEMS MICROBIOL REV, V35, P475, DOI 10.1111/j.1574-6976.2010.00259.x; Gao LY, 2003, MOL MICROBIOL, V49, P1547, DOI 10.1046/j.1365-2958.2003.03667.x; Grzegorzewicz AE, 2012, NAT CHEM BIOL, V8, P334, DOI [10.1038/NCHEMBIO.794, 10.1038/nchembio.794]; He ZG, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-21; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hett EC, 2008, MICROBIOL MOL BIOL R, V72, P126, DOI 10.1128/MMBR.00028-07; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Jani C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-327; Joyce Graham, 2011, BMC Res Notes, V4, P73, DOI 10.1186/1756-0500-4-73; Kang CM, 2008, MICROBIOL-SGM, V154, P725, DOI 10.1099/mic.0.2007/014076-0; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Khan S, 2010, J BIOL CHEM, V285, P37860, DOI 10.1074/jbc.M110.143131; Kremer L, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P173; Laval F, 2001, ANAL CHEM, V73, P4537, DOI 10.1021/ac0105181; Lenarcic R, 2009, EMBO J, V28, P2272, DOI 10.1038/emboj.2009.129; Letek M, 2008, ANTON LEEUW INT J G, V94, P99, DOI 10.1007/s10482-008-9224-4; Letek Michal, 2012, Int J Cell Biol, V2012, P905832, DOI 10.1155/2012/905832; Lindner AB, 2008, P NATL ACAD SCI USA, V105, P3076, DOI 10.1073/pnas.0708931105; Makarov V, 2009, SCIENCE, V324, P801, DOI 10.1126/science.1171583; Maloney E, 2011, TUBERCULOSIS, V91, pS150, DOI 10.1016/j.tube.2011.10.025; Maloney E, 2009, TUBERCULOSIS, V89, pS65, DOI 10.1016/S1472-9792(09)70015-0; Marrakchi H, 2014, CHEM BIOL, V21, P67, DOI 10.1016/j.chembiol.2013.11.011; Minnikin DE, 2002, CHEM BIOL, V9, P545, DOI 10.1016/S1074-5521(02)00142-4; Mir M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002182; Molle V, 2006, J BIOL CHEM, V281, P30094, DOI 10.1074/jbc.M601691200; Molle V, 2010, MOL MICROBIOL, V78, P1591, DOI 10.1111/j.1365-2958.2010.07446.x; Munshi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060143; Nguyen L, 2007, J BACTERIOL, V189, P7896, DOI 10.1128/JB.00726-07; Parish T, 2007, J BACTERIOL, V189, P3721, DOI 10.1128/JB.01740-06; Richards DM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002423; Rudner DZ, 2002, P NATL ACAD SCI USA, V99, P8701, DOI 10.1073/pnas.132235899; Santi I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3470; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Swarts BM, 2012, J AM CHEM SOC, V134, P16123, DOI 10.1021/ja3062419; Tahlan K, 2012, ANTIMICROB AGENTS CH, V56, P1797, DOI 10.1128/AAC.05708-11; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Thanky NR, 2007, TUBERCULOSIS, V87, P231, DOI 10.1016/j.tube.2006.10.004; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Varela C, 2012, CHEM BIOL, V19, P498, DOI 10.1016/j.chembiol.2012.03.006; Veyron-Churlet R, 2005, J MOL BIOL, V353, P847, DOI 10.1016/j.jmb.2005.09.016; Veyron-Churlet R, 2004, MOL MICROBIOL, V54, P1161, DOI 10.1111/j.1365-2958.2004.04334.x; Veyron-Churlet R, 2010, J BIOL CHEM, V285, P12714, DOI 10.1074/jbc.M110.105189; Veyron-Churlet R, 2009, J BIOL CHEM, V284, P6414, DOI 10.1074/jbc.M806537200; Vilcheze C, 2000, J BACTERIOL, V182, P4059, DOI 10.1128/JB.182.14.4059-4067.2000; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Wakamoto Y, 2013, SCIENCE, V339, P91, DOI 10.1126/science.1229858; Winkler J, 2010, EMBO J, V29, P910, DOI 10.1038/emboj.2009.412; Wirth SE, 2012, MOL MICROBIOL, V83, P654, DOI 10.1111/j.1365-2958.2011.07958.x; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07; Zumla A, 2012, NAT REV DRUG DISCOV, V11, P170, DOI 10.1038/nrd3694	75	51	51	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97148	10.1371/journal.pone.0097148	http://dx.doi.org/10.1371/journal.pone.0097148			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24817274	Green Submitted, Green Published, gold			2022-12-27	WOS:000336838000108
J	Cerny, J; Bolfikova, BC; Valdes, JJ; Grubhoffer, L; Ruzek, D				Cerny, Jiri; Bolfikova, Barbora Cerna; Valdes, James J.; Grubhoffer, Libor; Ruzek, Daniel			Evolution of Tertiary Structure of Viral RNA Dependent Polymerases	PLOS ONE			English	Article							C VIRUS-RNA; CRYSTAL-STRUCTURE; POSITIVE-STRAND; REVERSE-TRANSCRIPTASE; ACTIVE-SITE; HIGHER TAXONOMY; TELL US; PROTEIN; SEQUENCE; MECHANISM	Viral RNA dependent polymerases (vRdPs) are present in all RNA viruses; unfortunately, their sequence similarity is too low for phylogenetic studies. Nevertheless, vRdP protein structures are remarkably conserved. In this study, we used the structural similarity of vRdPs to reconstruct their evolutionary history. The major strength of this work is in unifying sequence and structural data into a single quantitative phylogenetic analysis, using powerful a Bayesian approach. The resulting phylogram of vRdPs demonstrates that RNA-dependent DNA polymerases (RdDPs) of viruses within Retroviridae family cluster in a clearly separated group of vRdPs, while RNA-dependent RNA polymerases (RdRPs) of dsRNA and +ssRNA viruses are mixed together. This evidence supports the hypothesis that RdRPs replicating +ssRNA viruses evolved multiple times from RdRPs replicating +dsRNA viruses, and vice versa. Moreover, our phylogram may be presented as a scheme for RNA virus evolution. The results are in concordance with the actual concept of RNA virus evolution. Finally, the methods used in our work provide a new direction for studying ancient virus evolution.	[Cerny, Jiri; Valdes, James J.; Grubhoffer, Libor; Ruzek, Daniel] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic; [Cerny, Jiri; Grubhoffer, Libor] Univ South Bohemia Ceske Budejovice, Fac Sci, Ceske Budejovice, Czech Republic; [Bolfikova, Barbora Cerna] Czech Univ Life Sci Prague, Fac Trop AgriSci, Prague, Czech Republic; [Ruzek, Daniel] Vet Res Inst, CS-62132 Brno, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Czech University of Life Sciences Prague; Czech Veterinary Research Institute	Cerny, J (corresponding author), Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic.	cernyj02@prf.jcu.cz	Valdés, James/G-9812-2014; Růžek, Daniel/G-9275-2014; Cerny, Jiri/Q-4140-2016; Bolfikova, Barbora Cerna/I-6620-2019; Grubhoffer, Libor/G-9762-2014	Valdés, James/0000-0002-0237-8061; Růžek, Daniel/0000-0003-4655-2380; Cerny, Jiri/0000-0003-0891-0693; Bolfikova, Barbora Cerna/0000-0001-8059-4889; Grubhoffer, Libor/0000-0003-0885-1849	Czech Science Foundation [P502/11/2116, P302/12/2490, 14-29256S]; Grant Agency of University of South Bohemia [155/2013/P, Z60220518]; ANTIGONE [278976]; European Social Fund; state budget of Czech Republic [CZ.1.07/2.3.00/30.0032]; AdmireVet project [ED006/01/01]; CIGA [20134311]	Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of University of South Bohemia; ANTIGONE; European Social Fund(European Social Fund (ESF)); state budget of Czech Republic; AdmireVet project; CIGA	This work was supported by the Czech Science Foundation (P502/11/2116 to DR and P302/12/2490 to LG., www.gacr.cz), by Grant Agency of University of South Bohemia (155/2013/P to LG and Z60220518 to DR, http://www.jcu.cz/research/gaju), by ANTIGONE (278976 to LG, http://www.antigonefp7.eu/ant/), by European Social Fund and the state budget of Czech Republic (CZ.1.07/2.3.00/30.0032 to JJV, http://www.msmt.cz/strukturalni-fondy/op-vpk-obdobi-2007-2013), by AdmireVet project (ED006/01/01 to DR, http://www.vri.cz/en/admirevet), and by the Czech Science Foundation (14-29256S to DR) and CIGA (20134311 to BCB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Ahlquist P, 2006, NAT REV MICROBIOL, V4, P371, DOI 10.1038/nrmicro1389; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Aravind L, 2002, PROTEINS, V48, P1, DOI 10.1002/prot.10064; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; BALTIMORE D, 1971, BACTERIOL REV, V35, P235, DOI 10.1128/MMBR.35.3.235-241.1971; Bamford DH, 2005, CURR OPIN STRUC BIOL, V15, P655, DOI 10.1016/j.sbi.2005.10.012; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bruenn JA, 2003, NUCLEIC ACIDS RES, V31, P1821, DOI 10.1093/nar/gkg277; BRUENN JA, 1991, NUCLEIC ACIDS RES, V19, P217, DOI 10.1093/nar/19.2.217; Buck KW, 1996, ADV VIRUS RES, V47, P159, DOI 10.1016/S0065-3527(08)60736-8; Butcher SJ, 2001, NATURE, V410, P235, DOI 10.1038/35065653; Cabanillas L, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-11; CHO MW, 1993, J VIROL, V67, P3010, DOI 10.1128/JVI.67.6.3010-3018.1993; Choi KH, 2004, PROTEIN SCI, V13, P2685, DOI 10.1110/ps.04872204; CLEAVES GR, 1979, VIROLOGY, V96, P159, DOI 10.1016/0042-6822(79)90181-8; Martin MCS, 2009, VIRUS RES, V144, P344, DOI 10.1016/j.virusres.2009.05.007; Das D, 2004, STRUCTURE, V12, P819, DOI 10.1016/j.str.2004.02.032; Das K, 2012, NAT STRUCT MOL BIOL, V19, P253, DOI 10.1038/nsmb.2223; DOBOS P, 1995, VIROLOGY, V208, P19, DOI 10.1006/viro.1995.1125; Dolja VV, 2011, CURR OPIN VIROL, V1, P322, DOI 10.1016/j.coviro.2011.09.007; Dolja VV, 1992, SEMINARS VIROLOGY, V3, P315; Eickbush Thomas H., 1994, P121; Ferrer-Orta C, 2006, CURR OPIN STRUC BIOL, V16, P27, DOI 10.1016/j.sbi.2005.12.002; Ferrer-Orta C, 2004, J BIOL CHEM, V279, P47212, DOI 10.1074/jbc.M405465200; Ferrer-Orta C, 2007, P NATL ACAD SCI USA, V104, P9463, DOI 10.1073/pnas.0700518104; Ferrero D, 2012, ACTA CRYSTALLOGR F, V68, P1263, DOI 10.1107/S1744309112037529; Forterre P, 2002, CURR OPIN MICROBIOL, V5, P525, DOI 10.1016/S1369-5274(02)00360-0; Fullerton SWB, 2007, J VIROL, V81, P1858, DOI 10.1128/JVI.01462-06; Garriga D, 2007, P NATL ACAD SCI USA, V104, P20540, DOI 10.1073/pnas.0704447104; Gohara DW, 2000, J BIOL CHEM, V275, P25523, DOI 10.1074/jbc.M002671200; GOLDBACH R, 1994, ARCH VIROL, P87; Gong P, 2010, P NATL ACAD SCI USA, V107, P22505, DOI 10.1073/pnas.1007626107; Goodfellow I, 2011, CURR OPIN VIROL, V1, P355, DOI 10.1016/j.coviro.2011.09.003; GORBALENYA AE, 1988, NUCLEIC ACIDS RES, V16, P7735, DOI 10.1093/nar/16.15.7735; Gorbalenya AE, 2002, J MOL BIOL, V324, P47, DOI 10.1016/S0022-2836(02)01033-1; Graham SC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002085; Gruez A, 2008, J VIROL, V82, P9577, DOI 10.1128/JVI.00631-08; Hansen JL, 1997, STRUCTURE, V5, P1109, DOI 10.1016/S0969-2126(97)00261-X; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Holmes EC, 2011, J VIROL, V85, P5247, DOI 10.1128/JVI.02203-10; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Illergard K, 2009, PROTEINS, V77, P499, DOI 10.1002/prot.22458; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kidmose RT, 2010, P NATL ACAD SCI USA, V107, P10884, DOI 10.1073/pnas.1003015107; King AM, 2012, 9 REPORT INT COMMITT, P770; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Koonin EV, 2008, NAT REV MICROBIOL, V6, P925, DOI 10.1038/nrmicro2030; Koonin EV, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-54; KOONIN EV, 1993, CRIT REV BIOCHEM MOL, V28, P375, DOI 10.3109/10409239309078440; Koonin EV, 2006, VIRUS RES, V117, P1, DOI 10.1016/j.virusres.2006.01.018; KOONIN EV, 1991, J GEN VIROL, V72, P2197, DOI 10.1099/0022-1317-72-9-2197; Korneeva VS, 2007, J BIOL CHEM, V282, P16135, DOI 10.1074/jbc.M610090200; Krupovic M, 2010, J VIROL, V84, P12476, DOI 10.1128/JVI.01489-10; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Lang DM, 2013, NUCLEIC ACIDS RES, V41, P1464, DOI 10.1093/nar/gks1251; Lawton JA, 2000, ADV VIRUS RES, V55, P185, DOI 10.1016/S0065-3527(00)55004-0; Love RA, 2004, STRUCTURE, V12, P1533, DOI 10.1016/j.str.2004.05.024; Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549; Lu X, 2008, STRUCTURE, V16, P1678, DOI 10.1016/j.str.2008.09.006; Lukashevich IS, 1997, J GEN VIROL, V78, P547, DOI 10.1099/0022-1317-78-3-547; Makeyev EV, 2002, MOL CELL, V10, P1417, DOI 10.1016/S1097-2765(02)00780-3; Mastrangelo E, 2012, J MOL BIOL, V419, P198, DOI 10.1016/j.jmb.2012.03.008; McGowen MR, 2009, MOL PHYLOGENET EVOL, V53, P891, DOI 10.1016/j.ympev.2009.08.018; Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339; Mizuguchi K, 1998, BIOINFORMATICS, V14, P617, DOI 10.1093/bioinformatics/14.7.617; MULLER R, 1994, J GEN VIROL, V75, P1345, DOI 10.1099/0022-1317-75-6-1345; Ng KKS, 2008, CURR TOP MICROBIOL, V320, P137; Ng KKS, 2002, J BIOL CHEM, V277, P1381, DOI 10.1074/jbc.M109261200; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; O'Farrell D, 2003, J MOL BIOL, V326, P1025, DOI 10.1016/S0022-2836(02)01439-0; Pan JH, 2007, P NATL ACAD SCI USA, V104, P7385, DOI 10.1073/pnas.0611599104; Perard J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2611; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pickett BE, 2011, J VIRAL HEPATITIS, V18, P608, DOI 10.1111/j.1365-2893.2010.01342.x; POCH O, 1990, J GEN VIROL, V71, P1153, DOI 10.1099/0022-1317-71-5-1153; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; Pond SLK, 2012, METHODS MOL BIOL, V856, P239, DOI 10.1007/978-1-61779-585-5_10; Poranen MM, 2012, ADV EXP MED BIOL, V726, P379, DOI 10.1007/978-1-4614-0980-9_17; Ravantti J, 2013, J STRUCT BIOL, V183, P47, DOI 10.1016/j.jsb.2013.05.007; Ren J, 2002, P NATL ACAD SCI USA, V99, P14410, DOI 10.1073/pnas.222366699; Rice Charles M, 2011, Top Antivir Med, V19, P117; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Salgado PS, 2006, PLOS BIOL, V4, P2274, DOI 10.1371/journal.pbio.0040434; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049; Scheel TKH, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003228; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shatskaya GS, 2013, BIOCHEMISTRY-MOSCOW+, V78, P231, DOI 10.1134/S0006297913030036; Smith DB, 2012, J GEN VIROL, V93, P259, DOI 10.1099/vir.0.036392-0; Smith LM, 2013, VIROLOGY, V435, P258, DOI 10.1016/j.virol.2012.08.041; STEINHAUER DA, 1992, GENE, V122, P281, DOI 10.1016/0378-1119(92)90216-C; Takeshita D, 2012, NAT STRUCT MOL BIOL, V19, P229, DOI 10.1038/nsmb.2204; Takeshita D, 2010, P NATL ACAD SCI USA, V107, P15733, DOI 10.1073/pnas.1006559107; Tao YZ, 2002, CELL, V111, P733, DOI 10.1016/S0092-8674(02)01110-8; Urcuqui-Inchima S, 2010, ADV VIRUS RES, V77, P1, DOI 10.1016/S0065-3527(10)77001-9; van Dijk AA, 2004, J GEN VIROL, V85, P1077, DOI 10.1099/vir.0.19731-0; van Duin J, 2006, BACTERIOPHAGES; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; WANG CY, 1993, J VIROL, V67, P3338, DOI 10.1128/JVI.67.6.3338-3344.1993; WARD CW, 1993, RES VIROLOGY, V144, P419, DOI 10.1016/S0923-2516(06)80059-2; Wiens JJ, 2004, SYST BIOL, V53, P653, DOI 10.1080/10635150490472959; WILGENBUSCH JC, 2004, AWTY SYSTEM GRAPHICA; WIMMER E, 1993, ANNU REV GENET, V27, P353, DOI 10.1146/annurev.ge.27.120193.002033; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06; Zamyatkin DF, 2008, J BIOL CHEM, V283, P7705, DOI 10.1074/jbc.M709563200; Zanotto PMD, 1996, J VIROL, V70, P6083, DOI 10.1128/JVI.70.9.6083-6096.1996	108	41	41	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96070	10.1371/journal.pone.0096070	http://dx.doi.org/10.1371/journal.pone.0096070			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816789	Green Submitted, Green Published, gold			2022-12-27	WOS:000336838000021
J	Hofmeyr, SD; Symes, CT; Underhill, LG				Hofmeyr, Sally D.; Symes, Craig T.; Underhill, Leslie G.			Secretarybird Sagittarius serpentarius Population Trends and Ecology: Insights from South African Citizen Science Data	PLOS ONE			English	Article							BIRD POPULATIONS; CONSERVATION; GRASSLANDS; FIRE	Data from two long-term citizen science projects were used to examine the status and ecology of a Red List species, the Secretarybird Sagittarius serpentarius (Vulnerable), in South Africa. The first phase of the Southern African Bird Atlas Project operated from 1987 until 1992, and the second phase began in 2007. The Coordinated Avifaunal Roadcounts (CAR) project began in 1993 and by 1998 had expanded to cover much of the south-eastern half of the country. Data submitted up until April 2013 were used. A new method of comparing reporting rates between atlas projects was developed. Changing reporting rates are likely to reflect changes in abundance; in this instance the data suggest that the Secretarybird population decreased across much of South Africa between the two atlas projects, with a widespread important decrease in the Kruger National Park. Habitat data from the CAR project were analysed to gain insight into the ecology of the species. Secretarybirds tended to avoid transformed habitats across much of the area covered by the CAR project. In the winter rainfall region of the Western Cape, which is characterised by heavily transformed fynbos vegetation, at least 50% of Secretarybirds recorded were in transformed environments. This implies that in the Fynbos biome, at least, Secretarybirds have adapted to transformed environments to some degree. However, in the rest of the country it is likely that habitat loss, largely through widespread bush encroachment but also through agriculture, afforestation, and urbanisation, is a major threat to the species. The methods developed here represent a new approach to analysing data from long-term citizen science projects, which can provide important insights into a species' conservation status and ecology.	[Hofmeyr, Sally D.; Symes, Craig T.] Univ Witwatersrand, Sch Anim Plant & Environm Sci, Johannesburg, Gauteng, South Africa; [Hofmeyr, Sally D.; Underhill, Leslie G.] Univ Cape Town, Dept Biol Sci, Anim Demog Unit, ZA-7925 Cape Town, Western Cape, South Africa	University of Witwatersrand; University of Cape Town	Hofmeyr, SD (corresponding author), Univ Witwatersrand, Sch Anim Plant & Environm Sci, Johannesburg, Gauteng, South Africa.	salhofmeyr@gmail.com		Underhill, Les/0000-0002-8758-1527; Symes, Craig/0000-0002-8027-7055	University of the Witwatersrand University Research Committee; Tswalu Foundation; National Research Foundation; University of Cape Town; Harry Oppenheimer Memorial Fellowship	University of the Witwatersrand University Research Committee; Tswalu Foundation; National Research Foundation; University of Cape Town; Harry Oppenheimer Memorial Fellowship	The University of the Witwatersrand University Research Committee and Tswalu Foundation funded SDH. LGU acknowledges support from the National Research Foundation, the University of Cape Town and the Harry Oppenheimer Memorial Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN DG, 1994, OSTRICH, V65, P95, DOI 10.1080/00306525.1994.9639671; Allan DG, 1997, BIOL CONSERV, V79, P173, DOI 10.1016/S0006-3207(96)00098-5; Allan DG, 1993, THESIS U CAPE TOWN S; [Anonymous], 2009, MOS LAND COV MAP 200; Baker N, 2010, STATUS SECRETARYBIRD; BirdLife International, 2013, SPEC FACTSH SAG SERP; Bond WJ, 2010, BIOL CONSERV, V143, P2395, DOI 10.1016/j.biocon.2009.12.012; Bond WJ, 2008, ANNU REV ECOL EVOL S, V39, P641, DOI 10.1146/annurev.ecolsys.39.110707.173411; Bond WJ, 2003, GLOBAL CHANGE BIOL, V9, P973, DOI 10.1046/j.1365-2486.2003.00577.x; Boshoff AF, 1997, ATLAS SO AFRICAN BIR, V1, P152; Cohn JP, 2008, BIOSCIENCE, V58, P192, DOI 10.1641/B580303; Conover W. J., 1971, PRACTICAL NONPARAMET; CSIR ARC, 2005, NAT LAND COV DAT 20; Dean WRJ, 2005, ROBERTS BIRDS SO AFR, P542; Eckhardt HC, 2000, AFR J ECOL, V38, P108, DOI 10.1046/j.1365-2028.2000.00217.x; Environmental Systems Research Institute Inc, 1998, ARCVIEW GIS VERS 3 1; Greenwood JJD, 2007, J ORNITHOL, V148, pS77, DOI 10.1007/s10336-007-0239-9; Griffioen P., 2001, THESIS TROBE U AUSTR; Harrison JA, 2008, S AFR J SCI, V104, P82; Harrison J. A., 1997, ATLAS SO AFRICAN BIR, VI; Harrison JA, 1997, ATLAS SO AFRICAN BIR, V1, pxliii; Higgins SI, 2000, J ECOL, V88, P213, DOI 10.1046/j.1365-2745.2000.00435.x; HOCKEY PAR, 2005, ROBERTS BIRDS SO AFR; Hoffman MT, 1999, LAND DEGRADATI UNPUB, P164; Hoffman T., 2001, NATURE DIVIDED LAND; Hofmeyr SD, 2012, THESIS U CAPE TOWN S; JACOBS J, 1974, OECOLOGIA, V14, P413, DOI 10.1007/BF00384581; Kemp AC, 1995, OSTRICH, V66, P61, DOI 10.1080/00306525.1995.9633760; Kemp AC, 1994, HDB BIRDS WORLD, V2, P206; Loftie-Eaton M., 2014, THESIS U CAPE TOWN S; MACDONALD IAW, 1989, BIOTIC DIVERSITY IN SOUTHERN AFRICA : CONCEPTS AND CONSERVATION, P51; Mucina L., 2006, VEGETATION S AFRICA; ROBERTSON A, 1995, BIOL CONSERV, V71, P87, DOI 10.1016/0006-3207(94)00024-K; Schulze R.E., 2007, 1489106 WRC; Shaw JM, 2010, OSTRICH, V81, P109, DOI 10.2989/00306525.2010.488421; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; Sirami C, 2012, DIVERS DISTRIB, V18, P390, DOI 10.1111/j.1472-4642.2011.00810.x; Thompson MW, 1999, S AFRICAN NATL LAND; Tukey JW, 1977, EXPLORATORY DATA ANA; Underhill L, 2002, CONSERV BIOL SER, V7, P34; UNDERHILL LG, 1992, IBIS, V134, P99; Underhill LG, 1988, LONG TERM DATA SERIE, P468; Underhill LG, 1996, INTROSTAT; Wigley BJ, 2009, AFR J ECOL, V47, P62, DOI 10.1111/j.1365-2028.2008.01051.x; Wigley BJ, 2010, GLOBAL CHANGE BIOL, V16, P964, DOI 10.1111/j.1365-2486.2009.02030.x; Wright D, 2011, THESIS U CAPE TOWN S; Young DJ, 2003, 19932001 MAZD CAR U	47	14	15	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96772	10.1371/journal.pone.0096772	http://dx.doi.org/10.1371/journal.pone.0096772			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816839	Green Published, gold, Green Submitted			2022-12-27	WOS:000336838000063
J	Jodczyk, S; Fergusson, DM; Horwood, LJ; Pearson, JF; Kennedy, MA				Jodczyk, Sarah; Fergusson, David M.; Horwood, L. John; Pearson, John F.; Kennedy, Martin A.			No Association between Mean Telomere Length and Life Stress Observed in a 30 Year Birth Cohort	PLOS ONE			English	Article							CHILDHOOD; EXPOSURE; HEALTH; ADJUSTMENT; MORTALITY; VIOLENCE; EROSION; OBESITY; CANCER; GENES	Telomeres are specialised structures that cap the ends of chromosomes. They shorten with each cell division and have been proposed as a marker of cellular aging. Previous studies suggest that early life stressors increase the rate of telomere shortening with potential impact on disease states and mortality later in life. This study examined the associations between telomere length and exposure to a number of stressors that arise during development from the antenatal/perinatal period through to young adulthood. Participants were from the Christchurch Health and Development Study (CHDS), a New Zealand longitudinal birth cohort which has followed participants from birth until age 30. Telomere length was obtained on DNA from peripheral blood samples collected from consenting participants (n = 677) at age 28-30, using a quantitative PCR assay. These data were assessed for associations with 26 measures of life course adversity or stress which occurred prior to 25 years of age. No associations were found between telomere length measured at age 28-30 years and life course adversity or stress for specific measures and for the summary risk scores for each developmental domain. The correlations were very small ranging from 20.06 to 0.06 with a median of 0.01, and none were statistically significant. Our results in this well-studied birth cohort do not support prior reports of such associations, and underscore the need for more extensive replication of proposed links between stress and telomere biology in larger cohorts with appropriate phenotypic data.	[Jodczyk, Sarah; Kennedy, Martin A.] Univ Otago, Gene Struct & Funct Lab, Dept Pathol, Christchurch, New Zealand; [Fergusson, David M.; Horwood, L. John] Univ Otago, Dept Psychol Med, Christchurch Hlth & Dev Study, Christchurch, New Zealand; [Pearson, John F.] Univ Otago, Dept Dean, Christchurch, New Zealand	University of Otago; University of Otago; University of Otago	Fergusson, DM (corresponding author), Univ Otago, Dept Psychol Med, Christchurch Hlth & Dev Study, Christchurch, New Zealand.	dm.fergusson@otago.ac.nz	Pearson, John F/D-7428-2012; Kennedy, Martin A/A-4942-2008; Kennedy, Martin/O-4540-2019	Pearson, John F/0000-0001-5607-4517; Kennedy, Martin A/0000-0002-6445-8526; Kennedy, Martin/0000-0002-6445-8526; Horwood, L./0000-0003-4881-1956	Health Research Council of New Zealand [11/792]; New Zealand Lottery Grants Board; University of Otago	Health Research Council of New Zealand(Health Research Council of New Zealand); New Zealand Lottery Grants Board; University of Otago	This research was funded by grants from the Health Research Council of New Zealand (11/792; www.hrc.govt.nz), the New Zealand Lottery Grants Board (http://www.dia.govt.nz/lotterygrantsboard), and the University of Otago (http://www.otago.ac.nz/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLSHIRE RC, 1989, NUCLEIC ACIDS RES, V17, P4611, DOI 10.1093/nar/17.12.4611; Aviv A, 2006, INT J EPIDEMIOL, V35, P1424, DOI 10.1093/ije/dyl169; Aviv A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr634; BLACKBURN EH, 1978, J MOL BIOL, V120, P33, DOI 10.1016/0022-2836(78)90294-2; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Buxton JL, 2011, J CLIN ENDOCR METAB, V96, P1500, DOI 10.1210/jc.2010-2924; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chen W, 2011, J GERONTOL A-BIOL, V66, P312, DOI 10.1093/gerona/glq223; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; Codd V, 2010, NAT GENET, V42, P197, DOI 10.1038/ng.532; Cohen J.E., 1988, STAT POWER ANAL BEHA; Damjanovic AK, 2007, J IMMUNOL, V179, P4249, DOI 10.4049/jimmunol.179.6.4249; Drury S S, 2012, Mol Psychiatry, V17, P719, DOI 10.1038/mp.2011.53; Ehrlenbach S, 2009, INT J EPIDEMIOL, V38, P1725, DOI 10.1093/ije/dyp273; Entringer S, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.11.033; Entringer S, 2011, P NATL ACAD SCI USA, V108, pE513, DOI 10.1073/pnas.1107759108; Epel E, 2009, ANN NY ACAD SCI, V1172, P34, DOI 10.1111/j.1749-6632.2009.04414.x; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Fergusson DM, 2008, CHILD ABUSE NEGLECT, V32, P607, DOI 10.1016/j.chiabu.2006.12.018; Fergusson DM, 2011, BRIT J PSYCHIAT, V198, P129, DOI 10.1192/bjp.bp.110.085993; Fergusson DM, 2000, PSYCHOL MED, V30, P529, DOI 10.1017/S0033291799002111; Fergusson DM, 2005, J CHILD PSYCHOL PSYC, V46, P837, DOI 10.1111/j.1469-7610.2004.00387.x; Fergusson DM, 2001, AUST NZ J PSYCHIAT, V35, P287, DOI 10.1046/j.1440-1614.2001.00902.x; Fergusson DM, 1998, CHILD ABUSE NEGLECT, V22, P339, DOI 10.1016/S0145-2134(98)00004-0; Glass Daniel, 2010, Biol Psychiatry, V68, pe21, DOI 10.1016/j.biopsych.2010.02.026; Greider C, 1989, NATURE; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; Harris SE, 2006, NEUROSCI LETT, V406, P260, DOI 10.1016/j.neulet.2006.07.055; Harris SE, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.11.013; Ja Shaffer, 2012, PLOS ONE, V7; Kananen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010826; Kao HT, 2008, MOL PSYCHIATR, V13, P118, DOI 10.1038/sj.mp.4002105; Kiecolt-Glaser JK, 2011, PSYCHOSOM MED, V73, P16, DOI 10.1097/PSY.0b013e31820573b6; Kim SM, 2009, CANCER EPIDEM BIOMAR, V18, P816, DOI 10.1158/1055-9965.EPI-08-0935; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; Levy D, 2010, P NATL ACAD SCI USA, V107, P9293, DOI 10.1073/pnas.0911494107; Lin J, 2012, MUTAT RES-FUND MOL M, V730, P85, DOI 10.1016/j.mrfmmm.2011.08.003; Mangino M, 2012, HUM MOL GENET, V21, P5385, DOI 10.1093/hmg/dds382; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Mulder R. T., 2013, AUSTR NZ J PSYCHIAT; Nordfjall K, 2008, OBESITY, V16, P2682, DOI 10.1038/oby.2008.413; O'Donovan A, 2011, BIOL PSYCHIAT, V70, P465, DOI 10.1016/j.biopsych.2011.01.035; PARKER G, 1979, BRIT J MED PSYCHOL, V52, P1, DOI 10.1111/j.2044-8341.1979.tb02487.x; Parks CG, 2009, CANCER EPIDEM BIOMAR, V18, P551, DOI 10.1158/1055-9965.EPI-08-0614; Raudino A, 2013, J ADOLESCENCE, V36, P331, DOI 10.1016/j.adolescence.2012.12.002; Shalev I, 2012, MOL PSYCHIAT; Simon NM, 2006, BIOL PSYCHIAT, V60, P432, DOI 10.1016/j.biopsych.2006.02.004; Steenstrup T, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt370; STRAUS MA, 1979, J MARRIAGE FAM, V41, P75, DOI 10.2307/351733; Surtees PG, 2011, J GERONTOL A-BIOL, V66, P1152, DOI 10.1093/gerona/glr112; Tyrka AR, 2010, BIOL PSYCHIAT, V67, P531, DOI 10.1016/j.biopsych.2009.08.014; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Vera E, 2012, AGING-US, V4, P379, DOI 10.18632/aging.100462; *WHO, 1997, COMP INT DIAGN INT C; Wolkowitz OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017837	57	50	50	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97102	10.1371/journal.pone.0097102	http://dx.doi.org/10.1371/journal.pone.0097102			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816913	gold, Green Published, Green Submitted			2022-12-27	WOS:000336838000103
J	Klose, J; Stankov, MV; Kleine, M; Ramackers, W; Panayotova-Dimitrova, D; Jager, MD; Klempnauer, J; Winkler, M; Bektas, H; Behrens, GMN; Vondran, FWR				Klose, Johannes; Stankov, Metodi V.; Kleine, Moritz; Ramackers, Wolf; Panayotova-Dimitrova, Diana; Jaeger, Mark D.; Klempnauer, Juergen; Winkler, Michael; Bektas, Hueseyin; Behrens, Georg M. N.; Vondran, Florian W. R.			Inhibition of Autophagic Flux by Salinomycin Results in Anti-Cancer Effect in Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							THYMIDINE ANALOGS; CANCER-CELLS; MITOCHONDRIA; INDUCTION; APOPTOSIS; SURVIVAL; GROWTH; HEPATOCYTES; MAINTENANCE; ACTIVATION	Salinomycin raised hope to be effective in anti-cancer therapies due to its capability to overcome apoptosis-resistance in several types of cancer cells. Recently, its effectiveness against human hepatocellular carcinoma (HCC) cells both in vitro and in vivo was demonstrated. However, the mechanism of action remained unclear. Latest studies implicated interference with the degradation pathway of autophagy. This study aimed to determine the impact of Salinomycin on HCC-autophagy and whether primary human hepatocytes (PHH) likewise are affected. Following exposure of HCC cell lines HepG2 and Huh7 to varying concentrations of Salinomycin (0-10 mu M), comprehensive analysis of autophagic activity using western-blotting and flow-cytometry was performed. Drug effects were analyzed in the settings of autophagy stimulation by starvation or PP242-treatment and correlated with cell viability, proliferation, apoptosis induction, mitochondrial mass accumulation and reactive oxygen species (ROS) formation. Impact on apoptosis induction and cell function of PHH was analyzed. Constitutive and stimulated autophagic activities both were effectively suppressed in HCC by Salinomycin. This inhibition was associated with dysfunctional mitochondria accumulation, increased apoptosis and decreased proliferation and cell viability. Effects of Salinomycin were dose and time dependent and could readily be replicated by pharmacological and genetic inhibition of HCC-autophagy alone. Salinomycin exposure to PHH resulted in transient impairment of synthesis function and cell viability without apoptosis induction. In conclusion, our data suggest that Salinomycin suppresses late stages of HCC-autophagy, leading to impaired recycling and accumulation of dysfunctional mitochondria with increased ROS-production all of which are associated with induction of apoptosis.	[Klose, Johannes] Heidelberg Univ, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany; [Klose, Johannes; Kleine, Moritz; Ramackers, Wolf; Jaeger, Mark D.; Klempnauer, Juergen; Winkler, Michael; Bektas, Hueseyin; Vondran, Florian W. R.] Hannover Med Sch, Dept Gen Visceral & Transplantat Surg, Hannover, Germany; [Stankov, Metodi V.; Behrens, Georg M. N.] Hannover Med Sch, Dept Clin Immunol & Rheumatol, Hannover, Germany; [Panayotova-Dimitrova, Diana] Heidelberg Univ, Med Fac Mannheim, Dept Dermatol Venereol & Allergol, Mannheim, Germany; [Behrens, Georg M. N.; Vondran, Florian W. R.] German Ctr Res DZIF, Hannover, Germany	Ruprecht Karls University Heidelberg; Hannover Medical School; Hannover Medical School; Ruprecht Karls University Heidelberg; German Center for Infection Research	Klose, J (corresponding author), Heidelberg Univ, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany.	Johannes.Klose@med.uni-heidelberg.de	Behrens, Georg MN/Q-4486-2016	Stankov, Metodi/0000-0003-3001-2478	Heidelberger Stiftung Chirurgie; Gesellschaft der Freunde fur Chirurgie [KFO 250, Rebirth EXC 62/1]; Else Kroner-Fresenius-Stiftung (FWRV) [2010_A49]; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg	Heidelberger Stiftung Chirurgie; Gesellschaft der Freunde fur Chirurgie; Else Kroner-Fresenius-Stiftung (FWRV); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg	This study was supported by Heidelberger Stiftung Chirurgie and Gesellschaft der Freunde fur Chirurgie (JK), KFO 250 (GB, MVS), Rebirth EXC 62/1 (GB), and Else Kroner-Fresenius-Stiftung (FWRV; 2010_A49). The authors acknowledge financial support by Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Callaway T R, 2003, Curr Issues Intest Microbiol, V4, P43; Chan LLY, 2012, AUTOPHAGY, V8, P1371, DOI 10.4161/auto.21028; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Daugschies A, 1998, VET PARASITOL, V76, P163, DOI 10.1016/S0304-4017(97)00203-3; Dong TT, 2011, ANN SURG ONCOL, V18, P1797, DOI 10.1245/s10434-011-1561-2; Fuchs D, 2010, BIOCHEM BIOPH RES CO, V394, P1098, DOI 10.1016/j.bbrc.2010.03.138; Fuchs D, 2009, BIOCHEM BIOPH RES CO, V390, P743, DOI 10.1016/j.bbrc.2009.10.042; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Huczynski A, 2012, CHEM BIOL DRUG DES, V79, P235, DOI 10.1111/j.1747-0285.2011.01287.x; Jangamreddy JR, 2013, BBA-MOL CELL RES, V1833, P2057, DOI 10.1016/j.bbamcr.2013.04.011; Kanki T, 2010, MOL MICROBIOL, V75, P795, DOI 10.1111/j.1365-2958.2009.07035.x; Ketola K, 2012, BRIT J CANCER, V106, P99, DOI 10.1038/bjc.2011.530; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kim JH, 2011, BRIT J PHARMACOL, V162, P773, DOI 10.1111/j.1476-5381.2010.01089.x; Kleine M, 2008, XENOTRANSPLANTATION, V15, P208, DOI 10.1111/j.1399-3089.2008.00478.x; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kosal ME, 2004, J ANIM SCI, V82, P3394; Li T, 2013, AUTOPHAGY, V9; Lieke T, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-466; LINDEMANN MD, 1985, J ANIM SCI, V61, P782, DOI 10.2527/jas1985.614782x; Lu DS, 2011, P NATL ACAD SCI USA, V108, P13253, DOI 10.1073/pnas.1110431108; Maluccio M, 2012, CA-CANCER J CLIN, V62, P394, DOI 10.3322/caac.21161; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Naujokat C, 2010, MOL MED REP, V3, P555, DOI 10.3892/mmr_00000296; PLUMLEE KH, 1995, J VET DIAGN INVEST, V7, P419, DOI 10.1177/104063879500700327; Stankov MV, 2013, ANTIMICROB AGENTS CH, V57, P543, DOI 10.1128/AAC.01560-12; Stankov MV, 2012, AIDS, V26, P1995, DOI 10.1097/QAD.0b013e32835804f9; Stankov MV, 2010, ANTIMICROB AGENTS CH, V54, P280, DOI 10.1128/AAC.00914-09; Stankov MV, 2013, LEUKEMIA IN PRESS; Story Phillipa, 2004, N Z Med J, V117, pU799; Verdoodt B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044132; Vondran FWR, 2008, ARTIF ORGANS, V32, P205, DOI 10.1111/j.1525-1594.2007.00524.x; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050638; Yue W, 2013, AUTOPHAGY, V9, P714, DOI 10.4161/auto.23997; Zhang Y, 2007, AUTOPHAGY, V3, P337, DOI 10.4161/auto.4127	41	47	50	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e95970	10.1371/journal.pone.0095970	http://dx.doi.org/10.1371/journal.pone.0095970			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816744	Green Submitted, gold, Green Published			2022-12-27	WOS:000336838000019
J	Kwak, K; Jiang, R; Wang, JW; Jagu, S; Kirnbauer, R; Roden, RBS				Kwak, Kihyuck; Jiang, Rosie; Wang, Joshua W.; Jagu, Subhashini; Kirnbauer, Reinhard; Roden, Richard B. S.			Impact of Inhibitors and L2 Antibodies upon the Infectivity of Diverse Alpha and Beta Human Papillomavirus Types	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; CROSS-PROTECTIVE EFFICACY; SURFACE HEPARAN-SULFATE; MINOR CAPSID PROTEIN; HUMAN KERATINOCYTES; CERVICAL-CANCER; GENE-EXPRESSION; GAMMA SECRETASE; L1 PROTEIN; HPV TYPES	The licensed human papillomavirus (HPV) vaccines elicit type-restricted immunity but do not target cutaneous HPV types of the beta genus that are associated with non-melanoma skin cancer in immune-compromised patients, and it is unclear if these diverse types share a common mechanism of infection. Residues 11-88 of minor capsid protein L2 contain cross-protective epitopes, and vaccination with concatamers of this region derived from as many as eight alpha HPV (L2 alpha 11-88x8) is being developed as an alternative prophylactic vaccine with potentially broader efficacy. There is also interest in developing broadly protective topical microbicides, such as carrageenan or heparin that block HPV receptor interactions, or small molecule inhibitors of infection. Here we have examined several inhibitors of HPV infection and antisera to L2 alpha 11-88x8 for their breadth of activity against infection by 34 HPV types from within both the alpha and beta families using pseudovirions (PsV) carrying a luciferase reporter as surrogates for native virus. We observed that both heparin and carrageenan prevented infection by mucosatropic HPV types, but surprisingly PsV of several epidermotropic alpha4 and beta HPV types exhibited increased infectivity especially at low inhibitor concentrations. Furin and c-secretase inhibitors and L2 alpha 11-88x8 antiserum blocked infection by all HPV PsV types tested. These findings suggest that the distinct tropism of mucosal and cutaneous HPV may reflect distinct cell surface receptor interactions, but a common uptake mechanism dependent upon furin and c-secretase proteolytic activities. Carrageenan, which is being tested as a vaginal microbicide, broadly inhibited infection by the high-risk mucosatropic HPV PsV, but not most skin tropic alpha and beta HPV. Vaccination with an L2 multimer derived exclusively from alpha papillomavirus sequences induced antibodies that broadly neutralized PsV of all 34 HPVs from within both the alpha and beta families, suggesting each displays conserved L2 neutralizing epitopes.	[Kwak, Kihyuck; Jiang, Rosie; Wang, Joshua W.; Jagu, Subhashini; Roden, Richard B. S.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21218 USA; [Roden, Richard B. S.] Johns Hopkins Univ, Dept Gynecol & Obstet, Baltimore, MD USA; [Roden, Richard B. S.] Johns Hopkins Univ, Dept Oncol, Baltimore, MD USA; [Kirnbauer, Reinhard] Med Univ Vienna MUW, Lab Viral Oncol, Dept Dermatol, Div Immunol Allergy & Infect Dis, Vienna, Austria	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Medical University of Vienna	Roden, RBS (corresponding author), Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21218 USA.	roden@jhmi.edu	Kwak, Kihyuck/Y-4377-2018	Kwak, Kihyuck/0000-0002-7386-9589	Public Health Service grant [P50 CA098252, RO1 CA133749, CA118790]; V Foundation; Austrian Science Foundation [P18990B13]; Vienna Science and Technology Fund (WWTF) [LS11-006]; Sanofi Pasteur; NATIONAL CANCER INSTITUTE [R01CA133749, P50CA098252, R01CA118790] Funding Source: NIH RePORTER	Public Health Service grant(United States Department of Health & Human ServicesUnited States Public Health Service); V Foundation; Austrian Science Foundation(Austrian Science Fund (FWF)); Vienna Science and Technology Fund (WWTF); Sanofi Pasteur; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was funded by Public Health Service grant P50 CA098252, RO1 CA133749, and CA118790, the V Foundation, the Austrian Science Foundation (P18990B13) and the Vienna Science and Technology Fund (WWTF) (Life Science Call 2011) (LS11-006) as well as commercial funding from Sanofi Pasteur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER TS, 1991, BIOPHYS J, V60, P1445, DOI 10.1016/S0006-3495(91)82181-6; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bienkowska-Haba M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000524; Bossis L, 2005, J VIROL, V79, P6723, DOI 10.1128/JVI.79.11.6723-6731.2005; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brown DR, 2009, J INFECT DIS, V199, P926, DOI 10.1086/597307; Buck CB, 2005, METH MOLEC MED, V119, P445; Buck CB, 2008, J VIROL, V82, P5190, DOI 10.1128/JVI.02726-07; Buck CB, 2006, PLOS PATHOG, V2, P671, DOI 10.1371/journal.ppat.0020069; Cerqueira C, 2013, CELLULAR MICROBIOLOG; Chen XJS, 2000, MOL CELL, V5, P557, DOI 10.1016/S1097-2765(00)80449-9; Cruz L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068379; Dasgupta J, 2011, J BIOL CHEM, V286, P2617, DOI 10.1074/jbc.M110.160184; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Faust H, 2013, J GEN VIROL, V94, P1096, DOI 10.1099/vir.0.048561-0; Giroglou T, 2001, J VIROL, V75, P1565, DOI 10.1128/JVI.75.3.1565-1570.2001; Huang HS, 2010, VIROLOGY, V407, P391, DOI 10.1016/j.virol.2010.09.002; Imbimbo BP, 2011, EXPERT OPIN INV DRUG, V20, P325, DOI 10.1517/13543784.2011.550572; Jagu S, 2013, J VIROL, V87, P6127, DOI 10.1128/JVI.03218-12; Jagu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055538; Jagu S, 2009, JNCI-J NATL CANCER I, V101, P782, DOI 10.1093/jnci/djp106; Johansson C, 2013, NAT REV MICROBIOL, V11, P239, DOI 10.1038/nrmicro2984; Johnson KM, 2009, J VIROL, V83, P2067, DOI 10.1128/JVI.02190-08; Joyce JG, 1999, J BIOL CHEM, V274, P5810, DOI 10.1074/jbc.274.9.5810; Kamper N, 2006, J VIROL, V80, P759, DOI 10.1128/JVI.80.2.759-768.2006; Karanam B, 2010, J VIROL, V84, P10661, DOI 10.1128/JVI.01081-10; Kines RC, 2009, P NATL ACAD SCI USA, V106, P20458, DOI 10.1073/pnas.0908502106; Knappe M, 2007, J BIOL CHEM, V282, P27913, DOI 10.1074/jbc.M705127200; Kondo K, 2006, VIROLOGY; Kwak K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060507; Leder C, 2001, J VIROL, V75, P9201, DOI 10.1128/JVI.75.19.9201-9209.2001; Malagon T, 2012, LANCET INFECT DIS, V12, P781, DOI 10.1016/S1473-3099(12)70187-1; Marais D, 2011, ANTIVIR THER, V16, P1219, DOI 10.3851/IMP1890; Marusic MB, 2012, TRAFFIC, V13, P455, DOI 10.1111/j.1600-0854.2011.01320.x; Mistry N, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-118; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nindl I, 2007, DIS MARKERS, V23, P247, DOI 10.1155/2007/942650; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Pastrana DV, 2004, VIROLOGY, V321, P205, DOI 10.1016/j.virol.2003.12.027; Patterson NA, 2005, J VIROL, V79, P6838, DOI 10.1128/JVI.79.11.6838-6847.2005; Richards RM, 2006, P NATL ACAD SCI USA, V103, P1522, DOI 10.1073/pnas.0508815103; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; Roberts JN, 2011, JNCI-J NATL CANCER I, V103, P737, DOI 10.1093/jnci/djr061; Roden RBS, 2001, J VIROL, V75, P10493, DOI 10.1128/JVI.75.21.10493-10497.2001; Roden RBS, 1996, J VIROL, V70, P5875, DOI 10.1128/JVI.70.9.5875-5883.1996; Roden Richard, 2006, Discov Med, V6, P175; Roden R, 2006, NAT REV CANCER, V6, P753, DOI 10.1038/nrc1973; Sehr P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075677; Senger T, 2010, VACCINE, V28, P1583, DOI 10.1016/j.vaccine.2009.11.048; Shafti-Keramat S, 2003, J VIROL, V77, P13125, DOI 10.1128/JVI.77.24.13125-13135.2003; Surviladze Z, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002519; Wheeler CM, 2012, LANCET ONCOL, V13, P100, DOI 10.1016/S1470-2045(11)70287-X; Woodham AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043519; Zhou J, 1999, J VIROL, V73, P4972, DOI 10.1128/JVI.73.6.4972-4982.1999; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	57	28	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97232	10.1371/journal.pone.0097232	http://dx.doi.org/10.1371/journal.pone.0097232			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816794	Green Published, gold, Green Submitted			2022-12-27	WOS:000336838000119
J	Moon, J; Park, SH				Moon, Jiyoung; Park, Sang-Hyun			Reassembly of JIP1 Scaffold Complex in JNK MAP Kinase Pathway Using Heterologous Protein Interactions	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; ACTIVATION; CASCADES; MAMMALS; MODULES; FAMILY; DOMAIN; YEAST	Formation of signaling protein complexes is crucial for proper signal transduction. Scaffold proteins in MAP kinase pathways are thought to facilitate complex assembly, thereby promoting efficient and specific signaling. To elucidate the assembly mechanism of scaffold complexes in mammals, we attempted to rationally rewire JIP1-dependent JNK MAP kinase pathway via alternative assembly of JIP1 complex. When JIP1-JNK docking interaction in the complex was replaced with heterologous protein interaction domains, such as PDZ domains and JNK-binding domains, a functional scaffold complex was reconstituted, and JNK signaling was rescued. Reassembly of JIP1 complex using heterologous protein interactions was sufficient for restoring of JNK MAP kinase pathway to induce signaling responses, including JNK activation and cell death. These results suggest a simple yet modular mechanism for JIP1 scaffold assembly in mammals.	[Moon, Jiyoung; Park, Sang-Hyun] Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea	Seoul National University (SNU)	Park, SH (corresponding author), Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea.	biopark@snu.ac.kr		Moon, Jiyoung/0000-0003-3664-0870	National Research Foundation of Korea [NRF-2011-0006427, NRF-2012R1A1A2009248]	National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported by grants from the National Research Foundation of Korea (NRF-2011-0006427 and NRF-2012R1A1A2009248) to S.-H. P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Brancho D, 2005, MOL CELL BIOL, V25, P3670, DOI 10.1128/MCB.25.9.3670-3681.2005; Brown MD, 2009, CELL SIGNAL, V21, P462, DOI 10.1016/j.cellsig.2008.11.013; Bruna A, 2003, EMBO J, V22, P6035, DOI 10.1093/emboj/cdg590; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Dueber JE, 2004, CURR OPIN STRUC BIOL, V14, P690, DOI 10.1016/j.sbi.2004.10.004; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Ho DT, 2006, J BIOL CHEM, V281, P13169, DOI 10.1074/jbc.M601010200; Im JY, 2003, J NEUROSCI RES, V74, P326, DOI 10.1002/jnr.10761; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Nihalani D, 2001, EMBO J, V20, P3447, DOI 10.1093/emboj/20.13.3447; Nihalani D, 2003, J BIOL CHEM, V278, P28694, DOI 10.1074/jbc.M304212200; Oh Y, 2012, CELL DEATH DIFFER, V19, P1196, DOI 10.1038/cdd.2011.209; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pawson T, 2000, GENE DEV, V14, P1027; Remenyi A, 2006, CURR OPIN STRUC BIOL, V16, P676, DOI 10.1016/j.sbi.2006.10.008; Song JJ, 2005, J BIOL CHEM, V280, P26845, DOI 10.1074/jbc.M502318200; Whitmarsh AJ, 2006, BIOCHEM SOC T, V34, P828, DOI 10.1042/BST0340828; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Whitmarsh AJ, 2001, GENE DEV, V15, P2421, DOI 10.1101/gad.922801; Xu ZH, 2001, MOL CELL BIOL, V21, P4713, DOI 10.1128/MCB.21.14.4713-4724.2001; Yasuda J, 1999, MOL CELL BIOL, V19, P7245; Yoshioka K, 2004, J BIOCHEM, V135, P657, DOI 10.1093/jb/mvh079; Zalatan JG, 2012, SCIENCE, V337, P1218, DOI 10.1126/science.1220683	30	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96797	10.1371/journal.pone.0096797	http://dx.doi.org/10.1371/journal.pone.0096797			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816971	Green Submitted, Green Published, gold			2022-12-27	WOS:000336838000067
J	Trapp, M; Trapp, EM; Egger, JW; Domej, W; Schillaci, G; Avian, A; Rohrer, PM; Hoerlesberger, N; Magometschnigg, D; Cervar-Zivkovic, M; Komericki, P; Velik, R; Baulmann, J				Trapp, Michael; Trapp, Eva-Maria; Egger, Josef W.; Domej, Wolfgang; Schillaci, Giuseppe; Avian, Alexander; Rohrer, Peter M.; Hoerlesberger, Nina; Magometschnigg, Dieter; Cervar-Zivkovic, Mila; Komericki, Peter; Velik, Rosemarie; Baulmann, Johannes			Impact of Mental and Physical Stress on Blood Pressure and Pulse Pressure under Normobaric versus Hypoxic Conditions	PLOS ONE			English	Article							ARTERIAL STIFFNESS; CENTRAL HEMODYNAMICS; HIGH-ALTITUDE; SELF-EFFICACY; EXERCISE; DISEASE; HEALTH; HYPERTENSION; ADOLESCENTS; ADAPTATION	Objective: Hypobaric hypoxia, physical and psychosocial stress may influence key cardiovascular parameters including blood pressure (BP) and pulse pressure (PP). We investigated the effects of mild hypobaric hypoxia exposure on BP and PP reactivity to mental and physical stress and to passive elevation by cable car. Methods: 36 healthy volunteers participated in a defined test procedure consisting of a period of rest 1, mental stress task (KLT-R), period of rest 2, combined mental (KLT-R) and physical task (bicycle ergometry) and a last period of rest both at Graz, Austria (353 m asl) and at the top station Dachstein (2700 m asl). Beat-to-beat heart rate and BP were analysed both during the test procedures at Graz and at Dachstein and during passive 1000 m elevation by cable car (from 1702 m to 2700 m). Results: A significant interaction of kind of stress (mental vs. combined mental and physical) and study location (Graz vs. Dachstein) was found in the systolic BP (p = .007) and PP (p = .002) changes indicating that during the combined mental and physical stress task sBP was significantly higher under hypoxic conditions whereas sBP and PP were similar during mental stress both under normobaric normoxia (Graz) and under hypobaric hypoxia (Dachstein). During the passive ascent in cable car less trivialization (psychological coping strategy) was associated with an increase in PP (p = .004). Conclusion: Our data show that combined mental and physical stress causes a significant higher raise in sBP and PP under hypoxic conditions whereas isolated mental stress did not affect sBP and PP under hypoxic conditions. PP-reaction to ascent in healthy subjects is not uniform. BP reactions to ascent that represents an accumulation of physical (mild hypobaric hypoxia) and psychological stressors depend on predetermined psychological traits (stress coping strategies). Thus divergent cardiovascular reactions can be explained by applying the multidimensional aspects of the biopsychosocial concept.	[Trapp, Michael; Trapp, Eva-Maria; Egger, Josef W.; Rohrer, Peter M.; Hoerlesberger, Nina] Med Univ Graz, Dept Med Psychol & Psychotherapy, Res Unit Behav Med Hlth Psychol & Empir Psychosom, Graz, Austria; [Trapp, Eva-Maria] Med Univ Graz, Univ Clin Psychiat, Graz, Austria; [Domej, Wolfgang] Med Univ Graz, Dept Pneumol, Graz, Austria; [Schillaci, Giuseppe] Univ Perugia, Dept Med, Terni, Italy; [Schillaci, Giuseppe] Terni Univ Hosp, Terni, Italy; [Avian, Alexander] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria; [Magometschnigg, Dieter] Inst Hypertens, Vienna, Austria; [Cervar-Zivkovic, Mila] Med Univ Graz, Dept Obstet & Gynecol, Graz, Austria; [Komericki, Peter] Med Univ Graz, Dept Dermatol, Graz, Austria; [Velik, Rosemarie] CTR Carinthian Tech Res, Villach, Austria; [Baulmann, Johannes] UKSH Univ Klinikum Schleswig Holstein, Lubeck, Germany	Medical University of Graz; Medical University of Graz; Medical University of Graz; University of Perugia; Medical University of Graz; Medical University of Graz; Medical University of Graz; Carinthian Tech Research AG (CTR); University of Kiel; Schleswig Holstein University Hospital	Baulmann, J (corresponding author), UKSH Univ Klinikum Schleswig Holstein, Campus Lubeck, Lubeck, Germany.	jbaulmann@yahoo.com		Avian, Alexander/0000-0003-1084-5763				Ariff F, 2011, SINGAP MED J, V52, P29; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Blumenthal JA, 2005, JAMA-J AM MED ASSOC, V293, P1626, DOI 10.1001/jama.293.13.1626; Calbet JAL, 2003, J PHYSIOL-LONDON, V551, P379, DOI 10.1113/jphysiol.2003.045112; Casey DP, 2012, J PHYSIOL-LONDON, V590, P6321, DOI 10.1113/jphysiol.2012.242396; Crawford JH, 2006, BLOOD, V107, P566, DOI 10.1182/blood-2005-07-2668; Dietz LJ, 2011, J ADOLESCENT HEALTH, V48, P579, DOI 10.1016/j.jadohealth.2010.09.001; Duker H, 2001, KLT R KONZENTRATIONS; Egger J.W., 2008, PSYCHOLOGISCHE MED, V19, P12; Egger JW., 2005, PSYCHOL MED, V16, P3; Erdmann G., 2008, SVF STRESSVERARBEITU; Fahrenberg J, 2001, FREIBURGER PERSONLIC; Guger C, 2005, NEUROSCI LETT, V377, P53, DOI 10.1016/j.neulet.2004.11.065; Hainsworth R, 2007, RESP PHYSIOL NEUROBI, V158, P204, DOI 10.1016/j.resp.2007.05.006; Hainsworth R, 2007, CLIN AUTON RES, V17, P13, DOI 10.1007/s10286-006-0395-7; Hanada A, 2003, J PHYSIOL-LONDON, V551, P635, DOI 10.1113/jphysiol.2003.044024; Harmell AL, 2011, BRIT J HEALTH PSYCH, V16, P317, DOI 10.1348/135910710X504932; International Society of Biopsychosocial M, 2011, VEN DECL; Jeleazcov C, 2010, BRIT J ANAESTH, V105, P264, DOI 10.1093/bja/aeq143; Lazarus R.S., 1984, EMOTION ADAPTATION; Lee HY, 2010, CIRC J, V74, P2257, DOI 10.1253/circj.CJ-10-0910; Lewis TT, 2010, J GERONTOL A-BIOL, V65, P1079, DOI 10.1093/gerona/glq089; Lipman RD, 2002, J GERONTOL A-BIOL, V57, pB279, DOI 10.1093/gerona/57.7.B279; Little MO, 2011, MED CLIN N AM, V95, P525, DOI 10.1016/j.mcna.2011.02.002; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; Midei AJ, 2009, HEALTH PSYCHOL, V28, P347, DOI 10.1037/a0014214; Naeije R, 2010, PROG CARDIOVASC DIS, V52, P456, DOI 10.1016/j.pcad.2010.03.004; O'Donovan Aoife, 2007, Int J Adolesc Med Health, V19, P523; Planai-Hochwurzen-Bahnen Gmb H, OP INSTR DACHST SUDW; Raij L, 2011, CURR OPIN NEPHROL HY, V20, P457, DOI 10.1097/MNH.0b013e3283499d7b; Raikkonen K, 2008, J PERS, V76, P605, DOI 10.1111/j.1467-6494.2008.00498.x; Reppel M, 2013, INT J CARDIOL, V166, P627, DOI 10.1016/j.ijcard.2011.11.096; Rozanski A, 2005, PSYCHOSOM MED, V67, pS47, DOI 10.1097/01.psy.0000164253.69550.49; Sanz A, 2006, BIOL PSYCHOL, V71, P20, DOI 10.1016/j.biopsycho.2005.01.010; Selg H, 2010, FPI R FREIBURGER PER; SHERWOOD A, 1990, PSYCHOPHYSIOLOGY, V27, P656, DOI 10.1111/j.1469-8986.1990.tb03189.x; Skoglund PH, 2012, AMBULATORY PULSE PRE; Van Bortel LMAB, 2001, HYPERTENSION, V38, P914, DOI 10.1161/hy1001.095773; Verdecchia P, 2007, ADV CARDIOL, V44, P150, DOI 10.1159/000096727; Vlachopoulos C, 2006, PSYCHOSOM MED, V68, P231, DOI 10.1097/01.psy.0000203171.33348.72; Vlachopoulos C, 2010, EUR HEART J, V31, P1865, DOI 10.1093/eurheartj/ehq024; Vlachopoulos C, 2009, PSYCHOSOM MED, V71, P446, DOI 10.1097/PSY.0b013e318198dcd4	43	27	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e89005	10.1371/journal.pone.0089005	http://dx.doi.org/10.1371/journal.pone.0089005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24817135	Green Published, gold, Green Submitted			2022-12-27	WOS:000336838000001
J	Cao, Z; Moore, BT; Wang, Y; Peng, XH; Lappe, JM; Recker, RR; Xiao, P				Cao, Zheng; Moore, Benjamin T.; Wang, Yang; Peng, Xian-Hao; Lappe, Joan M.; Recker, Robert R.; Xiao, Peng			MiR-422a as a Potential Cellular MicroRNA Biomarker for Postmenopausal Osteoporosis	PLOS ONE			English	Article							BONE-MINERAL DENSITY; GENE-EXPRESSION; MECHANISM; OSTEOIMMUNOLOGY; DIFFERENTIATION; ASSOCIATION; INVOLVEMENT; RESORPTION; WOMEN; IGF	Background: MicroRNAs (miRNAs) are a class of short non-coding RNA molecules that regulate gene expression by targeting mRNAs. Recently, miRNAs have been shown to play important roles in the etiology of various diseases. However, little is known about their roles in the development of osteoporosis. Circulating monocytes are osteoclast precursors that also produce various factors important for osteoclastogenesis. Previously, we have identified a potential biomarker miR-133a in circulating monocytes for postmenopausal osteoporosis. In this study, we aimed to further identify significant miRNA biomarkers in human circulating monocytes underlying postmenopausal osteoporosis. Methodology/Principal Findings: We used ABI TaqMan miRNA array followed by qRT-PCR validation in human circulating monocytes from 10 high BMD and 10 low BMD postmenopausal Caucasian women to identify miRNA biomarkers. MiR-422a was up-regulated with marginal significance (P = 0.065) in the low compared with the high BMD group in the array analysis. However, a significant up-regulation of miR-422a was identified in the low BMD group by qRT-PCR analysis (P = 0.029). We also performed bioinformatic target gene analysis and found several potential target genes of miR-422a which are involved in osteoclastogenesis. Further qRT-PCR analyses of the target genes in the same study subjects showed that the expression of five of these genes (CBL, CD226, IGF1, PAG1, and TOB2) correlated negatively with miR-422a expression. Conclusions/Significance: Our study suggests that miR-422a in human circulating monocytes (osteoclast precursors) is a potential miRNA biomarker underlying postmenopausal osteoporosis.	[Cao, Zheng] Cent S Univ, Xiangya Hosp 2, Dept Orthoped, Changsha, Hunan, Peoples R China; [Cao, Zheng; Moore, Benjamin T.; Wang, Yang; Peng, Xian-Hao; Lappe, Joan M.; Recker, Robert R.; Xiao, Peng] Creighton Univ, Sch Med, Osteoporosis Res Ctr, Omaha, NE 68178 USA	Central South University; Creighton University	Xiao, P (corresponding author), Creighton Univ, Sch Med, Osteoporosis Res Ctr, Omaha, NE 68178 USA.	pxiao@creighton.edu			NIH [R01AR04054496-03S1]; State of Nebraska [LB692, LB595]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Nebraska	This study was partially supported by the grant from the NIH (R01AR04054496-03S1) and grants from the State of Nebraska (LB692 and LB595). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajima R, 2008, FEBS LETT, V582, P1313, DOI 10.1016/j.febslet.2008.03.012; Arron JR, 2000, NATURE, V408, P535, DOI 10.1038/35046196; Bae YJ, 2012, HUM MOL GENET, V21, P2991, DOI 10.1093/hmg/dds129; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bidzhekov K, 2012, THROMB HAEMOSTASIS, V107, P619, DOI 10.1160/TH11-09-0607; Chen XD, 2010, J BONE MINER RES, V25, P339, DOI 10.1359/jbmr.090724; Cheng P, 2013, J BONE MINER RES, V28, P1180, DOI 10.1002/jbmr.1845; COHENSOLAL ME, 1993, J CLIN ENDOCR METAB, V77, P1648, DOI 10.1210/jc.77.6.1648; Crane JL, 2014, J MOL MED, V92, P107, DOI 10.1007/s00109-013-1084-3; Deng FY, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011700; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Faltejskova P, 2012, J CELL MOL MED, V16, P2655, DOI 10.1111/j.1582-4934.2012.01579.x; Fujikawa Y, 1996, ENDOCRINOLOGY, V137, P4058, DOI 10.1210/en.137.9.4058; Gillberg P, 2002, CALCIFIED TISSUE INT, V70, P22, DOI 10.1007/s002230020048; Gougelet A, 2011, INT J CANCER, V129, P680, DOI 10.1002/ijc.25715; Hassan MQ, 2010, P NATL ACAD SCI USA, V107, P19879, DOI 10.1073/pnas.1007698107; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Inose H, 2009, P NATL ACAD SCI USA, V106, P20794, DOI 10.1073/pnas.0909311106; Kagiya T, 2013, J PERIODONTAL RES, V48, P373, DOI 10.1111/jre.12017; Kakehi S, 2007, MOL CELL BIOCHEM, V301, P209, DOI 10.1007/s11010-007-9413-x; Kapinas K, 2010, J BIOL CHEM, V285, P25221, DOI 10.1074/jbc.M110.116137; Kim JH, 2010, J BIOL CHEM, V285, P5224, DOI 10.1074/jbc.M109.042812; Langlois JA, 1998, J CLIN ENDOCR METAB, V83, P4257, DOI 10.1210/jc.83.12.4257; Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Liu YZ, 2005, J BIOL CHEM, V280, P29011, DOI 10.1074/jbc.M501164200; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Matsubara T, 2010, J BONE MINER RES, V25, P1068, DOI 10.1359/jbmr.091039; Mizoguchi F, 2010, J CELL BIOCHEM, V109, P866, DOI 10.1002/jcb.22228; Mizuno Y, 2008, BIOCHEM BIOPH RES CO, V368, P267, DOI 10.1016/j.bbrc.2008.01.073; Nakasa T, 2011, ARTHRITIS RHEUM-US, V63, P1582, DOI 10.1002/art.30321; Palmieri A, 2008, IMPLANT DENT, V17, P100, DOI 10.1097/ID.0b013e318166d182; Siegel SR, 2012, MOL BIOL REP, V39, P6219, DOI 10.1007/s11033-011-1441-7; Song KH, 2010, J LIPID RES, V51, P2223, DOI 10.1194/jlr.M004531; Sugatani T, 2011, BLOOD, V117, P3648, DOI 10.1182/blood-2010-10-311415; Sugatani T, 2009, J BIOL CHEM, V284, P4667, DOI 10.1074/jbc.M805777200; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Wang Ping, 2010, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V24, P535; Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034641; Yamaguchi T, 2006, CALCIFIED TISSUE INT, V78, P18, DOI 10.1007/s00223-005-0163-z	40	85	91	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97098	10.1371/journal.pone.0097098	http://dx.doi.org/10.1371/journal.pone.0097098			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24820117	gold, Green Published, Green Submitted			2022-12-27	WOS:000336653300072
J	Chapman, RW; Reading, BJ; Sullivan, CV				Chapman, Robert W.; Reading, Benjamin J.; Sullivan, Craig V.			Ovary Transcriptome Profiling via Artificial Intelligence Reveals a Transcriptomic Fingerprint Predicting Egg Quality in Striped Bass, Morone saxatilis	PLOS ONE			English	Article							MAJOR DEVELOPMENTAL TRANSITION; EARLY XENOPUS-EMBRYOS; COP9 SIGNALOSOME; RNA; IDENTIFICATION; CHRYSOPS; CANCER; OOCYTE; ZYGOTE; FISH	Inherited gene transcripts deposited in oocytes direct early embryonic development in all vertebrates, but transcript profiles indicative of embryo developmental competence have not previously been identified. We employed artificial intelligence to model profiles of maternal ovary gene expression and their relationship to egg quality, evaluated as production of viable mid-blastula stage embryos, in the striped bass (Morone saxatilis), a farmed species with serious egg quality problems. In models developed using artificial neural networks (ANNs) and supervised machine learning, collective changes in the expression of a limited suite of genes (233) representing <2% of the queried ovary transcriptome explained >90% of the eventual variance in embryo survival. Egg quality related to minor changes in gene expression (<0.2-fold), with most individual transcripts making a small contribution (<1%) to the overall prediction of egg quality. These findings indicate that the predictive power of the transcriptome as regards egg quality resides not in levels of individual genes, but rather in the collective, coordinated expression of a suite of transcripts constituting a transcriptomic "fingerprint". Correlation analyses of the corresponding candidate genes indicated that dysfunction of the ubiquitin-26S proteasome, COP9 signalosome, and subsequent control of the cell cycle engenders embryonic developmental incompetence. The affected gene networks are centrally involved in regulation of early development in all vertebrates, including humans. By assessing collective levels of the relevant ovarian transcripts via ANNs we were able, for the first time in any vertebrate, to accurately predict the subsequent embryo developmental potential of eggs from individual females. Our results show that the transcriptomic fingerprint evidencing developmental dysfunction is highly predictive of, and therefore likely to regulate, egg quality, a biologically complex trait crucial to reproductive fitness.	[Chapman, Robert W.] South Carolina Dept Nat Resources, Marine Resources Div, Charleston, SC USA; [Chapman, Robert W.] Hollings Marine Lab, Marine Genom Core Facil, Charleston, SC USA; [Reading, Benjamin J.] N Carolina State Univ, Dept Appl Ecol, Raleigh, NC 27695 USA; [Sullivan, Craig V.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Sullivan, CV (corresponding author), Carolina AquaGyn, Raleigh, NC USA.	aquagyn.nc@gmail.com	Sullivan, Craig V/B-3863-2014	Sullivan, Craig V/0000-0002-3609-9458; Reading, Benjamin/0000-0002-0778-4069	Center of Excellence in Oceans; Human Health Center for Marine Genomics at Hollings Marine Laboratory; U.S. Department of Agriculture (USDA) [2008-34368-191136, 2009-34368-19776]; National Institute of Food and Agriculture (NIFA); North Carolina Sea Grant [R/AF49, R/12-SSS-3, R/MG-1019]; SC Sea Grant Consortium [R41-1, R/CF-19]; USDA-NIFA; National Animal Genome Research Project - Aquaculture Genome Project [NRSP-8]	Center of Excellence in Oceans; Human Health Center for Marine Genomics at Hollings Marine Laboratory; U.S. Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); National Institute of Food and Agriculture (NIFA); North Carolina Sea Grant; SC Sea Grant Consortium; USDA-NIFA(United States Department of Agriculture (USDA)); National Animal Genome Research Project - Aquaculture Genome Project	This work was supported by core funding of the Center of Excellence in Oceans and Human Health Center for Marine Genomics at Hollings Marine Laboratory (http://www. carolinas. noaa. gov/spotlight/hollings_ 0609. html) where the microarray analyses were performed, special grants (2008-34368-191136 and 2009-34368-19776) from the U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA) (http://www. csrees. usda. gov/), grants (R/AF49, R/12-SSS-3, and R/MG-1019) from North Carolina Sea Grant (http://www. ncseagrant. org/), grants (R41-1 and R/CF-19) from the SC Sea Grant Consortium (http://www. scseagrant. org/), and a special award from the USDA-NIFA, National Animal Genome Research Project (NRSP-8) - Aquaculture Genome Project (http://www.animalgenome.org/aquaculture/) for microarray costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanes H, 2011, GENOME RES, V21, P1328, DOI 10.1101/gr.116012.110; Aegerter S, 2005, MOL REPROD DEV, V72, P377, DOI 10.1002/mrd.20361; Aegerter S, 2004, MOL REPROD DEV, V67, P127, DOI 10.1002/mrd.10384; Ajduk A, 2013, MOL ASPECTS MED, V34, P903, DOI 10.1016/j.mam.2013.03.001; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bazzaro M, 2006, CANCER RES, V66, P3754, DOI 10.1158/0008-5472.CAN-05-2321; Bech-Otschir D, 2002, J CELL SCI, V115, P467; Bobe J, 2010, GEN COMP ENDOCR, V165, P535, DOI 10.1016/j.ygcen.2009.02.011; Bonnet E, 2007, AQUACULTURE, V268, P13, DOI 10.1016/j.aquaculture.2007.04.027; Bonnet E, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-55; Brooks S, 1997, REV FISH BIOL FISHER, V7, P387, DOI 10.1023/A:1018400130692; Cerda J, 2008, REV FISH SCI, V16, P56, DOI 10.1080/10641260802324685; Chapman RW, 2011, MOL ECOL, V20, P1431, DOI 10.1111/j.1365-294X.2011.05018.x; Chapman RW, 2009, MOL ECOL, V18, P2415, DOI 10.1111/j.1365-294X.2009.04194.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Couch CR, 2006, MOL ECOL NOTES, V6, P667, DOI 10.1111/j.1471-8286.2006.01292.x; Detrich HW, 2011, METHOD CELL BIOL, V104, P1; Edwards AC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r76; Garber AF, 2006, AQUAC RES, V37, P319, DOI 10.1111/j.1365-2109.2005.01439.x; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Hodson R. G., 1993, Aquaculture and Fisheries Management, V24, P389, DOI 10.1111/j.1365-2109.1993.tb00562.x; Jones GM, 2008, HUM REPROD, V23, P1138, DOI 10.1093/humrep/den085; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; KANE DA, 1993, DEVELOPMENT, V119, P447; KJORSVIK E, 1990, ADV MAR BIOL, V26, P71, DOI 10.1016/S0065-2881(08)60199-6; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Liu SX, 2012, MAR BIOTECHNOL, V14, P237, DOI 10.1007/s10126-011-9407-2; Lyman-Gingerich Jamie, 2007, P141, DOI 10.1007/978-1-4020-6235-3_6; Mathavan S, 2005, PLOS GENET, V1, P260, DOI 10.1371/journal.pgen.0010029; Migaud H, 2013, REV AQUACULT, V5, pS194, DOI 10.1111/raq.12025; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Naumann M, 1999, J BIOL CHEM, V274, P35297, DOI 10.1074/jbc.274.50.35297; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Pelegri F, 2003, DEV DYNAM, V228, P535, DOI 10.1002/dvdy.10390; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Reading Benjamin J., 2012, BMC Research Notes, V5, P111, DOI 10.1186/1756-0500-5-111; Rebhan M, 1997, TRENDS GENET, V13, P163, DOI 10.1016/S0168-9525(97)01103-7; Rees R. A., 1990, CULTURE PROPAGATION, P43; Reich A, 2011, J BIOL CHEM, V286, P40743, DOI 10.1074/jbc.M111.289868; Rexroad C, 2006, CONSERV GENET, V7, P971, DOI 10.1007/s10592-006-9122-0; Stitzel ML, 2007, SCIENCE, V316, P407, DOI 10.1126/science.1138236; Stone EA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000479; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Traverso JM, 2012, AQUACULTURE BIOTECHNOLOGY, P177; Venturelli PA, 2009, P ROY SOC B-BIOL SCI, V276, P919, DOI 10.1098/rspb.2008.1507; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364	54	45	49	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96818	10.1371/journal.pone.0096818	http://dx.doi.org/10.1371/journal.pone.0096818			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24820964	Green Submitted, gold, Green Published			2022-12-27	WOS:000336653300035
J	Gray, GC; Krueger, WS; Chum, C; Putnam, SD; Wierzba, TF; Heil, GL; Anderson, BD; Yasuda, CY; Williams, M; Kasper, MR; Saphonn, V; Blair, PJ				Gray, Gregory C.; Krueger, Whitney S.; Chum, Channimol; Putnam, Shannon D.; Wierzba, Thomas F.; Heil, Gary L.; Anderson, Benjamin D.; Yasuda, Chadwick Y.; Williams, Maya; Kasper, Matthew R.; Saphonn, Vonthanak; Blair, Patrick J.			Little Evidence of Subclinical Avian Influenza Virus Infections among Rural Villagers in Cambodia	PLOS ONE			English	Article							A H5N1 VIRUS; SWINE WORKERS; UNITED-STATES; POULTRY; EPIDEMIOLOGY; SURVEILLANCE; TRANSMISSION; RISK	In 2008, 800 adults living within rural Kampong Cham Province, Cambodia were enrolled in a prospective cohort study of zoonotic influenza transmission. After enrollment, participants were contacted weekly for 24 months to identify acute influenza-like illnesses (ILI). Follow-up sera were collected at 12 and 24 months. A transmission substudy was also conducted among the family contacts of cohort members reporting ILI who were influenza A positive. Samples were assessed using serological or molecular techniques looking for evidence of infection with human and avian influenza viruses. Over 24 months, 438 ILI investigations among 284 cohort members were conducted. One cohort member was hospitalized with a H5N1 highly pathogenic avian influenza (HPAI) virus infection and withdrew from the study. Ninety-seven ILI cases (22.1%) were identified as influenza A virus infections by real-time RT-PCR; none yielded evidence for AIV. During the 2 years of follow-up, 21 participants (3.0%) had detectable antibody titers (>= 1:10) against the studied AIVs: 1 against an avian-like A/Migratory duck/Hong Kong/MPS180/2003(H4N6), 3 against an avian-like A/Teal/Hong Kong/w312/97(H6N1), 9 (3 of which had detectible antibody titers at both 12- and 24-month follow-up) against an avian-like A/Hong Kong/1073/1999(H9N2), 6 (1 detected at both 12- and 24-month follow-up) against an avian-like A/Duck/Memphis/546/74(H11N9), and 2 against an avian-like A/Duck/Alberta/60/76(H12N5). With the exception of the one hospitalized cohort member with H5N1 infection, no other symptomatic avian influenza infections were detected among the cohort. Serological evidence for subclinical infections was sparse with only one subject showing a 4-fold rise in microneutralization titer over time against AvH12N5. In summary, despite conducting this closely monitored cohort study in a region enzootic for H5N1 HPAI, we were unable to detect subclinical avian influenza infections, suggesting either that these infections are rare or that our assays are insensitive at detecting them.	[Gray, Gregory C.; Krueger, Whitney S.; Heil, Gary L.; Anderson, Benjamin D.] Univ Florida, Coll Publ Hlth, Gainesville, FL 32611 USA; [Gray, Gregory C.; Krueger, Whitney S.; Heil, Gary L.; Anderson, Benjamin D.] Univ Florida, Hlth Profess & Emerging Pathogens Inst, Gainesville, FL USA; [Chum, Channimol; Putnam, Shannon D.; Wierzba, Thomas F.; Yasuda, Chadwick Y.; Williams, Maya; Kasper, Matthew R.; Blair, Patrick J.] Natl Inst Publ Hlth, Naval Med Res Ctr Asia, Phnom Penh, Cambodia; [Saphonn, Vonthanak] Natl Inst Publ Hlth, Minist Hlth, Phnom Penh, Cambodia	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Gray, GC (corresponding author), Univ Florida, Coll Publ Hlth, Gainesville, FL 32611 USA.	gcgray@phhp.ufl.edu	Gray, Gregory C./ABF-1298-2020	Gray, Gregory/0000-0002-4628-5908	US Armed Forces Health Surveillance Center - Global Emerging Infections Surveillance Operation; ARRA supplement grant from the National Institute of Allergy and Infectious Diseases [R01 AI068803]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068803] Funding Source: NIH RePORTER	US Armed Forces Health Surveillance Center - Global Emerging Infections Surveillance Operation; ARRA supplement grant from the National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the US Armed Forces Health Surveillance Center - Global Emerging Infections Surveillance Operations (multiple grants to G.C.G., P.J.B., S.D.P., and I.U.) and an ARRA supplement grant from the National Institute of Allergy and Infectious Diseases (R01 AI068803-Dr. Gray). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blair PJ, 2010, EPIDEMIOL INFECT, V138, P199, DOI 10.1017/S095026880999063X; Blair PJ, 2013, J INFECT PUBLIC HEAL, V6, P69, DOI 10.1016/j.jiph.2012.11.005; Buchy P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010864; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Cavailler P, 2010, J CLIN VIROL, V48, P123, DOI 10.1016/j.jcv.2010.02.021; Chen MI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012474; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Fournie G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037986; Gill JS, 2006, EMERG INFECT DIS, V12, P1284, DOI 10.3201/eid1708.060492; Gray GC, 2007, EMERG INFECT DIS, V13, P1871, DOI 10.3201/eid1312.061323; Horm SV, 2013, EMERG INFECT DIS, V19, P305, DOI 10.3201/eid1902.121201; Humphries-Waa K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-549; Jernigan DB, 2011, CLIN INFECT DIS, V52, pS36, DOI 10.1093/cid/ciq020; Kayali G, 2008, J CLIN VIROL, V43, P73, DOI 10.1016/j.jcv.2008.04.013; Kendal AP, 1982, CONCEPTS PROCEDURES; Khuntirat BP, 2011, CLIN INFECT DIS, V53, pE107, DOI 10.1093/cid/cir525; Lau LLH, 2010, J INFECT DIS, V201, P1509, DOI 10.1086/652241; Mardy S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-168; Myers KP, 2007, CLIN INFECT DIS, V45, P4, DOI 10.1086/518579; Myers KP, 2006, CLIN INFECT DIS, V42, P14, DOI 10.1086/498977; Papenburg J, 2010, CLIN INFECT DIS, V51, P1033, DOI 10.1086/656582; Ramirez A, 2006, EMERG INFECT DIS, V12, P997, DOI 10.3201/eid1206.051576; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Sorn S, 2013, INFECT GENET EVOL, V15, P87, DOI 10.1016/j.meegid.2012.05.013; Theary R, 2012, AVIAN DIS, V56, P861, DOI 10.1637/10195-041012-ResNote.1; Van Kerkhove MD, 2009, VACCINE, V27, P6345, DOI 10.1016/j.vaccine.2009.05.004; Vong S, 2006, EMERG INFECT DIS, V12, P1542, DOI 10.3201/eid1210.060424; Vong S, 2009, J INFECT DIS, V199, P1744, DOI 10.1086/599208; WHO, 2013, 23 NEW HUM CAS AV IN; Yang J, 2009, CLIN INFECT DIS, V49, P1622, DOI 10.1086/644775; Yasuda C, 2012, SE ASIAN J TROP MED, V43, P68	32	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97097	10.1371/journal.pone.0097097	http://dx.doi.org/10.1371/journal.pone.0097097			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819948	Green Published, gold			2022-12-27	WOS:000336653300071
J	Lemyze, M; Taufour, P; Duhamel, A; Temime, J; Nigeon, O; Vangrunderbeeck, N; Barrailler, S; Gasan, G; Pepy, F; Thevenin, D; Mallat, J				Lemyze, Malcolm; Taufour, Pauline; Duhamel, Alain; Temime, Johanna; Nigeon, Olivier; Vangrunderbeeck, Nicolas; Barrailler, Stephanie; Gasan, Gaelle; Pepy, Florent; Thevenin, Didier; Mallat, Jihad			Determinants of Noninvasive Ventilation Success or Failure in Morbidly Obese Patients in Acute Respiratory Failure	PLOS ONE			English	Article							POSITIVE-PRESSURE VENTILATION; EXPIRATORY FLOW LIMITATION; HYPOVENTILATION SYNDROME; MECHANICAL VENTILATION; TASK-FORCE; MANAGEMENT; PREVALENCE; GUIDELINES; DISORDERS; SEVERITY	Purpose: Acute respiratory failure (ARF) is a common life-threatening complication in morbidly obese patients with obesity hypoventilation syndrome (OHS). We aimed to identify the determinants of noninvasive ventilation (NIV) success or failure for this indication. Methods: We prospectively included 76 consecutive patients with BMI>40 kg/m(2) diagnosed with OHS and treated by NIV for ARF in a 15-bed ICU of a tertiary hospital. Results: NIV failed to reverse ARF in only 13 patients. Factors associated with NIV failure included pneumonia (n = 12/13, 92% vs n = 9/63, 14%; p<0.0001), high SOFA (10 vs 5; p<0.0001) and SAPS2 score (63 vs 39; p<0.0001) at admission. These patients often experienced poor outcome despite early resort to endotracheal intubation (in-hospital mortality, 92.3% vs 17.5%; p<0.001). The only factor significantly associated with successful response to NIV was idiopathic decompensation of OHS (n = 30, 48% vs n = 0, 0%; p = 0.001). In the NIV success group (n = 63), 33 patients (53%) experienced a delayed response to NIV (with persistent hypercapnic acidosis during the first 6 hours). Conclusions: Multiple organ failure and pneumonia were the main factors associated with NIV failure and death in morbidly obese patients in hypoxemic ARF. On the opposite, NIV was constantly successful and could be safely pushed further in case of severe hypercapnic acute respiratory decompensation of OHS.	[Lemyze, Malcolm; Taufour, Pauline; Temime, Johanna; Barrailler, Stephanie; Gasan, Gaelle; Pepy, Florent; Thevenin, Didier; Mallat, Jihad] Schaffner Hosp, Dept Resp & Crit Care Med, Lens, France; [Duhamel, Alain] CHRU Lille, Lille Univ Hosp, Dept Biostat, Lille, France; [Nigeon, Olivier; Vangrunderbeeck, Nicolas] Schaffner Hosp, Resp Step Down Unit, Lens, France	Universite de Lille - ISITE; CHU Lille	Lemyze, M (corresponding author), Schaffner Hosp, Dept Resp & Crit Care Med, Lens, France.	malcolmlemyze@yahoo.fr	Duhamel, Alain/A-4899-2013					[Anonymous], 1960, BMJ-BRIT MED J, V2, P1665; [Anonymous], 1998, WHONUTNCD981; Antonelli M, 2001, INTENS CARE MED, V27, P1718, DOI 10.1007/s00134-001-1114-4; BaHammam A, 2005, RESP MED, V99, P718, DOI 10.1016/j.rmed.2004.10.021; Baydur A, 2004, CHEST, V125, P98, DOI 10.1378/chest.125.1.98; BROCHARD L, 1995, NEW ENGL J MED, V333, P817, DOI 10.1056/NEJM199509283331301; Carrillo A, 2012, AM J RESP CRIT CARE, V186, P1279, DOI 10.1164/rccm.201206-1101OC; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; de Llano LAP, 2005, CHEST, V128, P587, DOI 10.1378/chest.128.2.587; Duarte AG, 2007, CRIT CARE MED, V35, P732, DOI 10.1097/01.CCM.0000256842.39767.41; El-Solh A, 2001, CHEST, V120, P1989, DOI 10.1378/chest.120.6.1989; Esteban A, 2004, NEW ENGL J MED, V350, P2452, DOI 10.1056/NEJMoa032736; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Ferretti A, 2001, CHEST, V119, P1401, DOI 10.1378/chest.119.5.1401; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Futier E, 2011, ANESTHESIOLOGY, V114, P1354, DOI 10.1097/ALN.0b013e31821811ba; Hart N, 2014, THORAX, V69, P83, DOI 10.1136/thoraxjnl-2013-204298; KELLY BJ, 1993, CHEST, V104, P1818, DOI 10.1378/chest.104.6.1818; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Lemyze M, 2013, CRIT CARE MED, V41, P481, DOI 10.1097/CCM.0b013e31826ab4af; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Marik PE, 2012, OBES REV, V13, P902, DOI 10.1111/j.1467-789X.2012.01014.x; Marik PE, 2013, J INTENSIVE CARE MED, V28, P124, DOI 10.1177/0885066612444261; Martino JL, 2011, CHEST, V140, P1198, DOI 10.1378/chest.10-3023; Masa JF, 2001, CHEST, V119, P1102, DOI 10.1378/chest.119.4.1102; Mokhlesi B, 2010, RESP CARE, V55, P1347; Moretti M, 2000, THORAX, V55, P819, DOI 10.1136/thorax.55.10.819; Nava S, 2009, LANCET, V374, P250, DOI 10.1016/S0140-6736(09)60496-7; Nowbar S, 2004, AM J MED, V116, P1, DOI 10.1016/j.amjmed.2003.08.022; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Pelosi P, 1997, J APPL PHYSIOL, V82, P811, DOI 10.1152/jappl.1997.82.3.811; Piper AJ, 2011, AM J RESP CRIT CARE, V183, P292, DOI 10.1164/rccm.201008-1280CI; Priou P, 2010, CHEST, V138, P84, DOI 10.1378/chest.09-2472; Raurich JM, 2010, RESP CARE, V55, P1442; Steier J, 2009, THORAX, V64, P719, DOI 10.1136/thx.2008.109728; Torbicki A, 2008, EUR HEART J, V29, P2276, DOI 10.1093/eurheartj/ehn310; Yamane T, 2008, AM J RESP CRIT CARE, V178, P295, DOI 10.1164/rccm.200801-113OC; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; ZWILLICH CW, 1975, AM J MED, V59, P343, DOI 10.1016/0002-9343(75)90392-7	41	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97563	10.1371/journal.pone.0097563	http://dx.doi.org/10.1371/journal.pone.0097563			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819141	Green Published, gold, Green Submitted			2022-12-27	WOS:000336653300123
J	Lopez, C; Suarez, CF; Cadavid, LF; Patarroyo, ME; Patarroyo, MA				Lopez, Carolina; Suarez, Carlos F.; Cadavid, Luis F.; Patarroyo, Manuel E.; Patarroyo, Manuel A.			Characterising a Microsatellite for DRB Typing in Aotus vociferans and Aotus nancymaae (Platyrrhini)	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; OWL MONKEYS AOTUS; INTRAGENIC RECOMBINATION; CONVERGENT EVOLUTION; MHC; GENES; ORIGIN; ALLELES; IDENTIFICATION; DIVERSITY	Non-human primates belonging to the Aotus genus have been shown to be excellent experimental models for evaluating drugs and vaccine candidates against malaria and other human diseases. The immune system of this animal model must be characterised to assess whether the results obtained here can be extrapolated to humans. Class I and II major histocompatibility complex (MHC) proteins are amongst the most important molecules involved in response to pathogens; in spite of this, the techniques available for genotyping these molecules are usually expensive and/or time-consuming. Previous studies have reported MHC-DRB class II gene typing by microsatellite in Old World primates and humans, showing that such technique provides a fast, reliable and effective alternative to the commonly used ones. Based on this information, a microsatellite present in MHC-DRB intron 2 and its evolutionary patterns were identified in two Aotus species (A. vociferans and A. nancymaae), as well as its potential for genotyping class II MHC-DRB in these primates.	[Lopez, Carolina; Suarez, Carlos F.; Patarroyo, Manuel A.] Fdn Inst Inmunol Colombia FIDIC, Mol Biol & Immunol Dept, Bogota, Cundinamarca, Colombia; [Lopez, Carolina; Suarez, Carlos F.; Patarroyo, Manuel A.] Univ Rosario, Sch Med & Hlth Sci, Bogota, Cundinamarca, Colombia; [Lopez, Carolina] Univ Nacl Colombia, Inst Biotecnol IBUN, MSc Microbiol Programme, Bogota, Cundinamarca, Colombia; [Cadavid, Luis F.] Univ Nacl Colombia, Genet Inst, Bogota, Cundinamarca, Colombia; [Patarroyo, Manuel E.] Univ Nacl Colombia, Sch Med, Bogota, Cundinamarca, Colombia	Universidad del Rosario; Universidad Nacional de Colombia; Universidad Nacional de Colombia; Universidad Nacional de Colombia	Patarroyo, MA (corresponding author), Fdn Inst Inmunol Colombia FIDIC, Mol Biol & Immunol Dept, Bogota, Cundinamarca, Colombia.	mapatarr.fidic@gmail.com	Patarroyo, Manuel A/I-8046-2016; Martínez, Carlos Fernando Suárez/ABH-7784-2020; Murillo, Manuel Elkin M.E Patarroyo/S-1422-2017; Suárez Martínez, Carlos/L-9787-2016; López-Santana, Carolina/L-8580-2016	Patarroyo, Manuel A/0000-0002-4751-2500; Martínez, Carlos Fernando Suárez/0000-0001-8423-408X; Murillo, Manuel Elkin M.E Patarroyo/0000-0002-1119-6040; Suárez Martínez, Carlos/0000-0001-8423-408X; López-Santana, Carolina/0000-0003-1313-7607; Cadavid, Luis F./0000-0002-6778-7958	Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS) [0309-2013]	Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This research was supported by the "Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS)", contract RC#0309-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Whitehouse K, 2006, TRENDS ECOL EVOL, V21, P433, DOI 10.1016/j.tree.2006.05.010; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSSON G, 1987, J BIOL CHEM, V262, P8748; ASHLEY MV, 1995, INT J PRIMATOL, V16, P793, DOI 10.1007/BF02735720; Baquero JE, 2006, IMMUNOGENETICS, V58, P590, DOI 10.1007/s00251-006-0101-x; Bergstrom TF, 1999, AM J HUM GENET, V64, P1709, DOI 10.1086/302401; BONE JF, 1970, LAB ANIM CARE, V20, P946; Bontrop RE, 1999, IMMUNOL REV, V167, P339, DOI 10.1111/j.1600-065X.1999.tb01403.x; Bontrop RE, 2001, IMMUNOL REV, V183, P5, DOI 10.1034/j.1600-065x.2001.1830101.x; de Groot N, 2008, IMMUNOGENETICS, V60, P737, DOI 10.1007/s00251-008-0333-z; de Groot NG, 2012, IMMUNOGENETICS, V64, P615, DOI 10.1007/s00251-012-0617-1; de Groot NG, 2009, MOL IMMUNOL, V47, P381, DOI 10.1016/j.molimm.2009.09.003; Diaz D, 2000, IMMUNOGENETICS, V51, P528, DOI 10.1007/s002510000189; Doxiadis GGM, 2009, TISSUE ANTIGENS, V74, P486, DOI 10.1111/j.1399-0039.2009.01369.x; Doxiadis GGM, 2008, MOL IMMUNOL, V45, P2743, DOI 10.1016/j.molimm.2008.02.017; Doxiadis GGM, 2007, P NATL ACAD SCI USA, V104, P8907, DOI 10.1073/pnas.0702964104; Doxiadis GGM, 2010, IMMUNOGENETICS, V62, P137, DOI 10.1007/s00251-010-0422-7; Du LM, 2013, J HERED, V104, P154, DOI 10.1093/jhered/ess082; Efron B, 1996, P NATL ACAD SCI USA, V93, P13429, DOI 10.1073/pnas.93.23.13429; Epplen C, 1997, HUM GENET, V99, P399, DOI 10.1007/s004390050379; Guerrero JE, 2003, TISSUE ANTIGENS, V62, P472, DOI 10.1046/j.1399-0039.2003.00130.x; Gusev VD, 1999, BIOINFORMATICS, V15, P994; GUSTAFSSON K, 1994, IMMUNOGENETICS, V39, P355, DOI 10.1007/BF00189233; Gustafsson K., 1991, NATO ASI Series Series H Cell Biology, V59, P119; Gysin J, 1988, MALARIA PARASITE BIO, P419; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Jones FR, 2006, INFECT IMMUN, V74, P790, DOI 10.1128/IAI.74.1.790-793.2006; KLEIN J, 1987, HUM IMMUNOL, V19, P155, DOI 10.1016/0198-8859(87)90066-8; Klein J, 2007, ANNU REV GENET, V41, P281, DOI 10.1146/annurev.genet.41.110306.130137; Knapp LA, 1997, IMMUNOGENETICS, V45, P171, DOI 10.1007/s002510050186; Kriener K, 2000, IMMUNOGENETICS, V51, P169, DOI 10.1007/s002510050028; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lenz TL, 2008, GENE, V427, P117, DOI 10.1016/j.gene.2008.09.013; LUJAN R, 1986, AM J TROP MED HYG, V35, P1103, DOI 10.4269/ajtmh.1986.35.1103; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Menezes AN, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-248; Middleton SA, 2004, IMMUNOGENETICS, V55, P785, DOI 10.1007/s00251-003-0634-1; National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals Institute for Laboratory Animal Research (US) and National Academies Press (US), 2011, GUIDE CARE USE LAB A; Nino-Vasquez JJ, 2000, IMMUNOGENETICS, V51, P219, DOI 10.1007/s002510050035; Noya O, 1998, ACTA TROP, V70, P257, DOI 10.1016/S0001-706X(98)00028-X; OHUIGIN C, 1995, IMMUNOL REV, V143, P123, DOI 10.1111/j.1600-065X.1995.tb00673.x; Otu HH, 2003, BIOINFORMATICS, V19, P2122, DOI 10.1093/bioinformatics/btg295; Pico de Coana Y, 2003, VACCINE, V21, P3930, DOI 10.1016/S0264-410X(03)00278-0; POLOTSKY YE, 1994, ANN NY ACAD SCI, V730, P318, DOI 10.1111/j.1749-6632.1994.tb44279.x; PREMIER Biosoft International PA CA USA, 2013, NETPRIMER; R Core Team, 2021, R LANGUAGE ENV STAT; Reusch TBH, 2005, J MOL EVOL, V61, P531, DOI 10.1007/s00239-004-0340-0; RIESS O, 1990, IMMUNOGENETICS, V32, P110; Robinson J, 2013, NUCLEIC ACIDS RES, V41, pD1222, DOI 10.1093/nar/gks949; Schrago CG, 2003, MOL BIOL EVOL, V20, P1620, DOI 10.1093/molbev/msg172; Sitnikova T, 1996, MOL BIOL EVOL, V13, P605, DOI 10.1093/oxfordjournals.molbev.a025620; Srithayakumar V, 2012, IMMUNOGENETICS, V64, P289, DOI 10.1007/s00251-011-0588-7; Suarez CF, 2006, IMMUNOGENETICS, V58, P542, DOI 10.1007/s00251-006-0127-0; Suarez CF, 2003, TISSUE ANTIGENS, V61, P362, DOI 10.1034/j.1399-0039.2003.00045.x; Takahata N, 1998, GENETICA, V102-3, P157, DOI 10.1023/A:1017029613342; Takahata N, 1998, IMMUNOGENETICS, V47, P430, DOI 10.1007/s002510050380; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trtkova K, 1995, MOL PHYLOGENET EVOL, V4, P408, DOI 10.1006/mpev.1995.1038; Ujvari B, 2011, INT J MOL SCI, V12, P5168, DOI 10.3390/ijms12085168; Ward JM, 2012, TRENDS GENET, V28, P586, DOI 10.1016/j.tig.2012.09.003; Yeager M, 1999, IMMUNOL REV, V167, P45, DOI 10.1111/j.1600-065X.1999.tb01381.x	61	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96973	10.1371/journal.pone.0096973	http://dx.doi.org/10.1371/journal.pone.0096973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24820773	gold, Green Published, Green Submitted			2022-12-27	WOS:000336653300056
J	Zeytuni, N; Uebe, R; Maes, M; Davidov, G; Baram, M; Raschdorf, O; Friedler, A; Miller, Y; Schuler, D; Zarivach, R				Zeytuni, Natalie; Uebe, Rene; Maes, Michal; Davidov, Geula; Baram, Michal; Raschdorf, Oliver; Friedler, Assaf; Miller, Yifat; Schueler, Dirk; Zarivach, Raz			Bacterial Magnetosome Biomineralization - A Novel Platform to Study Molecular Mechanisms of Human CDF-Related Type-II Diabetes	PLOS ONE			English	Article							DIFFUSION FACILITATOR FAMILY; PARTICLE MESH EWALD; MAGNETOSPIRILLUM-GRYPHISWALDENSE; CYTOSOLIC DOMAIN; TRANSPORTER; PROTEIN; HYPERMANGANESEMIA; CRYSTALLIZATION; POLYCYTHEMIA; AGGREGATION	Cation diffusion facilitators (CDF) are part of a highly conserved protein family that maintains cellular divalent cation homeostasis in all organisms. CDFs were found to be involved in numerous human health conditions, such as Type-II diabetes and neurodegenerative diseases. In this work, we established the magnetite biomineralizing alphaproteobacterium Magnetospirillum gryphiswaldense as an effective model system to study CDF-related Type-II diabetes. Here, we introduced two ZnT-8 Type-II diabetes-related mutations into the M. gryphiswaldense MamM protein, a magnetosome-associated CDF transporter essential for magnetite biomineralization within magnetosome vesicles. The mutations' effects on magnetite biomineralization and iron transport within magnetosome vesicles were tested in vivo. Additionally, by combining several in vitro and in silico methodologies we provide new mechanistic insights for ZnT-8 polymorphism at position 325, located at a crucial dimerization site important for CDF regulation and activation. Overall, by following differentiated, easily measurable, magnetism-related phenotypes we can utilize magnetotactic bacteria for future research of CDF-related human diseases.	[Zeytuni, Natalie; Davidov, Geula; Zarivach, Raz] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Zeytuni, Natalie; Davidov, Geula; Zarivach, Raz] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Baram, Michal; Miller, Yifat] Ben Gurion Univ Negev, Dept Chem, IL-84105 Beer Sheva, Israel; [Baram, Michal; Miller, Yifat] Ben Gurion Univ Negev, Ilse Katz Inst Nanoscale Sci & Technol, IL-84105 Beer Sheva, Israel; [Maes, Michal; Friedler, Assaf] Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel; [Uebe, Rene; Raschdorf, Oliver; Schueler, Dirk] Univ Munich, Dept Biol 1, Martinsried, Germany	Ben Gurion University; Ben Gurion University; Ben Gurion University; Ben Gurion University; Hebrew University of Jerusalem; University of Munich	Zarivach, R (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	zarivach@bgu.ac.il	Zeytuni, Natalie/AAP-7850-2021; ZARIVACH, RAZ/F-1671-2012	ZARIVACH, RAZ/0000-0001-6543-0296; Davidov, Geula/0000-0001-5153-4940; Zeytuni, Natalie/0000-0002-5708-4095; Raschdorf, Oliver/0000-0003-1558-059X; Maes, Michal/0000-0002-7406-3982; Schuler, Dirk/0000-0002-2327-0762	GIF (German-Israeli Foundation for Scientific Research and Development); European Cooperation in Science and Technology (COST action) [CM0902]; Israeli Ministry of Science and Technology, the Deutsche Forschungsgemeinschaft [SCHU 1080/13-1]; FP7 of the European Union [NMP4-SL-2010-245542-Bio2MaN4MRI]; European Research Council under the European Community's Seventh Framework Programme (FP7)/ERC [203413]; Minerva Center for bio-hybrid complex systems; FP7-PEOPLE-2011-CIG [303741]	GIF (German-Israeli Foundation for Scientific Research and Development)(German-Israeli Foundation for Scientific Research and Development); European Cooperation in Science and Technology (COST action)(European Cooperation in Science and Technology (COST)); Israeli Ministry of Science and Technology, the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); FP7 of the European Union; European Research Council under the European Community's Seventh Framework Programme (FP7)/ERC(European Research Council (ERC)); Minerva Center for bio-hybrid complex systems; FP7-PEOPLE-2011-CIG	This research was supported by grants from the GIF (German-Israeli Foundation for Scientific Research and Development), the European Cooperation in Science and Technology (COST action CM0902), the Israeli Ministry of Science and Technology, the Deutsche Forschungsgemeinschaft (grant SCHU 1080/13-1) and the FP7 of the European Union (collaborative grant NMP4-SL-2010-245542-Bio2MaN4MRI). AF is supported by a starting grant from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement no 203413 and by the Minerva Center for bio-hybrid complex systems. YM is supported by the FP7-PEOPLE-2011-CIG, research grant no. 303741. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; Anton A, 1999, J BACTERIOL, V181, P6876, DOI 10.1128/JB.181.22.6876-6881.1999; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Cherezov V, 2008, STRUCTURE, V16, P1378, DOI 10.1016/j.str.2008.05.014; Coudray N, 2013, P NATL ACAD SCI US; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Delhaize E, 2003, PLANT CELL, V15, P1131, DOI 10.1105/tpc.009134; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Etzion Y, 2008, J CARDIOVASC ELECTR, V19, P157, DOI 10.1111/j.1540-8167.2007.01008.x; Faivre D, 2008, CHEM REV, V108, P4875, DOI 10.1021/cr078258w; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Grass G, 2005, ARCH MICROBIOL, V183, P9, DOI 10.1007/s00203-004-0739-4; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haney CJ, 2005, J IND MICROBIOL BIOT, V32, P215, DOI 10.1007/s10295-005-0224-3; Hattori M, 2007, ACTA CRYSTALLOGR F, V63, P771, DOI 10.1107/S1744309107038948; Higuchi T, 2009, PROTEINS, V76, P768, DOI 10.1002/prot.22444; Jiang F, 2012, BIOMED ENVIRON SCI, V25, P23, DOI 10.3967/0895-3988.2012.01.004; Jogler C, 2009, ANNU REV MICROBIOL, V63, P501, DOI 10.1146/annurev.micro.62.081307.162908; Jorgensen WL, J PHYS, V79, P926; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Katzmann E, 2010, MOL MICROBIOL, V77, P208, DOI 10.1111/j.1365-2958.2010.07202.x; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; Mackerell AD, ALL ATOM EMPIRICAL P, V5647, P3586; Mahoney MW, 2001, J CHEM PHYS, V115, P10758, DOI 10.1063/1.1418243; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Miller Y, 2011, BIOCHEMISTRY-US, V50, P5172, DOI 10.1021/bi200400u; Miller Y, 2010, P NATL ACAD SCI USA, V107, P9490, DOI 10.1073/pnas.0913114107; Munkelt D, 2004, J BACTERIOL, V186, P8036, DOI 10.1128/JB.186.23.8036-8043.2004; Murat D, 2010, P NATL ACAD SCI USA, V107, P5593, DOI 10.1073/pnas.0914439107; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Patrushev N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033211; Paulsen IT, 1997, J MEMBRANE BIOL, V156, P99, DOI 10.1007/s002329900192; Persans MW, 2001, P NATL ACAD SCI USA, V98, P9995, DOI 10.1073/pnas.171039798; Quadri M, 2012, AM J HUM GENET, V90, P467, DOI 10.1016/j.ajhg.2012.01.017; Raz Y, 2013, PHYS CHEM CHEM PHYS; Raz Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073303; Schuler D, 2004, ARCH MICROBIOL, V181, P1, DOI 10.1007/s00203-003-0631-7; SCHULER D, 1995, FEMS MICROBIOL LETT, V132, P139, DOI 10.1016/0378-1097(95)00300-T; Tuschl K, 2012, AM J HUM GENET, V90, P457, DOI 10.1016/j.ajhg.2012.01.018; Uebe R, 2011, MOL MICROBIOL, V82, P818, DOI 10.1111/j.1365-2958.2011.07863.x; Uebe R, 2010, J BACTERIOL, V192, P4192, DOI 10.1128/JB.00319-10; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Zeytuni N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092141; Zeytuni N, 2012, ACTA CRYSTALLOGR F, V68, P927, DOI 10.1107/S1744309112025638; Zeytuni N, 2011, P NATL ACAD SCI USA, V108, pE480, DOI 10.1073/pnas.1103367108	50	14	16	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97154	10.1371/journal.pone.0097154	http://dx.doi.org/10.1371/journal.pone.0097154			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819161	Green Published, gold, Green Submitted			2022-12-27	WOS:000336653300084
J	Alhazmi, A; Stojanovski, E; Garg, ML; McEvoy, M				Alhazmi, Amani; Stojanovski, Elizabeth; Garg, Manohar L.; McEvoy, Mark			Fasting Whole Blood Fatty Acid Profile and Risk of Type 2 Diabetes in Adults: A Nested Case Control Study	PLOS ONE			English	Article							DIETARY-FAT; FISH CONSUMPTION; ADIPOSE-TISSUE; SERUM; OMEGA-3-FATTY-ACIDS; LIPIDS; SUPPLEMENTATION; QUESTIONNAIRE; METAANALYSIS; PRESSURE	Objective: to determine the association of fasting whole blood fatty acid concentrations with incidence of type 2 diabetes in adults. Methods: A nested case-control study of 187 subjects from a cohort of men and women aged 55-85 years from the Hunter Region, New South Wales, Australia. Fasting whole blood fatty acids were measured using gas chromatography and incidence of type 2 diabetes was ascertained by self-reported questionnaire at the study follow-up. Results: After adjustment for potential confounding variables, positive associations with type 2 diabetes were seen for dihomo-gamma-linolenic acid (DGLA) (OR = 1.04, 95% CI: 1.01-1.07, P = 0.01); arachidonic acid (ARA) (OR = 1.01, 95% CI: 1.00-1.01, P = 0.002); alpha-linolenic acid (ALA) (OR = 1.10, 95% CI: 1.03-1.18, P = 0.01); eicosapentaenoic acid (EPA) (OR = 1.05, 95% CI: 1.02-1.08, P = 0.001); and docosahexaenoic acid (DHA) (OR = 1.03, 95% CI: 1.02-1.05, P < 0.0001). Lignoceric acid is significantly associated with lower type 2 diabetes risk (OR = 0.95, 95% CI: 0.92-0.99, P = 0.01). Conclusion: These data suggest that higher fasting whole blood concentrations of omega-6 polyunsaturated fatty acids (n-6PUFA) (ARA and DGLA) as well as omega-3 polyunsaturated fatty acid (n-3PUFA) (ALA, EPA, and DHA) are associated with an increased risk of diabetes, whereas increased fasting whole blood concentrations of lignoceric acid is inversely associated with diabetes risk.	[Alhazmi, Amani] Univ Newcastle, Sch Hlth Sci, Fac Hlth & Med, Callaghan, NSW 2308, Australia; [Alhazmi, Amani] Minist Higher Educ, Riyadh, Saudi Arabia; [Stojanovski, Elizabeth] Univ Newcastle, Sch Math & Phys Sci, Fac Sci & Informat Technol, Callaghan, NSW 2308, Australia; [Garg, Manohar L.] Univ Newcastle, Sch Biomed Sci & Pharm, Fac Hlth & Med, Callaghan, NSW 2308, Australia; [McEvoy, Mark] Univ Newcastle, Ctr Clin Epidemiol & Biostat, Fac Hlth & Med, Callaghan, NSW 2308, Australia	University of Newcastle; University of Newcastle; University of Newcastle; University of Newcastle	Garg, ML (corresponding author), Univ Newcastle, Sch Biomed Sci & Pharm, Fac Hlth & Med, Callaghan, NSW 2308, Australia.	Manohar.Garg@newcastle.edu.au	Alhazmi, Amani/HGF-3100-2022; Garg, Manohar L/A-5795-2009	Garg, Manohar/0000-0003-0514-0865; Alhazmi, Amani/0000-0002-4062-1640; McEvoy, Mark/0000-0002-5505-5557	Ministry of Higher Education, Riyadh, Saudi Arabia	Ministry of Higher Education, Riyadh, Saudi Arabia	Amani Alhazmi is supported by a scholarship from the Ministry of Higher Education, Riyadh, Saudi Arabia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert CM, 2002, NEW ENGL J MED, V346, P1113, DOI 10.1056/NEJMoa012918; Alhazmi A, 2014, PUBLIC HEALTH NUTR, V17, P1587, DOI 10.1017/S1368980013001870; Alhazmi A, 2012, J AM COLL NUTR, V31, P243, DOI 10.1080/07315724.2012.10720425; Baylin A, 2005, AM J EPIDEMIOL, V162, P373, DOI 10.1093/aje/kwi213; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carpentier YA, 2006, AM J CLIN NUTR, V83, p1499S, DOI 10.1093/ajcn/83.6.1499S; Das UN, 2013, PROSTAG LEUKOTR ESS, V88, P201, DOI 10.1016/j.plefa.2012.11.009; DAYTON S, 1966, J LIPID RES, V7, P103; Djousse L, 2011, AM J CLIN NUTR, V94, P527, DOI 10.3945/ajcn.111.013334; Djousse L, 2011, AM J CLIN NUTR, V93, P143, DOI 10.3945/ajcn.110.005603; El Fakiri F, 2007, J CLIN EPIDEMIOL, V60, P1271, DOI 10.1016/j.jclinepi.2007.02.014; FAN YY, 1992, J NUTR, V122, P1600, DOI 10.1093/jn/122.8.1600; Food Standards Australia New Zealand, 2006, NUTTAB AUSTR FOOD CO; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Godley PA, 1996, CANCER EPIDEM BIOMAR, V5, P115; Hodge AM, 2007, AM J CLIN NUTR, V86, P189, DOI 10.1093/ajcn/86.1.189; Hu FB, 2001, DIABETOLOGIA, V44, P805, DOI 10.1007/s001250100547; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; Kaushik M, 2009, AM J CLIN NUTR, V90, P613, DOI 10.3945/ajcn.2008.27424; Laaksonen DE, 2002, DIABETIC MED, V19, P456, DOI 10.1046/j.1464-5491.2002.00707.x; LEPAGE G, 1986, J LIPID RES, V27, P114; Lowe J, 2010, J EVAL CLIN PRACT, V16, P887, DOI 10.1111/j.1365-2753.2009.01208.x; Mata P, 1996, ARTERIOSCL THROM VAS, V16, P1347, DOI 10.1161/01.ATV.16.11.1347; McEvoy M, 2010, INT J EPIDEMIOL, V39, P1452, DOI 10.1093/ije/dyp343; Meyer KA, 2001, DIABETES CARE, V24, P1528, DOI 10.2337/diacare.24.9.1528; Montanaro MA, 2003, LIPIDS, V38, P827, DOI 10.1007/s11745-003-1132-7; Mostad IL, 2006, AM J CLIN NUTR, V84, P540, DOI 10.1093/ajcn/84.3.540; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; PUHAKAINEN I, 1995, AM J CLIN NUTR, V61, P121, DOI 10.1093/ajcn/61.1.121; SACKS FM, 1987, J AM COLL NUTR, V6, P179; Salmeron J, 2001, AM J CLIN NUTR, V73, P1019; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Smith W, 1998, AUST NZ J PUBL HEAL, V22, P456, DOI 10.1111/j.1467-842X.1998.tb01414.x; van Dam RM, 2002, DIABETES CARE, V25, P417, DOI 10.2337/diacare.25.3.417; VESSBY B, 1994, DIABETES, V43, P1353, DOI 10.2337/diabetes.43.11.1353; Vidgren HM, 1997, LIPIDS, V32, P697, DOI 10.1007/s11745-997-0089-x; Villegas R, 2011, AM J CLIN NUTR, V94, P543, DOI 10.3945/ajcn.111.013193; Wallin A, 2012, DIABETES CARE, V35, P918, DOI 10.2337/dc11-1631; Wang L, 2003, AM J CLIN NUTR, V78, P91; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Williams Michael D, 2007, Curr Diab Rep, V7, P242, DOI 10.1007/s11892-007-0038-y; Woodman RJ, 2002, AM J CLIN NUTR, V76, P1007, DOI 10.1093/ajcn/76.5.1007	43	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97001	10.1371/journal.pone.0097001	http://dx.doi.org/10.1371/journal.pone.0097001			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816459	Green Published, Green Submitted, gold			2022-12-27	WOS:000336838000092
J	Cohen, A; Whitfield, TW; Kreifeldt, M; Koebel, P; Kieffer, BL; Contet, C; George, O; Koob, GF				Cohen, Ami; Whitfield, Timothy W.; Kreifeldt, Max; Koebel, Pascale; Kieffer, Brigitte L.; Contet, Candice; George, Olivier; Koob, George F.			Virus-Mediated shRNA Knockdown of Prodynorphin in the Rat Nucleus Accumbens Attenuates Depression-Like Behavior and Cocaine Locomotor Sensitization	PLOS ONE			English	Article							KAPPA-OPIOID RECEPTOR; FORCED SWIM TEST; GENE-EXPRESSION; MESSENGER-RNA; DYNORPHIN; DOPAMINE; STRESS; DRUG; ACTIVATION; INCREASES	Dynorphins, endogenous opioid peptides that arise from the precursor protein prodynorphin (Pdyn), are hypothesized to be involved in the regulation of mood states and the neuroplasticity associated with addiction. The current study tested the hypothesis that dynorphin in the nucleus accumbens (NAcc) mediates such effects. More specifically, we examined whether knockdown of Pdyn within the NAcc in rats would alter the expression of depressive-like and anxiety-like behavior, as well as cocaine locomotor sensitization. Wistar rats were injected with adeno-associated viral (AAV) vectors encoding either a Pdyn-specific short hairpin RNA (AAV-shPdyn) or a scrambled shRNA (AAV-shScr) as control. Four weeks later, rats were tested for anxiety-like behavior in the elevated plus maze test and depressive-like behavior in the forced swim test (FST). Finally, rats received one daily injection of saline or cocaine (20 mg/kg, i.p.), followed by assessment of locomotion for 4 consecutive days. Following 3 days of abstinence, the rats completed 2 additional daily cocaine/saline locomotor trials. Pdyn knockdown in the NAcc led to a significant reduction in depressive-like behavior in the FST, but had no effect on anxiety-like behavior in the elevated plus maze. Pdyn knockdown did not alter baseline locomotor behavior, the locomotor response to acute cocaine, or the initial sensitization of the locomotor response to cocaine over the first 4 cocaine treatment days. However, following 3 days abstinence the locomotor response to the cocaine challenge returned to their original levels in the AAV-shPdyn rats while remaining heightened in the AAV-shScr rats. These results suggest that dynorphin in a very specific area of the nucleus accumbens contributes to depressive-like states and may be involved in neuroadaptations in the NAcc that contribute to the development of cocaine addiction as a persistent and lasting condition.	[Cohen, Ami; Whitfield, Timothy W.; Kreifeldt, Max; Contet, Candice; George, Olivier; Koob, George F.] Scripps Res Inst, Comm Neurobiol Addict Disorders, La Jolla, CA 92037 USA; [Koebel, Pascale; Kieffer, Brigitte L.] Univ Strasbourg, Translat Med & Neurogenet Programme, INSERM, Inst Genet Biol Mol & Cellulaire,CNRS,U964,UMR710, Illkirch Graffenstaden, France	Scripps Research Institute; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Cohen, A (corresponding author), Scripps Res Inst, Comm Neurobiol Addict Disorders, La Jolla, CA 92037 USA.	cohen@scripps.edu	George, Olivier/G-9921-2011; Contet, Candice/H-2774-2019	George, Olivier/0000-0002-3700-5003; Contet, Candice/0000-0002-4459-9540	National Institute on Drug Abuse [DA004398, AA006420]; Pearson Center for Alcoholism and Addiction Research; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA006420, P60AA006420, T32AA007456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004398] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Pearson Center for Alcoholism and Addiction Research; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by National Institute on Drug Abuse grants DA004398 (GFK) and AA006420 (CC) and the Pearson Center for Alcoholism and Addiction Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CP, 2013, PSYCHOPHARMACOLOGY, V226, P571, DOI 10.1007/s00213-012-2930-7; Bailey A, 2007, J NEUROCHEM, V102, P1817, DOI 10.1111/j.1471-4159.2007.04661.x; BALSKUBIK R, 1993, J PHARMACOL EXP THER, V264, P489; Beardsley PM, 2005, PSYCHOPHARMACOLOGY, V183, P118, DOI 10.1007/s00213-005-0167-4; Britt JP, 2008, J NEUROSCI, V28, P1672, DOI 10.1523/JNEUROSCI.4275-07.2008; Bruchas MR, 2010, BRAIN RES, V1314, P44, DOI 10.1016/j.brainres.2009.08.062; Bruchas MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008528; Bruijnzeel AW, 2009, BRAIN RES REV, V62, P127, DOI 10.1016/j.brainresrev.2009.09.008; Butelman ER, 2012, TRENDS NEUROSCI, V35, P587, DOI 10.1016/j.tins.2012.05.005; Caputi FF, 2014, PROG NEURO-PSYCHOPH, V49, P36, DOI 10.1016/j.pnpbp.2013.10.016; Carlezon WA, 2009, PHARMACOL THERAPEUT, V123, P334, DOI 10.1016/j.pharmthera.2009.05.008; Carlezon WA, 2009, NEUROPHARMACOLOGY, V56, P122, DOI 10.1016/j.neuropharm.2008.06.075; Chefer VI, 2006, EUR J NEUROSCI, V23, P229, DOI 10.1111/j.1460-9568.2005.04525.x; Clarke S, 2003, NEUROSCIENCE, V122, P479, DOI 10.1016/j.neuroscience.2003.07.011; Darcq E, 2011, LEARN MEMORY, V18, P574, DOI 10.1101/lm.2221011; Deroche V, 1999, EUR J NEUROSCI, V11, P2731, DOI 10.1046/j.1460-9568.1999.00696.x; Di Chiara G, 2002, BEHAV BRAIN RES, V137, P75, DOI 10.1016/S0166-4328(02)00286-3; DICHIARA G, 1988, J PHARMACOL EXP THER, V244, P1067; FALLON JH, 1986, J COMP NEUROL, V249, P293, DOI 10.1002/cne.902490302; Femenia T, 2011, J PSYCHOPHARMACOL, V25, P87, DOI 10.1177/0269881110367724; GEORGE SR, 1994, BIOCHEM BIOPH RES CO, V205, P1438, DOI 10.1006/bbrc.1994.2826; HEIDBREDER CA, 1994, NEUROREPORT, V5, P1797, DOI 10.1097/00001756-199409080-00028; HEIDBREDER CA, 1995, J PHARMACOL EXP THER, V275, P150; Hjelmstad GO, 2003, J NEUROPHYSIOL, V89, P2389, DOI 10.1152/jn.01115.2002; KALIVAS PW, 1991, BRAIN RES REV, V16, P223, DOI 10.1016/0165-0173(91)90007-U; Kallupi M, 2013, BIOL PSYCHIAT, V74, P520, DOI 10.1016/j.biopsych.2013.04.028; Kastenberger I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034251; Knoll AT, 2007, J PHARMACOL EXP THER, V323, P838, DOI 10.1124/jpet.107.127415; Knoll AT, 2011, BIOL PSYCHIAT, V70, P425, DOI 10.1016/j.biopsych.2011.03.017; Knoll AT, 2010, BRAIN RES, V1314, P56, DOI 10.1016/j.brainres.2009.09.074; Kreek MJ, 1998, DRUG ALCOHOL DEPEN, V51, P23, DOI 10.1016/S0376-8716(98)00064-7; Land BB, 2009, P NATL ACAD SCI USA, V106, P19168, DOI 10.1073/pnas.0910705106; Mague SD, 2003, J PHARMACOL EXP THER, V305, P323, DOI 10.1124/jpet.102.046433; MAISONNEUVE IM, 1994, NEUROSCI LETT, V181, P57, DOI 10.1016/0304-3940(94)90559-2; MANSOUR A, 1995, TRENDS NEUROSCI, V18, P22, DOI 10.1016/0166-2236(95)93946-U; Margolis EB, 2006, P NATL ACAD SCI USA, V103, P2938, DOI 10.1073/pnas.0511159103; McLaughlin JP, 2003, J NEUROSCI, V23, P5674, DOI 10.1523/jneurosci.23-13-05674.2003; Merg F, 2006, J NEUROCHEM, V97, P292, DOI 10.1111/j.1471-4159.2006.03732.x; Muschamp JW, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a012005; Muschamp JW, 2011, J NEUROSCI, V31, P3095, DOI 10.1523/JNEUROSCI.5973-10.2011; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Newton SS, 2002, J NEUROSCI, V22, P10883; Patel JG, 2004, SYNAPSE, V52, P73, DOI 10.1002/syn.10308; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Petit-Demouliere B, 2005, PSYCHOPHARMACOLOGY, V177, P245, DOI 10.1007/s00213-004-2048-7; PFEIFFER A, 1986, SCIENCE, V233, P774, DOI 10.1126/science.3016896; Porsolt R D, 2001, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0810as14; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Raynor K, 1996, NIDA Res Monogr, V161, P83; Rex A, 2004, PHARMACOL BIOCHEM BE, V77, P303, DOI 10.1016/j.pbb.2003.11.001; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Sabino V, 2009, BEHAV BRAIN RES, V198, P472, DOI 10.1016/j.bbr.2008.11.036; Schindler AG, 2012, J NEUROSCI, V32, P17582, DOI 10.1523/JNEUROSCI.3220-12.2012; Schlosburg JE, 2013, J NEUROSCI, V33, P19384, DOI 10.1523/JNEUROSCI.1979-13.2013; Schwarzer C, 2009, PHARMACOL THERAPEUT, V123, P353, DOI 10.1016/j.pharmthera.2009.05.006; Shippenberg TS, 1997, PHARMACOL BIOCHEM BE, V57, P449, DOI 10.1016/S0091-3057(96)00450-9; Shirayama Y, 2004, J NEUROCHEM, V90, P1258, DOI 10.1111/j.1471-4159.2004.02589.x; SHUSTER L, 1977, PSYCHOPHARMACOLOGY, V52, P185, DOI 10.1007/BF00439108; Slattery DA, 2012, NAT PROTOC, V7, P1009, DOI 10.1038/nprot.2012.044; Tejeda HA, 2013, NEUROPSYCHOPHARMACOL, V38, P1770, DOI 10.1038/npp.2013.76; Todtenkopf MS, 2004, PSYCHOPHARMACOLOGY, V172, P463, DOI 10.1007/s00213-003-1680-y; Van't Veer A, 2013, NEUROPSYCHOPHARMACOL, V38, P1585, DOI 10.1038/npp.2013.58; VANBOCKSTAELE EJ, 1995, J COMP NEUROL, V351, P117, DOI 10.1002/cne.903510111; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; Wadenberg MLG, 2003, CNS DRUG REV, V9, P187; Wee S, 2009, PSYCHOPHARMACOLOGY, V205, P565, DOI 10.1007/s00213-009-1563-y; Wittmann W, 2009, NEUROPSYCHOPHARMACOL, V34, P775, DOI 10.1038/npp.2008.142; Zhou L, 2003, NEUROSCIENCE, V120, P783, DOI 10.1016/S0306-4522(03)00326-9	68	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97216	10.1371/journal.pone.0097216	http://dx.doi.org/10.1371/journal.pone.0097216			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816773	Green Published, Green Submitted, gold			2022-12-27	WOS:000336838000118
J	Gavrilova, ES; Bobrovnik, SA; Sherriff, G; Myslivets, AA; Tarasov, SA; Epstein, OI				Gavrilova, Elena S.; Bobrovnik, Sergey A.; Sherriff, Gordon; Myslivets, Andrey A.; Tarasov, Sergey A.; Epstein, Oleg I.			Novel Approach to Activity Evaluation for Release-Active Forms of Anti-Interferon-Gamma Antibodies Based on Enzyme-Linked Immunoassay	PLOS ONE			English	Article							ANAFERON PEDIATRIC FORMULATION; FUSION ANTIBODY; INFLUENZA; INFECTION; MICE; ERGOFERON; CONSTANT; BINDING; FUTURE; TRIAL	Selection of a suitable assay to measure the activity of drug agents based on release-active forms of anti-interferon-gamma antibodies (RA forms of Abs) is an important step forward in the investigation of such agents. In this study, the enzyme-linked immunosorbent assay was utilized to examine the effect of RA forms of Abs specific for human interferon gamma on the interaction between monoclonal anti-interferon gamma antibodies and recombinant human interferon gamma. The experimental data and the results obtained by using relevant mathematical analysis showed that such RA forms of Abs are able to modulate the monoclonal antibody interaction with both soluble and immobilized (to the assay plate well) interferon gamma. These data demonstrated the importance of using relatively low concentrations of both soluble and plate-immobilized interferon gamma to detect the effects of RA forms of Abs to interferon gamma on the binding of monoclonal antibodies to interferon gamma. It has been suggested that the observed influence of RA forms of Abs on 'antibody-antigen' interaction could be used to detect and analyze the activity of drugs containing RA forms of Abs.	[Gavrilova, Elena S.; Myslivets, Andrey A.; Tarasov, Sergey A.; Epstein, Oleg I.] OOO NPF MAT MEDICA HOLDING, Moscow, Russia; [Bobrovnik, Sergey A.] Natl Acad Sci Ukraine, Dept Mol Immunol, Palladin Inst Biochem, Kiev, Ukraine; [Sherriff, Gordon] Ab Biotechnol Ltd, Penicuik, Midlothian, Scotland	National Academy of Sciences Ukraine; Palladin Institute of Biochemistry of NASU	Gavrilova, ES (corresponding author), OOO NPF MAT MEDICA HOLDING, Moscow, Russia.	GavrilovaES@materiamedica.ru	Don, Elena/L-6765-2018	Don, Elena/0000-0001-8219-0482; Epstein, Oleg/0000-0003-3992-6639; Tarasov, Sergey/0000-0002-6650-6958	OOO "NPF "MATERIA MEDICA HOLDING"; Ab Biotechnology Limited	OOO "NPF "MATERIA MEDICA HOLDING"; Ab Biotechnology Limited	The work was sponsored by OOO "NPF "MATERIA MEDICA HOLDING". The funder & Ab Biotechnology Limited provided support in the form of salaries for authors ESG, AAM, SAT, OIE and GS but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Averyanov A. V., 2012, Antibiotiki i Khimioterapiya, V57, P23; Bailbe D, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/763125; Boado RJ, 2007, BIOCONJUGATE CHEM, V18, P447, DOI 10.1021/bc060349x; Bobrovnik S. A., 1998, Ukrainskii Biokhimicheskii Zhurnal, V70, P118; Bobrovnik SA, 1998, J BIOCHEM BIOPH METH, V37, P53, DOI 10.1016/S0165-022X(98)00019-0; Buss NAPS, 2012, CURR OPIN PHARMACOL, V12, P615, DOI 10.1016/j.coph.2012.08.001; Cao M, 2009, APPL BIOCHEM BIOTECH, V157, P562, DOI 10.1007/s12010-008-8434-6; Chames P, 2009, BRIT J PHARMACOL, V157, P220, DOI 10.1111/j.1476-5381.2009.00190.x; Dugina JL, 2005, INT J TISSUE REACT, V27, P15; Epstein O. I., 2013, Uspekhi Fiziologicheskikh Nauk, V44, P54; Epstein OI, 2012, B EXP BIOL MED+, V154, P54, DOI 10.1007/s10517-012-1874-6; Epstein OI, 2004, B EXP BIOL MED+, V137, P460, DOI 10.1023/B:BEBM.0000038153.60142.84; Epstein OI, 2009, ULTRALOW DOSES HIST; Epstein OI, 1996, INFORM ONTOLOGICAL M; Erman ES, 2009, B EXP BIOL MED+, V148, P270, DOI 10.1007/s10517-009-0705-x; Frenzel A, 2012, CURR BIOTECHNOL, V1, P33, DOI DOI 10.2174/2211550111201010033; FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4; Guggenheim EA, 1926, PHILOS MAG, V2, P538; Hansel TT, 2010, NAT REV DRUG DISCOV, V9, P325, DOI 10.1038/nrd3003; ICH Harmonised Tripartite Guideline, 2005, VAL AN PROC TEXT MET; Kezdy FJ, 1958, B SOC CHEM BELGES, V67, P687, DOI [DOI 10.1002/BSCB.19580671104, 10.1002/bscb.19580671104]; Lipman NS, 2005, ILAR J, V46, P258, DOI 10.1093/ilar.46.3.258; Nicoll J, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/925874; NYGREN H, 1987, J IMMUNOL METHODS, V101, P63, DOI 10.1016/0022-1759(87)90217-1; Sakat SS, 2014, INFLAMMATION, V37, P1, DOI 10.1007/s10753-013-9705-0; Shishkina LN, 2010, B EXP BIOL MED+, V149, P612, DOI 10.1007/s10517-010-1006-0; Shishkina LN, 2008, B EXP BIOL MED+, V146, P763, DOI 10.1007/s10517-009-0378-5; STEVENS FJ, 1987, MOL IMMUNOL, V24, P1055, DOI 10.1016/0161-5890(87)90073-3; SWINBOURNE ES, 1960, J CHEM SOC, P2371; Tarasov SA, 2012, ANTIVIR RES, V93, P219, DOI 10.1016/j.antiviral.2011.11.018; Vanhove B, 2003, BLOOD, V102, P564, DOI 10.1182/blood-2002-08-2480; Vasilyev K. N., 2008, Antibiotiki i Khimioterapiya, V53, P32; Verevshchikov V. K., 2011, Antibiotiki i Khimioterapiya, V56, P23; WERTHEN M, 1993, BIOCHIM BIOPHYS ACTA, V1162, P326, DOI 10.1016/0167-4838(93)90298-6	34	11	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97017	10.1371/journal.pone.0097017	http://dx.doi.org/10.1371/journal.pone.0097017			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816648	gold, Green Published			2022-12-27	WOS:000336838000095
J	Kooiman, J; van Rein, N; Spaans, B; van Beers, KAJ; Bank, JR; de Peppel, WRV; del Sol, AI; Cannegieter, SC; Rabelink, TJ; Lip, GYH; Klok, FA; Huisman, MV				Kooiman, Judith; van Rein, Nienke; Spaans, Bas; van Beers, Koen A. J.; Bank, Jonna R.; de Peppel, Wilke R. van; del Sol, Antonio Iglesias; Cannegieter, Suzanne C.; Rabelink, Ton J.; Lip, Gregory Y. H.; Klok, Frederikus A.; Huisman, Menno V.			Efficacy and Safety of Vitamin K-Antagonists (VKA) for Atrial Fibrillation in Non-Dialysis Dependent Chronic Kidney Disease	PLOS ONE			English	Article							MAJOR BLEEDING COMPLICATIONS; ANTICOAGULATED PATIENTS; RENAL DYSFUNCTION; WARFARIN; STROKE; OUTCOMES; UPDATE; VARIABILITY; IMPAIRMENT; THERAPY	Background: Essential information regarding efficacy and safety of vitamin K-antagonists (VKA) treatment for atrial fibrillation (AF) in non-dialysis dependent chronic kidney disease (CKD) is still lacking in current literature. The aim of our study was to compare the risks of stroke or transient ischemic attack (TIA) and major bleeds between patients without CKD (eGFR >60 ml/min), and those with moderate (eGFR 30-60 ml/min), or severe non-dialysis dependent CKD (eGFR <30 ml/min). Methods: We included 300 patients without CKD, 294 with moderate, and 130 with severe non-dialysis dependent CKD, who were matched for age and sex. Uni- and multivariate Cox regression analyses were performed reporting hazard ratios (HRs) for the endpoint of stroke or TIA and the endpoint of major bleeds as crude values and adjusted for comorbidity and platelet-inhibitor use. Results: Overall, 6.2% (45/724, 1.7/100 patient years) of patients developed stroke or TIA and 15.6% (113/724, 4.8/100 patient years) a major bleeding event. Patients with severe CKD were at high risk of stroke or TIA and major bleeds during VKA treatment compared with those without renal impairment, HR 2.75 (95% CI 1.25-6.05) and 1.66 (95% CI 0.97-2.86), or with moderate CKD, HR 3.93(1.71-9.00) and 1.86 (95% CI 1.08-3.21), respectively. These risks were similar for patients without and with moderate CKD. Importantly, both less time spent within therapeutic range and high INR-variability were associated with increased risks of stroke or TIA and major bleeds in severe CKD patients. Conclusions: VKA treatment for AF in patients with severe CKD has a poor safety and efficacy profile, likely related to suboptimal anticoagulation control. Our study findings stress the need for better tailored individualised anticoagulant treatment approaches for patients with AF and severe CKD.	[Kooiman, Judith; van Rein, Nienke; Spaans, Bas; van Beers, Koen A. J.; Bank, Jonna R.; de Peppel, Wilke R. van; Klok, Frederikus A.; Huisman, Menno V.] Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, Leiden, Netherlands; [van Rein, Nienke] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [del Sol, Antonio Iglesias] Rijnland Hosp, Dept Internal Med, Leiderdorp, Netherlands; [Cannegieter, Suzanne C.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Rabelink, Ton J.] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [Lip, Gregory Y. H.] Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Haemostasis Thrombosis & Vasc Biol Unit, Birmingham, W Midlands, England	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Rijnland Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Birmingham	Kooiman, J (corresponding author), Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, Leiden, Netherlands.	j.kooiman@lumc.nl	Klok, Erik/U-4870-2019; Rabelink, Ton J./A-5316-2008; Cannegieter, Suzanne/W-3696-2019; del Sol, Antonio/M-7431-2017	Klok, Erik/0000-0001-9961-0754; Rabelink, Ton J./0000-0001-6780-5186; Cannegieter, Suzanne/0000-0003-4707-2303; del Sol, Antonio/0000-0002-9926-617X				Abdelhafiz AH, 2009, CLIN THER, V31, P1534, DOI 10.1016/j.clinthera.2009.07.015; Amouyel P, 2009, EUR J INTERN MED, V20, P63, DOI 10.1016/j.ejim.2008.04.005; BACHMANN K, 1977, J CLIN PHARMACOL, V17, P292, DOI 10.1002/j.1552-4604.1977.tb04608.x; BACHMANN K, 1976, J CLIN PHARMACOL, V16, P468; Beyth RJ, 2000, ANN INTERN MED, V133, P687, DOI 10.7326/0003-4819-133-9-200011070-00010; Camm AJ, 2012, EUROPACE, V14, P1385, DOI [10.1093/europace/eus305, 10.1093/eurheartj/ehs253]; CANNEGIETER SC, 1995, NEW ENGL J MED, V333, P11, DOI 10.1056/NEJM199507063330103; Connolly SJ, 2013, EUR HEART J, V34, P1498, DOI 10.1093/eurheartj/eht039; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Dreisbach AW, 2003, SEMIN DIALYSIS, V16, P45, DOI 10.1046/j.1525-139X.2003.03011.x; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hart RG, 2013, CAN J CARDIOL, V29, pS71, DOI 10.1016/j.cjca.2013.04.005; Hart RG, 2011, CLIN J AM SOC NEPHRO, V6, P2599, DOI 10.2215/CJN.02400311; Herzog CA, 2011, KIDNEY INT, V80, P572, DOI 10.1038/ki.2011.223; Hylek EM, 2003, NEW ENGL J MED, V349, P1019, DOI 10.1056/NEJMoa022913; Ibrahim S, 2013, J THROMB HAEMOST, V11, P1540, DOI 10.1111/jth.12322; Klok FA, 2010, AM J RESP CRIT CARE, V181, P501, DOI 10.1164/rccm.200907-1141OC; Kooiman J, 2011, J THROMB HAEMOST, V9, P1652, DOI 10.1111/j.1538-7836.2011.04347.x; Koren-Morag N, 2006, NEUROLOGY, V67, P224, DOI 10.1212/01.wnl.0000229099.62706.a3; Lai HM, 2009, INT J NEPHROL RENOV, V2, P33; Leblond F, 2001, J AM SOC NEPHROL, V12, P326, DOI 10.1681/ASN.V122326; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; McManus DD, 2012, CIRCULATION, V126, pE143, DOI 10.1161/CIRCULATIONAHA.112.129759; Ng KP, 2013, AM J KIDNEY DIS, V62, P615, DOI 10.1053/j.ajkd.2013.02.381; Olesen JB, 2012, NEW ENGL J MED, V367, P625, DOI 10.1056/NEJMoa1105594; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Reynolds MW, 2004, CHEST, V126, P1938, DOI 10.1378/chest.126.6.1938; Roldan V, 2013, AM J CARDIOL, V111, P1159, DOI 10.1016/j.amjcard.2012.12.045; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Tsukamoto Y, 2012, J STROKE CEREBROVASC, V21, P547, DOI 10.1016/j.jstrokecerebrovasdis.2010.12.005; Van Leeuwen Y, 2008, J THROMB HAEMOST, V6, P451, DOI 10.1111/j.1538-7836.2007.02874.x; Van Pottelbergh G, 2010, AGE AGEING, V39, P542, DOI 10.1093/ageing/afq091; Wieloch M, 2013, THROMB RES, V131, P481, DOI 10.1016/j.thromres.2013.01.006; Winkelmayer WC, 2013, CIRCULATION, V127, P560, DOI 10.1161/CIRCULATIONAHA.112.000640	35	27	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e94420	10.1371/journal.pone.0094420	http://dx.doi.org/10.1371/journal.pone.0094420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24817475	Green Submitted, Green Published, gold			2022-12-27	WOS:000336838000008
J	Mercier, G; Naro, G				Mercier, Gregoire; Naro, Gerald			Costing Hospital Surgery Services: The Method Matters	PLOS ONE			English	Article								Background: Accurate hospital costs are required for policy-makers, hospital managers and clinicians to improve efficiency and transparency. However, different methods are used to allocate direct costs, and their agreement is poorly understood. The aim of this study was to assess the agreement between bottom-up and top-down unit costs of a large sample of surgical operations in a French tertiary centre. Methods: Two thousand one hundred and thirty consecutive procedures performed between January and October 2010 were analysed. Top-down costs were based on pre-determined weights, while bottom-up costs were calculated through an activity-based costing (ABC) model. The agreement was assessed using correlation coefficients and the Bland and Altman method. Variables associated with the difference between methods were identified with bivariate and multivariate linear regressions. Results: The correlation coefficient amounted to 0.73 (95% CI: 0.72; 0.76). The overall agreement between methods was poor. In a multivariate analysis, the cost difference was independently associated with age (Beta = -2.4; p = 0.02), ASA score (Beta = 76.3; p<0.001), RCI (Beta = 5.5; p<0.001), staffing level (Beta = 437.0; p<0.001) and intervention duration (Beta = -10.5; p<0.001). Conclusions: The ability of the current method to provide relevant information to managers, clinicians and payers is questionable. As in other European countries, a shift towards time-driven activity-based costing should be advocated.	[Mercier, Gregoire] CHU Montpellier, Montpellier, France; [Mercier, Gregoire; Naro, Gerald] Univ Montpellier I, Montpellier Res Management, Montpellier, France	Universite de Montpellier; CHU de Montpellier; Universite de Montpellier	Mercier, G (corresponding author), CHU Montpellier, Montpellier, France.	g-mercier@chu-montpellier.fr	Naro, Gérald/K-2085-2019; Mercier, Gregoire/B-8897-2016; NARO, GERALD/N-3053-2015	Naro, Gérald/0000-0002-9746-3890; NARO, GERALD/0000-0002-7518-2270	University Montpellier 1 [BQR UM1 1111B117]	University Montpellier 1	This work has been partly funded by a research grant from the University Montpellier 1 (BQR UM1 1111B117) (http://www.univ-montp1.fr/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Baker J J, 1997, J Health Care Finance, V24, P1; Baratti D, 2010, EJSO-EUR J SURG ONC, V36, P463, DOI 10.1016/j.ejso.2010.03.005; Bellanger Martine M, 2006, Health Care Manag Sci, V9, P295, DOI 10.1007/s10729-006-9097-x; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Busse R, 2011, DIAGNOSIS RELATED GR; Chapko MK, 2009, HEALTH ECON, V18, P1188, DOI 10.1002/hec.1422; Cinquini L, 2009, BUS PROCESS MANAG J, V15, P895, DOI 10.1108/14637150911003775; Clement FM, 2009, HEALTH ECON, V18, P377, DOI 10.1002/hec.1363; COOPER R, 1988, HARVARD BUS REV, V66, P96; Daabiss M, 2011, INDIAN J ANAESTH, V55, P111, DOI 10.4103/0019-5049.79879; Demeere N, 2009, HEALTH POLICY, V92, P296, DOI 10.1016/j.healthpol.2009.05.003; DGOS, 2011, GUID METH COMP AN HO; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Emmett Dennis, 2005, J Hosp Mark Public Relations, V15, P79; Fetter RB, 1980, MED CARE S, V18, P1; Finkler S. A., 2007, ESSENTIALS COST ACCO; Grandlich Cheryl, 2004, AORN J, V79, P189, DOI 10.1016/S0001-2092(06)61152-6; Kaplan RS, 2004, HARVARD BUS REV, V82, P131, DOI 10.2139/ssrn.485443; Korol E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083743; Larsen J, 2004, HEALTH POLICY, V67, P293, DOI 10.1016/j.healthpol.2003.07.004; LEHMAN M, 1993, ANN FR ANESTH, V12, P533, DOI 10.1016/S0750-7658(05)80618-5; Lipscomb J, 2009, MED CARE, V47, pS1, DOI 10.1097/MLR.0b013e3181a7e401; Negrini D, 2004, J Health Organ Manag, V18, P195, DOI 10.1108/14777260410548437; Or Z., 2011, DIAGNOSIS RELATED GR, P221; Patris A, 2003, INFO SANTE, P16; Porter ME, 2010, NEW ENGL J MED, V363, P2477, DOI 10.1056/NEJMp1011024; Raikou M, 2000, HEALTH ECON, V9, P191, DOI 10.1002/(SICI)1099-1050(200004)9:3<191::AID-HEC510>3.0.CO;2-1; Riewpaiboon A, 2007, TROP MED INT HEALTH, V12, P554, DOI 10.1111/j.1365-3156.2007.01815.x; Rittenhouse BE, 1999, HEALTH ECON, V8, P213, DOI 10.1002/(SICI)1099-1050(199905)8:3<213::AID-HEC429>3.0.CO;2-O; SHLEIFER A, 1985, RAND J ECON, V16, P319, DOI 10.2307/2555560; Tan SS, 2009, EUR J HEALTH ECON, V10, P39, DOI 10.1007/s10198-008-0101-x; Tan SS, 2011, DIAGNOSIS RELATED GR, P59; Vogl M, 2013, HEALTH POLICY, V109, P290, DOI 10.1016/j.healthpol.2012.09.008; Whiting JF, 1999, SURGERY, V125, P217, DOI 10.1016/S0039-6060(99)70268-0; Willan AR, 2001, HEALTH ECON, V10, P363, DOI 10.1002/hec.615; Wordsworth Sarah, 2005, Eur J Health Econ, V6, P38, DOI 10.1007/s10198-004-0259-9; Zheng B, 2012, CAN J SURG, V55, P371, DOI 10.1503/cjs.011311	37	39	39	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97290	10.1371/journal.pone.0097290	http://dx.doi.org/10.1371/journal.pone.0097290			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4LX	24817167	Green Submitted, Green Published, gold			2022-12-27	WOS:000336838000127
J	Ragab, D; Abdallah, DM; El-Abhar, HS				Ragab, Diaa; Abdallah, Dalaal M.; El-Abhar, Hanan S.			Cilostazol Renoprotective Effect: Modulation of PPAR-gamma, NGAL, KIM-1 and IL-18 Underlies Its Novel Effect in a Model of Ischemia-Reperfusion	PLOS ONE			English	Article							KIDNEY INJURY MOLECULE-1; DELAYED GRAFT FUNCTION; ACUTE-RENAL-FAILURE; III PHOSPHODIESTERASE INHIBITOR; VASCULAR ENDOTHELIAL-CELLS; FOCAL CEREBRAL-ISCHEMIA; SMOOTH-MUSCLE-CELLS; DIABETIC-RATS; KAPPA-B; ISCHEMIA/REPERFUSION INJURY	Cilostazol, a phosphodiesterase-III inhibitor, reportedly exhibits positive effects against ischemia/reperfusion (I/R)-induced injury in several models. However, its potential role against the renal I/R insult has not been elucidated. To test whether the PPAR-gamma (of peroxisome proliferator activated receptor gamma) pathway is involved in the cilostazol effect, rats were randomized into sham, I/R, cilostazol (50 and 100 mg/kg per day, orally), pioglitazone (3 and 10 mg/kg per day, orally) and their combination at the low dose levels. Drugs regimens were administered for 14 days prior to the I/R induction. Pretreatment with cilostazol or pioglitazone provided significant protection against the I/R-induced renal injury as manifested by the attenuated serum levels of creatinine, blood urea nitrogen and cystatin C. Both drugs have also opposed the I/R-induced elevation in tissue contents/activity of neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (Kim-1), nuclear factor-kappa B, interleukin-18, caspase-1, as well as malondialdehyde, iNOS, myeloperoxidase, ICAM-1 and VCAM-1. Nevertheless, the drugs increased both the PPAR-gamma transcriptional activity and the content of glutathione. Furthermore, combining the two low doses of both drugs produced effects comparable to that of the high dose level of either drug, advocating the fortification of pioglitazone renoprotective effect when given concomitantly with cilostazol. In conclusion, cilostazol purveyed conceivable novel renoprotective mechanisms and alleviated incidents associated with acute renal injury either alone or in combination with pioglitazone partially via the elevation of PPAR-gamma besides the amendment of the aforementioned biomarkers.	[Ragab, Diaa] October Six Univ, Dept Pharmacol & Toxicol, Giza, Egypt; [Abdallah, Dalaal M.; El-Abhar, Hanan S.] Cairo Univ, Dept Pharmacol & Toxicol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); October 6 University (O6U); Egyptian Knowledge Bank (EKB); Cairo University	El-Abhar, HS (corresponding author), Cairo Univ, Dept Pharmacol & Toxicol, Cairo, Egypt.	hanan.elabhar@pharma.cu.edu.eg	El-Abhar, Hanan/L-2289-2019; Abdallah, Dalaal/GVT-0783-2022	El-Abhar, Hanan/0000-0001-8819-9891; 				Abdelrahman M, 2005, CARDIOVASC RES, V65, P772, DOI 10.1016/j.cardiores.2004.12.008; AHMED AE, 1989, TOXICOL APPL PHARM, V100, P271, DOI 10.1016/0041-008X(89)90313-X; Akhtar AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012800; Ascon DB, 2006, J IMMUNOL, V177, P3380, DOI 10.4049/jimmunol.177.5.3380; Bailly V, 2002, J BIOL CHEM, V277, P39739, DOI 10.1074/jbc.M200562200; Bonventre JV, 2009, NEPHROL DIAL TRANSPL, V24, P3265, DOI 10.1093/ndt/gfp010; Bonventre JV, 2004, KIDNEY INT, V66, P480, DOI 10.1111/j.1523-1755.2004.761_2.x; Bonventre JV, 2003, J AM SOC NEPHROL, V14, P2199, DOI 10.1097/01.ASN.0000079785.13922.F6; BOWERS LD, 1980, CLIN CHEM, V26, P551; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Chatterjee PK, 2002, KIDNEY INT, V61, P862, DOI 10.1046/j.1523-1755.2002.00234.x; Chatterjee PK, 2000, KIDNEY INT, V58, P658, DOI 10.1046/j.1523-1755.2000.00212.x; Choi JM, 2002, J PHARMACOL EXP THER, V300, P787, DOI 10.1124/jpet.300.3.787; Devarajan P, 2008, SCAND J CLIN LAB INV, V68, P89, DOI 10.1080/00365510802150158; Devarajan P, 2006, J AM SOC NEPHROL, V17, P1503, DOI 10.1681/ASN.2006010017; Fantuzzi G, 1998, BLOOD, V91, P2118, DOI 10.1182/blood.V91.6.2118.2118_2118_2125; Faubel S, 2008, ADV CHRONIC KIDNEY D, V15, P211, DOI 10.1053/j.ackd.2008.04.001; Gao L, 2006, J PHARMACOL EXP THER, V318, P53, DOI 10.1124/jpet.106.101444; Gerdes N, 2002, J EXP MED, V195, P245, DOI 10.1084/jem.20011022; GROSS SS, 1995, ANNU REV PHYSIOL, V57, P737, DOI 10.1146/annurev.ph.57.030195.003513; Hall IE, 2010, J AM SOC NEPHROL, V21, P189, DOI 10.1681/ASN.2009030264; Hammerman MR, 2000, KIDNEY INT, V57, P742, DOI 10.1046/j.1523-1755.2000.00896.x; Han WK, 2002, KIDNEY INT, V62, P237, DOI 10.1046/j.1523-1755.2002.00433.x; Hatipoglu NK, 2013, J ENDOUROL; Hattori Y, 2009, CARDIOVASC RES, V81, P133, DOI 10.1093/cvr/cvn226; He F, 2008, OBESITY, V16, P1735, DOI 10.1038/oby.2008.269; Heinzelmann M, 1999, AM J KIDNEY DIS, V34, P384, DOI 10.1016/S0272-6386(99)70375-6; Herget-Rosenthal S, 2004, KIDNEY INT, V66, P1115, DOI 10.1111/j.1523-1755.2004.00861.x; Honda F, 2006, STROKE, V37, P223, DOI 10.1161/01.STR.0000196977.76702.6d; Hu HL, 2012, J SURG RES, V178, P460, DOI 10.1016/j.jss.2012.01.012; Ichimura T, 2008, J CLIN INVEST, V118, P1657, DOI 10.1172/JCI34487; Ichimura T, 2012, KIDNEY INT, V81, P809, DOI 10.1038/ki.2012.11; Iwama D, 2007, J THROMB HAEMOST, V5, P818, DOI 10.1111/j.1538-7836.2007.02425.x; Ji YY, 2011, CYTOKINE, V55, P409, DOI 10.1016/j.cyto.2011.05.020; Kelly KJ, 1996, J CLIN INVEST, V97, P1056, DOI 10.1172/JCI118498; Ko GJ, 2010, IMMUNOL RES, V47, P78, DOI 10.1007/s12026-009-8140-7; Lameire Norbert H, 2004, Best Pract Res Clin Anaesthesiol, V18, P21, DOI 10.1016/j.bpa.2003.09.008; Lee WC, 2010, BIOSCI BIOTECH BIOCH, V74, P1355, DOI 10.1271/bbb.90938; Legrand M, 2008, MOL MED, V14, P502, DOI 10.2119/2008-00006.Legrand; Leslie JA, 2008, J SURG RES, V145, P170, DOI 10.1016/j.jss.2007.03.037; Liu YG, 2001, CARDIOVASC DRUG REV, V19, P369, DOI 10.1111/j.1527-3466.2001.tb00076.x; Macdonald J, 2006, AM J KIDNEY DIS, V48, P712, DOI 10.1053/j.ajkd.2006.07.001; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Melnikov VY, 2002, J CLIN INVEST, V110, P1083, DOI 10.1172/JCI200215623; Miglio G, 2011, BRIT J PHARMACOL, V162, P111, DOI 10.1111/j.1476-5381.2010.01032.x; MOLITORIS BA, 1985, J CLIN INVEST, V76, P2097, DOI 10.1172/JCI112214; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; Ojo AO, 1997, TRANSPLANTATION, V63, P968, DOI 10.1097/00007890-199704150-00011; Omi H, 2004, MICROVASC RES, V68, P119, DOI 10.1016/j.mvr.2004.05.002; Onem G, 2012, TURK GOGUS KALP DAMA, V20, P577, DOI 10.5606/tgkdc.dergisi.2012.110; Paragas N, 2012, BBA-MOL CELL RES, V1823, P1451, DOI 10.1016/j.bbamcr.2012.06.014; Parikh CR, 2006, AM J TRANSPLANT, V6, P1639, DOI 10.1111/j.1600-6143.2006.01352.x; Park SY, 2009, J PHARMACOL EXP THER, V329, P571, DOI 10.1124/jpet.108.146456; Park SY, 2008, ATHEROSCLEROSIS, V201, P258, DOI 10.1016/j.atherosclerosis.2008.02.006; Pereira MG, 2006, INT IMMUNOPHARMACOL, V6, P1943, DOI 10.1016/j.intimp.2006.07.024; Perico N, 2004, LANCET, V364, P1814, DOI 10.1016/S0140-6736(04)17406-0; Sahin MA, 2011, HEART SURG FORUM, V14, pE171, DOI 10.1532/HSF98.20101126; Shah N, 2010, RECENT RES SCI TECHN, V2; SPRINGER TA, 1995, ANNU REV PHYSIOL, V57, P827, DOI 10.1146/annurev.ph.57.030195.004143; TABACCO A, 1979, CLIN CHEM, V25, P336; Tani T, 2000, ATHEROSCLEROSIS, V152, P299, DOI 10.1016/S0021-9150(99)00480-3; Tawfik MK, 2012, EUR REV MED PHARMACO, V16, P600; Tsirella E, 2012, J PHYSIOL PHARMACOL, V63, P201; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Wu HL, 2008, J AM SOC NEPHROL, V19, P2331, DOI 10.1681/ASN.2008020170; Yoshimura R, 2004, TRANSPL P, V36, P1946, DOI 10.1016/j.transproceed.2004.08.039; Zou C, 2013, J SURG RES, V184, P1092, DOI 10.1016/j.jss.2013.03.027	67	43	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e95313	10.1371/journal.pone.0095313	http://dx.doi.org/10.1371/journal.pone.0095313			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816434	Green Submitted, Green Published, gold			2022-12-27	WOS:000336838000013
J	Colombini, A; Brayda-Bruno, M; Lombardi, G; Croiset, SJ; Vrech, V; Maione, V; Banfi, G; Cauci, S				Colombini, Alessandra; Brayda-Bruno, Marco; Lombardi, Giovanni; Croiset, Samantha Jennifer; Vrech, Valentina; Maione, Vincenzo; Banfi, Giuseppe; Cauci, Sabina			FokI Polymorphism in the Vitamin D Receptor Gene (VDR) and Its Association with Lumbar Spine Pathologies in the Italian Population: A Case-Control Study	PLOS ONE			English	Article							DEGENERATIVE DISC DISEASE; LOW-BACK-PAIN; FAMILIAL PREDISPOSITION; RISK-FACTORS; EPIDEMIOLOGY; PREDICTORS; OCCUPATION; HERNIATION	Alterations in vitamin D homeostasis, mainly involving its nuclear receptor (VDR), could have a role in the pathophysiology of the spine. The association between VDR polymorphisms and spine disorders has been analyzed in different ethnic groups, focusing on the functional FokI polymorphism. However, so far, inconsistent findings were reported. The aims of this study were to evaluate, in the Italian white population, the VDR FokI polymorphism frequencies distribution in subjects with clearly defined lumbar spinal pathologies compared to asymptomatic controls and to analyze the interplay of genetic and conventional risk factors. Using a case-control design, 267 patients with spinal disorders and 220 asymptomatic controls were enrolled, evaluating their exposition to putative risk factors. Patients' clinical assessment was performed by Magnetic Resonance Imaging. FokI polymorphism (rs2228570) was detected by PCR-RFLP. Genotypes were designated by a lowercase letter (f allele, T nucleotide) for the presence of the restriction site and by a capital letter (F allele, C nucleotide) for its absence. Family history, higher age and BMI, exposure to vibration, physical job demand, smoking habit and lower practice of leisure physical activity were associated with spinal disorders. The FF genotype and F allele represented approximately 2-fold risk factors to develop discopathies and/or osteochondrosis concomitant with disc herniation, while f allele was protective. In conclusion, the link we observed between VDR FokI variants and specific lumbar spine pathologies suggests that spinal tissue degeneration is influenced by the genetic background. Future studies should evaluate the signaling pathways involving alterations in VDR and influencing the development and/or progression of spine disorders.	[Colombini, Alessandra; Lombardi, Giovanni; Croiset, Samantha Jennifer; Banfi, Giuseppe] IRCCS Ist Ortoped Galeazzi, Lab Expt Biochem & Mol Biol, Milan, Italy; [Brayda-Bruno, Marco] IRCCS Ist Ortoped Galeazzi, Dept Orthoped & Traumatol Vertebral Surg Scoliosi, Milan, Italy; [Vrech, Valentina; Maione, Vincenzo; Cauci, Sabina] Univ Udine, Dept Med & Biol Sci, I-33100 Udine, Italy; [Banfi, Giuseppe] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy	IRCCS Istituto Ortopedico Galeazzi; IRCCS Istituto Ortopedico Galeazzi; University of Udine; University of Milan	Colombini, A (corresponding author), IRCCS Ist Ortoped Galeazzi, Lab Expt Biochem & Mol Biol, Milan, Italy.	alessandra.colombini@grupposandonato.it	Colombini, Alessandra/I-2441-2012; Maione, Vincenzo/E-2627-2015; Brayda-Bruno, Marco/B-8639-2017; Lombardi, Giovanni/I-2414-2012; Banfi, Giuseppe/K-6585-2015	Colombini, Alessandra/0000-0002-1800-3424; Maione, Vincenzo/0000-0002-0420-5009; Brayda-Bruno, Marco/0000-0002-8608-0114; Lombardi, Giovanni/0000-0002-8365-985X; Cauci, Sabina/0000-0001-7443-1899; Banfi, Giuseppe/0000-0001-9578-5338	European Community [567, 568, HEALTH-F2-2008-201626]	European Community(European Commission)	This work was supported by European Community's Seventh 567 Framework Programme (FP7, 2007-2013 under Grant Agreement 568 No. HEALTH-F2-2008-201626). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1994; Ala-Kokko L, 2002, ANN MED, V34, P42, DOI 10.1080/078538902317338634; Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; Arai H, 1997, J BONE MINER RES, V12, P915, DOI 10.1359/jbmr.1997.12.6.915; ARNOLDI CC, 1976, CLIN ORTHOP RELAT R, P4; Battie MC, 1995, SPINE, V20, P2601, DOI 10.1097/00007632-199512150-00001; Boos N, 2008, SPINAL DISORDERS FUN, P161; Borenstein DG, 2001, CURR OPIN RHEUMATOL, V13, P128, DOI 10.1097/00002281-200103000-00006; Carlberg C, 2012, CURR TOP MED CHEM, V12, P528, DOI 10.2174/156802612799436623; Colombini A, 2013, J STEROID BIOCHEM, V138, P24, DOI 10.1016/j.jsbmb.2013.03.001; Colombini A, 2012, INT J BIOCHEM CELL B, V44, P1019, DOI 10.1016/j.biocel.2012.03.012; Eser B, 2010, GENET TEST MOL BIOMA, V14, P313, DOI 10.1089/gtmb.2009.0202; Frymoyer J W, 1992, Instr Course Lect, V41, P217; Gruber HE, 2008, SPINE, V33, P755, DOI 10.1097/BRS.0b013e3181695d59; GUNZBURG R, 1990, J BONE JOINT SURG BR, V72, P914, DOI 10.1302/0301-620X.72B5.2211783; HapMap, 2013, RS10735810 SNP HAPMA; Haussler MR, 1997, J ENDOCRINOL, V154, pS57; HELIOVAARA M, 1989, ANN MED, V21, P254, DOI 10.3109/07853898909149202; Herzog RJ, 1996, SPINE, V21, pS19, DOI 10.1097/00007632-199612151-00004; Jurutka P W, 2001, Rev Endocr Metab Disord, V2, P203, DOI 10.1023/A:1010062929140; Jurutka PW, 2000, MOL ENDOCRINOL, V14, P401, DOI 10.1210/me.14.3.401; Karppinen J, 2008, SPINE, V33, P1236, DOI 10.1097/BRS.0b013e318170fd0e; Leclerc A, 2003, OCCUP MED-OXFORD, V53, P384, DOI 10.1093/occmed/kqg072; Leone A, 2008, IMAGING RACHIDE VECC, P27; Luoma K, 2000, SPINE, V25, P487, DOI 10.1097/00007632-200002150-00016; MAGORA A, 1973, SCAND J REHABIL MED, V5, P186; MATSUI H, 1992, SPINE, V17, P1323, DOI 10.1097/00007632-199211000-00011; Matsui H, 1998, SPINE, V23, P1029, DOI 10.1097/00007632-199805010-00013; Miranda H, 2002, SPINE, V27, P1102, DOI 10.1097/00007632-200205150-00017; Neyestani TR, 2013, DIABETES CARE, V36, P550, DOI 10.2337/dc12-0919; Noponen-Hietala N, 2003, ANN RHEUM DIS, V62, P1208, DOI 10.1136/ard.2003.008334; Nunes Francine Teresa Brioni, 2007, Acta ortop. bras., V15, P9; Omair Ahmad, 2012, Open Orthop J, V6, P164, DOI 10.2174/1874325001206010164; Pani MA, 2000, DIABETES, V49, P504, DOI 10.2337/diabetes.49.3.504; Richardson JK, 1997, SPINE, V22, P1487, DOI 10.1097/00007632-199707010-00012; RIIHIMAKI H, 1994, SPINE, V19, P138, DOI 10.1097/00007632-199401001-00003; Rubin DI, 2007, NEUROL CLIN, V25, P353, DOI 10.1016/j.ncl.2007.01.004; Sakai Y, 2007, SPINE, V32, P1279, DOI 10.1097/BRS.0b013e318059af8a; Sambrook PN, 1999, ARTHRITIS RHEUM-US, V42, P366, DOI 10.1002/1529-0131(199902)42:2<366::AID-ANR20>3.0.CO;2-6; Simmons ED, 1996, SPINE, V21, P1527, DOI 10.1097/00007632-199607010-00007; Tubach F, 2004, J CLIN EPIDEMIOL, V57, P174, DOI 10.1016/S0895-4356(03)00257-9; Uitterlinden AG, 2004, GENE, V338, P143, DOI 10.1016/j.gene.2004.05.014; VARLOTTA GP, 1991, J BONE JOINT SURG AM, V73A, P124, DOI 10.2106/00004623-199173010-00016; Videman T, 1999, SPINE, V24, P1164, DOI 10.1097/00007632-199906010-00020; Videman T, 1998, SPINE, V23, P2477, DOI 10.1097/00007632-199812010-00002; Virtanen IM, 2007, SPINE, V32, P1129, DOI 10.1097/01.brs.0000261473.03274.5c; Watters WC, 2009, SPINE J, V9, P609, DOI 10.1016/j.spinee.2009.03.016; Xu G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050243; Yoo K, 1998, J NEUROSURG, V89, P139, DOI 10.3171/jns.1998.89.1.0139; ZAMANI MH, 1982, J PEDIATR ORTHOPED, V2, P528, DOI 10.1097/01241398-198212000-00012	50	45	48	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e97027	10.1371/journal.pone.0097027	http://dx.doi.org/10.1371/journal.pone.0097027			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810167	Green Submitted, Green Published, gold			2022-12-27	WOS:000338213300109
J	Husakova, I; Munzbergova, Z				Husakova, Iveta; Muenzbergova, Zuzana			Relative Importance of Current and Past Landscape Structure and Local Habitat Conditions for Plant Species Richness in Dry Grassland-Like Forest Openings	PLOS ONE			English	Article							RURAL HEMIBOREAL LANDSCAPE; LAND-USE HISTORY; EXTINCTION DEBT; AREA RELATIONSHIPS; INDICATOR VALUES; DIVERSITY; ENVIRONMENT; FRAGMENTATION; VEGETATION; TRAITS	In fragmented landscapes, plant species richness may depend not only on local habitat conditions but also on landscape structure. In addition, both present and past landscape structure may be important for species richness. There are, however, only a few studies that have investigated the relative importance of all of these factors. The aim of this study was to examine the effect of current and past landscape structures and habitat conditions on species richness at dry grassland-like forest openings in a forested landscape and to assess their relative importance for species richness. We analyzed information on past and present landscape structures using aerial photographs from 1938, 1973, 1988, 2000 and 2007. We calculated the area of each locality and its isolation in the present and in the past and the continuity of localities in GIS. At each locality, we recorded all vascular plant species (296 species in 110 forest openings) and information on abiotic conditions of the localities. We found that the current species richness of the forest openings was significantly determined by local habitat conditions as well as by landscape structure in the present and in the past. The highest species richness was observed on larger and more heterogeneous localities with rocks and shallow soils, which were already large and well connected to other localities in 1938. The changes in the landscape structure in the past can thus have strong effects on current species richness. Future studies attempting to understand determinants of species diversity in fragmented landscapes should also include data on past landscape structure, as it may in fact be more important than the present structure.	[Husakova, Iveta; Muenzbergova, Zuzana] Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic; [Muenzbergova, Zuzana] Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic	Charles University Prague; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences	Husakova, I (corresponding author), Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic.	iveta.husakova@volny.cz; zuzmun@natur.cuni.cz	Münzbergová, Zuzana/F-6321-2013; Husáková, Iveta/W-1324-2017	Münzbergová, Zuzana/0000-0002-4026-6220; Husáková, Iveta/0000-0002-4778-1874	Grant Agency of the Czech Republic [P504/10/0456]; RVO [67985939]; MSMT	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); RVO; MSMT(Ministry of Education, Youth & Sports - Czech Republic)	This study was supported by Grant Agency of the Czech Republic P504/10/0456 (www.gacr.cz) and also partially by institutional research support by RVO 67985939 and MSMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaens D, 2006, BIOL CONSERV, V133, P212, DOI 10.1016/j.biocon.2006.06.006; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Brose U, 2001, ECOGRAPHY, V24, P722, DOI 10.1034/j.1600-0587.2001.240610.x; Bruun HH, 2001, ECOGRAPHY, V24, P569, DOI 10.1034/j.1600-0587.2001.d01-212.x; Bruun HH, 2000, ECOGRAPHY, V23, P641, DOI 10.1034/j.1600-0587.2000.230601.x; Chylova T, 2008, PRESLIA, V80, P183; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; Cousins SAO, 2002, LANDSCAPE ECOL, V17, P517, DOI 10.1023/A:1021400513256; Cousins SAO, 2001, ECOGRAPHY, V24, P461, DOI 10.1034/j.1600-0587.2001.d01-202.x; Cousins SAO, 2007, LANDSCAPE ECOL, V22, P723, DOI 10.1007/s10980-006-9067-1; Crawley M. J, 2002, STAT COMPUTING INTRO; Definiens A., 2006, ECOGNITION PROFESSIO; DIEKMANN M, 1995, ECOGRAPHY, V18, P178, DOI 10.1111/j.1600-0587.1995.tb00339.x; Diekmann M, 2003, BASIC APPL ECOL, V4, P493, DOI 10.1078/1439-1791-00185; Diekmann M, 1996, FOREST ECOL MANAG, V86, P1, DOI 10.1016/S0378-1127(96)03795-4; Dornbush ME, 2010, J ECOL, V98, P117, DOI 10.1111/j.1365-2745.2009.01605.x; Dupre C, 2002, J ECOL, V90, P796, DOI 10.1046/j.1365-2745.2002.00717.x; Ehrlen J, 2000, ECOLOGY, V81, P1667, DOI 10.1890/0012-9658(2000)081[1667:DLAPOI]2.0.CO;2; Ellenberg H., 1992, SCRIPTA GEOBOT, V18, P1, DOI DOI 10.1002/FEDR.19931040323; Eriksson O, 1996, OIKOS, V77, P248, DOI 10.2307/3546063; Eriksson O, 2002, J VEG SCI, V13, P743, DOI 10.1111/j.1654-1103.2002.tb02102.x; ESRI, 2006, ARCGIS 9 2; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Graae BJ, 2000, ECOGRAPHY, V23, P720, DOI 10.1034/j.1600-0587.2000.t01-1-230509.x; Helm A, 2006, ECOL LETT, V9, P72, DOI 10.1111/j.1461-0248.2005.00841.x; Herault B, 2005, J BIOGEOGR, V32, P2069, DOI 10.1111/j.1365-2699.2005.01351.x; Herben T, 2006, J ECOL, V94, P131, DOI 10.1111/j.1365-2745.2005.01063.x; Herben T, 1987, DYNAMIKA INVAZE ORTH; Honnay O., 2004, FOREST BIODIVERSITY; Honnay O, 2008, OIKOS, V117, P1, DOI 10.1111/j.2007.0030-1299.16188.x; Huerta-Martinez FM, 2004, INTERCIENCIA, V29, P435; Jackson ST, 2010, TRENDS ECOL EVOL, V25, P153, DOI 10.1016/j.tree.2009.10.001; Jacquemyn H, 2001, J BIOGEOGR, V28, P801, DOI 10.1046/j.1365-2699.2001.00590.x; Janisova M, AGR ECOSYST ENV, DOI 101016/jagee201305022; Knappova J, 2012, LANDSCAPE ECOL, V27, P97, DOI 10.1007/s10980-011-9680-5; KOHN DD, 1994, J ECOL, V82, P367, DOI 10.2307/2261304; Kolb A, 2005, CONSERV BIOL, V19, P929, DOI 10.1111/j.1523-1739.2005.00065.x; Kolb A, 2004, J VEG SCI, V15, P199, DOI 10.1111/j.1654-1103.2004.tb02255.x; Kolbek J, 2003, ACADEMIA; Kolbek J, 1996, PRIRODA PRAHA, V5, P85; Kolbek J, 2001, ACADEMIA; Kopecky M, 2010, APPL VEG SCI, V13, P450, DOI 10.1111/j.1654-109X.2010.01083.x; Krauss J, 2004, BIODIVERS CONSERV, V13, P1427, DOI 10.1023/B:BIOC.0000021323.18165.58; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; Kubat K, 2002, KLIC KE KVETENE CR; Kucera T, 1997, THESIS CHARLES U PRA; Kuussaari M, 2009, TRENDS ECOL EVOL, V24, P564, DOI 10.1016/j.tree.2009.04.011; Legendre P., 1998, DEV ENV MODELLING; Lindborg R, 2004, ECOLOGY, V85, P1840, DOI 10.1890/04-0367; Lobel S, 2006, FOLIA GEOBOT, V41, P377, DOI 10.1007/BF02806555; LOZEK V., 2005, OCHRANA PRIRODY, V60, P195; MAC ARTHUR ROBERT H., 1967; McCune B, 2002, J VEG SCI, V13, P603, DOI 10.1111/j.1654-1103.2002.tb02087.x; McEuen AB, 2006, PLANT ECOL, V184, P297, DOI 10.1007/s11258-005-9074-3; McMaster RT, 2005, J BIOGEOGR, V32, P475, DOI 10.1111/j.1365-2699.2004.01200.x; Merunkova K, 2012, PRESLIA, V84, P311; Munzbergova Z, 2013, PLANT BIOLOGY, V15, P195, DOI 10.1111/j.1438-8677.2012.00601.x; Munzbergova Z, 2006, FOLIA GEOBOT, V41, P137, DOI 10.1007/BF02806475; Oberndorfer EC, 2009, BIODIVERS CONSERV, V18, P1523, DOI 10.1007/s10531-008-9539-5; OKLAND RH, 1994, J VEG SCI, V5, P117, DOI 10.2307/3235645; Oster M, 2007, J VEG SCI, V18, P859, DOI 10.1111/j.1654-1103.2007.tb02602.x; Outlaw DC, 2008, J BIOGEOGR, V35, P739, DOI 10.1111/j.1365-2699.2007.01821.x; Ozinga WA, 2005, OIKOS, V108, P555, DOI 10.1111/j.0030-1299.2005.13632.x; PCI Geomatics Enterprises Inc, 2006, PCI GEN VERS 100; Peintinger M, 2003, BASIC APPL ECOL, V4, P385, DOI 10.1078/1439-1791-00181; Petrik P, 2011, TUEXENIA, P283; Piessens K, 2004, J BIOGEOGR, V31, P1683, DOI 10.1111/j.1365-2699.2004.01056.x; PYSEK P, 1995, J VEG SCI, V6, P711, DOI 10.2307/3236442; Ricklefs RE, 1999, J ANIM ECOL, V68, P1142, DOI 10.1046/j.1365-2656.1999.00358.x; Soons M.B., 2003, HABITAT FRAGMENTATIO; Soons MB, 2002, J ECOL, V90, P1033, DOI 10.1046/j.1365-2745.2002.00729.x; *STATSOFT INC, 2004, STATISTICA DAT AN SO; Stuessy TF, 2003, BASIC APPL ECOL, V4, P287, DOI 10.1078/1439-1791-00160; Tremlova K, 2007, ECOLOGY, V88, P965, DOI 10.1890/06-0924; Turtureanu PD, 2012, PLANT ECOL, V213, P67, DOI 10.1007/s11258-011-0007-z; Valtr V, 2011, THESIS CHARLES U PRA; Vellend M, 2006, ECOLOGY, V87, P542, DOI 10.1890/05-1182; Zulka KP, AGR ECOSYST ENV, DOI 101016/jagee201311016	78	10	10	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e97110	10.1371/journal.pone.0097110	http://dx.doi.org/10.1371/journal.pone.0097110			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809474	gold, Green Published, Green Submitted			2022-12-27	WOS:000338213300123
J	Peng, JC; Chen, TC; Raja, JAJ; Yang, CF; Chien, WC; Lin, CH; Liu, FL; Wu, HW; Yeh, SD				Peng, Jui-Chu; Chen, Tsung-Chi; Raja, Joseph A. J.; Yang, Ching-Fu; Chien, Wan-Chu; Lin, Chen-Hsuan; Liu, Fang-Lin; Wu, Hui-Wen; Yeh, Shyi-Dong			Broad-Spectrum Transgenic Resistance against Distinct Tospovirus Species at the Genus Level	PLOS ONE			English	Article							TOMATO-SPOTTED-WILT; CUCUMBER-MOSAIC-VIRUS; SILVER-MOTTLE VIRUS; REPLICASE-MEDIATED RESISTANCE; PAPAYA RINGSPOT VIRUS; COMPLETE NUCLEOTIDE-SEQUENCE; MOLECULAR CHARACTERIZATION; LYCOPERSICON-ESCULENTUM; SILENCING SUPPRESSOR; ARTIFICIAL MICRORNAS	Thrips-borne tospoviruses cause severe damage to crops worldwide. In this investigation, tobacco lines transgenic for individual WLm constructs containing the conserved motifs of the L RNA-encoded RNA-dependent RNA polymerase (L) gene of Watermelon silver mottle virus (WSMoV) were generated by Agrobacterium-mediated transformation. The WLm constructs included: (i) translatable WLm in a sense orientation; (ii) untranslatable WLmt with two stop codons; (iii) untranslatable WLmts with stop codons and a frame-shift; (iv) untranslatable antisense WLmA; and (v) WLmhp with an untranslatable inverted repeat of WLm containing the tospoviral S RNA 39-terminal consensus sequence (5'-ATTGCTCT-3') and an NcoI site as a linker to generate a double-stranded hairpin transcript. A total of 46.7-70.0% transgenic tobacco lines derived from individual constructs showed resistance to the homologous WSMoV; 35.7-100% plants of these different WSMoV-resistant lines exhibited broad-spectrum resistance against four other serologically unrelated tospoviruses Tomato spotted wilt virus, Groundnut yellow spot virus, Impatiens necrotic spot virus and Groundnut chlorotic fan-spot virus. The selected transgenic tobacco lines also exhibited broad-spectrum resistance against five additional tospoviruses from WSMoV and Iris yellow spot virus clades, but not against RNA viruses from other genera. Northern analyses indicated that the broad-spectrum resistance is mediated by RNA silencing. To validate the L conserved region resistance in vegetable crops, the constructs were also used to generate transgenic tomato lines, which also showed effective resistance against WSMoV and other tospoviruses. Thus, our approach of using the conserved motifs of tospoviral L gene as a transgene generates broad-spectrum resistance against tospoviruses at the genus level.	[Peng, Jui-Chu; Chen, Tsung-Chi; Yang, Ching-Fu; Lin, Chen-Hsuan; Liu, Fang-Lin; Wu, Hui-Wen; Yeh, Shyi-Dong] Natl Chung Hsing Univ, Dept Plant Pathol, Taichung 40227, Taiwan; [Peng, Jui-Chu] COA, Tainan Dist Agr Res & Extens Stn, Div Crop Environm, Tainan, Taiwan; [Chen, Tsung-Chi] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Raja, Joseph A. J.; Yang, Ching-Fu; Yeh, Shyi-Dong] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan; [Raja, Joseph A. J.; Chien, Wan-Chu] Natl Chung Hsing Univ, NCHU UCD Plant & Food Biotechnol Ctr, Taichung 40227, Taiwan	National Chung Hsing University; Asia University Taiwan; National Chung Hsing University; National Chung Hsing University	Yeh, SD (corresponding author), Natl Chung Hsing Univ, Dept Plant Pathol, Taichung 40227, Taiwan.	sdyeh@nchu.edu.tw			National Science Council [NSC92-2317-B-005-024, NSC-101-2911-I-005-301, NSC-102-2911-I-005-301]; Ministry of Education, Taiwan, R.O.C. under the ATU plan	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan, R.O.C. under the ATU plan(Ministry of Education, Taiwan)	The authors thank the funding supports of the National Science Council (NSC92-2317-B-005-024, NSC-101-2911-I-005-301 and NSC-102-2911-I-005-301), and the Ministry of Education, Taiwan, R.O.C. under the ATU plan for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL PP, 1986, SCIENCE, V232, P738, DOI 10.1126/science.3457472; Bag S, 2010, ARCH VIROL, V155, P275, DOI 10.1007/s00705-009-0568-5; Bucher E, 2006, J GEN VIROL, V87, P3697, DOI 10.1099/vir.0.82276-0; Canto T, 1999, MOL PLANT MICROBE IN, V12, P743, DOI 10.1094/MPMI.1999.12.8.743; CARR JP, 1994, VIROLOGY, V199, P439, DOI 10.1006/viro.1994.1142; CARR JP, 1992, MOL PLANT MICROBE IN, V5, P397, DOI 10.1094/MPMI-5-397; Chen CC, 2005, PLANT DIS, V89, P440, DOI 10.1094/PD-89-0440; Chen CC, 2003, PLANT DIS, V87, P901, DOI 10.1094/PDIS.2003.87.8.901; CHEN H, 1994, BIOTECHNIQUES, V16, P664; Chen TC, 2008, PLANT PATHOL, V57, P765, DOI 10.1111/j.1365-3059.2007.01791.x; Chen TC, 2012, PLANT PATHOL, V61, P183, DOI 10.1111/j.1365-3059.2011.02484.x; Chen TC, 2013, VIRUS GENES, V46, P487, DOI 10.1007/s11262-013-0880-8; Chen TC, 2010, ARCH VIROL, V155, P1085, DOI 10.1007/s00705-010-0688-y; Cheng YH, 2000, BOT BULL ACAD SINICA, V41, P1; Chiemsombat P, 2008, ARCH VIROL, V153, P571, DOI 10.1007/s00705-007-0024-3; Chu FH, 2001, PHYTOPATHOLOGY, V91, P361, DOI 10.1094/PHYTO.2001.91.4.361; Chu FH, 2001, PHYTOPATHOLOGY, V91, P856, DOI 10.1094/PHYTO.2001.91.9.856; Chu FH, 1998, PHYTOPATHOLOGY, V88, P351, DOI 10.1094/PHYTO.1998.88.4.351; Cortes I, 1998, PHYTOPATHOLOGY, V88, P1276, DOI 10.1094/PHYTO.1998.88.12.1276; de Oliveira AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038634; DEAVILA AC, 1993, J GEN VIROL, V74, P153, DOI 10.1099/0022-1317-74-2-153; DEHAAN P, 1990, J GEN VIROL, V71, P1001, DOI 10.1099/0022-1317-71-5-1001; DEHAAN P, 1991, J GEN VIROL, V72, P2207, DOI 10.1099/0022-1317-72-9-2207; Dong JH, 2008, ARCH VIROL, V153, P855, DOI 10.1007/s00705-008-0054-5; Hassani-Mehraban A, 2005, PHYTOPATHOLOGY, V95, P852, DOI 10.1094/PHYTO-95-0852; Hassani-Mehraban A, 2007, ARCH VIROL, V152, P85, DOI 10.1007/s00705-006-0827-7; Hassani-Mehraban A, 2009, MOL PLANT MICROBE IN, V22, P1250, DOI 10.1094/MPMI-22-10-1250; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Hsu Hei-Ti, 2000, Journal of General Plant Pathology, V66, P167, DOI 10.1007/PL00012940; IWAKI M, 1984, PLANT DIS, V68, P1006, DOI 10.1094/PD-69-1006; Jahn M, 2000, MOL PLANT MICROBE IN, V13, P673, DOI 10.1094/MPMI.2000.13.6.673; Jan FJ, 2003, ENCY VIROLOGY, P399; Khatabi B, 2012, EUR J PLANT PATHOL, V133, P783, DOI 10.1007/s10658-012-9969-5; King AM, 2012, 9 REPORT INT COMMITT, P770; Knierim D, 2006, ARCH VIROL, V151, P1761, DOI 10.1007/s00705-006-0749-4; KORMELINK R, 1992, J GEN VIROL, V73, P2795, DOI 10.1099/0022-1317-73-11-2795; Kung YJ, 2012, MOL PLANT PATHOL, V13, P303, DOI 10.1111/j.1364-3703.2011.00747.x; Kunkalikar SR, 2011, PHYTOPATHOLOGY, V101, P367, DOI 10.1094/PHYTO-02-10-0046; LAW MD, 1990, J GEN VIROL, V71, P933, DOI 10.1099/0022-1317-71-4-933; LEBAS BSM, 2007, CHARACTERIZATION DIA, V4, P221; Li JT, 2011, ARCH VIROL, V156, P359, DOI 10.1007/s00705-010-0881-z; Lin Shih-Shun, 1998, Plant Protection Bulletin (Taichung), V40, P163; Lin YH, 2005, PHYTOPATHOLOGY, V95, P1482, DOI 10.1094/PHYTO-95-1482; Lindbo JA, 2005, ANNU REV PHYTOPATHOL, V43, P191, DOI 10.1146/annurev.phyto.43.040204.140228; Lopez C, 2011, J GEN VIROL, V92, P210, DOI 10.1099/vir.0.026708-0; MACFARLANE SA, 1992, P NATL ACAD SCI USA, V89, P5829, DOI 10.1073/pnas.89.13.5829; Margaria P, 2007, MOL PLANT MICROBE IN, V20, P547, DOI 10.1094/MPMI-20-5-0547; MCCORMICK S, 1986, PLANT CELL REP, V5, P81, DOI 10.1007/BF00269239; MUELLER E, 1995, PLANT J, V7, P1001, DOI 10.1046/j.1365-313X.1995.07061001.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nguyen L, 1996, P NATL ACAD SCI USA, V93, P12643, DOI 10.1073/pnas.93.22.12643; Niu QW, 2006, NAT BIOTECHNOL, V24, P1420, DOI 10.1038/nbt1255; Pang SZ, 1996, PLANT J, V9, P899, DOI 10.1046/j.1365-313X.1996.9060899.x; PANG SZ, 1994, PHYTOPATHOLOGY, V84, P243, DOI 10.1094/Phyto-84-243; PANG SZ, 1993, BIO-TECHNOL, V11, P819, DOI 10.1038/nbt0793-819; PANG SZ, 1993, PHYTOPATHOLOGY, V83, P728, DOI 10.1094/Phyto-83-728; PANG SZ, 1992, PHYTOPATHOLOGY, V82, P1223, DOI 10.1094/Phyto-82-1223; Parrella G, 2003, J PLANT PATHOL, V85, P227; PRINS M, 1995, MOL PLANT MICROBE IN, V8, P85, DOI 10.1094/MPMI-8-0085; Prins M, 1998, TRENDS MICROBIOL, V6, P31, DOI 10.1016/S0966-842X(97)01173-6; Prins M, 2003, TRENDS BIOTECHNOL, V21, P373, DOI 10.1016/S0167-7799(03)00183-5; Prins M, 1996, ARCH VIROL, V141, P2259, DOI 10.1007/BF01718629; Prins M, 1997, PLANT MOL BIOL, V33, P235, DOI 10.1023/A:1005729808191; Rosello S, 1998, EUR J PLANT PATHOL, V104, P499, DOI 10.1023/A:1008622128504; Rudolph C, 2003, P NATL ACAD SCI USA, V100, P4429, DOI 10.1073/pnas.0730832100; SANFORD JC, 1985, J THEOR BIOL, V113, P395, DOI 10.1016/S0022-5193(85)80234-4; Schwach F, 2004, MOL PLANT PATHOL, V5, P309, DOI 10.1111/j.1364-3703.2004.00229.x; Shimomoto Y, 2014, J GEN PLANT PATHOL, V80, P169, DOI 10.1007/s10327-014-0503-9; Singh SJ, 1995, INT S TOSP THRIPS FL, P42; STEVENS MR, 1991, EUPHYTICA, V59, P9; Storms MMH, 1998, PLANT J, V13, P131, DOI 10.1046/j.1365-313X.1998.00007.x; Takeda A, 2002, FEBS LETT, V532, P75, DOI 10.1016/S0014-5793(02)03632-3; Tsompana M., 2008, ENCY VIROLOGY, V5, P157; Wintermantel WM, 1997, VIROLOGY, V231, P248, DOI 10.1006/viro.1997.8533; Wintermantel WM, 2000, J GEN VIROL, V81, P587, DOI 10.1099/0022-1317-81-3-587; YEH SD, 1992, J GEN VIROL, V73, P2531, DOI 10.1099/0022-1317-73-10-2531; YEH SD, 1992, PLANT DIS, V76, P835, DOI 10.1094/PD-76-0835; YEH SD, 1984, PHYTOPATHOLOGY, V74, P1273, DOI 10.1094/Phyto-74-1273; YEH SD, 1995, PHYTOPATHOLOGY, V85, P58, DOI 10.1094/Phyto-85-58; Yeh SD, 1996, ACTA HORTIC, V431, P244; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506	81	25	27	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96073	10.1371/journal.pone.0096073	http://dx.doi.org/10.1371/journal.pone.0096073			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24811071	Green Published, gold, Green Submitted			2022-12-27	WOS:000338213300018
J	Pumirat, P; Broek, CV; Juntawieng, N; Muangsombut, V; Kiratisin, P; Pattanapanyasat, K; Stevens, JM; Stevens, MP; Korbsrisate, S				Pumirat, Pornpan; Broek, Charles Vander; Juntawieng, Niramol; Muangsombut, Veerachat; Kiratisin, Pattarachai; Pattanapanyasat, Kovit; Stevens, Joanne M.; Stevens, Mark P.; Korbsrisate, Sunee			Analysis of the Prevalence, Secretion and Function of a Cell Cycle-Inhibiting Factor in the Melioidosis Pathogen Burkholderia pseudomallei	PLOS ONE			English	Article							COLI EFFECTOR CIF; III SECRETION; PHOTORHABDUS-LUMINESCENS; BACTERIAL EFFECTORS; NEDD8 DEAMIDATION; CYCLOMODULIN CIF; PROTEIN; MECHANISM; APOPTOSIS; VIRULENCE	Enteropathogenic and enterohaemorrhagic Escherichia coli express a cell cycle-inhibiting factor (Cif), that is injected into host cells via a Type III secretion system (T3SS) leading to arrest of cell division, delayed apoptosis and cytoskeletal rearrangements. A homologue of Cif has been identified in Burkholderia pseudomallei (CHBP; Cif homologue in B. pseudomallei; BPSS1385), which shares catalytic activity, but its prevalence, secretion and function are ill-defined. Among 43 available B. pseudomallei genome sequences, 33 genomes (76.7%) harbor the gene encoding CHBP. Western blot analysis using antiserum raised to a synthetic CHBP peptide detected CHBP in 46.6% (7/15) of clinical B. pseudomallei isolates from the endemic area. Secretion of CHBP into bacterial culture supernatant could not be detected under conditions where a known effector (BopE) was secreted in a manner dependent on the Bsa T3SS. In contrast, CHBP could be detected in U937 cells infected with B. pseudomallei by immunofluorescence microscopy and Western blotting in a manner dependent on bsaQ. Unlike E. coli Cif, CHBP was localized within the cytoplasm of B. pseudomallei-infected cells. A B. pseudomallei chbP insertion mutant showed a significant reduction in cytotoxicity and plaque formation compared to the wild-type strain that could be restored by plasmid-mediated trans-complementation. However, there was no defect in actin-based motility or multinucleated giant cell formation by the chbP mutant. The data suggest that the level or timing of CHBP secretion differs from a known Bsa-secreted effector and that CHBP is required for selected virulence-associated phenotypes in vitro.	[Pumirat, Pornpan] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok 10700, Thailand; [Pumirat, Pornpan; Juntawieng, Niramol; Muangsombut, Veerachat; Korbsrisate, Sunee] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Immunol, Bangkok 10700, Thailand; [Broek, Charles Vander; Stevens, Joanne M.; Stevens, Mark P.] Univ Edinburgh, Roslin Inst, Edinburgh EH8 9YL, Midlothian, Scotland; [Broek, Charles Vander; Stevens, Joanne M.; Stevens, Mark P.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH8 9YL, Midlothian, Scotland; [Kiratisin, Pattarachai] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok 10700, Thailand; [Pattanapanyasat, Kovit] Mahidol Univ, Siriraj Hosp, Fac Med, Ctr Excellence Flow Cytometry, Bangkok 10700, Thailand	Mahidol University; Mahidol University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Mahidol University; Mahidol University	Korbsrisate, S (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Dept Immunol, Bangkok 10700, Thailand.	sunee.kor@mahidol.ac.th	Jitprasutwit, Niramol/AAU-5244-2021	Jitprasutwit, Niramol/0000-0002-4576-5408; Stevens, Mark/0000-0003-2174-5039	Siriraj Grant for Research and Development; Faculty of Medicine Siriraj Hospital, Mahidol University; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001116, BBS/E/D/20231761] Funding Source: researchfish; BBSRC [BBS/E/D/20231761] Funding Source: UKRI	Siriraj Grant for Research and Development; Faculty of Medicine Siriraj Hospital, Mahidol University; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Siriraj Grant for Research and Development. PP and VM were supported by the post-doctoral and research scientist scholarships, respectively, under the Faculty of Medicine Siriraj Hospital, Mahidol University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeyev MF, 1999, BIOTECHNIQUES, V26, P824, DOI 10.2144/99265bm05; Boh BK, 2011, J MOL BIOL, V413, P430, DOI 10.1016/j.jmb.2011.08.030; Charpentier X, 2004, J BACTERIOL, V186, P5486, DOI 10.1128/JB.186.16.5486-5495.2004; Chavez CV, 2010, MICROBES INFECT, V12, P1208, DOI 10.1016/j.micinf.2010.09.006; Cornelis GR, 2000, PHILOS T R SOC B, V355, P681, DOI 10.1098/rstb.2000.0608; Crow A, 2012, P NATL ACAD SCI USA, V109, pE1830, DOI 10.1073/pnas.1112107109; Crow A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005582; Cui JX, 2010, SCIENCE, V329, P1215, DOI 10.1126/science.1193844; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Felgner PL, 2009, P NATL ACAD SCI USA, V106, P13499, DOI 10.1073/pnas.0812080106; Gong L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017852; Heeb S, 2002, J BACTERIOL, V184, P1046, DOI 10.1128/jb.184.4.1046-1056.2002; Hseu YC, 2013, J MICROBIOL IN PRESS; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Jubelin G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001128; Jubelin G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004855; Kespichayawattana W, 2000, INFECT IMMUN, V68, P5377, DOI 10.1128/IAI.68.9.5377-5384.2000; Korbsrisate S, 2007, MICROBIOL-SGM, V153, P1907, DOI 10.1099/mic.0.2006/003004-0; Marches O, 2003, MOL MICROBIOL, V50, P1553, DOI 10.1046/j.1365-2958.2003.03821.x; Muangman S, 2011, FEMS MICROBIOL LETT, V323, P75, DOI 10.1111/j.1574-6968.2011.02359.x; Muangsombut V, 2008, ARCH MICROBIOL, V190, P623, DOI 10.1007/s00203-008-0413-3; Nougayrede JP, 2005, TRENDS MICROBIOL, V13, P103, DOI 10.1016/j.tim.2005.01.002; Samba-Louaka A, 2008, CELL MICROBIOL, V10, P2496, DOI 10.1111/j.1462-5822.2008.01224.x; Samba-Louaka A, 2009, INFECT IMMUN, V77, P5471, DOI 10.1128/IAI.00860-09; Sitthidet C, 2008, J CLIN MICROBIOL, V46, P2418, DOI 10.1128/JCM.00368-08; Stevens MP, 2004, MICROBIOL-SGM, V150, P2669, DOI 10.1099/mic.0.27146-0; Stevens MP, 2003, J BACTERIOL, V185, P4992, DOI 10.1128/JB.185.16.4992-4996.2003; Stevens MP, 2002, MOL MICROBIOL, V46, P649, DOI 10.1046/j.1365-2958.2002.03190.x; Suparak S, 2005, J BACTERIOL, V187, P6556, DOI 10.1128/JB.187.18.6556-6560.2005; Washington EJ, 2013, MICROBIOL MOL BIOL R, V77, P527, DOI 10.1128/MMBR.00013-13; Whitlock Gregory C, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS127, DOI 10.1016/S0035-9203(08)70029-4; Yao Q, 2012, P NATL ACAD SCI USA, V109, P20395, DOI 10.1073/pnas.1210831109; Yao Q, 2009, P NATL ACAD SCI USA, V106, P3716, DOI 10.1073/pnas.0900212106	33	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96298	10.1371/journal.pone.0096298	http://dx.doi.org/10.1371/journal.pone.0096298			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809950	Green Submitted, Green Published, gold			2022-12-27	WOS:000338213300028
J	Liu, N; Gu, B; Liu, N; Nie, X; Zhang, B; Zhou, X; Deng, MJ				Liu, Na; Gu, Bin; Liu, Ning; Nie, Xin; Zhang, Bo; Zhou, Xia; Deng, Manjing			Wnt/beta-Catenin Pathway Regulates Cementogenic Differentiation of Adipose Tissue-Deprived Stem Cells in Dental Follicle Cell-Conditioned Medium	PLOS ONE			English	Article							OSTEOGENIC DIFFERENTIATION; BETA-CATENIN; BONE MASS; TOOTH; EXPRESSION; MINERALIZATION; PROLIFERATION; PHENOTYPE; LEADS; LEF1	The formation and attachment of new cementum is crucial for periodontium regeneration. Tissue engineering is currently explored to achieve complete, reliable and reproducible regeneration of the periodontium. The capacity of multipotency and self-renewal makes adipose tissue-deprived stem cells (ADSCs) an excellent cell source for tissue regeneration and repair. After rat ADSCs were cultured in dental follicle cell-conditioned medium (DFC-CM) supplemented with DKK-1, an inhibitor of the Wnt pathway, followed by 7 days of induction, they exhibited several phenotypic characteristics of cementoblast lineages, as indicated by upregulated expression levels of CAP, ALP, BSP and OPN mRNA, and accelerated expression of BSP and CAP proteins. The Wnt/beta-catenin signaling pathway controls differentiation of stem cells by regulating the expression of target genes. Cementoblasts share phenotypical features with osteoblasts. In this study, we demonstrated that culturing ADSCs in DFC-CM supplemented with DKK-1 results in inhibition of beta-catenin nuclear translocation and down-regulates TCF-4 and LEF-1 mRNA expression levels. We also found that DKK-1 could promote cementogenic differentiation of ADSCs, which was evident by the up-regulation of CAP, ALP, BSP and OPN gene expressions. On the other hand, culturing ADSCs in DFC-CM supplemented with 100 ng/mL Wnt3a, which activates the Wnt/beta-catenin pathway, abrogated this effect. Taken together, our study indicates that the Wnt/beta-catenin signaling pathway plays an important role in regulating cementogenic differentiation of ADSCs cultured in DFC-CM. These results raise the possibility of using ADSCs for periodontal regeneration by modifying the Wnt/beta-catenin pathway.	[Liu, Na; Gu, Bin; Liu, Ning] Chinese Peoples Liberat Army Gen Hosp, Dept Stomatol, Beijing, Peoples R China; [Liu, Ning] Chinese PLA 15 Hosp, Dept Stomatol, Lanzhou, Peoples R China; [Nie, Xin; Zhou, Xia; Deng, Manjing] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Stomatol, Chongqing, Peoples R China; [Zhang, Bo] Third Mil Med Univ, Daping Hosp, Inst Surg Res, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China	Chinese People's Liberation Army General Hospital; Army Medical University; Army Medical University	Deng, MJ (corresponding author), Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Stomatol, Chongqing, Peoples R China.	iradeng@163.com			Natural Science Foundation of Chongqing [CSTC2011BA5013]; Natural Science Foundation of China [31200741]; China Postdoctoral Science Foundation [2013M532108]	Natural Science Foundation of Chongqing(Natural Science Foundation of Chongqing); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by grants from the Natural Science Foundation of Chongqing (CSTC2011BA5013 to Manjing Deng), the Natural Science Foundation of China (31200741 to Na Liu) and China Postdoctoral Science Foundation (2013M532108 to Na Liu). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Aurrekoetxea M, 2012, BIOL CELL, V104, P603, DOI 10.1111/boc.201100075; BarKana I, 2000, J DENT RES, V79, P1482, DOI 10.1177/00220345000790070901; Bartold PM, 2006, PERIODONTOL 2000, V40, P164, DOI 10.1111/j.1600-0757.2005.00139.x; Brinkmeler ML, 2007, DEV BIOL, V311, P396, DOI 10.1016/j.ydbio.2007.08.046; Chen Y, 2007, PLOS MED, V4, P1216, DOI 10.1371/journal.pmed.0040249; Cho HH, 2006, TISSUE ENG, V12, P111, DOI 10.1089/ten.2006.12.111; Cochran DL, 1999, PERIODONTOL 2000, V19, P40, DOI 10.1111/j.1600-0757.1999.tb00146.x; de Boer J, 2004, BONE, V34, P818, DOI 10.1016/j.bone.2004.01.016; De Boer J, 2004, TISSUE ENG, V10, P393, DOI 10.1089/107632704323061753; Declercq HA, 2013, BIOMATERIALS, V34, P1004, DOI 10.1016/j.biomaterials.2012.10.051; Diekwisch TGH, 2001, INT J DEV BIOL, V45, P695; El-Tanani M, 2004, J BIOL CHEM, V279, P20794, DOI 10.1074/jbc.M311131200; Engert S, 2013, DEVELOPMENT, V140, P3128, DOI 10.1242/dev.088765; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Guo WH, 2009, BIOMATERIALS, V30, P6708, DOI 10.1016/j.biomaterials.2009.08.034; Ibarretxe G, 2012, CELL TISSUE RES, V350, P95, DOI 10.1007/s00441-012-1459-8; Ikeda E, 2006, BIOCHEM BIOPH RES CO, V342, P1257, DOI 10.1016/j.bbrc.2006.02.101; Ivanovski S, 2006, ORAL DIS, V12, P358, DOI 10.1111/j.1601-0825.2006.01253.x; Jahagirdar BN, 2005, STEM CELL REV, V1, P53, DOI 10.1385/SCR:1:1:053; Jarvinen E, 2006, P NATL ACAD SCI USA, V103, P18627, DOI 10.1073/pnas.0607289103; Kahler RA, 2008, MATRIX BIOL, V27, P330, DOI 10.1016/j.matbio.2008.01.002; Kim TH, 2013, J DENT RES, V92, P215, DOI 10.1177/0022034512470137; Kim TH, 2011, BIOCHEM BIOPH RES CO, V412, P549, DOI 10.1016/j.bbrc.2011.07.116; Komaki M, 2012, J CELL PHYSIOL, V227, P649, DOI 10.1002/jcp.22770; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Ling L, 2009, GENE, V433, P1, DOI 10.1016/j.gene.2008.12.008; Liu F, 2008, DEV BIOL, V313, P210, DOI 10.1016/j.ydbio.2007.10.016; Liu GZ, 2009, J CELL BIOL, V185, P67, DOI 10.1083/jcb.200810137; Liu N, 2011, J BONE MINER RES, V26, P2082, DOI 10.1002/jbmr.440; Liu SY, 2011, TISSUE ENG PT A, V17, P725, DOI [10.1089/ten.tea.2010.0331, 10.1089/ten.TEA.2010.0331]; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nemoto E, 2009, BONE, V44, P805, DOI 10.1016/j.bone.2008.12.029; Noh T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005438; Ouyang H, 2013, J CLIN INVEST, V123, P1422, DOI 10.1172/JCI69324; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Sarkar L, 1999, MECH DEVELOP, V85, P197, DOI 10.1016/S0925-4773(99)00095-7; Scheller EL, 2008, J DENT RES, V87, P126, DOI 10.1177/154405910808700206; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Shiraishi T, 2012, J DENT RES, V91, P592, DOI 10.1177/0022034512445633; Tobita M, 2013, CYTOTHERAPY, pS1465; van der Horst G, 2005, J BONE MINER RES, V20, P1867, DOI 10.1359/JBMR.050614; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Wen XJ, 2011, BIOCHEM BIOPH RES CO, V409, P583, DOI 10.1016/j.bbrc.2011.05.067; Zeichner-David M, 2003, DEV DYNAM, V228, P651, DOI 10.1002/dvdy.10404; Zhu XJ, 2013, J BIOL CHEM, V288, P12080, DOI 10.1074/jbc.M113.462473	47	20	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e93364	10.1371/journal.pone.0093364	http://dx.doi.org/10.1371/journal.pone.0093364			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806734	Green Submitted, Green Published, gold			2022-12-27	WOS:000335728900005
J	Wersinger, DB; Benkafadar, N; Jagodzinska, J; Hamel, C; Tanizawa, Y; Lenaers, G; Delettre, C				Wersinger, Delphine Bonnet; Benkafadar, Nesrine; Jagodzinska, Jolanta; Hamel, Christian; Tanizawa, Yukio; Lenaers, Guy; Delettre, Cecile			Impairment of Visual Function and Retinal ER Stress Activation in Wfs 1-Deficient Mice	PLOS ONE			English	Article							UNFOLDED-PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; PANCREATIC BETA-CELLS; WOLFRAM DIDMOAD SYNDROME; WFS1 GENE; AUTOPHAGY GENE; EXPRESSION; DEATH; ELECTRORETINOGRAPHY; DISRUPTION	Wolfram syndrome is an early onset genetic disease (1/180,000) featuring diabetes mellitus and optic neuropathy, associated to mutations in the WFS1 gene. Wfs1(-/-) mouse model shows pancreatic beta cell atrophy, but its visual performance has not been investigated, prompting us to study its visual function and histopathology of the retina and optic nerve. Electroretinogram and visual evoked potentials (VEPs) were performed in Wfs1 and Wfs1(-/-) mice at 3, 6, 9 and 12 months of age. Fundi were pictured with Micron III apparatus. Retinal ganglion cell (RGC) abundance was determined from Brn3a immunolabeling of retinal sections. RGC axonal loss was quantified by electron microscopy in transversal optic nerve sections. Endoplasmic reticulum stress was assessed using immunoglobulin binding protein (BiP), protein disulfide isomerase (PDI) and inositol-requiring enzyme 1 alpha (Ire1 alpha) markers. Electroretinograms amplitudes were slightly reduced and latencies increased with time in Wfs1(-/-) mice. Similarly, VEPs showed decreased N+P amplitudes and increased N-wave latency. Analysis of unfolded protein response signaling revealed an activation of endoplasmic reticulum stress in Wfs1 2/2 mutant mouse retinas. Altogether, progressive VEPs alterations with minimal neuronal cell loss suggest functional alteration of the action potential in the Wfs1(-/-) optic pathways.	[Wersinger, Delphine Bonnet; Benkafadar, Nesrine; Jagodzinska, Jolanta; Hamel, Christian; Lenaers, Guy; Delettre, Cecile] INSERM, Inst Neurosci Montpellier, U1051, F-75654 Paris 13, France; [Wersinger, Delphine Bonnet; Benkafadar, Nesrine; Jagodzinska, Jolanta; Hamel, Christian; Lenaers, Guy; Delettre, Cecile] Univ Montpellier I, Montpellier, France; [Wersinger, Delphine Bonnet; Benkafadar, Nesrine; Jagodzinska, Jolanta; Hamel, Christian; Lenaers, Guy; Delettre, Cecile] Univ Montpellier 2, Montpellier, France; [Hamel, Christian] Ctr Hosp Univ, Montpellier, France; [Tanizawa, Yukio] Yamaguchi Univ, Grad Sch Med, Div Endocrinol Metab Hematol Sci & Therapeut, Yamaguchi, Japan	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Yamaguchi University	Delettre, C (corresponding author), INSERM, Inst Neurosci Montpellier, U1051, F-75654 Paris 13, France.	cecile.delettre@inserm.fr	Lenaers, guy/X-4727-2019; Delettre, Cécile/AAC-3096-2020; LENAERS, Guy/K-2421-2015	Delettre, Cécile/0000-0003-3269-2155; LENAERS, Guy/0000-0003-2736-3349; BENKAFADAR, Nesrine/0000-0002-7390-7688	French Ministry for National Education and Inserm	French Ministry for National Education and Inserm	This work was supported by private foundations (French association against Myopathies (AFM), Retina France, Association du Syndrome de Wolfram, Fondation de France), the French Ministry for National Education and Inserm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, ALLENBRAINATLAS; Baltanas R, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003312; BARRETT TG, 1995, LANCET, V346, P1458, DOI 10.1016/S0140-6736(95)92473-6; Barrett TG, 1997, EYE, V11, P882, DOI 10.1038/eye.1997.226; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Cahill H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002055; Castillo K, 2011, EMBO J, V30, P4465, DOI 10.1038/emboj.2011.318; Chaussenot A, 2011, ANN NEUROL, V69, P501, DOI 10.1002/ana.22160; Chekroud K, 2011, OPHTHALMIC RES, V45, P174, DOI 10.1159/000321118; CILLINO S, 1989, GRAEF ARCH CLIN EXP, V227, P131, DOI 10.1007/BF02169784; Daido S, 2004, CANCER RES, V64, P4286, DOI 10.1158/0008-5472.CAN-03-3084; de Heredia ML, 2013, GENET MED, V15, P497, DOI 10.1038/gim.2012.180; Fonseca SG, 2005, J BIOL CHEM, V280, P39609, DOI 10.1074/jbc.M507426200; Fonseca SG, 2010, J CLIN INVEST, V120, P744, DOI 10.1172/JCI39678; Fouillet A, 2012, AUTOPHAGY, V8, P915, DOI 10.4161/auto.19716; Furlong RA, 1999, NEUROSCI LETT, V277, P123, DOI 10.1016/S0304-3940(99)00865-4; Galluzzi P, 1999, NEURORADIOLOGY, V41, P729, DOI 10.1007/s002340050832; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Hardy C, 1999, AM J HUM GENET, V65, P1279, DOI 10.1086/302609; Hatanaka M, 2011, HUM MOL GENET, V20, P1274, DOI 10.1093/hmg/ddq568; Hershey T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040604; Hu P, 2006, MOL CELL BIOL, V26, P3071, DOI 10.1128/MCB.26.8.3071-3084.2006; Ishihara H, 2004, HUM MOL GENET, V13, P1159, DOI 10.1093/hmg/ddh125; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Labunskyy VM, 2009, BIOCHEMISTRY-US, V48, P8458, DOI 10.1021/bi900717p; Langwinska-Wosko E, 2012, DOC OPHTHALMOL, V124, P133, DOI 10.1007/s10633-011-9308-8; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Matus S, 2012, AUTOPHAGY, V8, P997, DOI 10.4161/auto.20748; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Osman AA, 2003, J BIOL CHEM, V278, P52755, DOI 10.1074/jbc.M310331200; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Rando RA, 1992, NEUROLOGY, V42, P1220; Rigoli L, 2011, CLIN GENET, V79, P103, DOI 10.1111/j.1399-0004.2010.01522.x; Safran A B, 1996, Curr Opin Ophthalmol, V7, P53, DOI 10.1097/00055735-199612000-00009; Schmidt-Kastner R, 2009, EXP EYE RES, V89, P568, DOI 10.1016/j.exer.2009.05.007; Seynaeve H, 1994, Bull Soc Belge Ophtalmol, V252, P75; Simsek E, 2003, ACTA PAEDIATR, V92, P55; Swift RG, 1998, MOL PSYCHIATR, V3, P86, DOI 10.1038/sj.mp.4000344; Takei D, 2006, WFS1 PROTEIN MODULAT; Ueda K, 2005, EUR J ENDOCRINOL, V153, P167, DOI 10.1530/eje.1.01945; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wolfram D.J., 1938, MAYO CLIN PROC, V13, P715; Yamada T, 2006, HUM MOL GENET, V15, P1600, DOI 10.1093/hmg/ddl081; Yang ZY, 2007, INVEST OPHTH VIS SCI, V48, P5539, DOI 10.1167/iovs.07-0542; Yoshiki A, 2006, ILAR J, V47, P94, DOI 10.1093/ilar.47.2.94; Yu GA, 2010, ENDOCRINE, V38, P147, DOI 10.1007/s12020-010-9350-4; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	48	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97222	10.1371/journal.pone.0097222	http://dx.doi.org/10.1371/journal.pone.0097222			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24823368	Green Published, gold			2022-12-27	WOS:000336369200073
J	Harford-Wright, E; Lewis, KM; Ghabriel, MN; Vink, R				Harford-Wright, Elizabeth; Lewis, Kate M.; Ghabriel, Mounir N.; Vink, Robert			Treatment with the NK1 Antagonist Emend Reduces Blood Brain Barrier Dysfunction and Edema Formation in an Experimental Model of Brain Tumors	PLOS ONE			English	Article							SUBSTANCE-P IMMUNOREACTIVITY; CELL-LINES; NEUROGENIC INFLAMMATION; PERITUMORAL EDEMA; ENDOTHELIAL-CELLS; ANTITUMOR ACTION; MITOGENIC ACTION; ISCHEMIC-STROKE; NK-1 RECEPTOR; NUDE-MICE	The neuropeptide substance P (SP) has been implicated in the disruption of the blood-brain barrier (BBB) and development of cerebral edema in acute brain injury. Cerebral edema accumulates rapidly around brain tumors and has been linked to several tumor-associated deficits. Currently, the standard treatment for peritumoral edema is the corticosteroid dexamethasone, prolonged use of which is associated with a number of deleterious side effects. As SP is reported to increase in many cancer types, this study examined whether SP plays a role in the genesis of brain peritumoral edema. A-375 human melanoma cells were injected into the right striatum of male Balb/c nude mice to induce brain tumor growth, with culture medium injected in animals serving as controls. At 2, 3 or 4 weeks following tumor cell inoculation, non-treated animals were perfusion fixed for immunohistochemical detection of Albumin, SP and NK1 receptor. A further subgroup of animals was treated with a daily injection of the NK1 antagonist Emend (3 mg/kg), dexamethasone (8 mg/kg) or saline vehicle at 3 weeks post-inoculation. Animals were sacrificed a week later to determine BBB permeability using Evan's Blue and brain water content. Non-treated animals demonstrated a significant increase in albumin, SP and NK1 receptor immunoreactivity in the peritumoral area as well as increased perivascular staining in the surrounding brain tissue. Brain water content and BBB permeability was significantly increased in tumor-inoculated animals when compared to controls (p<0.05). Treatment with Emend and dexamethasone reduced BBB permeability and brain water content when compared to vehicle-treated tumor-inoculated mice. The increase in peritumoral staining for both SP and the NK1 receptor, coupled with the reduction in brain water content and BBB permeability seen following treatment with the NK1 antagonist Emend, suggests that SP plays a role in the genesis of peritumoral edema, and thus warrants further investigation as a potential anti-edematous treatment.	[Harford-Wright, Elizabeth; Lewis, Kate M.; Ghabriel, Mounir N.; Vink, Robert] Univ Adelaide, Sch Med Sci, Adelaide Ctr Neurosci Res, Adelaide, SA, Australia	University of Adelaide	Harford-Wright, E (corresponding author), Univ Adelaide, Sch Med Sci, Adelaide Ctr Neurosci Res, Adelaide, SA, Australia.	Elizabeth.harfordwright@adelaide.edu.au	Vink, Robert/S-5616-2019; Vink, Robert/J-7351-2012	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667	Neurosurgical Research Foundation	Neurosurgical Research Foundation	This work was supported by a grant from the Neurosurgical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or the preparation of this manuscript.	AIHW, 2010, CANC AUSTR CANC STAT; Akazawa T, 2009, J NEUROCHEM, V109, P1079, DOI 10.1111/j.1471-4159.2009.06032.x; Bafaloukos D, 2004, CANCER TREAT REV, V30, P515, DOI 10.1016/j.ctrv.2004.05.001; Barnholtz-Sloan JS, 2004, J CLIN ONCOL, V22, P2865, DOI 10.1200/JCO.2004.12.149; BORSON DB, 1991, AM J PHYSIOL, V260, pL83, DOI 10.1152/ajplung.1991.260.2.L83; Cioni C, 1998, J NEUROIMMUNOL, V84, P76, DOI 10.1016/S0165-5728(97)00235-X; CRISCUOLO GR, 1993, YALE J BIOL MED, V66, P277; Dietrich Jorg, 2011, Expert Rev Clin Pharmacol, V4, P233, DOI 10.1586/ecp.11.1; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; Engelhorn T, 2009, CANCER SCI, V100, P1856, DOI 10.1111/j.1349-7006.2009.01259.x; Esteban F, 2009, HISTOPATHOLOGY, V54, P258, DOI 10.1111/j.1365-2559.2008.03193.x; Gabrielian Levon, 2013, Acta Neurochir Suppl, V118, P201, DOI 10.1007/978-3-7091-1434-6_37; GROGER U, 1994, ACTA NEUROCHIR, P373; HAFSTROM I, 1989, J RHEUMATOL, V16, P1033; Harford-Wright E, 2014, NEUROSCIENCE, V261, P85, DOI 10.1016/j.neuroscience.2013.12.027; Harford-Wright E, 2013, RECENT PAT CNS DRUG; Harford-Wright E, 2010, NEUROSCI LETT, V481, P26, DOI 10.1016/j.neulet.2010.06.044; Hariri R J, 1994, Neurosurg Clin N Am, V5, P687; Harrison S, 2001, INT J BIOCHEM CELL B, V33, P555, DOI 10.1016/S1357-2725(01)00031-0; HASEGAWA H, 1983, J NEUROSURG, V59, P304, DOI 10.3171/jns.1983.59.2.0304; Helps SC, 2012, APPL IMMUNOHISTO M M, V20, P82, DOI 10.1097/PAI.0b013e31821fc8cd; Hockey B, 2009, J CLIN NEUROSCI, V16, P1389, DOI 10.1016/j.jocn.2009.03.007; Ito U, 1990, Adv Neurol, V52, P459; JAMSHIDI J, 1992, J NEURO-ONCOL, V12, P197; Johansson B B, 1990, Adv Exp Med Biol, V274, P25; Kleinig TJ, 2010, ROLE SUBSTANCE P EXP; Leonard AV, 2013, J NEUROTRAUM, V30, P1812, DOI 10.1089/neu.2013.2993; Lewis KM, 2013, ANTI-CANCER DRUG, V24, P344, DOI 10.1097/CAD.0b013e32835ef440; Lewis KM, 2012, J NEUROIMMUNOL; Lewis KM, 2012, CLIN EXP METASTASIS; Lin RCS, 1995, NEUROREPORT, V7, P310, DOI 10.1097/00001756-199512000-00074; Lu-Emerson Christine, 2012, Continuum (Minneap Minn), V18, P295, DOI 10.1212/01.CON.0000413659.12304.a6; MENDELSOHN FAO, 1982, J CLIN INVEST, V70, P684, DOI 10.1172/JCI110663; Munoz M, 2005, INVEST OPHTH VIS SCI, V46, P2567, DOI 10.1167/iovs.04-1530; Munoz M, 2010, LAB INVEST, V90, P1259, DOI 10.1038/labinvest.2010.92; Palma C, 2006, CURR DRUG TARGETS, V7, P1043, DOI 10.2174/138945006778019282; Papadopoulos MC, 2004, NEUROSCIENCE, V129, P1011, DOI 10.1016/j.neuroscience.2004.05.044; Patchell RA, 2003, CANCER TREAT REV, V29, P533, DOI 10.1016/S0305-7372(03)00105-1; Quinlan KL, 1999, J IMMUNOL, V163, P5656; Richardson JD, 2002, J PHARMACOL EXP THER, V302, P839, DOI 10.1124/jpet.102.032797; Rodriguez PL, 2013, INT J CANC; Rosso M, 2008, TUMOR BIOL, V29, P245, DOI 10.1159/000152942; Rosso M, 2012, SCI WORLD J, DOI 10.1100/2012/381434; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Schaffer M, 1998, ARCH SURG-CHICAGO, V133, P1107, DOI 10.1001/archsurg.133.10.1107; SHARKEY FE, 1984, CANCER METAST REV, V3, P341, DOI 10.1007/BF00051459; SHIBATA S, 1989, ACTA NEUROPATHOL, V78, P561, DOI 10.1007/BF00691283; Siu Timothy L, 2010, Cancers (Basel), V2, P364, DOI 10.3390/cancers2020364; Skidgel R A, 1987, Agents Actions Suppl, V22, P289; Turner RJ, 2006, ACTA NEUROCHIR SUPPL, V96, P263; Turner RJ, 2011, BRAIN RES, V1393, P84, DOI 10.1016/j.brainres.2011.03.066; Vink R, 2003, ACT NEUR S, V86, P257; Watanabe Y, 2008, J PHARMACOL SCI, V106, P121, DOI 10.1254/jphs.FP0071400; ZHANG RD, 1992, AM J PATHOL, V141, P1115	54	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97002	10.1371/journal.pone.0097002	http://dx.doi.org/10.1371/journal.pone.0097002			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24818961	Green Published, gold, Green Submitted			2022-12-27	WOS:000336653300061
J	He, SB; Yan, SH; Wang, P; Zhu, W; Wang, XW; Shen, Y; Shao, KJ; Xin, HP; Li, SH; Li, LJ				He, Shibin; Yan, Shihan; Wang, Pu; Zhu, Wei; Wang, Xiangwu; Shen, Yao; Shao, Kejia; Xin, Haiping; Li, Shaohua; Li, Lijia			Comparative Analysis of Genome-Wide Chromosomal Histone Modification Patterns in Maize Cultivars and Their Wild Relatives	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; B-CHROMOSOMES; CHROMATIN; HETEROCHROMATIN; METHYLATION; EVOLUTION; PLANT; ACETYLATION; INHERITANCE; HYBRIDS	Recent advances demonstrate that epigenome changes can also cause phenotypic diversity and can be heritable across generations, indicating that they may play an important role in evolutionary processes. In this study, we analyzed the chromosomal distribution of several histone modifications in five elite maize cultivars (B73, Mo17, Chang7-2, Zheng58, ZD958) and their two wild relatives (Zea mays L. ssp. parviglumis and Zea nicaraguensis) using a three-dimensional (3D) epigenome karyotyping approach by combining immunostaining and 3D reconstruction with deconvolution techniques. The distribution of these histone modifications along chromosomes demonstrated that the histone modification patterns are conserved at the chromosomal level and have not changed significantly following domestication. The comparison of histone modification patterns between metaphase chromosomes and interphase nuclei showed that some of the histone modifications were retained as the cell progressed from interphase into metaphase, although remodelling existed. This study will increase comprehension of the function of epigenetic modifications in the structure and evolution of the maize genome.	[He, Shibin; Yan, Shihan; Wang, Pu; Li, Lijia] Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China; [He, Shibin; Shen, Yao; Shao, Kejia] Henan Univ, Coll Life Sci, State Key Lab Cotton Biol, Kaifeng, Peoples R China; [Zhu, Wei; Xin, Haiping; Li, Shaohua] Chinese Acad Sci, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan Bot Garden, Wuhan, Peoples R China; [Wang, Xiangwu] Henan Univ, Sch Phys & Elect, Kaifeng, Peoples R China	Wuhan University; Henan University; Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Henan University	He, SB (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China.	sbhe@henu.edu.cn; ljli@whu.edu.cn	Zhu, Wei/HGA-4471-2022	Zhu, Wei/0000-0003-1459-6733; Yan, Shihan/0000-0001-9814-769X	NSFC [31171186]; Hubei Province Natural Science Fund; Fundamental Research Funds for the Central Universities [2012204020202]; Henan University Research Fund [2012YBZR028]; He'nan Province Postdoctoral Science Fund	NSFC(National Natural Science Foundation of China (NSFC)); Hubei Province Natural Science Fund; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Henan University Research Fund; He'nan Province Postdoctoral Science Fund	This work was supported by the NSFC (No. 31171186; http://www.nsfc.gov.cn/publish/portal0/default.htm), Hubei Province Natural Science Fund, Fundamental Research Funds for the Central Universities (No. 2012204020202), Henan University Research Fund (No. 2012YBZR028) and He'nan Province Postdoctoral Science Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LK, 2006, GENOME RES, V16, P115, DOI [10.1101/gr.4249906, 10.1101/gr4249906]; Bonduriansky R, 2009, ANNU REV ECOL EVOL S, V40, P103, DOI 10.1146/annurev.ecolsys.39.110707.173441; Carchilan M, 2007, PLANT CELL, V19, P1738, DOI 10.1105/tpc.106.046946; DOEBLEY J, 1990, P NATL ACAD SCI USA, V87, P9888, DOI 10.1073/pnas.87.24.9888; Ellneskog-Staam P, 2007, HEREDITAS, V144, P96, DOI 10.1111/j.2007.0018-0661.01989.x; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Fuchs J, 2008, CHROMOSOME RES, V16, P891, DOI 10.1007/s10577-008-1252-4; Fuchs J, 2006, TRENDS PLANT SCI, V11, P199, DOI 10.1016/j.tplants.2006.02.008; Fuchs J, 2012, PLANT GENET GENOMICS, V4, P231, DOI 10.1007/978-0-387-70869-0_9; Furusawa C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061251; Hansey CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033071; He GM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r57; He GM, 2010, PLANT CELL, V22, P17, DOI 10.1105/tpc.109.072041; He SB, 2009, CROP SCI, V49, P2285, DOI 10.2135/cropsci2009.01.0034; Houben A, 2003, PLANT J, V33, P967, DOI 10.1046/j.1365-313X.2003.01681.x; Hu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022132; Jasencakova Z, 2001, CHROMOSOMA, V110, P83, DOI 10.1007/s004120100132; Jeppesen P, 1997, BIOESSAYS, V19, P67, DOI 10.1002/bies.950190111; Jin WW, 2008, CHROMOSOME RES, V16, P1203, DOI 10.1007/s10577-008-1269-8; Kato A, 2004, P NATL ACAD SCI USA, V101, P13554, DOI 10.1073/pnas.0403659101; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kruhlak MJ, 2001, J BIOL CHEM, V276, P38307; Lai JS, 2010, NAT GENET, V42, P1027, DOI 10.1038/ng.684; Li GH, 2011, CURR OPIN GENET DEV, V21, P175, DOI 10.1016/j.gde.2011.01.022; Li LJ, 2005, CYTOM PART A, V63A, P114, DOI 10.1002/cyto.a.20111; Liu JY, 2004, CHROMOSOMA, V113, P16, DOI 10.1007/s00412-004-0289-1; Makarevitch I, 2013, PLANT CELL, V25, P780, DOI 10.1105/tpc.112.106427; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Marks H, 2009, GENOME RES, V19, P1361, DOI 10.1101/gr.092643.109; Moghaddam AMB, 2011, PLANT J, V67, P691, DOI 10.1111/j.1365-313X.2011.04628.x; Morrell PL, 2012, NAT REV GENET, V13, P85, DOI 10.1038/nrg3097; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Pennisi E, 2013, SCIENCE, V341, P1055, DOI 10.1126/science.341.6150.1055; Rapp RA, 2005, NEW PHYTOL, V168, P81, DOI 10.1111/j.1469-8137.2005.01491.x; Robinson TJ, 2012, HEREDITY, V108, P1, DOI 10.1038/hdy.2011.117; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; SCHWARZ PM, 1994, J BIOL CHEM, V269, P16284; Shi JH, 2006, GENETICS, V173, P1571, DOI 10.1534/genetics.106.056853; Soppe WJJ, 2002, EMBO J, V21, P6549, DOI 10.1093/emboj/cdf657; Terrenoire E, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r110; Vaughn MW, 2007, PLOS BIOL, V5, P1617, DOI 10.1371/journal.pbio.0050174; Wang XF, 2009, PLANT CELL, V21, P1053, DOI 10.1105/tpc.109.065714; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123	44	27	27	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97364	10.1371/journal.pone.0097364	http://dx.doi.org/10.1371/journal.pone.0097364			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819606	Green Published, Green Submitted, gold			2022-12-27	WOS:000336653300108
J	Steele, AK; Lee, EJ; Vestal, B; Hecht, D; Dong, Z; Rapaport, E; Koeppe, J; Campbell, TB; Wilson, CC				Steele, Amanda K.; Lee, Eric J.; Vestal, Brian; Hecht, Daniel; Dong, Zachary; Rapaport, Eric; Koeppe, John; Campbell, Thomas B.; Wilson, Cara C.			Contribution of Intestinal Barrier Damage, Microbial Translocation and HIV-1 Infection Status to an Inflammaging Signature	PLOS ONE			English	Article							COMBINATION ANTIRETROVIRAL THERAPY; T-CELL RESPONSES; IMMUNE ACTIVATION; CARDIOVASCULAR-DISEASE; SKELETAL-MUSCLE; OLDER-ADULTS; MARKERS; ASSOCIATION; RISK; AGE	Systemic inflammation is a characteristic of both HIV-1 infection and aging ("inflammaging''). Intestinal epithelial barrier damage (IEBD) and microbial translocation (MT) contribute to HIV-associated inflammation, but their impact on inflammaging remains unclear. Methods: Plasma biomarkers for IEBD (iFABP), MT (LPS, sCD14), T-cell activation (sCD27), and inflammation (hsCRP, IL-6) were measured in 88 HIV-1 uninfected (HIVneg) and 83 treated, HIV-1-infected (HIVpos) adults from 20-100 years old. Results: Age positively correlated with iFABP (r = 0.284, p = 0.008), sCD14 (r = 0.646, p = < 0.0001) and LPS (r = 0.421, p = 0.0002) levels in HIVneg but not HIVpos subjects. Age also correlated with sCD27, hsCRP, and IL-6 levels regardless of HIV status. Middle-aged HIVpos subjects had elevated plasma biomarker levels similar to or greater than those of elderly HIVneg subjects with the exception of sCD14. Clustering analysis described an inflammaging phenotype (IP) based on iFABP, sCD14, sCD27, and hsCRP levels in HIVneg subjects over 60 years of age. The IP in HIVneg subjects was used to develop a classification model that was applied to HIVpos subjects to determine whether HIVpos subjects under 60 years of age were IP+. HIVpos IP+ subjects were similar in age to IP-subjects but had a greater risk of cardiovascular disease (CVD) based on Framingham risk score (p = 0.01). Conclusions: We describe a novel IP that incorporates biomarkers of IEBD, MT, immune activation as well as inflammation. Application of this novel IP in HIV-infected subjects identified a group at higher risk of CVD.	[Steele, Amanda K.; Lee, Eric J.; Hecht, Daniel; Dong, Zachary; Rapaport, Eric; Koeppe, John; Campbell, Thomas B.; Wilson, Cara C.] Univ Colorado, Sch Med, Dept Med, Aurora, CO USA; [Koeppe, John; Campbell, Thomas B.; Wilson, Cara C.] Univ Colorado, Sch Med, Dept Immunol, Aurora, CO USA; [Vestal, Brian] Univ Colorado, Colorado Biostat Consortium Res Consulting Lab, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Wilson, CC (corresponding author), Univ Colorado, Sch Med, Dept Med, Aurora, CO USA.	Cara.wilson@ucdenver.edu	Vestal, Brian/AAE-9289-2020		National Institute for Allergy and Infectious Disease at the National Institutes of Health; RO1 [R01 DK088663]; Colorado HIV-1 Research Training Program [NIH2T32AI007447-21]; NIH/NCATS Colorado CTSI [UL1 TR000154]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082, UL1TR000154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088663] Funding Source: NIH RePORTER	National Institute for Allergy and Infectious Disease at the National Institutes of Health; RO1(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Colorado HIV-1 Research Training Program; NIH/NCATS Colorado CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by funding from the National Institute for Allergy and Infectious Disease at the National Institutes of Health by an RO1 awarded to CW [R01 DK088663]. AS was supported by funds from the Colorado HIV-1 Research Training Program [NIH2T32AI007447-21]. BV was supported by NIH/NCATS Colorado CTSI Grant Number UL1 TR000154. Contents are the authors' sole responsibility and do not necessarily represent official NIH views. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blanco JR, 2010, AIDS REV, V12, P218; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Cassol E, 2010, J INFECT DIS, V202, P723, DOI 10.1086/655229; Cesari M, 2003, AM J CARDIOL, V92, P522, DOI 10.1016/S0002-9149(03)00718-5; Chironi G, 2011, INT J CARDIOL, V151, P200, DOI 10.1016/j.ijcard.2010.05.024; De Milito A, 2002, CLIN EXP IMMUNOL, V127, P486, DOI 10.1046/j.1365-2249.2002.01786.x; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; del Campo R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029577; Dillon SM, 2012, J IMMUNOL, V189, P885, DOI 10.4049/jimmunol.1200681; Erlandson KM, 2013, J INFECT DIS, V208, P249, DOI 10.1093/infdis/jit147; Ferguson JF, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-63; Ferrando-Martinez S, 2013, AGE, V35, P251, DOI 10.1007/s11357-011-9341-2; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Georges JL, 2003, AM J CARDIOL, V92, P515, DOI 10.1016/S0002-9149(03)00717-3; Haddad F, 2005, J APPL PHYSIOL, V98, P911, DOI 10.1152/japplphysiol.01026.2004; Han JY, 2009, JAIDS-J ACQ IMM DEF, V52, P553, DOI 10.1097/QAI.0b013e3181c1d4fe; Hand TW, 2012, SCIENCE, V337, P1553, DOI 10.1126/science.1220961; Hearps AC, 2012, AGING CELL, V11, P867, DOI 10.1111/j.1474-9726.2012.00851.x; High KP, 2012, JAIDS-J ACQ IMM DEF, V60, pS1, DOI 10.1097/QAI.0b013e31825a3668; Howe R, 2009, CLIN IMMUNOL, V131, P317, DOI 10.1016/j.clim.2008.12.003; Hsue PY, 2006, AIDS, V20, P2275, DOI 10.1097/QAD.0b013e3280108704; Hsue PY, 2012, J INFECT DIS, V205, pS375, DOI 10.1093/infdis/jis200; Il'yasova D, 2005, CANCER EPIDEM BIOMAR, V14, P2413, DOI 10.1158/1055-9965.EPI-05-0316; Kamat A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030881; Karlamangla AS, 2002, J CLIN EPIDEMIOL, V55, P696, DOI 10.1016/S0895-4356(02)00399-2; Larbi A, 2008, PHYSIOLOGY, V23, P64, DOI 10.1152/physiol.00040.2007; Tran L, 2013, J GERONTOL A-BIOL, V68, P1045, DOI 10.1093/gerona/glt106; Leng SX, 2011, AGE AGEING, V40, P475, DOI 10.1093/ageing/afr047; Lo J, 2010, AIDS, V24, P243, DOI 10.1097/QAD.0b013e328333ea9e; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; Loke P, 2010, BLOOD, V115, pE20, DOI 10.1182/blood-2009-12-257451; Manuzak JA, 2013, J VIROL; Manuzak J, 2012, CLIN VACCINE IMMUNOL, V19, P1207, DOI 10.1128/CVI.00282-12; Mavigner M, 2012, J CLIN INVEST, V122, P62, DOI 10.1172/JCI59011; McDonald B, 2013, AIDS RES HUM RETROV, V29, P993, DOI [10.1089/aid.2012.0309, 10.1089/AID.2012.0309]; Merino A, 2011, J IMMUNOL, V186, P1809, DOI 10.4049/jimmunol.1001866; Mirani M, 2002, J IMMUNOL, V169, P6361, DOI 10.4049/jimmunol.169.11.6361; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Pedersen KK, 2013, JAIDS-J ACQ IMM DEF, V63, P272, DOI 10.1097/QAI.0b013e318289bced; Pedersen KK, 2013, J ACQUIR IMMUNE DEFI; Penninx BWJH, 2004, J AM GERIATR SOC, V52, P1105, DOI 10.1111/j.1532-5415.2004.52308.x; Qian F, 2012, AGING CELL, V11, P104, DOI 10.1111/j.1474-9726.2011.00759.x; Reiner AP, 2013, ARTERIOSCL THROM VAS, V33, P158, DOI 10.1161/ATVBAHA.112.300421; Reus S, 2013, JAIDS-J ACQ IMM DEF, V62, P129, DOI 10.1097/QAI.0b013e3182745ab0; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Simanek AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016103; Vary TC, 2006, SHOCK, V26, P631, DOI 10.1097/01.shk.0000230299.78515.2c; Vesterbacka J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055038; Wikby A, 2002, EXP GERONTOL, V37, P445, DOI 10.1016/S0531-5565(01)00212-1; WIKBY A, 1994, EXP GERONTOL, V29, P531, DOI 10.1016/0531-5565(94)90036-1; Wikby A, 2008, BIOGERONTOLOGY, V9, P299, DOI 10.1007/s10522-008-9138-6; Yaffe K, 2003, NEUROLOGY, V61, P76, DOI 10.1212/01.WNL.0000073620.42047.D7; Yim HCH, 2009, AIDS, V23, P1473, DOI 10.1097/QAD.0b013e32832d7abe	54	46	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97171	10.1371/journal.pone.0097171	http://dx.doi.org/10.1371/journal.pone.0097171			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819230	Green Submitted, Green Published, gold			2022-12-27	WOS:000336653300085
J	Zhao, H; Wu, QQ; Cao, LF; Qing, HY; Zhang, C; Chen, YH; Wang, H; Liu, RR; Xu, DX				Zhao, Hui; Wu, Qing-Qing; Cao, Lin-Feng; Qing, Hou-Ying; Zhang, Cheng; Chen, Yuan-Hua; Wang, Hua; Liu, Rong-Ru; Xu, De-Xiang			Melatonin Inhibits Endoplasmic Reticulum Stress and Epithelial-Mesenchymal Transition during Bleomycin-Induced Pulmonary Fibrosis in Mice	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ANTIOXIDANT ENZYMES; ER STRESS; CELLULAR STRESS; ANIMAL-MODEL; VIRAL ORIGIN; NITRIC-OXIDE; LUNG INJURY; NF-B; CELLS	Several reports indicate that melatonin alleviates bleomycin (BLM)-induced pulmonary fibrosis in rodent animals. Nevertheless, the exact mechanism remains obscure. The present study investigated the effects of melatonin on endoplasmic reticulum (ER) stress and epithelial-mesenchymal transition (EMT) during BLM-induced lung fibrosis. For the induction of pulmonary fibrosis, mice were intratracheally injected with a single dose of BLM (5.0 mg/kg). Some mice were intraperitoneally injected with melatonin (5 mg/kg) daily for a period of 3 wk. Twenty-one days after BLM injection, lung fibrosis was evaluated. As expected, melatonin significantly alleviated BLM-induced pulmonary fibrosis, as evidenced by Sirius red staining. Moreover, melatonin significantly attenuated BLM-induced EMT to myofibroblasts, as determined by its repression of alpha-SMA expression. Further analysis showed that melatonin markedly attenuated BLM-induced GRP78 up-regulation and elevation of the cleaved ATF6 in the lungs. Moreover, melatonin obviously attenuated BLM-induced activation of pulmonary eIF2 alpha, a downstream target of the PERK pathway. Finally, melatonin repressed BLM-induced pulmonary IRE1 alpha phosphorylation. Correspondingly, melatonin inhibited BLM-induced activation of XBP-1 and JNK, two downstream targets of the IRE1 pathway. Taken together, these results suggest that melatonin alleviates ER stress and ER stress-mediated EMT in the process of BLM-induced pulmonary fibrosis.	[Zhang, Cheng; Chen, Yuan-Hua; Wang, Hua; Xu, De-Xiang] Anhui Med Univ, Dept Toxicol, Hefei, Peoples R China; [Zhao, Hui; Liu, Rong-Ru] Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China; [Zhao, Hui; Wu, Qing-Qing; Cao, Lin-Feng; Qing, Hou-Ying] Anhui Med Univ, Affiliated Hosp 2, Hefei, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University	Liu, RR (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China.	rongyuliu@gmail.com; xudex@126.com			National Natural Science Foundation of China [30671786, 31000664]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (30671786,31000664). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON IYR, 1974, AM J PATHOL, V77, P185; Arslan SO, 2002, J PINEAL RES, V32, P21, DOI 10.1034/j.1600-079x.2002.10796.x; Borchers AT, 2011, CLIN REV ALLERG IMMU, V40, P117, DOI 10.1007/s12016-010-8211-5; Choi EY, 2011, J PINEAL RES, V50, P197, DOI 10.1111/j.1600-079X.2010.00829.x; Crespo I, 2010, J PINEAL RES, V49, P193, DOI 10.1111/j.1600-079X.2010.00787.x; Galano A, 2013, J PINEAL RES, V54, P245, DOI 10.1111/jpi.12010; Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x; Genovese T, 2005, J PINEAL RES, V39, P105, DOI 10.1111/j.1600-079X.2005.00229.x; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hetz C, 2011, PHYSIOL REV, V91, P1219, DOI 10.1152/physrev.00001.2011; Hu B, 2011, AM J PATHOL, V178, P1500, DOI 10.1016/j.ajpath.2011.01.002; Huang LS, 2013, AM J RESP CELL MOL, V49, P912, DOI 10.1165/rcmb.2013-0070OC; Ji YL, 2012, J PINEAL RES, V52, P71, DOI 10.1111/j.1600-079X.2011.00921.x; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Kohno K, 2007, ANTIOXID REDOX SIGN, V9, P2295, DOI 10.1089/ars.2007.1819; Korfei M, 2008, AM J RESP CRIT CARE, V178, P838, DOI 10.1164/rccm.200802-313OC; Lawson WE, 2008, AM J PHYSIOL-LUNG C, V294, pL1119, DOI 10.1152/ajplung.00382.2007; Lawson WE, 2011, P NATL ACAD SCI USA, V108, P10562, DOI 10.1073/pnas.1107559108; Lee YD, 2009, J PINEAL RES, V46, P53, DOI 10.1111/j.1600-079X.2008.00621.x; Lin AMY, 2007, J PINEAL RES, V43, P163, DOI 10.1111/j.1600-079X.2007.00456.x; Min KJ, 2012, J PINEAL RES, V52, P296, DOI 10.1111/j.1600-079X.2011.00943.x; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Muro AF, 2008, AM J RESP CRIT CARE, V177, P638, DOI 10.1164/rccm.200708-1291OC; Park HJ, 2007, J PINEAL RES, V43, P121, DOI 10.1111/j.1600-079X.2007.00452.x; Richter HG, 2009, J PINEAL RES, V46, P357, DOI 10.1111/j.1600-079X.2009.00671.x; Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Shi DB, 2012, J PINEAL RES, V53, P154, DOI 10.1111/j.1600-079X.2012.00982.x; Tanjore H, 2011, J BIOL CHEM, V286, P30972, DOI 10.1074/jbc.M110.181164; Tunon MJ, 2013, J PINEAL RES, V55, P221, DOI 10.1111/jpi.12063; Vyas-Read S, 2007, AM J PHYSIOL-LUNG C, V293, pL212, DOI 10.1152/ajplung.00475.2006; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang H, 2011, J PINEAL RES, V50, P418, DOI 10.1111/j.1600-079X.2011.00860.x; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Wu CC, 2012, J PINEAL RES, V52, P460, DOI 10.1111/j.1600-079X.2011.00960.x; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Xia MZ, 2012, J PINEAL RES, V53, P325, DOI 10.1111/j.1600-079X.2012.01002.x; Xu DX, 2007, J PINEAL RES, V43, P74, DOI 10.1111/j.1600-079X.2007.00445.x; Yildirim Z, 2006, J PINEAL RES, V40, P27, DOI 10.1111/j.1600-079X.2005.00272.x; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zhong Q, 2011, AM J RESP CELL MOL, V45, P498, DOI 10.1165/rcmb.2010-0347OC	44	66	72	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97266	10.1371/journal.pone.0097266	http://dx.doi.org/10.1371/journal.pone.0097266			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24818755	gold, Green Published, Green Submitted			2022-12-27	WOS:000336653300100
J	Buskiewicz, IA; Koenig, A; Roberts, B; Russell, J; Shi, CX; Lee, SH; Jung, JU; Huber, SA; Budd, RC				Buskiewicz, Iwona A.; Koenig, Andreas; Roberts, Brian; Russell, Jennifer; Shi, Cuixia; Lee, Sun-Hwa; Jung, Jae U.; Huber, Sally A.; Budd, Ralph C.			c-FLIP-Short Reduces Type I Interferon Production and Increases Viremia with Coxsackievirus B3	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; NF-KAPPA-B; ANTIVIRAL SIGNALING PROTEIN; POLYMERASE-CHAIN-REACTION; SEX-RELATED DIFFERENCES; DOUBLE-STRANDED-RNA; T-REGULATORY-CELLS; B3-INDUCED MYOCARDITIS; VIRUS-INFECTION; ADAPTER PROTEIN	Cellular FLIP (c-FLIP) is an enzymatically inactive paralogue of caspase-8 and as such can block death receptor-induced apoptosis. However, independent of death receptors, c-FLIP-Long (c-FLIPL) can heterodimerize with and activate caspase-8. This is critical for promoting the growth and survival of T lymphocytes as well as the regulation of the RIG-I helicase pathway for type I interferon production in response to viral infections. Truncated forms of FLIP also exist in mammalian cells (c-FLIPS) and certain viruses (v-FLIP), which lack the C-terminal domain that activates caspase-8. Thus, the ratio of c-FLIPL to these short forms of FLIP may greatly influence the outcome of an immune response. We examined this model in mice transgenically expressing c-FLIPS in T cells during infection with Coxsackievirus B3 (CVB3). In contrast to our earlier findings of reduced myocarditis and mortality with CVB3 infection of c-FLIPL-transgenic mice, c-FLIPS-transgenic mice were highly sensitive to CVB3 infection as manifested by increased cardiac virus titers, myocarditis score, and mortality compared to wild-type C57BL/6 mice. This observation was paralleled by a reduction in serum levels of IL-10 and IFN-alpha in CVB3-infected c-FLIPS mice. In vitro infection of c-FLIPS T cells with CVB3 confirmed these results. Furthermore, molecular studies revealed that following infection of cells with CVB3, c-FLIPL associates with mitochondrial antiviral signaling protein (MAVS), increases caspase-8 activity and type I IFN production, and reduces viral replication, whereas c-FLIPS promotes the opposite phenotype.	[Buskiewicz, Iwona A.; Roberts, Brian; Huber, Sally A.] Univ Vermont, Dept Pathol, Vermont Ctr Immunol & Infect Dis, Burlington, VT 05405 USA; [Koenig, Andreas; Russell, Jennifer; Shi, Cuixia; Budd, Ralph C.] Univ Vermont, Dept Med, Vermont Ctr Immunol & Infect Dis, Burlington, VT USA; [Lee, Sun-Hwa; Jung, Jae U.] Univ So Calif, Dept Mol Microbiol & Immunol, Los Angeles, CA USA	University of Vermont; University of Vermont; University of Southern California	Buskiewicz, IA (corresponding author), Univ Vermont, Dept Pathol, Vermont Ctr Immunol & Infect Dis, Burlington, VT 05405 USA.	ibuskiew@uvm.edu			National Institutes of Health [HL86549, HL93604, HL108371, GM103496, AI36333, AI45666, CA82057, CA31363, DE019085, AI073099, AI083025, HL110609]; Hastings Foundation; Fletcher Jones Foundation; NATIONAL CANCER INSTITUTE [R01CA031363, R01CA082057] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL093604, R01HL110609, R01HL108371, R01HL086549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073099, R01AI036333, P01AI045666, U19AI083025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [P01DE019085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hastings Foundation; Fletcher Jones Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (www.nih.gov) grants HL86549, HL93604, HL108371, GM103496, AI36333, AI45666, CA82057, CA31363, DE019085, AI073099, AI083025, and HL110609, as well as the Hastings Foundation (www.hastingseducationfoundation.org) and the Fletcher Jones Foundation (www.fletcherjonesfdn.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2012, ANTIMICROB AGENTS CH, V56, P3516, DOI 10.1128/AAC.06050-12; Altfeld M, 2011, NAT REV IMMUNOL, V11, P176, DOI 10.1038/nri2935; Althof N, 2013, J VIROL, V87, P2823, DOI 10.1128/JVI.03004-12; Asselin-Paturel C, 2005, J EXP MED, V201, P1157, DOI 10.1084/jem.20041930; Bartlett EJ, 2004, IMMUNOL CELL BIOL, V82, P119, DOI 10.1046/j.0818-9641.2004.01234.x; Bjorck P, 2004, J IMMUNOL, V172, P5396, DOI 10.4049/jimmunol.172.9.5396; BORROW P, 1995, J VIROL, V69, P1059, DOI 10.1128/JVI.69.2.1059-1070.1995; Bowles, 2000, Curr Infect Dis Rep, V2, P308, DOI 10.1007/s11908-000-0008-x; Bowles NE, 2003, J AM COLL CARDIOL, V42, P466, DOI 10.1016/S0735-1097(03)00648-X; Bowles NE, 2002, J AM COLL CARDIOL, V39, P892, DOI 10.1016/S0735-1097(02)01688-1; CAPOBIANCHI M R, 1991, Viral Immunology, V4, P103, DOI 10.1089/vim.1991.4.103; Chen ZH, 2007, J VIROL, V81, P964, DOI 10.1128/JVI.02076-06; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Drahos J, 2009, J VIROL, V83, P11581, DOI 10.1128/JVI.01490-09; Duan XZ, 2004, J CLIN IMMUNOL, V24, P637, DOI 10.1007/s10875-004-6249-y; Feng Q, 2012, CELL REP, V2, P1187, DOI 10.1016/j.celrep.2012.10.005; Feuer R, 2002, J VIROL, V76, P4430, DOI 10.1128/JVI.76.9.4430-4440.2002; Feuer R, 2009, J VIROL, V83, P9356, DOI 10.1128/JVI.02382-07; Finke JS, 2004, J CLIN IMMUNOL, V24, P647, DOI 10.1007/s10875-004-6250-5; Fujio K, 2010, ADV IMMUNOL, V105, P99, DOI 10.1016/S0065-2776(10)05004-2; Fung MC, 2004, J IMMUNOL METHODS, V284, P177, DOI 10.1016/j.jim.2003.10.012; Golks A, 2005, J BIOL CHEM, V280, P14507, DOI 10.1074/jbc.M414425200; Gulzar N, 2008, CURR HIV RES, V6, P585, DOI 10.2174/157016208786501544; Gulzar Naveed, 2008, Open AIDS J, V2, P43, DOI 10.2174/1874613600802010043; GUTHRIE M, 1984, CELL IMMUNOL, V88, P558, DOI 10.1016/0008-8749(84)90188-6; He MX, 2013, CELL DEATH DIFFER, V20, P188, DOI 10.1038/cdd.2012.148; Heim A, 2004, MED MICROBIOL IMMUN, V193, P149, DOI 10.1007/s00430-003-0200-3; Helfer B, 2006, CANCER RES, V66, P4273, DOI 10.1158/0008-5472.CAN-05-4183; HENKE A, 1995, J VIROL, V69, P6720, DOI 10.1128/JVI.69.11.6720-6728.1995; Hinshaw-Makepeace J, 2008, EUR J IMMUNOL, V38, P54, DOI 10.1002/eji.200636956; Huber S, 2000, ANTIGENIC MIMICRY SE, P57; Huber SA, 2008, VIROLOGY, V378, P292, DOI 10.1016/j.virol.2008.05.015; HUBER SA, 1981, INFECT IMMUN, V32, P68, DOI 10.1128/IAI.32.1.68-73.1981; Huber SA, 1999, J VIROL, V73, P4689, DOI 10.1128/JVI.73.6.4689-4695.1999; HUBER SA, 1984, AM J PATHOL, V116, P21; Huber SA, 2002, J VIROL, V76, P10785, DOI 10.1128/JVI.76.21.10785-10790.2002; HUBER SA, 1981, J IMMUNOL, V126, P1336; Huber SA, 2001, J VIROL, V75, P5860, DOI 10.1128/JVI.75.13.5860-5869.2001; Huber S, 2006, IMMUNOLOGY, V119, P541, DOI 10.1111/j.1365-2567.2006.02469.x; Huber SA, 2006, CIRC RES, V99, P1109, DOI 10.1161/01.RES.0000249405.13536.49; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Jia W, 2011, J IMMUNOL, V186, P5313, DOI 10.4049/jimmunol.1002404; Jia W, 2011, J IMMUNOL, V186, P1564, DOI 10.4049/jimmunol.1001822; Kanto T, 2004, J INFECT DIS, V190, P1919, DOI 10.1086/425425; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kaya Z, 2002, J IMMUNOL, V168, P1552, DOI 10.4049/jimmunol.168.4.1552; Kemball CC, 2010, J VIROL, V84, P12110, DOI 10.1128/JVI.01417-10; Kennedy NJ, 1999, J EXP MED, V190, P1891, DOI 10.1084/jem.190.12.1891; KISHIMOTO C, 1988, CARDIOVASC RES, V22, P732, DOI 10.1093/cvr/22.10.732; Klingel K, 1996, J VIROL, V70, P8888, DOI 10.1128/JVI.70.12.8888-8895.1996; Knowlton KU, 1999, CIRC RES, V85, P559, DOI 10.1161/01.RES.85.6.559; Knowlton KU, 1996, J VIROL, V70, P7811, DOI 10.1128/JVI.70.11.7811-7818.1996; Kovalenko A, 2009, J EXP MED, V206, P2161, DOI 10.1084/jem.20090616; Lee JS, 2009, NAT CELL BIOL, V11, P1355, DOI 10.1038/ncb1980; Lee LN, 2009, J IMMUNOL, V182, P7178, DOI 10.4049/jimmunol.0802526; Lens SMA, 2002, MOL CELL BIOL, V22, P5419, DOI 10.1128/MCB.22.15.5419-5433.2002; Leverrier S, 2011, CELL DEATH DIFFER, V18, P90, DOI 10.1038/cdd.2010.69; Li LN, 2010, VIROLOGY, V396, P59, DOI 10.1016/j.virol.2009.10.013; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Liu P, 2000, NAT MED, V6, P429, DOI 10.1038/74689; Lund JM, 2006, J IMMUNOL, V177, P7510, DOI 10.4049/jimmunol.177.11.7510; LUTTON CW, 1985, J INTERFERON RES, V5, P137, DOI 10.1089/jir.1985.5.137; LYDEN DC, 1987, AM J PATHOL, V126, P432; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Micheau O, 2002, J BIOL CHEM, V277, P45162, DOI 10.1074/jbc.M206882200; Mukherjee A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001311; Opavsky MA, 1999, CIRC RES, V85, P551, DOI 10.1161/01.RES.85.6.551; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pop C, 2011, BIOCHEM J, V433, P447, DOI 10.1042/BJ20101738; Potter SJ, 2003, VIROLOGY, V305, P339, DOI 10.1006/viro.2002.1703; Pua HH, 2009, AUTOPHAGY, V5, P745, DOI 10.4161/auto.5.5.8702; Punj V, 2009, BLOOD, V113, P5660, DOI 10.1182/blood-2008-10-186403; Rajput A, 2011, IMMUNITY, V34, P340, DOI 10.1016/j.immuni.2010.12.018; Ritthipichai K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039438; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sevilla N, 2000, J EXP MED, V192, P1249, DOI 10.1084/jem.192.9.1249; Smit JJ, 2006, J EXP MED, V203, P1153, DOI 10.1084/jem.20052359; Sturzl M, 1999, J NATL CANCER I, V91, P1725, DOI 10.1093/jnci/91.20.1725; Swiecki M, 2011, J EXP MED, V208, P2367, DOI 10.1084/jem.20110654; Swiecki M, 2010, IMMUNITY, V33, P955, DOI 10.1016/j.immuni.2010.11.020; Tabor-Godwin JM, 2010, J NEUROSCI, V30, P8676, DOI 10.1523/JNEUROSCI.1860-10.2010; Takahashi K, 2006, J IMMUNOL, V176, P4520, DOI 10.4049/jimmunol.176.8.4520; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Tschopp J, 1998, CURR OPIN IMMUNOL, V10, P552, DOI 10.1016/S0952-7915(98)80223-9; VANHOUTEN N, 1991, J VIROL, V65, P1286, DOI 10.1128/JVI.65.3.1286-1290.1991; VLASPOLDER F, 1988, ARCH VIROL, V98, P123, DOI 10.1007/BF01321013; Wang JP, 2010, J VIROL, V84, P254, DOI 10.1128/JVI.00631-09; Wessely R, 1998, CIRCULATION, V98, P450, DOI 10.1161/01.CIR.98.5.450; Wessely R, 1998, J CLIN INVEST, V102, P1444, DOI 10.1172/JCI1972; Wessely R, 2001, CIRCULATION, V103, P756; Wong J, 2008, J VIROL, V82, P9143, DOI 10.1128/JVI.00641-08; WOODRUFF JF, 1979, J IMMUNOL, V123, P31; WOODRUFF JF, 1974, J IMMUNOL, V113, P1726; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yang Y, 2007, P NATL ACAD SCI USA, V104, P7253, DOI 10.1073/pnas.0611506104; Zuniga EI, 2008, CELL HOST MICROBE, V4, P374, DOI 10.1016/j.chom.2008.08.016	99	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96156	10.1371/journal.pone.0096156	http://dx.doi.org/10.1371/journal.pone.0096156			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816846	Green Published, Green Submitted, gold			2022-12-27	WOS:000336838000024
J	Qin, FF; Shen, ZW; Peng, LH; Wu, RH; Hu, X; Zhang, GS; Tang, SJ				Qin, Feifei; Shen, Zhiwei; Peng, Lihong; Wu, Renhua; Hu, Xiao; Zhang, Guishan; Tang, Shijie			Metabolic Characterization of All-Trans-Retinoic Acid (ATRA)-Induced Craniofacial Development of Murine Embryos Using In Vivo Proton Magnetic Resonance Spectroscopy	PLOS ONE			English	Article							CLEFT-PALATE; OROFACIAL CLEFTS; MR SPECTROSCOPY; CELL-DEATH; LIP; APOPTOSIS; CANCER	Aim: To characterize the abnormal metabolic profile of all-trans-retinoic acid (ATRA)-induced craniofacial development in mouse embryos using proton magnetic resonance spectroscopy (H-1-MRS). Methods: Timed-pregnant mice were treated by oral gavage on the morning of embryonic gestation day 11 (E11) with alltrans-retinoic acid (ATRA). Dosing solutions were adjusted by maternal body weight to provide 30, 70, or 100 mg/kg RA. The control group was given an equivalent volume of the carrier alone. Using an Agilent 7.0 T MR system and a combination of surface coil coils, a 3 mmx3 mmx3 mm H-1-MRS voxel was selected along the embryonic craniofacial tissue. H-1-MRS was performed with a single-voxel method using PRESS sequence and analyzed using LCModel software. Hematoxylin and eosin was used to detect and confirm cleft palate. Result: H-1-MRS revealed elevated choline levels in embryonic craniofacial tissue in the RA70 and RA100 groups compared to controls (P<0.05). Increased choline levels were also found in the RA70 and RA100 groups compared with the RA30 group (P<0.01). High intra-myocellular lipids at 1.30 ppm (IMCL13) in the RA100 group compared to the RA30 group were found (P<0.01). There were no significant changes in taurine, intra-myocellular lipids at 2.10 ppm (IMCL21), and extra-myocellular lipids at 2.30 ppm (EMCL23). Cleft palate formation was observed in all fetuses carried by mice administered 70 and 100 mg/kg RA. Conclusions: This novel study suggests that the elevated choline and lipid levels found by H-1-MRS may represent early biomarkers of craniofacial defects. Further studies will determine performance of this test and pathogenetic mechanisms of craniofacial malformation.	[Qin, Feifei; Peng, Lihong; Tang, Shijie] Shantou Univ, Coll Med, Affiliated Hosp 2, Cleft Lip & Palate Treatment Ctr, Shantou, Guangdong, Peoples R China; [Shen, Zhiwei; Wu, Renhua; Zhang, Guishan] Shantou Univ, Coll Med, Affiliated Hosp 2, Dept Med Imaging, Shantou, Guangdong, Peoples R China; [Hu, Xiao] Guangzhou Red Cross Hosp, Dept Plast & Burn Surg, Guangzhou, Guangdong, Peoples R China	Shantou University; Shantou University	Tang, SJ (corresponding author), Shantou Univ, Coll Med, Affiliated Hosp 2, Cleft Lip & Palate Treatment Ctr, Shantou, Guangdong, Peoples R China.	tang2302@163.com	TANG, Shi/GXH-5719-2022		Shantou University Medical College Clinical Research Enhancement Initiative	Shantou University Medical College Clinical Research Enhancement Initiative	This work was sponsored by Shantou University Medical College Clinical Research Enhancement Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermans MMG, 2011, NUTR REV, V69, P613, DOI 10.1111/j.1753-4887.2011.00425.x; Beaty TH, 2010, NAT GENET, V42, P525, DOI 10.1038/ng.580; Begley JKP, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3132; BLUSZTAJN JK, 1983, SCIENCE, V221, P614, DOI 10.1126/science.6867732; Campbell JL, 2004, BIRTH DEFECTS RES B, V71, P289, DOI 10.1002/bdrb.20015; Castillo M, 1996, AM J NEURORADIOL, V17, P1; Chai Y, 2006, DEV DYNAM, V235, P2353, DOI 10.1002/dvdy.20833; Conti F, 2006, Clin Ter, V157, P549; Cuervo R, 2002, DEV BIOL, V245, P145, DOI 10.1006/dbio.2002.0620; den Heijer T, 2006, NEUROLOGY, V66, P540, DOI 10.1212/01.wnl.0000198256.54809.0e; Denison FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042926; Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933; Gomez-Casati DF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/792527; Hu D, 1999, DEVELOPMENT, V126, P4873; Jugessur A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039240; Little J, 2004, B WORLD HEALTH ORGAN, V82, P213; Lodi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026155; Meisamy S, 2004, RADIOLOGY, V233, P424, DOI 10.1148/radiol.2332031285; Murray JC, 2004, J CLIN INVEST, V113, P1676, DOI 10.1172/JCI200422154; Murray JC, 2002, CLIN GENET, V61, P248, DOI 10.1034/j.1399-0004.2002.610402.x; Nicholson JK, 2012, NATURE, V491, P384, DOI 10.1038/nature11708; Okano J, 2007, TOXICOL APPL PHARM, V221, P42, DOI 10.1016/j.taap.2007.02.019; Penet MF, 2011, CANCER RES, V71, P6948, DOI 10.1158/0008-5472.CAN-11-1095; Qian JC, 2010, J NEUROTRAUM, V27, P599, DOI 10.1089/neu.2009.1145; Ross AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069333; Shih CM, 2005, ANN NY ACAD SCI, V1042, P488, DOI 10.1196/annals.1338.042; Story L, 2011, EUR J OBSTET GYN R B, V158, P3, DOI 10.1016/j.ejogrb.2010.03.003; van der Graaf M, 2010, EUR BIOPHYS J BIOPHY, V39, P527, DOI 10.1007/s00249-009-0517-y; Wehby GL, 2010, ORAL DIS, V16, P11, DOI 10.1111/j.1601-0825.2009.01587.x; Wehby GL, 2010, ORAL DIS, V16, P3, DOI 10.1111/j.1601-0825.2009.01588.x; Wu T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088088; Yu ZL, 2006, TOXICOL SCI, V89, P504, DOI 10.1093/toxsci/kfj046; Zhou JL, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/509043	33	19	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96010	10.1371/journal.pone.0096010	http://dx.doi.org/10.1371/journal.pone.0096010			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816763	Green Published, Green Submitted, gold			2022-12-27	WOS:000336838000020
J	Quinn, DM; Williams, MK; Quintana, F; Gaskins, JL; Overstreet, NM; Pishori, A; Earnshaw, VA; Perez, G; Chaudoir, SR				Quinn, Diane M.; Williams, Michelle K.; Quintana, Francisco; Gaskins, Jennifer L.; Overstreet, Nicole M.; Pishori, Alefiyah; Earnshaw, Valerie A.; Perez, Giselle; Chaudoir, Stephenie R.			Examining Effects of Anticipated Stigma, Centrality, Salience, Internalization, and Outness on Psychological Distress for People with Concealable Stigmatized Identities	PLOS ONE			English	Article							CHILD SEXUAL-ABUSE; MENTAL-HEALTH; SELF-STIGMA; RACIAL IDENTITY; PERCEIVED DISCRIMINATION; ILLNESS; IMPACT; MODEL; HIV; ATTRIBUTION	Understanding how stigmatized identities contribute to increased rates of depression and anxiety is critical to stigma reduction and mental health treatment. There has been little research testing multiple aspects of stigmatized identities simultaneously. In the current study, we collected data from a diverse, urban, adult community sample of people with a concealed stigmatized identity (CSI). We targeted 5 specific CSIs - mental illness, substance abuse, experience of domestic violence, experience of sexual assault, and experience of childhood abuse - that have been shown to put people at risk for increased psychological distress. We collected measures of the anticipation of being devalued by others if the identity became known (anticipated stigma), the level of defining oneself by the stigmatized identity (centrality), the frequency of thinking about the identity (salience), the extent of agreement with negative stereotypes about the identity (internalized stigma), and extent to which other people currently know about the identity (outness). Results showed that greater anticipated stigma, greater identity salience, and lower levels of outness each uniquely and significantly predicted variance in increased psychological distress (a composite of depression and anxiety). In examining communalities and differences across the five identities, we found that mean levels of the stigma variables differed across the identities, with people with substance abuse and mental illness reporting greater anticipated and internalized stigma. However, the prediction pattern of the variables for psychological distress was similar across the substance abuse, mental illness, domestic violence, and childhood abuse identities (but not sexual assault). Understanding which components of stigmatized identities predict distress can lead to more effective treatment for people experiencing psychological distress.	[Quinn, Diane M.; Williams, Michelle K.; Quintana, Francisco; Gaskins, Jennifer L.; Pishori, Alefiyah; Perez, Giselle] Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA; [Overstreet, Nicole M.; Earnshaw, Valerie A.] Yale Univ, Ctr Interdisciplinary Res AIDS, Hew Haven, CT USA; [Chaudoir, Stephenie R.] Coll Holy Cross, Dept Psychol, Worcester, MA 01610 USA	University of Connecticut; Yale University; College of the Holy Cross	Quinn, DM (corresponding author), Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA.	diane.quinn@uconn.edu	Quinn, Diane/X-3584-2019; Quintana, Francisco Javier/AAB-6915-2020	Quinn, Diane/0000-0003-4492-7580; 	National Institute of Mental Health (NIMH) of the National Institutes of Health [R01MH82916]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082916, T32MH020031, P30MH062294] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH) of the National Institutes of Health; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Research was supported by the National Institute of Mental Health (NIMH) of the National Institutes of Health under award number R01MH82916 to Diane M. Quinn and Michelle K. Williams. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern J, 2007, DRUG ALCOHOL DEPEN, V88, P188, DOI 10.1016/j.drugalcdep.2006.10.014; Allision JA, 1993, RAPE MISUNDERSTOOD C; [Anonymous], 2005, SIGMA MENTAL ILLNESS; Archer J, 2002, AGGRESS VIOLENT BEH, V7, P313, DOI 10.1016/S1359-1789(01)00061-1; Axelrod J., 1999, CULTURAL DIVERSITY E, P263, DOI [10.1037/1099-9809.5.3.263, DOI 10.1037/1099-9809.5.3.263]; Baumann AE, 2007, INT REV PSYCHIATR, V19, P131, DOI 10.1080/09540260701278739; Berger BE, 2001, RES NURS HEALTH, V24, P518, DOI 10.1002/nur.10011; Black Michele C, 2006, Violence Vict, V21, P445, DOI 10.1891/vivi.21.4.445; Bowleg L, 2008, SEX ROLES, V59, P312, DOI 10.1007/s11199-008-9400-z; Boysen GA, 2008, J SOC CLIN PSYCHOL, V27, P447, DOI 10.1521/jscp.2008.27.5.447; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Briere J, 2003, CHILD ABUSE NEGLECT, V27, P1205, DOI 10.1016/j.chiabu.2003.09.008; Burrow AL, 2010, SELF IDENTITY, V9, P383, DOI 10.1080/15298860903192496; Byrne Barbara M., 2013, STRUCTURAL EQUATION; CAETANO R, 1987, J STUD ALCOHOL, V48, P153, DOI 10.15288/jsa.1987.48.153; Cole SW, 1997, J PERS SOC PSYCHOL, V72, P320, DOI 10.1037/0022-3514.72.2.320; Corrigan P, 2003, J HEALTH SOC BEHAV, V44, P162, DOI 10.2307/1519806; Corrigan PW, 2013, AM J PUBLIC HEALTH, V103, P794, DOI 10.2105/AJPH.2012.301037; Corrigan PW, 2012, PSYCHIAT RES, V199, P65, DOI 10.1016/j.psychres.2012.04.009; Corrigan PW, 2011, PSYCHIAT RES, V189, P339, DOI 10.1016/j.psychres.2011.05.024; Corrigan PW, 2002, CLIN PSYCHOL-SCI PR, V9, P35, DOI 10.1093/clipsy/9.1.35; CUNNINGHAM JA, 1993, J STUD ALCOHOL, V54, P693, DOI 10.15288/jsa.1993.54.693; DEAN JC, 1984, INT J ADDICT, V19, P859, DOI 10.3109/10826088409061991; DOWNEY G, 1990, PSYCHOL BULL, V108, P50, DOI 10.1037/0033-2909.108.1.50; Earnshaw VA, 2015, J HEALTH PSYCHOL, V20, P1083, DOI 10.1177/1359105313507964; Earnshaw VA, 2013, J BEHAV MED, V36, P270, DOI 10.1007/s10865-012-9422-4; Earnshaw VA, 2012, CHRONIC ILLN, V8, P79, DOI 10.1177/1742395311429393; Earnshaw VA, 2012, J HEALTH PSYCHOL, V17, P157, DOI 10.1177/1359105311414952; Earnshaw VA, 2009, AIDS BEHAV, V13, P1160, DOI 10.1007/s10461-009-9593-3; Eisenberg D, 2009, MED CARE RES REV, V66, P522, DOI 10.1177/1077558709335173; Feiring C, 2000, Child Maltreat, V5, P311, DOI 10.1177/1077559500005004003; Fischbach RL, 1997, SOC SCI MED, V45, P1161, DOI 10.1016/S0277-9536(97)00022-1; Frable DES, 1998, J PERS SOC PSYCHOL, V74, P909, DOI 10.1037/0022-3514.74.4.909; Gibson LE, 2001, CHILD ABUSE NEGLECT, V25, P1343, DOI 10.1016/S0145-2134(01)00279-4; Grubb A, 2012, AGGRESS VIOLENT BEH, V17, P443, DOI 10.1016/j.avb.2012.06.002; Hatzenbuehler ML, 2009, PSYCHOL BULL, V135, P707, DOI 10.1037/a0016441; Hayes AF, 2012, PROCESS VERSATILE OC; Herr NR, 2007, J FAM PSYCHOL, V21, P694, DOI 10.1037/0893-3200.21.4.694; Huebner DM, 2005, J SOC CLIN PSYCHOL, V24, P723, DOI 10.1521/jscp.2005.24.5.723; HUGHES HM, 1988, AM J ORTHOPSYCHIAT, V58, P77, DOI 10.1111/j.1939-0025.1988.tb01568.x; Jacoby A, 2007, EPILEPSIA, V48, P6, DOI 10.1111/j.1528-1167.2007.01391.x; Janulis P, 2013, J APPL SOC PSYCHOL, V43, P1065, DOI 10.1111/jasp.12070; Jarvis B. G., 2006, MEDIA LAB VERSION 20; Kalichman SC, 2009, AIDS CARE, V21, P87, DOI 10.1080/09540120802032627; Kessler R.C., 2002, NEUROPSYCHOPHARMACOL; Kessler RC, 1999, J HEALTH SOC BEHAV, V40, P208, DOI 10.2307/2676349; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 2012, PSYCHIAT CLIN N AM, V35, P1, DOI 10.1016/j.psc.2011.11.005; Klein DN, 2005, PSYCHOL MED, V35, P353, DOI 10.1017/S0033291704003587; Koss MP, 2002, J CONSULT CLIN PSYCH, V70, P926, DOI 10.1037//0022-006X.70.4.926; Kurzban R, 2001, PSYCHOL BULL, V127, P187, DOI 10.1037//0033-2909.127.2.187; Lawerence S, 2004, DEPRESSION SUBSTANCE; Leach CW, 2008, J PERS SOC PSYCHOL, V95, P144, DOI 10.1037/0022-3514.95.1.144; Leach CW, 2010, J SOC ISSUES, V66, P535, DOI 10.1111/j.1540-4560.2010.01661.x; Lee RS, 2002, AIDS BEHAV, V6, P309, DOI DOI 10.1023/A:1021144511957; Legate N, 2012, SOC PSYCHOL PERS SCI, V3, P145, DOI 10.1177/1948550611411929; Limandri B J, 1989, Arch Psychiatr Nurs, V3, P69; Link BG, 2001, PSYCHIATR SERV, V52, P1621, DOI 10.1176/appi.ps.52.12.1621; LINK BG, 1987, AM SOCIOL REV, V52, P96, DOI 10.2307/2095395; Livingston JD, 2010, SOC SCI MED, V71, P2150, DOI 10.1016/j.socscimed.2010.09.030; Lucksted A, 2011, PSYCHIATR REHABIL J, V35, P51, DOI 10.2975/35.1.2011.51.54; LUHTANEN R, 1992, PERS SOC PSYCHOL B, V18, P302, DOI 10.1177/0146167292183006; Luoma JB, 2007, ADDICT BEHAV, V32, P1331, DOI 10.1016/j.addbeh.2006.09.008; Mackey T, 1992, Arch Psychiatr Nurs, V6, P10, DOI 10.1016/0883-9417(92)90050-S; McCann I L, 1992, J Am Coll Health, V40, P189; McCauley J, 1998, J GEN INTERN MED, V13, P549, DOI 10.1046/j.1525-1497.1998.00166.x; Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674; Morris JF, 2001, AM J ORTHOPSYCHIAT, V71, P61, DOI 10.1037/0002-9432.71.1.61; National Institute of Mental Health, TOT EXP 5 MOST COSTL; Newcomb ME, 2010, CLIN PSYCHOL REV, V30, P1019, DOI 10.1016/j.cpr.2010.07.003; Overstreet NM, 2013, BASIC APPL SOC PSYCH, V35, P109, DOI 10.1080/01973533.2012.746599; Quinn DM, 2011, SOC ISS POLICY REV, V5, P160, DOI 10.1111/j.1751-2409.2011.01029.x; Quinn DM, 2009, J PERS SOC PSYCHOL, V97, P634, DOI 10.1037/a0015815; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rind B, 1998, PSYCHOL BULL, V124, P22, DOI 10.1037/0033-2909.124.1.22; Ritsher JB, 2004, PSYCHIAT RES, V129, P257, DOI 10.1016/j.psychres.2004.08.003; Rose D, 2012, PUBLIC HLTH ASPECTS; Rusch N, 2014, BRIT J PSYCHIAT, V204, P391, DOI 10.1192/bjp.bp.113.135772; Sellers RM, 2003, J HEALTH SOC BEHAV, V44, P302, DOI 10.2307/1519781; Sellers RM, 2003, J PERS SOC PSYCHOL, V84, P1079, DOI 10.1037/0022-3514.84.5.1079; Sirey JA, 2001, PSYCHIAT SERV, V52, P1615, DOI 10.1176/appi.ps.52.12.1615; Smart L, 1999, J PERS SOC PSYCHOL, V77, P474, DOI 10.1037/0022-3514.77.3.474; Soto JA, 2012, CULT DIVERS ETHN MIN, V18, P384, DOI 10.1037/a0029781; Spielberger C.D., 1980, STRESS ANXIETY, P95; Starr Sharon, 2002, Issues Ment Health Nurs, V23, P291, DOI 10.1080/016128402753543027; Strauss M. A., 1990, PHYS VIOLENCE AM FAM; Substance Abuse and Mental Health Services Administration, 2013, NSDUH SER H, VH-46; Varni SE, 2012, J SOC CLIN PSYCHOL, V31, P123, DOI 10.1521/jscp.2012.31.2.123; Vyavaharkar M, 2011, AIDS EDUC PREV, V23, P78, DOI 10.1521/aeap.2011.23.1.78; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P629, DOI 10.1001/archpsyc.62.6.629; WEIDNER G, 1983, J PERS, V51, P152; WEINER B, 1988, J PERS SOC PSYCHOL, V55, P738, DOI 10.1037/0022-3514.55.5.738; Weinstock LM, 2006, J CONSULT CLIN PSYCH, V74, P1192, DOI 10.1037/0022-006X.74.6.1192; Woods SA, 2005, EUR J PERSONALITY, V19, P373, DOI 10.1002/per.542; Yanos PT, 2012, PSYCHOL SERV, V9, P248, DOI 10.1037/a0028048; Zhao GX, 2012, COMMUNITY MENT HLT J, V48, P275, DOI 10.1007/s10597-011-9424-7	96	121	122	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96977	10.1371/journal.pone.0096977	http://dx.doi.org/10.1371/journal.pone.0096977			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4LX	24817189	Green Submitted, Green Published, gold			2022-12-27	WOS:000336838000088
J	Shaw-Hallgren, G; Masoumi, KC; Zarrizi, R; Hellman, U; Karlsson, P; Helou, K; Massoumi, R				Shaw-Hallgren, Gina; Masoumi, Katarzyna Chmielarska; Zarrizi, Reihaneh; Hellman, Ulf; Karlsson, Per; Helou, Khalil; Massoumi, Ramin			Association of Nuclear-Localized Nemo-Like Kinase with Heat-Shock Protein 27 Inhibits Apoptosis in Human Breast Cancer Cells	PLOS ONE			English	Article							C-MYB; HEPATOCELLULAR-CARCINOMA; MESODERM INDUCTION; ANTERIOR FORMATION; SIGNALING PATHWAY; PHOSPHORYLATION; NLK; DEGRADATION; HSP27; DOWNSTREAM	Nemo-like kinase (NLK), a proline-directed serine/threonine kinase regulated by phosphorylation, can be localized in the cytosol or in the nucleus. Whether the localization of NLK can affect cell survival or cell apoptosis is yet to be disclosed. In the present study we found that NLK was mainly localized in the nuclei of breast cancer cells, in contrast to a cytosolic localization in non-cancerous breast epithelial cells. The nuclear localization of NLK was mediated through direct interaction with Heat shock protein 27 (HSP27) which further protected cancer cells from apoptosis. The present study provides evidence of a novel mechanism by which HSP27 recognizes NLK in the breast cancer cells and prevents NLK-mediated cell apoptosis.	[Shaw-Hallgren, Gina; Masoumi, Katarzyna Chmielarska; Zarrizi, Reihaneh; Massoumi, Ramin] Lund Univ, Dept Lab Med, Translat Canc Res, Lund, Sweden; [Hellman, Ulf] Ludwig Inst Canc Res, S-75124 Uppsala, Sweden; [Karlsson, Per; Helou, Khalil] Univ Gothenburg, Inst Clin Sci, Dept Oncol, Gothenburg, Sweden	Lund University; Ludwig Institute for Cancer Research; University of Gothenburg	Massoumi, R (corresponding author), Lund Univ, Dept Lab Med, Translat Canc Res, Lund, Sweden.	Ramin.Massoumi@med.lu.se	Massoumi, Ramin/AAG-4786-2019	Masoumi, Katarzyna/0000-0002-9277-6505	Swedish Cancer Foundation; Swedish Medical Research Council; Gunnar Nilsson Foundation; Gyllenstiernska Kapperups Foundation; BioCARE program; Magnus Bergvall Foundation; Royal Physiographic Society in Lund; European Research Council (ERC), under the European Union [260460]	Swedish Cancer Foundation; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Gunnar Nilsson Foundation; Gyllenstiernska Kapperups Foundation; BioCARE program; Magnus Bergvall Foundation; Royal Physiographic Society in Lund; European Research Council (ERC), under the European Union(European Research Council (ERC))	The study was supported by the Swedish Cancer Foundation, the Swedish Medical Research Council, the Gunnar Nilsson Foundation, the Gyllenstiernska Kapperups Foundation, the BioCARE program, the Magnus Bergvall Foundation, the Royal Physiographic Society in Lund, and by funding from the European Research Council (ERC), under the European Union's Seventh Framework Programme for Research and Technology Development, grant agreement no. [260460], awarded to RM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brott BK, 1998, P NATL ACAD SCI USA, V95, P963, DOI 10.1073/pnas.95.3.963; CIOCCA DR, 1993, JNCI-J NATL CANCER I, V85, P1558, DOI 10.1093/jnci/85.19.1558; Coulombe P, 2007, BBA-MOL CELL RES, V1773, P1376, DOI 10.1016/j.bbamcr.2006.11.001; Emami KH, 2009, PROSTATE, V69, P1481, DOI 10.1002/pros.20998; Geum D, 2002, J BIOL CHEM, V277, P19913, DOI 10.1074/jbc.M104396200; Hansen RK, 1999, BREAST CANCER RES TR, V56, P187; Hellman U, 2002, RAPID COMMUN MASS SP, V16, P1851, DOI 10.1002/rcm.805; Ishitani S, 2011, MOL BIOL CELL, V22, P266, DOI 10.1091/mbc.E10-07-0605; Ishitani T, 2003, MOL CELL BIOL, V23, P1379, DOI 10.1128/MCB.23.4.1379-1389.2003; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Ishitani T, NATURE CELL BIOL, V12, P278; Ishitani T, 2009, J NEUROCHEM, V111, P1104, DOI 10.1111/j.1471-4159.2009.06400.x; Jung KH, 2010, J CELL BIOCHEM, V110, P687, DOI 10.1002/jcb.22579; KAMPINGA HH, 1994, BIOCHEM BIOPH RES CO, V204, P1170, DOI 10.1006/bbrc.1994.2586; Kanei-Ishii C, 2004, J BIOL CHEM, V279, P44582, DOI 10.1074/jbc.M407831200; Kanei-Ishii C, 2004, GENE DEV, V18, P816, DOI 10.1101/gad.1170604; Kanei-Ishii C, 2008, J BIOL CHEM, V283, P30540, DOI 10.1074/jbc.M804340200; Kang SH, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-286; Kim S, 2010, J BIOL CHEM, V285, P8122, DOI 10.1074/jbc.M110.101824; Kojima H, 2005, P NATL ACAD SCI USA, V102, P4524, DOI 10.1073/pnas.0500679102; Kostenko S, 2009, CELL MOL LIFE SCI, V66, P3289, DOI 10.1007/s00018-009-0086-3; Kurahashi T, 2005, MOL BIOL CELL, V16, P4705, DOI 10.1091/mbc.E05-05-0470; Li M, 2010, J BIOL CHEM, V285, P13397, DOI 10.1074/jbc.M109.083246; Meneghini MD, 1999, NATURE, V399, P793, DOI 10.1038/21666; Myung Jae-Kyung, 2004, Proteome Sci, V2, P8, DOI 10.1186/1477-5956-2-8; Nifuji A, 2010, EXP CELL RES, V316, P1127, DOI 10.1016/j.yexcr.2010.01.023; Ohkawara B, 2004, GENE DEV, V18, P381, DOI 10.1101/gad.1166904; Ohnishi E, 2010, MOL CELL BIOL, V30, P675, DOI 10.1128/MCB.00576-09; Pannem RR, 2014, CARCINOGENESIS, V35, P461, DOI 10.1093/carcin/bgt335; Rottinger E, 2006, DEVELOPMENT, V133, P4341, DOI 10.1242/dev.02603; Satoh K, 2007, MOL CELL BIOL, V27, P7623, DOI 10.1128/MCB.01481-07; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smit L, 2004, J BIOL CHEM, V279, P17232, DOI 10.1074/jbc.M307801200; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Takada I, 2009, EXPERT OPIN THER TAR, V13, P593, DOI [10.1517/14728220902915310 , 10.1517/14728220902915310]; Williams K, 1998, ELECTROPHORESIS, V19, P333, DOI 10.1002/elps.1150190231; Yamada M, 2006, J BIOL CHEM, V281, P20749, DOI 10.1074/jbc.M602089200; Yasuda J, 2004, CANCER SCI, V95, P52, DOI 10.1111/j.1349-7006.2004.tb03170.x; Yasuda J, 2003, BIOCHEM BIOPH RES CO, V308, P227, DOI 10.1016/S0006-291X(03)01343-3; Zeng YA, 2007, DEVELOPMENT, V134, P2061, DOI 10.1242/dev.02853	40	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96506	10.1371/journal.pone.0096506	http://dx.doi.org/10.1371/journal.pone.0096506			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816797	Green Submitted, gold, Green Published			2022-12-27	WOS:000336838000040
J	Mehra, R; Barile, D; Marotta, M; Lebrilla, CB; Chu, C; German, JB				Mehra, Raj; Barile, Daniela; Marotta, Mariarosaria; Lebrilla, Carlito B.; Chu, Caroline; German, J. Bruce			Novel High-Molecular Weight Fucosylated Milk Oligosaccharides Identified in Dairy Streams	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; LACTOSE-DERIVED OLIGOSACCHARIDES; BOVINE-MILK; NEUTRAL TRISACCHARIDES; MALDI-MS; COLOSTRUM; LACTATION; BINDING; SIALYLOLIGOSACCHARIDES; SPECTROMETRY	Oligosaccharides are the third largest component in human milk. This abundance is remarkable because oligosaccharides are not digestible by the newborn, and yet they have been conserved and amplified during evolution. In addition to encouraging the growth of a protective microbiota dominated by bifidobacteria, oligosaccharides have anti-infective activity, preventing pathogens from binding to intestinal cells. Although it would be advantageous adding these valuable molecules to infant milk formula, the technologies to reproduce the variety and complexity of human milk oligosaccharides by enzymatic/organic synthesis are not yet mature. Consequently, there is an enormous interest in alternative sources of these valuable oligosaccharides. Recent research has demonstrated that bovine milk and whey permeate also contain oligosaccharides. Thus, a thorough characterization of oligosaccharides in bovine dairy streams is an important step towards fully assessing their specific functionalities. In this study, bovine milk oligosaccharides (BMOs) were concentrated by membrane filtration from a readily available dairy stream called "mother liquor", and analyzed by high accuracy MALDI FT-ICR mass spectrometry. The combination of HPLC and accurate mass spectrometry allowed the identification of ideal processing conditions leading to the production of Kg amount of BMO enriched powders. Among the BMOs identified, 18 have high-molecular weight and corresponded in size to the most abundant oligosaccharides present in human milk. Notably 6 oligosaccharides contained fucose, a sugar monomer that is highly abundant in human milk, but is rarely observed in bovine milk. This work shows that dairy streams represent a potential source of complex milk oligosaccharides for commercial development of unique dairy ingredients in functional foods that reproduce the benefits of human milk.	[Mehra, Raj; Marotta, Mariarosaria] Teagasc Food Res Ctr, Fermoy, Cork, Ireland; [Barile, Daniela; German, J. Bruce] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA; [Lebrilla, Carlito B.; Chu, Caroline] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Lebrilla, Carlito B.; German, J. Bruce] Univ Calif Davis, Foods Hlth Inst, Davis, CA 95616 USA	Teagasc; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Barile, D (corresponding author), Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA.	dbarile@ucdavis.edu	barile, daniela/AAA-3892-2020; Lebrilla, Carlito Bangeles/ABE-6369-2020	barile, daniela/0000-0002-3889-1596; 	University of California Discovery Program [05GEB01NHB]; National Institute of Environmental Health Sciences [P42ES004699]; National Institutes of Health award [R01AT00707]; California Dairy Research Foundation [08 GEB-04 NH]; CHARGE study [P01 ES11269]; Irish Department of Agriculture, Fisheries and Food through the Food Institutional Research Measure [FIRM-05/RD/TD/368]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT000707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004699, P01ES011269] Funding Source: NIH RePORTER	University of California Discovery Program; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Dairy Research Foundation; CHARGE study; Irish Department of Agriculture, Fisheries and Food through the Food Institutional Research Measure; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This project was supported by the University of California Discovery Program (05GEB01NHB), the National Institute of Environmental Health Sciences (P42ES004699), the National Institutes of Health award R01AT00707, the California Dairy Research Foundation (08 GEB-04 NH) and the CHARGE study (P01 ES11269). The authors acknowledge financial support from the Irish Department of Agriculture, Fisheries and Food through the Food Institutional Research Measure (FIRM-05/R&D/TD/368). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Environmental Health Sciences or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldredge DL, 2013, GLYCOBIOLOGY, V23, P664, DOI 10.1093/glycob/cwt007; Balagtas JV, 2003, J DAIRY SCI, V86, P1662, DOI 10.3168/jds.S0022-0302(03)73752-7; Barile D, 2010, J DAIRY SCI, V93, P3940, DOI 10.3168/jds.2010-3156; Barile D, 2009, INT DAIRY J, V19, P524, DOI 10.1016/j.idairyj.2009.03.008; Bode L, 2012, GLYCOBIOLOGY, V22, P1147, DOI 10.1093/glycob/cws074; Coppa GV, 2004, J CLIN GASTROENTEROL, V38, pS80, DOI 10.1097/01.mcg.0000128926.14285.25; CRANE JK, 1994, J NUTR, V124, P2358, DOI 10.1093/jn/124.12.2358; Finke B, 2000, ANAL BIOCHEM, V284, P256, DOI 10.1006/abio.2000.4680; Finke B, 1999, ANAL CHEM, V71, P3755, DOI 10.1021/ac990094z; Gopal Pramod K., 2000, British Journal of Nutrition, V84, pS69; Kobata A, 2010, P JPN ACAD B-PHYS, V86, P731, DOI 10.2183/pjab.86.731; Kunz C, 2008, ADV EXP MED BIOL, V606, P455, DOI 10.1007/978-0-387-74087-4_18; Kunz C, 1999, CLIN PERINATOL, V26, P307, DOI 10.1016/S0095-5108(18)30055-1; Kunz C, 2006, INT DAIRY J, V16, P1341, DOI 10.1016/j.idairyj.2006.06.020; Marino K, 2011, GLYCOBIOLOGY, V21, P1317, DOI 10.1093/glycob/cwr067; Martin-Sosa S, 2003, J DAIRY SCI, V86, P52, DOI 10.3168/jds.S0022-0302(03)73583-8; Martinez-Ferez A, 2006, INT DAIRY J, V16, P173, DOI 10.1016/j.idairyj.2005.02.003; Martinez-Ferez A, 2009, DESALINATION, V245, P730, DOI 10.1016/j.desal.2009.02.044; McJarrow P, 2004, INT DAIRY J, V14, P571, DOI 10.1016/j.idairyj.2003.11.006; Meyrand M, 2013, SMALL RUMINANT RES, V113, P411, DOI 10.1016/j.smallrumres.2013.03.014; Nakajima K, 2006, ANAL BIOCHEM, V348, P105, DOI 10.1016/j.ab.2005.10.010; Nakamura T, 2003, J DAIRY SCI, V86, P1315, DOI 10.3168/jds.S0022-0302(03)73715-1; Newburg DS, 2009, J ANIM SCI, V87, P26, DOI 10.2527/jas.2008-1347; Newburg DS, 2004, GLYCOBIOLOGY, V14, P253, DOI 10.1093/glycob/cwh020; Ninonuevo MR, 2006, J AGR FOOD CHEM, V54, P7471, DOI 10.1021/jf0615810; Peters RH, 2005, INT DAIRY J, V15, P537, DOI 10.1016/j.idairyj.2004.11.009; Ruiz-Palacios GM, 2003, J BIOL CHEM, V278, P14112, DOI 10.1074/jbc.M207744200; SAITO T, 1987, CARBOHYD RES, V165, P43, DOI 10.1016/0008-6215(87)80076-9; Simon PM, 1997, INFECT IMMUN, V65, P750, DOI 10.1128/IAI.65.2.750-757.1997; Stepans MBF, 2006, BREASTFEED MED, V1, P207, DOI 10.1089/bfm.2006.1.207; Sundekilde UK, 2012, J AGR FOOD CHEM, V60, P6188, DOI 10.1021/jf300015j; Tao N, 2008, J DAIRY SCI, V91, P3768, DOI 10.3168/jds.2008-1305; Tao N, 2009, J DAIRY SCI, V92, P2991, DOI 10.3168/jds.2008-1642; URASHIMA T, 1994, CARBOHYD RES, V262, P173, DOI 10.1016/0008-6215(94)84177-2; Urashima T, 2013, BIOSCI BIOTECH BIOCH, V77, P455, DOI 10.1271/bbb.120810; Ward RE, 2006, APPL ENVIRON MICROB, V72, P4497, DOI 10.1128/AEM.02515-05; Wu SA, 2010, J PROTEOME RES, V9, P4138, DOI 10.1021/pr100362f	37	46	48	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96040	10.1371/journal.pone.0096040	http://dx.doi.org/10.1371/journal.pone.0096040			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810963	Green Published, gold, Green Submitted			2022-12-27	WOS:000338213300017
J	Nuss, JE; Kehn-Hall, K; Benedict, A; Costantino, J; Ward, M; Peyser, BD; Retterer, CJ; Tressler, LE; Wanner, LM; McGovern, HF; Zaidi, A; Anthony, SM; Kota, KP; Bavari, S; Hakami, RM				Nuss, Jonathan E.; Kehn-Hall, Kylene; Benedict, Ashwini; Costantino, Julie; Ward, Michael; Peyser, Brian D.; Retterer, Cary J.; Tressler, Lyal E.; Wanner, Laura M.; McGovern, Hugh F.; Zaidi, Anum; Anthony, Scott M.; Kota, Krishna P.; Bavari, Sina; Hakami, Ramin M.			Multi-Faceted Proteomic Characterization of Host Protein Complement of Rift Valley Fever Virus Virions and Identification of Specific Heat Shock Proteins, Including HSP90, as Important Viral Host Factors	PLOS ONE			English	Article							OXIDATIVELY DAMAGED PROTEINS; MASS-SPECTROMETRY ANALYSIS; TRANSPORT CHAIN COMPLEXES; RAPID DETECTION; CYCLOPHILIN-A; HIV-1 VIRIONS; LASSA VIRUS; CELLS; INFECTION; REPLICATION	Rift Valley fever is a potentially fatal disease of humans and domestic animals caused by Rift Valley fever virus (RVFV). Infection with RVFV in ruminants can cause near 100% abortion rates and recent outbreaks in naive human populations have suggested case fatality rates of greater than thirty percent. To elucidate the roles that host proteins play during RVFV infection, proteomic analysis of RVFV virions was conducted using complementary analytical approaches, followed by functional validation studies of select identified host factors. Coupling the more traditional Gel LC/MS/MS approach (SDS PAGE followed by liquid chromatography tandem mass spectrometry) with an alternative technique that preserves protein complexes allowed the protein complement of these viral particles to be thoroughly examined. In addition to viral proteins present within the virions and virion-associated host proteins, multiple macromolecular complexes were identified. Bioinformatic analysis showed that host chaperones were among over-represented protein families associated with virions, and functional experiments using siRNA gene silencing and small molecule inhibitors identified several of these heat shock proteins, including heat shock protein 90 (HSP90), as important viral host factors. Further analysis indicated that HSP inhibition effects occur during the replication/transcription phase of the virus life cycle, leading to significant lowering of viral titers without compromising the functional capacity of released virions. Overall, these studies provide much needed further insight into interactions between RVFV and host cells, increasing our understanding of the infection process and suggesting novel strategies for anti-viral development. In particular, considering that several HSP90 inhibitors have been advancing through clinical trials for cancer treatment, these results also highlight the exciting potential of repurposing HSP90 inhibitors to treat RVF.	[Nuss, Jonathan E.; Costantino, Julie; Ward, Michael; Peyser, Brian D.; Retterer, Cary J.; Tressler, Lyal E.; Wanner, Laura M.; McGovern, Hugh F.; Zaidi, Anum; Kota, Krishna P.; Bavari, Sina] US Army Med Res Inst Infect Dis, Frederick, MD 21701 USA; [Kehn-Hall, Kylene; Benedict, Ashwini; Hakami, Ramin M.] George Mason Univ, Sch Syst Biol, Manassas, VA USA; [Kehn-Hall, Kylene; Benedict, Ashwini; Hakami, Ramin M.] George Mason Univ, Natl Ctr Biodef & Infect Dis, Manassas, VA USA; [Anthony, Scott M.] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA	United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army; George Mason University; George Mason University; University of Texas System; University of Texas Health Science Center Houston	Bavari, S (corresponding author), US Army Med Res Inst Infect Dis, Frederick, MD 21701 USA.	sina.bavari@us.army.mil; rhakami@gmu.edu	Kota, Krishna/GPF-8474-2022; Bavari, Sina/L-3642-2019; Peyser, Brian/ABB-8010-2020; Kehn-Hall, Kylene/I-5752-2013	Bavari, Sina/0000-0001-8424-5635; Peyser, Brian/0000-0002-3455-5181; Kehn-Hall, Kylene/0000-0001-8036-7213; Anthony, Scott/0000-0002-1590-7401	U.S. Army Medical Research and Materiel Command (MRMC) [W81XWH-11-P-0310]; George Mason University; Defense Threat Reduction Agency Transformational Medical Technologies [TMTI0048_09_RD_T]	U.S. Army Medical Research and Materiel Command (MRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); George Mason University; Defense Threat Reduction Agency Transformational Medical Technologies	This research was supported by funding awarded to R.M.H. by the U.S. Army Medical Research and Materiel Command (MRMC) (W81XWH-11-P-0310) and George Mason University, and by a grant awarded to S.B. from the Defense Threat Reduction Agency Transformational Medical Technologies [TMTI0048_09_RD_T]. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Rahim IHA, 1999, REV SCI TECH OIE, V18, P741, DOI 10.20506/rst.18.3.1195; AMICI C, 1994, J VIROL, V68, P6890, DOI 10.1128/JVI.68.11.6890-6899.1994; ARTHUR RR, 1993, LANCET, V342, P1149, DOI 10.1016/0140-6736(93)92128-G; Banerji U, 2009, CLIN CANCER RES, V15, P9, DOI 10.1158/1078-0432.CCR-08-0132; Bechtel JT, 2005, J VIROL, V79, P4952, DOI 10.1128/JVI.79.8.4952-4964.2005; BERINSTEIN A, 1995, J VIROL, V69, P2664, DOI 10.1128/JVI.69.4.2664-2666.1995; Bitto E, 1999, BIOCHEMISTRY-US, V38, P14094, DOI 10.1021/bi990457p; Bukrinskaya A, 1998, J EXP MED, V188, P2113, DOI 10.1084/jem.188.11.2113; Chang WM, 2003, CELL SIGNAL, V15, P57, DOI 10.1016/S0898-6568(02)00055-4; Chase G, 2008, VIROLOGY, V377, P431, DOI 10.1016/j.virol.2008.04.040; Chertova E, 2006, J VIROL, V80, P9039, DOI 10.1128/JVI.01013-06; Choksi KB, 2008, FREE RADICAL BIO MED, V45, P826, DOI 10.1016/j.freeradbiomed.2008.06.006; Choksi KB, 2007, FREE RADICAL BIO MED, V43, P1423, DOI 10.1016/j.freeradbiomed.2007.07.027; Chu JJH, 2004, J BIOL CHEM, V279, P54533, DOI 10.1074/jbc.M410208200; Connor JH, 2007, VIROLOGY, V362, P109, DOI 10.1016/j.virol.2006.12.026; Cseke G, 2009, P NATL ACAD SCI USA, V106, P1566, DOI 10.1073/pnas.0801433106; DIGOUTTE JP, 1989, RES VIROLOGY, V140, P27, DOI 10.1016/S0923-2516(89)80081-0; DIGOUTTE JP, 1989, RES VIROLOGY, V140, P31, DOI 10.1016/S0923-2516(89)80082-2; Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002; Dupuy AG, 2008, J CELL SCI, V121, P1773, DOI 10.1242/jcs.018036; Fackler OT, 2006, CURR OPIN MICROBIOL, V9, P409, DOI 10.1016/j.mib.2006.06.010; Falsone SF, 2005, FEBS LETT, V579, P6350, DOI 10.1016/j.febslet.2005.10.020; Flick R, 2011, J BIOTERR BIODEF, V2, P108; Fontana J, 2008, CELL MICROBIOL, V10, P2012, DOI 10.1111/j.1462-5822.2008.01184.x; FRANKE EK, 1994, NATURE, V372, P359, DOI 10.1038/372359a0; Gerrard SR, 2002, VIROLOGY, V301, P226, DOI 10.1006/viro.2002.1588; GIORGI C, 1991, VIROLOGY, V180, P738, DOI 10.1016/0042-6822(91)90087-R; Grantham J, 2000, J BIOL CHEM, V275, P4587, DOI 10.1074/jbc.275.7.4587; Harmon B, 2012, J VIROL, V86, P12954, DOI 10.1128/JVI.02242-12; Hung JJ, 2002, J VIROL, V76, P1379, DOI 10.1128/JVI.76.3.1379-1390.2002; Ikegami T, 2011, VIRUSES-BASEL, V3, P493, DOI 10.3390/v3050493; Ikegami T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000287; Johannsen E, 2004, P NATL ACAD SCI USA, V101, P16286, DOI 10.1073/pnas.0407320101; Kattenhorn LM, 2004, J VIROL, V78, P11187, DOI 10.1128/JVI.78.20.11187-11197.2004; Larson RS, 2005, J VIROL, V79, P7319, DOI 10.1128/JVI.79.12.7319-7326.2005; Le Roux CA, 2009, J CLIN MICROBIOL, V47, P645, DOI 10.1128/JCM.01412-08; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Mudhasani R, 2013, J VIROL, V87, P8451, DOI 10.1128/JVI.03382-12; Nakagawa S, 2007, BIOCHEM BIOPH RES CO, V353, P882, DOI 10.1016/j.bbrc.2006.12.117; Nydegger S, 2006, J CELL BIOL, V173, P795, DOI 10.1083/jcb.200508165; Panchal RG, 2010, J BIOMOL SCREEN, V15, P755, DOI 10.1177/1087057110374357; Radoshitzky SR, 2010, J VIROL, V84, P10569, DOI 10.1128/JVI.00103-10; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Sharov VS, 2002, ANAL BIOCHEM, V308, P328, DOI 10.1016/S0003-2697(02)00261-0; Shaw ML, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000085; Smith DR, 2010, ANTIVIR RES, V87, P187, DOI 10.1016/j.antiviral.2010.04.015; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Sorin M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000463; Spurgers KB, 2010, MOL CELL PROTEOMICS, V9, P2690, DOI 10.1074/mcp.M110.003418; STRUTHERS JK, 1982, J GEN VIROL, V60, P381, DOI 10.1099/0022-1317-60-2-381; THALI M, 1994, NATURE, V372, P363, DOI 10.1038/372363a0; Varnum SM, 2004, J VIROL, V78, P10960, DOI 10.1128/JVI.78.20.10960-10966.2004; Vialat P, 1997, VIRUS RES, V52, P43, DOI 10.1016/S0168-1702(97)00097-X; WATTS DM, 1988, AM J TROP MED HYG, V39, P611, DOI 10.4269/ajtmh.1988.39.611; WILSON ML, 1994, AM J TROP MED HYG, V50, P663, DOI 10.4269/ajtmh.1994.50.663; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yadani FZ, 1999, J VIROL, V73, P5018, DOI 10.1128/JVI.73.6.5018-5025.1999; Yoder JD, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-10; Yokota S, 2000, CANCER RES, V60, P2942	60	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e93483	10.1371/journal.pone.0093483	http://dx.doi.org/10.1371/journal.pone.0093483			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809507	Green Published, gold, Green Submitted			2022-12-27	WOS:000338213300004
J	Sun, S; Selmer, M; Andersson, DI				Sun, Song; Selmer, Maria; Andersson, Dan I.			Resistance to beta-Lactam Antibiotics Conferred by Point Mutations in Penicillin-Binding Proteins PBP3, PBP4 and PBP6 in Salmonella enterica	PLOS ONE			English	Article							ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; STREPTOCOCCUS-PNEUMONIAE; PEPTIDOGLYCAN; DEACYLATION; EVOLUTION; LOCALIZATION; SEQUENCE; STRAINS; FAMILY	Penicillin-binding proteins (PBPs) are enzymes responsible for the polymerization of the glycan strand and the cross-linking between glycan chains as well as the target proteins for beta-lactam antibiotics. Mutational alterations in PBPs can confer resistance either by reducing binding of the antibiotic to the active site or by evolving a beta-lactamase activity that degrades the antibiotic. As no systematic studies have been performed to examine the potential of all PBPs present in one bacterial species to evolve increased resistance against beta-lactam antibiotics, we explored the ability of fifteen different defined or putative PBPs in Salmonella enterica to acquire increased resistance against penicillin G. We could after mutagenesis and selection in presence of penicillin G isolate mutants with amino-acid substitutions in the PBPs, FtsI, DacB and DacC (corresponding to PBP3, PBP4 and PBP6) with increased resistance against b-lactam antibiotics. Our results suggest that: (i) most evolved PBPs became 'generalists" with increased resistance against several different classes of b-lactam antibiotics, (ii) synergistic interactions between mutations conferring antibiotic resistance are common and (iii) the mechanism of resistance of these mutants could be to make the active site more accessible for water allowing hydrolysis or less binding to b-lactam antibiotics.	[Sun, Song; Andersson, Dan I.] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Selmer, Maria] Uppsala Univ, Dept Cell & Mol Biol, Uppsala, Sweden	Uppsala University; Uppsala University	Andersson, DI (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.	Dan.Anderssson@imbim.uu.se		Andersson, Dan/0000-0001-6640-2174	Swedish Research Council [2012-3482, 2013-5930]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by grants from the Swedish Research Council to DIA (grant 2012-3482) and MS (grant 2013-5930). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam M, 1997, J BACTERIOL, V179, P6005, DOI 10.1128/jb.179.19.6005-6009.1997; Barbosa AR, 2011, J ANTIMICROB CHEMOTH, V66, P788, DOI 10.1093/jac/dkq533; Chen Y, 2009, J AM CHEM SOC, V131, P14345, DOI 10.1021/ja903773f; Chesnel L, 2002, EUR J BIOCHEM, V269, P1678, DOI 10.1046/j.1432-1327.2002.02815.x; Davies C, 2001, J BIOL CHEM, V276, P616, DOI 10.1074/jbc.M004471200; Deka RK, 2002, J BIOL CHEM, V277, P41857, DOI 10.1074/jbc.M207402200; Ghosh AS, 2008, TRENDS MICROBIOL, V16, P309, DOI 10.1016/j.tim.2008.04.006; GHUYSEN JM, 1991, ANNU REV MICROBIOL, V45, P37, DOI 10.1146/annurev.mi.45.100191.000345; Goffin C, 1998, MICROBIOL MOL BIOL R, V62, P1079, DOI 10.1128/MMBR.62.4.1079-1093.1998; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hakenbeck R, 2012, FUTURE MICROBIOL, V7, P395, DOI [10.2217/FMB.12.2, 10.2217/fmb.12.2]; Han S, 2011, J AM CHEM SOC, V133, P20536, DOI 10.1021/ja208835z; Josephine HR, 2006, BIOCHEMISTRY-US, V45, P15873, DOI 10.1021/bi061804f; Kawai F, 2010, J MOL BIOL, V396, P634, DOI 10.1016/j.jmb.2009.11.055; KELLY JA, 1986, SCIENCE, V231, P1429, DOI 10.1126/science.3082007; Knox JR, 1996, CHEM BIOL, V3, P937, DOI 10.1016/S1074-5521(96)90182-9; LIVERMORE DM, 1987, J ANTIMICROB CHEMOTH, V19, P733, DOI 10.1093/jac/19.6.733; Massova I, 1998, ANTIMICROB AGENTS CH, V42, P1; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Meroueh SO, 2003, J AM CHEM SOC, V125, P9612, DOI 10.1021/ja034861u; Meroueh SO, 2006, P NATL ACAD SCI USA, V103, P4404, DOI 10.1073/pnas.0510182103; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nguyen-Disteche M, 1998, CELL MOL LIFE SCI, V54, P309, DOI 10.1007/s000180050157; Nicholas RA, 2003, J BIOL CHEM, V278, P52826, DOI 10.1074/jbc.M310177200; Peimbert M, 2003, PROTEIN ENG, V16, P27, DOI 10.1093/proeng/gzg008; Powell AJ, 2009, J BIOL CHEM, V284, P1202, DOI 10.1074/jbc.M805761200; Sainsbury S, 2011, J MOL BIOL, V405, P173, DOI 10.1016/j.jmb.2010.10.024; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005; Spratt BG, 1975, P NATL ACAD SCI USA, V72, P2999; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Urbach C, 2008, J BIOL CHEM, V283, P32516, DOI 10.1074/jbc.M805375200; Zapun A, 2008, FEMS MICROBIOL REV, V32, P361, DOI 10.1111/j.1574-6976.2007.00095.x	34	25	26	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e97202	10.1371/journal.pone.0097202	http://dx.doi.org/10.1371/journal.pone.0097202			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810745	Green Published, gold, Green Submitted			2022-12-27	WOS:000338213300135
J	Timmusk, S; Abd El-Daim, IA; Copolovici, L; Tanilas, T; Kannaste, A; Behers, L; Nevo, E; Seisenbaeva, G; Stenstrom, E; Niinemets, U				Timmusk, Salme; Abd El-Daim, Islam A.; Copolovici, Lucian; Tanilas, Triin; Kannaste, Astrid; Behers, Lawrence; Nevo, Eviatar; Seisenbaeva, Gulaim; Stenstrom, Elna; Niinemets, Ulo			Drought-Tolerance of Wheat Improved by Rhizosphere Bacteria from Harsh Environments: Enhanced Biomass Production and Reduced Emissions of Stress Volatiles	PLOS ONE			English	Article							SPECTROMETRY PTR-MS; PLANT-GROWTH; WATER-STRESS; ALGINATE PRODUCTION; ORGANIC-COMPOUNDS; LEAF VOLATILES; DEFENSE; ROOT; PHOTOSYNTHESIS; RESISTANCE	Water is the key resource limiting world agricultural production. Although an impressive number of research reports have been published on plant drought tolerance enhancement via genetic modifications during the last few years, progress has been slower than expected. We suggest a feasible alternative strategy by application of rhizospheric bacteria coevolved with plant roots in harsh environments over millions of years, and harboring adaptive traits improving plant fitness under biotic and abiotic stresses. We show the effect of bacterial priming on wheat drought stress tolerance enhancement, resulting in up to 78% greater plant biomass and five-fold higher survivorship under severe drought. We monitored emissions of seven stress-related volatiles from bacterially-primed drought-stressed wheat seedlings, and demonstrated that three of these volatiles are likely promising candidates for a rapid non-invasive technique to assess crop drought stress and its mitigation in early phases of stress development. We conclude that gauging stress by elicited volatiles provides an effectual platform for rapid screening of potent bacterial strains and that priming with isolates of rhizospheric bacteria from harsh environments is a promising, novel way to improve plant water use efficiency. These new advancements importantly contribute towards solving food security issues in changing climates.	[Timmusk, Salme; Abd El-Daim, Islam A.; Behers, Lawrence; Stenstrom, Elna] SLU, Uppsala BioCtr, Dept Forest Mycol & Plant Pathol, Uppsala, Sweden; [Copolovici, Lucian; Tanilas, Triin; Kannaste, Astrid; Niinemets, Ulo] Estonian Univ Life Sci, Dept Plant Physiol, Tartu, Estonia; [Nevo, Eviatar] Univ Haifa, Inst Evolut, IL-31999 Haifa, Israel; [Seisenbaeva, Gulaim] SLU, Uppsala BioCtr, Dept Chem & Biotechnol, Uppsala, Sweden; [Niinemets, Ulo] Estonian Acad Sci, EE-200103 Tallinn, Estonia	Swedish University of Agricultural Sciences; Estonian University of Life Sciences; University of Haifa; Swedish University of Agricultural Sciences; Estonian Academy of Sciences	Timmusk, S (corresponding author), SLU, Uppsala BioCtr, Dept Forest Mycol & Plant Pathol, Uppsala, Sweden.	salme.timmusk@slu.se	Niinemets, Ülo/A-3816-2008; Kannaste, Astrid/AAL-7565-2020; Copolovici, Lucian/B-6552-2011; /AAD-1608-2020; Seisenbaeva, Gulaim/Y-8024-2019	Niinemets, Ülo/0000-0002-3078-2192; Kannaste, Astrid/0000-0002-9753-7677; Copolovici, Lucian/0000-0002-4454-200X; /0000-0002-7089-2994; Seisenbaeva, Gulaim/0000-0003-0072-6082; timmusk, s/0000-0001-8465-1043	European Commission through European Regional Fund (the Centre of Excellence in Environmental Adaptation); European Research Council [322603]; European Union [FP7:247669]; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning [2009-243]; Carl Tryggers Stiftelse for vetenskaplig forskning [CTS09:385]; Stiftelsen Oscar och Lili Lamms Minne [DO2009-0052]; Estonian Ministry of Science and Education (institutional grant [IUT-8-3]	European Commission through European Regional Fund (the Centre of Excellence in Environmental Adaptation); European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); Carl Tryggers Stiftelse for vetenskaplig forskning; Stiftelsen Oscar och Lili Lamms Minne; Estonian Ministry of Science and Education (institutional grant	Financial support for the study was provided by the European Commission through European Regional Fund (the Centre of Excellence in Environmental Adaptation), and the European Research Council (advanced grant 322603, SIP-VOL+), European Union FP7:247669, the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning 2009-243, Carl Tryggers Stiftelse for vetenskaplig forskning CTS09:385, Stiftelsen Oscar och Lili Lamms Minne DO2009-0052, and by the Estonian Ministry of Science and Education (institutional grant IUT-8-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin IT, 2010, CURR BIOL, V20, pR392, DOI 10.1016/j.cub.2010.02.052; Beauchamp J, 2005, PLANT CELL ENVIRON, V28, P1334, DOI 10.1111/j.1365-3040.2005.01383.x; Beis A, 2010, FUNCT PLANT BIOL, V37, P139, DOI 10.1071/FP09034; Belimov AA, 2009, NEW PHYTOL, V181, P413, DOI 10.1111/j.1469-8137.2008.02657.x; Brilli F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020419; Cavender-Bares J, 2000, OECOLOGIA, V124, P8, DOI 10.1007/PL00008865; Chang WS, 2007, J BACTERIOL, V189, P8290, DOI 10.1128/JB.00727-07; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Chaves MM, 2002, ANN BOT-LONDON, V89, P907, DOI 10.1093/aob/mcf105; Chen F, 2003, PLANT CELL, V15, P481, DOI 10.1105/tpc.007989; Choudhary DK, 2008, CURR SCI INDIA, V94, P595; Clark RT, 2011, PLANT PHYSIOL, V156, P455, DOI 10.1104/pp.110.169102; Conrath U, 2006, MOL PLANT MICROBE IN, V19, P1062, DOI 10.1094/MPMI-19-1062; Copaciu F, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1478-4; Copolovici L, 2012, J PLANT PHYSIOL, V169, P664, DOI 10.1016/j.jplph.2011.12.019; Copolovici L, 2011, J CHEM ECOL, V37, P18, DOI 10.1007/s10886-010-9897-9; Copolovici L, 2010, PLANT CELL ENVIRON, V33, P1582, DOI 10.1111/j.1365-3040.2010.02166.x; Copolovici L, 2009, STUD U BABES-BOL CHE, V54, P329; Dimkpa C, 2009, PLANT CELL ENVIRON, V32, P1682, DOI 10.1111/j.1365-3040.2009.02028.x; Donati I, 2009, MICROBIOL MONOGR, V13, P1, DOI 10.1007/978-3-540-92679-5_1; Fleury D, 2010, J EXP BOT, V61, P3211, DOI 10.1093/jxb/erq152; Flexas J, 2002, ANN BOT-LONDON, V89, P183, DOI 10.1093/aob/mcf027; Flexas J, 2013, PHOTOSYNTH RES, V117, P1; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Gouinguene SP, 2002, PLANT PHYSIOL, V129, P1296, DOI 10.1104/pp.001941; Halverson LJ., 2009, ALGINATES BIOL APPL, P136; Hay ID, 2013, MICROB BIOTECHNOL, V6, P637, DOI 10.1111/1751-7915.12076; Heil M, 2007, P NATL ACAD SCI USA, V104, P5467, DOI 10.1073/pnas.0610266104; Holopainen JK, 2010, TRENDS PLANT SCI, V15, P176, DOI 10.1016/j.tplants.2010.01.006; Holopainen JK, 2004, TRENDS PLANT SCI, V9, P529, DOI 10.1016/j.tplants.2004.09.006; HOSSAIN MA, 1984, PLANT CELL PHYSIOL, V25, P385; Ionenko IF, 2001, BIOL PLANTARUM, V44, P247, DOI 10.1023/A:1010203510065; Iriti M, 2009, INT J MOL SCI, V10, P3371, DOI 10.3390/ijms10083371; Ivanchenko MG, 2008, PLANT J, V55, P335, DOI 10.1111/j.1365-313X.2008.03528.x; Jordan A, 2009, INT J MASS SPECTROM, V286, P122, DOI 10.1016/j.ijms.2009.07.005; Kim SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068092; Kim YC, 2013, PLANT RESPONSES DROU; Knorzer OC, 1996, PHYSIOL PLANTARUM, V97, P388, DOI 10.1034/j.1399-3054.1996.970225.x; Lindinger W, 1998, INT J MASS SPECTROM, V173, P191, DOI 10.1016/S0168-1176(97)00281-4; Lindinger W, 1998, CHEM SOC REV, V27, P347, DOI 10.1039/a827347z; Loreto F, 2010, TRENDS PLANT SCI, V15, P154, DOI 10.1016/j.tplants.2009.12.006; Mastouri F, 2012, MOL PLANT MICROBE IN, V25, P1264, DOI 10.1094/MPMI-09-11-0240; Mata CG, 2001, PLANT PHYSIOL, V126, P1196, DOI 10.1104/pp.126.3.1196; Mayak S, 2004, PLANT SCI, V166, P525, DOI 10.1016/j.plantsci.2003.10.025; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Nautiyal CS, 1999, FEMS MICROBIOL LETT, V170, P265, DOI 10.1111/j.1574-6968.1999.tb13383.x; Niinemets U, 2004, ADV PLANT PHYSIOL, V7, P233; Niinemets U, ENV EXPT IN PRESS; Niinemets U, 2011, BIOGEOSCIENCES, V8, P2209, DOI 10.5194/bg-8-2209-2011; Niinemets U, 2010, FOREST ECOL MANAG, V260, P1623, DOI 10.1016/j.foreco.2010.07.054; Niinemets U, 2010, TRENDS PLANT SCI, V15, P145, DOI 10.1016/j.tplants.2009.11.008; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Opris O, 2013, ECOTOX ENVIRON SAFE, V87, P70, DOI 10.1016/j.ecoenv.2012.09.019; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; Penrose DM, 2003, PHYSIOL PLANTARUM, V118, P10, DOI 10.1034/j.1399-3054.2003.00086.x; Price AH, 2002, J EXP BOT, V53, P989, DOI 10.1093/jexbot/53.371.989; SHARKEY TD, 1993, OECOLOGIA, V95, P328, DOI 10.1007/BF00320984; SMITH IK, 1989, PHYSIOL PLANTARUM, V77, P449, DOI 10.1111/j.1399-3054.1989.tb05666.x; Smol JP, 2012, NATURE, V483, pS12, DOI 10.1038/483S12a; Timmusk S, 2005, APPL ENVIRON MICROB, V71, P7292, DOI 10.1128/AEM.71.11.7292-7300.2005; Timmusk S, 1999, MOL PLANT MICROBE IN, V12, P951, DOI 10.1094/MPMI.1999.12.11.951; Timmusk S, PLOS ONE IN PRESS; Timmusk S, 2003, THESIS UPPSALA U UPP, P1; Timmusk S, 2012, ENHANCING DROUGHT TO; Timmusk S, 2013, J FOOD SECURITY V, VV1, P10, DOI DOI 10.HTTPS://D0I.0RG/10.12691/JFS-1-1-2; Timmusk S., 2012, IRRIG DRAIN, V12, P2168, DOI [DOI 10.4172/2168-9768.1000E4111, 10.4172/2168-9768.1000e4111]; Timmusk S, 2011, BACTERIA IN AGROBIOLOGY: PLANT NUTRIENT MANAGEMENT, P285, DOI 10.1007/978-3-642-21061-7_12; Timmusk S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017968; Toome M, 2010, PLANTA, V232, P235, DOI 10.1007/s00425-010-1169-y; vandenBoogaard R, 1996, PHYSIOL PLANTARUM, V98, P493, DOI 10.1111/j.1399-3054.1996.tb05704.x; Wang CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052565; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Winkel T, 2001, NEW PHYTOL, V149, P71, DOI 10.1046/j.1469-8137.2001.00008.x; Xiong LM, 2006, PLANT PHYSIOL, V142, P1065, DOI 10.1104/pp.106.084632; Yang J, 2009, TRENDS PLANT SCI, V14, P1, DOI 10.1016/j.tplants.2008.10.004	75	257	273	12	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96086	10.1371/journal.pone.0096086	http://dx.doi.org/10.1371/journal.pone.0096086			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24811199	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000338213300019
J	Gallardo, CM; Hsu, CT; Gunapala, KM; Parfyonov, M; Chang, CH; Mistlberger, RE; Steele, AD				Gallardo, Christian M.; Hsu, Cynthia T.; Gunapala, Keith M.; Parfyonov, Maksim; Chang, Chris H.; Mistlberger, Ralph E.; Steele, Andrew D.			Behavioral and Neural Correlates of Acute and Scheduled Hunger in C57BL/6 Mice	PLOS ONE			English	Article							FOOD-ANTICIPATORY ACTIVITY; DORSOMEDIAL HYPOTHALAMIC NUCLEUS; CIRCADIAN-RHYTHMS; SUPRACHIASMATIC NUCLEUS; DEFICIENT MICE; PALATABLE MEAL; EXPRESSION; ENTRAINMENT; TEMPERATURE; RATS	In rodents, daily feeding schedules induce food anticipatory activity (FAA) rhythms with formal properties suggesting mediation by food-entrained circadian oscillators (FEOs). The search for the neuronal substrate of FEOs responsible for FAA is an active area of research, but studies spanning several decades have yet to identify unequivocally a brain region required for FAA. Variability of results across studies leads to questions about underlying biology versus methodology. Here we describe in C57BL/ 6 male mice the effects of varying the 'dose' of caloric restriction (0%, 60%, 80%, 110%) on the expression of FAA as measured by a video-based analysis system, and on the induction of c-Fos in brain regions that have been implicated in FAA. We determined that more severe caloric restriction (60%) leads to a faster onset of FAA with increased magnitude. Using the 60% caloric restriction, we found little evidence for unique signatures of neuronal activation in the brains of mice anticipating a daily mealtime compared to mice that were fasted acutely or fed ad-libitum-even in regions such as the dorsomedial and ventrolateral hypothalamus, nucleus accumbens, and cerebellum that have previously been implicated in FAA. These results underscore the importance of feeding schedule parameters in determining quantitative features of FAA in mice, and demonstrate dissociations between behavioral FAA and neural activity in brain areas thought to harbor FEOs or participate in their entrainment or output.	[Gallardo, Christian M.; Hsu, Cynthia T.; Gunapala, Keith M.; Steele, Andrew D.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Parfyonov, Maksim; Mistlberger, Ralph E.] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada; [Chang, Chris H.] Scripps Coll, Pitzer Coll, Claremont Mckenna Coll, WM Keck Sci Dept, Claremont, CA 91711 USA; [Steele, Andrew D.] Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA	California Institute of Technology; Simon Fraser University; Claremont Colleges; Claremont Graduate School; Claremont McKenna College; Pitzer College; Scripps College; California State University System; California State Polytechnic University Pomona	Steele, AD (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	adsteele@csupomona.edu	Parfyonov, Maksim/AAP-7478-2020	Parfyonov, Maksim/0000-0003-0582-0852; Gallardo, Christian/0000-0001-5702-0852	Broad Fellows Program in Brain Circuitry at Caltech; Ellison Medical Foundation New Scholar Award; Klarman Family Foundation	Broad Fellows Program in Brain Circuitry at Caltech; Ellison Medical Foundation New Scholar Award(Lawrence Ellison Foundation); Klarman Family Foundation	Funding for these studies was provided by the Broad Fellows Program in Brain Circuitry at Caltech, an Ellison Medical Foundation New Scholar Award to ADS, a Grants Program in Eating Disorders Research award from the Klarman Family Foundation to ADS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Galvan G, 2011, P NATL ACAD SCI USA, V108, P5813, DOI 10.1073/pnas.1015551108; Akiyama M, 2004, EUR J NEUROSCI, V20, P3054, DOI 10.1111/j.1460-9568.2004.03749.x; Angeles-Castellanos M, 2008, NEUROSCIENCE, V155, P297, DOI 10.1016/j.neuroscience.2008.06.001; Angeles-Castellanos M, 2010, NEUROSCIENCE, V165, P1115, DOI 10.1016/j.neuroscience.2009.11.061; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Blum ID, 2012, NEUROSCI BIOBEHAV R, V36, P254, DOI 10.1016/j.neubiorev.2011.06.003; Blum ID, 2009, NEUROSCIENCE, V164, P351, DOI 10.1016/j.neuroscience.2009.08.009; Blum ID, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036117; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Canteras NS, 2011, BRAIN RES REV, V65, P150, DOI 10.1016/j.brainresrev.2010.09.006; Challet E, 2010, CELL TISSUE RES, V341, P1, DOI 10.1007/s00441-010-1001-9; Chen D, 2005, SCIENCE, V310, P1641, DOI 10.1126/science.1118357; De Vasconcelos AP, 2006, NEUROSCIENCE, V139, P741, DOI 10.1016/j.neuroscience.2005.12.045; Deurveilher S, 2005, NEUROSCIENCE, V130, P165, DOI 10.1016/j.neuroscience.2004.08.030; Escobar C, 2009, EUR J NEUROSCI, V30, P1665, DOI 10.1111/j.1460-9568.2009.06972.x; Feillet CA, 2008, MOL CELL NEUROSCI, V37, P209, DOI 10.1016/j.mcn.2007.09.010; Gallardo CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041161; Gooley JJ, 2006, NAT NEUROSCI, V9, P398, DOI 10.1038/nn1651; Gravotta L, 2011, J MOL NEUROSCI; Gunapala KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018377; Gunapala KM, 2010, PRION, V4, P302, DOI 10.4161/pri.4.4.13721; Kaur S, 2008, BRAIN RES, V1205, P47, DOI 10.1016/j.brainres.2008.02.026; Lamont EW, 2012, NEUROSCIENCE, V218, P12, DOI 10.1016/j.neuroscience.2012.05.046; Landry GJ, 2006, AM J PHYSIOL-REG I, V290, pR1527, DOI 10.1152/ajpregu.00874.2005; Landry GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024187; LeSauter J, 2009, P NATL ACAD SCI USA, V106, P13582, DOI 10.1073/pnas.0906426106; Luby MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037992; Mendoza J, 2005, EUR J NEUROSCI, V22, P2855, DOI 10.1111/j.1460-9568.2005.04461.x; Mendoza J, 2005, NEUROSCIENCE, V133, P293, DOI 10.1016/j.neuroscience.2005.01.064; Mendoza J, 2005, BEHAV BRAIN RES, V158, P133, DOI 10.1016/j.bbr.2004.08.016; Mendoza J, 2010, GENES BRAIN BEHAV, V9, P467, DOI 10.1111/j.1601-183X.2010.00576.x; Mendoza J, 2010, J NEUROSCI, V30, P1894, DOI 10.1523/JNEUROSCI.5855-09.2010; Mieda M, 2006, P NATL ACAD SCI USA, V103, P12150, DOI 10.1073/pnas.0604189103; Mistlberger RE, 2006, CURR BIOL, V16, pR968, DOI 10.1016/j.cub.2006.10.020; Mistlberger RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031772; Mistlberger RE, 2011, PHYSIOL BEHAV, V104, P535, DOI 10.1016/j.physbeh.2011.04.015; Mistlberger Ralph E, 2009, J Circadian Rhythms, V7, P11, DOI 10.1186/1740-3391-7-11; MISTLBERGER RE, 1992, BEHAV BRAIN RES, V47, P159, DOI 10.1016/S0166-4328(05)80122-6; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; Morin LP, 2006, BRAIN RES REV, V51, P1, DOI 10.1016/j.brainresrev.2005.08.003; Morin LP, 2013, EXP NEUROL, V243, P4, DOI 10.1016/j.expneurol.2012.06.026; Moriya T, 2009, EUR J NEUROSCI, V29, P1447, DOI 10.1111/j.1460-9568.2009.06697.x; Paxinos G, 2007, MOUSE BRAIN STEREOTA; Pendergast JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004860; Pitts SN, 2003, AM J PHYSIOL-REG I, V285, pR57, DOI 10.1152/ajpregu.00023.2003; Poulin AM, 2008, BRAIN RES, V1227, P128, DOI 10.1016/j.brainres.2008.06.039; Ribeiro AC, 2007, P NATL ACAD SCI USA, V104, P20078, DOI 10.1073/pnas.0710096104; Schroeder AM, 2013, TRENDS PHARMACOL SCI, V34, P605, DOI 10.1016/j.tips.2013.09.002; Steele AD, 2007, P NATL ACAD SCI USA, V104, P1983, DOI 10.1073/pnas.0610779104; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P545, DOI 10.1016/S0163-1047(79)90332-7; STEPHAN FK, 1983, BEHAV BRAIN RES, V7, P81, DOI 10.1016/0166-4328(83)90006-2; Storch KF, 2009, P NATL ACAD SCI USA, V106, P6808, DOI 10.1073/pnas.0902063106; Sutton GM, 2008, J NEUROSCI, V28, P12946, DOI 10.1523/JNEUROSCI.3615-08.2008; Szentirmai E, 2010, AM J PHYSIOL-REG I, V298, pR467, DOI 10.1152/ajpregu.00557.2009; Tahara Y, 2013, NEUROSCIENCE, V253, P78, DOI 10.1016/j.neuroscience.2013.08.049; Takasu NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048892; Verwey M, 2011, NEUROSCIENCE, V192, P304, DOI 10.1016/j.neuroscience.2011.07.016	57	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e95990	10.1371/journal.pone.0095990	http://dx.doi.org/10.1371/journal.pone.0095990			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806659	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000335728900028
J	Phosri, C; Watling, R; Suwannasai, N; Wilson, A; Martin, MP				Phosri, Cherdchai; Watling, Roy; Suwannasai, Nuttika; Wilson, Andrew; Martin, Maria P.			A New Representative of Star-Shaped Fungi: Astraeus sirindhorniae sp nov from Thailand	PLOS ONE			English	Article							PHYLOGENETIC INFERENCE; SEQUENCES; DIVERSIFICATION; IDENTIFICATION; MUSHROOMS; INOCYBE; RPB1	Phu Khieo Wildlife Sanctuary (PKWS) is a major hotspot of biological diversity in Thailand but its fungal diversity has not been thouroughly explored. A two-year macrofungal study of this remote locality has resulted in the recognition of a new species of a star-shaped gasteroid fungus in the genus Astraeus. This fungus has been identified based on a morphological approach and the molecular study of five loci (LSU nrDNA, 5.8S nrDNA, RPB1, RPB2 and EF1-a). Multigene phylogenetic analysis of this new species places it basal relative to other Astraeus, providing additional evidence for the SE Asian orgin of the genus. The fungus is named in honour of Her Majesty Princess Sirindhorn on the occasion the 84th birthday of her father, who have both been supportive of natural heritage studies in Thailand.	[Phosri, Cherdchai] Nakhon Phanom Univ, Dept Biol, Fac Sci, Nakhon Phanom, Thailand; [Watling, Roy] Caledonian Mycol Enterprises, Edinburgh, Midlothian, Scotland; [Suwannasai, Nuttika] Srinakharinwirot Univ, Dept Biol, Fac Sci, Bangkok, Thailand; [Wilson, Andrew] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA; [Martin, Maria P.] RJB CSIC, Real Jardin Bot, Dept Micol, Madrid, Spain	Nakhon Phanom University; Srinakharinwirot University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid	Phosri, C (corresponding author), Nakhon Phanom Univ, Dept Biol, Fac Sci, Nakhon Phanom, Thailand.	cherd_phosri@yahoo.co.uk	Martín, María/H-8069-2012; phosri, Cherdchai/H-2747-2014; Wilson, Andrew/AAE-9363-2022; Wilson, Andrew/AFD-8298-2022; Martín, María/HDL-9512-2022	Martín, María/0000-0002-1235-4418; Phosri, Cherdchai/0000-0003-3963-752X	National Research Council of Thailand (NRCT); Masumae International Foundation (MIF)	National Research Council of Thailand (NRCT)(National Research Council of Thailand (NRCT)); Masumae International Foundation (MIF)	This study was funded in part by National Research Council of Thailand (NRCT) and the Masumae International Foundation (MIF) to C. Phosri. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ASEAN Centre for Biodiversity, 2010, ASEAN BIOD OUTL; Binder M, 2006, MYCOLOGIA, V98, P971, DOI 10.3852/mycologia.98.6.971; Coker W.C., 1928, GASTEROMYCETES E US; Cunningham G.H., 1944, GASTEROMYCETES AUSTR; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HAWKSWORTH DL, 1991, MYCOL RES, V95, P641, DOI 10.1016/S0953-7562(09)80810-1; Hibbett DS, 2009, NEW PHYTOL, V184, P279, DOI 10.1111/j.1469-8137.2009.03042.x; Hosaka K, 2006, MYCOLOGIA, V98, P949, DOI 10.3852/mycologia.98.6.949; Largent D, 1977, IDENTIFY MUSHROOMS G; LIU B., 1984, GASTEROMYCETES CHINA; Liu YJJ, 1999, MOL BIOL EVOL, V16, P1799, DOI 10.1093/oxfordjournals.molbev.a026092; Lloyd CG, 1902, GEASTRAE; Maddison W.P., 2008, MESQUITE MODULAR SYS; Matheny PB, 2005, MOL PHYLOGENET EVOL, V35, P1, DOI 10.1016/j.ympev.2004.11.014; Matheny PB, 2002, AM J BOT, V89, P688, DOI 10.3732/ajb.89.4.688; Miller M. A., 2010, CIPRES PORTALS; Mongkol K, 1999, BIODIVERSITY VERTEBR; Nouhra Eduardo R., 1998, Mycologist, V12, P112; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Phosri C, 2004, MYCOTAXON, V89, P453; Phosri C, 2007, MYCOL RES, V111, P275, DOI 10.1016/j.mycres.2007.01.004; Phosri C, 2013, IMA FUNGUS, V4, P347, DOI 10.5598/imafungus.2013.04.02.13; Rehner SA, 2005, MYCOLOGIA, V97, P84, DOI 10.3852/mycologia.97.1.84; RFD & Kasetsart, 2002, SOC LAND SURV PHUKH; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Watling R, 2008, SYNOPSIS FUNGORUM, V24, P1; Wilson AW, 2012, NEW PHYTOL, V194, P1079, DOI 10.1111/j.1469-8137.2012.04109.x	32	16	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e71160	10.1371/journal.pone.0071160	http://dx.doi.org/10.1371/journal.pone.0071160			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806455	Green Published, Green Submitted, gold			2022-12-27	WOS:000335728900001
J	Jaworski, E; Saifuddin, M; Sampey, G; Shafagati, N; Van Duyne, R; Iordanskiy, S; Kehn-Hall, K; Liotta, L; Petricoin, E; Young, M; Lepene, B; Kashanchi, F				Jaworski, Elizabeth; Saifuddin, Mohammed; Sampey, Gavin; Shafagati, Nazly; Van Duyne, Rachel; Iordanskiy, Sergey; Kehn-Hall, Kylene; Liotta, Lance; Petricoin, Emanuel, III; Young, Mary; Lepene, Benjamin; Kashanchi, Fatah			The Use of Nanotrap Particles Technology in Capturing HIV-1 Virions and Viral Proteins from Infected Cells	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HYDROGEL PARTICLES; RESIDUAL HIV-1; TAT PROTEIN; PLASMA; BIOMARKER; TRANSACTIVATOR; TRANSMISSION; ACTIVATION; DIAGNOSIS	HIV-1 infection results in a chronic but incurable illness since long-term HAART can keep the virus to an undetectable level. However, discontinuation of therapy rapidly increases viral burden. Moreover, patients under HAART frequently develop various metabolic disorders and HIV-associated neuronal disease. Today, the main challenge of HIV-1 research is the elimination of the residual virus in infected individuals. The current HIV-1 diagnostics are largely comprised of serological and nucleic acid based technologies. Our goal is to integrate the nanotrap technology into a standard research tool that will allow sensitive detection of HIV-1 infection. This study demonstrates that majority of HIV-1 virions in culture supernatants and Tat/Nef proteins spiked in culture medium can be captured by nanotrap particles. To determine the binding affinities of different baits, we incubated target molecules with nanotrap particles at room temperature. After short sequestration, materials were either eluted or remained attached to nanotrap particles prior to analysis. The unique affinity baits of nanotrap particles preferentially bound HIV-1 materials while excluded albumin. A high level capture of Tat or Tat peptide by NT082 and NT084 particles was measured by western blot (WB). Intracellular Nef protein was captured by NT080, while membrane-associated Nef was captured by NT086 and also detected by WB. Selective capture of HIV-1 particles by NT073 and NT086 was measured by reverse transcriptase assay, while capture of infectious HIV-1 by these nanoparticles was demonstrated by functional transactivation in TZM-bl cells. We also demonstrated specific capture of HIV-1 particles and exosomes-containing TAR-RNA in patients' serum by NT086 and NT082 particles, respectively, using specific qRT-PCR. Collectively, our data indicate that certain types of nanotrap particles selectively capture specific HIV-1 molecules, and we propose to use this technology as a platform to enhance HIV-1 detection by concentrating viral proteins and infectious virions from infected samples.	[Jaworski, Elizabeth; Saifuddin, Mohammed; Sampey, Gavin; Shafagati, Nazly; Van Duyne, Rachel; Iordanskiy, Sergey; Kehn-Hall, Kylene; Kashanchi, Fatah] George Mason Univ, Natl Ctr Biodefense & Infect Dis, Manassas, VA 20110 USA; [Van Duyne, Rachel] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA; [Liotta, Lance; Petricoin, Emanuel, III] George Mason Univ, Ctr Appl Prote & Mol Med, Manassas, VA USA; [Young, Mary] Georgetown Univ, Div Infect Dis, Washington, DC USA; [Lepene, Benjamin] Ceres Nanosci, Manassas, VA USA	George Mason University; George Washington University; George Mason University; Georgetown University	Kashanchi, F (corresponding author), George Mason Univ, Natl Ctr Biodefense & Infect Dis, Manassas, VA 20110 USA.	fkashanc@gmu.edu	Van Duyne, Rachel/ABI-2429-2020; Van Duyne, Rachel/I-7365-2019; Kehn-Hall, Kylene/I-5752-2013	Van Duyne, Rachel/0000-0003-2914-6874; Kehn-Hall, Kylene/0000-0001-8036-7213	National Institutes of Health [AI070740]; National Institute of Allergy and Infectious Diseases [UO1-AI-35004, UO1-AI-31834, UO1-AI-34994, UO1-AI-34989, UO1-AI-34993, UO1-AI-42590]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [UO1-HD-32632]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD032632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI034994, U01AI034989, R21AI070740, R01AI043894, U01AI042590, U01AI031834, U01AI034993, U01AI035004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS099029] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding provided by National Institutes of Health grant AI070740 to FK. The WIHS was funded by the National Institute of Allergy and Infectious Diseases (UO1-AI-35004, UO1-AI-31834, UO1-AI-34994, UO1-AI-34989, UO1-AI-34993, and UO1-AI-42590) and by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (UO1-HD-32632). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbottah E, 2006, VIROLOGY, V345, P373, DOI 10.1016/j.virol.2005.09.062; Deminice R, 2013, NUTRITION, V29, P1326, DOI 10.1016/j.nut.2013.04.017; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Dinoso JB, 2009, P NATL ACAD SCI USA, V106, P9403, DOI 10.1073/pnas.0903107106; DONEGAN E, 1990, ANN INTERN MED, V113, P733, DOI 10.7326/0003-4819-113-10-733; Dreux M, 2012, CELL HOST MICROBE, V12, P558, DOI 10.1016/j.chom.2012.08.010; Duong YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033328; Eisele E, 2012, IMMUNITY, V37, P377, DOI 10.1016/j.immuni.2012.08.010; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Feleke Yeweyenhareg, 2012, Ethiop Med J, V50, P221; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Fields BN, 2013, FIELDS VIROLOGY; Fredolini C, 2010, AAPS J, V12, P504, DOI 10.1208/s12248-010-9211-3; Fredolini C, 2009, DRUG TEST ANAL, V1, P447, DOI 10.1002/dta.96; Gaardbo JC, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/161584; GIANAZZA E, 1982, BIOCHEM J, V203, P637, DOI 10.1042/bj2030637; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Hu G, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.114; Johnson TP, 2013, P NATL ACAD SCI USA, V110, P13588, DOI 10.1073/pnas.1308673110; KAPLAN EH, 1992, J ACQ IMMUN DEF SYND, V5, P1116; KASHANCHI F, 1992, NUCLEIC ACIDS RES, V20, P4673, DOI 10.1093/nar/20.17.4673; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kiage JN, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-50; Kilembe W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037154; Laird GM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003398; LASPIA MF, 1989, CELL, V59, P283, DOI 10.1016/0092-8674(89)90290-0; Leonard JA, 2011, J VIROL, V85, P6867, DOI 10.1128/JVI.00229-11; Lindback S, 2000, AIDS, V14, P2333, DOI 10.1097/00002030-200010200-00014; Longo C, 2011, EXP DERMATOL, V20, P29, DOI 10.1111/j.1600-0625.2010.01187.x; Longo C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004763; Luchini A, 2008, NANO LETT, V8, P350, DOI 10.1021/nl072174l; Luchini A, 2009, J MATER CHEM, V19, P5071, DOI 10.1039/b822264a; McArthur JC, 2005, LANCET NEUROL, V4, P543, DOI 10.1016/S1474-4422(05)70165-4; Miller WC, 2010, CURR OPIN HIV AIDS, V5, P277, DOI 10.1097/COH.0b013e32833a0d3a; Narayanan A, 2013, J BIOL CHEM, V288, P20014, DOI 10.1074/jbc.M112.438895; Ndirangu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051493; Okulicz JF, 2011, CURR OPIN HIV AIDS, V6, P163, DOI 10.1097/COH.0b013e328344f35e; Okulicz JF, 2009, J INFECT DIS, V200, P1714, DOI 10.1086/646609; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Pilcher CD, 2004, J CLIN INVEST, V113, P937, DOI [10.1172/JCI200421540, 10.1172/JCI21540]; Platt EJ, 2009, J VIROL, V83, P8289, DOI 10.1128/JVI.00709-09; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Sahu GK, 2010, J VIROL, V84, P8348, DOI 10.1128/JVI.00362-10; Schacker T, 1996, ANN INTERN MED, V125, P257, DOI 10.7326/0003-4819-125-4-199608150-00001; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033; Shafagati N, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002296; Tamburro D, 2011, J AM CHEM SOC, V133, P19178, DOI 10.1021/ja207515j; Tang SX, 2010, J INFECT DIS, V201, pS59, DOI 10.1086/650386; Teeparuksapun K, 2010, ANAL CHEM, V82, P8406, DOI 10.1021/ac102144a; The Henry J, 2014, HIV AIDS POL FACT SH; UNAIDS Report on the Global AIDS Epidemic, 2012, UNAIDS REP GLOB AIDS; van der Sluis RM, 2013, CURR OPIN VIROL; Varghese B, 2002, SEX TRANSM DIS, V29, P38, DOI 10.1097/00007435-200201000-00007; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Wang SQ, 2010, BIOTECHNOL ADV, V28, P770, DOI 10.1016/j.biotechadv.2010.06.004; WEEKS BS, 1995, J NEUROSCI RES, V42, P34, DOI 10.1002/jnr.490420105; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Zetola NM, 2008, PUBLIC HEALTH REP, V123, P41, DOI 10.1177/00333549081230S306; Zheng L, 2012, MOLECULES, V17, P5988, DOI 10.3390/molecules17055988	60	48	48	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96778	10.1371/journal.pone.0096778	http://dx.doi.org/10.1371/journal.pone.0096778			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24820173	gold, Green Published, Green Submitted			2022-12-27	WOS:000336653300031
J	Reddy, SMW; Groves, T; Nagavarapu, S				Reddy, Sheila M. W.; Groves, Theodore; Nagavarapu, Sriniketh			Consequences of a Government-Controlled Agricultural Price Increase on Fishing and the Coral Reef Ecosystem in the Republic of Kiribati	PLOS ONE			English	Article							NORTHERN LINE ISLANDS; JOB-SATISFACTION; LIVELIHOODS APPROACH; OPEN ACCESS; BASE-LINES; FISHERIES; MANAGEMENT; DEFORESTATION; THRESHOLDS; INDONESIA	Background: Economic development policies may have important economic and ecological consequences beyond the sector they target. Understanding these consequences is important to improving these policies and finding opportunities to align economic development with natural resource conservation. These issues are of particular interest to governments and non-governmental organizations that have new mandates to pursue multiple benefits. In this case study, we examined the direct and indirect economic and ecological effects of an increase in the government-controlled price for the primary agricultural product in the Republic of Kiribati, Central Pacific. Methods/Principal Findings: We conducted household surveys and underwater visual surveys of the coral reef to examine how the government increase in the price of copra directly affected copra labor and indirectly affected fishing and the coral reef ecosystem. The islands of Kiribati are coral reef atolls and the majority of households participate in copra agriculture and fishing on the coral reefs. Our household survey data suggest that the 30% increase in the price of copra resulted in a 32% increase in copra labor and a 38% increase in fishing labor. Households with the largest amount of land in coconut production increased copra labor the most and households with the smallest amount of land in coconut production increased fishing the most. Our ecological data suggests that increased fishing labor may result in a 20% decrease in fish stocks and 4% decrease in coral reef-builders. Conclusions/Significance: We provide empirical evidence to suggest that the government increase in the copra price in Kiribati had unexpected and indirect economic and ecological consequences. In this case, the economic development policy was not in alignment with conservation. These results emphasize the importance of accounting for differences in household capital and taking a systems approach to policy design and evaluation, as advocated by sustainable livelihood and ecosystem-based management frameworks.	[Reddy, Sheila M. W.] Nature Conservancy, Cent Sci Div, Arlington, VA 22209 USA; [Reddy, Sheila M. W.] Brown Univ, Environm Change Initiat, Providence, RI 02912 USA; [Groves, Theodore] Univ Calif San Diego, Dept Econ, La Jolla, CA 92093 USA; [Nagavarapu, Sriniketh] Brown Univ, Dept Econ, Providence, RI 02912 USA; [Nagavarapu, Sriniketh] Brown Univ, Ctr Environm Studies, Providence, RI 02912 USA	Nature Conservancy; Brown University; University of California System; University of California San Diego; Brown University; Brown University	Reddy, SMW (corresponding author), Nature Conservancy, Cent Sci Div, 1815 N Lynn St, Arlington, VA 22209 USA.	sreddy@tnc.org			NSF Graduate Research Fellowship; NSF Graduate Teaching Fellow in K-12 Education; ISRS/Ocean Conservancy Fellowship; PADI Foundation Research Grant; UCSD International and Comparative Areas Studies Travel Grant; Brown University Environmental Change Initiative Voss Postdoctoral Fellowship	NSF Graduate Research Fellowship(National Science Foundation (NSF)); NSF Graduate Teaching Fellow in K-12 Education; ISRS/Ocean Conservancy Fellowship; PADI Foundation Research Grant; UCSD International and Comparative Areas Studies Travel Grant; Brown University Environmental Change Initiative Voss Postdoctoral Fellowship	This research was funded by an NSF Graduate Research Fellowship, NSF Graduate Teaching Fellow in K-12 Education, ISRS/Ocean Conservancy Fellowship, PADI Foundation Research Grant, UCSD International and Comparative Areas Studies Travel Grant, and Brown University Environmental Change Initiative Voss Postdoctoral Fellowship to SMWR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti M., 2011, B ECOL SOC AM, V92, P218, DOI DOI 10.1890/0012-9623-92.2.218; Allison EH, 2006, MAR POLICY, V30, P757, DOI 10.1016/j.marpol.2006.02.001; Allison EH, 2001, MAR POLICY, V25, P377, DOI 10.1016/S0308-597X(01)00023-9; Angelsen A, 1999, J DEV ECON, V58, P185, DOI 10.1016/S0304-3878(98)00108-4; Angrist J, 2002, EFFECT HIGH SCH MATR; [Anonymous], 1998, SUSTAINABLE RURAL LI; APOSTLE R, 1985, CAN J FISH AQUAT SCI, V42, P256, DOI 10.1139/f85-033; Baland JM, 2005, J PUBLIC ECON, V89, P211, DOI 10.1016/j.jpubeco.2004.02.002; Beck MW, 2012, COASTAL HABITATS RIS; BLUFFSTONE RA, 1995, J ENVIRON ECON MANAG, V29, P42, DOI 10.1006/jeem.1995.1030; Carilli J, 2012, MAR ECOL PROG SER, V456, P87, DOI 10.3354/meps09684; Catala R. L. A., 1957, Atoll Res Bull Washington, Vno. 59, P1; Christensen NL, 1996, ECOL APPL, V6, P665, DOI 10.2307/2269460; Crepin AS, 2007, ENVIRON RESOUR ECON, V36, P191, DOI 10.1007/s10640-006-9029-8; Dasgupta P., 2001, HUMAN WELL BEING NAT; Dinsdale EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001584; Ellis F, 1998, J DEV STUD, V35, P1, DOI 10.1080/00220389808422553; Farzin YH, 2009, Q REV ECON FINANC, V49, P1236, DOI 10.1016/j.qref.2009.09.001; GATEWOOD JB, 1990, HUM ORGAN, V49, P14, DOI 10.17730/humo.49.1.957t468k40831313; Huffman GJ, 2001, J HYDROMETEOROL, V2, P36, DOI 10.1175/1525-7541(2001)002<0036:GPAODD>2.0.CO;2; Hughes TP, 1994, AIDS RES HUM RETR S1, V265; KITCHELL JF, 1979, BIOSCIENCE, V29, P28, DOI 10.2307/1307570; KNOWLTON N, 1992, AM ZOOL, V32, P674; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; KREMEN C, 1994, CONSERV BIOL, V8, P388, DOI 10.1046/j.1523-1739.1994.08020388.x; Lee M., 2005, MICROECONOMETRICS PO; Liese C, 2007, ENVIRON DEV ECON, V12, P123, DOI 10.1017/S1355770X06003421; Macurdy T, 2007, HBK ECON, V2, P4057, DOI 10.1016/S1573-4412(07)06062-X; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; MEA, 2005, MILL ECOS ASS SYNTH; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Muller J, 2004, RESOUR ENERGY ECON, V26, P185, DOI 10.1016/j.reseneeco.2003.11.007; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Newman MJH, 2006, ECOL LETT, V9, P1216, DOI 10.1111/j.1461-0248.2006.00976.x; NRC, 1951, HDB AT RES; NRC, 2013, SUST NAT RES CONN GO; Pendleton LH, 2002, LAND ECON, V78, P1, DOI 10.2307/3146919; POLLNAC RB, 1988, AM ANTHROPOL, V90, P888, DOI 10.1525/aa.1988.90.4.02a00070; Pollnac R, 2012, SOC INDIC RES, V109, P119, DOI 10.1007/s11205-012-0059-z; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Sauni S, 2005, FISHY TALES KIRIBATI; Scheffer M, 2005, TRENDS ECOL EVOL, V20, P579, DOI 10.1016/j.tree.2005.08.018; Sievanen L, 2005, OCEAN COAST MANAGE, V48, P297, DOI 10.1016/j.ocecoaman.2005.04.015; SMITH CL, 1981, LAND ECON, V57, P181, DOI 10.2307/3145785; Smith JE, 2010, OECOLOGIA, V163, P497, DOI 10.1007/s00442-009-1546-z; SWIFT J, 1989, IDS BULL-I DEV STUD, V20, P8, DOI 10.1111/j.1759-5436.1989.mp20002002.x; UN Millennium Project, 2005, INV DEV PRACT PLAN A; Walsh S. M., 2011, J MARINE BIOL; WALSH SM, 2009, THESIS U CALIFORNIA	49	9	9	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96817	10.1371/journal.pone.0096817	http://dx.doi.org/10.1371/journal.pone.0096817			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI1ZC	24820734	Green Published, Green Submitted, gold			2022-12-27	WOS:000336653300034
J	Yu, C; Achazi, K; Moller, L; Schulzke, JD; Niedrig, M; Bucker, R				Yu, Chao; Achazi, Katharina; Moeller, Lars; Schulzke, Joerg D.; Niedrig, Matthias; Buecker, Roland			Tick-Borne Encephalitis Virus Replication, Intracellular Trafficking, and Pathogenicity in Human Intestinal Caco-2 Cell Monolayers	PLOS ONE			English	Article							RAW GOAT MILK; EPITHELIAL BARRIER; IN-VIVO; INFECTION; MACROPINOCYTOSIS; ENTRY; TRANSMISSION; PERMEABILITY; CONSUMPTION; INHIBITION	Tick-borne encephalitis virus (TBEV) is one of the most important vector-borne viruses in Europe and Asia. Its transmission mainly occurs by the bite of an infected tick. However, consuming milk products from infected livestock animals caused TBEV cases. To better understand TBEV transmission via the alimentary route, we studied viral infection of human intestinal epithelial cells. Caco-2 cells were used to investigate pathological effects of TBEV infection. TBEV-infected Caco-2 monolayers showed morphological changes including cytoskeleton rearrangements and cytoplasmic vacuolization. Ultrastructural analysis revealed dilatation of the rough endoplasmic reticulum and further enlargement to TBEV containing caverns. Caco-2 monolayers maintained an intact epithelial barrier with stable transepithelial electrical resistance (TER) during early stage of infection. Concomitantly, viruses were detected in the basolateral medium, implying a transcytosis pathway. When Caco-2 cells were pre-treated with inhibitors of cellular pathways of endocytosis TBEV cell entry was efficiently blocked, suggesting that actin filaments (Cytochalasin) and microtubules (Nocodazole) are important for PI3Kdependent (LY294002) virus endocytosis. Moreover, experimental fluid uptake assay showed increased intracellular accumulation of FITC-dextran containing vesicles. Immunofluorescence microscopy revealed co-localization of TBEV with early endosome antigen-1 (EEA1) as well as with sorting nexin-5 (SNX5), pointing to macropinocytosis as trafficking mechanism. In the late phase of infection, further evidence was found for translocation of virus via the paracellular pathway. Five days after infection TER was slightly decreased. Epithelial barrier integrity was impaired due to increased epithelial apoptosis, leading to passive viral translocation. These findings illuminate pathomechanisms in TBEV infection of human intestinal epithelial cells and viral transmission via the alimentary route.	[Yu, Chao; Niedrig, Matthias] Robert Koch Inst, Ctr Biol Threats & Special Pathogens, ZBS Highly Pathogen Viruses 1, Berlin, Germany; [Achazi, Katharina] Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany; [Moeller, Lars] Robert Koch Inst, Ctr Biol Threats & Special Pathogens, ZBS Adv Light & Elect Microscopy 4, Berlin, Germany; [Schulzke, Joerg D.; Buecker, Roland] Charite, Campus Benjamin Franklin, Dept Gastroenterol Infect Dis & Rheumatol, Div Nutr Med, D-13353 Berlin, Germany	Robert Koch Institute; Free University of Berlin; Robert Koch Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Niedrig, M (corresponding author), Charite, Campus Benjamin Franklin, Dept Gastroenterol Infect Dis & Rheumatol, Div Nutr Med, D-13353 Berlin, Germany.	joerg.schulzke@charite.de	Bücker, Roland/O-2233-2015; Achazi, Katharina/E-5215-2015	Bücker, Roland/0000-0002-1345-4146; Achazi, Katharina/0000-0003-2189-291X	Deutsche Forschungsgemeinschaft (DFG) [559/11]; China Scholarship Council [CSC 2009617027]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); China Scholarship Council(China Scholarship Council)	The study was supported by the Deutsche Forschungsgemeinschaft (DFG Schu 559/11). Chao Yu was supported by the China Scholarship Council (CSC 2009617027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achazi K, 2011, J VIROL METHODS, V171, P34, DOI 10.1016/j.jviromet.2010.09.026; AVSICZUPANC T, 1995, CLIN DIAGN VIROL, V4, P51, DOI 10.1016/0928-0197(94)00062-Y; Balogh Z, 2012, INTERVIROLOGY, V55, P194, DOI 10.1159/000324023; Balogh Z, 2010, J VIROL METHODS, V163, P481, DOI 10.1016/j.jviromet.2009.10.003; Bissonnette P, 1996, AM J PHYSIOL-GASTR L, V270, pG833, DOI 10.1152/ajpgi.1996.270.5.G833; Bojarski C, 2001, J PHYSIOL-LONDON, V535, P541, DOI 10.1111/j.1469-7793.2001.00541.x; Bucker R, 2014, GUT; Bucker R, 2012, SCI REP-UK, V2, DOI 10.1038/srep00994; Burckhardt CJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000621; Caini S, 2012, EUROSURVEILLANCE, V17, P17; Cencic A, 2010, INT J FOOD MICROBIOL, V141, pS4, DOI 10.1016/j.ijfoodmicro.2010.03.026; de Vries E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001329; Dickman KG, 2000, AM J PHYSIOL-GASTR L, V279, pG757, DOI 10.1152/ajpgi.2000.279.4.G757; Engle MJ, 1998, J CELL PHYSIOL, V174, P362, DOI 10.1002/(SICI)1097-4652(199803)174:3<362::AID-JCP10>3.0.CO;2-B; Epple HJ, 2010, GASTROENTEROLOGY, V139, P1289, DOI 10.1053/j.gastro.2010.06.065; GODDETTE DW, 1986, J BIOL CHEM, V261, P5974; Gritsun TS, 2003, ANTIVIR RES, V57, P129, DOI 10.1016/S0166-3542(02)00206-1; Hamasaki M, 2004, ANAT REC PART A, V277A, P298, DOI 10.1002/ar.a.20027; Heinz FX, 2007, VACCINE, V25, P7559, DOI 10.1016/j.vaccine.2007.08.024; Hering NA, 2011, LAB INVEST, V91, P310, DOI 10.1038/labinvest.2010.180; Hillenbrand B, 2010, SCAND J GASTROENTERO, V45, P1307, DOI 10.3109/00365521.2010.483013; Holzmann H, 2009, EMERG INFECT DIS, V15, P1671, DOI 10.3201/eid1510.090743; Hudopisk N, 2013, EMERG INFECT DIS, V19, P806, DOI 10.3201/eid1905.121442; Iwasaki A, 2002, J INFECT DIS, V186, P585, DOI 10.1086/342682; KENYON RH, 1992, MICROB PATHOGENESIS, V13, P399, DOI 10.1016/0882-4010(92)90083-Z; Koivusalo M, 2010, J CELL BIOL, V188, P547, DOI 10.1083/jcb.200908086; Krieger SE, 2013, J VIROL; Krieger SE, 2013, J VIROL, V87, P8884, DOI 10.1128/JVI.03415-12; Krzyzaniak MA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003309; Laue M, 2010, METHOD CELL BIOL, V96, P1, DOI 10.1016/S0091-679X(10)96001-9; Lim JP, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-58; Lindquist L, 2008, LANCET, V371, P1861, DOI 10.1016/S0140-6736(08)60800-4; Liu NQ, 2002, J VIROL, V76, P6689, DOI 10.1128/JVI.76.13.6689-6700.2002; Lorenz IC, 2003, J VIROL, V77, P4370, DOI 10.1128/JVI.77.7.4370-4382.2003; Mansfield KL, 2009, J GEN VIROL, V90, P1781, DOI 10.1099/vir.0.011437-0; Martin-Latil S, 2012, BLOOD, V120, P572, DOI 10.1182/blood-2011-08-374637; Medigeshi GR, 2009, J VIROL, V83, P6125, DOI 10.1128/JVI.02617-08; Melik W, 2012, VIRUS RES, V169, P54, DOI 10.1016/j.virusres.2012.07.001; Mercer J, 2010, P NATL ACAD SCI USA, V107, P9346, DOI 10.1073/pnas.1004618107; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Moghaddam A, 1997, SCIENCE, V276, P2030, DOI 10.1126/science.276.5321.2030; Moser LA, 2007, J VIROL, V81, P11937, DOI 10.1128/JVI.00942-07; NIEDRIG M, 1994, ACTA VIROL, V38, P141; Nielsen HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023858; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; POGODINA V V, 1960, Vopr Virusol, V5, P279; POGODINA V V, 1958, Vopr Virusol, V3, P271; Potokar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086219; Read JS, 2003, PEDIATRICS, V112, P1196, DOI 10.1542/peds.112.5.1196; Ruprecht RM, 1999, J INFECT DIS, V179, pS408, DOI 10.1086/314794; Ruzek D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020472; Ruzek D, 2009, J GEN VIROL, V90, P1649, DOI 10.1099/vir.0.010058-0; Sandgren KJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000866; Schmitz H, 2002, AIDS, V16, P983, DOI 10.1097/00002030-200205030-00004; Suss J, 2003, VACCINE, V21, pS19, DOI 10.1016/S0264-410X(02)00812-5; SUSS J, 2008, EURO SURVEILL, V13; Troeger H, 2009, GUT, V58, P1070, DOI 10.1136/gut.2008.160150; VAN TONGEREN H A, 1955, Arch Gesamte Virusforsch, V6, P158; Vasquez RJ, 1997, MOL BIOL CELL, V8, P973, DOI 10.1091/mbc.8.6.973; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4	60	11	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96957	10.1371/journal.pone.0096957	http://dx.doi.org/10.1371/journal.pone.0096957			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24820351	Green Published, gold			2022-12-27	WOS:000336653300054
J	Huang, XY; Zhang, C; Cai, JB; Shi, GM; Ke, AW; Dong, ZR; Zhang, PF; Fan, J; Peng, BG; Zhou, J				Huang, Xiao-Yong; Zhang, Chi; Cai, Jia-Bin; Shi, Guo-Ming; Ke, Ai-Wu; Dong, Zhao-Ru; Zhang, Peng-Fei; Fan, Jia; Peng, Bao-Gang; Zhou, Jian			Comprehensive Multiple Molecular Profile of Epithelial Mesenchymal Transition in Intrahepatic Cholangiocarcinoma Patients	PLOS ONE			English	Article							NF-KAPPA-B; BETA-CATENIN; E-CADHERIN; SNAIL; EXPRESSION; CANCER; CELLS; METASTASIS; INDUCTION; PROGNOSIS	Background: The aim of this study is to investigate the expression profile of multiple epithelial mesenchymal transition (EMT)-related molecules in intrahepatic cholangiocarcinoma (ICC) and the related prognostic significance. Methods: Immunohistochemistry was performed to determine the expression of E-cadherin, Vimentin, Snail, slug and beta-catenin in a tissue microarray consisting of tumor tissues of 140 ICC patients undergoing curative resection. The correlation between the expression of these molecules and the clinicopathological characteristics of ICC patients was analyzed, and their prognostic implication was evaluated. Results: Reduced E-cadherin and increased Vimentin expression, the characteristic changes of EMT, identified in 55.0% and 55.7% of primary ICCs, respectively, were correlated with lymphatic metastasis and poorer overall survival (OS) and disease-free survival (DFS) of ICCs. The overexpression of snail and nonmembranous beta-catenin, which are the major regulators of the EMT, were identified in 49.2% and 45.7% of primary ICCs, while little slug expression was detected in ICCs. Cytoplasmic/nuclear b-catenin did not significantly predict worse DFS and was not related with E-cadherin loss. The overexpression of snail predicted worse OS and DFS. Snail overexpression correlated with the down-regulation of E-cadherin and the up-regulation of Vimentin. Inhibition of snail in an ICC cell line decreased the expression of E-cadherin, enhanced the expression of Vimentin and impaired the invasion and migration ability of ICC cells. Conclusions: These data support the hypothesis that EMT plays vital roles in ICC progression and suggest that snail but not slug and beta-catenin plays a crucial role in the EMT induction of ICC.	[Huang, Xiao-Yong; Peng, Bao-Gang] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Xiao-Yong; Zhang, Chi; Cai, Jia-Bin; Shi, Guo-Ming; Ke, Ai-Wu; Dong, Zhao-Ru; Zhang, Peng-Fei; Fan, Jia; Zhou, Jian] Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Shanghai 200433, Peoples R China; [Zhou, Jian] Fudan Univ, Inst Biomed Sci, Ctr Canc, Shanghai 200433, Peoples R China; [Zhou, Jian] Shanghai Key Lab Organ Transplantat, Shanghai, Peoples R China	Sun Yat Sen University; Fudan University; Fudan University	Peng, BG (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Guangzhou 510275, Guangdong, Peoples R China.	pengbaogang@medmail.com.cn; zhou.jian@zs-hospital.sh.cn	Fan, Jia/C-6689-2017	Zhou, Jian/0000-0002-7650-7540; Ke, Ai-Wu/0000-0002-7964-6909	National Science Fund for Distinguished Young Scholars of China [81225019]; Major Program of National Natural Science Foundation of China [81030038]; National Key Sci-Tech Project [2012ZX10002-016]; Program of Shanghai Excellent Subject Leaders [10XD1401200]; NSFC [81071741, 81172023, 81172277]; Ph.D. Programs Foundation of the Ministry of Education of China [20110072120050]; Shanghai Municipal Natural Science Foundation [11ZR1428300, 114119a5000]; new Ph.D. academic Foundation of the Ministry of Education of China [JFF152004]	National Science Fund for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Major Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Sci-Tech Project; Program of Shanghai Excellent Subject Leaders; NSFC(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of the Ministry of Education of China(Ministry of Education, China); Shanghai Municipal Natural Science Foundation; new Ph.D. academic Foundation of the Ministry of Education of China(Ministry of Education, China)	This work was supported by National Science Fund for Distinguished Young Scholars of China (81225019), the Major Program of National Natural Science Foundation of China (81030038), the National Key Sci-Tech Project (2012ZX10002-016), the Program of Shanghai Excellent Subject Leaders (10XD1401200), NSFC (81071741, 81172023, 81172277), the Ph.D. Programs Foundation of the Ministry of Education of China (20110072120050), the Shanghai Municipal Natural Science Foundation (11ZR1428300, 114119a5000) and the new Ph.D. academic Foundation of the Ministry of Education of China (JFF152004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; BEHRENS J, 1993, J CELL BIOL, V120, P757, DOI 10.1083/jcb.120.3.757; Brabletz T, 2005, CELLS TISSUES ORGANS, V179, P56, DOI 10.1159/000084509; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Come C, 2006, CLIN CANCER RES, V12, P5395, DOI 10.1158/1078-0432.CCR-06-0478; DOMAGALA W, 1990, AM J PATHOL, V137, P1299; Enjoji M, 1997, IN VITRO CELL DEV-AN, V33, P681; Huang XY, CANCER, V116, P5440; Jaiswal M, 2000, CANCER RES, V60, P184; Julien S, 2007, ONCOGENE, V26, P7445, DOI 10.1038/sj.onc.1210546; Kase S, 2000, CLIN CANCER RES, V6, P4789; Ke AW, 2011, GASTROENTEROLOGY, V140, P1629, DOI 10.1053/j.gastro.2011.02.008; Ke AW, 2009, HEPATOLOGY, V49, P491, DOI 10.1002/hep.22639; Kim K, 2002, CELL BIOL INT, V26, P463, DOI 10.1006/cbir.2002.0901; Kudo-Saito C, 2009, CANCER CELL, V15, P195, DOI 10.1016/j.ccr.2009.01.023; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Orsulic S, 1999, J CELL SCI, V112, P1237; Patel T, 2011, NAT REV GASTRO HEPAT, V8, P189, DOI 10.1038/nrgastro.2011.20; RAYMOND WA, 1989, J PATHOL, V158, P107, DOI 10.1002/path.1711580205; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Stockinger A, 2001, J CELL BIOL, V154, P1185, DOI 10.1083/jcb.200104036; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Wei Y, 2002, HEPATOLOGY, V36, P692, DOI 10.1053/jhep.2002.35342; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Yang MH, 2009, HEPATOLOGY, V50, P1464, DOI 10.1002/hep.23221; Yao X, 2012, ONCOTARGETS THER, V5, P255, DOI 10.2147/OTT.S36213; Yokoo H, 2004, HEPATOLOGY, V40, P609, DOI 10.1002/hep.20372	30	15	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96860	10.1371/journal.pone.0096860	http://dx.doi.org/10.1371/journal.pone.0096860			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816558	Green Published, gold, Green Submitted			2022-12-27	WOS:000336838000073
J	Kim, MS; Kim, S; Myung, H				Kim, Min Soo; Kim, Sunghoon; Myung, Heejoon			Degradation of AIMP1/p43 Induced by Hepatitis C Virus E2 Leads to Upregulation of TGF-beta Signaling and Increase in Surface Expression of gp96	PLOS ONE			English	Article							TRANSFER-RNA SYNTHETASE; SHOCK-PROTEIN GP96; INDUCED LIVER FIBROSIS; AUTOIMMUNE-DISEASES; ENVELOPE PROTEIN; INFECTION; RECEPTOR; PATHWAY; FIBROGENESIS; ACTIVATION	Hepatitis C virus (HCV) causes chronic hepatitis leading to liver fibrosis and autoimmune diseases. AIMP1/p43 is a multifunctional protein initially known as a cofactor of aminoacyl tRNA synthetase complex. Its function includes negative regulation of TGF-beta signaling and suppression of Lupus-like autoimmune disease by inhibition of surface expression of gp96. HCV E2 was shown to directly interact with AIMP1/p43 by GST pulldown assay and coimmunoprecipitation. Their subcellular colocalization was observed in an immunofluorescence confocal microscopy. We showed that HCV E2 led to degradation of AIMP1/p43 in two ways. First, in the presence of HCV E2, endogenous AIMP1/p43 was shown to be degraded in an ubiquitin-dependent proteasome pathway. Second, grp78, an ER chaperone, was shown to interact with and stabilize AIMP1/p43. And HCV E2 inhibited this interaction leading to reduction of cellular AIMP1/p43. The degradation of AIMP1/p43 by HCV E2 resulted in increase of TGF-beta signaling and cell surface expression of gp96. Thus we suggest that these are novel mechanisms responsible for liver fibrosis and autoimmune diseases caused by HCV.	[Kim, Min Soo; Myung, Heejoon] Hankuk Univ Foreign Studies, Dept Biosci & Biotechnol, Yongin, Gyung Gi Do, South Korea; [Kim, Sunghoon] Seoul Natl Univ, Coll Pharm, Med Bioconvergence Res Ctr, Seoul, South Korea	Hankuk University Foreign Studies; Seoul National University (SNU)	Myung, H (corresponding author), Hankuk Univ Foreign Studies, Dept Biosci & Biotechnol, Yongin, Gyung Gi Do, South Korea.	hjmyung@hufs.ac.kr	Myung, Heejoon/AAB-3422-2019; Kim, Sunghoon/AAE-8314-2020	Myung, Heejoon/0000-0001-7478-7676; kim, sunghoon/0000-0002-1570-3230	Korea NRF grant [S2-2008-000-01461-1]; Korea NRF [20100017136]; GRRC	Korea NRF grant(National Research Foundation of Korea); Korea NRF(National Research Foundation of Korea); GRRC	MSK was supported by Korea NRF grant (S2-2008-000-01461-1). This study was supported by Korea NRF grant 20100017136 and 2013 GRRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banhegyi G, 2007, ANN NY ACAD SCI, V1113, P58, DOI 10.1196/annals.1391.007; BARTENSCHLAGER R, 1994, J VIROL, V68, P5045, DOI 10.1128/JVI.68.8.5045-5055.1994; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Benedicto I, 2009, J VIROL, V83, P8012, DOI 10.1128/JVI.00038-09; Cheng PL, 2004, ONCOGENE, V23, P7821, DOI 10.1038/sj.onc.1208066; Choi SH, 2006, J BIOL CHEM, V281, P7468, DOI 10.1074/jbc.M512438200; Choi SH, 2007, GASTROENTEROLOGY, V132, P343, DOI 10.1053/j.gastro.2006.10.038; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Ferri S, 2008, CURR PHARM DESIGN, V14, P1678, DOI 10.2174/138161208784746824; Gale M, 2005, NATURE, V436, P939, DOI 10.1038/nature04078; Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner; Han JM, 2007, AM J PATHOL, V170, P2042, DOI 10.2353/ajpath.2007.061266; Kanzler S, 1999, AM J PHYSIOL-GASTR L, V276, pG1059, DOI 10.1152/ajpgi.1999.276.4.G1059; Kasprzak A, 2008, HEPATOL RES, V38, P1, DOI 10.1111/j.1872-034X.2007.00261.x; Ko YG, 2001, J BIOL CHEM, V276, P23028, DOI 10.1074/jbc.M101544200; Lee DK, 2001, GENE DEV, V15, P455, DOI 10.1101/gad.856201; Lee SH, 2008, HEPATOLOGY, V47, P854, DOI 10.1002/hep.22107; Lee YS, 2008, BIOCHEM BIOPH RES CO, V371, P395, DOI 10.1016/j.bbrc.2008.04.099; Lee YS, 2006, MOL CELLS, V21, P213; Liberman E, 1999, J VIROL, V73, P3718, DOI 10.1128/JVI.73.5.3718-3722.1999; LIN C, 1994, J VIROL, V68, P5063, DOI 10.1128/JVI.68.8.5063-5073.1994; Liu B, 2003, P NATL ACAD SCI USA, V100, P15824, DOI 10.1073/pnas.2635458100; MacParland SA, 2006, J GEN VIROL, V87, P3577, DOI 10.1099/vir.0.81868-0; Matsuzaki K, 2007, HEPATOLOGY, V46, P48, DOI 10.1002/hep.21672; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Otto GA, 2004, CELL, V119, P369, DOI 10.1016/j.cell.2004.09.038; Park SG, 2010, IUBMB LIFE, V62, P296, DOI 10.1002/iub.324; Park SG, 2002, J BIOL CHEM, V277, P45243, DOI 10.1074/jbc.M207934200; Pavio N, 2002, J VIROL, V76, P1265, DOI 10.1128/JVI.76.3.1265-1272.2002; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Rosenberg S, 2001, J MOL BIOL, V313, P451, DOI 10.1006/jmbi.2001.5055; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Schuppan D, 2003, CELL DEATH DIFFER, V10, pS59, DOI 10.1038/sj.cdd.4401163; Seeff Leonard B, 2003, Clin Liver Dis, V7, P261, DOI 10.1016/S1089-3261(02)00078-8; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Suzuki R, 1999, INTERVIROLOGY, V42, P145, DOI 10.1159/000024973; Vabulas RM, 2002, J BIOL CHEM, V277, P20847, DOI 10.1074/jbc.M200425200; Wells RG, 2000, AM J PHYSIOL-GASTR L, V279, pG845, DOI 10.1152/ajpgi.2000.279.5.G845; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S	41	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96302	10.1371/journal.pone.0096302	http://dx.doi.org/10.1371/journal.pone.0096302			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816397	Green Published, Green Submitted, gold			2022-12-27	WOS:000336838000032
J	Levin, RA; Felsen, CN; Yang, J; Lin, JY; Whitney, MA; Nguyen, QT; Tsien, RY				Levin, Rachel A.; Felsen, Csilla N.; Yang, Jin; Lin, John Y.; Whitney, Michael A.; Nguyen, Quyen T.; Tsien, Roger Y.			An Optimized Triple Modality Reporter for Quantitative In Vivo Tumor Imaging and Therapy Evaluation	PLOS ONE			English	Article							GENE-EXPRESSION; PROTEINS; BIOLUMINESCENCE; FLUORESCENT; VECTORS; DESIGN; MODEL	We present an optimized triple modality reporter construct combining a far-red fluorescent protein (E2-Crimson), enhanced firefly luciferase enzyme (Luc2), and truncated wild type herpes simplex virus I thymidine kinase (wttk) that allows for sensitive, long-term tracking of tumor growth in vivo by fluorescence, bioluminescence, and positron emission tomography. Two human cancer cell lines (MDA-MB-231 breast cancer and HT-1080 fibrosarcoma cancer) were successfully transduced to express this triple modality reporter. Fluorescence and bioluminescence imaging of the triple modality reporter were used to accurately quantify the therapeutic responses of MDA-MB-231 tumors to the chemotherapeutic agent monomethyl auristatin E in vivo in athymic nude mice. Positive correlation was observed between the fluorescence and bioluminescence signals, and these signals were also positively correlated with the ex vivo tumor weights. This is the first reported use of both fluorescence and bioluminescence signals from a multi-modality reporter construct to measure drug efficacy in vivo.	[Levin, Rachel A.; Felsen, Csilla N.; Yang, Jin; Lin, John Y.; Whitney, Michael A.; Tsien, Roger Y.] Univ Calif San Diego, Dept Pharmacol, UCSD Sch Med, La Jolla, CA 92093 USA; [Nguyen, Quyen T.] Univ Calif San Diego, Div Otolaryngol Head & Neck Surg, La Jolla, CA 92093 USA; [Tsien, Roger Y.] Howard Hughes Med Inst, La Jolla, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute	Tsien, RY (corresponding author), Univ Calif San Diego, Dept Pharmacol, UCSD Sch Med, La Jolla, CA 92093 USA.	rtsien@ucsd.edu		Lin, John/0000-0002-1723-4597	training grant [5R25CA153915]; F30 fellowship [1F30HL118998-01]; Foundation of Research, Science and Technology New Zealand; Burrough-Wellcome Fund (CAMS); NIH [5K08EB008122, R01 CA158448]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R25CA153915, R01CA158448] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL118998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K08EB008122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198] Funding Source: NIH RePORTER	training grant; F30 fellowship; Foundation of Research, Science and Technology New Zealand(New Zealand Foundation for Research, Science and Technology); Burrough-Wellcome Fund (CAMS); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a training grant (5R25CA153915) and F30 fellowship (1F30HL118998-01) to C.N. Felsen, a grant from the Foundation of Research, Science and Technology New Zealand to J.Y. Lin, grants from the Burrough-Wellcome Fund (CAMS) and NIH (5K08EB008122) to Q. T. Nguyen, an NIH grant R01 CA158448 to R.Y. Tsien, and the Howard Hughes Medical Institute to R.Y. Tsien. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angst E, 2010, MOL IMAGING BIOL, V12, P570, DOI 10.1007/s11307-010-0310-4; Blasberg R, 2002, EUR J CANCER, V38, P2137, DOI 10.1016/S0959-8049(02)00390-8; Doronina SO, 2006, BIOCONJUGATE CHEM, V17, P114, DOI 10.1021/bc0502917; Doronina SO, 2008, BIOCONJUGATE CHEM, V19, P1960, DOI 10.1021/bc800289a; Ibrahimi A, 2009, HUM GENE THER, V20, P845, DOI 10.1089/hum.2008.188; Jensen Mette Munk, 2008, BMC Med Imaging, V8, P16, DOI 10.1186/1471-2342-8-16; Kesarwala AH, 2006, MOL IMAGING, V5, P465, DOI 10.2310/7290.2006.00024; Kim JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009364; Lin MZ, 2009, CHEM BIOL, V16, P1169, DOI 10.1016/j.chembiol.2009.10.009; Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Nakahara T, 2011, CANCER SCI, V102, P614, DOI 10.1111/j.1349-7006.2010.01834.x; Patil YB, 2010, BIOMATERIALS, V31, P358, DOI 10.1016/j.biomaterials.2009.09.048; Ponomarev V, 2004, EUR J NUCL MED MOL I, V31, P740, DOI 10.1007/s00259-003-1441-5; Ray P, 2004, CANCER RES, V64, P1323, DOI 10.1158/0008-5472.CAN-03-1816; Ray P, 2007, CANCER RES, V67, P3085, DOI 10.1158/0008-5472.CAN-06-2402; Shu XK, 2009, SCIENCE, V324, P804, DOI 10.1126/science.1168683; Steiner JL, 2013, INT J ONCOL, V42, P1466, DOI 10.3892/ijo.2013.1827; Stout DB, 2005, MOL IMAGING BIOL, V7, P393, DOI 10.1007/s11307-005-0015-2; Strack RL, 2009, BIOCHEMISTRY-US, V48, P8279, DOI 10.1021/bi900870u; Szymczak AL, 2005, EXPERT OPIN BIOL TH, V5, P627, DOI 10.1517/14712598.5.5.627; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Troy Tamara, 2004, Mol Imaging, V3, P9, DOI 10.1162/153535004773861688; van der Horst G, 2011, EUR UROL, V60, P337, DOI 10.1016/j.eururo.2011.05.005; Wang L, 2004, P NATL ACAD SCI USA, V101, P16745, DOI 10.1073/pnas.0407752101; Yaghoubi S, 2001, J NUCL MED, V42, P1225	28	13	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97415	10.1371/journal.pone.0097415	http://dx.doi.org/10.1371/journal.pone.0097415			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816650	Green Published, Green Submitted, gold			2022-12-27	WOS:000336838000135
J	Neto, JBA; da Silva, CR; Neta, MAS; Campos, RS; Siebra, JT; Silva, RAC; Gaspar, DM; Magalhaes, HIF; de Moraes, MO; Lobo, MDP; Grangeiro, TB; Carvalho, TSC; Diogo, EBT; da Silva, EN; Rodrigues, FAR; Cavalcanti, BC; Junior, HVN				Neto, Joao B. A.; da Silva, Cecilia R.; Neta, Maria A. S.; Campos, Rosana S.; Siebra, Janaina T.; Silva, Rose A. C.; Gaspar, Danielle M.; Magalhaes, Hemerson I. F.; de Moraes, Manoel O.; Lobo, Marina D. P.; Grangeiro, Thalles B.; Carvalho, Tatiane S. C.; Diogo, Emilay B. T.; da Silva Junior, Eufranio N.; Rodrigues, Felipe A. R.; Cavalcanti, Bruno C.; Junior, Helio V. N.			Antifungal Activity of Naphthoquinoidal Compounds In Vitro against Fluconazole-Resistant Strains of Different Candida Species: A Special Emphasis on Mechanisms of Action on Candida tropicalis	PLOS ONE			English	Article							INDUCED APOPTOSIS; FLOW-CYTOMETRY; DNA-DAMAGE; YEAST; BRAZIL; SPP.; HOSPITALS; ALBICANS; CELLS	In recent decades, the incidence of candidemia in tertiary hospitals worldwide has substantially increased. These infections are a major cause of morbidity and mortality; in addition, they prolong hospital stays and raise the costs associated with treatment. Studies have reported a significant increase in infections by non-albicans Candida species, especially C. tropicalis. The number of antifungal drugs on the market is small in comparison to the number of antibacterial agents available. The limited number of treatment options, coupled with the increasing frequency of cross-resistance, makes it necessary to develop new therapeutic strategies. The objective of this study was to evaluate and compare the antifungal activities of three semisynthetic naphthofuranquinone molecules against fluconazole-resistant Candida spp. strains. These results allowed to us to evaluate the antifungal effects of three naphthofuranquinones on fluconazole-resistant C. tropicalis. The toxicity of these compounds was manifested as increased intracellular ROS, which resulted in membrane damage and changes in cell size/granularity, mitochondrial membrane depolarization, and DNA damage (including oxidation and strand breakage). In conclusion, the tested naphthofuranquinones (compounds 1-3) exhibited in vitro cytotoxicity against fluconazole-resistant Candida spp. strains.	[Neto, Joao B. A.; da Silva, Cecilia R.; Neta, Maria A. S.; Campos, Rosana S.; Siebra, Janaina T.; Silva, Rose A. C.; Magalhaes, Hemerson I. F.; Junior, Helio V. N.] Univ Fed Ceara, Sch Pharm, Dept Clin & Toxicol Anal, Lab Bioprospect & Expt Yeast LABEL, Fortaleza, Ceara, Brazil; [da Silva, Cecilia R.; Neta, Maria A. S.; Campos, Rosana S.; Cavalcanti, Bruno C.; Junior, Helio V. N.] Univ Fed Ceara, Sch Med, Dept Pathol & Legal Med, Lab Bioprospect & Expt Yeast LABEL, Fortaleza, Ceara, Brazil; [Magalhaes, Hemerson I. F.] Univ Fed Paraiba, Ctr Toxicol Assistance, Dept Pharmaceut Sci, BR-58059900 Joao Pessoa, Paraiba, Brazil; [Gaspar, Danielle M.; de Moraes, Manoel O.; Rodrigues, Felipe A. R.; Cavalcanti, Bruno C.; Junior, Helio V. N.] Univ Fed Ceara, Dept Physiol & Pharmacol, Expt Oncol Lab, Fortaleza, Ceara, Brazil; [Lobo, Marina D. P.; Grangeiro, Thalles B.] Univ Fed Ceara, Dept Biol, SciCtr, Mol Genet Lab, Fortaleza, Ceara, Brazil; [Carvalho, Tatiane S. C.] Univ Fed Rio de Janeiro, Nat Prod Res Nucleus, Rio De Janeiro, Brazil; [Diogo, Emilay B. T.; da Silva Junior, Eufranio N.] Univ Fed Minas Gerais, Inst Exact Sci, Dept Chem, Lab Synthet & Heterocycl Chem, Belo Horizonte, MG, Brazil	Universidade Federal do Ceara; Universidade Federal do Ceara; Universidade Federal da Paraiba; Universidade Federal do Ceara; Universidade Federal do Ceara; Universidade Federal do Rio de Janeiro; Universidade Federal de Minas Gerais	Junior, HVN (corresponding author), Univ Fed Ceara, Sch Pharm, Dept Clin & Toxicol Anal, Lab Bioprospect & Expt Yeast LABEL, Fortaleza, Ceara, Brazil.	labelufc11@gmail.com	da Silva Júnior, Eufrânio/AAQ-6570-2020; Grangeiro, Thalles Barbosa/E-9606-2010; Macedo, Danielle/E-3424-2014; da Silva Júnior, Eufrânio Nunes/C-6114-2013; Coêlho Cavalcanti, Bruno/F-1555-2015; RODRIGUES, FELIPE/H-4259-2012	da Silva Júnior, Eufrânio/0000-0003-1281-5453; Grangeiro, Thalles Barbosa/0000-0001-8276-3092; Macedo, Danielle/0000-0001-8980-9970; RODRIGUES, FELIPE/0000-0002-8241-3903; Silva, Cecilia/0000-0003-4964-351X; Junior, Helio/0000-0003-0156-5882	CNPq; CAPES/Brazil; FUNCAP/Ceara; Federal University of Ceara	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES/Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FUNCAP/Ceara(Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP)); Federal University of Ceara	This work was funded by CNPq and CAPES/Brazil and FUNCAP/Ceara. The funders (Federal University of Ceara) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Yamamoto ACA, 2012, REV IBEROAM MICOL, V29, P164, DOI 10.1016/j.riam.2012.01.001; Almeida B, 2008, BBA-MOL CELL RES, V1783, P1436, DOI 10.1016/j.bbamcr.2008.01.005; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Cavalcanti BC, 2012, PHARM BIOL, V50, P980, DOI 10.3109/13880209.2012.654921; Cavalcanti BC, 2009, J APPL TOXICOL, V29, P560, DOI 10.1002/jat.1439; Chi HW, 2011, J MICROBIOL IMMUNOL, V44, P369, DOI 10.1016/j.jmii.2010.08.010; Cho J, 2011, BIOCHIMIE, V93, P1873, DOI 10.1016/j.biochi.2011.07.011; Clinical and Laboratory Standard Institute, 2012, REF METH BROTH DIL A; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; da Silva CR, 2013, ANTIMICROB AGENTS CH, V57, P1691, DOI 10.1128/AAC.00966-12; da Silva EN, 2011, EUR J MED CHEM, V46, P399, DOI 10.1016/j.ejmech.2010.11.006; da Silva MN, 2003, QUIM NOVA, V26, P407, DOI 10.1590/S0100-40422003000300019; Emadi A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010846; Guo J, 2012, ENVIRON TOXICOL PHAR, V33, P408, DOI 10.1016/j.etap.2012.01.005; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; Hinrichsen SL, 2009, BRAZ J MICROBIOL, V40, P325, DOI [10.1590/S1517-83822009000200021, 10.1590/S1517-838220090002000021]; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hwang IS, 2012, MYCOPATHOLOGIA, V173, P207, DOI 10.1007/s11046-011-9503-x; Joung YH, 2007, J INFECTION, V54, P504, DOI 10.1016/j.jinf.2006.09.016; Kothavade RJ, 2010, J MED MICROBIOL, V59, P873, DOI 10.1099/jmm.0.013227-0; Kumagai Y, 2012, ANNU REV PHARMACOL, V52, P221, DOI 10.1146/annurev-pharmtox-010611-134517; Ludovico P, 2001, MICROBIOL-SGM, V147, P3335, DOI 10.1099/00221287-147-12-3335; Miloshev G, 2002, MUTAT RES-GEN TOX EN, V513, P69, DOI 10.1016/S1383-5718(01)00286-8; Murakami K, 2010, TOXICOL IN VITRO, V24, P905, DOI 10.1016/j.tiv.2009.11.018; Oliveira MH, 2012, ELECT J PHARM, V9, P62; Pfaller MA, 2012, J CLIN MICROBIOL, V50, P2846, DOI 10.1128/JCM.00937-12; Pfaller MA, 2012, AM J MED, V125, pS3, DOI 10.1016/j.amjmed.2011.11.001; Pina-Vaz C, 2010, METHOD MOL BIOL, P638; Pinkerton DM, 2010, CHEM BIODIVERS, V7, P1311, DOI 10.1002/cbdv.201000030; Sambrook J., 1989, CONDENSED PROTOCOLS; Silva RSF, 2006, EUR J MED CHEM, V41, P526, DOI 10.1016/j.ejmech.2005.12.006; Storti LR, 2012, REV SOC BRAS MED TRO, V45, P225, DOI 10.1590/S0037-86822012000200017; Tobudic S, 2012, MYCOSES, V55, P24, DOI 10.1111/j.1439-0507.2011.02146.x; Freire CPV, 2010, MEDCHEMCOMM, V1, P229, DOI 10.1039/c0md00074d; Warner Simon A. J., 1996, P51; White T. J, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Xu CL, 2010, FEMS YEAST RES, V10, P297, DOI 10.1111/j.1567-1364.2010.00615.x	37	42	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e93698	10.1371/journal.pone.0093698	http://dx.doi.org/10.1371/journal.pone.0093698			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24817320	gold, Green Published, Green Submitted			2022-12-27	WOS:000336838000005
J	Thang, ND; Yajima, I; Kumasaka, MY; Kato, M				Nguyen Dinh Thang; Yajima, Ichiro; Kumasaka, Mayuko Y.; Kato, Masashi			Bidirectional Functions of Arsenic as a Carcinogen and an Anti-Cancer Agent in Human Squamous Cell Carcinoma	PLOS ONE			English	Article							TRIOXIDE-INDUCED APOPTOSIS; CANCER-CELLS; N-CADHERIN; ADHESION MOLECULES; MALIGNANT-MELANOMA; DOWN-REGULATION; LEUKEMIA-CELLS; P21 EXPRESSION; UP-REGULATION; WEST-BENGAL	Bidirectional cancer-promoting and anti-cancer effects of arsenic for cancer cells have been revealed in previous studies. However, each of these effects (cancer-promoting or anti-cancer) was found in different cells at different treated-concentration of arsenic. In this study, we for the first time indicated that arsenic at concentration of 3 mu M, equal to average concentration in drinking water in cancer-prone areas in Bangladesh, simultaneously expressed its bidirectional effects on human squamous cell carcinoma HSC5 cells with distinct pathways. Treatment with 3 mu M of arsenic promoted cell invasion via upregulation of expression of MT1-MMP and downregulation of expression of p14ARF and simultaneously induced cell apoptosis through inhibition of expression of N-cadherin and increase of expression of p21(WAF1/CIP1) at both transcript and protein levels in HSC5 cells. We also showed that inhibition of MT1-MMP expression by NSC405020 resulted in decrease of arsenic-mediated invasion of HSC5 cells involving decrease in phosphorylated extracellular signal-regulated kinases (pERK). Taken together, our biological and biochemical findings suggested that arsenic expressed bidirectional effects as a carcinogen and an anti-cancer agent in human squamous cell carcinoma HSC5 cells with distinct pathways. Our results might play an important scientific evident for further studies to find out a better way in treatment of arsenic-induced cancers, especially in squamous cell carcinoma.	[Nguyen Dinh Thang] Vietnam Natl Univ, Dept Biochem & Plant Physiol, VNU Univ Sci, Hanoi, Vietnam; [Yajima, Ichiro; Kumasaka, Mayuko Y.; Kato, Masashi] Nagoya Univ, Dept Occupat & Environm Hlth, Grad Sch Med, Nagoya, Aichi 4648601, Japan	Vietnam National University Hanoi; Nagoya University	Thang, ND (corresponding author), Vietnam Natl Univ, Dept Biochem & Plant Physiol, VNU Univ Sci, Hanoi, Vietnam.	ndthang@hus.edu.vn	KATO, Masashi/I-7250-2014; YAJIMA, Ichiro/I-7467-2014		Vietnam National Foundation for Science and Technology Development (NAFOSTED) [106-NN.02-2013.07]	Vietnam National Foundation for Science and Technology Development (NAFOSTED)(National Foundation for Science & Technology Development (NAFOSTED))	This research is funded by Vietnam National Foundation for Science and Technology Development (NAFOSTED) under grant number 106-NN.02-2013.07. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplin AE, 1999, CURR OPIN CELL BIOL, V11, P737, DOI 10.1016/S0955-0674(99)00045-9; Berg M, 2007, SCI TOTAL ENVIRON, V372, P413, DOI 10.1016/j.scitotenv.2006.09.010; Bottazzi ME, 1999, J CELL BIOL, V146, P1255, DOI 10.1083/jcb.146.6.1255; Chakraborti D, 2010, WATER RES, V44, P5789, DOI 10.1016/j.watres.2010.06.051; Cheng TH, 2009, J CANCER RES CLIN, V135, P1577, DOI 10.1007/s00432-009-0605-5; Chiang KC, 2013, J STEROID BIOCHEM, V138, P427, DOI 10.1016/j.jsbmb.2013.09.002; Chowdhury UK, 2000, ENVIRON HEALTH PERSP, V108, P393, DOI 10.2307/3454378; Ciolczyk-Wierzbicka D, 2012, CURR MED CHEM, V19, P145, DOI 10.2174/092986712803414006; Derycke LDM, 2004, INT J DEV BIOL, V48, P463, DOI 10.1387/ijdb.041793ld; Gebel TW, 1999, SCIENCE, V283, P1458; Hassani S, 2013, ANN HEMATOL, V92, P1207, DOI 10.1007/s00277-013-1763-8; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Hsia DA, 2003, J CELL BIOL, V160, P753, DOI 10.1083/jcb.200212114; Huang HS, 2002, FREE RADICAL BIO MED, V33, P864, DOI 10.1016/S0891-5849(02)00983-8; Huang HS, 2011, TOXICOL SCI, V121, P101, DOI 10.1093/toxsci/kfr023; Jiang XH, 2001, INT J CANCER, V91, P173, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1039>3.0.CO;2-D; Johnson JP, 1999, CANCER METAST REV, V18, P345, DOI 10.1023/A:1006304806799; Kato M, 2008, J TOXICOL ENV HEAL A, V71, P1053, DOI 10.1080/15287390802114998; Kim HG, 2012, J BIOL CHEM, V287, P31920, DOI 10.1074/jbc.M112.360362; Kim YJ, 2011, TOXICOLOGY, V285, P142, DOI 10.1016/j.tox.2011.04.013; LANSDOWN ABG, 1995, CRIT REV TOXICOL, V25, P397, DOI 10.3109/10408449509049339; Li YA, 2010, TOXICOL SCI, V116, P174, DOI 10.1093/toxsci/kfq109; Lin TH, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-58; Ling Y, 2014, DIS ESOPHAGUS, V27, P182, DOI 10.1111/j.1442-2050.2012.01413.x; Liu P, 2010, J CELL PHYSIOL, V225, P810, DOI 10.1002/jcp.22292; Liu ZM, 2008, TOXICOL APPL PHARM, V233, P297, DOI 10.1016/j.taap.2008.08.015; Lunghi P, 2004, BLOOD, V104, P519, DOI 10.1182/blood-2003-08-2743; Thang ND, 2012, J DERMATOL SCI, V65, P207, DOI 10.1016/j.jdermsci.2011.10.010; Thang ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025636; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Nriagu J, 2012, SCI TOTAL ENVIRON, V420, P65, DOI 10.1016/j.scitotenv.2012.01.007; Ota I, 2009, P NATL ACAD SCI USA, V106, P20318, DOI 10.1073/pnas.0910962106; Pi JB, 2008, FREE RADICAL BIO MED, V45, P651, DOI 10.1016/j.freeradbiomed.2008.05.020; Roovers K, 2000, BIOESSAYS, V22, P818, DOI 10.1002/1521-1878(200009)22:9<818::AID-BIES7>3.3.CO;2-Y; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Sugiyama N, 2010, CANCER RES, V70, P7851, DOI 10.1158/0008-5472.CAN-10-1223; Takino T, 2010, BIOCHEM BIOPH RES CO, V396, P1042, DOI 10.1016/j.bbrc.2010.05.059; Torii S, 2006, CANCER SCI, V97, P697, DOI 10.1111/j.1349-7006.2006.00244.x; Yajima I, 2012, ARCH TOXICOL, V86, P961, DOI 10.1007/s00204-012-0848-9; Yu J, 2007, GYNECOL ONCOL, V106, P400, DOI 10.1016/j.ygyno.2007.04.016; Zhang MB, 2013, ONCOL LETT, V6, P381, DOI 10.3892/ol.2013.1381; Zhang Y, 2011, CANCER-AM CANCER SOC, V117, P1227, DOI 10.1002/cncr.25605	43	11	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96945	10.1371/journal.pone.0096945	http://dx.doi.org/10.1371/journal.pone.0096945			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816914	Green Published, gold, Green Submitted			2022-12-27	WOS:000336838000084
J	Schiller, C; Nowak, C; Diakopoulos, KN; Weidle, UH; Weiss, EH				Schiller, Christian; Nowak, Carina; Diakopoulos, Kalliope N.; Weidle, Ulrich H.; Weiss, Elisabeth H.			An Upstream Open Reading Frame Regulates LST1 Expression during Monocyte Differentiation	PLOS ONE			English	Article							TRANSLATIONAL CONTROL; GENE-EXPRESSION; STOP CODONS; GCN4; INITIATION; PROTEINS; REINITIATION; EFFICIENCY; PATTERN; REGION	The regulation of gene expression depends on the interplay of multiple factors at the transcriptional and translational level. Upstream open reading frames (uORFs) play an important role as translational repressors of main ORFs and their presence or usage in transcripts can be regulated by different mechanisms. The main objective of the present study was to assess whether uORFs regulate the expression of the MHC class III gene LST1. We report that expression of LST1 is tightly regulated by alternative transcription initiation and the presence of an uORF in the 5'-UTR of transcripts. Specifically, using EGFP reporter constructs in human HeLa and HEK-293T cells and flow cytometry as well as western blot analysis we found the uORF to reduce the expression of the main ORF by roughly two-thirds. Furthermore, we were able to correlate a previously detected increase in LST1 protein expression during monocyte differentiation with an increase of transcription initiation at an alternative exon that does not contain an uORF.	[Schiller, Christian; Nowak, Carina; Diakopoulos, Kalliope N.; Weiss, Elisabeth H.] Ludwig Maximilians Univ Munchen, Dept Biol 2, Munich, Germany; [Weidle, Ulrich H.] Roche Diagnost, Div Pharma, Penzberg, Germany	University of Munich; Roche Holding	Schiller, C (corresponding author), Ludwig Maximilians Univ Munchen, Dept Biol 2, Munich, Germany.	elisabeth.weiss@lmu.de		Diakopoulos, Kalliope/0000-0002-9236-0489	Helmholtz Zentrum Munchen PhD Program, Research Field "Infection and Immunity"	Helmholtz Zentrum Munchen PhD Program, Research Field "Infection and Immunity"	This work was supported by the Helmholtz Zentrum Munchen PhD Program, Research Field "Infection and Immunity". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajay SS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-155; Barbosa C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003529; Brown CY, 1999, ONCOGENE, V18, P5631, DOI 10.1038/sj.onc.1202949; Burdek M, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-90; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Cao JH, 1996, MOL CELL BIOL, V16, P7109; Davuluri RV, 2000, GENOME RES, V10, P1807, DOI 10.1101/gr.GR-1460R; deBaey A, 1997, GENOMICS, V45, P591, DOI 10.1006/geno.1997.4963; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Draber P, 2012, J BIOL CHEM, V287, P22812, DOI 10.1074/jbc.M112.339143; GRANT CM, 1994, MOL CELL BIOL, V14, P606, DOI 10.1128/MCB.14.1.606; HOLZINGER I, 1995, IMMUNOGENETICS, V42, P315, DOI 10.1007/BF00179392; Hood HM, 2009, ANNU REV MICROBIOL, V63, P385, DOI 10.1146/annurev.micro.62.081307.162835; Hughes TA, 2005, J BIOL CHEM, V280, P8581, DOI 10.1074/jbc.M410806200; Hughes TA, 2006, TRENDS GENET, V22, P119, DOI 10.1016/j.tig.2006.01.001; Iacono M, 2005, GENE, V349, P97, DOI 10.1016/j.gene.2004.11.041; Lehner B, 2004, GENOMICS, V83, P153, DOI 10.1016/S0888-7543(03)00235-0; LUUKKONEN BGM, 1995, J VIROL, V69, P4086, DOI 10.1128/JVI.69.7.4086-4094.1995; Medenbach J, 2011, CELL, V145, P902, DOI 10.1016/j.cell.2011.05.005; Meijer HA, 2002, BIOCHEM J, V367, P1, DOI 10.1042/BJ20011706; Mewar D, 2006, GENES IMMUN, V7, P625, DOI 10.1038/sj.gene.6364339; MILLER PF, 1989, GENE DEV, V3, P1217, DOI 10.1101/gad.3.8.1217; Mulcahy H, 2006, IMMUNOGENETICS, V57, P893, DOI 10.1007/s00251-005-0057-2; Nagy GR, 2006, CLIN CHEM, V52, P2013, DOI 10.1373/clinchem.2006.074971; Rollinger-Holzinger I, 2000, J IMMUNOL, V164, P3169, DOI 10.4049/jimmunol.164.6.3169; Schiller C, 2013, J CELL SCI, V126, P767, DOI 10.1242/jcs.114033; Schiller C, 2013, HUM IMMUNOL, V74, P412, DOI 10.1016/j.humimm.2012.11.026; Schiller C, 2009, HYBRIDOMA, V28, P281, DOI 10.1089/hyb.2009.0021; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sobczak K, 2002, J BIOL CHEM, V277, P17349, DOI 10.1074/jbc.M109162200; Somers J, 2013, INT J BIOCHEM CELL B, V45, P1690, DOI 10.1016/j.biocel.2013.04.020; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Stepanek O, 2014, CELL SIGNAL, V26, P895, DOI 10.1016/j.cellsig.2014.01.007; Stricker D, 2008, COMPUT METH PROG BIO, V92, P135, DOI 10.1016/j.cmpb.2008.06.010; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Yu XF, 2000, J BIOL CHEM, V275, P34597, DOI 10.1074/jbc.M004700200; Zhang F, 2011, NUCLEIC ACIDS RES, V39, P3128, DOI 10.1093/nar/gkq1251	37	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96245	10.1371/journal.pone.0096245	http://dx.doi.org/10.1371/journal.pone.0096245			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816991	Green Submitted, Green Published, gold			2022-12-27	WOS:000336838000027
J	Chaturvedi, S; Randive, B; Diwan, V; De Costa, A				Chaturvedi, Sarika; Randive, Bharat; Diwan, Vishal; De Costa, Ayesha			Quality of Obstetric Referral Services in India's JSY Cash Transfer Programme for Institutional Births: A Study from Madhya Pradesh Province	PLOS ONE			English	Article							MATERNAL MORTALITY; DISTRICT; CARE; SYSTEM; FACILITIES; SURVIVAL; DEATHS; HEALTH	Background: India launched JSY cash transfer programme to increase access to emergency obstetric and neonatal care (EmONC) by incentivising in-facility births. This increased in-facility births from 30% in 2005 to 73% in 2012 however, decline in maternal mortality follows a secular trend. Dysfunctional referral services can contribute to poor programme impact on outcomes. We hence describe inter-facility referrals and study quality of referral services in JSY. Methods and Results: Women accessing intra natal care (n = 1182) at facilities (reporting >10 deliveries/month, n = 96) were interviewed in a 5 day cross sectional survey in 3 districts of Madhya Pradesh province. A nested matched case control study (n = 68 pairs) was performed to study association between maternal referral and adverse birth outcomes. There were 111 (9.4%) in referrals and 69 (5.8%) out referrals. Secondary level facilities sent most referrals and 40% were for conditions expected to be treated at this level. There were 36 adverse birth outcomes (intra partum and in-facility deaths). After matching for type of complication and place of delivery, conditional logistic regression model showed maternal referral at term delivery was associated with higher odds of adverse birth outcomes (OR-2.6, 95% CI: 1.0-6.6 p = 0.04). Maternal death record review (April 10-March 12) was conducted at the CEmOC facility in one district. Spatial analysis of transfer time from sending to the receiving CEmOC facility among in-facility maternal deaths was conducted in ArcGIS10 applying two hours (equated to 100 Km) as desired transfer time. There were 124 maternal deaths, 55 of which were among mothers referred in. Buffer analysis revealed 98% mothers were referred from <2 hours. Median time between arrival and death was 6.75 hours. Conclusions: High odds of adverse birth outcomes associated with maternal referral and high maternal deaths despite spatial access to referral care indicate poor quality of referral services.	[Chaturvedi, Sarika; Randive, Bharat; Diwan, Vishal] RD Gardi Med Coll, Dept Publ Hlth & Environm, Ujjain, Madhya Pradesh, India; [Chaturvedi, Sarika; Diwan, Vishal; De Costa, Ayesha] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Randive, Bharat] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Diwan, Vishal] RD Gardi Med Coll, Int Ctr Hlth Res, Ujjain, Madhya Pradesh, India	Karolinska Institutet; Umea University	Chaturvedi, S (corresponding author), RD Gardi Med Coll, Dept Publ Hlth & Environm, Ujjain, Madhya Pradesh, India.	sarikabharat2005@gmail.com		Chaturvedi, Sarika/0000-0003-2927-1229; Diwan, Vishal/0000-0001-7948-8579; De Costa, Ayesha/0000-0003-1869-5990	EU FP 7 grant; Swedish Research Council	EU FP 7 grant; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by EU FP 7 grant to project MATIND. Support was also received from Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouZahr C, 1998, ANT POSTP HAEM; [Anonymous], 2012, WHO UNICEF UNFPA WOR; Ansong-Tornui Janet, 2007, Ghana Med J, V41, P125; Bailey PE, 2011, INT J GYNECOL OBSTET, V115, P300, DOI 10.1016/j.ijgo.2011.09.004; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Dogba M, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-13; George A, 2007, REPROD HEALTH MATTER, V15, P91, DOI 10.1016/S0968-8080(07)30318-2; Gupta J, 2000, Health Serv Manage Res, V13, P6; Hitesh J, 1996, J FAM WELFARE, V42, P24; HUNDLEY VA, 1994, BRIT MED J, V309, P1400, DOI 10.1136/bmj.309.6966.1400; Hussein J, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001264; Jahn A, 2001, SAFE MOTHERHOOD STRA; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Khan R, 2006, TXB POSTPARTUM HAEMO, P62; Knight HE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063846; Kongnyuy EJ, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-190; Kruk ME, 2009, HEALTH POLICY PLANN, V24, P279, DOI 10.1093/heapol/czp011; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Mann S, 2006, JT COMM J QUAL PATIE, V32, P497, DOI 10.1016/S1553-7250(06)32065-X; McClure EM, 2011, ACTA OBSTET GYN SCAN, V90, P1379, DOI 10.1111/j.1600-0412.2011.01275.x; Ministry of Health and Family Welfare, 2006, JAN SUR YOJ REV GUID; Moodley J, 2000, S AFR MED J, V90, P367; Murray SF, 2006, SOC SCI MED, V62, P2205, DOI 10.1016/j.socscimed.2005.10.025; Murray SF, 2001, HEALTH POLICY PLANN, V16, P353, DOI 10.1093/heapol/16.4.353; Narang Manish, 2013, Indian J Public Health, V57, P100, DOI 10.4103/0019-557X.115003; National Health Systems Resource Centre, 2011, PROGR EV JAN SUR YOJ; National Rural Health Mission, 2010, OP GUID MAT NEWB HLT; Ndour C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064157; Paxton A, 2005, INT J GYNECOL OBSTET, V88, P181, DOI 10.1016/j.ijgo.2004.11.026; Ploemacher Janneke, 2013, Ned Tijdschr Geneeskd, V157, pA5267; Powell-Jackson T., 2011, FINANCIAL INCENTIVES; Rana TG, 2003, HEALTH POLICY PLANN, V18, P330, DOI 10.1093/heapol/czg039; Randive B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067452; Registrar General of India, 2012, CENS IND 2011; Registrar General of India, 2013, SPEC B MAT MORT IND; Sri BS, 2012, REPROD HEALTH MATTER, V20, P11, DOI 10.1016/S0968-8080(12)39599-2; Strand R T, 2009, Afr J Reprod Health, V13, P75; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; United Nations Children Fund, 2011, COV EV SURV REP 2009; United Nations Population Fund India, 2009, CONC ASS JAN SUR YOJ; WHO, 1994, MOTH BAB PACK IMPL S; World Health Organization (WHO); UNFPA; UNICEF; Columbia University. Mailman School of Public Health, 2009, MON EM OBST CAR HDB	42	45	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96773	10.1371/journal.pone.0096773	http://dx.doi.org/10.1371/journal.pone.0096773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK1XT	24810416	gold, Green Published, Green Submitted			2022-12-27	WOS:000338213300071
J	Herault, F; Vincent, A; Dameron, O; Le Roy, P; Cherel, P; Damon, M				Herault, Frederic; Vincent, Annie; Dameron, Olivier; Le Roy, Pascale; Cherel, Pierre; Damon, Marie			The Longissimus and Semimembranosus Muscles Display Marked Differences in Their Gene Expression Profiles in Pig	PLOS ONE			English	Article							WATER-HOLDING CAPACITY; SKELETAL-MUSCLE; MYOBLAST FUSION; EXTRACELLULAR-MATRIX; SEMANTIC SIMILARITY; SATELLITE CELLS; QUALITY TRAITS; MEAT QUALITY; N-CADHERIN; MICROARRAY	Background: Meat quality depends on skeletal muscle structure and metabolic properties. While most studies carried on pigs focus on the Longissimus muscle (LM) for fresh meat consumption, Semimembranosus (SM) is also of interest because of its importance for cooked ham production. Even if both muscles are classified as glycolytic muscles, they exhibit dissimilar myofiber composition and metabolic characteristics. The comparison of LM and SM transcriptome profiles undertaken in this study may thus clarify the biological events underlying their phenotypic differences which might influence several meat quality traits. Methodology/Principal Findings: Muscular transcriptome analyses were performed using a custom pig muscle microarray: the 15 K Genmascqchip. A total of 3823 genes were differentially expressed between the two muscles (Benjamini-Hochberg adjusted P value <= 0.05), out of which 1690 and 2133 were overrepresented in LM and SM respectively. The microarray data were validated using the expression level of seven differentially expressed genes quantified by real-time RT-PCR. A set of 1047 differentially expressed genes with a muscle fold change ratio above 1.5 was used for functional characterization. Functional annotation emphasized five main clusters associated to transcriptome muscle differences. These five clusters were related to energy metabolism, cell cycle, gene expression, anatomical structure development and signal transduction/immune response. Conclusions/Significance: This study revealed strong transcriptome differences between LM and SM. These results suggest that skeletal muscle discrepancies might arise essentially from different post-natal myogenic activities.	[Herault, Frederic; Vincent, Annie; Le Roy, Pascale; Damon, Marie] INRA, UMR1348, PEGASE, F-35590 St Gilles, France; [Herault, Frederic; Vincent, Annie; Le Roy, Pascale; Damon, Marie] Agrocampus Ouest, PEGASE, UMR1348, F-35000 Rennes, France; [Dameron, Olivier] Univ Rennes 1, F-35000 Rennes, France; [Dameron, Olivier] IRISA Team Dyliss, F-35000 Rennes, France; [Cherel, Pierre] Univ Nice Sophia Antipolis, iBV Inst Biol Valrose, CNRS, UMR 7277,INSERM,U1091, F-06108 Nice, France	INRAE; Institut Agro; Agrocampus Ouest; Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Herault, F (corresponding author), INRA, UMR1348, PEGASE, F-35590 St Gilles, France.	Frederic.Herault@rennes.inra.fr		Dameron, Olivier/0000-0001-8959-7189; Herault, Frederic/0000-0001-5824-4081	ANR-Agence Nationale de la Recherche-The French National Research Agency [ARN-PNRA-2006-25]	ANR-Agence Nationale de la Recherche-The French National Research Agency(French National Research Agency (ANR))	This work was carried out with financial support from the ANR-Agence Nationale de la Recherche-The French National Research Agency under the Programme National de Recherche en Alimentation, project ARN-PNRA-2006-25, GENMASCQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amthor H, 2004, DEV BIOL, V270, P19, DOI 10.1016/j.ydbio.2004.01.046; Bae GU, 2008, J BIOL CHEM, V283, P8301, DOI 10.1074/jbc.M706730200; Bai QF, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-8; Baker DJ, 2007, CELL MOL LIFE SCI, V64, P589, DOI 10.1007/s00018-007-6443-1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Blomen VA, 2007, CELL MOL LIFE SCI, V64, P3084, DOI 10.1007/s00018-007-7271-z; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Campbell WG, 2001, AM J PHYSIOL-CELL PH, V280, pC763, DOI 10.1152/ajpcell.2001.280.4.C763; Canovas A, 2012, J ANIM SCI, V90, P3325, DOI 10.2527/jas.2011-4799; Casar JC, 2004, DEV BIOL, V268, P358, DOI 10.1016/j.ydbio.2003.12.025; Casel Pierrot, 2009, BMC Proc, V3 Suppl 4, pS3, DOI 10.1186/1753-6561-3-S4-S3; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Charlton CA, 1997, J CELL BIOL, V138, P331, DOI 10.1083/jcb.138.2.331; Cherel P, 2012, J ANIM SCI, V90, P699, DOI 10.2527/jas.2011-4198; Chiquet M, 1999, MATRIX BIOL, V18, P417, DOI 10.1016/S0945-053X(99)00039-6; Damon M, 2011, NATURE PRECEDINGS, DOI [10.1038/npre.2011.5730.1031, DOI 10.1038/NPRE.2011.5730.1031]; Duncan D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S4-P10; Ferrante MI, 2011, J CELL SCI, V124, P565, DOI 10.1242/jcs.071274; Fiaschi T, 2009, CELL RES, V19, P584, DOI 10.1038/cr.2009.39; Fluck M, 2008, P NATL ACAD SCI USA, V105, P13662, DOI 10.1073/pnas.0805365105; Frenette J, 2000, AM J PATHOL, V156, P2103, DOI 10.1016/S0002-9440(10)65081-X; Galbiati F, 1999, J BIOL CHEM, V274, P30315, DOI 10.1074/jbc.274.42.30315; Gentry JG, 2004, J ANIM SCI, V82, P209; Goetsch SC, 2003, PHYSIOL GENOMICS, V14, P261, DOI 10.1152/physiolgenomics.00056.2003; Gorni C, 2011, ANIM GENET, V42, P161, DOI 10.1111/j.1365-2052.2010.02098.x; Hackstadt AJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-11; Hollnagel A, 2002, MOL CELL BIOL, V22, P4760, DOI 10.1128/MCB.22.13.4760-4770.2002; Hornshoj H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001203; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kelder T, 2011, NUCLEIC ACIDS RES, DOI [10.1093/nar/gkr1074, DOI 10.1093/NAR/GKR1074.]; Kontrogianni-Konstantopoulos A, 2009, PHYSIOL REV, V89, P1217, DOI 10.1152/physrev.00017.2009; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Kuo WP, 2002, BIOINFORMATICS, V18, P405, DOI 10.1093/bioinformatics/18.3.405; Kwasiborski A, 2009, ANIM GENET, V40, P852, DOI 10.1111/j.1365-2052.2009.01925.x; Lange S, 2006, TRENDS CELL BIOL, V16, P11, DOI 10.1016/j.tcb.2005.11.007; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Lefaucheur L, 2010, MEAT SCI, V84, P257, DOI 10.1016/j.meatsci.2009.05.004; LEFAUCHEUR L, 1995, DEV DYNAM, V203, P27, DOI 10.1002/aja.1002030104; Lefaucheur L, 2010, J ANIM SCI, P996; Li J, 2002, TOXICOL SCI, V69, P383, DOI 10.1093/toxsci/69.2.383; Li Y, 2010, INT J BIOL SCI, V6, P350; Liu JS, 2009, J AGR FOOD CHEM, V57, P3808, DOI 10.1021/jf8033144; Liu Y, 2009, AM J PHYSIOL-ENDOC M, V297, pE657, DOI 10.1152/ajpendo.00186.2009; Lobjois V, 2008, ANIM GENET, V39, P147, DOI 10.1111/j.1365-2052.2007.01695.x; McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; MEGE RM, 1992, J CELL SCI, V103, P897; Melody JL, 2004, J ANIM SCI, V82, P1195; Michele DE, 1999, J CELL BIOL, V145, P1483, DOI 10.1083/jcb.145.7.1483; Milan D, 2000, SCIENCE, V288, P1248, DOI 10.1126/science.288.5469.1248; Moreno-Sanchez N, 2010, FUNCT INTEGR GENOMIC, V10, P609, DOI 10.1007/s10142-010-0175-2; Mylona E, 2006, J CELL PHYSIOL, V209, P314, DOI 10.1002/jcp.20724; OTSU K, 1992, GENOMICS, V13, P835, DOI 10.1016/0888-7543(92)90163-M; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Picard B, 2002, REPROD NUTR DEV, V42, P415, DOI 10.1051/rnd:2002035; Ponsuksili S, 2008, J AGR FOOD CHEM, V56, P10311, DOI 10.1021/jf800881y; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Richardson BE, 2008, TRAFFIC, V9, P1050, DOI 10.1111/j.1600-0854.2008.00756.x; Rosenvold K, 2003, MEAT SCI, V64, P219, DOI 10.1016/S0309-1740(02)00186-9; Rui YN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001208; Ruusunen M, 2004, MEAT SCI, V67, P533, DOI 10.1016/j.meatsci.2003.12.008; Schwab CR, 2006, J ANIM SCI, V84, P1577, DOI 10.2527/2006.8461577x; Stretch C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065380; Tan PK, 2003, NUCLEIC ACIDS RES, V31, P5676, DOI 10.1093/nar/gkg763; Tonino P, 2010, J CELL SCI, V123, P384, DOI 10.1242/jcs.042234; van Leuken R, 2008, BBA-REV CANCER, V1786, P49, DOI 10.1016/j.bbcan.2008.05.002; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Volonte D, 2003, MOL BIOL CELL, V14, P4075, DOI 10.1091/mbc.E03-03-0161; Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Warren GL, 2007, J PHYSIOL-LONDON, V582, P825, DOI 10.1113/jphysiol.2007.132373; WHALEN RG, 1990, DEV BIOL, V141, P24, DOI 10.1016/0012-1606(90)90099-5; Yan Z, 2003, J BIOL CHEM, V278, P8826, DOI 10.1074/jbc.M209879200; Yu GC, 2010, BIOINFORMATICS, V26, P976, DOI 10.1093/bioinformatics/btq064; Zammit PS, 2008, J CELL SCI, V121, P2975, DOI 10.1242/jcs.019661; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhu BM, 2005, GENOMICS, V85, P657, DOI 10.1016/j.ygeno.2005.02.012	80	13	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96491	10.1371/journal.pone.0096491	http://dx.doi.org/10.1371/journal.pone.0096491			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809746	Green Published, Green Submitted, gold			2022-12-27	WOS:000338213300046
J	Maharjan, S; Singh, B; Bok, JD; Kim, JI; Jiang, T; Cho, CS; Kang, SK; Choi, YJ				Maharjan, Sushila; Singh, Bijay; Bok, Jin-Duck; Kim, Jeong-In; Jiang, Tao; Cho, Chong-Su; Kang, Sang-Kee; Choi, Yun-Jaie			Exploring Codon Optimization and Response Surface Methodology to Express Biologically Active Transmembrane RANKL in E. coli	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; KAPPA-B LIGAND; OSTEOCLAST DIFFERENTIATION FACTOR; FACTOR RECEPTOR FAMILY; ESCHERICHIA-COLI; PROTEIN EXPRESSION; GENE-EXPRESSION; OSTEOPROTEGERIN-LIGAND; EPITHELIAL-CELLS; FACTOR-ALPHA	Receptor activator of nuclear factor (NF)-B ligand (RANKL), a master cytokine that drives osteoclast differentiation, activation and survival, exists in both transmembrane and extracellular forms. To date, studies on physiological role of RANKL have been mainly carried out with extracellular RANKL probably due to difficulties in achieving high level expression of functional transmembrane RANKL (mRANKL). In the present study, we took advantage of codon optimization and response surface methodology to optimize the soluble expression of mRANKL in E. coli. We optimized the codon usage of mRANKL sequence to a preferred set of codons for E. coli changing its codon adaptation index from 0.64 to 0.76, tending to increase its expression level in E. coli. Further, we utilized central composite design to predict the optimum combination of variables (cell density before induction, lactose concentration, post-induction temperature and post-induction time) for the expression of mRANKL. Finally, we investigated the effects of various experimental parameters using response surface methodology. The best combination of response variables was 0.6 OD600, 7.5 mM lactose, 26 degrees C post-induction temperature and 5 h post-induction time that produced 52.4 mg/L of fusion mRANKL. Prior to functional analysis of the protein, we purified mRANKL to homogeneity and confirmed the existence of trimeric form of mRANKL by native gel electrophoresis and gel filtration chromatography. Further, the biological activity of mRANKL to induce osteoclast formation on RAW264.7 cells was confirmed by tartrate resistant acid phosphatase assay and quantitative real-time polymerase chain reaction assays. Importantly, a new finding from this study was that the biological activity of mRANKL is higher than its extracellular counterpart. To the best of our knowledge, this is the first time to report heterologous expression of mRANKL in soluble form and to perform a comparative study of functional properties of both forms of RANKL.	[Maharjan, Sushila; Singh, Bijay; Kim, Jeong-In; Jiang, Tao; Cho, Chong-Su; Kang, Sang-Kee; Choi, Yun-Jaie] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Maharjan, Sushila; Singh, Bijay; Cho, Chong-Su; Choi, Yun-Jaie] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Bok, Jin-Duck; Kang, Sang-Kee] Seoul Natl Univ, Res Inst Ecofriendly Anim Sci, Inst Green Bio Sci & Technol, Kangwon Do, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kang, SK (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.	kangsk01@snu.ac.kr; cyjcow@snu.ac.kr	Maharjan, Sushila/L-8197-2016; Singh, Bijay/G-6327-2016	Maharjan, Sushila/0000-0003-3957-3976; Singh, Bijay/0000-0002-3125-3655	National Research Foundation of Korea (NRF), Korea government (MEST) [2011-0029416]	National Research Foundation of Korea (NRF), Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government)	This research is supported by National Research Foundation of Korea (NRF), Korea government (MEST) (Project No. 2011-0029416). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cai YJ, 2008, J THEOR BIOL, V254, P123, DOI 10.1016/j.jtbi.2008.05.010; Chambers Stephen P., 2009, V498, P19, DOI 10.1007/978-1-59745-196-3_2; Crockett JC, 2011, OSTEOPOROSIS INT, V22, P1, DOI 10.1007/s00198-010-1272-8; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; Francis D.M., 2010, CURR PROTOC PROTEIN, V24, P21; Gallois A, 2010, J BONE MINER RES, V25, P661, DOI 10.1359/jbmr.090829; Gao WT, 2004, BIOTECHNOL PROGR, V20, P443, DOI 10.1021/bp0300467; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; Hanada R, 2009, NATURE, V462, P505, DOI 10.1038/nature08596; Hatfield GW, 2007, BIOTECHNOL ANN REV, V13, P27, DOI 10.1016/S1387-2656(07)13002-7; Henry I, 2007, MOL BIOL EVOL, V24, P10, DOI 10.1093/molbev/msl148; Hikita A, 2007, ADV EXP MED BIOL, V602, P15; Hikita A, 2009, BIOCHEM CELL BIOL, V87, P581, DOI [10.1139/O09-015, 10.1139/o09-015]; Hikosaka Y, 2008, IMMUNITY, V29, P438, DOI 10.1016/j.immuni.2008.06.018; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Ikeda T, 2001, ENDOCRINOLOGY, V142, P1419, DOI 10.1210/en.142.4.1419; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Khosla S, 2001, ENDOCRINOLOGY, V142, P5050, DOI 10.1210/en.142.12.5050; Kim N, 2000, P NATL ACAD SCI USA, V97, P10905, DOI 10.1073/pnas.200294797; Knoop KA, 2009, J IMMUNOL, V183, P5738, DOI 10.4049/jimmunol.0901563; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 2012, NAT REV DRUG DISCOV, V11, P401, DOI 10.1038/nrd3705; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lum L, 1999, J BIOL CHEM, V274, P13613, DOI 10.1074/jbc.274.19.13613; Makrides SC, 1996, MICROBIOL REV, V60, P512, DOI 10.1128/MMBR.60.3.512-538.1996; Mason R.L., 2003, STAT DESIGN ANAL EXP; MINKIN C, 1982, CALCIFIED TISSUE INT, V34, P285, DOI 10.1007/BF02411252; Myers RH., 2016, RESPONSE SURFACE MET; Nakashima T, 2000, BIOCHEM BIOPH RES CO, V275, P768, DOI 10.1006/bbrc.2000.3379; Nikolova V, 2009, CARCINOGENESIS, V30, P397, DOI 10.1093/carcin/bgp001; Papaneophytou CP, 2013, PROTEIN EXPRES PURIF, V90, P9, DOI 10.1016/j.pep.2013.04.005; Roodman GD, 1996, ENDOCR REV, V17, P308, DOI 10.1210/er.17.4.308; Rossi SW, 2007, J EXP MED, V204, P1267, DOI 10.1084/jem.20062497; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Sorensen HP, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-1; Sorensen HP, 2005, J BIOTECHNOL, V115, P113, DOI 10.1016/j.jbiotec.2004.08.004; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Tian HS, 2011, INT J PEPT RES THER, V17, P123, DOI 10.1007/s10989-011-9249-9; Troen BR, 2006, ANN NY ACAD SCI, V1068, P165, DOI 10.1196/annals.1346.018; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Wong BR, 1998, J BIOL CHEM, V273, P28355, DOI 10.1074/jbc.273.43.28355; Wong BR, 1997, J EXP MED, V186, P2075, DOI 10.1084/jem.186.12.2075; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597	51	13	14	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96259	10.1371/journal.pone.0096259	http://dx.doi.org/10.1371/journal.pone.0096259			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809485	Green Published, Green Submitted, gold			2022-12-27	WOS:000338213300024
J	Wu, AM; Zhou, Y; Li, QL; Wu, XL; Jin, YL; Luo, P; Chi, YL; Wang, XY				Wu, Ai-Min; Zhou, Yong; Li, Qing-Long; Wu, Xin-Lei; Jin, Yong-Long; Luo, Peng; Chi, Yong-Long; Wang, Xiang-Yang			Interspinous Spacer versus Traditional Decompressive Surgery for Lumbar Spinal Stenosis: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							NEUROGENIC INTERMITTENT CLAUDICATION; 2-YEAR FOLLOW-UP; X-STOP; DISTRACTION DEVICE; SURGICAL-TREATMENT; IMPLANT; COMPLICATIONS; DISEASE; QUALITY; TRIAL	Background: Dynamic interspinous spacers, such as X-stop, Coflex, DIAM, and Aperius, are widely used for the treatment of lumbar spinal stenosis. However, controversy remains as to whether dynamic interspinous spacer use is superior to traditional decompressive surgery. Methods: Medline, Embase, Cochrane Library, and the Cochrane Controlled Trials Register were searched during August 2013. A track search was performed on February 27, 2014. Study was included in this review if it was: (1) a randomized controlled trial (RCT) or non-randomized prospective comparison study, (2) comparing the clinical outcomes for interspinous spacer use versus traditional decompressive surgery, (3) in a minimum of 30 patients, (4) with a follow-up duration of at least 12 months. Results: Two RCTs and three non-randomized prospective studies were included, with 204 patients in the interspinous spacer (IS) group and 217 patients in the traditional decompressive surgery (TDS) group. Pooled analysis showed no significant difference between the IS and TDS groups for low back pain (WMD: 1.2; 95% CI: -10.12, 12.53; P = 0.03; I-2 = 66%), leg pain (WMD: 7.12; 95% CI: -3.88, 18.12; P = 0.02; I-2 = 70%), ODI (WMD: 6.88; 95% CI: -14.92, 28.68; P = 0.03; I-2 = 79%), RDQ (WMD: -1.30, 95% CI: -3.07, 0.47; P = 0.00; I-2 = 0%), or complications (RR: 1.39; 95% CI: 0.61, 3.14; P = 0.23; I-2 = 28%). The TDS group had a significantly lower incidence of reoperation (RR: 3.34; 95% CI: 1.77, 6.31; P = 0.60; I-2 = 0%). Conclusion: Although patients may obtain some benefits from interspinous spacers implanted through a minimally invasive technique, interspinous spacer use is associated with a higher incidence of reoperation and higher cost. The indications, risks, and benefits of using an interspinous process device should be carefully considered before surgery.	[Wu, Ai-Min; Li, Qing-Long; Jin, Yong-Long; Luo, Peng; Chi, Yong-Long; Wang, Xiang-Yang] Wenzhou Med Univ, Zhejiang Spinal Res Ctr, Affiliated Hosp 2, Dept Spinal Surg, Wenzhou, Zhejiang, Peoples R China; [Zhou, Yong] Wenzhou Med Univ, Med Coll 1, Wenzhou, Zhejiang, Peoples R China; [Wu, Xin-Lei] Wenzhou Med Univ, Inst Digitized Med, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Wang, XY (corresponding author), Wenzhou Med Univ, Zhejiang Spinal Res Ctr, Affiliated Hosp 2, Dept Spinal Surg, Wenzhou, Zhejiang, Peoples R China.	knightman@yeah.net		Wu, Xinlei/0000-0001-7383-8961	National Natural Sciences Foundation of China [81372014, 81371988]; Natural Sciences Foundation of Zhejiang Province [LR12H06001]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Sciences Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by the National Natural Sciences Foundation of China (81372014; 81371988) and the Natural Sciences Foundation of Zhejiang Province for Distinguished Young Scholars (LR12H06001). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfieri A, 2012, NEUROSURG REV, V35, P477, DOI 10.1007/s10143-012-0394-1; Beyer F, 2013, EUR SPINE J, V22, P2015, DOI 10.1007/s00586-013-2790-9; Borg A, 2012, BRIT J NEUROSURG, V26, P445, DOI 10.3109/02688697.2012.680630; Bowers C, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.3.FOCUS1047; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Fabrizi AP, 2011, EUR SPINE J, V20, P20, DOI 10.1007/s00586-011-1753-2; Hobart J, 2013, EUR SPINE J, V22, pS47, DOI 10.1007/s00586-012-2650-z; Kim DH, 2011, SPINE, V36, pE1080, DOI 10.1097/BRS.0b013e318204066a; Kim K Anthony, 2007, Neurosurg Focus, V22, pE7; Kovacs FM, 2011, SPINE, V36, pE1335, DOI 10.1097/BRS.0b013e31820c97b1; Menchetti PPM, 2011, ACTA NEUROCHIR SUPPL, V108, P183, DOI 10.1007/978-3-211-99370-5_27; Moojen WA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6415; Nandakumar A, 2013, J SPINAL DISORD TECH, V26, P1, DOI 10.1097/BSD.0b013e318227ea2b; Park SC, 2009, J KOREAN NEUROSURG S, V46, P292, DOI 10.3340/jkns.2009.46.4.292; Ploumis A, 2012, J ORTHOP SURG RES, V7, DOI 10.1186/1749-799X-7-35; Richards JC, 2005, SPINE, V30, P744, DOI 10.1097/01.brs.0000157483.28505.e3; Richter A, 2012, J SPINAL DISORD TECH; Siddiqui M, 2005, SPINE, V30, P2677, DOI 10.1097/01.brs.0000187878.79676.26; Siddiqui M, 2007, SPINE, V32, P1345, DOI 10.1097/BRS.0b013e31805b7694; Slatis P, 2011, EUR SPINE J, V20, P1174, DOI 10.1007/s00586-010-1652-y; Sobottke R, 2009, EUR SPINE J, V18, P1494, DOI 10.1007/s00586-009-1081-y; Stromqvist BH, 2013, SPINE, V38, P1436, DOI 10.1097/BRS.0b013e31828ba413; Sur YJ, 2011, EUR SPINE J, V20, P280, DOI 10.1007/s00586-010-1599-z; Tian NF, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.3.FOCUS12406; Van Meirhaeghe J, 2012, EUR SPINE J, V21, P2565, DOI 10.1007/s00586-012-2330-z; Wilke HJ, 2008, EUR SPINE J, V17, P1049, DOI 10.1007/s00586-008-0657-2; Xu C, 2013, INT ORTHOP, V37, P2199, DOI 10.1007/s00264-013-2006-2; Zucherman JF, 2005, SPINE, V30, P1351, DOI 10.1097/01.brs.0000166618.42749.d1	28	49	54	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e97142	10.1371/journal.pone.0097142	http://dx.doi.org/10.1371/journal.pone.0097142			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809680	Green Published, Green Submitted, gold			2022-12-27	WOS:000338213300125
J	Signorotti, L; Cappa, F; d'Ettorre, P; Cervo, R				Signorotti, Lisa; Cappa, Federico; d'Ettorre, Patrizia; Cervo, Rita			Novel Insights into the Ontogeny of Nestmate Recognition in Polistes Social Wasps	PLOS ONE			English	Article							PAPER WASP; DOMINULUS HYMENOPTERA; KIN RECOGNITION; FUSCATUS HYMENOPTERA; CUTICULAR LIPIDS; MATE RECOGNITION; SURFACE-LIPIDS; BEHAVIOR; HYDROCARBONS; ANT	The importance of early experience in animals' life is unquestionable, and imprinting-like phenomena may shape important aspects of behaviour. Early learning typically occurs during a sensitive period, which restricts crucial processes of information storage to a specific developmental phase. The characteristics of the sensitive period have been largely investigated in vertebrates, because of their complexity and plasticity, both in behaviour and neurophysiology, but early learning occurs also in invertebrates. In social insects, early learning appears to influence important social behaviours such as nestmate recognition. Yet, the mechanisms underlying recognition systems are not fully understood. It is currently believed that Polistes social wasps are able to discriminate nestmates from non-nestmates following the perception of olfactory cues present on the paper of their nest, which are learned during a strict sensitive period, immediately after emergence. Here, through differential odour experience experiments, we show that workers of Polistes dominula develop correct nestmate recognition abilities soon after emergence even in absence of what have been so far considered the necessary cues (the chemicals spread on nest paper). P. dominula workers were exposed for the first four days of adult life to paper fragments from their nest, or from a foreign conspecific nest or to a neutral condition. Wasps were then transferred to their original nests where recognition abilities were tested. Our results show that wasps do not alter their recognition ability if exposed only to nest material, or in absence of nest material, during the early phase of adult life. It thus appears that the nest paper is not used as a source of recognition cues to be learned in a specific time window, although we discuss possible alternative explanations. Our study provides a novel perspective for the study of the ontogeny of nestmate recognition in Polistes wasps and in other social insects.	[Signorotti, Lisa; d'Ettorre, Patrizia] Univ Paris 13, Sorbonne Paris Cite, Lab Expt & Comparat Ethol LEEC, F-93430 Villetaneuse, France; [Signorotti, Lisa; Cappa, Federico; Cervo, Rita] Univ Florence, Dipartimento Biol, Sesto Fiorentino, Italy	Universite Paris 13; University of Florence	Signorotti, L (corresponding author), Univ Paris 13, Sorbonne Paris Cite, Lab Expt & Comparat Ethol LEEC, F-93430 Villetaneuse, France.	lisasigno@hotmail.it	Cappa, Federico/AAF-8489-2020; CERVO, Rita/B-5441-2018	CERVO, Rita/0000-0002-0405-6402	University of Florence; Marie Curie Reintegration Grant [FP7-MC-ERG-2009-256524]; University Franco Italienne	University of Florence; Marie Curie Reintegration Grant(European Commission); University Franco Italienne	Financial support was provided by the University of Florence to RC and by Marie Curie Reintegration Grant "Identity Code'' FP7-MC-ERG-2009-256524 to PDE. The University Franco Italienne has provided financial support to LS PhD project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOLHUIS JJ, 1991, BIOL REV, V66, P303, DOI 10.1111/j.1469-185X.1991.tb01145.x; Bolhuis JJ, 1998, TRENDS NEUROSCI, V21, P306, DOI 10.1016/S0166-2236(98)01258-2; Bos N, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00083; Boulay R, 2003, P ROY SOC B-BIOL SCI, V270, P971, DOI 10.1098/rspb.2002.2325; Boulay R, 2001, BEHAV PROCESS, V55, P67, DOI 10.1016/S0376-6357(01)00163-2; BREED MD, 1995, ANIM BEHAV, V50, P489, DOI 10.1006/anbe.1995.0263; Breed MD, 2004, INSECT SOC, V51, P12, DOI 10.1007/s00040-003-0698-9; Breed MD, 1998, ANIM BEHAV, V55, P13, DOI 10.1006/anbe.1997.0581; Bruschini C, 2010, VITAM HORM, V83, P447, DOI 10.1016/S0083-6729(10)83019-5; Cappa F, 2014, NATURWISSENSCHFTEN, P1; Carpenter James M., 1996, P18; CAUBET Y, 1992, Q J EXP PSYCHOL-B, V44B, P165; Cervo R, 2000, INSECT SOC, V47, P155, DOI 10.1007/PL00001694; CERVO R, 1989, ETHOL ECOL EVOL, V1, P185, DOI 10.1080/08927014.1989.9525522; CERVO R, 1996, INSECT SOC, V41, P1; Cervo R, 2006, ANN ZOOL FENN, V43, P531; CHAMPALBERT A, 1990, ANIM BEHAV, V39, P850, DOI 10.1016/S0003-3472(05)80949-2; Cini A, 2013, BEHAV ECOL SOCIOBIOL, P1; Cini A, 2009, BIOL LETTERS, V5, P459, DOI 10.1098/rsbl.2009.0140; Costanzi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065107; Cotoneschi C, 2007, J INSECT PHYSIOL, V53, P954, DOI 10.1016/j.jinsphys.2006.12.016; Crozier RH., 1996, EVOLUTION SOCIAL INS, P306; D'Ettorre P, 2006, ANIM BEHAV, V71, P773, DOI 10.1016/j.anbehav.2005.05.014; d'Ettorre P, 2010, ANT ECOLOGY, P194; Dani FR, 2004, P ROY SOC B-BIOL SCI, V271, P745, DOI 10.1098/rspb.2003.2646; DANI FR, 1992, BEHAV PROCESS, V28, P51, DOI 10.1016/0376-6357(92)90048-I; Dapporto L, 2007, CHEM SENSES, V32, P795, DOI 10.1093/chemse/bjm047; Dreier S, 2009, J EVOLUTION BIOL, V22, P644, DOI 10.1111/j.1420-9101.2008.01668.x; ESPELIE KE, 1990, J CHEM ECOL, V16, P1841, DOI 10.1007/BF01020498; ESPELIE KE, 1990, J CHEM ECOL, V16, P2229, DOI 10.1007/BF01026933; Field J, 1998, AM NAT, V151, P545, DOI 10.1086/286140; Gamboa George J., 1996, P161; GAMBOA GJ, 1986, ANIM BEHAV, V34, P685, DOI 10.1016/S0003-3472(86)80053-7; Gamboa GJ, 2004, ANN ZOOL FENN, V41, P789; GAMBOA GJ, 1986, ANNU REV ENTOMOL, V31, P431, DOI 10.1146/annurev.en.31.010186.002243; GETZ WM, 1983, NATURE, V302, P147, DOI 10.1038/302147a0; GETZ WM, 1986, ANIM BEHAV, V34, P1617, DOI 10.1016/S0003-3472(86)80250-0; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hinde R.A, 1961, CURRENT PROBLEMS ANI, P175; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Ichinose K, 2010, INSECT SOC, V57, P453, DOI 10.1007/s00040-010-0103-4; Knudsen EI, 2004, J COGNITIVE NEUROSCI, V16, P1412, DOI 10.1162/0898929042304796; Leadbeater E, 2011, SCIENCE, V333, P874, DOI 10.1126/science.1205140; Lenoir A, 1999, INFORMATION PROCESSING IN SOCIAL INSECTS, P219; Liebert AE, 2006, ANN ZOOL FENN, V43, P595; Lorenz K. Z., 1937, Auk, V1937, P245; Lorenzi MC, 2006, ANN ZOOL FENN, V43, P550; Lorenzi MC, 2004, J INSECT PHYSIOL, V50, P935, DOI 10.1016/j.jinsphys.2004.07.005; LORENZI MC, 1992, ETHOL ECOL EVOL, P61; Lorenzi MC, 1999, J INSECT BEHAV, V12, P147, DOI 10.1023/A:1020906631121; Mateo JM, 2004, ANN ZOOL FENN, V41, P729; Michel GF, 2005, DEV PSYCHOBIOL, V46, P156, DOI 10.1002/dev.20058; Monnin T, 2009, P R SOC B, V276, P1593, DOI 10.1098/rspb.2008.1739; MOREL L, 1988, BIOL BEHAV, V13, P59; MOREL L, 1983, CR ACAD SCI III-VIE, V296, P449; Panek LM, 2001, ETHOLOGY, V107, P55, DOI 10.1046/j.1439-0310.2001.00633.x; Pardi L., 1942, BOLL IST ENT UNIV BOLOGNA, V14, P1; Pardi L., 1946, B I ENT U BOLOGNA, V15, P25; Pardi Leo, 1996, P1; PFENNIG DW, 1983, ANIM BEHAV, V31, P412, DOI 10.1016/S0003-3472(83)80060-8; PFENNIG DW, 1983, BEHAV ECOL SOCIOBIOL, V13, P299, DOI 10.1007/BF00299677; Queller DC, 2000, NATURE, V405, P784, DOI 10.1038/35015552; RAMSAY A. OGDEN, 1954, WILSON BULL, V66, P196; Reeve HK, 2000, P ROY SOC B-BIOL SCI, V267, P75, DOI 10.1098/rspb.2000.0969; Dani FR, 2006, ANN ZOOL FENN, V43, P500; Seppa P, 2002, BEHAV ECOL, V13, P531, DOI 10.1093/beheco/13.4.531; Signorotti L, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2579; SINGER TL, 1992, J CHEM ECOL, V18, P785, DOI 10.1007/BF00994615; SINGER TL, 1992, ANIM BEHAV, V44, P63, DOI 10.1016/S0003-3472(05)80755-9; STUART RJ, 1992, BEHAV ECOL SOCIOBIOL, V30, P403; Turillazzi S, 2000, NATURWISSENSCHAFTEN, V87, P172, DOI 10.1007/s001140050697; Van Hooser CA, 2002, ETHOL ECOL EVOL, V14, P141; van Zweden JS, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P222, DOI 10.1017/CBO9780511711909.012; Zacchi F., 1996, Insect Social Life, V1, P125; Zanette LRS, 2008, MOL ECOL, V17, P2590, DOI 10.1111/j.1365-294X.2008.03785.x; [No title captured]	76	12	12	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e97024	10.1371/journal.pone.0097024	http://dx.doi.org/10.1371/journal.pone.0097024			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806637	Green Published, gold, Green Submitted			2022-12-27	WOS:000335728900127
J	Guo, HY; Song, XG; Wang, GL; Yang, K; Wang, Y; Niu, LB; Chen, XY; Fang, RX				Guo, Hongyan; Song, Xiaoguang; Wang, Guiling; Yang, Kun; Wang, Yu; Niu, Libo; Chen, Xiaoying; Fang, Rongxiang			Plant-Generated Artificial Small RNAs Mediated Aphid Resistance	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; GENE; INTERFERENCE; EXPRESSION; MICRORNAS	Background: RNA silencing is an important mechanism for regulation of endogenous gene expression and defense against genomic intruders in plants. This natural defense system was adopted to generate virus-resistant plants even before the mechanism of RNA silencing was unveiled. With the clarification of that mechanism, transgenic antiviral plants were developed that expressed artificial virus-specific hairpin RNAs (hpRNAs) or microRNAs (amiRNAs) in host plants. Previous works also showed that plant-mediated RNA silencing technology could be a practical method for constructing insect-resistant plants by expressing hpRNAs targeting essential genes of insects. Methodology/Principal findings: In this study, we chose aphid Myzus persicae of order Hemiptera as a target insect. To screen for aphid genes vulnerable to attack by plant-mediated RNA silencing to establish plant aphid resistance, we selected nine genes of M. persicae as silencing targets, and constructed their hpRNA-expressing vectors. For the acetylcholinesterase 2 coding gene (MpAChE2), two amiRNA-expressing vectors were also constructed. The vectors were transformed into tobacco plants (Nicotiana tabacum cv. Xanti). Insect challenge assays showed that most of the transgenic plants gained aphid resistance, among which those expressing hpRNAs targeting V-type proton ATPase subunit E-like (V-ATPaseE) or tubulin folding cofactor D (TBCD) genes displayed stronger aphicidal activity. The transgenic plants expressing amiRNAs targeting two different sites in the MpAChE2 gene exhibited better aphid resistance than the plants expressing MpAChE2-specific hpRNA. Conclusions/Significance: Our results indicated that plant-mediated insect-RNA silencing might be an effective way to develop plants resistant to insects with piercing-sucking mouthparts, and both the selection of vulnerable target genes and the biogenetic type of the small RNAs were crucial for the effectiveness of aphid control. The expression of insect-specific amiRNA is a promising and preferable approach to engineer plants resistant to aphids and, possibly, to other plant-infesting insects.	[Guo, Hongyan; Song, Xiaoguang; Wang, Guiling; Wang, Yu; Niu, Libo; Chen, Xiaoying; Fang, Rongxiang] Chinese Acad Sci, Inst Microbiol, State Key Lab Plant Genom, Beijing, Peoples R China; [Guo, Hongyan; Song, Xiaoguang; Chen, Xiaoying; Fang, Rongxiang] Natl Plant Gene Res Ctr, Beijing, Peoples R China; [Guo, Hongyan; Song, Xiaoguang] Univ Chinese Acad Sci, Beijing, Peoples R China; [Yang, Kun] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu 610054, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Electronic Science & Technology of China	Chen, XY (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Plant Genom, Beijing, Peoples R China.	chenxy@im.ac.cn; fangrx@im.ac.cn	Song, Xiaoguang/HIR-2561-2022		Chinese Academy of Sciences [KSCX2-EW-N-06-3]	Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grant KSCX2-EW-N-06-3 from the Chinese Academy of Sciences (http://www.cas.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL PP, 1986, SCIENCE, V232, P738, DOI 10.1126/science.3457472; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Bhatia V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046343; Bucher G, 2002, CURR BIOL, V12, pR85, DOI 10.1016/S0960-9822(02)00666-8; Cogoni C, 1996, EMBO J, V15, P3153, DOI 10.1002/j.1460-2075.1996.tb00678.x; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Duan Cheng-Guo, 2012, Silence, V3, P5, DOI 10.1186/1758-907X-3-5; Dzitoyeva S, 2001, MOL PSYCHIATR, V6, P665, DOI 10.1038/sj.mp.4000955; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GOLEMBOSKI DB, 1990, P NATL ACAD SCI USA, V87, P6311, DOI 10.1073/pnas.87.16.6311; Gordon KHJ, 2007, NAT BIOTECHNOL, V25, P1231, DOI 10.1038/nbt1107-1231; HONG YG, 1995, J GEN VIROL, V76, P2415, DOI 10.1099/0022-1317-76-10-2415; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Jaubert-Possamai S, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-63; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Mao JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048718; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Mutti NS, 2006, J INSECT SCI, V6, DOI 10.1673/031.006.3801; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Niu QW, 2006, NAT BIOTECHNOL, V24, P1420, DOI 10.1038/nbt1255; Nowara D, 2010, PLANT CELL, V22, P3130, DOI 10.1105/tpc.110.077040; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Pitino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025709; Prins M, 2008, MOL PLANT PATHOL, V9, P73, DOI [10.1111/J.1364-3703.2007.00447.X, 10.1111/j.1364-3703.2007.00447.x]; Qu J, 2007, J VIROL, V81, P6690, DOI 10.1128/JVI.02457-06; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Sabater-Munoz B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r21; Shakesby AJ, 2009, INSECT BIOCHEM MOLEC, V39, P1, DOI 10.1016/j.ibmb.2008.08.008; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Warthmann N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001829; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Zhang Junli, 2009, Sheng Wu Gong Cheng Xue Bao, V25, P1394; Zhao T, 2009, PLANT J, V58, P157, DOI 10.1111/j.1365-313X.2008.03758.x; Zhu JQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038572	37	50	53	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97410	10.1371/journal.pone.0097410	http://dx.doi.org/10.1371/journal.pone.0097410			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819752	Green Submitted, gold, Green Published			2022-12-27	WOS:000336653300110
J	Herrera, D; Rojas, OL; Duarte-Rey, C; Mantilla, RD; Angel, J; Franco, MA				Herrera, Daniel; Rojas, Olga L.; Duarte-Rey, Carolina; Mantilla, Ruben D.; Angel, Juana; Franco, Manuel A.			Simultaneous Assessment of Rotavirus-Specific Memory B Cells and Serological Memory after B Cell Depletion Therapy with Rituximab	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; AUTOREACTIVE PLASMA-CELLS; AMERICAN-COLLEGE; CITRULLINATED PROTEINS; RHEUMATOID-ARTHRITIS; IMMUNOLOGICAL MEMORY; ANTIBODY; BLOOD; MAINTENANCE; IMMUNITY	The mechanisms that contribute to the maintenance of serological memory are still unclear. Rotavirus (RV) memory B cells (mBc) are enriched in IgM(+) and CD27(-) subpopulations, which are associated with autoimmune diseases pathogenesis. In patients with autoimmune diseases treated with Rituximab (RTX), some autoantibodies (auto-Abs) decrease after treatment, but other auto-Abs and pathogen-specific IgG Abs remain unchanged. Thus, maintenance of autoimmune and pathogen-specific serological memory may depend on the type of antigen and/or Ab isotype evaluated. Antigen-specific mBc and antigen-specific Abs of different isotypes have not been simultaneously assessed in patients after RTX treatment. To study the relationship between mBc subpopulations and serological memory we characterized total, RV- and tetanus toxoid (TT)specific mBc by flow cytometry in patients with autoimmune diseases before and after treatment with RTX. We also measured total, RV- and TT-Abs, and some auto-Abs by kinetic nephelometry, ELISA, and EliA tests, respectively. Minor differences were observed between the relative frequencies of RV-mBc in healthy controls and patients with autoimmune disease. After RTX treatment, naive Bc and total, RV- and TT-specific mBc [IgM(+), switched (IgA(+)/IgG(+)), IgM(+) only, IgD(+) only, and CD27(-) (IgA(+)/IgG(+)/IgM(+))] were significantly diminished. An important decrease in total plasma IgM and minor decreases in total IgG and IgA levels were also observed. IgM rheumatoid factor, IgG anti-CCP, and IgG anti-dsDNA were significantly diminished. In contrast, RV-IgA, RV-IgG and RV-IgG1, and TT-IgG titers remained stable. In conclusion, in patients with autoimmunity, serological memory against RV and TT seem to be maintained by long-lived plasma cells, unaffected by RTX, and an important proportion of total IgM and serological memory against some auto-antigens seem to be maintained by short-lived plasma cells, dependent on mBc precursors depleted by RTX.	[Herrera, Daniel; Angel, Juana; Franco, Manuel A.] Pontificia Univ Javeriana, Fac Med, Inst Genet Humana, Bogota, Colombia; [Rojas, Olga L.] Univ Rosario, Unidad Inmunol, Escuela Med & Ciencias Salud, Bogota, Colombia; [Duarte-Rey, Carolina; Mantilla, Ruben D.] Riesgo Fractura SA CAYRE IPS, Bogota, Colombia	Pontificia Universidad Javeriana; Universidad del Rosario	Franco, MA (corresponding author), Pontificia Univ Javeriana, Fac Med, Inst Genet Humana, Bogota, Colombia.	mafranco@javeriana.edu.co	CORTES, Manuel Antonio FRANCO/M-7517-2014; Angel, Juana/O-2908-2014; Duarte-Rey, Carolina/I-7129-2016	CORTES, Manuel Antonio FRANCO/0000-0002-0265-0563; Angel, Juana/0000-0001-6623-5337; Duarte-Rey, Carolina/0000-0003-2195-7963	Pontificia Universidad Javeriana [ID3867]	Pontificia Universidad Javeriana	This work was supported by Pontificia Universidad Javeriana (ID3867). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Ahuja A, 2008, P NATL ACAD SCI USA, V105, P4802, DOI 10.1073/pnas.0800555105; Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Alwayn IPJ, 2001, XENOTRANSPLANTATION, V8, P157, DOI 10.1034/j.1399-3089.2001.008003157.x; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Amanna IJ, 2012, HUM IMMUNOL, V73, P1082, DOI 10.1016/j.humimm.2012.07.328; Amanna IJ, 2010, IMMUNOL REV, V236, P125, DOI 10.1111/j.1600-065X.2010.00912.x; Anolik JH, 2009, IMMUNOL RES, V45, P144, DOI 10.1007/s12026-009-8096-7; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Bertsias G, 2008, ANN RHEUM DIS, V67, P195, DOI 10.1136/ard.2007.070367; Beum PV, 2011, J IMMUNOL, V187, P3438, DOI 10.4049/jimmunol.1101189; Cambridge G, 2003, ARTHRITIS RHEUM-US, V48, P2146, DOI 10.1002/art.11181; Cambridge G, 2006, ARTHRITIS RHEUM-US, V54, P3612, DOI 10.1002/art.22211; Campana D, 2009, HEMATOL ONCOL CLIN N, V23, P1083, DOI 10.1016/j.hoc.2009.07.010; Charpilienne A, 2001, J BIOL CHEM, V276, P29361, DOI 10.1074/jbc.M101935200; Di Genova G, 2006, BLOOD, V107, P2806, DOI 10.1182/blood-2005-08-3255; DiLillo DJ, 2008, J IMMUNOL, V180, P361, DOI 10.4049/jimmunol.180.1.361; Dunning AJ, 2006, STAT MED, V25, P1485, DOI 10.1002/sim.2282; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Fecteau JF, 2006, J IMMUNOL, V177, P3728, DOI 10.4049/jimmunol.177.6.3728; GRAUBALLE PC, 1986, J MED VIROL, V18, P277, DOI 10.1002/jmv.1890180309; Hansen A, 2002, ARTHRITIS RHEUM-US, V46, P2160, DOI 10.1002/art.10445; Hiepe F, 2011, NAT REV RHEUMATOL, V7, P170, DOI 10.1038/nrrheum.2011.1; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; HOSHINO Y, 1984, J INFECT DIS, V149, P694, DOI 10.1093/infdis/149.5.694; Huang HC, 2010, P NATL ACAD SCI USA, V107, P4658, DOI 10.1073/pnas.1001074107; Kallewaard NL, 2008, J IMMUNOL, V180, P3980, DOI 10.4049/jimmunol.180.6.3980; Keenan RA, 2008, SCIENCE, V321, P696, DOI 10.1126/science.1157533; Leandro MJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar3908; Li J, 2010, J IMMUNOL, V184, P6142, DOI 10.4049/jimmunol.0903489; Rojas OL, 2008, VIROLOGY, V380, P234, DOI 10.1016/j.virol.2008.08.004; Mamani-Matsuda M, 2008, BLOOD, V111, P4653, DOI 10.1182/blood-2007-11-123844; Mesa MC, 2007, VIROLOGY, V366, P174, DOI 10.1016/j.virol.2007.04.007; Mesa MC, 2010, VIROLOGY, V399, P77, DOI 10.1016/j.virol.2009.12.016; Narvaez CF, 2012, J VIROL, V86, P10829, DOI 10.1128/JVI.01466-12; Parez N, 2004, J VIROL, V78, P12489, DOI 10.1128/JVI.78.22.12489-12496.2004; Peng H, 2013, CLIN RHEUMATOL, V32, P1255, DOI 10.1007/s10067-013-2294-3; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Peters AL, 2009, SEMIN IMMUNOL, V21, P293, DOI 10.1016/j.smim.2009.05.012; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Reynaud CA, 2012, CELL MOL LIFE SCI, V69, P1625, DOI 10.1007/s00018-012-0971-z; Richard K, 2008, J IMMUNOL, V181, P1746, DOI 10.4049/jimmunol.181.3.1746; Rodriguez-Bayona B, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3042; Rojas OL, 2007, VIRAL IMMUNOL, V20, P300, DOI 10.1089/vim.2006.0105; Schroder C, 2003, TRANSPL IMMUNOL, V12, P19, DOI 10.1016/S0966-3274(03)00059-5; Seifert M, 2009, J EXP MED, V206, P2659, DOI 10.1084/jem.20091087; Singh JA, 2012, ARTHRIT CARE RES, V64, P625, DOI 10.1002/acr.21641; Souto-Carneiro MM, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2718; Tangye SG, 2003, J IMMUNOL, V170, P261, DOI 10.4049/jimmunol.170.1.261; Teng YKO, 2009, ANN RHEUM DIS, V68, P1011, DOI 10.1136/ard.2008.092791; Tian CX, 2008, J IMMUNOL, V180, P3279, DOI 10.4049/jimmunol.180.5.3279; Tokoyoda K, 2010, NAT REV IMMUNOL, V10, P193, DOI 10.1038/nri2727; Traggiai E, 2003, VACCINE, V21, pS35, DOI 10.1016/S0264-410X(03)00198-1; Uysal H, 2010, IMMUNOL REV, V233, P9, DOI 10.1111/j.0105-2896.2009.00853.x; Vallerskog T, 2007, CLIN IMMUNOL, V122, P62, DOI 10.1016/j.clim.2006.08.016; Wegner N, 2010, IMMUNOL REV, V233, P34, DOI 10.1111/j.0105-2896.2009.00850.x; Wei C, 2007, J IMMUNOL, V178, P6624, DOI 10.4049/jimmunol.178.10.6624; Youngman KR, 2002, J IMMUNOL, V168, P2173, DOI 10.4049/jimmunol.168.5.2173; Zhang J, 2009, J AUTOIMMUN, V33, P270, DOI 10.1016/j.jaut.2009.03.011	59	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97087	10.1371/journal.pone.0097087	http://dx.doi.org/10.1371/journal.pone.0097087			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819618	Green Published, gold			2022-12-27	WOS:000336653300069
J	Naegele, RP; Boyle, S; Quesada-Ocampo, LM; Hausbeck, MK				Naegele, Rachel P.; Boyle, Samantha; Quesada-Ocampo, Lina M.; Hausbeck, Mary K.			Genetic Diversity, Population Structure, and Resistance to Phytophthora capsici of a Worldwide Collection of Eggplant Germplasm	PLOS ONE			English	Article							SOLANUM-MELONGENA L.; LINKAGE DISEQUILIBRIUM; FRUIT SHAPE; MOLECULAR DIVERSITY; WILD RELATIVES; PEPPER; TOMATO; ROT; NICOTIANA; LANDRACES	Eggplant (Solanum melongena L.) is an important solanaceous crop with high phenotypic diversity and moderate genotypic diversity. Ninety-nine genotypes of eggplant germplasm (species (S. melongena, S. incanum, S. linnaeanum and S. gilo), landraces and heirloom cultivars) from 32 countries and five continents were evaluated for genetic diversity, population structure, fruit shape, and disease resistance to Phytophthora fruit rot. Fruits from each line were measured for fruit shape and evaluated for resistance to two Phytophthora capsici isolates seven days post inoculation. Only one accession (PI 413784) was completely resistant to both isolates evaluated. Partial resistance to Phytophthora fruit rot was found in accessions from all four eggplant species evaluated in this study. Genetic diversity and population structure were assessed using 22 polymorphic simple sequence repeats (SSRs). The polymorphism information content (PIC) for the population was moderate (0.49) in the population. Genetic analyses using the program STRUCTURE indicated the existence of four genetic clusters within the eggplant collection. Population structure was detected when eggplant lines were grouped by species, continent of origin, country of origin, fruit shape and disease resistance.	[Naegele, Rachel P.; Boyle, Samantha; Hausbeck, Mary K.] Michigan State Univ, Dept Plant & Microbial Sci, E Lansing, MI 48824 USA; [Quesada-Ocampo, Lina M.] N Carolina State Univ, Dept Plant Pathol, Raleigh, NC 27695 USA	Michigan State University; University of North Carolina; North Carolina State University	Hausbeck, MK (corresponding author), Michigan State Univ, Dept Plant & Microbial Sci, E Lansing, MI 48824 USA.	hausbec1@anr.msu.edu	Quesada-Ocampo, Lina/D-5780-2018	Quesada-Ocampo, Lina/0000-0002-9072-7531	MSU GREEEN grant [GR12-006]	MSU GREEEN grant	Funding was provided by MSU GREEEN grant GR12-006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali Z, 2011, GENET MOL RES, V10, P1141, DOI 10.4238/vol10-2gmr1279; Behera TK, 2006, SCI HORTIC-AMSTERDAM, V107, P352, DOI 10.1016/j.scienta.2005.11.004; Benetka V, 2012, TREE GENET GENOMES, V8, P1073, DOI 10.1007/s11295-012-0487-6; Bubici G, 2008, EUPHYTICA, V164, P339, DOI 10.1007/s10681-008-9663-z; Cao K, 2012, TREE GENET GENOMES, V8, P975, DOI 10.1007/s11295-012-0477-8; Chen XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044510; Courtois B, 2012, CROP SCI, V52, P1663, DOI 10.2135/cropsci2011.11.0588; Daunay M. C, 2001, GENETIC RESOURCES EG, P251; Daunay M-C, 2008, HDB CROP BREEDING VE; Daunay MC., 1991, SOLANACEAE, P389; Diamanti J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046470; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Foster JM, 2013, PLANT DIS, V97, P1037, DOI 10.1094/PDIS-06-12-0562-RE; Foster JM, 2010, PLANT DIS, V94, P24, DOI 10.1094/PDIS-94-1-0024; Fricano A, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-18; Furini A, 2004, THEOR APPL GENET, V108, P197, DOI 10.1007/s00122-003-1439-1; Gevens A. J., 2011, VEGETABLE DIS CAUSED; Granke LL, 2012, PLANT DIS, V96, P1588, DOI 10.1094/PDIS-02-12-0211-FE; Hasan S. M. Z., 1992, Acta Horticulturae, P123; Hurtado M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041748; Iqbal MJ, 2012, THEOR APPL GENET, V125, P517, DOI 10.1007/s00122-012-1850-6; JONES D, 1985, ENTOMOL EXP APPL, V38, P157, DOI 10.1007/BF00361927; KARIHALOO JL, 1995, THEOR APPL GENET, V90, P767, DOI 10.1007/BF00222010; Lamour KH, 2000, PHYTOPATHOLOGY, V90, P396, DOI 10.1094/PHYTO.2000.90.4.396; Laserna-Ruiz I, 2012, EUPHYTICA, V188, P153, DOI 10.1007/s10681-012-0752-7; Li HZ, 2010, SCI HORTIC-AMSTERDAM, V125, P19, DOI 10.1016/j.scienta.2010.02.023; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Mace ES, 1999, THEOR APPL GENET, V99, P626, DOI 10.1007/s001220051277; Meyer RS, 2012, MOL PHYLOGENET EVOL, V63, P685, DOI 10.1016/j.ympev.2012.02.006; Minamiyama Y, 2007, BREEDING SCI, V57, P129, DOI 10.1270/jsbbs.57.129; Munoz-Falcon JE, 2009, ANN APPL BIOL, V154, P453, DOI 10.1111/j.1744-7348.2009.00314.x; Munoz-Falcon JE, 2011, SCI HORTIC-AMSTERDAM, V129, P238, DOI 10.1016/j.scienta.2011.03.034; Murray J., 1910, REPORTS SCI EXPEDITI, P17; Naegele RP, 2014, PHYTOPATHOLOGY, V104, P479, DOI 10.1094/PHYTO-05-13-0143-R; Nunome T, 2001, BREEDING SCI, V51, P19, DOI 10.1270/jsbbs.51.19; Polignano G, 2010, GENET RESOUR CROP EV, V57, P171, DOI 10.1007/s10722-009-9459-6; Pritchard JK, 2000, GENETICS, V155, P945; Prohens J, 2005, J AM SOC HORTIC SCI, V130, P54, DOI 10.21273/JASHS.130.1.54; Qiao Jun, 2012, Acta Horticulturae Sinica, V39, P1115; Quesada-Ocampo LM, 2011, PHYTOPATHOLOGY, V101, P1061, DOI 10.1094/PHYTO-11-10-0325; Quesada-Ocampo LM, 2010, PHYTOPATHOLOGY, V100, P619, DOI 10.1094/PHYTO-100-6-0619; R Development Core Team, 2012, R LANG ENV STAT COMP; Rodriguez GR, 2011, PLANT PHYSIOL, V156, P275, DOI 10.1104/pp.110.167577; Soto-Cerda BJ, 2012, MOL BREEDING, V30, P875, DOI 10.1007/s11032-011-9670-y; SPOONER DM, 1994, AM POTATO J, V71, P325, DOI 10.1007/BF02849059; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsaballa A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-46; Vilanova S, 2012, MOL BREEDING, V30, P647, DOI 10.1007/s11032-011-9650-2; Wang JX, 2008, ANN BOT-LONDON, V102, P891, DOI 10.1093/aob/mcn179; Wang ML, 2011, THEOR APPL GENET, V123, P1307, DOI 10.1007/s00122-011-1668-7; Waterhouse GM, 1963, KEY SPECIES PHYTOPHT; Weese TL, 2010, TAXON, V59, P49, DOI 10.1002/tax.591006; Xu JX, 2013, THEOR APPL GENET, V126, P567, DOI 10.1007/s00122-012-2002-8; Yun SJ, 2005, CROP SCI, V45, P2563, DOI 10.2135/cropsci2005.0236; Zygier S, 2005, THEOR APPL GENET, V111, P437, DOI 10.1007/s00122-005-2015-7	57	24	24	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e95930	10.1371/journal.pone.0095930	http://dx.doi.org/10.1371/journal.pone.0095930			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819601	gold, Green Published, Green Submitted			2022-12-27	WOS:000336653300008
J	Park, JH; Lee, H; Makaryus, R; Yu, M; Smith, SD; Sayed, K; Feng, T; Holland, E; Van der Linden, A; Bolwig, TG; Enikolopov, G; Benveniste, H				Park, June-Hee; Lee, Hedok; Makaryus, Rany; Yu, Mei; Smith, S. David; Sayed, Kasim; Feng, Tian; Holland, Eric; Van der Linden, Annemie; Bolwig, Tom G.; Enikolopov, Grigori; Benveniste, Helene			Metabolic Profiling of Dividing Cells in Live Rodent Brain by Proton Magnetic Resonance Spectroscopy ((HMRS)-H-1) and LCModel Analysis	PLOS ONE			English	Article							NEURAL PROGENITOR CELLS; MR SPECTROSCOPY; ADULT NEUROGENESIS; STEM-CELLS; ELECTROCONVULSIVE-THERAPY; H-1-NMR SPECTRA; VISIBLE LIPIDS; GLIOMA MODELS; RAT-BRAIN; NILE RED	Rationale: Dividing cells can be detected in the live brain by positron emission tomography or optical imaging. Here we apply proton magnetic resonance spectroscopy ((HMRS)-H-1) and a widely used spectral fitting algorithm to characterize the effect of increased neurogenesis after electroconvulsive shock in the live rodent brain via spectral signatures representing mobile lipids resonating at similar to 1.30 ppm. In addition, we also apply the same (HMRS)-H-1 methodology to metabolically profile glioblastomas with actively dividing cells growing in RCAS-PDGF mice. Methods: (HMRS)-H-1 metabolic profiles were acquired on a 9.4T MRI instrument in combination with LCModel spectral analysis of: 1) rat brains before and after ECS or sham treatments and 2) RCAS-PDGF mice with glioblastomas and wild-type controls. Quantified (HMRS)-H-1 data were compared to post-mortem histology. Results: Dividing cells in the rat hippocampus increased similar to 3-fold after ECS compared to sham treatment. Quantification of hippocampal metabolites revealed significant decreases in N-acetyl-aspartate but no evidence of an elevated signal at similar to 1.3 ppm (Lip13a+Lip13b) in the ECS compared to the sham group. In RCAS-PDGF mice a high density (22%) of dividing cells characterized glioblastomas. Nile Red staining revealed a small fraction (3%) of dying cells with intracellular lipid droplets in the tumors of RCAS-PDGF mice. Concentrations of NAA were lower, whereas lactate and Lip13a+Lip13b were found to be significantly higher in glioblastomas of RCAS-PDGF mice, when compared to normal brain tissue in the control mice. Conclusions: Metabolic profiling using (HMRS)-H-1 in combination with LCModel analysis did not reveal correlation between Lip13a+Lip13b spectral signatures and an increase in neurogenesis in adult rat hippocampus after ECS. However, increases in Lip13a+Lip13b were evident in glioblastomas suggesting that a higher density of actively dividing cells and/or the presence of lipid droplets is necessary for LCModel to reveal mobile lipids.	[Park, June-Hee; Sayed, Kasim; Enikolopov, Grigori] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Lee, Hedok; Makaryus, Rany; Yu, Mei; Smith, S. David; Benveniste, Helene] Stony Brook Med, Dept Anesthesiol, Stony Brook, NY USA; [Feng, Tian] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA; [Holland, Eric] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Van der Linden, Annemie] Univ Antwerp, Bioimaging Lab, Dept Biomed Sci, Antwerp, Belgium; [Bolwig, Tom G.] Copenhagen Univ Hosp, Neuropsychiat Lab, Copenhagen, Denmark; [Benveniste, Helene] Stony Brook Med, Dept Radiol, Stony Brook, NY USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Fred Hutchinson Cancer Center; University of Antwerp; University of Copenhagen; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital	Benveniste, H (corresponding author), Stony Brook Med, Dept Anesthesiol, Stony Brook, NY USA.	helene.benveniste@stonybrookmedicine.edu	Van der Linden, Annemie/L-7855-2017; Enikolopov, Grigori/P-5731-2019	Van der Linden, Annemie/0000-0003-2941-6520; Enikolopov, Grigori/0000-0001-8178-8917	National Institute of Aging [R01AG040209]; National Institute of Mental Health [R01MH092928]; Ellison Medical Foundation; New York State Stem Cell Science (NYSTEM); NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040209] Funding Source: NIH RePORTER	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Ellison Medical Foundation(Lawrence Ellison Foundation); New York State Stem Cell Science (NYSTEM); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institute of Aging (R01AG040209), National Institute of Mental Health (R01MH092928), The Ellison Medical Foundation, and New York State Stem Cell Science (NYSTEM) to GE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JB, 2011, NEURON, V70, P589, DOI 10.1016/j.neuron.2011.05.010; Antoine JP, 2001, NMR BIOMED, V14, P265, DOI 10.1002/nbm.699; BEHAR KL, 1994, MAGNET RESON MED, V32, P294, DOI 10.1002/mrm.1910320304; Biedermann S, 2012, WORLD J BIOL PSYCHIA, V13, P447, DOI 10.3109/15622975.2011.580778; Chesler David A, 2012, Front Biosci (Schol Ed), V4, P190; Delikatny EJ, 2011, NMR BIOMED, V24, P592, DOI 10.1002/nbm.1661; Doblas S, 2012, NMR BIOMED, V25, P685, DOI 10.1002/nbm.1785; Doblas S, 2010, J MAGN RESON IMAGING, V32, P267, DOI 10.1002/jmri.22263; Dong Z, 2009, AM J NEURORADIOL, V30, P1096, DOI 10.3174/ajnr.A1557; Du F, 2009, MAGN RESON MED, V62, P1385, DOI 10.1002/mrm.22146; Encinas JM, 2008, EXP NEUROL, V210, P274, DOI 10.1016/j.expneurol.2007.10.021; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Encinas JM, 2008, METHOD CELL BIOL, V85, P243, DOI 10.1016/S0091-679X(08)85011-X; Ende G, 2000, ARCH GEN PSYCHIAT, V57, P937, DOI 10.1001/archpsyc.57.10.937; Fountas KN, 2000, STEREOT FUNCT NEUROS, V74, P83, DOI 10.1159/000056467; FOWLER SD, 1985, J HISTOCHEM CYTOCHEM, V33, P833, DOI 10.1177/33.8.4020099; Friedman SD, 2008, SCIENCE, V321, DOI 10.1126/science.1153484; Geurts JJG, 2004, J MAGN RESON IMAGING, V20, P366, DOI 10.1002/jmri.20138; Gould E, 2002, J NEUROSCI, V22, P619, DOI 10.1523/JNEUROSCI.22-03-00619.2002; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Griffin JL, 2007, FEBS J, V274, P1132, DOI 10.1111/j.1742-4658.2007.05676.x; Hakumaki JM, 2000, TRENDS BIOCHEM SCI, V25, P357, DOI 10.1016/S0968-0004(00)01614-5; Hambardzumyan D, 2009, TRANSL ONCOL, V2, P89, DOI 10.1593/tlo.09100; Hoch JC, 2008, AIDS RES HUM RETRO S, V321, P640; Holland EC, 2000, TOXICOL PATHOL, V28, P171, DOI 10.1177/019262330002800122; Howe FA, 2003, MAGNET RESON MED, V49, P223, DOI 10.1002/mrm.10367; Iltis I, 2008, MAGN RESON MED, V59, P631, DOI 10.1002/mrm.21502; Jansen JFA, 2006, RADIOLOGY, V240, P318, DOI 10.1148/radiol.2402050314; Kaminogo M, 2001, NEURORADIOLOGY, V43, P353, DOI 10.1007/s002340000473; Kanowski M, 2004, MAGNET RESON MED, V51, P904, DOI 10.1002/mrm.20063; Knobloch M, 2013, NATURE, V493, P226, DOI 10.1038/nature11689; Loewenbruck KF, 2011, REJUV RES, V14, P371, DOI 10.1089/rej.2010.1102; Maletic-Savatic M, 2008, COLD SH Q B, V73, P389, DOI 10.1101/sqb.2008.73.021; Manganas LN, 2007, SCIENCE, V318, P980, DOI 10.1126/science.1147851; Mantamadiotis T, 2011, FRONT BIOSCI-LANDMRK, V16, P598, DOI 10.2741/3708; Michael N, 2003, NEUROPSYCHOPHARMACOL, V28, P720, DOI 10.1038/sj.npp.1300085; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mlynarik V, 2012, NMR BIOMED, V25, P506, DOI 10.1002/nbm.1763; Obergriesser T, 2003, J CLIN PSYCHIAT, V64, P775, DOI 10.4088/JCP.v64n0706; Oshiro S, 2007, ANTICANCER RES, V27, P3757; Peterson DA, 1999, METHODS, V18, P493, DOI 10.1006/meth.1999.0818; Pfeuffer J, 1999, J MAGN RESON, V141, P104, DOI 10.1006/jmre.1999.1895; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Rakic P, 2002, J NEUROSCI, V22, P614, DOI 10.1523/JNEUROSCI.22-03-00614.2002; Ramm P, 2011, STEM CELLS DEV, V20, P2189, DOI 10.1089/scd.2010.0567; Reumers V, 2008, STEM CELLS, V26, P2382, DOI 10.1634/stemcells.2007-1062; Rueger MA, 2010, J NEUROSCI, V30, P6454, DOI 10.1523/JNEUROSCI.6092-09.2010; Samuels BA, 2011, EUR J NEUROSCI, V33, P1152, DOI 10.1111/j.1460-9568.2011.07614.x; Sartorius A, 2003, BIOL PSYCHIAT, V53, P620, DOI 10.1016/S0006-3223(02)01600-1; Sasaki K, 1988, Gan No Rinsho, V34, P13; Schirmer T, 2000, NMR BIOMED, V13, P28, DOI 10.1002/(SICI)1099-1492(200002)13:1<28::AID-NBM606>3.0.CO;2-L; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Stoyanova R, 2001, NMR BIOMED, V14, P271, DOI 10.1002/nbm.700; Tabatabai G, 2011, CELL TISSUE RES, V343, P459, DOI 10.1007/s00441-010-1123-0; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Vanhamme L, 2001, NMR BIOMED, V14, P233, DOI 10.1002/nbm.695; Zandt HJAI, 2001, NMR BIOMED, V14, P224, DOI 10.1002/nbm.707; Zoula S, 2003, NMR BIOMED, V16, P199, DOI 10.1002/nbm.831; Zoula S, 2003, BRIT J CANCER, V88, P1439, DOI 10.1038/sj.bjc.6600837	60	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e94755	10.1371/journal.pone.0094755	http://dx.doi.org/10.1371/journal.pone.0094755			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819091	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000336653300003
J	Wang, K; Wen, L; Peng, WH; Li, HL; Zhuang, JH; Lu, YY; Liu, BX; Li, XK; Li, WM; Xu, YW				Wang, Ke; Wen, Li; Peng, Wenhui; Li, Hailing; Zhuang, Jianhui; Lu, Yuyan; Liu, Baoxin; Li, Xiankai; Li, Weiming; Xu, Yawei			Vinpocetine Attenuates Neointimal Hyperplasia in Diabetic Rat Carotid Arteries after Balloon Injury	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; KAPPA-B; SIGNALING PATHWAYS; PROLIFERATION; APOPTOSIS; MIGRATION; MODEL; ATHEROSCLEROSIS; ACTIVATION; EXPRESSION	Background: Diabetes exacerbates abnormal vascular smooth muscle cell (VSMC) accumulation in response to arterial wall injury. Vinpocetine has been shown to improve vascular remolding; however, little is known about the direct effects of vinpocetine on vascular complications mediated by diabetes. The objective of this study was to determine the effects of vinpocetine on hyperglycemia-facilitated neointimal hyperplasia and explore its possible mechanism. Materials and Methods: Nondiabetic and diabetic rats were subjected to balloon injury of the carotid artery followed by 3-week treatment with either vinpocetine (10 mg/kg/day)or saline. Morphological analysis and proliferating cell nuclear antigen (PCNA) immunostaining were performed on day 21. Rat VSMCs proliferation was determined with 5-ethynyl-20-deoxyuridine cell proliferation assays. Chemokinesis was monitored with scratch assays, and production of reactive oxygen species (ROS) was assessed using a 2',7'-dichlorodihydrofluorescein diacetate (H2DCFDA) flow cytometric assay. Apoptosis was detected by annexin V-FITC/PI flow cytometric assay. Cell signaling was assessed by immunblotting. Results: Vinpocetine prevented intimal hyperplasia in carotid arteries in both normal (I/M ratio: 93.83 +/- 26.45% versus 143.2 +/- 38.18%, P<0.05) and diabetic animals (I/M ratio: 120.+/- 6 42.55% versus 233.46 +/- 33.98%, P<0.05) when compared to saline. The in vitro study demonstrated that vinpocetine significantly inhibited VSMCs proliferation and chemokinesis as well as ROS generation and apoptotic resistance, which was induced by high glucose (HG) treatment. Vinpocetine significantly abolished HG-induced phosphorylation of Akt and JNK1/2 without affecting their total levels. For downstream targets, HGinduced phosphorylation of I kappa B alpha was significantly inhibited by vinpocetine. Vinpocetine also attenuated HG-enhanced expression of PCNA, cyclin D1 and Bcl-2. Conclusions: Vinpocetine attenuated neointimal formation in diabetic rats and inhibited HG-induced VSMCs proliferation, chemokinesis and apoptotic resistance by preventing ROS activation and affecting MAPK, PI3K/Akt, and NF-kappa B signaling.	[Wang, Ke; Peng, Wenhui; Li, Hailing; Zhuang, Jianhui; Lu, Yuyan; Liu, Baoxin; Li, Xiankai; Li, Weiming; Xu, Yawei] Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Cardiol, Shanghai 200092, Peoples R China; [Wen, Li] Tongji Univ, Shanghai Pulm Hosp, Sch Med, Dept Cardiopulmonary Circulat, Shanghai 200092, Peoples R China	Tongji University; Tongji University	Li, WM (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Cardiol, Shanghai 200092, Peoples R China.	lwmsoncentury@126.com; xuyawei@tongji.edu.cn	黎, 伟/GXM-4040-2022; li, wj/HGD-7322-2022		National Natural Science Foundation of China [81370391, 81000113]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Natural Science Foundation of China No. 81370391 and No. 81000113. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagoly Edit, 2007, Orvosi Hetilap, V148, P1353, DOI 10.1556/OH.2007.28115; Beckman JA, 2013, EUR HEART J     0411; BOCHATONPIALLAT ML, 1995, AM J PATHOL, V146, P1059; Bonoczk P, 2000, BRAIN RES BULL, V53, P245, DOI 10.1016/S0361-9230(00)00354-3; Cai YJ, 2012, J PHARMACOL EXP THER, V343, P479, DOI 10.1124/jpet.112.195446; Chan S, 2011, CURR OPIN PHARMACOL, V11, P720, DOI 10.1016/j.coph.2011.09.002; Flaherty JD, 2005, JAMA-J AM MED ASSOC, V293, P1501, DOI 10.1001/jama.293.12.1501; Frobert O, 2009, J AM COLL CARDIOL, V53, P1660, DOI 10.1016/j.jacc.2009.01.054; Giordano A, 2006, AM J PHYSIOL-HEART C, V290, pH2459, DOI 10.1152/ajpheart.00750.2005; Hall JL, 2000, CIRC RES, V87, P574, DOI 10.1161/01.RES.87.7.574; HAN DKM, 1995, AM J PATHOL, V147, P267; Huang EW, 2012, APOPTOSIS, V17, P1120, DOI 10.1007/s10495-012-0743-0; Igarashi M, 2007, J ATHEROSCLER THROMB, V14, P235, DOI 10.5551/jat.E514; Indolfi C, 2001, CIRCULATION, V103, P2980, DOI 10.1161/01.CIR.103.24.2980; Inoguchi T, 2003, J AM SOC NEPHROL, V14, pS227, DOI 10.1097/01.ASN.0000077407.90309.65; Isenovic Esma R., 2009, Cardiovascular & Hematological Disorders - Drug Targets, V9, P172; Jeon KI, 2010, P NATL ACAD SCI USA, V107, P9795, DOI 10.1073/pnas.0914414107; Lee RM, 2006, J CELL BIOCHEM, V99, P835, DOI 10.1002/jcb.20903; Li HL, 2013, ATHEROSCLEROSIS, V228, P61, DOI 10.1016/j.atherosclerosis.2013.02.013; Li HK, 2005, DIABETES, V54, P540, DOI 10.2337/diabetes.54.2.540; Liehn Elisa A., 2006, Archives of Physiology and Biochemistry, V112, P229, DOI 10.1080/13813450601093583; Luscher TF, 2003, CIRCULATION, V108, P1655, DOI 10.1161/01.CIR.0000089189.70578.E2; Marx SO, 2011, CIRC-CARDIOVASC INTE, V4, P104, DOI 10.1161/CIRCINTERVENTIONS.110.957332; Members T.F., 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/ehv320; Nagel DJ, 2006, CIRC RES, V98, P777, DOI 10.1161/01.RES.0000215576.27615.fd; Park SH, 2001, CIRCULATION, V104, P815, DOI 10.1161/hc3301.092789; POLGAR M, 1985, J PHARMACEUT BIOMED, V3, P131, DOI 10.1016/0731-7085(85)80016-9; Son DJ, 2006, J PHARMACOL EXP THER, V317, P627, DOI 10.1124/jpet.105.095901; Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004; Srivastava S, 2006, DIABETES, V55, P901, DOI 10.2337/diabetes.55.04.06.db05-0932; Suzuki LA, 2001, DIABETES, V50, P851, DOI 10.2337/diabetes.50.4.851; Tsujimoto A, 2006, J CARDIOVASC PHARM, V48, P160, DOI 10.1097/01.fjc.0000245989.89771.1b; Wang SX, 2009, AM J PHYSIOL-HEART C, V297, pH2075, DOI 10.1152/ajpheart.00521.2009; Watson PA, 2001, J BIOL CHEM, V276, P46142, DOI 10.1074/jbc.M104770200; Yoon JJ, 2010, J CELL BIOCHEM, V111, P1501, DOI 10.1002/jcb.22880; Zhu LH, 2010, FREE RADICAL BIO MED, V48, P471, DOI 10.1016/j.freeradbiomed.2009.10.040	36	17	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96894	10.1371/journal.pone.0096894	http://dx.doi.org/10.1371/journal.pone.0096894			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819198	gold, Green Published, Green Submitted			2022-12-27	WOS:000336653300044
J	Chu, TJ; Sheng, Q; Wang, SK; Wu, JH				Chu, Tianjiang; Sheng, Qiang; Wang, Sikai; Wu, Jihua			Variability of Polychaete Secondary Production in Intertidal Creek Networks along a Stream-Order Gradient	PLOS ONE			English	Article							POPULATION-DYNAMICS; SALT-MARSH; ESTUARINE POPULATION; NEREIS-DIVERSICOLOR; ORGANIC-MATTER; GROWTH; COMMUNITIES; BAY; CRUSTACEANS; SHOREBIRDS	Dendritic tidal creek networks are important habitats for sustaining biodiversity and ecosystem functioning in salt marsh wetlands. To evaluate the importance of creek heterogeneity in supporting benthic secondary production, we assess the spatial distribution and secondary production of a representative polychaete species (Dentinephtys glabra) in creek networks along a stream-order gradient in a Yangtze River estuarine marsh. Density, biomass, and secondary production of polychaetes were found to be highest in intermediate order creeks. In high order (3rd and 4th) creeks, the density and biomass of D. glabra were higher in creek edge sites than in creek bottom sites, whereas the reverse was true for low order (1st and 2nd) creeks. Secondary production was highest in 2nd order creeks (559.7 mg AFDM m(-2) year(-1)) and was ca. 2 folds higher than in 1st and 4th order creeks. Top fitting AIC models indicated that the secondary production of D. glabra was mainly associated with geomorphological characters including cross-sectional area and bank slope. This suggests that hydrodynamic forces are essential factors influencing secondary production of macrobenthos in salt marshes. This study emphasizes the importance of microhabitat variability when evaluating secondary production and ecosystem functions.	[Wu, Jihua] Fudan Univ, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Shanghai 200433, Peoples R China; Fudan Univ, Inst Biodivers Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Wu, JH (corresponding author), Fudan Univ, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Shanghai 200433, Peoples R China.	jihuawu@fudan.edu.cn	Sheng, Qiang/AAG-2548-2019	Sheng, Qiang/0000-0002-7385-0407	National Science and Technology Ministry [2013CB430404]; Science and Technology Department of Shanghai [12231204700]	National Science and Technology Ministry; Science and Technology Department of Shanghai	This study was financially supported by National Science and Technology Ministry (2013CB430404), and Science and Technology Department of Shanghai (12231204700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alla AA, 2006, ESTUAR COAST SHELF S, V70, P633, DOI 10.1016/j.ecss.2006.01.028; [Anonymous], 2008, WETLANDS; BENKE AC, 1979, LIMNOL OCEANOGR, V24, P168, DOI 10.4319/lo.1979.24.1.0168; Benke AC, 2010, J N AM BENTHOL SOC, V29, P264, DOI 10.1899/08-075.1; Benke Arthur C., 2007, P691, DOI 10.1016/B978-012332908-0.50041-3; Blackburn NJ, 2013, MAR ECOL PROG SER, V474, P135, DOI 10.3354/meps10103; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chaplin GI, 2009, ESTUAR COAST, V32, P319, DOI 10.1007/s12237-008-9117-9; CHEN JK, 2003, SCI INVESTIGATIONS S; Chu TJ, 2013, CRUSTACEANA, V86, P278, DOI 10.1163/15685403-00003167; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; Gayanilo Jr F. C., 1997, FAO COMPUTERIZED INF, V8, P1; Gong Zhijun, 2001, Hupo Kexue, V13, P79; HARREL RC, 1968, AM MIDL NAT, V80, P220, DOI 10.2307/2423611; HORTON RE, 1945, GEOL SOC AM BULL, V56, P275, DOI 10.1130/0016-7606(1945)56[275:edosat]2.0.co;2; HYNES HBN, 1968, LIMNOL OCEANOGR, V13, P569, DOI 10.4319/lo.1968.13.4.0569; Jin BS, 2010, ESTUAR COAST SHELF S, V88, P419, DOI 10.1016/j.ecss.2010.04.023; Jing K, 2007, ECOL RES, V22, P559, DOI 10.1007/s11284-006-0302-7; Kang SJ, 2009, GEODERMA, V151, P233, DOI 10.1016/j.geoderma.2009.04.008; Kneib RT, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P267; Lerberg SB, 2000, ESTUARIES, V23, P838, DOI 10.2307/1353001; Levin L, 1997, J MAR RES, V55, P595, DOI 10.1357/0022240973224337; Levin L.A., 2002, CONCEPTS CONTROVERSI; LORENZEN CJ, 1967, LIMNOL OCEANOGR, V12, P343, DOI 10.4319/lo.1967.12.2.0343; Martin JP, 2006, J MAR BIOL ASSOC UK, V86, P235, DOI 10.1017/S0025315406013087; McGrath MT, 2003, WILDLIFE MONOGR, P1; Minello TJ, 2008, T AM FISH SOC, V137, P129, DOI 10.1577/T06-276.1; Minello TJ, 2003, MAR ECOL PROG SER, V246, P39, DOI 10.3354/meps246039; Neira C, 2005, MAR ECOL PROG SER, V292, P111, DOI 10.3354/meps292111; Otegui MBP, 2012, HELGOLAND MAR RES, V66, P479, DOI 10.1007/s10152-011-0284-x; OYENEKAN JA, 1986, MAR BIOL, V93, P217, DOI 10.1007/BF00508259; OYENEKAN JA, 1987, MAR BIOL, V95, P267; Palomo G, 2003, J EXP MAR BIOL ECOL, V290, P211, DOI 10.1016/S0022-0981(03)00074-1; Paramor OAL, 2004, J APPL ECOL, V41, P449, DOI 10.1111/j.0021-8901.2004.00916.x; Riera P, 2000, MAR ECOL PROG SER, V199, P205, DOI 10.3354/meps199205; ROBERTSON AI, 1979, OECOLOGIA, V38, P193, DOI 10.1007/BF00346563; ROZAS LP, 1987, ESTUARIES, V10, P36, DOI 10.2307/1352023; Rush SA, 2010, ESTUAR COAST, V33, P963, DOI 10.1007/s12237-010-9281-6; SARDA R, 1995, MAR BIOL, V121, P431, DOI 10.1007/BF00349452; Sarda R, 1998, ESTUAR COAST SHELF S, V46, P657, DOI 10.1006/ecss.1997.0322; [宋慈玉 Song Ciyu], 2011, [复旦学报. 自然科学版, Journal of Fudan University. Natural Sciences], V50, P253; Stehlik LL, 2000, ESTUARIES, V23, P381, DOI 10.2307/1353330; STEIMLE FW, 1990, OPHELIA, V31, P105, DOI 10.1080/00785326.1990.10430855; Sun RP, 2004, FAUNA SINICA POLYCHA; Toomey WA, 1997, THESIS N CAROLINA ST; Vlaswinkel BM, 2011, EARTH SURF PROC LAND, V36, P739, DOI 10.1002/esp.2099; Wang JQ, 2009, ECOL ENG, V35, P1685, DOI 10.1016/j.ecoleng.2009.05.002; WARWICK RM, 1975, J MAR BIOL ASSOC UK, V55, P1, DOI 10.1017/S0025315400015721; Washburn T, 2013, HYDROBIOLOGIA, V702, P15, DOI 10.1007/s10750-012-1297-4; Washburn T, 2011, ENVIRON MONIT ASSESS, V180, P177, DOI 10.1007/s10661-010-1780-1; Yuan Xing-Zhong, 2001, Zoological Research, V22, P211; Zimmerman RJ, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P293	52	1	1	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97287	10.1371/journal.pone.0097287	http://dx.doi.org/10.1371/journal.pone.0097287			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24817092	Green Published, gold, Green Submitted			2022-12-27	WOS:000336838000126
J	Khabsa, M; Giles, CL				Khabsa, Madian; Giles, C. Lee			The Number of Scholarly Documents on the Public Web	PLOS ONE			English	Article								The number of scholarly documents available on the web is estimated using capture/recapture methods by studying the coverage of two major academic search engines: Google Scholar and Microsoft Academic Search. Our estimates show that at least 114 million English-language scholarly documents are accessible on the web, of which Google Scholar has nearly 100 million. Of these, we estimate that at least 27 million (24%) are freely available since they do not require a subscription or payment of any kind. In addition, at a finer scale, we also estimate the number of scholarly documents on the web for fifteen fields: Agricultural Science, Arts and Humanities, Biology, Chemistry, Computer Science, Economics and Business, Engineering, Environmental Sciences, Geosciences, Material Science, Mathematics, Medicine, Physics, Social Sciences, and Multidisciplinary, as defined by Microsoft Academic Search. In addition, we show that among these fields the percentage of documents defined as freely available varies significantly, i.e., from 12 to 50%.	[Khabsa, Madian; Giles, C. Lee] Penn State Univ, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Giles, CL (corresponding author), Penn State Univ, University Pk, PA 16802 USA.	giles@ist.psu.edu			National Science Foundation [0958143, 1348712, 1143921]; Division Of Computer and Network Systems [0958143] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Computer and Network Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was partially funded by the National Science Foundation, grants 0958143, 1348712, and 1143921. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There has been no additional external funding received for this study.	Bar-Ilan J, 2008, SCIENTOMETRICS, V74, P257, DOI 10.1007/s11192-008-0216-y; Bar-Ilan J, 2010, SCIENTOMETRICS, V82, P495, DOI 10.1007/s11192-010-0185-9; Bharat K, 1998, COMPUT NETWORKS ISDN, V30, P379, DOI 10.1016/S0169-7552(98)00127-5; Bjork BC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011273; Bjork BC, 2009, INFORM RES, V14; Broder AZ, 1997, COMPUT NETWORKS ISDN, V29, P1157, DOI 10.1016/S0169-7552(97)00031-7; Dobra A, 2004, WEB DYNAMICS: ADAPTING TO CHANGE IN CONTENT, SIZE TOPOLOG AND USE, P23; Gargouri Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013636; Hajjem C., 2005, IEEE DATA ENG B, V28, P39; Hogg R.V., 2010, PROBABILITY STAT INF, V9th ed.; Lawrence S, 1999, NATURE, V400, P107, DOI 10.1038/21987; Lawrence S, 1998, SCIENCE, V280, P98, DOI 10.1126/science.280.5360.98; Norris M, 2008, J AM SOC INF SCI TEC, V59, P1963, DOI 10.1002/asi.20898; Page L., 1999, 199966 STANF INFOLAB; Van Noorden R, 2013, NATURE, V495, P426, DOI 10.1038/495426a	15	173	173	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e93949	10.1371/journal.pone.0093949	http://dx.doi.org/10.1371/journal.pone.0093949			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4LX	24817403	gold, Green Published, Green Submitted			2022-12-27	WOS:000336838000007
J	Wang, L; Zhu, MJ; Ren, AM; Wu, HF; Han, WM; Tan, RY; Tu, RQ				Wang, Lin; Zhu, Miao-Jun; Ren, Ai-Min; Wu, Hong-Fei; Han, Wu-Mei; Tan, Ruo-Ying; Tu, Rui-Qin			A Ten-MicroRNA Signature Identified from a Genome-Wide MicroRNA Expression Profiling in Human Epithelial Ovarian Cancer	PLOS ONE			English	Article							PATHOGENESIS; STATISTICS; INVASION	Epithelial ovarian cancer (EOC) is the most common gynecologic malignancy. To identify the micro-ribonucleic acids (miRNAs) expression profile in EOC tissues that may serve as a novel diagnostic biomarker for EOC detection, the expression of 1722 miRNAs from 15 normal ovarian tissue samples and 48 ovarian cancer samples was profiled by using a quantitative real-time polymerase chain reaction (qRT-PCR) assay. A ten-microRNA signature (hsa-miR-1271-5p, hsa-miR-574-3p, hsa-miR-182-5p, hsa-miR-183-5p, hsa-miR-96-5p, hsa-miR-15b-5p, hsa-miR-182-3p, hsa-miR-141-5p, hsa-miR-130b-5p, and hsa-miR-135b-3p) was identified to be able to distinguish human ovarian cancer tissues from normal tissues with 97% sensitivity and 92% specificity. Two miRNA clusters of miR183-96-183 (miR-96-5p, and miR-182, miR183) and miR200 (miR-141-5p, miR200a, b, c and miR429) are significantly up-regulated in ovarian cancer tissue samples compared to those of normal tissue samples, suggesting theses miRNAs may be involved in ovarian cancer development.	[Wang, Lin; Ren, Ai-Min; Tu, Rui-Qin] Fudan Univ, Shanghai Zhongshan Hosp, Dept Obstet & Gynecol, Shanghai 200433, Peoples R China; [Zhu, Miao-Jun; Wu, Hong-Fei; Han, Wu-Mei; Tan, Ruo-Ying] Biovue Technol China Ltd, Shanghai, Peoples R China	Fudan University	Tan, RY (corresponding author), Biovue Technol China Ltd, Shanghai, Peoples R China.	tan@biovuetech.com; ruiqin@zs-hospital.sh.cn						Ahmed FY, 1996, J CLIN ONCOL, V14, P2968, DOI 10.1200/JCO.1996.14.11.2968; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chan JK, 2006, OBSTET GYNECOL, V108, P521, DOI 10.1097/01.AOG.0000231680.58221.a7; Etzioni R, 2003, NAT REV CANCER, V3, P243, DOI 10.1038/nrc1041; Gloss BS, 2012, CANC LETT; Hu XX, 2009, GYNECOL ONCOL, V114, P457, DOI 10.1016/j.ygyno.2009.05.022; Huang Y, 2010, RUSS J BIOORG CHEM+, V36, P684, DOI 10.1134/S1068162010060026; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kan CWS, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-627; Kuhlmann JD, 2012, CLIN CHEM LAB MED, V50, P601, DOI 10.1515/cclm-2011-0847; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Li J, 2012, ONCOL REP, V27, P1835, DOI 10.3892/or.2012.1744; Li XL, 2014, MOL CELL BIOL, V34, P533, DOI 10.1128/MCB.01043-13; Liu ZJ, 2012, J PATHOL, V228, P204, DOI 10.1002/path.4000; Menon U, 2012, INT J GYNECOL CANCER, V22, pS18, DOI 10.1097/IGC.0b013e318251cb47; Mezzanzanica D, 2010, INT J BIOCHEM CELL B, V42, P1262, DOI 10.1016/j.biocel.2009.12.017; Peart TM, 2012, CLIN EXP METASTAS, V29, P293, DOI 10.1007/s10585-011-9451-3; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; SZABO CI, 1995, HUM MOL GENET, V4, P1811, DOI 10.1093/hmg/4.suppl_1.1811; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Wang XW, 2009, RNA, V15, P716, DOI 10.1261/rna.1460509; Wang YQ, 2013, J CELL BIOCHEM, V114, P1464, DOI 10.1002/jcb.24488; Wright JD, 2009, CANCER-AM CANCER SOC, V115, P4118, DOI 10.1002/cncr.24461; Xu XF, 2013, INT J BIOCHEM CELL B, V45, P536, DOI 10.1016/j.biocel.2012.12.010	27	78	81	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96472	10.1371/journal.pone.0096472	http://dx.doi.org/10.1371/journal.pone.0096472			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816756	Green Published, Green Submitted, gold			2022-12-27	WOS:000336838000038
J	Zhao, Q; Wong, PF; Lee, SST; Leung, SO; Cheung, WT; Wang, JZ				Zhao, Qi; Wong, Pui-Fan; Lee, Susanna S. T.; Leung, Shui-On; Cheung, Wing-Tai; Wang, Jun-Zhi			Generation of Anti-Idiotype scFv for Pharmacokinetic Measurement in Lymphoma Patients Treated with Chimera Anti-CD22 Antibody SM03	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; CELL; ANTIGEN; SURFACE; GLYCOSYLATION; RITUXIMAB; MURINE; ELISA; CD22	Pre-clinical and clinical studies of therapeutic antibodies require highly specific reagents to examine their immune responses, bio-distributions, immunogenicity, and pharmacodynamics in patients. Selective antigen-mimicking anti-idiotype antibody facilitates the assessment of therapeutic antibody in the detection, quantitation and characterization of antibody immune responses. Using mouse specific degenerate primer pairs and splenocytic RNA, we generated an idiotype antibody-immunized phage-displayed scFv library in which an anti-idiotype antibody against the therapeutic chimera anti-CD22 antibody SM03 was isolated. The anti-idiotype scFv recognized the idiotype of anti-CD22 antibody and inhibited binding of SM03 to CD22 on Raji cell surface. The anti-idiotype scFv was subsequently classified as Ab2 gamma type. Moreover, our results also demonstrated firstly that the anti-idiotype scFv could be used for pharmacokinetic measurement of circulating residual antibody in lymphoma patients treated with chimera anti-CD22 monoclonal antibody SM03. Of important, the present approach could be easily adopted to generate anti-idiotype antibodies for therapeutic antibodies targeting membrane proteins, saving the cost and time for producing a soluble antigen.	[Zhao, Qi; Wong, Pui-Fan; Cheung, Wing-Tai] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Leung, Shui-On] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Lee, Susanna S. T.] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China; [Wang, Jun-Zhi] Natl Inst Food & Drug Control, Beijing, Peoples R China	Chinese University of Hong Kong; Fudan University; Chinese University of Hong Kong; National Institute of Food & Drug Control - China	Cheung, WT (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China.	wtcheung@cuhk.edu.hk; wangjz@nifdc.org.cn		Cheung, Wing-Tai/0000-0001-6358-7855; Zhao, Qi/0000-0002-5969-6407	HKSAR Research Grant Council [2041780]; HKSAR Innovation and Technology Commission [GHP/030/06]	HKSAR Research Grant Council; HKSAR Innovation and Technology Commission	This work was partly supported by a Direct Grant (2041780) from HKSAR Research Grant Council, and a research grant from HKSAR Innovation and Technology Commission (GHP/030/06) to WTC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addona TA, 2009, NAT BIOTECHNOL, V27, P633, DOI 10.1038/nbt.1546; Austin EB, 2001, VOX SANG, V80, P179, DOI 10.1046/j.1423-0410.2001.00031.x; Bhattacharya-Chatterjee M, 2002, EXPERT OPIN BIOL TH, V2, P869, DOI 10.1517/14712598.2.8.869; Bikkavilli RK, 2006, BIOCHEM PHARMACOL, V71, P319, DOI 10.1016/j.bcp.2005.10.050; Blasco H, 2007, J IMMUNOL METHODS, V325, P127, DOI 10.1016/j.jim.2007.06.011; Cheng M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027406; Coelho M, 2004, BRIT J CANCER, V90, P2032, DOI 10.1038/sj.bjc.6601825; Cragg MS, 2004, BLOOD, V104, P2540, DOI 10.1182/blood-2004-05-1733; Gruber R, 2000, CANCER RES, V60, P1921; Hong K, 2004, J IMMUNOL METHODS, V294, P189, DOI 10.1016/j.jim.2004.09.003; HONJO T, 1985, ANNU REV BIOCHEM, V54, P803, DOI 10.1146/annurev.bi.54.070185.004103; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; Jilani I, 2004, LEUKEMIA RES, V28, P1255, DOI 10.1016/j.leukres.2004.04.003; Krishnaswamy S, 2011, J IMMUNOL METHODS, V366, P60, DOI 10.1016/j.jim.2011.01.006; Leonard JP, 2007, ONCOGENE, V26, P3704, DOI 10.1038/sj.onc.1210370; LEUNG SO, 1995, INT J CANCER, V60, P534, DOI 10.1002/ijc.2910600418; Li S, 2012, MABS-AUSTIN, V4, P256, DOI 10.4161/mabs.4.2.19136; [梁瑞安 LIANG Ruian], 2006, [中国新药杂志, Chinese Journal New Drugs], V15, P1832; Liu ZQ, 2003, HYBRIDOMA HYBRIDOM, V22, P219, DOI 10.1089/153685903322328947; LOSMAN MJ, 1995, CANCER RES, V55, pS5978; Mellstedt H, 2003, DRUG TODAY, V39, P1; PAN Y, 1995, FASEB J, V9, P43, DOI 10.1096/fasebj.9.1.7821758; Rahman M.M., 2011, PLANT BIOSYST, V1, P1; Rehm BHA, 2001, BIOCHEM J, V358, P263, DOI 10.1042/0264-6021:3580263; SCHWARTZALBIEZ R, 1991, INT IMMUNOL, V3, P623, DOI 10.1093/intimm/3.7.623; Stoddart A, 1997, INT IMMUNOL, V9, P1571, DOI 10.1093/intimm/9.10.1571; Tometta M, 2007, J IMMUNOL METHODS, V328, P34, DOI 10.1016/j.jim.2007.08.008; Tripathi PK, 1998, MOL IMMUNOL, V35, P853, DOI 10.1016/S0161-5890(98)00072-8; [杨蕾 YANG Lei], 2006, [中国新药杂志, Chinese Journal New Drugs], V15, P186; Zhao Q, 2009, PROTEIN EXPRES PURIF, V68, P190, DOI 10.1016/j.pep.2009.08.004	30	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96697	10.1371/journal.pone.0096697	http://dx.doi.org/10.1371/journal.pone.0096697			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816427	Green Published, Green Submitted, gold			2022-12-27	WOS:000336838000052
J	Zhou, R; Zhou, HD; Cui, M; Chen, L; Xu, JZ				Zhou, Rui; Zhou, Huadong; Cui, Min; Chen, Lin; Xu, Jianzhong			The Association between Aortic Calcification and Fracture Risk in Postmenopausal Women in China: The Prospective Chongqing Osteoporosis Study	PLOS ONE			English	Article							BONE-MINERAL DENSITY; CARDIOVASCULAR-DISEASE; ABDOMINAL-AORTA; ELDERLY-MEN; ADIPONECTIN; OSTEOCALCIN; PROGRESSION; POPULATION; PREDICTOR; MORTALITY	Purpose: Fractures are associated with cardiovascular diseases in the elderly. The purpose of the present study was to investigate the association between aortic calcification (AC) and the risk of vertebral fractures in postmenopausal Chinese women. Methods: A prospective study with 5 years of follow-up in 1724 postmenopausal women (aged 50 years old and older) was conducted from July 2005 to June 2010. Dual energy X-ray absorptiometry was utilized to evaluate bone mineral density (BMD). Aortic calcification score (ACS) was determined by a semi-quantitative method and was further categorized into four groups. Cox proportional hazards models were established to assess the association between AC and the risk of vertebral fractures. Results: For subjects with AC, the incidence of vertebral fractures was higher than that of those without AC (p < 0.01). After adjustment for age and other potential confounders, it was found that severe AC (G4, ACS>6; G3, ACS = 3-6) was associated with vertebral fractures. Severe AC (G4) was associated with non-vertebral fractures. There were higher risk for the vertebral fractures in two groups and higher risk for non-vertebral fractures in one group. Conclusions: The results of the current study indicate that severe AC is associated with a significantly increased risk of vertebral fractures and non-vertebral fractures in postmenopausal women in China.	[Zhou, Rui; Xu, Jianzhong] Third Mil Med Univ, Southwest Hosp, Dept Orthoped, Orthoped Surg Ctr Chinese PLA, Chongqing, Peoples R China; [Zhou, Huadong; Cui, Min] Third Mil Med Univ, Daping Hosp, Dept Neurol, Chongqing, Peoples R China; [Chen, Lin] Third Mil Med Univ, Daping Hosp, State Key Lab Trauma Burns & Combined Injury, Trauma Ctr,Inst Surg Res, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Xu, JZ (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Orthoped, Orthoped Surg Ctr Chinese PLA, Chongqing, Peoples R China.	jzx_tmmu@163.com		Xu, Jianzhong/0000-0003-0434-5148	Chongqing Educational Commission [KJTD201337]	Chongqing Educational Commission	This study was supported by funding from Chongqing Educational Commission (KJTD201337). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araneta MRG, 2009, J BONE MINER RES, V24, P2016, DOI [10.1359/JBMR.090519, 10.1359/jbmr.090519]; Bagger YZ, 2006, J INTERN MED, V259, P598, DOI 10.1111/j.1365-2796.2006.01640.x; Barbour KE, 2011, J BONE MINER RES, V26, P1568, DOI 10.1002/jbmr.361; Basurto L, 2009, EUR J ENDOCRINOL, V160, P289, DOI 10.1530/EJE-08-0569; BOSTROM K, 1993, J CLIN INVEST, V91, P1800, DOI 10.1172/JCI116391; Celermajer DS, 2012, J AM COLL CARDIOL, V60, P1207, DOI 10.1016/j.jacc.2012.03.074; Chen JS, 2011, CALCIFIED TISSUE INT, V88, P9, DOI 10.1007/s00223-010-9431-7; El Maghraoui A, 2013, BONE, V56, P213, DOI 10.1016/j.bone.2013.05.022; Giachelli CM, 2004, J AM SOC NEPHROL, V15, P2959, DOI 10.1097/01.ASN.0000145894.57533.C4; GIACHELLI CM, 1993, J CLIN INVEST, V92, P1686, DOI 10.1172/JCI116755; Golestani R, 2010, ANN MED, V42, P539, DOI 10.3109/07853890.2010.515604; Johansson H, 2012, J BONE MINER RES, V27, P1390, DOI 10.1002/jbmr.1591; Kauppila LI, 1997, ATHEROSCLEROSIS, V132, P245, DOI 10.1016/S0021-9150(97)00106-8; Kim KJ, 2012, CALCIFIED TISSUE INT, V91, P370, DOI 10.1007/s00223-012-9642-1; LEVY RJ, 1983, AM J PATHOL, V113, P143; Lian X, 2011, CHIN J OSTEOPOROS, V18, P183; MCCLOSKEY EV, 1993, OSTEOPOROSIS INT, V3, P138, DOI 10.1007/BF01623275; Melton LJ, 2013, OSTEOPOROSIS INT, V24, P1689, DOI 10.1007/s00198-012-2225-1; Mohammad A, 2013, J CLIN DENSITOM, V27, pS1094; Naves M, 2008, OSTEOPOROSIS INT, V19, P1161, DOI 10.1007/s00198-007-0539-1; Schulz E, 2004, J CLIN ENDOCR METAB, V89, P4246, DOI 10.1210/jc.2003-030964; Sennerby U, 2007, OSTEOPOROSIS INT, V18, P1355, DOI 10.1007/s00198-007-0386-0; Simon SP, 2014, ENDOCR RES, V39, P1, DOI 10.3109/07435800.2013.794425; STEFENELLI T, 1993, AM J MED, V95, P197, DOI 10.1016/0002-9343(93)90260-V; Steitz SA, 2001, CIRC RES, V89, P1147, DOI 10.1161/hh2401.101070; Svejme O, 2012, BJOG-INT J OBSTET GY, V119, P810, DOI 10.1111/j.1471-0528.2012.03324.x; Szulc P, 2008, J BONE MINER RES, V23, P95, DOI 10.1359/JBMR.070903; Vogt MT, 1997, J AM GERIATR SOC, V45, P140, DOI 10.1111/j.1532-5415.1997.tb04498.x; Wang TKM, 2010, J BONE MINER RES, V25, P2501, DOI 10.1002/jbmr.183; Wang Y, 2009, OSTEOPOROSIS INT, V20, P1651, DOI 10.1007/s00198-009-0925-y; Weber P, 2001, NUTRITION, V17, P880, DOI 10.1016/S0899-9007(01)00709-2	31	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e93882	10.1371/journal.pone.0093882	http://dx.doi.org/10.1371/journal.pone.0093882			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24817329	Green Published, gold, Green Submitted			2022-12-27	WOS:000336838000006
J	Eccard, JA; Liesenjohann, T				Eccard, Jana A.; Liesenjohann, Thilo			The Importance of Predation Risk and Missed Opportunity Costs for Context-Dependent Foraging Patterns	PLOS ONE			English	Article							BEHAVIOR; FEAR; LANDSCAPES; HIERARCHIES; VOLES	Correct assessment of risks and costs of foraging is vital for the fitness of foragers. Foragers should avoid predation risk and balance missed opportunities. In risk-heterogeneous landscapes animals prefer safer locations over riskier, constituting a landscape of fear. Risk-uniform landscapes do not offer this choice, all locations are equally risky. Here we investigate the effects of predation risk in patches, travelling risk between patches, and missed social opportunities on foraging decisions in risk-uniform and risk-heterogeous landscapes. We investigated patch leaving decisions of 20 common voles (M. arvalis) in three experimental landscapes: safe risk-uniform, risky risk-uniform and risk-heterogeneous. We varied both the predation risk level and the predation risk distribution between two patches experimentally and in steps, assuming that our manipulation consequently yield different distributions and levels of risk while foraging, risk while travelling, and costs of missed, social opportunities (MSOCs). We measured mean GUDs (giving-up density of food left in the patch) for both patches as a measure of foraging gain, and delta GUD, the differences among patches, as a measure of the spatial distribution of foraging effort over a period of six hours. Distribution of foraging effort was most even in the safe risk-uniform landscapes and least even in the risk-heterogeneous landscape, with risky risk-uniform landscapes in between. Foraging gain was higher in the safe than in the two riskier landscapes (both uniform and heterogeneous). Results supported predictions for the effects of risk in foraging patches and while travelling between patches, however predictions for the effects of missed social opportunities were not met in this short term experiment. Thus, both travelling and foraging risk contribute to distinct patterns observable high risk, risk-uniform landscapes.	[Eccard, Jana A.; Liesenjohann, Thilo] Univ Potsdam, Potsdam, Germany; [Eccard, Jana A.; Liesenjohann, Thilo] Univ Bielefeld, D-33615 Bielefeld, Germany; [Liesenjohann, Thilo] BioConsult SH GmbH, BioConsult, Husum, Germany	University of Potsdam; University of Bielefeld	Eccard, JA (corresponding author), Univ Potsdam, Potsdam, Germany.	eccard@uni-potsdam.de			German Research Foundation (DFG) [EC361/2]	German Research Foundation (DFG)(German Research Foundation (DFG))	The German Research Foundation (DFG) supported this study with a grant to JAE (EC361/2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Baker MA, 2010, FUNCT ECOL, V24, P1313, DOI 10.1111/j.1365-2435.2010.01757.x; Bianchi FJJA, 2009, OIKOS, V118, P1363, DOI 10.1111/j.1600-0706.2009.17319.x; BROWN JS, 1988, BEHAV ECOL SOCIOBIOL, V22, P37, DOI 10.1007/BF00395696; Brown JS, 1999, J MAMMAL, V80, P385, DOI 10.2307/1383287; Bujalska Gabriela, 2000, Polish Journal of Ecology, V48, P97; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Eccard JA, 2008, OECOLOGIA, V157, P725, DOI 10.1007/s00442-008-1100-4; Eccard JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003438; Garb J, 2000, OIKOS, V88, P291, DOI 10.1034/j.1600-0706.2000.880207.x; GREEN RF, 1980, THEOR POPUL BIOL, V18, P244, DOI 10.1016/0040-5809(80)90051-9; HALLE S, 1987, OECOLOGIA, V71, P568, DOI 10.1007/BF00379299; HOLT RD, 1984, AM NAT, V124, P377, DOI 10.1086/284280; Krause ET, 2012, BEHAVIOUR, V149, P1, DOI 10.1163/156853912X623748; Laundre JW, 2001, CAN J ZOOL, V79, P1401, DOI 10.1139/cjz-79-8-1401; Liesenjohann T., 2008, BMC Ecology, V8, P19, DOI 10.1186/1472-6785-8-19; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; McIntyre NE, 1999, LANDSCAPE ECOL, V14, P437, DOI 10.1023/A:1008074407036; Olsson O, 2006, OIKOS, V112, P285, DOI 10.1111/j.0030-1299.2006.13549.x; Olsson O, 1999, OIKOS, V87, P251, DOI 10.2307/3546740; Olsson O, 2007, ISR J ECOL EVOL, V53, P263, DOI 10.1560/IJEE.53.3.263; Searle KR, 2008, BEHAV ECOL, V19, P475, DOI 10.1093/beheco/arn004; SENFT RL, 1987, BIOSCIENCE, V37, P789, DOI 10.2307/1310545; Verdolin JL, 2006, BEHAV ECOL SOCIOBIOL, V60, P457, DOI 10.1007/s00265-006-0172-6	23	10	10	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e94107	10.1371/journal.pone.0094107	http://dx.doi.org/10.1371/journal.pone.0094107			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809666	Green Published, gold, Green Submitted			2022-12-27	WOS:000338213300005
J	Han, F; Dong, Y; Liu, WB; Ma, XX; Shi, RH; Chen, HQ; Cui, ZH; Ao, L; Zhang, HD; Cao, J; Liu, JY				Han, Fei; Dong, Yan; Liu, Wenbin; Ma, Xuexiang; Shi, Ronghui; Chen, Hongqiang; Cui, Zhihong; Ao, Lin; Zhang, Huidong; Cao, Jia; Liu, Jinyi			Epigenetic Regulation of Sox30 Is Associated with Testis Development in Mice	PLOS ONE			English	Article							DNA METHYLATION PATTERNS; GERM-CELLS; MAMMALIAN DEVELOPMENT; MOUSE TESTIS; A SPERMATOGONIA; GENE-EXPRESSION; PATERNAL GENOME; STEM-CELLS; DEMETHYLATION; METHYLTRANSFERASE	DNA methylation is involved in tissue-specific and developmentally regulated gene expression. Here, we screened a novel methylation gene Sox30, whose methylation might contribute to its regulation and testis development in mice. Sox30 is a member of Sox transcription factors, and is considered to be involved in spermatogonial differentiation and spermatogenesis. However, the precise function and regulatory expression pattern remain unclear. In the present study, we found that Sox30 is highly expressed in adult testes but not in ovaries. Sox30 expression begins in early development, and in the testes, it is specifically increased coincidentally with development until adulthood. Moreover, Sox30 is expressed not only in testis germ cells, but also in sertoli cells. Sox30 is hypo-methylated in testis, epididymis and lung of adult mice, in which Sox30 is expressed. By contrast, Sox30 is hypermethylated in ovary, heart, brain, liver, kidney, spleen, pancreas, muscle, intestine, pituitary gland, blood and hippocampus of adult mice, in which the Sox30 is absent. Importantly, decreased methylation at CpG islands of Sox30 is observed in mouse developmental testes after birth, which is associated with enhanced Sox30 expression. However, the hypermethylated status of Sox30 is maintained in ovaries that does not express Sox30 during this period. Further, following demethylation treatment using 5-aza-dC, Sox30 expression is restored in GC2, TM3 and TM4 cell lines. This observation convincingly confirms that methylation really contributes to Sox30 silencing. In summary, we show that Sox30 expression is under the control of DNA methylation status, and this expression pattern is associated with testis development in mice.	[Han, Fei; Dong, Yan; Liu, Wenbin; Ma, Xuexiang; Shi, Ronghui; Chen, Hongqiang; Cui, Zhihong; Ao, Lin; Zhang, Huidong; Cao, Jia; Liu, Jinyi] Third Mil Med Univ, Key Lab Med Protect Electromagnet Radiat, Minist Educ China, Inst Toxicol,Coll Prevent Med, Chongqing, Peoples R China	Army Medical University; Ministry of Education, China	Liu, JY (corresponding author), Third Mil Med Univ, Key Lab Med Protect Electromagnet Radiat, Minist Educ China, Inst Toxicol,Coll Prevent Med, Chongqing, Peoples R China.	jinyiliutmmu@163.com	Han, Fei/AAG-9260-2020; liu, wen/HGE-3071-2022; Han, Fei/AAH-2028-2020	Han, Fei/0000-0002-0265-5487; Zhang, Huidong/0000-0001-7845-3331; Cui, Zhihong/0000-0001-9729-5375	National Natural Science Foundation of China [81030052, 81172714]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Nos. 81030052; 81172714). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballow D, 2006, DEV BIOL, V294, P161, DOI 10.1016/j.ydbio.2006.02.027; BENOIT G, 1994, BIOL REPROD, V50, P1312, DOI 10.1095/biolreprod50.6.1312; Bernardino J, 2000, CHROMOSOME RES, V8, P513, DOI 10.1023/A:1009271706488; Bernardino-Sgherri J, 2002, CHROMOSOMA, V111, P341, DOI 10.1007/s00412-002-0217-1; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Cho JH, 2001, ENDOCRINOLOGY, V142, P3389, DOI 10.1210/en.142.8.3389; Coffigny H, 1999, CYTOGENET CELL GENET, V87, P175, DOI 10.1159/000015460; De Carvalho DD, 2010, TRENDS CELL BIOL, V20, P609, DOI 10.1016/j.tcb.2010.08.003; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Dirami G, 1999, BIOL REPROD, V61, P225, DOI 10.1095/biolreprod61.1.225; Eden S, 1998, NATURE, V394, P842, DOI 10.1038/29680; Hamra FK, 2005, P NATL ACAD SCI USA, V102, P17430, DOI 10.1073/pnas.0508780102; Han F, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-98; Hirabayashi K, 2013, BMC GENOMIC IN PRESS; Imamura T, 2001, GENOMICS, V76, P117, DOI 10.1006/geno.2001.6607; Izadyar F, 2002, REPRODUCTION, V124, P85, DOI 10.1530/rep.0.1240085; Jiang T, 2013, MOL BIOL REP, V40, P2187, DOI 10.1007/s11033-012-2279-3; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Liu WB, 2012, BIOCHEM BIOPH RES CO, V429, P180, DOI 10.1016/j.bbrc.2012.10.116; Lydka Marta, 2012, Spermatogenesis, V2, P294; Marchal R, 2004, CYTOGENET GENOME RES, V105, P316, DOI 10.1159/000078204; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nicholls PK, 2009, ENDOCRINOLOGY, V150, P2481, DOI 10.1210/en.2008-1048; Ogawa T, 2004, ARCH HISTOL CYTOL, V67, P297, DOI 10.1679/aohc.67.297; Ohgane J, 2002, BIOCHEM BIOPH RES CO, V290, P701, DOI 10.1006/bbrc.2001.6258; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Osaki E, 1999, NUCLEIC ACIDS RES, V27, P2503, DOI 10.1093/nar/27.12.2503; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Shi YQ, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/181282; Shiota K, 2002, GENES CELLS, V7, P961, DOI 10.1046/j.1365-2443.2002.00574.x; Shiota K, 2002, DIFFERENTIATION, V69, P162, DOI 10.1046/j.1432-0436.2002.690406.x; Su LL, 2010, INT J BIOCHEM CELL B, V42, P1864, DOI 10.1016/j.biocel.2010.08.004; TAWA R, 1990, DIFFERENTIATION, V45, P44, DOI 10.1111/j.1432-0436.1990.tb00455.x; TRASLER JM, 1992, NUCLEIC ACIDS RES, V20, P2541, DOI 10.1093/nar/20.10.2541; TRASLER JM, 1990, MOL CELL BIOL, V10, P1828, DOI 10.1128/MCB.10.4.1828; Yagi S, 2008, GENOME RES, V18, P1969, DOI 10.1101/gr.074070.107; Zhou Feng C, 2012, Front Biol (Beijing), V7, P485; Zhou LY, 2007, ENDOCRINOLOGY, V148, P4282, DOI 10.1210/en.2007-0487	45	31	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e97203	10.1371/journal.pone.0097203	http://dx.doi.org/10.1371/journal.pone.0097203			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810894	gold, Green Published, Green Submitted			2022-12-27	WOS:000338213300136
J	Kolli, V; Stechschulte, LA; Dowling, AR; Rahman, S; Czernik, PJ; Lecka-Czernik, B				Kolli, Vipula; Stechschulte, Lance A.; Dowling, Abigail R.; Rahman, Sima; Czernik, Piotr J.; Lecka-Czernik, Beata			Partial Agonist, Telmisartan, Maintains PPAR gamma Serine 112 Phosphorylation, and Does Not Affect Osteoblast Differentiation and Bone Mass	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; MESENCHYMAL STEM-CELLS; BROWN ADIPOSE-TISSUE; MOLECULAR CHARACTERIZATION; INSULIN-RESISTANCE; DIABETIC-PATIENTS; RECEPTOR; FAT; OSTEOPOROSIS; INCREASES	Peroxisome proliferator activated receptor gamma (PPAR gamma) controls both glucose metabolism and an allocation of marrow mesenchymal stem cells (MSCs) toward osteoblast and adipocyte lineages. Its activity is determined by interaction with a ligand which directs posttranscriptional modifications of PPAR gamma protein including dephosphorylation of Ser112 and Ser273, which results in acquiring of pro-adipocytic and insulin-sensitizing activities, respectively. PPAR gamma full agonist TZD rosiglitazone (ROSI) decreases phosphorylation of both Ser112 and Ser273 and its prolonged use causes bone loss in part due to diversion of MSCs differentiation from osteoblastic toward adipocytic lineage. Telmisartan (TEL), an anti-hypertensive drug from the class of angiotensin receptor blockers, also acts as a partial PPAR gamma agonist with insulin-sensitizing and a weak pro-adipocytic activity. TEL decreased (S273)pPPAR gamma and did not affect (S112)pPPAR gamma levels in a model of marrow MSC differentiation, U-33/gamma 2 cells. In contrast to ROSI, TEL did not affect osteoblast phenotype and actively blocked ROSI-induced anti-osteoblastic activity and dephosphorylation of (S112)pPPAR gamma. The effect of TEL on bone was tested side-by-side with ROSI. In contrast to ROSI, TEL administration did not affect bone mass and bone biomechanical properties measured by micro-indentation method and did not induce fat accumulation in bone, and it partially protected from ROSI-induced bone loss. In addition, TEL induced "browning'' of epididymal white adipose tissue marked by increased expression of UCP1, FoxC2, Wnt10b and IGFBP2 and increased overall energy expenditure. These studies point to the complexity of mechanisms by which PPAR gamma acquires anti-osteoblastic and pro-adipocytic activities and suggest an importance of Ser112 phosphorylation status as being a part of the mechanism regulating this process. These studies showed that TEL acts as a full PPAR gamma agonist for insulin-sensitizing activity and as a partial agonist/partial antagonist for pro-adipocytic and antiosteoblastic activities. They also suggest a relationship between PPAR gamma fat "browning'' activity and a lack of antiosteoblastic activity.	[Kolli, Vipula; Stechschulte, Lance A.; Rahman, Sima; Czernik, Piotr J.; Lecka-Czernik, Beata] Univ Toledo, Dept Orthopaed Surg, Coll Med, Toledo, OH 43606 USA; [Dowling, Abigail R.; Lecka-Czernik, Beata] Univ Toledo, Dept Physiol & Pharmacol, Coll Med, Toledo, OH 43606 USA; [Kolli, Vipula; Stechschulte, Lance A.; Dowling, Abigail R.; Rahman, Sima; Lecka-Czernik, Beata] Univ Toledo, Ctr Diabet & Endocrine Res, Coll Med, Toledo, OH 43606 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo	Lecka-Czernik, B (corresponding author), Univ Toledo, Dept Orthopaed Surg, Coll Med, 2801 W Bancroft St, Toledo, OH 43606 USA.	beata.leckaczernik@utoledo.edu		Stechschulte, Lance/0000-0001-9783-6194	NIH [AG028935]; American Diabetes Association [N-120614]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028935] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH AG028935 and American Diabetes Association N-120614. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Amano Y, 2012, HYPERTENS RES, V35, P715, DOI 10.1038/hr.2012.17; Araki K, 2006, HYPERTENSION, V48, P51, DOI 10.1161/01.HYP.0000225402.69580.1d; Asaba Y, 2009, J BONE MINER RES, V24, P241, DOI [10.1359/jbmr.081006, 10.1359/JBMR.081006]; Benson SC, 2004, HYPERTENSION, V43, P993, DOI 10.1161/01.HYP.0000123072.34629.57; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Cawthorn WP, 2012, BONE, V50, P477, DOI 10.1016/j.bone.2011.08.010; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Furuhashi M, 2003, HYPERTENSION, V42, P76, DOI 10.1161/01.HYP.0000078490.59735.6E; Grainger DJ, 1999, OSTEOPOROSIS INT, V9, P398, DOI 10.1007/s001980050163; Gu SS, 2012, BIOSCI BIOTECH BIOCH, V76, P1367, DOI 10.1271/bbb.120123; Hedbacker K, 2010, CELL METAB, V11, P11, DOI 10.1016/j.cmet.2009.11.007; Henriksen EJ, 2001, HYPERTENSION, V38, P884, DOI 10.1161/hy1101.092970; Hinds TD, 2011, J BIOL CHEM, V286, P42911, DOI 10.1074/jbc.M111.311662; Holdsworth DW, 2002, TRENDS BIOTECHNOL, V20, pS34, DOI 10.1016/S0167-7799(02)02004-8; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Huang S, 2010, BONE, V46, P1138, DOI 10.1016/j.bone.2009.12.020; Izu Y, 2009, J BIOL CHEM, V284, P4857, DOI 10.1074/jbc.M807610200; Katavetin Pisut, 2006, Journal of the Medical Association of Thailand, V89, P170; Kawai M, 2011, J BIOL CHEM, V286, P14670, DOI 10.1074/jbc.M110.193334; Lazarenko OP, 2006, BONE, V38, P74, DOI 10.1016/j.bone.2005.07.008; Lazarenko OP, 2007, ENDOCRINOLOGY, V148, P2669, DOI 10.1210/en.2006-1587; Lecka-Czernik B, 2002, ENDOCRINOLOGY, V143, P2376, DOI 10.1210/en.143.6.2376; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; Lecka-Czernik Beata, 2010, Curr Osteoporos Rep, V8, P178, DOI 10.1007/s11914-010-0027-y; Lewis G, 2008, J BIOMED MATER RES B, V87B, P286, DOI 10.1002/jbm.b.31092; Li YQ, 2009, CAN J PHYSIOL PHARM, V87, P51, DOI 10.1139/Y08-097; Liu LC, 2013, BONE, V52, P247, DOI 10.1016/j.bone.2012.09.038; Liu LC, 2012, CALCIFIED TISSUE INT, V91, P139, DOI 10.1007/s00223-012-9623-4; Lynn H, 2006, BONE, V38, P584, DOI 10.1016/j.bone.2005.09.011; Ma L, 2010, BONE, V47, P5, DOI 10.1016/j.bone.2010.03.016; Moerman EJ, 2004, AGING CELL, V3, P379, DOI 10.1111/j.1474-9728.2004.00127.x; Mori H, 2012, ADV THER, V29, P635, DOI 10.1007/s12325-012-0032-x; Nedergaard J, 2010, CELL METAB, V11, P268, DOI 10.1016/j.cmet.2010.03.007; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Olmsted-Davis E, 2007, AM J PATHOL, V170, P620, DOI 10.2353/ajpath.2007.060692; Qiang L, 2012, CELL, V150, P620, DOI 10.1016/j.cell.2012.06.027; Rahman S, 2013, ENDOCRINOLOGY, V154, P2687, DOI 10.1210/en.2012-2162; Rahman S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051746; Rzonca SO, 2004, ENDOCRINOLOGY, V145, P401, DOI 10.1210/en.2003-0746; Salisbury E, 2012, HUM PATHOL, V43, P2213, DOI 10.1016/j.humpath.2012.03.013; Schupp M, 2005, DIABETES, V54, P3442, DOI 10.2337/diabetes.54.12.3442; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Shimizu H, 2008, FASEB J, V22, P2465, DOI 10.1096/fj.07-098954; Shiota A, 2012, EUR J PHARMACOL, V692, P84, DOI 10.1016/j.ejphar.2012.07.026; Shockley KR, 2009, J CELL BIOCHEM, V106, P232, DOI 10.1002/jcb.21994; Storka A, 2008, EUR J CLIN INVEST, V38, P820, DOI 10.1111/j.1365-2362.2008.02025.x; Tagami T, 2009, ENDOCRINOLOGY, V150, P862, DOI 10.1210/en.2008-0502; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Usui I, 2007, DIABETES RES CLIN PR, V77, P210, DOI 10.1016/j.diabres.2006.11.014; Wan YH, 2007, NAT MED, V13, P1496, DOI 10.1038/nm1672; Wolff GL, 1999, PHYSIOL GENOMICS, V1, P151, DOI 10.1152/physiolgenomics.1999.1.3.151; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Younis F, 2010, METABOLISM, V59, P1200, DOI 10.1016/j.metabol.2009.11.013	56	35	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96323	10.1371/journal.pone.0096323	http://dx.doi.org/10.1371/journal.pone.0096323			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810249	gold, Green Submitted, Green Published			2022-12-27	WOS:000338213300030
J	Ooba, N; Sato, T; Wakana, A; Orii, T; Kitamura, M; Kokan, A; Kurata, H; Shimodozono, Y; Matsui, K; Yoshida, H; Yamaguchi, T; Kageyama, S; Kubota, K				Ooba, Nobuhiro; Sato, Tsugumichi; Wakana, Akira; Orii, Takao; Kitamura, Masaki; Kokan, Akira; Kurata, Hideaki; Shimodozono, Yoshihiro; Matsui, Kenichi; Yoshida, Hiroshi; Yamaguchi, Takuhiro; Kageyama, Shigeru; Kubota, Kiyoshi			A Prospective Stratified Case-Cohort Study on Statins and Multiple Adverse Events in Japan	PLOS ONE			English	Article							DISEASE; SAFETY; METAANALYSIS	Purpose: To assess the association between statins and diverse adverse events in Japanese population. Methods: New users of statin who started statin after 6-month period of non-use were identified in 68 hospitals between January 2008 and July 2010. In addition to the random sample subcohort, we selected additional subcohort members to make the stratified sample subcohort have at least one patient in all subgroups stratified by each combination of statin and hospital. By abstraction from medical records, detailed information was obtained for all potential cases and pre-selected subcohort members. The event review committee consisting of 3 specialists judged whether possible cases met the definition of one of the adverse events of interest, and for adjudicated cases the committee further judged whether statin was a certain, probable or possible cause of the occurrence of the event. Adjusted for covariates including age, gender, status of "switcher'', use of high daily dose and comorbidities at baseline, hazard ratio (HR) was estimated by the Cox proportional hazards model with Barlow's weighting method. Data were also analyzed by the method proposed by Breslow in 2009. Results: A total of 6,877 new users of a statin were identified (median age: 66 years; males: 52%). The hazard ratios of increase in serum creatinine for atorvastatin and fluvastatin have wide confidence intervals, but both of the point estimates were around 2.5. Estimates of hazard ratios by the method of Barlow (1999) were similar to those by the method of Breslow (2009). Conclusions: Use of statin was not associated with a significant increased risk for renal, liver and muscle events. However, the hazard ratio of increase in serum creatinine tended to be high with atorvastatin and fluvastatin to require further studies.	[Ooba, Nobuhiro; Kubota, Kiyoshi] Univ Tokyo, Grad Sch Med, Dept Pharmacoepidemiol, Tokyo, Japan; [Sato, Tsugumichi] Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Pharm, Chiba, Japan; [Sato, Tsugumichi] Drug Safety Res Unit Japan, Tokyo, Japan; [Wakana, Akira] MSD KK, Tokyo, Japan; [Orii, Takao] NTT Med Ctr Tokyo, Tokyo, Japan; [Kitamura, Masaki] Jikei Univ, Sch Med, Dept Pharm, Tokyo, Japan; [Kokan, Akira] EliLilly Japan KK, Kobe, Hyogo, Japan; [Kurata, Hideaki] Jikei Univ, Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol, Tokyo, Japan; [Shimodozono, Yoshihiro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Clin Pharm & Pharmacol, Kagoshima 890, Japan; [Matsui, Kenichi] Showa Univ, Off Promoting Med Res, Tokyo, Japan; [Yoshida, Hiroshi] Jikei Univ, Kashiwa Hosp, Dept Lab Med, Chiba, Japan; [Yamaguchi, Takuhiro] Tohoku Univ, Grad Sch Med, Dept Publ Hlth & Forens Med, Sendai, Miyagi 980, Japan; [Kageyama, Shigeru] Jikei Univ, Sch Med, Div Clin Pharmacol & Therapeut, Tokyo, Japan	University of Tokyo; Tokyo University of Science; Merck & Company; Kanto Medical Center NTT EC; Jikei University; Jikei University; Kagoshima University; Showa University; Jikei University; Tohoku University; Jikei University	Ooba, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Pharmacoepidemiol, Tokyo, Japan.	n-ooba@umin.net			Astellas Pharma Japan; AstraZeneca Japan; Daiichi-Sankyo Japan; Kowa Pharmaceutical; Shionogi	Astellas Pharma Japan(Astellas Pharmaceuticals); AstraZeneca Japan(AstraZeneca); Daiichi-Sankyo Japan(Daiichi Sankyo Company Limited); Kowa Pharmaceutical; Shionogi	This study was conducted by the unconditional research funding provided by Astellas Pharma Japan, AstraZeneca Japan, Daiichi-Sankyo Japan, Kowa Pharmaceutical and Shionogi. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberton M, 2012, QJM-INT J MED, V105, P145, DOI 10.1093/qjmed/hcr158; [Anonymous], 2011, YAKUJI HDB 2011; Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Breslow NE, 2009, AM J EPIDEMIOL, V169, P1398, DOI 10.1093/aje/kwp055; Chung YH, 2013, PHARMACOEPIDEM DR S, V22, P583, DOI 10.1002/pds.3433; Colhoun HM, 2009, AM J KIDNEY DIS, V54, P810, DOI 10.1053/j.ajkd.2009.03.022; DiPietro NA, 2010, PHARMACOTHERAPY, V30, P973, DOI 10.1592/phco.30.10.973; Dormuth CR, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f880; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; FDA, GUID IND DRUG IND LI; Hippisley-Cox Julia, 2010, BMJ, V340, pc2197, DOI 10.1136/bmj.c2197; Holdaas H, 2007, INT J CARDIOL, V117, P64, DOI 10.1016/j.ijcard.2006.06.003; Jacobson TA, 2006, AM J CARDIOL, V97, p44C, DOI 10.1016/j.amjcard.2005.12.009; Klepper MJ, 2010, DRUG SAFETY DATA ANA; Kubota K, 2011, EPIDEMIOLOGY, V22, P279, DOI 10.1097/EDE.0b013e3182087650; LANGHOLZ B, 1990, AM J EPIDEMIOL, V131, P169, DOI 10.1093/oxfordjournals.aje.a115471; Law M, 2006, AM J CARDIOL, V97, p52C, DOI 10.1016/j.amjcard.2005.12.010; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; McClure DL, 2007, PHARMACOEPIDEM DR S, V16, P132, DOI 10.1002/pds.1341; Ministry of Health Labour and Welfare (MHLW), HLTH STAT 2008; Ministry of Health Labour and Welfare (MHLW), NAT VIT STAT 2008; Ministry of Health Labour and Welfare (MHLW), ADV COMM APPL APPR D; Naci H, 2013, CIRC-CARDIOVASC QUAL, V6, P390, DOI 10.1161/CIRCOUTCOMES.111.000071; Pasternak RC, 2002, J AM COLL CARDIOL, V40, P567, DOI 10.1016/S0735-1097(02)02030-2; PRENTICE RL, 1986, BIOMETRIKA, V73, P1; Shannon JA, 2013, J PHARM TECHNOL, V29, P219, DOI DOI 10.1177/8755122513500915; Shepherd J, 2007, CLIN J AM SOC NEPHRO, V2, P1131, DOI 10.2215/CJN.04371206; Tanaka K, 2001, PHARMACOEPIDEM DR S, V10, P653, DOI 10.1002/pds.642; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Wolfe SM, 2004, LANCET, V363, P2189, DOI 10.1016/S0140-6736(04)16513-6; Yoshida S, 2007, PROG MED, V27, P1159	32	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96919	10.1371/journal.pone.0096919	http://dx.doi.org/10.1371/journal.pone.0096919			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810427	Green Published, gold, Green Submitted			2022-12-27	WOS:000338213300091
J	Tang, XY; Yoshida, S; Hsu, J; Huisman, TAGM; Faria, AV; Oishi, K; Kutten, K; Poretti, A; Li, Y; Miller, MI; Mori, S				Tang, Xiaoying; Yoshida, Shoko; Hsu, John; Huisman, Thierry A. G. M.; Faria, Andreia V.; Oishi, Kenichi; Kutten, Kwame; Poretti, Andrea; Li, Yue; Miller, Michael I.; Mori, Susumu			Multi-Contrast Multi-Atlas Parcellation of Diffusion Tensor Imaging of the Human Brain	PLOS ONE			English	Article							PROBABILISTIC ATLAS; WHITE-MATTER; SPATIAL NORMALIZATION; MR-IMAGES; ALZHEIMERS-DISEASE; LABEL FUSION; SEGMENTATION; REGISTRATION; MODEL; VALIDATION	In this paper, we propose a novel method for parcellating the human brain into 193 anatomical structures based on diffusion tensor images (DTIs). This was accomplished in the setting of multi-contrast diffeomorphic likelihood fusion using multiple DTI atlases. DTI images are modeled as high dimensional fields, with each voxel exhibiting a vector valued feature comprising of mean diffusivity (MD), fractional anisotropy (FA), and fiber angle. For each structure, the probability distribution of each element in the feature vector is modeled as a mixture of Gaussians, the parameters of which are estimated from the labeled atlases. The structure-specific feature vector is then used to parcellate the test image. For each atlas, a likelihood is iteratively computed based on the structure-specific vector feature. The likelihoods from multiple atlases are then fused. The updating and fusing of the likelihoods is achieved based on the expectation-maximization (EM) algorithm for maximum a posteriori (MAP) estimation problems. We first demonstrate the performance of the algorithm by examining the parcellation accuracy of 18 structures from 25 subjects with a varying degree of structural abnormality. Dice values ranging 0.8-0.9 were obtained. In addition, strong correlation was found between the volume size of the automated and the manual parcellation. Then, we present scan-rescan reproducibility based on another dataset of 16 DTI images - an average of 3.73%, 1.91%, and 1.79% for volume, mean FA, and mean MD respectively. Finally, the range of anatomical variability in the normal population was quantified for each structure.	[Tang, Xiaoying; Kutten, Kwame; Miller, Michael I.; Mori, Susumu] Johns Hopkins Univ, Ctr Imaging Sci, Baltimore, MD 21218 USA; [Tang, Xiaoying] Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA; [Yoshida, Shoko; Hsu, John; Huisman, Thierry A. G. M.; Faria, Andreia V.; Oishi, Kenichi; Poretti, Andrea; Li, Yue; Mori, Susumu] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA; [Li, Yue; Miller, Michael I.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Mori, Susumu] Kennedy Krieger Inst, FM Kirby Res Ctr Funct Brain Imaging, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Kennedy Krieger Institute	Mori, S (corresponding author), Johns Hopkins Univ, Ctr Imaging Sci, Baltimore, MD 21218 USA.	susumu@mri.jhu.edu	Huisman, Thierry/GYD-4734-2022; Poretti, Andrea/H-6269-2019; Oishi, Kenichi/H-1371-2013	Poretti, Andrea/0000-0002-9594-3858; Oishi, Kenichi/0000-0002-1200-8611	National Institutes of Health (NIH) [P41EB015909, RO1 AG020012, R01 EB000975, P41 EB015909, R01 MH084803, S10 RR025053]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015909, R01EB017638, R01EB000975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020012] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by National Institutes of Health (NIH) P41EB015909, RO1 AG020012, R01 EB000975, P41 EB015909, R01 MH084803, and S10 RR025053. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DC, 2000, COMPUT VIS IMAGE UND, V77, P233, DOI 10.1006/cviu.1999.0817; Alexander DC, 2001, IEEE T MED IMAGING, V20, P1131, DOI 10.1109/42.963816; Aljabar P, 2009, NEUROIMAGE, V46, P726, DOI 10.1016/j.neuroimage.2009.02.018; Artaechevarria X, 2009, IEEE T MED IMAGING, V28, P1266, DOI 10.1109/TMI.2009.2014372; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Asman AJ, 2013, MED IMAGE ANAL, V17, P194, DOI 10.1016/j.media.2012.10.002; Asman AJ, 2012, IEEE T MED IMAGING, V31, P1326, DOI 10.1109/TMI.2012.2190992; Asman AJ, 2011, IEEE T MED IMAGING, V30, P1779, DOI 10.1109/TMI.2011.2147795; Awate SP, 2007, LECT NOTES COMPUT SC, V4584, P296; Baillard C, 2001, MED IMAGE ANAL, V5, P185, DOI 10.1016/S1361-8415(01)00039-1; Cao Y, 2005, IEEE T MED IMAGING, V24, P1216, DOI 10.1109/TMI.2005.853923; Cardoso MJ, 2011, MICCAI WORKSH MULT L, V25, P25; Carmichael OT, 2005, NEUROIMAGE, V27, P979, DOI 10.1016/j.neuroimage.2005.05.005; Ceritoglu C, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00151; Ceritoglu C, 2009, NEUROIMAGE, V47, P618, DOI 10.1016/j.neuroimage.2009.04.057; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Collins DL, 1995, HUM BRAIN MAPP, V3, P190, DOI 10.1002/hbm.460030304; Collins DL, 1997, INT J PATTERN RECOGN, V11, P1271, DOI 10.1142/S0218001497000597; COOTES TF, 1994, IMAGE VISION COMPUT, V12, P355, DOI 10.1016/0262-8856(94)90060-4; Coupe P, 2011, NEUROIMAGE, V54, P940, DOI 10.1016/j.neuroimage.2010.09.018; Crum WR, 2001, NEUROIMAGE, V13, P847, DOI 10.1006/nimg.2001.0744; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Duta N, 1998, IEEE T MED IMAGING, V17, P1049, DOI 10.1109/42.746716; Faria AV, 2011, NEUROIMAGE, V54, P1854, DOI 10.1016/j.neuroimage.2010.09.061; Faria AV, 2010, NEUROIMAGE, V52, P415, DOI 10.1016/j.neuroimage.2010.04.238; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fox P. T., 1994, ADV FUNCTIONAL NEURO, P95; Haller JW, 1997, RADIOLOGY, V202, P504, DOI 10.1148/radiology.202.2.9015081; Hammers A, 2003, HUM BRAIN MAPP, V19, P224, DOI 10.1002/hbm.10123; Heckemann RA, 2006, NEUROIMAGE, V33, P115, DOI 10.1016/j.neuroimage.2006.05.061; Held K, 1997, IEEE T MED IMAGING, V16, P878, DOI 10.1109/42.650883; Hogan RE, 2000, RADIOLOGY, V216, P291, DOI 10.1148/radiology.216.1.r00jl41291; Isgum I, 2009, IEEE T MED IMAGING, V28, P1000, DOI 10.1109/TMI.2008.2011480; Jones DK, 2002, NEUROIMAGE, V17, P592, DOI 10.1006/nimg.2002.1148; Kittler J, 2003, IEEE T PATTERN ANAL, V25, P110, DOI 10.1109/TPAMI.2003.1159950; Kittler J, 1998, IEEE T PATTERN ANAL, V20, P226, DOI 10.1109/34.667881; Landman BA, 2011, NEUROIMAGE, V54, P2854, DOI 10.1016/j.neuroimage.2010.11.047; Langerak TR, 2010, IEEE T MED IMAGING, V29, P2000, DOI 10.1109/TMI.2010.2057442; Lotjonen JMP, 2010, NEUROIMAGE, V49, P2352, DOI 10.1016/j.neuroimage.2009.10.026; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; MILLER MI, 1993, P NATL ACAD SCI USA, V90, P11944, DOI 10.1073/pnas.90.24.11944; Miller MI, 2002, ANNU REV BIOMED ENG, V4, P375, DOI 10.1146/annurev.bioeng.4.092101.125733; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Muller HP, 2007, PHYS MED BIOL, V52, pN99, DOI 10.1088/0031-9155/52/6/N01; Oishi K, 2009, NEUROIMAGE, V46, P486, DOI 10.1016/j.neuroimage.2009.01.002; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; Park H, 2003, IEEE T MED IMAGING, V22, P483, DOI 10.1109/TMI.2003.809139; Park HJ, 2003, NEUROIMAGE, V20, P1995, DOI 10.1016/j.neuroimage.2003.08.008; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Pham DL, 1999, IEEE T MED IMAGING, V18, P737, DOI 10.1109/42.802752; Pohl KA, 2006, NEUROIMAGE, V31, P228, DOI 10.1016/j.neuroimage.2005.11.044; Rohlfing T, 2004, NEUROIMAGE, V21, P1428, DOI 10.1016/j.neuroimage.2003.11.010; Ruiz-Alzola J, 2002, MED IMAGE ANAL, V6, P143, DOI 10.1016/S1361-8415(02)00055-5; Sabuncu MR, 2010, IEEE T MED IMAGING, V29, P1714, DOI 10.1109/TMI.2010.2050897; Shattuck DW, 2008, NEUROIMAGE, V39, P1064, DOI 10.1016/j.neuroimage.2007.09.031; Shen DG, 2001, IEEE T MED IMAGING, V20, P257, DOI 10.1109/42.921475; Tang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065591; Tang Xu, 2012, Microcomputer Information, P123; Thompson PM, 1997, J COMPUT ASSIST TOMO, V21, P567, DOI 10.1097/00004728-199707000-00008; Tu Z, 2008, IEEE T MED IMAGING, V27, P495, DOI 10.1109/TMI.2007.908121; Van Leemput K, 2006, LECT NOTES COMPUT SC, V4190, P704; van Rikxoort EM, 2010, MED IMAGE ANAL, V14, P39, DOI 10.1016/j.media.2009.10.001; Vemuri BC, 2003, MED IMAGE ANAL, V7, P1, DOI 10.1016/S1361-8415(02)00063-4; Wakana S, 2005, MAGN RESON MED, V53, P649, DOI 10.1002/mrm.20386; Wang HZ, 2013, IEEE T PATTERN ANAL, V35, P611, DOI 10.1109/TPAMI.2012.143; Warfield S, 1999, BRAIN WARPING, V4, P67; Warfield SK, 2004, IEEE T MED IMAGING, V23, P903, DOI 10.1109/TMI.2004.828354; Weisenfeld NI, 2011, LECT NOTES COMPUT SC, V6893, P322, DOI 10.1007/978-3-642-23626-6_40; Wells WM, 1996, IEEE T MED IMAGING, V15, P429, DOI 10.1109/42.511747; Williams E.J., 1959, REGRESSION ANAL; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; Xu DR, 2003, MAGN RESON MED, V50, P175, DOI 10.1002/mrm.10489; Xue Z, 2006, NEUROIMAGE, V33, P855, DOI 10.1016/j.neuroimage.2006.08.007; Yang J, 2004, MED IMAGE ANAL, V8, P285, DOI 10.1016/j.media.2004.06.008; Yushkevich PA, 2008, NEUROIMAGE, V41, P448, DOI 10.1016/j.neuroimage.2008.01.013; Zhang H, 2006, MED IMAGE ANAL, V10, P764, DOI 10.1016/j.media.2006.06.004; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	78	45	46	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96985	10.1371/journal.pone.0096985	http://dx.doi.org/10.1371/journal.pone.0096985			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809486	Green Published, gold, Green Submitted			2022-12-27	WOS:000338213300103
J	Zielinski, T; Moore, AM; Troup, E; Halliday, KJ; Millar, AJ				Zielinski, Tomasz; Moore, Anne M.; Troup, Eilidh; Halliday, Karen J.; Millar, Andrew J.			Strengths and Limitations of Period Estimation Methods for Circadian Data	PLOS ONE			English	Article							ENTROPY SPECTRAL-ANALYSIS; BIOLOGICAL TIME-SERIES; RHYTHMS; CLOCK; MODEL; EXPRESSION; GENETICS; SEARCH; HES1	A key step in the analysis of circadian data is to make an accurate estimate of the underlying period. There are many different techniques and algorithms for determining period, all with different assumptions and with differing levels of complexity. Choosing which algorithm, which implementation and which measures of accuracy to use can offer many pitfalls, especially for the non-expert. We have developed the BioDare system, an online service allowing data-sharing (including public dissemination), data-processing and analysis. Circadian experiments are the main focus of BioDare hence performing period analysis is a major feature of the system. Six methods have been incorporated into BioDare: Enright and Lomb-Scargle periodograms, FFT-NLLS, mFourfit, MESA and Spectrum Resampling. Here we review those six techniques, explain the principles behind each algorithm and evaluate their performance. In order to quantify the methods' accuracy, we examine the algorithms against artificial mathematical test signals and model-generated mRNA data. Our reimplementation of each method in Java allows meaningful comparisons of the computational complexity and computing time associated with each algorithm. Finally, we provide guidelines on which algorithms are most appropriate for which data types, and recommendations on experimental design to extract optimal data for analysis.	[Zielinski, Tomasz; Moore, Anne M.; Halliday, Karen J.; Millar, Andrew J.] Univ Edinburgh, SynthSys, Edinburgh, Midlothian, Scotland; [Troup, Eilidh] Univ Edinburgh, EPCC, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Millar, AJ (corresponding author), Univ Edinburgh, SynthSys, Edinburgh, Midlothian, Scotland.	andrew.millar@ed.ac.uk	Millar, Andrew J/G-2423-2012	Millar, Andrew J/0000-0003-1756-3654; Zielinski, Tomasz/0000-0002-0194-5706; Halliday, Karen/0000-0003-0467-104X	BBSRC; EPSRC [BB/F005237, BB/D019621]; BBSRC [BB/J009423]; EU [245143]; Biotechnology and Biological Sciences Research Council [BB/F005296/1, BB/F005237/1, BB/D019621/1, BB/F005296/2] Funding Source: researchfish; BBSRC [BB/F005296/1, BB/F005296/2, BB/F005237/1, BB/D019621/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EU(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the BBSRC and EPSRC systems biology projects ROBuST (award BB/F005237) and SynthSys (award BB/D019621), BBSRC award BB/J009423 and by the EU FP7 Integrated Project TiMet (award 245143). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN N, 1974, GEOPHYSICS, V39, P69, DOI 10.1190/1.1440413; BARRODALE I, 1980, GEOPHYSICS, V45, P420, DOI 10.1190/1.1441091; Bloomfield P., 2000, FOURIER ANAL TIME SE, P261; Bretthorst G.L., 1988, LECT NOTES STAT, V48; BURG JP, 1972, GEOPHYSICS, V37, P375, DOI 10.1190/1.1440265; Cohen AL, 2012, J THEOR BIOL, V314, P182, DOI 10.1016/j.jtbi.2012.08.038; Costa MJ, 2013, BIOSTATISTICS, P1; Darnell MZ, 2010, MAR BIOL, V157, P2415, DOI 10.1007/s00227-010-1506-5; Dong GG, 2008, CURR OPIN MICROBIOL, V11, P541, DOI 10.1016/j.mib.2008.10.003; Dowse Harold B, 2013, J Circadian Rhythms, V11, P6, DOI 10.1186/1740-3391-11-6; DOWSE HB, 1989, J THEOR BIOL, V139, P487, DOI 10.1016/S0022-5193(89)80067-0; Edwards KD, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.81; ENRIGHT JT, 1965, J THEOR BIOL, V8, P426, DOI 10.1016/0022-5193(65)90021-4; Glynn EF, 2006, BIOINFORMATICS, V22, P310, DOI 10.1093/bioinformatics/bti789; GOLDBETER A, 1991, P NATL ACAD SCI USA, V88, P9107, DOI 10.1073/pnas.88.20.9107; Gould PD, 2006, PLANT CELL, V18, P1177, DOI 10.1105/tpc.105.039990; Halberg F., 1967, CELLULAR ASPECTS BIO, P20, DOI DOI 10.1007/978-3-642-88394-1; Heron EA, 2007, BIOINFORMATICS, V23, P2596, DOI 10.1093/bioinformatics/btm367; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Johnson M, 2010, ESSENTIAL NUMERICAL; JOHNSON ML, 1985, METHOD ENZYMOL, V117, P301; Leise TL, 2011, J BIOL RHYTHM, V26, P454, DOI 10.1177/0748730411416330; Lichtenberg U, 2005, BIOINFORMATICS, V21, P1191; Locke JCW, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100018; LOMB NR, 1976, ASTROPHYS SPACE SCI, V39, P447, DOI 10.1007/BF00648343; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Mackey SR, 2007, TRENDS MICROBIOL, V15, P381, DOI 10.1016/j.tim.2007.08.005; Maier B, 2009, GENE DEV, V23, P708, DOI 10.1101/gad.512209; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; Monk NAM, 2003, CURR BIOL, V13, P1409, DOI 10.1016/S0960-9822(03)00494-9; Moore A, 2014, METHODS MOL IN PRESS; Price TS, 2008, BIOINFORMATICS, V24, P2794, DOI 10.1093/bioinformatics/btn521; REFINETTI R, 1993, PHYSIOL BEHAV, V54, P869, DOI 10.1016/0031-9384(93)90294-P; Refinetti R, 2004, J THEOR BIOL, V227, P571, DOI 10.1016/j.jtbi.2003.11.032; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Southern MM, 2005, METHOD ENZYMOL, V393, P23, DOI 10.1016/S0076-6879(05)93002-4; STRAUME M, 1991, TOPICS FLUORESCENCE, V2, P117; Trancart T, 2012, ESTUAR COAST SHELF S, V99, P191, DOI 10.1016/j.ecss.2011.12.032; Ukai H, 2010, ANNU REV PHYSIOL, V72, P579, DOI 10.1146/annurev-physiol-073109-130051; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031	41	139	140	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96462	10.1371/journal.pone.0096462	http://dx.doi.org/10.1371/journal.pone.0096462			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809473	Green Published, gold, Green Submitted			2022-12-27	WOS:000338213300043
J	Hynds, PD; Thomas, MK; Pintar, KDM				Hynds, Paul Dylan; Thomas, M. Kate; Pintar, Katarina Dorothy Milena			Contamination of Groundwater Systems in the US and Canada by Enteric Pathogens, 1990-2013: A Review and Pooled-Analysis	PLOS ONE			English	Review							ESCHERICHIA-COLI O157-H7; DRINKING-WATER; RISK-FACTORS; SUNLIGHT INACTIVATION; CAMPYLOBACTER-JEJUNI; INDICATOR ORGANISMS; OUTBREAKS; QUALITY; CRYPTOSPORIDIUM; MANAGEMENT	Background: Up to 150 million North Americans currently use a groundwater system as their principal drinking water source. These systems are a potential source of exposure to enteric pathogens, contributing to the burden of waterborne disease. Waterborne disease outbreaks have been associated with US and Canadian groundwater systems over the past two decades. However, to date, this literature has not been reviewed in a comprehensive manner. Methods and Principal Findings: A combined review and pooled-analysis approach was used to investigate groundwater contamination in Canada and the US from 1990 to 2013; fifty-five studies met eligibility criteria. Four study types were identified. It was found that study location affects study design, sample rate and studied pathogen category. Approximately 15% (316/2210) of samples from Canadian and US groundwater sources were positive for enteric pathogens, with no difference observed based on system type. Knowledge gaps exist, particularly in exposure assessment for attributing disease to groundwater supplies. Furthermore, there is a lack of consistency in risk factor reporting (local hydrogeology, well type, well use, etc). The widespread use of fecal indicator organisms in reported studies does not inform the assessment of human health risks associated with groundwater supplies. Conclusions: This review illustrates how groundwater study design and location are critical for subsequent data interpretation and use. Knowledge gaps exist related to data on bacterial, viral and protozoan pathogen prevalence in Canadian and US groundwater systems, as well as a need for standardized approaches for reporting study design and results. Fecal indicators are examined as a surrogate for health risk assessments; caution is advised in their widespread use. Study findings may be useful during suspected waterborne outbreaks linked with a groundwater supply to identify the likely etiological agent and potential transport pathway.	[Hynds, Paul Dylan; Thomas, M. Kate; Pintar, Katarina Dorothy Milena] Publ Hlth Agcy Canada, Ctr Food Borne Environm & Zoonot Infect Dis, Ottawa, ON, Canada	Public Health Agency of Canada	Pintar, KDM (corresponding author), Publ Hlth Agcy Canada, Ctr Food Borne Environm & Zoonot Infect Dis, Ottawa, ON, Canada.	Katarina.pintar@phac-aspc.gc.ca			Public Health Agency of Canada, a Canadian government department	Public Health Agency of Canada, a Canadian government department	Funding was provided by core funding within the Public Health Agency of Canada, a Canadian government department. As such, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2010, ANAL ORDINAL CATEGOR, DOI [DOI 10.1002/9780470594001, 10.1002/9780470594001]; Anderson ML, 2005, APPL ENVIRON MICROB, V71, P3041, DOI 10.1128/AEM.71.6.3041-3048.2005; Aramini J, 2000, DRINKING WATER QUALI, P79; Balbus JM, 2002, CURR OPIN GASTROEN, V18, P46, DOI 10.1097/00001574-200201000-00008; Baum R, 2013, ENVIRON SCI TECHNOL, V47, P1994, DOI 10.1021/es304284f; Borchardt MA, 2012, ENV HLTH PERSPECT, V120; Carrique-Mas J, 2005, SCAND J INFECT DIS, V37, P101, DOI 10.1080/00365540510027165; Charrois JWA, 2010, CANADIAN MED ASS J, V182; Close M, 2008, J WATER HEALTH, V6, P83, DOI 10.2166/wh.2007.020; Conboy MJ, 2001, WATER AIR SOIL POLL, V129, P101, DOI 10.1023/A:1010393927600; Corkal D, 2004, J TOXICOL ENV HEAL A, V67, P1619, DOI 10.1080/15287390490491918; Craun GF, 2005, INT J ENVIRON HEAL R, V15, P243, DOI 10.1080/09603120500155716; Craun GF, 2010, CLIN MICROBIOL REV, V23, P507, DOI 10.1128/CMR.00077-09; Craun MF, 2006, J WATER HLTH S2, V04; Environment Canada, 2013, HYDR CAN; Ferguson AS, 2012, SCI TOTAL ENVIRON, V431, P314, DOI 10.1016/j.scitotenv.2012.05.060; Fong TT, 2007, ENVIRON HEALTH PERSP, V115, P856, DOI 10.1289/ehp.9430; Gagliardi JV, 2000, APPL ENVIRON MICROB, V66, P877, DOI 10.1128/AEM.66.3.877-883.2000; Gardner KK, 2005, GROUND WATER, V43, P343, DOI 10.1111/j.1745-6584.2005.0031.x; GAUT S, 2005, THESIS NORWEGIAN U S; Gerba CP, 2005, J ENVIRON QUAL, V34, P42; Gerba CP, 1996, INT J FOOD MICROBIOL, V30, P113, DOI 10.1016/0168-1605(96)00996-8; Graham JP, 2013, ENVIRON HEALTH PERSP, V121, P521, DOI 10.1289/ehp.1206028; Gray N.F., 2004, BIOL WASTEWATER TREA, V2nd; Hancock CM, 1998, J AM WATER WORKS ASS, V90, P58; Hanninen ML, 2003, APPL ENVIRON MICROB, V69, P1391, DOI 10.1128/AEM.69.3.1391-1396.2003; Hexemer AM, 2008, J WATER HLTH, V6; Hibler C. P., 1988, Advances in Giardia research., P237; Howard G, 2003, WATER RES, V37, P3421, DOI 10.1016/S0043-1354(03)00235-5; Hrudey S.E., 2011, CD HOWE I COMMENT; Huck PM, 2004, J TOXICOL ENV HEAL A, V67, P1581, DOI 10.1080/15287390490491891; Hynds PD, 2012, WATER RESOUR RES, V48, DOI 10.1029/2012WR012492; Jones AQ, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-94; Kabore H, 2010, ZOONOSES PUBLIC HLTH, V57, pE195, DOI 10.1111/j.1863-2378.2010.01328.x; Kistemann T, 2002, APPL ENVIRON MICROB, V68, P2188, DOI 10.1128/AEM.68.5.2188-2197.2002; Konikow L.F., 2013, US GEOLOGICAL SURVEY, V53, P63, DOI [10.1111/gwat.12306, DOI 10.1111/GWAT.12306]; Kreutzwiser R, 2011, J ENVIRON MANAGE, V92, P1104, DOI 10.1016/j.jenvman.2010.11.017; Lapworth DJ, 2012, ENVIRON POLLUT, V163, P287, DOI 10.1016/j.envpol.2011.12.034; Leclerc H, 2001, ANNU REV MICROBIOL, V55, P201, DOI 10.1146/annurev.micro.55.1.201; LIEBERMAN RJ, 2002, 90914 AM WAT WORKS A; Locas A, 2008, CAN J MICROBIOL, V54, P472, DOI [10.1139/W08-028, 10.1139/w08-028]; Macler BA, 2000, HYDROGEOL J, V8, P29, DOI 10.1007/PL00010972; MAWDSLEY JL, 1995, APPL SOIL ECOL, V2, P1, DOI 10.1016/0929-1393(94)00039-A; Michaud S, 2004, EMERG INFECT DIS, V10, P1844, DOI 10.3201/eid1010.040228; Morris B., 2003, PRIVATE WATER SUPPLI; Morris BL, 2000, WATER SCI TECHNOL, V41, P67, DOI 10.2166/wst.2000.0117; Ramirez E, 2010, AIR SOIL WATER RES, V3, P105, DOI 10.4137/ASWR.S4823; Reynolds KA, 2008, REV ENVIRON CONTAM T, V192, P117, DOI 10.1007/978-0-387-71724-1_4; Robertson W., 2001, 2001 EARTH OD P 54 C, P45; ROSE JB, 1991, ENVIRON SCI TECHNOL, V25, P1393, DOI 10.1021/es00020a005; Rose JB, 2002, FEMS MICROBIOL REV, V26, P113, DOI 10.1111/j.1574-6976.2002.tb00604.x; Sargeant JM, 2006, PREV VET MED, V75, P141, DOI 10.1016/j.prevetmed.2006.03.002; Schets FM, 2005, WATER RES, V39, P4485, DOI 10.1016/j.watres.2005.08.025; Schuster CJ, 2005, CAN J PUBLIC HEALTH, V96, P254, DOI 10.1007/BF03405157; Sharpe D, 2007, HYDROGEOLOGICAL REGI; Sinton L, 2007, J WATER HEALTH, V5, P357, DOI 10.2166/wh.2007.031; Sinton LW, 2002, APPL ENVIRON MICROB, V68, P1122, DOI 10.1128/AEM.68.3.1122-1131.2002; SMITH HV, 2003, HDB WATER WASTEWATER, P619; Spruill TB, 2002, J ENVIRON QUAL, V31, P1538, DOI 10.2134/jeq2002.1538; Statistics Canada, 2013, CENS CAN; Uhlmann S, 2009, J WATER HEALTH, V7, P692, DOI 10.2166/wh.2009.108; Wallender EK, 2014, GROUNDWATER, V52, P886, DOI 10.1111/gwat.12121	62	70	70	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e93301	10.1371/journal.pone.0093301	http://dx.doi.org/10.1371/journal.pone.0093301			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806545	Green Published, Green Submitted, gold			2022-12-27	WOS:000335728900004
J	Akhmadishina, LV; Eremeeva, TP; Trotsenko, OE; Ivanova, OE; Mikhailov, MI; Lukashev, AN				Akhmadishina, Ludmila V.; Eremeeva, Tatiana P.; Trotsenko, Olga E.; Ivanova, Olga E.; Mikhailov, Mikhail I.; Lukashev, Alexander N.			Seroepidemiology and Molecular Epidemiology of Enterovirus 71 in Russia	PLOS ONE			English	Article							MOUTH-DISEASE; CHILDREN; TAIWAN; FOOT; HAND; SEROPREVALENCE; INFECTION; SEQUENCES; SINGAPORE; EVOLUTION	Enterovirus 71 (EV71) is an emerging human pathogen causing massive epidemics of hand, foot and mouth disease with severe neurological complications in Asia. EV71 also circulates in Europe, however it does not cause large outbreaks. The reason for distinct epidemiological patterns of EV71 infection in Europe and Asia and the risk of EV71 epidemic in Europe and Russia remain unknown. Seroepidemiology of EV71 and molecular epidemiology of occasional EV71 isolates were studied to explore circulation of EV71 in Russia. In six regions of Russian Federation, seroprevalence of EV71 in sera collected in 2008 ranged from 5% to 20% in children aged 1-2 years and from 19% to 83% in children aged 3-5 years. The seroprevalence among elder children was significantly higher (41-83% vs. 19-27%) in Asian regions of Russia. EV71 strains identified in Russia in 2001-2011 belonged to subtypes C1 and C2, while genotype C4 that was causing epidemics in Asia since 1998 emerged in 2009 and became dominant in 2013.	[Akhmadishina, Ludmila V.; Eremeeva, Tatiana P.; Ivanova, Olga E.; Mikhailov, Mikhail I.; Lukashev, Alexander N.] Chumakov Inst Poliomyelitis & Viral Encephalitide, Moscow, Russia; [Trotsenko, Olga E.] Khabarovsk Inst Epidemiol & Microbiol, Khabarovsk, Russia	Chumakov Federal Scientific Center for Research & Development of Immune & Biological Products of Russian Academy of Sciences	Lukashev, AN (corresponding author), Chumakov Inst Poliomyelitis & Viral Encephalitide, Moscow, Russia.	alexander_lukashev@hotmail.com	Mikhailov, Mikhail/E-3531-2014; Ivanova, Olga E/D-9734-2014; Mikhailov, Mikhail Ivanovich/AAD-6917-2022; Eremeeva, Tatiana/D-9735-2014; Trotsenko, Olga/AAG-6456-2020; Lukashev, Alexander/G-2777-2013	Ivanova, Olga E/0000-0003-1784-4827; Mikhailov, Mikhail Ivanovich/0000-0002-6636-6801; Lukashev, Alexander/0000-0001-7365-0352	Chumakov Institute of Poliomyelitis and Viral Encephalitides	Chumakov Institute of Poliomyelitis and Viral Encephalitides	The study was supported by the core (intramural) funding of Chumakov Institute of Poliomyelitis and Viral Encephalitides. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; [Anonymous], 2002, RES ALL RUSS CENS PO; Bible JM, 2008, J CLIN MICROBIOL, V46, P3192, DOI 10.1128/JCM.00628-08; Bible JM, 2007, REV MED VIROL, V17, P371, DOI 10.1002/rmv.538; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Chang LY, 2008, PEDIATRICS, V122, P1271, DOI 10.1542/peds.2007-3735; Chang LY, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e88; Diedrich S, 2009, ARCH VIROL, V154, P1139, DOI 10.1007/s00705-009-0413-x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Huang WC, 2012, J MICROBIOL IMMUNOL, V45, P96, DOI 10.1016/j.jmii.2011.09.025; Lu CY, 2002, J MED VIROL, V67, P217, DOI 10.1002/jmv.2210; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Ooi EE, 2002, EMERG INFECT DIS, V8, P995, DOI 10.3201/eid0809.010397; Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Rabenau HF, 2010, MED MICROBIOL IMMUN, V199, P45, DOI 10.1007/s00430-009-0133-6; Schuffenecker I, 2011, J CLIN VIROL, V50, P50, DOI 10.1016/j.jcv.2010.09.019; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Tran Chau Bich Nguyen, 2011, PLoS One, V6, pe21116, DOI 10.1371/journal.pone.0021116; van der Sanden S, 2009, J CLIN MICROBIOL, V47, P2826, DOI 10.1128/JCM.00507-09; Witso E, 2007, VIRUS RES, V123, P19, DOI 10.1016/j.virusres.2006.07.015; World Health Organization (WHO), 1997, MAN VIR INV POL; Yang KD, 2001, J INFECT DIS, V183, P850, DOI 10.1086/319255; Zhu Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-300	25	22	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97404	10.1371/journal.pone.0097404	http://dx.doi.org/10.1371/journal.pone.0097404			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819617	Green Published, Green Submitted, gold			2022-12-27	WOS:000336653300109
J	Arroniz-Crespo, M; Perez-Ortega, S; De los Rios, A; Green, TGA; Ochoa-Hueso, R; Casermeiro, MA; de la Cruz, MT; Pintado, A; Palacios, D; Rozzi, R; Tysklind, N; Sancho, LG				Arroniz-Crespo, Maria; Perez-Ortega, Sergio; De los Rios, Asuncion; Green, T. G. Allan; Ochoa-Hueso, Raul; Angel Casermeiro, Miguel; Teresa de la Cruz, Maria; Pintado, Ana; Palacios, David; Rozzi, Ricardo; Tysklind, Niklas; Sancho, Leopoldo G.			Bryophyte-Cyanobacteria Associations during Primary Succession in Recently Deglaciated Areas of Tierra del Fuego (Chile)	PLOS ONE			English	Article							NITROGEN-FIXATION; ACETYLENE-REDUCTION; FEATHER-MOSS; BOREAL FOREST; GLACIER BAY; CARBON; CHRONOSEQUENCE; VEGETATION; DIVERSITY; BACTERIAL	Bryophyte establishment represents a positive feedback process that enhances soil development in newly exposed terrain. Further, biological nitrogen (N) fixation by cyanobacteria in association with mosses can be an important supply of N to terrestrial ecosystems, however the role of these associations during post-glacial primary succession is not yet fully understood. Here, we analyzed chronosequences in front of two receding glaciers with contrasting climatic conditions (wetter vs drier) at Cordillera Darwin (Tierra del Fuego) and found that most mosses had the capacity to support an epiphytic flora of cyanobacteria and exhibited high rates of N2 fixation. Pioneer moss-cyanobacteria associations showed the highest N-2 fixation rates (4.60 and 4.96 mu g N g(-1) bryo. d(-1)) very early after glacier retreat (4 and 7 years) which may help accelerate soil development under wetter conditions. In drier climate, N-2 fixation on bryophyte-cyanobacteria associations was also high (0.94 and 1.42 mu g N g(-1) bryo. d(-1)) but peaked at intermediate-aged sites (26 and 66 years). N-2 fixation capacity on bryophytes was primarily driven by epiphytic cyanobacteria abundance rather than community composition. Most liverworts showed low colonization and N-2 fixation rates, and mosses did not exhibit consistent differences across life forms and habitat (saxicolous vs terricolous). We also found a clear relationship between cyanobacteria genera and the stages of ecological succession, but no relationship was found with host species identity. Glacier forelands in Tierra del Fuego show fast rates of soil transformation which imply large quantities of N inputs. Our results highlight the potential contribution of bryophyte-cyanobacteria associations to N accumulation during post-glacial primary succession and further describe the factors that drive N-2-fixation rates in post-glacial areas with very low N deposition.	[Arroniz-Crespo, Maria; Green, T. G. Allan; Pintado, Ana; Sancho, Leopoldo G.] Univ Complutense Madrid, Dept Biol Vegetal 2, Madrid, Spain; [Arroniz-Crespo, Maria] Bangor Univ, Sch Environm Nat Resources & Geog, Bangor, Gwynedd, Wales; [Perez-Ortega, Sergio; De los Rios, Asuncion] CSIC, MNCN, Dept Biol Ambiental, Madrid, Spain; [Green, T. G. Allan] Univ Waikato, Hamilton, New Zealand; [Ochoa-Hueso, Raul] Museo Nacl Ciencias Nat, Dept Biogeog & Cambio Global, Madrid, Spain; [Angel Casermeiro, Miguel; Teresa de la Cruz, Maria] Univ Complutense Madrid, Dept Edafol, Madrid, Spain; [Palacios, David] Univ Complutense Madrid, Dept Geog Fis, Madrid, Spain; [Rozzi, Ricardo] Univ N Texas, Sub Antarctic Biocultural Conservat Program, Denton, TX 76203 USA; [Rozzi, Ricardo] Univ Magallanes, Inst Ecol & Biodivers, Puerto Williams, Chile; [Tysklind, Niklas] Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales	Complutense University of Madrid; Bangor University; Consejo Superior de Investigaciones Cientificas (CSIC); University of Waikato; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Complutense University of Madrid; Complutense University of Madrid; University of North Texas System; University of North Texas Denton; Universidad de Magallanes; Bangor University	Arroniz-Crespo, M (corresponding author), Univ Complutense Madrid, Dept Biol Vegetal 2, Madrid, Spain.	maria.arroniz@gmail.com	PALACIOS, DAVID/H-3737-2015; Tysklind, Niklas/A-5275-2017; Pintado, Ana/G-9881-2015; SANCHO, LEOPOLDO G/G-9120-2015; Casermeiro, Miguel Angel/G-7202-2017; Hueso, Raúl Ochoa/K-1113-2016; Rozzi, Ricardo/G-1047-2012; Casermeiro, Miguel Angel/W-6105-2019; Arróniz-Crespo, María/O-1198-2018; Pérez-Ortega, Sergio/G-1257-2016; de los Rios, Asuncion/L-3694-2014	PALACIOS, DAVID/0000-0002-8289-0398; Tysklind, Niklas/0000-0002-6617-7875; SANCHO, LEOPOLDO G/0000-0002-4751-7475; Casermeiro, Miguel Angel/0000-0002-1415-9528; Hueso, Raúl Ochoa/0000-0002-1839-6926; Rozzi, Ricardo/0000-0001-5265-8726; Casermeiro, Miguel Angel/0000-0002-1415-9528; Arróniz-Crespo, María/0000-0003-0246-7432; Pérez-Ortega, Sergio/0000-0002-5411-3698; de los Rios, Asuncion/0000-0002-0266-3516; PINTADO, ANA/0000-0003-3007-1486; Cruz, Maria Teresa/0000-0002-8270-8760	Ministerio de Ciencia e Innovacion of Spain [CTM2009-12838-C04-01, CTM2009-12838-C04-03]; Spanish Ministry of Economy and Competitiveness [CTM2012-38222-C02-02]; Institute of Ecology and Biodiversity (IEB-Chile) [P05-002 ICM, CONICYT PFB-23]	Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Economy and Competitiveness(Spanish Government); Institute of Ecology and Biodiversity (IEB-Chile)	This work was funded by the Ministerio de Ciencia e Innovacion of Spain (Projects CTM2009-12838-C04-01 and CTM2009-12838-C04-03). SPO is supported by the grant CTM2012-38222-C02-02 from the Spanish Ministry of Economy and Competitiveness. The authors are grateful to the Universidad de Magallanes (UMAG) and the Institute of Ecology and Biodiversity (IEB-Chile, grants P05-002 ICM and CONICYT PFB-23) for logistic and scientific support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; BASILIER K, 1979, LINDBERGIA, V5, P84; BASILIER K, 1980, OIKOS, V34, P239, DOI 10.2307/3544188; BATES JW, 2009, BRYOPHYTE BIOL; Bernasconi SM, 2011, VADOSE ZONE J, V10, P867, DOI 10.2136/vzj2010.0129; BOWDEN RD, 1991, ECOL MONOGR, V61, P207, DOI 10.2307/1943008; Brankatschk R, 2011, ISME J, V5, P1025, DOI 10.1038/ismej.2010.184; CHAPIN DM, 1991, CAN J BOT, V69, P2744, DOI 10.1139/b91-345; CHAPIN FS, 1994, ECOL MONOGR, V64, P149, DOI 10.2307/2937039; Cubero OF, 1999, PLANT SYST EVOL, V216, P243, DOI 10.1007/BF01084401; de los Rios A, 2010, INT MICROBIOL, V13, P79, DOI 10.2436/20.1501.01.113; DeLuca TH, 2002, NATURE, V419, P917, DOI 10.1038/nature01051; DeLuca TH, 2008, SCIENCE, V320, P1181, DOI 10.1126/science.1154836; Dentener F, 2006, ENVIRON SCI TECHNOL, V40, P3586, DOI 10.1021/es0523845; DODDS WK, 1995, J PHYCOL, V31, P2, DOI 10.1111/j.0022-3646.1995.00002.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elbert W, 2012, NAT GEOSCI, V5, P459, DOI 10.1038/ngeo1486; Fernandez-Martinez MA, 2013, MICROB ECOL, V66, P335, DOI 10.1007/s00248-013-0223-2; Filzmoser P, 1999, ENVIRONMETRICS, V10, P363, DOI 10.1002/(SICI)1099-095X(199907/08)10:4<363::AID-ENV362>3.0.CO;2-0; Gavazov KS, 2010, PLANT SOIL, V333, P507, DOI 10.1007/s11104-010-0374-6; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gundale MJ, 2012, NEW PHYTOL, V194, P453, DOI 10.1111/j.1469-8137.2012.04071.x; Gundale MJ, 2009, CAN J FOREST RES, V39, P2542, DOI 10.1139/X09-160; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hill TCJ, 2003, FEMS MICROBIOL ECOL, V43, P1, DOI 10.1111/j.1574-6941.2003.tb01040.x; Hothorn T., 2010, PARTY LAB RECURSIVE; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ininbergs K, 2011, NEW PHYTOL, V192, P507, DOI 10.1111/j.1469-8137.2011.03809.x; ISRIC, 2002, PROCEDURES SOIL ANAL; Knelman JE, 2012, SOIL BIOL BIOCHEM, V46, P172, DOI 10.1016/j.soilbio.2011.12.001; Kohls SJ, 2003, PLANT SOIL, V254, P11, DOI 10.1023/A:1024950913234; Koppes M, 2009, J GLACIOL, V55, P207, DOI 10.3189/002214309788608796; Liengen T, 1999, CAN J MICROBIOL, V45, P223, DOI 10.1139/cjm-45-3-223; Lindo Z, 2013, GLOBAL CHANGE BIOL, V19, P2022, DOI 10.1111/gcb.12175; LINE MA, 1992, POLAR BIOL, V11, P601; Masiokas MH, 2008, GLOBAL PLANET CHANGE, V60, P85, DOI 10.1016/j.gloplacha.2006.07.031; Menge DNL, 2009, ECOLOGY, V90, P2190, DOI 10.1890/08-0877.1; MILLBANK JW, 1981, NEW PHYTOL, V89, P647, DOI 10.1111/j.1469-8137.1981.tb02343.x; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Nenadic O, 2007, J STAT SOFTW, V20; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; PANDEY KD, 1992, ISRAEL J BOT, V41, P187; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Raggio J, 2012, SYMBIOSIS, V56, P55, DOI 10.1007/s13199-012-0159-1; Rozzi R, 2008, FRONT ECOL ENVIRON, V6, P131, DOI 10.1890/070020; Sancho LG, 2011, POLAR BIOL, V34, P813, DOI 10.1007/s00300-010-0935-4; SANTANA A, 2006, AN INST PATAGON SER, V34, P5; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmidt SK, 2008, P ROY SOC B-BIOL SCI, V275, P2793, DOI 10.1098/rspb.2008.0808; SMITH VR, 1982, POLAR BIOL, V1, P153, DOI 10.1007/BF00287001; Solheim B, 2002, CYANOBACTERIA IN SYMBIOSIS, P137; Solheim B, 1996, POLAR BIOL, V16, P35, DOI 10.1007/BF02388733; Sorensen PL, 2006, ARCT ANTARCT ALP RES, V38, P263, DOI 10.1657/1523-0430(2006)38[263:NFDAEN]2.0.CO;2; Sorensen PL, 2012, PLANT ECOL, V213, P695, DOI 10.1007/s11258-012-0034-4; Stackebrandt E., 2006, MICROBIOL TODAY, V33, P152; Stewart KJ, 2011, ARCT ANTARCT ALP RES, V43, P267, DOI 10.1657/1938-4246-43.2.267; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; VAL J, 1994, J CHROMATOGR SCI, V32, P286, DOI 10.1093/chromsci/32.7.286; Vincent WF, 2000, ECOLOGY CYANOBACTERI, P321, DOI DOI 10.1007/0-306-46855-7_12; WEBER MG, 1984, CAN J FOREST RES, V14, P278, DOI 10.1139/x84-053; Wickland KP, 2007, ECOSYSTEMS, V10, P1323, DOI 10.1007/s10021-007-9101-4; Wilson JA, 1999, CAN J BOT, V77, P564, DOI 10.1139/cjb-77-4-564; Zackrisson O, 2009, OECOLOGIA, V160, P309, DOI 10.1007/s00442-009-1299-8; Zielke M, 2005, ARCT ANTARCT ALP RES, V37, P372, DOI 10.1657/1523-0430(2005)037[0372:NFITHA]2.0.CO;2; Zumsteg A, 2012, MICROB ECOL, V63, P552, DOI 10.1007/s00248-011-9991-8	66	31	34	1	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96081	10.1371/journal.pone.0096081	http://dx.doi.org/10.1371/journal.pone.0096081			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819926	Green Published, Green Submitted, gold			2022-12-27	WOS:000336653300011
J	Lashley, MA; Thompson, JR; Chitwood, MC; DePerno, CS; Moorman, CE				Lashley, Marcus A.; Thompson, Jeffrey R.; Chitwood, M. Colter; DePerno, Christopher S.; Moorman, Christopher E.			Evaluation of Methods to Estimate Understory Fruit Biomass	PLOS ONE			English	Article							SOUTHERN APPALACHIANS; TROPICAL FOREST; BLACK BEARS; SOFT MAST; AVAILABILITY; ABUNDANCE; INDEX; TREES	Fleshy fruit is consumed by many wildlife species and is a critical component of forest ecosystems. Because fruit production may change quickly during forest succession, frequent monitoring of fruit biomass may be needed to better understand shifts in wildlife habitat quality. Yet, designing a fruit sampling protocol that is executable on a frequent basis may be difficult, and knowledge of accuracy within monitoring protocols is lacking. We evaluated the accuracy and efficiency of 3 methods to estimate understory fruit biomass (Fruit Count, Stem Density, and Plant Coverage). The Fruit Count method requires visual counts of fruit to estimate fruit biomass. The Stem Density method uses counts of all stems of fruit producing species to estimate fruit biomass. The Plant Coverage method uses land coverage of fruit producing species to estimate fruit biomass. Using linear regression models under a censored-normal distribution, we determined the Fruit Count and Stem Density methods could accurately estimate fruit biomass; however, when comparing AIC values between models, the Fruit Count method was the superior method for estimating fruit biomass. After determining that Fruit Count was the superior method to accurately estimate fruit biomass, we conducted additional analyses to determine the sampling intensity (i.e., percentage of area) necessary to accurately estimate fruit biomass. The Fruit Count method accurately estimated fruit biomass at a 0.8% sampling intensity. In some cases, sampling 0.8% of an area may not be feasible. In these cases, we suggest sampling understory fruit production with the Fruit Count method at the greatest feasible sampling intensity, which could be valuable to assess annual fluctuations in fruit production.	[Lashley, Marcus A.; Chitwood, M. Colter; DePerno, Christopher S.; Moorman, Christopher E.] SAS Inst Inc, Raleigh, NC USA; [Thompson, Jeffrey R.] SAS Inst Inc, Cary, NC USA	SAS Institute Inc; SAS Institute Inc	Lashley, MA (corresponding author), SAS Inst Inc, 110 Brooks Ave, Raleigh, NC USA.	marcus_lashley@ncsu.edu		Chitwood, Colter/0000-0001-7240-7430	United States Department of Defense and Fort Bragg Military Installation	United States Department of Defense and Fort Bragg Military Installation	We thank the United States Department of Defense and Fort Bragg Military Installation for financial contributions to this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1977, J R STAT SOC C-APPL, P27; Borchert R, 1998, CLIMATIC CHANGE, V39, P381, DOI 10.1023/A:1005383020063; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Campo JJ, 1980, SEAFWA, V34, P470; Cantrell M.A., 1995, RED COCKADED WOODPEC; Carter III JH, 1995, RED COCKADED WOODPEC, P248; CHAPMAN CA, 1992, BIOTROPICA, V24, P527, DOI 10.2307/2389015; CHAPMAN CA, 1994, BIOTROPICA, V26, P160, DOI 10.2307/2388805; DAUBENMIRE R., 1959, NORTHWEST SCI, V33, P43; Galetti M, 1998, J APPL ECOL, V35, P286, DOI 10.1046/j.1365-2664.1998.00294.x; Greenberg CH, 2007, J WILDLIFE MANAGE, V71, P1654, DOI 10.2193/2006-295; Greenberg CH, 2007, J WILDLIFE MANAGE, V71, P321, DOI 10.2193/2005-747; Greenberg CH, 2012, J WILDLIFE MANAGE, V76, P1036, DOI 10.1002/jwmg.343; Greenberg CH, 2011, MANAG FOR ECOSYST, V21, P1, DOI 10.1007/978-94-007-1620-9; Herrera CM, 1998, AM NAT, V152, P576, DOI 10.1086/286191; Howe H.F., 1986, P123; Jackson S. W., 2007, P NATL WILD TURKEY S, V9, P199; Johnson AS, 1978, J WILDL MGT, V42, P594; Jordano P., 2000, SEEDS ECOLOGY REGENE; Lashley M.A., 2009, P ANN C SE ASS FISH, V63, P21; Lashley MA, 2014, ECOL INDIC, V38, P212, DOI 10.1016/j.ecolind.2013.11.006; Lashley MA, 2012, SOUTHEAST NAT, V11, P699, DOI 10.1656/058.011.0409; Lashley MA, 2011, J WILDLIFE MANAGE, V75, P1467, DOI 10.1002/jwmg.176; McCarty JP, 2002, FOREST ECOL MANAG, V164, P277, DOI 10.1016/S0378-1127(01)00612-0; McCord JM, 2014, WILDLIFE SOC B, V38, P265, DOI 10.1002/wsb.403; Miller J.H., 1999, FOREST PLANTS SE THE; Mitchell MS, 2003, J WILDLIFE MANAGE, V67, P692, DOI 10.2307/3802676; Mitchell MS, 2002, WILDLIFE SOC B, V30, P794; Parrado-Rosselli A, 2006, BIOTROPICA, V38, P267, DOI 10.1111/j.1744-7429.2006.00125.x; Perry RW, 1999, WILDLIFE SOC B, V27, P915; Reynolds-Hogland MJ, 2006, FOREST ECOL MANAG, V237, P103, DOI 10.1016/j.foreco.2006.09.035; Samuels IA, 2005, FUNCT ECOL, V19, P365, DOI 10.1111/j.1365-2435.2005.00973.x; SAS Institute Inc, 2012, SAS ETS 12 1 US GUID; SCHUPP EW, 1990, ECOLOGY, V71, P504, DOI 10.2307/1940304; Shaw CE, 2010, J FISH WILDL MANAG, V1, P64, DOI 10.3996/102009-JFWM-016; Wright SJ, 1999, ECOLOGY, V80, P1632, DOI 10.2307/176552	36	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96898	10.1371/journal.pone.0096898	http://dx.doi.org/10.1371/journal.pone.0096898			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819253	Green Published, gold, Green Submitted			2022-12-27	WOS:000336653300045
J	Ribeiro-Rodrigues, R; Kim, S; da Silva, FDC; Uzelac, A; Collins, L; Palaci, M; Alland, D; Dietze, R; Ellner, JJ; Jones-Lopez, E; Salgame, P				Ribeiro-Rodrigues, Rodrigo; Kim, Soyeon; Coelho da Silva, Favia Dias; Uzelac, Aleksandra; Collins, Lauren; Palaci, Moises; Alland, David; Dietze, Reynaldo; Ellner, Jerrold J.; Jones-Lopez, Edward; Salgame, Padmini			Discordance of Tuberculin Skin Test and Interferon Gamma Release Assay in Recently Exposed Household Contacts of Pulmonary TB Cases in Brazil	PLOS ONE			English	Article							HEALTH-CARE WORKERS; LATENT TUBERCULOSIS; GOLD TEST; INFECTION; DIAGNOSIS; CHILDREN; IP-10; IMMUNODIAGNOSIS; VARIABILITY; CONCORDANCE	Interferon-gamma (IFN-gamma) release assays (IGRAs) such as the Quantiferon Gold In-tube test are in vitro assays that measure IFN-gamma release from T cells in response to M. tuberculosis (Mtb)-specific antigens. Unlike the tuberculin skin test (TST), IGRA is specific and able to distinguish Mtb-infection from BCG vaccination. In this study we evaluated the concordance between TST and IGRA and the efficacy of IGRA in diagnosing new Mtb infection in household contacts (HHC) of pulmonary tuberculosis (PTB) cases. A total of 357 HHC of TB cases in Vitoria, Brazil were studied. A TST was performed within 2 weeks following enrollment of the HHC and if negative a second TST was performed at 8-12 weeks. HHC were categorized as initially TST positive (TST+), persistently TST negative (TST-), or TST converters (TSTc), the latter representative of new infection. IGRA was performed at 8-12 weeks following enrollment and the test results were positive in 82% of TST+, 48% of TSTc, and 12% of TST-, indicating poor concordance between the two test results among HHC in each category. Evaluating CXCL10 levels in a subset of IGRA supernatants or lowering the IGRA cutoff value to define a positive test increased agreement between TST and IGRA test results. However, ROC curves demonstrated that this resulted in a trade-off between sensitivity and specificity of IGRA with respect to TST. Together, the findings suggest that until the basis for the discordance between TST and IGRA is fully understood, it may be necessary to utilize both tests to diagnose new Mtb infection in recently exposed HHC. Operationally, in IGRA negative HHC, it may be useful to employ a lower cutoff value for IGRA to allow closer monitoring for potential conversion.	[Ribeiro-Rodrigues, Rodrigo; Coelho da Silva, Favia Dias; Dietze, Reynaldo] Univ Fed Espirito Santo, Nucl Doencas Infecciosas, Cellular & Mol Immunol Lab, Vitoria, Brazil; [Kim, Soyeon] Univ Med & Dent New Jersey, New Jersey Med Sch, Rutgers Biomed & Hlth Sci, Dept Prevent Med & Community Hlth, Newark, NJ 07103 USA; [Uzelac, Aleksandra; Alland, David; Salgame, Padmini] Univ Med & Dent New Jersey, New Jersey Med Sch, Rutgers Biomed & Hlth Sci, Dept Med,Div Infect Dis, Newark, NJ 07103 USA; [Collins, Lauren; Ellner, Jerrold J.; Jones-Lopez, Edward] Boston Univ, Sch Med, Boston, MA 02118 USA; [Palaci, Moises] Univ Fed Espirito Santo, NDI, Mycobacteriol Lab, Vitoria, Brazil; [Ellner, Jerrold J.; Jones-Lopez, Edward] Boston Med Ctr, Dept Med, Infect Dis Sect, Boston, MA USA	Universidade Federal do Espirito Santo; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Boston University; Universidade Federal do Espirito Santo; Boston Medical Center	Jones-Lopez, E (corresponding author), Boston Med Ctr, Dept Med, Infect Dis Sect, Boston, MA USA.	Edward.Jones-Lopez@bmc.org; salgampa@njms.rutgers.edu	Uzelac, Aleksandra/GQI-2085-2022; Ribeiro-Rodrigues, Rodrigo/AAY-7820-2020	Uzelac, Aleksandra/0000-0002-1424-0123; Ribeiro-Rodrigues, Rodrigo/0000-0002-0675-110X; Collins, Lauren/0000-0002-0170-5454; Jones Lopez, Edward/0000-0001-6323-286X; Dietze, Reynaldo/0000-0002-6995-8001	National Institutes of Health [U01AI065663]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI065663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health U01AI065663. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adetifa IMO, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-122; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; Anibarro L, 2011, SCAND J INFECT DIS, V43, P424, DOI 10.3109/00365548.2011.558912; [Anonymous], 2002, CONTR TUB UMA PROP I; Arend SM, 2007, AM J RESP CRIT CARE, V175, P618, DOI 10.1164/rccm.200608-1099OC; Barnes PF, 2004, AM J RESP CRIT CARE, V170, P5, DOI 10.1164/rccm.2404004; BASS JB, 1985, AM REV RESPIR DIS, V132, P379; Chegou NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064226; Denkinger CM, 2011, CLIN MICROBIOL INFEC, V17, P806, DOI 10.1111/j.1469-0691.2011.03555.x; Detjen AK, 2009, CLIN VACCINE IMMUNOL, V16, P1170, DOI 10.1128/CVI.00168-09; Dheda K, 2009, CURR OPIN PULM MED, V15, P188, DOI 10.1097/MCP.0b013e32832a0adc; Diel R, 2012, CHEST, V142, P63, DOI 10.1378/chest.11-3157; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Kampmann B, 2009, EUR RESPIR J, V33, P1374, DOI 10.1183/09031936.00153408; Kang YA, 2005, JAMA-J AM MED ASSOC, V293, P2756, DOI 10.1001/jama.293.22.2756; Lalvani A, 2005, LANCET INFECT DIS, V5, P322, DOI 10.1016/S1473-3099(05)70118-3; Lalvani A, 2010, ENFERM INFEC MICR CL, V28, P245, DOI 10.1016/j.eimc.2009.05.012; Lee YM, 2013, RISK FACTORS FALSE N; Lighter J, 2009, INT J TUBERC LUNG D, V13, P731; Machado A, 2009, INT J TUBERC LUNG D, V13, P446; Mahan CS, 2011, INT J TUBERC LUNG D, V15, P174; Mancuso JD, 2013, AM J RESP CRIT CARE, V187, P122, DOI 10.1164/rccm.201211-2033ED; Mancuso JD, 2012, AM J RESP CRIT CARE, V185, P427, DOI 10.1164/rccm.201107-1244OC; Mantegani P, 2006, CLIN MED RES, V4, P266, DOI 10.3121/cmr.4.4.266; Mardani M, 2010, ANN THORAC MED, V5, P43, DOI 10.4103/1817-1737.58959; Mazurek Gerald H., 2005, Morbidity and Mortality Weekly Report, V54, P49; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Metcalfe JZ, 2013, AM J RESP CRIT CARE, V187, P206, DOI 10.1164/rccm.201203-0430OC; Moran-Mendoza O, 2013, INT J TUBERC LUNG D, V17, P1273, DOI 10.5588/ijtld.13.0147; Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9; Mulder C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060130; Munoz L, 2013, J INFECTION, V66, P381, DOI 10.1016/j.jinf.2012.12.005; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2009, INT J TUBERC LUNG D, V13, P84; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; Pineiro R, 2012, EUR J PEDIATR, V171, P1625, DOI 10.1007/s00431-012-1783-8; Prasad TSK, 2013, CLIN PROTEOM, V10, DOI 10.1186/1559-0275-10-8; Ringshausen FC, 2011, CLIN VACCINE IMMUNOL, V18, P1176, DOI 10.1128/CVI.05058-11; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Ruhwald M, 2011, TUBERCULOSIS, V91, P260, DOI 10.1016/j.tube.2011.01.001; Ruhwald M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002858; Sauzullo I, 2011, TUBERCULOSIS, V91, P322, DOI 10.1016/j.tube.2011.05.004; Slater ML, 2013, AM J RESP CRIT CARE, V188, P1005, DOI 10.1164/rccm.201305-0831OC; Tissot F, 2005, CLIN INFECT DIS, V40, P211, DOI 10.1086/426434; Trajman A, 2013, PULM MED, V2013, DOI 10.1155/2013/601737; Tuuminen T, 2013, CLIN VACCINE IMMUNOL, V20, P1778, DOI 10.1128/CVI.00476-13; Whittaker E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003901; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2021, 10 THREATS GLOB HLTH; Yassin MA, 2013, EUR RESPIR J, V41, P644, DOI 10.1183/09031936.00012212; Zwerling A, 2012, THORAX, V67, P62, DOI 10.1136/thx.2010.143180	56	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96564	10.1371/journal.pone.0096564	http://dx.doi.org/10.1371/journal.pone.0096564			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819060	Green Published, gold, Green Submitted			2022-12-27	WOS:000336653300022
J	Wade, ASI; Barov, B; Burfield, IJ; Gregory, RD; Norris, K; Vorisek, P; Wu, TY; Butler, SJ				Wade, Amy S. I.; Barov, Boris; Burfield, Ian J.; Gregory, Richard D.; Norris, Ken; Vorisek, Petr; Wu, Taoyang; Butler, Simon J.			A Niche-Based Framework to Assess Current Monitoring of European Forest Birds and Guide Indicator Species' Selection	PLOS ONE			English	Article							MINIMAL DOMINATING SETS; FARMLAND BIODIVERSITY; COMBINATORIAL BOUNDS; POPULATION TRENDS; WOODLAND BIRDS; CONSERVATION; MANAGEMENT; DIVERSITY; INTEGRITY; RICHNESS	Concern that European forest biodiversity is depleted and declining has provoked widespread efforts to improve management practices. To gauge the success of these actions, appropriate monitoring of forest ecosystems is paramount. Multi-species indicators are frequently used to assess the state of biodiversity and its response to implemented management, but generally applicable and objective methodologies for species' selection are lacking. Here we use a niche-based approach, underpinned by coarse quantification of species' resource use, to objectively select species for inclusion in a pan-European forest bird indicator. We identify both the minimum number of species required to deliver full resource coverage and the most sensitive species' combination, and explore the trade-off between two key characteristics, sensitivity and redundancy, associated with indicators comprising different numbers of species. We compare our indicator to an existing forest bird indicator selected on the basis of expert opinion and show it is more representative of the wider community. We also present alternative indicators for regional and forest type specific monitoring and show that species' choice can have a significant impact on the indicator and consequent projections about the state of the biodiversity it represents. Furthermore, by comparing indicator sets drawn from currently monitored species and the full forest bird community, we identify gaps in the coverage of the current monitoring scheme. We believe that adopting this niche-based framework for species' selection supports the objective development of multi-species indicators and that it has good potential to be extended to a range of habitats and taxa.	[Wade, Amy S. I.; Norris, Ken] Univ Reading, Sch Agr Policy & Dev, Ctr Agrienvironm Res, Reading, Berks, England; [Barov, Boris] BirdLife Europe, Brussels, Belgium; [Burfield, Ian J.] BirdLife Int, Cambridge, England; [Gregory, Richard D.] Lodge, Royal Soc Protect Birds, Sandy, Beds, England; [Vorisek, Petr] Czech Soc Ornithol, Prague, Czech Republic; [Vorisek, Petr] Palacky Univ, Fac Sci, Dept Zool, CR-77147 Olomouc, Czech Republic; [Vorisek, Petr] Palacky Univ, Fac Sci, Ornithol Lab, CR-77147 Olomouc, Czech Republic; [Wu, Taoyang] Univ E Anglia, Sch Comp Sci, Norwich NR4 7TJ, Norfolk, England; [Butler, Simon J.] Univ E Anglia, Norwich Res Park, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	University of Reading; BirdLife International; Royal Society for Protection of Birds; Palacky University Olomouc; Palacky University Olomouc; University of East Anglia; University of East Anglia	Butler, SJ (corresponding author), Univ E Anglia, Norwich Res Park, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England.	simon.j.butler@uea.ac.uk	Vorisek, Petr/E-3336-2012; Wade, Amy/GSO-1924-2022; Barov, Boris/GQZ-8085-2022; Wade, Amy/GSN-9485-2022; Butler, Simon/H-1703-2011	Wu, Taoyang/0000-0002-2663-2001; Butler, Simon/0000-0002-5111-5639; Gregory, Richard/0000-0002-7419-5053	Alliance for Beverage Cartons and the Environment (ACE); NGO from the European Commission; Natural Environment Research Council Postdoctoral Fellowship [NE/I020350/1]; BBSRC [BB/F011911/1] Funding Source: UKRI; NERC [NE/I020350/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F011911/1] Funding Source: researchfish; Natural Environment Research Council [NE/I020350/1] Funding Source: researchfish	Alliance for Beverage Cartons and the Environment (ACE); NGO from the European Commission; Natural Environment Research Council Postdoctoral Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Alliance for Beverage Cartons and the Environment (ACE). BB and IJB were supported partly by an NGO operating grant from the European Commission (DG Environment, under the LIFE+ programme) to Stichting BirdLife Europe. SJB was supported by a Natural Environment Research Council Postdoctoral Fellowship (NE/I020350/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelstam P., 2004, Ecological Bulletins, V51, P427; Auld G, 2008, ANNU REV ENV RESOUR, V33, P187, DOI 10.1146/annurev.environ.33.013007.103754; Bengtsson J, 2000, FOREST ECOL MANAG, V132, P39, DOI 10.1016/S0378-1127(00)00378-9; Bladt J, 2008, ANIM CONSERV, V11, P546, DOI 10.1111/j.1469-1795.2008.00211.x; Bradbury RB, 2010, J APPL ECOL, V47, P986, DOI 10.1111/j.1365-2664.2010.01843.x; Bryce SA, 2002, ENVIRON MANAGE, V30, P294, DOI 10.1007/s00267-002-2702-y; Butler SJ, 2007, SCIENCE, V315, P381, DOI 10.1126/science.1136607; Butler SJ, 2010, AGR ECOSYST ENVIRON, V137, P348, DOI 10.1016/j.agee.2010.03.005; Butler SJ, 2012, METHODS ECOL EVOL, V3, P317, DOI 10.1111/j.2041-210X.2011.00173.x; Butler SJ, 2009, J APPL ECOL, V46, P1154, DOI 10.1111/j.1365-2664.2009.01709.x; Carignan V, 2002, ENVIRON MONIT ASSESS, V78, P45, DOI 10.1023/A:1016136723584; Couturier JF, 2012, LECT NOTES COMPUT SC, V7147, P202; Dale Virginia H., 2001, Ecological Indicators, V1, P3, DOI 10.1016/S1470-160X(01)00003-6; Fomin FV, 2008, ACM T ALGORITHMS, V5, DOI 10.1145/1435375.1435384; Forest Europe UNECE FAO, 2011, STAT EUR FOR STAT TR; Fuller RJ, 2007, IBIS, V149, P261, DOI 10.1111/j.1474-919X.2007.00775.x; Gil-Tena A, 2009, GLOBAL CHANGE BIOL, V15, P474, DOI 10.1111/j.1365-2486.2008.01730.x; Gregory R.D., 2003, Ornis Hungarica, V12-13, P11; Gregory RD, 2005, PHILOS T R SOC B, V360, P269, DOI 10.1098/rstb.2004.1602; Gregory RD, 2008, BIRD CONSERV INT, V18, pS223, DOI 10.1017/S0959270908000312; Gregory RD, 2007, IBIS, V149, P78, DOI 10.1111/j.1474-919X.2007.00698.x; Gregory RD, 2010, ORNITHOL SCI, V9, P3, DOI 10.2326/osj.9.3; Kovacs A, 2008, AMBIO, V37, P408, DOI 10.1579/0044-7447(2008)37[408:EMFRAO]2.0.CO;2; Legendre P., 2012, NUMERICAL ECOLOGY; Legendre P., 2008, LMODEL2 MODEL 2 REGR; Lewandowski AS, 2010, CONSERV BIOL, V24, P1367, DOI 10.1111/j.1523-1739.2010.01513.x; Mikusinski G, 2001, CONSERV BIOL, V15, P208, DOI 10.1046/j.1523-1739.2001.99236.x; Niemeijer D, 2008, ECOL INDIC, V8, P14, DOI 10.1016/j.ecolind.2006.11.012; Niemi GJ, 2004, ANNU REV ECOL EVOL S, V35, P89, DOI 10.1146/annurev.ecolsys.35.112202.130132; Norris K, 2004, P ROY SOC B-BIOL SCI, V271, P123, DOI 10.1098/rspb.2003.2576; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; Paillet Y, 2010, CONSERV BIOL, V24, P101, DOI 10.1111/j.1523-1739.2009.01399.x; Pullin AS, 2009, CONSERV BIOL, V23, P818, DOI 10.1111/j.1523-1739.2009.01283.x; Roberge JM, 2006, BIOL CONSERV, V130, P134, DOI 10.1016/j.biocon.2005.12.008; Saetersdal M, 2005, BIOL CONSERV, V122, P305, DOI 10.1016/j.biocon.2004.07.020; Snow D.W., 1998, BIRDS W PALEARCTIC; Telleria JL, 2003, J BIOGEOGR, V30, P621, DOI 10.1046/j.1365-2699.2003.00869.x; Thaxter CB, 2010, BIOL CONSERV, V143, P2006, DOI 10.1016/j.biocon.2010.05.004; Tucker G.M., 1997, HABITATS BIRDS EUROP; Wade ASI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064552	40	12	13	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97217	10.1371/journal.pone.0097217	http://dx.doi.org/10.1371/journal.pone.0097217			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819734	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000336653300090
J	De Puysseleyr, K; De Puysseleyr, L; Geldhof, J; Cox, E; Vanrompay, D				De Puysseleyr, Kristien; De Puysseleyr, Leentje; Geldhof, Julie; Cox, Eric; Vanrompay, Daisy			Development and Validation of a Real-Time PCR for Chlamydia suis Diagnosis in Swine and Humans	PLOS ONE			English	Article							QUANTITATIVE DETECTION; CHLAMYDOPHILA-FELIS; INFECTION; PIGS; IDENTIFICATION; PNEUMONIAE; PSITTACI; ASSAY; SENSITIVITY; PREVALENCE	Pigs are the natural host for Chlamydia suis, a pathogen which is phylogenetically highly related to the human pathogen C. trachomatis. Chlamydia suis infections are generally treated with tetracyclines. In 1998, tetracyline resistant C. suis strains emerged on U. S. pig farms and they are currently present in the Belgian, Cypriote, German, Israeli, Italian and Swiss pig industry. Infections with tetracycline resistant C. suis strains are mainly associated with severe reproductive failure leading to marked economical loss. We developed a sensitive and specific TaqMan probe-based C. suis real-time PCR for examining clinical samples of both pigs and humans. The analytical sensitivity of the real-time PCR is 10 rDNA copies/reaction without cross-amplifying DNA of other Chlamydia species. The PCR was successfully validated using conjunctival, pharyngeal and stool samples of slaughterhouse employees, as well as porcine samples from two farms with evidence of reproductive failure and one farm without clinical disease. Chlamydia suis was only detected in diseased pigs and in the eyes of humans. Positive humans had no clinical complaints. PCR results were confirmed by culture in McCoy cells. In addition, Chlamydia suis isolates were also examined by the tet(C) PCR, designed for demonstrating the tetracycline resistance gene tet(C). The tet(C) gene was only present in porcine C. suis isolates.	[De Puysseleyr, Kristien; De Puysseleyr, Leentje; Geldhof, Julie; Vanrompay, Daisy] Univ Ghent, Fac Biosci Engn, Dept Mol Biotechnol, B-9000 Ghent, Belgium; [Cox, Eric] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, B-9000 Ghent, Belgium	Ghent University; Ghent University	De Puysseleyr, K (corresponding author), Univ Ghent, Fac Biosci Engn, Dept Mol Biotechnol, B-9000 Ghent, Belgium.	Kristien.DePuysseleyr@ugent.be		Cox, Eric/0000-0003-4281-2990	Federal Public Service of Health, Safety of the Food Chain and Environment [RF-10/6234]; Ghent University; MSD Animal Health (Boxmeer, The Netherlands)	Federal Public Service of Health, Safety of the Food Chain and Environment; Ghent University(Ghent University); MSD Animal Health (Boxmeer, The Netherlands)	This study was funded by the Federal Public Service of Health, Safety of the Food Chain and Environment (convention RF-10/6234; http://www.health.belgium.be/eportal?fodnlang=en), Ghent University (IOF/STARTT/002) and MSD Animal Health (Boxmeer, The Netherlands; http://nl.msd-animal-health.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen A, 1998, CHLAMYDIAL INFECTION, P313, DOI DOI 10.1016/J.TTBDIS.2012.11.013; Becker A, 2007, J VET MED A, V54, P307, DOI 10.1111/j.1439-0442.2007.00963.x; Borel N, 2012, VET MICROBIOL, V156, P143, DOI 10.1016/j.vetmic.2011.10.011; Borel N, 2008, MOL CELL PROBE, V22, P55, DOI 10.1016/j.mcp.2007.06.003; Camenisch U, 2004, VET REC, V155, P593, DOI 10.1136/vr.155.19.593; Dean D, 2013, EMERG INFECT DIS, V19, P1948, DOI 10.3201/eid1912.130656; DeGraves FJ, 2003, J CLIN MICROBIOL, V41, P1726, DOI 10.1128/JCM.41.4.1726-1729.2003; Di Francesco A, 2006, VET REC, V159, P849; Dugan J, 2004, ANTIMICROB AGENTS CH, V48, P3989, DOI 10.1128/AAC.48.10.3989-3995.2004; Eggemann G, 2000, DEUT TIERARZTL WOCH, V107, P3; Ehricht R, 2006, MOL CELL PROBE, V20, P60, DOI 10.1016/j.mcp.2005.09.003; Everett KDE, 1999, INT J SYST BACTERIOL, V49, P415, DOI 10.1099/00207713-49-2-415; Geens T, 2005, VET RES, V36, P787, DOI 10.1051/vetres:2005035; Guscetti F, 2009, VET MICROBIOL, V135, P157, DOI 10.1016/j.vetmic.2008.09.038; Hardick J, 2004, J MOL DIAGN, V6, P132, DOI 10.1016/S1525-1578(10)60501-6; Helps C, 2003, J CLIN MICROBIOL, V41, P2734, DOI 10.1128/JCM.41.6.2734-2736.2003; Helps C, 2001, J CLIN MICROBIOL, V39, P2675, DOI 10.1128/JCM.39.7.2675-2676.2001; Kuoppa Y, 2002, J CLIN MICROBIOL, V40, P2273, DOI 10.1128/JCM.40.6.2273-2274.2002; Lenart J, 2001, ANTIMICROB AGENTS CH, V45, P2198, DOI 10.1128/AAC.45.8.2198-2203.2001; Pantchev A, 2010, COMP IMMUNOL MICROB, V33, P473, DOI 10.1016/j.cimid.2009.08.002; Pospischil A, 2009, VET MICROBIOL, V135, P147, DOI 10.1016/j.vetmic.2008.09.035; Reinhold P, 2008, VET RES, V39, DOI 10.1051/vetres:2008012; Rogers DG, 1996, J VET DIAGN INVEST, V8, P433, DOI 10.1177/104063879600800405; Rozen S, 2000, Methods Mol Biol, V132, P365; Sachse K, 2005, MOL CELL PROBE, V19, P41, DOI 10.1016/j.mcp.2004.09.005; Sandoz KM, 2010, FUTURE MICROBIOL, V5, P1427, DOI [10.2217/fmb.10.96, 10.2217/FMB.10.96]; SARMA DK, 1983, VET REC, V112, P525, DOI 10.1136/vr.112.22.525-a; Schautteet K, 2012, J MED MICROBIOLOGY; Schautteet K, 2013, J MED MICROBIOL, V62, P331, DOI 10.1099/jmm.0.042861-0; Schautteet K, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-29; Solomon AW, 2003, LANCET, V362, P198, DOI 10.1016/S0140-6736(03)13909-8; Suchland RJ, 2009, ANTIMICROB AGENTS CH, V53, P4604, DOI 10.1128/AAC.00477-09; Sykes JE, 2001, VET MICROBIOL, V81, P95, DOI 10.1016/S0378-1135(01)00340-6; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tondella MLC, 2002, J CLIN MICROBIOL, V40, P575, DOI 10.1128/JCM.40.2.575-583.2002; Vanrompay D, 2004, VET MICROBIOL, V99, P59, DOI 10.1016/j.vetmic.2003.08.014; VANROMPAY D, 1992, J VET MED B, V39, P105, DOI 10.1111/j.1439-0450.1992.tb01144.x; Welti M, 2003, DIAGN MICR INFEC DIS, V45, P85, DOI 10.1016/S0732-8893(02)00484-4; WILLIGAN DONALD A., 1955, JOUR AMER VET MED ASSOC, V126, P118; WOOLLEN N, 1990, J AM VET MED ASSOC, V197, P600; ZAHN I, 1995, J VET MED B, V42, P266, DOI 10.1111/j.1439-0450.1995.tb00710.x	41	25	27	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96704	10.1371/journal.pone.0096704	http://dx.doi.org/10.1371/journal.pone.0096704			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816542	Green Submitted, gold, Green Published			2022-12-27	WOS:000336838000053
J	Garcia, C; Gutmann, DH				Garcia, Cynthia; Gutmann, David H.			Nf2/Merlin Controls Spinal Cord Neural Progenitor Function in a Rac1/ErbB2-Dependent Manner	PLOS ONE			English	Article							CELL-GROWTH; RADIAL GLIA; NF2; MERLIN; EXPRESSION; GENE; DIFFERENTIATION; PROLIFERATION; EPENDYMOMAS; INHIBITION	Objective: Individuals with the neurofibromatosis type 2 (NF2) cancer predisposition syndrome develop spinal cord glial tumors (ependymomas) that likely originate from neural progenitor cells. Whereas many spinal ependymomas exhibit indolent behavior, the only treatment option for clinically symptomatic tumors is surgery. In this regard, medical therapies are unfortunately lacking due to an incomplete understanding of the critical growth control pathways that govern the function of spinal cord (SC) neural progenitor cells (NPCs). Methods: To identify potential therapeutic targets for these tumors, we leveraged primary mouse Nf2-deficient spinal cord neural progenitor cells. Results: We demonstrate that the Nf2 protein, merlin, negatively regulates spinal neural progenitor cell survival and glial differentiation in an ErbB2-dependent manner, and that NF2-associated spinal ependymomas exhibit increased ErbB2 activation. Moreover, we show that Nf2-deficient SC NPC ErbB2 activation results from Rac1-mediated ErbB2 retention at the plasma membrane. Significance: Collectively, these findings establish ErbB2 as a potential rational therapeutic target for NF2-associated spinal ependymoma.	[Garcia, Cynthia; Gutmann, David H.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	Washington University (WUSTL)	Gutmann, DH (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	gutmannd@neuro.wustl.edu		Gutmann, David/0000-0002-3127-5045	National Institutes of Health [F31NS079047]; Malia Cord Foundation [PDS89547]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS079047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Malia Cord Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institutes of Health: F31NS079047. Malia Cord Foundation: PDS89547. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad ZK, 2011, OTOL NEUROTOL, V32, P841, DOI 10.1097/MAO.0b013e31821f7d88; Begnami MD, 2007, HUM PATHOL, V38, P1345, DOI 10.1016/j.humpath.2007.01.027; Bosco EE, 2010, ONCOGENE, V29, P2540, DOI 10.1038/onc.2010.20; BOURN D, 1995, HUM GENET, V95, P572; Bush ML, 2012, OTOL NEUROTOL, V33, P244, DOI 10.1097/MAO.0b013e31823e287f; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cole BK, 2008, MOL CELL BIOL, V28, P1274, DOI 10.1128/MCB.01139-07; Curto M, 2007, J CELL BIOL, V177, P893, DOI 10.1083/jcb.200703010; Dasgupta B, 2005, J NEUROSCI, V25, P5584, DOI 10.1523/JNEUROSCI.4693-04.2005; Ebert C, 1999, AM J PATHOL, V155, P627, DOI 10.1016/S0002-9440(10)65158-9; Ghashghaei HT, 2007, GENE DEV, V21, P3258, DOI 10.1101/gad.1580407; Gilbertson RJ, 2002, CLIN CANCER RES, V8, P3054; Giovannini M, 2000, GENE DEV, V14, P1617; Gutmann DH, 1997, NEUROLOGY, V49, P267, DOI 10.1212/WNL.49.1.267; Hegedus B, 2007, CELL STEM CELL, V1, P443, DOI 10.1016/j.stem.2007.07.008; Houshmandi SS, 2009, MOL CELL BIOL, V29, P1472, DOI 10.1128/MCB.01392-08; James MF, 2009, MOL CELL BIOL, V29, P4250, DOI 10.1128/MCB.01581-08; Johnson RA, 2010, NATURE, V466, P632, DOI 10.1038/nature09173; Kaul A, 2012, GENE DEV, V26, P2561, DOI 10.1101/gad.200907.112; Lee DY, 2010, GENE DEV, V24, P2317, DOI 10.1101/gad.1957110; Manchanda N, 2005, J BIOL CHEM, V280, P12517, DOI 10.1074/jbc.C400583200; Manchanda PK, 2013, ONCOGENE, V32, P3491, DOI 10.1038/onc.2012.374; MAUTNER VF, 1995, AM J ROENTGENOL, V165, P951, DOI 10.2214/ajr.165.4.7676998; Milde T, 2012, BRAIN PATHOL, V22, P848, DOI 10.1111/j.1750-3639.2012.00600.x; Morris ZS, 2009, P NATL ACAD SCI USA, V106, P9767, DOI 10.1073/pnas.0902031106; Moynihan Timothy J, 2003, Curr Treat Options Oncol, V4, P517, DOI 10.1007/s11864-003-0052-5; Plotkin SR, 2011, J NEUROSURG-SPINE, V14, P543, DOI 10.3171/2010.11.SPINE10350; Ritch PS, 2005, GLIA, V51, P217, DOI 10.1002/glia.20197; RUBIO MP, 1994, CANCER RES, V54, P45; Schmid RS, 2003, P NATL ACAD SCI USA, V100, P4251, DOI 10.1073/pnas.0630496100; Schmitz KJ, 2005, BREAST CANCER RES, V7, pR194, DOI 10.1186/bcr977; Sherman L, 1997, ONCOGENE, V15, P2505, DOI 10.1038/sj.onc.1201418; Singh PK, 2002, MODERN PATHOL, V15, P526, DOI 10.1038/modpathol.3880558; Striedinger K, 2008, NEOPLASIA, V10, P1204, DOI 10.1593/neo.08642; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; The WHO, 2020, CLASSIFICATION TUMOU; Uhlmann EJ, 2004, GLIA, V47, P180, DOI 10.1002/glia.20036; Wong HK, 2012, NEOPLASIA, V14, P84, DOI 10.1593/neo.111600; Xu HM, 1998, J NEUROSCI RES, V51, P403, DOI 10.1002/(SICI)1097-4547(19980201)51:3<403::AID-JNR13>3.0.CO;2-7; Yi CL, 2011, CANCER CELL, V19, P527, DOI 10.1016/j.ccr.2011.02.017	40	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97320	10.1371/journal.pone.0097320	http://dx.doi.org/10.1371/journal.pone.0097320			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24817309	Green Published, gold, Green Submitted			2022-12-27	WOS:000336838000130
J	Holton, SE; Bergamaschi, A; Katzenellenbogen, BS; Bhargava, R				Holton, Sarah E.; Bergamaschi, Anna; Katzenellenbogen, Benita S.; Bhargava, Rohit			Integration of Molecular Profiling and Chemical Imaging to Elucidate Fibroblast-Microenvironment Impact on Cancer Cell Phenotype and Endocrine Resistance in Breast Cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; ESTROGEN-RECEPTOR-ALPHA; TUMOR MICROENVIRONMENT; FTIR SPECTROSCOPY; EXPRESSION; CARCINOMA; PROGRESSION; TAMOXIFEN; IMMUNOHISTOCHEMISTRY; CLASSIFICATION	The tumor microenvironment is known to play a key role in altering the properties and behavior of nearby cancer cells. Its influence on resistance to endocrine therapy and cancer relapse, however, is poorly understood. Here we investigate the interaction of mammary fibroblasts and estrogen receptor-positive breast cancer cells in three-dimensional culture models in order to characterize gene expression, cellular changes, and the secreted protein factors involved in the cellular cross-talk. We show that fibroblasts, which are the predominant cell type found in the stroma adjacent to the cancer cells in a tumor, induce an epithelial-to-mesenchymal transition in the cancer cells, leading to hormone-independent growth, a more invasive phenotype, and resistance to endocrine therapy. Here, we applied a label-free chemical imaging modality, Fourier transform infrared (FT-IR) spectroscopic imaging, to identify cells that had transitioned to hormone-independent growth. Both the molecular and chemical profiles identified here were translated from cell culture to patient samples: a secreted protein signature was used to stratify patient populations based on gene expression and FT-IR was used to characterize breast tumor patient biopsies. Our findings underscore the role of mammary fibroblasts in promoting aggressiveness and endocrine therapy resistance in ER-positive breast cancers and highlight the utility of FT-IR for the further characterization of breast cancer samples.	[Holton, Sarah E.; Bhargava, Rohit] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA; [Holton, Sarah E.; Bhargava, Rohit] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL USA; [Bergamaschi, Anna; Katzenellenbogen, Benita S.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL USA; [Bergamaschi, Anna; Katzenellenbogen, Benita S.] Univ Illinois, Dept Cell Biol, Urbana, IL USA; [Bergamaschi, Anna; Katzenellenbogen, Benita S.] Univ Illinois, Dept Dev Biol, Urbana, IL USA; [Katzenellenbogen, Benita S.; Bhargava, Rohit] Univ Illinois, Univ Illinois, Ctr Canc, Urbana, IL USA; [Bhargava, Rohit] Univ Illinois, Dept Mech Sci & Engn, Urbana, IL USA; [Bhargava, Rohit] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL USA; [Bhargava, Rohit] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Bhargava, R (corresponding author), Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA.	rxb@illinois.edu		Bhargava, Rohit/0000-0001-7360-994X; Holton, Sarah/0000-0002-6373-3768	National Institutes of Health [R01CA138882, R01EB009745]; NATIONAL CANCER INSTITUTE [R01CA138882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009745] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study was funded by the National Institutes of Health via grant numbers R01CA138882 and R01EB009745. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Al-Rakan MA, 2013, J PATHOL, V231, P457, DOI 10.1002/path.4256; Alonso-Magdalena P, 2009, P NATL ACAD SCI USA, V106, P2859, DOI 10.1073/pnas.0812666106; [Anonymous], 1998, LANCET, V351, P1451; Balduyck M, 2000, CLIN EXP METASTAS, V18, P171, DOI 10.1023/A:1006762425323; Bauer M, 2010, INTEGR BIOL-UK, V2, P371, DOI 10.1039/c0ib00001a; Bergamaschi A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2913; Bhargava R, 2007, ANAL BIOANAL CHEM, V389, P1155, DOI 10.1007/s00216-007-1511-9; Bhargava R, 2007, ADV ANAT PATHOL, V14, P93, DOI 10.1097/PAP.0b013e31803244d5; Bhargava R, 2006, BBA-BIOMEMBRANES, V1758, P830, DOI 10.1016/j.bbamem.2006.05.007; Bhargava R, 2012, APPL SPECTROSC, V66, P1091, DOI 10.1366/12-06801; Boersma BJ, 2008, INT J CANCER, V122, P1324, DOI 10.1002/ijc.23237; Cardamone MD, 2009, P NATL ACAD SCI USA, V106, P7420, DOI 10.1073/pnas.0903033106; CASAL HL, 1984, BIOCHIM BIOPHYS ACTA, V779, P381, DOI 10.1016/0304-4157(84)90017-0; Casbas-Hernandez P, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3476; Casbas-Hernandez P, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/520987; CLARK GM, 1984, J CLIN ONCOL, V2, P1102, DOI 10.1200/JCO.1984.2.10.1102; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dehdashti F, 2009, BREAST CANCER RES TR, V113, P509, DOI 10.1007/s10549-008-9953-0; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Elenbaas B, 2001, EXP CELL RES, V264, P169, DOI 10.1006/excr.2000.5133; Fang H, 2013, CANCER RES, V73, P4965, DOI 10.1158/0008-5472.CAN-13-0661; Fernandez DC, 2005, NAT BIOTECHNOL, V23, P469, DOI 10.1038/nbt1080; Filipits M, 2011, CLIN CANCER RES, V17, P6012, DOI 10.1158/1078-0432.CCR-11-0926; Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085; Frasor J, 2006, CANCER RES, V66, P7334, DOI 10.1158/0008-5472.CAN-05-4269; Gazi E, 2003, J PATHOL, V201, P99, DOI 10.1002/path.1421; Gazi E, 2009, VIB SPECTROSC, V50, P99, DOI 10.1016/j.vibspec.2008.09.006; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Holton SE, 2011, BIOPHYS J, V101, P1513, DOI 10.1016/j.bpj.2011.07.055; Hutcheson IR, 2003, BREAST CANCER RES TR, V81, P81, DOI 10.1023/A:1025484908380; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jahkola T, 1998, EUR J CANCER, V34, P1687, DOI 10.1016/S0959-8049(98)00215-9; KEITH FN, 2008, PRACTICAL PROTOCOLS, P85310; Kimlin LC, 2013, MOL CARCINOGEN, V52, P167, DOI 10.1002/mc.21844; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; Ma L, 2001, J PATHOL, V194, P413, DOI 10.1002/path.902; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; Mourant JR, 2003, BIOPHYS J, V85, P1938, DOI 10.1016/S0006-3495(03)74621-9; Muggerud AA, 2010, MOL ONCOL, V4, P357, DOI 10.1016/j.molonc.2010.06.007; Muranen T, 2012, CANCER CELL, V21, P227, DOI 10.1016/j.ccr.2011.12.024; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Nelson CM, 2008, NAT PROTOC, V3, P674, DOI 10.1038/nprot.2008.35; Olumi AF, 1999, CANCER RES, V59, P5002; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Pontiggia O, 2012, BREAST CANCER RES TR, V133, P459, DOI 10.1007/s10549-011-1766-x; Reddy RK, 2013, APPL SPECTROSC, V67, P93, DOI 10.1366/11-06568; Reddy RK, 2010, ANALYST, V135, P2818, DOI 10.1039/c0an00350f; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; RonnovJessen L, 1996, PHYSIOL REV, V76, P69, DOI 10.1152/physrev.1996.76.1.69; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Schuetz CS, 2006, CANCER RES, V66, P5278, DOI 10.1158/0008-5472.CAN-05-4610; Steiner G, 2002, P SOC PHOTO-OPT INS, V4614, P127, DOI 10.1117/12.460789; Stossi F, 2012, ONCOGENE, V31, P1825, DOI 10.1038/onc.2011.370; TANG RP, 1992, J CELL BIOCHEM, V50, P350, DOI 10.1002/jcb.240500403; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Tse JC, 2007, J CELL BIOCHEM, V101, P816, DOI 10.1002/jcb.21215; Vizoso FJ, 2007, BRIT J CANCER, V96, P903, DOI 10.1038/sj.bjc.6603666; Walsh MJ, 2008, STEM CELLS, V26, P108, DOI 10.1634/stemcells.2007-0196; Walsh MJ, 2012, VIB SPECTROSC, V60, P23, DOI 10.1016/j.vibspec.2012.01.010; Walsh MJ, 2009, STEM CELL RES, V3, P15, DOI 10.1016/j.scr.2009.02.003; Ward A, 2013, ONCOGENE, V32, P1173, DOI 10.1038/onc.2012.128; Wik E, 2013, CLIN CANCER RES, V19, P1094, DOI 10.1158/1078-0432.CCR-12-3039; Wood BR, 2004, GYNECOL ONCOL, V93, P59, DOI 10.1016/j.ygyno.2003.12.028; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009	68	34	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96878	10.1371/journal.pone.0096878	http://dx.doi.org/10.1371/journal.pone.0096878			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816718	Green Published, Green Submitted, gold			2022-12-27	WOS:000336838000076
J	Li, J; Zhu, L; Lu, GX; Zhan, XB; Lin, CC; Zheng, ZY				Li, Jing; Zhu, Li; Lu, Guangxing; Zhan, Xiao-Bei; Lin, Chi-Chung; Zheng, Zhi-Yong			Curdlan beta-1,3-Glucooligosaccharides Induce the Defense Responses against Phytophthora infestans Infection of Potato (Solanum tuberosum L. cv. McCain G1) Leaf Cells	PLOS ONE			English	Article							KINESIN-LIKE PROTEIN; PHENYLPROPANOID PATHWAY; PLANT DEFENSE; GENES; RESISTANCE; ELICITOR; ACID; IDENTIFICATION; BIOSYNTHESIS; EXPRESSION	Activation of the innate immune system before the invasion of pathogens is a promising way to improve the resistance of plant against infection while reducing the use of agricultural chemicals. Although several elicitors were used to induce the resistance of potato plant to microbial pathogen infection, the role of curdlan oligosaccharide (CurdO) has not been established. In the current study, the defense responses were investigated at biochemical and proteomic levels to elucidate the elicitation effect of CurdOs in foliar tissues of potato (Solanum tuberosum L. cv. McCain G1). The results indicate that the CurdOs exhibit activation effect on the early-and late-defense responses in potato leaves. In addition, glucopentaose was proved to be the shortest active curdlan molecule based on the accumulation of H2O2 and salicylic acid and the activities of phenylalanine amino-lyase, beta-1,3-glucanase and chitinase. The 2D-PAGE analysis reveals that CurdOs activate the integrated response reactions in potato cells, as a number of proteins with various functions are up-regulated including disease/defense, metabolism, transcription, and cell structure. The pathogenesis assay shows that the ratio of lesion area of potato leaf decreased from 15.82% +/- 5.44% to 7.79% +/- 3.03% when the plants were treated with CurdOs 1 day before the infection of Phytophthora infestans. Furthermore, the results on potato yield and induction reactions indicate that the defense responses induced by CurdOs lasted for short period of time but disappeared gradually.	[Li, Jing; Lu, Guangxing; Zhan, Xiao-Bei; Lin, Chi-Chung; Zheng, Zhi-Yong] Jiangnan Univ, Minist Educ, Key Lab Carbohydrate Chem & Biotechnol, Wuxi, Jiangsu, Peoples R China; [Zhu, Li; Zhan, Xiao-Bei] Jiangsu Rayguang Biotech Co Ltd, Wuxi, Jiangsu, Peoples R China	Jiangnan University	Zhan, XB (corresponding author), Jiangnan Univ, Minist Educ, Key Lab Carbohydrate Chem & Biotechnol, Wuxi, Jiangsu, Peoples R China.	xbzhan@yahoo.com; CCL92122@yahoo.com	Lin, Chi-Chung/L-2197-2019	Lin, Chi-Chung/0000-0003-2794-7707; Li, Jing/0000-0002-6945-9851; Zheng, Zhiyong/0000-0002-9716-9325	National Natural Science Foundation of China [31171640, 31271888]; National Hightech R&D Program of China [2012AA021505, 2011BAD23B04]; Program for the Wuxi Bio-Agriculture Entrepreneurial Leader; Jiangsu Rayguang Biotech Company Ltd.	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Hightech R&D Program of China(National High Technology Research and Development Program of China); Program for the Wuxi Bio-Agriculture Entrepreneurial Leader; Jiangsu Rayguang Biotech Company Ltd.	This work is supported by the research grants from the National Natural Science Foundation of China (31171640, 31271888, http://www.nsfc.gov.cn), National Hightech R&D Program of China (2012AA021505, 2011BAD23B04, http://www.863.gov.cn), and Program for the Wuxi Bio-Agriculture Entrepreneurial Leader (130 Plan, http://www.wuxi.gov.cn). The funders above had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This project was also partially funded by Jiangsu Rayguang Biotech Company Ltd. The funder provided support in the form of salaries for authors LZ and XBZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alexopoulos C. J., 1996; Andreu A, 1998, EUR J PLANT PATHOL, V104, P777, DOI 10.1023/A:1008602910733; Bevan M, 1998, NATURE, V391, P485, DOI 10.1038/35140; Chan RL, 1998, BBA-GENE STRUCT EXPR, V1442, P1, DOI 10.1016/S0167-4781(98)00119-5; CHEONG JJ, 1991, PLANT CELL, V3, P137, DOI 10.1105/tpc.3.2.137; COSIO EG, 1992, EUR J BIOCHEM, V204, P1115, DOI 10.1111/j.1432-1033.1992.tb16736.x; Dietz KJ, 2003, ANNU REV PLANT BIOL, V54, P93, DOI 10.1146/annurev.arplant.54.031902.134934; Dixon RA, 2002, MOL PLANT PATHOL, V3, P371, DOI 10.1046/j.1364-3703.2002.00131.x; Do HM, 2003, MOL PLANT MICROBE IN, V16, P196, DOI 10.1094/MPMI.2003.16.3.196; Duceppe MO, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-73; El Modafar C, 2012, SCI HORTIC-AMSTERDAM, V138, P55, DOI 10.1016/j.scienta.2012.02.011; Facchini PJ, 2001, ANNU REV PLANT PHYS, V52, P29, DOI 10.1146/annurev.arplant.52.1.29; Fluhr R, 2012, PHYSIOL PLANTARUM, V145, P95, DOI 10.1111/j.1399-3054.2011.01540.x; Fu YB, 2011, CARBOHYD POLYM, V86, P774, DOI 10.1016/j.carbpol.2011.05.022; Gazendam I, 2004, PHYSIOL MOL PLANT P, V65, P145, DOI 10.1016/j.pmpp.2005.01.002; Gebhardt C, 2001, ANNU REV PHYTOPATHOL, V39, P79, DOI 10.1146/annurev.phyto.39.1.79; Glaczinski H, 2002, POTATO RES, V45, P163, DOI 10.1007/BF02736112; Henriquez MA, 2012, PLANT PHYSIOL BIOCH, V60, P119, DOI 10.1016/j.plaphy.2012.07.027; Ippolito A, 2000, POSTHARVEST BIOL TEC, V19, P265, DOI 10.1016/S0925-5214(00)00104-6; Jain M, 2008, FEBS J, V275, P2845, DOI 10.1111/j.1742-4658.2008.06424.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Klarzynski O, 2003, MOL PLANT MICROBE IN, V16, P115, DOI 10.1094/MPMI.2003.16.2.115; Klarzynski O, 2000, PLANT PHYSIOL, V124, P1027, DOI 10.1104/pp.124.3.1027; Kombrink E, 1995, ADV BOT RES, V21, P1; Kuc J, 1997, ACTA PHYSIOL PLANT, V19, P551, DOI 10.1007/s11738-997-0053-2; Li J, 2013, APPL MICROBIOL BIOT, V97, P8495, DOI 10.1007/s00253-013-5125-1; Li J, 2012, PROTOPLASMA, V249, P95, DOI 10.1007/s00709-011-0357-3; Li MY, 2003, J PHYTOPATHOL, V151, P540, DOI 10.1046/j.1439-0434.2003.00765.x; Li SJ, 2013, FOREST PATHOL, V43, P67, DOI 10.1111/j.1439-0329.2012.00797.x; Lim S, 2012, J PROTEOME RES, V11, P2594, DOI 10.1021/pr201004k; Matsuda F, 2005, PLANT CELL PHYSIOL, V46, P454, DOI 10.1093/pcp/pci042; Matsui M, 2006, BIOL CHEM, V387, P1535, DOI 10.1515/BC.2006.191; McDowell JM, 2000, TRENDS BIOCHEM SCI, V25, P79, DOI 10.1016/S0968-0004(99)01532-7; Mochizuki R, 2003, BIOCHEM BIOPH RES CO, V310, P1219, DOI 10.1016/j.bbrc.2003.09.153; Montesano M, 2003, MOL PLANT PATHOL, V4, P73, DOI 10.1046/j.1364-3703.2003.00150.x; Montesano M, 2001, MOL PLANT PATHOL, V2, P339, DOI 10.1046/j.1464-6722.2001.00083.x; Mukherjee K, 2009, MOL BIOL EVOL, V26, P2775, DOI 10.1093/molbev/msp201; Oppenheimer DG, 1997, P NATL ACAD SCI USA, V94, P6261, DOI 10.1073/pnas.94.12.6261; PAUTOT V, 1993, P NATL ACAD SCI USA, V90, P9906, DOI 10.1073/pnas.90.21.9906; Rempelos L, 2013, MOL BREEDING, V31, P363, DOI 10.1007/s11032-012-9795-7; Roberts TH, 2008, FUNCT INTEGR GENOMIC, V8, P1, DOI 10.1007/s10142-007-0059-2; Slocum RD, 2005, PLANT PHYSIOL BIOCH, V43, P729, DOI 10.1016/j.plaphy.2005.06.007; Smith CJ, 1996, NEW PHYTOL, V132, P1, DOI 10.1111/j.1469-8137.1996.tb04506.x; Spicer EJF, 1999, FOOD CHEM TOXICOL, V37, P455, DOI 10.1016/S0278-6915(99)00013-7; Tripathi BN, 2009, PROTOPLASMA, V235, P3, DOI 10.1007/s00709-009-0032-0; Urbany C, 2012, J PROTEOME RES, V11, P703, DOI 10.1021/pr2006186; van der Hoorn RAL, 2004, CURR OPIN PLANT BIOL, V7, P400, DOI 10.1016/j.pbi.2004.04.003; Van Loon LC, 1997, EUR J PLANT PATHOL, V103, P753, DOI 10.1023/A:1008638109140; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; van Spronsen PC, 2003, MOL PLANT MICROBE IN, V16, P83, DOI 10.1094/MPMI.2003.16.1.83; Vera J, 2011, MAR DRUGS, V9, P2514, DOI 10.3390/md9122514; Wang JW, 2004, NITRIC OXIDE-BIOL CH, V11, P298, DOI 10.1016/j.niox.2004.10.003; Wolski EA, 2005, CARBOHYD RES, V340, P619, DOI 10.1016/j.carres.2004.12.020; Wolski EA, 2006, PHYSIOL MOL PLANT P, V69, P93, DOI 10.1016/j.pmpp.2007.02.001; Xu CP, 2006, PHYTOCHEMISTRY, V67, P2431, DOI 10.1016/j.phytochem.2006.09.002; Zhan XB, 2012, APPL MICROBIOL BIOT, V93, P525, DOI 10.1007/s00253-011-3740-2; Zhong RQ, 2002, PLANT CELL, V14, P3101, DOI 10.1105/tpc.005801; Zhu SX, 2012, TRANSGENIC RES, V21, P89, DOI 10.1007/s11248-011-9510-1	58	15	17	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97197	10.1371/journal.pone.0097197	http://dx.doi.org/10.1371/journal.pone.0097197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816730	Green Published, gold, Green Submitted			2022-12-27	WOS:000336838000116
J	Nkuipou-Kenfack, E; Duranton, F; Gayrard, N; Argiles, A; Lundin, U; Weinberger, KM; Dakna, M; Delles, C; Mullen, W; Husi, H; Klein, J; Koeck, T; Zurbig, P; Mischak, H				Nkuipou-Kenfack, Esther; Duranton, Flore; Gayrard, Nathalie; Argiles, Angel; Lundin, Ulrika; Weinberger, Klaus M.; Dakna, Mohammed; Delles, Christian; Mullen, William; Husi, Holger; Klein, Julie; Koeck, Thomas; Zuerbig, Petra; Mischak, Harald			Assessment of Metabolomic and Proteomic Biomarkers in Detection and Prognosis of Progression of Renal Function in Chronic Kidney Disease	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS SPECTROMETRY; LIPID-METABOLISM; CARNITINE; PLASMA; ACYLCARNITINES; DYSREGULATION; MECHANISMS; DIAGNOSIS; SYSTEM; ADMA	Chronic kidney disease (CKD) is part of a number of systemic and renal diseases and may reach epidemic proportions over the next decade. Efforts have been made to improve diagnosis and management of CKD. We hypothesised that combining metabolomic and proteomic approaches could generate a more systemic and complete view of the disease mechanisms. To test this approach, we examined samples from a cohort of 49 patients representing different stages of CKD. Urine samples were analysed for proteomic changes using capillary electrophoresis-mass spectrometry and urine and plasma samples for metabolomic changes using different mass spectrometry-based techniques. The training set included 20 CKD patients selected according to their estimated glomerular filtration rate (eGFR) at mild (59.9 +/- 16.5 mL/min/1.73 m(2); n = 10) or advanced (8.9 +/- 4.5 mL/min/1.73 m(2); n = 10) CKD and the remaining 29 patients left for the test set. We identified a panel of 76 statistically significant metabolites and peptides that correlated with CKD in the training set. We combined these biomarkers in different classifiers and then performed correlation analyses with eGFR at baseline and follow-up after 2.8 +/- 0.8 years in the test set. A solely plasma metabolite biomarker-based classifier significantly correlated with the loss of kidney function in the test set at baseline and follow-up (rho = -0.8031; p < 0.0001 and rho = -0.6009; p = 0.0019, respectively). Similarly, a urinary metabolite biomarker-based classifier did reveal significant association to kidney function (rho = 20.6557; p = 0.0001 and rho = -0.6574; p = 0.0005). A classifier utilising 46 identified urinary peptide biomarkers performed statistically equivalent to the urinary and plasma metabolite classifier (rho = -0.7752; p < 0.0001 and rho = -0.8400; p < 0.0001). The combination of both urinary proteomic and urinary and plasma metabolic biomarkers did not improve the correlation with eGFR. In conclusion, we found excellent association of plasma and urinary metabolites and urinary peptides with kidney function, and disease progression, but no added value in combining the different biomarkers data.	[Nkuipou-Kenfack, Esther; Dakna, Mohammed; Klein, Julie; Koeck, Thomas; Zuerbig, Petra; Mischak, Harald] Mosa Diagnost GmbH, Hannover, Germany; [Nkuipou-Kenfack, Esther] Hannover Med Sch, Dept Toxicol, Hannover, Germany; [Duranton, Flore; Gayrard, Nathalie; Argiles, Angel] RD Nephrol, Montpellier, France; [Lundin, Ulrika; Weinberger, Klaus M.] Biocrates Life Sci AG, Innsbruck, Austria; [Weinberger, Klaus M.] SAnalytiCo Ltd, Belfast, Antrim, North Ireland; [Weinberger, Klaus M.] Private Univ Hlth Sci Med Informat & Technol, Dept Biomed Informat & Mechatron, Hall In Tirol, Austria; [Argiles, Angel] Nephrol Dialyse St Guilhem, Sete, France; [Argiles, Angel] Serv Nephrol Dialyse Peritoneale & Transplantat, Montpellier, France; [Delles, Christian; Mullen, William; Husi, Holger; Mischak, Harald] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland	Modular Open Systems Approach (MOSA) Solutions; Hannover Medical School; University of Glasgow	Mischak, H (corresponding author), Mosa Diagnost GmbH, Hannover, Germany.	mischak@mosaiques-diagnostics.com	Duranton, Flore/A-8373-2015; Duranton, Flore/ABB-6225-2021; Mullen, William/GWC-8078-2022; gayrard, nathalie/AAO-2888-2020; Klein, Julie/M-7088-2017; Klein, Julie/ABE-2622-2020	Duranton, Flore/0000-0003-3202-0551; Duranton, Flore/0000-0003-3202-0551; gayrard, nathalie/0000-0001-8283-8429; Klein, Julie/0000-0002-3279-0559; Klein, Julie/0000-0002-3279-0559; Mischak, Harald/0000-0003-0323-0306; Weinberger, Klaus/0000-0002-8947-5306; Zurbig, Petra/0000-0003-3465-2173; Mullen, William/0000-0002-5685-1563; Argiles, Angel/0000-0001-7029-4532	EU-MASCARA [GA 31354, GA 251368, HEALTH-2011-278249]; SysKID [HEALTH-F2-2009-241544]; Eurotransbio Program	EU-MASCARA; SysKID; Eurotransbio Program	The project was partly funded by grant GA 31354 (CodeAge) FP7-PEOPLE-2011-ITN program, GA 251368 (Protoclin) from the FP7-PEOPLE-2009-IAPP program, through EU-MASCARA (HEALTH-2011-278249), SysKID (HEALTH-F2-2009-241544), and the Eurotransbio Program. AA and HM are members of the European Uraemic Toxin working group of the European Society of Artificial Organs (ESAO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SJ, 2013, NAT REV NEPHROL, V9, P623, DOI [10.1038/nrneph.2013.4, 10.1038/nrneph.2013.184, 10.1038/nrneph.2012.256, 10.1038/nrneph.2013.3, 10.1038/nrneph.2013.141]; Argiles A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062837; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boger RH, 2003, ATHEROSCLEROSIS SUPP, V4, P23, DOI 10.1016/S1567-5688(03)00030-8; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Cheng S, 2006, FASEB J, V20, P1898, DOI 10.1096/fj.06-5898fje; Dakna M, 2009, J CHROMATOGR B, V877, P1250, DOI 10.1016/j.jchromb.2008.10.048; Deininger SO, 2008, J PROTEOME RES, V7, P5230, DOI 10.1021/pr8005777; Drosatos Konstantinos, 2013, Curr Heart Fail Rep, V10, P109, DOI 10.1007/s11897-013-0133-0; Duranton F, 2013, CLIN J AM SOC NEPHRO; Duranton F, 2014, CLIN J AM SOC NEPHRO, V9, P37, DOI 10.2215/CJN.06000613; Eibl G, 2008, RAPID COMMUN MASS SP, V22, P2248, DOI 10.1002/rcm.3591; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fouque D, 2006, J RENAL NUTR, V16, P125, DOI 10.1053/j.jrn.2006.01.004; Girolami Mark, 2006, Drug Discov Today Technol, V3, P13, DOI 10.1016/j.ddtec.2006.03.010; Goek ON, 2013, NEPHROL DIAL TRANSPL, V28, P2131, DOI 10.1093/ndt/gft217; Good DM, 2010, MOL CELL PROTEOMICS, V9, P2424, DOI 10.1074/mcp.M110.001917; Guebre-Egziabher F, 2013, BIOCHIMIE, V95, P1971, DOI 10.1016/j.biochi.2013.07.017; Haubitz M, 2009, MOL CELL PROTEOMICS, V8, P2296, DOI 10.1074/mcp.M800529-MCP200; Jantos-Siwy J, 2009, J PROTEOME RES, V8, P268, DOI 10.1021/pr800401m; Jin K, 2013, NEPHROL DIAL TRANSPL, V28, P313, DOI 10.1093/ndt/gfs350; Kielstein JT, 2006, STROKE, V37, P2024, DOI 10.1161/01.STR.0000231640.32543.11; Kielstein JT, 1999, J AM SOC NEPHROL, V10, P594; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Li LO, 2010, BBA-MOL CELL BIOL L, V1801, P246, DOI 10.1016/j.bbalip.2009.09.024; Miller WG, 2009, CLIN CHEM, V55, P24, DOI 10.1373/clinchem.2008.106567; Mischak H, 2014, J PROTEOMICS, V96, pA1, DOI 10.1016/j.jprot.2013.12.002; Mischak H, 2013, CLIN BIOCHEM, V46, P432, DOI 10.1016/j.clinbiochem.2012.09.025; Mischak H, 2012, EUR J CLIN INVEST, V42, P1027, DOI 10.1111/j.1365-2362.2012.02674.x; Mischak H, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001249; Neilson EG, 2006, NAT CLIN PRACT NEPHR, V2, P101, DOI 10.1038/ncpneph0093; Neuhoff NV, 2004, RAPID COMMUN MASS SP, V18, P149, DOI 10.1002/rcm.1294; Pawlak K, 2009, BLOOD COAGUL FIBRIN, V20, P590, DOI 10.1097/MBC.0b013e32832da16d; Pawlak K, 2009, ATHEROSCLEROSIS, V204, P309, DOI 10.1016/j.atherosclerosis.2008.08.014; Posada-Ayala M, 2014, KIDNEY INT, V85, P103, DOI 10.1038/ki.2013.328; Prajczer S, 2010, NEPHROL DIAL TRANSPL, V25, P1896, DOI 10.1093/ndt/gfp748; R Core Team, 2018, R LANG ENV STAT COMP; Rebouche CJ, 2004, ANN NY ACAD SCI, V1033, P30, DOI 10.1196/annals.1320.003; Reuter SE, 2012, CLIN PHARMACOKINET, V51, P553, DOI 10.2165/11633940-000000000-00000; Rhee EP, 2013, J AM SOC NEPHROL, V24, P1330, DOI 10.1681/ASN.2012101006; Rodriguez-Iturbe B, 2005, KIDNEY INT, V68, P2131, DOI 10.1111/j.1523-1755.2005.00669.x; Rodriguez-Suarez E, 2013, BIOCH BIOPHYS ACTA; Roscioni SS, 2013, DIABETOLOGIA, V56, P259, DOI 10.1007/s00125-012-2755-2; Ruster C, 2006, J AM SOC NEPHROL, V17, P2985, DOI 10.1681/ASN.2006040356; SCHMIDTSOMMERFELD E, 1990, PEDIATR RES, V28, P158, DOI 10.1203/00006450-199028020-00016; Shah VO, 2013, CLIN J AM SOC NEPHRO, V8, P363, DOI 10.2215/CJN.05540512; Silberring J, 2010, TRAC-TREND ANAL CHEM, V29, P128, DOI 10.1016/j.trac.2009.11.007; Tankiewicz A, 2003, ADV EXP MED BIOL, V527, P409; Tsikas D, 2000, FEBS LETT, V478, P1, DOI 10.1016/S0014-5793(00)01686-0; Unterwurzacher I, 2008, CLIN CHEM LAB MED, V46, P1589, DOI 10.1515/CCLM.2008.323; Vaziri ND, 2009, SEMIN DIALYSIS, V22, P644, DOI 10.1111/j.1525-139X.2009.00661.x; Vogl T, 2004, BLOOD, V104, P4260, DOI 10.1182/blood-2004-02-0446; WANNER C, 1987, KIDNEY INT, V32, pS132; Yang ZR, 2004, BRIEF BIOINFORM, V5, P328, DOI 10.1093/bib/5.4.328; Zhou JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071023; Zurbig P, 2012, DIABETES, V61, P3304, DOI 10.2337/db12-0348	56	74	76	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96955	10.1371/journal.pone.0096955	http://dx.doi.org/10.1371/journal.pone.0096955			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24817014	gold, Green Published, Green Accepted			2022-12-27	WOS:000336838000086
J	Opyrchal, M; Salisbury, JL; Zhang, SY; McCubrey, J; Hawse, J; Goetz, MP; Lomberk, GA; Haddad, T; Degnim, A; Lange, C; Ingle, JN; Galanis, E; D'Assoro, AB				Opyrchal, Mateusz; Salisbury, Jeffrey L.; Zhang, Shuya; McCubrey, James; Hawse, John; Goetz, Mattew P.; Lomberk, Gwen A.; Haddad, Tufia; Degnim, Amy; Lange, Carol; Ingle, James N.; Galanis, Evanthia; D'Assoro, Antonino B.			Aurora-A Mitotic Kinase Induces Endocrine Resistance through Down-Regulation of ER alpha Expression in Initially ER alpha plus Breast Cancer Cells	PLOS ONE			English	Article							CENTROSOME AMPLIFICATION; MESENCHYMAL TRANSITION; STEM-CELLS; MECHANISMS; TAMOXIFEN; ESTROGEN; RESPONSIVENESS; INSTABILITY	Development of endocrine resistance during tumor progression represents a major challenge in the management of estrogen receptor alpha (ER alpha) positive breast tumors and is an area under intense investigation. Although the underlying mechanisms are still poorly understood, many studies point towards the 'cross-talk' between ER alpha and MAPK signaling pathways as a key oncogenic axis responsible for the development of estrogen-independent growth of breast cancer cells that are initially ER alpha+ and hormone sensitive. In this study we employed a metastatic breast cancer xenograft model harboring constitutive activation of Raf-1 oncogenic signaling to investigate the mechanistic linkage between aberrant MAPK activity and development of endocrine resistance through abrogation of the ER alpha signaling axis. We demonstrate for the first time the causal role of the Aurora-A mitotic kinase in the development of endocrine resistance through activation of SMAD5 nuclear signaling and down-regulation of ER alpha expression in initially ER alpha+ breast cancer cells. This contribution is highly significant for the treatment of endocrine refractory breast carcinomas, because it may lead to the development of novel molecular therapies targeting the Aurora-A/SMAD5 oncogenic axis. We postulate such therapy to result in the selective eradication of endocrine resistant ER alpha(low/-) cancer cells from the bulk tumor with consequent benefits for breast cancer patients.	[Opyrchal, Mateusz; Goetz, Mattew P.; Lomberk, Gwen A.; Haddad, Tufia; Ingle, James N.; Galanis, Evanthia; D'Assoro, Antonino B.] Mayo Clin, Dept Med Oncol, Coll Med, Rochester, MN 55905 USA; [Salisbury, Jeffrey L.; Zhang, Shuya; Hawse, John; D'Assoro, Antonino B.] Mayo Clin, Dept Biochem & Mol Biol, Coll Med, Rochester, MN USA; [Galanis, Evanthia] Mayo Clin, Dept Mol Med, Coll Med, Rochester, MN USA; [Degnim, Amy] Mayo Clin, Dept Gen Surg, Coll Med, Rochester, MN USA; [McCubrey, James] E Carolina Univ, Dept Microbiol & Immunol, Greenville, NC USA; [Lange, Carol] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Lange, Carol] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of North Carolina; East Carolina University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Galanis, E (corresponding author), Mayo Clin, Dept Med Oncol, Coll Med, Rochester, MN 55905 USA.	Galanis.evanthia@mayo.edu; Dassoro.antonio@mayo.edu	Goetz, Matthew P/AAH-2333-2020; Lomberk, Gwen/AAL-8490-2020	Lomberk, Gwen/0000-0001-5463-789X; McCubrey, James/0000-0001-6027-3156; Lange, Carol/0000-0003-2751-3976; Harrington, Jon/0000-0003-1293-5201	Atwater Foundation; USAMRMC [BC022276]; Intramural RECDA Award; Mayo Clinic Breast Cancer Specialized Program of Research Excellence NIH [CA116201]; NCI [CA72836]; Mayo Clinic School of Medicine; NATIONAL CANCER INSTITUTE [P50CA116201, R01CA072836, K12CA090628, R01CA178627, P30CA015083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER	Atwater Foundation; USAMRMC(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Intramural RECDA Award; Mayo Clinic Breast Cancer Specialized Program of Research Excellence NIH; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mayo Clinic School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the Atwater Foundation to E. G., USAMRMC BC022276 and Intramural RECDA Award to A. B. D., the Mayo Clinic Breast Cancer Specialized Program of Research Excellence NIH CA116201 to J.I., NCI CA72836 to J.L.S. and the Mayo Clinic School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhola NE, 2013, J CLIN INVEST, V123, P1348, DOI 10.1172/JCI65416; Chang CJ, 2011, CANCER CELL, V19, P86, DOI 10.1016/j.ccr.2010.10.035; Colleoni M, 2009, ANN ONCOL, V20, P1344, DOI 10.1093/annonc/mdp024; D'Assoro AB, 2014, ONCOGENE, V33, P599, DOI 10.1038/onc.2012.628; D'Assoro AB, 2002, ONCOGENE, V21, P6146, DOI 10.1038/sj.onc.1205772; Dhasarathy A, 2007, MOL ENDOCRINOL, V21, P2907, DOI 10.1210/me.2007-0293; Di Leo A, 2012, J CLIN ONCOL, V30, P1897, DOI 10.1200/JCO.2012.41.7394; Dodwell D, 2006, BREAST, V15, P584, DOI 10.1016/j.breast.2006.01.007; Goepfert TM, 2007, INT J CANCER, V120, P985, DOI 10.1002/ijc.22420; Haughian JM, 2012, P NATL ACAD SCI USA, V109, P2742, DOI 10.1073/pnas.1106509108; Horwitzt KB, 2008, P NATL ACAD SCI USA, V105, P5774, DOI 10.1073/pnas.0706216105; Hwang-Verslues WW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008377; Ithimakin S, 2013, CANCER RES, V73, P1635, DOI 10.1158/0008-5472.CAN-12-3349; Lee YY, 2012, CANCER RES, V72, DOI [10.1158/1538-7445.AM2012-4651, 10.1158/0008-5472.CAN-12-2397]; Leontovich AA, 2012, INT J ONCOL, V40, P1858, DOI 10.3892/ijo.2012.1407; Li CI, 2003, J CLIN ONCOL, V21, P28, DOI 10.1200/JCO.2003.03.088; Li JJ, 2004, P NATL ACAD SCI USA, V101, P18123, DOI 10.1073/pnas.0408273101; Likhite VS, 2006, MOL ENDOCRINOL, V20, P3120, DOI 10.1210/me.2006-0068; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Miller WR, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr2931; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Qi W, 2012, LEUKEMIA RES, V37, P434; Ring A, 2004, ENDOCR-RELAT CANCER, V11, P643, DOI 10.1677/erc.1.00776; Robertson JFR, 2003, CANCER, V98, P229, DOI 10.1002/cncr.11468; Schiff R, 2004, CLIN CANCER RES, V10, p331S, DOI 10.1158/1078-0432.CCR-031212; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Staff S, 2010, ONCOL REP, V23, P307, DOI 10.3892/or_00000637; Yamamoto Y, 2009, BREAST CANCER-TOKYO, V16, P260, DOI 10.1007/s12282-009-0150-8; Ye Y, 2010, ONCOGENE, V29, P1451, DOI 10.1038/onc.2009.433	29	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96995	10.1371/journal.pone.0096995	http://dx.doi.org/10.1371/journal.pone.0096995			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816249	Green Published, gold, Green Submitted			2022-12-27	WOS:000336838000091
J	Yao, H; Nabika, T				Yao, Hiroshi; Nabika, Toru			Excess Salt Increases Infarct Size Produced by Photothrombotic Distal Middle Cerebral Artery Occlusion in Spontaneously Hypertensive Rats	PLOS ONE			English	Article							FOCAL ISCHEMIA; HEMORRHAGIC TRANSFORMATION; VASCULAR RELAXATION; BRAIN; REPERFUSION; DIET; STROKE; THROMBOLYSIS; MECHANISMS; SODIUM	Cerebral circulation is known to be vulnerable to high salt loading. However, no study has investigated the effects of excess salt on focal ischemic brain injury. After 14 days of salt loading (0.9% saline) or water, spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto rats (WKY) were subjected to photothrombotic middle cerebral artery occlusion (MCAO), and infarct volume was determined at 48 h after MCAO: albumin and hemoglobin contents in discrete brain regions were also determined in SHR. Salt loading did not affect blood pressure levels in SHR and WKY. After MCAO, regional cerebral blood flow (CBF), determined with two ways of laser-Doppler flowmetry (one-point measurement or manual scanning), was more steeply decreased in the salt-loaded group than in the control group. In SHR/Izm, infarct volume in the salt-loaded group was 112 +/- 27 mm(3), which was significantly larger than 77612 mm(3) in the control group (p = 0.002), while the extents of blood-brain barrier disruption (brain albumin and hemoglobin levels) were not affected by excess salt. In WKY, salt loading did not significantly increase infarct size. These results show the detrimental effects of salt loading on intra-ischemic CBF and subsequent brain infarction produced by phototrhombotic MCAO in hypertensive rats.	[Yao, Hiroshi] Natl Hosp Org Hizen Psychiat Ctr, Lab Neurochem, Saga, Japan; [Nabika, Toru] Shimane Univ Sch Med, Dept Funct Pathol, Saga, Japan	Shimane University	Yao, H (corresponding author), Natl Hosp Org Hizen Psychiat Ctr, Lab Neurochem, Saga, Japan.	hyao@hizen2.hosp.go.jp	Yao, Hiroshi/K-1374-2019		Japan Society for the Promotion of Science (JSPS) KAKENHI [25461098]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 25461098. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1326; Ahn WS, 2005, CANCER SCI, V96, P197, DOI 10.1111/j.1349-7006.2005.00029.x; Belayev L, 1996, BRAIN RES, V739, P88, DOI 10.1016/S0006-8993(96)00815-3; Brozici M, 2003, STROKE, V34, P2750, DOI 10.1161/01.STR.0000095791.85737.65; Cai H, 1998, EUR J PHARMACOL, V341, P73, DOI 10.1016/S0014-2999(97)01459-3; EATON SB, 1985, NEW ENGL J MED, V312, P283, DOI 10.1056/NEJM198501313120505; FERRELL F, 1985, HYPERTENSION, V7, P326, DOI 10.1161/01.HYP.7.3_Pt_1.326; Flynn FW, 2003, PHYSIOL BEHAV, V78, P689, DOI 10.1016/S0031-9384(03)00062-3; Fredriksson I., 2007, LASER DOPPLER FLOWME; Gandolgor TA, 2013, HYPERTENSION, V62, P55, DOI 10.1161/HYPERTENSIONAHA.111.00488; Gardener H, 2012, STROKE, V43, P1200, DOI 10.1161/STROKEAHA.111.641043; Guerrini U, 2002, STROKE, V33, P825, DOI 10.1161/hs0302.104111; He FJ, 2011, LANCET, V378, P380, DOI 10.1016/S0140-6736(11)61174-4; Henning EC, 2008, STROKE, V39, P3405, DOI 10.1161/STROKEAHA.108.520304; Jin R, 2010, NEUROBIOL DIS, V38, P376, DOI 10.1016/j.nbd.2010.03.008; Kim-Mitsuyama S, 2005, STROKE, V36, P1077, DOI 10.1161/01.STR.0000163084.16505.e3; Liu YP, 1999, HYPERTENSION, V33, P686, DOI 10.1161/01.HYP.33.2.686; Lombard JH, 2003, AM J PHYSIOL-HEART C, V284, pH1124, DOI 10.1152/ajpheart.00835.2002; McEwen ST, 2009, MICROCIRCULATION, V16, P220, DOI 10.1080/10739680802544177; Michell A R, 1989, Nutr Res Rev, V2, P149, DOI 10.1079/NRR19890012; Seam N, 2007, CLIN CHEM, V53, P1915, DOI 10.1373/clinchem.2007.091736; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Sumii T, 2002, STROKE, V33, P831, DOI 10.1161/hs0302.104542; Sylvester FA, 2002, AM J PHYSIOL-HEART C, V283, pH353, DOI 10.1152/ajpheart.00127.2002; WATSON BD, 1985, ANN NEUROL, V17, P497, DOI 10.1002/ana.410170513; Yamashita T, 2009, J CEREBR BLOOD F MET, V29, P715, DOI 10.1038/jcbfm.2008.164; Yao H, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-139; Yao H, 2011, CELL MOL NEUROBIOL, V31, P57, DOI 10.1007/s10571-010-9553-5; Yao H, 2009, NEUROCHEM RES, V34, P1999, DOI 10.1007/s11064-009-9988-6; Yao H, 2009, J CEREBR BLOOD F MET, V29, P565, DOI 10.1038/jcbfm.2008.147	30	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97109	10.1371/journal.pone.0097109	http://dx.doi.org/10.1371/journal.pone.0097109			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816928	Green Submitted, Green Published, gold			2022-12-27	WOS:000336838000104
J	Zhang, YL; Zhao, ZM; Guan, L; Mao, LJ; Li, SQ; Guan, XX; Chen, M; Guo, LX; Ding, LH; Cong, CC; Wen, T; Zhao, JY				Zhang, Yanlin; Zhao, Zanmei; Guan, Li; Mao, Lijun; Li, Shuqiang; Guan, Xiaoxu; Chen, Ming; Guo, Lixia; Ding, Lihua; Cong, Cuicui; Wen, Tao; Zhao, Jinyuan			N-Acetyl-Heparin Attenuates Acute Lung Injury Caused by Acid Aspiration Mainly by Antagonizing Histones in Mice	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; NEUTROPHIL EXTRACELLULAR TRAPS; CIRCULATING HISTONES; SMOKE-INHALATION; GLYCOCALYX; MEDIATORS; BINDING; PATHOGENESIS; SEPSIS; DEATH	Acute lung injury (ALI) is the leading cause of death in intensive care units. Extracellular histones have recently been recognized to be pivotal inflammatory mediators. Heparin and its derivatives can bind histones through electrostatic interaction. The purpose of this study was to investigate 1) the role of extracellular histones in the pathogenesis of ALI caused by acid aspiration and 2) whether N-acetyl-heparin (NAH) provides more protection than heparin against histones at the high dose. ALI was induced in mice via intratracheal instillation of hydrochloric acid (HCl). Lethality rate, blood gas, myeloperoxidase (MPO) activity, lung edema and pathological changes were used to evaluate the degree of ALI. Heparin/NAH was administered intraperitoneally, twice a day, for 3 days or until death. Acid aspiration caused an obvious increase in extracellular histones. A significant correlation existed between the concentration of HCl aspirated and the circulating histones. Heparin/NAH (10 mg/kg) improved the lethality rate, blood gas, MPO activity, lung edema and pathological score. At a dose of 20 mg/kg, NAH still provided protection, however heparin tended to aggravate the injury due to hemorrhagic complications. The specific interaction between heparin and histones was verified by the binding assay. In summary, high levels of extracellular histones can be pathogenic in ALI caused by acid aspiration. By neutralizing extracellular histones, heparin/NAH can offer similar protection at the moderate doses. At the high dose, NAH provides better protection than heparin.	[Zhang, Yanlin; Zhao, Zanmei; Guan, Li; Mao, Lijun; Li, Shuqiang; Guan, Xiaoxu; Chen, Ming; Guo, Lixia; Ding, Lihua; Cong, Cuicui; Zhao, Jinyuan] Peking Univ, Res Ctr Occupat Med, Hosp 3, Beijing 100871, Peoples R China; [Wen, Tao] Capital Med Univ, Beijing Inst Hepatol, Beijing Youan Hosp, Beijing, Peoples R China	Peking University; Capital Medical University	Wen, T (corresponding author), Capital Med Univ, Beijing Inst Hepatol, Beijing Youan Hosp, Beijing, Peoples R China.	wentao528@gmail.com; zhaojinyuan@sina.com			National Science Foundation Committee of China (NSFC) [30571551, 81372094]	National Science Foundation Committee of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Science Foundation Committee of China (NSFC, No. 30571551, 81372094). http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla S, 2013, ACTA ANAESTH BELG, V64, P1; Abrams ST, 2013, AM J RESP CRIT CARE, V187, P160, DOI 10.1164/rccm.201206-1037OC; Alcantara FF, 1999, J IMMUNOL METHODS, V226, P11, DOI 10.1016/S0022-1759(99)00043-5; BARZU T, 1986, BIOCHEM J, V238, P847, DOI 10.1042/bj2380847; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Casu B, 2010, MATRIX BIOL, V29, P442, DOI 10.1016/j.matbio.2010.04.003; Caudrillier A, 2012, J CLIN INVEST, V122, P2661, DOI 10.1172/JCI61303; Ciesla DJ, 2005, SURGERY, V138, P749, DOI 10.1016/j.surg.2005.07.020; COX CS, 1993, SURG GYNECOL OBSTET, V176, P339; Freeman CG, 2013, BIOMATERIALS, V34, P5670, DOI 10.1016/j.biomaterials.2013.03.091; Fuchs TA, 2011, BLOOD, V118, P3708, DOI 10.1182/blood-2011-01-332676; Furnrohr BG, 2007, AUTOIMMUNITY, V40, P322, DOI 10.1080/08916930701356457; Gamberucci A, 1998, BIOCHEM J, V331, P623, DOI 10.1042/bj3310623; Ganapathy V, 2005, LIFE SCI, V76, P2631, DOI 10.1016/j.lfs.2005.01.002; Hayashi T, 2013, CIRC J, V77, P338, DOI 10.1253/circj.CJ-12-0743; HIRSCH JG, 1958, J EXP MED, V108, P925, DOI 10.1084/jem.108.6.925; Huang H, 2011, HEPATOLOGY, V54, P999, DOI 10.1002/hep.24501; Kleine TJ, 1997, AM J PHYSIOL-CELL PH, V273, pC1925, DOI 10.1152/ajpcell.1997.273.6.C1925; Ludwig Ralf J, 2009, Curr Drug Discov Technol, V6, P281; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Matthay MA, 2005, AM J RESP CELL MOL, V33, P319, DOI 10.1165/rcmb.F305; Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; MONESTIER M, 1993, MOL IMMUNOL, V30, P1069, DOI 10.1016/0161-5890(93)90153-3; Murakami K, 2003, CLIN SCI, V104, P349, DOI 10.1042/CS20020258; Nakamura T, 2001, ANN THORAC SURG, V72, P1183, DOI 10.1016/S0003-4975(01)02959-9; OLSSON GL, 1986, ACTA ANAESTH SCAND, V30, P84, DOI 10.1111/j.1399-6576.1986.tb02373.x; PAL PK, 1983, THROMB RES, V31, P69, DOI 10.1016/0049-3848(83)90008-7; Raghavendran K, 2011, CRIT CARE MED, V39, P818, DOI 10.1097/CCM.0b013e31820a856b; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Raoof M, 2010, J TRAUMA, V68, P1328, DOI 10.1097/TA.0b013e3181dcd28d; Schmidt EP, 2012, NAT MED, V18, P1217, DOI 10.1038/nm.2843; Su X, 2003, INTENS CARE MED, V29, P2034, DOI 10.1007/s00134-003-2017-3; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tsukamoto T, 2010, INJURY, V41, P21, DOI 10.1016/j.injury.2009.07.010; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Warren BL, 2001, JAMA-J AM MED ASSOC, V286, P1869, DOI 10.1001/jama.286.15.1869; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; Xu J, 2011, J IMMUNOL, V187, P2626, DOI 10.4049/jimmunol.1003930; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Zhang HB, 2013, AM J RESP CRIT CARE, V187, P118, DOI 10.1164/rccm.201211-2025ED; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhao DM, 2012, INFLAMMATION, V35, P1825, DOI 10.1007/s10753-012-9503-0	43	14	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97074	10.1371/journal.pone.0097074	http://dx.doi.org/10.1371/journal.pone.0097074			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816808	gold, Green Submitted, Green Published			2022-12-27	WOS:000336838000100
J	Yu, CX; Lopez, CA; Hu, H; Xia, Y; Freedman, DS; Reddington, AP; Daaboul, GG; Unlu, MS; Genco, CA				Yu, Chunxiao; Lopez, Carlos A.; Hu, Han; Xia, Yu; Freedman, David S.; Reddington, Alexander P.; Daaboul, George G.; Uenlue, M. Selim; Genco, Caroline Attardo			A High-Throughput Method to Examine Protein-Nucleotide Interactions Identifies Targets of the Bacterial Transcriptional Regulatory Protein Fur	PLOS ONE			English	Article							FERRIC UPTAKE REGULATOR; SMALL RNA; NEISSERIA-GONORRHOEAE; CRYSTAL-STRUCTURE; HAEMOPHILUS-INFLUENZAE; HELICOBACTER-PYLORI; LABEL-FREE; IRON; GENES; REPRESSOR	The Ferric uptake regulatory protein (Fur) is a transcriptional regulatory protein that functions to control gene transcription in response to iron in a number of pathogenic bacteria. In this study, we applied a label-free, quantitative and high-throughput analysis method, Interferometric Reflectance Imaging Sensor (IRIS), to rapidly characterize Fur-DNA interactions in vitro with predicted Fur binding sequences in the genome of Neisseria gonorrhoeae, the causative agent of the sexually transmitted disease gonorrhea. IRIS can easily be applied to examine multiple protein-protein, protein-nucleotide and nucleotide-nucleotide complexes simultaneously and demonstrated here that seventy percent of the predicted Fur boxes in promoter regions of iron-induced genes bound to Fur in vitro with a range of affinities as observed using this microarray screening technology. Combining binding data with mRNA expression levels in a gonococcal fur mutant strain allowed us to identify five new gonococcal genes under Fur-mediated direct regulation.	[Yu, Chunxiao; Genco, Caroline Attardo] Boston Univ, Sch Med, Dept Med, Infect Dis Sect, Boston, MA 02118 USA; [Lopez, Carlos A.; Reddington, Alexander P.; Uenlue, M. Selim] Boston Univ, Dept Elect & Comp Engn, Boston, MA 02215 USA; [Genco, Caroline Attardo] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Freedman, David S.; Daaboul, George G.; Uenlue, M. Selim] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Hu, Han; Xia, Yu] Boston Univ, Bioinformat Grad Program, Boston, MA 02215 USA; [Uenlue, M. Selim] Boston Univ, Dept Phys, Boston, MA 02215 USA	Boston University; Boston University; Boston University; Boston University; Boston University; Boston University	Genco, CA (corresponding author), Boston Univ, Sch Med, Dept Med, Infect Dis Sect, Boston, MA 02118 USA.	cgenco@bu.edu	Xia, Yu/W-6150-2019	Xia, Yu/0000-0002-5596-5518	NIH/NIAID [RO1AI048611]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048611] Funding Source: NIH RePORTER; Direct For Computer & Info Scie & Enginr [1219007] Funding Source: National Science Foundation	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work is supported by the NIH/NIAID grant RO1AI048611. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2005, INFECT IMMUN, V73, P4281, DOI 10.1128/IAI.73.7.4281-4287.2005; Agarwal S, 2008, J BACTERIOL, V190, P3129, DOI 10.1128/JB.01830-07; Ahn S, 2012, BIOPHYS J, V103, P1510, DOI 10.1016/j.bpj.2012.08.030; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; BAGG A, 1987, BIOCHEMISTRY-US, V26, P5471, DOI 10.1021/bi00391a039; Baumler AJ, 1996, GENE, V183, P207, DOI 10.1016/S0378-1119(96)00560-4; Butcher BG, 2011, J BACTERIOL, V193, P4598, DOI 10.1128/JB.00340-11; Carpenter BM, 2009, INFECT IMMUN, V77, P2590, DOI 10.1128/IAI.00116-09; Cretich M, 2004, ANAL BIOCHEM, V332, P67, DOI 10.1016/j.ab.2004.05.041; Daaboul GG, 2011, BIOSENS BIOELECTRON, V26, P2221, DOI 10.1016/j.bios.2010.09.038; Dame RT, 2005, MOL MICROBIOL, V56, P858, DOI 10.1111/j.1365-2958.2005.04598.x; Daou N, 2013, INFECT IMMUN, V81, P3652, DOI 10.1128/IAI.00298-13; Davis BM, 2005, J BACTERIOL, V187, P4005, DOI 10.1128/JB.187.12.4005-4014.2005; Delany I, 2006, J BACTERIOL, V188, P2483, DOI 10.1128/JB.188.7.2483-2492.2006; Delany I, 2004, MOL MICROBIOL, V52, P1081, DOI 10.1111/j.1365-2958.2004.04030.x; DELORENZO V, 1987, J BACTERIOL, V169, P2624, DOI 10.1128/jb.169.6.2624-2630.1987; Ducey TF, 2005, J BACTERIOL, V187, P4865, DOI 10.1128/JB.187.14.4865-4874.2005; Escolar L, 1998, J MOL BIOL, V283, P537, DOI 10.1006/jmbi.1998.2119; Forng RY, 1997, J BACTERIOL, V179, P3047, DOI 10.1128/jb.179.9.3047-3052.1997; Gaballa A, 2008, P NATL ACAD SCI USA, V105, P11927, DOI 10.1073/pnas.0711752105; Grifantini R, 2003, P NATL ACAD SCI USA, V100, P9542, DOI 10.1073/pnas.1033001100; Jackson LA, 2010, J BACTERIOL, V192, P77, DOI 10.1128/JB.00741-09; Ledala N, 2010, APPL ENVIRON MICROB, V76, P406, DOI 10.1128/AEM.01389-09; Lee HJ, 2007, J BACTERIOL, V189, P2629, DOI 10.1128/JB.01791-06; Lopez CA, 2011, JOVE-J VIS EXP, DOI 10.3791/2694; Lopez CA, 2011, BIOSENS BIOELECTRON, V26, P3432, DOI 10.1016/j.bios.2011.01.019; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Mellin JR, 2007, J BACTERIOL, V189, P3686, DOI 10.1128/JB.01890-06; Mellin JR, 2010, MICROBIOL-SGM, V156, P2316, DOI 10.1099/mic.0.039040-0; Merrell DS, 2003, INFECT IMMUN, V71, P6510, DOI 10.1128/IAI.71.11.6510-6525.2003; Miles S, 2010, J MICROBIOL, V48, P378, DOI 10.1007/s12275-010-0022-0; Mills SA, 2005, BIOCHEMISTRY-US, V44, P13553, DOI 10.1021/bi0507579; MORSE SA, 1980, CAN J MICROBIOL, V26, P13, DOI 10.1139/m80-003; Myers KS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003565; Ozkumur E, 2008, P NATL ACAD SCI USA, V105, P7988, DOI 10.1073/pnas.0711421105; Ozkumur E, 2010, BIOSENS BIOELECTRON, V25, P1789, DOI 10.1016/j.bios.2009.12.032; Ozkumur E, 2009, BIOSENS BIOELECTRON, V25, P167, DOI 10.1016/j.bios.2009.06.033; Pirri G, 2004, ANAL CHEM, V76, P1352, DOI 10.1021/ac0352629; Pohl E, 2003, MOL MICROBIOL, V47, P903, DOI 10.1046/j.1365-2958.2003.03337.x; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sebastian S, 2002, J BACTERIOL, V184, P3965, DOI 10.1128/JB.184.14.3965-3974.2002; Sheikh MA, 2009, MOL MICROBIOL, V72, P1208, DOI 10.1111/j.1365-2958.2009.06718.x; Srikhanta YN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000400; Thomas-Chollier M, 2008, NUCLEIC ACIDS RES, V36, pW119, DOI 10.1093/nar/gkn304; Troxell B, 2011, J BACTERIOL, V193, P497, DOI 10.1128/JB.00942-10; Vassinova N, 2000, MICROBIOL-SGM, V146, P3171, DOI 10.1099/00221287-146-12-3171; Whitby PW, 2006, J BACTERIOL, V188, P5640, DOI 10.1128/JB.00417-06; Whitby PW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-6; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101; Yang Q, 2014, STRUCTURE, V22, P209, DOI 10.1016/j.str.2013.10.018; Yang Q, 2014, J MOL BIOL, V426, P43, DOI 10.1016/j.jmb.2013.09.025; Yang Q, 2014, ACTA CRYSTALLOGR F, V70, P68, DOI 10.1107/S2053230X1303241X; Yang Q, 2011, RNA BIOL, V8, P748, DOI 10.4161/rna.8.5.16040; Yang Q, 2011, STRUCTURE, V19, P368, DOI 10.1016/j.str.2010.12.021; Yang Q, 2011, ACTA CRYSTALLOGR F, V67, P241, DOI 10.1107/S1744309110051110; Yang Q, 2010, P NATL ACAD SCI USA, V107, P10062, DOI 10.1073/pnas.1000848107; Yu CX, 2012, J BACTERIOL, V194, P6372, DOI 10.1128/JB.00262-12; Yu CX, 2012, J BACTERIOL, V194, P1730, DOI 10.1128/JB.06176-11; Zhou DS, 2006, FEMS MICROBIOL LETT, V258, P9, DOI 10.1111/j.1574-6968.2006.00208.x	59	3	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96832	10.1371/journal.pone.0096832	http://dx.doi.org/10.1371/journal.pone.0096832			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24811061	Green Submitted, gold, Green Published			2022-12-27	WOS:000338213300078
J	Zhang, HY; Lei, YL; Yuan, P; Li, LJ; Luo, C; Gao, R; Tian, J; Feng, ZH; Nice, EC; Sun, J				Zhang, Haiyuan; Lei, Yunlong; Yuan, Ping; Li, Lingjun; Luo, Chao; Gao, Rui; Tian, Jun; Feng, Zuohua; Nice, Edouard C.; Sun, Jun			ROS-Mediated Autophagy Induced by Dysregulation of Lipid Metabolism Plays a Protective Role in Colorectal Cancer Cells Treated with Gambogic Acid	PLOS ONE			English	Article							MALIGNANT GLIOMA-CELLS; INDUCED APOPTOSIS; TUMOR PROGRESSION; OXIDATIVE STRESS; REDOX REGULATION; KAPPA-B; OXYGEN; DEATH; ACTIVATION; INDUCTION	Gambogic acid (GA), the main active component of gamboge resin, has potent antitumor activity both in vivo and in vitro. However, the underlying molecular mechanisms remain unclear. In this study, we found that GA could initiate autophagy in colorectal cancer cells, and inhibition of the autophagy process accelerated the effect of proliferative inhibition and apoptotic cell death induced by GA, implying a protective role of autophagy. Two-dimensional electrophoresis-based proteomics showed that GA treatment altered the expression of multiple proteins involved in redox signaling and lipid metabolism. Functional studies revealed that GA-induced dysregulation of lipid metabolism could activate 5-lipoxygenase (5-LOX), resulting in intracellular ROS accumulation, followed by inhibition of Akt-mTOR signaling and autophagy initiation. Finally, results using a xenograft model suggested ROS-induced autophagy protect against the antitumor effect of GA. Taken together, these data showed new biological activities of GA against colorectal cancer underlying the protective role of ROS-induced autophagy. This study will provide valuable insights for future studies regarding the anticancer mechanisms of GA.	[Zhang, Haiyuan; Yuan, Ping; Li, Lingjun; Luo, Chao; Gao, Rui; Tian, Jun; Feng, Zuohua; Sun, Jun] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Biochem & Mol Biol, Wuhan 430074, Peoples R China; [Lei, Yunlong] Chongqing Med Univ, Dept Biochem & Mol Biol, Chongqing, Peoples R China; [Lei, Yunlong] Chongqing Med Univ, Mol Med & Canc Res Ctr, Chongqing, Peoples R China; [Nice, Edouard C.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia	Huazhong University of Science & Technology; Chongqing Medical University; Chongqing Medical University; Monash University	Sun, J (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Biochem & Mol Biol, Wuhan 430074, Peoples R China.	sun_jun99@163.com		Lei, Yunlong/0000-0002-7918-0221	National Natural Science Foundation of China [30672480]; National High Technology Research and Development Program of China (863 Program) [2012AA020201]; National 973 Basic Research Program of China [2013CB911300]; Education Department of Hubei province science and technology research projects of outstanding young talent project [Q20091207]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National 973 Basic Research Program of China(National Basic Research Program of China); Education Department of Hubei province science and technology research projects of outstanding young talent project	This work was supported by grants from National Natural Science Foundation of China (Grant number: 30672480), National High Technology Research and Development Program of China (863 Program; No. 2012AA020201), the National 973 Basic Research Program of China (2013CB911300) and the Education Department of Hubei province science and technology research projects of outstanding young talent project(Q20091207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI [10.1089/ars.2008.2270, 10.1089/ARS.2008.2270]; Bishayee K, 2013, ACTA BIOCH BIOPHYSIC; Bommareddy A, 2009, CANCER RES, V69, P3704, DOI 10.1158/0008-5472.CAN-08-4344; Brech A, 2009, MOL ONCOL, V3, P366, DOI 10.1016/j.molonc.2009.05.007; Carew Jennifer S, 2008, Biologics, V2, P201; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chandel NS, 2007, FREE RADICAL BIO MED, V42, P165, DOI 10.1016/j.freeradbiomed.2006.10.048; Chiarugi P, 2003, J CELL BIOL, V161, P933, DOI 10.1083/jcb.200211118; Cho KJ, 2011, MOL CELLS, V32, P1, DOI 10.1007/s10059-011-1021-7; Cotter MA, 2007, CLIN CANCER RES, V13, P5952, DOI 10.1158/1078-0432.CCR-07-1187; Covey TM, 2007, ONCOGENE, V26, P5784, DOI 10.1038/sj.onc.1210391; Daido S, 2004, CANCER RES, V64, P4286, DOI 10.1158/0008-5472.CAN-03-3084; Davies RJ, 2005, NAT REV CANCER, V5, P199, DOI 10.1038/nrc1569; Deng LF, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.142; Dewaele M, 2010, AUTOPHAGY, V6, P838, DOI 10.4161/auto.6.7.12113; Espert L, 2006, J CLIN INVEST, V116, P2161, DOI 10.1172/JCI26185; Etzioni R, 2003, NAT REV CANCER, V3, P243, DOI 10.1038/nrc1041; Fang LH, 2012, INT J NANOMED, V7, P4109, DOI 10.2147/IJN.S32475; Filomeni G, 2010, AUTOPHAGY, V6, P999, DOI 10.4161/auto.6.7.12754; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; Guizzunti G, 2012, INVEST NEW DRUG, V30, P1841, DOI 10.1007/s10637-011-9745-y; Haggar Fatima A, 2009, Clin Colon Rectal Surg, V22, P191, DOI 10.1055/s-0029-1242458; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Huang HB, 2011, CANCER LETT, V301, P221, DOI 10.1016/j.canlet.2010.12.015; Inokuma T, 2009, HEPATO-GASTROENTEROL, V56, P343; Jin SK, 2007, AUTOPHAGY, V3, P28, DOI 10.4161/auto.3269; Kanzawa T, 2003, CANCER RES, V63, P2103; Kisslov L, 2012, BBA-MOL CELL BIOL L, V1821, P1224, DOI 10.1016/j.bbalip.2012.06.005; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Lepage C, 2010, INT J ONCOL, V36, P1183, DOI 10.3892/ijo_00000601; Levine B, 2009, CELL DEATH DIFFER, V16, P1, DOI 10.1038/cdd.2008.139; Li JY, 2010, AUTOPHAGY, V6, P711, DOI 10.4161/auto.6.6.12397; Li QL, 2010, BIOL PHARM BULL, V33, P415, DOI 10.1248/bpb.33.415; Li ZY, 2011, BIOCHEM BIOPH RES CO, V414, P5, DOI 10.1016/j.bbrc.2011.09.046; LIESENKLAS W, 1966, ARCHIV PHARM BERICHT, V299, P797, DOI 10.1002/ardp.19662990911; Liu W, 2005, WORLD J GASTROENTERO, V11, P3655, DOI 10.3748/wjg.v11.i24.3655; Lopez-Lazaro M, 2007, CANCER LETT, V252, P1, DOI 10.1016/j.canlet.2006.10.029; Luo GX, 2012, ASIAN PAC J CANCER P, V13, P6211, DOI 10.7314/APJCP.2012.13.12.6211; Mack Hildegard I D, 2012, Cells, V1, P204, DOI 10.3390/cells1030204; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Melstrom LG, 2008, CLIN CANCER RES, V14, P6525, DOI 10.1158/1078-0432.CCR-07-4631; Merolla F, 2013, PROSTATE CANC SHIFTI, P57; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mone A, 2013, ISSUES SCREENING SUR; Mujumdar N, 2010, GASTROENTEROLOGY, V139, P598, DOI 10.1053/j.gastro.2010.04.046; Mukhtar E, 2012, CURR DRUG TARGETS, V13, P1831, DOI 10.2174/138945012804545489; Murata H, 2003, J BIOL CHEM, V278, P50226, DOI 10.1074/jbc.M310171200; Nie FF, 2009, TOXICOLOGY, V260, P60, DOI 10.1016/j.tox.2009.03.010; O'Donovan TR, 2011, AUTOPHAGY, V7, P509, DOI 10.4161/auto.7.5.15066; Ohd JF, 2003, GASTROENTEROLOGY, V124, P57, DOI 10.1053/gast.2003.50011; Ostuni MA, 2010, FREE RADICAL BIO MED, V49, P900, DOI 10.1016/j.freeradbiomed.2010.06.021; Paglin S, 2005, CANCER RES, V65, P11061, DOI 10.1158/0008-5472.CAN-05-1083; Pandey MK, 2007, BLOOD, V110, P3517, DOI 10.1182/blood-2007-03-079616; Panthong A, 2007, J ETHNOPHARMACOL, V111, P335, DOI 10.1016/j.jep.2006.11.038; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Poli G, 2004, CURR MED CHEM, V11, P1163, DOI 10.2174/0929867043365323; Rahman MA, 2013, MOL CELL BIOCHEM, P1; Reddy DB, 2009, J ETHNOPHARMACOL, V124, P506, DOI 10.1016/j.jep.2009.05.022; Rubinstein AD, 2012, J CELL SCI, V125, P5259, DOI 10.1242/jcs.115865; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Scarlatti F, 2009, CELL DEATH DIFFER, V16, P12, DOI 10.1038/cdd.2008.101; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Shi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051076; Soumaoro LT, 2006, WORLD J GASTROENTERO, V12, P6355, DOI 10.3748/wjg.v12.i39.6355; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Thorburn A, 2008, APOPTOSIS, V13, P1, DOI 10.1007/s10495-007-0154-9; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Truong TH, 2013, CRIT REV BIOCHEM MOL, V48, P332, DOI 10.3109/10409238.2013.790873; Vara D, 2011, CELL DEATH DIFFER, V18, P1099, DOI 10.1038/cdd.2011.32; Wang J., 2013, CELL BIOCHEM BIOPHYS, P1, DOI DOI 10.4018/978-1-4666-1873-2; Wang JX, 2010, EUR J MED CHEM, V45, P4343, DOI 10.1016/j.ejmech.2010.04.037; Wang JX, 2009, EUR J MED CHEM, V44, P2611, DOI 10.1016/j.ejmech.2008.09.034; Wang K, 2011, AUTOPHAGY, V7, P966, DOI 10.4161/auto.7.9.15863; Wang XJ, 2011, EUR J MED CHEM, V46, P1280, DOI 10.1016/j.ejmech.2011.01.051; Woo CH, 2000, J BIOL CHEM, V275, P32357, DOI 10.1074/jbc.M005638200; Wu WS, 2006, CANCER METAST REV, V25, P695, DOI 10.1007/s10555-006-9037-8; Xu JY, 2013, CHINESE J CANCER RES, V25, P183, DOI 10.3978/j.issn.1000-9604.2013.02.06; Yang LJ, 2012, ONCOL LETT, V3, P1159, DOI 10.3892/ol.2012.634; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yu J, 2007, CARCINOGENESIS, V28, P632, DOI 10.1093/carcin/bgl168; Yuan KF, 2011, J BIOL CHEM, V286, P21814, DOI 10.1074/jbc.M111.237628; Zeng ZZ, 2002, J BIOL CHEM, V277, P41213, DOI 10.1074/jbc.M204508200; Zhang BL, 2005, CANCER RES, V65, P7283, DOI 10.1158/0008-5472.CAN-05-0633; Zhang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031458; Zhao L, 2004, BIOL PHARM BULL, V27, P998, DOI 10.1248/bpb.27.998; Zhao Q, 2008, CANCER LETT, V262, P223, DOI 10.1016/j.canlet.2007.12.002; Zhou S, 2012, MASS SPECTROMETRY RE; [周政涛 ZHOU Zhengtao], 2007, [中国新药杂志, Chinese Journal New Drugs], V16, P79; Zou ZY, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-58	91	44	47	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96418	10.1371/journal.pone.0096418	http://dx.doi.org/10.1371/journal.pone.0096418			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810758	Green Published, Green Submitted, gold			2022-12-27	WOS:000338213300035
J	Peng, X; Yang, L; Chang, HX; Dai, G; Wang, FY; Duan, XJ; Guo, L; Zhang, Y; Chen, GX				Peng, Xu; Yang, Liu; Chang, Hongxing; Dai, Gang; Wang, Fuyou; Duan, Xiaojun; Guo, Lin; Zhang, Ying; Chen, Guangxing			Wnt/beta-Catenin Signaling Regulates the Proliferation and Differentiation of Mesenchymal Progenitor Cells through the p53 Pathway	PLOS ONE			English	Article							MARROW STROMAL CELLS; STEM-CELLS; ARTICULAR-CARTILAGE; OSTEOARTHRITIS; IDENTIFICATION; EXPRESSION; DEATH; MICE	Objective: Mesenchymal progenitor cells (MPCs) are found in articular cartilage from normal controls and patients with osteoarthritis (OA). Nevertheless, the molecular mechanisms of the proliferation and differentiation of these cells remain unclear. In this study, we aimed to determine the involvement of Wnt/beta-catenin signaling in regulating the proliferation and differentiation of MPCs. Methods: MPCs were isolated from the articular cartilage of normal and OA patients. Cells were sorted by immunomagnetic cell separation. Cell proliferation capacity was evaluated using the MTT assay. Toluidine blue staining and immunostaining with anti-collagen II or anti-aggrecan antibodies were used to determine the chondrogenic differentiation capabilities of MPCs. The mRNA and protein expression of target genes were examined by quantitative real-time polymerase chain reaction and Western blotting, respectively. Knock-down of p53 expression was achieved with RNA interference. Results: Most cells isolated from the normal and OA patients were CD105(+) and CD166(+) positive (Normal subjects: CD105(+)/CD166(+), 94.6% +/- 61.1%; OA: CD105(+)/CD166(+), 93.5% +/- 61.1%). MPCs derived from OA subjects exhibited decreased differentiation capabilities and enhanced Wnt/b-catenin activity. Inhibition of Wnt/b-catenin signaling promoted proliferation and differentiation, whereas activation of this pathway by treatment with rWnt3a protein decreased the proliferation and differentiation of normal MPCs. Additionally, Wnt/beta-catenin signaling positively regulated p53 expression, and silencing of p53 increased proliferation and differentiation of MPCs. Conclusions: Wnt/beta-catenin regulated the proliferation and differentiation of MPCs through the p53 pathway.	[Peng, Xu; Yang, Liu; Chang, Hongxing; Dai, Gang; Wang, Fuyou; Duan, Xiaojun; Guo, Lin; Zhang, Ying; Chen, Guangxing] Third Mil Med Univ, Southwest Hosp, Ctr Joint Surg, Chongqing, Peoples R China	Army Medical University	Yang, L (corresponding author), Third Mil Med Univ, Southwest Hosp, Ctr Joint Surg, Chongqing, Peoples R China.	cqjoint@hotmail.com; cgx7676@hotmail.com	liu, yang/HHY-8583-2022; yang, liu/GVU-8760-2022		National Natural Science Foundation of China [30901576]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (Grant No. 30901576). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsalameh S, 2004, ARTHRITIS RHEUM-US, V50, P1522, DOI 10.1002/art.20269; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Charbord P, 2010, HUM GENE THER, V21, P1045, DOI 10.1089/hum.2010.115; Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Gerson SL, 1999, NAT MED, V5, P262, DOI 10.1038/6470; Hardy KM, 2008, DEV BIOL, V320, P391, DOI 10.1016/j.ydbio.2008.05.546; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hosseini-Farahabadi S, 2013, MATRIX BIOL, V32, P252, DOI 10.1016/j.matbio.2013.02.005; Imai K, 2006, BIOCHEM BIOPH RES CO, V345, P1615, DOI 10.1016/j.bbrc.2006.05.075; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kikuchi A, 2009, TRENDS CELL BIOL, V19, P119, DOI 10.1016/j.tcb.2009.01.003; Kim NH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001744; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Maiuri MC, 2010, CURR OPIN CELL BIOL, V22, P181, DOI 10.1016/j.ceb.2009.12.001; Pietsch EC, 2008, ONCOGENE, V27, P6507, DOI 10.1038/onc.2008.315; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rodier F, 2007, NUCLEIC ACIDS RES, V35, P7475, DOI 10.1093/nar/gkm744; Rother K, 2004, ONCOGENE, V23, P3376, DOI 10.1038/sj.onc.1207464; Stolzing A, 2006, AGING CELL, V5, P213, DOI 10.1111/j.1474-9726.2006.00213.x; Tell S, 2006, BIOCHEM BIOPH RES CO, V349, P261, DOI 10.1016/j.bbrc.2006.08.044; Thomas CM, 2007, OSTEOARTHR CARTILAGE, V15, P27, DOI 10.1016/j.joca.2006.06.012; Thomas RS, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3536; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Xu L, 2007, ARTHRITIS RHEUM, V56, P2663, DOI 10.1002/art.22761; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhang DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021397; Zhu M, 2009, J BONE MINER RES, V24, P12, DOI 10.1359/JBMR.080901	30	23	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97283	10.1371/journal.pone.0097283	http://dx.doi.org/10.1371/journal.pone.0097283			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819053	gold, Green Submitted, Green Published			2022-12-27	WOS:000336653300102
J	Pineda, S; Milne, RL; Calle, ML; Rothman, N; de Maturana, EL; Herranz, J; Kogevinas, M; Chanock, SJ; Tardon, A; Marquez, M; Guey, LT; Garcia-Closas, M; Lloreta, J; Baum, E; Gonzalez-Neira, A; Carrato, A; Navarro, A; Silverman, DT; Real, FX; Malats, N				Pineda, Silvia; Milne, Roger L.; Luz Calle, M.; Rothman, Nathaniel; Lopez de Maturana, Evangelina; Herranz, Jesus; Kogevinas, Manolis; Chanock, Stephen J.; Tardon, Adonina; Marquez, Mirari; Guey, Lin T.; Garcia-Closas, Montserrat; Lloreta, Josep; Baum, Erin; Gonzalez-Neira, Anna; Carrato, Alfredo; Navarro, Arcadi; Silverman, Debra T.; Real, Francisco X.; Malats, Nuria			Genetic Variation in the TP53 Pathway and Bladder Cancer Risk. A Comprehensive Analysis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ARG72PRO POLYMORPHISM; SUSCEPTIBILITY; MUTATIONS; SELECTION; MARKERS	Introduction: Germline variants in TP63 have been consistently associated with several tumors, including bladder cancer, indicating the importance of TP53 pathway in cancer genetic susceptibility. However, variants in other related genes, including TP53 rs1042522 (Arg72Pro), still present controversial results. We carried out an in depth assessment of associations between common germline variants in the TP53 pathway and bladder cancer risk. Material and Methods: We investigated 184 tagSNPs from 18 genes in 1,058 cases and 1,138 controls from the Spanish Bladder Cancer/EPICURO Study. Cases were newly-diagnosed bladder cancer patients during 1998-2001. Hospital controls were age-gender, and area matched to cases. SNPs were genotyped in blood DNA using Illumina Golden Gate and TaqMan assays. Cases were subphenotyped according to stage/grade and tumor p53 expression. We applied classical tests to assess individual SNP associations and the Least Absolute Shrinkage and Selection Operator (LASSO)-penalized logistic regression analysis to assess multiple SNPs simultaneously. Results: Based on classical analyses, SNPs in BAK1 (1), IGF1R (5), P53AIP1 (1), PMAIP1 (2), SERINPB5 (3), TP63 (3), and TP73 (1) showed significant associations at p-value <= 0.05. However, no evidence of association, either with overall risk or with specific disease subtypes, was observed after correction for multiple testing (p-value >= 0.8). LASSO selected the SNP rs6567355 in SERPINB5 with 83% of reproducibility. This SNP provided an OR = 1.21, 95% CI 1.05-1.38, p-value = 0.006, and a corrected p-value = 0.5 when controlling for over-estimation. Discussion: We found no strong evidence that common variants in the TP53 pathway are associated with bladder cancer susceptibility. Our study suggests that it is unlikely that TP53 Arg72Pro is implicated in the UCB in white Europeans. SERPINB5 and TP63 variation deserve further exploration in extended studies.	[Pineda, Silvia; Milne, Roger L.; Lopez de Maturana, Evangelina; Herranz, Jesus; Marquez, Mirari; Guey, Lin T.; Baum, Erin; Gonzalez-Neira, Anna; Real, Francisco X.; Malats, Nuria] Spanish Natl Canc Res Ctr CNIO, Madrid, Spain; [Luz Calle, M.] Univ Vic, Dept Syst Biol, Vic, Spain; [Rothman, Nathaniel; Chanock, Stephen J.; Garcia-Closas, Montserrat; Silverman, Debra T.] NCI, Div Canc Epidemiol & Genet, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Kogevinas, Manolis] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Kogevinas, Manolis; Lloreta, Josep] Hosp del Mar, Inst Municipal Invest Med, Barcelona, Spain; [Tardon, Adonina] Univ Oviedo, Dept Prevent Med, Oviedo, Spain; [Lloreta, Josep] Hosp del Mar IMAS, Dept Patol, Barcelona, Spain; [Carrato, Alfredo] Hosp Univ Elche, Serv Oncol, Elche, Spain; [Carrato, Alfredo] Hosp Univ Ramon y Cajal, Serv Oncol, Madrid, Spain; [Navarro, Arcadi; Real, Francisco X.] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Spain; [Navarro, Arcadi] Inst Biol Evolut UPF CSIC, Barcelona, Spain; [Navarro, Arcadi] ICREA, Barcelona, Spain; [Navarro, Arcadi] Inst Nacl Bioinformat, Barcelona, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Oviedo; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Hospital Universitario Ramon y Cajal; Pompeu Fabra University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); ICREA	Malats, N (corresponding author), Spanish Natl Canc Res Ctr CNIO, Madrid, Spain.	nmalats@cnio.es	Malats, Nuria/H-7041-2015; Lloreta-Trull, Josep/AAZ-1229-2020; Calle, M.Luz/D-2704-2015; TARDON, ADONINA/B-6563-2014; Lloreta-Trull, Josep/GRR-9682-2022; Arribas, Francisco X Real/H-5275-2015; Kogevinas, Manolis/C-3918-2017; Navarro, Arcadi/F-1592-2011; Lloreta, J/I-2112-2014; Garcia-Closas, Montserrat/AAZ-6930-2021; Garcia-Closas, Montserrat/F-3871-2015; Gonzalez-Neira, Anna/C-5791-2015; Herranz Valera, Jesus/M-8657-2014	Malats, Nuria/0000-0003-2538-3784; Calle, M.Luz/0000-0001-9334-415X; TARDON, ADONINA/0000-0001-5150-1209; Arribas, Francisco X Real/0000-0001-9501-498X; Kogevinas, Manolis/0000-0002-9605-0461; Navarro, Arcadi/0000-0003-2162-8246; Lloreta, J/0000-0003-1644-9470; Garcia-Closas, Montserrat/0000-0003-1033-2650; Garcia-Closas, Montserrat/0000-0003-1033-2650; Gonzalez-Neira, Anna/0000-0002-5421-2020; Lopez de Maturana, Evangelina/0000-0001-9425-3911; CARRATO, ALFREDO/0000-0001-7749-8140; Pineda SanJuan, Silvia/0000-0003-4017-1480; Herranz Valera, Jesus/0000-0002-7385-1311	Fondo de Investigacion Sanitaria, Spain [00/0745, PI051436, PI061614, G03/174]; Red Tematica de Investigacion Cooperativa en Cancer, Spain [RD06/0020-RTICC]; Marato TV3 [050830]; European Commission [EU-FP7-HEALTH-F2-2008-201663-UROMOL]; US National Institutes of Health [USA-NIH-RO1-CA089715]; Intramural Research Program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute at the National Institutes of Health, USA; Consolider ONCOBIO (Ministerio de Economia y Competitividad, Madrid, Spain); NATIONAL CANCER INSTITUTE [R01CA089715] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	Fondo de Investigacion Sanitaria, Spain(Instituto de Salud Carlos III); Red Tematica de Investigacion Cooperativa en Cancer, Spain; Marato TV3; European Commission(European CommissionEuropean Commission Joint Research Centre); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute at the National Institutes of Health, USA; Consolider ONCOBIO (Ministerio de Economia y Competitividad, Madrid, Spain); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ICREA(ICREA)	This work was supported by the Fondo de Investigacion Sanitaria, Spain (grant numbers 00/0745, PI051436, PI061614, G03/174); Red Tematica de Investigacion Cooperativa en Cancer (grant number RD06/0020-RTICC), Spain; Marato TV3 (grant number 050830); European Commission (grant numbers EU-FP7-HEALTH-F2-2008-201663-UROMOL; US National Institutes of Health (grant number USA-NIH-RO1-CA089715); and the Intramural Research Program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute at the National Institutes of Health, USA; Consolider ONCOBIO (Ministerio de Economia y Competitividad, Madrid, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Epstein JI, 1998, AM J SURG PATHOL, V22, P1435, DOI 10.1097/00000478-199812000-00001; Ferlay J, 2010, CANC INCIDENCE MORTA; Friedman J, 2001, SPRINGER SERIES STAT, V533, P214; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Goeman JJ, 2010, BIOMETRICAL J, V52, P70, DOI 10.1002/bimj.200900028; Guey LT, 2010, EUR UROL, V57, P283, DOI 10.1016/j.eururo.2009.08.001; Hoh J, 2003, NAT REV GENET, V4, P701, DOI 10.1038/nrg1155; Jiang DK, 2010, UROLOGY, V76, DOI 10.1016/j.urology.2010.04.044; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Klug SJ, 2009, LANCET ONCOL, V10, P772, DOI 10.1016/S1470-2045(09)70187-1; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lin HY, 2013, UROL ONCOL-SEMIN ORI, V31, P1231, DOI 10.1016/j.urolonc.2011.11.031; Liu KJ, 2012, MOL BIOL REP, V39, P8265, DOI 10.1007/s11033-012-1674-0; Lorente-Galdos B, 2012, INT J DATA MIN BIOIN, V6, P324, DOI 10.1504/IJDMB.2012.049249; Louhelainen JP, 2006, ONCOGENE, V25, P2409, DOI 10.1038/sj.onc.1209228; Luis NM, 2007, CLIN TRANSL ONCOL, V9, P5, DOI 10.1007/s12094-007-0003-x; Malats N, 2008, SCAND J UROL NEPHROL, V42, P131, DOI 10.1080/03008880802285172; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Malkin D, 1997, NEW ENGL J MED, V336, P734, DOI 10.1056/NEJM199703063361018; Mitra AP, 2012, SEMIN ONCOL, V39, P524, DOI 10.1053/j.seminoncol.2012.08.008; Naccarati A, 2012, MUTAGENESIS, V27, P211, DOI 10.1093/mutage/ger067; Qiao Q, 2013, LUNG, V191, P369, DOI 10.1007/s00408-013-9461-9; Real FX, 2007, LANCET ONCOL, V8, P91, DOI 10.1016/S1470-2045(07)70008-6; Rothman N, 2010, NAT GENET, V42, P978, DOI 10.1038/ng.687; Samanic C, 2006, CANCER EPIDEM BIOMAR, V15, P1348, DOI 10.1158/1055-9965.EPI-06-0021; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; Wu TT, 2009, BIOINFORMATICS, V25, P714, DOI 10.1093/bioinformatics/btp041; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697; Yan LL, 2009, INT J CANCER, V125, P2903, DOI 10.1002/ijc.24603; Yang ZL, 2013, GENE, V512, P408, DOI 10.1016/j.gene.2012.09.085; Zhang ZZ, 2010, BREAST CANCER RES TR, V120, P509, DOI 10.1007/s10549-009-0480-4; Zhou H, 2010, BIOINFORMATICS, V26, P2375, DOI 10.1093/bioinformatics/btq448; Zhou Y, 2007, INT J CANCER, V121, P1481, DOI 10.1002/ijc.22833	36	17	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e89952	10.1371/journal.pone.0089952	http://dx.doi.org/10.1371/journal.pone.0089952			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24818791	Green Published, gold			2022-12-27	WOS:000336653300001
J	Ventura, T; Cummins, SF; Fitzgibbon, Q; Battaglene, S; Elizur, A				Ventura, Tomer; Cummins, Scott F.; Fitzgibbon, Quinn; Battaglene, Stephen; Elizur, Abigail			Analysis of the Central Nervous System Transcriptome of the Eastern Rock Lobster Sagmariasus verreauxi Reveals Its Putative Neuropeptidome	PLOS ONE			English	Article							PROTEIN HORMONES; IDENTIFICATION; PEPTIDE; GENOMICS; PRECURSORS; EVOLUTION; TOOL	Neuropeptides have been discovered in many arthropod species including crustaceans. The nature of their biological function is well studied and varies from behavior modulation to physiological regulation of complex biochemical processes such as metabolism, molt and reproduction. Due to their key role in these fundamental processes, neuropeptides are often targeted for modulating these processes to align with market demands in commercially important species. We generated a comprehensive transcriptome of the eyestalk and brain of one of the few commercially important spiny lobster species in the southern Hemisphere, the Eastern rock lobster Sagmariasus verreauxi and mined it for novel neuropeptide and protein hormone-encoding transcripts. We then characterized the predicted mature hormones to verify their validity based on conserved motifs and features known from previously reported hormones. Overall, 37 transcripts which are predicted to encode mature full-length/partial peptides/proteins were identified, representing 21 peptide/protein families/subfamilies. All transcripts had high similarity to hormones that were previously characterized in other decapod crustacean species or, where absent in crustaceans, in other arthropod species. These included, in addition to other proteins previously described in crustaceans, prohormone-3 and prohormone-4 which were previously identified only in insects. A homolog of the crustacean female sex hormone (CFSH), recently found to be female-specific in brachyuran crabs was found to have the same levels of expression in both male and female eyestalks, suggesting that the CFSH female specificity is not conserved throughout decapod crustaceans. Digital gene expression showed that 24 out of the 37 transcripts presented in this study have significant changes in expression between eyestalk and brain. In some cases a trend of difference between males and females could be seen. Taken together, this study provides a comprehensive neuropeptidome of a commercially important crustacean species with novel peptides and protein hormones identified for the first time in decapods.	[Ventura, Tomer; Cummins, Scott F.; Elizur, Abigail] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, GeneCol Res Ctr, Sunshine Coast, Qld, Australia; [Fitzgibbon, Quinn; Battaglene, Stephen] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia	University of the Sunshine Coast; University of Tasmania	Ventura, T (corresponding author), Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, GeneCol Res Ctr, Sunshine Coast, Qld, Australia.	tventura@usc.edu.au	Ventura, T./H-9832-2019; Battaglene, Stephen/H-9683-2014; Cummins, Scott/I-6420-2016	Ventura, T./0000-0002-0777-2367; Battaglene, Stephen/0000-0003-3533-6762; Elizur, Abigail/0000-0002-2960-302X; Fitzgibbon, Quinn/0000-0002-1104-3052; Cummins, Scott/0000-0002-1454-2076	Australian Research Council [DE130101089]; Collaborative Research Network seed	Australian Research Council(Australian Research Council); Collaborative Research Network seed	This study was supported in part by the Australian Research Council (http://www.arc.gov.au/) through a Discovery Early Career Research Award granted to Dr. Tomer Ventura (DECRA, Grant No. DE130101089), as well as a Collaborative Research Network seed grant awarded to Dr. Tomer Ventura. All the funding or sources of support had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amare A, 2007, PEPTIDES, V28, P1282, DOI 10.1016/j.peptides.2007.04.014; Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; Chen SH, 2004, MAR BIOTECHNOL, V6, P83, DOI 10.1007/s10126-003-0014-8; Christie AE, 2010, J EXP BIOL, V213, P118, DOI 10.1242/jeb.037077; Christie AE, 2013, GEN COMP ENDOCR, V187, P117, DOI 10.1016/j.ygcen.2013.03.018; Christie AE, 2010, CELL MOL LIFE SCI, V67, P4135, DOI 10.1007/s00018-010-0482-8; Christie AE, 2010, GEN COMP ENDOCR, V167, P164, DOI 10.1016/j.ygcen.2010.01.005; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; De Santis C, 2011, J EXP BIOL, V214, P2671, DOI 10.1242/jeb.056374; Dickinson PS, 2009, J EXP BIOL, V212, P1140, DOI 10.1242/jeb.028621; East P, 1996, REGUL PEPTIDES, V67, P1, DOI 10.1016/S0167-0115(96)00109-7; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hauser F, 2010, J PROTEOME RES, V9, P5296, DOI 10.1021/pr100570j; Huberman A, 2000, AQUACULTURE, V191, P191, DOI 10.1016/S0044-8486(00)00428-2; Hui LM, 2013, GEN COMP ENDOCR, V184, P22, DOI 10.1016/j.ygcen.2012.12.008; Hui LM, 2012, PEPTIDES, V36, P230, DOI 10.1016/j.peptides.2012.05.007; Hummon AB, 2006, SCIENCE, V314, P647, DOI 10.1126/science.1124128; Huybrechts J, 2010, INSECT MOL BIOL, V19, P87, DOI 10.1111/j.1365-2583.2009.00951.x; Jeffs AG, 2013, LOBSTERS: BIOLOGY, MANAGEMENT, AQUACULTURE AND FISHERIES, 2ND EDITION, P259; Jensen MA, 2013, AQUACULTURE, V376, P162, DOI 10.1016/j.aquaculture.2012.11.025; KELLER R, 1992, EXPERIENTIA, V48, P439, DOI 10.1007/BF01928162; Li B, 2008, GENOME RES, V18, P113, DOI 10.1101/gr.6714008; Luo CW, 2005, P NATL ACAD SCI USA, V102, P2820, DOI 10.1073/pnas.0409916102; Ma MM, 2010, PEPTIDES, V31, P27, DOI 10.1016/j.peptides.2009.10.007; Ma MM, 2009, J PROTEOME RES, V8, P2426, DOI 10.1021/pr801047v; Ma MM, 2009, GEN COMP ENDOCR, V161, P320, DOI 10.1016/j.ygcen.2009.01.015; Martinez-Perez F, 2011, PEPTIDES, V32, P509, DOI 10.1016/j.peptides.2010.10.007; Nassel DR, 2010, PROG NEUROBIOL, V92, P42, DOI 10.1016/j.pneurobio.2010.04.010; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Roller L, 2008, INSECT BIOCHEM MOLEC, V38, P1147, DOI 10.1016/j.ibmb.2008.04.009; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toullec JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071609; VEENSTRA JA, 1989, FEBS LETT, V250, P231, DOI 10.1016/0014-5793(89)80727-6; Wegener C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r131; Yan XC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046513	37	64	65	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97323	10.1371/journal.pone.0097323	http://dx.doi.org/10.1371/journal.pone.0097323			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819537	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000336653300107
J	Bentley, B; O'Connor, M; Kane, R; Breen, LJ				Bentley, Brenda; O'Connor, Moira; Kane, Robert; Breen, Lauren J.			Feasibility, Acceptability, and Potential Effectiveness of Dignity Therapy for People with Motor Neurone Disease	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; QUALITY-OF-LIFE; CLINICAL-SIGNIFICANCE; ASSISTED SUICIDE; PALLIATIVE CARE; TERMINALLY-ILL; ALS; END; EXPERIENCE; DISTRESS	Background: Motor neurone disease (MND) practice guidelines suggest developing interventions that will promote hope, meaning, and dignity to alleviate psychological distress, but very little research has been done. This study begins to address this need by exploring the use of dignity therapy with people with MND. Dignity therapy is a brief psychotherapy that promotes hope, meaning and dignity, and enhances the end of life for people with advanced cancer. The aims of this study are to assess the feasibility, acceptability, and potential effectiveness of dignity therapy for people with MND. Methods/design: This cross-sectional feasibility study used a one-group pre-test post-test design with 29 people diagnosed with MND. Study participants completed the following self-report questionnaires: Herth Hope Index, FACIT-sp, Patient Dignity Inventory, ALS Assessment Questionnaire, ALS Cognitive Behavioural Screen, and a demographic and health history questionnaire. Acceptability was measured with a 25-item feedback questionnaire. Feasibility was assessed by examining the length of time taken to complete dignity therapy and how symptoms common in MND affected the intervention. Generalised linear mixed models and reliable change scores were used to analyse the data. Results: There were no significant pre-test post-test changes for hopefulness, spirituality or dignity on the group level, but there were changes in hopefulness on the individual level. The results of the feedback questionnaire indicates dignity therapy is highly acceptable to people with MND, who report benefits similar to those in the international randomised controlled trial on dignity therapy, a population who primarily had end-stage cancer. Benefits include better family relationships, improved sense of self and greater acceptance. Dignity therapy with people with MND is feasible if the therapist can overcome time and communication difficulties. Conclusions: Dignity therapy for people with MND is feasible and acceptable. Further research is warranted to explore its ability to diminish distress.	[Bentley, Brenda; O'Connor, Moira; Kane, Robert; Breen, Lauren J.] Curtin Univ, Sch Psychol & Speech Pathol, Perth, WA 6845, Australia	Curtin University	Bentley, B (corresponding author), Curtin Univ, Sch Psychol & Speech Pathol, Perth, WA 6845, Australia.	brenda.bentley@curtin.edu.au	Breen, Lauren J/B-8746-2013	Breen, Lauren J/0000-0002-0463-0363; Bentley, Brenda/0000-0003-4663-9662	Australian Research Council [LP 0991305, DE120101640]; Motor Neurone Disease Association of Western Australia (MNDAWA)	Australian Research Council(Australian Research Council); Motor Neurone Disease Association of Western Australia (MNDAWA)	This study was funded by a Linkage Grant (LP 0991305) from the Australian Research Council and the Motor Neurone Disease Association of Western Australia (MNDAWA). The fourth author is supported by the Australian Research Council (DE120101640). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MNDAWA assisted with recruitment of study participants as described in the manuscript.	Albers G, 2010, PALLIATIVE MED, V24, P17, DOI 10.1177/0269216309346593; Bascom PB, 2002, JAMA-J AM MED ASSOC, V288, P91, DOI 10.1001/jama.288.1.91; Bentley B, 2012, J PALLIATIVE MED, V15; Bentley B, 2014, BMC PALLIAT CARE, V13, DOI 10.1186/1472-684X-13-12; Bentley B, 2012, BMC PALLIAT CARE, V11, DOI 10.1186/1472-684X-11-18; Buckley Jenny, 2004, Nurs Stand, V19, P33; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Chochinov HM, 2011, LANCET ONCOL, V12, P753, DOI 10.1016/S1470-2045(11)70153-X; Chochinov HM, 2008, J PAIN SYMPTOM MANAG, V36, P559, DOI 10.1016/j.jpainsymman.2007.12.018; Chochinov HM, 2005, J CLIN ONCOL, V23, P5520, DOI 10.1200/JCO.2005.08.391; Chochinov HM, 2002, LANCET, V360, P2026, DOI 10.1016/S0140-6736(02)12022-8; Chochinov HM., 2012, DIGNITY THERAPY FINA; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Evans CJ, 2013, PALLIATIVE MED, V27, P885, DOI 10.1177/0269216312467489; Fang F, 2008, BRAIN, V131, P2729, DOI 10.1093/brain/awn161; Fanos JH, 2008, J PALLIAT MED, V11, P470, DOI 10.1089/jpm.2007.0098; Fegg MJ, 2010, AMYOTROPH LATERAL SC, V11, P469, DOI 10.3109/17482961003692604; Felgoise SH, 2010, AMYOTROPH LATERAL SC, V11, P351, DOI 10.3109/17482961003667630; Foley G, 2007, AMYOTROPH LATERAL SC, V8, P164, DOI 10.1080/17482960601164532; Ganzini L, 1999, NEUROLOGY, V52, P1434, DOI 10.1212/WNL.52.7.1434; Ganzini L, 2002, J PAIN SYMPTOM MANAG, V24, P312, DOI 10.1016/S0885-3924(02)00496-7; Ganzini L, 1998, NEW ENGL J MED, V339, P967, DOI 10.1056/NEJM199810013391406; Hall Sue, 2011, BMJ Support Palliat Care, V1, P315, DOI 10.1136/bmjspcare-2011-000054; HERTH K, 1992, J ADV NURS, V17, P1251, DOI 10.1111/j.1365-2648.1992.tb01843.x; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Jenkinson C, 2007, CLIN REHABIL, V21, P266, DOI 10.1177/0269215506071123; Johnston M, 1999, BRIT J HEALTH PSYCH, V4, P127, DOI 10.1348/135910799168524; Kasarskis EJ, 2005, AMYOTROPH LATERAL SC, V6, P50, DOI 10.1080/14660820510027107; KATZMAN R, 1983, AM J PSYCHIAT, V140, P734; McClement S, 2007, J PALLIAT MED, V10, P1076, DOI 10.1089/jpm.2007.0002; McDermott CJ, 2008, BMJ-BRIT MED J, V336, P658, DOI 10.1136/bmj.39493.511759.BE; MCDONALD ER, 1994, ARCH NEUROL-CHICAGO, V51, P17, DOI 10.1001/archneur.1994.00540130027010; Mitchell JD, 2007, LANCET, V369, P2031, DOI 10.1016/S0140-6736(07)60944-1; Montross L, 2011, J PALLIAT MED, V14, P729, DOI 10.1089/jpm.2010.0449; Neudert Christian, 2004, J Palliat Med, V7, P551, DOI 10.1089/1096621041838443; Passik Steven D, 2004, Palliat Support Care, V2, P149; Peterman AH, 2002, ANN BEHAV MED, V24, P49, DOI 10.1207/S15324796ABM2401_06; Robbins RA, 2001, NEUROLOGY, V56, P442, DOI 10.1212/WNL.56.4.442; Schneider S, 2010, J BEHAV MED, V33, P1, DOI 10.1007/s10865-009-9227-2; Wise EA, 2004, J PERS ASSESS, V82, P50, DOI 10.1207/s15327752jpa8201_10; Woolley SC, 2010, AMYOTROPH LATERAL SC, V11, P303, DOI 10.3109/17482961003727954	41	35	37	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96888	10.1371/journal.pone.0096888	http://dx.doi.org/10.1371/journal.pone.0096888			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4LX	24816742	Green Published, gold			2022-12-27	WOS:000336838000077
J	Drugowitsch, J; Moreno-Bote, R; Pouget, A				Drugowitsch, Jan; Moreno-Bote, Ruben; Pouget, Alexandre			Relation between Belief and Performance in Perceptual Decision Making	PLOS ONE			English	Article							SENSORY DISCRIMINATION; SIGNAL-DETECTION; RESPONSE-TIME; CONFIDENCE; UNCERTAINTY; INTEGRATION; HUMANS; MODELS; CHOICE; UNDERCONFIDENCE	In an uncertain and ambiguous world, effective decision making requires that subjects form and maintain a belief about the correctness of their choices, a process called meta-cognition. Prediction of future outcomes and self-monitoring are only effective if belief closely matches behavioral performance. Equality between belief and performance is also critical for experimentalists to gain insight into the subjects' belief by simply measuring their performance. Assuming that the decision maker holds the correct model of the world, one might indeed expect that belief and performance should go hand in hand. Unfortunately, we show here that this is rarely the case when performance is defined as the percentage of correct responses for a fixed stimulus, a standard definition in psychophysics. In this case, belief equals performance only for a very narrow family of tasks, whereas in others they will only be very weakly correlated. As we will see it is possible to restore this equality in specific circumstances but this remedy is only effective for a decision-maker, not for an experimenter. We furthermore show that belief and performance do not match when conditioned on task difficulty - as is common practice when plotting the psychometric curve - highlighting common pitfalls in previous neuroscience work. Finally, we demonstrate that miscalibration and the hard-easy effect observed in humans' and other animals' certainty judgments could be explained by a mismatch between the experimenter's and decision maker's expected distribution of task difficulties. These results have important implications for experimental design and are of relevance for theories that aim to unravel the nature of metacognition.	[Drugowitsch, Jan; Pouget, Alexandre] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14623 USA; [Drugowitsch, Jan] Ecole Normale Super, Inst Natl Sante & Rech Med, F-75231 Paris, France; [Drugowitsch, Jan; Pouget, Alexandre] Univ Geneva, Dept Neurosci Fondamentales, Geneva, Switzerland; [Moreno-Bote, Ruben] Parc Sanitari St Joan de Deu, Res Unit, Barcelona, Spain; [Moreno-Bote, Ruben] Univ Barcelona, Barcelona, Spain; [Moreno-Bote, Ruben] Ctr Invest Biomed Red Salud Mental CIBERSAM, Barcelona, Spain	University of Rochester; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of Geneva; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM	Drugowitsch, J (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14623 USA.	jdrugo@gmail.com		Pouget, Alexandre/0000-0003-3054-6365; Moreno-Bote, Ruben/0000-0003-0398-014X	Ramon y Cajal Spanish Award; Marie Curie FP7-PEOPLE-2010-IRG grant [PIRG08-GA-2010-276795]; National Science Foundation [BCS0446730, REESE 1109366]; Multidisciplinary University Research Initiative [N00014-07-1-0937]; James McDonnell Foundation	Ramon y Cajal Spanish Award; Marie Curie FP7-PEOPLE-2010-IRG grant; National Science Foundation(National Science Foundation (NSF)); Multidisciplinary University Research Initiative(MURI); James McDonnell Foundation	R.M.B. was supported by a Ramon y Cajal Spanish Award and by the Marie Curie FP7-PEOPLE-2010-IRG grant (PIRG08-GA-2010-276795). A. P. was supported by grants from the National Science Foundation (BCS0446730 and REESE 1109366), a Multidisciplinary University Research Initiative (N00014-07-1-0937) and the James McDonnell Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; [Anonymous], 1982, JUDGMENT UNCERTAINTY; Baranski JV, 1999, PERCEPT PSYCHOPHYS, V61, P1369, DOI 10.3758/BF03206187; Battaglia PW, 2003, J OPT SOC AM A, V20, P1391, DOI 10.1364/JOSAA.20.001391; BAUM CW, 1994, IEEE T INFORM THEORY, V40, P1994, DOI 10.1109/18.340472; Beck JM, 2012, NEURON, V74, P30, DOI 10.1016/j.neuron.2012.03.016; Beck JM, 2008, NEURON, V60, P1142, DOI 10.1016/j.neuron.2008.09.021; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Cox D. R., 1965, THEORY STOCHASTIC PR; De Martino B, 2013, NAT NEUROSCI, V16, P105, DOI 10.1038/nn.3279; Dragalin VP, 1999, IEEE T INFORM THEORY, V45, P2448, DOI 10.1109/18.796383; Drugowitsch J, 2012, J NEUROSCI, V32, P3612, DOI 10.1523/JNEUROSCI.4010-11.2012; EREV I, 1994, PSYCHOL REV, V101, P519, DOI 10.1037/0033-295X.101.3.519; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; FERRELL WR, 1980, ORGAN BEHAV HUM PERF, V26, P32, DOI 10.1016/0030-5073(80)90045-8; FERRELL WR, 1995, PERCEPT PSYCHOPHYS, V57, P246, DOI 10.3758/BF03206511; Fetsch CR, 2012, NAT NEUROSCI, V15, P146, DOI 10.1038/nn.2983; Fishman M. M., 1987, SOV J COMMUN TECHNOL, V30, P2541; Galvin SJ, 2003, PSYCHON B REV, V10, P843, DOI 10.3758/BF03196546; GIGERENZER G, 1991, PSYCHOL REV, V98, P506, DOI 10.1037/0033-295X.98.4.506; Green DM, 1966, SIGNAL DETECTION THE; Grinband J, 2006, NEURON, V49, P757, DOI 10.1016/j.neuron.2006.01.032; Juslin P, 1997, J BEHAV DECIS MAKING, V10, P189, DOI 10.1002/(SICI)1099-0771(199709)10:3<189::AID-BDM258>3.0.CO;2-4; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Kepecs A, 2012, PHILOS T R SOC B, V367, P1322, DOI 10.1098/rstb.2012.0037; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; LICHTENSTEIN S, 1977, ORGAN BEHAV HUM PERF, V20, P159, DOI 10.1016/0030-5073(77)90001-0; LORDEN G, 1977, ANN STAT, V5, P1, DOI 10.1214/aos/1176343737; Maniscalco B, 2012, CONSCIOUS COGN, V21, P422, DOI 10.1016/j.concog.2011.09.021; Merkle EC, 2006, J EXP PSYCHOL GEN, V135, P391, DOI 10.1037/0096-3445.135.3.391; Merkle EC, 2009, PSYCHON B REV, V16, P204, DOI 10.3758/PBR.16.1.204; Metcalfe J., 1994, METACOGNITION KNOWIN; Moore DA, 2008, PSYCHOL REV, V115, P502, DOI 10.1037/0033-295X.115.2.502; Moreno-Bote R, 2010, NEURAL COMPUT, V22, P1786, DOI 10.1162/neco.2010.12-08-930; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; PFEIFER PE, 1994, ORGAN BEHAV HUM DEC, V58, P203, DOI 10.1006/obhd.1994.1034; Pleskac TJ, 2010, PSYCHOL REV, V117, P864, DOI 10.1037/a0019737; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Ratcliff R, 2009, PSYCHOL REV, V116, P59, DOI 10.1037/a0014086; Risken H., 1989, FOKKER PLANCK EQUATI, DOI DOI 10.1007/978-3-642-61544-3; Smith J.D., 2003, BEHAV BRAIN SCI, V26, P340; Smith JD, 2003, BEHAV BRAIN SCI, V26, P317; Smith PL, 2000, J MATH PSYCHOL, V44, P408, DOI 10.1006/jmps.1999.1260; vanBeers RJ, 1996, EXP BRAIN RES, V111, P253, DOI 10.1007/BF00227302; Vickers D., 1979, DECISION PROCESSES V; WALD A, 1948, ANN MATH STAT, V19, P326, DOI 10.1214/aoms/1177730197; Wald A., 1947, SEQUENTIAL ANAL; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Zylberberg A, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00079	50	42	42	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96511	10.1371/journal.pone.0096511	http://dx.doi.org/10.1371/journal.pone.0096511			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4LX	24816801	Green Published, gold, Green Submitted			2022-12-27	WOS:000336838000041
J	Lee, LA; Yu, JF; Lo, YL; Chen, NH; Fang, TJ; Huang, CG; Cheng, WN; Li, HY				Lee, Li-Ang; Yu, Jen-Fang; Lo, Yu-Lun; Chen, Ning-Hung; Fang, Tuan-Jen; Huang, Chung-Guei; Cheng, Wen-Nuan; Li, Hsueh-Yu			Comparative Effects of Snoring Sound between Two Minimally Invasive Surgeries in the Treatment of Snoring: A Randomized Controlled Trial	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; RADIOFREQUENCY-ASSISTED UVULOPALATOPLASTY; VOLUMETRIC TISSUE REDUCTION; PLACEBO-CONTROLLED TRIAL; SOFT PALATE IMPLANTS; OUTCOMES SURVEY; METAANALYSIS; VALIDATION; ABLATION; EFFICACY	Background: Minimally invasive surgeries of the soft palate have emerged as a less-invasive treatment for habitual snoring. To date, there is only limited information available comparing the effects of snoring sound between different minimally invasive surgeries in the treatment of habitual snoring. Objective: To compare the efficacy of palatal implant and radiofrequency surgery, in the reduction of snoring through subjective evaluation of snoring and objective snoring sound analysis. Patients and Method: Thirty patients with habitual snoring due to palatal obstruction (apnea-hypopnea index <= 15, body max index <= 30) were prospectively enrolled and randomized to undergo a single session of palatal implant or temperature-controlled radiofrequency surgery of the soft palate under local anesthesia. Snoring was primarily evaluated by the patient with a 10 cm visual analogue scale (VAS) at baseline and at a 3-month follow-up visit and the change in VAS was the primary outcome. Moreover, life qualities, measured by snore outcomes survey, and full-night snoring sounds, analyzed by a sound analytic program (Snore Map), were also investigated at the same time. Results: Twenty-eight patients completed the study; 14 received palatal implant surgery and 14 underwent radiofrequency surgery. The VAS and snore outcomes survey scores were significantly improved in both groups. However, the good response (postoperative VAS <= 3 or postoperative VAS <= 5 plus snore outcomes survey score >= 60) rate of the palatal implant group was significantly higher than that of the radiofrequency group (79% vs. 29%, P = 0.021). The maximal loudness of low-frequency (40-300 Hz) snores was reduced significantly in the palatal implant group. In addition, the snoring index was significantly reduced in the radiofrequency group. Conclusions: Both palatal implants and a single-stage radiofrequency surgery improve subjective snoring outcomes, but palatal implants have a greater effect on most measures of subjective and objective snoring. Multi-stage radiofrequency surgery was not tested.	[Lee, Li-Ang; Fang, Tuan-Jen; Li, Hsueh-Yu] Chang Gung Univ, Dept Otorhinolaryngol Head & Neck Surg, Chang Gung Mem Hosp Linkou, Sch Med,Coll Med, Taoyuan, Taiwan; [Lee, Li-Ang; Lo, Yu-Lun; Chen, Ning-Hung; Fang, Tuan-Jen; Li, Hsueh-Yu] Chang Gung Mem Hosp Linkou, Sleep Ctr, Taoyuan, Taiwan; [Lee, Li-Ang] Xiamen Chang Gung Hosp, Dept Otolaryngol, Xiamen, Fujian Province, Peoples R China; [Yu, Jen-Fang] Chang Gung Univ, Taiouan Interdisciplinary Otolaryngol Lab, Grad Inst Med Mechatron, Taoyuan, Taiwan; [Lo, Yu-Lun; Chen, Ning-Hung] Chang Gung Univ, Dept Pulm & Crit Care Med, Chang Gung Mem Hosp Linkou, Sch Med,Coll Med, Taoyuan, Taiwan; [Huang, Chung-Guei] Chang Gung Univ, Dept Lab Med, Chang Gung Mem Hosp Linkou, Coll Med, Taoyuan, Taiwan; [Cheng, Wen-Nuan] Taipei Phys Educ Coll, Grad Sch Recreat & Sports Management, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; University of Taipei	Li, HY (corresponding author), Chang Gung Univ, Dept Otorhinolaryngol Head & Neck Surg, Chang Gung Mem Hosp Linkou, Sch Med,Coll Med, Taoyuan, Taiwan.	hyli38@cgmh.org.tw	Li-Ang, Lee/AAO-6876-2020	Li-Ang, Lee/0000-0001-8414-595X; YU, JEN-FANG/0000-0002-3202-8433; Fang, TuanJen/0000-0002-7805-3458	National Science Council, Taiwan [NSC 99-2314-B-182A-099-MY2]; Chang Gung Memorial Hospital, Taiwan [CMRPG3A1501-2]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This study was financially supported by a grant from the National Science Council, Taiwan (NSC 99-2314-B-182A-099-MY2) and the Chang Gung Memorial Hospital, Taiwan (CMRPG3A1501-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoros-Sebastia LI, 2011, ACTA OTORRINOLAR ESP, V62, P300, DOI 10.1016/j.otorri.2011.03.002; Back LJJ, 2009, LARYNGOSCOPE, V119, P1621, DOI 10.1002/lary.20562; Back LJJ, 2009, LARYNGOSCOPE, V119, P1241, DOI 10.1002/lary.20215; Back LJJ, 2002, AM J RESP CRIT CARE, V166, P865, DOI 10.1164/rccm.2104110; Balsevicius T, 2013, SLEEP BREATH, V17, P695, DOI 10.1007/s11325-012-0744-9; Bassiouny A, 2007, EUR ARCH OTO-RHINO-L, V264, P659, DOI 10.1007/s00405-007-0244-x; Ben-Israel N, 2012, SLEEP, V35, P1299, DOI 10.5665/sleep.2092; Blumen MB, 2008, OTOLARYNG HEAD NECK, V138, P294, DOI 10.1016/j.otohns.2007.11.008; Blumen MB, 2013, LARYNGOSCOPE, V123, P1556, DOI 10.1002/lary.23800; Blumen MB, 2002, OTOLARYNG HEAD NECK, V126, P67, DOI 10.1067/mhn.2002.121017; Caples SM, 2010, SLEEP, V33, P1396, DOI 10.1093/sleep/33.10.1396; Chen NH, 2002, QUAL LIFE RES, V11, P601, DOI 10.1023/A:1016337008763; Choi JH, 2013, LARYNGOSCOPE, V123, P269, DOI 10.1002/lary.23470; Coleman SC, 2000, OTOLARYNG HEAD NECK, V122, P387, DOI 10.1016/S0194-5998(00)70054-4; Courey MS, 1999, LARYNGOSCOPE, V109, P1316, DOI 10.1097/00005537-199908000-00025; Fang TJ, 2003, INT J CLIN PRACT, V57, P769; Franklin KA, 2009, SLEEP, V32, P27; Friedman M, 2008, OTOLARYNG HEAD NECK, V138, P209, DOI 10.1016/j.otohns.2007.10.026; Galgiani JN, 2000, ANN INTERN MED, V133, P676, DOI 10.7326/0003-4819-133-9-200011070-00009; Gliklich RE, 2002, ARCH OTOLARYNGOL, V128, P819, DOI 10.1001/archotol.128.7.819; Goessler UR, 2007, ACTA OTO-LARYNGOL, V127, P527, DOI 10.1080/00016480600951392; Ho WK, 2004, ARCH OTOLARYNGOL, V130, P753, DOI 10.1001/archotol.130.6.753; Iber C., 2007, AASM MANUAL SCORING; Iseri M, 2005, OTOLARYNG HEAD NECK, V133, P224, DOI 10.1016/j.otohns.2005.04.018; Lee LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053481; Maurer JT, 2012, EUR ARCH OTO-RHINO-L, V269, P1851, DOI 10.1007/s00405-011-1920-4; Michael H, 2008, EUR ARCH OTO-RHINO-L, V265, P105, DOI 10.1007/s00405-007-0408-8; Neruntarat C, 2011, EUR ARCH OTO-RHINO-L, V268, P1077, DOI 10.1007/s00405-011-1511-4; Nordgard S, 2006, OTOLARYNG HEAD NECK, V134, P565, DOI 10.1016/j.otohns.2005.11.034; Powell NB, 1998, CHEST, V113, P1163, DOI 10.1378/chest.113.5.1163; Rotenberg BW, 2012, LARYNGOSCOPE, V122, P696, DOI 10.1002/lary.22510; Sher AE, 2001, OTOLARYNG HEAD NECK, V125, P312, DOI 10.1067/mhn.2001.119141; Skjostad KW, 2006, OTOLARYNG HEAD NECK, V134, P63, DOI 10.1016/j.otohns.2005.10.006; Steward DL, 2008, OTOLARYNG HEAD NECK, V139, P506, DOI 10.1016/j.otohns.2008.07.021; Stuck BA, 2005, SLEEP, V28, P847, DOI 10.1093/sleep/28.7.847; Stuck BA, 2004, SLEEP, V27, P551, DOI 10.1093/sleep/27.3.551; Terris DJ, 2002, OTOLARYNG HEAD NECK, V127, P315, DOI 10.1067/mhn.2002.128345; Weaver TE, 1997, SLEEP, V20, P835	38	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97186	10.1371/journal.pone.0097186	http://dx.doi.org/10.1371/journal.pone.0097186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816691	gold, Green Published, Green Submitted			2022-12-27	WOS:000336838000115
J	Martin, EG; Palmer, C				Martin, Elizabeth G.; Palmer, Colin			Air Space Proportion in Pterosaur Limb Bones Using Computed Tomography and Its Implications for Previous Estimates of Pneumaticity	PLOS ONE			English	Article							POSTCRANIAL SKELETON; LONG BONES; BODY-MASS; FLIGHT; PNEUMATIZATION; BIOMECHANICS; THICKNESS	Air Space Proportion (ASP) is a measure of how much air is present within a bone, which allows for a quantifiable comparison of pneumaticity between specimens and species. Measured from zero to one, higher ASP means more air and less bone. Conventionally, it is estimated from measurements of the internal and external bone diameter, or by analyzing cross-sections. To date, the only pterosaur ASP study has been carried out by visual inspection of sectioned bones within matrix. Here, computed tomography (CT) scans are used to calculate ASP in a small sample of pterosaur wing bones (mainly phalanges) and to assess how the values change throughout the bone. These results show higher ASPs than previous pterosaur pneumaticity studies, and more significantly, higher ASP values in the heads of wing bones than the shaft. This suggests that pneumaticity has been underestimated previously in pterosaurs, birds, and other archosaurs when shaft cross-sections are used to estimate ASP. Furthermore, ASP in pterosaurs is higher than those found in birds and most sauropod dinosaurs, giving them among the highest ASP values of animals studied so far, supporting the view that pterosaurs were some of the most pneumatized animals to have lived. The high degree of pneumaticity found in pterosaurs is proposed to be a response to the wing bone bending stiffness requirements of flight rather than a means to reduce mass, as is often suggested. Mass reduction may be a secondary result of pneumaticity that subsequently aids flight.	[Martin, Elizabeth G.] Univ Southampton, Sch Ocean & Earth Sci, Southampton, Hants, England; [Palmer, Colin] Univ Bristol, Sch Earth Sci, Bristol, Avon, England	NERC National Oceanography Centre; University of Southampton; University of Bristol	Martin, EG (corresponding author), Univ Southampton, Sch Ocean & Earth Sci, Waterfront Campus, Southampton, Hants, England.	e.g.martin@soton.ac.uk	Martin-Silverstone, Elizabeth/M-4721-2019	Martin-Silverstone, Elizabeth/0000-0003-0139-2109				Andres B, 2012, EARTH ENV SCI T R SO, V103, P383, DOI 10.1017/S1755691013000303; Benson RBJ, 2012, BIOL REV, V87, P168, DOI 10.1111/j.1469-185X.2011.00190.x; Bonde Niels, 2003, Geological Society Special Publication, V217, P217, DOI 10.1144/GSL.SP.2003.217.01.13; BRAMWELL CD, 1974, PHILOS T R SOC B, V267, P503, DOI 10.1098/rstb.1974.0007; Britt BB., 1993, THESIS U CALGARY; Brower J.C., 1983, Journal of Vertebrate Paleontology, V3, P84; Butler RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034094; Butler RJ, 2009, BIOL LETTERS, V5, P557, DOI 10.1098/rsbl.2009.0139; Claessens LPAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004497; Cubo J, 2000, ZOOL J LINN SOC-LOND, V130, P499, DOI 10.1006/zjls.1999.0238; Currey J.D., 2002, BONES STRUCTURE MECH; CURREY JD, 1985, J ZOOL, V206, P453; Dumont ER, 2010, P ROY SOC B-BIOL SCI, V277, P2193, DOI 10.1098/rspb.2010.0117; Elgin RA, 2013, CRETACEOUS RES, V45, P16, DOI 10.1016/j.cretres.2013.06.006; Elgin RA, 2011, ACTA PALAEONTOL POL, V56, P99, DOI 10.4202/app.2009.0145; Fastnacht M, 2005, ACTA PALAEONTOL POL, V50, P273; Habib Michael B., 2008, Zitteliana Reihe B, V28, P159; Henderson DM, 2010, J VERTEBR PALEONTOL, V30, P768, DOI 10.1080/02724631003758334; Martin EG, 2012, THESIS U BRISTOL; Martin EG, 2014, J VERTEBRAT IN PRESS; Naish D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058451; Nessov L. A., 1991, VESTNIK LENINGRADS 7, V2, P14; O'Connor PM, 2006, J MORPHOL, V267, P1199, DOI 10.1002/jmor.10470; O'Connor PM, 2004, J MORPHOL, V261, P141, DOI 10.1002/jmor.10190; Schwarz D, 2007, ACTA PALAEONTOL POL, V52, P167; Suhai B, 2006, J BIOMECH, V39, P2140, DOI 10.1016/j.jbiomech.2005.06.013; Taylor MP, 2013, PEERJ, V1, DOI 10.7717/peerj.36; Unwin David M., 2003, Geological Society Special Publication, V217, P139, DOI 10.1144/GSL.SP.2003.217.01.11; Wedel MJ, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P201; Witmer LM, 2003, NATURE, V425, P950, DOI 10.1038/nature02048; Witton MP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013982; Witton Mark P., 2008, Zitteliana Reihe B, V28, P143	32	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97159	10.1371/journal.pone.0097159	http://dx.doi.org/10.1371/journal.pone.0097159			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24817312	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000336838000109
J	Srivastava, A; Balaji, PV				Srivastava, Alka; Balaji, Petety V.			Interplay of Sequence, Topology and Termini Charge in Determining the Stability of the Aggregates of GNNQQNY Mutants: A Molecular Dynamics Study	PLOS ONE			English	Article							AMYLOID-FORMING PEPTIDE; SIDE-CHAIN INTERACTIONS; CROSS-BETA-SPINE; STRUCTURAL STABILITY; FIBRIL FORMATION; ALZHEIMERS-DISEASE; EARLY STEPS; SIMULATIONS; ORGANIZATION; MECHANISMS	This study explores the stabilities of single sheet parallel systems of three sequence variants of (1)GNNQQNY(7), N2D, N2S and N6D, with variations in aggregate size (5-8) and termini charge (charged or neutral). The aggregates were simulated at 300 and 330 K. These mutations decrease amyloid formation in the yeast prion protein Sup35. The present study finds that these mutations cause instability even in the peptide context. The protonation status of termini is found to be a key determinant of stabilities; other determinants are sequence, position of mutation and aggregate size. All systems with charged termini are unstable, whereas both stable and unstable systems are found when the termini are neutral. When termini are charged, the largest stable aggregate for the N2S and N6D systems has 3 to 4 peptides whereas N2D mutation supports oligomers of larger size (5-and 6-mers) as well. Mutation at 2nd position (N2S and N2D) results in fewer H-bonds at the mutated as well as neighboring (Gly1/Gln4) positions. However, no such effect is found if mutation is at 6th position (N6D). The effect of Asn -> Asp mutation depends on the position and termini charge: it is more destabilizing at the 2nd position than at the 6th in case of neutral termini, however, the opposite is true in case of charged termini. Appearance of twist in stable systems and in smaller aggregates formed in unstable systems suggests that twist is integral to amyloid arrangement. Disorder, dissociation or rearrangement of peptides, disintegration or collapse of aggregates and formation of amorphous aggregates observed in these simulations are likely to occur during the early stages of aggregation also. The smaller aggregates formed due to such events have a variety of arrangements of peptides. This suggests polymorphic nature of oligomers and presence of a heterogeneous mixture of oligomers during early stages of aggregation.	[Srivastava, Alka; Balaji, Petety V.] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Balaji, PV (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.	balaji@iitb.ac.in		Balaji, Petety/0000-0002-6018-6957	Indian Council of Medical Research, INDIA	Indian Council of Medical Research, INDIA(Indian Council of Medical Research (ICMR))	AS received fellowship from Indian Council of Medical Research, INDIA. The infrastructure and other facilities has been provided by Indian Institute of Technology Bombay, INDIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balbach JJ, 2002, BIOPHYS J, V83, P1205, DOI 10.1016/S0006-3495(02)75244-2; Balbirnie M, 2001, P NATL ACAD SCI USA, V98, P2375, DOI 10.1073/pnas.041617698; Bemporad F, 2006, ACCOUNTS CHEM RES, V39, P620, DOI 10.1021/ar050067x; Berhanu WM, 2012, BIOPOLYMERS, V98, P131, DOI 10.1002/bip.21731; Berhanu WM, 2011, BIOPOLYMERS, V95, P573, DOI 10.1002/bip.21611; Berhanu WM, 2010, BIOPHYS CHEM, V149, P12, DOI 10.1016/j.bpc.2010.03.003; Berhanu WM, 2012, J MOL MODEL, V18, P1129, DOI 10.1007/s00894-011-1123-3; Berhanu WM, 2012, J MOL MODEL, V18, P891, DOI 10.1007/s00894-011-1030-7; Berhanu WM, 2011, J MOL MODEL, V17, P2423, DOI 10.1007/s00894-010-0912-4; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chen HF, 2009, COMPUT BIOL CHEM, V33, P41, DOI 10.1016/j.compbiolchem.2008.07.023; Colombo G, 2008, PROTEINS, V70, P863, DOI 10.1002/prot.21648; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; de la Paz ML, 2005, J MOL BIOL, V349, P583, DOI 10.1016/j.jmb.2005.03.081; De Simone A, 2008, BIOPHYS J, V95, P1965, DOI 10.1529/biophysj.108.129213; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; Dubay KF, 2004, J MOL BIOL, V341, P1317, DOI 10.1016/j.jmb.2004.06.043; Esposito L, 2008, BIOPHYS J, V94, P4031, DOI 10.1529/biophysj.107.118935; Esposito L, 2006, P NATL ACAD SCI USA, V103, P11533, DOI 10.1073/pnas.0602345103; Fandrich M, 2012, J MOL BIOL, V421, P427, DOI 10.1016/j.jmb.2012.01.006; Flock D, 2006, PROTEINS, V65, P914, DOI 10.1002/prot.21168; Friedman R, 2011, BIOCHEM J, V438, P415, DOI 10.1042/BJ20110369; Gazit E, 2005, FEBS J, V272, P5971, DOI 10.1111/j.1742-4658.2005.05022.x; Greenwald J, 2012, J MOL BIOL, V421, P417, DOI 10.1016/j.jmb.2012.04.015; Gsponer J, 2003, P NATL ACAD SCI USA, V100, P5154, DOI 10.1073/pnas.0835307100; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Han W, 2007, PROTEINS, V66, P575, DOI 10.1002/prot.21232; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iconomidou VA, 2006, J STRUCT BIOL, V156, P480, DOI 10.1016/j.jsb.2006.08.011; Idicula-Thomas S, 2005, PROTEIN ENG DES SEL, V18, P175, DOI 10.1093/protein/gzi022; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kajava AV, 2005, J MOL BIOL, V348, P247, DOI 10.1016/j.jmb.2005.02.029; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Langkilde AE, 2009, FEBS LETT, V583, P2600, DOI 10.1016/j.febslet.2009.05.040; Lewandowski JR, 2011, J AM CHEM SOC, V133, P14686, DOI 10.1021/ja203736z; Lin YF, 2010, BIOPOLYMERS, V94, P269, DOI 10.1002/bip.21322; Lipfert J, 2005, J MOL BIOL, V349, P648, DOI 10.1016/j.jmb.2005.03.083; Makin OS, 2005, FEBS J, V272, P5950, DOI 10.1111/j.1742-4658.2005.05025.x; Marshall KE, 2010, BIOPHYS J, V98, P330, DOI 10.1016/j.bpj.2009.10.020; Matthes D, 2012, J MOL BIOL, V421, P390, DOI 10.1016/j.jmb.2012.02.004; Matthes D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019129; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; McLaughlin RW, 2006, PROTEIN SCI, V15, P1710, DOI 10.1110/ps.051997606; Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144; Myers SL, 2006, BIOCHEMISTRY-US, V45, P2311, DOI 10.1021/bi052434i; Nakano M, 2009, INTERDISCIP SCI, V1, P21, DOI 10.1007/s12539-008-0020-7; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Nerelius C, 2010, BIOCHEM BIOPH RES CO, V396, P2, DOI 10.1016/j.bbrc.2010.02.105; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Pagel K, 2005, ORG BIOMOL CHEM, V3, P3843, DOI 10.1039/b510098d; Periole X, 2009, J PHYS CHEM B, V113, P1728, DOI 10.1021/jp8078259; Ramachandran G, 2012, J MOL BIOL, V421, P296, DOI 10.1016/j.jmb.2012.01.007; Reddy AS, 2010, BIOPHYS J, V98, P1038, DOI 10.1016/j.bpj.2009.10.057; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Song W, 2008, J PHYS CHEM B, V112, P4410, DOI 10.1021/jp710592v; Srivastava A, 2012, BBA-PROTEINS PROTEOM, V1824, P963, DOI 10.1016/j.bbapap.2012.05.003; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Strodel B, 2007, J AM CHEM SOC, V129, P16005, DOI 10.1021/ja075346p; Takeda T, 2009, J PHYS CHEM B, V113, P11848, DOI 10.1021/jp904070w; Tsai HH, 2005, P NATL ACAD SCI USA, V102, P8174, DOI 10.1073/pnas.0408653102; Tsai HH, 2004, BIOPHYS J, V87, P146, DOI 10.1529/biophysj.104.040352; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van der Wel PCA, 2007, J AM CHEM SOC, V129, P5117, DOI 10.1021/ja068633m; van der Wel PCA, 2010, BIOCHEMISTRY-US, V49, P9457, DOI 10.1021/bi100077x; Vitagliano L, 2008, BIOCHEM BIOPH RES CO, V377, P1036, DOI 10.1016/j.bbrc.2008.10.039; Wang J, 2008, BIOPHYS J, V95, P5037, DOI 10.1529/biophysj.108.131672; Waxman EA, 2009, BBA-MOL BASIS DIS, V1792, P616, DOI 10.1016/j.bbadis.2008.09.013; Wei GH, 2004, BIOPHYS J, V87, P3648, DOI 10.1529/biophysj.104.047688; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P5036, DOI 10.1073/pnas.87.13.5036; Wu C, 2004, BIOPHYS J, V87, P3000, DOI 10.1529/biophysj.104.047076; Ye W, 2013, ACTA BIOCH BIOPH SIN, V45, P503, DOI 10.1093/abbs/gmt026; Zanuy D, 2003, J MOL BIOL, V329, P565, DOI 10.1016/S0022-2836(03)00491-1; Zhang ZQ, 2007, BIOPHYS J, V93, P1484, DOI 10.1529/biophysj.106.100537; Zheng J, 2006, BIOPHYS J, V91, P824, DOI 10.1529/biophysj.106.083246	79	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96660	10.1371/journal.pone.0096660	http://dx.doi.org/10.1371/journal.pone.0096660			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24817093	Green Published, gold, Green Submitted			2022-12-27	WOS:000336838000048
J	Duan, FJ; Song, CH; Dai, LP; Cui, SL; Zhang, XQ; Zhao, X				Duan, Fujiao; Song, Chunhua; Dai, Liping; Cui, Shuli; Zhang, Xiaoqin; Zhao, Xia			The Significance of Exo1 K589E Polymorphism on Cancer Susceptibility: Evidence Based on a Meta-Analysis	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; DNA-REPAIR GENES; MISMATCH REPAIR; EXONUCLEASE 1; CHINESE POPULATION; LUNG-CANCER; RISK; SMOKING; TAIWAN; HOGG1	The exonuclease1 (Exo1) gene is a key component of mismatch repair (MMR) by resecting the damaged strand, which is the only exonuclease involved in the human MMR system. The gene product is a member of the RAD2 nuclease family and functions in DNA replication, repair and recombination. However, whether Exo1 is required to activate MMR-dependent DNA damage response (DDR) remains unknown, the conclusions of the Exo1 polymorphisms on cancer susceptibility studies were not consistent. We carried out a meta-analysis of 7 case-control studies to clarify the association between the Exo1 K589E polymorphism and cancer risk. Overall, a significant association of the Exo1 K589E polymorphism with cancer risk in all genetic models (Lys vs Glu: OR = 1.51, 95% CI: 1.39-1.99, P<0.01; Glu/Lys vs Glu/Glu: OR = 1.43, 95% CI: 1.28-1.60, P<0.01; Lys/Lys vs Glu/Glu: OR = 2.45, 95% CI: 1.90-3.17, P<0.01; Lys/Lys+Glu/Lys vs Glu/Glu: OR = 1.53, 95% CI: 1.38-1.71, P<0.01; Glu/Glu vs Glu/Lys+Lys/Lys: OR = 2.27, 95% CI: 1.79-2.89, P<0.01). In the stratified analysis by ethnicity, significantly increased risk was observed in Asian population (Lys vs Glu: OR = 1.53, 95% CI: 1.39-1.69, P<0.01; Glu/Lys vs Glu/Glu: OR = 1.50, 95% CI: 1.34-1.69, P<0.01; Lys/Lys vs Glu/Glu: OR = 2.48, 95% CI: 1.84-3.34, P<0.01; Lys/Lys+ Glu/Lys vs Glu/Glu: OR = 1.58, 95% CI: 1.41-1.78, P<0.01; Glu/Glu vs Glu/Lys+Lys/Lys: OR = 2.18, 95% CI: 1.62-2.93, P<0.01). Subgroup analysis based on smoking suggested Exo1 K589E polymorphism conferred significant risk among smokers (Lys/Lys+ Glu/Lys vs Glu/Glu: OR = 2.16, 95% CI: 1.77-2.63, P<0.01), but not in non-smokers (Lys/Lys+ Glu/Lys vs Glu/Glu: OR = 0.89, 95% CI: 0.64-1.24, P = 0.50). In conclusion, Exo1 K589E Lys allele may be used as a novel biomarker for cancer susceptibility, particularly in smokers.	[Duan, Fujiao; Zhang, Xiaoqin; Zhao, Xia] Zhengzhou Univ, Henan Tumor Hosp, Affiliated Tumor Hosp, Dept Hosp Infect Management, Zhengzhou 450052, Henan, Peoples R China; [Song, Chunhua; Dai, Liping] Zhengzhou Univ, Coll Publ Hlth, Dept Epidemiol, Zhengzhou 450052, Henan, Peoples R China; [Song, Chunhua; Dai, Liping] Henan Key Lab Tumor Epidemiol, Zhengzhou, Henan, Peoples R China; [Cui, Shuli] Northeastern Univ, Coll Profess Study, Boston, MA 02115 USA	Zhengzhou University; Zhengzhou University; Northeastern University	Zhao, X (corresponding author), Zhengzhou Univ, Henan Tumor Hosp, Affiliated Tumor Hosp, Dept Hosp Infect Management, Zhengzhou 450052, Henan, Peoples R China.	zhaoxiagrb@126.com	Dai, Liping/E-6089-2013	Duan, Fujiao/0000-0002-5731-5463	People's Republic of China National Natural Science Foundation of China [81202278]; Program for Science and Technology Innovation Talents in Universities of Henan Province [2010HASTIT027]; Excellent Youth Foundation of He'nan Scientific Committee [124100510007]	People's Republic of China National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Science and Technology Innovation Talents in Universities of Henan Province; Excellent Youth Foundation of He'nan Scientific Committee	This research was supported by People's Republic of China National Natural Science Foundation of China (No. 81202278), and Program for Science and Technology Innovation Talents in Universities of Henan Province (No. 2010HASTIT027), and Excellent Youth Foundation of He'nan Scientific Committee (No. 124100510007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bau DT, 2009, CHINESE J PHYSIOL, V52, P411, DOI 10.4077/CJP.2009.AMH076; Bayram S, 2012, MOL BIOL REP, V39, P5943, DOI 10.1007/s11033-011-1406-x; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Chang JS, 2008, CANCER EPIDEM BIOMAR, V17, P1368, DOI 10.1158/1055-9965.EPI-07-2830; Cho EY, 2003, CANCER EPIDEM BIOMAR, V12, P1100; Cleaver JE, 2002, FRONT BIOSCI-LANDMRK, V7, pD1024, DOI 10.2741/cleaver; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Goode EL, 2002, CANCER EPIDEM BIOMAR, V11, P1513; Hsu NY, 2009, ANTICANCER RES, V29, P725; Izumchenko E, 2012, DNA REPAIR, V11, P951, DOI 10.1016/j.dnarep.2012.09.004; Jin GF, 2008, LUNG CANCER, V60, P340, DOI 10.1016/j.lungcan.2007.11.003; Kapoor S, 2013, EUR J GASTROEN HEPAT, V25, P385, DOI 10.1097/MEG.0b013e32835d0b00; Lee B, 2002, NUCLEIC ACIDS RES, V30, P942, DOI 10.1093/nar/30.4.942; Li CY, 2009, INT J CANCER, V124, P999, DOI 10.1002/ijc.24126; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Luo XP, 2012, INT J GYNECOL CANCER, V22, P220, DOI 10.1097/IGC.0b013e318234fd8a; Mantel N, 2004, CHALLENGE EPIDEMIOLO, V1, P533; Marti TM, 2002, J CELL PHYSIOL, V191, P28, DOI 10.1002/jcp.10077; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Schmutte C, 1998, CANCER RES, V58, P4537; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stern MC, 2001, CANCER EPIDEM BIOMAR, V10, P125; Tran PT, 2004, DNA REPAIR, V3, P1549, DOI 10.1016/j.dnarep.2004.05.015; Tsai MH, 2009, ORAL ONCOL, V45, pE90, DOI 10.1016/j.oraloncology.2009.03.011; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang HC, 2009, ANTICANCER RES, V29, P3897; Wang Y. L., 2013, 2013 Abstracts IEEE International Conference on Plasma Science (ICOPS), DOI 10.1109/PLASMA.2013.6633252; Wilson DM, 1998, NUCLEIC ACIDS RES, V26, P3762, DOI 10.1093/nar/26.16.3762; Xing DY, 2001, INT J CANCER, V95, P140, DOI 10.1002/1097-0215(20010520)95:3&lt;140::AID-IJC1024&gt;3.0.CO;2-2; Yang SY, 2013, INT J CANCER, V132, P449, DOI 10.1002/ijc.27630; Yu X-L, 2013, TUMOR BIOL, P1; Zhou Y, 2013, J OPTIMIZ THEORY APP, V156, P1, DOI 10.1007/s10957-013-0271-2	34	8	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96764	10.1371/journal.pone.0096764	http://dx.doi.org/10.1371/journal.pone.0096764			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810280	gold, Green Published, Green Submitted			2022-12-27	WOS:000338213300070
J	Gao, X; Wu, M; Xu, RN; Wang, XR; Pan, RQ; Kim, HJ; Liao, H				Gao, Xiang; Wu, Man; Xu, Ruineng; Wang, Xiurong; Pan, Ruqian; Kim, Hye-Ji; Liao, Hong			Root Interactions in a Maize/Soybean Intercropping System Control Soybean Soil-Borne Disease, Red Crown Rot	PLOS ONE			English	Article							PHOSPHORUS UPTAKE; CROPPING SYSTEMS; EXUDATION; DIVERSITY; RESISTANCE; ACIDS	Background: Within-field multiple crop species intercropping is well documented and used for disease control, but the underlying mechanisms are still unclear. As roots are the primary organ for perceiving signals in the soil from neighboring plants, root behavior may play an important role in soil-borne disease control. Principal Findings: In two years of field experiments, maize/soybean intercropping suppressed the occurrence of soybean red crown rot, a severe soil-borne disease caused by Cylindrocladium parasiticum (C. parasiticum). The suppressive effects decreased with increasing distance between intercropped plants under both low P and high P supply, suggesting that root interactions play a significant role independent of nutrient status. Further detailed quantitative studies revealed that the diversity and intensity of root interactions altered the expression of important soybean PR genes, as well as, the activity of corresponding enzymes in both P treatments. Furthermore, 5 phenolic acids were detected in root exudates of maize/soybean intercropped plants. Among these phenolic acids, cinnamic acid was released in significantly greater concentrations when intercropped maize with soybean compared to either crop grown in monoculture, and this spike in cinnamic acid was found dramatically constrain C. parasiticum growth in vitro. Conclusions: To the best of our knowledge, this study is the first report to demonstrate that intercropping with maize can promote resistance in soybean to red crown rot in a root-dependent manner. This supports the point that intercropping may be an efficient ecological strategy to control soil-borne plant disease and should be incorporated in sustainable agricultural management practices.	[Gao, Xiang; Wu, Man; Xu, Ruineng; Wang, Xiurong; Pan, Ruqian; Liao, Hong] South China Agr Univ, Root Biol Ctr, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China; [Kim, Hye-Ji] Univ Hawaii Manoa, Coll Trop Agr & Human Resources, Dept Trop Plants & Soil Sci, Honolulu, HI 96822 USA	South China Agricultural University; University of Hawaii System; University of Hawaii Manoa	Liao, H (corresponding author), South China Agr Univ, Root Biol Ctr, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China.	hliao@scau.edu.cn	gao, xiang/AFP-7274-2022	gao, xiang/0000-0003-0359-9533	National Natural Science Foundation of China [31025022]; National Key Basic Research Special Funds of China [2011CB100301]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Special Funds of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (grant no. 31025022) and National Key Basic Research Special Funds of China (grant no. 2011CB100301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AE N, 1990, SCIENCE, V248, P477, DOI 10.1126/science.248.4954.477; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Bais HP, 2005, NATURE, V434, P217, DOI 10.1038/nature03356; Bais HP, 2003, SCIENCE, V301, P1377, DOI 10.1126/science.1083245; Bardgett RD, 1999, ECOL LETT, V2, P357; BELL DK, 1966, PHYTOPATHOLOGY, V56, P1361; BROWNING JA, 1969, ANNU REV PHYTOPATHOL, V7, P355, DOI 10.1146/annurev.py.07.090169.002035; Dordas C, 2008, AGRON SUSTAIN DEV, V28, P33, DOI 10.1051/agro:2007051; Fang SQ, 2013, P NATL ACAD SCI USA, V110, P2670, DOI 10.1073/pnas.1222821110; Fang SQ, 2011, PLANT PHYSIOL, V155, P1277, DOI 10.1104/pp.110.167304; Gao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033977; Gomez-Rodriguez O, 2003, FIELD CROP RES, V83, P27, DOI 10.1016/S0378-4290(03)00053-4; Guan M, 2010, PLANT DIS, V94, P485, DOI 10.1094/PDIS-94-4-0485B; Hao WY, 2010, PLANT SOIL, V336, P485, DOI 10.1007/s11104-010-0505-0; He Y, 2013, SOIL BIOL BIOCHEM, V57, P625, DOI 10.1016/j.soilbio.2012.07.027; HOFFLAND E, 1992, NEW PHYTOL, V122, P675, DOI 10.1111/j.1469-8137.1992.tb00096.x; Kuruppu PU, 2004, PLANT DIS, V88, P613, DOI 10.1094/PDIS.2004.88.6.613; Li CY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008049; Li L, 2003, NUTR CYCL AGROECOSYS, V65, P61, DOI 10.1023/A:1021885032241; Li L, 2007, P NATL ACAD SCI USA, V104, P11192, DOI 10.1073/pnas.0704591104; Liao H, 2006, PLANT PHYSIOL, V141, P674, DOI 10.1104/pp.105.076497; Ling N, 2011, PLANT SOIL, V341, P485, DOI 10.1007/s11104-010-0660-3; Meynard JM, 2003, CR BIOL, V326, P37, DOI 10.1016/S1631-0691(03)00006-4; Ratnadass A, 2012, AGRON SUSTAIN DEV, V32, P273, DOI 10.1007/s13593-011-0022-4; Ren LX, 2008, SOIL BIOL BIOCHEM, V40, P834, DOI 10.1016/j.soilbio.2007.11.003; SMEDEGAARDPETERSEN V, 1985, ANNU REV PHYTOPATHOL, V23, P475, DOI 10.1146/annurev.py.23.090185.002355; Song YAYA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013324; TRENBATH BR, 1993, FIELD CROP RES, V34, P381, DOI 10.1016/0378-4290(93)90123-5; Upchurch RG, 2010, PHYSIOL MOL PLANT P, V75, P64, DOI 10.1016/j.pmpp.2010.08.007; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; van Wees SCM, 2000, P NATL ACAD SCI USA, V97, P8711, DOI 10.1073/pnas.130425197; Wang XR, 2011, MYCORRHIZA, V21, P173, DOI 10.1007/s00572-010-0319-1; Weir TL, 2004, CURR OPIN PLANT BIOL, V7, P472, DOI 10.1016/j.pbi.2004.05.007; Wu HS, 2009, SOIL SCI SOC AM J, V73, P1150, DOI 10.2136/sssaj2008.0266; Yu JQ, 1999, J CHEM ECOL, V25, P2409, DOI 10.1023/A:1020809805081; Zhu YY, 2000, NATURE, V406, P718, DOI 10.1038/35021046	36	64	78	10	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e95031	10.1371/journal.pone.0095031	http://dx.doi.org/10.1371/journal.pone.0095031			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810161	Green Published, gold, Green Submitted			2022-12-27	WOS:000338213300009
J	Jingi, AM; Noubiap, JJN; Kamdem, P; Kingue, S				Jingi, Ahmadou M.; Noubiap, Jean Jacques N.; Kamdem, Philippe; Kingue, Samuel			Determinants and Improvement of Electrocardiographic Diagnosis of Left Ventricular Hypertrophy in a Black African Population	PLOS ONE			English	Article							CRITERIA; HYPERTENSION; SPECIFICITY; SENSITIVITY; ASSOCIATION; COMMITTEE; OBESITY; MASS; AGE	Background: Left ventricular hypertrophy (LVH) is a major cardiovascular risk factor. The electrocardiogram (ECG) has been shown to be a poor tool in detecting LVH due to cardiac and extracardiac factors. We studied the determinants and possibility of improving the test performance of the ECG in a group of Black Africans. Methods: We studied echocardiograms and electrocardiograms of 182 Cameroonian patients among whom 113 (62.1%) were having an echocardiographic LVH. Echocardiographic LVH was defined as Left Ventricular Mass Indexed to height (2.7)(LVMI)>48 g/m(2.7) in men, and >44 g/m(2.7) in women or Body Surface Area >= 116 g/m(2) in men, and >= 96 g/m(2) in women. Test performances were calculated for 6 classic ECG criteria Sokolow-Lyon, Cornell, Cornell product, Gubner-Ungerleiger, amplitudes of R in aVL, V-5 and V-6. Results: The most sensitive criteria were Cornell (37.2%) and Sokolow-Lyon index (26.5%). The most specific criteria were Gubner (98.6%), RaVL (97.1%), RV5/V-6 (95.7%) and Cornell product (94.2%). The performance of the ECG in diagnosing LVH significantly increased with the severity of LVH for Cornell index (r = 0.420, p<0.0001) and Sokolow index (r = 0.212, p = 0.002). It decreased with body habitus (r = 20.248, p = 0.001) for Sokolow-Lyon index. Cornell index was less affected (age p = 0.766; body habitus: p = 0.209). After sex-specific adjustment for BMI, Cornell BMI sensitivity increased from 37.2% to 69% (r = 0.472, p<0.0001), and Sokolow-Lyon BMI sensitivity increased from 26.5% to 58.4% (r = 0.270, p<0.001). Conclusion: The test performance of the ECG in diagnosing LVH is low in this Black African population, due to extracardiac factors such as age, sex, body habitus, and cardiac factors such as LVH severity and geometry. However, this performance is improved after adjustment for extracardiac factors.	[Jingi, Ahmadou M.; Kingue, Samuel] Univ Yaounde I, Fac Med & Biomed Sci, Dept Internal Med & Specialties, Yaounde, Cameroon; [Noubiap, Jean Jacques N.] Edea Reg Hosp, Internal Med Unit, Edea, Cameroon; [Kamdem, Philippe] Ctr Med Trinite, Bafoussam, Cameroon; [Kingue, Samuel] Yaounde Gen Hosp, Dept Internal Med, Yaounde, Cameroon	University of Yaounde I	Noubiap, JJN (corresponding author), Edea Reg Hosp, Internal Med Unit, Edea, Cameroon.	noubiapjj@yahoo.fr		Noubiap, Jean Jacques/0000-0002-7722-9757				Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Akobeng AK, 2007, ACTA PAEDIATR, V96, P338, DOI 10.1111/j.1651-2227.2006.00180.x; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Dada A, 2005, ETHNIC DIS, V15, P578; DESIMONE G, 1994, HYPERTENSION, V23, P600, DOI 10.1161/01.HYP.23.5.600; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Dzudie A, 2006, 1 PANAFRICAN C HYP O; Kingue S, 2000, P 12 NAT MED C CAM Y; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; LEVY D, 1990, CIRCULATION, V81, P815, DOI 10.1161/01.CIR.81.3.815; LEVY D, 1987, J ELECTROCARDIOL, V20, P44; Mbanya JCN, 1998, INT J EPIDEMIOL, V27, P181, DOI 10.1093/ije/27.2.181; National High Blood Pressure Education Program, 1998, ARCH INTERN MED, V157, P241; Norman JE, 1996, J ELECTROCARDIOL, V29, P241, DOI 10.1016/S0022-0736(96)80070-7; Okin PM, 1996, J ELECTROCARDIOL, V29, P256, DOI 10.1016/S0022-0736(96)80072-0; Okin PM, 2000, HYPERTENSION, V35, P13, DOI 10.1161/01.HYP.35.1.13; Rodrigues SL, 2008, ARQ BRAS CARDIOL, V90, P46, DOI 10.1590/S0066-782X2008000100008; SCHILLACI G, 1994, AM J CARDIOL, V74, P714, DOI 10.1016/0002-9149(94)90316-6; Verdecchia P, 2000, Ital Heart J, V1, P207	20	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96783	10.1371/journal.pone.0096783	http://dx.doi.org/10.1371/journal.pone.0096783			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810594	Green Published, Green Submitted, gold			2022-12-27	WOS:000338213300073
J	Ke, B; Song, XN; Liu, N; Zhang, RP; Wang, CL; Liang, H				Ke, Bin; Song, Xi-Na; Liu, Ning; Zhang, Ru-Peng; Wang, Chang-Li; Liang, Han			Prognostic Value of the Lymph Node Ratio in Stage III Gastric Cancer Patients Undergoing Radical Resection	PLOS ONE			English	Article							SYSTEM; LYMPHADENECTOMY; CARCINOMA; SURVIVAL; NUMBER	Objective: The aim of this study was to investigate the prognostic value of metastatic lymph node ratio (LNR) in patients having radical resection for stage III gastric cancer. Methods: A total of 365 patients with stage III gastric cancer who underwent radical resection between 2002 and 2008 at Tianjin Medical University Cancer Institute and Hospital were analyzed. The cut-point survival analysis was adopted to determine the appropriate cutoffs for LNR. Kaplan-Meier survival curves and log-rank tests were used for the survival analysis. Results: By cut-point survival analysis, the LNR staging system was generated using 0.25 and 0.50 as the cutoff values. Pearson's correlation test revealed that the LNR was related with metastatic lymph nodes but not related with total harvested lymph nodes. Cox regression analysis showed that depth of invasion and LNR were the independent predictors of survival (p<0.05). There was a significant difference in survival between each pN stages classified by the LNR staging, however no significant difference was found in survival rate between each LNR stages classified by the pN staging. Conclusions: The LNR is an independent prognostic factor for survival in stage III gastric cancer and is superior to the pN category in TNM staging. It may be considered as a prognostic variable in future staging system.	[Ke, Bin; Liu, Ning; Zhang, Ru-Peng; Liang, Han] Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Dept Gastr Canc, Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China; [Wang, Chang-Li] Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Tianjin Lung Canc Ctr, Dept Lung Canc,Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China; [Song, Xi-Na] Union Stemcell & Gene Engn Co LTD, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University	Wang, CL (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Tianjin Lung Canc Ctr, Dept Lung Canc,Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China.	wang_changli@163.com; tj_lianghan@126.com			National Basic Research Program of China (973 Program) [2010CB529301]; Key Program for Anti-cancer Research of Tianjin Municipal Science and Technology Commission [12ZCDZSY15400, 12ZCDSY16400]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Key Program for Anti-cancer Research of Tianjin Municipal Science and Technology Commission	This study was supported by the National Basic Research Program of China (973 Program) (2010CB529301), the Key Program for Anti-cancer Research of Tianjin Municipal Science and Technology Commission (12ZCDZSY15400, 12ZCDSY16400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurello P, 2007, AM SURGEON, V73, P359; Chen S, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048747, 10.1371/journal.pone.0046703, 10.1371/journal.pone.0029579, 10.1371/journal.pone.0050850]; Coburn NG, 2006, CANCER-AM CANCER SOC, V107, P2143, DOI 10.1002/cncr.22229; Giuliani A, 2004, J EXP CLIN CANC RES, V23, P215; Huang CM, 2010, WORLD J GASTROENTERO, V16, P2055, DOI 10.3748/wjg.v16.i16.2055; Inoue K, 2002, ANN SURG ONCOL, V9, P27, DOI 10.1245/aso.2002.9.1.27; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kong SH, 2012, ANN SURG, V255, P50, DOI 10.1097/SLA.0b013e31821d4d75; Lee E, 2002, CANCER, V94, P2867, DOI 10.1002/cncr.10562; Lee SY, 2010, INT J ONCOL, V36, P1461, DOI 10.3892/ijo_00000632; Lee SR, 2012, WORLD J SURG, V36, P1096, DOI 10.1007/s00268-012-1520-5; Lin YS, 2011, WORLD J GASTROENTERO, V17, P4421, DOI 10.3748/wjg.v17.i39.4421; Liu H, 2013, INT J SURG; Nakajima Toshifusa, 2002, Gastric Cancer, V5, P1, DOI 10.1007/s101200200000; Pedrazzani C, 2010, WORLD J SURG, V34, P85, DOI 10.1007/s00268-009-0288-8; Sobin LHGM., 2010, INT UNION CANC TNM C; Sun Z, 2012, ANN SURG ONCOL, V19, P1918, DOI 10.1245/s10434-011-2206-1; Toth D, 2013, GASTRIC CANCER, V16, P201, DOI 10.1007/s10120-012-0170-5; Ueno S, 2001, HEPATOLOGY, V34, P529, DOI 10.1053/jhep.2001.27219; Wang JP, 2012, ANN SURG, V255, P478, DOI 10.1097/SLA.0b013e31824857e2; Xu DZ, 2009, ANN SURG ONCOL, V16, P319, DOI 10.1245/s10434-008-0240-4; Yu CJ, 2011, ANN SURG ONCOL, V18, pS216, DOI 10.1245/s10434-010-1525-y; Zhou YB, 2013, GASTRIC CANCER, V16, P309, DOI 10.1007/s10120-012-0190-1; Zu HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054502	24	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96455	10.1371/journal.pone.0096455	http://dx.doi.org/10.1371/journal.pone.0096455			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24811256	Green Submitted, Green Published, gold			2022-12-27	WOS:000338213300040
J	Lockwood, PL; Seara-Cardoso, A; Viding, E				Lockwood, Patricia L.; Seara-Cardoso, Ana; Viding, Essi			Emotion Regulation Moderates the Association between Empathy and Prosocial Behavior	PLOS ONE			English	Article							PRO-SOCIAL BEHAVIOR; INDIVIDUAL-DIFFERENCES; PERSONAL DISTRESS; SUPPRESSION; STRATEGIES; COSTS	Theory and evidence suggest that empathy is an important motivating factor for prosocial behaviour and that emotion regulation, i.e. the capacity to exert control over an emotional response, may moderate the degree to which empathy is associated with prosocial behaviour. However, studies to date have not simultaneously explored the associations between different empathic processes and prosocial behaviour, nor whether different types of emotion regulation strategies (e. g. cognitive reappraisal and expressive suppression) moderate associations between empathy and prosocial behaviour. One hundred-and-ten healthy adults completed questionnaire measures of empathy, emotion regulation and prosocial tendencies. In this sample, both affective and cognitive empathy predicted self-reported prosocial tendencies. In addition, cognitive reappraisal moderated the association between affective empathy and prosocial tendencies. Specifically, there was a significant positive association between empathy and prosocial tendencies for individuals with a low or average tendency to reappraise but not for those with a high tendency to reappraise. Our findings suggest that, in general, empathy is positively associated with prosocial behaviour. However, this association is not significant for individuals with a high tendency for cognitive reappraisal.	[Lockwood, Patricia L.; Seara-Cardoso, Ana; Viding, Essi] UCL, Div Psychol & Language Sci, London, England	University of London; University College London	Lockwood, PL (corresponding author), UCL, Div Psychol & Language Sci, London, England.	p.lockwood@ucl.ac.uk	Lockwood, Patricia/V-2066-2019	Lockwood, Patricia/0000-0001-7195-9559; Seara-Cardoso, Ana/0000-0002-7618-9124; Viding, Essi/0000-0001-8468-8874	Medical Research Council; Royal Society; Medical Research Council [1069029] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Doctoral Training Account studentship from the Medical Research Council awarded to Patricia L. Lockwood. Essi Viding is a Royal Society Wolfson Research Merit Award holder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron-Cohen S, 2003, PHILOS T ROY SOC B, V358, P361, DOI 10.1098/rstb.2002.1206; Batson C. D., 1998, HDB SOCIAL PSYCHOL, V2, P282, DOI DOI 10.1002/0471264385.WEI0519; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carlo G, 1999, BASIC APPL SOC PSYCH, V21, P189, DOI 10.1207/15324839951036362; Carlo G, 2003, J EARLY ADOLESCENCE, V23, P107, DOI 10.1177/0272431602239132; Carlo G, 2002, J YOUTH ADOLESCENCE, V31, P31, DOI 10.1023/A:1014033032440; Davis M. H., 1980, JSAS CATALOG SELECTE, V10, P1, DOI DOI 10.1037/0022-3514.44.1.113; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Eisenberg N, 2000, ANNU REV PSYCHOL, V51, P665, DOI 10.1146/annurev.psych.51.1.665; EISENBERG N, 1989, J PERS SOC PSYCHOL, V57, P55, DOI 10.1037/0022-3514.57.1.55; EISENBERG N, 1988, PERS SOC PSYCHOL B, V14, P298, DOI 10.1177/0146167288142008; Eisenberg N, 1992, REV PERSONALITY SOCI, P119; Eisenberg N, 2010, SOC ISS POLICY REV, V4, P143, DOI 10.1111/j.1751-2409.2010.01020.x; EYSENCK SBG, 1978, PSYCHOL REP, V43, P1247, DOI 10.2466/pr0.1978.43.3f.1247; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Gross JJ, 2013, EMOTION, V13, P359, DOI 10.1037/a0032135; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; GROSS JJ, 1993, J PERS SOC PSYCHOL, V64, P970, DOI 10.1037/0022-3514.64.6.970; Gross JJ, 2001, CURR DIR PSYCHOL SCI, V10, P214, DOI 10.1111/1467-8721.00152; Gross JJ, 2007, HDB EMOTION REGULATI, P3, DOI DOI 10.1080/00140130600971135; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hoffman M. L., 2001, EMPATHY MORAL DEV IM; Hoffman ML., 2008, HDB EMOTIONS, P440; HOGAN R, 1969, J CONSULT CLIN PSYCH, V33, P307, DOI 10.1037/h0027580; John OP, 2004, J PERS, V72, P1301, DOI 10.1111/j.1467-6494.2004.00298.x; Lockwood PL, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00760; Oakley BA, 2013, P NATL ACAD SCI USA, V110, P10408, DOI 10.1073/pnas.1302547110; Penner LA, 2005, ANNU REV PSYCHOL, V56, P365, DOI 10.1146/annurev.psych.56.091103.070141; Ray RD, 2005, COGN AFFECT BEHAV NE, V5, P156, DOI 10.3758/CABN.5.2.156; Reniers RLEP, 2011, J PERS ASSESS, V93, P84, DOI 10.1080/00223891.2010.528484; Richards JM, 2000, J PERS SOC PSYCHOL, V79, P410, DOI 10.1037//0022-3514.79.3.410; Schipper M, 2013, SOC NEUROSCI-UK, V8, P101, DOI 10.1080/17470919.2012.761650; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; Soto JA, 2011, EMOTION, V11, P1450, DOI 10.1037/a0023340; Srivastava S, 2009, J PERS SOC PSYCHOL, V96, P883, DOI 10.1037/a0014755; Swart M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005751; Szolnoki A, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.042805; Szolnoki A, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/38002	39	116	118	6	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96555	10.1371/journal.pone.0096555	http://dx.doi.org/10.1371/journal.pone.0096555			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK1XT	24810604	Green Published, gold, Green Submitted			2022-12-27	WOS:000338213300053
J	Mori, M; Smedberg, M; Klaude, M; Tjader, I; Norberg, A; Rooyackers, O; Wernerman, J				Mori, Maiko; Smedberg, Marie; Klaude, Maria; Tjader, Inga; Norberg, Ake; Rooyackers, Olav; Wernerman, Jan			A Tracer Bolus Method for Investigating Glutamine Kinetics in Humans	PLOS ONE			English	Article							STEADY-STATE; AMINO-ACIDS; METABOLISM; SUPPLEMENTATION; EXERCISE; TRIAL	Glutamine transport between tissues is important for the outcome of critically ill patients. Investigation of glutamine kinetics is, therefore, necessary to understand glutamine metabolism in these patients in order to improve future intervention studies. Endogenous glutamine production can be measured by continuous infusion of a glutamine tracer, which necessitates a minimum measurement time period. In order to reduce this problem, we used and validated a tracer bolus injection method. Furthermore, this method was used to measure the glutamine production in healthy volunteers in the post-absorptive state, with extra alanine and with glutamine supplementation and parenteral nutrition. Healthy volunteers received a bolus injection of [1-C-13] glutamine, and blood was collected from the radial artery to measure tracer enrichment over 90 minutes. Endogenous rate of appearance (endoR(a)) of glutamine was calculated from the enrichment decay curve and corrected for the extra glutamine supplementation. The glutamine endoR(a) of healthy volunteers was 6.1 +/- 0.9 mmol/kg/min in the post-absorptive state, 6.9 +/- 1.0 mmol/kg/min with extra alanyl-glutamine (p = 0.29 versus control), 6.1 +/- 0.4 mmol/kg/min with extra alanine only (p = 0.32 versus control), and 7.5 +/- 0.9 mmol/kg/min with extra alanylglutamine and parenteral nutrition (p = 0.049 versus control). In conclusion, a tracer bolus injection method to measure glutamine endoR(a) showed good reproducibility and small variation at baseline as well as during parenteral nutrition. Additionally, we showed that parenteral nutrition including alanyl-glutamine increased glutamine endoR(a) in healthy volunteers, which was not attributable to the alanine part of the dipeptide.	[Mori, Maiko; Smedberg, Marie; Klaude, Maria; Tjader, Inga; Norberg, Ake; Rooyackers, Olav; Wernerman, Jan] Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Anesthesiol & Intens Care Med, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital	Wernerman, J (corresponding author), Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Anesthesiol & Intens Care Med, Stockholm, Sweden.	jan.wernerman@karolinska.se			Swedish Research Council [04210, 14244]; Stockholm County Council [502033, 511126]; Ajinomoto Co., Inc	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); Ajinomoto Co., Inc	The studies were supported by grants from the Swedish Research Council (projects 04210 and 14244), Stockholm County Council (projects 502033 and 511126) and an unrestricted research grant from Ajinomoto Co., Inc to support MM for 2 years. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg A, 2007, INTENS CARE MED, V33, P660, DOI 10.1007/s00134-007-0547-9; Berg A, 2008, CLIN NUTR, V27, P816, DOI 10.1016/j.clnu.2008.06.006; DARMAUN D, 1986, AM J PHYSIOL, V251, pE117, DOI 10.1152/ajpendo.1986.251.1.E117; DASNEVES HJC, 1987, J CHROMATOGR, V392, P249, DOI 10.1016/S0021-9673(01)94270-0; Heyland D, 2013, NEW ENGL J MED, V368, P1489, DOI 10.1056/NEJMoa1212722; Jackson NC, 1999, AM J PHYSIOL-ENDOC M, V276, pE163, DOI 10.1152/ajpendo.1999.276.1.E163; Kreider ME, 1997, AM J PHYSIOL-ENDOC M, V272, pE621, DOI 10.1152/ajpendo.1997.272.4.E621; MATTHEWS DE, 1992, AM J CLIN NUTR, V55, P963, DOI 10.1093/ajcn/55.5.963; NEWSHOLME EA, 1985, Q J EXP PHYSIOL CMS, V70, P473, DOI 10.1113/expphysiol.1985.sp002935; Oudemans-van Straaten HM, 2001, INTENS CARE MED, V27, P84, DOI 10.1007/s001340000703; Rodas PC, 2012, CLIN SCI, V122, P591, DOI 10.1042/CS20110520; Singleton KD, 2007, AM J PHYSIOL-REG I, V292, pR1839, DOI 10.1152/ajpregu.00755.2006; van Acker BAC, 1998, CLIN SCI, V95, P339, DOI 10.1042/CS19980053; VANDERHULST RRWJ, 1993, LANCET, V341, P1363, DOI 10.1016/0140-6736(93)90939-E; VANHALL G, 1995, J PHYSIOL-LONDON, V489, P251, DOI 10.1113/jphysiol.1995.sp021047; Wernerman J, 2011, ACTA ANAESTH SCAND, V55, P812, DOI 10.1111/j.1399-6576.2011.02453.x; Williams BD, 1998, MED SCI SPORT EXER, V30, P1053, DOI 10.1097/00005768-199807000-00005	17	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96601	10.1371/journal.pone.0096601	http://dx.doi.org/10.1371/journal.pone.0096601			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810895	Green Submitted, Green Published, gold			2022-12-27	WOS:000338213300056
J	Schmidt, S; Berens, C; Klotzsche, M				Schmidt, Sebastian; Berens, Christian; Klotzsche, Marcus			A Novel TetR-Regulating Peptide Turns off rtTA-Mediated Activation of Gene Expression	PLOS ONE			English	Article							TETRACYCLINE REPRESSOR; ESCHERICHIA-COLI; MAMMALIAN-CELLS; HUMAN GENOME; IN-VIVO; SEQUENCE; OPERATOR; GENERATION; ALLOSTERY; MUTANTS	Conditional regulation of gene expression is a powerful and indispensable method for analyzing gene function. The "Tet-On'' system is a tool widely used for that purpose. Here, the transregulator rtTA mediates expression of a gene of interest after addition of the small molecule effector doxycycline. Although very effective in rapidly turning on gene expression, the system is hampered by the long half-life of doxycycline which makes shutting down gene expression rapidly very difficult to achieve. We isolated an rtTA-binding peptide by in vivo selection that acts as a doxycycline antagonist and leads to rapid and efficient shut down of rtTA-mediated reporter gene expression in a human cell line. This peptide represents the basis for novel effector molecules which complement the "Tet-system'' by enabling the investigator to rapidly turn gene expression not just on at will, but now also off.	[Schmidt, Sebastian; Berens, Christian; Klotzsche, Marcus] Univ Erlangen Nurnberg, Dept Biol, Lehrstuhl Mikrobiol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Klotzsche, M (corresponding author), Univ Erlangen Nurnberg, Dept Biol, Lehrstuhl Mikrobiol, D-91054 Erlangen, Germany.	mklotz@biologie.uni-erlangen.de			Volkswagen Foundation [I/81614]; Deutsche Forschungsgemeinschaft [Sonderforschungbereich 473/B3, Sonderforschungbereich 796/C4]; Staedtler Stiftung; Friedrich Alexander Universitat	Volkswagen Foundation(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Staedtler Stiftung; Friedrich Alexander Universitat	Funding provided by Volkswagen Foundation (I/81614) (http://www.volkswagenstiftung.de/en/foundation.html), Deutsche Forschungsgemeinschaft through Sonderforschungbereich 473/B3 and Sonderforschungbereich 796/C4 (http://www.dfg.de/foerderung/programme/koordinierte_programme/sfb/), and Staedtler Stiftung (http://www.staedtler.de/de/unternehmen/staedtler-stiftung/). The authors acknowledge support by the Deutsche Forschungsgemeinschaft and the Friedrich Alexander Universitat within the open access publishing funding program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin CP, 2004, ANNU REV MED, V55, P1, DOI 10.1146/annurev.med.55.091902.104426; Baron U, 2000, METHOD ENZYMOL, V327, P401, DOI 10.1016/S0076-6879(00)27292-3; Berens C, 2003, EUR J BIOCHEM, V270, P3109, DOI 10.1046/j.1432-1033.2003.03694.x; Berens C, 2006, CHEMBIOCHEM, V7, P1320, DOI 10.1002/cbic.200600226; Bertram R, 2008, MICROB BIOTECHNOL, V1, P2, DOI 10.1111/j.1751-7915.2007.00001.x; BRENT R, 1985, CELL, V43, P729, DOI 10.1016/0092-8674(85)90246-6; ChrastBalz J, 1996, NUCLEIC ACIDS RES, V24, P2900, DOI 10.1093/nar/24.15.2900; Cutler SR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001875; Daam J, 2008, GENE, V423, P201, DOI 10.1016/j.gene.2008.07.004; DINGERMANN T, 1992, EMBO J, V11, P1487, DOI 10.1002/j.1460-2075.1992.tb05193.x; Dow LE, 2012, NAT PROTOC, V7, P374, DOI 10.1038/nprot.2011.446; Fulkerson PC, 2006, AM J RESP CELL MOL, V35, P337, DOI 10.1165/rcmb.2005-0474OC; Fussenegger M, 2000, NAT BIOTECHNOL, V18, P1203, DOI 10.1038/81208; GATZ C, 1991, MOL GEN GENET, V227, P229, DOI 10.1007/BF00259675; Goeke D, 2012, J MOL BIOL, V416, P33, DOI 10.1016/j.jmb.2011.12.009; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Grahame-Smith DG, 1992, OXFORD TXB CLIN PHAR, P26; Guo ZS, 2008, TRENDS MOL MED, V14, P410, DOI 10.1016/j.molmed.2008.07.003; Haenebalcke L, 2013, CELL REP, V3, P335, DOI 10.1016/j.celrep.2013.01.016; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Jackstadt R, 2013, J EXP MED, V210, P1331, DOI 10.1084/jem.20120812; Klotzsche M, 2005, J BIOL CHEM, V280, P24591, DOI 10.1074/jbc.M501872200; Klotzsche M, 2007, NUCLEIC ACIDS RES, V35, P3945, DOI 10.1093/nar/gkm357; Krueger C, 2003, NUCLEIC ACIDS RES, V31, P3050, DOI 10.1093/nar/gkg421; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Luckner SR, 2007, J MOL BIOL, V368, P780, DOI 10.1016/j.jmb.2007.02.030; Michalon A, 2005, GENESIS, V43, P205, DOI 10.1002/gene.20175; MULLER G, 1995, NAT STRUCT BIOL, V2, P693, DOI 10.1038/nsb0895-693; Orth P, 2000, NAT STRUCT BIOL, V7, P215; Pao W, 2003, P NATL ACAD SCI USA, V100, P8764, DOI 10.1073/pnas.1133333100; Ponting CP, 2011, GENOME RES, V21, P1769, DOI 10.1101/gr.116814.110; Roses A, 2003, NAT GENET, V33, pS217; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Savory JGA, 1999, MOL CELL BIOL, V19, P1025; Sevvana M, 2012, J MOL BIOL, V416, P46, DOI 10.1016/j.jmb.2011.12.008; Sheng Y, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-17; Simons JP, 2013, P NATL ACAD SCI USA, V110, P16115, DOI 10.1073/pnas.1306621110; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Weber W, 2011, CURR OPIN CHEM BIOL, V15, P414, DOI 10.1016/j.cbpa.2011.03.003; Wimmert C, 2013, J MOL BIOL, V425, P1839, DOI 10.1016/j.jmb.2013.02.007; WISSMANN A, 1991, GENETICS, V128, P225; Zhou X, 2006, GENE THER, V13, P1382, DOI 10.1038/sj.gt.3302780	43	2	3	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96546	10.1371/journal.pone.0096546	http://dx.doi.org/10.1371/journal.pone.0096546			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810590	Green Published, gold			2022-12-27	WOS:000338213300052
J	Zhang, CL; Li, CQ; Li, J; Han, JW; Shang, DS; Zhang, YP; Zhang, W; Yao, QL; Han, L; Xu, YJ; Yan, W; Bao, ZS; You, G; Jiang, T; Kang, CS; Li, X				Zhang, Chunlong; Li, Chunquan; Li, Jing; Han, Junwei; Shang, Desi; Zhang, Yunpeng; Zhang, Wei; Yao, Qianlan; Han, Lei; Xu, Yanjun; Yan, Wei; Bao, Zhaoshi; You, Gan; Jiang, Tao; Kang, Chunsheng; Li, Xia			Identification of miRNA-Mediated Core Gene Module for Glioma Patient Prediction by Integrating High-Throughput miRNA, mRNA Expression and Pathway Structure	PLOS ONE			English	Article							MICRORNA TARGET PREDICTION; BREAST-CANCER; SURVIVAL; PROGRESSION; SIGNATURE; DATABASE; PATTERN; KINASE; GROWTH; STAT3	The prognosis of glioma patients is usually poor, especially in patients with glioblastoma (World Health Organization (WHO) grade IV). The regulatory functions of microRNA (miRNA) on genes have important implications in glioma cell survival. However, there are not many studies that have investigated glioma survival by integrating miRNAs and genes while also considering pathway structure. In this study, we performed sample-matched miRNA and mRNA expression profilings to systematically analyze glioma patient survival. During this analytical process, we developed pathway-based random walk to identify a glioma core miRNA-gene module, simultaneously considering pathway structure information and multi-level involvement of miRNAs and genes. The core miRNA-gene module we identified was comprised of four apparent sub-modules; all four sub-modules displayed a significant correlation with patient survival in the testing set (P-values <= 0.001). Notably, one sub-module that consisted of 6 miRNAs and 26 genes also correlated with survival time in the high-grade subgroup (WHO grade III and IV), P-value = 0.0062. Furthermore, the 26-gene expression signature from this sub-module had robust predictive power in four independent, publicly available glioma datasets. Our findings suggested that the expression signatures, which were identified by integration of miRNA and gene level, were closely associated with overall survival among the glioma patients with various grades.	[Zhang, Chunlong; Li, Chunquan; Li, Jing; Han, Junwei; Shang, Desi; Zhang, Yunpeng; Yao, Qianlan; Xu, Yanjun; Jiang, Tao; Li, Xia] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China; [Zhang, Wei; Yan, Wei; Bao, Zhaoshi; You, Gan; Jiang, Tao] Capital Med Univ, Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Han, Lei; Kang, Chunsheng] Tianjin Med Univ Gen Hosp, Dept Neurosurg, Lab Neurotrauma Variat & Regenerat, Lab Neurooncol,Tianjin Neurol Inst,Minist Educ, Tianjin, Peoples R China; [Han, Lei; Kang, Chunsheng] Tianjin Municipal Govt, Tianjin, Peoples R China; [Li, Jing] Fujian Med Univ, Sch Basic Med Sci, Dept Bioinformat, Fuzhou, Peoples R China	Harbin Medical University; Capital Medical University; Tianjin Medical University; Fujian Medical University	Jiang, T (corresponding author), Capital Med Univ, Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China.	taojiang1964@yahoo.com.cn; kang97061@yahoo.com; lixia@hrbmu.edu.cn	Jiang, Tao/N-8142-2014; Kang, Chunsheng/AAM-5979-2021; li, xia/HHZ-7468-2022; Li, Chunquan/AAI-1072-2020; jiang, tao/GWC-7108-2022; Han, Junwei/T-9849-2018; shang, desi/GOJ-9200-2022	Kang, Chunsheng/0000-0002-3255-3369; Li, Chunquan/0000-0002-4700-5496; Han, Junwei/0000-0002-3276-0819; qianlan, yao/0000-0003-0737-4147	National Natural Science Foundation of China [81121003, 61170154, 91129710, 31200996]; National High Technology Research and Development Program [2012AA02A508]; International Science and Technology Cooperation Program [2012DFA30470]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20102307120027, 20102307110022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program(National High Technology Research and Development Program of China); International Science and Technology Cooperation Program; Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Foundation of China (Grant Nos. 81121003), the National Natural Science Foundation of China (Grant Nos. 61170154, 91129710 and 31200996), the National High Technology Research and Development Program (No. 2012AA02A508), the International Science and Technology Cooperation Program (No. 2012DFA30470) and the Specialized Research Fund for the Doctoral Program of Higher Education of China (Grant Nos. 20102307120027 and 20102307110022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay S, 2009, BIOINFORMATICS, V25, P2625, DOI 10.1093/bioinformatics/btp503; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bhattacharya R, 2009, CANCER RES, V69, P9090, DOI 10.1158/0008-5472.CAN-09-2552; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Chen LC, 2012, INT J BIOCHEM CELL B, V44, P1711, DOI 10.1016/j.biocel.2012.06.027; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chinnaiyan AM, 2008, NEOPLASIA, V10, P79, DOI 10.1593/neo.07859; Dobbin K, 2005, BIOSTATISTICS, V6, P27, DOI 10.1093/biostatistics/kxh015; Dong H, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-163; Dong H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S3-S16; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Enright AJ, 2004, GENOME BIOL, V5; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gao L, 2010, INT J RADIAT ONCOL, V77, P1223, DOI 10.1016/j.ijrobp.2009.12.036; Gladson CL, 2010, ANNU REV PATHOL-MECH, V5, P33, DOI 10.1146/annurev-pathol-121808-102109; HE L, 2004, NAT REV GENET, V5, P522; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kefas B, 2010, NEURO-ONCOLOGY, V12, P1102, DOI 10.1093/neuonc/noq080; Kefas B, 2009, J NEUROSCI, V29, P15161, DOI 10.1523/JNEUROSCI.4966-09.2009; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Khalil AA, 2012, BRAIN TUMOR PATHOL; Kim JH, 2011, J NEUROCHEM, V117, P494, DOI 10.1111/j.1471-4159.2011.07219.x; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee Y, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-52; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li CQ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt161; Li CQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047326; Li CQ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp667; Li X, 2012, BRIEF BIOINFORM, V13, P175, DOI 10.1093/bib/bbr043; Li X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021131; Malzkorn B, 2010, BRAIN PATHOL, V20, P539, DOI 10.1111/j.1750-3639.2009.00328.x; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Murat A, 2008, J CLIN ONCOL, V26, P3015, DOI 10.1200/JCO.2007.15.7164; Naderi A, 2007, ONCOGENE, V26, P1507, DOI 10.1038/sj.onc.1209920; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Srinivasan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017438; Sun JC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002488; Van der Auwera I, 2010, BRIT J CANCER, V103, P532, DOI 10.1038/sj.bjc.6605787; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Zhang CZ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-229; Zhang JX, 2013, NEURO-ONCOLOGY, V15, P279, DOI 10.1093/neuonc/nos306; Zhang W, 2012, CANCER; Zhu M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r77	51	53	56	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96908	10.1371/journal.pone.0096908	http://dx.doi.org/10.1371/journal.pone.0096908			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809850	Green Published, gold, Green Submitted			2022-12-27	WOS:000338213300087
J	Nel, JL; Le Maitre, DC; Nel, DC; Reyers, B; Archibald, S; van Wilgen, BW; Forsyth, GG; Theron, AK; O'Farrell, PJ; Kahinda, JMM; Engelbrecht, FA; Kapangaziwiri, E; van Niekerk, L; Barwell, L				Nel, Jeanne L.; Le Maitre, David C.; Nel, Deon C.; Reyers, Belinda; Archibald, Sally; van Wilgen, Brian W.; Forsyth, Greg G.; Theron, Andre K.; O'Farrell, Patrick J.; Kahinda, Jean-Marc Mwenge; Engelbrecht, Francois A.; Kapangaziwiri, Evison; van Niekerk, Lara; Barwell, Laurie			Natural Hazards in a Changing World: A Case for Ecosystem-Based Management	PLOS ONE			English	Article							INVASIVE ALIEN PLANTS; CLIMATE-CHANGE; SOUTH-AFRICA; WATER-RESOURCES; FIRE BEHAVIOR; FYNBOS; MODEL; WILDFIRE; TRENDS; CONSEQUENCES	Communities worldwide are increasingly affected by natural hazards such as floods, droughts, wildfires and storm-waves. However, the causes of these increases remain underexplored, often attributed to climate changes or changes in the patterns of human exposure. This paper aims to quantify the effect of climate change, as well as land cover change, on a suite of natural hazards. Changes to four natural hazards (floods, droughts, wildfires and storm-waves) were investigated through scenario-based models using land cover and climate change drivers as inputs. Findings showed that human-induced land cover changes are likely to increase natural hazards, in some cases quite substantially. Of the drivers explored, the uncontrolled spread of invasive alien trees was estimated to halve the monthly flows experienced during extremely dry periods, and also to double fire intensities. Changes to plantation forestry management shifted the 1: 100 year flood event to a 1: 80 year return period in the most extreme scenario. Severe 1: 100 year storm-waves were estimated to occur on an annual basis with only modest human-induced coastal hardening, predominantly from removal of coastal foredunes and infrastructure development. This study suggests that through appropriate land use management (e. g. clearing invasive alien trees, re-vegetating clear-felled forests, and restoring coastal foredunes), it would be possible to reduce the impacts of natural hazards to a large degree. It also highlights the value of intact and well-managed landscapes and their role in reducing the probabilities and impacts of extreme climate events.	[Nel, Jeanne L.; Le Maitre, David C.; Reyers, Belinda; van Wilgen, Brian W.; Forsyth, Greg G.; Theron, Andre K.; O'Farrell, Patrick J.; van Niekerk, Lara; Barwell, Laurie] CSIR, Stellenbosch, Western Cape, South Africa; [Nel, Deon C.] World Wide Fund Nat WWF, Cape Town, Western Cape, South Africa; [Archibald, Sally] Univ Witwatersrand, Sch Anim Plant & Environm Sci, Johannesburg, Gauteng, South Africa; [Archibald, Sally; Kahinda, Jean-Marc Mwenge; Engelbrecht, Francois A.; Kapangaziwiri, Evison] CSIR, ZA-0001 Pretoria, Gauteng, South Africa; [van Wilgen, Brian W.] Univ Stellenbosch, Dept Bot & Zool, Ctr Invas Biol, ZA-7600 Stellenbosch, Western Cape, South Africa	Council for Scientific & Industrial Research (CSIR) - South Africa; University of Witwatersrand; Council for Scientific & Industrial Research (CSIR) - South Africa; Stellenbosch University	Nel, JL (corresponding author), CSIR, Stellenbosch, Western Cape, South Africa.	jnel@csir.co.za	van Niekerk, Lara/AAG-8064-2021; Le Maitre, David/M-8791-2015; Kahinda, Jean-marc J Mwenge/B-5492-2009; Van Niekerk, Lara/AAG-9835-2021; O'Farrell, Patrick J/B-6898-2008; Reyers, Belinda/AAF-6225-2019; Archibald, Sally/O-1659-2015; O'Farrell, Patrick/AAQ-7728-2021	Le Maitre, David/0000-0003-1037-6637; Kahinda, Jean-marc J Mwenge/0000-0002-1737-7213; Van Niekerk, Lara/0000-0001-5761-1337; O'Farrell, Patrick J/0000-0002-9538-8831; Reyers, Belinda/0000-0002-2194-8656; Archibald, Sally/0000-0003-2786-3976; O'Farrell, Patrick/0000-0002-9538-8831; Kapangaziwiri, Evison/0000-0001-9411-6669	CSIR; Santam Limited; Global Environmental Facility under the auspices of UNEP's Project for Ecosystem Services	CSIR(Council of Scientific & Industrial Research (CSIR) - India); Santam Limited; Global Environmental Facility under the auspices of UNEP's Project for Ecosystem Services	Financial support was provided by the CSIR (www.csir.co.za), Santam Limited (santam.co.za)and the Global Environmental Facility under the auspices of UNEP's Project for Ecosystem Services (www.unep.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CPO1 NOAA OAR; Aronson James, 2007, RESTORING NATURAL CA; Barbier EB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058715; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Bates B.C., 2008, TECHNICAL PAPER INTE, DOI DOI 10.1016/S0960-9822(97)70976-X; Booij N, 1999, J GEOPHYS RES-OCEANS, V104, P7649, DOI 10.1029/98JC02622; Bradstock RA, 2009, INT J WILDLAND FIRE, V18, P932, DOI 10.1071/WF08133; Brooks ML, 2004, BIOSCIENCE, V54, P677, DOI 10.1641/0006-3568(2004)054[0677:EOIAPO]2.0.CO;2; Brown K., 2011, ANNU REV ENV RESOUR, V36, P1, DOI DOI 10.1146/ANNUREV-ENVIR0N-052610-092905; Bullock A, 2003, HYDROL EARTH SYST SC, V7, P358, DOI 10.5194/hess-7-358-2003; Byram G., 1959, FOREST FIRE CONTROL, P155; Cartwright A., 2013, ENVIRON URBAN, V25, P1; Cutter SL, 2008, GLOBAL ENVIRON CHANG, V18, P598, DOI 10.1016/j.gloenvcha.2008.07.013; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Das S, 2009, P NATL ACAD SCI USA, V106, P7357, DOI 10.1073/pnas.0810440106; Day JW, 2007, SCIENCE, V315, P1679, DOI 10.1126/science.1137030; Dubgaard A., 2004, Journal of Water and Land Development, P87; DWAF, 2005, 3A DWAF; Ehrenfeld JG, 2010, ANNU REV ECOL EVOL S, V41, P59, DOI 10.1146/annurev-ecolsys-102209-144650; Engelbrecht FA, 2011, WATER SA, V37, P647, DOI 10.4314/wsa.v37i5.2; Field CB, 2012, SPECIAL REPORT WORKI; Gill AM, 2013, ECOL APPL, V23, P438, DOI 10.1890/10-2213.1; Godsmark R, 2007, IMPACT 2007 PLANTATI; Gorgens AHM, 2004, S AFR J SCI, V100, P27; Hewitson BC, 2006, INT J CLIMATOL, V26, P1315, DOI 10.1002/joc.1314; Higgins SI, 2000, ECOL APPL, V10, P1833, DOI 10.1890/1051-0761(2000)010[1833:UADLMF]2.0.CO;2; HOLLOWAY A, 2012, 1020112012 LG STELL; Hughes DA, 2010, J HYDROL, V387, P221, DOI 10.1016/j.jhydrol.2010.04.010; Hughes DA, 2004, WATER SA, V30, P393; Hughes DA, 2011, K520182 WAT RES COMM; Jewitt GPW, 1999, WATER SA, V25, P483; Jones HP, 2012, NAT CLIM CHANGE, V2, P504, DOI 10.1038/NCLIMATE1463; Kapangaziwiri E, 2008, WATER SA, V34, P183; Kruger AC, 2006, INT J CLIMATOL, V26, P2275, DOI 10.1002/joc.1368; Kruger AC, 2004, INT J CLIMATOL, V24, P1929, DOI 10.1002/joc.1096; LeMaitre DC, 1996, J APPL ECOL, V33, P161, DOI 10.2307/2405025; Lynch S.D., 2004, 1156104 WRC; MA, 2005, ECOSYSTEMS HUMAN WEL; Malherbe J, 2013, CLIM DYNAM, V40, P2867, DOI 10.1007/s00382-012-1635-2; Mallory S., 2011, 04B500083103 PWMA DE; Marais C, 2004, S AFR J SCI, V100, P97; McCaw L, 2013, AUSTR FOR, V76, P110; McGregor JL, 2008, HIGH RESOLUTION NUMERICAL MODELLING OF THE ATMOSPHERE AND OCEAN, P51, DOI 10.1007/978-0-387-49791-4_4; Mercer DE, 2005, FOREST POLICY ECON, V7, P782, DOI 10.1016/j.forpol.2005.03.003; Middleton B. J, 2009, 38008 TT WAT RES COM; Midgley D. C., 1994, 298194 WAT RES COMM; Milly PCD, 2008, SCIENCE, V319, P573, DOI 10.1126/science.1151915; Moberg F, 2003, OCEAN COAST MANAGE, V46, P27, DOI 10.1016/S0964-5691(02)00119-9; Moeller J., 2010, THESIS RHODES U GRAH; Mori N, 2010, HYDROL RES LETT, V4, P15, DOI [10.3178/hrl.4.15, 10.3178/HRL.4.15]; Munang R, 2013, CURR OPIN ENV SUST, V5, P67, DOI 10.1016/j.cosust.2012.12.001; Nakicenovic N., 2000, IPCC SPECIAL REPORT; Naude A., 2007, CSIRBEPSSIR20070104B; NCEP, 2013, OFFSH DAT WAV HEIGH; Nel DC, 2010, CSIRNREECOS2011066B; NIELSEN P, 1991, J COASTAL RES, V7, P1139; NOBLE IR, 1980, AUST J ECOL, V5, P201, DOI 10.1111/j.1442-9993.1980.tb01243.x; Parry M.L., 2007, IMPACTS ADAPTATION V; Pitman W. V., 1973, 273 U WITW; RADAR, 2010, RADAR W CAP 2010 RIS; RICHARDSON DM, 1986, S AFR J BOT, V52, P529, DOI 10.1016/S0254-6299(16)31486-7; Rossouw M, 2012, MARITIME TRANSPORT C; Royappen M, 2002, 1193102 WAT RES COMM; Schulze R.E., 2008, 1489108 WAT RES COMM; Schulze RE, 2000, AMBIO, V29, P12, DOI 10.1639/0044-7447(2000)029[0012:MHRTLU]2.0.CO;2; SCOTT DF, 1993, J HYDROL, V150, P409, DOI 10.1016/0022-1694(93)90119-T; Shakesby RA, 2006, EARTH-SCI REV, V74, P269, DOI 10.1016/j.earscirev.2005.10.006; Shepard CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027374; Singleton AT, 2007, INT J CLIMATOL, V27, P295, DOI 10.1002/joc.1399; Smakhtin VU, 2001, J HYDROL, V240, P147, DOI 10.1016/S0022-1694(00)00340-1; SMITHERS J, 1995, ACRU AGROHYDROLOGICA; Statistics South Africa, 2012, 030149 STAT S AFR; Taljaard J, 1985, 14 S AFR WEATH BUR; Theron A.K., 2010, SCI REAL REL CSIR 3; Thomalla F, 2006, DISASTERS, V30, P39, DOI 10.1111/j.1467-9523.2006.00305.x; Tolman HL, 2002, WEATHER FORECAST, V17, P311, DOI 10.1175/1520-0434(2002)017<0311:DAIOWG>2.0.CO;2; UNISDR, 2013, GLOB ASS REP DIS RIS; UNISDR, 2009, UNISDR TERM DIS RISK; US Interagency Advisory Committee on Water Data, 1982, B HYDR COMM B; VAN DEN BERG EC, 2008, GWA200886 ARC CSIR; van Slobbe E, 2013, NAT HAZARDS, V65, P947, DOI 10.1007/s11069-012-0342-y; van Wilgen BW, 2012, BIOL CONSERV, V148, P28, DOI 10.1016/j.biocon.2011.12.035; van Wilgen BW, 2010, J APPL ECOL, V47, P631, DOI 10.1111/j.1365-2664.2010.01800.x; van Wilgen BW, 2004, S AFR J SCI, V100, P113; VANWILGEN BW, 1985, J APPL ECOL, V22, P207, DOI 10.2307/2403338; VANWILGEN BW, 1985, J APPL ECOL, V22, P955, DOI 10.2307/2403243; Versfeld D. B., 1986, The ecology and management of biological invasions in Southern Africa. Proceedings of the National Synthesis Symposium on the ecology of biological invasions., P239; Vromans DC., 2010, GARDEN ROUTE BIODIVE; Warburton ML, 2010, CHANGE, V2, P3; Weldon D, 2014, THEOR APPL CLIMATOL, V115, P177, DOI 10.1007/s00704-013-0882-4; Wilhite D. A., 1985, Water International, V10, P111, DOI 10.1080/02508068508686328; Yu XB, 2009, CLIM DEV, V1, P241, DOI 10.3763/cdev.2009.0023; Zedler JB, 2005, ANNU REV ENV RESOUR, V30, P39, DOI 10.1146/annurev.energy.30.050504.144248	93	42	46	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e95942	10.1371/journal.pone.0095942	http://dx.doi.org/10.1371/journal.pone.0095942			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806527	Green Published, gold			2022-12-27	WOS:000335728900027
J	Srinivasan, VB; Singh, BB; Priyadarshi, N; Chauhan, NK; Rajamohan, G				Srinivasan, Vijaya Bharathi; Singh, Bharat Bhushan; Priyadarshi, Nitesh; Chauhan, Neeraj Kumar; Rajamohan, Govindan			Role of Novel Multidrug Efflux Pump Involved in Drug Resistance in Klebsiella pneumoniae	PLOS ONE			English	Article							ESCHERICHIA-COLI; MECHANISMS; EPIDEMIOLOGY; EXPRESSION; GENE	Background: Multidrug resistant Klebsiella pneumoniae have caused major therapeutic problems worldwide due to the emergence of the extended-spectrum b-lactamase producing strains. Although there are > 10 major facilitator super family (MFS) efflux pumps annotated in the genome sequence of the K. pneumoniae bacillus, apparently less is known about their physiological relevance. Principal Findings: Insertional inactivation of kpnGH resulting in increased susceptibility to antibiotics such as azithromycin, ceftazidime, ciprofloxacin, ertapenem, erythromycin, gentamicin, imipenem, ticarcillin, norfloxacin, polymyxin-B, piperacillin, spectinomycin, tobramycin and streptomycin, including dyes and detergents such as ethidium bromide, acriflavine, deoxycholate, sodium dodecyl sulphate, and disinfectants benzalkonium chloride, chlorhexidine and triclosan signifies the wide substrate specificity of the transporter in K. pneumoniae. Growth inactivation and direct fluorimetric efflux assays provide evidence that kpnGH mediates antimicrobial resistance by active extrusion in K. pneumoniae. The kpnGH isogenic mutant displayed decreased tolerance to cell envelope stressors emphasizing its added role in K. pneumoniae physiology. Conclusions and Significance: The MFS efflux pump KpnGH involves in crucial physiological functions besides being an intrinsic resistance determinant in K. pneumoniae.	[Srinivasan, Vijaya Bharathi; Singh, Bharat Bhushan; Priyadarshi, Nitesh; Chauhan, Neeraj Kumar; Rajamohan, Govindan] Council Sci Ind Res, Inst Microbial Technol, Bacterial Signaling & Drug Resistance Lab, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Srinivasan, VB (corresponding author), Council Sci Ind Res, Inst Microbial Technol, Bacterial Signaling & Drug Resistance Lab, Chandigarh, India.	vijirmohan@gmail.com	PRIYADARSHI, NITESH/AGD-5378-2022	Govindan, Rajamohan/0000-0002-0208-3546	intramural fund from IMTECH; intramural fund from DBT	intramural fund from IMTECH; intramural fund from DBT	The research has been supported by intramural funds from IMTECH and DBT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; Brown MH, 2001, J MOL MICROB BIOTECH, V3, P163; Clinical and Laboratory Standards Institute, 2010, M100S20U CLSI; Daikos GL, 2011, CLIN MICROBIOL INFEC, V17, P1135, DOI 10.1111/j.1469-0691.2011.03553.x; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Fernandez L, 2012, CLIN MICROBIOL REV, V25, P661, DOI 10.1128/CMR.00043-12; FURUKAWA H, 1993, J BACTERIOL, V175, P3723, DOI 10.1128/JB.175.12.3723-3729.1993; Gnanadhas DP, 2013, EXPERT OPIN INV DRUG, V22, P191, DOI 10.1517/13543784.2013.748035; Gunn JS, 2000, MICROBES INFECT, V2, P907, DOI 10.1016/S1286-4579(00)00392-0; Hennequin C, 2009, INFECT IMMUN, V77, P5449, DOI 10.1128/IAI.00837-09; Kobayashi A, 2006, J BACTERIOL, V188, P5693, DOI 10.1128/JB.00217-06; Li DW, 2008, BIOL PHARM BULL, V31, P577, DOI 10.1248/bpb.31.577; Ogawa W, 2006, BIOL PHARM BULL, V29, P550, DOI 10.1248/bpb.29.550; Ogawa W, 2012, GENE, V498, P177, DOI 10.1016/j.gene.2012.02.008; Padilla E, 2010, ANTIMICROB AGENTS CH, V54, P177, DOI 10.1128/AAC.00715-09; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; Ping Y, 2007, BIOL PHARM BULL, V30, P1962, DOI 10.1248/bpb.30.1962; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Rajamohan G, 2010, J ANTIMICROB CHEMOTH, V65, P1919, DOI 10.1093/jac/dkq195; Rapp RP, 2012, PHARMACOTHERAPY, V32, P399, DOI 10.1002/j.1875-9114.2012.01035.x; Roca I, 2009, ANTIMICROB AGENTS CH, V53, P4013, DOI 10.1128/AAC.00584-09; Rossolini GM, 2007, NEW MICROBIOL, V30, P332; Russell AD, 2002, J ANTIMICROB CHEMOTH, V49, P597, DOI 10.1093/jac/49.4.597; Srinivasan VB, 2013, ANTIMICROB AGENTS CH, V57, P4449, DOI 10.1128/AAC.02284-12; Srinivasan VB, 2012, FEBS LETT, V586, P3778, DOI 10.1016/j.febslet.2012.09.007; Srinivasan VB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041505; Srinivasan VB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033777; Villagra NA, 2008, J ANTIMICROB CHEMOTH, V62, P1273, DOI 10.1093/jac/dkn407; Wu KM, 2009, J BACTERIOL, V191, P4492, DOI 10.1128/JB.00315-09; YOSHIDA H, 1990, J BACTERIOL, V172, P6942, DOI 10.1128/jb.172.12.6942-6949.1990	32	61	67	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96288	10.1371/journal.pone.0096288	http://dx.doi.org/10.1371/journal.pone.0096288			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24823362	Green Published, Green Submitted, gold			2022-12-27	WOS:000336369200013
J	An, N; Andrukhov, O; Tang, Y; Falkensammer, F; Bantleon, HP; Ouyang, XY; Rausch-Fan, X				An, Na; Andrukhov, Oleh; Tang, Yan; Falkensammer, Frank; Bantleon, Hans-Peter; Ouyang, Xiangying; Rausch-Fan, Xiaohui			Effect of Nicotine and Porphyromonas gingivalis Lipopolysaccharide on Endothelial Cells In Vitro	PLOS ONE			English	Article							ADHESION MOLECULE EXPRESSION; FIMBRIA-DEPENDENT ACTIVATION; PERIODONTAL-DISEASE; LEUKOCYTE ADHESION; CIGARETTE-SMOKING; ATHEROSCLEROSIS; INTERLEUKIN-8; MIGRATION; CYTOKINES; EXPOSURE	Smoking is considered a significant risk factor for both periodontal disease and cardiovascular disease (CVD). Endothelial cells play an important role in the progression of both diseases. In the present study, we investigated in vitro the impact of nicotine on functional properties of human umbilical vein endothelial cells (HUVECs) stimulated with lipopolysaccharide (LPS) of periodontal pathogen Porphyromonas gingivalis. HUVECs were stimulated with different concentrations of nicotine (10 mu M-10 mM) and/or P. gingivalis LPS. Expression levels of intercellular adhesion molecule-1, vascular cell adhesion molecule-1, E-selectin, monocyte chemoattractant protein 1, and interleukin-8 were measured on both gene and protein levels. Cell proliferation/viability, apoptosis, and migration were also investigated. Nicotine at a concentration of 10 mM significantly decreased P. gingivalis LPS-induced expression of all investigated proteins after 4 h stimulation, while lower nicotine concentrations had no significant effect on protein expression with or without P. gingivalis LPS. Proliferation/viability of HUVECs was also significantly inhibited by 10-mM nicotine but not by lower concentrations. Migration of HUVECs was significantly decreased by nicotine at concentrations of 1-10 mM. Nicotine at a concentration similar to that observed in the serum of smokers had no significant effect on the functional properties of HUVECs. However, high concentrations of nicotine, similar to that observed in the oral cavity of smokers, inhibited the inflammatory response of HUVECs. This effect of nicotine might be associated with decreased gingival bleeding indices in smoking periodontitis patients.	[An, Na] Peking Univ, Sch & Hosp Stomatol, Dept Gen Dent 2, Beijing 100871, Peoples R China; [Andrukhov, Oleh; Tang, Yan; Rausch-Fan, Xiaohui] Med Univ Vienna, Bernhard Gottlieb Sch Dent, Div Oral Biol, Vienna, Austria; [Tang, Yan] Capital Med Univ, Xuanwu Hosp, Dept Stomatol, Beijing, Peoples R China; [Falkensammer, Frank; Bantleon, Hans-Peter; Rausch-Fan, Xiaohui] Med Univ Vienna, Bernhard Gottlieb Sch Dent, Div Orthodont, Vienna, Austria; [Ouyang, Xiangying] Peking Univ, Sch & Hosp Stomatol, Dept Periodontol, Beijing 100871, Peoples R China	Peking University; Medical University of Vienna; Capital Medical University; Medical University of Vienna; Peking University	Rausch-Fan, X (corresponding author), Med Univ Vienna, Bernhard Gottlieb Sch Dent, Div Oral Biol, Vienna, Austria.	xiaohui.rausch-fan@meduniwien.ac.at	Andrukhov, Oleh/H-9851-2018	Andrukhov, Oleh/0000-0002-0485-2142; Rausch-Fan, Xiaohui/0000-0002-8010-1914	Ministry of Science and Technology of China under contract International Science & Technology Cooperation Program Foundation [1019]	Ministry of Science and Technology of China under contract International Science & Technology Cooperation Program Foundation	This work was supported by Ministry of Science and Technology of China under contract International Science & Technology Cooperation Program Foundation Nr. 1019. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Albaugh G, 2004, ANN VASC SURG, V18, P302, DOI 10.1007/s10016-004-0030-9; Allam E, 2013, ORAL DIS, V19, P660, DOI 10.1111/odi.12050; Andrukhov O, 2013, ODONTOLOGY; Andrukhov O, 2013, ACTA ODONTOL SCAND; Andrukhov O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090301; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; BERGSTROM J, 1988, SCAND J DENT RES, V96, P34; Chambrone L, 2009, J AM DENT ASSOC, V140, P294, DOI 10.14219/jada.archive.2009.0158; Eppihimer MJ, 1997, AM J PHYSIOL-HEART C, V273, pH1903, DOI 10.1152/ajpheart.1997.273.4.H1903; FEYERABEND C, 1982, BRIT MED J, V284, P1002, DOI 10.1136/bmj.284.6321.1002; GEMMELL E, 1994, J PERIODONTAL RES, V29, P46, DOI 10.1111/j.1600-0765.1994.tb01090.x; Heasman L, 2006, J CLIN PERIODONTOL, V33, P241, DOI 10.1111/j.1600-051X.2006.00902.x; Heeschen C, 2003, J AM COLL CARDIOL, V41, P489, DOI 10.1016/S0735-1097(02)02818-8; Heng BC, 2011, CYTOTHERAPY, V13, P606, DOI 10.3109/14653249.2010.542455; Honda T, 2005, ORAL MICROBIOL IMMUN, V20, P82, DOI 10.1111/j.1399-302X.2004.00193.x; Johnson GK, 2007, PERIODONTOL 2000, V44, P178, DOI 10.1111/j.1600-0757.2007.00212.x; Khlgatian M, 2002, INFECT IMMUN, V70, P257, DOI 10.1128/IAI.70.1.257-267.2002; Kocgozlu L, 2009, J DENT RES, V88, P741, DOI 10.1177/0022034509341166; Li XW, 2006, LIFE SCI, V78, P1863, DOI 10.1016/j.lfs.2005.08.031; Libby P, 2000, J INTERN MED, V247, P349, DOI 10.1046/j.1365-2796.2000.00654.x; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; Lubos E, 2010, FASEB J, V24, P2525, DOI 10.1096/fj.09-147421; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Mavropoulos A, 2007, J PERIODONTOL, V78, P1774, DOI 10.1902/jop.2007.060472; MOUGHAL NA, 1992, J PERIODONTAL RES, V27, P623, DOI 10.1111/j.1600-0765.1992.tb01746.x; Nakamura N, 2008, ATHEROSCLEROSIS, V196, P59, DOI 10.1016/j.atherosclerosis.2007.01.039; Nassar H, 2002, INFECT IMMUN, V70, P268, DOI 10.1128/IAI.70.1.268-276.2002; Ng MKC, 2007, ARTERIOSCL THROM VAS, V27, P106, DOI 10.1161/01.ATV.0000251517.98396.4a; Paoletti R, 2004, CIRCULATION, V109, P20, DOI 10.1161/01.CIR.0000131514.71167.2e; Park HS, 2011, J CARDIOVASC PHARM, V57, P287, DOI 10.1097/FJC.0b013e318206b5d9; Park YJ, 2008, VASC PHARMACOL, V49, P32, DOI 10.1016/j.vph.2008.05.001; Patton GW, 2006, INT IMMUNOPHARMACOL, V6, P26, DOI 10.1016/j.intimp.2005.07.005; Pepine CJ, 1998, CLIN CARDIOL, V21, P795, DOI 10.1002/clc.4960211103; Qu Z, 2010, ORAL SURG ORAL MED O, V109, P924, DOI 10.1016/j.tripleo.2010.01.007; Quyyumi Arshed A., 1998, American Journal of Medicine, V105, p32S, DOI 10.1016/S0002-9343(98)00209-5; Rivera-Hidalgo F, 2003, PERIODONTOL 2000, V32, P50, DOI 10.1046/j.0906-6713.2003.03205.x; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; RUSSELL MAH, 1980, BMJ-BRIT MED J, V280, P972, DOI 10.1136/bmj.280.6219.972; Saeed RW, 2005, J EXP MED, V201, P1113, DOI 10.1084/jem.20040463; SEOW WK, 1994, INFLAMMATION, V18, P119, DOI 10.1007/BF01534553; Silva TA, 2007, J DENT RES, V86, P306, DOI 10.1177/154405910708600403; Snajdar RM, 2001, J SURG RES, V96, P10, DOI 10.1006/jsre.2000.6055; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; SOCRANSKY SS, 1992, J PERIODONTOL, V63, P322, DOI 10.1902/jop.1992.63.4s.322; Takahashi Y, 2006, CELL MICROBIOL, V8, P738, DOI 10.1111/j.1462-5822.2005.00661.x; Villablanca AC, 1998, J APPL PHYSIOL, V84, P2089, DOI 10.1152/jappl.1998.84.6.2089; Wu JCF, 2009, J CELL BIOCHEM, V108, P433, DOI 10.1002/jcb.22270; Zhang SL, 2001, ATHEROSCLEROSIS, V154, P277, DOI 10.1016/S0021-9150(00)00475-5	48	22	25	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96942	10.1371/journal.pone.0096942	http://dx.doi.org/10.1371/journal.pone.0096942			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24820118	Green Published, gold, Green Submitted			2022-12-27	WOS:000336653300052
J	Assirelli, E; Pulsatelli, L; Dolzani, P; Platano, D; Olivotto, E; Filardo, G; Trisolino, G; Facchini, A; Borzi, RM; Meliconi, R				Assirelli, Elisa; Pulsatelli, Lia; Dolzani, Paolo; Platano, Daniela; Olivotto, Eleonora; Filardo, Giuseppe; Trisolino, Giovanni; Facchini, Andrea; Borzi, Rosa Maria; Meliconi, Riccardo			Human Osteoarthritic Cartilage Shows Reduced In Vivo Expression of IL-4, a Chondroprotective Cytokine that Differentially Modulates IL-1 beta-Stimulated Production of Chemokines and Matrix-Degrading Enzymes In Vitro	PLOS ONE			English	Article							NF-KAPPA-B; HUMAN ARTICULAR CHONDROCYTES; GENE-EXPRESSION; INTERLEUKIN-4 RECEPTOR; ADAMTS4 AGGRECANASE-1; INTRAARTICULAR INJECTION; EXTRACELLULAR-MATRIX; TRANSCRIPTION FACTOR; CHONDROITIN SULFATE; ANABOLIC CYTOKINES	Background: In osteoarthritis (OA), an inflammatory environment is responsible for the imbalance between the anabolic and catabolic activity of chondrocytes and, thus, for articular cartilage derangement. This study was aimed at providing further insight into the impairment of the anabolic cytokine IL-4 and its receptors in human OA cartilage, as well as the potential ability of IL-4 to antagonize the catabolic phenotype induced by IL-1 beta. Methodology/Principal Findings: The in vivo expression of IL-4 and IL-4 receptor subunits (IL-4R, IL-2R gamma, IL-13R alpha 1) was investigated on full thickness OA or normal knee cartilage. IL-4 expression was found to be significantly lower in OA, both in terms of the percentage of positive cells and the amount of signal per cell. IL-4 receptor type I and II were mostly expressed in mid-deep cartilage layers. No significant difference for each IL-4 receptor subunit was noted. IL-4 anti-inflammatory and anti-catabolic activity was assessed in vitro in the presence of IL-1 beta and/or IL-4 for 24 hours using differentiated high density primary OA chondrocyte also exhibiting the three IL-4 R subunits found in vivo. Chemokines, extracellular matrix degrading enzymes and their inhibitors were evaluated at mRNA (real time PCR) and protein (ELISA or western blot) levels. IL-4 did not affect IL-1 beta-induced mRNA expression of GRO-alpha/CXCL1, IL-8/CXCL8, ADAMTS-5, TIMP-1 or TIMP-3. Conversely, IL-4 significantly inhibited RANTES/CCL5, MIP-1 alpha/CCL3, MIP-1 beta/CCL4, MMP-13 and ADAMTS-4. These results were confirmed at protein level for RANTES/CCL5 and MMP-13. Conclusions/Significance: Our results indicate for the first time that OA cartilage has a significantly lower expression of IL-4. Furthermore, we found differences in the spectrum of biological effects of IL-4. The findings that IL-4 has the ability to hamper the IL-1 beta-induced release of both MMP-13 and CCL5/RANTES, both markers of OA chondrocytes, strongly indicates IL-4 as a pivotal anabolic cytokine in cartilage whose impairment impacts on OA pathogenesis.	[Assirelli, Elisa; Pulsatelli, Lia; Dolzani, Paolo; Platano, Daniela; Olivotto, Eleonora; Facchini, Andrea; Borzi, Rosa Maria] Rizzoli Orthopaed Inst, RAMSES, Lab Immunorheumatol & Tissue Regenerat, Bologna, Italy; [Filardo, Giuseppe] Rizzoli Orthopaed Inst, Lab Biomechan & Technol Innovat, Orthopaed & Traumatol Clin 2, Bologna, Italy; [Trisolino, Giovanni] Rizzoli Orthopaed Inst, Bologna, Italy; [Facchini, Andrea; Meliconi, Riccardo] Univ Bologna, Bologna, Italy; [Meliconi, Riccardo] Rizzoli Orthopaed Inst, Med & Rheumatol Unit, Bologna, Italy	IRCCS Istituto Ortopedico Rizzoli; IRCCS Istituto Ortopedico Rizzoli; IRCCS Istituto Ortopedico Rizzoli; University of Bologna; IRCCS Istituto Ortopedico Rizzoli	Meliconi, R (corresponding author), Univ Bologna, Bologna, Italy.	riccardo.meliconi@unibo.it	Borzì, Rosa Maria/ABI-2279-2020; Olivotto, Eleonora/C-6938-2019; Olivotto, Eleonora/AAE-5763-2020; Dolzani, Paolo/C-6955-2019; Pulsatelli, Lia/D-4092-2019; Assirelli, Elisa/F-1435-2019; Trisolino, Giovanni/I-3717-2019; Filardo, Giuseppe/K-5088-2016	Borzì, Rosa Maria/0000-0003-4133-4894; Olivotto, Eleonora/0000-0002-6726-3177; Dolzani, Paolo/0000-0002-9341-2703; Pulsatelli, Lia/0000-0003-3031-170X; Assirelli, Elisa/0000-0001-5678-6506; Trisolino, Giovanni/0000-0002-0361-9920; Filardo, Giuseppe/0000-0002-8136-0977	Rizzoli Orthopaedic Institute (Ricerca Corrente); University of Bologna (RFO); MIUR [FIRB-RBAP10KCNS]; "Cinque per mille" Funds	Rizzoli Orthopaedic Institute (Ricerca Corrente)(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Corrente (MOH-RC)); University of Bologna (RFO); MIUR(Ministry of Education, Universities and Research (MIUR)); "Cinque per mille" Funds	This work was supported by grants from Rizzoli Orthopaedic Institute (Ricerca Corrente); University of Bologna (RFO); MIUR (FIRB-RBAP10KCNS); "Cinque per mille" Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amer Y, 2001, J CLIN INVEST, V107, P1375, DOI 10.1172/JCI10530; Alaaeddine N, 2001, ARTHRITIS RHEUM-US, V44, P1633, DOI 10.1002/1529-0131(200107)44:7<1633::AID-ART286>3.0.CO;2-Z; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Attur MG, 2002, OSTEOARTHR CARTILAGE, V10, P1, DOI 10.1053/joca.2001.0488; Bondeson J, 2007, J RHEUMATOL, V34, P523; Borzi RM, 2004, CLIN ORTHOP RELAT R, pS53, DOI 10.1097/01.blo.0000143805.64755.4f; Borzi RM, 1999, FEBS LETT, V455, P238, DOI 10.1016/S0014-5793(99)00886-8; Borzi RM, 2010, ARTHRITIS RHEUM-US, V62, P2370, DOI 10.1002/art.27512; Cawston TE, 2006, BEST PRACT RES CL RH, V20, P983, DOI 10.1016/j.berh.2006.06.007; Chen Z, 2003, J IMMUNOL, V171, P3627, DOI 10.4049/jimmunol.171.7.3627; Chowdhury TT, 2006, BIOCHEM BIOPH RES CO, V339, P241, DOI 10.1016/j.bbrc.2005.11.016; De Ceuninck F, 2004, BIOCHEM BIOPH RES CO, V323, P960, DOI 10.1016/j.bbrc.2004.08.184; Doi H, 2008, ACTA MED OKAYAMA, V62, P119; DONNELLY RP, 1991, J IMMUNOL, V146, P3431; El Mabrouk M, 2008, J CELL BIOCHEM, V103, P588, DOI 10.1002/jcb.21434; Elo LL, 2010, IMMUNITY, V32, P852, DOI 10.1016/j.immuni.2010.06.011; Flannery CR, 2002, J BIOL CHEM, V277, P42775, DOI 10.1074/jbc.M205309200; Forster T, 2004, HUM GENET, V114, P391, DOI 10.1007/s00439-004-1083-0; Gao G, 2004, J BIOL CHEM, V279, P10042, DOI 10.1074/jbc.M312100200; Gao G, 2002, J BIOL CHEM, V277, P11034, DOI 10.1074/jbc.M107443200; Gauci S. J., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P308; Genin P, 2000, J IMMUNOL, V164, P5352, DOI 10.4049/jimmunol.164.10.5352; Goldring MB, 2008, ANN RHEUM DIS, V67, P75, DOI 10.1136/ard.2008.098764; Goldring MB, 2011, EUR CELLS MATER, V21, P202, DOI 10.22203/eCM.v021a16; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Guicheux J, 2002, J CELL PHYSIOL, V192, P93, DOI 10.1002/jcp.10121; Guidotti S, 2013, STEM CELLS DEV, V22, P1588, DOI 10.1089/scd.2012.0399; Hamilton TA, 2002, IMMUNOL RES, V25, P229, DOI 10.1385/IR:25:3:229; Hebenstreit D, 2006, CYTOKINE GROWTH F R, V17, P173, DOI 10.1016/j.cytogfr.2006.01.004; Henriquet C, 2007, LUNG CANCER, V56, P167, DOI 10.1016/j.lungcan.2006.12.003; Hermansson M, 2004, J BIOL CHEM, V279, P43514, DOI 10.1074/jbc.M407041200; Huang K, 2008, J INT MED RES, V36, P1149, DOI 10.1177/147323000803600601; Jiang H, 2000, J ALLERGY CLIN IMMUN, V105, P1063, DOI 10.1067/mai.2000.107604; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Koshy PJT, 2002, ARTHRITIS RHEUM, V46, P961, DOI 10.1002/art.10212; Lin RT, 1999, MOL CELL BIOL, V19, P959; Liu JG, 2005, J BIOL CHEM, V280, P24347, DOI 10.1074/jbc.M500973200; Loeser RF, 2002, BIORHEOLOGY, V39, P119; Luo L, 1997, BIOCHEM J, V324, P653, DOI 10.1042/bj3240653; Luzina IG, 2012, J LEUKOCYTE BIOL, V92, P753, DOI 10.1189/jlb.0412214; Madhavan S, 2006, OSTEOARTHR CARTILAGE, V14, P1023, DOI 10.1016/j.joca.2006.03.016; Marcais A, 2006, J IMMUNOL, V177, P4451, DOI 10.4049/jimmunol.177.7.4451; Marcu KB, 2010, CURR DRUG TARGETS, V11, P599, DOI 10.2174/138945010791011938; Matsukawa T, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4164; Merz D, 2003, J IMMUNOL, V171, P4406, DOI 10.4049/jimmunol.171.8.4406; Mijatovic T, 1997, J BIOL CHEM, V272, P14394, DOI 10.1074/jbc.272.22.14394; Millward-Sadler SJ, 2006, OSTEOARTHR CARTILAGE, V14, P991, DOI 10.1016/j.joca.2006.03.013; Millward-Sadler SJ, 2000, ARTHRITIS RHEUM, V43, P2091, DOI 10.1002/1529-0131(200009)43:9<2091::AID-ANR21>3.0.CO;2-C; Millward-Sadler SJ, 1999, J CELL BIOL, V145, P183, DOI 10.1083/jcb.145.1.183; Murata T, 1995, J BIOL CHEM, V270, P30829, DOI 10.1074/jbc.270.51.30829; Murata T, 1998, BLOOD, V91, P3884; Naito S, 2007, PATHOL INT, V57, P703, DOI 10.1111/j.1440-1827.2007.02167.x; Nishisaka F, 2001, Pathophysiology, V7, P289, DOI 10.1016/S0928-4680(00)00061-4; Ohmori Y, 2000, J BIOL CHEM, V275, P38095, DOI 10.1074/jbc.M006227200; Ohmori Y, 1997, J IMMUNOL, V159, P5474; Olivotto E, 2007, J CELL PHYSIOL, V210, P417, DOI 10.1002/jcp.20864; Otero M, 2012, METHODS MOL BIOL, V806, P301, DOI 10.1007/978-1-61779-367-7_21; Pratta MA, 2003, ARTHRITIS RHEUM, V48, P119, DOI 10.1002/art.10726; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Pulsatelli L, 1999, J RHEUMATOL, V26, P1992; Rachakonda PS, 2008, CYTOKINE, V44, P179, DOI 10.1016/j.cyto.2008.07.470; Raingeaud J, 2005, FEBS LETT, V579, P3953, DOI 10.1016/j.febslet.2005.06.019; Salter DM, 2001, CLIN ORTHOP RELAT R, pS49; Sandell LJ, 2008, OSTEOARTHR CARTILAGE, V16, P1560, DOI 10.1016/j.joca.2008.04.027; SEITZ M, 1994, J IMMUNOL, V152, P2060; Silvestri T, 2006, OSTEOARTHR CARTILAGE, V14, P717, DOI 10.1016/j.joca.2006.02.015; Song RH, 2007, ARTHRITIS RHEUM-US, V56, P575, DOI 10.1002/art.22334; Sylvester J, 2013, RHEUMATOL INT, V33, P517, DOI 10.1007/s00296-011-2187-1; Tortorella MD, 1999, SCIENCE, V284, P1664, DOI 10.1126/science.284.5420.1664; Ulivi V, 2006, J CELL PHYSIOL, V206, P728, DOI 10.1002/jcp.20511; van den Berg WB, 2011, OSTEOARTHR CARTILAGE, V19, P338, DOI 10.1016/j.joca.2011.01.022; van Lent PLEM, 2002, OSTEOARTHR CARTILAGE, V10, P234, DOI 10.1053/joca.2001.0501; van Meegeren MER, 2013, RHEUMATOLOGY, V52, P1563, DOI 10.1093/rheumatology/ket005; van Meegeren MER, 2013, BRIT J HAEMATOL, V160, P515, DOI 10.1111/bjh.12148; Vargiolu M, 2010, OSTEOARTHR CARTILAGE, V18, P810, DOI 10.1016/j.joca.2010.02.005; WATT FM, 1988, J CELL SCI, V89, P373; Wong M, 2003, BONE, V33, P1, DOI 10.1016/S8756-3282(03)00083-8; Yorimitsu M, 2008, OSTEOARTHR CARTILAGE, V16, P764, DOI 10.1016/j.joca.2007.11.006; Zhang ZQ, 2010, J BIOL CHEM, V285, P33092, DOI 10.1074/jbc.M110.130377	79	42	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96925	10.1371/journal.pone.0096925	http://dx.doi.org/10.1371/journal.pone.0096925			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819779	Green Submitted, Green Published, gold			2022-12-27	WOS:000336653300050
J	Danneels, EL; Gerlo, S; Heyninck, K; Van Craenenbroeck, K; De Bosscher, K; Haegeman, G; de Graaf, DC				Danneels, Ellen L.; Gerlo, Sarah; Heyninck, Karen; Van Craenenbroeck, Kathleen; De Bosscher, Karolien; Haegeman, Guy; de Graaf, Dirk C.			How the Venom from the Ectoparasitoid Wasp Nasonia vitripennis Exhibits Anti-Inflammatory Properties on Mammalian Cell Lines	PLOS ONE			English	Article							NF-KAPPA-B; PAIN-RELATED BEHAVIORS; WALKER HYMENOPTERA; FLESH FLY; SARCOPHAGA-BULLATA; GENE-EXPRESSION; SIGNAL-TRANSDUCTION; TARGET GENES; P65 SUBUNIT; ACTIVATION	With more than 150,000 species, parasitoids are a large group of hymenopteran insects that inject venom into and then lay their eggs in or on other insects, eventually killing the hosts. Their venoms have evolved into different mechanisms for manipulating host immunity, physiology and behavior in such a way that enhance development of the parasitoid young. The venom from the ectoparasitoid Nasonia vitripennis inhibits the immune system in its host organism in order to protect their offspring from elimination. Since the major innate immune pathways in insects, the Toll and Imd pathways, are homologous to the NF-kappa B pathway in mammals, we were interested in whether a similar immune suppression seen in insects could be elicited in a mammalian cell system. A well characterized NF-kappa B reporter gene assay in fibrosarcoma cells showed a dose-dependent inhibition of NF-kappa B signaling caused by the venom. In line with this NF-kappa B inhibitory action, N. vitripennis venom dampened the expression of IL-6, a prototypical proinflammatory cytokine, from LPS-treated macrophages. The venom also inhibited the expression of two NF-kappa B target genes, I kappa B alpha and A20, that act in a negative feedback loop to prevent excessive NF-kappa B activity. Surprisingly, we did not detect any effect of the venom on the early events in the canonical NF-kappa B activation pathway, leading to NF-kappa B nuclear translocation, which was unaltered in venom-treated cells. The MAP kinases ERK, p38 and JNK are other crucial regulators of immune responses. We observed that venom treatment did not affect p38 and ERK activation, but induced a prolonged JNK activation. In summary, our data indicate that venom from N. vitripennis inhibits NF-kappa B signaling in mammalian cells. We identify venom-induced up regulation of the glucocorticoid receptor-regulated GILZ as a most likely molecular mediator for this inhibition.	[Danneels, Ellen L.; de Graaf, Dirk C.] Univ Ghent, Dept Physiol, Lab Zoophysiol, B-9000 Ghent, Belgium; [Gerlo, Sarah; De Bosscher, Karolien] Univ Ghent, VIB Dept Med Prot Res, Ghent, Belgium; [Heyninck, Karen; Van Craenenbroeck, Kathleen; Haegeman, Guy] Univ Ghent, Dept Physiol, Lab Eukaryot Gene Express & Signal Transduct, B-9000 Ghent, Belgium	Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Danneels, EL (corresponding author), Univ Ghent, Dept Physiol, Lab Zoophysiol, B-9000 Ghent, Belgium.	Ellen.Danneels@UGent.be	de Graaf, Dirk C./HGD-4017-2022	De Bosscher, Karolien/0000-0001-5059-9718; Danneels, Ellen/0000-0002-2266-6298				Abt M, 2007, J INVERTEBR PATHOL, V94, P108, DOI 10.1016/j.jip.2006.09.004; Almawi WY, 2002, J MOL ENDOCRINOL, V28, P69, DOI 10.1677/jme.0.0280069; Asgari S, 2011, ANNU REV ENTOMOL, V56, P313, DOI 10.1146/annurev-ento-120709-144849; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; Bae S, 2009, J INVERTEBR PATHOL, V102, P79, DOI 10.1016/j.jip.2009.06.007; Bharti AC, 2002, BIOCHEM PHARMACOL, V64, P883, DOI 10.1016/S0006-2952(02)01154-1; BILLINGHAM ME, 1973, NATURE, V245, P163, DOI 10.1038/245163a0; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Brasier AR, 2006, CARDIOVASC TOXICOL, V6, P111, DOI 10.1385/CT:6:2:111; Chen YN, 2006, NEUROSCIENCE, V138, P631, DOI 10.1016/j.neuroscience.2005.11.022; Christman JW, 2000, CHEST, V117, P1482, DOI 10.1378/chest.117.5.1482; D'Acquisto Fulvio, 2002, Mol Interv, V2, P22, DOI 10.1124/mi.2.1.22; Danneels EL, 2013, INSECT BIOCHEM MOLEC, V43, P1189, DOI 10.1016/j.ibmb.2013.10.003; Danneels EL, 2010, TOXINS, V2, P494, DOI 10.3390/toxins2040494; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; De Bosscher K, 2005, P NATL ACAD SCI USA, V102, P15827, DOI 10.1073/pnas.0505554102; de Graaf DC, 2010, INSECT MOL BIOL, V19, P11, DOI 10.1111/j.1365-2583.2009.00914.x; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Dkhil MA, 2010, AFR J PHARM PHARMACO, V4, P115; Formesyn EM, 2013, J INSECT PHYSIOL, V59, P795, DOI 10.1016/j.jinsphys.2013.05.004; Formesyn EM, 2012, PARASITOID VIRUSES: SYMBIONTS AND PATHOGENS, P233, DOI 10.1016/B978-0-12-384858-1.00019-9; Franklin CC, 1997, J BIOL CHEM, V272, P16917, DOI 10.1074/jbc.272.27.16917; Fry BG, 2009, ANNU REV GENOM HUM G, V10, P483, DOI 10.1146/annurev.genom.9.081307.164356; Gilmore TD, 2006, ONCOGENE, V25, P6887, DOI 10.1038/sj.onc.1209982; Gueguen G, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003580; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Gundersen-Rindal DE, 2006, J GEN VIROL, V87, P311, DOI 10.1099/vir.0.81326-0; Hatada EN, 2000, CURR OPIN IMMUNOL, V12, P52, DOI 10.1016/S0952-7915(99)00050-3; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hayden MS, 2011, CELL RES, V21, P223, DOI 10.1038/cr.2011.13; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Heyninck K, 2005, TRENDS BIOCHEM SCI, V30, P1, DOI 10.1016/j.tibs.2004.11.001; Igaki T, 2002, EMBO J, V21, P3009, DOI 10.1093/emboj/cdf306; Inoue H, 2001, EMBO J, V20, P5421, DOI 10.1093/emboj/20.19.5421; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Kroemer JA, 2005, J VIROL, V79, P7617, DOI 10.1128/JVI.79.12.7617-7628.2005; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Lim YM, 1999, GENETICS, V153, P763; Liu T, 2007, EUR J PHARMACOL, V575, P46, DOI 10.1016/j.ejphar.2007.07.057; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Moreau SJM, 2005, INSECT BIOCHEM MOLEC, V35, P1209, DOI 10.1016/j.ibmb.2005.07.003; NAUMANN M, 1994, EMBO J, V13, P4597, DOI 10.1002/j.1460-2075.1994.tb06781.x; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Park HJ, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-7; Plaisance S, 1997, MOL CELL BIOL, V17, P3733, DOI 10.1128/MCB.17.7.3733; Qian C, 2013, ARCH INSECT BIOCHEM, V83, P211, DOI 10.1002/arch.21107; Rajendra W, 2004, TOXICON, V44, P1, DOI 10.1016/j.toxicon.2004.04.014; Riccardi C, 2001, ADV EXP MED BIOL, V495, P31; Rivers DB, 2010, J INSECT PHYSIOL, V56, P1935, DOI 10.1016/j.jinsphys.2010.08.019; Rivers DB, 2005, J INSECT PHYSIOL, V51, P149, DOI 10.1016/j.jinsphys.2004.05.002; Rivers DB, 2002, J INSECT PHYSIOL, V48, P1053, DOI 10.1016/S0022-1910(02)00193-2; RIVERS DB, 1994, J INSECT PHYSIOL, V40, P121, DOI 10.1016/0022-1910(94)90083-3; RIVERS DB, 1994, J INSECT PHYSIOL, V40, P207, DOI 10.1016/0022-1910(94)90044-2; Rivers DB, 2002, TOXICON, V40, P9, DOI 10.1016/S0041-0101(01)00132-5; Rivkin H, 2006, J GEN VIROL, V87, P2217, DOI 10.1099/vir.0.81918-0; Ruland J, 2011, NAT IMMUNOL, V12, P709, DOI 10.1038/ni.2055; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Schaecke H, 2007, MOL CELL ENDOCRINOL, V275, P109, DOI 10.1016/j.mce.2007.05.014; Schlenke TA, 2007, PLOS PATHOG, V3, P1486, DOI 10.1371/journal.ppat.0030158; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Small C, 2012, JOVE-J VIS EXP, DOI 10.3791/3347; Souza A.H., 2011, TOXICON, V58, P626, DOI 10.1016/j.txicon.2011.09.008; Srinivasan M, 2011, J BIOL CHEM, V286, P44799, DOI 10.1074/jbc.M111.279257; Staudt LM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000109; Teixeira C, 2009, TOXICON, V54, P988, DOI 10.1016/j.toxicon.2009.05.026; Thoetkiattikul H, 2005, P NATL ACAD SCI USA, V102, P11426, DOI 10.1073/pnas.0505240102; Tian HY, 2013, J NAT PROD, V76, P1842, DOI 10.1021/np400174f; Tsai SH, 2007, TOXICON, V50, P914, DOI 10.1016/j.toxicon.2007.06.025; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; Wilkinson MG, 1998, GENE DEV, V12, P1391, DOI 10.1101/gad.12.10.1391; Wong ET, 2009, CLIN SCI, V116, P451, DOI 10.1042/CS20080502; Wong ESW, 2012, GENE, V496, P1, DOI 10.1016/j.gene.2012.01.009; Wullaert A, 2006, BIOCHEM PHARMACOL, V72, P1090, DOI 10.1016/j.bcp.2006.07.003; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914; Zhang Z, 2005, TOXICON, V46, P337, DOI 10.1016/j.toxicon.2005.05.005	84	23	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							c96825	10.1371/journal.pone.0096825	http://dx.doi.org/10.1371/journal.pone.0096825			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24821138	Green Published, gold			2022-12-27	WOS:000336653300036
J	Diefenbacher, ME; Reich, D; Dahley, O; Kemler, D; Litfin, M; Herrlich, P; Kassel, O				Diefenbacher, Markus E.; Reich, Daniela; Dahley, Oliver; Kemler, Denise; Litfin, Margarethe; Herrlich, Peter; Kassel, Olivier			The LIM Domain Protein nTRIP6 Recruits the Mediator Complex to AP-1-Regulated Promoters	PLOS ONE			English	Article							BIMOLECULAR FLUORESCENCE COMPLEMENTATION; NUCLEAR EXPORT SIGNAL; GLUCOCORTICOID-RECEPTOR; C-JUN; TRANSCRIPTIONAL COACTIVATORS; HISTONE ACETYLTRANSFERASES; REPRESSING SIGNALS; ANDROGEN RECEPTOR; DOWN-MODULATION; FAMILY-MEMBERS	Several LIM domain proteins regulate transcription. They are thought to act through their LIM protein-protein interaction domains as adaptors for the recruitment of transcriptional co-regulators. An intriguing example is nTRIP6, the nuclear isoform of the focal adhesion protein TRIP6. nTRIP6 interacts with AP-1 and enhances its transcriptional activity. nTRIP6 is also essential for the transrepression of AP-1 by the glucocorticoid receptor (GR), by mediating GR tethering to promoter-bound AP-1. Here we report on the molecular mechanism by which nTRIP6 exerts these effects. Both the LIM domains and the pre-LIM region of nTRIP6 are necessary for its co-activator function for AP-1. Discrete domains within the pre-LIM region mediate the dimerization of nTRIP6 at the promoter, which enables the recruitment of the Mediator complex subunits THRAP3 and Med1. This recruitment is blocked by GR, through a competition between GR and THRAP3 for the interaction with the LIM domains of nTRIP6. Thus, nTRIP6 both positively and negatively regulates transcription by orchestrating the recruitment of the Mediator complex to AP-1-regulated promoters.	[Diefenbacher, Markus E.; Dahley, Oliver; Kemler, Denise; Litfin, Margarethe; Kassel, Olivier] KIT, Inst Toxicol & Genet, Karlsruhe, Germany; [Reich, Daniela; Herrlich, Peter] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Kassel, O (corresponding author), KIT, Inst Toxicol & Genet, Karlsruhe, Germany.	olivier.kassel@kit.edu	Diefenbacher, Markus Elmar/AAY-8650-2021; Kassel, Olivier/H-2117-2013	Diefenbacher, Markus Elmar/0000-0002-7402-7949; Kassel, Olivier/0000-0002-8616-3091	German Science Foundation (DFG) [HE551]; Biointerfaces Programme of the Helmholtz Association	German Science Foundation (DFG)(German Research Foundation (DFG)); Biointerfaces Programme of the Helmholtz Association	This work was supported in part by the German Science Foundation (DFG grant no. HE551 to PH; www.dfg.de). The only other source of funding was the Biointerfaces Programme of the Helmholtz Association (core institutional funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa H, 2004, J CELL BIOL, V164, P395, DOI 10.1083/jcb.200309159; Aoyagi S, 2008, MOL CELL ENDOCRINOL, V280, P1, DOI 10.1016/j.mce.2007.08.016; Ayyanathan K, 2007, CANCER RES, V67, P9097, DOI 10.1158/0008-5472.CAN-07-2987; Bakiri L, 2002, MOL CELL BIOL, V22, P4952, DOI 10.1128/MCB.22.13.4952-4964.2002; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bedford DC, 2010, EPIGENETICS-US, V5, P9, DOI 10.4161/epi.5.1.10449; Beli P, 2012, MOL CELL, V46, P212, DOI 10.1016/j.molcel.2012.01.026; Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; Bracken CP, 2008, CANCER RES, V68, P7621, DOI 10.1158/0008-5472.CAN-08-1217; Cirillo G, 1999, MOL CELL BIOL, V19, P6240; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Dawid IB, 1998, TRENDS GENET, V14, P156, DOI 10.1016/S0168-9525(98)01424-3; De Bosscher K, 2014, CELL MOL LIFE SCI, V71, P143, DOI 10.1007/s00018-013-1367-4; DECESARE D, 1995, ONCOGENE, V11, P365; Diefenbacher M, 2008, MOL ENDOCRINOL, V22, P1767, DOI 10.1210/me.2007-0574; Diefenbacher ME, 2010, MOL CELL ENDOCRINOL, V320, P58, DOI 10.1016/j.mce.2010.02.010; Ester C, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-29; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Fimia GM, 2000, MOL CELL BIOL, V20, P8613, DOI 10.1128/MCB.20.22.8613-8622.2000; Fondell JD, 1996, P NATL ACAD SCI USA, V93, P8329, DOI 10.1073/pnas.93.16.8329; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Hervy M, 2006, CURR OPIN CELL BIOL, V18, P524, DOI 10.1016/j.ceb.2006.08.006; Hittelman AB, 1999, EMBO J, V18, P5380, DOI 10.1093/emboj/18.19.5380; Hou ZY, 2010, P NATL ACAD SCI USA, V107, P2938, DOI 10.1073/pnas.0908656107; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Ito M, 1999, MOL CELL, V3, P361, DOI 10.1016/S1097-2765(00)80463-3; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Kassel O, 2004, GENE DEV, V18, P2518, DOI 10.1101/gad.322404; Kassel O, 2007, MOL CELL ENDOCRINOL, V275, P13, DOI 10.1016/j.mce.2007.07.003; Katano-Toki A, 2013, MOL ENDOCRINOL, V27, P769, DOI 10.1210/me.2012-1332; Kotitschke A, 2009, MOL ENDOCRINOL, V23, P1726, DOI 10.1210/me.2008-0462; Lande-Diner L, 2013, P NATL ACAD SCI USA, V110, P16021, DOI 10.1073/pnas.1305980110; Le PP, 2005, PLOS GENET, V1, P159, DOI 10.1371/journal.pgen.0010016; Lee KM, 2010, NUCLEIC ACIDS RES, V38, P3340, DOI 10.1093/nar/gkq017; Lin VTG, 2011, CELL SIGNAL, V23, P1691, DOI 10.1016/j.cellsig.2011.06.004; Lu Z, 2006, ONCOGENE, V25, P2920, DOI 10.1038/sj.onc.1209318; LUCIBELLO FC, 1990, EMBO J, V9, P2827, DOI 10.1002/j.1460-2075.1990.tb07471.x; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Martynova NY, 2008, DEV DYNAM, V237, P736, DOI 10.1002/dvdy.21471; Matthews JM, 2008, BIOCHEM SOC T, V36, P1393, DOI 10.1042/BST0361393; Muller JM, 2000, EMBO J, V19, P359, DOI 10.1093/emboj/19.3.359; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Petit MMR, 2000, MOL BIOL CELL, V11, P117, DOI 10.1091/mbc.11.1.117; Ratman D, 2013, MOL CELL ENDOCRINOL, V380, P41, DOI 10.1016/j.mce.2012.12.014; Ries D, 2011, SEMIN CELL DEV BIOL, V22, P735, DOI 10.1016/j.semcdb.2011.08.004; Rogatsky I, 2001, EMBO J, V20, P6071, DOI 10.1093/emboj/20.21.6071; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; Schneikert J, 1996, J BIOL CHEM, V271, P23907, DOI 10.1074/jbc.271.39.23907; Schock SC, 2008, J NEUROSCI, V28, P12433, DOI 10.1523/JNEUROSCI.2897-08.2008; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; SHEMSHEDINI L, 1991, EMBO J, V10, P3839, DOI 10.1002/j.1460-2075.1991.tb04953.x; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Shimizu N, 2003, CANCER RES, V63, P5281; Shimizu N, 2001, CANCER RES, V61, P6987; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; Smith E, 2010, MOL CELL, V40, P689, DOI 10.1016/j.molcel.2010.11.031; Srichai MB, 2004, J BIOL CHEM, V279, P14398, DOI 10.1074/jbc.M314155200; TOURAY M, 1991, ONCOGENE, V6, P1227; Wang Y, 2001, BBA-MOL CELL RES, V1538, P260, DOI 10.1016/S0167-4889(01)00077-5; Wang Y, 2003, BBA-MOL CELL RES, V1593, P115, DOI 10.1016/S0167-4889(02)00349-X; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; Weg-Remers S, 2001, EMBO J, V20, P4194, DOI 10.1093/emboj/20.15.4194; Weiss C, 2005, ONCOGENE, V24, P4975, DOI 10.1038/sj.onc.1208679; Willier S, 2011, BIOL CELL, V103, P573, DOI 10.1042/BC20110077; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; Yi JS, 1998, GENOMICS, V49, P314, DOI 10.1006/geno.1998.5248; Zheng Q, 2007, BIOL CELL, V99, P489, DOI 10.1042/BC20060126	71	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97549	10.1371/journal.pone.0097549	http://dx.doi.org/10.1371/journal.pone.0097549			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819052	Green Published, gold			2022-12-27	WOS:000336653300122
J	Nunez, B; de Mena, RM; Obregon, MJ; Font-Llitjos, M; Nunes, V; Palacin, M; Dumitrescu, AM; Morte, B; Bernal, J				Nunez, Barbara; Martinez de Mena, Raquel; Jesus Obregon, Maria; Font-Llitjos, Mariona; Nunes, Virginia; Palacin, Manuel; Dumitrescu, Alexandra M.; Morte, Beatriz; Bernal, Juan			Cerebral Cortex Hyperthyroidism of Newborn Mct8-Deficient Mice Transiently Suppressed by Lat2 Inactivation	PLOS ONE			English	Article							THYROID-HORMONE TRANSPORT; MONOCARBOXYLATE TRANSPORTER-8; IODOTHYRONINE DEIODINASE; BRAIN-DEVELOPMENT; MCT8; METABOLISM; MUTATIONS; LACKING; GENES	Thyroid hormone entry into cells is facilitated by transmembrane transporters. Mutations of the specific thyroid hormone transporter, MCT8 (Monocarboxylate Transporter 8, SLC16A2) cause an X-linked syndrome of profound neurological impairment and altered thyroid function known as the Allan-Herndon-Dudley syndrome. MCT8 deficiency presumably results in failure of thyroid hormone to reach the neural target cells in adequate amounts to sustain normal brain development. However during the perinatal period the absence of Mct8 in mice induces a state of cerebral cortex hyperthyroidism, indicating increased brain access and/or retention of thyroid hormone. The contribution of other transporters to thyroid hormone metabolism and action, especially in the context of MCT8 deficiency is not clear. We have analyzed the role of the heterodimeric aminoacid transporter Lat2 (Slc7a8), in the presence or absence of Mct8, on thyroid hormone concentrations and on expression of thyroid hormone-dependent cerebral cortex genes. To this end we generated Lat2(-/-), and Mct8(-/y) Lat2(-/-) mice, to compare with wild type and Mct8(-/y) mice during postnatal development. As described previously the single Mct8 KO neonates had a transient increase of 3,5,3'-triiodothyronine concentration and expression of thyroid hormone target genes in the cerebral cortex. Strikingly the absence of Lat2 in the double Mct8Lat2 KO prevented the effect of Mct8 inactivation in newborns. The Lat2 effect was not observed from postnatal day 5 onwards. On postnatal day 21 the Mct8 KO displayed the typical pattern of thyroid hormone concentrations in plasma, decreased cortex 3,5,3'-triiodothyronine concentration and Hr expression, and concomitant Lat2 inactivation produced little to no modifications. As Lat2 is expressed in neurons and in the choroid plexus, the results support a role for Lat2 in the supply of thyroid hormone to the cerebral cortex during early postnatal development.	[Nunez, Barbara; Martinez de Mena, Raquel; Jesus Obregon, Maria; Morte, Beatriz; Bernal, Juan] CSIC, Inst Invest Biomed, Madrid, Spain; [Nunez, Barbara; Martinez de Mena, Raquel; Jesus Obregon, Maria; Morte, Beatriz; Bernal, Juan] Univ Autonoma Madrid, Madrid, Spain; [Font-Llitjos, Mariona; Nunes, Virginia] IDIBELL, Genet Mol Lab, Barcelona, Spain; [Font-Llitjos, Mariona; Nunes, Virginia] Ctr Biomed Res Rare Dis CIBERER, Unit 730, Barcelona, Spain; [Nunes, Virginia] Univ Barcelona, Fac Med, Dept Ciencias Fisiol 2, Secc Genet, Barcelona, Spain; [Palacin, Manuel] IRB, Barcelona, Spain; [Palacin, Manuel] CIBERER, Unit 731, Barcelona, Spain; [Dumitrescu, Alexandra M.] Univ Chicago, Chicago, IL 60637 USA; [Morte, Beatriz; Bernal, Juan] CIBERER, Unit 708, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Chicago; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Morte, B (corresponding author), CSIC, Inst Invest Biomed, Madrid, Spain.	bmorte@iib.uam.es; jbernal@iib.uam.es	Bernal, Juan/J-6086-2014; Nunes, Virginia/AAD-1014-2019; Palacín, Manuel/G-9786-2015	Bernal, Juan/0000-0002-5867-4951; Nunes, Virginia/0000-0002-5747-9310; Palacin, Manuel/0000-0002-8670-293X; Martinez de Mena, Raquel Rosa/0000-0001-5866-0560; Morte, Beatriz/0000-0003-0702-7815	Plan Nacional de Investigacion Cientifica [SAF2011-25608, SAF2012-32491, SAF2009-120606-C02-01, SAF2009-120606-C02-02, SAF2012-40080-C02-01]; Fundacion ARECES; CIBERER, Instituto Carlos III, Spain [09/708.1, 10/708.1]; Generalitat de Catalunya [SGR2009-1490, SGR2009-1355]; Comunidad de Madrid [S2010/BMD-2423]; USA National Institutes of Health [DK15070, DK091016]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER	Plan Nacional de Investigacion Cientifica(Instituto de Salud Carlos IIIEuropean Commission); Fundacion ARECES; CIBERER, Instituto Carlos III, Spain; Generalitat de Catalunya(Generalitat de Catalunya); Comunidad de Madrid(Comunidad de Madrid); USA National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Supported by grants from the Plan Nacional de Investigacion Cientifica SAF2011-25608 (to JB), SAF2012-32491 (to MJO), SAF2009-120606-C02-01 and 02 and SAF2012-40080-C02-01 to (to MP and VN); Fundacion ARECES (to BM): intramural grants 09/708.1 and 10/708.1 from the CIBERER, Instituto Carlos III, Spain (to JB, MP and VN); Generalitat de Catalunya SGR2009-1490 (to VN) and SGR2009-1355 (to MP); Comunidad de Madrid S2010/BMD-2423 (to MJO); the USA National Institutes of Health, DK15070 and DK091016 (to AMD). The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], UNUB; [Anonymous], BIOCHIM BIOPHYS ACTA; Bernal J, 2007, NAT CLIN PRACT ENDOC, V3, P249, DOI 10.1038/ncpendmet0424; Bernal J, 2011, CURR OPIN ENDOCRINOL, V18, P295, DOI 10.1097/MED.0b013e32834a78b3; Bernal Juan, 2002, Methods Mol Biol, V202, P71; Braun D, 2011, BIOCHEM J, V439, P249, DOI 10.1042/BJ20110759; Braun D, 2011, GLIA, V59, P463, DOI 10.1002/glia.21116; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Ceballos A, 2009, ENDOCRINOLOGY, V150, P2491, DOI 10.1210/en.2008-1616; CONTEMPRE B, 1993, J CLIN ENDOCR METAB, V77, P1719, DOI 10.1210/jc.77.6.1719; DEESCOBAR GM, 1985, ENDOCRINOLOGY, V117, P1890, DOI 10.1210/endo-117-5-1890; Dumitrescu AM, 2006, ENDOCRINOLOGY, V147, P4036, DOI 10.1210/en.2006-0390; Dumitrescu AM, 2004, AM J HUM GENET, V74, P168, DOI 10.1086/380999; Ferrara AM, 2013, ENDOCRINOLOGY, V154, P2533, DOI 10.1210/en.2012-2031; Freitas BCG, 2010, J CLIN INVEST, V120, P2206, DOI 10.1172/JCI41977; Friesema ECH, 2004, LANCET, V364, P1435, DOI 10.1016/S0140-6736(04)17226-7; Friesema ECH, 2003, J BIOL CHEM, V278, P40128, DOI 10.1074/jbc.M300909200; Grijota-Martinez C, 2011, ENDOCRINOLOGY, V152, P1713, DOI 10.1210/en.2010-1014; GuadanoFerraz A, 1997, P NATL ACAD SCI USA, V94, P10391, DOI 10.1073/pnas.94.19.10391; Kinne A, 2010, J BIOL CHEM, V285, P28054, DOI 10.1074/jbc.M110.129577; Mayerl S, 2014, J CLIN INVE IN PRESS; Mayerl S, 2012, ENDOCRINOLOGY, V153, P1528, DOI 10.1210/en.2011-1633; Morte B, 2010, ENDOCRINOLOGY, V151, P2381, DOI 10.1210/en.2009-0944; Muller J, 2014, ENDOCRINOLOGY, V155, P315, DOI 10.1210/en.2013-1800; Nucera C, 2010, J CELL MOL MED, V14, P2417, DOI 10.1111/j.1582-4934.2009.00947.x; Roberts LM, 2008, ENDOCRINOLOGY, V149, P6251, DOI 10.1210/en.2008-0378; Saunders NR, 2000, CELL MOL NEUROBIOL, V20, P29, DOI 10.1023/A:1006991809927; Schwartz CE, 2005, AM J HUM GENET, V77, P41, DOI 10.1086/431313; Tohyama K, 2004, ENDOCRINOLOGY, V145, P4384, DOI 10.1210/en.2004-0058; Trajkovic M, 2007, J CLIN INVEST, V117, P627, DOI 10.1172/JCI28253; Visser WE, 2008, TRENDS ENDOCRIN MET, V19, P50, DOI 10.1016/j.tem.2007.11.003; Wirth EK, 2009, J NEUROSCI, V29, P9439, DOI 10.1523/JNEUROSCI.6055-08.2009; Zavacki AM, 2005, ENDOCRINOLOGY, V146, P1568, DOI 10.1210/en.2004-1392	33	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96915	10.1371/journal.pone.0096915	http://dx.doi.org/10.1371/journal.pone.0096915			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819605	Green Submitted, Green Published, gold			2022-12-27	WOS:000336653300048
J	Shearn, CT; Mercer, KE; Orlicky, DJ; Hennings, L; Smathers-McCullough, RL; Stiles, BL; Ronis, MJJ; Petersen, DR				Shearn, Colin T.; Mercer, Kelly E.; Orlicky, David J.; Hennings, Leah; Smathers-McCullough, Rebecca L.; Stiles, Bangyan L.; Ronis, Martin J. J.; Petersen, Dennis R.			Short Term Feeding of a High Fat Diet Exerts an Additive Effect on Hepatocellular Damage and Steatosis in Liver-Specific PTEN Knockout Mice	PLOS ONE			English	Article							HEPATIC GENE-EXPRESSION; LIPID-PEROXIDATION; TUMOR-SUPPRESSOR; NONALCOHOLIC STEATOHEPATITIS; DEFICIENT MICE; PHOSPHATASE; ETHANOL; METABOLISM; ACTIVATION; BINDING	Background: Hepatospecific deletion of PTEN results in constitutive activation of Akt and increased lipogenesis. In mice, the addition of a high fat diet (HFD) downregulates lipogenesis. The aim of this study was to determine the effects of a HFD on hepatocellular damage induced by deletion of PTEN. Methods: 12 Week old male flox/flox hepatospecific PTEN mice (PTENf/f) or Alb-Cre controls were fed a HFD composed of 45% fat-derived calories (from corn oil) or a normal chow. Animals were then analyzed for hepatocellular damage, oxidative stress and expression of enzymes involved in fatty acid metabolism. Results: In the Alb-Cre animals, the addition of a HFD resulted in a significant increase in liver triglycerides and altered REDOX capacity as evidenced by increased GPX activity, decreased GST activity and decreased hepatic concentrations of GSSG. In addition, SCD2, ACLY and FASN were all downregulated by the addition of HFD. Furthermore, expression of PPAR alpha and PPAR alpha-dependent proteins Cyp4a and ACSL1 were upregulated. In the PTENf/f mice, HFD resulted in significant increased in ALT, serum triglycerides and decreased REDOX capacity. Although expression of fatty acid synthetic enzymes was elevated in the chow fed PTENf/f group, the addition of HFD resulted in SCD2, ACLY and FASN downregulation. Compared to the Alb-Cre HFD group, expression of PGC1 alpha, PPARa and its downstream targets ACSL and Cyp4a were upregulated in PTENf/f mice. Conclusions: These data suggest that during conditions of constitutive Akt activation and increased steatosis, the addition of a HFD enhances hepatocellular damage due to increased CD36 expression and altered REDOX status. In addition, this work indicates HFD-induced hepatocellular damage occurs in part, independently of Akt signaling.	[Shearn, Colin T.; Petersen, Dennis R.] Univ Colorado, Dept Pharmaceut Sci, Aurora, CO USA; [Orlicky, David J.] Univ Colorado, Dept Pathol, Aurora, CO USA; [Mercer, Kelly E.; Hennings, Leah; Ronis, Martin J. J.] Univ Arkansas Med Sci, Arkansas Childrens Nutr Ctr, Little Rock, AR 72205 USA; [Ronis, Martin J. J.] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Smathers-McCullough, Rebecca L.] Cleveland Clin, Dept Pathobiol, Cleveland, OH 44106 USA; [Stiles, Bangyan L.] Univ So Calif, Dept Pharmaceut Sci, Los Angeles, CA USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; Cleveland Clinic Foundation; University of Southern California	Petersen, DR (corresponding author), Univ Colorado, Dept Pharmaceut Sci, Denver Anchutz Med Campus, Aurora, CO USA.	Dennis.Petersen@ucdenver.edu			National Institutes of Health/National Institutes of Alcoholism and Alcohol Abuse [5F32AA01861303 CTS, 5R37AA009300-18 DRP, 5R01DK074487-06 DRP]; NATIONAL CANCER INSTITUTE [R01CA154986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F32AA018613, R37AA009300] Funding Source: NIH RePORTER	National Institutes of Health/National Institutes of Alcoholism and Alcohol Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Studies were supported by the National Institutes of Health/National Institutes of Alcoholism and Alcohol Abuse under grant numbers 5F32AA01861303 CTS, 5R37AA009300-18 DRP, 5R01DK074487-06 DRP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basaranoglu M, 2013, WORLD J GASTROENTERO, V19, P1158, DOI 10.3748/wjg.v19.i8.1158; Chalasani N, 2004, AM J GASTROENTEROL, V99, P1497, DOI 10.1111/j.1572-0241.2004.30159.x; Chandran M, 2003, DIABETES CARE, V26, P2442, DOI 10.2337/diacare.26.8.2442; Derdak Z, 2013, J HEPATOL, V58, P785, DOI 10.1016/j.jhep.2012.11.042; Falcon A, 2010, AM J PHYSIOL-ENDOC M, V299, pE384, DOI 10.1152/ajpendo.00226.2010; Galicia VA, 2010, GASTROENTEROLOGY, V139, P2170, DOI 10.1053/j.gastro.2010.09.002; Galligan JJ, 2011, J PROTEOME RES, V10, P1837, DOI 10.1021/pr101101s; Go Young-Mi, 2008, V464, P303; Handa P, 2013, HEPTAOLOGY; Hardwick RN, 2010, DRUG METAB DISPOS, V38, P2293, DOI 10.1124/dmd.110.035006; HARTLEY DP, 1995, ARCH BIOCHEM BIOPHYS, V316, P197, DOI 10.1006/abbi.1995.1028; Hashizume H, 2007, EUR J GASTROEN HEPAT, V19, P827, DOI 10.1097/MEG.0b013e3282748ef2; He LN, 2010, AM J PATHOL, V176, P2302, DOI 10.2353/ajpath.2010.090931; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Ioannou GN, 2013, J LIPID RES, V54, P1326, DOI 10.1194/jlr.M034876; Jones DP, 2010, DIABETES OBES METAB, V12, P116, DOI 10.1111/j.1463-1326.2010.01266.x; Jones DP, 2008, AM J PHYSIOL-CELL PH, V295, pC849, DOI 10.1152/ajpcell.00283.2008; Jump DB, 2005, J NUTR, V135, P2503, DOI 10.1093/jn/135.11.2503; Leavens KF, 2009, CELL METAB, V10, P405, DOI 10.1016/j.cmet.2009.10.004; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Li Y, 2013, J BIOL CHEM, V288, P25007, DOI 10.1074/jbc.M113.450353; Liao Y, 2010, AM J TRANSL RES, V2, P19; Maehama T, 1999, TRENDS CELL BIOL, V9, P125, DOI 10.1016/S0962-8924(99)01519-6; Meuillet EJ, 2004, ARCH BIOCHEM BIOPHYS, V429, P123, DOI 10.1016/j.abb.2004.04.020; Miyazaki M, 2005, P NATL ACAD SCI USA, V102, P12501, DOI 10.1073/pnas.0503132102; Muir K, 2013, CANCER RES, V73, P4722, DOI 10.1158/0008-5472.CAN-12-3797; Nobili V, 2005, CLIN CHIM ACTA, V355, P105, DOI 10.1016/j.cccn.2004.12.022; Panchal SK, 2013, EUR J NUTR, V52, P559, DOI 10.1007/s00394-012-0358-9; Patsouris D, 2006, ENDOCRINOLOGY, V147, P1508, DOI 10.1210/en.2005-1132; Ren LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030816; Richardson MM, 2007, GASTROENTEROLOGY, V133, P80, DOI 10.1053/j.gastro.2007.05.012; Ronis MJJ, 2012, PHYSIOL GENOMICS, V44, P1073, DOI 10.1152/physiolgenomics.00069.2012; Ross SH, 2007, CELL SIGNAL; Sampey BP, 2003, ALCOHOL CLIN EXP RES, V27, P1015, DOI 10.1097/01.ALC.0000071928.16732.26; Sato W, 2006, HEPATOL RES, V34, P256, DOI 10.1016/j.hepres.2006.01.003; Seki S, 2002, J HEPATOL, V37, P56, DOI 10.1016/S0168-8278(02)00073-9; Shearn CT, 2013, FREE RADICAL BIO MED, V65, P680, DOI 10.1016/j.freeradbiomed.2013.07.011; Shearn CT, 2013, J NUTR BIOCHEM, V24, P1436, DOI 10.1016/j.jnutbio.2012.12.002; Shearn CT, 2011, MOL PHARMACOL, V79, P941, DOI 10.1124/mol.110.069534; Shearn CT, 2013, J NUTR BIOCH; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Shimomura I, 1998, J BIOL CHEM, V273, P35299, DOI 10.1074/jbc.273.52.35299; Sid B, 2013, BIOCHEM PHARMACOL, V86, P200, DOI 10.1016/j.bcp.2013.05.007; Smathers RL, 2011, CHEM-BIOL INTERACT, V192, P107, DOI 10.1016/j.cbi.2011.02.021; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Turner N, 2013, DIABETOLOGIA, V56, P1638, DOI 10.1007/s00125-013-2913-1; Watanabe S, 2005, HEPATOL RES, V33, P161, DOI 10.1016/j.hepres.2005.09.026; Watanabe S, 2007, J GASTROEN HEPATOL, V22, pS96, DOI 10.1111/j.1440-1746.2006.04665.x; Weltman MD, 1998, HEPATOLOGY, V27, P128, DOI 10.1002/hep.510270121; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Yimin H. F., 2011, LAB INVEST, V92, P265; You M, 2004, GASTROENTEROLOGY, V127, P1798, DOI 10.1053/j.gastro.2004.09.049; Yuan MS, 2012, J BIOL CHEM, V287, P29579, DOI 10.1074/jbc.M112.386854; Zeng N, 2011, MOL CANCER RES, V9, P1708, DOI 10.1158/1541-7786.MCR-11-0299	54	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96553	10.1371/journal.pone.0096553	http://dx.doi.org/10.1371/journal.pone.0096553			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24818992	gold, Green Published, Green Submitted			2022-12-27	WOS:000336653300021
J	Yu, G; Liu, Y; Thung, KH; Shen, D				Yu, Guan; Liu, Yufeng; Thung, Kim-Han; Shen, Dinggang			Multi-Task Linear Programming Discriminant Analysis for the Identification of Progressive MCI Individuals	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; CLASSIFICATION; BIOMARKERS; PREDICTION; ALGORITHM; SELECTION; PATTERNS; ATROPHY; MODEL	Accurately identifying mild cognitive impairment (MCI) individuals who will progress to Alzheimer's disease (AD) is very important for making early interventions. Many classification methods focus on integrating multiple imaging modalities such as magnetic resonance imaging (MRI) and fluorodeoxyglucose positron emission tomography (FDG-PET). However, the main challenge for MCI classification using multiple imaging modalities is the existence of a lot of missing data in many subjects. For example, in the Alzheimer's Disease Neuroimaging Initiative (ADNI) study, almost half of the subjects do not have PET images. In this paper, we propose a new and flexible binary classification method, namely Multi-task Linear Programming Discriminant (MLPD) analysis, for the incomplete multi-source feature learning. Specifically, we decompose the classification problem into different classification tasks, i.e., one for each combination of available data sources. To solve all different classification tasks jointly, our proposed MLPD method links them together by constraining them to achieve the similar estimated mean difference between the two classes (under classification) for those shared features. Compared with the state-of-the-art incomplete Multi-Source Feature (iMSF) learning method, instead of constraining different classification tasks to choose a common feature subset for those shared features, MLPD can flexibly and adaptively choose different feature subsets for different classification tasks. Furthermore, our proposed MLPD method can be efficiently implemented by linear programming. To validate our MLPD method, we perform experiments on the ADNI baseline dataset with the incomplete MRI and PET images from 167 progressive MCI (pMCI) subjects and 226 stable MCI (sMCI) subjects. We further compared our method with the iMSF method (using incomplete MRI and PET images) and also the single-task classification method (using only MRI or only subjects with both MRI and PET images). Experimental results show very promising performance of our proposed MLPD method.	[Yu, Guan; Liu, Yufeng] Univ N Carolina, Dept Stat & Operat Res, Chapel Hill, NC 27515 USA; [Liu, Yufeng] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Liu, Yufeng] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Thung, Kim-Han; Shen, Dinggang] Univ N Carolina, Dept Radiol, Chapel Hill, NC USA; [Thung, Kim-Han; Shen, Dinggang] Univ N Carolina, Biomed Res Imaging Ctr, Chapel Hill, NC USA; [Shen, Dinggang] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Korea University	Liu, Y (corresponding author), Univ N Carolina, Dept Stat & Operat Res, Chapel Hill, NC 27515 USA.	yfliu@email.unc.edu; dinggang_shen@med.unc.edu	Thung, Kim Han/B-3950-2009; Shen, Dinggang/ABF-6812-2020	Thung, Kim Han/0000-0003-1379-2185; Shen, Dinggang/0000-0002-7934-5698	National Institutes of Health (NIH) [AG041721, EB006733, EB008374, EB009634]; NIH/NCI [R01 CA-149569]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006733, R01EB009634, R01EB008374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG042599, R01AG041721] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health (NIH) grants AG041721, EB006733, EB008374, EB009634 and NIH/NCI grant R01 CA-149569 (http://grants.nih.gov/grants/oer.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain LJ, 2008, ALZHEIMERS DEMENT, V4, P443, DOI 10.1016/j.jalz.2008.08.006; Bi JB, 2008, LECT NOTES ARTIF INT, V5211, P117; Bickel PJ, 2004, BERNOULLI, V10, P989, DOI 10.3150/bj/1106314847; Boyd Stephen, 2010, Foundations and Trends in Machine Learning, V3, P1, DOI 10.1561/2200000016; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Cai JF, 2010, SIAM J OPTIMIZ, V20, P1956, DOI 10.1137/080738970; Cai T, 2011, J AM STAT ASSOC, V106, P1566, DOI 10.1198/jasa.2011.tm11199; Candes EJ, 2010, IEEE T INFORM THEORY, V56, P2053, DOI 10.1109/TIT.2010.2044061; DANTZIG GB, 1961, ECONOMETRICA, V29, P767, DOI 10.2307/1911818; Oliveira PPD, 2010, J ALZHEIMERS DIS, V19, P1263, DOI 10.3233/JAD-2010-1322; Du AT, 2007, BRAIN, V130, P1159, DOI 10.1093/brain/awm016; Fan JQ, 2008, ANN STAT, V36, P2605, DOI 10.1214/07-AOS504; Fan Y, 2008, NEUROIMAGE, V41, P277, DOI 10.1016/j.neuroimage.2008.02.043; Fan Y, 2008, NEUROIMAGE, V39, P1731, DOI 10.1016/j.neuroimage.2007.10.031; Fan Y, 2007, NEUROIMAGE, V36, P1189, DOI 10.1016/j.neuroimage.2007.04.009; Fjell AM, 2010, J NEUROSCI, V30, P2088, DOI 10.1523/JNEUROSCI.3785-09.2010; Grady CL, 2003, J NEUROSCI, V23, P986, DOI 10.1523/jneurosci.23-03-00986.2003; Grundman M, 2004, ARCH NEUROL-CHICAGO, V61, P59, DOI 10.1001/archneur.61.1.59; Hastie T, 1999, D91 SECURESCM; Hebert LE, 2001, ALZ DIS ASSOC DIS, V15, P169, DOI 10.1097/00002093-200110000-00002; Hinrichs C, 2009, NEUROIMAGE, V48, P138, DOI 10.1016/j.neuroimage.2009.05.056; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Lao ZQ, 2004, NEUROIMAGE, V21, P46, DOI 10.1016/j.neuroimage.2003.09.027; Li Y, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.11.008; Liu F, 2014, NEUROIMAGE, V84, P466, DOI 10.1016/j.neuroimage.2013.09.015; Liu MH, 2012, NEUROIMAGE, V60, P1106, DOI 10.1016/j.neuroimage.2012.01.055; MacDonald D.J., 1998, NEUROIMAGE, V7, pS717, DOI [10.1016/S1053-8119(18)31550-7, DOI 10.1016/S1053-8119(18)31550-7]; Machulda MM, 2009, J INT NEUROPSYCH SOC, V15, P372, DOI 10.1017/S1355617709090523; Magnin B, 2009, NEURORADIOLOGY, V51, P73, DOI 10.1007/s00234-008-0463-x; McEvoy LK, 2009, RADIOLOGY, V251, P195, DOI 10.1148/radiol.2511080924; Misra C, 2009, NEUROIMAGE, V44, P1415, DOI 10.1016/j.neuroimage.2008.10.031; Nestor PJ, 2004, NAT MED, V10, pS34, DOI 10.1038/nrn1433; Pihlajamiki M, 2008, FUTUR NEUROL, V3, P409, DOI 10.2217/14796708.3.4.409; Reiman EM, 2010, BIOMARK MED, V4, P3, DOI [10.2217/bmm.09.91, 10.2217/BMM.09.91]; Schott JM, 2010, NEUROBIOL AGING, V31, P1452, DOI 10.1016/j.neurobiolaging.2010.04.011; Shen DG, 2002, IEEE T MED IMAGING, V21, P1421, DOI 10.1109/TMI.2002.803111; Silveira Margarida, 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P2556, DOI 10.1109/ICPR.2010.626; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wang YP, 2011, LECT NOTES COMPUT SC, V6893, P635, DOI 10.1007/978-3-642-23626-6_78; Wee CY, 2012, NEUROIMAGE, V59, P2045, DOI 10.1016/j.neuroimage.2011.10.015; Wee CY, 2011, NEUROIMAGE, V54, P1812, DOI 10.1016/j.neuroimage.2010.10.026; Yang Xiaolin, 2009, ADV NEURAL INFORM PR, P2151; Ye J., 2008, P 14 ACM SIGKDD INT, P1025, DOI DOI 10.1145/1401890.1402012; Yuan L, 2012, NEUROIMAGE, V61, P622, DOI 10.1016/j.neuroimage.2012.03.059; Zhang DQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033182; Zhang DQ, 2012, NEUROIMAGE, V59, P895, DOI 10.1016/j.neuroimage.2011.09.069; Zhang DQ, 2011, NEUROIMAGE, V55, P856, DOI 10.1016/j.neuroimage.2011.01.008; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zhou L, 2011, PLOS ONE, V6	50	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96458	10.1371/journal.pone.0096458	http://dx.doi.org/10.1371/journal.pone.0096458			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24820966	Green Published, gold, Green Submitted			2022-12-27	WOS:000336653300017
J	Li, YC; Hsieh, CC				Li, Yi-Chieh; Hsieh, Chang-Chi			Lactoferrin Dampens High-Fructose Corn Syrup-Induced Hepatic Manifestations of the Metabolic Syndrome in a Murine Model	PLOS ONE			English	Article							FATTY LIVER; BOVINE LACTOFERRIN; INSULIN-RESISTANCE; PEPTIDES; REGION; ADIPONECTIN; BINDING; STEATOHEPATITIS; PATHOGENESIS; DEFENSE	Hepatic manifestations of the metabolic syndrome are related obesity, type 2 diabetes/insulin resistance and non-alcoholic fatty liver disease. Here we investigated how the anti-inflammatory properties of lactoferrin can protect against the onset of hepatic manifestations of the metabolic syndrome by using a murine model administered with high-fructose corn syrup. Our results show that a high-fructose diet stimulates intestinal bacterial overgrowth and increases intestinal permeability, leading to the introduction of endotoxin into blood circulation and liver. Immunohistochemical staining of Toll-like receptor-4 and thymic stromal lymphopoietin indicated that lactoferrin can modulate lipopolysaccharide-mediated inflammatory cascade. The important regulatory roles are played by adipokines including interleukin-1b, interleukin-6, tumor necrosis factor-a, monocyte chemotactic protein-1, and adiponectin, ultimately reducing hepatitis and decreasing serum alanine aminotransferase release. These beneficial effects of lactoferrin related to the downregulation of the lipopolysaccharide-induced inflammatory cascade in the liver. Furthermore, lactoferrin reduced serum and hepatic triglycerides to prevent lipid accumulation in the liver, and reduced lipid peroxidation, resulting in 4-hydroxynonenal accumulation. Lactoferrin reduced oral glucose tolerance test and homeostasis model assessment-insulin resistance. Lactoferrin administration thus significantly lowered liver weight, resulting from a decrease in the triglyceride and cholesterol synthesis that activates hepatic steatosis. Taken together, these results suggest that lactoferrin protected against high-fructose corn syrup induced hepatic manifestations of the metabolic syndrome.	[Li, Yi-Chieh; Hsieh, Chang-Chi] Tunghai Univ, Dept Anim Sci & Biotechnol, Taichung 40704, Taiwan	Tunghai University	Hsieh, CC (corresponding author), Tunghai Univ, Dept Anim Sci & Biotechnol, Taichung 40704, Taiwan.	cchsieh@thu.edu.tw		Hsieh, Chang-Chi/0000-0002-1905-3570	Ministry of Science and Technology, Taiwan, R.O.C. [NSC 99-2622-E-029-002-CC3, NSC 100-2221-E-029-004]	Ministry of Science and Technology, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	This work was supported, in whole or in part, by grants from the Ministry of Science and Technology, Taiwan, R.O.C. (NSC 99-2622-E-029-002-CC3, NSC 100-2221-E-029-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An L, 2012, ARCH TOXICOL, V86, P1337, DOI 10.1007/s00204-012-0814-6; Baeuerle PA, 1998, CURR BIOL, V8, pR19, DOI 10.1016/S0960-9822(98)70010-7; Baranova A, 2007, EXPERT REV MOL DIAGN, V7, P195, DOI 10.1586/14737159.7.2.195; Basciano Heather, 2005, Nutr Metab (Lond), V2, P5, DOI 10.1186/1743-7075-2-5; BECKNIELSEN H, 1980, AM J CLIN NUTR, V33, P273, DOI 10.1093/ajcn/33.2.273; BELLAMY W, 1992, J APPL BACTERIOL, V73, P472, DOI 10.1111/j.1365-2672.1992.tb05007.x; BLAKELY SR, 1981, J NUTR, V111, P307, DOI 10.1093/jn/111.2.307; Brock JH, 2002, BIOCHEM CELL BIOL, V80, P1, DOI 10.1139/o01-212; Castro GSF, 2011, ACTA CIR BRAS, V26, P45, DOI 10.1590/S0102-86502011000800009; Chapple DS, 2004, ANTIMICROB AGENTS CH, V48, P2190, DOI 10.1128/AAC.48.6.2190-2198.2004; Chapple DS, 1998, ADV EXP MED BIOL, V443, P215; Chapple DS, 1998, INFECT IMMUN, V66, P2434, DOI 10.1128/IAI.66.6.2434-2440.1998; COOK GC, 1969, CLIN SCI, V37, P675; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; ElassRochard E, 1995, BIOCHEM J, V312, P839, DOI 10.1042/bj3120839; ELLISON RT, 1988, INFECT IMMUN, V56, P2774, DOI 10.1128/IAI.56.11.2774-2781.1988; Farnaud S, 2004, FEMS MICROBIOL LETT, V238, P221, DOI 10.1016/j.femsle.2004.07.038; Feng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024358; Fernandez-Musoles R, 2014, J AGR FOOD CHEM, V62, P173, DOI 10.1021/jf404616f; Fiorini RN, 2004, CLIN TRANSPLANT, V18, P700, DOI 10.1111/j.1399-0012.2004.00282.x; Fischer R, 2007, INT IMMUNOPHARMACOL, V7, P1387, DOI 10.1016/j.intimp.2007.05.019; Haversen L, 2002, CELL IMMUNOL, V220, P83, DOI 10.1016/S0008-8749(03)00006-6; Hsieh CC, 2008, J ETHNOPHARMACOL, V119, P117, DOI 10.1016/j.jep.2008.06.002; Hsu CS, 2012, J FORMOS MED ASSOC, V111, P527, DOI 10.1016/j.jfma.2012.07.002; Ishimoto T, 2013, HEPATOLOGY, V58, P1632, DOI 10.1002/hep.26594; KEIDAR S, 1992, METABOLISM, V41, P1185, DOI 10.1016/0026-0495(92)90007-W; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MattsbyBaltzer I, 1996, PEDIATR RES, V40, P257, DOI 10.1203/00006450-199608000-00011; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Moreno-Navarrete JM, 2009, J CLIN ENDOCR METAB, V94, P4036, DOI 10.1210/jc.2009-0215; Morishita S, 2013, J OLEO SCI, V62, P97, DOI 10.5650/jos.62.97; Nseir W, 2010, WORLD J GASTROENTERO, V16, P2579, DOI 10.3748/wjg.v16.i21.2579; Ouchi N, 2000, CIRCULATION, V102, P1296, DOI 10.1161/01.CIR.102.11.1296; Ouchi N, 2003, CURR OPIN LIPIDOL, V14, P561, DOI 10.1097/00041433-200312000-00003; Petit JM, 2001, J HEPATOL, V35, P279, DOI 10.1016/S0168-8278(01)00143-X; Petschow BW, 1999, J MED MICROBIOL, V48, P541, DOI 10.1099/00222615-48-6-541; Puddu P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022504; Rutledge AC, 2007, NUTR REV, V65, pS13, DOI [10.1111/j.1753-4887.2007.tb00322.x, 10.1301/nr.2007.jun.S13-S23]; Rytila P, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-69; Saito T, 2007, INTERNAL MED, V46, P101, DOI 10.2169/internalmedicine.46.1784; Schuppan D, 2013, J GASTROEN HEPATOL, V28, P68, DOI 10.1111/jgh.12212; Sherman MP, 2004, BIOMETALS, V17, P285, DOI 10.1023/B:BIOM.0000027706.51112.62; Spahr L, 2001, J HEPATOL, V35, P308, DOI 10.1016/S0168-8278(01)00082-4; Spruss A, 2009, J NUTR BIOCHEM, V20, P657, DOI 10.1016/j.jnutbio.2009.05.006; Sullivan TJ, 2013, METABOLISM, V62, P1623, DOI 10.1016/j.metabol.2013.06.008; Takeuchi T, 2004, EXP PHYSIOL, V89, P263, DOI 10.1113/expphysiol.2003.026633; Takeuchi T, 2004, BRIT J NUTR, V91, P533, DOI 10.1079/BJN20041090; Valenti P, 2005, CELL MOL LIFE SCI, V62, P2576, DOI 10.1007/s00018-005-5372-0; Wanninger J, 2012, MOL CELL ENDOCRINOL, V349, P248, DOI 10.1016/j.mce.2011.10.032; Xu G, 2010, J APPL MICROBIOL, V109, P1311, DOI 10.1111/j.1365-2672.2010.04751.x; YAMAUCHI K, 1993, INFECT IMMUN, V61, P719, DOI 10.1128/IAI.61.2.719-728.1993; Yang JP, 2013, INT J MOL MED, V31, P1429, DOI 10.3892/ijmm.2013.1350	53	14	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97341	10.1371/journal.pone.0097341	http://dx.doi.org/10.1371/journal.pone.0097341			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816278	Green Published, gold, Green Submitted			2022-12-27	WOS:000336838000131
J	Evans, A; Caudarella, A; Ratnapalan, S; Chan, K				Evans, Andrea; Caudarella, Alexander; Ratnapalan, Savithiri; Chan, Kevin			The Cost and Impact of the Interim Federal Health Program Cuts on Child Refugees in Canada	PLOS ONE			English	Article							IMMIGRANT POPULATION; CARE	Introduction: On June 30, 2012, Interim Federal Health Program (IFHP) funding was cut for refugee claimant healthcare. The potential financial and healthcare impacts of these cuts on refugee claimants are unknown. Methods: We conducted a one-year retrospective chart review spanning 6 months before and after IFHP funding cuts at The Hospital for Sick Children, a tertiary care children's hospital in Toronto. We analyzed emergency room visits characteristics, admission rates, reasons for admission, and financial records including billing from Medavie Blue Cross. Results: There were 173 refugee children visits to the emergency room in the six months before and 142 visits in the six months after funding cuts. The total amount billed to the IFHP program during the one-year of this study was $131,615. Prior to the IFHP cuts, 46% of the total emergency room bills were paid by IFHP compared to 7% after the cuts (p<0.001). Interpretation: After the cuts to the IFHP, The Hospital for Sick Children was unable to obtain federal health coverage for the vast majority of refugee claimant children registered under the IFHP. This preliminary analysis showed that post-IFHP cuts healthcare costs at the largest tertiary pediatric institution in the country increased.	[Evans, Andrea; Ratnapalan, Savithiri] Univ Toronto, Hosp Sick Children, Dept Paediat, Toronto, ON M5G 1X8, Canada; [Caudarella, Alexander] Univ Toronto, St Michaels Hosp, Dept Family Med, Toronto, ON, Canada; [Ratnapalan, Savithiri] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Chan, Kevin] Mem Univ Newfoundland, Dept Paediat, Eastern Hlth, St John, NF, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Memorial University Newfoundland	Chan, K (corresponding author), Mem Univ Newfoundland, Dept Paediat, Eastern Hlth, St John, NF, Canada.	kevin.chan@easternhealth.ca						Arya N, 2012, CAN MED ASSOC J, V184, P1875, DOI 10.1503/cmaj.120938; Barnes S, 2013, REAL COST CUTTING RE; Beiser M, 2005, CAN J PUBLIC HEALTH, V96, pS30, DOI 10.1007/BF03403701; Canadian Medical Association, 2013, HLTH GEN PROSP EC 20; Caulford P, 2006, CAN MED ASSOC J, V174, P1253, DOI 10.1503/cmaj.051206; Citizenship and Immigration. Government of Canada, 2013, FACTS FIG; DesMeules Marie, 2005, J Immigr Health, V7, P221, DOI 10.1007/s10903-005-5118-y; Government of Canada, 2012, BACKGR DES COUNTR OR; Government of Canada Citizenship and Immigration Canada, 2012, INT FED HLTH PROGR S; Government of Canada Citizenship and Immigration Canada, 2012, PERM RES CAT 2008 20; Government of Canada Department of Justice, 2012, SI201226 GOV CAN DEP; Human Rights Research Education Centre, 2012, IRB REF STAT DET; Kirmayer LJ, 2011, CAN MED ASSOC J, V183, pE959, DOI 10.1503/cmaj.090292; Newbold B, 2009, ETHNIC HEALTH, V14, P315, DOI 10.1080/13557850802609956; Newbold KB, 2009, INT J HEALTH SERV, V39, P545, DOI 10.2190/HS.39.3.g; Newbold KB, 2003, SOC SCI MED, V57, P1981, DOI 10.1016/S0277-9536(03)00064-9; Sanmartin Claudia, 2006, Healthc Policy, V1, P103; Sullivan P, 2013, 8 GROUPS ONE MESSAGE; ter Kuile S, 2007, INT J MIGR HEALTH SO, V3, P15, DOI 10.1108/17479894200700003; UNHCR, 1951, CONV PROT REL STAT R	20	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96902	10.1371/journal.pone.0096902	http://dx.doi.org/10.1371/journal.pone.0096902			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809676	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000338213300085
J	Rotili, D; Tarantino, D; Marrocco, B; Gros, C; Masson, V; Poughon, V; Ausseil, F; Chang, YQ; Labella, D; Cosconati, S; Di Maro, S; Novellino, E; Schnekenburger, M; Grandjenette, C; Bouvy, C; Diederich, M; Cheng, XD; Arimondo, PB; Mai, A				Rotili, Dante; Tarantino, Domenico; Marrocco, Biagina; Gros, Christina; Masson, Veronique; Poughon, Valerie; Ausseil, Frederic; Chang, Yanqi; Labella, Donatella; Cosconati, Sandro; Di Maro, Salvatore; Novellino, Ettore; Schnekenburger, Michael; Grandjenette, Cindy; Bouvy, Celine; Diederich, Marc; Cheng, Xiaodong; Arimondo, Paola B.; Mai, Antonello			Properly Substituted Analogues of BIX-01294 Lose Inhibition of G9a Histone Methyltransferase and Gain Selective Anti-DNA Methyltransferase 3A Activity	PLOS ONE			English	Article							CHROMATIN-MODIFYING AGENTS; HISTONE/PROTEIN METHYLTRANSFERASE; THERAPEUTIC APPLICATIONS; METHYLATION; CANCER; IDENTIFICATION; LEUKEMIA; DESIGN; CELLS	Chemical manipulations performed on the histone H3 lysine 9 methyltransferases (G9a/GLP) inhibitor BIX-01294 afforded novel desmethoxyquinazolines able to inhibit the DNA methyltransferase DNMT3A at low micromolar levels without any significant inhibition of DNMT1 and G9a. In KG-1 cells such compounds, when tested at sub-toxic doses, induced the luciferase re-expression in a stable construct controlled by a cytomegalovirus (CMV) promoter silenced by methylation (CMV-luc assay). Finally, in human lymphoma U-937 and RAJI cells, the N-(1-benzylpiperidin-4-yl)-2-(4-phenylpiperazin-1-yl) quinazolin-4-amine induced the highest proliferation arrest and cell death induction starting from 10 mu M, in agreement with its DNMT3A inhibitory potency.	[Rotili, Dante; Tarantino, Domenico; Marrocco, Biagina; Labella, Donatella; Mai, Antonello] Univ Roma La Sapienza, Dipartimento Chim & Tecnol Farmaco, I-00185 Rome, IT, Italy; [Gros, Christina; Masson, Veronique; Poughon, Valerie; Ausseil, Frederic; Arimondo, Paola B.] CRDPF, CNRS, Pierre Fabre ETaC, USR3388, Toulouse, France; [Chang, Yanqi; Cheng, Xiaodong] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Cosconati, Sandro] Seconda Univ Napoli, DiSTABiF, Caserta, Italy; [Di Maro, Salvatore; Novellino, Ettore] Univ Naples Federico II, Dipartimento Farm, Naples, Italy; [Schnekenburger, Michael; Grandjenette, Cindy; Bouvy, Celine; Diederich, Marc] LBMCC, Luxembourg, Luxembourg; [Diederich, Marc] Seoul Natl Univ, Coll Pharm, Dept Pharm, Seoul, South Korea; [Mai, Antonello] Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, IT, Italy	Sapienza University Rome; Centre National de la Recherche Scientifique (CNRS); Emory University; Universita della Campania Vanvitelli; University of Naples Federico II; Seoul National University (SNU); Fondazione Cenci Bolognetti; Sapienza University Rome	Mai, A (corresponding author), Univ Roma La Sapienza, Dipartimento Chim & Tecnol Farmaco, Piazzale Aldo Moro 5, I-00185 Rome, IT, Italy.	antonello.mai@uniroma1.it	Cosconati, Sandro/A-8678-2019; Schnekenburger, Michael/I-4647-2012; Diederich, Marc/O-7335-2015; Rotili, Dante/J-9157-2016; Grandjenette, Cindy/C-9732-2019; Mai, Antonello/AAC-2144-2019; Arimondo, Paola B/R-9095-2017	Cosconati, Sandro/0000-0002-8900-0968; Schnekenburger, Michael/0000-0003-0550-9538; Diederich, Marc/0000-0003-0115-4725; Arimondo, Paola B/0000-0001-5175-4396; Novellino, Ettore/0000-0002-2181-2142; Di Maro, Salvatore/0000-0002-9286-4433; Mai, Antonello/0000-0001-9176-2382; Rotili, Dante/0000-0002-8428-8763; Jacob (Gros), Christina/0000-0001-8869-9028	PRIN [2009PX2T2E]; FIRB [RBFR10ZJQT]; Progetto Ateneo Sapienza; Progetto IIT-Sapienza; U.S. National Institutes of Health [5R01GM049245-20, 1DP3DK094346-01]; FNRS Televie Luxembourg grant [7.4612.12.F]; Recherche Cancer et Sang foundation; Recherches Scientifiques Luxembourg association; Een Haerz fir Kriibskrank Kanner association; ATIP CNRS; Region Midi-Pyrenees (Equipe d'Excellence); Region Midi-Pyrenees (FEDER); "Waxweiler grant for cancer prevention research" from the Action Lions "Vaincre le Cancer"; Fondation de la Recherche Medicale; FNRS Televie Luxembourg; NRF by the MEST of Korea [GCRC 2012-0001184];  [BLUEPRINT/282510];  [COST/TD0905]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK094346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049245] Funding Source: NIH RePORTER	PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Progetto Ateneo Sapienza; Progetto IIT-Sapienza; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FNRS Televie Luxembourg grant; Recherche Cancer et Sang foundation; Recherches Scientifiques Luxembourg association; Een Haerz fir Kriibskrank Kanner association; ATIP CNRS(Centre National de la Recherche Scientifique (CNRS)); Region Midi-Pyrenees (Equipe d'Excellence)(Region Occitanie); Region Midi-Pyrenees (FEDER)(Region Occitanie); "Waxweiler grant for cancer prevention research" from the Action Lions "Vaincre le Cancer"; Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); FNRS Televie Luxembourg; NRF by the MEST of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by PRIN 2009PX2T2E, FIRB RBFR10ZJQT, Progetto Ateneo Sapienza 2012, Progetto IIT-Sapienza, FP7 Projects BLUEPRINT/282510 and COST/TD0905, the U.S. National Institutes of Health (5R01GM049245-20 and 1DP3DK094346-01), the FNRS Televie Luxembourg grant 7.4612.12.F, the Recherche Cancer et Sang foundation, and the "Recherches Scientifiques Luxembourg and "Een Haerz fir Kriibskrank Kanner associations. X. Cheng is a Georgia Research Alliance Eminent Scholar. P. B. Arimondo is supported by ATIP CNRS and Region Midi-Pyrenees (Equipe d'Excellence and FEDER). M. Schnekenburger is supported by a "Waxweiler grant for cancer prevention research" from the Action Lions "Vaincre le Cancer". C. Gros is supported by Fondation de la Recherche Medicale. C. Grandjenette is a recipient of a postdoctoral grant from FNRS Televie Luxembourg. M. Diederich is supported by the NRF by the MEST of Korea for Tumor Microenvironment GCRC 2012-0001184 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, GLID; [Anonymous], 2009, EPIK VERS 2 0; Castellano S, 2010, CHEMMEDCHEM, V5, P398, DOI 10.1002/cmdc.200900459; Ceccaldi A, 2013, ACS CHEM BIOL, V8, P543, DOI 10.1021/cb300565z; Ceccaldi A, 2011, CHEMBIOCHEM, V12, P1337, DOI 10.1002/cbic.201100130; Chang YQ, 2010, J MOL BIOL, V400, P1, DOI 10.1016/j.jmb.2010.04.048; Chang YQ, 2009, NAT STRUCT MOL BIOL, V16, P312, DOI 10.1038/nsmb.1560; Cheng DH, 2011, J MED CHEM, V54, P4928, DOI 10.1021/jm200453n; Datta J, 2009, CANCER RES, V69, P4277, DOI 10.1158/0008-5472.CAN-08-3669; DERUITER J, 1986, J MED CHEM, V29, P627, DOI 10.1021/jm00155a007; Florean C, 2011, EPIGENOMICS-UK, V3, P581, DOI [10.2217/EPI.11.73, 10.2217/epi.11.73]; Gros C, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt753; Gros C, 2012, BIOCHIMIE, V94, P2280, DOI 10.1016/j.biochi.2012.07.025; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Lee BH, 2005, J BIOL CHEM, V280, P40749, DOI 10.1074/jbc.M505593200; Mai A, 2008, J MED CHEM, V51, P2279, DOI 10.1021/jm701595q; Mai A, 2007, CHEMMEDCHEM, V2, P987, DOI 10.1002/cmdc.200700023; Mai A, 2010, EPIGENOMICS-UK, V2, P307, DOI [10.2217/epi.10.7, 10.2217/EPI.10.7]; Mai A, 2009, INT J BIOCHEM CELL B, V41, P199, DOI 10.1016/j.biocel.2008.08.020; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ragno R, 2007, J MED CHEM, V50, P1241, DOI 10.1021/jm061213n; Seidel C, 2012, BIOCHIMIE, V94, P2264, DOI 10.1016/j.biochi.2012.05.012; Upadhyay AK, 2012, J MOL BIOL, V416, P319, DOI 10.1016/j.jmb.2011.12.036; Valente S, 2014, J MED CHEM, V57, P701, DOI 10.1021/jm4012627; Valente S, 2012, BIOCHIMIE, V94, P2308, DOI 10.1016/j.biochi.2012.06.003; Vedadi M, 2011, NAT CHEM BIOL, V7, P566, DOI [10.1038/NCHEMBIO.599, 10.1038/nchembio.599]; Yoo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062152; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008	29	28	29	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96941	10.1371/journal.pone.0096941	http://dx.doi.org/10.1371/journal.pone.0096941			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810902	Green Published, Green Submitted, gold			2022-12-27	WOS:000338213300096
J	Stanley, RM; Ridley, K; Olds, TS; Dollman, J				Stanley, Rebecca M.; Ridley, Kate; Olds, Timothy S.; Dollman, James			Increasing Specificity of Correlate Research: Exploring Correlates of Children's Lunchtime and After-School Physical Activity	PLOS ONE			English	Article							SEDENTARY BEHAVIORS; SELF-DETERMINATION; MISSING DATA; TIME; RECESS; DETERMINANTS; EDUCATION; YOUTH; ACCELEROMETER; PARTICIPATION	Background: The lunchtime and after-school contexts are critical windows in a school day for children to be physically active. While numerous studies have investigated correlates of children's habitual physical activity, few have explored correlates of physical activity occurring at lunchtime and after-school from a social-ecological perspective. Exploring correlates that influence physical activity occurring in specific contexts can potentially improve the prediction and understanding of physical activity. Using a context-specific approach, this study investigated correlates of children's lunchtime and after-school physical activity. Methods: Cross-sectional data were collected from 423 South Australian children aged 10.0-13.9 years (200 boys; 223 girls) attending 10 different schools. Lunchtime and after-school physical activity was assessed using accelerometers. Correlates were assessed using purposely developed context-specific questionnaires. Correlated Component Regression analysis was conducted to derive correlates of context-specific physical activity and determine the variance explained by prediction equations. Results: The model of boys' lunchtime physical activity contained 6 correlates and explained 25% of the variance. For girls, the model explained 17% variance from 9 correlates. Enjoyment of walking during lunchtime was the strongest correlate for both boys and girls. Boys' and girls' after-school physical activity models explained 20% variance from 14 correlates and 7% variance from the single item correlate, "I do an organised sport or activity after-school because it gets you fit'', respectively. Conclusions: Increasing specificity of correlate research has enabled the identification of unique features of, and a more indepth interpretation of, lunchtime and after-school physical activity behaviour and is a potential strategy for advancing the physical activity correlate research field. The findings of this study could be used to inform and tailor gender-specific public health messages and interventions for promoting lunchtime and after-school physical activity in children.	[Stanley, Rebecca M.; Dollman, James] Univ S Australia, Sch Hlth Sci, Exercise Hlth & Human Performance Grp, Adelaide, SA 5001, Australia; [Ridley, Kate] Flinders Univ S Australia, Sch Educ, Sport Hlth & Phys Educ Grp, Adelaide, SA 5001, Australia; [Olds, Timothy S.] Univ S Australia, Sch Hlth Sci, Hlth & Use Time Grp, Adelaide, SA 5001, Australia	University of South Australia; Flinders University South Australia; University of South Australia	Stanley, RM (corresponding author), Univ S Australia, Sch Hlth Sci, Exercise Hlth & Human Performance Grp, Adelaide, SA 5001, Australia.	rebecca.stanley@mymail.unisa.edu.au	Stanley, Rebecca M/P-6720-2016; Olds, Tim/A-1223-2008; Dollman, James/A-5277-2010	Stanley, Rebecca M/0000-0001-7007-3406; Olds, Tim/0000-0001-6894-5519; Dollman, James/0000-0002-6427-2115; Ridley, Kate/0000-0001-6260-2347	University of South Australia; Australian Postgraduate Award Scholarship; University of South Australia Top Up Scholarship	University of South Australia; Australian Postgraduate Award Scholarship; University of South Australia Top Up Scholarship	Rebecca Stanley acknowledges the support from University of South Australia for providing the resources necessary to complete this study. This work was conducted during a PhD candidature in which Rebecca was supported by an Australian Postgraduate Award Scholarship and a University of South Australia Top Up Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzen I., 1985, ACTION CONTROL, P11, DOI DOI 10.1007/978-3-642-69746-3_2; Andridge RR, 2010, INT STAT REV, V78, P40, DOI 10.1111/j.1751-5823.2010.00103.x; Atkin AJ, 2011, INT J BEHAV MED, V18, P176, DOI 10.1007/s12529-010-9111-z; Australian Bureau of Statistics, 2006, INF PAP INTR SOC IND; Baranowski T, 1998, AM J PREV MED, V15, P266, DOI 10.1016/S0749-3797(98)00080-4; Barr-Anderson DJ, 2008, RES Q EXERCISE SPORT, V79, P18, DOI 10.5641/193250308X13086753542735; Bauman AE, 2002, AM J PREV MED, V23, P5, DOI 10.1016/S0749-3797(02)00469-5; Beets MW, 2013, HEALTH EDUC BEHAV, V40, P296, DOI 10.1177/1090198112459051; Biddle SJH, 2004, J R SOC PROMO HEALTH, V124, P29, DOI 10.1177/146642400312400110; Black J.T, 1992, MULTIVARIATE DATA AN; Brockman R, 2010, PREV MED, V51, P144, DOI 10.1016/j.ypmed.2010.05.012; Brodersen NH, 2005, ANN BEHAV MED, V29, P2, DOI 10.1207/s15324796abm2901_2; Bronfenbrenner U., 1994, INT ENCY ED; Burdette HL, 2004, ARCH PEDIAT ADOL MED, V158, P353, DOI 10.1001/archpedi.158.4.353; Centers for Disease Control and Prevention, 2010, CDC TABL CALC BOD MA; de Vries SI, 2006, J CLIN EPIDEMIOL, V59, P670, DOI 10.1016/j.jclinepi.2005.11.020; DISHMAN RK, 1992, MED SCI SPORT EXER, V24, P904; Dishman RK, 2010, J PEDIATR PSYCHOL, V35, P188, DOI 10.1093/jpepsy/jsp042; Epstein LH, 1996, MED SCI SPORT EXER, V28, P1157, DOI 10.1097/00005768-199609000-00012; Esliger DW, 2005, J PHYS ACTIVITY HLTH, V3, P366, DOI DOI 10.1186/1479-5868-8-62; Fox-Wasylyshyn SM, 2005, RES NURS HEALTH, V28, P488, DOI 10.1002/nur.20100; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Giles-Corti B, 2005, EXERC SPORT SCI REV, V33, P175, DOI 10.1097/00003677-200510000-00005; Hagger MS, 2003, J EDUC PSYCHOL, V95, P784, DOI 10.1037/0022-0663.95.4.784; Hawthorne G, 2005, AUST NZ J PSYCHIAT, V39, P583, DOI 10.1080/j.1440-1614.2005.01630.x; Hohepa M, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-54; Humpel N, 2004, AM J HEALTH PROMOT, V18, P239, DOI 10.4278/0890-1171-18.3.239; Katzmarzyk PT, 1998, PEDIATR EXERC SCI, V10, P378, DOI 10.1123/pes.10.4.378; Lewis N, 2006, THESIS U S AUSTR ADE; Lubans DR, 2012, HEALTH EDUC RES, V27, P115, DOI 10.1093/her/cyr039; Magidson J, 2010, CORRELATED COMPONENT, P1; Marfell-Jones M, 2006, INT STANDARDS ANTHRO; Mark AE, 2008, J PUBLIC HEALTH-UK, V30, P153, DOI 10.1093/pubmed/fdn022; Masse LC, 2005, MED SCI SPORT EXER, V37, pS544, DOI 10.1249/01.mss.0000185674.09066.8a; Mathews L, 2008, NUTR PHYS ACTIVITY C; MCCULLAGH P, 1993, PEDIATR EXERC SCI, V5, P224; McKenzie TL, 1997, RES Q EXERCISE SPORT, V68, P195, DOI 10.1080/02701367.1997.10607998; Mota J, 2005, J SPORT SCI, V23, P269, DOI 10.1080/02640410410001730124; Mota J, 2003, AM J HUM BIOL, V15, P547, DOI 10.1002/ajhb.10163; Okely AD, 2001, MED SCI SPORT EXER, V33, P1899, DOI 10.1097/00005768-200111000-00015; Ommundsen Y, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-32; Parrish A, 2009, BRIT J SCH NURSING, V4, P6, DOI DOI 10.12968/BJSN.2009.4.1.39188; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Portney LG, 2000, FDN CLIN RES APPL PR, V2; Ridgers ND, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-74; Ridgers ND, 2012, BRIT J SPORT MED, V46, P741, DOI 10.1136/bjsm.2011.084921; Robusto KM, 2012, J SPORT SCI, V30, P1429, DOI 10.1080/02640414.2012.710761; Rodger S., 2006, OCCUPATIONAL THERAPY; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Sallis JF, 2001, AM J PUBLIC HEALTH, V91, P618, DOI 10.2105/AJPH.91.4.618; Sallis JF, 2008, HLTH BEHAV HLTH ED T, V260, P465; Sardinha LB, 2008, DIABETES CARE, V31, P569, DOI 10.2337/dc07-1286; Shen B, 2007, RES Q EXERCISE SPORT, V78, P328, DOI 10.5641/193250307X13082505158101; Smith A., 2008, YOUTH PHYS ACTIVITY; Spence JC, 2003, PSYCHOL SPORT EXERC, V4, P7, DOI 10.1016/S1469-0292(02)00014-6; Standage M, 2006, RES Q EXERCISE SPORT, V77, P100, DOI 10.5641/027013606X13080769704046; Stanley RM, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-50; Stanley RM, 2012, J SCI MED SPORT, V15, P44, DOI 10.1016/j.jsams.2011.08.002; Stanley RM, 2013, J PHYS ACT HEALTH, V10, P33, DOI 10.1123/jpah.10.1.33; Stellino MB, 2010, J SCHOOL HEALTH, V80, P436, DOI 10.1111/j.1746-1561.2010.00525.x; Stratton G, 2005, PREV MED, V41, P828, DOI 10.1016/j.ypmed.2005.07.009; Thompson AM, 2003, MED SCI SPORT EXER, V35, P1684, DOI 10.1249/01.MSS.0000089244.44914.1F; Trost SG, 1998, MED SCI SPORT EXER, V30, P629, DOI 10.1097/00005768-199804000-00023; Trost SG, 2002, J ADOLESCENT HEALTH, V31, P226, DOI 10.1016/S1054-139X(02)00375-0; Trost SG, 1996, J SCHOOL HEALTH, V66, P145; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; Tudor-Locke C, 2006, MED SCI SPORT EXER, V38, P1732, DOI 10.1249/01.mss.0000230212.55119.98; Veitch J, 2006, CHILDRENS ADOLESCENT; Verstraete SJM, 2006, EUR J PUBLIC HEALTH, V16, P415, DOI 10.1093/eurpub/ckl008; Wechsler H, 2000, PREV MED, V31, pS121, DOI 10.1006/pmed.2000.0649; Weisner Kristie K, 2002, N C Med J, V63, P308; Willenberg LJ, 2010, J SCI MED SPORT, V13, P210, DOI 10.1016/j.jsams.2009.02.011	72	9	9	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96460	10.1371/journal.pone.0096460	http://dx.doi.org/10.1371/journal.pone.0096460			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK1XT	24809440	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000338213300042
J	Villasenor, NR; Driscoll, DA; Escobar, MAH; Gibbons, P; Lindenmayer, DB				Villasenor, Nelida R.; Driscoll, Don A.; Escobar, Martin A. H.; Gibbons, Philip; Lindenmayer, David B.			Urbanization Impacts on Mammals across Urban-Forest Edges and a Predictive Model of Edge Effects	PLOS ONE			English	Article							POSSUMS TRICHOSURUS-VULPECULA; NEW-SOUTH-WALES; ARBOREAL MARSUPIALS; FRAGMENTED LANDSCAPES; HABITAT EDGES; RESPONSES; AUSTRALIA; DYNAMICS; SCALE; CONSERVATION	With accelerating rates of urbanization worldwide, a better understanding of ecological processes at the wildland-urban interface is critical to conserve biodiversity. We explored the effects of high and low-density housing developments on forest-dwelling mammals. Based on habitat characteristics, we expected a gradual decline in species abundance across forest-urban edges and an increased decline rate in higher contrast edges. We surveyed arboreal mammals in sites of high and low housing density along 600 m transects that spanned urban areas and areas turn on adjacent native forest. We also surveyed forest controls to test whether edge effects extended beyond our edge transects. We fitted models describing richness, total abundance and individual species abundance. Low-density housing developments provided suitable habitat for most arboreal mammals. In contrast, high-density housing developments had lower species richness, total abundance and individual species abundance, but supported the highest abundances of an urban adapter (Trichosurus vulpecula). We did not find the predicted gradual decline in species abundance. Of four species analysed, three exhibited no response to the proximity of urban boundaries, but spilled over into adjacent urban habitat to differing extents. One species (Petaurus australis) had an extended negative response to urban boundaries, suggesting that urban development has impacts beyond 300 m into adjacent forest. Our empirical work demonstrates that high-density housing developments have negative effects on both community and species level responses, except for one urban adapter. We developed a new predictive model of edge effects based on our results and the literature. To predict animal responses across edges, our framework integrates for first time: (1) habitat quality/preference, (2) species response with the proximity to the adjacent habitat, and (3) spillover extent/sensitivity to adjacent habitat boundaries. This framework will allow scientists, managers and planners better understand and predict both species responses across edges and impacts of development in mosaic landscapes.	[Villasenor, Nelida R.; Driscoll, Don A.; Gibbons, Philip; Lindenmayer, David B.] Australian Natl Univ, Fenner Sch Environm & Soc, NERP Environm Decis Hub, ARC Ctr Excellence Environm Decis, Canberra, ACT, Australia; [Escobar, Martin A. H.] Univ Chile, Sch Nat Resources, Santiago, Chile	Australian National University; Universidad de Chile	Villasenor, NR (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, NERP Environm Decis Hub, ARC Ctr Excellence Environm Decis, Canberra, ACT, Australia.	nelida.villasenor@anu.edu.au	Lindenmayer, David B/P-7183-2017; Villasenor, Nelida/E-8820-2014; Driscoll, Don/I-1703-2013; Gibbons, Philip/I-8248-2012	Lindenmayer, David B/0000-0002-4766-4088; Villasenor, Nelida/0000-0001-8624-4484; Driscoll, Don/0000-0002-1560-5235	BECAS CHILE-CONICYT; Government of Chile	BECAS CHILE-CONICYT; Government of Chile	NRV was supported by BECAS CHILE-CONICYT granted by the Government of Chile during her PhD studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong K.N., 2008, MAMMALS AUSTR, P470; Bates D, 2013, IME4 LINEAR MIXED EF; Biamonte E, 2011, LANDSCAPE ECOL, V26, P183, DOI 10.1007/s10980-010-9564-0; Blewett CM, 2005, CONDOR, V107, P678, DOI 10.1650/0010-5422(2005)107[0678:EOUSOS]2.0.CO;2; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brearley G, 2010, BIOL CONSERV, V143, P60, DOI 10.1016/j.biocon.2009.09.003; Bureau of Meteorology, 2013, ANN CLIM SUMM NEW S; Catling PC, 1997, WILDLIFE RES, V24, P417, DOI 10.1071/WR96073; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Collinge SK, 2002, LANDSCAPE ECOL, V17, P647, DOI 10.1023/A:1021536302195; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Downie IS, 1996, ECOGRAPHY, V19, P29, DOI 10.1111/j.1600-0587.1996.tb00152.x; DUELLI P, 1990, BIOL CONSERV, V54, P193, DOI 10.1016/0006-3207(90)90051-P; Emery K., 2010, NSW LAND USE MAPPING; Ewers RM, 2008, P NATL ACAD SCI USA, V105, P5426, DOI 10.1073/pnas.0800460105; Eymann Jutta, 2006, Australian Mammalogy, V28, P153; Eyre TJ, 1997, FOREST ECOL MANAG, V98, P281, DOI 10.1016/S0378-1127(97)00111-4; Fletcher RJ, 2003, AUK, V120, P799, DOI 10.1642/0004-8038(2003)120[0799:SROBDO]2.0.CO;2; FLOYD DA, 1987, J ECOL, V75, P221, DOI 10.2307/2260547; Fonderflick J, 2013, OIKOS, V122, P42, DOI 10.1111/j.1600-0706.2012.20308.x; Fontana CS, 2011, URBAN ECOSYST, V14, P341, DOI 10.1007/s11252-011-0156-9; Forman R., 2014, ECOLOGICAL DESIGN PL, P217; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Fuller Todd K., 2010, P13; Gibbons P., 2002, TREE HOLLOWS WILDLIF, DOI [10.1071/9780643090033, DOI 10.1071/9780643090033]; Harding EK, 2006, WILDLIFE RES, V33, P121, DOI 10.1071/WR04059; Harper KA, 2005, CONSERV BIOL, V19, P768, DOI 10.1111/j.1523-1739.2005.00045.x; Harper MJ, 2005, WILDLIFE RES, V32, P681, DOI 10.1071/WR04072; Hennings LA, 2003, CONDOR, V105, P288, DOI 10.1650/0010-5422(2003)105[0288:RBCSIP]2.0.CO;2; Hodgson P, 2007, LANDSCAPE URBAN PLAN, V79, P266, DOI 10.1016/j.landurbplan.2006.02.012; Ikin K, 2014, OECOLOGIA, V174, P545, DOI 10.1007/s00442-013-2793-6; Jokimaki J, 2003, J BIOGEOGR, V30, P1183, DOI 10.1046/j.1365-2699.2003.00896.x; Laurance WF, 1996, BIOTROPICA, V28, P310, DOI 10.2307/2389195; Laurance WF, 2008, CONSERV BIOL, V22, P1154, DOI 10.1111/j.1523-1739.2008.00981.x; Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Lidicker William Z. Jr., 1996, P85; Lidicker WZ, 1999, LANDSCAPE ECOL, V14, P333, DOI 10.1023/A:1008056817939; Lin BB, 2013, J APPL ECOL, V50, P1161, DOI 10.1111/1365-2664.12118; Lindenmayer DB, 2008, AUST J ZOOL, V56, P1, DOI 10.1071/ZO08054; Lindenmayer DB, 1999, ECOL APPL, V9, P594, DOI 10.1890/1051-0761(1999)009[0594:TROAMT]2.0.CO;2; Lindenmayer DB, 2000, J MAMMAL, V81, P787, DOI 10.1644/1545-1542(2000)081<0787:HFLCAM>2.3.CO;2; Lizee MH, 2011, ECOL INDIC, V11, P353, DOI 10.1016/j.ecolind.2010.06.003; Maindonald J, 2010, DATA ANAL GRAPHICS U; Mazerolle M. C., 2013, AICCMODAVG MODEL SEL; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Ordenana MA, 2010, J MAMMAL, V91, P1322, DOI 10.1644/09-MAMM-A-312.1; Palomino D, 2006, LANDSCAPE URBAN PLAN, V77, P276, DOI 10.1016/j.landurbplan.2005.04.003; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Pickett STA, 2011, J ENVIRON MANAGE, V92, P331, DOI 10.1016/j.jenvman.2010.08.022; Pressey RL, 2000, BIOL CONSERV, V96, P55, DOI 10.1016/S0006-3207(00)00050-1; Prevedello JA, 2013, ECOGRAPHY, V36, P287, DOI 10.1111/j.1600-0587.2012.07820.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Radeloff VC, 2005, ECOL APPL, V15, P799, DOI 10.1890/04-1413; Randa LA, 2006, J MAMMAL, V87, P1154, DOI 10.1644/05-MAMM-A-224R2.1; Ries L, 2004, ECOLOGY, V85, P2917, DOI 10.1890/03-8021; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Sacchi R, 2002, CAN J ZOOL, V80, P48, DOI 10.1139/Z01-202; Schtickzelle N, 2003, J ANIM ECOL, V72, P533, DOI 10.1046/j.1365-2656.2003.00723.x; Sekhon JS, 2011, J STAT SOFTW, V42, P1; SOUTHWELL C, 1996, MEASURING MONITORING, P193; Statham M, 1997, WILDLIFE RES, V24, P715, DOI 10.1071/WR96092; Sushinsky JR, 2013, GLOBAL CHANGE BIOL, V19, P401, DOI 10.1111/gcb.12055; Turner WR, 2003, LANDSCAPE URBAN PLAN, V65, P149, DOI 10.1016/S0169-2046(03)00012-4; United Nations, 2011, WORLD POP PROSP REV; United Nations, 2012, WORLD URB PROSP 2011; URBAN DL, 1987, BIOSCIENCE, V37, P119, DOI 10.2307/1310366; WIENS JA, 1985, OIKOS, V45, P421, DOI 10.2307/3565577; Wilby RL, 2006, PROG PHYS GEOG, V30, P73, DOI 10.1191/0309133306pp470ra; Wintle BA, 2005, J WILDLIFE MANAGE, V69, P905, DOI 10.2193/0022-541X(2005)069[0905:EADWDI]2.0.CO;2; Youngentob KN, 2012, BIOL CONSERV, V155, P68, DOI 10.1016/j.biocon.2012.05.015	73	38	44	2	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e97036	10.1371/journal.pone.0097036	http://dx.doi.org/10.1371/journal.pone.0097036			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810286	gold, Green Published, Green Submitted			2022-12-27	WOS:000338213300110
J	Wu, KK; Liu, WW; Mar, TT; Liu, Y; Wu, YF; Wang, XF				Wu, Keke; Liu, Wenwen; Mar, Thithi; Liu, Yan; Wu, Yunfeng; Wang, Xifeng			Sequencing and Validation of Reference Genes to Analyze Endogenous Gene Expression and Quantify Yellow Dwarf Viruses Using RT-qPCR in Viruliferous Rhopalosiphum padi	PLOS ONE			English	Article							REAL-TIME PCR; COMPLETE NUCLEOTIDE-SEQUENCE; VECTOR-SPECIFIC TRANSMISSION; HOUSEKEEPING GENES; CIRCULATIVE TRANSMISSION; APHID TRANSMISSION; READTHROUGH DOMAIN; HEMIPTERAN INSECT; POLEROVIRUS; GENOME	The bird cherry-oat aphid (Rhopalosiphum padi), an important pest of cereal crops, not only directly sucks sap from plants, but also transmits a number of plant viruses, collectively the yellow dwarf viruses (YDVs). For quantifying changes in gene expression in vector aphids, reverse transcription-quantitative polymerase chain reaction (RT-qPCR) is a touchstone method, but the selection and validation of housekeeping genes (HKGs) as reference genes to normalize the expression level of endogenous genes of the vector and for exogenous genes of the virus in the aphids is critical to obtaining valid results. Such an assessment has not been done, however, for R. padi and YDVs. Here, we tested three algorithms (GeNorm, NormFinder and BestKeeper) to assess the suitability of candidate reference genes (EF-1 alpha, ACT1, GAPDH, 18S rRNA) in 6 combinations of YDV and vector aphid morph. EF-1 alpha and ACT1 together or in combination with GAPDH or with GAPDH and 18S rRNA could confidently be used to normalize virus titre and expression levels of endogenous genes in winged or wingless R. padi infected with Barley yellow dwarf virus isolates (BYDV)-PAV and BYDV-GAV. The use of only one reference gene, whether the most stably expressed (EF-1 alpha) or the least stably expressed (18S rRNA), was not adequate for obtaining valid relative expression data from the RT-qPCR. Because of discrepancies among values for changes in relative expression obtained using 3 regions of the same gene, different regions of an endogenous aphid gene, including each terminus and the middle, should be analyzed at the same time with RT-qPCR. Our results highlight the necessity of choosing the best reference genes to obtain valid experimental data and provide several HKGs for relative quantification of virus titre in YDV-viruliferous aphids.	[Wu, Keke; Wu, Yunfeng] Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China; [Wu, Keke; Liu, Wenwen; Mar, Thithi; Liu, Yan; Wang, Xifeng] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Northwest A&F University - China; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Wu, YF (corresponding author), Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China.	wuyf@nwsuaf.edu.cn; xfwang@ippcaas.cn	Wang, Xifeng/A-6476-2016	Liu, Yan/0000-0001-9230-5853; Wang, Xifeng/0000-0002-4982-8947	Special Fund for Agro-scientific Research in the Public Interest [201303021]; Natural Science Foundation of China [NSFC31272017]	Special Fund for Agro-scientific Research in the Public Interest; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The Special Fund for Agro-scientific Research in the Public Interest (201303021); and the Natural Science Foundation of China (NSFC31272017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Balaji B, 2003, PHYTOPATHOLOGY, V93, P1386, DOI 10.1094/PHYTO.2003.93.11.1386; Ban L, 2007, J VIROL METHODS, V142, P136, DOI 10.1016/j.jviromet.2007.01.014; Bansal R, 2013, INT J MOL SCI, V14, P3786, DOI 10.3390/ijms14023786; Bansal R, 2012, INT J BIOL SCI, V8, P1323, DOI 10.7150/ijbs.4189; Bansal R, 2012, J ECON ENTOMOL, V105, P1432, DOI 10.1603/EC12095; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhatia V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046343; Burrows ME, 2006, PHYTOPATHOLOGY, V96, P828, DOI 10.1094/PHYTO-96-0828; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Canning ESG, 1996, J VIROL METHODS, V56, P191, DOI 10.1016/0166-0934(95)01959-6; Chay CA, 1996, VIROLOGY, V219, P57, DOI 10.1006/viro.1996.0222; Cilia M, 2011, J VIROL, V85, P2148, DOI 10.1128/JVI.01504-10; D'Arcy CJ., 2005, VIRUS TAXONOMY 8 REP, P891; Descamps LR, 2011, CHIL J AGR RES, V71, P390, DOI 10.4067/S0718-58392011000300007; Du ZQ, 2007, J PLANT PATHOL, V89, P251; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; Fu W, 2013, INT J BIOL SCI, V9, P792, DOI 10.7150/ijbs.5862; GILDOW FE, 1993, PHYTOPATHOLOGY, V83, P1293, DOI 10.1094/Phyto-83-1293; GILDOW FE, 1993, PHYTOPATHOLOGY, V83, P270, DOI 10.1094/Phyto-83-270; Gopaulchan D, 2013, SCI HORTIC-AMSTERDAM, V153, P1, DOI 10.1016/j.scienta.2013.01.024; Gray S, 2003, ANNU REV PHYTOPATHOL, V41, P539, DOI 10.1146/annurev.phyto.41.012203.105815; Hadi BAR, 2012, J ENTOMOL SCI, V47, P35; Hesler LS, 2005, J ECON ENTOMOL, V98, P603, DOI 10.1603/0022-0493-98.2.603; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Jarosova J, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-146; Jaubert-Possamai S, 2010, MOL BIOL EVOL, V27, P979, DOI 10.1093/molbev/msp256; Kim H, 2008, SYST ENTOMOL, V33, P711, DOI 10.1111/J.1365-3113.2008.00440.x; Kliot A, 2013, VIRUSES-BASEL, V5, P1516, DOI 10.3390/v5061516; Krueger EN, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00205; Liu F, 2007, ARCH VIROL, V152, P1365, DOI 10.1007/s00705-007-0947-8; Liu SJ, 2010, VIROLOGY, V401, P107, DOI 10.1016/j.virol.2010.02.009; Liu WW, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-173; Liu Y, 2007, J VIROL METHODS, V145, P22, DOI 10.1016/j.jviromet.2007.05.006; Liu Y, 2012, J GEN VIROL, V93, P1825, DOI 10.1099/vir.0.042135-0; Ma LM, 2013, MAR GENOM, V11, P67, DOI 10.1016/j.margen.2013.08.002; Maroniche GA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-308; Moran NA, 1999, SYST ENTOMOL, V24, P85, DOI 10.1046/j.1365-3113.1999.00076.x; Normark BB, 1999, EVOLUTION, V53, P1458, DOI [10.2307/2640892, 10.1111/j.1558-5646.1999.tb05410.x]; Ortiz-Rivas B, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-216; Peter KA, 2009, J VIROL, V83, P5419, DOI 10.1128/JVI.02312-08; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Puinean AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000999; Reim T, 2013, APIDOLOGIE, V44, P342, DOI 10.1007/s13592-012-0184-3; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Rubie C, 2005, MOL CELL PROBE, V19, P101, DOI 10.1016/j.mcp.2004.10.001; Sambrook J., 2001, MOL CLONING LAB MANU; Seddas P, 2004, VIROLOGY, V325, P399, DOI 10.1016/j.virol.2004.05.014; Tamborindeguy C, 2010, INSECT MOL BIOL, V19, P259, DOI 10.1111/j.1365-2583.2009.00956.x; Teng XL, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.6001; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang XF, 2003, CHINESE SCI BULL, V48, P2083, DOI 10.1360/03wc0153; Watanabe S, 2013, VIRUSES-BASEL, V5, P758, DOI 10.3390/v5020758; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Wu BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016896; Yang XL, 2008, J VIROL, V82, P291, DOI 10.1128/JVI.01736-07; You MS, 2013, NAT GENET, V45, P220, DOI 10.1038/ng.2524; ZHANG M, 2013, BMC GENOMICS, V14; Zhang WW, 2009, ARCH VIROL, V154, P1125, DOI 10.1007/s00705-009-0415-8; Zhang X, 2008, J VIROL METHODS, V151, P181, DOI 10.1016/j.jviromet.2008.05.024	62	12	14	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e97038	10.1371/journal.pone.0097038	http://dx.doi.org/10.1371/journal.pone.0097038			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810421	gold, Green Published, Green Submitted			2022-12-27	WOS:000338213300111
J	Zeng, QC; Song, R; Ao, LH; Xu, DL; Venardos, N; Fullerton, DA; Meng, XZ				Zeng, Qingchun; Song, Rui; Ao, Lihua; Xu, Dingli; Venardos, Neil; Fullerton, David A.; Meng, Xianzhong			Augmented Osteogenic Responses in Human Aortic Valve Cells Exposed to oxLDL and TLR4 Agonist: A Mechanistic Role of Notch1 and NF-kappa B Interaction	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; TOLL-LIKE RECEPTOR-4; INTERSTITIAL-CELLS; OXIDIZED LDL; EXPRESSION; STENOSIS; MACROPHAGES; CALCIFICATION; ACTIVATION; TOLL-LIKE-RECEPTOR-4	Aortic valve calcification causes the progression of calcific aortic valve disease (CAVD). Stimulation of aortic valve interstitial cells (AVICs) with lipopolysaccharide (LPS) up-regulates the expression of osteogenic mediators, and NF-kappa B plays a central role in mediating AVIC osteogenic responses to Toll-like receptor 4 (TLR4) stimulation. Diseased aortic valves exhibit greater levels of oxidized low-density lipoprotein (oxLDL). This study tested the hypothesis that oxLDL augments the osteogenic responses in human AVICs through modulation of NF-kappa B and Notch1 activation. AVICs isolated from normal human aortic valves were treated with LPS (0.1 mu g/ml), oxLDL (20 mu g/ml) or LPS plus oxLDL for 48 h. OxLDL alone increased cellular bone morphogenetic protein-2 (BMP-2) levels while it had no effect on alkaline phosphatase (ALP) levels. Cells exposed to LPS plus oxLDL produced higher levels of BMP-2 and ALP than cells exposed to LPS alone. Further, LPS plus oxLDL induced greater NF-kappa B activation, and inhibition of NF-kappa B markedly reduced the expression of BMP-2 and ALP in cells treated with LPS plus oxLDL. OxLDL also induced Notch1 activation and resulted in augmented Notch1 activation when it was combined with LPS. Inhibition of Notch1 cleavage attenuated NF-kappa B activation induced by LPS plus oxLDL, and inhibition of NF-kappa B suppressed the expression of BMP-2 and ALP induced by the synergistic effect of Jagged1 and LPS. These findings demonstrate that oxLDL up-regulates BMP-2 expression in human AVICs and synergizes with LPS to elicit augmented AVIC osteogenic responses. OxLDL exerts its effect through modulation of the Notch1-NF-kappa B signaling cascade. Thus, oxLDL may play a role in the mechanism underlying CAVD progression.	[Zeng, Qingchun; Song, Rui; Ao, Lihua; Venardos, Neil; Fullerton, David A.; Meng, Xianzhong] Univ Colorado Denver, Dept Surg, Aurora, CO 80045 USA; [Zeng, Qingchun; Xu, Dingli] Southern Med Univ, Nanfang Hosp, Dept Cardiol, Guangzhou, Guangdong, Peoples R China; [Song, Rui] Southern Med Univ, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Southern Medical University - China; Southern Medical University - China	Meng, XZ (corresponding author), Univ Colorado Denver, Dept Surg, Aurora, CO 80045 USA.	xianzhong.meng@ucdenver.edu	Xu, Dingli/AAA-6176-2019	Xu, Dingli/0000-0002-3193-4354; Zeng, Qingchun/0000-0001-7665-8237	National Institutes of Heart, Lung and Blood Grant [HL106582]; American Heart Association grant [11GRNT7900016]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106582] Funding Source: NIH RePORTER	National Institutes of Heart, Lung and Blood Grant; American Heart Association grant(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part by National Institutes of Heart, Lung and Blood Grant HL106582 and American Heart Association grant 11GRNT7900016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cha J, 2008, ANN THORAC SURG, V85, P1678, DOI 10.1016/j.athoracsur.2008.01.043; Cohen DJ, 2004, ANN THORAC SURG, V77, P537, DOI 10.1016/S0003-4975(03)01454-1; Cote C, 2008, HEART, V94, P1175, DOI 10.1136/hrt.2007.125740; Edvinsson M, 2010, INT J CARDIOL, V143, P57, DOI 10.1016/j.ijcard.2009.01.052; Espinosa L, 2010, CANCER CELL, V18, P268, DOI 10.1016/j.ccr.2010.08.006; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Fratta Pasini A, 2007, ARTERIOSCL THROM VAS, V27, P1991, DOI 10.1161/ATVBAHA.107.142695; Galle J, 2006, ATHEROSCLEROSIS, V185, P219, DOI 10.1016/j.atherosclerosis.2005.10.005; Gibson FC, 2007, CURR PHARM DESIGN, V13, P3665, DOI 10.2174/138161207783018554; Groeneweg M, 2006, J LIPID RES, V47, P2259, DOI 10.1194/jlr.M600181-JLR200; Katsargyris A, 2011, CEREBROVASC DIS, V31, P29, DOI 10.1159/000320259; Marson A, 2004, J BIOL CHEM, V279, P28781, DOI 10.1074/jbc.M313207200; Mehrabi MR, 2000, CARDIOVASC RES, V45, P874, DOI 10.1016/S0008-6363(99)00389-2; Meng XZ, 2008, AM J PHYSIOL-CELL PH, V294, pC29, DOI 10.1152/ajpcell.00137.2007; MESSIER RH, 1994, J SURG RES, V57, P1, DOI 10.1006/jsre.1994.1102; Messika-Zeitoun D, 2007, ARTERIOSCL THROM VAS, V27, P642, DOI 10.1161/01.ATV.0000255952.47980.c2; Miller YI, 2003, J BIOL CHEM, V278, P1561, DOI 10.1074/jbc.M209634200; Mohler ER, 2004, AM J CARDIOL, V94, P1396, DOI 10.1016/j.amjcard.2004.08.013; Mohty D, 2008, ARTERIOSCL THROM VAS, V28, P187, DOI 10.1161/ATVBAHA.107.154989; Monsalve E, 2009, EUR J IMMUNOL, V39, P2556, DOI 10.1002/eji.200838722; Nakano K, 2009, ORAL MICROBIOL IMMUN, V24, P64, DOI 10.1111/j.1399-302X.2008.00479.x; Novaro GM, 2001, J HEART VALVE DIS, V10, P19; Nowicki M, 2010, J NEUROSCI RES, V88, P403, DOI 10.1002/jnr.22205; Ohlsson BG, 1996, J CLIN INVEST, V98, P78, DOI 10.1172/JCI118780; Olsson M, 1999, ARTERIOSCL THROM VAS, V19, P1218, DOI 10.1161/01.ATV.19.5.1218; Osman L, 2006, CIRCULATION, V114, pI547, DOI 10.1161/CIRCULATIONAHA.105.001115; OTTO CM, 1994, CIRCULATION, V90, P844, DOI 10.1161/01.CIR.90.2.844; Palaga T, 2008, EUR J IMMUNOL, V38, P174, DOI 10.1002/eji.200636999; Rossebo AB, 2004, CURR OPIN LIPIDOL, V15, P447, DOI 10.1097/01.mol.0000137229.00020.fe; Rusanescu G, 2008, CURR CARDIOL REV, V4, P148, DOI 10.2174/157340308785160552; Sato S, 2000, J IMMUNOL, V165, P7096, DOI 10.4049/jimmunol.165.12.7096; Skowasch D, 2009, J HEART VALVE DIS, V18, P411; Song R, 2012, ARTERIOSCL THROM VAS, V32, P2711, DOI 10.1161/ATVBAHA.112.300116; Su X, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.214619; Su X, 2010, CYTOKINE, V51, P60, DOI 10.1016/j.cyto.2010.04.014; Vilimas T, 2007, NAT MED, V13, P70, DOI 10.1038/nm1524; Xu WY, 2007, MOL IMMUNOL, V44, P2315, DOI 10.1016/j.molimm.2006.11.013; Xu XH, 2001, CIRCULATION, V104, P3103, DOI 10.1161/hc5001.100631; Yang XP, 2009, J AM COLL CARDIOL, V53, P491, DOI 10.1016/j.jacc.2008.09.052; Zeng QC, 2013, ARTERIOSCL THROM VAS, V33, P1580, DOI 10.1161/ATVBAHA.112.300912; Zeng QC, 2012, CIRCULATION, V126, pS222, DOI 10.1161/CIRCULATIONAHA.111.083675	41	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e95400	10.1371/journal.pone.0095400	http://dx.doi.org/10.1371/journal.pone.0095400			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810405	Green Published, gold, Green Submitted			2022-12-27	WOS:000338213300011
J	Yashiro, Y; Nomura, Y; Kanazashi, M; Noda, K; Hanada, N; Nakamura, Y				Yashiro, Yuichi; Nomura, Yoshiaki; Kanazashi, Mikimoto; Noda, Koji; Hanada, Nobuhiro; Nakamura, Yoshiki			Function of Chemokine (CXC Motif) Ligand 12 in Periodontal Ligament Fibroblasts	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; P38 MAP KINASE; BONE-MARROW; FACTOR-I; ALKALINE-PHOSPHATASE; COLLAGEN-SYNTHESIS; PERIPHERAL-BLOOD; RAPID TURNOVER; MIGRATION; EXPRESSION	The periodontal ligament (PDL) is one of the connective tissues located between the tooth and bone. It is characterized by rapid turnover. Periodontal ligament fibroblasts (PDLFs) play major roles in the rapid turnover of the PDL. Microarray analysis of human PDLFs (HPDLFs) and human dermal fibroblasts (HDFs) demonstrated markedly high expression of chemokine (CXC motif) ligand 12 (CXCL12) in the HPDLFs. CXCL12 plays an important role in the migration of mesenchymal stem cells (MSCs). The function of CXCL12 in the periodontal ligament was investigated in HPDLFs. Expression of CXCL12 in HPDLFs and HDFs was examined by RT-PCR, qRT-PCR and ELISA. Chemotactic ability of CXCL12 was evaluated in both PDLFs and HDFs by migration assay of MSCs. CXCL12 was also immunohistochemically examined in the PDL in vivo. Expression of CXCL12 in the HPDLFs was much higher than that in HDFs in vitro. Migration assay demonstrated that the number of migrated MSCs by HPDLFs was significantly higher than that by HDFs. In addition, the migrated MSCs also expressed CXCL12 and several genes that are familiar to fibroblasts. CXCL12 was immunohistochemically localized in the fibroblasts in the PDL of rat molars. The results suggest that PDLFs synthesize and secrete CXCL12 protein and that CXCL12 induces migration of MSCs in the PDL in order to maintain rapid turnover of the PDL.	[Yashiro, Yuichi; Noda, Koji; Nakamura, Yoshiki] Tsurumi Univ, Sch Dent Med, Dept Orthodont, Yokohama, Kanagawa, Japan; [Nomura, Yoshiaki; Hanada, Nobuhiro] Tsurumi Univ, Sch Dent Med, Dept Translat Res, Yokohama, Kanagawa, Japan; [Kanazashi, Mikimoto] Tsurumi Univ, Sch Dent Med, Dept Periodontol, Yokohama, Kanagawa, Japan	Tsurumi University; Tsurumi University; Tsurumi University	Nakamura, Y (corresponding author), Tsurumi Univ, Sch Dent Med, Dept Orthodont, Yokohama, Kanagawa, Japan.	nakamura-ys@tsurumi-u.ac.jp	Hanada, Nobuhiro/C-5308-2011	Nomura, Yoshiaki/0000-0002-0814-0572				Alsayed Y, 2007, BLOOD, V109, P2708, DOI 10.1182/blood-2006-07-035857; Arai C, 2010, HISTOCHEM CELL BIOL, V134, P337, DOI 10.1007/s00418-010-0737-3; BEERTSEN W, 1975, ARCH ORAL BIOL, V20, P659, DOI 10.1016/0003-9969(75)90134-X; Beertsen W, 1997, PERIODONTOL 2000, V13, P20, DOI 10.1111/j.1600-0757.1997.tb00094.x; Chen YJ, 2012, J PERIODONTAL RES; CHO MI, 1992, CALCIFIED TISSUE INT, V50, P459, DOI 10.1007/BF00296778; Chong PP, 2012, J ORTHOP RES, V30, P634, DOI 10.1002/jor.21556; Cojoc Monica, 2013, Onco Targets Ther, V6, P1347, DOI 10.2147/OTT.S36109; Du LQ, 2012, J PERIODONTOL, V83, P379, DOI 10.1902/jop.2011.110201; Fu WL, 2012, TISSUE ENG PT A, V18, P1793, DOI [10.1089/ten.tea.2011.0530, 10.1089/ten.TEA.2011.0530]; Fujita Tomohisa, 2005, J Oral Sci, V47, P177, DOI 10.2334/josnusd.47.177; Gong QM, 2010, J ENDODONT, V36, P1499, DOI 10.1016/j.joen.2010.05.011; GORSKI JP, 1992, CRIT REV ORAL BIOL M, V3, P185, DOI 10.1177/10454411920030030201; GOULD TRL, 1980, J PERIODONTAL RES, V15, P20, DOI 10.1111/j.1600-0765.1980.tb00258.x; Handa K, 2002, CONNECT TISSUE RES, V43, P406, DOI 10.1080/03008200290001023; Hartman NW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015856; Havens AM, 2008, J PERIODONTOL, V79, P845, DOI [10.1902/jop.2008.070514, 10.1902/jop.2008.070514 ]; Hu C, 2013, J SURG RES; Huang YC, 2012, ACTA BIOMATER, V8, P1048, DOI 10.1016/j.actbio.2011.12.009; Kakita A, 2004, PROSTAG LEUKOTR ESS, V70, P469, DOI 10.1016/j.plefa.2003.09.003; Kimoto K, 2004, INVEST OPHTH VIS SCI, V45, P2431, DOI 10.1167/iovs.03-1276; Kono K, 2013, CELL TISSUE RES, V352, P249, DOI 10.1007/s00441-012-1543-0; Kook SH, 2011, J APPL PHYSIOL, V111, P1575, DOI 10.1152/japplphysiol.00348.2011; Kou I, 2007, J BIOL CHEM, V282, P32193, DOI 10.1074/jbc.M706262200; Lallier TE, 2005, J PERIODONTOL, V76, P1044, DOI 10.1902/jop.2005.76.7.1044; Lallier TE, 2007, CELL TISSUE RES, V327, P93, DOI 10.1007/s00441-006-0282-5; Liu XL, 2011, PROTEIN CELL, V2, P845, DOI 10.1007/s13238-011-1097-z; Madoka S, 2002, J INVEST DERMATOL, V118, P704; Mao JJ, 2006, J DENT RES, V85, P966, DOI 10.1177/154405910608501101; Marquez-Curtis LA, 2013, CYTOTHERAPY, V15, P840, DOI 10.1016/j.jcyt.2013.02.009; MCCULLOCH CAG, 1991, J PERIODONTAL RES, V26, P144, DOI 10.1111/j.1600-0765.1991.tb01638.x; Morandini ACF, 2010, J PERIODONTOL, V81, P310, DOI 10.1902/jop.2009.090375; Murakami Y, 2003, J PERIODONTOL, V74, P780, DOI 10.1902/jop.2003.74.6.780; Nakamura Y, 2004, HISTOCHEM CELL BIOL, V121, P39, DOI 10.1007/s00418-003-0599-z; Nakamura Y, 2003, J PERIODONTAL RES, V38, P343, DOI 10.1034/j.1600-0765.2003.00671.x; Naveh GRS, 2012, ARCH ORAL BIOL, V57, P1575, DOI 10.1016/j.archoralbio.2012.07.006; Noda K, 2006, ORTHOD WAVES, V65, P73, DOI 10.1016/j.odw.2006.03.002; Noda K, 2009, EUR J ORTHODONT, V31, P37, DOI 10.1093/ejo/cjn075; NOJIMA N, 1990, J PERIODONTAL RES, V25, P179, DOI 10.1111/j.1600-0765.1990.tb01041.x; Nomura Y, 2012, HISTOCHEM CELL BIOL, V137, P719, DOI 10.1007/s00418-012-0923-6; Nowwarote N, 2013, PHYTOTHER RES, V27, P457, DOI 10.1002/ptr.4742; Poiate IAVP, 2009, J PERIODONTOL, V80, P1859, DOI 10.1902/jop.2009.090220; ROBERTS WE, 1982, AM J ANAT, V165, P373, DOI 10.1002/aja.1001650403; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; SHORE RC, 1979, ARCH ORAL BIOL, V24, P155, DOI 10.1016/0003-9969(79)90064-5; SODEK J, 1988, COLLAGEN REL RES, V8, P11; SODEK J, 1977, ARCH ORAL BIOL, V22, P647, DOI 10.1016/0003-9969(77)90094-2; SODEK J, 1976, BIOCHEM J, V160, P243, DOI 10.1042/bj1600243; SOMERMAN MJ, 1988, J DENT RES, V67, P66, DOI 10.1177/00220345880670011301; Suzuki A, 1999, ENDOCRINOLOGY, V140, P3177, DOI 10.1210/en.140.7.3177; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; TENCATE AR, 1974, ARCH ORAL BIOL, V19, P339; Terranova VP, 1996, J DENT RES, V75, P993, DOI 10.1177/00220345960750041501; Tsukada S, 2005, J BIOL CHEM, V280, P10055, DOI 10.1074/jbc.M409381200; VANROSSEN IP, 1990, J PROSTHET DENT, V64, P198, DOI 10.1016/0022-3913(90)90179-G; Yang DZ, 2013, CELL REPROGRAM, V15, P206, DOI 10.1089/cell.2012.0046; Zhao M, 2002, J BONE MINER RES, V17, P1441, DOI 10.1359/jbmr.2002.17.8.1441; Zimmermann MC, 2010, J PHARMACOL EXP THER, V332, P35, DOI 10.1124/jpet.109.160382	59	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e95676	10.1371/journal.pone.0095676	http://dx.doi.org/10.1371/journal.pone.0095676			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806431	Green Published, Green Submitted, gold			2022-12-27	WOS:000335728900023
J	Blount, RJ; Tran, B; Jarlsberg, LG; Phan, H; Hoang, VT; Nguyen, NV; Lewinsohn, DA; Nahid, P				Blount, Robert J.; Bao Tran; Jarlsberg, Leah G.; Ha Phan; Van Thanh Hoang; Nhung Viet Nguyen; Lewinsohn, Deborah A.; Nahid, Payam			Childhood Tuberculosis in Northern Viet Nam: A Review of 103 Cases	PLOS ONE			English	Article							XPERT MTB/RIF ASSAY; PULMONARY TUBERCULOSIS; GASTRIC LAVAGE; PEDIATRIC TUBERCULOSIS; INDUCED SPUTUM; SOUTH-AFRICA; CAPE-TOWN; CHILDREN; DIAGNOSIS; EPIDEMIOLOGY	Background: Childhood tuberculosis causes significant morbidity and mortality in Southeast Asia, yet little is known about the epidemiology and clinical characteristics of this disease in Viet Nam. Objectives: To determine the demographics, clinical presentations, radiographic and microbiologic findings, treatment regimens, and outcomes of children admitted with tuberculosis (TB) to a national referral hospital in Viet Nam. Methods: We conducted a retrospective case series study of children <= 15 years old with bacteriologically confirmed or clinically diagnosed TB admitted to a national referral hospital in Ha Noi, Viet Nam from January through December 2007. Results: One hundred three children were identified: median age 5 years (IQR 2-10), 44% female, 99% Kinh ethnicity, 27% residing in Ha Noi, 88% with BCG vaccination, 27% with known TB contact, and 38% malnourished. Intrathoracic TB was present in 62%, extrathoracic in 52%, both intra and extrathoracic in 19%, and undetermined site in 5%. The most common extrathoracic manifestation was peripheral lymphadenitis, and children under 5 were more likely to have miliary TB or both intra and extrathoracic TB. Fever and failure to thrive were common presenting symptoms among all participants (65% and 56%, respectively), 66% of those with intrathoracic TB presented with cough, and 92% of those with TB meningitis presented with severe neurologic impairment. Acid-fast bacilli smears and mycobacterial cultures were positive in 18% and 21% of children tested, and histopathology was positive in 88% of those biopsied. There were no adverse drug reactions necessitating change in therapy, and no inpatient mortality. Conclusions: Extrathoracic TB was common, treatment well tolerated and clinical outcomes excellent. Culture confirmation rates were low and emphasize the need for improved diagnostics.	[Blount, Robert J.; Bao Tran; Jarlsberg, Leah G.; Ha Phan; Nahid, Payam] Univ Calif San Francisco, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; [Van Thanh Hoang; Nhung Viet Nguyen] Natl Lung Hosp, Hanoi, Vietnam; [Van Thanh Hoang; Nhung Viet Nguyen] Viet Nam Natl TB Program, Hanoi, Vietnam; [Lewinsohn, Deborah A.] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA	University of California System; University of California San Francisco; Oregon Health & Science University	Blount, RJ (corresponding author), Univ Calif San Francisco, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA.	robert.blount@ucsf.edu	blount, robert/ABI-5978-2020	Tran, Bao/0000-0002-0980-7594; Blount, Robert/0000-0001-6177-7436; Nahid, Payam/0000-0003-2811-1311; Jarlsberg, Leah/0000-0001-6548-6337	NIH [F32 ES022582-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F32ES022582] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding provided by NIH F32 ES022582-01 PI: Blount, http://grants.nih.gov/training/nrsa.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates M, 2013, LANCET INFECT DIS, V13, P36, DOI 10.1016/S1473-3099(12)70245-1; Buonsenso D, 2012, PEDIATR INFECT DIS J, V31, P1022, DOI 10.1097/INF.0b013e3182615270; Cegielski JP, 2004, INT J TUBERC LUNG D, V8, P286; Chemtob D, 2006, ISRAEL MED ASSOC J, V8, P21; Cruz AT, 2007, PAEDIATR RESPIR REV, V8, P107, DOI 10.1016/j.prrv.2007.04.008; Cruz AT, 2013, PEDIATR INFECT DIS J, V32, P937, DOI 10.1097/INF.0b013e3182933214; DARBYSHIRE JH, 1989, ARCH DIS CHILD, V64, P1004, DOI 10.1136/adc.64.7.1004; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS15; Dodd LE, 2013, LANCET INFECT DIS, V13, P3, DOI 10.1016/S1473-3099(12)70290-6; Donald PR, 2011, PEDIATRIC REP, V3, P51, DOI 10.4081/pr.2011.e16; Donald PR, 2010, LANCET, V375, P1852, DOI 10.1016/S0140-6736(10)60580-6; Feja K, 2005, CLIN CHEST MED, V26, P295, DOI 10.1016/j.ccm.2005.02.010; Fox GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049880; Harries AD, 2002, INT J TUBERC LUNG D, V6, P424; Hatherill M, 2009, ARCH DIS CHILD, V94, P195, DOI 10.1136/adc.2007.136929; Hoa NB, 2013, INT J TUBERC LUNG D, V17, P738, DOI 10.5588/ijtld.12.0200; Hoa NB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-367; Jaganath D, 2012, J INFECT DIS, V206, P1809, DOI 10.1093/infdis/jis608; Lolekha R, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-94; Maher D, 2006, INT J TUBERC LUNG D, V10, P1331; Maltezou HC, 2000, ARCH DIS CHILD, V83, P342, DOI 10.1136/adc.83.4.342; Marais BJ, 2006, PEDIATRICS, V118, pE1350, DOI 10.1542/peds.2006-0519; Marais BJ, 2006, CLIN INFECT DIS, V42, pE69, DOI 10.1086/502652; Marais BJ, 2004, INT J TUBERC LUNG D, V8, P392; Ministry of Health, 2009, VIET NAM HIV AIDS ES; Nelson LJ, 2004, PEDIATRICS, V114, P333, DOI 10.1542/peds.114.2.333; Nelson LJ, 2004, INT J TUBERC LUNG D, V8, P636; Newton SM, 2008, LANCET INFECT DIS, V8, P498, DOI 10.1016/S1473-3099(08)70182-8; Nicol MP, 2011, LANCET INFECT DIS, V11, P819, DOI 10.1016/S1473-3099(11)70167-0; Nong BR, 2009, J MICROBIOL IMMUNOL, V42, P516; Ormerod LP, 1996, TUBERCLE LUNG DIS, V77, P37, DOI 10.1016/S0962-8479(96)90073-8; Perez-Velez CM, 2012, NEW ENGL J MED, V367, P348, DOI 10.1056/NEJMra1008049; Phongsamart W, 2009, PEDIATR INFECT DIS J, V28, P416, DOI 10.1097/INF.0b013e3181920d4d; Rachow A, 2012, CLIN INFECT DIS, V54, P1388, DOI 10.1093/cid/cis190; Schaaf HS, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-140; Tran ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072100; Stop TB Partnership Childhood TB Subgroup World Health Organization, 2006, Int J Tuberc Lung Dis, V10, P1091; Thanh DH, 2010, INT J TUBERC LUNG D, V14, P986; TOPPET M, 1991, EUR J PEDIATR, V150, P331, DOI 10.1007/BF01955934; United Nations Population Fund, 2011, ETHN GROUPS VIET NAM; VALLEJO JG, 1994, PEDIATRICS, V94, P1; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Zar HJ, 2012, CLIN INFECT DIS, V55, P1088, DOI 10.1093/cid/cis598; Zar HJ, 2005, LANCET, V365, P130, DOI 10.1016/S0140-6736(05)17702-2	44	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97267	10.1371/journal.pone.0097267	http://dx.doi.org/10.1371/journal.pone.0097267			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24818967	Green Published, gold, Green Submitted			2022-12-27	WOS:000336653300101
J	Little, D; Thompson, JW; Dubois, LG; Ruch, DS; Moseley, MA; Guilak, F				Little, Dianne; Thompson, J. Will; Dubois, Laura G.; Ruch, David S.; Moseley, M. Arthur; Guilak, Farshid			Proteomic Differences between Male and Female Anterior Cruciate Ligament and Patellar Tendon	PLOS ONE			English	Article							OLIGOMERIC MATRIX PROTEIN; COLLAGEN-VI CHAINS; EXTRACELLULAR-MATRIX; ARTICULAR-CARTILAGE; TISSUE INHIBITOR; MEMBRANE ATTACK; GENE-EXPRESSION; MYOCILIN; SEX; COMPLEMENT	The risk of anterior cruciate ligament (ACL) injury and re-injury is greater for women than men. Among other factors, compositional differences may play a role in this differential risk. Patellar tendon (PT) autografts are commonly used during reconstruction. The aim of the study was to compare protein expression in male and female ACL and PT. We hypothesized that there would be differences in key structural components between PT and ACL, and that components of the proteome critical for response to mechanical loading and response to injury would demonstrate significant differences between male and female. Two-dimensional liquid chromatography-tandem mass spectrometry and a label-free quantitative approach was used to identify proteomic differences between male and female PT and ACL. ACL contained less type I and more type III collagen than PT. There were tissue-specific differences in expression of proteoglycans, and ACL was enriched in elastin, tenascin C and X, cartilage oligomeric matrix protein, thrombospondin 4 and periostin. Between male and female donors, alcohol dehydrogenase 1B and complement component 9 were enriched in female compared to male. Myocilin was the major protein enriched in males compared to females. Important compositional differences between PT and ACL were identified, and we identified differences in pathways related to extracellular matrix regulation, complement, apoptosis, metabolism of advanced glycation end-products and response to mechanical loading between males and females. Identification of proteomic differences between male and female PT and ACL has identified novel pathways which may lead to improved understanding of differential ACL injury and re-injury risk between males and females.	[Little, Dianne; Ruch, David S.; Guilak, Farshid] Duke Univ, Med Ctr, Dept Orthopaed Surg, Durham, NC 27706 USA; [Thompson, J. Will; Dubois, Laura G.; Moseley, M. Arthur] Duke Univ, Med Ctr, Inst Genome Sci & Policy, Prote Core Facil, Durham, NC USA; [Guilak, Farshid] Duke Univ, Med Ctr, Dept Biomed Engn, Durham, NC USA	Duke University; Duke University; Duke University	Little, D (corresponding author), Duke Univ, Med Ctr, Dept Orthopaed Surg, Durham, NC 27706 USA.	dianne.little@duke.edu	Guilak, Farshid/AAF-8558-2020; Little, Dianne/H-5994-2011	Guilak, Farshid/0000-0001-7380-0330; 	Duke University's CTSA [UL1 RR024128]; National Institutes of Health [AR48852, AG15768, AR50245, AR59784]; DePuy Synthes; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR059784, P01AR050245, R01AR048852] Funding Source: NIH RePORTER	Duke University's CTSA; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DePuy Synthes; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by Duke University's CTSA grant UL1 RR024128 (JWT, LGD, MAM, DL), National Institutes of Health grants AR48852 (FG), AG15768 (FG), AR50245 (FG), AR59784 (DL) and DePuy Synthes (DL, DSR, FG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlden M, 2012, AM J SPORT MED, V40, P2230, DOI 10.1177/0363546512457348; Almekinders LC, 2003, CLIN SPORT MED, V22, P703, DOI 10.1016/S0278-5919(03)00067-X; AMIEL D, 1990, MATRIX, V9, P421, DOI 10.1016/S0934-8832(11)80010-7; AMIEL D, 1984, Journal of Orthopaedic Research, V1, P257; Boles CA, 2010, RADIOL CLIN N AM, V48, P1249, DOI 10.1016/j.rcl.2010.07.015; Butt RH, 2006, J PROTEOME RES, V5, P437, DOI 10.1021/pr0503634; Carr SA, 2014, MOL CELL PROTEOMICS, V13, P907, DOI 10.1074/mcp.M113.036095; Chen YJ, 2008, CONNECT TISSUE RES, V49, P7, DOI 10.1080/03008200701818561; Chiquet M, 1996, BIOCHEM CELL BIOL, V74, P737, DOI 10.1139/o96-080; Cimino F, 2010, AM FAM PHYSICIAN, V82, P917; Cohen J., 1988, STAT POWER ANAL BEHA, P467; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Dismuke WM, 2012, BIOCHEMISTRY-US, V51, P3606, DOI 10.1021/bi300073r; Dowell JA, 2008, ANAL CHEM, V80, P6715, DOI 10.1021/ac8007994; Dunkman AA, 2013, MATRIX BIOL, V32, P3, DOI 10.1016/j.matbio.2012.11.005; Fitzgerald J, 2008, J BIOL CHEM, V283, P20170, DOI 10.1074/jbc.M710139200; Foos MJ, 2001, J ORTHOPAED RES, V19, P642, DOI 10.1016/S0736-0266(00)00071-1; Gara SK, 2008, J BIOL CHEM, V283, P10658, DOI 10.1074/jbc.M709540200; Gilar M, 2005, ANAL CHEM, V77, P6426, DOI 10.1021/ac050923i; Gilar M, 2005, J SEP SCI, V28, P1694, DOI 10.1002/jssc.200500116; GILLARD GC, 1979, CONNECT TISSUE RES, V7, P37, DOI 10.3109/03008207909152351; Griffin L Y, 2000, J Am Acad Orthop Surg, V8, P141; Grover J, 1996, GENOMICS, V38, P109, DOI 10.1006/geno.1996.0605; Gruber HE, 2006, BIOTECH HISTOCHEM, V81, P119, DOI 10.1080/10520290600988239; Gruber HE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2660; Gwinn DE, 2000, AM J SPORT MED, V28, P98, DOI 10.1177/03635465000280012901; Hadjicostas PT, 2008, KNEE SURG SPORT TR A, V16, P1099, DOI 10.1007/s00167-008-0603-1; Han GY, 2011, EXP BIOL MED, V236, P783, DOI 10.1258/ebm.2011.010358; Happonen KE, 2012, J BIOL CHEM, V287, P8092, DOI 10.1074/jbc.M111.291476; Happonen KE, 2010, ARTHRITIS RHEUM-US, V62, P3574, DOI 10.1002/art.27720; Harris RD, 2003, BIOMED SCI INSTRUM, V39, P493; Hasegawa A, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4165; Hasegawa A, 2012, ARTHRITIS RHEUM-US, V64, P696, DOI 10.1002/art.33417; Hedhli N, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/406273; HEINEGARD D, 1986, J BIOL CHEM, V261, P3866; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hynes RO, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a004903; Jelinsky SA, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-86; Jelinsky SA, 2010, J ORTHOP RES, V28, P289, DOI 10.1002/jor.20999; Jelski W, 2009, EXP MOL PATHOL, V87, P59, DOI 10.1016/j.yexmp.2009.03.001; Jiang YK, 2011, BIOMATERIALS, V32, P4085, DOI 10.1016/j.biomaterials.2011.02.033; Jielile J, 2011, APPL BIOCHEM BIOTECH, V165, P1092, DOI 10.1007/s12010-011-9327-7; Joe MK, 2012, J BIOL CHEM, V287, P13216, DOI 10.1074/jbc.M111.224063; Johnson MT, 2009, FRONT BIOSCI-LANDMRK, V14, P1505, DOI 10.2741/3321; Jollymore A, 2009, J MOL BIOL, V385, P1277, DOI 10.1016/j.jmb.2008.11.038; Kalamajski S, 2009, BIOCHEM J, V423, P53, DOI 10.1042/BJ20090542; Kalamajski S, 2009, J BIOL CHEM, V284, P534, DOI 10.1074/jbc.M805721200; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Kielty CM, 2002, J CELL SCI, V115, P2817; Kwon HS, 2009, MOL CELL BIOL, V29, P2139, DOI 10.1128/MCB.01274-08; Lamande SR, 1998, J BIOL CHEM, V273, P7423, DOI 10.1074/jbc.273.13.7423; LeMoine JK, 2009, AM J PHYSIOL-REG I, V296, pR119, DOI 10.1152/ajpregu.90607.2008; Leong NL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035980; Lewis EC, 2012, MOL MED, V18, P957, DOI 10.2119/molmed.2011.00196; Liang Cynthia, 2012, Methods Mol Biol, V854, P181, DOI 10.1007/978-1-61779-573-2_13; Liu Z, 2000, CELL, V102, P647, DOI 10.1016/S0092-8674(00)00087-8; Lo IKY, 2004, AM J SPORT MED, V32, P1223, DOI 10.1177/0363546503262200; Ludwig C, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013987; Maeda T, 2011, CURR BIOL, V21, P933, DOI 10.1016/j.cub.2011.04.007; MANOLIO TA, 1992, CLIN CHEM, V38, P1853; Margaron Y, 2010, BIOPHYS CHEM, V147, P87, DOI 10.1016/j.bpc.2009.12.011; MCPHERSON K, 1978, CLIN CHIM ACTA, V84, P373, DOI 10.1016/0009-8981(78)90254-1; Millar NL, 2012, ANN RHEUM DIS, V71, P302, DOI 10.1136/ard.2011.154229; Naba A, 2012, MATRIX BIOL, V31, P371, DOI 10.1016/j.matbio.2012.11.008; Naba A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014647; Nacu N, 2008, J IMMUNOL, V180, P5036, DOI 10.4049/jimmunol.180.7.5036; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Oliva K, 2013, J ENDOCRINOL; Olsson MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027505; Olsson MG, 2010, FREE RADICAL BIO MED, V48, P284, DOI 10.1016/j.freeradbiomed.2009.10.052; Onnerfjord P, 2012, J BIOL CHEM, V287, P18913, DOI 10.1074/jbc.M111.298968; Pasarica M, 2009, J CLIN ENDOCR METAB, V94, P5155, DOI 10.1210/jc.2009-0947; Pearse RV, 2009, J ORTHOP RES, V27, P427, DOI 10.1002/jor.20774; Peters DM, 2005, EXP CELL RES, V303, P218, DOI 10.1016/j.yexcr.2004.09.026; Petersen W, 1999, ANAT EMBRYOL, V200, P325, DOI 10.1007/s004290050283; Poon IKH, 2010, INT J BIOCHEM CELL B, V42, P1507, DOI 10.1016/j.biocel.2010.05.008; Reddy GK, 2004, EXP DIABESITY RES, V5, P143, DOI 10.1080/15438600490277860; Reddy GK, 2002, ARCH BIOCHEM BIOPHYS, V399, P174, DOI 10.1006/abbi.2001.2747; Reidel B, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002469; Renstrom P, 2008, BRIT J SPORT MED, V42, P394, DOI 10.1136/bjsm.2008.048934; Saka HA, 2011, MOL MICROBIOL, V82, P1185, DOI 10.1111/j.1365-2958.2011.07877.x; Samiric T, 2009, MATRIX BIOL, V28, P230, DOI 10.1016/j.matbio.2009.04.001; Scott A, 2008, SCAND J MED SCI SPOR, V18, P427, DOI 10.1111/j.1600-0838.2007.00735.x; SELLIN S, 1991, BIOCHEMISTRY-US, V30, P2514, DOI 10.1021/bi00223a031; Shliaha PV, 2013, J PROTEOME RES, V12, P2323, DOI 10.1021/pr300775k; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P589, DOI 10.1074/mcp.M500321-MCP200; Slauterbeck JR, 2006, ORTHOP CLIN N AM, V37, P585, DOI 10.1016/j.ocl.2006.09.001; Sodersten F, 2007, CONNECT TISSUE RES, V48, P254, DOI 10.1080/03008200701587505; Stevenson H, 1998, Iowa Orthop J, V18, P64; Sullivan BE, 2009, J APPL PHYSIOL, V106, P468, DOI 10.1152/japplphysiol.91341.2008; Tasheva ES, 2004, MOL VIS, V10, P403; Tasheva ES, 2002, MOL VIS, V8, P407; Tegla CA, 2011, IMMUNOL RES, V51, P45, DOI 10.1007/s12026-011-8239-5; Tischer T, 2007, ARCH ORTHOP TRAUM SU, V127, P735, DOI 10.1007/s00402-007-0320-0; Tsuru M, 2013, STEM CELLS DEV, V22, P2057, DOI 10.1089/scd.2012.0695; Valiyaveettil M, 2005, CONNECT TISSUE RES, V46, P83, DOI 10.1080/03008200590954113; Venkatraman L, 2012, BIOPHYS J, V103, P1060, DOI 10.1016/j.bpj.2012.06.050; Vogel KG, 1999, CLIN ORTHOP RELAT R, pS344, DOI 10.1097/00003086-199910001-00033; Wilson R, 2010, MOL CELL PROTEOMICS, V9, P1296, DOI 10.1074/mcp.M000014-MCP201; Yamada S, 2007, J BIOL CHEM, V282, P23070, DOI 10.1074/jbc.M611181200; Yoshida K, 2005, BBA-GEN SUBJECTS, V1725, P152, DOI 10.1016/j.bbagen.2005.06.009	103	40	42	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96526	10.1371/journal.pone.0096526	http://dx.doi.org/10.1371/journal.pone.0096526			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24818782	Green Submitted, Green Published, gold			2022-12-27	WOS:000336653300020
J	Ye, XW; Zong, G; Liu, X; Liu, G; Gan, W; Zhu, JW; Lu, L; Sun, L; Li, HX; Hu, FB; Lin, X				Ye, Xingwang; Zong, Geng; Liu, Xin; Liu, Gang; Gan, Wei; Zhu, Jingwen; Lu, Ling; Sun, Liang; Li, Huaixing; Hu, Frank B.; Lin, Xu			Development of a New Risk Score for Incident Type 2 Diabetes Using Updated Diagnostic Criteria in Middle-Aged and Older Chinese	PLOS ONE			English	Article							C-REACTIVE PROTEIN; HEALTH MANAGEMENT CENTER; A1C-BASED DIAGNOSIS; PREVALENCE; HEMOGLOBIN; ASSOCIATION; RETINOPATHY; ETHNICITY; OBESITY; MODELS	Type 2 diabetes mellitus (T2DM) reaches an epidemic proportion among adults in China. However, no simple score has been created for the prediction of T2DM incidence diagnosed by updated criteria with hemoglobin A1c (HbA1c) >= 6.5% included in Chinese. In a 6-year follow-up cohort in Beijing and Shanghai, China, we recruited a total of 2529 adults aged 50-70 years in 2005 and followed them up in 2011. Fasting plasma glucose (FPG), HbA1c, and C-reactive protein (CRP) were measured and incident diabetes was identified by the recently updated criteria. Of the 1912 participants without T2DM at baseline, 924 were identified as having T2DM at follow-up, and most of them (72.4%) were diagnosed using the HbA1c criterion. Baseline body mass index, FPG, HbA1c, CRP, hypertension, and female gender were all significantly associated with incident T2DM. Based upon these risk factors, a simple score was developed with an estimated area under the receiver operating characteristic curve of 0.714 (95% confidence interval: 0.691, 0.737), which performed better than most of existing risk score models developed for eastern Asian populations. This simple, newly constructed score of six parameters may be useful in predicting T2DM in middle-aged and older Chinese.	[Ye, Xingwang; Zong, Geng; Liu, Xin; Liu, Gang; Gan, Wei; Zhu, Jingwen; Lu, Ling; Sun, Liang; Li, Huaixing; Lin, Xu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China; [Ye, Xingwang; Zong, Geng; Liu, Xin; Liu, Gang; Gan, Wei; Zhu, Jingwen; Lu, Ling; Sun, Liang; Li, Huaixing; Lin, Xu] Univ Chinese Acad Sci, Shanghai, Peoples R China; [Ye, Xingwang; Sun, Liang] Chinese Acad Sci, Shanghai Inst Biol Sci, SIBS Novo Nordisk Translat Res Ctr PreDiabet, Shanghai, Peoples R China; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Novo Nordisk; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Lin, X (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China.	xlin@sibs.ac.cn	Zong, Geng/ABG-6946-2021; Liu, Gang/H-6420-2019	Liu, Gang/0000-0002-1430-3016	National Natural Science Foundation of China [81200581, 30930081, 81021002, 81202272]; National Key Basic Research Program of Ministry of Science and Technology [2012CB524905]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-R-10]; Key Discipline of Shanghai Public Health-Food and Nutritional Sciences [12GWZX0702]; Novo Nordisk A/S	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of Ministry of Science and Technology; Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Key Discipline of Shanghai Public Health-Food and Nutritional Sciences; Novo Nordisk A/S(Novo Nordisk)	This study was mainly supported by the National Natural Science Foundation of China (81200581, 30930081, 81021002, 81202272), the National Key Basic Research Program of Ministry of Science and Technology (2012CB524905), the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-R-10), and the Key Discipline of Shanghai Public Health-Food and Nutritional Sciences (12GWZX0702) and the Novo Nordisk A/S. The funder Novo Nordisk A/S provided support in the form of salaries for authors [Xingwang Ye and Liang Sun], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Bower JK, 2013, DIABETES CARE, V36, P569, DOI 10.2337/dc12-0404; Brier G. W., 1950, MONTHLY WEATHER REVI, V78, P1, DOI DOI 10.1175/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2; Carson AP, 2010, DIABETES CARE, V33, P95, DOI 10.2337/dc09-1227; Chien K, 2009, DIABETOLOGIA, V52, P443, DOI 10.1007/s00125-008-1232-4; Christensen DL, 2010, DIABETES CARE, V33, P580, DOI 10.2337/dc09-1843; Chuang SY, 2011, DIABETES RES CLIN PR, V92, P128, DOI 10.1016/j.diabres.2010.12.022; Colagiuri S, 2011, DIABETES CARE, V34, P145, DOI 10.2337/dc10-1206; Dallmeier D, 2012, J AM HEART ASSOC, V1, DOI DOI 10.1161/JAHA.112.000869; Doi Y, 2005, DIABETES CARE, V28, P2497, DOI 10.2337/diacare.28.10.2497; Doi Y, 2012, DIABETIC MED, V29, P107, DOI 10.1111/j.1464-5491.2011.03376.x; Du TT, 2013, CLIN EXP PHARMACOL P, V40, P63, DOI 10.1111/1440-1681.12038; Glumer C, 2006, DIABETES CARE, V29, P410, DOI 10.2337/diacare.29.02.06.dc05-0945; Hare MJ, 2012, DIABETES CARE; HARRIS MI, 1992, DIABETES CARE, V15, P815, DOI 10.2337/diacare.15.7.815; Heianza Y, 2012, DIABETOLOGIA, V55, P3213, DOI 10.1007/s00125-012-2712-0; Heianza Y, 2012, DIABETES RES CLIN PR, V95, P283, DOI 10.1016/j.diabres.2011.10.024; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Khoo CM, 2011, DIABETES CARE, V34, P1120, DOI 10.2337/dc10-2097; Kim CH, 2011, DIABETES RES CLIN PR, V91, pE8, DOI 10.1016/j.diabres.2010.09.025; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Lim NK, 2012, CIRC J, V76, P1904, DOI 10.1253/circj.CJ-11-1236; Liu M, 2011, DIABETES TECHNOL THE, V13, P501, DOI 10.1089/dia.2010.0106; Nakanishi S, 2003, DIABETES CARE, V26, P2754, DOI 10.2337/diacare.26.10.2754; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Noble D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7163; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Sabanayagam C, 2011, DIABETOLOGIA, V54, P767, DOI 10.1007/s00125-011-2052-5; Salomaa V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010100; Shai I, 2006, DIABETES CARE, V29, P1585, DOI 10.2337/dc06-0057; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Sun F, 2009, DIABETES RES CLIN PR, V85, P228, DOI 10.1016/j.diabres.2009.05.005; Tsugawa Y, 2012, DIABETES, V61, P3280, DOI 10.2337/db12-0103; Wang X, 2013, DIABETES CARE, V36, P166, DOI 10.2337/dc12-0702; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Ye XW, 2007, J AM COLL CARDIOL, V49, P1798, DOI 10.1016/j.jacc.2007.01.065; Ye XW, 2009, CLIN ENDOCRINOL, V70, P854, DOI 10.1111/j.1365-2265.2008.03399.x	38	18	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97042	10.1371/journal.pone.0097042	http://dx.doi.org/10.1371/journal.pone.0097042			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819157	gold, Green Published, Green Submitted			2022-12-27	WOS:000336653300064
J	Fofana, MO; Knight, GM; Gomez, GB; White, RG; Dowdy, DW				Fofana, Mariam O.; Knight, Gwenan M.; Gomez, Gabriela B.; White, Richard G.; Dowdy, David W.			Population-Level Impact of Shorter-Course Regimens for Tuberculosis: A Model-Based Analysis	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; DRUG DEVELOPMENT; MOXIFLOXACIN; TRIAL; TRANSMISSION; CHEMOTHERAPY; REINFECTION; PREVALENCE; ETHAMBUTOL; INFECTION	Despite current control efforts, global tuberculosis (TB) incidence is decreasing slowly. New regimens that can shorten treatment hold promise for improving treatment completion and success, but their impact on population-level transmission remains unclear. Earlier models projected that a four-month regimen could reduce TB incidence by 10% but assumed that an entire course of therapy must be completed to derive any benefit. We constructed a dynamic transmission model of TB disease calibrated to global estimates of incidence, prevalence, mortality, and treatment success. To account for the efficacy of partial treatment, we used data from clinical trials of early short-course regimens to estimate relapse rates among TB patients who completed one-third, one-half, two-thirds, and all of their first-line treatment regimens. We projected population-level incidence and mortality over 10 years, comparing standard six-month therapy to hypothetical shorter-course regimens with equivalent treatment success but fewer defaults. The impact of hypothetical four-month regimens on TB incidence after 10 years was smaller than estimated in previous modeling analyses (1.9% [95% uncertainty range 0.6-3.1%] vs. 10%). Impact on TB mortality was larger (3.5% at 10 years) but still modest. Transmission impact was most sensitive to the proportion of patients completing therapy: four-month therapy led to greater incidence reductions in settings where 25% of patients leave care ("default'') over six months. Our findings remained robust under one-way variation of model parameters. These findings suggest that novel regimens that shorten treatment duration may have only a modest effect on TB transmission except in settings of very low treatment completion.	[Fofana, Mariam O.; Dowdy, David W.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Fofana, Mariam O.] Johns Hopkins Sch Med, Med Scientist Training Program, Baltimore, MD USA; [Knight, Gwenan M.; White, Richard G.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, TB Ctr, TB Modelling Grp, London WC1, England; [Knight, Gwenan M.; White, Richard G.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Ctr Math Modelling Infect Dis, London WC1, England; [Gomez, Gabriela B.] Univ Amsterdam, Dept Global Hlth, Amsterdam, Netherlands; [Gomez, Gabriela B.] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Dowdy, David W.] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Amsterdam; Johns Hopkins University	Fofana, MO (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	mfofana4@jhmi.edu; ddowdy@jhsph.edu	Knight, Gwen/AGE-2703-2022; Knight, Gwen/AAF-1176-2020; Fofana, Mariam O./H-5208-2019; White, Richard G/D-5407-2009	Fofana, Mariam O./0000-0002-2874-471X; White, Richard G/0000-0003-4410-6635; Knight, Gwenan/0000-0002-7263-9896	National Institutes of Health [NIH T32 GM007309]; Paul and Daisy Soros Fellowship for New Americans; UK Medical Research Council [MR/J005088/1]; CDC/PEPFAR via the Aurum Institute [U2GPS0008111]; Bill and Melinda Gates Foundation [21675/OPP1084276, 19790.01]; B. Frank and Kathleen Polk Assistant Professorship in Epidemiology at the Johns Hopkins Bloomberg School of Public Health; Medical Research Council [MR/J005088/1] Funding Source: researchfish; MRC [MR/J005088/1] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul and Daisy Soros Fellowship for New Americans; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CDC/PEPFAR via the Aurum Institute; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); B. Frank and Kathleen Polk Assistant Professorship in Epidemiology at the Johns Hopkins Bloomberg School of Public Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health [NIH T32 GM007309 to [MOF], the Paul and Daisy Soros Fellowship for New Americans [MOF], the UK Medical Research Council [MR/J005088/1 to RGW], CDC/PEPFAR via the Aurum Institute [U2GPS0008111 to RGW], the Bill and Melinda Gates Foundation [21675/OPP1084276 (TB Modelling and Analysis Consortium) to RGW, 19790.01 (Consortium to Respond Effectively to the AIDS/TB Epidemic) to RGW, Work Order 10 (Modeling Impact for Novel TB Drug Regimens) [to DWD], and the B. Frank and Kathleen Polk Assistant Professorship in Epidemiology at the Johns Hopkins Bloomberg School of Public Health [DWD]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2009, P NATL ACAD SCI USA, V106, P13980, DOI 10.1073/pnas.0901720106; Andrews JR, 2012, CLIN INFECT DIS, V54, P784, DOI 10.1093/cid/cir951; [Anonymous], 1986, AM REV RESP DIS, V133, P779; BLOWER SM, 1995, NAT MED, V1, P815, DOI 10.1038/nm0895-815; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Burman WJ, 2006, AM J RESP CRIT CARE, V174, P331, DOI 10.1164/rccm.200603-360OC; Conde MB, 2009, LANCET, V373, P1183, DOI 10.1016/S0140-6736(09)60333-0; Diacon AH, 2012, LANCET, V380, P986, DOI 10.1016/S0140-6736(12)61080-0; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; Dye C, 1998, LANCET, V352, P1886, DOI 10.1016/S0140-6736(98)03199-7; Flexner C, 2007, NAT REV DRUG DISCOV, V6, P959, DOI 10.1038/nrd2336; FOX W, 1981, BRIT J DIS CHEST, V75, P331, DOI 10.1016/0007-0971(81)90022-X; Garnett GP, 2011, LANCET, V378, P515, DOI 10.1016/S0140-6736(10)61505-X; Ginsberg AM, 2007, NAT MED, V13, P290, DOI 10.1038/nm0307-290; Ginsberg AM, 2010, TUBERCULOSIS, V90, P162, DOI 10.1016/j.tube.2010.03.003; Harries AD, 2006, ANN TROP MED PARASIT, V100, P415, DOI 10.1179/136485906X91477; Harries AD, 2001, INT J TUBERC LUNG D, V5, P1000; Horsburgh CR, 2010, AM J RESP CRIT CARE, V182, P420, DOI 10.1164/rccm.200909-1355OC; Johnson JL, 2009, AM J RESP CRIT CARE, V180, P558, DOI 10.1164/rccm.200904-0536OC; Jonnalagada S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-921; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Kruk ME, 2008, TROP MED INT HEALTH, V13, P703, DOI 10.1111/j.1365-3156.2008.02042.x; Ma ZK, 2010, LANCET, V375, P2100, DOI 10.1016/S0140-6736(10)60359-9; Maher D, 2007, B WORLD HEALTH ORGAN, V85, P341, DOI 10.2471/BLT.06.037820; Menzies D, 1997, INFECT CONT HOSP EP, V18, P582; Moolphate S, 2011, INT J GEN MED, V4, P181, DOI 10.2147/IJGM.S16486; Owens JP, 2013, INT J TUBERC LUNG D, V17, P590, DOI 10.5588/ijtld.12.0776; Salomon JA, 2006, PLOS MED, V3, P1302, DOI 10.1371/journal.pmed.0030273; Sepkowitz KA, 1996, CLIN INFECT DIS, V23, P954, DOI 10.1093/clinids/23.5.954; Sharma S, 2011, AM J THER, V18, pE101, DOI 10.1097/MJT.0b013e3181c3509c; Spigelman M, 2006, LANCET, V367, P945, DOI 10.1016/S0140-6736(06)68388-8; SUTHERLAND I, 1982, TUBERCLE, V63, P255, DOI 10.1016/S0041-3879(82)80013-5; Tiemersma EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017601; United Nations Population Division, 2011, WORLD POP PROS 2010; Van Leth F, 2008, B WORLD HEALTH ORGAN, V86, P20, DOI 10.2471/BLT.06.037804; Vynnycky E, 1997, EPIDEMIOL INFECT, V119, P183, DOI 10.1017/S0950268897007917; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; 1984, AM REV RESP DIS, V130, P23	38	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96389	10.1371/journal.pone.0096389	http://dx.doi.org/10.1371/journal.pone.0096389			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816692	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000336838000036
J	Holyoak, M; Meese, RJ; Graves, EE				Holyoak, Marcel; Meese, Robert J.; Graves, Emily E.			Combining Site Occupancy, Breeding Population Sizes and Reproductive Success to Calculate Time-Averaged Reproductive Output of Different Habitat Types: An Application to Tricolored Blackbirds	PLOS ONE			English	Article							CONSERVATION; DYNAMICS	In metapopulations in which habitat patches vary in quality and occupancy it can be complicated to calculate the net time-averaged contribution to reproduction of particular populations. Surprisingly, few indices have been proposed for this purpose. We combined occupancy, abundance, frequency of occurrence, and reproductive success to determine the net value of different sites through time and applied this method to a bird of conservation concern. The Tricolored Blackbird (Agelaius tricolor) has experienced large population declines, is the most colonial songbird in North America, is largely confined to California, and breeds itinerantly in multiple habitat types. It has had chronically low reproductive success in recent years. Although young produced per nest have previously been compared across habitats, no study has simultaneously considered site occupancy and reproductive success. Combining occupancy, abundance, frequency of occurrence, reproductive success and nest failure rate we found that that large colonies in grain fields fail frequently because of nest destruction due to harvest prior to fledging. Consequently, net time-averaged reproductive output is low compared to colonies in non-native Himalayan blackberry or thistles, and native stinging nettles. Cattail marshes have intermediate reproductive output, but their reproductive output might be improved by active management. Harvest of grain-field colonies necessitates either promoting delay of harvest or creating alternative, more secure nesting habitats. Stinging nettle and marsh colonies offer the main potential sources for restoration or native habitat creation. From 20052011 breeding site occupancy declined 3x faster than new breeding colonies were formed, indicating a rapid decline in occupancy. Total abundance showed a similar decline. Causes of variation in the value for reproduction of nesting substrates and factors behind continuing population declines merit urgent investigation. The method we employ should be useful in other metapopulation studies for calculating time-averaged reproductive output for different sites.	[Holyoak, Marcel; Meese, Robert J.] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Graves, Emily E.] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA; [Graves, Emily E.] Univ Calif Davis, Avian Sci Grad Grp, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Holyoak, M (corresponding author), Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA.	maholyoak@ucdavis.edu	Holyoak, Marcel/C-3475-2009	Holyoak, Marcel/0000-0001-9727-3627	U.S. Fish & Wildlife Service; Calif. Dept. Fish and Wildlife; JiJi Foundation; California Dept. Fish and Wildlife	U.S. Fish & Wildlife Service(US Fish & Wildlife Service); Calif. Dept. Fish and Wildlife; JiJi Foundation; California Dept. Fish and Wildlife	The authors thank U.S. Fish & Wildlife Service, Calif. Dept. Fish and Wildlife, and the JiJi Foundation for funding RJM. MH was funded by a Hatch fund project and EEG was funded by California Dept. Fish and Wildlife. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong DP, 2005, CONSERV BIOL, V19, P1402, DOI 10.1111/j.1523-1739.2005.00117.x; Baayen RH, 2011, LANGUAGER DATA SETS; Bates DM, 2013, PACKAGE LME4 LINEAR; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; Beedy E. C., 1999, BIRDS N AM; Beedy E. C., 2008, STUDIES W BIRDS, V1, P437; Beedy EC, 1991, BREEDING STATUS DIST, P88; Bent AC, 1958, US NATL MUS B, V211; Brawn JD, 1996, ECOLOGY, V77, P3, DOI 10.2307/2265649; Bureau of Land Management, 2006, UPD AN SENS SPEC LIS; Cook LF, 2005, BIRD CONSERV INT, V15, P73, DOI 10.1017/S0959270905000067; CRASE FT, 1978, CALIF FISH GAME, V64, P255; DiTomaso JM, 2006, WEED TECHNOL, V20, P535, DOI 10.1614/WT-05-086R1.1; Graves EE, 2013, DRYAD DIGITAL REPOSI, DOI [10.5061/dryad.8vc80Accessed, DOI 10.5061/DRYAD.8VC80]; Graves EE, 2013, ECOL EVOL, V3, P2845, DOI 10.1002/ece3.681; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hamilton III W. J., 2006, HABITAT POPULATION C; Hamilton III WJ, 2013, HIST TRICOLORED BLAC; Hamilton III WJ, 1995, TRICOLORED BLACKBIRD; Hamilton WJ, 1998, CONDOR, V100, P218, DOI 10.2307/1370263; Hamilton WJ III, 2004, B CENTRAL VALLEY BIR, V7, P32; HANSKI I, 1997, METAPOPULATION BIOL; Ims Rolf A., 1997, P247, DOI 10.1016/B978-012323445-2/50015-8; IUCN, 2013, IUCN RED LIST THREAT; Kelly JP, 2007, WATERBIRDS, V30, P455, DOI 10.1675/1524-4695(2007)030[0455:STAIFT]2.0.CO;2; Kelsey R, 2008, RESULTS 2008 TRICOLO; Kyle K., 2001, RESULTS 2011 TRICOLO; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; McCoy TD, 1999, J WILDLIFE MANAGE, V63, P530, DOI 10.2307/3802639; Meese RJ, 2011, REPROD SUCCESS TRICO; Meese RJ, 2006, SETTLEMENT BREEDING, P40; Meese Robert J., 2013, Western Birds, V44, P98; Meese RJ, 2012, CALIF FISH GAME, V98, P47; Neff J. A., 1937, Condor Berkeley, V39, P61, DOI 10.2307/1363776; ORIANS GH, 1961, ECOL MONOGR, V31, P285, DOI 10.2307/1948556; Peery MZ, 2006, ECOL APPL, V16, P1516, DOI 10.1890/1051-0761(2006)016[1516:CDACAT]2.0.CO;2; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Robertson BA, 2006, ECOLOGY, V87, P1075, DOI 10.1890/0012-9658(2006)87[1075:AFFUET]2.0.CO;2; Stearns S.C., 1992, pi; Therneau T, 2013, PACKAGE SURVIAL ANAL; Tricolored Blackbird Working Group, 2007, CONSERVATION PLAN TR; United States Fish and Wildlife Service (USFWS), 2008, BIRDS CONSERVATION 2; Weintraub K, 2013, THESIS HUMBOLDT STAT	44	9	9	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96980	10.1371/journal.pone.0096980	http://dx.doi.org/10.1371/journal.pone.0096980			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24817307	gold, Green Published			2022-12-27	WOS:000336838000090
J	Rogers, SR; Tarpy, DR; Burrack, HJ				Rogers, Shelley R.; Tarpy, David R.; Burrack, Hannah J.			Bee Species Diversity Enhances Productivity and Stability in a Perennial Crop	PLOS ONE			English	Article							HABROPODA-LABORIOSA; RESPONSE DIVERSITY; PLANT DIVERSITY; APIS-MELLIFERA; NATIVE BEES; HONEY-BEES; FRUIT-SET; HYMENOPTERA; VACCINIUM; BIODIVERSITY	Wild bees provide important pollination services to agroecoystems, but the mechanisms which underlie their contribution to ecosystem functioning-and, therefore, their importance in maintaining and enhancing these services-remain unclear. We evaluated several mechanisms through which wild bees contribute to crop productivity, the stability of pollinator visitation, and the efficiency of individual pollinators in a highly bee-pollination dependent plant, highbush blueberry. We surveyed the bee community (through transect sampling and pan trapping) and measured pollination of both open-and singly-visited flowers. We found that the abundance of managed honey bees, Apis mellifera, and wild-bee richness were equally important in describing resulting open pollination. Wild-bee richness was a better predictor of pollination than wild-bee abundance. We also found evidence suggesting pollinator visitation (and subsequent pollination) are stabilized through the differential response of bee taxa to weather (i.e., response diversity). Variation in the individual visit efficiency of A. mellifera and the southeastern blueberry bee, Habropoda laboriosa, a wild specialist, was not associated with changes in the pollinator community. Our findings add to a growing literature that diverse pollinator communities provide more stable and productive ecosystem services.	[Rogers, Shelley R.; Tarpy, David R.; Burrack, Hannah J.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Rogers, SR (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	shelleyrogers@eml.cc	Burrack, Hannah/CAJ-5730-2022	Tarpy, David/0000-0001-8601-6094; Burrack, Hannah/0000-0002-8460-8245	NC Blueberry Council; NC State Beekeepers Apicultural Science Research Grant; NSF Graduate Research Fellowship	NC Blueberry Council; NC State Beekeepers Apicultural Science Research Grant; NSF Graduate Research Fellowship(National Science Foundation (NSF))	Funding was provided by the NC Blueberry Council, NC State Beekeepers Apicultural Science Research Grant, and a NSF Graduate Research Fellowship to SRR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson NL, 2011, THESIS VIRGINIA POLY; Allen-Wardell G, 1998, CONSERV BIOL, V12, P8; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bluthgen N, 2011, BASIC APPL ECOL, V12, P282, DOI 10.1016/j.baae.2010.11.001; Brittain C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2767; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; CANE JH, 1988, ANN ENTOMOL SOC AM, V81, P419, DOI 10.1093/aesa/81.3.419; Cane JH, 2000, J KANSAS ENTOMOL SOC, V73, P225; CANE JH, 1993, ANN ENTOMOL SOC AM, V86, P577, DOI 10.1093/aesa/86.5.577; Cane JH, 1997, ACTA HORTIC, P67, DOI 10.17660/ActaHortic.1997.446.8; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cariveau DP, 2013, ECOL LETT, V16, P903, DOI 10.1111/ele.12126; CHAGNON M, 1993, J ECON ENTOMOL, V86, P416, DOI 10.1093/jee/86.2.416; Delaplane K. S., 2000, Crop pollination by bees., DOI 10.1079/9780851994482.0000; Dogterom MH, 2000, AM J BOT, V87, P1584, DOI 10.2307/2656734; Droege S, 2010, VERY HANDY MANUAL CA; Droege S, 2010, INSECT CONSERV DIVER, V3, P15, DOI 10.1111/j.1752-4598.2009.00074.x; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Ebeling A, 2011, BASIC APPL ECOL, V12, P300, DOI 10.1016/j.baae.2011.04.005; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Garibaldi LA, 2011, ECOL LETT, V14, P1062, DOI 10.1111/j.1461-0248.2011.01669.x; Greenleaf SS, 2006, P NATL ACAD SCI USA, V103, P13890, DOI 10.1073/pnas.0600929103; Haddad NM, 2011, ECOL LETT, V14, P42, DOI 10.1111/j.1461-0248.2010.01548.x; Hoehn P, 2008, P ROY SOC B-BIOL SCI, V275, P2283, DOI 10.1098/rspb.2008.0405; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Huang YH, 1997, J AM SOC HORTIC SCI, V122, P616, DOI 10.21273/JASHS.122.5.616; INOUYE DW, 1980, ECOLOGY, V61, P1251, DOI 10.2307/1936841; INOUYE DW, 1978, ECOLOGY, V59, P672, DOI 10.2307/1938769; Klein AM, 2003, P ROY SOC B-BIOL SCI, V270, P955, DOI 10.1098/rspb.2002.2306; Lichtenberg EM, 2010, INSECT SOC, V57, P105, DOI 10.1007/s00040-009-0055-8; Lonsdorf E, 2009, ANN BOT-LONDON, V103, P1589, DOI 10.1093/aob/mcp069; LOOSE JL, 2005, MAINE AGR FOREST EXP, V191, P1; MacKenzie KE, 1996, J KANSAS ENTOMOL SOC, V69, P185; MACKENZIE KE, 1984, CAN ENTOMOL, V116, P965, DOI 10.4039/Ent116965-7; Mainland CM, 2012, P NC BLUEBERRY COUNC, V46, P26; Makino TT, 2005, BEHAV ECOL SOCIOBIOL, V57, P617, DOI 10.1007/s00265-004-0877-3; Michener C.D., 1986, Contributions of the American Entomological Institute, V22, P1; MICHENER CD, 1994, BEE GENERA N CENTRAL; Mitchell T. B., 1962, Technical Bulletin North Carolina Agricultural Experiment Station, Vno. 152, P1; MITCHELL THEODORE B., 1960, N CAROLINA AGRIC EXPT STA TECH BULL, V141, P1; MORSE DH, 1982, INSECT SOC, V29, P445, DOI 10.1007/BF02226159; Naeem S, 1998, CONSERV BIOL, V12, P39, DOI 10.1046/j.1523-1739.1998.96379.x; Pascarella JB, 2007, J APICULT RES, V46, P19, DOI 10.1080/00218839.2007.11101362; Pinkus-Rendon MA, 2005, CAN ENTOMOL, V137, P441; Ratti CM, 2008, CAN ENTOMOL, V140, P348, DOI 10.4039/N07-065; Rogers SR, 2013, ENVIRON ENTOMOL, V42, P1201, DOI 10.1603/EN12303; Rogers SR, 2013, APIDOLOGIE, V44, P621, DOI 10.1007/s13592-013-0210-0; Roulston TH, 2007, J KANSAS ENTOMOL SOC, V80, P179, DOI 10.2317/0022-8567(2007)80[179:ACOPTA]2.0.CO;2; Sanchez-Lafuente AM, 2012, OECOLOGIA, V168, P153, DOI 10.1007/s00442-011-2084-z; Sheffield CS, 2003, J KANSAS ENTOMOL SOC, V76, P357; Stubbs C. S., 1992, MAINE AGR EXPT STATI, V148; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Tuell JK, 2010, J ECON ENTOMOL, V103, P557, DOI 10.1603/EC09387; Tuell JK, 2009, ENTOMOL EXP APPL, V131, P93, DOI 10.1111/j.1570-7458.2009.00826.x; Tuell JK, 2009, ANN ENTOMOL SOC AM, V102, P275, DOI 10.1603/008.102.0209; Vicens N, 2000, ENVIRON ENTOMOL, V29, P413, DOI 10.1603/0046-225X-29.3.413; Westphal C, 2008, ECOL MONOGR, V78, P653, DOI 10.1890/07-1292.1; Williams NM, 2010, BIOL CONSERV, V143, P2280, DOI 10.1016/j.biocon.2010.03.024; Winfree R, 2009, P R SOC B, V276, P229, DOI 10.1098/rspb.2008.0709; Winfree R, 2007, ECOL LETT, V10, P1105, DOI 10.1111/j.1461-0248.2007.01110.x	61	47	49	5	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97307	10.1371/journal.pone.0097307	http://dx.doi.org/10.1371/journal.pone.0097307			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24817218	Green Published, Green Submitted, gold			2022-12-27	WOS:000336838000128
J	Bastien, M; Jaeger, A; Le Corre, M; Tortosa, P; Lebarbenchon, C				Bastien, Matthieu; Jaeger, Audrey; Le Corre, Matthieu; Tortosa, Pablo; Lebarbenchon, Camille			Haemoproteus iwa in Great Frigatebirds (Fregata minor) in the Islands of the Western Indian Ocean	PLOS ONE			English	Article							BLOOD PARASITES; SEABIRD COMMUNITY; PLASMODIUM; ABSENCE	Blood parasites of the sub-genus Haemoproteus have been reported in seabirds, in particular in species in the Suliformes order. These parasites are transmitted by hippoboscid flies of the genus Olfersia; strong specificity has been suggested between the vector and its vertebrate host. We investigated the prevalence of Haemoproteus infection in Suliformes and hippoboscid flies in two oceanic islands of the Western Indian Ocean: Europa and Tromelin. In total, 209 blood samples were collected from great frigatebirds (Fregata minor), masked boobies (Sula dactylatra) and red-footed boobies (Sula sula). Forty-one hippoboscid flies were also collected from birds. Seventeen frigatebirds and one fly collected on Europa tested positive for the presence of Haemoproteus parasites by polymerase chain reaction. Phylogenetic analyses based on partial sequences of the Cytochrome b gene showed that parasites were closely related to Haemoproteus iwa reported from frigatebirds in the Pacific Ocean and in the Caribbean. Plasmodium was also detected in a frigatebird on Europa; however, its placement on the phylogenetic tree could not be resolved. We provide strong support for transmission of blood parasites in seabirds in the Western Indian Ocean and suggest that migrations between the Pacific and the Indian oceans could favor the large-scale distribution of Haemoproteus iwa in frigatebird populations.	[Bastien, Matthieu; Tortosa, Pablo; Lebarbenchon, Camille] Ctr Rech & Veille Malad Emergentes Ocean Indien, St Clotilde, Reunion, France; [Bastien, Matthieu; Jaeger, Audrey; Le Corre, Matthieu] Univ Reunion, Lab Ecol Marine, St Denis, Reunion, France; [Tortosa, Pablo; Lebarbenchon, Camille] Univ Reunion, St Denis, Reunion, France	University of La Reunion; University of La Reunion	Lebarbenchon, C (corresponding author), Ctr Rech & Veille Malad Emergentes Ocean Indien, St Clotilde, Reunion, France.	camille.lebarbenchon@univ-reunion.fr	Lebarbenchon, Camille/H-7245-2013; Lebarbenchon, Camille/GLQ-7287-2022	Lebarbenchon, Camille/0000-0002-0922-7573; Lebarbenchon, Camille/0000-0002-0922-7573; Tortosa, Pablo/0000-0002-7928-7264; Jaeger, Audrey/0000-0002-5649-0315	FEDER "Pathogenes associes a la Faune Sauvage Ocean Indien" [2007-013, 31189]; CNRS-INEE/TAAF; European Union [263958]; "Federation Environnement-Biodiversite-Sante" training program fellowship	FEDER "Pathogenes associes a la Faune Sauvage Ocean Indien"; CNRS-INEE/TAAF; European Union(European Commission); "Federation Environnement-Biodiversite-Sante" training program fellowship	This work was supported by the FEDER "Pathogenes associes a la Faune Sauvage Ocean Indien" (Programme Operationnel de Cooperation Territoriale 2007-013; #31189) and by the CNRS-INEE/TAAF (AAP Iles Eparses "PathOrnithoTiques" and "OMABIO" projects). The research leading to these results has received funding from the European Union's Seventh Framework Program (FP7/2007-2013) under grant agreement no 263958 (A. Jaeger and C. Lebarbenchon post-doctoral fellowships). M. Bastien was supported by a "Federation Environnement-Biodiversite-Sante" training program fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; Bagny L., 2009, B SOC PATHOLOGIE EXO, V102, P192; BENNETT GF, 1966, J PARASITOL, V52, P647, DOI 10.2307/3276421; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hellgren O, 2004, J PARASITOL, V90, P797, DOI 10.1645/GE-184R1; Jovani R, 2001, WATERBIRDS, V24, P430, DOI 10.2307/1522076; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Le Corre M, 2005, ESTUAR COAST SHELF S, V63, P421, DOI 10.1016/j.ecss.2004.11.013; Lebarbenchon C, 2013, J WILDLIFE DIS, V49, P1056, DOI 10.7589/2012-09-227; LeCorre M, 1996, OSTRICH, V67, P155, DOI 10.1080/00306525.1996.9639704; Levin II, 2013, PARASITOLOGY, V140, P1061, DOI 10.1017/S0031182013000437; Levin II, 2012, J PARASITOL, V98, P924, DOI 10.1645/GE-3027.1; Levin II, 2011, INT J PARASITOL, V41, P1019, DOI 10.1016/j.ijpara.2011.03.014; Longmire JL, 1988, GENOMICS, V2, P14, DOI 10.1016/0888-7543(88)90104-8; LOWERY RS, 1971, PHILOS T R SOC B, V260, P577, DOI 10.1098/rstb.1971.0026; Madsen V, 2007, HORM BEHAV, V51, P156, DOI 10.1016/j.yhbeh.2006.09.010; Martinsen ES, 2008, MOL PHYLOGENET EVOL, V47, P261, DOI 10.1016/j.ympev.2007.11.012; Merino S, 2012, J PARASITOL, V98, P388, DOI 10.1645/GE-2415.1; Padilla LR, 2006, ORNITHOL MONOGR, P86; Quillfeldt P, 2011, FRONTIERS ZOOLOGY, V26, P1; Quillfeldt P, 2014, PARASITOLOGY, V141, P399, DOI 10.1017/S0031182013001649; R Core Team, 2021, R LANGUAGE ENV STAT; Valkiunas G, 2008, J PARASITOL, V94, P1395, DOI 10.1645/GE-1570.1; Weimerskirch H, 2006, CONDOR, V108, P220, DOI 10.1650/0010-5422(2006)108[0220:PMOFTW]2.0.CO;2	25	11	11	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e97185	10.1371/journal.pone.0097185	http://dx.doi.org/10.1371/journal.pone.0097185			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810172	gold, Green Published, Green Submitted			2022-12-27	WOS:000338213300129
J	Bhardwaj, A; Rosen, D; Liu, M; Liu, Y; Hao, Q; Ganesan, N; Etzel, CJ; Gullett, A; Albarracin, CT; Bedrosian, I				Bhardwaj, Anjana; Rosen, Daniel; Liu, Mei; Liu, Yan; Hao, Qiang; Ganesan, Nivetha; Etzel, Carol J.; Gullett, Ashley; Albarracin, Constance T.; Bedrosian, Isabelle			Suppression of Akt-mTOR Pathway-A Novel Component of Oncogene Induced DNA Damage Response Barrier in Breast Tumorigenesis	PLOS ONE			English	Article							CANCER SUSCEPTIBILITY; REPAIR GENES; CELL-LINES; GENOMIC INSTABILITY; EPITHELIAL-CELLS; CYCLIN-E; RISK; ATM; POLYMORPHISMS; PROGRESSION	DNA damage has been thought to be directly associated with the neoplastic progression by enabling mutations in tumor suppressor genes and activating/and amplifying oncogenes ultimately resulting in genomic instability. DNA damage causes activation of the DNA damage response (DDR) that is an important cellular mechanism for maintaining genomic integrity in the face of genotoxic stress. While the cellular response to genotoxic stress has been extensively studied in cancer models, less is known about the cellular response to oncogenic stress in the premalignant context. In the present study, by using breast tissues samples from women at different risk levels for invasive breast cancer (normal, proliferative breast disease and ductal carcinoma in situ) we found that DNA damage is inversely correlated with risk of invasive breast cancer. Similarly, in MCF10A based in vitro model system where we recapitulated high DNA damage conditions as seen in patient samples by stably cloning in cyclin E, we found that high levels of oncogene induced DNA damage, by triggering inhibition of a major proliferative pathway (AKT), inhibits cell growth and causes cells to die through autophagy. These data suggest that AKT-mTOR pathway is a novel component of oncogene induced DNA damage response in immortalized 'normal-like' breast cells and its suppression may contribute to growth arrest and arrest of the breast tumorigenesis.	[Bhardwaj, Anjana; Liu, Yan; Hao, Qiang; Ganesan, Nivetha; Bedrosian, Isabelle] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Liu, Mei; Etzel, Carol J.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Rosen, Daniel; Gullett, Ashley; Albarracin, Constance T.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Bedrosian, I (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA.	ibedrosian@mdanderson.org		Bhardwaj, Anjana/0000-0003-4234-0241	Komen grant [KG 090351]; American Society of Clinical Oncology/Conquer Cancer Foundation	Komen grant(Susan G. Komen Breast Cancer Foundation); American Society of Clinical Oncology/Conquer Cancer Foundation	This work was supported by Komen grant (KG 090351) and Advanced Clinical Research Award from American Society of Clinical Oncology/Conquer Cancer Foundation) awarded to IB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akli S, 2004, CANCER RES, V64, P3198, DOI 10.1158/0008-5472.CAN-03-3672; Akli S, 2007, CANCER RES, V67, P7212, DOI 10.1158/0008-5472.CAN-07-0599; Alexander A, 2010, P NATL ACAD SCI USA, V107, P4153, DOI 10.1073/pnas.0913860107; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2008, MOL ONCOL, V2, P296, DOI 10.1016/j.molonc.2008.09.007; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Concannon P, 2008, CANCER RES, V68, P6486, DOI 10.1158/0008-5472.CAN-08-0134; Crew KD, 2007, CANCER EPIDEM BIOMAR, V16, P2033, DOI 10.1158/1055-9965.EPI-07-0096; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Fiebiger W, 2011, CLIN TRANSL ONCOL, V13, P43, DOI 10.1007/s12094-011-0615-z; Fu YP, 2003, CANCER RES, V63, P2440; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Kadota M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009201; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kim SH, 2009, INT J CANCER, V124, P2813, DOI 10.1002/ijc.24278; Krajewska M, 2009, J HISTOCHEM CYTOCHEM, V57, P649, DOI 10.1369/jhc.2009.952812; Kuschel B, 2002, HUM MOL GENET, V11, P1399, DOI 10.1093/hmg/11.12.1399; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; MILLER FR, 1993, J NATL CANCER I, V85, P1725, DOI 10.1093/jnci/85.21.1725; Nagelkerke A, 2011, RADIOTHER ONCOL, V101, P39, DOI 10.1016/j.radonc.2011.07.009; RUSSO J, 1991, J CELL SCI, V99, P453; Santisteban M, 2010, BREAST CANCER RES TR, V121, P431, DOI 10.1007/s10549-009-0534-7; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Smith TR, 2003, CANCER EPIDEM BIOMAR, V12, P1200; So Jae Young, 2012, Mol Cell Pharmacol, V4, P31; SOULE HD, 1990, CANCER RES, V50, P6075; Tort F, 2006, CANCER RES, V66, P10258, DOI 10.1158/0008-5472.CAN-06-2178; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wang XS, 2008, CANCER RES, V68, P971, DOI 10.1158/0008-5472.CAN-07-6272	30	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e97076	10.1371/journal.pone.0097076	http://dx.doi.org/10.1371/journal.pone.0097076			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24811059	gold, Green Published, Green Submitted			2022-12-27	WOS:000338213300117
J	Boglione, C; Pulcini, D; Scardi, M; Palamara, E; Russo, T; Cataudella, S				Boglione, Clara; Pulcini, Domitilla; Scardi, Michele; Palamara, Elisa; Russo, Tommaso; Cataudella, Stefano			Skeletal Anomaly Monitoring in Rainbow Trout (Oncorhynchus mykiss, Walbaum 1792) Reared under Different Conditions	PLOS ONE			English	Article							SALMON SALMO-SALAR; ADAPTIVE PLASTICITY HYPOTHESIS; SOLE SOLEA-SENEGALENSIS; SEABREAM SPARUS-AURATA; ATLANTIC SALMON; VERTEBRAL COLUMN; SEA BREAM; OSTEOLOGICAL DEVELOPMENT; PHENOTYPIC PLASTICITY; MERISTIC COUNTS	The incidence of skeletal anomalies could be used as an indicator of the "quality" of rearing conditions as these anomalies are thought to result from the inability of homeostatic mechanisms to compensate for environmentally-induced stress and/or altered genetic factors. Identification of rearing conditions that lower the rate of anomalies can be an important step toward profitable aquaculture as malformed market-size fish have to be discarded, thus reducing fish farmers' profits. In this study, the occurrence of skeletal anomalies in adult rainbow trout grown under intensive and organic conditions was monitored. As organic aquaculture animal production is in its early stages, organic broodstock is not available in sufficient quantities. Non-organic juveniles could, therefore, be used for on-growing purposes in organic aquaculture production cycle. Thus, the adult fish analysed in this study experienced intensive conditions during juvenile rearing. Significant differences in the pattern of anomalies were detected between organically and intensively-ongrown specimens, although the occurrence of severe, commercially important anomalies, affecting 2-12.5% of individuals, was comparable in the two systems. Thus, organic aquaculture needs to be improved in order to significantly reduce the incidence of severe anomalies in rainbow trout.	[Boglione, Clara; Pulcini, Domitilla; Scardi, Michele; Palamara, Elisa; Russo, Tommaso; Cataudella, Stefano] Univ Roma Tor Vergata, Dept Biol, Lab Expt Ecol & Aquaculture, I-00173 Rome, Italy; [Pulcini, Domitilla] Council Res Agr, Anim Prod Ctr, Rome, Italy	University of Rome Tor Vergata	Pulcini, D (corresponding author), Univ Roma Tor Vergata, Dept Biol, Lab Expt Ecol & Aquaculture, I-00173 Rome, Italy.	domitillapulcini@fastwebnet.it	Boglione, Clara/B-5633-2013; Russo, Tommaso/C-6157-2014	Boglione, Clara/0000-0002-8313-0542; Pulcini, Domitilla/0000-0003-1651-1123; Russo, Tommaso/0000-0003-4047-959X	Italian Ministry of the Agricoltural Policy and Forestry	Italian Ministry of the Agricoltural Policy and Forestry	This study was funded by the Italian Ministry of the Agricoltural Policy and Forestry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel I, 2004, AQUACULT INT, V12, P523, DOI 10.1007/s10499-004-0349-9; Alvarez D, 2005, CAN J FISH AQUAT SCI, V62, P643, DOI 10.1139/F04-223; Andrades JA, 1996, AQUACULTURE, V141, P1, DOI 10.1016/0044-8486(95)01226-5; Araki H, 2007, SCIENCE, V318, P100, DOI 10.1126/science.1145621; AULSTAD D, 1971, J FISH RES BOARD CAN, V28, P1918, DOI 10.1139/f71-290; Balbelona MC, 1993, B EUR ASSOC FISH PAT, V13, P33; Behnke R.J., 1992, NATIVE TROUT W N AM; BENZECRI J.-P, 1973, LANALYSE DONNEES; Berejikian BA, 1995, CAN J FISH AQUAT SCI, V52, P2476, DOI 10.1139/f95-838; Bidgood BF, 1965, THESIS U GUELPH GUEL, P107; Boglione C, 2001, AQUACULTURE, V192, P1, DOI 10.1016/S0044-8486(00)00446-4; Boglione C, 2006, ECOL INDIC, V6, P712, DOI 10.1016/j.ecolind.2005.08.032; Boglione C, 2003, AQUACULTURE, V227, P373, DOI 10.1016/S0044-8486(03)00515-5; Boglione C, 2003, AQUACULT INT, V11, P17, DOI 10.1023/A:1024119032359; Boglione C, 2013, REV AQUACULT, V5, pS121, DOI 10.1111/raq.12016; Boglione Clara, 2011, P233; Braendle C, 2009, J BIOSCIENCES, V34, P543, DOI 10.1007/s12038-009-0073-8; Sanchez RC, 2011, AQUACULTURE, V316, P13, DOI 10.1016/j.aquaculture.2011.03.012; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Coughlin DJ, 2004, COMP BIOCHEM PHYS A, V137, P151, DOI 10.1016/S1095-6433(03)00285-X; Crawford SS, 2008, REV FISH BIOL FISHER, V18, P313, DOI 10.1007/s11160-007-9079-1; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; Debat V, 2001, TRENDS ECOL EVOL, V16, P555, DOI 10.1016/S0169-5347(01)02266-2; Deschamps MH, 2008, AQUACULTURE, V279, P11, DOI 10.1016/j.aquaculture.2008.03.036; Deschamps MH, 2010, J APPL ICHTHYOL, V26, P377, DOI 10.1111/j.1439-0426.2010.01438.x; Deschamps MH, 2009, AQUACULTURE, V296, P337, DOI 10.1016/j.aquaculture.2009.07.016; Dudley SA, 1996, AM NAT, V147, P445, DOI 10.1086/285860; Engrola S, 2009, AQUACULTURE, V288, P264, DOI 10.1016/j.aquaculture.2008.12.010; FAO. Food and Agriculture Organization of the UN (FAO), 2012, STAT WORLD FISH AQ; Fernandez I, 2010, J APPL ICHTHYOL, V26, P344, DOI 10.1111/j.1439-0426.2010.01432.x; Fernandez I, 2009, AQUACULTURE, V295, P250, DOI 10.1016/j.aquaculture.2009.06.046; Fjelldal G, 2007, AQUACULTURE, V273, P721, DOI 10.1016/j.aquaculture.2007.07.009; Fjelldal PG, 2009, AQUACULT NUTR, V15, P366, DOI 10.1111/j.1365-2095.2008.00601.x; Fjelldal PG, 2010, AQUACULTURE, V309, P131, DOI 10.1016/j.aquaculture.2010.09.027; Flatt T, 2005, Q REV BIOL, V80, P287, DOI 10.1086/432265; Fontagne S, 2009, AQUACULTURE, V297, P141, DOI 10.1016/j.aquaculture.2009.09.022; Gavaia PJ, 2002, AQUACULTURE, V211, P305, DOI 10.1016/S0044-8486(02)00167-9; Georgakopoulou E, 2010, AQUACULTURE, V308, P13, DOI 10.1016/j.aquaculture.2010.08.006; Gil-Martens L, 2010, J APPL ICHTHYOL, V26, P350, DOI 10.1111/j.1439-0426.2010.01433.x; Gil-Martens L, 2012, THESIS U BERGEN NORW; Gislason H, 2010, AQUACULTURE, V309, P86, DOI 10.1016/j.aquaculture.2010.09.016; Gjerde B, 2005, AQUACULTURE, V244, P77, DOI 10.1016/j.aquaculture.2004.12.002; Grini A, 2011, J FISH DIS, V34, P531, DOI 10.1111/j.1365-2761.2011.01265.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hamre K, 2013, REV AQUACULT, V5, pS26, DOI 10.1111/j.1753-5131.2012.01086.x; Hansen T, 2010, J APPL ICHTHYOL, V26, P355, DOI 10.1111/j.1439-0426.2010.01434.x; HANSEN T, 2009, WORKSH INT APPR FISH; Harder W, 1975, ANATOMY FISHES 1; Helland S, 2005, AQUACULTURE, V250, P364, DOI 10.1016/j.aquaculture.2005.03.032; Helland S, 2006, AQUACULTURE, V261, P603, DOI 10.1016/j.aquaculture.2006.08.027; HilomenGarcia GV, 1997, AQUACULTURE, V152, P155, DOI 10.1016/S0044-8486(96)01518-9; HOSE JE, 1984, ARCH ENVIRON CON TOX, V13, P675, DOI 10.1007/BF01055930; Izquierdo MS, 2010, J APPL ICHTHYOL, V26, P320, DOI 10.1111/j.1439-0426.2010.01429.x; Jezierska B, 2009, FISH PHYSIOL BIOCHEM, V35, P625, DOI 10.1007/s10695-008-9284-4; Kacem A, 2004, CYBIUM, V28, P15; Kause A, 2007, GENET SEL EVOL, V39, P529, DOI 10.1051/gse:2007019; KINCAID HL, 1976, J FISH RES BOARD CAN, V33, P2420, DOI 10.1139/f76-288; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Koumoundouros G, 1997, AQUACULTURE, V149, P215, DOI 10.1016/S0044-8486(96)01443-3; Koumoundouros G, 2001, AQUACULTURE, V200, P285, DOI 10.1016/S0044-8486(01)00552-X; Koumoundouros G., 2010, REC ADV AQUAC RES, V661, P125; Kvellestad A, 2000, DIS AQUAT ORGAN, V39, P97, DOI 10.3354/dao039097; Lindsey CC, 1978, ECOMORPHOLOGY FISHES, P199; MABEE PM, 1988, COPEIA, P827, DOI 10.2307/1445705; MACCRIMMON HR, 1971, J FISH RES BOARD CAN, V28, P663, DOI 10.1139/f71-098; MACGREGOR R B, 1977, Environmental Biology of Fishes, V1, P127, DOI 10.1007/BF00000405; MacGregor RB, 1975, THESIS U GUELPH GUEL, P200; Madsen L, 2001, AQUAC RES, V32, P235, DOI 10.1046/j.1365-2109.2001.00552.x; Martens LG, 2012, AQUACULT NUTR, V18, P12, DOI 10.1111/j.1365-2095.2011.00871.x; Martens LG, 2010, J FISH DIS, V33, P957, DOI 10.1111/j.1365-2761.2010.01201.x; Matsuoka M, 2003, JARQ-JPN AGR RES Q, V37, P21, DOI 10.6090/jarq.37.21; Matsuoka M, 1987, JAP J ICHTHYOL, V65, P1; MCCRIMMON HR, 1965, T AM FISH SOC, V94, P84, DOI 10.1577/1548-8659(1965)94[84:AVITRT]2.0.CO;2; Meunier FJ, 2006, CR PALEVOL, V5, P499, DOI 10.1016/j.crpv.2006.01.002; Naylor R, 2005, ANNU REV ENV RESOUR, V30, P185, DOI 10.1146/annurev.energy.30.081804.121034; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; Nijhout HF, 2002, BIOESSAYS, V24, P553, DOI 10.1002/bies.10093; OLLIVIER L, 1981, ELEMENTS GENETIQUE Q; Ostland VE, 1997, J FISH DIS, V20, P443, DOI 10.1046/j.1365-2761.1997.00323.x; POYNTON SL, 1987, J FISH DIS, V10, P53, DOI 10.1111/j.1365-2761.1987.tb00718.x; Prestinicola L, 2013, LARVI 13 FISH SHELLF, P382; Prestinicola L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055736; Price EO, 1998, GENETICS AND THE BEHAVIOR OF DOMESTIC ANIMALS, P31; Pulcini D, 2010, J APPL ICHTHYOL, V26, P298, DOI 10.1111/j.1439-0426.2010.01425.x; Pulcini D, 2014, AQUAC RES, V45, P397, DOI 10.1111/j.1365-2109.2012.03236.x; Ramzu M, 1999, ANN SCI NAT ZOOL, V20, P87, DOI 10.1016/S0003-4339(00)86973-7; Reinbold D, 2009, CAN J FISH AQUAT SCI, V66, P1025, DOI 10.1139/F09-064; ROGERS DJ, 1960, SCIENCE, V132, P1115, DOI 10.1126/science.132.3434.1115; Roo J, 2010, J APPL ICHTHYOL, V26, P372, DOI 10.1111/j.1439-0426.2010.01437.x; Russo T, 2011, AQUACULTURE, V315, P69, DOI 10.1016/j.aquaculture.2010.11.030; Russo T, 2010, J APPL ICHTHYOL, V26, P360, DOI 10.1111/j.1439-0426.2010.01435.x; Sadler J, 2001, AQUACULTURE, V198, P369, DOI 10.1016/S0044-8486(01)00508-7; SCHULTZE HP, 1989, ZOOL J LINN SOC-LOND, V97, P189, DOI 10.1111/j.1096-3642.1989.tb00547.x; Sfakianakis DG, 2006, AQUACULTURE, V254, P54, DOI 10.1016/j.aquaculture.2005.10.028; Spillman C-J., 1961, FAUNE FRANCE POISSON, V65; STEARNS SC, 1989, BIOSCIENCE, V39, P436, DOI 10.2307/1311135; Sullivan M, 2007, J FISH DIS, V30, P745, DOI 10.1111/j.1365-2761.2007.00889.x; Sullivan M, 2007, J FISH DIS, V30, P759, DOI 10.1111/j.1365-2761.2007.00890.x; Takle H, 2005, AQUACULTURE, V249, P515, DOI 10.1016/j.aquaculture.2005.04.043; Taylor JF, 2011, AQUACULTURE, V315, P61, DOI 10.1016/j.aquaculture.2010.11.029; Van Buskirk J, 2002, AM NAT, V160, P87, DOI 10.1086/340599; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; Waagbo R., 2005, WORKSH BON DIS INT A, P1; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Waddington CH, 1975, EVOLUTION EVOLUTIONI; Wagner A., 2005, ROBUSTNESS EVOLVABIL; Wargelius A, 2005, DEV GENES EVOL, V215, P350, DOI 10.1007/s00427-005-0482-0; Wargelius A, 2010, J APPL ICHTHYOL, V26, P366, DOI 10.1111/j.1439-0426.2010.01436.x; WEBB PW, 1977, J EXP BIOL, V68, P123; Westneat M.W., 2001, FISH PHYSIOL, P272, DOI DOI 10.1016/S1546-5098(01)19008-4; Witten, 2005, FISH VET J, V8, P71; Witten PE, 2006, AQUACULTURE, V258, P164, DOI 10.1016/j.aquaculture.2006.05.005; Witten PE, 2009, AQUACULTURE, V295, P6, DOI 10.1016/j.aquaculture.2009.06.037; Witten PE, 2005, DIS AQUAT ORGAN, V64, P237, DOI 10.3354/dao064237	114	23	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96983	10.1371/journal.pone.0096983	http://dx.doi.org/10.1371/journal.pone.0096983			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809347	Green Submitted, Green Published, gold			2022-12-27	WOS:000338213300101
J	Ezechi, OC; Pettersson, KO; Abu Okolo, C; Ujah, IAO; Ostergren, PO				Ezechi, Oliver Chukwujekwu; Pettersson, Karen Odberg; Abu Okolo, Clement; Ujah, Innocent Achaya O.; Ostergren, Per Olof			The Association between HIV Infection, Antiretroviral Therapy and Cervical Squamous Intraepithelial Lesions in South Western Nigerian Women	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; RISK-FACTORS; NATURAL-HISTORY; POSITIVE WOMEN; CANCER; PREVALENCE; MALIGNANCIES; TANZANIA; CYTOLOGY; KAMPALA	Introduction: Findings from studies that evaluated the effect of antiretroviral drug use on the development of cervical squamous intraepithelial lesion differed in their conclusions. This study investigated the association between HIV infection, antiretroviral drug use and cervical squamous intraepithelial lesion in a high HIV and cervical cancer burden setting-Nigeria. Methods: A cross sectional study among 1140 women of known HIV status enrolled in a randomised study to determine the test characteristics of visual inspection in detecting cytology diagnosed squamous intraepithelial lesion. Multivariate analysis was used to determine the association between HIV infection, antiretroviral drug use and the twin outcome variables of cervical squamous intraepithelial lesion (SIL) and High grade squamous intraepithelial lesion (HSIL) while controlling for confounders. Results: Prevalence of cervical squamous intraepithelial lesion was 8.5%, with a higher prevalence of 14.3% in HIV positive compared to 3.3% in HIV negative women (aOR: 5.4; 95% CI: 2.9-8.8). Not using antiretroviral drugs was found to be associated with an increased risk of SIL (aOR: 2.1; 95% CI: 1.4-3.5) and HSIL (aOR: 2.6; 95% CI: 1.1-6.4). Participants who had a CD4 cell count <200 cells/mm(3), were also found to be at increased risk for SIL (aOR: 1.9; 95% CI: 1.1-5.9) and HSIL (aOR: 5.7; 95% CI: 1.1-7.2). Conclusion: HIV infection and severe immunosuppression were found to be associated with increased risk of cervical squamous intraepithelial lesion but not viral load. For the first time, in the West African sub-region with specific HIV type and strains, we established the protective effect of antiretroviral drug use against the development of SIL. Integration of cervical cancer screening programme into HIV services and early initiation of antiretroviral drug in HIV positive women especially those with severe immune-suppression could therefore prove to be useful in preventing and controlling cervical cancer development in HIV positive women.	[Ezechi, Oliver Chukwujekwu; Ujah, Innocent Achaya O.] Nigerian Inst Med Res Yaba, Div Clin Sci, Lagos, Nigeria; [Ezechi, Oliver Chukwujekwu; Pettersson, Karen Odberg; Ostergren, Per Olof] Lund Univ, Fac Med, Lund, Sweden; [Abu Okolo, Clement] Univ Ibadan, Coll Med, Dept Pathol, Ibadan, Nigeria	Lund University; University of Ibadan	Ezechi, OC (corresponding author), Nigerian Inst Med Res Yaba, Div Clin Sci, Lagos, Nigeria.	oezechi@yahoo.co.uk			Nigerian Instiute of Medical Research (NIMR)	Nigerian Instiute of Medical Research (NIMR)	Funding from OE's research budget at Nigerian Instiute of Medical Research (NIMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler DH, 2010, CURR HIV RES, V8, P493, DOI 10.2174/157016210793499240; Agaba PA, 2009, INT J GYNECOL OBSTET, V107, P99, DOI 10.1016/j.ijgo.2009.06.006; Akinwuntan AL, 2008, J OBSTET GYNAECOL, V28, P638, DOI 10.1080/01443610802259977; Anorlu R I, 2007, West Afr J Med, V26, P143; Anorlu Rose I, 2003, J Obstet Gynaecol, V23, P285, DOI 10.1080/01443610310000100114; Banura C, 2008, J INFECT DIS, V197, P555, DOI 10.1086/526792; Bernstein WB, 2006, INT J HEMATOL, V84, P3, DOI 10.1532/IJH97.06088; Blitz S, 2013, J INFECT DIS, V208, P454, DOI 10.1093/infdis/jit181; Chalermchockcharoenkit A, 2006, J OBSTET GYNAECOL RE, V32, P324, DOI 10.1111/j.1447-0756.2006.00411.x; Chama C M, 2005, J Obstet Gynaecol, V25, P286, DOI 10.1080/01443610500107601; Chen YC, 2013, AID             1210; Davey DD, 2003, CANCER J, V9, P327, DOI 10.1097/00130404-200309000-00002; Durowade K A, 2012, J Prev Med Hyg, V53, P213; Ezechi OC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-46; Ezechi OC, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-5; Firnhaber C, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17382; Gates AE, 2002, ONCOLOGY-NY, V16, P657; Jevtovic D, 2014, BIOMED PHARMACOTHER, V68, P391, DOI 10.1016/j.biopha.2014.01.001; Kahesa C, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-262; Lehtovirta P, 2008, INT J STD AIDS, V19, P37, DOI 10.1258/ijsa.2007.005672; McKenzie KP, 2011, CURR HIV RES, V9, P180, DOI 10.2174/157016211795945214; Mogtomo Martin Luther Koanga, 2009, Infect Agent Cancer, V4, P9, DOI 10.1186/1750-9378-4-9; Musa Z, 2010, 5 NAT C HIV AIDS AB; National Agency for the control of AIDS, 2011, ANT THER NIG; Odida M, 2011, INFECT AGENTS CANCER, V6, DOI 10.1186/1750-9378-6-8; Odida M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-85; Pimentel VM, 2013, J LOW GENIT TRACT DI, V17, P203, DOI 10.1097/LGT.0b013e3182612042; SCHMAUZ R, 1989, INT J CANCER, V43, P805, DOI 10.1002/ijc.2910430511; Sekirime WK, 2007, GYNECOL OBSTET INVES, V63, P222, DOI 10.1159/000098197; Shah RM, 2012, J EXPT CLIN MED, V4, P239, DOI DOI 10.1016/J.JECM.2012.06.011; Strickler HD, 2005, J NATL CANCER I, V97, P577, DOI 10.1093/jnci/dji073; Swende TZ, 2012, INT J WOMENS HEALTH, V4, P55, DOI 10.2147/IJWH.S21205; TERMEULEN J, 1992, INT J CANCER, V51, P515; World Health Organization, 2008, TASK SHIFT RAT RED T; Xi LF, 2004, JNCI-J NATL CANCER I, V96, P1051, DOI 10.1093/jnci/djh223; Zeier MD, 2012, J LOW GENIT TRACT DI, V16, P243, DOI 10.1097/LGT.0b013e3182403d18	36	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e97150	10.1371/journal.pone.0097150	http://dx.doi.org/10.1371/journal.pone.0097150			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809726	Green Published, gold, Green Submitted			2022-12-27	WOS:000338213300126
J	Morales, LD; Pavon, EAC; Shin, JW; Garcia, A; Capetillo, M; Kim, DJ; Lieman, JH				Morales, Liza D.; Pavon, Edgar A. Casillas; Shin, Jun Wan; Garcia, Alexander; Capetillo, Mario; Kim, Dae Joon; Lieman, Jonathan H.			Protein Tyrosine Phosphatases PTP-1B, SHP-2, and PTEN Facilitate Rb/E2F-Associated Apoptotic Signaling	PLOS ONE			English	Article							FOCAL-ADHESION KINASE; CELL-CYCLE CONTROL; RB/E2F PATHWAY; CANCER; GENE; E2F1; SUPPRESSION; EXPRESSION; MUTATIONS; INDUCTION	To maintain tissue homeostasis, apoptosis is functionally linked to the cell cycle through the retinoblastoma (Rb)/E2F pathway. When the Rb tumor suppressor protein is functionally inactivated, E2F1 elicits an apoptotic response through both intrinsic (caspase-9 mediated) and extrinsic (caspase-8 mediated) apoptotic pathways in order to eliminate hyperproliferative cells. Rb/E2F-associated apoptosis has been demonstrated to be associated with the loss of constitutive transcriptional repression by Rb/E2F complexes and mediated by caspase-8. Protein tyrosine phosphatases (PTPs) PTP-1B and SHP-2 have been previously shown to be directly activated by loss of Rb/E2F repression during Rb/E2F-associated apoptosis. In this current study, we demonstrate that the PTEN tumor suppressor is also directly activated by loss of Rb/E2F repression. We also demonstrate that PTP-1B, SHP-2, and PTEN play a functional role in Rb/E2F-associated apoptosis. Knockdown of PTP1B, SHP2, or PTEN expression with small interfering RNA (siRNA) in apoptotic cells increases cell viability and rescues cells from the Rb/E2F-associated apoptotic response. Furthermore, rescue from apoptosis coincides with inhibition of caspase-8 and caspase-3 cleavage (activation). Our results indicate PTP-1B, SHP-2, and PTEN all play a functional role in Rb/E2F-associated apoptotic signal transduction and provide further evidence that PTP-1B, SHP-2, and PTEN can contribute to tumor suppression through an Rb/E2F-associated mechanism.	[Morales, Liza D.; Shin, Jun Wan; Kim, Dae Joon] Univ Texas Hlth Sci Ctr San Antonio, Edinburg Reg Acad Hlth Ctr, Div Med Res, Edinburg, TX 78539 USA; [Pavon, Edgar A. Casillas; Garcia, Alexander; Capetillo, Mario; Lieman, Jonathan H.] Univ Texas Pan Amer, Dept Biol, Edinburg, TX 78541 USA; [Kim, Dae Joon] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Lieman, Jonathan H.] South Texas Coll, Dept Biol, Mcallen, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Rio Grande Valley; University of Texas System; University of Texas Health San Antonio	Kim, DJ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Edinburg Reg Acad Hlth Ctr, Div Med Res, Edinburg, TX 78539 USA.	KimDJ@uthscsa.edu; jlieman@southtexascollege.edu		KIM, DAE/0000-0002-7977-9955; Morales, Liza/0000-0003-1056-9121	Faculty Research Council Grant from UTPA; Howard Hughes Medical Institute Science Education Grant from UTPA [52006321, 52007568]; National Institute of Environmental Health Sciences [ES022250]; NIH Cancer Center Support Grant [P30 CA054174]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES022250] Funding Source: NIH RePORTER	Faculty Research Council Grant from UTPA; Howard Hughes Medical Institute Science Education Grant from UTPA; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Faculty Research Council Grant from UTPA (to J. H. Lieman), Howard Hughes Medical Institute Science Education Grant #52006321 from UTPA (to E. A. Casillas Pavon), and Howard Hughes Medical Institute Science Education Grant #52007568 from UTPA (to M. Capetillo). This work was also supported by National Institute of Environmental Health Sciences Grant ES022250 and NIH Cancer Center Support Grant P30 CA054174 (to D. J. Kim). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044147; Baker SJ, 2007, CELL, V128, P25, DOI 10.1016/j.cell.2006.12.023; Bard-Chapeau EA, 2011, CANCER CELL, V19, P629, DOI 10.1016/j.ccr.2011.03.023; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Black EP, 2005, P NATL ACAD SCI USA, V102, P15948, DOI 10.1073/pnas.0504300102; Carracedo A, 2011, CANCER RES, V71, P629, DOI 10.1158/0008-5472.CAN-10-2488; Chen JS, 2010, CLIN EXP METASTAS, V27, P71, DOI 10.1007/s10585-010-9306-3; Covey TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013545; Delbridge AR, 2012, COLD SPRING HARB PER, V4; Denchi EL, 2005, EMBO REP, V6, P661, DOI 10.1038/sj.embor.7400452; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Dube N, 2004, CELL CYCLE, V3, P550; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Gabriel K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070047; Ghavami S, 2009, J MED GENET, V46, P497, DOI 10.1136/jmg.2009.066944; Ginsberg D, 2002, FEBS LETT, V529, P122, DOI 10.1016/S0014-5793(02)03270-2; Golubovskaya VM, 2012, CARCINOGENESIS, V33, P1004, DOI 10.1093/carcin/bgs120; Gupta A, 2009, MOL CELL ENDOCRINOL, V309, P55, DOI 10.1016/j.mce.2009.05.018; Halle M, 2007, CELL CYCLE, V6, P2773, DOI 10.4161/cc.6.22.4926; Hallstrom TC, 2009, CELL CYCLE, V8, P532, DOI 10.4161/cc.8.4.7609; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Harbour JW, 2000, CURR OPIN CELL BIOL, V12, P685, DOI 10.1016/S0955-0674(00)00152-6; Itoh S, 2004, CLIN CANCER RES, V10, P2812, DOI 10.1158/1078-0432.CCR-1046-03; Jiang CY, 2012, J CANCER RES CLIN, V138, P637, DOI 10.1007/s00432-011-1143-5; Jiang ZX, 2008, CANCER METAST REV, V27, P263, DOI 10.1007/s10555-008-9113-3; Kim DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010290; Lessard L, 2010, BBA-PROTEINS PROTEOM, V1804, P613, DOI 10.1016/j.bbapap.2009.09.018; Li Shuangwei, 2012, Front Med, V6, P275, DOI 10.1007/s11684-012-0216-4; Lieman JH, 2005, J BIOL CHEM, V280, P10484, DOI 10.1074/jbc.M409371200; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Mayhew CN, 2007, GASTROENTEROLOGY, V133, P976, DOI 10.1053/j.gastro.2007.06.025; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Mohi MG, 2007, CURR OPIN GENET DEV, V17, P23, DOI 10.1016/j.gde.2006.12.011; Morales LD, 2012, CELL MOL BIOL LETT, V17, P422, DOI 10.2478/s11658-012-0020-9; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Polager S, 2008, TRENDS CELL BIOL, V18, P528, DOI 10.1016/j.tcb.2008.08.003; Putzer BM, 2007, J CELL MOL MED, V11, P239, DOI 10.1111/j.1582-4934.2007.00030.x; Rafiq K, 2006, J BIOL CHEM, V281, P19781, DOI 10.1074/jbc.M513040200; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Siesser PMF, 2006, CLIN CANCER RES, V12, P3233, DOI 10.1158/1078-0432.CCR-06-0456; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Stevens C, 2003, ARCH BIOCHEM BIOPHYS, V412, P157, DOI 10.1016/S0003-9861(03)00054-7; Tamura M, 1999, JNCI-J NATL CANCER I, V91, P1820, DOI 10.1093/jnci/91.21.1820; Tamura M, 1999, J BIOL CHEM, V274, P20693, DOI 10.1074/jbc.274.29.20693; Tautz L, 2013, METHODS MOL BIOL, V1053, P179, DOI 10.1007/978-1-62703-562-0_13; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2003, FEBS LETT, V546, P140, DOI 10.1016/S0014-5793(03)00603-3; van Nimwegen MJ, 2007, BIOCHEM PHARMACOL, V73, P597, DOI 10.1016/j.bcp.2006.08.011; Ventura Juan-Jose, 2006, Clin Transl Oncol, V8, P153, DOI 10.1007/s12094-006-0005-0; Wong RSY, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-87; Xu Y, 2008, ONCOGENE, V27, P3501, DOI 10.1038/sj.onc.1211023; Yin Y, 2008, ONCOGENE, V27, P5443, DOI 10.1038/onc.2008.241; Young AP, 2003, ONCOGENE, V22, P7209, DOI 10.1038/sj.onc.1206804; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125; Zhang J, 2013, PHARM THER	61	9	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e97104	10.1371/journal.pone.0097104	http://dx.doi.org/10.1371/journal.pone.0097104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809452	Green Submitted, Green Published, gold			2022-12-27	WOS:000338213300122
J	Nemeth, CL; Gutman, DA; Majeed, W; Keilholz, SD; Neigh, GN				Nemeth, Christina L.; Gutman, David A.; Majeed, Waqas; Keilholz, Shella D.; Neigh, Gretchen N.			Microembolism Induces Anhedonia but No Detectable Changes in White Matter Integrity in Aged Rats	PLOS ONE			English	Article							LATE-LIFE DEPRESSION; INDUCED CEREBRAL-ISCHEMIA; MICROSPHERE EMBOLISM; SPATIAL MEMORY; BRAIN-INJURY; STROKE; MRI; ANTIDEPRESSANT; HYPOTHESIS; INFARCTION	Microvascular disease leads to alterations of cerebral vasculature including the formation of microembolic (ME) strokes. Though ME are associated with changes in mood and the severity and progression of cognitive decline, the effect of ME strokes on cerebral microstructure and its relationship to behavioral endpoints is unknown. Here, we used adult and aged male rats to test the hypotheses that ME lesions result in subtle changes to white and gray matter integrity as detected by high-throughput diffusion tensor imaging (DTI) and that these structural disruptions correspond to behavioral deficits. Two weeks post-surgery, aged animals showed depressive-like behaviors in the sucrose consumption test in the absence of altered cerebral diffusivity as assessed by ex-vivo DTI. Furthermore, DTI indices did not correlate with the degree of behavioral disruption in aged animals or in a subset of animals with observed tissue cavitation and subtle DTI alterations. Together, data suggest that behavioral deficits are not the result of damage to brain regions or white matter tracts, rather the activity of other systems may underlie functional disruption and recovery.	[Nemeth, Christina L.; Neigh, Gretchen N.] Emory Univ, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; [Nemeth, Christina L.; Neigh, Gretchen N.] Emory Univ, Dept Physiol, Atlanta, GA 30322 USA; [Gutman, David A.; Keilholz, Shella D.] Emory Univ, Dept Biomed Informat, Atlanta, GA 30322 USA; [Majeed, Waqas] Emory Univ, Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30322 USA; [Majeed, Waqas] LUMS, Sch Sci & Engn, Dept Elect Engn, Lahore, Pakistan	Emory University; Emory University; Emory University; Emory University; University System of Georgia; Georgia Institute of Technology; Lahore University of Management Sciences	Neigh, GN (corresponding author), Emory Univ, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA.	gretchen.neigh@emory.edu	Neigh, Gretchen/AAW-5691-2020; Gutman, David/U-2713-2018; Keilholz, Shella/J-5421-2019	Neigh, Gretchen/0000-0003-0955-9161; Gutman, David/0000-0002-1386-8701; 	American Heart Association (AHA); National Alliance for Research in Schizophrenia and Depression (NARSAD); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008605] Funding Source: NIH RePORTER	American Heart Association (AHA)(American Heart Association); National Alliance for Research in Schizophrenia and Depression (NARSAD)(NARSAD); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding sources include The American Heart Association (AHA) and The National Alliance for Research in Schizophrenia and Depression (NARSAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos GS, 1997, ARCH GEN PSYCHIAT, V54, P915; Andersen MB, 1999, PHARMACOL BIOCHEM BE, V62, P673, DOI 10.1016/S0091-3057(98)00204-4; Betz J, 2012, J NEUROTRAUM, V29, P1292, DOI 10.1089/neu.2011.2215; Chen RL, 2010, NAT REV NEUROL, V6, P256, DOI 10.1038/nrneurol.2010.36; Craft TKS, 2005, EUR J NEUROSCI, V21, P3117, DOI 10.1111/j.1460-9568.2005.04136.x; del Zoppo GJ, 2003, J CEREBR BLOOD F MET, V23, P879, DOI 10.1097/01.WCB.0000078322.96027.78; Dyrby TB, 2011, HUM BRAIN MAPP, V32, P544, DOI 10.1002/hbm.21043; FUJIKAWA T, 1993, STROKE, V24, P1631, DOI 10.1161/01.STR.24.11.1631; Fukuchi K, 1999, INVEST RADIOL, V34, P698, DOI 10.1097/00004424-199911000-00006; Grau-Olivares M, 2009, EXPERT REV NEUROTHER, V9, P1201, DOI [10.1586/ern.09.73, 10.1586/ERN.09.73]; Gutman DA, 2012, NEUROIMAGE, V63, P800, DOI 10.1016/j.neuroimage.2012.07.014; Hecht N, 2012, STROKE; Jiang Q, 2010, STROKE, V41, P410, DOI 10.1161/STROKEAHA.109.568048; Kales HC, 2005, AM J GERIAT PSYCHIAT, V13, P88, DOI 10.1176/appi.ajgp.13.2.88; Lyness Jeffrey M, 2002, CNS Spectr, V7, P712; Mayzel-Oreg O, 2004, MAGN RESON MED, V51, P1232, DOI 10.1002/mrm.20100; Miyake K, 2002, BRAIN RES, V935, P24, DOI 10.1016/S0006-8993(02)02420-4; Neigh GN, 2004, EUR J NEUROSCI, V20, P1865, DOI 10.1111/j.1460-9568.2004.03649.x; Nemeth CL, 2012, BEHAV BRAIN RES, V234, P259, DOI 10.1016/j.bbr.2012.06.014; O'Sullivan M, 2001, NEUROLOGY, V56, P628, DOI 10.1212/WNL.56.5.628; Pitkonen M, 2012, BRAIN RES, V1445, P103, DOI 10.1016/j.brainres.2012.01.043; Popa-Wagner A, 2007, CURR NEUROVASC RES, V4, P216; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Purandare N, 2012, AM J PSYCHIAT, V169, P300, DOI 10.1176/appi.ajp.2011.11010009; Rothwell PM, 2005, LANCET, V366, P1773, DOI 10.1016/S0140-6736(05)67702-1; Rubin RR, 2010, DIABETOLOGIA, V53, P1581, DOI 10.1007/s00125-010-1765-1; Santos M, 2009, BRAIN RES REV, V62, P19, DOI 10.1016/j.brainresrev.2009.08.003; Santos M, 2009, STROKE, V40, P3557, DOI 10.1161/STROKEAHA.109.548545; Shapira S, 2002, BRAIN RES, V925, P148, DOI 10.1016/S0006-8993(01)03270-X; Sheline YI, 2010, ARCH GEN PSYCHIAT, V67, P277, DOI 10.1001/archgenpsychiatry.2009.204; Shereen A, 2011, J CEREBR BLOOD F MET, V31, P1155, DOI 10.1038/jcbfm.2010.212; Shih AY, 2013, NAT NEUROSCI, V16, P55, DOI 10.1038/nn.3278; Sierra A, 2013, BRAIN STRUCT FUNCT; Small DL, 2000, BRIT MED BULL, V56, P307, DOI 10.1258/0007142001903238; Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786; TAGUCHI T, 1993, JPN J PHARMACOL, V62, P269, DOI 10.1254/jjp.62.269; Takagi N, 1997, BRAIN RES BULL, V43, P87, DOI 10.1016/S0361-9230(96)00350-4; Valton L, 1998, STROKE, V29, P2125, DOI 10.1161/01.STR.29.10.2125; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Xekardaki A, 2011, J AGING RES, V2011, P1; Xekardaki A, 2012, ACTA NEUROPATHOL, V124, P453, DOI 10.1007/s00401-012-1021-5; Zhu L, 2012, J SURG RES, V176, P679, DOI 10.1016/j.jss.2011.09.059	42	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96624	10.1371/journal.pone.0096624	http://dx.doi.org/10.1371/journal.pone.0096624			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24811070	Green Published, Green Submitted, gold			2022-12-27	WOS:000338213300058
J	Raz, Y; Tannenbaum, ED				Raz, Yoav; Tannenbaum, Emmanuel David			Repression/Depression of Conjugative Plasmids and Their Influence on the Mutation-Selection Balance in Static Environments	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; ESCHERICHIA-COLI K-12; QUASI-SPECIES MODEL; ANTIBIOTIC-RESISTANCE; R-FACTOR; EVOLUTION; ORIGIN; INCOMPATIBILITY; REPLICATION; POPULATIONS	We study the effect that conjugation-mediated Horizontal Gene Transfer (HGT) has on the mutation-selection balance of a population in a static environment. We consider a model whereby a population of unicellular organisms, capable of conjugation, comes to mutation-selection balance in the presence of an antibiotic, which induces a first-order death rate constant kappa(D) for genomes that are not resistant. We explicitly take into consideration the repression/de-repression dynamics of the conjugative plasmid, and assume that a de-repressed plasmid remains temporarily de-repressed after copying itself into another cell. We assume that both repression and de-repression are characterized by first-order rate constants k(+-) and k(-+), respectively. We find that conjugation has a deleterious effect on the mean fitness of the population, suggesting that HGT does not provide a selective advantage in a static environment, but is rather only useful for adapting to new environments. This effect can be ameliorated by repression, suggesting that while HGT is not necessarily advantageous for a population in a static environment, its deleterious effect on the mean fitness can be negated via repression. Therefore, it is likely that HGT is much more advantageous in a dynamic landscape. Furthermore, in the limiting case of a vanishing spontaneous de-repression rate constant, we find that the fraction of conjugators in the population undergoes a phase transition as a function of population density. Below a critical population density, the fraction of conjugators is zero, while above this critical population density the fraction of conjugators rises continuously to one. Our model for conjugation-mediated HGT is related to models of infectious disease dynamics, where the conjugators play the role of the infected (I) class, and the non-conjugators play the role of the susceptible (S) class.	[Raz, Yoav; Tannenbaum, Emmanuel David] Ben Gurion Univ Negev, Dept Chem, Beer Sheva, Israel	Ben Gurion University	Raz, Y (corresponding author), Ben Gurion Univ Negev, Dept Chem, Beer Sheva, Israel.	razyoav@post.bgu.ac.il	Atsmon-Raz, Yoav/H-1763-2013	Atsmon-Raz, Yoav/0000-0001-6476-9845	U.S.-Israel Binational Science Foundation; Israel Science Foundation	U.S.-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation)	This research was supported by the U.S.-Israel Binational Science Foundation (www.bsf.org.il) and by the Israel Science Foundation (www.isf.org.il). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andam CP, 2011, FEMS MICROBIOL REV, V35, P756, DOI 10.1111/j.1574-6976.2011.00274.x; ANDERSON ES, 1968, ANNU REV MICROBIOL, V22, P131, DOI 10.1146/annurev.mi.22.100168.001023; BRODA P, 1975, MOL GEN GENET, V138, P65, DOI 10.1007/BF00268828; Brown JR, 2003, NAT REV GENET, V4, P121, DOI 10.1038/nrg1000; Brumer Y, 2006, J THEOR BIOL, V241, P216, DOI 10.1016/j.jtbi.2005.11.018; Campos PRA, 1998, PHYS REV E, V58, P2664, DOI 10.1103/PhysRevE.58.2664; Carattoli A, 2013, INT J MED MICROBIOL, V303, P298, DOI 10.1016/j.ijmm.2013.02.001; CARO LG, 1966, P NATL ACAD SCI USA, V56, P126, DOI 10.1073/pnas.56.1.126; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Cohen E, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.098102; Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598; Cruz F, 1998, RHIZOBIACEAE, P281; Dahlberg C, 2003, GENETICS, V165, P1641; DAVIES J, 1994, SCIENCE, V264, P375, DOI 10.1126/science.8153624; de la Cruz F, 2000, TRENDS MICROBIOL, V8, P128, DOI 10.1016/S0966-842X(00)01703-0; Dixit NM, 2012, J COMPUT BIOL, V19, P1176, DOI 10.1089/cmb.2012.0064; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Filutowicz M, 2008, PLASMID, V60, P38, DOI 10.1016/j.plasmid.2008.03.004; Frost LS, 2010, FUTURE MICROBIOL, V5, P1057, DOI 10.2217/FMB.10.70; Ghigo JM, 2001, NATURE, V412, P442, DOI 10.1038/35086581; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046; Gorodetsky P, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.042901; Grillot-Courvalin C, 1998, NAT BIOTECHNOL, V16, P862, DOI 10.1038/nbt0998-862; Hanssen AM, 2006, FEMS IMMUNOL MED MIC, V46, P8, DOI 10.1111/j.1574-695X.2005.00009.x; Itan E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026513; Kamp Christel, 2002, Complexity, V8, P28, DOI 10.1002/cplx.10067; KRYSCIO RJ, 1989, J APPL PROBAB, V26, P685, DOI 10.2307/3214374; LUNDQUIST PD, 1986, GENETICS, V113, P483; Mazel D, 1999, CELL MOL LIFE SCI, V56, P742, DOI 10.1007/s000180050021; MERGEAY M, 1985, J BACTERIOL, V162, P328, DOI 10.1128/JB.162.1.328-334.1985; Munoz E, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.061921; Nasell I, 1996, ADV APPL PROBAB, V28, P895, DOI 10.2307/1428186; Norman A, 2009, PHILOS T R SOC B, V364, P2275, DOI 10.1098/rstb.2009.0037; NOVICK RP, 1987, MICROBIOL REV, V51, P381, DOI 10.1128/MMBR.51.4.381-395.1987; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Park JM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.058101; Park K, 2001, EMBO J, V20, P7323, DOI 10.1093/emboj/20.24.7323; Raz Y, 2010, GENETICS, V185, P327, DOI 10.1534/genetics.109.113613; Richter H, 2014, RECENT ADV THEORY AP, P529; Rivera MC, 2004, NATURE, V431, P152, DOI 10.1038/nature02848; Roberts MC, 2008, FEMS MICROBIOL LETT, V282, P147, DOI 10.1111/j.1574-6968.2008.01145.x; Robicsek A, 2006, LANCET INFECT DIS, V6, P629, DOI 10.1016/S1473-3099(06)70599-0; Russi Silvia, 2008, P183; Saakian DB, 2006, P NATL ACAD SCI USA, V103, P4935, DOI 10.1073/pnas.0504924103; SALYERS AA, 1995, MICROBIOL REV, V59, P579, DOI 10.1128/MMBR.59.4.579-590.1995; SANSEVERINO J, 1993, APPL ENVIRON MICROB, V59, P1931, DOI 10.1128/AEM.59.6.1931-1937.1993; SILVER S, 1988, ANNU REV MICROBIOL, V42, P717, DOI 10.1146/annurev.mi.42.100188.003441; Sun J, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.228107; Tannenbaum E, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.021903; Tannenbaum E, 2005, PHYS LIFE REV, V2, P290, DOI 10.1016/j.plrev.2005.08.001; TATUM EL, 1947, J BACTERIOL, V53, P673, DOI 10.1128/JB.53.6.673-684.1947; Turner PE, 1998, EVOLUTION, V52, P315, DOI 10.1111/j.1558-5646.1998.tb01634.x; UHLIN BE, 1975, J BACTERIOL, V124, P641, DOI 10.1128/JB.124.2.641-649.1975; WEISS G H, 1971, Mathematical Biosciences, V11, P261, DOI 10.1016/0025-5564(71)90087-3; Weldhagen GF, 2004, INT J ANTIMICROB AG, V23, P556, DOI 10.1016/j.ijantimicag.2004.03.007; WILLETTS NS, 1974, MOL GEN GENET, V129, P123, DOI 10.1007/BF00268626	57	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96839	10.1371/journal.pone.0096839	http://dx.doi.org/10.1371/journal.pone.0096839			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24811122	Green Published, Green Submitted, gold			2022-12-27	WOS:000338213300079
J	Yu, JY; Chen, WZ; Wu, C; Chen, H				Yu, Jiyan; Chen, Weizhong; Wu, Chi; Chen, Hao			PEG-Protein Interaction Induced Contraction of NalD Chains	PLOS ONE			English	Article							FLAVUS URATE OXIDASE; X-RAY-SCATTERING; POLY(ETHYLENE GLYCOL); POLYETHYLENE-GLYCOL; PSEUDOMONAS-AERUGINOSA; CRYSTALLIZATION; ASSOCIATION; COMPLEX; PEPSIN; WATER	In a recent attempt to crystallize a regulator of MexAB-OprM multi-drug efflux systems in Pseudomonas aeruginosa (NalD), we found that adding polyethylene glycol (PEG3350, Mw=3,350 g/mol) into the protein solution increases the speed of NalD migration in gel electrophoresis, signaling a smaller hydrodynamic size. At first we conjectured that NalD was degraded unexpectedly by PEG; however, we found that there was no change in its molar mass by MALDI-TOF characterization. Moreover, we found that adding polyacrylic acid (PAA) into the solution mixture returned the NalD migration to its normal speed. Furthermore, our analytic ultracentrifugation and dynamic laser light scattering results directly reveal that NalD interacts with PEG so that individual NalD chains gradually shrink as more PEG chains are added in the range of 10-50 mg/mL. Size exclusion chromatography also confirms that the NalD chain shrinks in the presence of PEG. A combination of these results indicates that PEG3350 chains can complex with NalD to induce an intra-protein chain contraction, presumably via the formation of hydrogen bond between -C-O-C- on PEG and -COOH on NalD, resulting in a smaller hydrodynamic size (faster migration) and a higher apparent molar mass. Note that because the presence of PEG affects osmotic pressure, it is considered to be a precipitator of protein crystallization. Our current finding reveals that the interaction of PEG/protein may play a significant role in protein crystallization. The complexation potentially makes the protein chain segments less flexible, and consequently makes crystallization easier. Hopefully, our current results will stimulate further studies in this direction.	[Yu, Jiyan; Chen, Weizhong; Wu, Chi] Univ Sci & Technol China, Dept Chem Phys, Hefei 230026, Peoples R China; [Yu, Jiyan; Chen, Weizhong; Chen, Hao] Nanjing Univ, Inst Coordinat Chem, Nanjing 210008, Jiangsu, Peoples R China; [Yu, Jiyan; Chen, Weizhong; Chen, Hao] Nanjing Univ, Sch Chem & Chem Engn, State Key Lab Coordinat Chem, Nanjing 210008, Jiangsu, Peoples R China; [Wu, Chi] Chinese Univ Hong Kong, Dept Chem, Hong Kong, Hong Kong, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Nanjing University; Nanjing University; Chinese University of Hong Kong	Chen, H (corresponding author), Nanjing Univ, Inst Coordinat Chem, Nanjing 210008, Jiangsu, Peoples R China.	chenhao@nju.edu.cn			National Natural Science Foundation of China [21071077, 91013009]; New Teachers' Fund for Doctor Stations, Ministry of Education of China [20100091120029]; Fundamental Research Funds for the Central Universities [1095020516, 1116020501]; Ministry of Science and Technology of China Key Project [2012CB933802]; Hong Kong Special Administration Region Earmarked Projects [CUHK4042/10P, 2130241, 2060405, CUHK4036/11P, 2130281, 2060431]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Teachers' Fund for Doctor Stations, Ministry of Education of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Ministry of Science and Technology of China Key Project; Hong Kong Special Administration Region Earmarked Projects	The financial support of the National Natural Science Foundation of China (21071077 and 91013009, http://www.nsfc.gov.cn/), the New Teachers' Fund for Doctor Stations, Ministry of Education of China (20100091120029, http://www.moe.edu.cn/), the Fundamental Research Funds for the Central Universities (1095020516 and 1116020501, http://www.moe.edu.cn/), the Ministry of Science and Technology of China Key Project (2012CB933802, http://www.most.gov.cn/), and the Hong Kong Special Administration Region Earmarked Projects (CUHK4042/10P, 2130241; 2060405; and CUHK4036/11P, 2130281; 2060431, http://www.ugc.edu.hk/eng/rgc/index.htm) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azegami S, 1999, LANGMUIR, V15, P940, DOI 10.1021/la9809269; Bonnete F, 2001, J CRYST GROWTH, V232, P330, DOI 10.1016/S0022-0248(01)01054-5; Choi HK, 1999, J APPL POLYM SCI, V73, P2749, DOI 10.1002/(SICI)1097-4628(19990923)73:13<2749::AID-APP23>3.0.CO;2-9; Chu B, 1991, LASER LIGHT SCATTERI; Finet S, 2001, J CRYST GROWTH, V232, P40, DOI 10.1016/S0022-0248(01)01160-5; Hao JK, 2010, MACROMOLECULES, V43, P2002, DOI 10.1021/ma9025515; Jeffery G.A., 1997, INTRO HYDROGEN BONDI; KOKUFUTA E, 1991, POLYM BULL, V26, P277, DOI 10.1007/BF00587970; Kulkarni AM, 2000, J CHEM PHYS, V113, P9863, DOI 10.1063/1.1321042; LU XY, 1995, MACROMOLECULES, V28, P3022, DOI 10.1021/ma00113a002; McPherson A., 1999, CRYSTALLIZATION BIOL; Morita Y, 2006, J BACTERIOL, V188, P8649, DOI 10.1128/JB.01342-06; Onuma K, 2009, CRYST GROWTH DES, V9, P2517, DOI 10.1021/cg900019e; Romanini D, 2007, J CHROMATOGR B, V857, P25, DOI 10.1016/j.jchromb.2007.06.025; Sevvana M, 2012, J MOL BIOL, V416, P46, DOI 10.1016/j.jmb.2011.12.008; Sobel ML, 2005, ANTIMICROB AGENTS CH, V49, P1782, DOI 10.1128/AAC.49.5.1782-1786.2005; Tanaka S, 2003, BIOPHYS J, V84, P3299, DOI 10.1016/S0006-3495(03)70054-X; Tanaka S, 2002, J CHEM PHYS, V117, P3504, DOI 10.1063/1.1477456; Vivares D, 2002, ACTA CRYSTALLOGR D, V58, P472, DOI 10.1107/S0907444902000124; XIA JL, 1993, MACROMOLECULES, V26, P6688, DOI 10.1021/ma00076a066	20	2	2	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96616	10.1371/journal.pone.0096616	http://dx.doi.org/10.1371/journal.pone.0096616			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810951	Green Published, Green Submitted, gold			2022-12-27	WOS:000338213300057
J	Fox, MC; Mitchum, AL				Fox, Mark C.; Mitchum, Ainsley L.			Confirming the Cognition of Rising Scores: Fox and Mitchum (2013) Predicts Violations of Measurement Invariance in Series Completion between Age-Matched Cohorts	PLOS ONE			English	Article							INTELLIGENCE-TEST; IQ GAINS; ABILITIES; TESTS; TIME	The trend of rising scores on intelligence tests raises important questions about the comparability of variation within and between time periods. Descriptions of the processes that mediate selection of item responses provide meaningful psychological criteria upon which to base such comparisons. In a recent paper, Fox and Mitchum presented and tested a cognitive theory of rising scores on analogical and inductive reasoning tests that is specific enough to make novel predictions about cohort differences in patterns of item responses for tests such as the Raven's Matrices. In this paper we extend the same proposal in two important ways by (1) testing it against a dataset that enables the effects of cohort to be isolated from those of age, and (2) applying it to two other inductive reasoning tests that exhibit large Flynn effects: Letter Series and Word Series. Following specification and testing of a confirmatory item response model, predicted violations of measurement invariance are observed between two age-matched cohorts that are separated by only 20 years, as members of the later cohort are found to map objects at higher levels of abstraction than members of the earlier cohort who possess the same overall level of ability. Results have implications for the Flynn effect and cognitive aging while underscoring the value of establishing psychological criteria for equating members of distinct groups who achieve the same scores.	[Fox, Mark C.] Univ Richmond, Dept Psychol, Richmond, VA 23173 USA; [Mitchum, Ainsley L.] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA	University of Richmond; State University System of Florida; Florida State University	Fox, MC (corresponding author), Univ Richmond, Dept Psychol, Richmond, VA 23173 USA.	mfox23@richmond.edu						Adams RJ, 1997, APPL PSYCH MEAS, V21, P1, DOI 10.1177/0146621697211001; Borsboom D, 2004, PSYCHOL REV, V111, P1061, DOI 10.1037/0033-295x.111.4.1061; Bowden SC, 2006, PSYCHOL ASSESSMENT, V18, P334, DOI 10.1037/1040-3590.18.3.334; CARPENTER PA, 1990, PSYCHOL REV, V97, P404, DOI 10.1037/0033-295X.97.3.404; Cattell RB, 1940, PSYCHOL REV, V31, P161; Flynn, 2007, WHAT IS INTELLIGENCE; Flynn JR, 2007, INT J TEST, V7, P209, DOI 10.1080/15305050701193587; Flynn JR, 2013, INTELLIGENCE, V41, P851, DOI 10.1016/j.intell.2013.06.014; FLYNN JR, 1987, PSYCHOL BULL, V101, P171, DOI 10.1037/0033-2909.101.2.171; FLYNN JR, 1984, PSYCHOL BULL, V95, P29, DOI 10.1037/0033-2909.95.1.29; Fox MC, 2013, J EXP PSYCHOL GEN, V142, P979, DOI 10.1037/a0030155; GUTTMAN L, 1992, MULTIVAR BEHAV RES, V27, P175, DOI 10.1207/s15327906mbr2702_2; HOLZMAN TG, 1983, J EDUC PSYCHOL, V75, P603; Lamiell JT, 2007, THEOR PSYCHOL, V17, P169, DOI 10.1177/0959354307075041; LAMIELL JT, 1981, AM PSYCHOL, V36, P276, DOI 10.1037/0003-066X.36.3.276; Meo M, 2007, INTELLIGENCE, V35, P359, DOI 10.1016/j.intell.2006.10.001; Must O, 2009, INTELLIGENCE, V37, P25, DOI 10.1016/j.intell.2008.05.002; Primi R, 2002, INTELLIGENCE, V30, P41, DOI 10.1016/S0160-2896(01)00067-8; Rijmen F, 2002, APPL PSYCH MEAS, V26, P271, DOI 10.1177/0146621602026003003; SCHAIE KW, 1989, DEV PSYCHOL, V25, P652, DOI 10.1037/0012-1649.25.4.652; SCHAIE KW, 1985, SCHAIE THURSTONE ADU; SIMON HA, 1963, PSYCHOL REV, V70, P534, DOI 10.1037/h0043901; STANKOV L, 1993, LEARN INDIVID DIFFER, V5, P137, DOI 10.1016/1041-6080(93)90009-H; Teasdale TW, 2005, PERS INDIV DIFFER, V39, P837, DOI 10.1016/j.paid.2005.01.029; Wicherts JM, 2004, INTELLIGENCE, V32, P509, DOI 10.1016/j.intell.2004.07.002; WRIGHT BD, 1977, J EDUC MEAS, V14, P97, DOI 10.1111/j.1745-3984.1977.tb00031.x; Yu F, 2009, RES NURS HEALTH, V32, P540, DOI 10.1002/nur.20340; Zelinski EM, 2007, PSYCHOL AGING, V22, P546, DOI 10.1037/0882-7974.22.3.546; Zelinski EM, 2003, PSYCHOL AGING, V18, P727, DOI 10.1037/0882-7974.18.4.727; Zelinski EM, 1997, PSYCHOL AGING, V12, P503, DOI 10.1037/0882-7974.12.3.503	30	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e95780	10.1371/journal.pone.0095780	http://dx.doi.org/10.1371/journal.pone.0095780			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG9HB	24806478	gold, Green Submitted, Green Published			2022-12-27	WOS:000335728900025
J	Ma, JL; Liu, C; Zhong, X; Wang, L; Chen, X				Ma, Jianling; Liu, Chang; Zhong, Xin; Wang, Lu; Chen, Xu			Emotional Body-Word Conflict Evokes Enhanced N450 and Slow Potential	PLOS ONE			English	Article							NEURAL TIME-COURSE; INFLUENCE RECOGNITION; BODILY EXPRESSIONS; COGNITIVE CONTROL; STROOP; INTERFERENCE; FEARFUL; FACE; THREAT; CORTEX	Emotional conflict refers to the influence of task irrelevant affective stimuli on current task set. Previously used emotional face-word tasks have produced certain electrophysiological phenomena, such as an enhanced N450 and slow potential; however, it remains unknown whether these effects emerge in other tasks. The present study used an emotional body-word conflict task to investigate the neural dynamics of emotional conflict as reflected by response time, accuracy, and event-related potentials, which were recorded with the aim of replicating the previously observed N450 and slow potential effect. Results indicated increased response time and decreased accuracy in the incongruent condition relative to the congruent condition, indicating a robust interference effect. Furthermore, the incongruent condition evoked pronounced N450 amplitudes and a more positive slow potential, which might be associated with conflict-monitoring and conflict resolution. The present finding extend our understanding of emotional conflict to the body-word domain.	[Ma, Jianling; Zhong, Xin; Wang, Lu; Chen, Xu] Minist Educ, Key Lab Cognit & Personal SWU, Chongqing, Peoples R China; [Ma, Jianling; Zhong, Xin; Wang, Lu; Chen, Xu] Southwest Univ SWU, Sch Psychol, Chongqing, Peoples R China; [Liu, Chang] Yangtze Normal Univ, Chongqing, Peoples R China	Southwest University - China; Yangtze Normal University	Chen, X (corresponding author), Minist Educ, Key Lab Cognit & Personal SWU, Chongqing, Peoples R China.	chenxu@swu.edu.cn	Chen, Xu/M-7975-2019	Ma, Jianling/0000-0003-2739-3943				Appelbaum LG, 2009, CEREB CORTEX, V19, P2508, DOI 10.1093/cercor/bhp036; Atkinson AP, 2012, NEUROIMAGE, V59, P1700, DOI 10.1016/j.neuroimage.2011.08.073; Aviezer H, 2012, SCIENCE, V338, P1225, DOI 10.1126/science.1224313; Bannerman RL, 2010, J VISION, V10, DOI 10.1167/10.5.23; Bannerman RL, 2009, P ROY SOC B-BIOL SCI, V276, P1635, DOI 10.1098/rspb.2008.1744; Citron FMM, 2012, BRAIN LANG, V122, P211, DOI 10.1016/j.bandl.2011.12.007; de Gelder B, 2006, NAT REV NEUROSCI, V7, P242, DOI 10.1038/nrn1872; de Gelder B, 2004, P NATL ACAD SCI USA, V101, P16701, DOI 10.1073/pnas.0407042101; de Gelder B, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00054; de Gelder B, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00181; de Gelder B, 2010, NEUROSCI BIOBEHAV R, V34, P513, DOI 10.1016/j.neubiorev.2009.10.008; de Gelder B, 2009, PHILOS T R SOC B, V364, P3475, DOI 10.1098/rstb.2009.0190; Donohue SE, 2012, COGN AFFECT BEHAV NE, V12, P1, DOI 10.3758/s13415-011-0060-z; Egner T, 2008, CEREB CORTEX, V18, P1475, DOI 10.1093/cercor/bhm179; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Gilbert T, 2011, COGNITION EMOTION, V25, P700, DOI 10.1080/02699931.2010.495881; Gu YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066762; Hadjikhani N, 2003, CURR BIOL, V13, P2201, DOI 10.1016/j.cub.2003.11.049; Hietanen JK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024408; Kana RK, 2012, SOC COGN AFFECT NEUR, V7, P446, DOI 10.1093/scan/nsr022; Kret ME, 2011, NEUROIMAGE, V54, P1755, DOI 10.1016/j.neuroimage.2010.08.012; Kret ME, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00810; Kret ME, 2010, EXP BRAIN RES, V203, P169, DOI 10.1007/s00221-010-2220-8; Larson MJ, 2009, NEUROPSYCHOLOGIA, V47, P663, DOI 10.1016/j.neuropsychologia.2008.11.013; Liotti M, 2000, NEUROPSYCHOLOGIA, V38, P701, DOI 10.1016/S0028-3932(99)00106-2; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Meeren HKM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071408; Meeren HKM, 2005, P NATL ACAD SCI USA, V102, P16518, DOI 10.1073/pnas.0507650102; Minnebusch DA, 2009, NEUROSCI BIOBEHAV R, V33, P1133, DOI 10.1016/j.neubiorev.2009.05.008; Mondloch CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073605; Mondloch CJ, 2012, J EXP CHILD PSYCHOL, V111, P180, DOI 10.1016/j.jecp.2011.08.003; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Peelen MV, 2007, SOC COGN AFFECT NEUR, V2, P274, DOI 10.1093/scan/nsm023; Pichon S, 2012, CEREB CORTEX, V22, P274, DOI 10.1093/cercor/bhr060; Pichon S, 2009, NEUROIMAGE, V47, P1873, DOI 10.1016/j.neuroimage.2009.03.084; Reeck C, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00232; Shen YM, 2013, NEUROSCI LETT, V541, P34, DOI 10.1016/j.neulet.2013.02.032; Sinke CBA, 2010, NEUROIMAGE, V49, P1717, DOI 10.1016/j.neuroimage.2009.09.065; Stekelenburg JJ, 2004, NEUROREPORT, V15, P777, DOI 10.1097/00001756-200404090-00007; Stienen BMC, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00132; Stienen BMC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025517; Stienen BMC, 2011, EMOTION, V11, P1182, DOI 10.1037/a0024032; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Szucs D, 2007, NEUROPSYCHOLOGIA, V45, P3190, DOI 10.1016/j.neuropsychologia.2007.06.013; Szucs D, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-35; Szucs D, 2010, BRAIN RES, V1325, P63, DOI 10.1016/j.brainres.2010.02.011; Szucs D, 2009, J COGNITIVE NEUROSCI, V21, P2195, DOI 10.1162/jocn.2009.21220; Szucs D, 2009, NEUROIMAGE, V47, P1960, DOI 10.1016/j.neuroimage.2009.05.048; Tamietto M, 2007, J COGNITIVE NEUROSCI, V19, P445, DOI 10.1162/jocn.2007.19.3.445; Tamietto M, 2009, P NATL ACAD SCI USA, V106, P17661, DOI 10.1073/pnas.0908994106; van de Riet W. A. C., 2008, NETHERLANDS J PSYCHO, V64, P143, DOI DOI 10.1007/BF03076417; Van den Stock J, 2007, EMOTION, V7, P487, DOI 10.1037/1528-3542.7.3.487; Van den Stock J, 2014, HUM BRAIN MAPP, V35, P492, DOI 10.1002/hbm.22195; Van den Stock J, 2012, NEUROBIOL LEARN MEM, V97, P321, DOI 10.1016/j.nlm.2012.01.007; Van den Stock J, 2009, BRAIN TOPOGR, V21, P216, DOI 10.1007/s10548-009-0099-0; Van den Stock J, 2008, BRAIN RES, V1242, P185, DOI 10.1016/j.brainres.2008.05.040; van Heijnsbergen CCRJ, 2007, BRAIN RES, V1186, P233, DOI 10.1016/j.brainres.2007.09.093; West R, 2000, BRAIN RES, V873, P102, DOI 10.1016/S0006-8993(00)02530-0; West R, 2004, PSYCHOPHYSIOLOGY, V41, P739, DOI 10.1111/j.1469-8986.2004.00205.x; West R, 2003, NEUROPSYCHOLOGIA, V41, P1122, DOI 10.1016/S0028-3932(02)00297-X; West R, 2012, PSYCHOPHYSIOLOGY, V49, P1309, DOI 10.1111/j.1469-8986.2012.01464.x; West R, 2010, INT J PSYCHOPHYSIOL, V76, P107, DOI 10.1016/j.ijpsycho.2010.03.002; Xin-tian L, 1983, ACTA PSYCHOL SINICA, V3, P4; Zhu XR, 2010, NEUROSCI LETT, V478, P1, DOI 10.1016/j.neulet.2010.04.036	64	14	14	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e95198	10.1371/journal.pone.0095198	http://dx.doi.org/10.1371/journal.pone.0095198			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819150	gold, Green Published, Green Submitted			2022-12-27	WOS:000336653300004
J	Mitarai, N; Heinsalu, E; Sneppen, K				Mitarai, Namiko; Heinsalu, Els; Sneppen, Kim			Speciation, Diversification, and Coexistence of Sessile Species That Compete for Space	PLOS ONE			English	Article							PUNCTUATED EQUILIBRIUM; SPATIAL COMPETITION; MODEL; BIODIVERSITY; EVOLUTION; PROMOTES	Speciation, diversification, and competition between species challenge the stability of complex ecosystems. Laboratory experiments often focus on one or two species competing under conditions where they may grow exponentially. Field studies, in contrast, emphasize multi-species communities characterized by many types of ecological interactions. A general problem is to understand conditions that support a dynamically maintained coexistence of many species in an ecosystem over a long time span. In the present paper we propose a lattice model of multiple competing and evolving sessile species. When allowing the interspecies interactions to mutate, we obtain coexistence of many species in a complex ecosystem, provided that there is a cost for each interaction. The diversity reached by the model incorporating speciation is found to be substantially higher than in the case when entirely new species appear due to immigration from outside of the considered ecosystem. The species self-organize their spatial distribution through competitive interactions to create many patches, implicitly protecting each other from competitively superior species, and speciation in each patch leads the system to high diversity. We also show that species that exist a long time tend to have a relatively small population, as this allows them to avoid encounter with competitive invaders.	[Mitarai, Namiko; Sneppen, Kim] Univ Copenhagen, Niels Bohr Inst, Ctr Models Life, DK-2100 Copenhagen, Denmark; [Heinsalu, Els] Univ Copenhagen, Niels Bohr Inst, Niels Bohr Int Acad, DK-2100 Copenhagen, Denmark; [Heinsalu, Els] NICPB, Tallinn, Estonia	University of Copenhagen; Niels Bohr Institute; University of Copenhagen; Niels Bohr Institute; National Institute of Chemical Physics & Biophysics (NICPB)	Mitarai, N (corresponding author), Univ Copenhagen, Niels Bohr Inst, Ctr Models Life, Blegdamsvej 17, DK-2100 Copenhagen, Denmark.	mitarai@nbi.dk	Mitarai, Namiko/AAK-8531-2021; Mitarai, Namiko/M-4575-2014	Mitarai, Namiko/0000-0003-0116-7606; Mitarai, Namiko/0000-0003-0116-7606; Sneppen, Kim/0000-0001-9820-3567	Danish National Research Council through the center for Models of Life; targeted financing project [SF0690030s09]; Estonian Science Foundation [9462]	Danish National Research Council through the center for Models of Life; targeted financing project; Estonian Science Foundation	This work has been supported by The Danish National Research Council, through the center for Models of Life (NM, KS), and by the targeted financing project SF0690030s09 and Estonian Science Foundation grant no. 9462 (EH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilee R, 2011, J EVOLUTION BIOL, V24, P2663, DOI 10.1111/j.1420-9101.2011.02392.x; Araujo MB, 2014, ECOGRAPHY, V37, P406, DOI 10.1111/j.1600-0587.2013.00643.x; BAK P, 1993, PHYS REV LETT, V71, P4083, DOI 10.1103/PhysRevLett.71.4083; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; BOERLIJST MC, 1991, PHYSICA D, V48, P17, DOI 10.1016/0167-2789(91)90049-F; Bornholdt S, 2000, P ROY SOC B-BIOL SCI, V267, P2281, DOI 10.1098/rspb.2000.1280; Bornholdt S, 1998, PHYS REV LETT, V81, P236, DOI 10.1103/PhysRevLett.81.236; Bornholdt S, 2009, THEOR BIOSCI, V128, P75, DOI 10.1007/s12064-008-0053-9; Christensen K, 2002, J THEOR BIOL, V216, P73, DOI 10.1006/jtbi.2002.2530; GOULD S J, 1977, Paleobiology, V3, P115; Haerter JO, 2012, MBIO, V3, DOI 10.1128/mBio.00126-12; Hall M, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.011904; HASSELL MP, 1994, NATURE, V370, P290, DOI 10.1038/370290a0; JACKSON JBC, 1975, P NATL ACAD SCI USA, V72, P5160, DOI 10.1073/pnas.72.12.5160; Jain S, 2002, P NATL ACAD SCI USA, V99, P2055, DOI 10.1073/pnas.032618499; Johnson CR, 2002, P ROY SOC B-BIOL SCI, V269, P655, DOI 10.1098/rspb.2001.1948; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; LANDE R, 1980, AM NAT, V116, P463, DOI 10.1086/283642; Mathiesen J, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.188101; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; Mayr E., 1954, EVOLUTION PROCESS, P157; Mitarai N, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.011929; Murrell DJ, 2003, ECOL LETT, V6, P48, DOI 10.1046/j.1461-0248.2003.00397.x; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Reichenbach T, 2007, NATURE, V448, P1046, DOI 10.1038/nature06095; SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; WILSON EO, 1987, J ANIM ECOL, V56, P1, DOI 10.2307/4795; Wright JP, 2002, OECOLOGIA, V132, P96, DOI 10.1007/s00442-002-0929-1	30	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96665	10.1371/journal.pone.0096665	http://dx.doi.org/10.1371/journal.pone.0096665			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819515	Green Published, gold, Green Submitted			2022-12-27	WOS:000336653300026
J	Arshad, W; Ihsan-ul-Haq; Waheed, MT; Mysore, KS; Mirza, B				Arshad, Waheed; Ihsan-ul-Haq; Waheed, Mohammad Tahir; Mysore, Kirankumar S.; Mirza, Bushra			Agrobacterium-Mediated Transformation of Tomato with rolB Gene Results in Enhancement of Fruit Quality and Foliar Resistance against Fungal Pathogens	PLOS ONE			English	Article							PLANT ONCOGENE; RHIZOGENES ROLB; SALICYLIC-ACID; EXPRESSION; AUXIN; ROOT; BIOSYNTHESIS; ACTIVATION; GROWTH; REGION	Tomato (Solanum lycopersicum L.) is the second most important cultivated crop next to potato, worldwide. Tomato serves as an important source of antioxidants in human diet. Alternaria solani and Fusarium oxysporum cause early blight and vascular wilt of tomato, respectively, resulting in severe crop losses. The foremost objective of the present study was to generate transgenic tomato plants with rolB gene and evaluate its effect on plant morphology, nutritional contents, yield and resistance against fungal infection. Tomato cv. Rio Grande was transformed via Agrobacterium tumefaciens harbouring rolB gene of Agrobacterium rhizogenes. rolB. Biochemical analyses showed considerable improvement in nutritional quality of transgenic tomato fruits as indicated by 62% increase in lycopene content, 225% in ascorbic acid content, 58% in total phenolics and 26% in free radical scavenging activity. Furthermore, rolB gene significantly improved the defence response of leaves of transgenic plants against two pathogenic fungal strains A. solani and F. oxysporum. Contrarily, transformed plants exhibited altered morphology and reduced fruit yield. In conclusion, rolB gene from A. rhizogenes can be used to generate transgenic tomato with increased nutritional contents of fruits as well as improved foliar tolerance against fungal pathogens.	[Arshad, Waheed; Waheed, Mohammad Tahir; Mirza, Bushra] Quaid I Azam Univ, Dept Biochem, Fac Biol Sci, Islamabad, Pakistan; [Ihsan-ul-Haq] Quaid I Azam Univ, Dept Pharm, Fac Biol Sci, Islamabad, Pakistan; [Mysore, Kirankumar S.] Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73402 USA	Quaid I Azam University; Quaid I Azam University; Noble Research Institute	Mirza, B (corresponding author), Quaid I Azam Univ, Dept Biochem, Fac Biol Sci, Islamabad, Pakistan.	dr.bushramirza@gmail.com	Mirza, Bushra/I-8013-2015; Mysore, Kirankumar/AAG-7112-2020; Waheed, Mohammad Tahir/T-5401-2019; Haq, Ihsan ul/A-6754-2015; Mirza, Bushra/AAC-5744-2022	Mysore, Kirankumar/0000-0002-9805-5741; Waheed, Mohammad Tahir/0000-0002-9861-462X; Haq, Ihsan ul/0000-0001-6413-5957; 				AGRIOS GN, 1997, PLANT PATHOLOGY; Ahmed I, 2009, J APPL GENET, V50, P105, DOI 10.1007/BF03195661; Altamura MM, 2004, PLANT CELL TISS ORG, V77, P89, DOI 10.1023/B:TICU.0000016609.22655.33; BAILEY BA, 1990, PLANT PHYSIOL, V94, P1849, DOI 10.1104/pp.94.4.1849; Barba AIO, 2006, FOOD CHEM, V95, P328, DOI 10.1016/j.foodchem.2005.02.028; Bettini P, 2003, THEOR APPL GENET, V107, P831, DOI 10.1007/s00122-003-1322-0; Bulgakov VP, 2008, BIOTECHNOL ADV, V26, P318, DOI 10.1016/j.biotechadv.2008.03.001; Bulgakov VP, 2013, ADV BIOCHEM ENG BIOT, V134, P1, DOI 10.1007/10_2013_179; Bulgakov VP, 2012, PLANT PHYSIOL, V158, P1371, DOI 10.1104/pp.111.191494; Bulgakov VP, 2005, PLANTA, V221, P471, DOI 10.1007/s00425-004-1457-5; Bulgakov VP, 2002, FITOTERAPIA, V73, P638, DOI 10.1016/S0367-326X(02)00231-9; Bulgakov VP, 2002, J BIOTECHNOL, V97, P213, DOI 10.1016/S0168-1656(02)00067-6; CAPONE I, 1989, MOL GEN GENET, V216, P239, DOI 10.1007/BF00334362; CARDARELLI M, 1987, MOL GEN GENET, V209, P475, DOI 10.1007/BF00331152; Erinle ID, 1979, EXTENSION B AGR EXTE, V31; ESTRUCH JJ, 1991, EMBO J, V10, P3125, DOI 10.1002/j.1460-2075.1991.tb04873.x; FILIPPINI F, 1994, PLANT CELL PHYSIOL, V35, P767, DOI 10.1093/oxfordjournals.pcp.a078655; Filippini F, 1996, NATURE, V379, P499, DOI 10.1038/379499a0; Geier T, 2008, PLANT CELL TISS ORG, V94, P269, DOI 10.1007/s11240-008-9352-6; Grunwald NJ, 2001, PHYTOPATHOLOGY, V91, P882, DOI 10.1094/PHYTO.2001.91.9.882; Helmenstine AM, 2007, VITAMIN C DETERMINAT; Kiselev KV, 2008, MOL BIOL+, V42, P243, DOI 10.1134/S0026893308020106; Kiselev KV, 2007, J BIOTECHNOL, V128, P681, DOI 10.1016/j.jbiotec.2006.11.008; Kiselev KV, 2009, PLANT CELL TISS ORG, V99, P141, DOI 10.1007/s11240-009-9586-y; Landi L, 2009, TRANSGENIC RES, V18, P933, DOI 10.1007/s11248-009-9279-7; Lattanzio V., 2006, Phytochemistry: advances in research, P23; Lossl AG, 2011, PLANT BIOTECHNOL J, V9, P527, DOI 10.1111/j.1467-7652.2011.00615.x; MARIOTTI D, 1989, Journal of Genetics and Breeding, V43, P157; MAUREL C, 1991, PLANT PHYSIOL, V97, P212, DOI 10.1104/pp.97.1.212; MAUREL C, 1994, PLANT PHYSIOL, V105, P1209, DOI 10.1104/pp.105.4.1209; McDonald S, 2001, FOOD CHEM, V73, P73, DOI 10.1016/S0308-8146(00)00288-0; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nilsson O, 1997, PHYSIOL PLANTARUM, V100, P463, DOI [10.1111/j.1399-3054.1997.tb03050.x, 10.1034/j.1399-3054.1997.1000307.x]; NILSSON O, 1993, PLANT J, V3, P681, DOI 10.1111/j.1365-313X.1993.00681.x; Obied HK, 2005, J AGR FOOD CHEM, V53, P9911, DOI 10.1021/jf0518352; Pham-Huy Lien Ai, 2008, Int J Biomed Sci, V4, P89; Ramani S, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-61; RODER FT, 1994, MOL GEN GENET, V243, P32, DOI 10.1007/BF00283873; Ross JJ, 2000, PLANT J, V21, P547, DOI 10.1046/j.1365-313x.2000.00702.x; Safdar N, 2011, PLANT BIOLOGY, V13, P620, DOI 10.1111/j.1438-8677.2010.00412.x; SCHMULLING T, 1988, EMBO J, V7, P2621, DOI 10.1002/j.1460-2075.1988.tb03114.x; Shabtai S, 2007, THEOR APPL GENET, V114, P1203, DOI 10.1007/s00122-007-0511-7; Shirasu K, 1997, PLANT CELL, V9, P261, DOI 10.1105/tpc.9.2.261; Shkryl YN, 2008, BIOTECHNOL BIOENG, V100, P118, DOI 10.1002/bit.21727; SPENA A, 1992, THEOR APPL GENET, V84, P520, DOI 10.1007/BF00224147; SPENA A, 1987, EMBO J, V6, P3891, DOI 10.1002/j.1460-2075.1987.tb02729.x; Tepfer R, 1988, NUCLEIC ACIDS RES, V16, P1875; VAKALOUNAKIS DJ, 1983, ANN APPL BIOL, V102, P138; VANALTVORST AC, 1992, PLANT SCI, V83, P77, DOI 10.1016/0168-9452(92)90064-S; vanderSalm TPM, 1997, MOL BREEDING, V3, P39, DOI 10.1023/A:1009617704014; vanderSalm TPM, 1996, PLANT MOL BIOL REP, V14, P207, DOI 10.1007/BF02671656; Zhao J, 2005, BIOTECHNOL ADV, V23, P283, DOI 10.1016/j.biotechadv.2005.01.003; Zhu LH, 2003, PLANT SCI, V165, P829, DOI 10.1016/S0168-9452(03)00279-6; Zia M, 2010, PLANT CELL TISS ORG, V103, P227, DOI 10.1007/s11240-010-9771-z	54	41	46	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96979	10.1371/journal.pone.0096979	http://dx.doi.org/10.1371/journal.pone.0096979			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24817272	Green Published, gold, Green Submitted			2022-12-27	WOS:000336838000089
J	Aoki, R; Aoki-Yoshida, A; Suzuki, C; Takayama, Y				Aoki, Reiji; Aoki-Yoshida, Ayako; Suzuki, Chise; Takayama, Yoshiharu			Protective Effect of Indole-3-Pyruvate against Ultraviolet B-Induced Damage to Cultured HaCaT Keratinocytes and the Skin of Hairless Mice	PLOS ONE			English	Article							MELATONIN; APOPTOSIS; ACID; STEROIDOGENESIS; CORTICOSTEROIDS; OVEREXPRESSION; FIBROBLASTS; IRRADIATION; EXPRESSION; PREVENTION	Previous investigations demonstrated that pyruvate protects human keratinocytes against cell damage stemming from exposure to ultraviolet B (UVB) radiation. This study endeavoured to elucidate the protective capacity of aromatic pyruvates (e. g., phenylpyruvate (PPyr), 4-hydroxyphenylpyruvate (HPPyr), and indole-3-pyruvate (IPyr)) against UVB-induced injury to skin cells, both in vitro and in vivo. Cultured human HaCaT keratinocytes were irradiated with UVB light (60 mJ/cm(2)) and maintained with or without test compounds (1-25 mM). In addition, the dorsal skin of hairless mice (HR-1) was treated with test compounds (100 mmol) and exposed to UVB light (1 J/cm(2)) for two times. The ability of the test compounds to ameliorate UVB-induced cytotoxicity and inflammation was then assessed. Aromatic pyruvates reduced cytotoxicity in UV-Birradiated HaCaT keratinocytes, and also diminished the expression of interleukin 1 beta (IL-1 beta) and interleukin 6 (IL-6). IPyr was more efficacious than either PPyr or HPPyr. Furthermore, only IPyr inhibited cyclooxygenase-2 (Cox-2) expression at both the mRNA and the protein level in UVB-treated keratinocytes. Topical application of IPyr to the dorsal skin of hairless mice reduced the severity of UVB-induced skin lesions, the augmentation of dermal thickness, and transepithelial water loss. Overproduction of IL-1 beta and IL-6 in response to UVB radiation was also suppressed in vivo by the topical administration of IPyr. These data strongly suggest that IPyr might find utility as a UVB-blocking reagent in therapeutic strategies to lessen UVB-induced inflammatory skin damage.	[Aoki, Reiji; Aoki-Yoshida, Ayako; Suzuki, Chise; Takayama, Yoshiharu] Natl Agr & Food Res Org, Funct Biomol Res Grp, Tsukuba, Ibaraki, Japan; [Aoki-Yoshida, Ayako] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo, Japan	National Agriculture & Food Research Organization - Japan; University of Tokyo	Takayama, Y (corresponding author), Natl Agr & Food Res Org, Funct Biomol Res Grp, Tsukuba, Ibaraki, Japan.	takay@affrc.go.jp	Takayama, Yoshiharu/M-8826-2019; SUZUKI, Chise/AAR-1986-2020; Takayama, Yoshiharu/E-3662-2010; Aoki, Ayako/GXV-4979-2022	Takayama, Yoshiharu/0000-0003-4532-7114; SUZUKI, Chise/0000-0001-7148-8101; Takayama, Yoshiharu/0000-0003-4532-7114; Aoki, Ayako/0000-0003-4535-8586	National Agriculture and Food Research Organization (NARO) of Japan	National Agriculture and Food Research Organization (NARO) of Japan	This study was supported by a grant from the National Agriculture and Food Research Organization (NARO) of Japan (C. S., Y.T., and R. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki-Yoshida A, 2013, BIOSCI BIOTECH BIOCH, V77, P1766, DOI 10.1271/bbb.120979; Aoki-Yoshida A, 2013, J BIOSCI BIOENG, V115, P442, DOI 10.1016/j.jbiosc.2012.11.004; Chen WX, 2001, ONCOGENE, V20, P3921, DOI 10.1038/sj.onc.1204530; Fernau NS, 2010, J BIOL CHEM, V285, P3896, DOI 10.1074/jbc.M109.081430; Fink MP, 2007, J INTERN MED, V261, P349, DOI 10.1111/j.1365-2796.2007.01789.x; Fischer TW, 2008, EXP DERMATOL, V17, P713, DOI 10.1111/j.1600-0625.2008.00767.x; Fischer TW, 2006, J PINEAL RES, V40, P18, DOI 10.1111/j.1600-079X.2005.00273.x; Hildesheim J, 2004, J INVEST DERMATOL, V122, P497, DOI 10.1111/j.1523-1747.2004.22229.x; Ichihashi M, 2003, TOXICOLOGY, V189, P21, DOI 10.1016/S0300-483X(03)00150-1; Izykowska I, 2009, IN VIVO, V23, P739; Kang JS, 2007, J INVEST DERMATOL, V127, P698, DOI 10.1038/sj.jid.5700572; Kao KK, 2010, BIOCHEM PHARMACOL, V80, P151, DOI 10.1016/j.bcp.2010.03.007; KIRNBAUER R, 1991, J INVEST DERMATOL, V96, P484, DOI 10.1111/1523-1747.ep12470181; Kondo S, 1994, Exp Dermatol, V3, P29, DOI 10.1111/j.1600-0625.1994.tb00263.x; Li JL, 2007, J BIOMED SCI, V14, P303, DOI 10.1007/s11373-007-9148-4; Martin J, 2009, FASEB J, V23, P720, DOI 10.1096/fj.08-119628; Nickel A, 2000, ARCH DERMATOL RES, V292, P366, DOI 10.1007/s004030000141; Poeggeler B, 1999, BRAIN RES, V815, P382, DOI 10.1016/S0006-8993(98)01027-0; Politi V, 1999, ADV EXP MED BIOL, V467, P227; Politi V, 1996, ADV EXP MED BIOL, V398, P291; Rundhaug JE, 2007, MOL CARCINOGEN, V46, P981, DOI 10.1002/mc.20340; Skobowiat C, 2013, GENE, V530, P1, DOI 10.1016/j.gene.2013.08.035; Skobowiat C, 2011, AM J PHYSIOL-ENDOC M, V301, pE484, DOI [10.1152/ajpendo.00217.2011, 10.1152/ajpendo.00217.2011.]; Slominski A, 2005, FASEB J, V19, P176, DOI 10.1096/fj.04-2079rev; Slominski A, 2005, AM J PHYSIOL-ENDOC M, V288, pE701, DOI 10.1152/ajpendo.00519.2004; Slominski A, 2000, BBA-GEN SUBJECTS, V1474, P1, DOI 10.1016/S0304-4165(99)00215-9; Slominski A, 2005, J NEUROIMMUNOL, V162, P97, DOI 10.1016/j.jneuroim.2005.01.014; SLOMINSKI A, 2013, J STEROID BIOCHEM, V137, P107, DOI [10.1016/.jsbmb.2013.02.006, DOI 10.1016/J.JSBMB.2013.02.006]; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski RM, 2012, MOL CELL ENDOCRINOL, V351, P152, DOI 10.1016/j.mce.2012.01.004; Stahl W, 2012, AM J CLIN NUTR, V96, p1179S, DOI 10.3945/ajcn.112.034819; Stojadinovic O, 2007, J BIOL CHEM, V282, P4021, DOI 10.1074/jbc.M606262200; Takayama Y, 1999, J BIOL CHEM, V274, P2291, DOI 10.1074/jbc.274.4.2291; Vukelic S, 2011, J BIOL CHEM, V286, P10265, DOI 10.1074/jbc.M110.188268; Yaar M, 2007, BRIT J DERMATOL, V157, P874, DOI 10.1111/j.1365-2133.2007.08108.x	35	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96804	10.1371/journal.pone.0096804	http://dx.doi.org/10.1371/journal.pone.0096804			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810606	Green Published, gold, Green Submitted			2022-12-27	WOS:000338213300074
J	Chen, MJ; Qian, YS; Dai, JH; Chu, RY				Chen, Minjie; Qian, Yishan; Dai, Jinhui; Chu, Renyuan			The Sonic Hedgehog Signaling Pathway Induces Myopic Development by Activating Matrix Metalloproteinase (MMP)-2 in Guinea Pigs	PLOS ONE			English	Article							FORM-DEPRIVATION MYOPIA; MESSENGER-RNA LEVELS; TREE SHREW SCLERA; MEDIATED ACTIVATION; GASTRIC-CANCER; CHICK EYES; EXPRESSION; CELLS; INVASIVENESS; RECOVERY	Purpose: To investigate whether the Sonic hedgehog (Shh) signaling induces myopic development by increasing the expression of matrix metalloproteinase (MMP)-2 in guinea pigs. Methods: A translucent diffuser was glued onto the right eye to induce form-deprivation myopia (FDM) in 10 guinea pigs. Four guinea pigs were served as a control group. The other 100 guinea pigs were subdivided into 5 groups (20 per group) and received a 10 mu l intravitreal injection every 2 days for 4 times. Two groups were injected with 20 or 50 mu g/ml Shh amino-terminal peptide (Shh-N) into the right eye and 0.1% bovine serum albumin into the other. FDM was induced in the right eyes of the three cyclopamine-treated groups and both eyes were injected with 50, 100, or 200 mu g/ml cyclopamine. Retinoscopic refraction and eye dimensions were assessed on Day 14 of treatment. MMP-2 protein expression was determined in both scleras by western blotting. Results: Both concentrations of Shh-N stimulated myopic development and axial growth as compared with control eyes. Myopia and axial elongation were significantly greater in the 50 mu g/ml than in the 20 mu g/ml Shh-N group (P < 0.001 and P = 0.0019, respectively). All three doses of cyclopamine significantly attenuated myopic development compared with the FDM group (P<0.0001). Cyclopamine at 100 or 200 mu g/ml significantly reduced axial elongation compared with the FDM group (P = 0.044 and P = 0.001, respectively). FDM-induced myopia and axial elongation were significantly greater in the 50 mu g/ml than in the 200 mu g/ml cyclopamine group (P<0.0001 and P = 0.008, respectively). MMP-2 expression was significantly greater in Shh-N-treated eyes than in the control eyes, and was lower in the cyclopamine plus FDM groups than in the FDM group. Conclusions: The Shh signaling pathway induces myopic development by activating MMP-2 in guinea pigs.	[Chen, Minjie; Qian, Yishan; Dai, Jinhui; Chu, Renyuan] Fudan Univ, EENT Hosp, Dept Ophthalmol, Shanghai 200433, Peoples R China; [Chen, Minjie; Qian, Yishan; Dai, Jinhui; Chu, Renyuan] Minist Hlth, Key Lab Myopia, Shanghai, Peoples R China	Fudan University	Dai, JH (corresponding author), Fudan Univ, EENT Hosp, Dept Ophthalmol, Shanghai 200433, Peoples R China.	daijinhui8@126.com			National Natural Science Foundation of China [81070750, 81300792]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grants 81070750 and Grants 81300792 from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu S, 2001, JPN J OPHTHALMOL, V45, P137, DOI 10.1016/S0021-5155(00)00360-9; Chen JS, 2013, CARCINOGENESIS, V34, P10, DOI 10.1093/carcin/bgs274; Chen Y, 2011, MOL VIS, V17, P3072; Cohen Y, 2012, EXP EYE RES, V103, P33, DOI 10.1016/j.exer.2012.08.004; Escano MFT, 2000, EXP EYE RES, V71, P459, DOI 10.1006/exer.2000.0898; Hammerschmidt M, 1997, TRENDS GENET, V13, P14, DOI 10.1016/S0168-9525(96)10051-2; JOHNSON RL, 1995, CELL, V81, P313, DOI 10.1016/0092-8674(95)90381-X; Kim KJ, 2012, INVEST OPHTH VIS SCI, V53, P6456, DOI 10.1167/iovs.12-9658; McBrien NA, 2003, PROG RETIN EYE RES, V22, P307, DOI 10.1016/S1350-9462(02)00063-0; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Nagai S, 2008, CANCER SCI, V99, P1377, DOI 10.1111/j.1349-7006.2008.00822.x; Penha AM, 2012, MOL VIS, V18, P2608; Qian YS, 2009, CURR EYE RES, V34, P623, DOI 10.1080/02713680903003492; Schippert R, 2007, INVEST OPHTH VIS SCI, V48, P11, DOI 10.1167/iovs.06-0851; Schmucker C, 2004, VISION RES, V44, P1857, DOI 10.1016/j.visres.2004.03.011; SEKO Y, 1994, GRAEF ARCH CLIN EXP, V232, P545, DOI 10.1007/BF00181998; SELTNER RLP, 1995, VISION RES, V35, P1265, DOI 10.1016/0042-6989(94)00244-G; Siegwart JT, 2005, INVEST OPHTH VIS SCI, V46, P3484, DOI 10.1167/iovs.05-0194; Siegwart JT, 2002, INVEST OPHTH VIS SCI, V43, P2067; Spence JR, 2004, DEVELOPMENT, V131, P4607, DOI 10.1242/dev.01298; Troilo D, 2006, INVEST OPHTH VIS SCI, V47, P1768, DOI 10.1167/iovs.05-0298; Yoo YA, 2008, CARCINOGENESIS, V29, P480, DOI 10.1093/carcin/bgm281; Yoo YA, 2011, CANCER RES, V71, P7061, DOI 10.1158/0008-5472.CAN-11-1338; Zhang Lei, 2013, Front Biosci (Schol Ed), V5, P661	24	14	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96952	10.1371/journal.pone.0096952	http://dx.doi.org/10.1371/journal.pone.0096952			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810957	gold, Green Published, Green Submitted			2022-12-27	WOS:000338213300097
J	Qian, Y				Qian, Yu			Time Delay and Long-Range Connection Induced Synchronization Transitions in Newman-Watts Small-World Neuronal Networks	PLOS ONE			English	Article							OSCILLATIONS	The synchronization transitions in Newman-Watts small-world neuronal networks (SWNNs) induced by time delay tau and long-range connection (LRC) probability P have been investigated by synchronization parameter and space-time plots. Four distinct parameter regions, that is, asynchronous region, transition region, synchronous region, and oscillatory region have been discovered at certain LRC probability P = 1: 0 as time delay is increased. Interestingly, desynchronization is observed in oscillatory region. More importantly, we consider the spatiotemporal patterns obtained in delayed Newman-Watts SWNNs are the competition results between long-range drivings (LRDs) and neighboring interactions. In addition, for moderate time delay, the synchronization of neuronal network can be enhanced remarkably by increasing LRC probability. Furthermore, lag synchronization has been found between weak synchronization and complete synchronization as LRC probability P is a little less than 1.0. Finally, the two necessary conditions, moderate time delay and large numbers of LRCs, are exposed explicitly for synchronization in delayed Newman-Watts SWNNs.	[Qian, Yu] Baoji Univ Arts & Sci, Nonlinear Res Inst, Baoji, Peoples R China; [Qian, Yu] Soochow Univ, Ctr Syst Biol, Suzhou, Peoples R China; [Qian, Yu] Chinese Acad Sci, Inst Theoret Phys, State Key Lab Theoret Phys, Beijing 100080, Peoples R China	Baoji University of Arts & Sciences; Soochow University - China; Chinese Academy of Sciences; Institute of Theoretical Physics, CAS	Qian, Y (corresponding author), Baoji Univ Arts & Sci, Nonlinear Res Inst, Baoji, Peoples R China.	qianyu0272@163.com	Qian, Yu/A-7862-2012		National Natural Science Foundation of China [11105003]; Natural Science Foundation of the Education Bureau of Shaanxi Province of China [2013JK0619]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of the Education Bureau of Shaanxi Province of China	This work was supported by the National Natural Science Foundation of China (Grant Nos. 11105003), and the Natural Science Foundation of the Education Bureau of Shaanxi Province of China (Grant No. 2013JK0619). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; BAR M, 1993, PHYS REV E, V48, pR1635; Bazhenov M, 2001, NEURON, V30, P553, DOI 10.1016/S0896-6273(01)00284-7; Buric N, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.036211; Dhamala M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.028101; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Guo DQ, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.061905; He DH, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.055204; Kandel E.R., 1991, PRINC NEUROSCI, V3rd ed.; Ko TW, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.056206; Liang XM, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.066202; Liu ZH, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.055201; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Newman MEJ, 1999, PHYS LETT A, V263, P341, DOI 10.1016/S0375-9601(99)00757-4; PECORA LM, 1990, PHYS REV LETT, V64, P821, DOI 10.1103/PhysRevLett.64.821; Pyragas K, 1996, PHYS REV E, V54, pR4508, DOI 10.1103/PhysRevE.54.R4508; Qi F, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.064102; Qian Y, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.026107; Qian Y, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.036101; Rosenblum MG, 1997, PHYS REV LETT, V78, P4193, DOI 10.1103/PhysRevLett.78.4193; Roxin A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.238103; SINHA S, 2007, PHYS REV E 2, V76; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Tang J, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046207; Usrey WM, 1999, ANNU REV PHYSIOL, V61, P435, DOI 10.1146/annurev.physiol.61.1.435; Wang QY, 2011, CHINESE PHYS B, V20, DOI 10.1088/1674-1056/20/4/040504; Wang QY, 2008, PHYS LETT A, V372, P5681, DOI 10.1016/j.physleta.2008.07.005; Wang QY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015851, 10.1371/journal.pone.0021006]; Wang QY, 2010, PHYSICA A, V389, P3299, DOI 10.1016/j.physa.2010.03.031; Wang QY, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026206; Wang QY, 2009, CHAOS, V19, DOI 10.1063/1.3133126; Wang QY, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/50008; Ward LM, 2003, TRENDS COGN SCI, V7, P553, DOI 10.1016/j.tics.2003.10.012; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; West BJ, 2008, PHYS REP, V468, P1, DOI 10.1016/j.physrep.2008.06.003; Yu HT, 2013, PHYSICA A, V392, P5473, DOI 10.1016/j.physa.2013.06.052; Yu HT, 2013, CHAOS SOLITON FRACT, V48, P68, DOI 10.1016/j.chaos.2012.05.005; Yu HT, 2011, CHAOS, V21, DOI 10.1063/1.3565027; Zumdieck A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.244103	41	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96415	10.1371/journal.pone.0096415	http://dx.doi.org/10.1371/journal.pone.0096415			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810595	Green Published, Green Submitted, gold			2022-12-27	WOS:000338213300033
J	Wendler, JP; Okombo, J; Amato, R; Miotto, O; Kiara, SM; Mwai, L; Pole, L; O'Brien, J; Manske, M; Alcock, D; Drury, E; Sanders, M; Oyola, SO; Malangone, C; Jyothi, D; Miles, A; Rockett, KA; MacInnis, BL; Marsh, K; Bejon, P; Nzila, A; Kwiatkowski, DP				Wendler, Jason P.; Okombo, John; Amato, Roberto; Miotto, Olivo; Kiara, Steven M.; Mwai, Leah; Pole, Lewa; O'Brien, John; Manske, Magnus; Alcock, Dan; Drury, Eleanor; Sanders, Mandy; Oyola, Samuel O.; Malangone, Cinzia; Jyothi, Dushyanth; Miles, Alistair; Rockett, Kirk A.; MacInnis, Bronwyn L.; Marsh, Kevin; Bejon, Philip; Nzila, Alexis; Kwiatkowski, Dominic P.			A Genome Wide Association Study of Plasmodium falciparum Susceptibility to 22 Antimalarial Drugs in Kenya	PLOS ONE			English	Article							IN-VITRO ACTIVITIES; CHLOROQUINE-RESISTANCE; AMODIAQUINE RESISTANCE; MALARIA; PFCRT; PARASITES; POLYMORPHISMS; SELECTION; QUININE; AFRICA	Background: Drug resistance remains a chief concern for malaria control. In order to determine the genetic markers of drug resistant parasites, we tested the genome-wide associations (GWA) of sequence-based genotypes from 35 Kenyan P. falciparum parasites with the activities of 22 antimalarial drugs. Methods and Principal Findings: Parasites isolated from children with acute febrile malaria were adapted to culture, and sensitivity was determined by in vitro growth in the presence of anti-malarial drugs. Parasites were genotyped using whole genome sequencing techniques. Associations between 6250 single nucleotide polymorphisms (SNPs) and resistance to individual anti-malarial agents were determined, with false discovery rate adjustment for multiple hypothesis testing. We identified expected associations in the pfcrt region with chloroquine (CQ) activity, and other novel loci associated with amodiaquine, quinazoline, and quinine activities. Signals for CQ and primaquine (PQ) overlap in and around pfcrt, and interestingly the phenotypes are inversely related for these two drugs. We catalog the variation in dhfr, dhps, mdr1, nhe, and crt, including novel SNPs, and confirm the presence of a dhfr-164L quadruple mutant in coastal Kenya. Mutations implicated in sulfadoxine-pyrimethamine resistance are at or near fixation in this sample set. Conclusions/Significance: Sequence-based GWA studies are powerful tools for phenotypic association tests. Using this approach on falciparum parasites from coastal Kenya we identified known and previously unreported genes associated with phenotypic resistance to anti-malarial drugs, and observe in high-resolution haplotype visualizations a possible signature of an inverse selective relationship between CQ and PQ.	[Wendler, Jason P.; Amato, Roberto; Miotto, Olivo; O'Brien, John; Miles, Alistair; Rockett, Kirk A.; MacInnis, Bronwyn L.; Bejon, Philip; Kwiatkowski, Dominic P.] Univ Oxford, MRC, Ctr Genom & Global Hlth, Oxford, England; [Okombo, John; Kiara, Steven M.; Mwai, Leah; Pole, Lewa; Marsh, Kevin; Bejon, Philip] Kenya Med Res Inst KEMRI Wellcome Trust Collabora, Kilifi, Kenya; [Miotto, Olivo] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand; [Wendler, Jason P.; Amato, Roberto; Miotto, Olivo; O'Brien, John; Manske, Magnus; Alcock, Dan; Drury, Eleanor; Sanders, Mandy; Oyola, Samuel O.; Malangone, Cinzia; Jyothi, Dushyanth; Miles, Alistair; Rockett, Kirk A.; MacInnis, Bronwyn L.; Kwiatkowski, Dominic P.] Wellcome Trust Sanger Inst, Cambridge, England; [Wendler, Jason P.; Amato, Roberto; Miotto, Olivo; O'Brien, John; Miles, Alistair; Rockett, Kirk A.; Bejon, Philip; Kwiatkowski, Dominic P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Nzila, Alexis] King Fahd Univ Petr & Minerals, Dept Biol, Dhahran 31261, Saudi Arabia	University of Oxford; Kenya Medical Research Institute; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Wellcome Trust Sanger Institute; University of Oxford; Wellcome Centre for Human Genetics; King Fahd University of Petroleum & Minerals	Kwiatkowski, DP (corresponding author), Univ Oxford, MRC, Ctr Genom & Global Hlth, Oxford, England.	dominic@well.ox.ac.uk	Miotto, Olivo/AAE-7124-2019; Jyothi, Dushyanth/H-9517-2014	Miotto, Olivo/0000-0001-8060-6771; Amato, Roberto/0000-0001-8633-9221; Oyola, Samuel O./0000-0002-6425-7345; Kwiatkowski, Dominic/0000-0002-5023-0176; Miles, Alistair/0000-0001-9018-4680; Manske, Magnus/0000-0001-5916-0947; Malangone, Cinzia/0000-0003-1639-8589; Jyothi, Dushyanth/0000-0002-0448-5303	Medical Research Council [G0600718]; Wellcome Trust [090770/Z/09/Z]; Wellcome Trust Centre for Human Genetics [090532/Z/09/Z]; Wellcome Trust Sanger Institute [098051]; Medical Research Council [G1002624] Funding Source: researchfish; MRC [G0600718, G1002624] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Wellcome Trust Centre for Human Genetics(Wellcome Trust); Wellcome Trust Sanger Institute(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by the Medical Research Council (G0600718) and The Wellcome Trust (090770/Z/09/Z). The Wellcome Trust also provide core awards to Wellcome Trust Centre for Human Genetics (090532/Z/09/Z) and the Wellcome Trust Sanger Institute (098051). http://www.wellcome.ac.uk/index. htm http://www.mrc.ac.uk/index.htm The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriantsoanirina V, 2009, ANTIMICROB AGENTS CH, V53, P4588, DOI 10.1128/AAC.00610-09; Baird JK, 2011, TRENDS PARASITOL, V27, P11, DOI 10.1016/j.pt.2010.08.005; Basco LK, 2003, ANTIMICROB AGENTS CH, V47, P1391, DOI 10.1128/AAC.47.4.1391-1394.2003; Beshir K, 2010, ANTIMICROB AGENTS CH, V54, P3714, DOI 10.1128/AAC.00358-10; Borrmann S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026005; Bray PG, 2005, BIOCHEM PHARMACOL, V70, P1158, DOI 10.1016/j.bcp.2005.07.021; Combrinck JM, 2013, ACS CHEM BIOL, V8, P133, DOI 10.1021/cb300454t; Daily JP, 2003, PARASITOLOGY, V126, P401, DOI 10.1017/S0031182003002981; DOMC, 2009, NAT MAL STRAT 2009 2; Duah NO, 2012, AM J TROPICAL MED HY; Ecker A, 2012, TRENDS PARASITOL, V28, P504, DOI 10.1016/j.pt.2012.08.002; Ferdig MT, 2004, MOL MICROBIOL, V52, P985, DOI 10.1111/j.1365-2958.2004.04035.x; Fidock DA, 2000, MOL BIOCHEM PARASIT, V110, P1, DOI 10.1016/S0166-6851(00)00249-8; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Ginsburg H, 1998, BIOCHEM PHARMACOL, V56, P1305, DOI 10.1016/S0006-2952(98)00184-1; Heis MD, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-166; Henry M, 2009, ANTIMICROB AGENTS CH, V53, P1926, DOI 10.1128/AAC.01243-08; Holmgren G, 2006, INFECT GENET EVOL, V6, P309, DOI 10.1016/j.meegid.2005.09.001; Kiara SM, 2009, ANTIMICROB AGENTS CH, V53, P3793, DOI 10.1128/AAC.00308-09; Kublin JG, 2003, J INFECT DIS, V187, P1870, DOI 10.1086/375419; Kwiatkowski D, 2008, NATURE, V456, P732, DOI 10.1038/nature07632; Laufer MK, 2010, J INFECT DIS, V202, P801, DOI 10.1086/655659; Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174; MARTIN SK, 1987, SCIENCE, V235, P899, DOI 10.1126/science.3544220; Mita T, 2004, MOL BIOCHEM PARASIT, V135, P159, DOI 10.1016/j.molbiopara.2004.01.011; Mwai L, 2009, ANTIMICROB AGENTS CH, V53, P5069, DOI 10.1128/AAC.00638-09; Mwai L, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-106; Nsobya SL, 2007, ANTIMICROB AGENTS CH, V51, P3023, DOI 10.1128/AAC.00012-07; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Ochong EO, 2003, AM J TROP MED HYG, V69, P184, DOI 10.4269/ajtmh.2003.69.184; Okombo J, 2012, ANTIMICROB AGENTS CH, V56, P1105, DOI 10.1128/AAC.05454-11; Okombo J, 2010, ANTIMICROB AGENTS CH, V54, P3302, DOI 10.1128/AAC.00325-10; Park DJ, 2012, P NATL ACAD SCI USA, V109, P13052, DOI 10.1073/pnas.1210585109; Patel JJ, 2010, MOL MICROBIOL, V78, P770, DOI 10.1111/j.1365-2958.2010.07366.x; Sa JM, 2009, P NATL ACAD SCI USA, V106, P18883, DOI 10.1073/pnas.0911317106; Sasi P, 2009, J INFECT DIS, V199, P1575, DOI 10.1086/598862; Shretta R, 2000, TROP MED INT HEALTH, V5, P755, DOI 10.1046/j.1365-3156.2000.00643.x; Sibley CH, 2010, TRENDS PARASITOL, V26, P221, DOI 10.1016/j.pt.2010.02.008; Sisowath C, 2009, J INFECT DIS, V199, P750, DOI 10.1086/596738; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Su XZ, 1997, CELL, V91, P593, DOI 10.1016/S0092-8674(00)80447-X; Vale N, 2009, EUR J MED CHEM, V44, P937, DOI 10.1016/j.ejmech.2008.08.011; Van Tyne D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001383; WATKINS WM, 1984, LANCET, V1, P357; WELLEMS TE, 1991, P NATL ACAD SCI USA, V88, P3382, DOI 10.1073/pnas.88.8.3382; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2007, MALARIA J; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813; Yuan J, 2011, SCIENCE, V333, P724, DOI 10.1126/science.1205216; Zheng G, 2006, AM J HUM GENET, V78, P350, DOI 10.1086/500054	50	18	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96486	10.1371/journal.pone.0096486	http://dx.doi.org/10.1371/journal.pone.0096486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809681	Green Published, gold, Green Submitted			2022-12-27	WOS:000338213300045
J	Jiang, F; Mu, J; Wang, XX; Ye, XQ; Si, L; Ning, SL; Li, Z; Li, Y				Jiang, Fei; Mu, Juan; Wang, Xingxing; Ye, Xianqing; Si, Lu; Ning, Shilong; Li, Zhong; Li, Yuan			The Repressive Effect of miR-148a on TGF beta-SMADs Signal Pathway Is Involved in the Glabridin-Induced Inhibition of the Cancer Stem Cells-Like Properties in Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; LIVER-CANCER; LICORICE ROOT; TUMOR-GROWTH; EXPRESSION; ISOFLAVAN; SURVIVAL; RECEPTOR; ANGIOGENESIS; METASTASIS	Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related mortality worldwide. Current standard practices for treatment of HCC are less than satisfactory because of cancer stem cells (CSCs)-mediated post-surgical recurrence. For this reason, targeting the CSCs or the cancer cells with CSCs-like properties has become a new approach for the treatment of HCC. GLA exhibits anti-tumor effects in that it attenuates the proliferation, migration, invasion, and angiogenesis of human cancer cells. However, the functions of GLA in the regulation of CSCs-like properties in HCC cells, and the molecular mechanisms underlying in remain obscure. Here we found that GLA attenuated the CSCs-like properties by the microRNA-148a (miR-148a)-mediated inhibition of transforming growth factor beta (TGF-beta)/SMAD2 signal pathway in HCC cell lines (HepG2, Huh-7, and MHCC97H). Indeed, GLA inhibited the activations/expressions of both TGF beta-induced and the endogenous SMAD2. Further, GLA improved the expression of miR-148a in a dose/time-dependent manner. MiR-148a, which targeted the SMAD2-39UTR, decreased the expression and function of SMAD2. Knockdown of miR-148a abolished the GLA-induced inhibition of TGF-beta/SMAD2 signal pathway and the CSCs-like properties in HCC cells. Our study found a novel mechanism that GLA inhibits the CSCs-like properties of HCC cells by miR-148a-mediated inhibition of TGF-beta/SMAD2 signal pathway, which may help to identify potential targets for the therapies of HCC.	[Jiang, Fei; Mu, Juan; Wang, Xingxing; Ye, Xianqing; Si, Lu; Ning, Shilong; Li, Zhong; Li, Yuan] Nanjing Med Univ, Sch Publ Hlth, Minist Educ, Key Lab Modern Toxicol,Dept Nutr & Food Hyg, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Li, Z (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Minist Educ, Key Lab Modern Toxicol,Dept Nutr & Food Hyg, Nanjing, Jiangsu, Peoples R China.	lz-ny@njmu.edu.cn; liyuannjmu@hotmail.com			National Natural Science Foundation of China [81171987, 30972507]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by National Natural Science Foundation of China (81171987, 30972507) and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augello C, 2012, LIVER INT, V32, P772, DOI 10.1111/j.1478-3231.2012.02795.x; Bhola NE, 2013, J CLIN INVEST, V123, P1348, DOI 10.1172/JCI65416; Brandl M, 2010, J CELL SCI, V123, P4231, DOI 10.1242/jcs.071100; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Bueno L, 2008, EUR J CANCER, V44, P142, DOI 10.1016/j.ejca.2007.10.008; Cohen MM, 2003, AM J MED GENET A, V116A, P1, DOI 10.1002/ajmg.a.10750; Eaves CJ, 2008, NATURE, V456, P581, DOI 10.1038/456581a; Hsu YL, 2011, MOL NUTR FOOD RES, V55, P318, DOI 10.1002/mnfr.201000148; Inagaki Y, 2007, GUT, V56, P284, DOI 10.1136/gut.2005.088690; Ji JF, 2012, SEMIN ONCOL, V39, P461, DOI 10.1053/j.seminoncol.2012.05.011; Jia Q, 2013, CELL REPROGRAM, V15, P143, DOI 10.1089/cell.2012.0048; Kang JS, 2005, J PHARMACOL EXP THER, V312, P1187, DOI 10.1124/jpet.104.077107; Kim HM, 2012, ANN SURG ONCOL, V19, pS539, DOI 10.1245/s10434-011-2040-5; KOLESKE AJ, 1995, P NATL ACAD SCI USA, V92, P1381, DOI 10.1073/pnas.92.5.1381; Kwon HS, 2008, CLIN EXP IMMUNOL, V151, P165, DOI 10.1111/j.1365-2249.2007.03539.x; Liu W, 2012, CANCER-AM CANCER SOC, V118, P1693, DOI 10.1002/cncr.26483; Liu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023311; Nabekura T, 2008, CANCER CHEMOTH PHARM, V62, P867, DOI 10.1007/s00280-007-0676-4; Song YJ, 2013, CANCER LETT, V339, P70, DOI 10.1016/j.canlet.2013.07.021; Takagi S, 2008, J BIOL CHEM, V283, P9674, DOI 10.1074/jbc.M709382200; Tamir S, 2000, CANCER RES, V60, P5704; Tang Y, 2008, P NATL ACAD SCI USA, V105, P2445, DOI 10.1073/pnas.0705395105; Tsai YM, 2011, INTEGR CANCER THER, V10, P341, DOI 10.1177/1534735410384860; Tsochatzis EA, 2012, NEW ENGL J MED, V366, P92, DOI 10.1056/NEJMc1112501; Uchida Y, 2010, ONCOL REP, V24, P1147, DOI 10.3892/or_00000966; Vaya J, 1997, FREE RADICAL BIO MED, V23, P302, DOI 10.1016/S0891-5849(97)00089-0; Veratti E, 2011, ANTICANCER RES, V31, P2209; Vittal R, 2013, AM J PHYSIOL-LUNG C, V304, pL401, DOI 10.1152/ajplung.00080.2012; Wu K, 2012, HEPATOLOGY, V56, P2255, DOI 10.1002/hep.26007; Yamashita T, 2013, HEPATOLOGY, V57, P1484, DOI 10.1002/hep.26168; Yan H, 2013, MOL CARCINOG; Yao CJ, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/617085; Yoshikawa S, 2009, WORLD J GASTROENTERO, V15, P4896, DOI 10.3748/wjg.15.4896; Yu XQ, 2008, LIFE SCI, V82, P68, DOI 10.1016/j.lfs.2007.10.019; Zhang H, 2011, CELL DEATH DIFFER, V18, P1702, DOI 10.1038/cdd.2011.28; Zhong ZJ, 2010, CLIN CANCER RES, V16, P1191, DOI 10.1158/1078-0432.CCR-09-1634	36	53	56	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96698	10.1371/journal.pone.0096698	http://dx.doi.org/10.1371/journal.pone.0096698			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806207	gold, Green Published, Green Submitted			2022-12-27	WOS:000335728900082
J	Nishiwaki, S; Nakayama, T; Murata, M; Nishida, T; Terakura, S; Saito, S; Kato, T; Mizuno, H; Imahashi, N; Seto, A; Ozawa, Y; Miyamura, K; Ito, M; Takeshita, K; Kato, H; Toyokuni, S; Nagao, K; Ueda, R; Naoe, T				Nishiwaki, Satoshi; Nakayama, Takayuki; Murata, Makoto; Nishida, Tetsuya; Terakura, Seitaro; Saito, Shigeki; Kato, Tomonori; Mizuno, Hiroki; Imahashi, Nobuhiko; Seto, Aika; Ozawa, Yukiyasu; Miyamura, Koichi; Ito, Masafumi; Takeshita, Kyosuke; Kato, Hidefumi; Toyokuni, Shinya; Nagao, Keisuke; Ueda, Ryuzo; Naoe, Tomoki			Dexamethasone Palmitate Ameliorates Macrophages-Rich Graft-versus-Host Disease by Inhibiting Macrophage Functions	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; HEMATOPOIETIC-CELL TRANSPLANTATION; ANTIGEN-PRESENTING CELLS; MICROWAVE IRRADIATION; MYELOID-LEUKEMIA; LANGERHANS CELLS; DENDRITIC CELL; MAST-CELLS; POLARIZATION; GVHD	Macrophage infiltration of skin GVHD lesions correlates directly with disease severity, but the mechanisms underlying this relationship remain unclear and GVHD with many macrophages is a therapeutic challenge. Here, we characterize the macrophages involved in GVHD and report that dexamethasone palmitate (DP), a liposteroid, can ameliorate such GVHD by inhibiting macrophage functions. We found that host-derived macrophages could exacerbate GVHD in a mouse model through expression of higher levels of pro-inflammatory TNF-alpha and IFN-gamma, and lower levels of anti-inflammatory IL-10 than resident macrophages in mice without GVHD. DP significantly decreased the viability and migration capacity of primary mouse macrophages compared to conventional dexamethasone in vitro. DP treatment on day 7 and day 14 decreased macrophage number, and attenuated GVHD score and subsequent mortality in a murine model. This is the first study to provide evidence that therapy for GVHD should be changed on the basis of infiltrating cell type.	[Nishiwaki, Satoshi; Murata, Makoto; Nishida, Tetsuya; Terakura, Seitaro; Saito, Shigeki; Kato, Tomonori; Mizuno, Hiroki; Imahashi, Nobuhiko; Naoe, Tomoki] Nagoya Univ, Dept Hematol & Oncol, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Nishiwaki, Satoshi] Japanese Red Cross Nagoya First Hosp, Japan Soc Promot Sci, Nagoya, Aichi, Japan; [Nishiwaki, Satoshi; Imahashi, Nobuhiko; Seto, Aika; Ozawa, Yukiyasu; Miyamura, Koichi] Japanese Red Cross Nagoya First Hosp, Dept Hematol, Nagoya, Aichi, Japan; [Nakayama, Takayuki; Kato, Hidefumi] Aichi Med Univ, Dept Transfus Med, Nagakute, Aichi 48011, Japan; [Ito, Masafumi] Japanese Red Cross Nagoya First Hosp, Dept Pathol, Nagoya, Aichi, Japan; [Takeshita, Kyosuke] Nagoya Univ, Dept Cardiol, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Toyokuni, Shinya] Nagoya Univ, Dept Pathol & Biol Responses, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Nagao, Keisuke] Keio Univ, Sch Med, Dept Dermatol, Shinjyuku Ku, Tokyo, Japan; [Ueda, Ryuzo] Aichi Med Univ, Dept Tumor Immunol, Nagakute, Aichi 48011, Japan	Nagoya University; Japan Society for the Promotion of Science; Red Cross Nagoya Daiichi Hospital; Red Cross Nagoya Daiichi Hospital; Aichi Medical University; Red Cross Nagoya Daiichi Hospital; Nagoya University; Nagoya University; Keio University; Aichi Medical University	Nakayama, T (corresponding author), Aichi Med Univ, Dept Transfus Med, Nagakute, Aichi 48011, Japan.	tnaka@aichi-med-u.ac.jp	nishida, tetsuya/I-7300-2014; Takeshita, Kyosuke/AAD-9515-2020; Nagao, Keisuke/J-5116-2013; Nagao, Keisuke/P-3837-2018; Takeshita, Kyosuke/B-7008-2012; Toyokuni, Shinya/ABE-7714-2021; Toyokuni, Shinya/C-1358-2010; Naoe, Tomoki/I-1888-2012; Murata, Makoto/I-7370-2014; Terakura, Seitaro/A-6188-2011	Takeshita, Kyosuke/0000-0002-8283-3799; Nagao, Keisuke/0000-0002-7005-3138; Nagao, Keisuke/0000-0002-7005-3138; Takeshita, Kyosuke/0000-0002-8283-3799; Toyokuni, Shinya/0000-0002-5757-1109; Toyokuni, Shinya/0000-0002-5757-1109; Nakayama, Takayuki/0000-0003-2389-2542; Terakura, Seitaro/0000-0002-1194-8046	Japan Society for the Promotion of Science;  [(C) 20591118]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	This study was supported in part by a grant from the Japan Society for the Promotion of Science to S.N., and in part by a Japanese Grant-in-Aid for Scientific Research [(C) 20591118] to T. Nakayama. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron F, 2012, LEUKEMIA, V26, P2462, DOI 10.1038/leu.2012.135; Blirando K, 2011, AM J PATHOL, V178, P640, DOI 10.1016/j.ajpath.2010.10.003; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; Everse LA, 2001, TRANSPLANTATION, V71, P611, DOI 10.1097/00007890-200103150-00006; Fuentes-Duculan J, 2010, J INVEST DERMATOL, V130, P2412, DOI 10.1038/jid.2010.165; GRATWOHL A, 1995, BLOOD, V86, P813, DOI 10.1182/blood.V86.2.813.bloodjournal862813; Hashimoto D, 2011, J EXP MED, V208, P1069, DOI 10.1084/jem.20101709; Hill GR, 1998, J CLIN INVEST, V102, P115, DOI 10.1172/JCI3132; Kaplan DH, 2004, J IMMUNOL, V173, P5467, DOI 10.4049/jimmunol.173.9.5467; Kondo S, 2002, CANCER LETT, V179, P87, DOI 10.1016/S0304-3835(01)00859-X; LEONG ASY, 1986, J PATHOL, V148, P183, DOI 10.1002/path.1711480209; Li NN, 2009, BLOOD, V113, P953, DOI 10.1182/blood-2008-06-165522; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Merad M, 2004, NAT MED, V10, P510, DOI 10.1038/nm1038; MULLER M, 1991, BIOCHIM BIOPHYS ACTA, V1088, P171, DOI 10.1016/0167-4781(91)90052-N; Nagao K, 2009, P NATL ACAD SCI USA, V106, P3312, DOI 10.1073/pnas.0807126106; Nakayama T, 2006, J LEUKOCYTE BIOL, V79, P95, DOI 10.1189/jlb.0405226; Nishiwaki S, 2009, BLOOD, V114, P3113, DOI 10.1182/blood-2009-03-209635; PAK CC, 1991, BIOTHERAPY, V3, P55, DOI 10.1007/BF02175099; Pullarkat V, 2008, BONE MARROW TRANSPL, V42, P799, DOI 10.1038/bmt.2008.262; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Ringden O, 1996, LEUKEMIA LYMPHOMA, V24, P71, DOI 10.3109/10428199609045715; Saito S, 2011, AM J PATHOL, V179, P1088, DOI 10.1016/j.ajpath.2011.05.027; Schaer DJ, 2007, ANTIOXID REDOX SIGN, V9, P991, DOI 10.1089/ars.2007.1576; Shin Seulmee, 2009, Immune Netw, V9, P255, DOI 10.4110/in.2009.9.6.255; Shlomchik WD, 1999, SCIENCE, V285, P412, DOI 10.1126/science.285.5426.412; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Stoy N, 2001, PATHOBIOLOGY, V69, P179, DOI 10.1159/000055944; Thiele J, 2000, VIRCHOWS ARCH, V437, P160, DOI 10.1007/s004280000224; Toyokuni S, 2003, PATHOL INT, V53, P259, DOI 10.1046/j.1320-5463.2003.01465.x; Van Lint MT, 2006, BLOOD, V107, P4177, DOI 10.1182/blood-2005-12-4851; Wilson J, 2009, J EXP MED, V206, P387, DOI 10.1084/jem.20070723; Xia W, 2009, BLOOD, V113, P438, DOI 10.1182/blood-2008-04-150789	35	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96252	10.1371/journal.pone.0096252	http://dx.doi.org/10.1371/journal.pone.0096252			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806147	Green Submitted, gold, Green Published			2022-12-27	WOS:000335728900042
J	Voigtlander, T; David, S; Thamm, K; Schlue, J; Metzger, J; Manns, MP; Lankisch, TO				Voigtlaender, Torsten; David, Sascha; Thamm, Kristina; Schlue, Jerome; Metzger, Jochen; Manns, Michael P.; Lankisch, Tim O.			Angiopoietin-2 and Biliary Diseases: Elevated Serum, but Not Bile Levels Are Associated with Cholangiocarcinoma	PLOS ONE			English	Article							PRIMARY SCLEROSING CHOLANGITIS; RISK-FACTORS; ANGIOGENESIS; DIAGNOSIS; PATHOGENESIS; MANAGEMENT; CARCINOMA; TRACT; LIVER; TIE2	Background: The diagnosis of cholangiocarcinoma (CC) is challenging especially in patients with primary sclerosing cholangitis (PSC) and often delayed due to the lack of reliable markers. Angiopoietin-2 (Angpt-2) has been employed as a biomarker of angiogenesis and might be involved in tumor neoangiogenesis. Aim: To evaluate the diagnostic potential of Angpt-2 as a biomarker to detect patients with CC. Methods: Bile and serum Angpt-2 levels were measured in patients with CC (n = 45), PSC (n = 74), CC complicating PSC (CC/PSC) (n = 11) and patients with bile duct stones (n = 37) in a cross sectional study. Diagnostic accuracy of Angpt-2 was compared to carbohydrate antigen 19-9 (CA19-9). Fluorescent immunohistochemistry from human CC liver tissue samples was performed to localize the origin of Angpt-2. Results: Serum Angpt-2 concentration was significantly elevated in patients with CC compared to control patients (p<0.05). Diagnostic accuracy of Angpt-2 as determined by receiver operating characteristic (ROC) analysis resulted in a higher area under the curve (AUC) value compared to CA19-9 (AUC: 0.85 versus 0.77; 95% confidence interval (CI): 0.74-0.93 versus 0.65-0.87, respectively). Angpt-2 was also detectable in bile, but was not associated with the presence of CC. Immunohistochemistry revealed a strong induction of Angpt-2 expression in the tumor vasculature. Conclusions: Circulating Angpt-2 in serum might be a promising protein candidate locally derived from the tumor vasculature in patients with CC. Measurement of Angpt-2 in serum may be useful for diagnosis and further clinical management of patients with CC.	[Voigtlaender, Torsten; Manns, Michael P.; Lankisch, Tim O.] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Voigtlaender, Torsten; Manns, Michael P.; Lankisch, Tim O.] Hannover Med Sch, Integrated Res & Treatment Ctr Transplantat IFB T, Hannover, Germany; [David, Sascha; Thamm, Kristina] Hannover Med Sch, Dept Hypertens & Nephrol, Hannover, Germany; [Schlue, Jerome] Hannover Med Sch, Inst Pathol, Hannover, Germany; [Metzger, Jochen] Mosa Diagnost GmbH, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School; Modular Open Systems Approach (MOSA) Solutions	Lankisch, TO (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany.	lankisch.tim@mh-hannover.de	David, Sascha/AAL-6909-2021	Metzger, Jochen/0000-0003-4475-4499				Alvaro D, 2007, ANN INTERN MED, V147, P451, DOI 10.7326/0003-4819-147-7-200710020-00003; Alvaro D, 2009, CURR OPIN GASTROEN, V25, P279, DOI 10.1097/MOG.0b013e328325a894; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Boberg KM, 2011, BEST PRACT RES CL GA, V25, P753, DOI 10.1016/j.bpg.2011.10.002; Chapman MH, 2012, EUR J GASTROEN HEPAT, V24, P1051, DOI 10.1097/MEG.0b013e3283554bbf; Di T, 2006, ONCOL REP, V15, P525; Diaz-Sanchez A, 2013, SCAND J GASTROENTERO, V48, P334, DOI 10.3109/00365521.2012.746391; Everhart JE, 2009, GASTROENTEROLOGY, V136, P1134, DOI 10.1053/j.gastro.2009.02.038; Karlsen TH, 2013, J HEPATOL, V59, P571, DOI 10.1016/j.jhep.2013.03.015; Khan SA, 2008, HPB, V10, P77, DOI 10.1080/13651820801992641; Koopmann J, 2004, CANCER-AM CANCER SOC, V101, P1609, DOI 10.1002/cncr.20469; Lankisch TO, 2011, HEPATOLOGY, V53, P875, DOI 10.1002/hep.24103; Leyva-Illades Dinorah, 2012, Transl Gastrointest Cancer, V1, P71; Li C, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0571-2; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Malhi H, 2006, ALIMENT PHARM THER, V23, P1287, DOI 10.1111/j.1365-2036.2006.02900.x; McDougall SR, 2006, J THEOR BIOL, V241, P564, DOI 10.1016/j.jtbi.2005.12.022; Metzger J, 2013, GUT, V62, P122, DOI 10.1136/gutjnl-2012-302047; Mobius C, 2007, EJSO-EUR J SURG ONC, V33, P1025, DOI 10.1016/j.ejso.2007.02.020; Naumnik W, 2013, ADV EXP MED BIOL, V788, P341, DOI 10.1007/978-94-007-6627-3_46; Negm AA, 2010, GASTROINTEST ENDOSC, V72, P284, DOI 10.1016/j.gie.2010.02.043; Nehls O, 2004, SEMIN LIVER DIS, V24, P139, DOI 10.1055/s-2004-828891; Razumilava N, 2013, CLIN GASTROENTEROL H, V11, P13, DOI 10.1016/j.cgh.2012.09.009; Rizvi S, 2013, GASTROENTEROLOGY, V145, P1215, DOI 10.1053/j.gastro.2013.10.013; Scholz A, 2007, AM J GASTROENTEROL, V102, P2471, DOI 10.1111/j.1572-0241.2007.01377.x; Sinakos E, 2011, CLIN GASTROENTEROL H, V9, P434, DOI 10.1016/j.cgh.2011.02.007; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Tyson GL, 2011, HEPATOLOGY, V54, P173, DOI 10.1002/hep.24351; Xu LB, 2010, WORLD J SURG, V34, P1039, DOI 10.1007/s00268-010-0417-4	29	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97046	10.1371/journal.pone.0097046	http://dx.doi.org/10.1371/journal.pone.0097046			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24823366	Green Submitted, Green Published, gold			2022-12-27	WOS:000336369200053
J	De Buyser, SL; Petrovic, M; Taes, YE; Vetrano, DL; Corsonello, A; Volpato, S; Onder, G				De Buyser, Stefanie L.; Petrovic, Mirko; Taes, Youri E.; Vetrano, Davide L.; Corsonello, Andrea; Volpato, Stefano; Onder, Graziano			Functional Changes during Hospital Stay in Older Patients Admitted to an Acute Care Ward: A Multicenter Observational Study	PLOS ONE			English	Article							LOWER-EXTREMITY FUNCTION; PHYSICAL PERFORMANCE-MEASURES; APPROPRIATE MEDICATION USE; SELF-REPORT; MORTALITY; MOBILITY; HEALTH; CRITERIA; OUTCOMES; DECLINE	Objectives: Changes in physical performance during hospital stay have rarely been evaluated. In this study, we examined functional changes during hospital stay by assessing both physical performance and activities of daily living. Additionally, we investigated characteristics of older patients associated with meaningful in-hospital improvement in physical performance. Methods: The CRiteria to assess appropriate Medication use among Elderly complex patients project recruited 1123 patients aged >= 65 years, consecutively admitted to geriatric or internal medicine acute care wards of seven Italian hospitals. We analyzed data from 639 participating participants with a Mini Mental State Examination score >= 18/30. Physical performance was assessed by walking speed and grip strength, and functional status by activities of daily living at hospital admission and at discharge. Meaningful improvement was defined as a measured change of at least 1 standard deviation. Multivariable logistic regression models predicting meaningful improvement, included age, gender, type of admission (through emergency room or elective), and physical performance at admission. Results: Mean age of the study participants was 79 years (range 65-98), 52% were female. Overall, mean walking speed and grip strength performance improved during hospital stay (walking speed improvement: 0.04 +/- 0.20 m/s, p<0.001; grip strength improvement: 0.43 +/- 5.66 kg, p = 0.001), no significant change was observed in activities of daily living. Patients with poor physical performance at admission had higher odds for in-hospital improvement. Conclusion: Overall, physical performance measurements show an improvement during hospital stay. The margin for meaningful functional improvement is larger in patients with poor physical function at admission. Nevertheless, most of these patients continue to have poor performance at discharge.	[De Buyser, Stefanie L.; Petrovic, Mirko] Ghent Univ Hosp, Dept Geriatr, Ghent, Belgium; [Taes, Youri E.] Ghent Univ Hosp, Dept Endocrinol, Ghent, Belgium; [Taes, Youri E.] Ghent Univ Hosp, Unit Osteoporosis & Metab Bone Dis, Ghent, Belgium; [Vetrano, Davide L.; Onder, Graziano] Univ Cattolica Sacro Cuore, Ctr Med Invecchiamento, Rome, Italy; [Corsonello, Andrea] IRCCS, INRCA, Unit Geriatr Pharmaco Epidemiol, Cosenza, Italy; [Volpato, Stefano] Univ Ferrara, Dept Med Sci, I-44100 Ferrara, Italy	Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS INRCA; University of Ferrara	De Buyser, SL (corresponding author), Ghent Univ Hosp, Dept Geriatr, Ghent, Belgium.	stefanie.debuyser@UGent.be	VOLPATO, STEFANO/H-2977-2014; Andrea, Corsonello/AAC-1845-2022; Vetrano, Davide Liborio/K-7417-2016	VOLPATO, STEFANO/0000-0003-4335-6034; Vetrano, Davide Liborio/0000-0002-3099-4830; De Buyser, Stefanie/0000-0002-9584-5529	Italian Ministry of Labour, Health and Social Policy; Postdoctoral Fellow - 'Fonds voor Wetenschappelijk Onderzoek - Vlaanderen' (FWO; Research Foundation)	Italian Ministry of Labour, Health and Social Policy(Ministry of Health, Italy); Postdoctoral Fellow - 'Fonds voor Wetenschappelijk Onderzoek - Vlaanderen' (FWO; Research Foundation)(FWO)	This work was supported by the Italian Ministry of Labour, Health and Social Policy who funded the CRIME project (Bando Giovani Ricercatori 2007, convenzione no 4). Youri Taes is a Postdoctoral Fellow with the 'Fonds voor Wetenschappelijk Onderzoek - Vlaanderen' (FWO; Research Foundation - Flanders; http://www. fwo. be/Postdoctoraal-onderzoeker.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley DE, 2011, J AM GERIATR SOC, V59, P1650, DOI 10.1111/j.1532-5415.2011.03560.x; Bautmans I, 2005, J GERONTOL A-BIOL, V60, P361, DOI 10.1093/gerona/60.3.361; Bean JF, 2011, PHYS THER, V91, P1804, DOI 10.2522/ptj.20100417; Ble A, 2003, J AM GERIATR SOC, V51, P1814, DOI 10.1046/j.1532-5415.2003.51572_1.x; Bodilsen AC, 2013, AM J PHYS MED REHAB, V92, P789, DOI 10.1097/PHM.0b013e31828cd2b6; Brown CJ, 2004, J AM GERIATR SOC, V52, P1263, DOI 10.1111/j.1532-5415.2004.52354.x; Corsonello A, 2009, J AM GERIATR SOC, V57, P1007, DOI 10.1111/j.1532-5415.2009.02266.x; Covinsky KE, 2003, J AM GERIATR SOC, V51, P451, DOI 10.1046/j.1532-5415.2003.51152.x; Covinsky KE, 1997, J GEN INTERN MED, V12, P203, DOI 10.1007/s11606-006-5041-5; CREDITOR MC, 1993, ANN INTERN MED, V118, P219, DOI 10.7326/0003-4819-118-3-199302010-00011; De Buyser SL, 2013, EUR J CLIN INVEST, V43, P379, DOI 10.1111/eci.12056; Diehr PH, 2013, J GERONTOL A-BIOL, V68, P1059, DOI 10.1093/gerona/glt038; FOLSTEIN MF, 1983, ARCH GEN PSYCHIAT, V40, P812; Fortinsky RH, 1999, J GERONTOL A-BIOL, V54, pM521, DOI 10.1093/gerona/54.10.M521; Fusco D, 2009, DRUG AGING, V26, P3, DOI 10.2165/11534620-000000000-00000; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; HOENIG HM, 1991, J AM GERIATR SOC, V39, P220, DOI 10.1111/j.1532-5415.1991.tb01632.x; Inouye SK, 1998, JAMA-J AM MED ASSOC, V279, P1187, DOI 10.1001/jama.279.15.1187; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; LANDEFELD CS, 1995, NEW ENGL J MED, V332, P1338, DOI 10.1056/NEJM199505183322006; Lauretani F, 2003, J APPL PHYSIOL, V95, P1851, DOI 10.1152/japplphysiol.00246.2003; MAHONEY F I, 1965, Md State Med J, V14, P61; Nitschke J E, 1999, J Hand Ther, V12, P25; Onder G, 2002, J GERONTOL A-BIOL, V57, pM289, DOI 10.1093/gerona/57.5.M289; Ostir GV, 2012, ARCH INTERN MED, V172, P353, DOI 10.1001/archinternmed.2011.1615; Palleschi L, 2011, J AM GERIATR SOC, V59, P193, DOI 10.1111/j.1532-5415.2010.03239.x; Perera S, 2006, J AM GERIATR SOC, V54, P743, DOI 10.1111/j.1532-5415.2006.00701.x; Purser JL, 2005, J REHABIL RES DEV, V42, P535, DOI 10.1682/JRRD.2004.07.0087; SAGER MA, 1992, J AM GERIATR SOC, V40, P457, DOI 10.1111/j.1532-5415.1992.tb02011.x; Sallinen J, 2010, J AM GERIATR SOC, V58, P1721, DOI 10.1111/j.1532-5415.2010.03035.x; Sleiman I, 2009, J GERONTOL A-BIOL, V64, P659, DOI 10.1093/gerona/glp015; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; Tosato M, 2013, CURR DRUG SAF, V8, P98, DOI 10.2174/1574886311308020002; Vetrano DL, 2014, EUR J INTERN MED, V25, P56, DOI 10.1016/j.ejim.2013.08.709; Volpato S, 2011, J GERONTOL A-BIOL, V66, P89, DOI 10.1093/gerona/glq167; Volpato S, 2008, J GERONTOL A-BIOL, V63, P1393, DOI 10.1093/gerona/63.12.1393; Wittink H, 2003, SPINE, V28, P2407, DOI 10.1097/01.BRS.0000085304.01483.17	38	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96398	10.1371/journal.pone.0096398	http://dx.doi.org/10.1371/journal.pone.0096398			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24820733	Green Published, gold, Green Submitted			2022-12-27	WOS:000336653300016
J	Evans, DS; Calton, MA; Kim, MJ; Kwok, PY; Miljkovic, I; Harris, T; Koster, A; Liu, YM; Tranah, GJ; Ahituv, N; Hsueh, WC; Vaisse, C				Evans, Daniel S.; Calton, Melissa A.; Kim, Mee J.; Kwok, Pui-Yan; Miljkovic, Iva; Harris, Tamara; Koster, Annemarie; Liu, Yongmei; Tranah, Gregory J.; Ahituv, Nadav; Hsueh, Wen-Chi; Vaisse, Christian			Genetic Association Study of Adiposity and Melanocortin-4 Receptor (MC4R) Common Variants: Replication and Functional Characterization of Non-Coding Regions	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; NERVOUS-SYSTEM; ADULT OBESITY; LOCI; INDIVIDUALS; POLYMORPHISMS; METAANALYSIS; MUTATIONS; AFRICAN	Common genetic variants 3 ' of MC4R within two large linkage disequilibrium (LD) blocks spanning 288 kb have been associated with common and rare forms of obesity. This large association region has not been refined and the relevant DNA segments within the association region have not been identified. In this study, we investigated whether common variants in the MC4R gene region were associated with adiposity-related traits in a biracial population-based study. Single nucleotide polymorphisms (SNPs) in the MC4R region were genotyped with a custom array and a genome-wide array and associations between SNPs and five adiposity-related traits were determined using race-stratified linear regression. Previously reported associations between lower BMI and the minor alleles of rs2229616/Val103lle and rs52820871/lle251Leu were replicated in white female participants. Among white participants, rs11152221 in a proximal 3 ' LD block (closer to MC4R) was significantly associated with multiple adiposity traits, but SNPs in a distal 3 ' LD block (farther from MC4R) were not. In a case-control study of severe obesity, rs11152221 was significantly associated. The association results directed our follow-up studies to the proximal LD block downstream of MC4R. By considering nucleotide conservation, the significance of association, and proximity to the MC4R gene, we identified a candidate MC4R regulatory region. This candidate region was sequenced in 20 individuals from a study of severe obesity in an attempt to identify additional variants, and the candidate region was tested for enhancer activity using in vivo enhancer assays in zebrafish and mice. Novel variants were not identified by sequencing and the candidate region did not drive reporter gene expression in zebrafish or mice. The identification of a putative insulator in this region could help to explain the challenges faced in this study and others to link SNPs associated with adiposity to altered MC4R expression.	[Evans, Daniel S.; Tranah, Gregory J.] Calif Pacific Med Ctr Res Inst, San Francisco, CA USA; [Calton, Melissa A.; Hsueh, Wen-Chi; Vaisse, Christian] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Calton, Melissa A.; Hsueh, Wen-Chi; Vaisse, Christian] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Kim, Mee J.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Kim, Mee J.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Kwok, Pui-Yan] Univ Calif San Francisco, Inst Cardiovasc Res, Inst Human Genet, San Francisco, CA 94143 USA; [Kwok, Pui-Yan] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; [Miljkovic, Iva] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Harris, Tamara; Koster, Annemarie] NIA, Bethesda, MD 20892 USA; [Liu, Yongmei] Wake Forest Univ, Dept Epidemiol & Prevent, Div Publ Hlth Sci, Winston Salem, NC 27109 USA	California Pacific Medical Center; California Pacific Medical Center Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Wake Forest University	Vaisse, C (corresponding author), Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA.	vaisse@diabetes.ucsf.edu	Koster, Annemarie/E-7438-2010	Koster, Annemarie/0000-0003-1583-7391; Miljkovic, Iva/0000-0002-3155-9777; Ahituv, Nadav/0000-0002-7434-8144	Intramural Research Program of the NIH; National Institute on Aging (NIA) [N01-AG-6-2101, N01-AG-6-2103, N01-AG-6-2106, R01-AG028050]; NINR [R01-NR012459]; NIDDK [1R01DK090382, R01DK060540]; NIA [1R01AG032098-01A1]; National Institutes of Health [HHSN268200782096C]; NIH [T32 DK007418, T32 GM007175]; Pharmaceutical Sciences and Pharmacogenomics; Amgen Research Excellence in Bioengineering and Therapeutic Sciences Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007418, R01DK060540, R01DK090382, P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR012459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG062101, R01AG032098, R01AG028050, N01AG062106, N01AG062103] Funding Source: NIH RePORTER	Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pharmaceutical Sciences and Pharmacogenomics; Amgen Research Excellence in Bioengineering and Therapeutic Sciences Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by the Intramural Research Program of the NIH, National Institute on Aging (NIA), and by NIA contracts N01-AG-6-2101, N01-AG-6-2103, N01-AG-6-2106, NIA grant R01-AG028050, NINR grant R01-NR012459, and NIDDK grants 1R01DK090382 and R01DK060540. The genome-wide association study was funded by NIA grant 1R01AG032098-01A1 to Wake Forest University Health Sciences and genotyping services were provided by the Center for Inherited Disease Research (CIDR). CIDR is fully funded through a federal contract from the National Institutes of Health to The Johns Hopkins University, contract number HHSN268200782096C. DSE was supported by NIH training grant T32 DK007418. MAC was supported by NIH training grant T32 GM007175, Pharmaceutical Sciences and Pharmacogenomics. MJK was supported in part by NIH training grant T32 GM007175 and the Amgen Research Excellence in Bioengineering and Therapeutic Sciences Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckers S, 2010, OBESITY FACTS, V3, P304, DOI 10.1159/000321565; Blackledge NP, 2009, NUCLEIC ACIDS RES, V37, P1086, DOI 10.1093/nar/gkn1056; Calton MA, 2009, HUM MOL GENET, V18, P1140, DOI 10.1093/hmg/ddn431; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Dempfle A, 2004, J MED GENET, V41, P795, DOI 10.1136/jmg.2004.018614; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Geller F, 2004, AM J HUM GENET, V74, P572, DOI 10.1086/382490; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hebebrand J, 2010, OBESITY FACTS, V3, P294, DOI 10.1159/000321537; Heid IM, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.027011; Hester JM, 2012, INT J OBESITY, V36, P465, DOI 10.1038/ijo.2011.131; Hinney A, 2010, EUR CHILD ADOLES PSY, V19, P297, DOI 10.1007/s00787-010-0096-6; Hou CH, 2010, P NATL ACAD SCI USA, V107, P3651, DOI 10.1073/pnas.0912087107; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Kang SJ, 2010, HUM MOL GENET, V19, P2725, DOI 10.1093/hmg/ddq154; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kistler-Heer V, 1998, J NEUROENDOCRINOL, V10, P133; KOTHARY R, 1988, NATURE, V335, P435, DOI 10.1038/335435a0; Li Q, 2010, DEV BIOL, V337, P484, DOI 10.1016/j.ydbio.2009.10.019; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Monda KL, 2013, NAT GENET, V45, P690, DOI 10.1038/ng.2608; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Murphy RA, 2013, J GERONTOL A-BIOL, V68, P661, DOI 10.1093/gerona/gls227; Nagy A., 2002, MANIPULATING MOUSE E; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Scherag A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013967; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Snijder MB, 2002, INT J OBESITY, V26, P984, DOI 10.1038/sj.ijo.0801968; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Stutzmann F, 2007, HUM MOL GENET, V16, P1837, DOI 10.1093/hmg/ddm132; Swarbrick MM, 2005, PLOS BIOL, V3, P1662, DOI 10.1371/journal.pbio.0030315; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Wang D, 2010, OBESITY, V18, P573, DOI 10.1038/oby.2009.268; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Xiang ZM, 2006, BIOCHEMISTRY-US, V45, P7277, DOI 10.1021/bi0600300; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Young EH, 2007, INT J OBESITY, V31, P1437, DOI 10.1038/sj.ijo.0803609	51	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96805	10.1371/journal.pone.0096805	http://dx.doi.org/10.1371/journal.pone.0096805			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24820477	Green Published, Green Accepted, gold			2022-12-27	WOS:000336653300033
J	Kitajima, K; Suenaga, Y; Kanda, T; Miyawaki, D; Yoshida, K; Ejima, Y; Sasaki, R; Komatsu, H; Saito, M; Otsuki, N; Nibu, K; Kiyota, N; Minamikawa, T; Sugimura, K				Kitajima, Kazuhiro; Suenaga, Yuko; Kanda, Tomonori; Miyawaki, Daisuke; Yoshida, Kenji; Ejima, Yasuo; Sasaki, Ryohei; Komatsu, Hirokazu; Saito, Miki; Otsuki, Naoki; Nibu, Ken-ichi; Kiyota, Naomi; Minamikawa, Tsutomu; Sugimura, Kazuro			Prognostic Value of FDG PET Imaging in Patients with Laryngeal Cancer	PLOS ONE			English	Article							STANDARDIZED UPTAKE VALUE; SQUAMOUS-CELL CARCINOMA; NECK-CANCER; HEAD; SUV; PROLIFERATION	Background and Purpose: To investigate the prognostic value of (18) F-fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with laryngeal cancer. Materials and Methods: The study included 51 patients of whom 30 underwent definitive radiotherapy with or without chemotherapy and 21 underwent radical surgery with or without adjuvant chemoradiation therapy. FDG uptake by both the primary lesion and the neck node was measured using the maximum standardized uptake value (SUVmax). The effects of clinicopathological factors including primary tumor SUVmax and nodal SUVmax on progression-free survival, local control, nodal progression-free survival, and distant metastasis-free survival were evaluated using the log-rank test and Cox method. Results: The median duration of follow-up was 48.6 months (range 8 to 82.1 months). Univariate analysis showed that nodal SUVmax, N status, and tumor TNM stage were significantly associated with recurrence, whereas primary tumor SUVmax, age, treatment strategy and T status were not. Multivariate analysis demonstrated that only the nodal SUVmax was a significantly unfavorable factor for progression-free survival (p = 0.029, hazard ratio 0.54, 95% CI 0.38-0.87) and nodal progression-free survival (p = 0.023, hazard ratio 0.51, 95% CI 0.34-0.81). ROC curve analysis and log-rank test showed that patients with a high nodal SUVmax (>= 4) had a significantly lower progression-free survival rate than those with a low SUVmax (<4; p<0.0001). Conclusions: The pretreatment SUVmax of nodal disease in patients with laryngeal cancer is prognostic for recurrence.	[Kitajima, Kazuhiro; Suenaga, Yuko; Sugimura, Kazuro] Kobe Univ, Grad Sch Med, Dept Radiol, Kobe, Hyogo 657, Japan; [Kanda, Tomonori] Teikyo Univ, Sch Med, Dept Radiol, Tokyo 173, Japan; [Miyawaki, Daisuke; Yoshida, Kenji; Ejima, Yasuo; Sasaki, Ryohei] Kobe Univ, Grad Sch Med, Dept Radiol, Div Radiat Oncol, Kobe, Hyogo 657, Japan; [Komatsu, Hirokazu; Saito, Miki; Otsuki, Naoki; Nibu, Ken-ichi] Kobe Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kobe, Hyogo 657, Japan; [Kiyota, Naomi] Kobe Univ, Grad Sch Med, Dept Med, Div Med Oncol Hematol, Kobe, Hyogo 657, Japan; [Minamikawa, Tsutomu] Kobe Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kobe, Hyogo 657, Japan	Kobe University; Teikyo University; Kobe University; Kobe University; Kobe University; Kobe University	Kitajima, K (corresponding author), Kobe Univ, Grad Sch Med, Dept Radiol, Kobe, Hyogo 657, Japan.	kitajima@med.kobe-u.ac.jp	Otsuki, Naoki/AAH-2468-2020; Kiyota, Naomi/K-3226-2016	Kiyota, Naomi/0000-0001-8021-6116; Ejima, Yasuo/0000-0002-1533-7891; Otsuki, Naoki/0000-0002-9682-2548				Allal AS, 2004, INT J RADIAT ONCOL, V59, P1295, DOI 10.1016/j.ijrobp.2003.12.039; Beaulieu S, 2003, J NUCL MED, V44, P1044; Demirci U, 2011, ASIAN PAC J CANCER P, V12, P1817; HABERKORN U, 1991, J NUCL MED, V32, P1548; Inokuchi H, 2011, INT J RADIAT ONCOL, V79, P747, DOI 10.1016/j.ijrobp.2009.11.034; KEYES JW, 1995, J NUCL MED, V36, P1836; Kubicek GJ, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-19; LINDHOLM P, 1993, J NUCL MED, V34, P1; MINN H, 1995, J NUCL MED, V36, P252; Schoder H, 2004, J NUCL MED, V45, P559; Tang C, 2012, INT J RADIAT ONCOL, V83, P1514, DOI 10.1016/j.ijrobp.2011.10.023; Xie P, 2011, J CANCER RES CLIN, V137, P1085, DOI 10.1007/s00432-010-0972-y; Zhang BT, 2010, ACTA OTO-LARYNGOL, V130, P756, DOI 10.3109/00016480903402981	13	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96999	10.1371/journal.pone.0096999	http://dx.doi.org/10.1371/journal.pone.0096999			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24818750	gold, Green Submitted, Green Published			2022-12-27	WOS:000336653300060
J	Tang, L; Peng, SL; Bi, YM; Shan, P; Hu, XY				Tang, Liang; Peng, Silong; Bi, Yiming; Shan, Peng; Hu, Xiyuan			A New Method Combining LDA and PLS for Dimension Reduction	PLOS ONE			English	Article							PARTIAL LEAST-SQUARES; REGRESSION; EFFICIENT; ALGORITHM	Linear discriminant analysis (LDA) is a classical statistical approach for dimensionality reduction and classification. In many cases, the projection direction of the classical and extended LDA methods is not considered optimal for special applications. Herein we combine the Partial Least Squares (PLS) method with LDA algorithm, and then propose two improved methods, named LDA-PLS and ex-LDA-PLS, respectively. The LDA-PLS amends the projection direction of LDA by using the information of PLS, while ex-LDA-PLS is an extension of LDA-PLS by combining the result of LDA-PLS and LDA, making the result closer to the optimal direction by an adjusting parameter. Comparative studies are provided between the proposed methods and other traditional dimension reduction methods such as Principal component analysis (PCA), LDA and PLS-LDA on two data sets. Experimental results show that the proposed method can achieve better classification performance.	[Tang, Liang; Peng, Silong; Bi, Yiming; Shan, Peng; Hu, Xiyuan] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China; [Tang, Liang] Harbin Univ Sci & Technol, Network Informat Ctr, Harbin, Peoples R China	Chinese Academy of Sciences; Institute of Automation, CAS; Harbin University of Science & Technology	Tang, L (corresponding author), Chinese Acad Sci, Inst Automat, Beijing, Peoples R China.	liang.tang@ia.ac.cn	Hu, Xiyuan/AAF-7773-2021	Hu, Xiyuan/0000-0002-7095-6986; Bi, Yiming/0000-0002-4368-3783	State Key Program of National Natural Science of China [61032007]; Natural Science Foundation of China [61201375]	State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research is supported in part by the State Key Program of National Natural Science of China (61032007) and the Natural Science Foundation of China (61201375). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ADDRESSING CURSE IMB; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Bastien P, 2005, COMPUT STAT DATA AN, V48, P17, DOI 10.1016/j.csda.2004.02.005; Belhumeur PN, 1997, IEEE T PATTERN ANAL, V19, P711, DOI 10.1109/34.598228; Bergholt MS, 2011, INT J CANCER, V128, P2673, DOI 10.1002/ijc.25618; Cai D., 2006, SEMISUPERVISED REGRE; Cai D, 2008, IEEE T KNOWL DATA EN, V20, P1, DOI 10.1109/TKDE.2007.190669; Cai Deng, 2007, SPECTRAL REGRESSION; Cerquides J, 2005, LECT NOTES ARTIF INT, V3720, P72, DOI 10.1007/11564096_12; CHAPMAN CA, 1952, AM J SCI, V250, P428, DOI 10.2475/ajs.250.6.428; Cheng Tan, 2009, 2009 IEEE Instrumentation and Measurement Technology Conference (I2MTC), P1144, DOI 10.1109/IMTC.2009.5168626; Chung DJ, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1492; DEJONG S, 1993, CHEMOMETR INTELL LAB, V18, P251, DOI 10.1016/0169-7439(93)85002-X; DING B, 2004, CLASSIFICATION USING; FRIEDMAN JH, 1989, J AM STAT ASSOC, V84, P165, DOI 10.2307/2289860; GARTHWAITE PH, 1994, J AM STAT ASSOC, V89, P122, DOI 10.2307/2291207; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; Howley T, 2006, KNOWL-BASED SYST, V19, P363, DOI 10.1016/j.knosys.2005.11.014; Indahl UG, 2007, J CHEMOMETR, V21, P529, DOI 10.1002/cem.1061; ISHIKAWA K, 1989, MAR BIOL, V102, P265, DOI 10.1007/BF00428288; James EAK, 2009, FIRST INTERNATIONAL CONFERENCE ON ADVANCED COMPUTING 2009 (ICAC 2009), P172, DOI 10.1109/ICADVC.2009.5378190; John G. H., 1995, Uncertainty in Artificial Intelligence. Proceedings of the Eleventh Conference (1995), P338; JOLLIFFE I., 2005, PRINCIPAL COMPONENT; Liang YZ, 2010, COMB CHEM HIGH T SCR, V13, P943, DOI 10.2174/138620710793360310; Liang YZ, 2008, SCI CHINA SER B, V51, P718, DOI 10.1007/s11426-008-0084-6; Liland KH, 2009, J CHEMOMETR, V23, P7, DOI 10.1002/cem.1186; Liu YS, 2007, COMPUTATION STAT, V22, P189, DOI 10.1007/s00180-007-0039-y; Marigheto NA, 1998, J AM OIL CHEM SOC, V75, P987, DOI 10.1007/s11746-998-0276-4; Martinez AM, 2001, IEEE T PATTERN ANAL, V23, P228, DOI 10.1109/34.908974; Marx BD, 1996, TECHNOMETRICS, V38, P374, DOI 10.2307/1271308; McLachlan G.J., 2004, DISCRIMINANT ANAL ST, VVolume 544; Nielsen F., 2013, MATRIX INFORM GEOMET; Nocairi H, 2005, COMPUT STAT DATA AN, V48, P139, DOI 10.1016/j.csda.2003.09.008; Peschke K-D, 2006, P 24 IASTED INT C BI, P288; Phatak A, 2002, J CHEMOMETR, V16, P361, DOI 10.1002/cem.728; Rosipal R, 2006, LECT NOTES COMPUT SC, V3940, P34, DOI 10.1007/11752790_2; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Tapp HS, 2003, J AGR FOOD CHEM, V51, P6110, DOI 10.1021/jf030232s; Telaar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055267; Vergara A, 2012, SENSOR ACTUAT B-CHEM, V166, P320, DOI 10.1016/j.snb.2012.01.074; Welling M, 2005, FISHER LINEAR DISCRI, P3; Wold H., 1985, PARTIAL LEAST SQUARE, P581; Wold H., 1975, PATH MODELS LATENT V, P307, DOI [10.1016/B978-0-12-103950-9.50017-4, DOI 10.1016/B978-0-12-103950-9.50017-4]; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Ye JP, 2004, PATTERN RECOGN, V37, P851, DOI 10.1016/j.patcog.2003.08.006; Ye Y., 2007, P 24 INT C MACH LEAR, P1087, DOI DOI 10.1145/1273496.1273633; Yi LZ, 2006, FEBS LETT, V580, P6837, DOI 10.1016/j.febslet.2006.11.043	47	24	25	13	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96944	10.1371/journal.pone.0096944	http://dx.doi.org/10.1371/journal.pone.0096944			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24820185	Green Submitted, Green Published, gold			2022-12-27	WOS:000336653300053
J	Zhang, YY; Foncea, R; Deis, JA; Guo, H; Bernlohr, DA; Chen, XL				Zhang, Yuanyuan; Foncea, Rocio; Deis, Jessica A.; Guo, Hong; Bernlohr, David A.; Chen, Xiaoli			Lipocalin 2 Expression and Secretion Is Highly Regulated by Metabolic Stress, Cytokines, and Nutrients in Adipocytes	PLOS ONE			English	Article							FACTOR-KAPPA-B; GELATINASE-ASSOCIATED LIPOCALIN; SMOOTH-MUSCLE-CELLS; INSULIN-RESISTANCE; PHYTANIC ACID; NEUTROPHIL GELATINASE; ENDOTHELIAL-CELLS; PPAR-ALPHA; ACTIVATION; MICE	Lipocalin 2 (Lcn2) has been recently characterized as a new adipokine having a role in innate immunity and energy metabolism. Nonetheless, the metabolic regulation of Lcn2 production in adipocytes has not been comprehensively studied. To better understand the Lcn2 biology, we investigated the regulation of Lcn2 expression in adipose tissue in response to metabolic stress in mice as well as the control of Lcn2 expression and secretion by cytokines and nutrients in 3T3-L1 adipocytes. Our results showed that the mRNA expression of Lcn2 was upregulated in white and brown adipose tissues as well as liver during fasting and cold stress in mice. Among pro-inflammatory cytokines TNF alpha, IL-1 beta, and IL-6, IL-1 beta showed most profound effect on Lcn2 expression and secretion in 3T3-L1 adipocytes. Insulin stimulated Lcn2 expression and secretion in a dose-dependent manner; this insulin effect was significantly abolished in the presence of low concentration of glucose. Moreover, insulin-stimulated Lcn2 expression and secretion was also attenuated when glucose was replaced by 3-O-methyl-d-glucose or by blocking NF kappa B pathway activation. Additionally, we showed that palmitate and oleate induced Lcn2 expression and secretion more significantly than EPA, while phytanic acid reduced Lcn2 production. Our results demonstrated that Lcn2 production in adipocytes is highly responsive to metabolic stress, cytokines, and nutrient signals, suggesting an important role of Lcn2 in adipocyte metabolism and inflammation.	[Zhang, Yuanyuan; Deis, Jessica A.; Guo, Hong; Chen, Xiaoli] Univ Minnesota Twin Cities, Dept Food Sci & Nutr, St Paul, MN USA; [Foncea, Rocio; Bernlohr, David A.] Univ Minnesota Twin Cities, Dept Biochem Mol Biol & Biophys, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Chen, XL (corresponding author), Univ Minnesota Twin Cities, Dept Food Sci & Nutr, St Paul, MN USA.	xlchen@umn.edu	Zhang, Yuanyuan/M-9602-2014	Zhang, Yuanyuan/0000-0002-5894-5387; Guo, Hong/0000-0001-8024-7086	National Institute of Diabetes and Digestive and Kidney Diseases and Minnesota Obesity Center [R01DK080743]; National Institute of Diabetes and Digestive and Kidney Diseases [2P30DK050456]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050456, R01DK080743] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases and Minnesota Obesity Center; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by grant (R01DK080743 to X.C.) from the National Institute of Diabetes and Digestive and Kidney Diseases and Minnesota Obesity Center (grant no. 2P30DK050456 from the National Institute of Diabetes and Digestive and Kidney Diseases). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner F, 2007, AM J TRANSPLANT, V7, P779, DOI 10.1111/j.1600-6143.2006.01723.x; Auguet T, 2011, OBESITY, V19, P2295, DOI 10.1038/oby.2011.61; Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103; Boden G, 2001, Endocr Pract, V7, P44; Du XL, 1999, FREE RADICAL BIO MED, V27, P752, DOI 10.1016/S0891-5849(99)00079-9; Ellinghaus P, 1999, J BIOL CHEM, V274, P2766, DOI 10.1074/jbc.274.5.2766; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; GarayRojas E, 1996, GENE, V170, P173, DOI 10.1016/0378-1119(95)00896-9; Gloerich J, 2005, J LIPID RES, V46, P716, DOI 10.1194/jlr.M400337-JLR200; Guo H, 2013, ENDOCRINOLOGY, V154, P3525, DOI 10.1210/en.2013-1289; Guo H, 2010, DIABETES, V59, P1376, DOI 10.2337/db09-1735; Hashimoto T, 2006, J NUTR, V136, P882, DOI 10.1093/jn/136.4.882; Hattori Y, 2000, CARDIOVASC RES, V46, P188, DOI 10.1016/S0008-6363(99)00425-3; Heim M, 2002, FASEB J, V16, P718, DOI 10.1096/fj.01-0816fje; Huang HL, 1999, J ENDOCRINOL, V162, P11, DOI 10.1677/joe.0.1620011; Jin DZ, 2011, FASEB J, V25, P754, DOI 10.1096/fj.10-165175; Karlsen JR, 2010, J BIOL CHEM, V285, P14088, DOI 10.1074/jbc.M109.017129; Kitareewan S, 1996, MOL BIOL CELL, V7, P1153, DOI 10.1091/mbc.7.8.1153; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; KJELDSEN L, 1994, BLOOD, V83, P799; LALONDE JM, 1994, FASEB J, V8, P1240, DOI 10.1096/fasebj.8.15.8001736; Law IKM, 2010, DIABETES, V59, P872, DOI 10.2337/db09-1541; McCarty MF, 2006, INTEGR CANCER THER, V5, P252, DOI 10.1177/1534735406291499; Morigi M, 1998, J CLIN INVEST, V101, P1905, DOI 10.1172/JCI656; Pieper GM, 1997, J CARDIOVASC PHARM, V30, P528, DOI 10.1097/00005344-199710000-00019; Roudkenar MH, 2007, J RADIAT RES, V48, P39, DOI 10.1269/jrr.06057; Roudkenar MH, 2009, EXP CELL RES, V315, P3140, DOI 10.1016/j.yexcr.2009.08.019; Schluter A, 2002, BIOCHEM J, V362, P61, DOI 10.1042/0264-6021:3620061; Schluter A, 2002, FEBS LETT, V517, P83, DOI 10.1016/S0014-5793(02)02583-8; Seth P, 2002, CANCER RES, V62, P4540; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; Sommer G, 2009, J CELL BIOCHEM, V106, P103, DOI 10.1002/jcb.21980; Tan BK, 2009, DIABETES CARE, V32, P129, DOI 10.2337/dc08-1236; Wang Y, 2007, CLIN CHEM, V53, P34, DOI 10.1373/clinchem.2006.075614; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Yerneni KKV, 1999, DIABETES, V48, P855, DOI 10.2337/diabetes.48.4.855; Zhang JH, 2008, MOL ENDOCRINOL, V22, P1416, DOI 10.1210/me.2007-0420; Zhao P, 2014, J BIOL CHEM, V289, P5960, DOI 10.1074/jbc.M113.532234; Zhao P, 2013, MOL METAB, V2, P161, DOI 10.1016/j.molmet.2013.04.003	39	68	68	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96997	10.1371/journal.pone.0096997	http://dx.doi.org/10.1371/journal.pone.0096997			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24818605	Green Published, gold, Green Submitted			2022-12-27	WOS:000336653300059
J	Boiteau, G; Vincent, C; Leskey, TC; Colpitts, BG; MacKinley, P; Lee, DH				Boiteau, Gilles; Vincent, Charles; Leskey, Tracy C.; Colpitts, Bruce G.; MacKinley, Pamela; Lee, Doo-Hyung			Impact of Host Plant Connectivity, Crop Border and Patch Size on Adult Colorado Potato Beetle Retention	PLOS ONE			English	Article							LEPTINOTARSA-DECEMLINEATA COLEOPTERA; HABITAT EDGES; TRAP CROPS; MOVEMENT; CHRYSOMELIDAE; FLIGHT; BEHAVIOR; DISPERSAL; RESPONSES; COLONIZATION	Tagged Colorado potato beetles (CPB), Leptinotarsa decemlineata (Say), were released on potato plants, Solanum tuberosum L., and tracked using a portable harmonic radar system to determine the impact of host plant spatial distribution on the tendency of the pest to remain on the colonized host plant or patch. Results confirmed the long residency time on the host plant and showed that close connection of the plant to neighboring plants hastened dispersal between plants. Tracking walking CPB for over 6 h in small potato plots revealed that all types of mixed borders tested (potato/bare ground, potato/timothy and potato/woodland) acted as a strong barrier and retained beetles within the patch. In another experiment in potato patches surrounded by bare ground borders, tracked walking CPB displayed similar behaviour for up to four days. The distribution of turning angles in the CPB walking paths was not uniform and corresponded to beetles following the edge rows of potato patches in response to the crop border barrier or reversing their direction as they reached the end of a row and therefore a border. Patch size had no or little effect on beetle retention in the patch. The relative distribution of counts of tagged beetles detected among small (16 m(2)), medium (64 m(2)) and large size (256 m(2)) patches of potato four days after initial release remained similar to that of numbers released. Even though mixed crop borders were a strong barrier to walking CPB emigrating from potato patches, the departure rate of beetles over time was high. Results suggest that the effect of mixed borders is largely limited to dispersal by walking and does not apply to beetles leaving host patches by flight. The manipulation of crop borders and patch size seem to have limited potential for the management of CPB emigrating from potato fields.	[Boiteau, Gilles; MacKinley, Pamela] Agr & Agri Food Canada, Potato Res Ctr, Fredericton, NB, Canada; [Vincent, Charles] Agr & Agri Food Canada, Hort Res & Dev Ctr, St Jean, PQ, Canada; [Leskey, Tracy C.; Lee, Doo-Hyung] ARS, USDA, Appalachian Fruit Res Stn, Kearneysville, WV USA; [Colpitts, Bruce G.] Univ New Brunswick, Dept Elect & Comp Engn, Fredericton, NB, Canada	Agriculture & Agri Food Canada; CGIAR; International Potato Center (CIP); Agriculture & Agri Food Canada; United States Department of Agriculture (USDA); University of New Brunswick	Boiteau, G (corresponding author), Agr & Agri Food Canada, Potato Res Ctr, Fredericton, NB, Canada.	gilles.boiteau@agr.gc.ca			Agriculture and Agri-Food Canada NOI/A base program	Agriculture and Agri-Food Canada NOI/A base program(Agriculture & Agri Food Canada)	This project was financed by Agriculture and Agri-Food Canada NOI/A base program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheampong S, 1997, ENTOMOL EXP APPL, V82, P83, DOI 10.1023/A:1002948008807; BACH CE, 1982, GREAT LAKES ENTOMOL, V15, P247; Baker Mitchell B., 2001, Biological Invasions, V3, P295, DOI 10.1023/A:1015242013929; Blom PE, 2004, ENVIRON ENTOMOL, V33, P267, DOI 10.1603/0046-225X-33.2.267; BOITEAU G, 1994, J ECON ENTOMOL, V87, P1325, DOI 10.1093/jee/87.5.1325; Boiteau G, 2003, CAN ENTOMOL, V135, P1; Boiteau G, 2002, CAN ENTOMOL, V134, P229, DOI 10.4039/Ent134229-2; Boiteau G, 2009, ENVIRON ENTOMOL, V38, P168, DOI 10.1603/022.038.0121; Boiteau G, 2001, ENTOMOL EXP APPL, V100, P187, DOI 10.1023/A:1019217331157; Boiteau G, 2013, INSECT PESTS OF POTATO: GLOBAL PERSPECTIVES ON BIOLOGY AND MANAGEMENT, P339, DOI 10.1016/B978-0-12-386895-4.00012-0; Boiteau G, 2013, CAN ENTOMOL, V145, P20, DOI 10.4039/tce.2012.85; Boiteau G, 2011, PEST MANAG SCI, V67, P213, DOI 10.1002/ps.2054; Colpitts BG, 2004, IEEE T ANTENN PROPAG, V52, P2825, DOI 10.1109/TAP.2004.835166; Conradt L, 2006, ECOLOGY, V87, P125, DOI 10.1890/05-0413; de Wilde J., 1976, Symposia Biologica Hungarica, V16, P291; Dusst J, 1943, CR HEBD ACAD SCI, V217, P622; Eilers W, 2010, ENV SUSTAINABILITY C, P236; Eycott AE, 2012, LANDSCAPE ECOL, V27, P1263, DOI 10.1007/s10980-012-9781-9; Follett PA, 1996, ENVIRON ENTOMOL, V25, P1304, DOI 10.1093/ee/25.6.1304; FRENCH NM, 1993, ENTOMOL EXP APPL, V68, P247, DOI 10.1007/BF02380777; Gui LY, 2012, AGR FOREST ENTOMOL, V14, P59, DOI 10.1111/j.1461-9563.2011.00539.x; Hannunen S, 2005, AGR FOREST ENTOMOL, V7, P11, DOI 10.1111/j.1461-9555.2005.00237.x; Holden MH, 2012, J APPL ECOL, V49, P715, DOI 10.1111/j.1365-2664.2012.02137.x; Hoy CW, 2000, ENTOMOL EXP APPL, V96, P193, DOI 10.1023/A:1004009901244; Hunt DWA, 1996, CAN ENTOMOL, V128, P407, DOI 10.4039/Ent128407-3; le Berre J.-R., 1980, Bulletin OEPP, V10, P413; Liu N, 2012, ENTOMOL EXP APPL, V143, P207, DOI 10.1111/j.1570-7458.2012.01259.x; Margosian ML, 2009, BIOSCIENCE, V59, P141, DOI 10.1525/bio.2009.59.2.7; MISENER GC, 1993, AM POTATO J, V70, P309, DOI 10.1007/BF02851424; Noronha C, 1999, CAN ENTOMOL, V131, P521, DOI 10.4039/Ent131521-4; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; Ries L, 2001, J ANIM ECOL, V70, P840, DOI 10.1046/j.0021-8790.2001.00546.x; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; RIVNAY E., 1928, JOUR NEW YORK ENT SOC, V36, P125; Sandeson PD, 2002, ENVIRON ENTOMOL, V31, P533, DOI 10.1603/0046-225X-31.3.533; SAS, 2002, SAS 9 3 WIND SAS STA; Schmera D, 2007, J APPL ENTOMOL, V131, P34, DOI 10.1111/j.1439-0418.2006.01100.x; Schtickzelle N, 2003, J ANIM ECOL, V72, P533, DOI 10.1046/j.1365-2656.2003.00723.x; Schultz CB, 2012, J ANIM ECOL, V81, P724, DOI 10.1111/j.1365-2656.2011.01947.x; Skorka P, 2013, LANDSCAPE ECOL, V28, P533, DOI 10.1007/s10980-013-9855-3; STAMPS JA, 1987, AM NAT, V129, P533, DOI 10.1086/284656; Szendrei Z, 2009, J APPL ENTOMOL, V133, P711, DOI 10.1111/j.1439-0418.2009.01429.x; Taylor PD, 2006, CONNECTIVITY CONSERV, P726; TERMIER M, 1988, ACTA OECOL-OEC APPL, V9, P219; Turchin Peter, 1998; UNRUH TR, 1993, CAN ENTOMOL, V125, P55, DOI 10.4039/Ent12555-1; VOSS RH, 1992, AM POTATO J, V69, P473, DOI 10.1007/BF02853836; Watts K, 2010, ECOL INDIC, V10, P552, DOI 10.1016/j.ecolind.2009.07.009; WEBER DC, 1994, J AGR ENTOMOL, V11, P17; WEBER DC, 1994, ADVANCES IN POTATO PEST, P54; WEBER DC, 1995, ENVIRON ENTOMOL, V24, P608, DOI 10.1093/ee/24.3.608; WILLIAMS CE, 1988, GREAT LAKES ENTOMOL, V21, P31; With KA, 1997, OIKOS, V78, P151, DOI 10.2307/3545811	53	2	3	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e95717	10.1371/journal.pone.0095717	http://dx.doi.org/10.1371/journal.pone.0095717			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816717	Green Submitted, Green Published, gold			2022-12-27	WOS:000336838000017
J	Goh, DA; Dong, YH; Lee, WY; Koay, WI; Tay, SZ; Soon, D; Chen, C; Brittain, CF; Lowe, SL; Wong, BS				Goh, Deborah Amanda; Dong, Yanhong; Lee, Wah Yean; Koay, Way Inn; Tay, Stephen Ziyang; Soon, Danny; Chen, Christopher; Brittain, Claire Frances; Lowe, Stephen Loucian; Wong, Boon-Seng			A Pilot Study to Examine the Correlation between Cognition and Blood Biomarkers in a Singapore Chinese Male Cohort with Type 2 Diabetes Mellitus	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; FASTING PLASMA-GLUCOSE; INSULIN-RESISTANCE; OLDER-ADULTS; DECLINE; IMPAIRMENT; STATINS; DISEASE; HYPERINSULINEMIA; HOMEOSTASIS	Background: Diabetes is reported to be linked to poorer cognitive function. The purpose of this study is to examine (a) clinical correlation between cognitive function and the biochemical perturbations in T2DM, and (b) the impact of statin treatment on cognitive function in diabetic subjects. Methods: Forty Singaporean Chinese males with diabetes and twenty Singaporean Chinese males without diabetes were recruited for this study. Twenty-two of the diabetic subjects were on statin therapy and all subjects were non-demented. This was a 2-period non-interventional case-control study in which subjects were assessed for cognitive function in period 1 and blood samples taken over 2 periods, approximately 1 week apart. Blood was collected to determine the level of total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), triglycerides, glucose and insulin. Cognitive performance was measured by a neuropsychological battery covering domains of attention, language, verbal and visual memory, visuomotor speed and executive function. Z-scores were derived for each cognitive domain using the mean and standard deviations (SDs), and they were used to compare between (a) diabetic and non-diabetic groups, and (b) diabetic subjects with and without statin treatment. ANCOVAs with age, education, BMI, and the duration of diabetes as covariates were employed to examine differences in mean score of cognitive domains and subtests between the two groups. Results: Overall cognitive function was similar among diabetics and age matched non-diabetic controls. Among diabetic statin users, HDL, LDL and total cholesterol were negatively correlated with executive function, whereas peripheral insulin levels and insulin resistance were negatively associated with attention. Conclusion: Diabetic statin users were likely to have poorer performance in attention and executive function. Increasing levels of the peripheral biomarkers are likely to contribute to poorer cognitive performance.	[Goh, Deborah Amanda; Tay, Stephen Ziyang; Wong, Boon-Seng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore; [Dong, Yanhong; Lee, Wah Yean; Koay, Way Inn; Tay, Stephen Ziyang; Chen, Christopher] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore; [Dong, Yanhong; Lee, Wah Yean; Koay, Way Inn; Tay, Stephen Ziyang; Chen, Christopher] NUHS, MACC, Singapore, Singapore; [Dong, Yanhong] Univ New S Wales, Ctr Hlth Brain Ageing, Sydney, NSW, Australia; [Dong, Yanhong] Univ New S Wales, Dementia Collaborat Res Ctr, Sch Psychiat, Sydney, NSW, Australia; [Soon, Danny; Lowe, Stephen Loucian] Lilly NUS Ctr Clin Pharmacol, Singapore, Singapore; [Brittain, Claire Frances] Lilly Erl Wood, Windlesham, Surrey, England	National University of Singapore; National University of Singapore; National University of Singapore; University of New South Wales Sydney; University of New South Wales Sydney; National University of Singapore	Dong, YH (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore.	yanhong_dong@nuhs.edu.sg; bswong@nus.edu.sg	Wong, Boon-Seng/G-2759-2012; Chen, Christopher/E-7023-2013	Wong, Boon-Seng/0000-0002-7118-8077; Chen, Christopher/0000-0002-1047-9225	Memory Aging & Cognition Centre, National University Health System from a National Medical Research Council Centre Grant (NMRC/CG/NUHS); Research Training Fellowship from the National Medical Research Council	Memory Aging & Cognition Centre, National University Health System from a National Medical Research Council Centre Grant (NMRC/CG/NUHS); Research Training Fellowship from the National Medical Research Council	This work was supported by a pilot grant to C.Y.D. and B. S. W. by the Memory Aging & Cognition Centre, National University Health System from a National Medical Research Council Centre Grant (NMRC/CG/NUHS/2010). C.Y.D. is supported by a Research Training Fellowship from the National Medical Research Council. Lilly-NUS provided the clinical facilities for subject screening, blood draws and neuropsychological assessments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson N, 2002, QUAL LIFE RES, V11, P193; Atzmon G, 2002, J GERONTOL A-BIOL, V57, pM712, DOI 10.1093/gerona/57.11.M712; Benito-Leon J, 2010, J ALZHEIMERS DIS, V21, P95, DOI 10.3233/JAD-2010-100180; Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; Bruce DG, 2003, DIABETES RES CLIN PR, V61, P59, DOI 10.1016/S0168-8227(03)00084-6; Carlsson CM, 2009, ALZ DIS ASSOC DIS, V23, P11, DOI 10.1097/WAD.0b013e3181850188; Chen CLH, 2010, BRIT J CLIN PHARMACO, V70, P886, DOI 10.1111/j.1365-2125.2010.03781.x; Cukierman-Yaffe T, 2009, DIABETES CARE, V32, P221, DOI 10.2337/dc08-1153; de la Monte SM, 2005, J ALZHEIMERS DIS, V7, P45; DEYO RA, 1991, CONTROL CLIN TRIALS, V12, pS142, DOI 10.1016/S0197-2456(05)80019-4; Dong YH, 2013, J NEUROL SCI, V333, P5, DOI 10.1016/j.jns.2013.05.011; Euser SM, 2010, DIABETES, V59, P1601, DOI 10.2337/db09-0568; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forstl H, 2010, BR J DIABETES VASC D, V10, P115, DOI [DOI 10.1177/1474651410368408, 10.1177/1474651410368408]; Gillum RF, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-26; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; Hachinski V, 2006, STROKE, V37, P2220, DOI 10.1161/01.STR.0000237236.88823.47; Heianza Y, 2011, LANCET, V378, P147, DOI 10.1016/S0140-6736(11)60472-8; Heng BH, 2010, ANN ACAD MED SINGAP, V39, P348; Hindmarch I, 1998, DEMENT GERIATR COGN, V9, P20, DOI 10.1159/000051195; Kaufer DI, 2000, J NEUROPSYCH CLIN N, V12, P233, DOI 10.1176/appi.neuropsych.12.2.233; Launer LJ, 2009, STROKE, V40, pS53, DOI 10.1161/STROKEAHA.108.533075; Logroscino G, 2004, BMJ-BRIT MED J, V328, P548, DOI 10.1136/bmj.37977.495729.EE; Mapous RL, 1995, CLIN NEUROPSYCHOLOGI; Marioni RE, 2010, DIABETES, V59, P710, DOI 10.2337/db09-1163; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mazzarella R, 1998, GENOME RES, V8, P1007, DOI 10.1101/gr.8.10.1007; Merched A, 2000, NEUROBIOL AGING, V21, P27, DOI 10.1016/S0197-4580(99)00103-7; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Okereke OI, 2008, J AM GERIATR SOC, V56, P1028, DOI 10.1111/j.1532-5415.2008.01686.x; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Reger MA, 2006, NEUROBIOL AGING, V27, P451, DOI 10.1016/j.neurobiolaging.2005.03.016; Sampson UK, 2011, CURR OPIN CARDIOL, V26, P342, DOI 10.1097/HCO.0b013e3283470359; Schreurs BG, 2010, NEUROSCI BIOBEHAV R, V34, P1366, DOI 10.1016/j.neubiorev.2010.04.010; Sims-Robinson C, 2010, NAT REV NEUROL, V6, P551, DOI 10.1038/nrneurol.2010.130; Solomon A, 2009, NEUROBIOL AGING, V30, P1006, DOI 10.1016/j.neurobiolaging.2007.09.012; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Takeda S, 2010, P NATL ACAD SCI USA, V107, P7036, DOI 10.1073/pnas.1000645107; Taubes G, 2003, SCIENCE, V301, P40, DOI 10.1126/science.301.5629.40; Taubes G, 2009, SCIENCE, V325, P256, DOI 10.1126/science.325_256; Thongtang N, 2011, AM J CARDIOL, V107, P387, DOI 10.1016/j.amjcard.2010.09.031; van den Kommer TN, 2009, NEUROBIOL AGING, V30, P534, DOI 10.1016/j.neurobiolaging.2007.08.005; van Elderen SGC, 2010, NEUROLOGY, V75, P997, DOI 10.1212/WNL.0b013e3181f25f06; Wessels AM, 2011, ALZHEIMERS DEMENT, V7, P418, DOI 10.1016/j.jalz.2010.07.003; Yaffe K, 2012, ARCH NEUROL-CHICAGO, V69, P1170, DOI 10.1001/archneurol.2012.1117; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Young SE, 2006, DIABETES CARE, V29, P2688, DOI 10.2337/dc06-0915; Zhao WQ, 2001, MOL CELL ENDOCRINOL, V177, P125, DOI 10.1016/S0303-7207(01)00455-5; Zhong Y, 2012, BIOMED ENVIRON SCI, V25, P8, DOI 10.3967/0895-3988.2012.01.002; Zhou H, 2010, NEUROSCI LETT, V473, P5, DOI 10.1016/j.neulet.2009.12.057	50	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96874	10.1371/journal.pone.0096874	http://dx.doi.org/10.1371/journal.pone.0096874			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816647	Green Published, Green Submitted, gold			2022-12-27	WOS:000336838000075
J	Henke, SK; Cronan, JE				Henke, Sarah K.; Cronan, John E.			Successful Conversion of the Bacillus subtilis BirA Group II Biotin Protein Ligase into a Group I Ligase	PLOS ONE			English	Article							ESCHERICHIA-COLI REPRESSOR; HOLOENZYME SYNTHETASE; CARRIER PROTEIN; DNA-BINDING; EXPRESSION; BIOSYNTHESIS; OPERON; MODEL; GENE; BIOTINYLATION	Group II biotin protein ligases (BPLs) are characterized by the presence of an N-terminal DNA binding domain that allows transcriptional regulation of biotin biosynthetic and transport genes whereas Group I BPLs lack this N-terminal domain. The Bacillus subtilis BPL, BirA, is classified as a Group II BPL based on sequence predictions of an N-terminal helix-turn-helix motif and mutational alteration of its regulatory properties. We report evidence that B. subtilis BirA is a Group II BPL that regulates transcription at three genomic sites: bioWAFDBI, yuiG and yhfUTS. Moreover, unlike the paradigm Group II BPL, E. coli BirA, the N-terminal DNA binding domain can be deleted from Bacillus subtilis BirA without adverse effects on its ligase function. This is the first example of successful conversion of a Group II BPL to a Group I BPL with retention of full ligase activity.	[Henke, Sarah K.; Cronan, John E.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Cronan, John E.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Cronan, JE (corresponding author), Univ Illinois, Dept Microbiol, 131 Burrill Hall, Urbana, IL 61801 USA.	j-cronan@life.uiuc.edu	Cronan, John/V-6626-2019		National Institutes of Health from the National Institute of Allergy and Infectious Diseases [AI15650]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI015650, R01AI015650] Funding Source: NIH RePORTER	National Institutes of Health from the National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant AI15650 from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hamid AM, 2007, J BACTERIOL, V189, P369, DOI 10.1128/JB.01373-06; ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bagautdinov B, 2008, J BIOL CHEM, V283, P14739, DOI 10.1074/jbc.M709116200; BARKER DF, 1980, J BACTERIOL, V143, P789, DOI 10.1128/JB.143.2.789-800.1980; BARKER DF, 1981, J MOL BIOL, V146, P469, DOI 10.1016/0022-2836(81)90043-7; Beckett D, 2007, ANNU REV GENET, V41, P443, DOI 10.1146/annurev.genet.41.042007.170450; Beckett D, 2009, J NUTR, V139, P167, DOI 10.3945/jn.108.095760; Berntsson RPA, 2012, P NATL ACAD SCI USA, V109, P13990, DOI 10.1073/pnas.1203219109; BOWER S, 1995, J BACTERIOL, V177, P2572, DOI 10.1128/jb.177.9.2572-2575.1995; Chakravartty V, 2013, J BIOL CHEM, V288, P36029, DOI 10.1074/jbc.M113.525618; Chakravartty V, 2012, J BACTERIOL, V194, P1113, DOI 10.1128/JB.06549-11; Chapman-Smith A, 1999, TRENDS BIOCHEM SCI, V24, P359, DOI 10.1016/S0968-0004(99)01438-3; CHAPMANSMITH A, 1994, BIOCHEM J, V302, P881, DOI 10.1042/bj3020881; Christensen QH, 2011, MOL MICROBIOL, V80, P350, DOI 10.1111/j.1365-2958.2011.07598.x; CHRISTNER JE, 1964, J BIOL CHEM, V239, P3997; Cronan JE, 2006, PLASMID, V55, P152, DOI 10.1016/j.plasmid.2005.07.001; CRONAN JE, 1988, J BIOL CHEM, V263, P10332; Cronan John E, 2008, EcoSal Plus, V3, DOI 10.1128/ecosalplus.3.6.3.5; Cui GF, 2006, J BIOL CHEM, V281, P20598, DOI 10.1074/jbc.M602660200; Daniels KG, 2010, BIOCHEMISTRY-US, V49, P5358, DOI 10.1021/bi1003958; DUBNAU D, 1971, J MOL BIOL, V56, P209, DOI 10.1016/0022-2836(71)90460-8; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Harwood C.R., 1990, MOL BIOL METHODS BAC; Hebbeln P, 2007, P NATL ACAD SCI USA, V104, P2909, DOI 10.1073/pnas.0609905104; Hsiao TL, 2010, NAT CHEM BIOL, V6, P34, DOI [10.1038/NCHEMBIO.266, 10.1038/nchembio.266]; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Lee JM, 2001, J BACTERIOL, V183, P7371, DOI 10.1128/JB.183.24.7371-7380.2001; Miller JH, 1972, EXPT MOL GENETICS, Vxvi; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; Pendini NR, 2013, PROTEIN SCI, V22, P762, DOI 10.1002/pro.2262; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PRAKASH O, 1979, P NATL ACAD SCI USA, V76, P5592, DOI 10.1073/pnas.76.11.5592; Purushothaman S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002320; ROCK CO, 1980, ANAL BIOCHEM, V102, P362, DOI 10.1016/0003-2697(80)90168-2; Rodionov DA, 2002, GENOME RES, V12, P1507, DOI 10.1101/gr.314502; SHENOY BC, 1988, FASEB J, V2, P2396, DOI 10.1096/fasebj.2.8.3360240; Solbiati J, 2010, CHEM BIOL, V17, P11, DOI 10.1016/j.chembiol.2009.12.007; SOMERVILLE RL, 1991, BIOCHEM BIOPH RES CO, V181, P1056, DOI 10.1016/0006-291X(91)92044-K; Streaker ED, 1998, BIOCHEMISTRY-US, V37, P3210, DOI 10.1021/bi9715019; Streaker ED, 1998, J MOL BIOL, V278, P787, DOI 10.1006/jmbi.1998.1733; Tron CM, 2009, J MOL BIOL, V387, P129, DOI 10.1016/j.jmb.2008.12.086; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; Weaver LH, 2001, P NATL ACAD SCI USA, V98, P6045, DOI 10.1073/pnas.111128198; WILSON KP, 1992, P NATL ACAD SCI USA, V89, P9257, DOI 10.1073/pnas.89.19.9257; Wood ZA, 2006, J MOL BIOL, V357, P509, DOI 10.1016/j.jmb.2005.12.066; Xu Y, 1995, BIOCHEMISTRY-US, V34, P16624, DOI 10.1021/bi00051a010; Xu Y, 1996, BIOCHEMISTRY-US, V35, P1783, DOI 10.1021/bi952269e; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	49	25	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96757	10.1371/journal.pone.0096757	http://dx.doi.org/10.1371/journal.pone.0096757			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816803	Green Published, gold, Green Submitted			2022-12-27	WOS:000336838000061
J	Kern, G; Mair, SM; Noppert, SJ; Jennings, P; Schramek, H; Rudnicki, M; Mueller, GA; Mayer, G; Koppelstaetter, C				Kern, Georg; Mair, Sabine M.; Noppert, Susie-Jane; Jennings, Paul; Schramek, Herbert; Rudnicki, Michael; Mueller, Gerhard A.; Mayer, Gert; Koppelstaetter, Christian			Tacrolimus Increases Nox4 Expression in Human Renal Fibroblasts and Induces Fibrosis-Related Genes by Aberrant TGF-Beta Receptor Signalling	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; EXTRACELLULAR-MATRIX; NAD(P)H OXIDASE; PANCREAS TRANSPLANTATION; IMMUNOPHILIN FKBP-12; EPITHELIAL-CELLS; KIDNEY; DIFFERENTIATION; ACTIVATION; MYOFIBROBLASTS	Chronic nephrotoxicity of immunosuppressives is one of the main limiting factors in the long-term outcome of kidney transplants, leading to tissue fibrosis and ultimate organ failure. The cytokine TGF-beta is considered a key factor in this process. In the human renal fibroblast cell line TK-173, the macrolide calcineurin inhibitor tacrolimus (FK-506) induced TGF-beta-like effects, manifested by increased expression of NAD(P) H-oxidase 4 (Nox4), transgelin, tropomyosin 1, and procollagen alpha 1(V) mRNA after three days. The macrolide mTOR inhibitor rapamycin had similar effects, while cyclosporine A did not induce fibrose-related genes. Concentration dependence curves were sigmoid, where mRNA expression was induced already at low nanomolar levels of tacrolimus, and reached saturation at 100-300 nM. The effects were independent of extracellular TGF-beta as confirmed by the use of neutralizing antibodies, and thus most likely caused by aberrant TGF-beta receptor signaling, where binding of tacrolimus to the regulatory FKBP12 protein results in a "leaky'' TGF-beta receptor. The myofibroblast marker alpha-smooth muscle actin was neither induced by tacrolimus nor by TGF-beta 1, indicating an incomplete activation of TK-173 fibroblasts under culture conditions. Tacrolimus-and TGF-beta 1-induced Nox4 protein upregulation was confirmed by Western blotting, and was accompanied by a rise in intracellular H2O2 concentration. Si-RNA mediated knockdown of Nox4 expression prevented up-regulation of procollagen alpha 1(V) mRNA in tacrolimus-treated cells, but induced procollagen alpha 1(V) expression in control cells. Nox4 knock-down had no significant effect on the other genes tested. TGF-beta is a key molecule in fibrosis, and the constant activation of aberrant receptor signaling by tacrolimus might contribute to the long-term development of interstitial kidney fibrosis in immunosuppressed patients. Nox4 levels possibly play a regulatory role in these processes.	[Kern, Georg; Mair, Sabine M.; Noppert, Susie-Jane; Jennings, Paul; Schramek, Herbert; Rudnicki, Michael; Mayer, Gert; Koppelstaetter, Christian] Med Univ Innsbruck, A-6020 Innsbruck, Austria; [Mueller, Gerhard A.] Univ Goettingen, Gottingen, Germany	Medical University of Innsbruck; University of Gottingen	Kern, G (corresponding author), Med Univ Innsbruck, A-6020 Innsbruck, Austria.	georg.kern@i-med.ac.at	Jennings, Paul/A-8670-2010	Jennings, Paul/0000-0002-6860-2898; Mayer, Gert/0000-0002-5039-543X	Medical University Innsbruck; Pfizer	Medical University Innsbruck; Pfizer(Pfizer)	Funding provided by MFI Grant of Medical University Innsbruck, www.i-med.ac.at, and support from Wyeth (now:Pfizer), www.pfizer.com. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara N, 2010, THORAX, V65, P733, DOI 10.1136/thx.2009.113456; Andreoni KA, 2007, AM J TRANSPLANT, V7, P1359, DOI 10.1111/j.1600-6143.2006.01781.x; Assinder SJ, 2009, INT J BIOCHEM CELL B, V41, P482, DOI 10.1016/j.biocel.2008.02.011; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bondi CD, 2010, J AM SOC NEPHROL, V21, P93, DOI 10.1681/ASN.2009020146; Borbely G, 2010, J MED CHEM, V53, P6758, DOI 10.1021/jm1004368; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; BORDER WA, 1994, CONTRIB NEPHROL, V107, P140; CALNE RY, 1978, LANCET, V2, P1323; Chen YG, 1997, EMBO J, V16, P3866, DOI 10.1093/emboj/16.13.3866; Choi HS, 2006, J IMMUNOASS IMMUNOCH, V27, P31, DOI 10.1080/15321810500403722; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; Dihazi H, 2011, J PROTEOMICS, V74, P304, DOI 10.1016/j.jprot.2010.11.007; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; Goettsch C, 2009, BIOCHEM BIOPH RES CO, V380, P355, DOI 10.1016/j.bbrc.2009.01.107; Goldfarb David A, 2003, J Urol, V169, P2436; Gorin Y, 2004, BIOCHEM J, V381, P231, DOI 10.1042/BJ20031614; Groningen MCRV, 2006, J AM SOC NEPHROL, V17, P881, DOI 10.1681/ASN.2005080891; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Jennings P, 2007, AM J PHYSIOL-RENAL, V293, pF831, DOI 10.1152/ajprenal.00005.2007; Khanna A, 2002, KIDNEY INT, V62, P2257, DOI 10.1046/j.1523-1755.2002.00668.x; Khanna AK, 2003, BIOCHEM BIOPH RES CO, V303, P266, DOI 10.1016/S0006-291X(03)00340-1; Li J, 2006, MOL BIOL CELL, V17, P3978, DOI 10.1091/mbc.E05-06-0532; Mandal CC, 2011, BIOCHEM J, V433, P393, DOI 10.1042/BJ20100357; Matl I, 2005, TRANSPLANT INT, V18, P668, DOI 10.1111/j.1432-2277.2005.00115.x; Mayer DCG, 1997, J CELL BIOL, V139, P1477, DOI 10.1083/jcb.139.6.1477; Mozes MM, 1999, J AM SOC NEPHROL, V10, P271; Nankivell Brian J., 2003, New England Journal of Medicine, V349, P2326, DOI 10.1056/NEJMoa020009; Pohlers D, 2009, BBA-MOL BASIS DIS, V1792, P746, DOI 10.1016/j.bbadis.2009.06.004; Popova AP, 2010, AM J PHYSIOL-LUNG C, V298, pL735, DOI 10.1152/ajplung.00347.2009; Schuttert JB, 2003, PFLUG ARCH EUR J PHY, V446, P387, DOI 10.1007/s00424-003-1026-y; Shiose A, 2001, J BIOL CHEM, V276, P1417, DOI 10.1074/jbc.M007597200; Slattery C, 2005, AM J PATHOL, V167, P395, DOI 10.1016/S0002-9440(10)62984-7; STARZL TE, 1989, LANCET, V2, P1000; Takac I, 2011, J BIOL CHEM, V286, P13304, DOI 10.1074/jbc.M110.192138; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; VLEMING LJ, 1995, CLIN NEPHROL, V44, P211; WANG TW, 1994, SCIENCE, V265, P674, DOI 10.1126/science.7518616; Wenstrup RJ, 2004, J BIOL CHEM, V279, P53331, DOI 10.1074/jbc.M409622200; Wieser M, 2008, AM J PHYSIOL-RENAL, V295, pF1365, DOI 10.1152/ajprenal.90405.2008; WOLF G, 1990, J AM SOC NEPHROL, V1, P918; Wu RF, 2010, MOL CELL BIOL, V30, P3553, DOI 10.1128/MCB.01445-09	43	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96377	10.1371/journal.pone.0096377	http://dx.doi.org/10.1371/journal.pone.0096377			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816588	Green Published, gold, Green Submitted			2022-12-27	WOS:000336838000034
J	Maresca, D; Adams, S; Maresca, B; van der Steen, AFW				Maresca, David; Adams, Samantha; Maresca, Bruno; van der Steen, Antonius F. W.			Mapping Intravascular Ultrasound Controversies in Interventional Cardiology Practice	PLOS ONE			English	Article							CORONARY ATHEROSCLEROSIS; FEASIBILITY	Intravascular ultrasound is a catheter-based imaging modality that was developed to investigate the condition of coronary arteries and assess the vulnerability of coronary atherosclerotic plaques in particular. Since its introduction in the clinic 20 years ago, use of intravascular ultrasound innovation has been relatively limited. Intravascular ultrasound remains a niche technology; its clinical practice did not vastly expand, except in Japan, where intravascular ultrasound is an appraised tool for guiding percutaneous coronary interventions. In this qualitative research study, we follow scholarship on the sociology of innovation in exploring both the current adoption practices and perspectives on the future of intravascular ultrasound. We conducted a survey of biomedical experts with experience in the technology, the practice, and the commercialization of intravascular ultrasound. The collected information enabled us to map intravascular ultrasound controversies as well as to outline the dynamics of the international network of experts that generates intravascular ultrasound innovations and uses intravascular ultrasound technologies. While the technology is praised for its capacity to measure coronary atherosclerotic plaque morphology and is steadily used in clinical research, the lack of demonstrated benefits of intravascular ultrasound guided coronary interventions emerges as the strongest factor that prevents its expansion. Furthermore, most of the controversies identified were external to intravascular ultrasound technology itself, meaning that decision making at the industrial, financial and regulatory levels are likely to determine the future of intravascular ultrasound. In light of opinions from the responding experts', a wider adoption of intravascular ultrasound as a stand-alone imaging modality seems rather uncertain, but the appeal for this technology may be renewed by improving image quality and through combination with complementary imaging modalities.	[Maresca, David; van der Steen, Antonius F. W.] Erasmus MC, Dept Biomed Engn, Rotterdam, Netherlands; [Adams, Samantha] Tilburg Univ, Tilburg Inst Law Technol & Soc, NL-5000 LE Tilburg, Netherlands; [Maresca, Bruno] Ctr Rech Etud & Observat Condit Vie, Paris, France; [van der Steen, Antonius F. W.] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands; [van der Steen, Antonius F. W.] Delft Univ Technol, Delft, Netherlands	Erasmus University Rotterdam; Erasmus MC; Tilburg University; Interuniversity Cardiology Institute of the Netherlands; Utrecht University; Delft University of Technology	Maresca, D (corresponding author), Erasmus MC, Dept Biomed Engn, Rotterdam, Netherlands.	david.maresca@espci.fr		Maresca, David/0000-0002-4921-6406	Dutch Technology Foundation STW	Dutch Technology Foundation STW(Technologiestichting STW)	Funding of the Dutch Technology Foundation STW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bom N, 1972, UK Patent, Patent No. 1402192; Borgatti S.P., 2002, UCINET 6 WINDOWS SOF; CALLON M, 1987, SOC MAKING STUDY TEC; Carlier SG, 1998, CIRCULATION, V97, P2575, DOI 10.1161/01.CIR.97.25.2575; Cespedes EI, 2000, ULTRASOUND MED BIOL, V26, P385, DOI 10.1016/S0301-5629(99)00169-6; Chandrana C, 2010, IEEE T ULTRASON FERR, V57, P1077, DOI 10.1109/TUFFC.2010.1519; Davies MJ, 1996, CIRCULATION, V94, P2013, DOI 10.1161/01.CIR.94.8.2013; Frijlink ME, 2006, IEEE T ULTRASON FERR, V53, P1844, DOI 10.1109/TUFFC.2006.116; GLAGOV S, 1987, NEW ENGL J MED, V316, P1371, DOI 10.1056/NEJM198705283162204; Goertz DE, 2006, INVEST RADIOL, V41, P631, DOI 10.1097/01.rli.0000229773.11715.da; GUSSENHOVEN EJ, 1991, AM J CARDIOL, V68, P1625, DOI 10.1016/0002-9149(91)90320-K; JANSEN K, 2012, PHOTOACOUSTIC IMAGIN; JANSEN K, 2014, ULTRASOUND IN PRESS; KUBO T, 2012, WHAT IS OPTIMAL IMAG; Li JW, 2014, JACC-CARDIOVASC IMAG, V7, P101, DOI 10.1016/j.jcmg.2013.07.012; Li WG, 1998, ULTRASOUND MED BIOL, V24, P203, DOI 10.1016/S0301-5629(97)00275-5; MacKenzie D. A., 1993, INVENTING ACCURACY H; Madder RD, 2013, JACC-CARDIOVASC INTE, V6, P838, DOI 10.1016/j.jcin.2013.04.012; Maresca D, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3679375; MARESCA D, 2014, ULTRASOUND IN PRESS; Morlacchi P, 2011, RES POLICY, V40, P511, DOI 10.1016/j.respol.2011.01.001; Muller J., 1989, CIRCULATION, V793, P733; NISSEN SE, 1991, CIRCULATION, V84, P1087, DOI 10.1161/01.CIR.84.3.1087; Rosenberg Lawrence, 2012, Bull Am Coll Surg, V97, P6; Schaar JA, 2003, CIRCULATION, V108, P2636, DOI 10.1161/01.CIR.0000097067.96619.1F; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Tsai WP, 2001, ACAD MANAGE J, V44, P996, DOI 10.2307/3069443; Ulucanlar S, 2013, SOC SCI MED, V98, P95, DOI 10.1016/j.socscimed.2013.09.008; Venturini T, 2010, PUBLIC UNDERST SCI, V19, P258, DOI 10.1177/0963662509102694; YOXEN E, 1987, SEEING SOUND STUDY D; [No title captured]	32	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97215	10.1371/journal.pone.0097215	http://dx.doi.org/10.1371/journal.pone.0097215			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816741	gold, Green Published			2022-12-27	WOS:000336838000117
J	Richards, DS; Griffith, RW; Romer, SH; Alvarez, FJ				Richards, Dannette S.; Griffith, Ronald W.; Romer, Shannon H.; Alvarez, Francisco J.			Motor Axon Synapses on Renshaw Cells Contain Higher Levels of Aspartate than Glutamate	PLOS ONE			English	Article							RAT SPINAL-CORD; ELECTRON-MICROSCOPIC IMMUNOCYTOCHEMISTRY; QUANTITATIVE IMMUNOGOLD ANALYSIS; DORSAL-ROOT GANGLIA; METHYL-D-ASPARTATE; VESICULAR GLUTAMATE; NEUROMUSCULAR-JUNCTION; PHOSPHATE TRANSPORTER; EXCITATORY ACTIONS; SKELETAL-MUSCLE	Motoneuron synapses on spinal cord interneurons known as Renshaw cells activate nicotinic, AMPA and NMDA receptors consistent with co-release of acetylcholine and excitatory amino acids (EAA). However, whether these synapses express vesicular glutamate transporters (VGLUTs) capable of accumulating glutamate into synaptic vesicles is controversial. An alternative possibility is that these synapses release other EAAs, like aspartate, not dependent on VGLUTs. To clarify the exact EAA concentrated at motor axon synapses we performed a quantitative postembedding colloidal gold immunoelectron analysis for aspartate and glutamate on motor axon synapses (identified by immunoreactivity to the vesicular acetylcholine transporter; VAChT) contacting calbindin-immunoreactive (-IR) Renshaw cell dendrites. The results show that 71% to 80% of motor axon synaptic boutons on Renshaw cells contained aspartate immunolabeling two standard deviations above average neuropil labeling. Moreover, VAChT-IR synapses on Renshaw cells contained, on average, aspartate immunolabeling at 2.5 to 2.8 times above the average neuropil level. In contrast, glutamate enrichment was lower; 21% to 44% of VAChT-IR synapses showed glutamate-IR two standard deviations above average neuropil labeling and average glutamate immunogold density was 1.7 to 2.0 times the neuropil level. The results were not influenced by antibody affinities because glutamate antibodies detected glutamate-enriched brain homogenates more efficiently than aspartate antibodies detecting aspartate-enriched brain homogenates. Furthermore, synaptic boutons with ultrastructural features of Type I excitatory synapses were always labeled by glutamate antibodies at higher density than motor axon synapses. We conclude that motor axon synapses co-express aspartate and glutamate, but aspartate is concentrated at higher levels than glutamate.	[Richards, Dannette S.; Romer, Shannon H.; Alvarez, Francisco J.] Wright State Univ, Dept Neurosci Cell Biol & Physiol, Dayton, OH 45435 USA; [Griffith, Ronald W.; Alvarez, Francisco J.] Emory Univ, Dept Physiol, Atlanta, GA 30322 USA	University System of Ohio; Wright State University Dayton; Emory University	Alvarez, FJ (corresponding author), Wright State Univ, Dept Neurosci Cell Biol & Physiol, Dayton, OH 45435 USA.	Francisco.j.alvarez@emory.edu	Alvarez, Francisco/GZL-1953-2022; Romer, Shannon/ABI-1775-2020; Alvarez, Francisco J/H-4929-2011	Romer, Shannon/0000-0002-0211-6926; Alvarez, Francisco J/0000-0001-7011-3244	NIH [R01 NS047357]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047357] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NIH grant R01 NS047357. The funding agency (National Institutes of Health) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez FJ, 1999, J PHYSIOL-LONDON, V515, P787, DOI 10.1111/j.1469-7793.1999.787ab.x; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; Bonnot A, 2009, J NEUROPHYSIOL, V101, P2995, DOI 10.1152/jn.90740.2008; Brunelli G, 2005, P NATL ACAD SCI USA, V102, P8752, DOI 10.1073/pnas.0500530102; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; CONNAUGHTON M, 1986, NEUROSCIENCE, V17, P205, DOI 10.1016/0306-4522(86)90237-X; Conradi S, 1969, Acta Physiol Scand Suppl, V332, P5; CURRAS MC, 1992, MOL PHARMACOL, V41, P520; d'Incamps BL, 2012, J NEUROSCI, V32, P8413, DOI 10.1523/JNEUROSCI.0181-12.2012; d'Incamps BL, 2008, J NEUROSCI, V28, P14121, DOI 10.1523/JNEUROSCI.3311-08.2008; Dale HH, 1936, J PHYSIOL-LONDON, V86, P353, DOI 10.1113/jphysiol.1936.sp003371; Dourado M, 2002, J NEUROPHYSIOL, V87, P3117, DOI 10.1152/jn.2002.87.6.3117; ECCLES JC, 1961, J PHYSIOL-LONDON, V159, P461, DOI 10.1113/jphysiol.1961.sp006821; ECCLES JC, 1954, J PHYSIOL-LONDON, V126, P524, DOI 10.1113/jphysiol.1954.sp005226; Fremeau RT, 2002, P NATL ACAD SCI USA, V99, P14488, DOI 10.1073/pnas.222546799; Gundersen V, 1998, J NEUROSCI, V18, P6059; Hertz Leif, 2013, Front Endocrinol (Lausanne), V4, P59, DOI 10.3389/fendo.2013.00059; Herzog E, 2004, EUR J NEUROSCI, V20, P1752, DOI 10.1111/j.1460-9568.2004.03628.x; Herzog E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-22-j0001.2001; Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641; LAGERBACK PA, 1981, BRAIN RES, V207, P247, DOI 10.1016/0006-8993(81)90363-2; Lamotte d'Incamps B, 2013, 2011 NEUR M PLANN; Landry M, 2004, J COMP NEUROL, V468, P380, DOI 10.1002/cne.10988; Li WC, 2004, P NATL ACAD SCI USA, V101, P15488, DOI 10.1073/pnas.0404864101; Liu TT, 2009, NEUROSCIENCE, V161, P111, DOI 10.1016/j.neuroscience.2009.03.034; Llewellyn-Smith IJ, 2007, J COMP NEUROL, V503, P741, DOI 10.1002/cne.21414; Malomouzh AI, 2003, J NEUROCHEM, V85, P206, DOI 10.1046/j.1471-4159.2003.01660.x; Matsubara A, 1996, J NEUROSCI, V16, P4457; Mays TA, 2009, MUSCLE NERVE, V39, P343, DOI 10.1002/mus.21099; Mentis GZ, 2005, P NATL ACAD SCI USA, V102, P7344, DOI 10.1073/pnas.0502788102; Miles GB, 2007, P NATL ACAD SCI USA, V104, P2448, DOI 10.1073/pnas.0611134104; Miyaji T, 2008, P NATL ACAD SCI USA, V105, P11720, DOI 10.1073/pnas.0804015105; Moechars D, 2006, J NEUROSCI, V26, P12055, DOI 10.1523/JNEUROSCI.2556-06.2006; Morland C, 2013, FASEB J, V27, P1264, DOI 10.1096/fj.12-206300; Nishimaru H, 2005, P NATL ACAD SCI USA, V102, P5245, DOI 10.1073/pnas.0501331102; Oliveira ALR, 2003, SYNAPSE, V50, P117, DOI 10.1002/syn.10249; OTTERSEN OP, 1987, EXP BRAIN RES, V69, P167; Petrov KA, 2013, EUR J NEUROSCI, V37, P181, DOI 10.1111/ejn.12029; Pinard A, 2003, EUR J NEUROSCI, V18, P3241, DOI 10.1111/j.1460-9568.2003.03028.x; Pizzi M, 2006, CURR OPIN NEUROBIOL, V16, P323, DOI 10.1016/j.conb.2006.05.013; Reimer RJ, 2004, PFLUG ARCH EUR J PHY, V447, P629, DOI 10.1007/s00424-003-1087-y; RENSHAW B, 1946, J NEUROPHYSIOL, V9, P191, DOI 10.1152/jn.1946.9.3.191; Rinholm JE, 2007, NEUROSCIENCE, V145, P579, DOI 10.1016/j.neuroscience.2006.12.041; SCHNEIDER SP, 1992, J NEUROPHYSIOL, V68, P397, DOI 10.1152/jn.1992.68.2.397; SHUPLIAKOV O, 1995, J NEUROSCI, V15, P7168; Siembab VC, 2010, J COMP NEUROL, V518, P4675, DOI 10.1002/cne.22441; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Varoqui H, 2002, J NEUROSCI, V22, P142, DOI 10.1523/JNEUROSCI.22-01-00142.2002; Verheijen FW, 1999, NAT GENET, V23, P462, DOI 10.1038/70585; WAERHAUG O, 1993, ANAT EMBRYOL, V188, P501; WALMSLEY B, 1981, BRAIN RES, V223, P170, DOI 10.1016/0006-8993(81)90818-0; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; Wootz H, 2013, J COMP NEUROL, V521, P1449, DOI 10.1002/cne.23266; Zagoraiou L, 2009, NEURON, V64, P645, DOI 10.1016/j.neuron.2009.10.017	54	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97240	10.1371/journal.pone.0097240	http://dx.doi.org/10.1371/journal.pone.0097240			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816812	Green Submitted, Green Published, gold			2022-12-27	WOS:000336838000120
J	Sedlacek, V; Klumpler, T; Marek, J; Kucera, I				Sedlacek, Vojtech; Klumpler, Tomas; Marek, Jaromir; Kucera, Igor			The Structural and Functional Basis of Catalysis Mediated by NAD(P)H:acceptor Oxidoreductase (FerB) of Paracoccus denitrificans	PLOS ONE			English	Article							QUINONE REDUCTASE-ACTIVITY; X-RAY-DIFFRACTION; CRYSTAL-STRUCTURE; BIOCHEMICAL-CHARACTERIZATION; FMN OXIDOREDUCTASE; BINDING; PROTEIN; VALIDATION; FLAVODOXIN; SCATTERING	FerB from Paracoccus denitrificans is a soluble cytoplasmic flavoprotein that accepts redox equivalents from NADH or NADPH and transfers them to various acceptors such as quinones, ferric complexes and chromate. The crystal structure and small-angle X-ray scattering measurements in solution reported here reveal a head-to-tail dimer with two flavin mononucleotide groups bound at the opposite sides of the subunit interface. The dimers tend to self-associate to a tetrameric form at higher protein concentrations. Amino acid residues important for the binding of FMN and NADH and for the catalytic activity are identified and verified by site-directed mutagenesis. In particular, we show that Glu77 anchors a conserved water molecule in close proximity to the O2 of FMN, with the probable role of facilitating flavin reduction. Hydride transfer is shown to occur from the 4-pro-S position of NADH to the solvent-accessible si side of the flavin ring. When using deuterated NADH, this process exhibits a kinetic isotope effect of about 6 just as does the NADH-dependent quinone reductase activity of FerB; the first, reductive half-reaction of flavin cofactor is thus rate-limiting. Replacing the bulky Arg95 in the vicinity of the active site with alanine substantially enhances the activity towards external flavins that obeys the standard bi-bi ping-pong reaction mechanism. The new evidence for a cryptic flavin reductase activity of FerB justifies the previous inclusion of this enzyme in the protein family of NADPH-dependent FMN reductases.	[Sedlacek, Vojtech; Kucera, Igor] Masaryk Univ, Fac Sci, Dept Biochem, CS-61137 Brno, Czech Republic; [Klumpler, Tomas; Marek, Jaromir] Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic	Masaryk University Brno; Masaryk University Brno	Kucera, I (corresponding author), Masaryk Univ, Fac Sci, Dept Biochem, CS-61137 Brno, Czech Republic.	ikucera@chemi.muni.cz			Czech Science Foundation [P503/10/P217, P503/12/0369]; project Employment of Best Young Scientists for International Cooperation Empowerment [CZ.1.07/2.3.00/30.0037]; European Social Fund; state budget of the Czech Republic	Czech Science Foundation(Grant Agency of the Czech Republic); project Employment of Best Young Scientists for International Cooperation Empowerment; European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic	This research was supported by grants P503/10/P217 (to VS) and P503/12/0369 (to IK) from the Czech Science Foundation (www.gacr.cz) and by project Employment of Best Young Scientists for International Cooperation Empowerment, reg. number CZ.1.07/2.3.00/30.0037 co-financed by the European Social Fund and the state budget of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2006, ACTA CRYSTALLOGR D, V62, P383, DOI [10.1107/S0907444906001600, 10.1107/S0904777906001600]; Barak Y, 2006, APPL ENVIRON MICROB, V72, P7074, DOI 10.1128/AEM.01334-06; Bastian M, 1997, BIOPHYS CHEM, V67, P27, DOI 10.1016/S0301-4622(97)00012-4; Bellamacina CR, 1996, FASEB J, V10, P1257, DOI 10.1096/fasebj.10.11.8836039; Blaesse M, 2000, EMBO J, V19, P6299, DOI 10.1093/emboj/19.23.6299; Bollen YJM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2010; Deller S, 2008, CELL MOL LIFE SCI, V65, P141, DOI 10.1007/s00018-007-7300-y; Deller S, 2006, BIOCHEMISTRY-US, V45, P7083, DOI 10.1021/bi052478r; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswaramoorthy S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036017; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; Gonzalez CF, 2005, J BIOL CHEM, V280, P22590, DOI 10.1074/jbc.M501654200; Grandori R, 1998, J BIOL CHEM, V273, P20960, DOI 10.1074/jbc.273.33.20960; Hefti MH, 2003, BBA-GEN SUBJECTS, V1619, P139, DOI 10.1016/S0304-4165(02)00474-9; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hubbard PA, 2003, J BIOL CHEM, V278, P37553, DOI 10.1074/jbc.M304642200; Hubbard PA, 2001, J BIOL CHEM, V276, P29163, DOI 10.1074/jbc.M101731200; Ji HF, 2006, J MOL STRUC-THEOCHEM, V764, P155, DOI 10.1016/j.theochem.2006.01.027; Jin HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042432; Joosten RP, 2012, ACTA CRYSTALLOGR D, V68, P484, DOI 10.1107/S0907444911054515; Klumpler T, 2010, MAT STRUCTURE CHEM B, V17, pb21; Klumpler T, 2010, ACTA CRYSTALLOGR F, V66, P431, DOI 10.1107/S1744309110005099; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LI RB, 1995, P NATL ACAD SCI USA, V92, P8846, DOI 10.1073/pnas.92.19.8846; Liu ZJ, 2007, ARCH BIOCHEM BIOPHYS, V463, P68, DOI 10.1016/j.abb.2007.03.003; Lostao A, 2000, J BIOL CHEM, V275, P9518, DOI 10.1074/jbc.275.13.9518; Massey V, 1990, FLAVINS FLAVOPROTEIN, P59; Mayhew SG, 1999, METH MOL B, V131, P49; Mazoch J, 2004, EUR J BIOCHEM, V271, P553, DOI 10.1046/j.1432-1033.2003.03957.x; Nissen MS, 2008, J BIOL CHEM, V283, P28710, DOI 10.1074/jbc.M804535200; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Ramirez-Diaz MI, 2008, BIOMETALS, V21, P321, DOI 10.1007/s10534-007-9121-8; Rohr AK, 2010, ANGEW CHEM INT EDIT, V49, P2324, DOI 10.1002/anie.200907143; Ryan A, 2010, J MOL BIOL, V400, P24, DOI 10.1016/j.jmb.2010.04.023; Sancho J, 2006, CELL MOL LIFE SCI, V63, P855, DOI 10.1007/s00018-005-5514-4; Sedlacek V, 2010, ARCH MICROBIOL, V192, P919, DOI 10.1007/s00203-010-0622-4; Sedlacek V, 2009, ARCH BIOCHEM BIOPHYS, V483, P29, DOI 10.1016/j.abb.2008.12.016; Sollner S, 2009, FEBS J, V276, P4313, DOI 10.1111/j.1742-4658.2009.07143.x; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Symons ZC, 2006, NAT PROD REP, V23, P845, DOI 10.1039/b502796a; TEDESCHI G, 1995, J BIOL CHEM, V270, P1198, DOI 10.1074/jbc.270.3.1198; Tedeschi G, 1997, BIOCHEMISTRY-US, V36, P16221, DOI 10.1021/bi970751m; Tesarik R, 2009, PROTEIN EXPRES PURIF, V68, P233, DOI 10.1016/j.pep.2009.07.014; Thorne SH, 2009, MOL CANCER THER, V8, P333, DOI 10.1158/1535-7163.MCT-08-0707	46	18	18	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96262	10.1371/journal.pone.0096262	http://dx.doi.org/10.1371/journal.pone.0096262			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24817153	Green Submitted, gold, Green Published			2022-12-27	WOS:000336838000029
J	Zhang, Q; Qi, J; Hou, SP; Du, LP; Yu, HS; Cao, QF; Zhou, Y; Liao, D; Kijlstra, A; Yang, PZ				Zhang, Qi; Qi, Jian; Hou, Shengping; Du, Liping; Yu, Hongsong; Cao, Qingfeng; Zhou, Yan; Liao, Dan; Kijlstra, Aize; Yang, Peizeng			A Functional Variant of PTPN22 Confers Risk for Vogt-Koyanagi-Harada Syndrome but Not for Ankylosing Spondylitis	PLOS ONE			English	Article							TYROSINE-PHOSPHATASE PTPN22; GENOME-WIDE ASSOCIATION; BEHCETS-DISEASE; PROMOTER POLYMORPHISM; EPIDEMIOLOGIC SURVEY; AUTOIMMUNE-DISEASES; DIAGNOSTIC-CRITERIA; GENETIC-VARIATION; SUSCEPTIBILITY; UVEITIS	Background: Protein tyrosine phosphatase non-receptor 22 (PTPN22) is a key negative regulator of T lymphocytes and has emerged as an important candidate susceptibility factor for a number of immune-related diseases. This study aimed to examine the predisposition of PTPN22 SNPs to Vogt-Koyanagi-Harada (VKH) syndrome and acute anterior uveitis (AAU) associated with ankylosing spondylitis (AS). Methods: A total of 1005 VKH syndrome, 302 AAU(+) AS(+) patients and 2010 normal controls among the Chinese Han population were enrolled in the study. Genotyping, PTPN22 expression, cell proliferation, cytokine production and cell activation were examined by PCR-RFLP, Real-time PCR, CCK8, ELISA and Flow cytometry. Results: The results showed significantly increased frequencies of the rs2488457 CC genotype and C allele but a decreased frequency of the GG genotype in VKH syndrome patients (P-Bonferroni correction (P-c) = 3.47x10(-7), OR = 1.54; P-c = 3.83 x 10(-8), OR = 1.40; P-c = 6.35x10(-4), OR = 0.62; respectively). No significant association of the tested SNPs with AAU(+) AS(+) patients was observed. Functional studies showed a decreased PTPN22 expression, impaired cell proliferation and lower production of IL-10 in rs2488457 CC cases compared to GG cases (P-c = 0.009, P-c = 0.015 and P-c = 0.048 respectively). No significant association was observed concerning T cell activation and rs2488457 genotype. Conclusions: The study showed that a functional variant of PTPN22 confers risk for VKH syndrome but not for AAU(+) AS(+) in a Chinese Han population, which may be due to a modulation of the PTPN22 expression, PBMC proliferation and IL-10 production.	[Zhang, Qi; Qi, Jian; Hou, Shengping; Du, Liping; Yu, Hongsong; Cao, Qingfeng; Zhou, Yan; Liao, Dan; Yang, Peizeng] Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China; [Zhang, Qi; Qi, Jian; Hou, Shengping; Du, Liping; Yu, Hongsong; Cao, Qingfeng; Zhou, Yan; Liao, Dan; Yang, Peizeng] Chongqing Eye Inst, Chongqing, Peoples R China; [Kijlstra, Aize] Univ Eye Clin Maastricht, Maastricht, Netherlands	Chongqing Medical University; Maastricht University; Maastricht University Medical Centre (MUMC)	Yang, PZ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China.	peizengycmu@126.com	Du, Liping/M-9495-2019; Cao, Qingfeng/C-2947-2017; Yu, Hongsong/J-9106-2014	Cao, Qingfeng/0000-0001-6252-5628; Yu, Hongsong/0000-0002-1209-2104	Natural Science Foundation [81130019]; National Basic Research Program of China (973 Program) [2011CB510200]; National Natural Science Foundation [81300754, 81270990, 81070722]; Clinic Key Project of Ministry of Health, Basic Research program of Chongqing [cstc2013jcyjC10001]; Chongqing Key Laboratory of Ophthalmology (CSTC) [2008CA5003]; Key Project of Health Bureau of Chongqing [2012-1-003]; Fund for PAR-EU Scholars Program	Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Clinic Key Project of Ministry of Health, Basic Research program of Chongqing; Chongqing Key Laboratory of Ophthalmology (CSTC)(Natural Science Foundation Project of CQ CSTC); Key Project of Health Bureau of Chongqing; Fund for PAR-EU Scholars Program	This work was supported by Key Project of Natural Science Foundation (81130019), National Basic Research Program of China (973 Program) (2011CB510200), National Natural Science Foundation Project (81300754, 81270990, 81070722), Clinic Key Project of Ministry of Health, Basic Research program of Chongqing (cstc2013jcyjC10001), Chongqing Key Laboratory of Ophthalmology (CSTC, 2008CA5003), Key Project of Health Bureau of Chongqing (2012-1-003) and Fund for PAR-EU Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnisalo J, 2008, J AUTOIMMUN, V31, P13, DOI 10.1016/j.jaut.2008.01.001; Anderson AC, 2004, J IMMUNOL, V173, P828, DOI 10.4049/jimmunol.173.2.828; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Behrens TW, 2011, NAT GENET, V43, P821, DOI 10.1038/ng.914; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-7; Burn GL, 2011, FEBS LETT, V585, P3689, DOI 10.1016/j.febslet.2011.04.032; Chew GYJ, 2013, J ALLERGY CLIN IMMUN, V131, P1130, DOI 10.1016/j.jaci.2012.06.023; Fousteri G, 2013, CLIN IMMUNOL, V149, P556, DOI 10.1016/j.clim.2013.10.006; Ge J, 2012, PLATELETS; Goto H, 2007, JPN J OPHTHALMOL, V51, P41, DOI 10.1007/s10384-006-0383-4; Gregersen PK, 2005, NAT GENET, V37, P1300, DOI 10.1038/ng1205-1300; Horie Y, 2009, MOL VIS, V15, P1115; Hou SP, 2012, HUM GENET, V131, P1841, DOI 10.1007/s00439-012-1200-4; Huang CH, 2013, RHEUMATOL INT; Huang JJ, 2012, RHEUMATOL INT, V32, P767, DOI 10.1007/s00296-010-1705-x; Ichimura M, 2008, THYROID, V18, P625, DOI 10.1089/thy.2007.0353; Kawasaki E, 2006, AM J MED GENET A, V140A, P586, DOI 10.1002/ajmg.a.31124; Kyogoku C, 2004, AM J HUM GENET, V75, P504, DOI 10.1086/423790; Lee HS, 2009, ARTHRITIS RHEUM-US, V60, P364, DOI 10.1002/art.24245; Lee YH, 2007, RHEUMATOLOGY, V46, P49, DOI 10.1093/rheumatology/kel170; Lin ZM, 2012, NAT GENET, V44, P73, DOI 10.1038/ng.1005; Martin MC, 2005, TISSUE ANTIGENS, V66, P314, DOI 10.1111/j.1399-0039.2005.00428.x; Martin TM, 2009, MOL VIS, V15, P208; Matesanz F, 2005, J NEUROL, V252, P994, DOI 10.1007/s00415-005-0795-y; McGonagle D, 2006, PLOS MED, V3, P1242, DOI 10.1371/journal.pmed.0030297; Mizuki N, 2010, NAT GENET, V42, P703, DOI 10.1038/ng.624; Mori M, 2005, J HUM GENET, V50, P264, DOI 10.1007/s10038-005-0246-8; Ohguro N, 2012, JPN J OPHTHALMOL, V56, P432, DOI 10.1007/s10384-012-0158-z; Orozco G, 2006, ANN RHEUM DIS, V65, P687, DOI 10.1136/ard.2005.046094; Orru V, 2009, HUM MOL GENET, V18, P569, DOI 10.1093/hmg/ddn363; Read RW, 2001, AM J OPHTHALMOL, V131, P647, DOI 10.1016/S0002-9394(01)00925-4; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; Rhee I, 2012, NAT IMMUNOL, V13, P439, DOI 10.1038/ni.2246; Rieck M, 2007, J IMMUNOL, V179, P4704, DOI 10.4049/jimmunol.179.7.4704; Shu QM, 2010, HUM IMMUNOL, V71, P988, DOI 10.1016/j.humimm.2010.06.020; Siminovitch KA, 2004, NAT GENET, V36, P1248, DOI 10.1038/ng1204-1248; Smith JR, 2002, ARTHRITIS RHEUM-US, V46, P309, DOI 10.1002/art.503; Tang ST, 2012, DIABETES RES CLIN PR, V97, P446, DOI 10.1016/j.diabres.2012.04.011; Taniyama M, 2010, HUM IMMUNOL, V71, P795, DOI 10.1016/j.humimm.2010.05.016; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Viken MK, 2007, TISSUE ANTIGENS, V70, P190, DOI 10.1111/j.1399-0039.2007.00871.x; Wagenleiter SEN, 2005, INT J IMMUNOGENET, V32, P323, DOI 10.1111/j.1744-313X.2005.00534.x; Wipff J, 2006, ANN RHEUM DIS, V65, P1230, DOI 10.1136/ard.2005.048181; Yamaki K, 2000, J IMMUNOL, V165, P7323, DOI 10.4049/jimmunol.165.12.7323; Yang PZ, 2008, OPHTHALMOLOGY, V115, P312, DOI 10.1016/j.ophtha.2007.04.056; Yang PZ, 2007, OPHTHALMOLOGY, V114, P606, DOI 10.1016/j.ophtha.2006.07.040; Yang PZ, 2005, CURR EYE RES, V30, P943, DOI 10.1080/02713680500263606; Zhang JY, 2011, NAT GENET, V43, P902, DOI 10.1038/ng.904; Zhang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031230; Zhang ZH, 2008, INT J IMMUNOGENET, V35, P433, DOI 10.1111/j.1744-313X.2008.00803.x; Zheng J, 2012, GENES IMMUN, V13, P641, DOI 10.1038/gene.2012.46	52	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96943	10.1371/journal.pone.0096943	http://dx.doi.org/10.1371/journal.pone.0096943			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816862	Green Submitted, gold, Green Published			2022-12-27	WOS:000336838000083
J	Chaikind, B; Ostermeier, M				Chaikind, Brian; Ostermeier, Marc			Directed Evolution of Improved Zinc Finger Methyltransferases	PLOS ONE			English	Article							CONTROLLING GENE-EXPRESSION; TARGETED DNA METHYLATION; CYTOSINE METHYLATION; RECOGNITION SPECIFICITY; TRANSCRIPTION FACTORS; PROTEIN; COMPLEMENTATION; SEQUENCES; SELECTION; AFFINITY	The ability to target DNA methylation toward a single, user-designated CpG site in vivo may have wide applicability for basic biological and biomedical research. A tool for targeting methylation toward single sites could be used to study the effects of individual methylation events on transcription, protein recruitment to DNA, and the dynamics of such epigenetic alterations. Although various tools for directing methylation to promoters exist, none offers the ability to localize methylation solely to a single CpG site. In our ongoing research to create such a tool, we have pursued a strategy employing artificially bifurcated DNA methyltransferases; each methyltransferase fragment is fused to zinc finger proteins with affinity for sequences flanking a targeted CpG site for methylation. We sought to improve the targeting of these enzymes by reducing the methyltransferase activity at non-targeted sites while maintaining high levels of activity at a targeted site. Here we demonstrate an in vitro directed evolution selection strategy to improve methyltransferase specificity and use it to optimize an engineered zinc finger methyltransferase derived from M. SssI. The unusual restriction enzyme McrBC is a key component of this strategy and is used to select against methyltransferases that methylate multiple sites on a plasmid. This strategy allowed us to quickly identify mutants with high levels of methylation at the target site (up to similar to 80%) and nearly unobservable levels of methylation at a off-target sites (<1%), as assessed in E. coli. We also demonstrate that replacing the zinc finger domains with new zinc fingers redirects the methylation to a new target CpG site flanked by the corresponding zinc finger binding sequences.	[Chaikind, Brian] Johns Hopkins Univ, Chem Biol Interface Grad Program, Baltimore, MD USA; [Ostermeier, Marc] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Ostermeier, M (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.	oster@jhu.edu	Ostermeier, Marc/A-2697-2010	Ostermeier, Marc/0000-0003-0900-3665	National Institute of General Medicine at the National Institutes of Health [R01 GM066972]; Chemistry-Biology Interface program training grant from the National Institute of General Medical Sciences at the National Institutes of Health [T32 GM080189]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066972, T32GM080189] Funding Source: NIH RePORTER	National Institute of General Medicine at the National Institutes of Health; Chemistry-Biology Interface program training grant from the National Institute of General Medical Sciences at the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by funding from the National Institute of General Medicine at the National Institutes of Health [R01 GM066972 to M.O.]. Brian Chaikind was supported in part by the Chemistry-Biology Interface program training grant from the National Institute of General Medical Sciences at the National Institutes of Health [T32 GM080189]. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beerli RR, 1998, P NATL ACAD SCI USA, V95, P14628, DOI 10.1073/pnas.95.25.14628; Bergman Y, 2013, NAT STRUCT MOL BIOL, V20, P274, DOI 10.1038/nsmb.2518; Blancafort P, 2003, NAT BIOTECHNOL, V21, P269, DOI 10.1038/nbt794; Carvin CD, 2003, NUCLEIC ACIDS RES, V31, P6493, DOI 10.1093/nar/gkg853; Carvin CD, 2003, P NATL ACAD SCI USA, V100, P7743, DOI 10.1073/pnas.1332672100; Chahar S, 2010, J MOL BIOL, V395, P79, DOI 10.1016/j.jmb.2009.09.027; Chaikind B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044852; Chen H, 2014, NUCLEIC ACIDS RES, V42, P1563, DOI 10.1093/nar/gkt1019; Choe W, 2005, BIOCHEM BIOPH RES CO, V334, P1233, DOI 10.1016/j.bbrc.2005.07.017; Cohen HM, 2004, PROTEIN ENG DES SEL, V17, P3, DOI 10.1093/protein/gzh001; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Darii MV, 2007, MOL BIOL+, V41, P110, DOI 10.1134/S0026893307010153; Darii MV, 2009, BBA-PROTEINS PROTEOM, V1794, P1654, DOI 10.1016/j.bbapap.2009.07.016; de Groote ML, 2014, INT J CANCER, V134, P280, DOI 10.1002/ijc.28375; de Groote ML, 2012, NUCLEIC ACIDS RES, V40, P10596, DOI 10.1093/nar/gks863; Dryden DTF, 2001, NUCLEIC ACIDS RES, V29, P3728, DOI 10.1093/nar/29.18.3728; Firnberg E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052031; Gerasimaite R, 2009, NUCLEIC ACIDS RES, V37, P7332, DOI 10.1093/nar/gkp772; Horsthemke B, 2008, ADV GENET, V61, P225, DOI 10.1016/S0065-2660(07)00008-9; Jolly CJ, 2001, IMMUNOL CELL BIOL, V79, P18, DOI 10.1046/j.1440-1711.2001.00968.x; Koudan EV, 2004, J BIOMOL STRUCT DYN, V22, P339, DOI 10.1080/07391102.2004.10507005; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; LEE KF, 1995, NUCLEIC ACIDS RES, V23, P103, DOI 10.1093/nar/23.1.103; Li FY, 2007, NUCLEIC ACIDS RES, V35, P100, DOI 10.1093/nar/gkl1035; Lukinavicius G, 2012, NUCLEIC ACIDS RES, V40, P11594, DOI 10.1093/nar/gks914; Magnenat L, 2004, J MOL BIOL, V341, P635, DOI 10.1016/j.jmb.2004.06.030; Mandell JG, 2006, NUCLEIC ACIDS RES, V34, pW516, DOI 10.1093/nar/gkl209; McNamara AR, 2002, NUCLEIC ACIDS RES, V30, P3818, DOI 10.1093/nar/gkf501; Meister GE, 2008, BIOCHEM BIOPH RES CO, V377, P226, DOI 10.1016/j.bbrc.2008.09.099; Meister GE, 2010, NUCLEIC ACIDS RES, V38, P1749, DOI 10.1093/nar/gkp1126; Nomura W, 2007, J AM CHEM SOC, V129, P8676, DOI 10.1021/ja0705588; POSFAI G, 1991, NUCLEIC ACIDS RES, V19, P4843, DOI 10.1093/nar/19.18.4843; RENBAUM P, 1990, NUCLEIC ACIDS RES, V18, P1145, DOI 10.1093/nar/18.5.1145; RENBAUM P, 1992, FEBS LETT, V313, P243, DOI 10.1016/0014-5793(92)81201-V; Renda M, 2007, J BIOL CHEM, V282, P33336, DOI 10.1074/jbc.M706213200; Rivenbark AG, 2012, EPIGENETICS-US, V7, P350, DOI 10.4161/epi.19507; Rockah-Shmuel L, 2012, NUCLEIC ACIDS RES, V40, P11627, DOI 10.1093/nar/gks944; Sambrook J., 2001, MOL CLONING LAB MANU; Sambrook J, 2001, MOL CLONING LAB MANU, pA15; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Segal DJ, 1999, P NATL ACAD SCI USA, V96, P2758, DOI 10.1073/pnas.96.6.2758; Siddique A, 2013, J MOL BIOL, V425, P479, DOI 10.1016/j.jmb.2012.11.038; Slaska-Kiss K, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-17; Smith AE, 2007, NUCLEIC ACIDS RES, V35, P740, DOI 10.1093/nar/gkl1053; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Stewart FJ, 1998, BIOL CHEM, V379, P611; SUTHERLAND E, 1992, J MOL BIOL, V225, P327, DOI 10.1016/0022-2836(92)90925-A; Timar E, 2004, NUCLEIC ACIDS RES, V32, P3898, DOI 10.1093/nar/gkh724; van der Gun BTF, 2010, BIOCONJUGATE CHEM, V21, P1239, DOI 10.1021/bc1000388; Wicki R, 1997, CELL CALCIUM, V22, P243, DOI 10.1016/S0143-4160(97)90063-4; Xu GL, 1997, NAT GENET, V17, P376, DOI 10.1038/ng1297-376; Zhang X, 2010, PROSTATE, V70, P765, DOI 10.1002/pros.21109	53	21	22	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96931	10.1371/journal.pone.0096931	http://dx.doi.org/10.1371/journal.pone.0096931			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810747	Green Published, Green Submitted, gold			2022-12-27	WOS:000338213300095
J	Clement, O; Garcia, SV; Libourel, PA; Arthaud, S; Fort, P; Luppi, PH				Clement, Olivier; Garcia, Sara Valencia; Libourel, Paul-Antoine; Arthaud, Sebastien; Fort, Patrice; Luppi, Pierre-Herve			The Inhibition of the Dorsal Paragigantocellular Reticular Nucleus Induces Waking and the Activation of All Adrenergic and Noradrenergic Neurons: A Combined Pharmacological and Functional Neuroanatomical Study	PLOS ONE			English	Article							C-FOS EXPRESSION; PARADOXICAL REM SLEEP; DOPAMINE-BETA-HYDROXYLASE; LOCUS COERULEUS NEURONS; STEM GABAERGIC NEURONS; EYE-MOVEMENT SLEEP; RAT BRAIN-STEM; AFFERENT-PROJECTIONS; PERIAQUEDUCTAL GRAY; MEDULLA-OBLONGATA	GABAergic neurons specifically active during paradoxical sleep (PS) localized in the dorsal paragigantocellular reticular nucleus (DPGi) are known to be responsible for the cessation of activity of the noradrenergic neurons of the locus coeruleus during PS. In the present study, we therefore sought to determine the role of the DPGi in PS onset and maintenance and in the inhibition of the LC noradrenergic neurons during this state. The effect of the inactivation of DPGi neurons on the sleep-waking cycle was examined in rats by microinjection of muscimol, a GABA(A) agonist, or clonidine, an alpha-2 adrenergic receptor agonist. Combining immunostaining of the different populations of wake-inducing neurons with that of c-FOS, we then determined whether muscimol inhibition of the DPGi specifically induces the activation of the noradrenergic neurons of the LC. Slow wave sleep and PS were abolished during 3 and 5 h after muscimol injection in the DPGi, respectively. The application of clonidine in the DPGi specifically induced a significant decrease in PS quantities and delayed PS appearance compared to NaCl. We further surprisingly found out that more than 75% of the noradrenergic and adrenergic neurons of all adrenergic and noradrenergic cell groups are activated after muscimol treatment in contrast to the other wake active systems significantly less activated. These results suggest that, in addition to its already know inhibition of LC noradrenergic neurons during PS, the DPGi might inhibit the activity of noradrenergic and adrenergic neurons from all groups during PS, but also to a minor extent during SWS and waking.	[Clement, Olivier; Garcia, Sara Valencia; Libourel, Paul-Antoine; Arthaud, Sebastien; Fort, Patrice; Luppi, Pierre-Herve] INSERM, U1028, F-69008 Lyon, France; [Clement, Olivier; Garcia, Sara Valencia; Libourel, Paul-Antoine; Arthaud, Sebastien; Fort, Patrice; Luppi, Pierre-Herve] CNRS, UMR5292, Lyon, France; [Clement, Olivier; Garcia, Sara Valencia; Libourel, Paul-Antoine; Arthaud, Sebastien; Fort, Patrice; Luppi, Pierre-Herve] Lyon Neurosci Res Ctr, Team SLEEP, Lyon, France; [Clement, Olivier; Garcia, Sara Valencia; Libourel, Paul-Antoine; Arthaud, Sebastien; Fort, Patrice; Luppi, Pierre-Herve] Univ Lyon 1, F-69365 Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Luppi, PH (corresponding author), INSERM, U1028, F-69008 Lyon, France.	luppi@sommeil.univ-lyon1.fr	Luppi, Pierre-Hervé/C-4333-2014; FORT, Patrice/G-6851-2017	Luppi, Pierre-Hervé/0000-0002-0503-423X; FORT, Patrice/0000-0003-1211-8631; Clement, Olivier/0000-0002-6890-671X; Clement, Olivier/0000-0002-7193-8931; Libourel, Paul-Antoine/0000-0001-6726-5829; Arthaud, Sebastien/0000-0001-7271-5468	INSERM; CNRS; University Claude Bernard Lyon 1; French ministry of research	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); University Claude Bernard Lyon 1; French ministry of research(Ministry of Research, FranceEuropean Commission)	This work was supported by INSERM, CNRS, University Claude Bernard Lyon 1 and the French ministry of research. O. Clement received a grant from the French ministry of research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASTONJONES G, 1981, J NEUROSCI, V1, P887; ASTONJONES G, 1981, J NEUROSCI, V1, P876; Baldo BA, 2003, J COMP NEUROL, V464, P220, DOI 10.1002/cne.10783; Bayer L, 2005, NEUROSCIENCE, V130, P807, DOI 10.1016/j.neuroscience.2004.10.032; Boissard R, 2002, EUR J NEUROSCI, V16, P1959, DOI 10.1046/j.1460-9568.2002.02257.x; Clement O, 2012, J NEUROSCI, V32, P16763, DOI 10.1523/JNEUROSCI.1885-12.2012; Clement O, 2011, SLEEP, V34, P419, DOI 10.1093/sleep/34.4.419; Corcoran KA, 2004, LEARN MEMORY, V11, P598, DOI 10.1101/lm.78704; Deurveilher S, 2006, J COMP NEUROL, V498, P667, DOI 10.1002/cne.21084; ENNIS M, 1989, J NEUROSCI, V9, P2973; ERICKSON JT, 1994, J COMP NEUROL, V348, P161, DOI 10.1002/cne.903480202; ERICSON H, 1991, J COMP NEUROL, V311, P45, DOI 10.1002/cne.903110105; Estabrooke IV, 2001, J NEUROSCI, V21, P1656, DOI 10.1523/JNEUROSCI.21-05-01656.2001; Fenik V, 2002, J APPL PHYSIOL, V93, P1448, DOI 10.1152/japplphysiol.00225.2002; Fort P, 2009, EUR J NEUROSCI, V29, P1741, DOI 10.1111/j.1460-9568.2009.06722.x; Gallopin T, 2000, NATURE, V404, P992, DOI 10.1038/35010109; Gervasoni D, 1998, EUR J NEUROSCI, V10, P964, DOI 10.1046/j.1460-9568.1998.00106.x; Gervasoni D, 2004, J NEUROSCI, V24, P11137, DOI 10.1523/JNEUROSCI.3524-04.2004; Gervasoni D, 2000, J NEUROSCI, V20, P4217; GLAVIN GB, 1985, NEUROSCI BIOBEHAV R, V9, P233, DOI 10.1016/0149-7634(85)90048-X; Goutagny R, 2008, NEUROSCIENCE, V152, P849, DOI 10.1016/j.neuroscience.2007.12.014; Greco MA, 2000, NEUROREPORT, V11, P437, DOI 10.1097/00001756-200002280-00002; Han F, 2003, WORLD J GASTROENTERO, V9, P1045; Haxhiu MA, 1996, RESP PHYSIOL, V105, P35, DOI 10.1016/0034-5687(96)00034-5; Hsieh KC, 2011, NEUROSCIENCE, V188, P55, DOI 10.1016/j.neuroscience.2011.05.016; Jones BE, 2005, TRENDS PHARMACOL SCI, V26, P578, DOI 10.1016/j.tips.2005.09.009; KALIA M, 1985, J COMP NEUROL, V233, P333, DOI 10.1002/cne.902330304; Kaur S, 2001, SYNAPSE, V42, P141, DOI 10.1002/syn.1109; Ko EM, 2003, BRAIN RES, V992, P220, DOI 10.1016/j.brainres.2003.08.044; Kovacs KJ, 2008, J NEUROENDOCRINOL, V20, P665, DOI 10.1111/j.1365-2826.2008.01734.x; Lee HS, 2005, J COMP NEUROL, V481, P179, DOI 10.1002/cne.20365; Leger L, 1998, HISTOCHEM CELL BIOL, V110, P517, DOI 10.1007/s004180050313; Leger L, 2010, J CHEM NEUROANAT, V39, P262, DOI 10.1016/j.jchemneu.2010.03.001; Leger L, 2009, J CHEM NEUROANAT, V37, P149, DOI 10.1016/j.jchemneu.2008.12.008; Lu J, 2006, J NEUROSCI, V26, P193, DOI 10.1523/JNEUROSCI.2244-05.2006; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; LUPPI PH, 1995, NEUROSCIENCE, V65, P119, DOI 10.1016/0306-4522(94)00481-J; Luppi PH, 2011, SLEEP MED REV, V15, P153, DOI 10.1016/j.smrv.2010.08.002; Maloney KJ, 1999, J NEUROSCI, V19, P3057; Maloney KJ, 2000, J NEUROSCI, V20, P4669, DOI 10.1523/JNEUROSCI.20-12-04669.2000; McKenna JT, 2009, BRAIN RES BULL, V80, P382, DOI 10.1016/j.brainresbull.2009.08.015; Modirrousta M, 2005, EUR J NEUROSCI, V21, P2807, DOI 10.1111/j.1460-9568.2005.04104.x; Morales FR, 2006, NEUROSCIENCE, V142, P37, DOI 10.1016/j.neuroscience.2006.05.066; MORGAN JI, 1986, NATURE, V322, P552, DOI 10.1038/322552a0; Nitz D, 1997, NEUROSCIENCE, V78, P795, DOI 10.1016/S0306-4522(96)00549-0; OHTAKE T, 1992, NEUROSCI RES, V14, P96, DOI 10.1016/0168-0102(92)90086-R; Rioja J, 2006, NEUROSCI LETT, V397, P190, DOI 10.1016/j.neulet.2005.12.021; Samson HH, 2001, PHYSIOL BEHAV, V74, P581, DOI 10.1016/S0031-9384(01)00607-2; Sanford LD, 2002, BRAIN RES, V956, P276, DOI 10.1016/S0006-8993(02)03552-7; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Sapin E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004272; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; Sirieix C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028724; Stevens DR, 2004, NEUROPHARMACOLOGY, V46, P1018, DOI 10.1016/j.neuropharm.2004.01.004; SWANSON LW, 1975, J COMP NEUROL, V163, P467, DOI 10.1002/cne.901630406; Tavares A, 1996, HYPERTENSION, V27, P449, DOI 10.1161/01.HYP.27.3.449; Uschakov A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016672; Verret L, 2006, J COMP NEUROL, V495, P573, DOI 10.1002/cne.20891; Verret L, 2005, EUR J NEUROSCI, V21, P2488, DOI 10.1111/j.1460-9568.2005.04060.x; Wang R, 1996, NEUROSCIENCE, V74, P199, DOI 10.1016/0306-4522(96)00116-9; Wong DL, 2007, STRESS, V10, P121, DOI 10.1080/10253890701393529; Zhao P, 2012, NEUROSCIENCE, V207, P218, DOI 10.1016/j.neuroscience.2012.01.022	62	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96851	10.1371/journal.pone.0096851	http://dx.doi.org/10.1371/journal.pone.0096851			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24811249	Green Published, Green Submitted, gold			2022-12-27	WOS:000338213300080
J	Jia, BX; Li, YQ; Wang, DC; Duan, R				Jia, Baoxiu; Li, Yuqin; Wang, Decai; Duan, Rui			Study on the Interaction of beta-Cyclodextrin and Berberine Hydrochloride and Its Analytical Application	PLOS ONE			English	Article								The fluorescence enhancement of berberine hydrochloride (BBH) as a result of complex with beta-cyclodextrin (beta-CD) is investigated. The mechanism of the inclusion was studied and discussed by spectrofluoremetry and infrared spectrograms. The results showed that a 1: 1 (beta-CD: BBH) complex was formed with an apparent association constant of 4.23x10(2) L/mol. Based on the enhancement of the fluorescent intensity of berberine hydrochloride, a new spectrofluorimetric method for the determination of BBH in the presence of beta-CD was developed. The linear range was 1.00 similar to 4.00 mu g/mL with the detection limit of 5.54 ng/mL. The proposed method was successfully applied to the determination of BBH in tablets.	[Jia, Baoxiu; Li, Yuqin; Wang, Decai; Duan, Rui] Taishan Med Univ, Coll Pharmaceut, Tai An, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences	Jia, BX (corresponding author), Taishan Med Univ, Coll Pharmaceut, Tai An, Shandong, Peoples R China.	bxjia@tsmc.edu.cn			Program for Natural Science Foundation of Shandong Province in China [ZR2013HL061]; High Level Project Development Scheme of Taishan Medical University [2013GCC05]	Program for Natural Science Foundation of Shandong Province in China(Natural Science Foundation of Shandong Province); High Level Project Development Scheme of Taishan Medical University	This work was supported by Program for Natural Science Foundation of Shandong Province in China (ZR2013HL061) and High Level Project Development Scheme of Taishan Medical University (No. 2013GCC05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodiwala HS, 2011, EUR J MED CHEM, V46, P1045, DOI 10.1016/j.ejmech.2011.01.016; Cao M, 2010, SPECTROCHIM ACTA A, V75, P1043, DOI 10.1016/j.saa.2009.12.050; Dong N, 2011, TALANTA, V84, P684, DOI 10.1016/j.talanta.2011.01.071; Hua WY, 2007, J PHARMACEUT BIOMED, V44, P931, DOI 10.1016/j.jpba.2007.03.022; Irving H.M.N.H., 1981, IUPAC COMPENDIUM ANA; Yi L, 2006, J CHROMATOGR B, V838, P50, DOI 10.1016/j.jchromb.2006.04.015; Ling J, 2008, J PHARMACEUT BIOMED, V47, P860, DOI 10.1016/j.jpba.2008.04.016; Liu F, 2007, TALANTA, V74, P140, DOI 10.1016/j.talanta.2007.05.048; Liu SP, 2006, ANAL CHIM ACTA, V572, P283, DOI 10.1016/j.aca.2006.05.058; Nevado JJB, 2001, TALANTA, V53, P951, DOI 10.1016/S0039-9140(00)00580-4; Samosorn S, 2009, BIOORGAN MED CHEM, V17, P3866, DOI 10.1016/j.bmc.2009.04.028; Shan WJ, 2011, EUR J MED CHEM, V46, P5885, DOI 10.1016/j.ejmech.2011.09.051; Szente L, 1996, COMPREHENSIVE SUPRAM, P253	13	14	15	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e95498	10.1371/journal.pone.0095498	http://dx.doi.org/10.1371/journal.pone.0095498			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810601	gold, Green Published, Green Submitted			2022-12-27	WOS:000338213300013
J	Subramani, R; Lopez-Valdez, R; Arumugam, A; Nandy, S; Boopalan, T; Lakshmanaswamy, R				Subramani, Ramadevi; Lopez-Valdez, Rebecca; Arumugam, Arunkumar; Nandy, Sushmita; Boopalan, Thiyagarajan; Lakshmanaswamy, Rajkumar			Targeting Insulin-Like Growth Factor 1 Receptor Inhibits Pancreatic Cancer Growth and Metastasis	PLOS ONE			English	Article							FACTOR-I RECEPTOR; CELL LUNG-CANCER; METABOLIC SYNDROME; SIGNALING PATHWAY; IGF-1 RECEPTOR; MESSENGER-RNA; EXPRESSION; AKT; PROLIFERATION; PROGRESSION	Pancreatic cancer is one of the most lethal cancers. Increasing incidence and mortality indicates that there is still much lacking in detection and management of the disease. This is partly due to a lack of specific symptoms during early stages of the disease. Several growth factor receptors have been associated with pancreatic cancer. Here, we have investigated if an RNA interference approach targeted to IGF-IR could be effective and efficient against pancreatic cancer growth and metastasis. For that, we evaluated the effects of IGF-1R inhibition using small interfering RNA (siRNAs) on tumor growth and metastasis in HPAC and PANC-1 pancreatic cancer cell lines. We found that silencing IGF-1R inhibits pancreatic cancer growth and metastasis by blocking key signaling pathways such AKT/PI3K, MAPK, JAK/STAT and EMT. Silencing IGF-1R resulted in an anti-proliferative effect in PANC-1 and HPAC pancreatic cancer cell lines. Matrigel invasion, transwell migration and wound healing assays also revealed a role for IGF-1R in metastatic properties of pancreatic cancer. These results were further confirmed using Western blotting analysis of key intermediates involved in proliferation, epithelial mesenchymal transition, migration, and invasion. In addition, soft agar assays showed that silencing IGF-1R also blocks the colony forming capabilities of pancreatic cancer cells in vitro. Western blots, as well as, flow cytometric analysis revealed the induction of apoptosis in IGF-1R silenced cells. Interestingly, silencing IGF-1R also suppressed the expression of insulin receptor beta. All these effects together significantly control pancreatic cancer cell growth and metastasis. To conclude, our results demonstrate the significance of IGF-1R in pancreatic cancer.	[Subramani, Ramadevi; Lopez-Valdez, Rebecca; Arumugam, Arunkumar; Nandy, Sushmita; Boopalan, Thiyagarajan; Lakshmanaswamy, Rajkumar] Texas Tech Univ, Hlth Sci Ctr, Paul L Foster Sch Med, Ctr Excellence Canc Res,Dept Biomed Sci MSB1, El Paso, TX 79905 USA	Texas Tech University System; Texas Tech University	Lakshmanaswamy, R (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Paul L Foster Sch Med, Ctr Excellence Canc Res,Dept Biomed Sci MSB1, El Paso, TX 79905 USA.	rajkumar.lakshmanaswamy@ttuhsc.edu			Texas Tech University Health Sciences Center Paul L. Foster School of Medicine funds	Texas Tech University Health Sciences Center Paul L. Foster School of Medicine funds	The study was supported by Texas Tech University Health Sciences Center Paul L. Foster School of Medicine funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	All-Ericsson C, 2002, INVEST OPHTH VIS SCI, V43, P1; Ashour AA, 2013, APOPTOSIS INT J PROG; Bahr C, 2005, GROWTH FACTORS, V23, P1, DOI 10.1080/08977190400020229; Braun S, 2011, INT J BIOL SCI, V7, P1003, DOI 10.7150/ijbs.7.1003; Cardillo TM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-170; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chan JM, 2002, J NATL CANCER I, V94, P1099; Chaves J, 2011, ANTI-CANCER DRUG, V22, P206, DOI 10.1097/CAD.0b013e32834258a1; Chen HX, 2013, CHIN J CANCER, V32, P242, DOI 10.5732/cjc.012.10263; Chen XF, 2001, ONCOGENE, V20, P6073, DOI 10.1038/sj.onc.1204736; Cheng H, 2012, EXP THER MED, V4, P181, DOI 10.3892/etm.2012.585; Costello L.C., 2013, PANCREATIC DISORD S4, V4; Delafontaine P, 2004, ARTERIOSCL THROM VAS, V24, P435, DOI 10.1161/01.ATV.0000105902.89459.09; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Fang YT, 2013, MED SCI MONITOR, V19, P916, DOI 10.12659/MSM.889636; Galet C, 2013, INT J MOL SCI, V14, P13782, DOI 10.3390/ijms140713782; Garcia-Carracedo D, 2013, CLIN CANC RES OFFICI; Cao H, 2013, ANTICANCER RES, V33, P1785; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kamrava M, 2011, AGEING RES REV, V10, P62, DOI 10.1016/j.arr.2009.10.007; Kandasamy K, 2002, CANCER RES, V62, P4929; Kaufmann SH, 2001, TRENDS CELL BIOL, V11, P526, DOI 10.1016/S0962-8924(01)02173-0; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Khan S, 2013, CYTOKINE GROWTH FACT; Kim WY, 2012, CANCER-AM CANCER SOC, V118, P3993, DOI 10.1002/cncr.26656; Leiphrakpam PD, 2013, ONCOLOGY REPORTS; Longati P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-95; Ma J, 1999, J NATL CANCER I, V91, P620, DOI 10.1093/jnci/91.7.620; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Morrione A, 1997, P NATL ACAD SCI USA, V94, P3777, DOI 10.1073/pnas.94.8.3777; Mughal TI, 2013, LEUKEMIA LYMPHOMA; Nair PN, 2001, ONCOGENE, V20, P8203, DOI 10.1038/sj.onc.1205044; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Philip B, 2013, GASTROENTEROLOGY, V145, P1449, DOI 10.1053/j.gastro.2013.08.018; Pothiwala P, 2009, METAB SYNDR RELAT D, V7, P279, DOI 10.1089/met.2008.0065; Qin B, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2644; Roy SK, 2010, J MOL SIGNALING, V5; Scagliotti GV, 2012, CANCER TREAT REV, V38, P292, DOI 10.1016/j.ctrv.2011.07.008; Silvestris N, 2013, CURRENT MED CHEM; St-Germain ME, 2004, INT J ONCOL, V24, P1311; Subbaramaiah K, 2011, CANCER PREV RES, V4, P329, DOI 10.1158/1940-6207.CAPR-10-0381; Tamburrino A, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00056; Tang J, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-71; Tomizawa M, 2010, WORLD J GASTROENTERO, V16, P1854, DOI 10.3748/wjg.v16.i15.1854; Vazquez-Martin A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02560; Yamada S, 2013, SURGERY, V154, P946, DOI 10.1016/j.surg.2013.05.004; Yao Z, 2002, PANCREAS, V24, P42, DOI 10.1097/00006676-200201000-00006; Zumsteg A, 2012, MOL CANCER RES, V10, P800, DOI 10.1158/1541-7786.MCR-11-0522	48	68	72	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e97016	10.1371/journal.pone.0097016	http://dx.doi.org/10.1371/journal.pone.0097016			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809702	gold, Green Published, Green Submitted			2022-12-27	WOS:000338213300106
J	Niu, C; Zhang, M; Min, ZG; Rana, N; Zhang, QL; Liu, X; Li, M; Lin, P				Niu, Chen; Zhang, Ming; Min, Zhigang; Rana, Netra; Zhang, Qiuli; Liu, Xin; Li, Min; Lin, Pan			Motor Network Plasticity and Low-Frequency Oscillations Abnormalities in Patients with Brain Gliomas: A Functional MRI Study	PLOS ONE			English	Article							BOLD SIGNAL FLUCTUATIONS; ALZHEIMERS-DISEASE; DEFAULT-MODE; CONNECTIVITY; LANGUAGE; FMRI; REORGANIZATION; AMPLITUDE; SURGERY; CORTEX	Brain plasticity is often associated with the process of slow-growing tumor formation, which remodels neural organization and optimizes brain network function. In this study, we aimed to investigate whether motor function plasticity would display deficits in patients with slow-growing brain tumors located in or near motor areas, but who were without motor neurological deficits. We used resting-state functional magnetic resonance imaging to probe motor networks in 15 patients with histopathologically confirmed brain gliomas and 15 age-matched healthy controls. All subjects performed a motor task to help identify individual motor activity in the bilateral primary motor cortex (PMC) and supplementary motor area (SMA). Frequency-based analysis at three different frequencies was then used to investigate possible alterations in the power spectral density (PSD) of low-frequency oscillations. For each group, the average PSD was determined for each brain region and a nonparametric test was performed to determine the difference in power between the two groups. Significantly reduced inter-hemispheric functional connectivity between the left and right PMC was observed in patients compared with controls (P < 0.05). We also found significantly decreased PSD in patients compared to that in controls, in all three frequency bands (low: 0.01-0.02 Hz; middle: 0.02-0.06 Hz; and high: 0.06-0.1 Hz), at three key motor regions. These findings suggest that in asymptomatic patients with brain tumors located in eloquent regions, inter-hemispheric connection may be more vulnerable. A comparison of the two approaches indicated that power spectral analysis is more sensitive than functional connectivity analysis for identifying the neurological abnormalities underlying motor function plasticity induced by slow-growing tumors.	[Niu, Chen; Zhang, Ming; Min, Zhigang; Rana, Netra; Zhang, Qiuli; Li, Min] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Med Imaging, Xian 710049, Shaanxi Provinc, Peoples R China; [Liu, Xin; Lin, Pan] Xi An Jiao Tong Univ, Inst Biomed Engn, Xian 710049, Shaanxi Provinc, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Zhang, M (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Med Imaging, Xian 710049, Shaanxi Provinc, Peoples R China.	profzmmri@gmail.com; linpan@mail.xjtu.edu.cn	zhang, qiu/GXG-5600-2022		National Natural Science Foundation of China [81171318, 31271061]; Doctoral Fund of Ministry of Education of China [20120201120071]; Fundamental Research Funds for the Central Universities of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This study was supported by the National Natural Science Foundation of China (Projects No. 81171318 and No. 31271061), the Doctoral Fund of Ministry of Education of China (20120201120071), and the Fundamental Research Funds for the Central Universities of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajaj S, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00013; Baliki MN, 2011, J NEUROSCI, V31, P13981, DOI 10.1523/JNEUROSCI.1984-11.2011; Bianciardi M, 2009, MAGN RESON IMAGING, V27, P1019, DOI 10.1016/j.mri.2009.02.004; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bokde ALW, 2006, BRAIN, V129, P1113, DOI 10.1093/brain/awl051; Briganti C, 2012, AM J NEURORADIOL, V33, P1983, DOI 10.3174/ajnr.A3064; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; de Jongh A, 2003, BRAIN TOPOGR, V15, P173, DOI 10.1023/A:1022658217474; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; De Pisapia N, 2012, CEREB CORTEX, V22, P639, DOI 10.1093/cercor/bhr146; Duff EP, 2008, HUM BRAIN MAPP, V29, P778, DOI 10.1002/hbm.20601; Duffau H, 2008, ADV TECH STAND NEURO, V33, P3, DOI 10.1007/978-3-211-72283-1_1; Duffau H, 2007, NEUROPHYSIOL CLIN, V37, P373, DOI 10.1016/j.neucli.2007.09.003; Duffau H, 2005, LANCET NEUROL, V4, P476, DOI 10.1016/S1474-4422(05)70140-X; Duffau H, 2003, J NEUROL NEUROSUR PS, V74, P901, DOI 10.1136/jnnp.74.7.901; Esposito R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040231; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Fukunaga M, 2008, J CEREBR BLOOD F MET, V28, P1377, DOI 10.1038/jcbfm.2008.25; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Guggisberg AG, 2008, ANN NEUROL, V63, P193, DOI 10.1002/ana.21224; Han Y, 2011, NEUROIMAGE, V55, P287, DOI 10.1016/j.neuroimage.2010.11.059; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Hertz-Pannier L, 2002, BRAIN, V125, P361, DOI 10.1093/brain/awf020; Hoptman MJ, 2010, SCHIZOPHR RES, V117, P13, DOI 10.1016/j.schres.2009.09.030; Hou BL, 2006, NEUROIMAGE, V32, P489, DOI 10.1016/j.neuroimage.2006.04.188; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Kadis DS, 2007, J INT NEUROPSYCH SOC, V13, P505, DOI 10.1017/S1355617707070397; Kamada K, 2001, J NEUROL SCI, V186, P13, DOI 10.1016/S0022-510X(01)00483-X; Kim JY, 2013, PAIN; Krings T, 2002, NEUROLOGY, V58, P381, DOI 10.1212/WNL.58.3.381; Liegeois F, 2004, BRAIN, V127, P1229, DOI 10.1093/brain/awh159; Lin P, 2011, CEREB CORTEX, V21, P821, DOI 10.1093/cercor/bhq151; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Martino J, 2009, ACTA NEUROCHIR, V151, P427, DOI 10.1007/s00701-009-0232-6; Oshino S, 2007, NEUROIMAGE, V34, P957, DOI 10.1016/j.neuroimage.2006.08.054; Otten ML, 2012, BRAIN, V135, P1017, DOI 10.1093/brain/aws041; Penttonen Markku, 2003, Thalamus & Related Systems, V2, P145, DOI 10.1016/S1472-9288(03)00007-4; Robinson S, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-137; Salvador R, 2008, NEUROIMAGE, V39, P279, DOI 10.1016/j.neuroimage.2007.08.018; Turner Katherine C, 2006, Behav Brain Funct, V2, P34, DOI 10.1186/1744-9081-2-34; Ulmer JL, 2004, NEUROSURGERY, V55, P569, DOI 10.1227/01.NEU.0000134384.94749.B2; Villalobos ME, 2005, NEUROIMAGE, V25, P916, DOI 10.1016/j.neuroimage.2004.12.022; Wu CW, 2009, NEUROIMAGE, V45, P694, DOI 10.1016/j.neuroimage.2008.12.066; Zaca D., 2013, J MAGNETIC RESONANCE; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhang JQ, 2013, BEHAV BRAIN RES, V252, P18, DOI 10.1016/j.bbr.2013.05.039; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	51	24	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96850	10.1371/journal.pone.0096850	http://dx.doi.org/10.1371/journal.pone.0096850			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806463	Green Submitted, Green Published, gold			2022-12-27	WOS:000335728900107
J	Puvenna, V; Brennan, C; Shaw, G; Yang, C; Marchi, N; Bazarian, JJ; Merchant-Borna, K; Janigro, D				Puvenna, Vikram; Brennan, Chanda; Shaw, Gerald; Yang, Cui; Marchi, Nicola; Bazarian, Jeffrey J.; Merchant-Borna, Kian; Janigro, Damir			Significance of Ubiquitin Carboxy-Terminal Hydrolase L1 Elevations in Athletes after Sub-Concussive Head Hits	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; CARBOHYDRATE-DEFICIENT TRANSFERRIN; CEREBROSPINAL-FLUID; BARRIER DISRUPTION; PERIPHERAL MARKERS; BIOMARKER; PROTEIN; S100-BETA; IMPACT; DAMAGE	The impact of sub-concussive head hits (sub-CHIs) has been recently investigated in American football players, a population at risk for varying degrees of post-traumatic sequelae. Results show how sub-CHIs in athletes translate in serum as the appearance of reporters of blood-brain barrier disruption (BBBD), how the number and severity of sub-CHIs correlate with elevations of putative markers of brain injury is unknown. Serum brain injury markers such as UCH-L1 depend on BBBD. We investigated the effects of sub-CHIs in collegiate football players on markers of BBBD, markers of cerebrospinal fluid leakage (serum beta 2-transferrin) and markers of brain damage. Emergency room patients admitted for a clinically-diagnosed mild traumatic brain injury (mTBI) were used as positive controls. Healthy volunteers were used as negative controls. Specifically this study was designed to determine the use of UCH-L1 as an aid in the diagnosis of sub-concussive head injury in athletes. The extent and intensity of head impacts and serum values of S100B, UCH-L1, and beta-2 transferrin were measured pre-and post-game from 15 college football players who did not experience a concussion after a game. S100B was elevated in players experiencing the most sub-CHIs; UCH-L1 levels were also elevated but did not correlate with S100B or sub-CHIs. Beta-2 transferrin levels remained unchanged. No correlation between UCH-L1 levels and mTBI were measured in patients. Low levels of S100B were able to rule out mTBI and high S100B levels correlated with TBI severity. UCH-L1 did not display any interpretable change in football players or in individuals with mild TBI. The significance of UCH-L1 changes in sub-concussions or mTBI needs to be further elucidated.	[Puvenna, Vikram; Brennan, Chanda; Marchi, Nicola; Janigro, Damir] Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Brennan, Chanda; Marchi, Nicola; Janigro, Damir] Cleveland Clin, Lerner Coll Med, Dept Neurosurg, Cleveland, OH 44106 USA; [Puvenna, Vikram; Brennan, Chanda; Marchi, Nicola; Janigro, Damir] Cleveland Clin, Lerner Coll Med, Dept Mol Med, Cleveland, OH 44106 USA; [Brennan, Chanda; Janigro, Damir] Cleveland State Univ, Dept Clin Bioanalyt Chem, Cleveland, OH 44115 USA; [Bazarian, Jeffrey J.; Merchant-Borna, Kian] Univ Rochester, Med Ctr, Dept Emergency Med, Rochester, NY 14642 USA; [Bazarian, Jeffrey J.; Merchant-Borna, Kian] Univ Rochester, Med Ctr, Dept Neurosurg, Rochester, NY 14642 USA; [Shaw, Gerald; Yang, Cui] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA	Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; University System of Ohio; Cleveland State University; University of Rochester; University of Rochester; State University System of Florida; University of Florida	Janigro, D (corresponding author), Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA.	janigrd@ccf.org	, Gerry/X-2377-2019; Marchi, Nicola/J-8607-2016	Marchi, Nicola/0000-0001-9124-0226	National Institutes of Health [R01NS078307, R01NS43284, R41MH093302, R21NS077236, R42MH093302, UH2TR000491, R21HD057256]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD057256] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH3TR000491, UH2TR000491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R41MH093302, R42MH093302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043284, R01NS078307, R21NS077236] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by: National Institutes of Health [R01NS078307, R01NS43284, R41MH093302, R21NS077236, R42MH093302, UH2TR000491, and R21HD057256 to Damir Janigro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt T, 2001, CLIN CHEM, V47, P13; Blyth BJ, 2011, J NEUROTRAUM, V28, P2453, DOI 10.1089/neu.2010.1653; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; Chan Danny T M, 2004, Asian J Surg, V27, P39, DOI 10.1016/S1015-9584(09)60242-6; Chen FJ, 2010, P NATL ACAD SCI USA, V107, P1636, DOI 10.1073/pnas.0911516107; DORAN JF, 1983, J NEUROCHEM, V40, P1542, DOI 10.1111/j.1471-4159.1983.tb08124.x; Fazio V, 2004, ANN THORAC SURG, V78, P46, DOI 10.1016/j.athoracsur.2003.11.042; Fleming M, 2004, J AM BOARD FAM PRACT, V17, P247, DOI 10.3122/jabfm.17.4.247; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Ichikawa T, 2010, BIOCHEM BIOPH RES CO, V391, P852, DOI 10.1016/j.bbrc.2009.11.151; Kanner AA, 2003, CANCER, V97, P2806, DOI 10.1002/cncr.11409; Kiechle K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084977; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liu MC, 2010, EUR J NEUROSCI, V31, P722, DOI 10.1111/j.1460-9568.2010.07097.x; Marchi N, 2004, CLIN CHIM ACTA, V342, P1, DOI 10.1016/j.cccn.2003.12.008; Marchi N, 2003, RESTOR NEUROL NEUROS, V21, P109; Marchi N, 2003, J NEUROSCI, V23, P1949; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; McGrath N, 2013, BRAIN INJURY, V27, P103, DOI 10.3109/02699052.2012.729282; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Mondello S, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-85; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; MOORE BW, 1965, BIOCHEM BIOPH RES CO, V19, P739, DOI 10.1016/0006-291X(65)90320-7; Neuwelt EA, 2011, NAT REV NEUROSCI, V12, P169, DOI 10.1038/nrn2995; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Sedaghat F, 2008, HIPPOKRATIA, V12, P198; Steiner J, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-2; Szabo Gyorgy, 2012, Orv Hetil, V153, P514, DOI 10.1556/OH.2012.29337; Warnecke A, 2004, ARCH OTOLARYNGOL, V130, P1178, DOI 10.1001/archotol.130.10.1178; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	34	53	62	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96296	10.1371/journal.pone.0096296	http://dx.doi.org/10.1371/journal.pone.0096296			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806476	Green Submitted, Green Published, gold			2022-12-27	WOS:000335728900045
J	Zhao, WD; Tian, YM; Cai, MJ; Wang, F; Wu, JZ; Gao, J; Liu, SH; Jiang, JG; Jiang, SB; Wang, HD				Zhao, Weidong; Tian, Yongmei; Cai, Mingjun; Wang, Feng; Wu, Jiazhen; Gao, Jing; Liu, Shuheng; Jiang, Junguang; Jiang, Shibo; Wang, Hongda			Studying the Nucleated Mammalian Cell Membrane by Single Molecule Approaches	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; SUPERRESOLUTION FLUORESCENCE MICROSCOPY; OPTICAL RECONSTRUCTION MICROSCOPY; FLUID MOSAIC MODEL; CRYSTAL-STRUCTURE; PLASMA-MEMBRANE; LIPID RAFTS; RECEPTOR; MICRODOMAINS; PROTEINS	The cell membrane plays a key role in compartmentalization, nutrient transportation and signal transduction, while the pattern of protein distribution at both cytoplasmic and ectoplasmic sides of the cell membrane remains elusive. Using a combination of single-molecule techniques, including atomic force microscopy (AFM), single molecule force spectroscopy (SMFS) and stochastic optical reconstruction microscopy (STORM), to study the structure of nucleated cell membranes, we found that (1) proteins at the ectoplasmic side of the cell membrane form a dense protein layer (4 nm) on top of a lipid bilayer; (2) proteins aggregate to form islands evenly dispersed at the cytoplasmic side of the cell membrane with a height of about 10-12 nm; (3) cholesterol-enriched domains exist within the cell membrane; (4) carbohydrates stay in microdomains at the ectoplasmic side; and (5) exposed amino groups are asymmetrically distributed on both sides. Based on these observations, we proposed a Protein Layer-Lipid-Protein Island (PLLPI) model, to provide a better understanding of cell membrane structure, membrane trafficking and viral fusion mechanisms.	[Zhao, Weidong; Tian, Yongmei; Cai, Mingjun; Wang, Feng; Wu, Jiazhen; Gao, Jing; Liu, Shuheng; Jiang, Junguang; Wang, Hongda] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China; [Zhao, Weidong; Tian, Yongmei; Wu, Jiazhen; Gao, Jing; Wang, Hongda] Univ Chinese Acad Sci, Beijing, Peoples R China; [Jiang, Shibo] Fudan Univ, Key Lab Med Mol Virol, Minist Educ, Shanghai 200433, Peoples R China; [Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Minist Hlth, Shanghai 200433, Peoples R China; [Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Fudan University; Fudan University; New York Blood Center	Jiang, SB (corresponding author), Fudan Univ, Key Lab Med Mol Virol, Minist Educ, Shanghai 200433, Peoples R China.	sjiang@nybloodcenter.org; hdwang@ciac.ac.cn	Jiang, Shibo/L-4500-2014	Jiang, Shibo/0000-0001-8283-7135; cai, ming jun/0000-0001-5677-5372	MOST - Ministry of Science and Technology of China [2011CB933600, 2012CB519001]; NSFC - National Natural Science Foundation of China [21373200, 31330082]; "100 Talent Program'' of CAS	MOST - Ministry of Science and Technology of China(Ministry of Science and Technology, China); NSFC - National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "100 Talent Program'' of CAS(Chinese Academy of Sciences)	This work was supported by MOST - Ministry of Science and Technology of China (Grant no. 2011CB933600 to HW, 2012CB519001 to SJ), NSFC - National Natural Science Foundation of China (Grant no. 21373200 to HW, and no. 31330082 to JJ) and the "100 Talent Program'' of CAS (to HW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai MJ, 2012, SMALL, V8, P1243, DOI 10.1002/smll.201102183; CHAPMAN D, 1975, Q REV BIOPHYS, V8, P185, DOI 10.1017/S0033583500001797; Chichili GR, 2009, CELL MOL LIFE SCI, V66, P2319, DOI 10.1007/s00018-009-0022-6; Davson H, 1936, BIOCHEM J, V30, P316, DOI 10.1042/bj0300316; Devaux PF, 2004, TRAFFIC, V5, P241, DOI 10.1111/j.1600-0854.2004.0170.x; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b; Edidin M, 2003, NAT REV MOL CELL BIO, V4, P414, DOI 10.1038/nrm1102; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Hao X, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3121; Hinterdorfer P, 2006, NAT METHODS, V3, P347, DOI 10.1038/NMETH871; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Ikezawa H, 2002, BIOL PHARM BULL, V25, P409, DOI 10.1248/bpb.25.409; JACOBSON K, 1995, SCIENCE, V268, P1441, DOI 10.1126/science.7770769; Jiang JG, 2009, NANO LETT, V9, P4489, DOI 10.1021/nl902803m; JOHNSON SJ, 1991, BIOPHYS J, V59, P289, DOI 10.1016/S0006-3495(91)82222-6; Kada G, 2008, NANO TODAY, V3, P12, DOI 10.1016/S1748-0132(08)70011-2; Leonard D, 2008, J CELL SCI, V121, P3445, DOI 10.1242/jcs.031484; Leung BO, 2011, APPL SPECTROSC, V65, P967, DOI 10.1366/11-06398; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; MOY VT, 1994, COLLOID SURFACE A, V93, P343, DOI 10.1016/0927-7757(94)02933-4; Muller DJ, 2008, NAT NANOTECHNOL, V3, P261, DOI 10.1038/nnano.2008.100; Muller DJ, 2008, BIOCHEMISTRY-US, V47, P7986, DOI 10.1021/bi800753x; Murphy SC, 2004, BLOOD, V103, P1920, DOI 10.1182/blood-2003-09-3165; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Peters LL, 1996, CELL, V86, P917, DOI 10.1016/S0092-8674(00)80167-1; Pike LJ, 2005, BBA-MOL CELL RES, V1746, P260, DOI 10.1016/j.bbamcr.2005.05.005; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Reverter D, 2004, J MOL BIOL, V338, P257, DOI 10.1016/j.jmb.2004.02.058; Rietz A, 2012, BRIT J PHARMACOL, V166, P1225, DOI 10.1111/j.1476-5381.2012.01917.x; ROBERTSON J. D., 1959, BIOCHEM SOC SYMPOSIA, V16, P3; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Sonnleitner A, 2002, P NATL ACAD SCI USA, V99, P12759, DOI 10.1073/pnas.192261499; Tian YM, 2013, RSC ADV, V3, P708, DOI 10.1039/c2ra22166g; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Vereb G, 2003, P NATL ACAD SCI USA, V100, P8053, DOI 10.1073/pnas.1332550100; Verkade P, 1997, HISTOCHEM CELL BIOL, V108, P211, DOI 10.1007/s004180050161; Wang HD, 2008, J AM CHEM SOC, V130, P8154, DOI 10.1021/ja802535p; Wang HD, 2010, ULTRAMICROSCOPY, V110, P305, DOI 10.1016/j.ultramic.2009.12.014; Wells A, 1999, INT J BIOCHEM CELL B, V31, P637, DOI 10.1016/S1357-2725(99)00015-1; Willemsen OH, 2000, BIOPHYS J, V79, P3267, DOI 10.1016/S0006-3495(00)76559-3; Wu J., 2013, CHEM RAPID COMMU, V1, P27; Wu JZ, 2013, NANOSCALE, V5, P11582, DOI 10.1039/c3nr03665k; Xu HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061596; Zhang DC, 2000, BLOOD, V96, P2925; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026; Ziegler U, 1998, FEBS LETT, V436, P179, DOI 10.1016/S0014-5793(98)01118-1	54	29	30	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e91595	10.1371/journal.pone.0091595	http://dx.doi.org/10.1371/journal.pone.0091595			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806512	gold, Green Submitted, Green Published			2022-12-27	WOS:000335728900003
J	Samarska, IV; Bouma, HR; Buikema, H; Mungroop, HE; Houwertjes, MC; Absalom, AR; Epema, AH; Henning, RH				Samarska, Iryna V.; Bouma, Hjalmar R.; Buikema, Hendrik; Mungroop, Hubert E.; Houwertjes, Martin C.; Absalom, Anthony R.; Epema, Anne H.; Henning, Robert H.			S1P(1) Receptor Modulation Preserves Vascular Function in Mesenteric and Coronary Arteries after CPB in the Rat Independent of Depletion of Lymphocytes	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; LONG-TERM SURVIVAL; SPHINGOSINE 1-PHOSPHATE RECEPTOR-1; COMPLETE RENAL ISCHEMIA; CARDIOPULMONARY BYPASS; MICROVASCULAR REACTIVITY; ENDOTHELIAL DYSFUNCTION; INFLAMMATORY RESPONSE; BARRIER ENHANCEMENT; FTY720 FINGOLIMOD	Background: Cardiopulmonary bypass (CPB) may induce systemic inflammation and vascular dysfunction. Sphingosine 1-phosphate (S1P) modulates various vascular and immune responses. Here we explored whether agonists of the S1P receptors, FTY720 and SEW2871 improve vascular reactivity after CPB in the rat. Methods: Experiments were done in male Wistar rats (total n = 127). Anesthesia was induced by isoflurane (2.5-3%) and maintained by fentanyl and midazolam during CPB. After catheterization of the left femoral artery, carotid artery and the right atrium, normothermic extracorporeal circulation was instituted for 60 minutes. In the first part of the study animals were euthanized after either 1 hour, 1 day, 2 or 5 days of the recovery period. In second part of the study animals were euthanized after 1 day of postoperative period. We evaluated the contractile response to phenylephrine (mesenteric arteries) or to serotonin (coronary artery) and vasodilatory response to acethylcholine (both arteries). Results: Contractile responses to phenylephrine were reduced at 1 day recovery after CPB and Sham as compared to healthy control animals (Emax, mN: 7.9 +/- 1.9, 6.5 +/- 1.5, and 11.3 +/- 1.3, respectively). Mainly FTY720, but not SEW2871, caused lymphopenia in both Sham and CPB groups. In coronary and mesenteric arteries, both FTY720 and SEW2871 normalized serotonin and phenylephrine-mediated vascular reactivity after CPB (p<0.05) and FTY720 increased relaxation to acetylcholine as compared with untreated rats that underwent CPB. Conclusion: Pretreatment with FTY720 or SEW2871 preserves vascular function in mesenteric and coronary artery after CPB. Therefore, pharmacological activation of S1P(1) receptors may provide a promising therapeutic intervention to prevent CPB-related vascular dysfunction in patients.	[Samarska, Iryna V.; Mungroop, Hubert E.; Houwertjes, Martin C.; Absalom, Anthony R.; Epema, Anne H.] Univ Groningen, Univ Med Ctr Groningen, Dept Anesthesiol, NL-9700 AB Groningen, Netherlands; [Bouma, Hjalmar R.; Buikema, Hendrik; Henning, Robert H.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, NL-9700 AB Groningen, Netherlands	University of Groningen; University of Groningen	Samarska, IV (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Anesthesiol, NL-9700 AB Groningen, Netherlands.	i.v.samarska@umcg.nl	Henning, Robert H/AAY-5222-2020; Samarska, Iryna/AAE-8268-2021; Bouma, Hjalmar/F-9737-2015; Absalom, Anthony/GPG-1582-2022	Bouma, Hjalmar/0000-0003-1032-321X; Samarska, Iryna/0000-0003-4092-0672; Henning, Robert/0000-0002-5135-4621; Absalom, Anthony/0000-0001-7563-9157	Ubbo Emmius bursary scholarship from Medical Faculty University of Groningen; Groningen University Institute of Drug Exploration (GUIDE); University Medical Center Groningen (UMCG)	Ubbo Emmius bursary scholarship from Medical Faculty University of Groningen; Groningen University Institute of Drug Exploration (GUIDE); University Medical Center Groningen (UMCG)	This work is funded by an Ubbo Emmius bursary scholarship from Medical Faculty University of Groningen to IVS, and a MD/PhD grant from the Groningen University Institute of Drug Exploration (GUIDE), University Medical Center Groningen (UMCG) to HRB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolakis EE, 2010, J CARDIOTHORAC SURG, V5, DOI 10.1186/1749-8090-5-1; Bouma HR, 2013, EUR J ANAESTH, V30, P492, DOI 10.1097/EJA.0b013e32835ce530; Brinkmann V, 2004, AM J TRANSPLANT, V4, P1019, DOI 10.1111/j.1600-6143.2004.00476.x; Brinkmann V, 2007, PHARMACOL THERAPEUT, V115, P84, DOI 10.1016/j.pharmthera.2007.04.006; Brinkmann V, 2009, BRIT J PHARMACOL, V158, P1173, DOI 10.1111/j.1476-5381.2009.00451.x; Camp SM, 2009, J PHARMACOL EXP THER, V331, P54, DOI 10.1124/jpet.109.153544; Delbridge MS, 2007, TRANSPLANTATION, V84, P187, DOI 10.1097/01.tp.0000269794.74990.da; Doguet F, 2004, ANN THORAC SURG, V77, P2130, DOI 10.1016/j.athoracsur.2003.10.034; Doguet F, 2012, ARTIF ORGANS, V36, P962, DOI 10.1111/j.1525-1594.2012.01492.x; Dudek SM, 2007, CELL SIGNAL, V19, P1754, DOI 10.1016/j.cellsig.2007.03.011; Egom EEA, 2010, J MOL CELL CARDIOL, V48, P406, DOI 10.1016/j.yjmcc.2009.10.009; Feng J, 2012, CIRCULATION, V126, pS73, DOI 10.1161/CIRCULATIONAHA.111.084590; Feng J, 2009, J SURG RES, V157, P123, DOI 10.1016/j.jss.2009.03.043; Fryer RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052985; Gonzalez-Diez M, 2008, THROMB HAEMOSTASIS, V100, P119, DOI 10.1160/TH07-11-0675; Graler MH, 2010, CELL PHYSIOL BIOCHEM, V26, P79, DOI 10.1159/000315108; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; Gschwend S, 2002, KIDNEY INT, V62, P181, DOI 10.1046/j.1523-1755.2002.00431.x; Guan Z, 2014, J AM SOC NEPHROL; Hasegawa Y, 2010, STROKE, V41, P368, DOI 10.1161/STROKEAHA.109.568899; Hirleman E, 2008, PERFUSION-UK, V23, P311, DOI 10.1177/0267659109105079; Hla T, 2011, NEUROLOGY, V76, pS3, DOI 10.1212/WNL.0b013e31820d5ec1; Huwiler A, 2008, BIOCHEM PHARMACOL, V75, P1893, DOI 10.1016/j.bcp.2007.12.018; Igarashi J, 2009, CARDIOVASC RES, V82, P212, DOI 10.1093/cvr/cvp064; Kaudel CP, 2007, TRANSPL P, V39, P499, DOI 10.1016/j.transproceed.2006.12.010; Kaudel CP, 2007, TRANSPL P, V39, P493, DOI 10.1016/j.transproceed.2007.01.021; Kaudel CP, 2006, TRANSPLANT P, V38, P679, DOI 10.1016/j.transproceed.2006.01.033; Khan TA, 2003, SURGERY, V134, P247, DOI 10.1067/msy.2003.229; Kienbaum P, 2008, ANAESTHESIA, V63, P121, DOI 10.1111/j.1365-2044.2007.05286.x; Kim MY, 2006, AM J PHYSIOL-CELL PH, V290, pC1000, DOI 10.1152/ajpcell.00353.2005; Le Guillou V, 2012, DIABETES VASC DIS RE, V9, P270, DOI 10.1177/1479164111434432; Lee KD, 2009, J NEUROTRAUM, V26, P2335, DOI 10.1089/neu.2008.0840; Lucke S, 2010, CELL PHYSIOL BIOCHEM, V26, P87, DOI 10.1159/000315109; Martini S, 2007, EXPERT OPIN INV DRUG, V16, P505, DOI 10.1517/13543784.16.4.505; Modine T, 2006, ANN THORAC SURG, V82, P672, DOI 10.1016/j.athoracsur.2006.03.061; Mullershausen F, 2009, NAT CHEM BIOL, V5, P428, DOI 10.1038/nchembio.173; Onorati F, 2011, INT J ARTIF ORGANS, V34, P469, DOI 10.5301/IJAO.2011.8329; Payne SG, 2007, BLOOD, V109, P1077, DOI 10.1182/blood-2006-03-011437; Rossoni LV, 2002, AM J PHYSIOL-HEART C, V283, pH2110, DOI 10.1152/ajpheart.00454.2002; Samarska IV, 2013, J PHARMACOL TOX MET, V67, P82, DOI 10.1016/j.vascn.2013.01.002; Sarai K, 2009, AM J PHYSIOL-CELL PH, V297, pC945, DOI 10.1152/ajpcell.00606.2008; Sodha NR, 2007, SURGERY, V142, P243, DOI 10.1016/j.surg.2007.03.010; Spijkers LJA, 2012, BRIT J PHARMACOL, V166, P1411, DOI 10.1111/j.1476-5381.2012.01865.x; Takuwa Y, 2008, BBA-MOL CELL BIOL L, V1781, P483, DOI 10.1016/j.bbalip.2008.04.003; Tolle M, 2005, CIRC RES, V96, P913, DOI 10.1161/01.RES.0000164321.91452.00; Waeber C, 2004, DRUG NEWS PERSPECT, V17, P365, DOI 10.1358/dnp.2004.17.6.829028; Wang L, 2011, EUR RESPIR J, V38, P78, DOI 10.1183/09031936.00047810; Xu Y, 2007, EUR J HEART FAIL, V9, P144, DOI 10.1016/j.ejheart.2006.05.003; Yatomi Y, 2006, CURR PHARM DESIGN, V12, P575, DOI 10.2174/138161206775474404; Zhang Z, 2008, EXP NEUROL, V210, P681, DOI 10.1016/j.expneurol.2007.12.025; Zhang Z, 2007, MINI-REV MED CHEM, V7, P845	51	7	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97196	10.1371/journal.pone.0097196	http://dx.doi.org/10.1371/journal.pone.0097196			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819611	Green Published, gold, Green Submitted			2022-12-27	WOS:000336653300089
J	Wang, L; Chen, L; Liu, ZH; Zheng, MH; Gu, Q; Xu, J				Wang, Ling; Chen, Lei; Liu, Zhihong; Zheng, Minghao; Gu, Qiong; Xu, Jun			Predicting mTOR Inhibitors with a Classifier Using Recursive Partitioning and Naive Bayesian Approaches	PLOS ONE			English	Article							EXTENDED-CONNECTIVITY FINGERPRINTS; MAMMALIAN TARGET; SELECTIVE INHIBITOR; ANTITUMOR-ACTIVITY; POTENT INHIBITOR; ADME EVALUATION; RAPAMYCIN; DISCOVERY; KINASE; PATHWAY	Background: Mammalian target of rapamycin (mTOR) is a central controller of cell growth, proliferation, metabolism, and angiogenesis. Thus, there is a great deal of interest in developing clinical drugs based on mTOR. In this paper, in silico models based on multi-scaffolds were developed to predict mTOR inhibitors or non-inhibitors. Methods: First 1,264 diverse compounds were collected and categorized as mTOR inhibitors and non-inhibitors. Two methods, recursive partitioning (RP) and naive Bayesian (NB), were used to build combinatorial classification models of mTOR inhibitors versus non-inhibitors using physicochemical descriptors, fingerprints, and atom center fragments (ACFs). Results: A total of 253 models were constructed and the overall predictive accuracies of the best models were more than 90% for both the training set of 964 and the external test set of 300 diverse compounds. The scaffold hopping abilities of the best models were successfully evaluated through predicting 37 new recently published mTOR inhibitors. Compared with the best RP and Bayesian models, the classifier based on ACFs and Bayesian shows comparable or slightly better in performance and scaffold hopping abilities. A web server was developed based on the ACFs and Bayesian method (http://rcdd.sysu.edu.cn/mtor/). This web server can be used to predict whether a compound is an mTOR inhibitor or non-inhibitor online. Conclusion: In silico models were constructed to predict mTOR inhibitors using recursive partitioning and naive Bayesian methods, and a web server (mTOR Predictor) was also developed based on the best model results. Compound prediction or virtual screening can be carried out through our web server. Moreover, the favorable and unfavorable fragments for mTOR inhibitors obtained from Bayesian classifiers will be helpful for lead optimization or the design of new mTOR inhibitors.	[Gu, Qiong] Sun Yat Sen Univ, Res Ctr Drug Discovery, Guangzhou 510275, Guangdong, Peoples R China; Sun Yat Sen Univ, Sch Pharmaceut Sci, Inst Human Virol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Gu, Q (corresponding author), Sun Yat Sen Univ, Res Ctr Drug Discovery, Guangzhou 510275, Guangdong, Peoples R China.	guqiong@mail.sysu.edu.cn; junxu@biochemomes.com		Zheng, Minghao/0000-0003-1185-4768; Liu, Zhihong/0000-0001-8370-2419; Gu, Qiong/0000-0001-6011-3697	National High-tech R&D Program of China (863 Program) [2012AA020307]; introduction of innovative R&D team program of Guangdong Province [2009010058]; National Natural Science Foundation of China [81173470]	National High-tech R&D Program of China (863 Program)(National High Technology Research and Development Program of China); introduction of innovative R&D team program of Guangdong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded in part of the National High-tech R&D Program of China (863 Program) (2012AA020307), the introduction of innovative R&D team program of Guangdong Province (NO. 2009010058), and the National Natural Science Foundation of China (No., 81173470). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, MOLECULES, V2, P131; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Bhagwat SV, 2011, MOL CANCER THER, V10, P1394, DOI 10.1158/1535-7163.MCT-10-1099; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Chen L, 2011, MOL PHARMACEUT, V8, P889, DOI 10.1021/mp100465q; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Estrada AA, 2013, J MED CHEM, V56, P3090, DOI 10.1021/jm400194n; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Ge H, 2013, J CHEM INF MODEL, V53, P2757, DOI 10.1021/ci400391s; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Guo YA, 2013, MOL CANCER RES, V11, P467, DOI 10.1158/1541-7786.MCR-12-0605; Jensen BF, 2007, J MED CHEM, V50, P501, DOI 10.1021/jm060333s; Khanfar MA, 2013, J MOL GRAPH MODEL, V42, P39, DOI 10.1016/j.jmgm.2013.02.009; Knight SD, 2010, ACS MED CHEM LETT, V1, P39, DOI 10.1021/ml900028r; Lee W, 2013, BIOORG MED CHEM LETT, V23, P5097, DOI 10.1016/j.bmcl.2013.07.027; Liu QS, 2011, J MED CHEM, V54, P1473, DOI 10.1021/jm101520v; Liu TQ, 2007, NUCLEIC ACIDS RES, V35, pD198, DOI 10.1093/nar/gkl999; LoRusso P, 2009, J CONTRACEPT FERTIL, V27, P3030; Lu F, 2012, BIOINFORMATION, V8, P110; McIntyre TA, 2009, XENOBIOTICA, V39, P487, DOI 10.1080/00498250902926906; Mortensen DS, 2013, BIOORG MED CHEM LETT, V23, P1588, DOI 10.1016/j.bmcl.2013.01.110; Mukherjee B, 2012, NEOPLASIA, V14, P34, DOI 10.1593/neo.111512; Prathipati P, 2008, J CHEM INF MODEL, V48, P2362, DOI 10.1021/ci800143n; Rogers D, 2005, J BIOMOL SCREEN, V10, P682, DOI 10.1177/1087057105281365; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Tanneeru K, 2012, MED CHEM RES, V21, P1207, DOI 10.1007/s00044-011-9629-x; Tanneeru K, 2012, J MOL MODEL, V18, P1611, DOI 10.1007/s00894-011-1184-3; Tian S, 2011, MOL PHARMACEUT, V8, P841, DOI 10.1021/mp100444g; Wander SA, 2011, J CLIN INVEST, V121, P1231, DOI 10.1172/JCI44145; Wang L, 2013, J CHEM INF MODEL, V53, P2409, DOI 10.1021/ci400322j; Wang ST, 2011, LETT DRUG DES DISCOV, V8, P339, DOI 10.2174/157018011794839493; Watson P, 2008, J CHEM INF MODEL, V48, P166, DOI 10.1021/ci7003253; Welker ME, 2013, BIOORGAN MED CHEM, V21, P4063, DOI 10.1016/j.bmc.2013.04.083; Xu J, 2002, J MED CHEM, V45, P5311, DOI 10.1021/jm010520k; Xu J, 2000, J CHEM INF COMP SCI, V40, P1177, DOI 10.1021/ci000026+; Yan X, 2013, J CHEM INF MODEL, V53, P1967, DOI 10.1021/ci300601q; Yan X, 2012, MOL DIVERS, V16, P759, DOI 10.1007/s11030-012-9403-0; Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122; Yuan J, 2011, MOL CANCER THER, V10, P2189, DOI 10.1158/1535-7163.MCT-11-0185; Zask A, 2011, EXPERT OPIN THER PAT, V21, P1109, DOI 10.1517/13543776.2011.584871; Zask A, 2009, J MED CHEM, V52, P5013, DOI 10.1021/jm900851f; Zhou HY, 2010, ANTI-CANCER AGENT ME, V10, P571, DOI 10.2174/187152010793498663	44	20	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e95221	10.1371/journal.pone.0095221	http://dx.doi.org/10.1371/journal.pone.0095221			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819222	gold, Green Published, Green Submitted			2022-12-27	WOS:000336653300005
J	Barros, A; Moreira, L; Santos, H; Ribeiro, N; Carvalho, L; Santos-Silva, F				Barros, Ana; Moreira, Luis; Santos, Helena; Ribeiro, Nuno; Carvalho, Luis; Santos-Silva, Filipe			"Cancer - Educate to Prevent'' - High-School Teachers, the New Promoters of Cancer Prevention Education Campaigns	PLOS ONE			English	Article								Cancer is one of the leading causes of death worldwide, and thus represents a priority for national public health programs. Prevention has been assumed as the best strategy to reduce cancer burden, however most cancer prevention programs are implemented by healthcare professionals, which constrain range and educational impacts. We developed an innovative approach for cancer prevention education focused on high-school biology teachers, considered privileged mediators in the socialization processes. A training program, "Cancer, Educate to Prevent'' was applied, so that the teachers were able to independently develop and implement prevention campaigns focused on students and school-related communities. The program encompassed different educational modules, ranging from cancer biology to prevention campaigns design. Fifty-four teachers were empowered to develop and implement their own cancer prevention campaigns in a population up to five thousands students. The success of the training program was assessed through quantitative evaluation questionnaires focused on teachers' cancer knowledge and perceptions, before the intervention (pre-test) and immediately after (post-test). The projects developed and implemented by teachers were also evaluated regarding the intervention design, educational contents and impact on the students' knowledge about cancer. This study presents and discusses the results concerning the training program "Cancer, Educate to Prevent'' and clearly shows a significant increase in teacher's cancer literacy (knowledge and perceptions) and teachers' acquired proficiency to develop and deliver cancer prevention campaigns with direct impact on students' knowledge about cancer. This pilot study reinforces the potential of high-school teachers and schools as cancer prevention promoters and opens a new perspective for the development and validation of cancer prevention education strategies, based upon focused interventions in restricted targets (students) through non-health professionals (teachers).	[Barros, Ana; Ribeiro, Nuno; Carvalho, Luis; Santos-Silva, Filipe] Univ Porto Ipatimup, Canc Inst Pathol & Mol Immunol, Publ Awareness Canc Unit, Oporto, Portugal; [Barros, Ana] Univ Porto FCUP, Fac Sci, Oporto, Portugal; [Moreira, Luis] Piaget Inst, Hlth Sch Vila Nova de Gaia, Dept Res Methodol & Data Anal, Vila Nova De Gaia, Portugal; [Santos, Helena] Univ Porto FEP, Fac Econ, Autonomous Sect Social Sci, Oporto, Portugal; [Santos-Silva, Filipe] Univ Porto FMUP, Fac Med, Dept Pathol & Oncol, Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto	Santos-Silva, F (corresponding author), Univ Porto Ipatimup, Canc Inst Pathol & Mol Immunol, Publ Awareness Canc Unit, Oporto, Portugal.	fsilva@ipatimup.pt	Ribeiro, Nuno/T-1154-2019; Barros, Ana/AAX-2696-2020; Santos-Silva, Filipe/J-4535-2013; Moreira, Luís Miguel/AAD-9685-2022	Ribeiro, Nuno/0000-0002-5829-7367; Barros, Ana/0000-0001-9935-1246; Santos-Silva, Filipe/0000-0001-7143-1025; Moreira, Luís Miguel/0000-0002-8426-6871	Portuguese High Commissioner for Health [010-98]	Portuguese High Commissioner for Health	This study was supported by Portuguese High Commissioner for Health - grant ref# 010-98. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; Chang S, 2009, CANCER EPIDEM BIOMAR, V18, P2348, DOI 10.1158/1055-9965.EPI-09-0664; Colditz GA, 2012, ANNU REV PUBL HEALTH, V33, P137, DOI 10.1146/annurev-publhealth-031811-124627; Direcao-Geral de Estatisticas da Educacao e Ciencia Ed, 2012, PERF DOC 2010 2011 B; Do CL, 2006, FONCTIONNEMENT DISPO; Gouveia J, 2008, EUR J CANCER, V44, P1457, DOI 10.1016/j.ejca.2008.02.006; Issel M., 2009, HLTH PROGRAM PLANNIN; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Marks R, 2011, HEALTH EDUC, V111, P340, DOI 10.1108/09654281111161194; Mason M, 2000, J PHILOS EDUC, V34, P343, DOI 10.1111/1467-9752.00177; Mayer AB, 2011, AM J HEALTH EDUC, V42, P349, DOI 10.1080/19325037.2011.10599206; McKenzie JF, 2013, PLANNING IMPLEMENTIN, P5; Mellstedt H, 2006, Ann Oncol, V17 Suppl 8, pviii24, DOI 10.1093/annonc/mdl984; Mendes A, 2004, PROGRAMA BIOL 12 ANO; Ministry of Health, 2012, NAT HLTH PLAN PORT 2; Passa a Palavra, 2007, MED CAMP CERV CANC H; Peterson FL, 2001, J SCHOOL HEALTH, V71, P138, DOI 10.1111/j.1746-1561.2001.tb01311.x; Portuguese Association of Cutaneous Cancer, 2012, C FOT 2012; Portuguese General Board of Health, 2008, INTR HPV VACC PORT P; Portuguese Ministry of Education and Science, 2005, SEX ED SCH; Rabier JR, 1989, EUROPEAN SURVEY TEAC, DOI [10.3886/ICPSR09407.v1, DOI 10.3886/ICPSR09407.V1]; Ryan RM, 2000, CONTEMP EDUC PSYCHOL, V25, P54, DOI 10.1006/ceps.1999.1020; Sener SF, 2005, J SURG ONCOL, V92, P1, DOI 10.1002/jso.20335; Summerfield LM, 2001, PREPARING CLASSROOM; Vilnius Resolution, 2009, BETT SCH TROUGH HLTH; WHO, 2011, GLOB STAT REP NONC D	27	43	43	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96672	10.1371/journal.pone.0096672	http://dx.doi.org/10.1371/journal.pone.0096672			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4LX	24817168	Green Published, gold, Green Submitted			2022-12-27	WOS:000336838000049
J	Huang, R; Zhao, L; Chen, H; Yin, RH; Li, CY; Zhan, YQ; Zhang, JH; Ge, CH; Yu, M; Yang, XM				Huang, Rui; Zhao, Long; Chen, Hui; Yin, Rong-Hua; Li, Chang-Yan; Zhan, Yi-Qun; Zhang, Jian-Hong; Ge, Chang-hui; Yu, Miao; Yang, Xiao-Ming			Megakaryocytic Differentiation of K562 Cells Induced by PMA Reduced the Activity of Respiratory Chain Complex IV	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; MITOCHONDRIAL PROTEIN-SYNTHESIS; PERMEABILITY TRANSITION; ERYTHROID-DIFFERENTIATION; INHIBITION; LEUKEMIA; RELEASE; MUTATION; CALCIUM; PARTICIPATION	Mitochondria are involved in the regulation of cell differentiation processes, but its function changes and molecular mechanisms are not yet clear. In this study, we found that mitochondrial functions changed obviously when K562 cells were induced to megakaryocytic differentiation by phorbol 12-myristate 13-acetate (PMA). During the cell differentiation, the reactive oxygen species (ROS) level was increased, mitochondrial membrane potential declined and respiratory chain complex IV activity was decreased. Treatment with specific inhibitor of mitochondrial respiratory chain complex IV led to a significant inhibition in mitochondrial membrane potential and reduction of PMA-induced cell differentiation. However, treatment with cyclosporine A, a stabilization reagent of mitochondrial membrane potential, did not improve the downregulation of mitochondrial respiratory chain complex IV induced by PMA. Furthermore, we found that the level of the complex IV core subunit COX3 and mitochondrial transport-related proteins Tim9 and Tim10 were decreased during the differentiation of K562 cells induced by PMA, suggesting an important role of these factors in mitochondrial functional changes. Our results suggest that changes in mitochondrial functions are involved in the PMA-induced K562 cell differentiation process, and the maintenance of the steady-state of mitochondrial functions plays a critical role in the regulation of cell differentiation.	[Huang, Rui; Zhao, Long; Chen, Hui; Yin, Rong-Hua; Li, Chang-Yan; Zhan, Yi-Qun; Zhang, Jian-Hong; Ge, Chang-hui; Yu, Miao; Yang, Xiao-Ming] Beijing Inst Radiat Med, Beijing, Peoples R China; [Huang, Rui; Zhao, Long; Chen, Hui; Yin, Rong-Hua; Li, Chang-Yan; Zhan, Yi-Qun; Zhang, Jian-Hong; Ge, Chang-hui; Yu, Miao; Yang, Xiao-Ming] Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing, Peoples R China	Academy of Military Medical Sciences - China; Academy of Military Medical Sciences - China	Yu, M (corresponding author), Beijing Inst Radiat Med, Beijing, Peoples R China.	yumiaoer@hotmail.com; xiaomingyang@sina.com			Major State Basic Research of China [2013CB910800]; National High-tech R&D Program of China [2012AA020200]; Chinese National Natural Science Fund [81070392]	Major State Basic Research of China; National High-tech R&D Program of China(National High Technology Research and Development Program of China); Chinese National Natural Science Fund(National Natural Science Foundation of China (NSFC))	This work was supported by Major State Basic Research of China (2013CB910800); National High-tech R&D Program of China: 2012AA020200; and Chinese National Natural Science Fund (81070392). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borutaite V, 2010, ENVIRON MOL MUTAGEN, V51, P406, DOI 10.1002/em.20564; BUTLER TM, 1990, CANCER RES, V50, P6323; Calvaruso MA, 2012, HUM MOL GENET, V21, P115, DOI 10.1093/hmg/ddr446; Camello-Almaraz C, 2006, AM J PHYSIOL-CELL PH, V291, pC1082, DOI 10.1152/ajpcell.00217.2006; Damdimopoulos AE, 2002, J BIOL CHEM, V277, P33249, DOI 10.1074/jbc.M203036200; Davidson SM, 2012, CARDIOVASC RES, V93, P445, DOI 10.1093/cvr/cvr349; Davidson SM, 2006, CELL CALCIUM, V40, P561, DOI 10.1016/j.ceca.2006.08.017; Ermak G, 2002, MOL IMMUNOL, V38, P713, DOI 10.1016/S0161-5890(01)00108-0; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gogvadze V, 2006, BBA-BIOENERGETICS, V1757, P639, DOI 10.1016/j.bbabio.2006.03.016; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hamai N, 1997, CELL STRUCT FUNCT, V22, P421, DOI 10.1247/csf.22.421; Hanna MG, 1998, AM J HUM GENET, V63, P29, DOI 10.1086/301910; HERZBERG NH, 1993, BIOCHIM BIOPHYS ACTA, V1181, P63, DOI 10.1016/0925-4439(93)90091-E; Higuchi M, 1998, ONCOGENE, V17, P2515, DOI 10.1038/sj.onc.1202485; Hirose K, 2013, J RADIAT RES, V54, P438, DOI 10.1093/jrr/rrs125; Huo XF, 2006, MOL CELL BIOCHEM, V292, P155, DOI 10.1007/s11010-006-9229-0; Ishii Y, 2002, CELL GROWTH DIFFER, V13, P19; Jia L, 1996, BLOOD, V87, P2401, DOI 10.1182/blood.V87.6.2401.bloodjournal8762401; KANEKO T, 1988, MOL CELL BIOL, V8, P3311, DOI 10.1128/MCB.8.8.3311; Kang CD, 1996, BIOCHEM BIOPH RES CO, V221, P95, DOI 10.1006/bbrc.1996.0551; Keightley JA, 1996, NAT GENET, V12, P410, DOI 10.1038/ng0496-410; Kidani A, 2009, INT J ONCOL, V35, P1435, DOI 10.3892/ijo_00000462; Komarova SV, 2000, AM J PHYSIOL-CELL PH, V279, pC1220, DOI 10.1152/ajpcell.2000.279.4.C1220; KOROHODA W, 1993, FOLIA HISTOCHEM CYTO, V31, P9; Kuznetsov AV, 2009, INT J MOL SCI, V10, P1911, DOI 10.3390/ijms10041911; LAENG H, 1988, EXP CELL RES, V179, P222, DOI 10.1016/0014-4827(88)90361-8; LAI CS, 1982, P NATL ACAD SCI-BIOL, V79, P1166, DOI 10.1073/pnas.79.4.1166; Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002; Muller JM, 2008, MOL BIOL CELL, V19, P226, DOI 10.1091/mbc.E07-08-0814; Pagano A, 2004, AM J PHYSIOL-LUNG C, V286, pL275, DOI 10.1152/ajplung.00181.2003; Pecina P, 2004, PHYSIOL RES, V53, pS213; Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311; Rehman J, 2010, J MOL MED, V88, P981, DOI 10.1007/s00109-010-0678-2; Ricci JE, 2003, J CELL BIOL, V160, P65, DOI 10.1083/jcb.200208089; Sardina JL, 2010, CELL DEATH DIFFER, V17, P1842, DOI 10.1038/cdd.2010.67; Schoenfeld R, 2010, MITOCHONDRION, V10, P143, DOI 10.1016/j.mito.2009.12.141; Spitkovsky D, 2004, FASEB J, V18, P1300, DOI 10.1096/fj.03-0520fje; Takeuchi N, 2003, J BIOL CHEM, V278, P45318, DOI 10.1074/jbc.M307620200; Tan F, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-91; Tiranti V, 2000, HUM MOL GENET, V9, P2733, DOI 10.1093/hmg/9.18.2733; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Van Raam BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002013; VAYSSIERE JL, 1992, IN VITRO CELL DEV-AN, V28A, P763; Vempati UD, 2009, J BIOL CHEM, V284, P4383, DOI 10.1074/jbc.M805972200; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Whalen AM, 1997, MOL CELL BIOL, V17, P1947, DOI 10.1128/MCB.17.4.1947; Whiteman M, 2005, FREE RADICAL BIO MED, V38, P1571, DOI 10.1016/j.freeradbiomed.2005.02.030; Wittig I, 2006, BBA-BIOENERGETICS, V1757, P1066, DOI 10.1016/j.bbabio.2006.05.006; Wong A, 2002, HUM MOL GENET, V11, P431, DOI 10.1093/hmg/11.4.431; Zeng YX, 1996, ONCOGENE, V12, P1557; Zhang YC, 2006, MOL PHARMACOL, V70, P1424, DOI 10.1124/mol.106.024323; Ziabreva I, 2010, GLIA, V58, P1827, DOI 10.1002/glia.21052; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	54	28	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96246	10.1371/journal.pone.0096246	http://dx.doi.org/10.1371/journal.pone.0096246			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24817082	Green Submitted, gold, Green Published			2022-12-27	WOS:000336838000028
J	Sandri, KJ; Verdenius, I; Bartley, MJ; Else, BM; Paynter, CA; Rosemergey, BE; Harris, GD; Malnar, GJ; Harper, SM; Griffith, RS; Bonham, AJ; Harper, DM				Sandri, Kelly Jo; Verdenius, Inge; Bartley, Mitchell J.; Else, Britney M.; Paynter, Christopher A.; Rosemergey, Beth E.; Harris, George D.; Malnar, Gerard J.; Harper, Sean M.; Griffith, R. Stephen; Bonham, Aaron J.; Harper, Diane M.			Urban and Rural Safety Net Health Care System Clinics: No Disparity in HPV4 Vaccine Completion Rates	PLOS ONE			English	Article							HPV-16/18 AS04-ADJUVANTED VACCINE; HUMAN-PAPILLOMAVIRUS VACCINATION; CERVICAL-CANCER; ADOLESCENT FEMALES; UNITED-STATES; YOUNG-WOMEN; PREVENTION; EFFICACY; IMMUNOGENICITY; INITIATION	Objective: Safety net health care centers in the US serve vulnerable and underinsured females. The primary aim of this work was to determine if HPV4 dosing compliance differs between females who receive doses at rural vs. urban core safety net health care locations. Methods: Females exclusively receiving health care in the Truman Medical Center (TMC) safety net system at the urban core and rural locations were identified by their HPV4 vaccine records. Dates and number of HPV4 doses as well as age, gravidity, parity and race/ethnicity were recorded from the electronic medical record (EMR). Appropriate HPV4 dosing intervals were referenced from the literature. Results: 1259 females, 10-26 years of age, received HPV4 vaccination at either the rural (23%) or urban core location (77%). At the rural location, 23% received three doses on time, equal to the 24% at the urban core. Females seen in the urban core were more likely to receive on-time doublet dosing than on-time triplet dosing (82% vs. 67%, p<0.001). Mistimed doses occurred equally often among females receiving only two doses, as well as those receiving three doses. Conclusions: Compliance with on-time HPV4 triplet dose completion was low at rural and urban core safety net health clinics, but did not differ by location.	[Sandri, Kelly Jo; Bartley, Mitchell J.; Else, Britney M.; Paynter, Christopher A.; Rosemergey, Beth E.; Harris, George D.; Griffith, R. Stephen; Harper, Diane M.] Univ Missouri, Kansas City Sch Med, Dept Community & Family Med, Kansas City, MO 64110 USA; [Verdenius, Inge] Radboud Univ Nijmegen, Dept Obstet & Gynecol, NL-6525 ED Nijmegen, Netherlands; [Malnar, Gerard J.; Harper, Diane M.] Univ Missouri, Kansas City Sch Med, Dept Obstet & Gynecol, Kansas City, MO 64110 USA; [Harper, Sean M.] Hampshire Coll, Amherst, MA 01002 USA; [Bonham, Aaron J.; Harper, Diane M.] Univ Missouri, Kansas City Sch Med, Dept Biomed & Hlth Informat, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City; Radboud University Nijmegen; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City	Harper, DM (corresponding author), Univ Missouri, Kansas City Sch Med, Dept Community & Family Med, Kansas City, MO 64110 USA.	diane.m.harper@gmail.com	Harper, Diane M./I-2180-2014	Harper, Diane M./0000-0001-7648-883X				Adams SA, 2013, 1 S CAR RUR HLTH RES; Battaglia TA, 2010, CANCER-AM CANCER SOC, V116, P913, DOI 10.1002/cncr.24851; Casey MM, 2001, AM J PREV MED, V21, P182, DOI 10.1016/S0749-3797(01)00349-X; Cook RL, 2010, J ADOLESCENT HEALTH, V47, P596, DOI 10.1016/j.jadohealth.2010.09.015; Demarteau N, 2012, PHARMACOECONOMICS, V30, P337, DOI 10.2165/11591560-000000000-00000; Dobson SRM, 2013, JAMA-J AM MED ASSOC, V309, P1793, DOI 10.1001/jama.2013.1625; Dorell C, 2011, MMWR-MORBID MORTAL W, V60, P671; Frick KD, 2001, J HEALTH CARE POOR U, V12, P429; Grant D, 2012, OEI041000430 DEP HLT; Harper Diane M, 2011, ISRN Obstet Gynecol, V2011, P457204, DOI 10.5402/2011/457204; Heitmann ER, 2012, CURR OBSTET GYNECOL, V1, P95, DOI 10.1007/s13669-012-0017-4; Hopenhayn C, 2008, CANCER-AM CANCER SOC, V113, P2974, DOI 10.1002/cncr.23749; IBM Corp, 2011, IBM SPSS STAT WIND V; IBM Corp, 2012, COCHR ARM TEST TREND; Kreimer AR, 2011, JNCI-J NATL CANCER I, V103, P1444, DOI 10.1093/jnci/djr319; Krieger JL, 2012, WOMEN HEALTH ISS, V22, pE19, DOI 10.1016/j.whi.2011.07.005; Markowitz Lauri E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Martin A, 2005, 17 S CAR RUR HLTH RE; Mills LA, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120183; Moss JL, 2012, CANCER EPIDEM BIOMAR, V21, P1913, DOI 10.1158/1055-9965.EPI-12-0509; Neuzil KM, 2011, JAMA-J AM MED ASSOC, V305, P1424, DOI 10.1001/jama.2011.407; Perkins RB, 2012, J WOMENS HEALTH, V21, P813, DOI 10.1089/jwh.2011.3364; Probst JC, 2005, J RURAL HEALTH, V21, P279, DOI 10.1111/j.1748-0361.2005.tb00096.x; Raymond P, 2011, HPV4 IMMUNIZATION PR; Regan J, 2003, J RURAL HEALTH, V19, P117, DOI 10.1111/j.1748-0361.2003.tb00552.x; Reiter PL, 2012, CANCER EPIDEM BIOMAR, V21, P2220, DOI 10.1158/1055-9965.EPI-12-0850; Scarinci IC, 2010, CANCER-AM CANCER SOC, V116, P2531, DOI 10.1002/cncr.25065; Schootman M, 1999, CANCER-AM CANCER SOC, V86, P1087, DOI 10.1002/(SICI)1097-0142(19990915)86:6&lt;1087::AID-CNCR27&gt;3.0.CO;2-I; Setia S, 2002, VACCINE, V20, P1148, DOI 10.1016/S0264-410X(01)00433-9; Smolen KK, 2012, VACCINE, V30, P3572, DOI 10.1016/j.vaccine.2012.03.051; Spoont M, 2011, VA EVIDENCE BASED SY; StatSoft Inc., 2010, STAT DAT AN SOFTW SY; Szarewski A, 2013, J INFECT DIS, V208, P1391, DOI 10.1093/infdis/jit360; Tiro JA, 2012, VACCINE, V30, P2368, DOI 10.1016/j.vaccine.2011.11.031; U. S. Department of Health and Human Services, 2011, AHRQ PUBL, V12-0006; Verdenius I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071295; Wheeler CM, 2012, LANCET ONCOL, V13, P100, DOI 10.1016/S1470-2045(11)70287-X; Williams Walter W., 2012, Morbidity and Mortality Weekly Report, V61, P66; Wu Xiaocheng, 2012, Morbidity and Mortality Weekly Report, V61, P258; Yabroff KR, 2005, J RURAL HEALTH, V21, P149, DOI 10.1111/j.1748-0361.2005.tb00075.x	40	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96277	10.1371/journal.pone.0096277	http://dx.doi.org/10.1371/journal.pone.0096277			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4LX	24816199	Green Submitted, Green Published, gold			2022-12-27	WOS:000336838000031
J	Silvis, A; Kniowski, AB; Gehrt, SD; Ford, WM				Silvis, Alexander; Kniowski, Andrew B.; Gehrt, Stanley D.; Ford, W. Mark			Roosting and Foraging Social Structure of the Endangered Indiana Bat (Myotis sodalis)	PLOS ONE			English	Article							FEMALE BECHSTEINS BATS; FISSION-FUSION DYNAMICS; LONG-EARED BATS; BIG BROWN BATS; INFORMATION-TRANSFER; NETWORK ANALYSIS; ASSOCIATION PATTERNS; COMMUNITY STRUCTURE; EPTESICUS-FUSCUS; RANGE OVERLAP	Social dynamics are an important but poorly understood aspect of bat ecology. Herein we use a combination of graph theoretic and spatial approaches to describe the roost and social network characteristics and foraging associations of an Indiana bat (Myotis sodalis) maternity colony in an agricultural landscape in Ohio, USA. We tracked 46 bats to 50 roosts (423 total relocations) and collected 2,306 foraging locations for 40 bats during the summers of 2009 and 2010. We found the colony roosting network was highly centralized in both years and that roost and social networks differed significantly from random networks. Roost and social network structure also differed substantially between years. Social network structure appeared to be unrelated to segregation of roosts between age classes. For bats whose individual foraging ranges were calculated, many shared foraging space with at least one other bat. Compared across all possible bat dyads, 47% and 43% of the dyads showed more than expected overlap of foraging areas in 2009 and 2010 respectively. Colony roosting area differed between years, but the roosting area centroid shifted only 332 m. In contrast, whole colony foraging area use was similar between years. Random roost removal simulations suggest that Indiana bat colonies may be robust to loss of a limited number of roosts but may respond differently from year to year. Our study emphasizes the utility of graphic theoretic and spatial approaches for examining the sociality and roosting behavior of bats. Detailed knowledge of the relationships between social and spatial aspects of bat ecology could greatly increase conservation effectiveness by allowing more structured approaches to roost and habitat retention for tree-roosting, socially-aggregating bat species.	[Silvis, Alexander; Kniowski, Andrew B.; Ford, W. Mark] Virginia Polytech Inst & State Univ, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA; [Gehrt, Stanley D.] Ohio State Univ, Sch Environm & Nat Resources, Columbus, OH 43210 USA; [Ford, W. Mark] Virginia Polytech Inst & State Univ, US Geol Survey, Virginia Cooperat Fish & Wildlife Res Unit, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; University System of Ohio; Ohio State University; United States Department of the Interior; United States Geological Survey; Virginia Polytechnic Institute & State University	Silvis, A (corresponding author), Virginia Polytech Inst & State Univ, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA.	silvis@vt.edu	Gehrt, Stanley D./J-8700-2012	Silvis, Alexander/0000-0003-1163-0123	Ohio Department of Transportation; Ohio Division of Wildlife; Ohio State University School of Environment and Natural Resources; Terrestrial Wildlife Ecology Laboratory	Ohio Department of Transportation; Ohio Division of Wildlife; Ohio State University School of Environment and Natural Resources; Terrestrial Wildlife Ecology Laboratory	The authors thank the Ohio Department of Transportation, the Ohio Division of Wildlife, The Ohio State University School of Environment and Natural Resources, and the Terrestrial Wildlife Ecology Laboratory for their funding and support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; Bagne KE, 2008, FOREST ECOL MANAG, V255, P99, DOI 10.1016/j.foreco.2007.08.024; Benhamou S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014592; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Borgatti SP, 1997, SOC NETWORKS, V19, P243, DOI 10.1016/S0378-8733(96)00301-2; BRIGHAM RM, 1986, CAN J ZOOL, V64, P1128, DOI 10.1139/z86-169; Britzke ER, 2003, SOUTHEAST NAT, V2, P235, DOI 10.1656/1528-7092(2003)002[0235:IBMSMR]2.0.CO;2; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Callahan EV, 1997, J MAMMAL, V78, P818, DOI 10.2307/1382939; Carter TC, 2005, FOREST ECOL MANAG, V219, P259, DOI 10.1016/j.foreco.2005.08.049; Chaverri G, 2007, ANIM BEHAV, V73, P157, DOI 10.1016/j.anbehav.2006.06.003; Chaverri G, 2013, BEHAV ECOL, V24, P481, DOI 10.1093/beheco/ars188; Chaverri G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028821; Chaverri G, 2010, ADV STUD BEHAV, V42, P275, DOI 10.1016/S0065-3454(10)42009-4; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Davison AC, 1997, BOOTSTRAP METHODS TH, DOI [DOI 10.2307/1271471, 10.1017/CBO9780511802843]; Dong J, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-24; ERDOS P, 1960, B INT STATIST INST, V38, P343; Fieberg J, 2005, J WILDLIFE MANAGE, V69, P1346, DOI 10.2193/0022-541X(2005)69[1346:QHOTIO]2.0.CO;2; Fortuna MA, 2009, ECOLOGY, V90, P934, DOI 10.1890/08-0174.1; Foster RW, 1999, J MAMMAL, V80, P659, DOI 10.2307/1383310; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Gardner James E., 2002, P9; Garroway CJ, 2007, CAN J ZOOL, V85, P956, DOI 10.1139/Z07-079; Gitzen RA, 2006, J WILDLIFE MANAGE, V70, P1334, DOI 10.2193/0022-541X(2006)70[1334:BSFFAO]2.0.CO;2; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Gumbert Mark W., 2002, P143; Harvey Michael J., 2002, P29; Homer C, 2004, PHOTOGRAMM ENG REM S, V70, P829, DOI 10.14358/PERS.70.7.829; HOPE ACA, 1968, J ROY STAT SOC B, V30, P582; HUMPHREY SR, 1977, J MAMMAL, V58, P334, DOI 10.2307/1379332; Jacoby DMP, 2012, METHODS ECOL EVOL, V3, P574, DOI 10.1111/j.2041-210X.2012.00187.x; James R, 2009, BEHAV ECOL SOCIOBIOL, V63, P989, DOI 10.1007/s00265-009-0742-5; Johnson JS, 2013, ACTA CHIROPTEROL, V15, P1, DOI 10.3161/150811013X667821; Johnson JS, 2012, J MAMMAL, V93, P1545, DOI 10.1644/12-MAMM-A-097.1; Johnson JB, 2012, FOREST ECOL MANAG, V266, P223, DOI 10.1016/j.foreco.2011.11.032; Jonker MN, 2010, ACTA CHIROPTEROL, V12, P197, DOI 10.3161/150811010X504699; Kerth G, 2001, BEHAV ECOL SOCIOBIOL, V50, P283, DOI 10.1007/s002650100352; Kerth G, 2003, P ROY SOC B-BIOL SCI, V270, P511, DOI 10.1098/rspb.2002.2267; Kerth G, 1999, BEHAVIOUR, V136, P1187, DOI 10.1163/156853999501711; Kerth G, 2008, CURR BIOL, V18, pR740, DOI 10.1016/j.cub.2008.07.038; Kerth G, 2008, BIOSCIENCE, V58, P737, DOI 10.1641/B580810; Kerth G, 2006, P ROY SOC B-BIOL SCI, V273, P2785, DOI 10.1098/rspb.2006.3647; Kerth G, 2011, P ROY SOC B-BIOL SCI, V278, P2761, DOI 10.1098/rspb.2010.2718; Kniowski AB, 2014, J WILDLIFE MANAGE, V78, P503, DOI 10.1002/jwmg.677; KOZHURINA EI, 1993, ETHOLOGY, V93, P89; Kunz TH, 2003, BAT ECOLOGY, P3; Kurta A, 2002, J MAMMAL, V83, P585, DOI 10.1644/1545-1542(2002)083<0585:PAMOBI>2.0.CO;2; KURTA A, 1993, AM MIDL NAT, V129, P132, DOI 10.2307/2426441; Kurta A., 2005, P IND BAT COAL MIN T, P29; Kurta Allen, 2002, P118; Lusseau D, 2004, P ROY SOC B-BIOL SCI, V271, pS477, DOI 10.1098/rsbl.2004.0225; Mann O, 2011, ACTA CHIROPTEROL, V13, P411, DOI 10.3161/150811011X624893; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Metheny JD, 2008, BEHAV ECOL SOCIOBIOL, V62, P1043, DOI 10.1007/s00265-007-0531-y; Miller G. S., 1928, Bulletin United States National Museum, Vno. 144, P1; Miller Nancy E., 2002, P165; Minnis AM, 2013, FUNGAL BIOL-UK, V117, P638, DOI 10.1016/j.funbio.2013.07.001; Moorman CE, 1999, FOREST ECOL MANAG, V118, P37, DOI 10.1016/S0378-1127(98)00482-4; Nams V. O, 2006, LOCATE 3 USERS GUIDE; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Opsahl T, 2009, THESIS QUEEN MARY U; Patriquin KJ, 2013, BEHAV ECOL, V24, P949, DOI 10.1093/beheco/art012; Patriquin KJ, 2010, BEHAV ECOL SOCIOBIOL, V64, P899, DOI 10.1007/s00265-010-0905-4; Popa-Lisseanu AG, 2008, ANIM BEHAV, V75, P471, DOI 10.1016/j.anbehav.2007.05.011; R Core Team, 2016, R FDN STAT COMP; Reckardt K, 2007, OECOLOGIA, V154, P581, DOI 10.1007/s00442-007-0843-7; Rhodes M, 2007, J MAMMAL, V88, P1252, DOI 10.1644/06-MAMM-A-374R1.1; Sih A, 2009, BEHAV ECOL SOCIOBIOL, V63, P975, DOI 10.1007/s00265-009-0725-6; Silvis A, 2014, BEHAV PROCESS, V103, P283, DOI 10.1016/j.beproc.2014.01.016; Sparks DW, 2003, NORTHEAST NAT, V10, P105, DOI 10.1656/1092-6194(2003)010[0105:DORBBW]2.0.CO;2; Sparks DW, 2005, FORAGING ECOLOGY END, P15; Timpone JC, 2010, AM MIDL NAT, V163, P115, DOI 10.1674/0003-0031-163.1.115; Wasserman S, 1994, SOCIAL NETWORK ANAL; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; West D.B., 1996, INTRO GRAPH THEORY, V2; Wey T, 2008, ANIM BEHAV, V75, P333, DOI 10.1016/j.anbehav.2007.06.020; Whitaker John O. Jr, 2002, P48; WILKINSON GS, 1992, ANIM BEHAV, V44, P501, DOI 10.1016/0003-3472(92)90059-I; Williams RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017645; Willis CKR, 2004, ANIM BEHAV, V68, P495, DOI 10.1016/j.anbehav.2003.08.028; Willis CKR, 2007, BEHAV ECOL SOCIOBIOL, V62, P97, DOI 10.1007/s00265-007-0442-y; Wisdom MJ, 2008, FOREST ECOL MANAG, V255, P2085, DOI 10.1016/j.foreco.2007.12.027	86	24	24	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96937	10.1371/journal.pone.0096937	http://dx.doi.org/10.1371/journal.pone.0096937			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816811	Green Published, Green Submitted, gold			2022-12-27	WOS:000336838000081
J	Srivastava, KR; Durani, S				Srivastava, Kinshuk Raj; Durani, Susheel			Design of a Zinc-Finger Hydrolase with a Synthetic alpha beta beta Protein	PLOS ONE			English	Article							DE-NOVO DESIGN; COMPUTATIONAL DESIGN; BINDING-PROTEIN; COMPLEXES; MODEL; HYDROLYSIS; STABILITY; SEQUENCE	Recent advances in protein design have opened avenues for the creation of artificial enzymes needed for biotechnological and pharmaceutical applications. However, designing efficient enzymes remains an unrealized ambition, as the design must incorporate a catalytic apparatus specific for the desired reaction. Here we present a de novo design approach to evolve a minimal carbonic anhydrase mimic. We followed a step-by-step design of first folding the main chain followed by sequence variation for substrate binding and catalysis. To optimize the fold, we designed an alpha beta beta protein based on a Zn-finger. We then inverse-designed the sequences to provide stability to the fold along with flexibility of linker regions to optimize Zn binding and substrate hydrolysis. The resultant peptides were synthesized and assessed for Zn and substrate binding affinity by fluorescence and ITC followed by evaluation of catalytic efficiency with UV-based enzyme kinetic assays. We were successful in mimicking carbonic anhydrase activity in a peptide of twenty two residues, using p-nitrophenyl acetate as a CO2 surrogate. Although our design had modest activity, being a simple structure is an advantage for further improvement in efficiency. Our approach opens a way forward to evolving an efficient biocatalyst for any industrial reaction of interest.	[Srivastava, Kinshuk Raj; Durani, Susheel] Indian Inst Technol, Dept Chem, Bombay 400076, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Srivastava, KR (corresponding author), Indian Inst Technol, Dept Chem, Bombay 400076, Maharashtra, India.	kinshukraj2@gmail.com		Srivastava, Kinshuk Raj/0000-0002-3688-9652	DST, Government of India [09DST028]; Council of Scientific and Industrial Research (CSIR)	DST, Government of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	The authors acknowledge DST (09DST028), Government of India, for financial support (www.dst.gov.in). KRS is a recipient of fellowships from Council of Scientific and Industrial Research (CSIR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allert M, 2004, P NATL ACAD SCI USA, V101, P7907, DOI 10.1073/pnas.0401309101; Andersen NH, 2006, J AM CHEM SOC, V128, P6101, DOI 10.1021/ja054971w; Arnold FH, 2001, NATURE, V409, P253, DOI 10.1038/35051731; BALLINGER MD, 1995, BIOCHEMISTRY-US, V34, P13312, DOI 10.1021/bi00041a006; Bazzicalupi C, 1997, INORG CHEM, V36, P2784, DOI 10.1021/ic961521j; Bolon DN, 2001, P NATL ACAD SCI USA, V98, P14274, DOI 10.1073/pnas.251555398; Butterfoss GL, 2006, ANNU REV BIOPH BIOM, V35, P49, DOI 10.1146/annurev.biophys.35.040405.102046; Chan WC, 1989, FMOC SOLID PHASE PEP; Chevalier BS, 2002, MOL CELL, V10, P895, DOI 10.1016/S1097-2765(02)00690-1; Cochran AG, 2001, P NATL ACAD SCI USA, V98, P5578, DOI 10.1073/pnas.091100898; Dahiyat BI, 1996, PROTEIN SCI, V5, P895, DOI 10.1002/pro.5560050511; Dahiyat BI, 1997, J MOL BIOL, V273, P789, DOI 10.1006/jmbi.1997.1341; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Gould SM, 2005, BIOCHEMISTRY-US, V44, P5444, DOI 10.1021/bi0475471; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; HANDEL T, 1990, J AM CHEM SOC, V112, P6710, DOI 10.1021/ja00174a039; Jairam R, 1999, J CHEM SOC PERK T 2, P363, DOI 10.1039/a804352c; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Joshi S, 2006, BIOPOLYMERS, V83, P122, DOI 10.1002/bip.20537; Khalifah R. G., 1991, CARBONIC ANHYDRASE K, P47; KIMURA E, 1990, J AM CHEM SOC, V112, P5805, DOI 10.1021/ja00171a020; Kiyokawa T, 2004, J PEPT RES, V63, P347, DOI 10.1111/j.1399-3011.2004.00109.x; Koerner TB, 2002, CAN J CHEM, V80, P183, DOI 10.1139/V02-001; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Lippow SM, 2007, CURR OPIN BIOTECH, V18, P305, DOI 10.1016/j.copbio.2007.04.009; Liu Y, 2006, NUCLEIC ACIDS RES, V34, pW235, DOI 10.1093/nar/gkl163; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; MULLER HN, 1994, BIOCHEMISTRY-US, V33, P14126; Nanda V, 2008, NAT CHEM BIOL, V4, P273, DOI 10.1038/nchembio0508-273; Nanda V, 2010, NAT CHEM, V2, P15, DOI [10.1038/NCHEM.473, 10.1038/nchem.473]; Olmo CP, 2007, INORG CHIM ACTA, V360, P1510, DOI 10.1016/j.ica.2006.08.021; Park S, 2004, CURR OPIN STRUC BIOL, V14, P487, DOI 10.1016/j.sbi.2004.06.002; Patel K, 2010, BIOORGAN MED CHEM, V18, P8270, DOI 10.1016/j.bmc.2010.10.003; PESSI A, 1993, NATURE, V362, P367, DOI 10.1038/362367a0; Privett HK, 2012, P NATL ACAD SCI USA, V109, P3790, DOI 10.1073/pnas.1118082108; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Sprigings TG, 2001, J CHEM SOC PERK T 2, P2063, DOI 10.1039/b107683n; Sterner R, 2004, SCIENCE, V304, P1916, DOI 10.1126/science.1100482; Tann CM, 2001, CURR OPIN CHEM BIOL, V5, P696, DOI 10.1016/S1367-5931(01)00268-X; Tegoni M, 2012, P NATL ACAD SCI USA, V109, P21234, DOI 10.1073/pnas.1212893110; VERPOORTE JA, 1967, J BIOL CHEM, V242, P4221; VITA C, 1995, P NATL ACAD SCI USA, V92, P6404, DOI 10.1073/pnas.92.14.6404; Zastrow ML, 2012, NAT CHEM, V4, P118, DOI [10.1038/NCHEM.1201, 10.1038/nchem.1201]	43	4	4	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96234	10.1371/journal.pone.0096234	http://dx.doi.org/10.1371/journal.pone.0096234			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816915	Green Published, gold, Green Submitted			2022-12-27	WOS:000336838000026
J	Thomson, R; Festo, C; Johanes, B; Kalolella, A; Bruxvoort, K; Nchimbi, H; Tougher, S; Cairns, M; Taylor, M; Kleinschmidt, I; Ye, Y; Mann, A; Ren, RL; Willey, B; Arnold, F; Hanson, K; Kachur, SP; Goodman, C				Thomson, Rebecca; Festo, Charles; Johanes, Boniface; Kalolella, Admirabilis; Bruxvoort, Katia; Nchimbi, Happy; Tougher, Sarah; Cairns, Matthew; Taylor, Mark; Kleinschmidt, Immo; Ye, Yazoume; Mann, Andrea; Ren, Ruilin; Willey, Barbara; Arnold, Fred; Hanson, Kara; Kachur, S. Patrick; Goodman, Catherine			Has Tanzania Embraced the Green Leaf? Results from Outlet and Household Surveys before and after Implementation of the Affordable Medicines Facility - Malaria	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS; COMBINATION THERAPIES; MARKET SHARE; AVAILABILITY; REGIONS; IMPACT; PRICE; AMFM; ACT	Background: The Affordable Medicines Facility - malaria (AMFm) is primarily an artemisinin combination therapy (ACT) subsidy, aimed at increasing availability, affordability, market share and use of quality-assured ACTs (QAACTs). Mainland Tanzania was one of eight national scale programmes where AMFm was introduced in 2010. Here we present findings from outlet and household surveys before and after AMFm implementation to evaluate its impact from both the supply and demand side. Methods: Outlet surveys were conducted in 49 randomly selected wards throughout mainland Tanzania in 2010 and 2011, and data on outlet characteristics and stocking patterns were collected from outlets stocking antimalarials. Household surveys were conducted in 240 randomly selected enumeration areas in three regions in 2010 and 2012. Questions about treatment seeking for fever and drugs obtained were asked of individuals reporting fever in the previous two weeks. Results: The availability of QAACTs increased from 25.5% to 69.5% among all outlet types, with the greatest increase among pharmacies and drug stores, together termed specialised drug sellers (SDSs), where the median QAACT price fell from $5.63 to $0.94. The market share of QAACTs increased from 26.2% to 42.2%, again with the greatest increase in SDSs. Household survey results showed a shift in treatment seeking away from the public sector towards SDSs. Overall, there was no change in the proportion of people with fever obtaining an antimalarial or ACT from baseline to endline. However, when broken down by treatment source, ACT use increased significantly among clients visiting SDSs. Discussion: Unchanged ACT use overall, despite increases in QAACT availability, affordability and market share in the private sector, reflected a shift in treatment seeking towards private providers. The reasons for this shift are unclear, but likely reflect both persistent stockouts in public facilities, and the increased availability of subsidised ACTs in the private sector.	[Thomson, Rebecca; Bruxvoort, Katia; Tougher, Sarah; Cairns, Matthew; Taylor, Mark; Kleinschmidt, Immo; Mann, Andrea; Willey, Barbara; Hanson, Kara; Goodman, Catherine] London Sch Hyg & Trop Med, London WC1, England; [Thomson, Rebecca; Festo, Charles; Johanes, Boniface; Kalolella, Admirabilis; Bruxvoort, Katia; Nchimbi, Happy] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Taylor, Mark] Trnava Univ, Dept Publ Hlth, Trnava, Slovakia; [Ye, Yazoume; Ren, Ruilin; Arnold, Fred] ICF Int, Int Hlth Div, Calverton, MD USA; [Kachur, S. Patrick] Ctr Dis Control & Prevent, Malaria Branch, Atlanta, GA USA	University of London; London School of Hygiene & Tropical Medicine; Ifakara Health Institute; University of Trnava; Centers for Disease Control & Prevention - USA	Thomson, R (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	Rebecca.thomson@lshtm.ac.uk	Kachur, Patrick/ABE-7220-2021	Tougher, Sarah/0000-0001-7990-4368; Taylor, Mark/0000-0002-7646-7905; Thomson, Rebecca/0000-0001-9683-9457; Bruxvoort, Katia/0000-0001-8277-2431; Goodman, Catherine/0000-0002-2241-3485	Bill and Melinda Gates Foundation through ACT Consortium [PHGB VG0410]; Global Fund to Fight AIDS, Tuberculosis and Malaria; MRC [MR/J012394/1] Funding Source: UKRI; Medical Research Council [MR/K012126/1, MR/J012394/1] Funding Source: researchfish	Bill and Melinda Gates Foundation through ACT Consortium; Global Fund to Fight AIDS, Tuberculosis and Malaria; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by the Bill and Melinda Gates Foundation (www.gatesfoundation.org), through a grant with the ACT Consortium (actconsortium.org), project code PHGB VG0410. The Independent Evaluation of AMFm was funded by the Global Fund to Fight AIDS, Tuberculosis and Malaria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyi O, 2010, LANCET, V376, P1869, DOI 10.1016/S0140-6736(10)61189-0; [Anonymous], 2009, NY TIMES; [Anonymous], AFF MED FAC MAL; [Anonymous], ENGAGING PRIVATE SEC; [Anonymous], ASTMH; [Anonymous], TANZ MAL PROGR REV; [Anonymous], 2012, IND EV PHAS 1 AFF ME; [Anonymous], TANZ HIV AIDS MAL IN; [Anonymous], DIAGN TEST RET PRIV; [Anonymous], COV MOSQ NETS IPTP P; [Anonymous], MAL CONTR SER; [Anonymous], GLOB FUND QUAL ASS P; Briggs MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094074; Bruxvoort K, 2013, TROP MED INT HEALTH, V18, P1269, DOI 10.1111/tmi.12168; Cohen JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070713; Dondorp AM, 2011, NEW ENGL J MED, V365, P1073, DOI 10.1056/NEJMp1108322; Institute of Medicine (US) Committee on the Economics of Antimalarial Drugs, 2004, SAVING LIVES BUYING; Kamal-Yanni M, 2010, LANCET, V375, P121, DOI 10.1016/S0140-6736(10)60048-7; Moon S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000106; National Bureau of Statistics of Tanzania ICF Macro, 2011, TANZ DEM HLTH SURV 2; Njau JD, 2006, TROP MED INT HEALTH, V11, P299, DOI 10.1111/j.1365-3156.2006.01569.x; O'Connell KA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-326; Patouillard E, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-50; Sabot OJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006857; Shewchuk T, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-325; Talisuna AO, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-370; Tougher S, 2012, LANCET, V380, P1916, DOI 10.1016/S0140-6736(12)61732-2; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Yadav P, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-299; Yeung S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-243	30	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e95607	10.1371/journal.pone.0095607	http://dx.doi.org/10.1371/journal.pone.0095607			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816649	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000336838000016
J	Wang, XJ; Lu, XG; Li, F; Yang, GH				Wang, Xiaojiao; Lu, Xingang; Li, Fang; Yang, Gaihe			Effects of Temperature and Carbon-Nitrogen (C/N) Ratio on the Performance of Anaerobic Co-Digestion of Dairy Manure, Chicken Manure and Rice Straw: Focusing on Ammonia Inhibition	PLOS ONE			English	Article							THERMOPHILIC DIGESTION; SWINE MANURE; FEEDING COMPOSITION; WASTE	Anaerobic digestion is a promising alternative to disposal organic waste and co-digestion of mixed organic wastes has recently attracted more interest. This study investigated the effects of temperature and carbon-nitrogen (C/N) ratio on the performance of anaerobic co-digestion of dairy manure (DM), chicken manure (CM) and rice straw (RS). We found that increased temperature improved the methane potential, but the rate was reduced from mesophilic (30 similar to 40 degrees C) to thermophilic conditions (50 similar to 60 degrees C), due to the accumulation of ammonium nitrogen and free ammonia and the occurrence of ammonia inhibition. Significant ammonia inhibition was observed with a C/N ratio of 15 at 35 degrees C and at a C/N ratio of 20 at 55 degrees C. The increase of C/N ratios reduced the negative effects of ammonia and maximum methane potentials were achieved with C/N ratios of 25 and 30 at 35 degrees C and 55 degrees C, respectively. When temperature increased, an increase was required in the feed C/N ratio, in order to reduce the risk of ammonia inhibition. Our results revealed an interactive effect between temperature and C/N on digestion performance.	[Wang, Xiaojiao; Li, Fang; Yang, Gaihe] Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China; [Lu, Xingang] NW Univ Xian, Sch Chem Engn, Xian 710069, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest University Xi'an	Wang, XJ (corresponding author), Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China.	w-xj@nwsuaf.edu.cn	Feng, Yongzhong/F-5090-2012	Feng, Yongzhong/0000-0002-5202-4368	Ministry of Science and Technology Department of the People's Republic of China [2011 BAD15B03]; Research Fund for the Doctoral Program of Higher Education of Northwest A & F University, China [2013BSJJ057]	Ministry of Science and Technology Department of the People's Republic of China(Ministry of Science and Technology, China); Research Fund for the Doctoral Program of Higher Education of Northwest A & F University, China	This work was supported by science and technology support projects 'the biological technology integration and demonstration of high yield biogas digestion from the mix ingredients' (2011 BAD15B03) from Ministry of Science and Technology Department of the People's Republic of China and Research Fund for the Doctoral Program of Higher Education of Northwest A & F University, China(2013BSJJ057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRING BK, 1992, WATER SCI TECHNOL, V25, P311, DOI 10.2166/wst.1992.0163; ANGELIDAKI I, 1994, WATER RES, V28, P727, DOI 10.1016/0043-1354(94)90153-8; ANGELIDAKI I, 1993, APPL MICROBIOL BIOT, V38, P560; Banks CJ, 1998, WATER SCI TECHNOL, V38, P29, DOI 10.1016/S0273-1223(98)00494-6; BRAUN R, 1981, BIOTECHNOL LETT, V3, P159; Calli B, 2005, PROCESS BIOCHEM, V40, P1285, DOI 10.1016/j.procbio.2004.05.008; Gallert C, 1997, APPL MICROBIOL BIOT, V48, P405, DOI 10.1007/s002530051071; Garcia ML, 2009, WATER RES, V43, P2373, DOI 10.1016/j.watres.2009.02.036; Hansen KH, 1999, WATER RES, V33, P1805, DOI 10.1016/S0043-1354(98)00410-2; Hansen KH, 1998, WATER RES, V32, P5, DOI 10.1016/S0043-1354(97)00201-7; HILLS DJ, 1979, AGR WASTES, V1, P267, DOI 10.1016/0141-4607(79)90011-8; Cuetos MJ, 2011, BIOTECHNOL BIOPROC E, V16, P1044, DOI 10.1007/s12257-011-0117-4; KAYHANIAN M, 1992, BIOCYCLE, V33, P58; Kayhanian M, 1999, ENVIRON TECHNOL, V20, P355, DOI 10.1080/09593332008616828; KOSTER IW, 1988, BIOL WASTE, V25, P51, DOI 10.1016/0269-7483(88)90127-9; KROEKER EJ, 1979, J WATER POLLUT CON F, V51, P718; MARCHAIM U, 1993, BIORESOURCE TECHNOL, V43, P195, DOI 10.1016/0960-8524(93)90031-6; PHA, 1995, STANDARD METHODS EXA; Prochazka J, 2012, APPL MICROBIOL BIOT, V93, P439, DOI 10.1007/s00253-011-3625-4; Siles JA, 2010, BIORESOURCE TECHNOL, V101, P6315, DOI 10.1016/j.biortech.2010.03.042; Wang XJ, 2013, BIORESOURCE TECHNOL, V131, P172, DOI 10.1016/j.biortech.2012.12.174; Wang XJ, 2012, BIORESOURCE TECHNOL, V120, P78, DOI 10.1016/j.biortech.2012.06.058; WIEGANT WM, 1986, AGR WASTES, V16, P243, DOI 10.1016/0141-4607(86)90056-9; Wu X, 2010, BIORESOURCE TECHNOL, V101, P4042, DOI 10.1016/j.biortech.2010.01.052; Yen HW, 2007, BIORESOURCE TECHNOL, V98, P130, DOI 10.1016/j.biortech.2005.11.010; ZEEMAN G, 1985, AGR WASTES, V14, P19, DOI 10.1016/S0141-4607(85)80014-7; Zeshan, 2012, BIORESOURCE TECHNOL, V113, P294, DOI 10.1016/j.biortech.2012.02.028; Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066845	28	169	177	5	173	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97265	10.1371/journal.pone.0097265	http://dx.doi.org/10.1371/journal.pone.0097265			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24817003	Green Published, Green Submitted, gold			2022-12-27	WOS:000336838000125
J	Cuvelier, D; Legendre, P; Laes, A; Sarradin, PM; Sarrazin, J				Cuvelier, Daphne; Legendre, Pierre; Laes, Agathe; Sarradin, Pierre-Marie; Sarrazin, Jozee			Rhythms and Community Dynamics of a Hydrothermal Tubeworm Assemblage at Main Endeavour Field - A Multidisciplinary Deep-Sea Observatory Approach	PLOS ONE			English	Article							FUCA RIDGE; TIME-SERIES; VENTS; TEMPERATURE; HABITAT; SEGMENT; PISCESAE; EDIFICE; 9-DEGREES-50'N; DISTRIBUTIONS	The NEPTUNE cabled observatory network hosts an ecological module called TEMPO-mini that focuses on hydrothermal vent ecology and time series, granting us real-time access to data originating from the deep sea. In 2011-2012, during TEMPO-mini's first deployment on the NEPTUNE network, the module recorded high-resolution imagery, temperature, iron (Fe) and oxygen on a hydrothermal assemblage at 2186 m depth at Main Endeavour Field (North East Pacific). 23 days of continuous imagery were analysed with an hourly frequency. Community dynamics were analysed in detail for Ridgeia piscesae tubeworms, Polynoidae, Pycnogonida and Buccinidae, documenting faunal variations, natural change and biotic interactions in the filmed tubeworm assemblage as well as links with the local environment. Semi-diurnal and diurnal periods were identified both in fauna and environment, revealing the influence of tidal cycles. Species interactions were described and distribution patterns were indicative of possible microhabitat preference. The importance of high-resolution frequencies (< 1 h) to fully comprehend rhythms in fauna and environment was emphasised, as well as the need for the development of automated or semi-automated imagery analysis tools.	[Cuvelier, Daphne; Sarradin, Pierre-Marie; Sarrazin, Jozee] IFREMER, REM EEP, Ctr Bretagne, Lab Environm Profond,Inst Carnot Ifremer EDROME, Plouzane, France; [Legendre, Pierre] Univ Montreal, Dept Sci Biol, Montreal, PQ H3C 3J7, Canada; [Laes, Agathe] IFREMER, REM RDT, Ctr Bretagne,Inst Carnot Ifremer EDROME, Lab Detect Capteur & Mesures, Plouzane, France	Ifremer; Universite de Bretagne Occidentale; Universite de Montreal; Ifremer; Universite de Bretagne Occidentale	Cuvelier, D (corresponding author), IFREMER, REM EEP, Ctr Bretagne, Lab Environm Profond,Inst Carnot Ifremer EDROME, Plouzane, France.	daphne.cuvelier@gmail.com	Legendre, Pierre/U-9266-2019; Legendre, Pierre/C-8279-2013; Cuvelier, Daphne/AAD-6392-2020	Legendre, Pierre/0000-0002-3838-3305; Legendre, Pierre/0000-0002-3838-3305; Cuvelier, Daphne/0000-0003-4042-8215; Laes, Agathe/0000-0001-5758-0956	"Laboratoire d'Excellence" LabexMER - French government [ANR-10-LABX-19]; Institut Carnot Ifremer EDROME	"Laboratoire d'Excellence" LabexMER - French government; Institut Carnot Ifremer EDROME	This work was supported by the "Laboratoire d'Excellence" LabexMER (ANR-10-LABX-19), co-funded by a grant from the French government under the program "Investissements d'Avenir" and by a postdoctoral fellowship (D. Cuvelier) from Institut Carnot Ifremer EDROME. NEPTUNE Canada (Ocean Networks Canada) has provided us with access to their cabled network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi J, 2003, J CRUSTACEAN BIOL, V23, P749, DOI 10.1651/C-2394; Aguzzi J, 2010, MAR ECOL PROG SER, V418, P47, DOI 10.3354/meps08835; Andersen AC, 2006, CAN J ZOOL, V84, P1810, DOI 10.1139/Z06-168; Auffret Y, 2009, MART 2009 C P; Bain AB, 2004, INVERTEBR REPROD DEV, V43, P63; Bamber RN, 2009, ZOOTAXA, P56, DOI 10.11646/zootaxa.2140.1.7; Bergquist DC, 2007, MAR ECOL PROG SER, V330, P49, DOI 10.3354/meps330049; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bright M, 2010, OCEANOGR MAR BIOL, V48, P213; Britayev TA, 1999, CAH BIOL MAR, V40, P359; CHEVALDONNE P, 1991, DEEP-SEA RES, V38, P1417, DOI 10.1016/0198-0149(91)90014-7; Copley JTP, 1999, MAR ECOL-P S Z N I, V20, P291, DOI 10.1046/j.1439-0485.1999.2034076.x; Cuvelier D, 2012, MAR ENVIRON RES, V82, P15, DOI 10.1016/j.marenvres.2012.09.001; Cuvelier D, 2011, LIMNOL OCEANOGR, V56, P1624, DOI 10.4319/lo.2011.56.5.1624; De la Cruz M., 2008, INTRO ANALISIS ESPAC, P76; Desbruyeres D, 1998, CAH BIOL MAR, V39, P241; Desbruyeres D., 2006, HDB DEEP SEA HYDROTH, V18; Devey CW, 2007, OCEANOGRAPHY, V20, P162, DOI 10.5670/oceanog.2007.90; Dixon PM, 2002, ECOSCIENCE, V9, P142, DOI 10.1080/11956860.2002.11682700; Govenar BW, 2002, CAH BIOL MAR, V43, P247; Hautala S, 2012, OCEANOGRAPHY, V25, P192, DOI 10.5670/oceanog.2012.17; Juniper SK, 2013, DEEP-SEA RES PT II, V92, P114, DOI 10.1016/j.dsr2.2013.03.038; Le Bris N, 2006, MAR CHEM, V98, P167, DOI 10.1016/j.marchem.2005.08.008; Legendre P, 2012, NUMERICAL ECOLOGY, P306; Legendre P, 2012, WHITTAKER ROBINSON P; Levesque C, 2006, DEEP-SEA RES PT I, V53, P726, DOI 10.1016/j.dsr.2006.01.007; Macdonald IR, 2002, CAH BIOL MAR, V43, P395; Marcus J, 2009, DEEP-SEA RES PT II, V56, P1586, DOI 10.1016/j.dsr2.2009.05.004; Martell KA, 2002, J MOLLUS STUD, V68, P45, DOI 10.1093/mollus/68.1.45; Martin JW, 1998, B MAR SCI, V63, P189; McDuff R. E., 1997, ENDEAVOUR HYDROTHERM, V8, P11; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Puillat I, 2012, OCEANOGRAPHY, P3; R Core Team, 2012, R LANG ENV STAT COMP; Rasband WS, 1997, IMAGEJ; Robert K, 2012, J EXP MAR BIOL ECOL, V420, P69, DOI 10.1016/j.jembe.2012.03.019; Sarrazin J, 1999, MAR ECOL PROG SER, V190, P89, DOI 10.3354/meps190089; Sarrazin J, 1997, MAR ECOL PROG SER, V153, P5, DOI 10.3354/meps153005; Sarrazin J, 1999, MAR ECOL PROG SER, V185, P1, DOI 10.3354/meps185001; Sarrazin J., 2007, OCEANS 07 IEEE AB JU; Shank TM, 1998, DEEP-SEA RES PT II, V45, P465, DOI 10.1016/S0967-0645(97)00089-1; Struck TH, 2005, MAR BIOL RES, V1, P243, DOI 10.1080/17451000500261951; Thomsen L, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052462; Tivey MK, 2002, EARTH PLANET SC LETT, V202, P693, DOI 10.1016/S0012-821X(02)00801-4; TIVEY MK, 1986, EARTH PLANET SC LETT, V77, P303, DOI 10.1016/0012-821X(86)90142-1; Tsurumi M, 2003, DEEP-SEA RES PT I, V50, P611, DOI 10.1016/S0967-0637(03)00039-6; Tsurumi M, 2001, CAN J FISH AQUAT SCI, V58, P530, DOI 10.1139/cjfas-58-3-530; Tunnicliffe V, 1997, DEEP-SEA RES PT I, V44, P1627, DOI 10.1016/S0967-0637(97)00041-1; TUNNICLIFFE V, 1990, DEEP-SEA RES, V37, P103, DOI 10.1016/0198-0149(90)90031-P; TUNNICLIFFE V, 1990, PROG OCEANOGR, V24, P1, DOI 10.1016/0079-6611(90)90015-T; TUNNICLIFFE V, 1987, CAN J ZOOL, V65, P2443, DOI 10.1139/z87-369; Urcuyo IA, 2003, DEEP-SEA RES PT I, V50, P763, DOI 10.1016/S0967-0637(03)00061-X; VANDOVER CL, 1994, BIOL BULL, V186, P134, DOI 10.2307/1542043; Vuillemin R, 2009, DEEP-SEA RES PT I, V56, P1391, DOI 10.1016/j.dsr.2009.02.002; Warnes GR, 2012, GPLOTS VARIOUS R PRO; Zambrano-Bigiarini M., 2012, HYDROTSM TIME SERIES, V3, P3	57	40	40	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96924	10.1371/journal.pone.0096924	http://dx.doi.org/10.1371/journal.pone.0096924			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810603	Green Published, gold			2022-12-27	WOS:000338213300093
J	Feyissa, TR; Genemo, GA				Feyissa, Tesfaye Regassa; Genemo, Gebi Agero			Determinants of Institutional Delivery among Childbearing Age Women in Western Ethiopia, 2013: Unmatched Case Control Study	PLOS ONE			English	Article							NORTHWEST ETHIOPIA; HOME DELIVERY; BIRTH; CARE; PREVALENCE; ATTENDANCE; SERVICES; DISTRICT	Background: Place of delivery is a crucial factor which affects the health and wellbeing of the mother and newborn. Institutional delivery helps the women to access skilled assistance, drugs, equipment, and referral transport. Even though 34% of pregnant women received at least one antenatal care from a skilled provider in Ethiopia by 2013, institutional delivery was 10%. The main objective of the study was to assess determinants of institutional delivery in Western Ethiopia. Methods: Retrospective unmatched case control study design was used to assess determinants of institutional delivery in Western Ethiopia from September to October 2013. A total of 320 respondents from six districts of East Wollega zone, West Ethiopia were included. Data were collected using pretested and structured questionnaires. Data were entered and cleaned by Epi-info then exported and analyzed using SPSS software. Statistical significance was determined through a 95% confidence level. Results: Education [Adjusted Odds Ratio (AOR) (95% Confidence Interval (CI)) = 2.754(1.510-8.911)], family size [AOR (95% CI) = .454(.209-.984)], residence [AOR (95% CI) = 3.822 (1.766-8.272)] were important predictors of place of delivery. Four or more antenatal care [(ANC) (AOR (95% CI) = 2.914(1.105-7.682)], birth order [(AOR (95% CI) =.136(.054-.344), age at last delivery [(AOR (95% CI) = 9.995(2.101-47.556)], birth preparedness [AOR (95% CI) = 6.957(2.422-19.987)], duration of labour [AOR (95% CI) = 3.541(1.732-7.239)] were significantly associated with institutional delivery. Moreover service related factors such as distance from health institutions [AOR (95% CI) =.665(.173-.954)], respondents' awareness of skill of health care professionals [AOR (95% CI) = 2.454 (1.663-6.255)], mode of transportations [AOR (95% CI) = .258(.122-.549)] were significantly associated with institutional delivery. Conclusions and Recommendations: Policy makers, health service organizations, community leaders and other concerned bodies have to consider the predictors of institutional delivery like education, birth order, antenatal care utilization and residence to improve institutional delivery in the area.	[Feyissa, Tesfaye Regassa] Wollega Univ, Coll Med & Hlth Sci, Nekemte, Oromia, Ethiopia; [Genemo, Gebi Agero] Adama Univ, Sch Hlth Sci, Asella, Oromia, Ethiopia	Adama Science & Technology University	Feyissa, TR (corresponding author), Wollega Univ, Coll Med & Hlth Sci, Nekemte, Oromia, Ethiopia.	regassatesfaye@gmail.com	Feyissa, Tesfaye R/K-1003-2017; Agero, Gebi/ABG-0900-2022	Agero, Gebi/0000-0002-4610-4724; Feyissa, Tesfaye Regassa/0000-0002-6883-7312	Wollega University	Wollega University	Wollega University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdella A, 2010, ETHIOP J HEALTH DEV, V24, P115; Abebe Fantu, 2012, BMC Res Notes, V5, P653, DOI 10.1186/1756-0500-5-653; Adegoke AA, 2009, BJOG-INT J OBSTET GY, V116, P33, DOI 10.1111/j.1471-0528.2009.02336.x; Adegoke A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040220; Agha S, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-31; Assfaw YT, 2010, DETERMINANTS ANTENAT; Baral YR, 2010, U MED J, V8, P525; Carolyn JT, 2007, BMC PREGNANCY CHILDB, V7, P30; Crowe S, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-4; EDHS, 2011, ETH DEM HLTH SURV, P82; FDRE C, 2008, SUMM STAT REP 2007 P; Fikre AA, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-33; Frankenberg E, 2009, STUD FAMILY PLANN, V40, P27, DOI 10.1111/j.1728-4465.2009.00184.x; Hatt L, 2007, B WORLD HEALTH ORGAN, V85, P774, DOI 10.2471/BLT.06.033472; Joharifard S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1049; Kabakyenga JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035747; Karkee R, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-193; Lamina MA, 2011, ISRN OBSTET GYNECOLO, P30; Mehari A., 2013, LEVELS DETERMINANTS; Mengesha ZB, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-130; Prata N, 2011, J HEALTH POPUL NUTR, V29, P81; Ronsmans C, 2003, TROP MED INT HEALTH, V8, P940, DOI 10.1046/j.1365-3156.2003.01111.x; Shimazaki Azusa, 2013, Asia Pac Fam Med, V12, P5, DOI 10.1186/1447-056X-12-5; Teferra AS, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-74; Titaley CR, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-43; Tsegay Y, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-30; UNECA, 2009, 6 SESS COMM FOOD SEC, P27; UNFPA, 2014, MAT MORT UPD 2004 DE, P14; United Nations Economic Commissions [UNEC], 2013, ASS PROGR AFR MILL D, P57; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; WHO, 2011, MILL DEV GOALS REP, P28; Worku AG, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-20	32	57	57	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e97194	10.1371/journal.pone.0097194	http://dx.doi.org/10.1371/journal.pone.0097194			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810609	Green Submitted, Green Published, gold			2022-12-27	WOS:000338213300134
J	Hajian, R; Yusof, NA; Faragi, T; Shams, N				Hajian, Reza; Yusof, Nor Azah; Faragi, Tayebe; Shams, Nafiseh			Fabrication of an Electrochemical Sensor Based on Gold Nanoparticles/Carbon Nanotubes as Nanocomposite Materials: Determination of Myricetin in Some Drinks	PLOS ONE			English	Article							GLASSY-CARBON ELECTRODE; FLAVONOIDS; SURFACES; QUERCETIN; STABILITY; OXIDATION; AMINES; LEVEL; RUTIN	In this paper, the electrochemical behavior of myricetin on a gold nanoparticle/ethylenediamine/multi-walled carbon-nanotube modified glassy carbon electrode (AuNPs/en/MWCNTs/GCE) has been investigated. Myricetin effectively accumulated on the AuNPs/en/MWCNTs/GCE and caused a pair of irreversible redox peaks at around 0.408 V and 0.191 V (vs. Ag/AgCl) in 0.1 mol L-1 phosphate buffer solution (pH 3.5) for oxidation and reduction reactions respectively. The heights of the redox peaks were significantly higher on AuNPs/en/MWNTs/GCE compare with MWCNTs/GC and there was no peak on bare GC. The electron-transfer reaction for myricetin on the surface of electrochemical sensor was controlled by adsorption. Some parameters including pH, accumulation potential, accumulation time and scan rate have been optimized. Under the optimum conditions, anodic peak current was proportional to myricetin concentration in the dynamic range of 5.0x10(-8) to 4.0x10(-5) mol L-1 with the detection limit of 1.2x10(-8) mol L-1. The proposed method was successfully used for the determination of myricetin content in tea and fruit juices.	[Hajian, Reza; Yusof, Nor Azah; Shams, Nafiseh] Univ Putra Malaysia, Inst Adv Technol, Serdang, Selangor, Malaysia; [Yusof, Nor Azah] Univ Putra Malaysia, Fac Sci, Dept Chem, Serdang, Selangor, Malaysia; [Faragi, Tayebe] Islamic Azad Univ, Gachsaran Branch, Fac Sci, Dept Chem, Gachsaran, Iran	Universiti Putra Malaysia; Universiti Putra Malaysia; Islamic Azad University	Hajian, R (corresponding author), Univ Putra Malaysia, Inst Adv Technol, Serdang, Selangor, Malaysia.	rezahajian@putra.upm.edu.my		Yusof, Nor Azah/0000-0002-1400-5764	Prototype Research Grant Scheme (PRGS) from Ministry of Education Malaysia (MOE) [5530100]	Prototype Research Grant Scheme (PRGS) from Ministry of Education Malaysia (MOE)	The authors wish to thank Prototype Research Grant Scheme (PRGS) vot number 5530100 from Ministry of Education Malaysia (MOE) for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adenier A, 2004, LANGMUIR, V20, P8243, DOI 10.1021/la049194c; BARBIER B, 1990, J ELECTROCHEM SOC, V137, P1757, DOI 10.1149/1.2086794; Bard A. J., 1980, ELECTROCHEMICAL METH, P218; BARD AJ, 1980, ELECTROCHEMICAL METH, P525; Chen SW, 1999, J PHYS CHEM B, V103, P9996, DOI 10.1021/jp992681u; Cruickshank AC, 2007, ELECTROCHEM COMMUN, V9, P1456, DOI 10.1016/j.elecom.2007.02.004; Cruickshank AC, 2009, ELECTROCHIM ACTA, V54, P5566, DOI 10.1016/j.electacta.2009.04.060; Dajas F, 2003, NEUROTOX RES, V5, P425, DOI 10.1007/BF03033172; DEINHAMMER RS, 1994, LANGMUIR, V10, P1306, DOI 10.1021/la00016a054; Downard AJ, 2006, NEW J CHEM, V30, P1283, DOI 10.1039/b605219c; Ensafi AA, 2006, ELECTROANAL, V18, P579, DOI 10.1002/elan.200503433; Haruta M, 1997, CATAL TODAY, V36, P153, DOI 10.1016/S0920-5861(96)00208-8; Iljima S, 1991, NATURE, V354, P56; Kumar A, 2009, ANAL CHIM ACTA, V631, P177, DOI 10.1016/j.aca.2008.10.038; Li JZ, 2001, CHEM COMMUN, P2170, DOI 10.1039/b106961f; Liu IM, 2006, J ETHNOPHARMACOL, V104, P199, DOI 10.1016/j.jep.2005.09.001; Melrnikova NB, 2002, CHEM NAT COMPD, V38, P33; Mira L, 2002, FREE RADICAL RES, V36, P1199, DOI 10.1080/1071576021000016463; NICHOLSON RS, 1964, ANAL CHEM, V36, P706, DOI 10.1021/ac60210a007; Sadik OA, 2003, ELECTROANAL, V15, P1149, DOI 10.1002/elan.200390140; SAFAVI A, 1991, ANAL CHIM ACTA, V252, P121, DOI 10.1016/0003-2670(91)87205-L; Scheidt HA, 2004, BBA-BIOMEMBRANES, V1663, P97, DOI 10.1016/j.bbamem.2004.02.004; Subramanian V, 2003, J PHYS CHEM B, V107, P7479, DOI 10.1021/jp0275037; Wang YR, 2008, CHINESE J ANAL CHEM, V36, P1011, DOI 10.1016/S1872-2040(08)60052-3; Welch CM, 2006, ANAL BIOANAL CHEM, V384, P601, DOI 10.1007/s00216-005-0230-3; Yang SL, 2010, J ELECTROANAL CHEM, V645, P115, DOI 10.1016/j.jelechem.2010.04.019; Yang SL, 2010, J ELECTROANAL CHEM, V639, P77, DOI 10.1016/j.jelechem.2009.11.025; Zhu T, 2011, CHINESE J CHEM, V29, P1759, DOI 10.1002/cjoc.201180280	28	26	27	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96686	10.1371/journal.pone.0096686	http://dx.doi.org/10.1371/journal.pone.0096686			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809346	Green Submitted, Green Published, gold			2022-12-27	WOS:000338213300061
J	Kim, KX; Sanneman, JD; Kim, HM; Harbidge, DG; Xu, J; Soleimani, M; Wangemann, P; Marcus, DC				Kim, Kyunghee X.; Sanneman, Joel D.; Kim, Hyoung-Mi; Harbidge, Donald G.; Xu, Jie; Soleimani, Manoocher; Wangemann, Philine; Marcus, Daniel C.			Slc26a7 Chloride Channel Activity and Localization in Mouse Reissner's Membrane Epithelium	PLOS ONE			English	Article							STRIA VASCULARIS; MARGINAL CELLS; COCHLEAR; HEARING; SELECTIVITY; EXPRESSION; TRANSPORT; PENDRIN; FAMILY	Several members of the SLC26 gene family have highly-restricted expression patterns in the auditory and vestibular periphery and mutations in mice of at least two of these (SLC26A4 and SLC26A5) lead to deficits in hearing and/or balance. A previous report pointed to SLC26A7 as a candidate gene important for cochlear function. In the present study, inner ears were assayed by immunostaining for Slc26a7 in neonatal and adult mice. Slc26a7 was detected in the basolateral membrane of Reissner's membrane epithelial cells but not neighboring cells, with an onset of expression at P5; gene knockout resulted in the absence of protein expression in Reissner's membrane. Whole-cell patch clamp recordings revealed anion currents and conductances that were elevated for NO3- over Cl- and inhibited by I- and NPPB. Elevated NO3- currents were absent in Slc26a7 knockout mice. There were, however, no major changes to hearing (auditory brainstem response) of knockout mice during early adult life under constitutive and noise exposure conditions. The lack of Slc26a7 protein expression found in the wild-type vestibular labyrinth was consistent with the observation of normal balance. We conclude that SLC26A7 participates in Cl- transport in Reissner's membrane epithelial cells, but that either other anion pathways, such as ClC-2, possibly substitute satisfactorily under the conditions tested or that Cl- conductance in these cells is not critical to cochlear function. The involvement of SLC26A7 in cellular pH regulation in other epithelial cells leaves open the possibility that SLC26A7 is needed in Reissner's membrane cells during local perturbations of pH.	[Kim, Kyunghee X.; Harbidge, Donald G.; Marcus, Daniel C.] Kansas State Univ, Dept Anat & Physiol, Cellular Biophys Lab, Manhattan, KS 66506 USA; [Sanneman, Joel D.; Kim, Hyoung-Mi; Wangemann, Philine] Kansas State Univ, Dept Anat & Physiol, Cell Physiol Lab, Manhattan, KS 66506 USA; [Xu, Jie; Soleimani, Manoocher] Univ Cincinnati, Dept Med, Cincinnati, OH USA; [Xu, Jie; Soleimani, Manoocher] Univ Cincinnati, Ctr Genet Transport, Cincinnati, OH USA	Kansas State University; Kansas State University; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Marcus, DC (corresponding author), Kansas State Univ, Dept Anat & Physiol, Cellular Biophys Lab, Manhattan, KS 66506 USA.	marcus@ksu.edu			National Institutes of Health [R01-DC012151, R01-DC00212, P20-RR017686]; Department of Veterans Affairs; Center on Genetics of Transport and Epithelial Biology at the University of Cincinnati; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012151, R01DC000212] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Center on Genetics of Transport and Epithelial Biology at the University of Cincinnati; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the National Institutes of Health: R01-DC012151 (PW), R01-DC00212 (DCM), and P20-RR017686 (DCM). Further support (MS) was from a Merit Review award from the Department of Veterans Affairs and from the Center on Genetics of Transport and Epithelial Biology at the University of Cincinnati. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper SL, 2013, MOL ASPECTS MED, V34, P494, DOI 10.1016/j.mam.2012.07.009; Eisen MD, 2007, CELL MOL LIFE SCI, V64, P566, DOI 10.1007/s00018-007-6417-3; Furukawa T, 1998, AM J PHYSIOL-CELL PH, V274, pC500, DOI 10.1152/ajpcell.1998.274.2.C500; HAGIWARA S, 1963, Arch Histol Jpn, V24, P187; Jabba SV, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-37; KIKUCHI T, 1995, ANAT EMBRYOL, V191, P101, DOI 10.1007/BF00186783; Kim CH, 2009, NEUROREPORT, V20, P1275, DOI 10.1097/WNR.0b013e32833017eb; Kim KH, 2005, J BIOL CHEM, V280, P6463, DOI 10.1074/jbc.M409162200; Kim KX, 2010, BIOCHEM BIOPH RES CO, V394, P434, DOI 10.1016/j.bbrc.2010.03.048; Kim SH, 2009, AM J PHYSIOL-CELL PH, V296, pC544, DOI 10.1152/ajpcell.00338.2008; King M, 1998, NEUROREPORT, V9, P2467, DOI 10.1097/00001756-199808030-00008; Kosiek O, 2007, PFLUG ARCH EUR J PHY, V454, P989, DOI 10.1007/s00424-007-0254-y; Lee JH, 2003, NEUROSCIENCE, V119, P3, DOI 10.1016/S0306-4522(03)00104-0; Li XM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003641; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Ma WH, 2012, PFLUG ARCH EUR J PHY, V463, P585, DOI 10.1007/s00424-012-1077-z; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; MARCUS DC, 1993, HEARING RES, V69, P124, DOI 10.1016/0378-5955(93)90100-F; Marcus DC, 2010, OXFORD HDB AUDITORY, P213; Marcus DC., 2012, CELL PHYSL SOURCE BO, V4th ed., P649; Muller M, 2005, HEARING RES, V202, P63, DOI 10.1016/j.heares.2004.08.011; Ohana E, 2009, J PHYSIOL-LONDON, V587, P2179, DOI 10.1113/jphysiol.2008.164863; Petrovic S, 2004, AM J PHYSIOL-RENAL, V286, pF161, DOI 10.1152/ajprenal.00219.2003; Shen ZJ, 1997, AUDIT NEUROSCI, V3, P215; Singh R, 2005, AM J PHYSIOL-CELL PH, V288, pC1179, DOI 10.1152/ajpcell.00258.2004; Takeuchi S, 1996, J MEMBRANE BIOL, V150, P47, DOI 10.1007/s002329900029; WANGEMANN P, 1992, HEARING RES, V62, P149, DOI 10.1016/0378-5955(92)90180-U; Wangemann P, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-30; Wangemann P, 2013, CELL PHYSIOL BIOCHEM, V32, P157, DOI 10.1159/000356635; Wangemann P, 2011, CELL PHYSIOL BIOCHEM, V28, P527, DOI 10.1159/000335113; Wangemann P, 2009, AM J PHYSIOL-RENAL, V297, pF1435, DOI 10.1152/ajprenal.00011.2009; Xu J, 2009, J BIOL CHEM, V284, P29470, DOI 10.1074/jbc.M109.044396; Yamazaki Muneharu, 2011, BMC Physiology, V11, P4, DOI 10.1186/1472-6793-11-4	33	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e97191	10.1371/journal.pone.0097191	http://dx.doi.org/10.1371/journal.pone.0097191			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810589	Green Published, gold, Green Submitted			2022-12-27	WOS:000338213300132
J	Donica, CL; Cui, Y; Shi, SP; Gutstein, HB				Donica, Courtney L.; Cui, Yan; Shi, Shanping; Gutstein, Howard B.			Platelet-Derived Growth Factor Receptor-beta Antagonism Restores Morphine Analgesic Potency against Neuropathic Pain	PLOS ONE			English	Article							NERVOUS-SYSTEM; B-CHAIN; MECHANISMS; TOLERANCE; MODEL; PDGF	Background: Chronic, intractable pain is a problem of pandemic proportions. Pain caused by nerve injuries (neuropathic pain) is extremely difficult to treat. For centuries, opiates such as morphine have been the first-line treatment for severe chronic pain. However, opiates are often ineffective against neuropathic pain, leaving few options for suffering patients. We previously demonstrated that platelet-derived growth factor-beta (PDGFR-beta) inhibition completely eliminated morphine tolerance. In these studies, we determined whether PDGFR-beta inhibition could improve the effectiveness of morphine for neuropathic pain treatment. Results and Findings: Spinal nerve ligation was performed in male Sprague-Dawley rats. The clinically used PDGFR antagonist imatinib did not relieve mechanical pain in a nerve injury model as determined by Von Frey assay. Surprisingly, combining imatinib with a previously ineffective dose of morphine led to complete pain relief. Scavenging released PDGF-B also markedly augmented the analgesic effect of morphine. Conclusions: These findings suggest the novel hypothesis that PDGF-B released by injured nerves renders animals resistant to morphine, implying that PDGFR-beta inhibition could potentially eliminate the tremendous suffering caused by neuropathic pain.	[Donica, Courtney L.; Cui, Yan; Shi, Shanping; Gutstein, Howard B.] Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol, Houston, TX 77030 USA; [Gutstein, Howard B.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Genes & Dev Grad Program, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Gutstein, HB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol, Houston, TX 77030 USA.	hgutstein@mdanderson.org	Hunt, Courtney/W-4413-2019	Donica, Courtney/0000-0001-5184-4113	Cancer Prevention and Research Institute of Texas [RP 120408]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036680] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by grant number RP 120408 from the Cancer Prevention and Research Institute of Texas to H.B.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIAN D, 1995, NEUROREPORT, V6, P1981, DOI 10.1097/00001756-199510010-00007; Board of Health Sciences Policy, 2011, REL PAIN AM BLUEPR T; Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chung JM, 2004, METH MOLEC MED, P35; Collett BJ, 1998, BRIT J ANAESTH, V81, P58, DOI 10.1093/bja/81.1.58; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Dworkin RH, 2007, PAIN, V132, P237, DOI 10.1016/j.pain.2007.08.033; ECCLESTON PA, 1993, DEV BIOL, V155, P459, DOI 10.1006/dbio.1993.1044; Gutstein HB, 2006, GOODMAN GILMANS PHAR, P547; MAO JR, 1995, PAIN, V62, P259, DOI 10.1016/0304-3959(95)00073-2; Masuda J, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-23; Mayer DJ, 1999, P NATL ACAD SCI USA, V96, P7731, DOI 10.1073/pnas.96.14.7731; Przewlocka B, 1999, EUR J PHARMACOL, V367, P189, DOI 10.1016/S0014-2999(98)00956-X; Przewlocki R, 2001, EUR J PHARMACOL, V429, P79, DOI 10.1016/S0014-2999(01)01308-5; Rice ASC, 2006, ANNU REV MED, V57, P535, DOI 10.1146/annurev.med.57.121304.131324; SASAHARA A, 1992, DEV BRAIN RES, V68, P41, DOI 10.1016/0165-3806(92)90246-S; SASAHARA M, 1991, CELL, V64, P217, DOI 10.1016/0092-8674(91)90223-L; Wang Y, 2012, NAT MED, V18, P385, DOI 10.1038/nm.2633; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; Xu JJ, 2006, ANESTH ANALG, V103, P714, DOI 10.1213/01.ane.0000226100.46866.ea	21	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97105	10.1371/journal.pone.0097105	http://dx.doi.org/10.1371/journal.pone.0097105			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24820332	Green Published, gold, Green Submitted			2022-12-27	WOS:000336653300074
J	Gunda, B; Porcher, R; Duering, M; Guichard, JP; Mawet, J; Jouvent, E; Dichgans, M; Chabriat, H				Gunda, Bence; Porcher, Raphael; Duering, Marco; Guichard, Jean-Pierre; Mawet, Jerome; Jouvent, Eric; Dichgans, Martin; Chabriat, Hugues			ADC Histograms from Routine DWI for Longitudinal Studies in Cerebral Small Vessel Disease: A Field Study in CADASIL	PLOS ONE			English	Article							WHOLE-BRAIN HISTOGRAM; DIFFUSION TENSOR MRI; COGNITIVE IMPAIRMENT; MULTIPLE-SCLEROSIS; GRAY-MATTER; TISSUE; LEUKOARAIOSIS; PROGRESSION; DISABILITY; ATROPHY	Diffusion tensor imaging (DTI) histogram metrics are correlated with clinical parameters in cerebral small vessel diseases (cSVD). Whether ADC histogram parameters derived from simple diffusion weighted imaging (DWI) can provide relevant markers for long term studies of cSVD remains unknown. CADASIL patients were evaluated by DWI and DTI in a large cohort study overa6-year period. ADC histogram parameters were compared to those derived from mean diffusivity (MD) histograms in 280 patients using intra-class correlation and Bland-Altman plots. Impact of image corrections applied to ADC maps was assessed and a mixed effect model was used for analyzing the effects of scanner upgrades. The results showed that ADC histogram parameters are strongly correlated to MD histogram parameters and that image corrections have only limited influence on these results. Unexpectedly, scanner upgrades were found to have major effects on diffusion measures with DWI or DTI that can be even larger than those related to patients' characteristics. These data support that ADC histograms from daily used DWI can provide relevant parameters for assessing cSVD, but the variability related to scanner upgrades as regularly performed in clinical centers should be determined precisely for longitudinal and multicentric studies using diffusion MRI in cSVD.	[Gunda, Bence] Semmelweis Univ, Dept Neurol, H-1085 Budapest, Hungary; [Gunda, Bence; Guichard, Jean-Pierre; Mawet, Jerome; Chabriat, Hugues] Univ Paris Denis Diderot, Paris, France; [Gunda, Bence; Mawet, Jerome; Chabriat, Hugues] APHP, DHU NeuroVasc, CHU Lariboisie, Dept Neurol, Paris, France; [Guichard, Jean-Pierre] APHP, DHU NeuroVasc, CHU Lariboisie, Dept Neurol, Paris, France; [Jouvent, Eric; Chabriat, Hugues] INSERM, UMR 1161, Paris, France; [Porcher, Raphael] Univ Paris 05, Paris, France; [Duering, Marco; Dichgans, Martin] Univ Munich, Klinikum Univ Munchen, Inst Stroke & Dementia Res, Munich, Germany; [Dichgans, Martin] Munich Cluster Syst Neurol, Munich, Germany	Semmelweis University; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Munich	Chabriat, H (corresponding author), APHP, DHU NeuroVasc, CHU Lariboisie, Dept Neurol, Paris, France.	hugues.chabriat@lrb.aphp.fr	Dichgans, Martin/HCH-3247-2022; Duering, Marco/AAE-6949-2021; Jouvent, Eric/B-4320-2014; Chabriat, Hugues/G-5699-2010	Dichgans, Martin/0000-0002-0654-387X; Duering, Marco/0000-0003-2302-3136; Jouvent, Eric/0000-0001-7797-2236; Chabriat, Hugues/0000-0001-8436-6074; Porcher, Raphael/0000-0002-5277-4679	European Federation of Neurological Societies (EFNS); Institut Servier; PHRC [AOR 02-001 (DRC/APHP)]	European Federation of Neurological Societies (EFNS); Institut Servier; PHRC	Dr. Bence Gunda received grants from the European Federation of Neurological Societies (EFNS) and Institut Servier for this research. This work was supported by PHRC grant AOR 02-001 (DRC/APHP) and performed with the help of ARNEVA (Association de Recherche en Neurologie VAsculaire), HApital Lariboisiere, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cercignani M, 2003, AM J NEURORADIOL, V24, P638; Chabriat H, 1999, STROKE, V30, P2637, DOI 10.1161/01.STR.30.12.2637; Chabriat H, 2005, STROKE, V36, P2526, DOI 10.1161/01.STR.0000189700.57117.11; Chabriat H, 1998, NEUROLOGY, V51, P452, DOI 10.1212/WNL.51.2.452; Chabriat H, 2009, LANCET NEUROL, V8, P643, DOI 10.1016/S1474-4422(09)70127-9; Charlton RA, 2010, J NEUROL NEUROSUR PS, V81, P13, DOI 10.1136/jnnp.2008.167288; Chua TC, 2008, CURR OPIN NEUROL, V21, P83, DOI 10.1097/WCO.0b013e3282f4594b; Della Nave R, 2007, AM J NEURORADIOL, V28, P1313, DOI 10.3174/ajnr.A0555; Dichgans M, 2003, AM J NEURORADIOL, V24, P1083; Fox RJ, 2012, AM J NEURORADIOL, V33, P695, DOI 10.3174/ajnr.A2844; Giannelli M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086280; Holtmannspotter M, 2005, STROKE, V36, P2559, DOI 10.1161/01.STR.0000189696.70989.a4; Jouvent E, 2007, STROKE, V38, P1786, DOI 10.1161/STROKEAHA.106.478263; Kin T, 2006, AM J NEURORADIOL, V27, P1463; Mascalchi M, 2002, NEUROLOGY, V59, P938, DOI 10.1212/WNL.59.6.938; Mascalchi M, 2005, RADIOL MED, V109, P155; Molko N, 2002, STROKE, V33, P2902, DOI 10.1161/01.STR.0000041681.25514.22; Molko N, 2001, STROKE, V32, P2049, DOI 10.1161/hs0901.094255; Nitkunan A, 2008, STROKE, V39, P1999, DOI 10.1161/STROKEAHA.107.507475; Nitkunan A, 2008, MAGN RESON MED, V59, P528, DOI 10.1002/mrm.21461; Nusbaum AO, 2000, NEUROLOGY, V54, P1421, DOI 10.1212/WNL.54.7.1421; Nusbaum AO, 2001, AM J NEURORADIOL, V22, P136; O'Sullivan M, 2004, NEUROLOGY, V62, P702, DOI 10.1212/01.WNL.0000113760.72706.D2; Pagani E, 2010, J MAGN RESON IMAGING, V31, P1458, DOI 10.1002/jmri.22186; Rovaris M, 2003, RADIOLOGY, V227, P731, DOI 10.1148/radiol.2273020721; Rovaris M, 2002, ARCH NEUROL-CHICAGO, V59, P1406, DOI 10.1001/archneur.59.9.1406; Schmidt R, 2010, STROKE, V41, pE402, DOI 10.1161/STROKEAHA.109.576629; Steens Stefan C A, 2004, Eur Radiol, V14, P425, DOI 10.1007/s00330-003-2121-3; Tessa C, 2008, AM J NEURORADIOL, V29, P674, DOI 10.3174/ajnr.A0900; Viswanathan A, 2006, BRAIN, V129, P2375, DOI 10.1093/brain/awl177; Vrenken H, 2006, J MAGN RESON IMAGING, V23, P628, DOI 10.1002/jmri.20564	31	18	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97173	10.1371/journal.pone.0097173	http://dx.doi.org/10.1371/journal.pone.0097173			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819368	Green Published, Green Submitted, gold			2022-12-27	WOS:000336653300086
J	Masani, MYA; Noll, GA; Parveez, GKA; Sambanthamurthi, R; Prufer, D				Masani, Mat Yunus Abdul; Noll, Gundula A.; Parveez, Ghulam Kadir Ahmad; Sambanthamurthi, Ravigadevi; Pruefer, Dirk			Efficient Transformation of Oil Palm Protoplasts by PEG-Mediated Transfection and DNA Microinjection	PLOS ONE			English	Article							GENE; EXPRESSION	Background: Genetic engineering remains a major challenge in oil palm (Elaeis guineensis) because particle bombardment and Agrobacterium-mediated transformation are laborious and/or inefficient in this species, often producing chimeric plants and escapes. Protoplasts are beneficial as a starting material for genetic engineering because they are totipotent, and chimeras are avoided by regenerating transgenic plants from single cells. Novel approaches for the transformation of oil palm protoplasts could therefore offer a new and efficient strategy for the development of transgenic oil palm plants. Methodology/Principal Findings: We recently achieved the regeneration of healthy and fertile oil palms from protoplasts. Therefore, we focused on the development of a reliable PEG-mediated transformation protocol for oil palm protoplasts by establishing and validating optimal heat shock conditions, concentrations of DNA, PEG and magnesium chloride, and the transfection procedure. We also investigated the transformation of oil palm protoplasts by DNA microinjection and successfully regenerated transgenic microcalli expressing green fluorescent protein as a visible marker to determine the efficiency of transformation. Conclusions/Significance: We have established the first successful protocols for the transformation of oil palm protoplasts by PEG-mediated transfection and DNA microinjection. These novel protocols allow the rapid and efficient generation of non-chimeric transgenic callus and represent a significant milestone in the use of protoplasts as a starting material for the development of genetically-engineered oil palm plants.	[Masani, Mat Yunus Abdul; Parveez, Ghulam Kadir Ahmad; Sambanthamurthi, Ravigadevi] MPOB, Adv Biotechnol & Breeding Ctr, Kuala Lumpur, Malaysia; [Noll, Gundula A.; Pruefer, Dirk] Univ Munster, Inst Biol & Biotechnol Pflanzen, D-48149 Munster, Germany; [Pruefer, Dirk] Fraunhofer Inst Molekularbiol & Angew Okol, D-48149 Munster, Germany	Malaysian Palm Oil Board; University of Munster; Fraunhofer Gesellschaft	Masani, MYA (corresponding author), MPOB, Adv Biotechnol & Breeding Ctr, Kuala Lumpur, Malaysia.	masani@mpob.gov.my; dpruefer@uni-muenster.de	Yunus, Abdul Masani Mat/AAE-1020-2020; Parveez, Ghulam Kadir Ahmad/E-8272-2015	Yunus, Abdul Masani Mat/0000-0003-0704-2900; Parveez, Ghulam Kadir Ahmad/0000-0002-1092-3437; Sambanthamurthi, Ravi/0000-0003-3023-9306; Noll, Gundula/0000-0002-1137-9891	MPOB-Fraunhofer collaborative project "Establishment of transgenic oil palm with high added value for commercial exploitation'' [T0003050000-RB01-J]; internal resources of the Institute of Plant Biology and Biotechnology of the Westfalische Wilhelms-Universitat Munster	MPOB-Fraunhofer collaborative project "Establishment of transgenic oil palm with high added value for commercial exploitation''; internal resources of the Institute of Plant Biology and Biotechnology of the Westfalische Wilhelms-Universitat Munster	This research was funded by the MPOB-Fraunhofer collaborative project "Establishment of transgenic oil palm with high added value for commercial exploitation'' (T0003050000-RB01-J) and internal resources of the Institute of Plant Biology and Biotechnology of the Westfalische Wilhelms-Universitat Munster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah R, 2005, ELECTRON J BIOTECHN, V8, P24; Bhore S. J., 2012, World Applied Sciences Journal, V16, P362; CHEAH SC, 1994, PLANT LIPID METABOLISM, P570; CROSSWAY A, 1986, MOL GEN GENET, V202, P179, DOI 10.1007/BF00331634; Gelvin SB, 1998, CURR OPIN BIOTECH, V9, P227, DOI 10.1016/S0958-1669(98)80120-1; GOULD J, 1991, PLANT PHYSIOL, V95, P426, DOI 10.1104/pp.95.2.426; Ismail I, 2010, AUST J CROP SCI, V4, P37; KOST B, 1995, J EXP BOT, V46, P1157, DOI 10.1093/jxb/46.9.1157; Lee MP, 2006, ELECTRON J BIOTECHN, V9, P117, DOI 10.2225/vol9-issue2-fulltext-3; MAAS C, 1989, PLANT CELL REP, V8, P148, DOI 10.1007/BF00716828; Majid N. A., 2007, ASIA PACIFIC J MOL B, V15, P1; Masani MYA, 2013, PLANT SCI, V210, P118, DOI 10.1016/j.plantsci.2013.05.021; Masani MYA, 2009, PLASMID, V62, P191, DOI 10.1016/j.plasmid.2009.08.002; Masli DIA, 2009, J OIL PALM RES, V21, P643; NEGRUTIU I, 1987, PLANT MOL BIOL, V8, P363, DOI 10.1007/BF00015814; Parveez G. K. A., 2003, AgBiotechNet, V5, P1; Parveez G. K. A., 1998, Journal of Oil Palm Research, V10, P29; Parveez G. K. A., 1998, THESIS U PUTRA MALAY; Parveez GKA, 2008, J OIL PALM RES, P77; Parveez GKA, 2000, BIOCHEM SOC T, V28, P969, DOI 10.1042/BST0280969; RAINERI DM, 1990, BIO-TECHNOL, V8, P33, DOI 10.1038/nbt0190-33; REICH TJ, 1986, BIO-TECHNOL, V4, P1001, DOI 10.1038/nbt1186-1001; Sambanthamurthi R., 2002, Planter, V78, P547; Sambanthamurthi R, 1996, PLANT CELL TISS ORG, V46, P35, DOI 10.1007/BF00039694; Schnorf Martin, 1991, Transgenic Research, V1, P23, DOI 10.1007/BF02512993; Tuteja N, 2012, J BIOSCIENCES, V37, P167, DOI 10.1007/s12038-012-9187-5; Twyman RM, 2002, MOLEC METH PLAN ANAL, V22, P1; Yunus AMM, 2008, J OIL PALM RES, P37; Yunus AMM, 2008, ELECTRON J BIOTECHN, V11, DOI 10.2225/vol11-issue3-fulltext-7	29	68	71	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96831	10.1371/journal.pone.0096831	http://dx.doi.org/10.1371/journal.pone.0096831			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24821306	gold, Green Published, Green Submitted			2022-12-27	WOS:000336653300037
J	Mera, P; Mir, JF; Fabrias, G; Casas, J; Costa, ASH; Malandrino, MI; Fernandez-Lopez, JA; Remesar, X; Gao, S; Chohnan, S; Rodriguez-Pena, MS; Petry, H; Asins, G; Hegardt, FG; Herrero, L; Serra, D				Mera, Paula; Francesc Mir, Joan; Fabrias, Gemma; Casas, Josefina; Costa, Ana S. H.; Ida Malandrino, Maria; Fernandez-Lopez, Jose-Antonio; Remesar, Xavier; Gao, Su; Chohnan, Shigeru; Rodriguez-Pena, Maria Sol; Petry, Harald; Asins, Guillermina; Hegardt, Fausto G.; Herrero, Laura; Serra, Dolors			Long-Term Increased Carnitine Palmitoyltransferase 1A Expression in Ventromedial Hypotalamus Causes Hyperphagia and Alters the Hypothalamic Lipidomic Profile	PLOS ONE			English	Article							FATTY-ACID-METABOLISM; ACETYL-COA CARBOXYLASE; MALONYL-COA; FOOD-INTAKE; BODY-WEIGHT; GHRELIN; ENERGY; NUCLEUS; NEURONS; RAT	Lipid metabolism in the ventromedial hypothalamus (VMH) has emerged as a crucial pathway in the regulation of feeding and energy homeostasis. Carnitine palmitoyltransferase (CPT) 1A is the rate-limiting enzyme in mitochondrial fatty acid beta-oxidation and it has been proposed as a crucial mediator of fasting and ghrelin orexigenic signalling. However, the relationship between changes in CPT1A activity and the intracellular downstream effectors in the VMH that contribute to appetite modulation is not fully understood. To this end, we examined the effect of long-term expression of a permanently activated CPT1A isoform by using an adeno-associated viral vector injected into the VMH of rats. Peripherally, this procedure provoked hyperghrelinemia and hyperphagia, which led to overweight, hyperglycemia and insulin resistance. In the mediobasal hypothalamus (MBH), long-term CPT1AM expression in the VMH did not modify acyl-CoA or malonyl-CoA levels. However, it altered the MBH lipidomic profile since ceramides and sphingolipids increased and phospholipids decreased. Furthermore, we detected increased vesicular gamma-aminobutyric acid transporter (VGAT) and reduced vesicular glutamate transporter 2 (VGLUT2) expressions, both transporters involved in this orexigenic signal. Taken together, these observations indicate that CPT1A contributes to the regulation of feeding by modulating the expression of neurotransmitter transporters and lipid components that influence the orexigenic pathways in VMH.	[Mera, Paula; Francesc Mir, Joan; Costa, Ana S. H.; Ida Malandrino, Maria; Asins, Guillermina; Hegardt, Fausto G.; Herrero, Laura; Serra, Dolors] Univ Barcelona, Fac Farm, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain; [Mera, Paula; Francesc Mir, Joan; Costa, Ana S. H.; Ida Malandrino, Maria; Fernandez-Lopez, Jose-Antonio; Remesar, Xavier; Asins, Guillermina; Hegardt, Fausto G.; Herrero, Laura; Serra, Dolors] Univ Barcelona, Inst Biomed, E-08028 Barcelona, Spain; [Mera, Paula; Francesc Mir, Joan; Costa, Ana S. H.; Ida Malandrino, Maria; Fernandez-Lopez, Jose-Antonio; Remesar, Xavier; Asins, Guillermina; Hegardt, Fausto G.; Herrero, Laura; Serra, Dolors] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBERobn, Barcelona, Spain; [Fabrias, Gemma; Casas, Josefina] CSIC, IQAC, Inst Adv Chem Catalonia, Dept Biomed Chem,Res Unit BioAct Mol, Barcelona, Spain; [Fernandez-Lopez, Jose-Antonio; Remesar, Xavier] Univ Barcelona, Fac Biol, Dept Nutr & Food Sci, E-08028 Barcelona, Spain; [Gao, Su] Scripps Res Inst, Jupiter, FL USA; [Chohnan, Shigeru] Ibaraki Univ, Coll Agr, Dept Bioresource Sci, Ibaraki, Japan; [Rodriguez-Pena, Maria Sol; Petry, Harald] UniQure, Amsterdam, Netherlands	University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); University of Barcelona; Scripps Research Institute; Ibaraki University	Herrero, L (corresponding author), Univ Barcelona, Fac Farm, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain.	lherrero@ub.edu; dserra@ub.edu	Herrero, Laura/D-4011-2014; López, José Antonio Fernández/C-5467-2017; MERA, PAULA/AAA-7018-2019; Serra, Dolors/L-3657-2014; Chohnan, Shigeru/W-1580-2019; Costa, Ana/HDL-9297-2022; Casas, Josefina/L-7934-2014; Gao, Su/E-6864-2016; Remesar, Xavier/G-5703-2013; Costa, Ana SH/H-2852-2012; Remesar, Xavier/L-4555-2019; Chohnan, Shigeru/AAS-8040-2020	Herrero, Laura/0000-0003-4244-4673; López, José Antonio Fernández/0000-0002-2856-7223; Serra, Dolors/0000-0002-4936-4206; Gao, Su/0000-0002-0403-5783; Remesar, Xavier/0000-0002-9707-7287; Costa, Ana SH/0000-0001-8932-6370; Remesar, Xavier/0000-0002-9707-7287; Chohnan_, Shigeru/0000-0002-4624-927X; Mir, Joan Francesc/0000-0001-8501-0969; Fabrias, Gemma/0000-0001-7162-3772; Mera, Paula/0000-0001-8941-4637	Spanish Ministry of Economy and Competitiveness [SAF2011-30520-C02-01, SAF2010-20039]; CIBER Fisiopatologia de la Obesidad y la Nutricion (CIBEROBN); Instituto de Salud Carlos III [CB06/03/0026]; European Foundation for the Study of Diabetes (EFSD)/Lilly and European Foundation for the Study of Diabetes (EFSD)/Janssen	Spanish Ministry of Economy and Competitiveness(Spanish Government); CIBER Fisiopatologia de la Obesidad y la Nutricion (CIBEROBN); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Foundation for the Study of Diabetes (EFSD)/Lilly and European Foundation for the Study of Diabetes (EFSD)/Janssen	This study was supported by the Spanish Ministry of Economy and Competitiveness (Grant SAF2011-30520-C02-01 to D.S., Grant SAF2010-20039 to L.H. and doctoral fellowships to J.F.M. and M.I.M.), by the CIBER Fisiopatologia de la Obesidad y la Nutricion (CIBEROBN), the Instituto de Salud Carlos III (Grant CB06/03/0026 to D.S. and X.R. and research contract to P.M.), and the European Foundation for the Study of Diabetes (EFSD)/Lilly and European Foundation for the Study of Diabetes (EFSD)/Janssen (research fellowships to L.H.), by Albert Renold Programme (Postdoctoral Fellowship to A.S.H.C.). UniQure provided support in the form of salaries for authors HP & MSRP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; ARDUINI A, 1994, J NEUROCHEM, V62, P1530; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Canals D, 2009, BIOORGAN MED CHEM, V17, P235, DOI 10.1016/j.bmc.2008.11.026; Chang MC, 2006, MOL CELL NEUROSCI, V31, P525, DOI 10.1016/j.mcn.2005.11.006; Choi YH, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00071; Delgado Teresa C, 2013, Front Endocrinol (Lausanne), V4, P103, DOI 10.3389/fendo.2013.00103; Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200; du Bois TM, 2005, PROG NEURO-PSYCHOPH, V29, P878, DOI 10.1016/j.pnpbp.2005.04.034; Gao S, 2013, AM J PHYSL ENDOCRINO; Gao S, 2007, P NATL ACAD SCI USA, V104, P17358, DOI 10.1073/pnas.0708385104; Gao S, 2013, PHYSIOL BEHAV, V118, P165, DOI 10.1016/j.physbeh.2013.03.030; Gao S, 2011, P NATL ACAD SCI USA, V108, P9691, DOI 10.1073/pnas.1103267108; Grimm D, 1998, HUM GENE THER, V9, P2745, DOI 10.1089/hum.1998.9.18-2745; Hetherington AW, 1942, J COMP NEUROL, V76, P475, DOI 10.1002/cne.900760308; Hu ZY, 2005, J BIOL CHEM, V280, P39681, DOI 10.1074/jbc.C500398200; Hu ZY, 2005, P NATL ACAD SCI USA, V102, P3972, DOI 10.1073/pnas.0500619102; Hu ZY, 2003, P NATL ACAD SCI USA, V100, P12624, DOI 10.1073/pnas.1834402100; Jo YH, 2012, J NEUROPHYSIOL, V107, P42, DOI 10.1152/jn.00353.2011; Kang L, 2004, DIABETES, V53, P549, DOI 10.2337/diabetes.53.3.549; KELLY J, 1979, PHYSIOL BEHAV, V23, P1123, DOI 10.1016/0031-9384(79)90306-8; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; King BA, 2006, PHYSIOL BEHAV, V87, P221, DOI 10.1016/j.physbeh.2005.10.007; Lage R, 2010, FASEB J, V24, P2670, DOI 10.1096/fj.09-150672; Lane MD, 2008, INT J OBESITY, V32, pS49, DOI 10.1038/ijo.2008.123; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; Lopez M, 2006, DIABETES, V55, P1327, DOI 10.2337/db05-1356; Lopez M, 2008, CELL METAB, V7, P389, DOI 10.1016/j.cmet.2008.03.006; Lopez M, 2007, BIOESSAYS, V29, P248, DOI 10.1002/bies.20539; Lopez M, 2010, NAT MED, V16, P1001, DOI 10.1038/nm.2207; Lundbaek JA, 2006, J PHYS-CONDENS MAT, V18, pS1305, DOI 10.1088/0953-8984/18/28/S13; de Morentin PBM, 2012, DIABETES, V61, P807, DOI 10.2337/db11-1079; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Mera P, 2009, BIOCHEM PHARMACOL, V77, P1084, DOI 10.1016/j.bcp.2008.11.020; Morillas M, 2003, J BIOL CHEM, V278, P9058, DOI 10.1074/jbc.M209999200; Nogueiras R, 2004, DIABETES, V53, P2552, DOI 10.2337/diabetes.53.10.2552; Obici S, 2003, NAT MED, V9, P756, DOI 10.1038/nm873; Obici S, 2002, DIABETES, V51, P271, DOI 10.2337/diabetes.51.2.271; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pocai A, 2006, J CLIN INVEST, V116, P1081, DOI 10.1172/JCI26640; Price NT, 2002, GENOMICS, V80, P433, DOI 10.1006/geno.2002.6845; Ramirez S, 2013, DIABETES; Sakkou M, 2007, CELL METAB, V5, P450, DOI 10.1016/j.cmet.2007.05.007; Sangiao-Alvarellos S, 2009, ENDOCRINOLOGY, V150, P4562, DOI 10.1210/en.2009-0482; Sasaki T, 2010, ENDOCR J, V57, P939, DOI 10.1507/endocrj.K10E-320; Schoene C, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00081; Schug ZT, 2012, ACTA ONCOL, V51, P301, DOI 10.3109/0284186X.2011.643823; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Sierra AY, 2008, J BIOL CHEM, V283, P6878, DOI 10.1074/jbc.M707965200; Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071; Sternson SM, 2005, NAT NEUROSCI, V8, P1356, DOI 10.1038/nn1550; Swierczynski J, 2008, NEUROSCI LETT, V444, P209, DOI 10.1016/j.neulet.2008.08.046; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; TAKAMURA Y, 1985, BIOCHIM BIOPHYS ACTA, V834, P1, DOI 10.1016/0005-2760(85)90170-5; Tarasenko A, 2012, NEUROCHEM INT, V61, P1044, DOI 10.1016/j.neuint.2012.07.021; Thai TP, 2001, HUM MOL GENET, V10, P127, DOI 10.1093/hmg/10.2.127; Theander-Carrillo C, 2006, J CLIN INVEST, V116, P1983, DOI 10.1172/JCI25811; Tong QC, 2007, CELL METAB, V5, P383, DOI 10.1016/j.cmet.2007.04.001; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; van den Pol AN, 2012, NEURON, V76, P98, DOI 10.1016/j.neuron.2012.09.014; Varela L, 2011, J MOL ENDOCRINOL, V46, pR43, DOI 10.1677/JME-10-0068; Williams G, 2001, PHYSIOL BEHAV, V74, P683, DOI 10.1016/S0031-9384(01)00612-6; Wittmann G, 2013, J COMP NEUROL, V521, P3287, DOI 10.1002/cne.23350; Woods SC, 2008, J CLIN ENDOCR METAB, V93, pS37, DOI 10.1210/jc.2008-1630; Wu Q, 2011, EUR J PHARMACOL, V660, P21, DOI 10.1016/j.ejphar.2010.10.110; Zhu WL, 2010, AM J PHYSIOL-ENDOC M, V298, pE971, DOI 10.1152/ajpendo.00749.2009	66	20	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97195	10.1371/journal.pone.0097195	http://dx.doi.org/10.1371/journal.pone.0097195			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819600	Green Submitted, Green Published, gold			2022-12-27	WOS:000336653300088
J	Yang, MH; Zeng, P; Kang, R; Yu, Y; Yang, LC; Tang, DL; Cao, LZ				Yang, Minghua; Zeng, Pei; Kang, Rui; Yu, Yan; Yang, Liangchun; Tang, Daolin; Cao, Lizhi			S100A8 Contributes to Drug Resistance by Promoting Autophagy in Leukemia Cells	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; MYELOID-LEUKEMIA; MOUSE MODELS; APOPTOSIS; PROTEINS; RAGE; INHIBITION; EXPRESSION; RECEPTOR; NETWORK	Autophagy is a double-edged sword in tumorigenesis and plays an important role in the resistance of cancer cells to chemotherapy. S100A8 is a member of the S100 calcium-binding protein family and plays an important role in the drug resistance of leukemia cells, with the mechanisms largely unknown. Here we report that S100A8 contributes to drug resistance in leukemia by promoting autophagy. S100A8 level was elevated in drug resistance leukemia cell lines relative to the nondrug resistant cell lines. Adriamycin and vincristine increased S100A8 in human leukemia cells, accompanied with upregulation of autophagy. RNA interference-mediated knockdown of S100A8 restored the chemosensitivity of leukemia cells, while overexpression of S100A8 enhanced drug resistance and increased autophagy. S100A8 physically interacted with the autophagy regulator BECN1 and was required for the formation of the BECN1-PI3KC3 complex. In addition, interaction between S100A8 and BECN1 relied upon the autophagic complex ULK1-mAtg13. Furthermore, we discovered that exogenous S100A8 induced autophagy, and RAGE was involved in exogenous S100A8-regulated autophagy. Our data demonstrated that S100A8 is involved in the development of chemoresistance in leukemia cells by regulating autophagy, and suggest that S100A8 may be a novel target for improving leukemia therapy.	[Yang, Minghua; Zeng, Pei; Yu, Yan; Yang, Liangchun; Cao, Lizhi] Cent S Univ, Xiangya Hosp, Dept Pediat, Changsha, Hunan, Peoples R China; [Tang, Daolin] Cent S Univ, Xiangya Hosp, Dept Infect Dis, Changsha, Hunan, Peoples R China; [Kang, Rui; Tang, Daolin] Univ Pittsburgh, Dept Surg, Inst Canc, Pittsburgh, PA USA	Central South University; Central South University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yang, MH (corresponding author), Cent S Univ, Xiangya Hosp, Dept Pediat, Changsha, Hunan, Peoples R China.	yamahua123@163.com; caolizhi318@163.com	Tang, Daolin/B-2905-2010; Tang, Daolin/ABD-5062-2021; Kang, Rui/ABD-5291-2021	Tang, Daolin/0000-0002-1903-6180; Kang, Rui/0000-0003-2725-1574	National Natural Sciences Foundation of China [81100359, 30973234, 31171328]; National Institutes of Health [R01CA160417]; NATIONAL CANCER INSTITUTE [R01CA160417] Funding Source: NIH RePORTER	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by The National Natural Sciences Foundation of China (81100359 to MY, 30973234 and 31171328 to LC) and a grant from the National Institutes of Health (R01CA160417 to DT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam T, 2006, J NATL CANCER I, V98, P1806, DOI 10.1093/jnci/djj498; Chavakis T, 2004, MICROBES INFECT, V6, P1219, DOI 10.1016/j.micinf.2004.08.004; Cross SS, 2005, HISTOPATHOLOGY, V46, P256, DOI 10.1111/j.1365-2559.2005.02097.x; Cui JW, 2004, CLIN CANCER RES, V10, P6887, DOI 10.1158/1078-0432.CCR-04-0307; Dikic I, 2010, CANCER RES, V70, P3431, DOI 10.1158/0008-5472.CAN-09-4027; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Evangelisti C, 2011, LEUKEMIA, V25, P781, DOI 10.1038/leu.2011.20; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Ghavami S, 2008, J LEUKOCYTE BIOL, V83, P1484, DOI 10.1189/jlb.0607397; Ghavami S, 2008, BBA-MOL CELL RES, V1783, P297, DOI 10.1016/j.bbamcr.2007.10.015; Han WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028491; Helgason GV, 2011, BLOOD, V118, P2035, DOI 10.1182/blood-2011-01-330621; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liu L, 2011, LEUKEMIA, V25, P23, DOI 10.1038/leu.2010.225; Liu LY, 2011, AUTOPHAGY, V7, P112, DOI 10.4161/auto.7.1.14005; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nacken W, 2003, MICROSC RES TECHNIQ, V60, P569, DOI 10.1002/jemt.10299; Nicolas E, 2011, LEUKEMIA, V25, P57, DOI 10.1038/leu.2010.251; Norgaard JM, 2004, CRIT REV ONCOL HEMAT, V50, P39, DOI 10.1016/S1040-8428(03)00173-2; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rubnitz JE, 2012, BRIT J HAEMATOL, V159, P259, DOI 10.1111/bjh.12040; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Shen S, 2011, ONCOGENE, V30, P4544, DOI 10.1038/onc.2011.168; Spijkers-Hagelstein JAP, 2012, LEUKEMIA, V26, P1255, DOI 10.1038/leu.2011.388; Sun Y, 2013, MOL IMMUNOL, V53, P443, DOI 10.1016/j.molimm.2012.10.002; Yang MH, 2011, LEUKEMIA LYMPHOMA, V52, P298, DOI 10.3109/10428194.2010.538776; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yonekawa K, 2011, ATHEROSCLEROSIS, V218, P486, DOI 10.1016/j.atherosclerosis.2011.06.020; Yu Y, 2012, LEUKEMIA, V26, P1752, DOI 10.1038/leu.2012.65; Zhu S, 2013, AUTOPHAGY, V9, P317, DOI 10.4161/auto.22923	39	56	65	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97242	10.1371/journal.pone.0097242	http://dx.doi.org/10.1371/journal.pone.0097242			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24820971	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000336653300097
J	Alexander, EL; Gardete, S; Bar, HY; Wells, MT; Tomasz, A; Rhee, KY				Alexander, Elizabeth L.; Gardete, Susana; Bar, Haim Y.; Wells, Martin T.; Tomasz, Alexander; Rhee, Kyu Y.			Intermediate-Type Vancomycin Resistance (VISA) in Genetically-Distinct Staphylococcus aureus Isolates Is Linked to Specific, Reversible Metabolic Alterations	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; IN-VIVO; EVOLUTION; ACID	Intermediate (VISA-type) vancomycin resistance in Staphylococcus aureus has been associated with a range of physiologic and genetic alterations. Previous work described the emergence of VISA-type resistance in two clonally-distinct series of isolates. In both series (the first belonging to MRSA clone ST8-USA300, and the second to ST5-USA100), resistance was conferred by a single mutation in yvqF (a negative regulator of the vraSR two-component system associated with vancomycin resistance). In the USA300 series, resistance was reversed by a secondary mutation in vraSR. In this study, we combined systems-level metabolomic profiling with statistical modeling techniques to discover specific, reversible metabolic alterations associated with the VISA phenotype.	[Alexander, Elizabeth L.; Rhee, Kyu Y.] Weill Cornell Med Coll, Dept Med, Div Infect Dis, New York, NY 10021 USA; [Gardete, Susana; Tomasz, Alexander] Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA; [Bar, Haim Y.] Univ Connecticut, Dept Stat, Storrs, CT 06269 USA; [Wells, Martin T.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA; [Wells, Martin T.] Cornell Univ, Dept Stat Sci, Ithaca, NY USA; [Rhee, Kyu Y.] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY USA	Cornell University; Rockefeller University; University of Connecticut; Cornell University; Cornell University; Cornell University	Alexander, EL (corresponding author), Weill Cornell Med Coll, Dept Med, Div Infect Dis, New York, NY 10021 USA.	ela2005@med.cornell.edu; kyr9001@med.cornell.edu		Tomasz, Alexander/0000-0003-1520-1983	National Center for Advancing Translational Sciences (NCATS, National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program) [UL1 TR000043-07S1]; Weill Cornell Medical College Clinical and Translational Science Center [KL2 UL1-RR024996]; National Institutes of Health [R01-GM083606, P60-MD08005]; William Randolph Hearst Foundation; US Public Health Service grant [2 RO1 AI457838-13]; Cary Guy Foundation; Palm Beach Infectious Disease Institute, Florida; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043, UL1TR000457] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083606] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R24MD008005] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences (NCATS, National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Weill Cornell Medical College Clinical and Translational Science Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William Randolph Hearst Foundation; US Public Health Service grant(United States Department of Health & Human ServicesUnited States Public Health Service); Cary Guy Foundation; Palm Beach Infectious Disease Institute, Florida; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by grant UL1 TR000043-07S1 from the National Center for Advancing Translational Sciences (NCATS, National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program (www.ncats.nih.gov) awarded to AT and KR. Additional support was provided by grants from the Weill Cornell Medical College Clinical and Translational Science Center. (EA, KL2 UL1-RR024996; weill.cornell.edu/ctsc); the National Institutes of Health (MW, R01-GM083606 and P60-MD08005); the William Randolph Hearst Foundation (to KR); and by a US Public Health Service grant (2 RO1 AI457838-13) awarded to AT. Additional support for this work was provided by the Cary Guy Foundation (to EA). SG was supported by a fellowship from the Palm Beach Infectious Disease Institute, Florida. The funders had no role in study design, data collection and analysis, decision to publish or preparation of this manuscript.	Bar HY, 2014, J AM STAT ASSOC, V109, P537, DOI 10.1080/01621459.2014.884502; Benjamini Y., 1995, J R STAT SOC B, V57, P499; Brauer MJ, 2006, P NATL ACAD SCI USA, V103, P19302, DOI 10.1073/pnas.0609508103; Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; Cui LZ, 2000, ANTIMICROB AGENTS CH, V44, P2276, DOI 10.1128/AAC.44.9.2276-2285.2000; de Carvalho LPS, 2010, CHEM BIOL, V17, P1122, DOI 10.1016/j.chembiol.2010.08.009; Eoh HJ, 2013, P NATL ACAD SCI USA, V110, P6554, DOI 10.1073/pnas.1219375110; Gardete S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002505; Hafer C, 2012, ANTIMICROB AGENTS CH, V56, P5845, DOI 10.1128/AAC.01139-12; Howden BP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002359; Howden BP, 2010, CLIN MICROBIOL REV, V23, P99, DOI 10.1128/CMR.00042-09; Kotera M, 2012, METHODS MOL BIOL, V802, P19, DOI 10.1007/978-1-61779-400-1_2; Makhlin J, 2007, J BACTERIOL, V189, P5976, DOI 10.1128/JB.00592-07; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; R Core Team, 2018, R LANG ENV STAT COMP; Sadykov MR, 2010, J BACTERIOL, V192, P1459, DOI 10.1128/JB.01377-09; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sana Theodore R, 2008, J Biomol Tech, V19, P258; Sieradzki K, 2003, J CLIN MICROBIOL, V41, P1687, DOI 10.1128/JCM.41.4.1687-1693.2003; STICH TM, 1990, ANAL BIOCHEM, V191, P343, DOI 10.1016/0003-2697(90)90229-3; Thurlow LR, 2013, CELL HOST MICROBE, V13, P100, DOI 10.1016/j.chom.2012.11.012; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; White D, 2000, PHYSL BIOCH PROKARYO; Zhou XX, 2012, BIOCHEMISTRY-US, V51, P8143, DOI 10.1021/bi3012115	24	11	12	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97137	10.1371/journal.pone.0097137	http://dx.doi.org/10.1371/journal.pone.0097137			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24817125	Green Published, Green Submitted, gold			2022-12-27	WOS:000336838000106
J	Coombs, G; Loggia, ML; Greve, DN; Holt, DJ				Coombs, Garth, III; Loggia, Marco L.; Greve, Douglas N.; Holt, Daphne J.			Amygdala Perfusion Is Predicted by Its Functional Connectivity with the Ventromedial Prefrontal Cortex and Negative Affect	PLOS ONE			English	Article							STATE-TRAIT ANXIETY; DEEP BRAIN-STIMULATION; INDIVIDUAL-DIFFERENCES; DEPRESSION; INVENTORY; EXTINCTION; RESPONSES; FEAR; PROJECTIONS; MODULATION	Background: Previous studies have shown that the activity of the amygdala is elevated in people experiencing clinical and subclinical levels of anxiety and depression (negative affect). It has been proposed that a reduction in inhibitory input to the amygdala from the prefrontal cortex and resultant over-activity of the amygdala underlies this association. Prior studies have found relationships between negative affect and 1) amygdala over-activity and 2) reduced amygdala-prefrontal connectivity. However, it is not known whether elevated amygdala activity is associated with decreased amygdala-prefrontal connectivity during negative affect states. Methods: Here we used resting-state arterial spin labeling (ASL) and blood oxygenation level dependent (BOLD) functional magnetic resonance imaging (fMRI) in combination to test this model, measuring the activity (regional cerebral blood flow, rCBF) and functional connectivity (correlated fluctuations in the BOLD signal) of one subregion of the amygdala with strong connections with the prefrontal cortex, the basolateral nucleus (BLA), and subsyndromal anxiety levels in 38 healthy subjects. Results: BLA rCBF was strongly correlated with anxiety levels. Moreover, both BLA rCBF and anxiety were inversely correlated with the strength of the functional coupling of the BLA with the caudal ventromedial prefrontal cortex. Lastly, BLA perfusion was found to be a mediator of the relationship between BLA-prefrontal connectivity and anxiety. Conclusions: These results show that both perfusion of the BLA and a measure of its functional coupling with the prefrontal cortex directly index anxiety levels in healthy subjects, and that low BLA-prefrontal connectivity may lead to increased BLA activity and resulting anxiety. Thus, these data provide key evidence for an often-cited circuitry model of negative affect, using a novel, multi-modal imaging approach.	[Coombs, Garth, III; Loggia, Marco L.; Holt, Daphne J.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Coombs, Garth, III; Loggia, Marco L.; Greve, Douglas N.; Holt, Daphne J.] MGH HST MIT Athinoula A Martinos Ctr Biomed Imagi, Charlestown, MA USA; [Coombs, Garth, III] Harvard Univ, Dept Psychol, Ctr Brain Sci, Cambridge, MA 02138 USA; [Loggia, Marco L.; Greve, Douglas N.; Holt, Daphne J.] Harvard Univ, Sch Med, Boston, MA USA; [Greve, Douglas N.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Holt, DJ (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA.	dholt@partners.org	Holt, Daphne J/O-2201-2017	Holt, Daphne J/0000-0002-6428-9603; Coombs III, Garth/0000-0002-1628-6870	National Institute of Mental Health [MH076054, MH095904]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095904, K23MH076054] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the National Institute of Mental Health (MH076054 and MH095904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abercrombie HC, 1998, NEUROREPORT, V9, P3301, DOI 10.1097/00001756-199810050-00028; AMARAL DG, 1984, J COMP NEUROL, V230, P465, DOI 10.1002/cne.902300402; Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Bados A, 2010, J PERS ASSESS, V92, P560, DOI 10.1080/00223891.2010.513295; BARBAS H, 1990, J COMP NEUROL, V300, P549, DOI 10.1002/cne.903000409; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bieling PJ, 1998, BEHAV RES THER, V36, P777, DOI 10.1016/S0005-7967(98)00023-0; Bishop SJ, 2004, J NEUROSCI, V24, P10364, DOI 10.1523/JNEUROSCI.2550-04.2004; Bishop SJ, 2007, TRENDS COGN SCI, V11, P307, DOI 10.1016/j.tics.2007.05.008; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blair J. R., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI DOI 10.1080/13854048908403285; Caci H, 2003, EUR PSYCHIAT, V18, P394, DOI 10.1016/j.eurpsy.2003.05.003; de Almeida JRC, 2009, BIOL PSYCHIAT, V66, P451, DOI 10.1016/j.biopsych.2009.03.024; Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2; DETRE JA, 1994, NMR BIOMED, V7, P75, DOI 10.1002/nbm.1940070112; Drevets WC, 1999, ANN NY ACAD SCI, V877, P614, DOI 10.1111/j.1749-6632.1999.tb09292.x; DREVETS WC, 1992, J NEUROSCI, V12, P3628; EBELING U, 1992, ACTA NEUROCHIR, V115, P143, DOI 10.1007/BF01406373; Etkin A, 2004, NEURON, V44, P1043, DOI 10.1016/j.neuron.2004.12.006; Etkin A, 2009, ARCH GEN PSYCHIAT, V66, P1361, DOI 10.1001/archgenpsychiatry.2009.104; EY H, 1978, HIST EXPLORATIONS ME, P204; First M.B., 2016, STRUCTURED CLIN INTE; Fischer H, 2001, NEUROREPORT, V12, P1635, DOI 10.1097/00001756-200106130-00024; Flett GL, 1997, PSYCHOL BULL, V121, P395, DOI 10.1037/0033-2909.121.3.395; Foland LC, 2008, PSYCHIAT RES-NEUROIM, V162, P27, DOI 10.1016/j.pscychresns.2007.04.007; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston K J, 1994, Hum Brain Mapp, V1, P210, DOI 10.1002/hbm.460010306; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Gros DF, 2007, PSYCHOL ASSESSMENT, V19, P369, DOI 10.1037/1040-3590.19.4.369; Hankin BL, 2005, J ABNORM PSYCHOL, V114, P96, DOI 10.1037/0021-843X.114.1.96; Hollingshead AB., 1957, 2 FACTOR INDEX SOCIA; Holmes AJ, 2012, J NEUROSCI, V32, P18087, DOI 10.1523/JNEUROSCI.2531-12.2012; Jackson J. H., 1931, SELECTED WRITINGS JH; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kennedy BL, 2001, PSYCHIAT QUART, V72, P263, DOI 10.1023/A:1010305200087; Kim H, 2003, NEUROREPORT, V14, P2317, DOI 10.1097/00001756-200312190-00006; Kim MJ, 2011, CEREB CORTEX, V21, P1667, DOI 10.1093/cercor/bhq237; Kim MJ, 2009, J NEUROSCI, V29, P11614, DOI 10.1523/JNEUROSCI.2335-09.2009; Kohn PM, 2008, J PERS ASSESS, V90, P499, DOI 10.1080/00223890802248844; Kumano H, 2007, J PSYCHIATR RES, V41, P591, DOI 10.1016/j.jpsychires.2006.03.006; Kvaal K, 2005, INT J GERIATR PSYCH, V20, P629, DOI 10.1002/gps.1330; Laruelle M, 2003, ANN NY ACAD SCI, V1003, P138, DOI 10.1196/annals.1300.063; Lehman JF, 2011, J NEUROSCI, V31, P10392, DOI 10.1523/JNEUROSCI.0595-11.2011; Luh WM, 1999, MAGNET RESON MED, V41, P1246, DOI 10.1002/(SICI)1522-2594(199906)41:6<1246::AID-MRM22>3.0.CO;2-N; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; Mayberg HS, 2000, BIOL PSYCHIAT, V48, P830, DOI 10.1016/S0006-3223(00)01036-2; McGorry PD, 2010, CAN J PSYCHIAT, V55, P486, DOI 10.1177/070674371005500803; Milad MR, 2007, BIOL PSYCHIAT, V62, P446, DOI 10.1016/j.biopsych.2006.10.011; Nahas Z, 2007, NEUROPSYCHOPHARMACOL, V32, P1649, DOI 10.1038/sj.npp.1301288; Ongur D, 2003, J COMP NEUROL, V460, P425, DOI 10.1002/cne.10609; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Pizzagalli DA, 2004, MOL PSYCHIATR, V9, P393, DOI 10.1038/sj.mp.4001469; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Preisig M, 2001, ACTA PSYCHIAT SCAND, V104, P96, DOI 10.1034/j.1600-0447.2001.00284.x; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; Roy AK, 2009, NEUROIMAGE, V45, P614, DOI 10.1016/j.neuroimage.2008.11.030; Roy M, 2012, TRENDS COGN SCI, V16, P147, DOI 10.1016/j.tics.2012.01.005; Royer S, 2002, NEUROSCIENCE, V115, P455, DOI 10.1016/S0306-4522(02)00455-4; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Shin LM, 2005, ARCH GEN PSYCHIAT, V62, P273, DOI 10.1001/archpsyc.62.3.273; Somerville LH, 2004, BIOL PSYCHIAT, V55, P897, DOI 10.1016/j.biopsych.2004.01.007; Sotres-Bayon F, 2010, CURR OPIN NEUROBIOL, V20, P231, DOI 10.1016/j.conb.2010.02.005; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Tailarach J., 1988, COPLANAR STEREOTAXIC; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Wang Y, 2011, NEUROIMAGE, V54, P1188, DOI 10.1016/j.neuroimage.2010.08.043; Wasan AD, 2011, ANESTHESIOLOGY, V115, P364, DOI 10.1097/ALN.0b013e318220e880; WATSON D, 1984, PSYCHOL BULL, V96, P465, DOI 10.1037/0033-2909.96.3.465; Williams LM, 2004, AM J PSYCHIAT, V161, P480, DOI 10.1176/appi.ajp.161.3.480; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Zar J. H., 1996, BIOSTATISTICAL ANAL	76	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97466	10.1371/journal.pone.0097466	http://dx.doi.org/10.1371/journal.pone.0097466			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816735	Green Published, gold, Green Submitted			2022-12-27	WOS:000336838000137
J	Garcia-Garcia, MI; Gil-Ortiz, F; Garcia-Carmona, F; Sanchez-Ferrer, A				Inmaculada Garcia-Garcia, Maria; Gil-Ortiz, Fernando; Garcia-Carmona, Francisco; Sanchez-Ferrer, Alvaro			First Functional and Mutational Analysis of Group 3 N-Acetylneuraminate Lyases from Lactobacillus antri and Lactobacillus sakei 23K	PLOS ONE			English	Article							SIALIC-ACID ALDOLASE; ESCHERICHIA-COLI; CLOSTRIDIUM-PERFRINGENS; PASTEURELLA-MULTOCIDA; PURIFICATION; MECHANISM; MUTAGENESIS; EXPRESSION; ALIGNMENT; CLONING	N-acetyl neuraminate lyases (NALs) catalyze the reversible aldol cleavage of N-acetyl neuraminic acid (Neu5Ac) to pyruvate and N-acetyl-D-mannosamine (ManNAc). Previous phylogenetic studies divided NALs into four different groups. Groups 1 and 2 have been well characterized at both kinetic and molecular levels, but no NAL from group 3 has been studied to date. In this work, a functional characterization of two group 3 members was performed using the recombinant NALs from Lactobacillus antri and Lactobacillus sakei 23K, revealing an optimal pH of between 6.0 and 7.0, low stability at basic pHs (>8.0), low optimal temperatures and, especially, low catalytic efficiency compared with their counterparts in group 1 and 2. The mutational analysis carried out showed that a plausible molecular reason for the low activity shown by Lactobacillus antri and Lactobacillus sakei 23k NALs compared with group 1 and 2 NALs could be the relatively small sugar-binding pocket they contain. A functional divergence analysis concluding that group 3 is more closely related to group 2 than to group 1.	[Inmaculada Garcia-Garcia, Maria; Garcia-Carmona, Francisco; Sanchez-Ferrer, Alvaro] Univ Murcia, Dept Biochem & Mol Biol A, Fac Biol, Murcia, Spain; [Inmaculada Garcia-Garcia, Maria; Garcia-Carmona, Francisco; Sanchez-Ferrer, Alvaro] Murcia Biomed Res Inst IMIB, Murcia, Spain; [Gil-Ortiz, Fernando] CELLS ALBA Synchrotron Light Source, Barcelona, Spain	University of Murcia	Sanchez-Ferrer, A (corresponding author), Univ Murcia, Dept Biochem & Mol Biol A, Fac Biol, Reg Campus Int Excellence Campus Mare Nostrum, Murcia, Spain.	alvaro@um.es	Garcia-Carmona, Francisco/K-6520-2017; GARCIA, MARIA/L-2643-2014; Sánchez-Ferrer, Alvaro/M-1631-2014	Sánchez-Ferrer, Alvaro/0000-0001-7266-4402; Gil-Ortiz, Fernando/0000-0001-5897-2724; Garcia-Carmona, Francisco/0000-0002-1318-7690	MINECO-FEDER [BIO2010-22225-C02-01]; Programa de Ayuda a Grupos de Excelencia de la Region de Murcia, Fundacion Seneca [04541/GERM/06]; Fundacion Seneca	MINECO-FEDER; Programa de Ayuda a Grupos de Excelencia de la Region de Murcia, Fundacion Seneca(Fundacion Seneca); Fundacion Seneca(Fundacion Seneca)	This study was partially supported by Spanish grants from MINECO-FEDER (BIO2010-22225-C02-01) and from the Programa de Ayuda a Grupos de Excelencia de la Region de Murcia, Fundacion Seneca (04541/GERM/06, Plan Regional de Ciencia y Tecnologia 2007-2010). M. I. G. G. is holder of predoctoral research grants associated to the above project from Fundacion Seneca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AISAKA K, 1991, BIOCHEM J, V276, P541, DOI 10.1042/bj2760541; AISAKA K, 1986, APPL ENVIRON MICROB, V51, P562, DOI 10.1128/AEM.51.3.562-565.1986; Almagro S, 2009, GUT MICROBES, V1, P45; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anba-Mondoloni J, 2013, APPL ENVIRON MICROB, V79, P2012, DOI 10.1128/AEM.03301-12; Barbosa JARG, 2000, J MOL BIOL, V303, P405, DOI 10.1006/jmbi.2000.4138; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brigham C, 2009, J BACTERIOL, V191, P3629, DOI 10.1128/JB.00811-08; Chou CY, 2011, J BIOL CHEM, V286, P14057, DOI 10.1074/jbc.M110.179465; Daniels AD, 2014, ACS CHEM BIOL, V9, P1025, DOI 10.1021/cb500067z; DEVRIES GH, 1972, ARCH BIOCHEM BIOPHYS, V151, P234, DOI 10.1016/0003-9861(72)90493-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcia MIG, 2012, J AGR FOOD CHEM, V60, P7450, DOI 10.1021/jf3014102; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gu X, 2002, BIOINFORMATICS, V18, P500, DOI 10.1093/bioinformatics/18.3.500; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jebors S, 2011, CHEM COMMUN, V47, P12307, DOI 10.1039/c1cc14930j; Li YH, 2008, APPL MICROBIOL BIOT, V79, P963, DOI 10.1007/s00253-008-1506-2; LIN CH, 1992, J AM CHEM SOC, V114, P10138, DOI 10.1021/ja00052a008; Montoro-Garcia S, 2009, J BACTERIOL, V191, P3076, DOI 10.1128/JB.01060-08; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Huynh N, 2013, BIOCHEMISTRY-US, V52, P8570, DOI 10.1021/bi4011754; RADEMACHER TW, 1988, ANNU REV BIOCHEM, V57, P785, DOI 10.1146/annurev.bi.57.070188.004033; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sanchez-Carron G, 2011, APPL ENVIRON MICROB, V77, P2471, DOI 10.1128/AEM.02927-10; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; Sola-Carvajal A, 2012, BIOCHIMIE, V94, P222, DOI 10.1016/j.biochi.2011.10.012; Tanner ME, 2005, BIOORG CHEM, V33, P216, DOI 10.1016/j.bioorg.2005.01.005; Tao F, 2010, APPL MICROBIOL BIOT, V87, P1281, DOI 10.1007/s00253-010-2700-6; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Traving C, 1997, GLYCOCONJUGATE J, V14, P821, DOI 10.1023/A:1018585920853; UCHIDA Y, 1984, J BIOCHEM-TOKYO, V96, P507, DOI 10.1093/oxfordjournals.jbchem.a134863; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002	33	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96976	10.1371/journal.pone.0096976	http://dx.doi.org/10.1371/journal.pone.0096976			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24817128	gold, Green Published, Green Submitted			2022-12-27	WOS:000336838000087
J	Mahmmoud, YA; Shattock, M; Cornelius, F; Pavlovic, D				Mahmmoud, Yasser A.; Shattock, Michael; Cornelius, Flemming; Pavlovic, Davor			Inhibition of K+ Transport through Na+, K+-ATPase by Capsazepine: Role of Membrane Span 10 of the alpha-Subunit in the Modulation of Ion Gating	PLOS ONE			English	Article							SODIUM-POTASSIUM PUMP; CRYSTAL-STRUCTURE; CATION OCCLUSION; NA/K-ATPASE; NA,K-ATPASE; NA+,K+-ATPASE; SITES; AFFINITY; RECONSTITUTION; STOICHIOMETRY	Capsazepine (CPZ) inhibits Na+, K+-ATPase-mediated K+-dependent ATP hydrolysis with no effect on Na+-ATPase activity. In this study we have investigated the functional effects of CPZ on Na+, K+-ATPase in intact cells. We have also used well established biochemical and biophysical techniques to understand how CPZ modifies the catalytic subunit of Na+, K+-ATPase. In isolated rat cardiomyocytes, CPZ abolished Na+, K+-ATPase current in the presence of extracellular K+. In contrast, CPZ stimulated pump current in the absence of extracellular K+. Similar conclusions were attained using HEK293 cells loaded with the Na+ sensitive dye Asante NaTRIUM green. Proteolytic cleavage of pig kidney Na+, K+-ATPase indicated that CPZ stabilizes ion interaction with the K+ sites. The distal part of membrane span 10 (M10) of the alpha-subunit was exposed to trypsin cleavage in the presence of guanidinum ions, which function as Na+ congener at the Na+ specific site. This effect of guanidinium was amplified by treatment with CPZ. Fluorescence of the membrane potential sensitive dye, oxonol VI, was measured following addition of substrates to reconstituted inside-out Na+, K+-ATPase. CPZ increased oxonol VI fluorescence in the absence of K+, reflecting increased Na+ efflux through the pump. Surprisingly, CPZ induced an ATP-independent increase in fluorescence in the presence of high extravesicular K+, likely indicating opening of an intracellular pathway selective for K+. As revealed by the recent crystal structure of the E-1 center dot AlF4-center dot ADP center dot 3Na(+) form of the pig kidney Na+, K+-ATPase, movements of M5 of the alpha-subunit, which regulate ion selectivity, are controlled by the C-terminal tail that extends from M10. We propose that movements of M10 and its cytoplasmic extension is affected by CPZ, thereby regulating ion selectivity and transport through the K+ sites in Na+, K+-ATPase.	[Mahmmoud, Yasser A.; Cornelius, Flemming] Univ Aarhus, Dept Biomed, DK-8000 Aarhus C, Denmark; [Shattock, Michael; Pavlovic, Davor] Kings Coll London, Div Cardiovasc, Rayne Inst, St Thomas Hosp, London WC2R 2LS, England	Aarhus University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Mahmmoud, YA (corresponding author), Univ Aarhus, Dept Biomed, DK-8000 Aarhus C, Denmark.	yam@biophys.au.dk	Cornelius, Flemming/C-1912-2019	Cornelius, Flemming/0000-0003-1566-0020; Shattock, Michael/0000-0001-6242-7585; Pavlovic, Davor/0000-0002-3171-3551	Novo Nordic foundation [A11272]; British Heart Foundation [RG/12/4/29426] Funding Source: researchfish	Novo Nordic foundation(Novo Nordisk Foundation); British Heart Foundation(British Heart Foundation)	This study was supported by the Novo Nordic foundation (grant A11272) to YAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APELL HJ, 1987, BIOCHIM BIOPHYS ACTA, V903, P480, DOI 10.1016/0005-2736(87)90055-1; Apell HJ, 2001, J MEMBRANE BIOL, V180, P1, DOI 10.1007/s002320010053; ARYSTARKHOVA E, 1995, J BIOL CHEM, V270, P8785, DOI 10.1074/jbc.270.15.8785; BAGINSKI ES, 1967, CLIN CHEM, V13, P326; BLOSTEIN R, 1983, J BIOL CHEM, V258, P2228; CAPASSO JM, 1992, J BIOL CHEM, V267, P1150; COOPER CE, 1990, BIOCHEMISTRY-US, V29, P3859, DOI 10.1021/bi00468a009; CORNELIUS F, 1991, BIOCHIM BIOPHYS ACTA, V1071, P19, DOI 10.1016/0304-4157(91)90011-K; CORNELIUS F, 1984, BIOCHIM BIOPHYS ACTA, V772, P357, DOI 10.1016/0005-2736(84)90153-6; CORNELIUS F, 1985, BIOCHIM BIOPHYS ACTA, V818, P211, DOI 10.1016/0005-2736(85)90572-3; Cornelius F, 2003, NEWS PHYSIOL SCI, V18, P119, DOI 10.1152/nips.01434.2003; Cornelius F, 2011, J BIOL CHEM, V286, P29882, DOI 10.1074/jbc.M111.259663; DAVID P, 1992, J BIOL CHEM, V267, P1141; Despa S, 2000, ANAL BIOCHEM, V281, P159, DOI 10.1006/abio.2000.4560; Ding YL, 2011, J MEMBRANE BIOL, V243, P35, DOI 10.1007/s00232-011-9390-6; Donnet C, 2001, J BIOL CHEM, V276, P7357, DOI 10.1074/jbc.M009131200; DRAPEAU P, 1980, J BIOL CHEM, V255, P7827; Einholm AP, 2010, J BIOL CHEM, V285, P26245, DOI 10.1074/jbc.M110.123976; Fuller W, 2009, AM J PHYSIOL-CELL PH, V296, pC1346, DOI 10.1152/ajpcell.00523.2008; Geering K, 2008, CURR OPIN NEPHROL HY, V17, P526, DOI 10.1097/MNH.0b013e3283036cbf; GLYNN IM, 1984, J PHYSIOL-LONDON, V351, P531, DOI 10.1113/jphysiol.1984.sp015261; GOLDSHLEGER R, 1995, BIOCHEMISTRY-US, V34, P8668, DOI 10.1021/bi00027a016; Gonzalez-Lebrero RM, 2002, J BIOL CHEM, V277, P5910, DOI 10.1074/jbc.M105886200; Holmgren M, 2000, NATURE, V403, P898, DOI 10.1038/35002599; Inesi G, 2008, J BIOL CHEM, V283, P1189, DOI 10.1074/jbc.M707189200; JORGENSEN PL, 1986, BIOCHIM BIOPHYS ACTA, V860, P570, DOI 10.1016/0005-2736(86)90555-9; Kanai R, 2013, NATURE, V502, P201, DOI 10.1038/nature12578; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; KAPLAN JH, 1983, AM J PHYSIOL, V245, pG327, DOI 10.1152/ajpgi.1983.245.3.G327; KARLISH SJD, 1990, P NATL ACAD SCI USA, V87, P4566, DOI 10.1073/pnas.87.12.4566; Kaufman SB, 2012, J PHYS CHEM B, V116, P3421, DOI 10.1021/jp2124108; Klodos I, 2002, KIDNEY INT, V62, P2097, DOI 10.1046/j.1523-1755.2002.00654.x; Lamy CM, 2011, NEUROIMAGE, V58, P572, DOI 10.1016/j.neuroimage.2011.06.074; Lingrel JB, 2010, ANNU REV PHYSIOL, V72, P395, DOI 10.1146/annurev-physiol-021909-135725; Mahmmoud YA, 2003, J BIOL CHEM, V278, P37427, DOI 10.1074/jbc.M305126200; Mahmmoud YA, 2008, P NATL ACAD SCI USA, V105, P1757, DOI 10.1073/pnas.0711838105; Mahmmoud YA, 2011, BBA-BIOMEMBRANES, V1808, P2413, DOI 10.1016/j.bbamem.2011.06.025; Moran MM, 2011, NAT REV DRUG DISCOV, V10, P601, DOI 10.1038/nrd3456; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Nyblom M, 2013, SCIENCE, V342, P123, DOI 10.1126/science.1243352; OR E, 1993, J BIOL CHEM, V268, P16929; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Pavlovic D, 2007, FASEB J, V21, P1539, DOI 10.1096/fj.06-7269com; Pavlovic D, 2013, J MOL CELL CARDIOL, V61, P164, DOI 10.1016/j.yjmcc.2013.04.013; Pavlovic D, 2010, EXP PHYSIOL, V95, P518, DOI 10.1113/expphysiol.2009.052126; Poulsen H, 2010, NATURE, V467, P99, DOI 10.1038/nature09309; Ratheal IM, 2010, P NATL ACAD SCI USA, V107, P18718, DOI 10.1073/pnas.1004214107; Rossini GP, 2011, TOXICON, V57, P429, DOI 10.1016/j.toxicon.2010.09.011; SHAINSKAYA A, 1994, J BIOL CHEM, V269, P10780; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Takeuchi A, 2008, NATURE, V456, P413, DOI 10.1038/nature07350; Toustrup-Jensen MS, 2009, J BIOL CHEM, V284, P18715, DOI 10.1074/jbc.M109.015099; Vedovato N, 2010, J GEN PHYSIOL, V136, P63, DOI 10.1085/jgp.201010407; Vilsen B, 1999, BIOCHEMISTRY-US, V38, P11389, DOI 10.1021/bi990951t; VILSEN B, 1995, BIOCHEMISTRY-US, V34, P1455, DOI 10.1021/bi00004a041; Yamamura H, 2004, J BIOL CHEM, V279, P44483, DOI 10.1074/jbc.M408929200; Yaragatupalli S, 2009, P NATL ACAD SCI USA, V106, P15507, DOI 10.1073/pnas.0903752106; Yu HB, 2011, NAT STRUCT MOL BIOL, V18, P1159, DOI 10.1038/nsmb.2113	58	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96909	10.1371/journal.pone.0096909	http://dx.doi.org/10.1371/journal.pone.0096909			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816799	gold, Green Published, Green Submitted			2022-12-27	WOS:000336838000079
J	Nie, P; Li, DD; Hu, LH; Jin, SX; Yu, Y; Cai, ZH; Shao, Q; Shen, JY; Yi, J; Xiao, H; Shen, LH; He, B				Nie, Peng; Li, Dandan; Hu, Liuhua; Jin, Shuxuan; Yu, Ying; Cai, Zhaohua; Shao, Qin; Shen, Jieyan; Yi, Jing; Xiao, Hua; Shen, Linghong; He, Ben			Atorvastatin Improves Plaque Stability in ApoE-Knockout Mice by Regulating Chemokines and Chemokine Receptors	PLOS ONE			English	Article							MOUSE MODEL; CELL ACCUMULATION; HUMAN MONOCYTES; DEFICIENT MICE; PPAR-GAMMA; IN-VITRO; ATHEROSCLEROSIS; EXPRESSION; STATINS; FRACTALKINE/CX3CR1	It is well documented that statins protect atherosclerotic patients from inflammatory changes and plaque instability in coronary arteries. However, the underlying mechanisms are not fully understood. Using a previously established mouse model for vulnerable atherosclerotic plaque, we investigated the effect of atorvastatin (10 mg/kg/day) on plaque morphology. Atorvastatin did not lower plasma total cholesterol levels or affect plaque progression at this dosage; however, vulnerable plaque numbers were significantly reduced in the atorvastatin-treated group compared to control. Detailed examinations revealed that atorvastatin significantly decreased macrophage infiltration and subendothelial lipid deposition, reduced intimal collagen content, and elevated collagenase activity and expression of matrix metalloproteinases (MMPs). Because vascular inflammation is largely driven by changes in monocyte/macrophage numbers in the vessel wall, we speculated that the anti-inflammatory effect of atorvastatin may partially result from decreased monocyte recruitment to the endothelium. Further experiments showed that atorvastatin downregulated expression of the chemokines monocyte chemoattractant protein (MCP)-1, chemokine (C-X3-C motif) ligand 1 (CX3CL1) and their receptors CCR2 and, CX3CR1, which are mainly responsible for monocyte recruitment. In addition, levels of the plasma inflammatory markers C-reactive protein (CRP) and tumor necrosis factor (TNF)-alpha were also significantly decrease in atorvastatin-treated mice. Collectively, our results demonstrate that atorvastatin can improve plaque stability in mice independent of plasma cholesterol levels. Given the profound inhibition of macrophage infiltration into atherosclerotic plaques, we propose that statins may partly exert protective effects by modulating levels of chemokines and their receptors. These findings elucidate yet another atheroprotective mechanism of statins.	[Nie, Peng; Li, Dandan; Hu, Liuhua; Jin, Shuxuan; Yu, Ying; Cai, Zhaohua; Shao, Qin; Shen, Jieyan; Xiao, Hua; Shen, Linghong; He, Ben] Shanghai Jiao Tong Univ, Dept Cardiol, Renji Hosp, Sch Med, Shanghai 200030, Peoples R China; [Yi, Jing] Shanghai Jiao Tong Univ, Dept Cell Biol, Key Lab,Sch Med, Educ Minist Cell Differentiat & Apoptosis,Inst Me, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Shen, LH (corresponding author), Shanghai Jiao Tong Univ, Dept Cardiol, Renji Hosp, Sch Med, Shanghai 200030, Peoples R China.	rjshenlinghong@126.com; rjheben@126.com	Nie, Peng/GQI-1872-2022; Cai, Zhaohua/CAH-8221-2022		National Natural Science Foundation [30800453, 30971185, 81370399, 81070239, 81100200, 81100199, 81270374, 81170192]; Shanghai Municipal Natural Science Foundation [10JC1409400, 11JC1407100, 11ZR1421600, 12140902600]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Natural Science Foundation	This work was supported by the Grant Numbers 30800453, 30971185, 81370399, 81070239, 81100200, 81100199, 81270374 and 81170192 from the National Natural Science Foundation and the Grant Numbers 10JC1409400, 11JC1407100, 11ZR1421600 and 12140902600 from the Shanghai Municipal Natural Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bea F, 2002, ARTERIOSCL THROM VAS, V22, P1832, DOI 10.1161/01.ATV.0000036081.01231.16; Chen YC, 2013, CIRC RES, V113, P252, DOI 10.1161/CIRCRESAHA.113.301562; Cho KY, 2013, J STROKE CEREBROVASC, V22, P910, DOI 10.1016/j.jstrokecerebrovasdis.2012.11.020; Clark AK, 2011, CURR PHARM BIOTECHNO, V12, P1707; Flierl U, 2012, THROMB HAEMOSTASIS, V108, P457, DOI 10.1160/TH12-04-0271; Fukumoto Y, 2001, CIRCULATION, V103, P993; Hu LH, 2012, MOL CELL BIOCHEM, V371, P105, DOI 10.1007/s11010-012-1427-3; Jerath MR, 2010, THROMB J, V8, DOI 10.1186/1477-9560-8-14; Jin SX, 2012, ARTERIOSCL THROM VAS, V32, P2372, DOI 10.1161/ATVBAHA.111.236158; Kleemann R, 2004, BLOOD, V103, P4188, DOI 10.1182/blood-2003-11-3791; Landsman L, 2009, BLOOD, V113, P963, DOI 10.1182/blood-2008-07-170787; Liu H, 2011, CLIN CHIM ACTA, V412, P1180, DOI 10.1016/j.cca.2011.03.036; Liu P, 2008, ARTERIOSCL THROM VAS, V28, P243, DOI 10.1161/ATVBAHA.107.158675; Liu P, 2006, ARTERIOSCL THROM VAS, V26, P2056, DOI 10.1161/01.ATV.0000234947.47788.8c; Martin G, 2001, J CLIN INVEST, V107, P1423, DOI 10.1172/JCI10852; Momi S, 2012, CARDIOVASC RES, V94, P428, DOI 10.1093/cvr/cvs100; Naert G, 2012, MOL MED, V18, P297, DOI 10.2119/molmed.2011.00306; Ruiz-Velasco N, 2004, BIOCHEM PHARMACOL, V67, P303, DOI 10.1016/j.bcp.2003.09.006; Shen LH, 2008, ATHEROSCLEROSIS, V199, P257, DOI 10.1016/j.atherosclerosis.2007.12.002; Soehnlein O, 2013, EMBO MOL MED, V5, P471, DOI 10.1002/emmm.201201717; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; van der Valk FM, 2012, CURR OPIN LIPIDOL, V23, P532, DOI 10.1097/MOL.0b013e3283587543; White GE, 2012, ARTERIOSCL THROM VAS, V32, P589, DOI 10.1161/ATVBAHA.111.237412; Zelvyte I, 2002, PHARMACOL RES, V45, P147, DOI 10.1006/phrs.2001.0922	24	42	44	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97009	10.1371/journal.pone.0097009	http://dx.doi.org/10.1371/journal.pone.0097009			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816562	gold, Green Published, Green Submitted			2022-12-27	WOS:000336838000093
J	Harma, V; Schukov, HP; Happonen, A; Ahonen, I; Virtanen, J; Siitari, H; Akerfelt, M; Lotjonen, J; Nees, M				Harma, Ville; Schukov, Hannu-Pekka; Happonen, Antti; Ahonen, Ilmari; Virtanen, Johannes; Siitari, Harri; Akerfelt, Malin; Lotjonen, Jyrki; Nees, Matthias			Quantification of Dynamic Morphological Drug Responses in 3D Organotypic Cell Cultures by Automated Image Analysis	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; TISSUE; MODELS; LINES; DIFFERENTIATION; MORPHOGENESIS; EXPRESSION; MICROSCOPY; SOFTWARE; MATRIGEL	Glandular epithelial cells differentiate into complex multicellular or acinar structures, when embedded in three-dimensional (3D) extracellular matrix. The spectrum of different multicellular morphologies formed in 3D is a sensitive indicator for the differentiation potential of normal, non-transformed cells compared to different stages of malignant progression. In addition, single cells or cell aggregates may actively invade the matrix, utilizing epithelial, mesenchymal or mixed modes of motility. Dynamic phenotypic changes involved in 3D tumor cell invasion are sensitive to specific small-molecule inhibitors that target the actin cytoskeleton. We have used a panel of inhibitors to demonstrate the power of automated image analysis as a phenotypic or morphometric readout in cell-based assays. We introduce a streamlined stand-alone software solution that supports large-scale high-content screens, based on complex and organotypic cultures. AMIDA (Automated Morphometric Image Data Analysis) allows quantitative measurements of large numbers of images and structures, with a multitude of different spheroid shapes, sizes, and textures. AMIDA supports an automated workflow, and can be combined with quality control and statistical tools for data interpretation and visualization. We have used a representative panel of 12 prostate and breast cancer lines that display a broad spectrum of different spheroid morphologies and modes of invasion, challenged by a library of 19 direct or indirect modulators of the actin cytoskeleton which induce systematic changes in spheroid morphology and differentiation versus invasion. These results were independently validated by 2D proliferation, apoptosis and cell motility assays. We identified three drugs that primarily attenuated the invasion and formation of invasive processes in 3D, without affecting proliferation or apoptosis. Two of these compounds block Rac signalling, one affects cellular cAMP/cGMP accumulation. Our approach supports the growing needs for user-friendly, straightforward solutions that facilitate large-scale, cell-based 3D assays in basic research, drug discovery, and target validation.	[Harma, Ville; Schukov, Hannu-Pekka; Virtanen, Johannes; Siitari, Harri; Akerfelt, Malin; Nees, Matthias] VTT Tech Res Ctr Finland, Med Biotechnol Knowledge Ctr, Turku, Finland; [Harma, Ville; Schukov, Hannu-Pekka; Virtanen, Johannes; Akerfelt, Malin; Nees, Matthias] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Happonen, Antti] Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland; [Ahonen, Ilmari] Univ Turku, Dept Informat Technol, Turku, Finland; [Lotjonen, Jyrki] VTT Tech Res Ctr Finland, Knowledge Intens Serv, Tampere, Finland	VTT Technical Research Center Finland; University of Turku; Tampere University; University of Turku; VTT Technical Research Center Finland	Nees, M (corresponding author), VTT Tech Res Ctr Finland, Med Biotechnol Knowledge Ctr, Turku, Finland.	matthias.nees@vtt.fi	Nees, Matthias/W-6596-2018; Nees, Matthias/AAT-5577-2020; Happonen, Antti/M-7644-2014	Nees, Matthias/0000-0002-9034-301X; Harma, Ville/0000-0001-5767-5226; Akerfelt, Malin/0000-0003-4810-7862	Academy of Finland [134472]	Academy of Finland(Academy of Finland)	This study was funded by a grant from Academy of Finland, Grant # 134472. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agus DB, 2013, PHYS SCI NETWORK CHA; Alexander S, 2012, TRENDS MOL MED, V18, P13, DOI 10.1016/j.molmed.2011.11.003; Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509; Bisson I, 2009, CELL RES, V19, P683, DOI 10.1038/cr.2009.43; Bjorkman M, 2012, ONCOGENE, V31, P3444, DOI 10.1038/onc.2011.512; Bright MD, 2009, CELL SIGNAL, V21, P1738, DOI 10.1016/j.cellsig.2009.07.005; Brugge JS, 2012, NAT CELL BIOL, V14, P332, DOI 10.1038/ncb2470; Brunner E, 2002, NONPARAMETRIC ANAL L; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cioce M, 2010, CELL CYCLE, V9, P2878, DOI 10.4161/cc.9.14.12371; DANIELSSON PE, 1980, COMPUT VISION GRAPH, V14, P227, DOI 10.1016/0146-664X(80)90054-4; DeRose Yoko S, 2013, Curr Protoc Pharmacol, VChapter 14, DOI 10.1002/0471141755.ph1423s60; Drewitz M, 2011, BIOTECHNOL J, V6, P1488, DOI 10.1002/biot.201100290; DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112; Egeblad M, 2010, CURR OPIN CELL BIOL, V22, P697, DOI 10.1016/j.ceb.2010.08.015; Elliott NT, 2011, J PHARM SCI-US, V100, P59, DOI 10.1002/jps.22257; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Ghajar CM, 2008, HISTOCHEM CELL BIOL, V130, P1105, DOI 10.1007/s00418-008-0537-1; Gligorich KM, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3452; Gray RS, 2010, CURR OPIN CELL BIOL, V22, P640, DOI 10.1016/j.ceb.2010.08.019; Guo CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034219; Guo Changyong, 2012, Methods Mol Biol, V879, P315, DOI 10.1007/978-1-61779-815-3_18; Hamilton N, 2009, TRAFFIC, V10, P951, DOI 10.1111/j.1600-0854.2009.00938.x; Han J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000684; Harma V, 2012, ONCOGENE, V31, P2075, DOI 10.1038/onc.2011.396; Harma V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010431; Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Katz E, 2012, ONCOTARGET, V3, P608; Katz E, 2011, ANAL CELL PATHOL, V34, P35, DOI [10.3233/ACP-2011-0003, 10.1155/2011/864847]; Katz E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017083; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Kimlin LC, 2013, MOL CARCINOGEN, V52, P167, DOI 10.1002/mc.21844; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Lang SH, 2001, BRIT J CANCER, V85, P590, DOI 10.1054/bjoc.2001.1967; Leeper AD, 2012, BIOMATERIALS, V33, P907, DOI 10.1016/j.biomaterials.2011.10.028; Lin KT, 2012, CANCER RES, V72, P3000, DOI 10.1158/0008-5472.CAN-11-2502; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Martin I, 2004, TRENDS BIOTECHNOL, V22, P80, DOI 10.1016/j.tibtech.2003.12.001; Megason SG, 2007, CELL, V130, P784, DOI 10.1016/j.cell.2007.08.031; Megason SG, 2003, MECH DEVELOP, V120, P1407, DOI 10.1016/j.mod.2003.07.005; Mirica KA, 2011, ADV MATER, V23, P4134, DOI 10.1002/adma.201101917; Muranen T, 2012, CANCER CELL, V21, P227, DOI 10.1016/j.ccr.2011.12.024; Nelson CM, 2005, SEMIN CANCER BIOL, V15, P342, DOI 10.1016/j.semcancer.2005.05.001; Rejniak KA, 2010, MATH MED BIOL; Rejniak KA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000900; Rejniak KA, 2010, EXP BIOL MED, V235, P411, DOI 10.1258/ebm.2009.009230; Ridley AJ, 2001, J CELL SCI, V114, P2713; Roerdink J. B. T. M., 2000, Fundamenta Informaticae, V41, P187; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Schmitt O, 2008, PATTERN RECOGN, V41, P1905, DOI 10.1016/j.patcog.2007.11.006; Schulz WA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-505; Schwartz MA, 2013, SCIENCE, V339, P402, DOI 10.1126/science.1233814; Selinummi J, 2006, NEUROSCI LETT, V396, P102, DOI 10.1016/j.neulet.2005.11.021; Selinummi J, 2005, BIOTECHNIQUES, V39, P859, DOI 10.2144/000112018; Sundstrom L, 2012, EXPERT OPIN DRUG DIS, V7, P525, DOI 10.1517/17460441.2012.686488; TSAI DM, 1995, PATTERN RECOGN LETT, V16, P653, DOI 10.1016/0167-8655(95)00005-2; Walia V, 2010, STEM CELLS DEV, V19, P1175, DOI 10.1089/scd.2009.0430; Wang Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010456	60	59	61	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96426	10.1371/journal.pone.0096426	http://dx.doi.org/10.1371/journal.pone.0096426			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810913	Green Published, gold, Green Submitted			2022-12-27	WOS:000338213300036
J	Wei, TQ; Bi, HY; Chen, BG; Liu, Y; Weng, XC; Wydell, TN				Wei, Tong-Qi; Bi, Hong-Yan; Chen, Bao-Guo; Liu, Ying; Weng, Xu-Chu; Wydell, Taeko N.			Developmental Changes in the Role of Different Metalinguistic Awareness Skills in Chinese Reading Acquisition from Preschool to Third Grade	PLOS ONE			English	Article							PHONOLOGICAL AWARENESS; MORPHOLOGICAL AWARENESS; CHARACTER ACQUISITION; SCHOOL-CHILDREN; PRINT EXPOSURE; HONG-KONG; DYSLEXIA; VOCABULARY; ENGLISH; KNOWLEDGE	The present study investigated the relationship between Chinese reading skills and metalinguistic awareness skills such as phonological, morphological, and orthographic awareness for 101 Preschool, 94 Grade-1, 98 Grade-2, and 98 Grade-3 children from two primary schools in Mainland China. The aim of the study was to examine how each of these metalinguistic awareness skills would exert their influence on the success of reading in Chinese with age. The results showed that all three metalinguistic awareness skills significantly predicted reading success. It further revealed that orthographic awareness played a dominant role in the early stages of reading acquisition, and its influence decreased with age, while the opposite was true for the contribution of morphological awareness. The results were in stark contrast with studies in English, where phonological awareness is typically shown as the single most potent metalinguistic awareness factor in literacy acquisition. In order to account for the current data, a three-stage model of reading acquisition in Chinese is discussed.	[Wei, Tong-Qi; Bi, Hong-Yan] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Chen, Bao-Guo] Beijing Normal Univ, Beijing Key Lab Appl Expt Psychol, Sch Psychol, Beijing 100875, Peoples R China; [Liu, Ying] China Capital Med Univ, Sch Hlth Care Management & Educ, Beijing, Peoples R China; [Weng, Xu-Chu] Hangzhou Normal Univ, Cent Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China; [Wydell, Taeko N.] Brunel Univ, Ctr Cognit & Neuroimaging, Dept Psychol, Sch Social Sci, Uxbridge UB8 3PH, Middx, England	Chinese Academy of Sciences; Institute of Psychology, CAS; Beijing Normal University; Capital Medical University; Hangzhou Normal University; Brunel University	Bi, HY (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	bihy@psych.ac.cn	Wei, Tongqi/AAP-6877-2020	Wei, Tongqi/0000-0003-1228-3960; Wydell, Taeko/0000-0001-9675-164X	National Natural Science Foundation of China [30770726, 30970910]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-J-8]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences)	This research was supported by the National Natural Science Foundation of China (30770726, 30970910), and Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-J-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 1990, BEGINNING READ; Anthony JL, 2004, J EDUC PSYCHOL, V96, P43, DOI 10.1037/0022-0663.96.1.43; Badian NA, 2001, ANN DYSLEXIA, V51, P179; BADIAN NA, 1994, ANN DYSLEXIA, V44, P3, DOI 10.1007/BF02648153; Bi HY, 2008, NEURAL REGEN RES, V3, P128; BRADY S, 1983, J EXP CHILD PSYCHOL, V35, P345, DOI 10.1016/0022-0965(83)90087-5; Burgess SR, 1998, J EXP CHILD PSYCHOL, V70, P117, DOI 10.1006/jecp.1998.2450; Carlisle J. F., 1995, MORPHOLOGICAL ASPECT, P189, DOI DOI 10.4236/PSYCH.2014.58103; Cartwright KB, 2012, EARLY EDUC DEV, V23, P24, DOI 10.1080/10409289.2011.615025; Castles A, 2004, COGNITION, V91, P77, DOI 10.1016/S0010-0277(03)00164-1; Chan L, 1998, APPL PSYCHOLINGUIST, V19, P115, DOI 10.1017/S0142716400010614; CHANEY C, 1994, APPL PSYCHOLINGUIST, V15, P371, DOI 10.1017/S0142716400004501; Chen P, 1999, THESIS PEKING U BEIJ; Chi MMY, 1986, THESIS OHIO STATE U; CUNNINGHAM AE, 1990, J EDUC PSYCHOL, V82, P733, DOI 10.1037/0022-0663.82.4.733; CUNNINGHAM AE, 1991, J EDUC PSYCHOL, V83, P264, DOI 10.1037/0022-0663.83.2.264; Deacon SH, 2007, DEV PSYCHOL, V43, P732, DOI 10.1037/0012-1649.43.3.732; Deacon SH, 2004, APPL PSYCHOLINGUIST, V25, P223, DOI 10.1017/S0142716404001110; DENCKLA MB, 1976, BRAIN LANG, V3, P1, DOI 10.1016/0093-934X(76)90001-8; DENCKLA MB, 1976, NEUROPSYCHOLOGIA, V14, P471, DOI 10.1016/0028-3932(76)90075-0; Ehri L. C., 1995, J RES READ, V18, P116, DOI [10.1111/j.14679817.1995.tb00077.x, DOI 10.1111/J.14679817.1995.TB00077.X, 10.1111/j.1467-9817.1995.tb00077.x, DOI 10.1111/J.1467-9817.1995.TB00077.X]; Frith U., 1985, SURFACE DYSLEXIA NEU, P301, DOI DOI 10.4324/9781315108346-18; Gathercole S. E., 1996, CHILDRENS TEST NONWO; Georgiou GK, 2013, J EXP CHILD PSYCHOL, V115, P218, DOI 10.1016/j.jecp.2012.10.015; Gottardo A, 2001, J EDUC PSYCHOL, V93, P530, DOI 10.1037/0022-0663.93.3.530; Gough P., 1992, READING ACQUISITION, P35; Ho CSH, 2007, J EXP CHILD PSYCHOL, V97, P61, DOI 10.1016/j.jecp.2007.01.002; Ho CSH, 2012, READ WRIT, V25, P857, DOI 10.1007/s11145-011-9303-1; Ho CSH, 1997, DEV PSYCHOL, V33, P946, DOI 10.1037/0012-1649.33.6.946; Ho CSH, 2004, COGNITION, V91, P43, DOI 10.1016/S0010-0277(03)00163-X; Ho CSH, 2003, J LIT RES, V35, P849, DOI 10.1207/s15548430jlr3503_3; Ho CSH, 1997, J PSYCHOLINGUIST RES, V26, P109, DOI 10.1023/A:1025016322316; Ho CSH, 2002, DEV PSYCHOL, V38, P543, DOI 10.1037//0012-1649.38.4.543; Hu C.F., 1998, SCI STUD READ, V2, P55, DOI [10.1207/s1532799xssr0201_3, DOI 10.1207/S1532799XSSR0201_3]; HUANG HS, 1995, COGNITION, V54, P73, DOI 10.1016/0010-0277(94)00641-W; KANG JS, 1993, INFORM ANAL USAGE CH, P68; Kirby JR, 2010, READ RES QUART, V45, P341, DOI 10.1598/RRQ.45.3.4; Kirby JR, 2008, CAN PSYCHOL, V49, P103, DOI 10.1037/0708-5591.49.2.103; Ku YM., 2003, READ WRIT, V16, P399, DOI [DOI 10.1023/A:1024227231216, 10.1016/j.cedpsych.2015.10.002, DOI 10.1016/J.CEDPSYCH.2015.10.002]; Li CharlesN., 1981, MANDARIN CHINESE FUN; Lin D, 2010, PSYCHOL SCI, V21, P1117, DOI 10.1177/0956797610375447; [刘文理 Liu Wenli], 2006, [心理学报, Acta Psychologica Sinica], V38, P681; McBride-Chang C, 2005, J EXP CHILD PSYCHOL, V92, P140, DOI 10.1016/j.jecp.2005.03.009; McBride-Chang C, 2000, J EDUC PSYCHOL, V92, P50, DOI 10.1037/0022-0663.92.1.50; McBride-Chang C, 2005, APPL PSYCHOLINGUIST, V26, P415, DOI 10.1017/S014271640505023X; McBride-Chang C, 2003, J EDUC PSYCHOL, V95, P743, DOI 10.1037/0022-0663.95.4.743; Metsala JL, 1999, J EDUC PSYCHOL, V91, P3, DOI 10.1037/0022-0663.91.1.3; Muter V, 2004, DEV PSYCHOL, V40, P665, DOI 10.1037/0012-1649.40.5.665; Nagy W, 2006, J EDUC PSYCHOL, V98, P134, DOI 10.1037/0022-0663.98.1.134; Nunes T, 1997, DEV PSYCHOL, V33, P637, DOI 10.1037/0012-1649.33.4.637; Peng DL, 1997, COGNITIVE PROCESSING, P86; Roman AA, 2009, J EXP CHILD PSYCHOL, V102, P96, DOI 10.1016/j.jecp.2008.01.004; Shu H, 1997, READ RES QUART, V32, P78, DOI 10.1598/RRQ.32.1.5; Shu H, 2006, J EDUC PSYCHOL, V98, P122, DOI 10.1037/0022-0663.98.1.122; Shu H, 2000, J EDUC PSYCHOL, V92, P56, DOI 10.1037//0022-0663.92.1.56; Shu H, 2008, DEVELOPMENTAL SCI, V11, P171, DOI 10.1111/j.1467-7687.2007.00654.x; Siok WT, 2001, DEV PSYCHOL, V37, P886, DOI 10.1037//0012-1649.37.6.886; Snowling M, 1998, READING AND SPELLING, P201; STANOVICH KE, 1991, PHONOLOGICAL PROCESSES IN LITERACY, P219; Su YF, 2010, READ WRIT, V23, P1085, DOI 10.1007/s11145-009-9197-3; Tan LH, 2005, P NATL ACAD SCI USA, V102, P8781, DOI 10.1073/pnas.0503523102; Tong XL, 2009, SCI STUD READ, V13, P426, DOI 10.1080/10888430903162910; Uno A, 2009, READ WRIT, V22, P755, DOI 10.1007/s11145-008-9128-8; Wang JJ, 2010, NEUROPSYCHOLOGIA, V48, P3627, DOI 10.1016/j.neuropsychologia.2010.08.015; Wu XY, 2009, SCI STUD READ, V13, P26, DOI 10.1080/10888430802631734; Wydell TN, 1999, COGNITION, V70, P273, DOI 10.1016/S0010-0277(99)00016-5; Yang Xipeng, 2003, CHINESE MORPHEME; Zhang H. C., 1985, CHINESE VERSION RAVE; Zhang J., 2011, WRITING SYSTEM RES, V3, P87, DOI [10.1093/wsr/wsr011, DOI 10.1093/WSR/WSR011]; Ziegler JC, 2005, PSYCHOL BULL, V131, P3, DOI 10.1037/0033-2909.131.1.3; Ziegler JC, 2010, PSYCHOL SCI, V21, P551, DOI 10.1177/0956797610363406	71	29	30	8	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96240	10.1371/journal.pone.0096240	http://dx.doi.org/10.1371/journal.pone.0096240			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK1XT	24809477	Green Published, Green Submitted, gold			2022-12-27	WOS:000338213300023
J	Blacher, S; Erpicum, C; Lenoir, B; Paupert, J; Moraes, G; Ormenese, S; Bullinger, E; Noel, A				Blacher, Silvia; Erpicum, Charlotte; Lenoir, Benedicte; Paupert, Jenny; Moraes, Gustavo; Ormenese, Sandra; Bullinger, Eric; Noel, Agnes			Cell Invasion in the Spheroid Sprouting Assay: A Spatial Organisation Analysis Adaptable to Cell Behaviour	PLOS ONE			English	Article							LYMPHATIC ENDOTHELIAL-CELLS; IN-VITRO; EXTRACELLULAR-MATRIX; VESSEL FORMATION; LYMPHANGIOGENESIS; ANGIOGENESIS; APOPTOSIS; CULTURE; SYSTEM; MODEL	The endothelial cell spheroid assay provides a suitable in vitro model to study (lymph) angiogenesis and test pro-and anti(lymph) angiogenic factors or drugs. Usually, the extent of cell invasion, observed through optical microscopy, is measured. The present study proposes the spatial distribution of migrated cells as a new descriptor of the (lymph) angiogenic response. The utility of this novel method rests with its capacity to locally characterise spheroid structure, allowing not only the investigation of single and collective cell invasion but also the evolution of the spheroid core itself. Moreover, the proposed method can be applied to 2D-projected spheroid images obtained by optical microscopy, as well as to 3D images acquired by confocal microscopy. To validate the proposed methodology, endothelial cell invasion was evaluated under different experimental conditions. The results were compared with widely used global parameters. The comparison shows that our method prevents local spheroid modifications from being overlooked and leading to the possible misinterpretation of results.	[Blacher, Silvia; Erpicum, Charlotte; Lenoir, Benedicte; Paupert, Jenny; Noel, Agnes] Univ Liege, GIGA Canc, Lab Tumor & Dev Biol, Liege, Belgium; [Lenoir, Benedicte] CRP Sante, Cardiovasc Res Lab, Luxembourg, Luxembourg; [Moraes, Gustavo; Ormenese, Sandra] Univ Liege, GIGA Imaging & Flow Cytometry Platform, Liege, Belgium; [Bullinger, Eric] Univ Liege, GIGA Syst Biol & Chem Biol, Liege, Belgium	University of Liege; Luxembourg Institute of Health; University of Liege; University of Liege	Noel, A (corresponding author), Univ Liege, GIGA Canc, Lab Tumor & Dev Biol, Liege, Belgium.	Agnes.noel@ulg.ac.be	Bullinger, Eric/B-6772-2008	Bullinger, Eric/0000-0002-8889-8286; Noel, Agnes/0000-0002-7670-6179; Paupert, Jenny/0000-0001-9550-9296	Fonds de la recherche scientifique (FNRS-FRS [3.4598.10]; Fondation contre le Cancer (Fondation of public interest, Belgium) [2010- 170]; Centre anticancereux pres de l'Universite de Liege; Fonds Leon Fredericq (University of Liege); Action de Recherche Concertees (University of Liege) [11/16-02]; Interuniversity Attraction Pole: phase [VII-P7/03]	Fonds de la recherche scientifique (FNRS-FRS(Fonds de la Recherche Scientifique - FNRS); Fondation contre le Cancer (Fondation of public interest, Belgium); Centre anticancereux pres de l'Universite de Liege; Fonds Leon Fredericq (University of Liege); Action de Recherche Concertees (University of Liege); Interuniversity Attraction Pole: phase	This work was supported by Fonds de la recherche scientifique (FNRS-FRS) no. 3.4598.10; Fondation contre le Cancer (Fondation of public interest, Belgium) no. 2010- 170; Centre anticancereux pres de l'Universite de Liege; Fonds Leon Fredericq (University of Liege); Action de Recherche Concertees (University of Liege) no. 11/16-02; and Interuniversity Attraction Pole: phase VII-P7/03 (IAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagci T, 2009, ONCOGENE, V28, P3537, DOI 10.1038/onc.2009.204; Bruyere F, 2008, NAT METHODS, V5, P431, DOI [10.1038/nmeth.1205, 10.1038/NMETH.1205]; de Sampaio PC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030753; De Wever O, 2010, INT J DEV BIOL, V54, P887, DOI 10.1387/ijdb.092948ow; Detry B, 2012, BLOOD, V119, P5048, DOI 10.1182/blood-2011-12-400267; Detry B, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-29; Diehl F, 2007, BLOOD, V109, P1472, DOI 10.1182/blood-2006-08-039651; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/BFb0056195; Fusenig N E, 1994, J Dermatol Sci, V7 Suppl, pS142, DOI 10.1016/0923-1811(94)90045-0; Ghosh S, 2007, FEBS LETT, V581, P4523, DOI 10.1016/j.febslet.2007.08.038; Gonzales RZ, 2008, DIGITAL IMAGE PROCES, P3; Hammer T, 2009, MICROVASC RES, V78, P25, DOI 10.1016/j.mvr.2009.02.007; Hirschhaeuser F, 2009, J BIOMOL SCREEN, V14, P980, DOI 10.1177/1087057109341766; Kalabis J, 2008, J CLIN INVEST, V118, P3860, DOI 10.1172/JCI35012; Karpanen T, 2008, ANNU REV PATHOL-MECH, V3, P367, DOI 10.1146/annurev.pathol.3.121806.151515; Koh W, 2008, METHOD ENZYMOL, V443, P83, DOI 10.1016/S0076-6879(08)02005-3; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341; Korff T, 2001, FASEB J, V15, P447, DOI 10.1096/fj.00-0139com; Korff T, 1999, J CELL SCI, V112, P3249; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Maquoi E, 2004, CLIN CANCER RES, V10, P4038, DOI 10.1158/1078-0432.CCR-04-0125; Maquoi E, 2012, ONCOGENE, V31, P480, DOI 10.1038/onc.2011.249; Nakatsu MN, 2008, METHOD ENZYMOL, V443, P65, DOI 10.1016/S0076-6879(08)02004-1; Nisato RE, 2004, AM J PATHOL, V165, P11, DOI 10.1016/S0002-9440(10)63271-3; Noel A, 2007, TRENDS MOL MED, V13, P345, DOI 10.1016/j.molmed.2007.06.005; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Paupert J, 2011, MOL ASPECTS MED, V32, P146, DOI 10.1016/j.mam.2011.04.002; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Scheubel RJ, 2006, EXP GERONTOL, V41, P540, DOI 10.1016/j.exger.2006.01.002; Schulz MMP, 2012, P NATL ACAD SCI USA, V109, pE2665, DOI 10.1073/pnas.1206036109; Sleeman JP, 2010, PHLEBOLYMPHOLOGY, V17, P99; Sleeman JP, 2009, INT J CANCER, V125, P2747, DOI 10.1002/ijc.24702; Sodek KL, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-223; Soille P, 1999, MORPHOLOGICAL ANAL P; Theuerkauf RS, 2010, J REPROD IMMUNOL, V85, P63, DOI 10.1016/j.jri.2010.01.004; Weber H, 2008, TOXICOL IN VITRO, V22, P531, DOI 10.1016/j.tiv.2007.09.014; Wiig H, 2010, MATRIX BIOL, V29, P645, DOI 10.1016/j.matbio.2010.08.001	37	36	36	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e97019	10.1371/journal.pone.0097019	http://dx.doi.org/10.1371/journal.pone.0097019			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806521	gold, Green Published, Green Submitted			2022-12-27	WOS:000335728900126
J	Lou, YW; Zhang, GZ; Geng, MH; Zhang, WQ; Cui, J; Liu, SX				Lou, Yunwei; Zhang, Guizhong; Geng, Minghong; Zhang, Wenqian; Cui, Jian; Liu, Suxia			TIPE2 Negatively Regulates Inflammation by Switching Arginine Metabolism from Nitric Oxide Synthase to Arginase	PLOS ONE			English	Article							ARTERIAL ENDOTHELIAL-CELLS; ACTIVATED PROTEIN-KINASE; IMMUNE HOMEOSTASIS; DEFICIENT MICE; MACROPHAGES; EXPRESSION; ATHEROSCLEROSIS; LIPOPOLYSACCHARIDE; SCC-S2; DIFFERENTIATION	TIPE2, the tumor necrosis factor (TNF)-alpha-induced protein 8-like 2 (TNFAIP8L2), plays an essential role in maintaining immune homeostasis. It is highly expressed in macrophages and negatively regulates inflammation through inhibiting Toll-like receptor signaling. In this paper, we utilized RAW264.7 cells stably transfected with a TIPE2 expression plasmid, as well as TIPE2- deficient macrophages to study the roles of TIPE2 in LPS-induced nitric oxide (NO) and urea production. The results showed that TIPE2- deficiency significantly upregulated the levels of iNOS expression and NO production in LPS-stimulated macrophages, but decreased mRNA levels of arginase I and urea production. However, TIPE2 overexpression in macrophages was capable of downregulating protein levels of LPS- induced iNOS and NO, but generated greater levels of arginase I and urea production. Furthermore, TIPE2(-/-) mice had higher iNOS protein levels in lung and liver and higher plasma NO concentrations, but lower levels of liver arginase I compared to LPS- treated WT controls. Interestingly, significant increases in I kappa B degradation and phosphorylation of JNK, p38, and I kappa B were observed in TIPE2- deficient macrophages following LPS challenge. These results strongly suggest that TIPE2 plays an important role in shifting L-arginase metabolism from production of NO to urea, during host inflammatory response.	[Lou, Yunwei; Zhang, Guizhong; Geng, Minghong; Zhang, Wenqian; Cui, Jian; Liu, Suxia] Shandong Univ, Sch Med, Dept Immunol, Jinan 250100, Peoples R China	Shandong University	Liu, SX (corresponding author), Shandong Univ, Sch Med, Dept Immunol, Jinan 250100, Peoples R China.	suxiasd@163.com	Cui, Jian/AAT-7713-2021	Cui, Jian/0000-0003-1228-8876	National Natural Science Foundation of China [81171578, 81100205]; Health Department of Shandong Province [2009HD009]; Excellent Young and Middle-aged Scientists of Shandong Province [BS2009YY007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Health Department of Shandong Province; Excellent Young and Middle-aged Scientists of Shandong Province	This work was supported by the grants from the National Natural Science Foundation of China (No. 81171578, No. 81100205), the Key grant from the Health Department of Shandong Province (2009HD009), and the Award Funds for Excellent Young and Middle-aged Scientists of Shandong Province (BS2009YY007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajizian SJ, 1999, J INFECT DIS, V179, P939, DOI 10.1086/314659; Bian K, 2003, FRONT BIOSCI-LANDMRK, V8, pD264, DOI 10.2741/997; Chan ED, 2001, AM J PHYSIOL-CELL PH, V280, pC441, DOI 10.1152/ajpcell.2001.280.3.C441; Chang CI, 1998, AM J PHYSIOL-HEART C, V274, pH342, DOI 10.1152/ajpheart.1998.274.1.H342; Chang CI, 2000, J IMMUNOL, V165, P2134, DOI 10.4049/jimmunol.165.4.2134; Chicoine LG, 2004, AM J PHYSIOL-LUNG C, V287, pL60, DOI 10.1152/ajplung.00194.2003; Cho SY, 2003, MOL CELL BIOCHEM, V243, P153, DOI 10.1023/A:1021624520740; Detmers PA, 2000, J IMMUNOL, V165, P3430, DOI 10.4049/jimmunol.165.6.3430; Gus-Brautbar Y, 2012, MOL CELL, V45, P610, DOI 10.1016/j.molcel.2012.01.006; Hwang SJ, 2013, INFLAMMATION RES OFF; Kanters E, 2003, J CLIN INVEST, V112, P1176, DOI 10.1172/JCI18580; Kepka-Lenhart D, 2000, AM J PHYSIOL-REG I, V279, pR2237; Klasen S, 2001, BRIT J PHARMACOL, V132, P1349, DOI 10.1038/sj.bjp.0703951; Kuhlencordt PJ, 2001, CIRCULATION, V103, P3099, DOI 10.1161/01.CIR.103.25.3099; Kumar D, 2004, ONCOGENE, V23, P612, DOI 10.1038/sj.onc.1207123; Kumar D, 2000, J BIOL CHEM, V275, P2973, DOI 10.1074/jbc.275.4.2973; Lewis ND, 2010, J IMMUNOL, V184, P2572, DOI 10.4049/jimmunol.0902436; Li H, 2002, AM J PHYSIOL-REG I, V282, pR64, DOI 10.1152/ajpregu.2002.282.1.R64; Lou YW, 2013, J IMMUNOL, V191, P4849, DOI 10.4049/jimmunol.1300053; Mao KR, 2013, CELL RES, V23, P201, DOI 10.1038/cr.2013.6; Mishra BB, 2013, NAT IMMUNOL, V14, P52, DOI 10.1038/ni.2474; Morris SM, 1998, AM J PHYSIOL-ENDOC M, V275, pE740, DOI 10.1152/ajpendo.1998.275.5.E740; Nelin LD, 2005, AM J RESP CELL MOL, V33, P394, DOI 10.1165/rcmb.2005-0039OC; Pauleau AL, 2004, J IMMUNOL, V172, P7565, DOI 10.4049/jimmunol.172.12.7565; Stanley KP, 2006, AM J PHYSIOL-LUNG C, V290, pL298, DOI 10.1152/ajplung.00140.2005; Sun HH, 2008, CELL, V133, P415, DOI 10.1016/j.cell.2008.03.026; Sun HH, 2012, J IMMUNOL, V189, P2768, DOI 10.4049/jimmunol.1103477; Vecchini F, 1997, CELL GROWTH DIFFER, V8, P261; Wang XP, 2013, EUROPEAN HEART J; Wang ZJ, 2012, P NATL ACAD SCI USA, V109, P15413, DOI 10.1073/pnas.1204525109; Witte MB, 2003, WOUND REPAIR REGEN, V11, P419, DOI 10.1046/j.1524-475X.2003.11605.x; Xi WJ, 2011, MOL IMMUNOL, V48, P1203, DOI 10.1016/j.molimm.2011.03.002; XIE QW, 1994, J BIOL CHEM, V269, P4705; Zhang CB, 2006, MOL THER, V13, P947, DOI 10.1016/j.ymthe.2005.11.020; Zhang GZ, 2013, CELL CYCLE, V12, P501, DOI 10.4161/cc.23325; Zhang GZ, 2010, MOL IMMUNOL, V47, P2435, DOI 10.1016/j.molimm.2010.06.016; Zhang SY, 2010, BBA-MOL BASIS DIS, V1802, P1078, DOI 10.1016/j.bbadis.2010.08.003; Zhang X, 2009, NAT STRUCT MOL BIOL, V16, P89, DOI 10.1038/nsmb.1522; Zhang Y, 2012, J BIOL CHEM, V287, P32546, DOI 10.1074/jbc.M112.348755	39	32	35	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96508	10.1371/journal.pone.0096508	http://dx.doi.org/10.1371/journal.pone.0096508			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806446	Green Submitted, Green Published, gold			2022-12-27	WOS:000335728900065
J	Balderston, NL; Schultz, DH; Baillet, S; Helmstetter, FJ				Balderston, Nicholas L.; Schultz, Douglas H.; Baillet, Sylvain; Helmstetter, Fred J.			Rapid Amygdala Responses during Trace Fear Conditioning without Awareness	PLOS ONE			English	Article							POTENTIALLY PHOBIC STIMULI; OSCILLATORY GAMMA-ACTIVITY; EMOTIONAL FACES; FACIAL EXPRESSIONS; PREFRONTAL CORTEX; OCCIPITAL CORTEX; NEURAL ACTIVITY; SINGLE NEURONS; DELAY; PERCEPTION	The role of consciousness in learning has been debated for nearly 50 years. Recent studies suggest that conscious awareness is needed to bridge the gap when learning about two events that are separated in time, as is true for trace fear conditioning. This has been repeatedly shown and seems to apply to other forms of classical conditioning as well. In contrast to these findings, we show that individuals can learn to associate a face with the later occurrence of a shock, even if they are unable to perceive the face. We used a novel application of magnetoencephalography (MEG) to non-invasively record neural activity from the amygdala, which is known to be important for fear learning. We demonstrate rapid (similar to 170-200 ms) amygdala responses during the stimulus free period between the face and the shock. These results suggest that unperceived faces can serve as signals for impending threat, and that rapid, automatic activation of the amygdala contributes to this process. In addition, we describe a methodology that can be applied in the future to study neural activity with MEG in other subcortical structures.	[Balderston, Nicholas L.; Schultz, Douglas H.; Helmstetter, Fred J.] Univ Wisconsin, Dept Psychol, Milwaukee, WI 53201 USA; [Baillet, Sylvain; Helmstetter, Fred J.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Baillet, Sylvain] McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ, Canada	University of Wisconsin System; University of Wisconsin Milwaukee; Medical College of Wisconsin; McGill University	Helmstetter, FJ (corresponding author), Univ Wisconsin, Dept Psychol, Milwaukee, WI 53201 USA.	fjh@uwm.edu	Schultz, Douglas/AAB-2365-2020; Balderston, Nicholas/U-9126-2019; Baillet, Sylvain/AAF-6512-2019	Schultz, Douglas/0000-0003-0809-9036; Balderston, Nicholas/0000-0002-8565-1544; Baillet, Sylvain/0000-0002-6762-5713; Helmstetter, Fred/0000-0003-3413-2418	National Institute of Mental Health [R01 MH069558]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069558] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health (R01 MH069558). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2008, CURR OPIN NEUROBIOL, V18, P166, DOI 10.1016/j.conb.2008.06.006; Asli O, 2009, PSYCHOPHYSIOLOGY, V46, P880, DOI 10.1111/j.1469-8986.2009.00809.x; Balderston NL, 2013, JOVE-J VIS EXP, DOI 10.3791/50212; Balderston NL, 2011, NEUROIMAGE, V55, P1889, DOI 10.1016/j.neuroimage.2011.01.034; Balderston NL, 2010, BEHAV NEUROSCI, V124, P478, DOI 10.1037/a0019927; Bauer EP, 2007, J NEUROSCI, V27, P9369, DOI 10.1523/JNEUROSCI.2153-07.2007; Bayle DJ, 2010, BRAIN RES, V1313, P113, DOI 10.1016/j.brainres.2009.11.060; Bayle DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008207; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Bertrand O, 2000, INT J PSYCHOPHYSIOL, V38, P211, DOI 10.1016/S0167-8760(00)00166-5; Beylin AV, 2001, NEUROBIOL LEARN MEM, V76, P447, DOI 10.1006/nlme.2001.4039; Bock E, 2010, IFMBE PROC, V28, P128; Carlson JM, 2009, NEUROPSYCHOLOGIA, V47, P1386, DOI 10.1016/j.neuropsychologia.2009.01.026; Carter RM, 2003, P NATL ACAD SCI USA, V100, P1399, DOI 10.1073/pnas.0334049100; Cheng DT, 2007, LEARN MEMORY, V14, P485, DOI 10.1101/lm.632007; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dannlowski U, 2008, NEUROPSYCHOPHARMACOL, V33, P418, DOI 10.1038/sj.npp.1301411; de Gelder B, 2010, NEUROSCI BIOBEHAV R, V34, P513, DOI 10.1016/j.neubiorev.2009.10.008; Delgado MR, 2008, NEURON, V59, P829, DOI 10.1016/j.neuron.2008.06.029; Dolan RJ, 2006, NEUROIMAGE, V32, P778, DOI 10.1016/j.neuroimage.2006.04.206; Dumas T, 2010, IFMBE PROC, V28, P330; Ekman P., 1976, PICTURES FACIAL AFFE; Feng WF, 2009, BRAIN RES, V1286, P147, DOI 10.1016/j.brainres.2009.06.059; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; FREDRIKSON M, 1976, BIOL PSYCHOL, V4, P305, DOI 10.1016/0301-0511(76)90021-1; Fruhholz S, 2011, BIOL PSYCHOL, V87, P265, DOI 10.1016/j.biopsycho.2011.03.008; Gilmartin MR, 2010, LEARN MEMORY, V17, P289, DOI 10.1101/lm.1597410; Gilmartin MR, 2005, BEHAV NEUROSCI, V119, P1496, DOI 10.1037/0735-7044.119.6.1496; Gilmartin MR, 2005, BEHAV NEUROSCI, V119, P164, DOI 10.1037/0735-7044.119.1.164; Goldenholz DM, 2009, HUM BRAIN MAPP, V30, P1077, DOI 10.1002/hbm.20571; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Hebb Donald O., 1949, ORG BEHAV; Hsiao FJ, 2005, NEUROSCI LETT, V380, P54, DOI 10.1016/j.neulet.2005.01.016; Huang MX, 1999, PHYS MED BIOL, V44, P423, DOI 10.1088/0031-9155/44/2/010; HUGDAHL K, 1980, PSYCHOPHYSIOLOGY, V17, P348, DOI 10.1111/j.1469-8986.1980.tb00161.x; Hung YW, 2010, NEUROIMAGE, V50, P727, DOI 10.1016/j.neuroimage.2009.12.093; Kim JJ, 2006, NEUROSCI BIOBEHAV R, V30, P188, DOI 10.1016/j.neubiorev.2005.06.005; Knight DC, 2006, COGN AFFECT BEHAV NE, V6, P157, DOI 10.3758/CABN.6.2.157; Knight DC, 2004, COGN AFFECT BEHAV NE, V4, P317, DOI 10.3758/CABN.4.3.317; Knight DC, 2009, NEUROIMAGE, V45, P208, DOI 10.1016/j.neuroimage.2008.11.015; Knight DC, 2004, J NEUROSCI, V24, P218, DOI 10.1523/JNEUROSCI.0433-03.2004; Krusemark EA, 2011, J NEUROSCI, V31, P3429, DOI 10.1523/JNEUROSCI.4394-10.2011; Kwapis JL, 2011, LEARN MEMORY, V18, P728, DOI 10.1101/lm.023945.111; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; Liddell BJ, 2005, NEUROIMAGE, V24, P235, DOI 10.1016/j.neuroimage.2004.08.016; Luo Q, 2010, J NEUROSCI, V30, P5825, DOI 10.1523/JNEUROSCI.BC-5668-09.2010; Luo Q, 2009, CEREB CORTEX, V19, P1896, DOI 10.1093/cercor/bhn216; Maratos FA, 2009, COGN AFFECT BEHAV NE, V9, P133, DOI 10.3758/CABN.9.2.133; Mitsudo T, 2011, CLIN NEUROPHYSIOL, V122, P708, DOI 10.1016/j.clinph.2010.10.004; Moratti S, 2006, PSYCHOPHYSIOLOGY, V43, P216, DOI 10.1111/j.1464-8986.2006.00386.x; Moratti S, 2005, COGNITIVE BRAIN RES, V25, P459, DOI 10.1016/j.cogbrainres.2005.07.006; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Moses SN, 2007, BRAIN RES BULL, V71, P452, DOI 10.1016/j.brainresbull.2006.08.016; Noguchi Y, 2005, NEUROIMAGE, V27, P178, DOI 10.1016/j.neuroimage.2005.03.032; OHMAN A, 1976, J EXP PSYCHOL GEN, V105, P313, DOI 10.1037/0096-3445.105.4.313; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Olsson A, 2007, NAT NEUROSCI, V10, P1095, DOI 10.1038/nn1968; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pesciarelli F, 2011, NEUROPSYCHOLOGIA, V49, P1154, DOI 10.1016/j.neuropsychologia.2011.02.003; Pessoa L, 2005, CURR OPIN NEUROBIOL, V15, P188, DOI 10.1016/j.conb.2005.03.002; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Pieper S, 2006, I S BIOMED IMAGING, P698; Popescu AT, 2009, NAT NEUROSCI, V12, P801, DOI 10.1038/nn.2305; Sato W, 2011, J COGN NEUROSCI; Sato W, 2011, NEUROPSYCHOLOGIA, V49, P612, DOI 10.1016/j.neuropsychologia.2010.12.025; Schultz DH, 2010, J EXP PSYCHOL-ANIM B, V36, P495, DOI 10.1037/a0020263; Schurger A, 2006, NEUROPSYCHOLOGIA, V44, P1796, DOI 10.1016/j.neuropsychologia.2006.03.015; SELIGMAN ME, 1971, BEHAV THER, V2, P307, DOI 10.1016/S0005-7894(71)80064-3; SELIGMAN ME, 1970, PSYCHOL REV, V77, P406, DOI 10.1037/h0029790; Suslow T, 2006, BRAIN COGNITION, V61, P243, DOI 10.1016/j.bandc.2006.01.005; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Tallon-Baudry C, 2005, CEREB CORTEX, V15, P654, DOI 10.1093/cercor/bhh167; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Tallon-Baudry C, 2009, FRONT BIOSCI-LANDMRK, V14, P321, DOI 10.2741/3246; Tamietto M, 2012, CURR BIOL, P1; Tamietto M, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00006; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; Taulu S, 2004, BRAIN TOPOGR, V16, P269, DOI 10.1023/b:brat.0000032864.93890.f9; Taulu S, 2009, HUM BRAIN MAPP, V30, P1524, DOI 10.1002/hbm.20627; Taylor MJ, 2011, BRAIN RES, V1381, P167, DOI 10.1016/j.brainres.2010.12.083; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Wagner A.R., 1981, P5; Weike AI, 2007, PSYCHOPHYSIOLOGY, V44, P170, DOI 10.1111/j.1469-8986.2006.00469.x; Whalen PJ, 2001, EMOTION, V1, P70, DOI 10.1037/1528-3542.1.1.70; Whalen PJ, 2004, SCIENCE, V306, P2061, DOI 10.1126/science.1103617; Whalen PJ, 1998, J NEUROSCI, V18, P411; Wiens S, 2008, EMOTION, V8, P810, DOI 10.1037/a0013731; Wright CI, 2001, NEUROREPORT, V12, P379, DOI 10.1097/00001756-200102120-00039; Yang Yuan, 2011, Shengli Xuebao, V63, P97	91	23	23	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96803	10.1371/journal.pone.0096803	http://dx.doi.org/10.1371/journal.pone.0096803			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24823365	Green Published, gold			2022-12-27	WOS:000336369200033
J	Boland, EG; Selvarajah, D; Hunter, M; Ezaydi, Y; Tesfaye, S; Ahmedzai, SH; Snowden, JA; Wilkinson, ID				Boland, Elaine G.; Selvarajah, Dinesh; Hunter, Mike; Ezaydi, Yousef; Tesfaye, Solomon; Ahmedzai, Sam H.; Snowden, John A.; Wilkinson, Iain D.			Central Pain Processing in Chronic Chemotherapy-Induced Peripheral Neuropathy: A Functional Magnetic Resonance Imaging Study	PLOS ONE			English	Article							SUBJECTIVE EXPERIENCE; THERMAL-STIMULATION; BRAIN ACTIVATION; NERVOUS-SYSTEM; REPRESENTATIONS; BORTEZOMIB; CORTEX; HEAT	Life expectancy in multiple myeloma has significantly increased. However, a high incidence of chemotherapy induced peripheral neuropathy (CIPN) can negatively influence quality of life during this period. This study applied functional magnetic resonance imaging (fMRI) to compare areas associated with central pain processing in patients with multiple myeloma who had chemotherapy induced peripheral neuropathy (MM-CIPN) with those from healthy volunteers (HV). Twenty-four participants (n = 12 MM-CIPN, n = 12 HV) underwent Blood Oxygen Level-Dependent (BOLD) fMRI at 3T whilst noxious heat-pain stimuli were applied to the foot and then thigh. Patients with MM-CIPN demonstrated greater activation during painful stimulation in the precuneus compared to HV (p = 0.014, FWE-corrected). Patients with MM-CIPN exhibited hypo-activation of the right superior frontal gyrus compared to HV (p = 0.031, FWE-corrected). Significant positive correlation existed between the total neuropathy score (reduced version) and activation in the frontal operculum (close to insular cortex) during foot stimulation in patients with MM-CIPN (p = 0.03, FWE-corrected; adjusted R-2 = 0.87). Painful stimuli delivered to MM-CIPN patients evoke differential activation of distinct cortical regions, reflecting a unique pattern of central pain processing compared with healthy volunteers. This characteristic activation pattern associated with pain furthers the understanding of the pathophysiology of painful chemotherapy induced peripheral neuropathy. Functional MRI provides a tool for monitoring cerebral changes during anti-cancer and analgesic treatment.	[Boland, Elaine G.; Wilkinson, Iain D.] Univ Sheffield, Fac Med Dent & Hlth, Acad Unit Radiol, Sheffield, S Yorkshire, England; [Boland, Elaine G.; Ahmedzai, Sam H.] Univ Sheffield, Dept Oncol, Acad Unit Support Care, Sheffield, S Yorkshire, England; [Selvarajah, Dinesh; Tesfaye, Solomon] Sheffield Teaching Hosp NHS Fdn Trust, Dept Diabet, Sheffield, S Yorkshire, England; [Hunter, Mike] Univ Sheffield, Dept Neurosci, Sheffield, S Yorkshire, England; [Ezaydi, Yousef; Snowden, John A.] Sheffield Teaching Hosp NHS Fdn Trust, Dept Haematol, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield	Boland, EG (corresponding author), Univ Sheffield, Fac Med Dent & Hlth, Acad Unit Radiol, Sheffield, S Yorkshire, England.	elaine.boland@nhs.net		Wilkinson, Iain/0000-0003-2703-6890; Boland, Elaine/0000-0003-2571-5929; Tesfaye, Solomon/0000-0003-1190-1472; Hunter, MaryCarol/0000-0003-2447-211X; SNOWDEN, JOHN/0000-0001-6819-3476; Ahmedzai, Sam/0000-0002-2028-8510; Selvarajah, Dinesh/0000-0001-7426-1105	University of Sheffield; Royal Hallamshire Hospital Leukaemia and Myeloma Research Fund; NAPP Research Bursaries - Association of Palliative Medicine	University of Sheffield; Royal Hallamshire Hospital Leukaemia and Myeloma Research Fund; NAPP Research Bursaries - Association of Palliative Medicine	The University of Sheffield, The Royal Hallamshire Hospital Leukaemia and Myeloma Research Fund and the NAPP Research Bursaries 2009 from the Association of Palliative Medicine funded this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque RJC, 2006, PAIN, V122, P223, DOI 10.1016/j.pain.2006.01.020; [Anonymous], 2009, PASW STAT 18 0; [Anonymous], EUROPEAN J PAIN; Apkarian AV, 2009, PROG NEUROBIOL, V87, P81, DOI 10.1016/j.pneurobio.2008.09.018; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Balayssac D, 2005, J PERIPHER NERV SYST, V10, P301, DOI 10.1111/j.1085-9489.2005.10308.x; Balayssac D, 2011, EXPERT OPIN DRUG SAF, V10, P407, DOI 10.1517/14740338.2011.543417; Baliki Marwan N, 2007, Curr Pain Headache Rep, V11, P171, DOI 10.1007/s11916-007-0187-3; Baumgartner U, 2010, J NEUROPHYSIOL, V104, P2863, DOI 10.1152/jn.00253.2010; Becerra LR, 1999, MAGN RESON MED, V41, P1044, DOI 10.1002/(SICI)1522-2594(199905)41:5<1044::AID-MRM25>3.0.CO;2-M; Bhagra Anjali, 2007, Curr Oncol Rep, V9, P290; Bird JM, 2011, BRIT J HAEMATOL, V154, P32, DOI 10.1111/j.1365-2141.2011.08573.x; Buvanendran A, 2010, PAIN PHYSICIAN, V13, pE337; Cata JP, 2007, J PAIN, V8, P296, DOI 10.1016/j.jpain.2006.09.014; Cavaletti G, 2007, J PERIPHER NERV SYST, V12, P210, DOI 10.1111/j.1529-8027.2007.00141.x; Cavaletti G, 2011, CURR TREAT OPTION NE, V13, P180, DOI 10.1007/s11940-010-0108-3; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Coghill RC, 2003, P NATL ACAD SCI USA, V100, P8538, DOI 10.1073/pnas.1430684100; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; Friebel U, 2011, NEUROIMAGE, V58, P1070, DOI 10.1016/j.neuroimage.2011.07.022; Fulbright RK, 2001, AM J ROENTGENOL, V177, P1205, DOI 10.2214/ajr.177.5.1771205; Geha PY, 2007, PAIN, V128, P88, DOI 10.1016/j.pain.2006.09.014; Gelnar PA, 1999, NEUROIMAGE, V10, P460, DOI 10.1006/nimg.1999.0482; Giesecke T, 2004, ARTHRITIS RHEUM-US, V50, P613, DOI 10.1002/art.20063; Hsieh JC, 1996, PAIN, V67, P59, DOI 10.1016/0304-3959(96)03066-7; HSIEH JC, 1995, PAIN, V63, P225, DOI 10.1016/0304-3959(95)00048-W; Iannetti GD, 2005, NEUROSCIENCE, V131, P199, DOI 10.1016/j.neuroscience.2004.10.035; Jaggi AS, 2011, BRAIN RES, V1381, P187, DOI 10.1016/j.brainres.2011.01.002; Kong J, 2010, PAIN, V148, P257, DOI 10.1016/j.pain.2009.11.008; Koyama T, 2005, P NATL ACAD SCI USA, V102, P12950, DOI 10.1073/pnas.0408576102; Mohty B, 2010, HAEMATOL-HEMATOL J, V95, P311, DOI 10.3324/haematol.2009.012674; Moisset X, 2011, EUR J PAIN, V15, P124, DOI 10.1016/j.ejpain.2010.06.006; Nieuwenhuizen L, 2008, EUR J HAEMATOL, V80, P1, DOI 10.1111/j.1600-0609.2007.00956.x; Polomano RC, 2001, PAIN MED, V2, P8, DOI 10.1046/j.1526-4637.2001.002001008.x; Quasthoff S, 2002, J NEUROL, V249, P9, DOI 10.1007/PL00007853; Richardson PG, 2009, BRIT J HAEMATOL, V144, P895, DOI 10.1111/j.1365-2141.2008.07573.x; Selvarajah D, 2008, DIABETOLOGIA, V51, P2088, DOI 10.1007/s00125-008-1139-0; Selvarajah D, 2011, DIABETES CARE, V34, P718, DOI 10.2337/dc10-1550; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Talairach J., 1988, COPLANAR STEREOTAXIC; Tamura Y, 2004, PAIN, V107, P107, DOI 10.1016/j.pain.2003.10.011; The Oxford Centre for Functional MRI of the Brain NDoCN University of Oxford, 2014, OXF CTR FUNCT MRI BR; Verstappen CCP, 2005, NEUROLOGY, V64, P1076, DOI 10.1212/01.WNL.0000154642.45474.28; Vowles KE, 2008, PAIN, V140, P284, DOI 10.1016/j.pain.2008.08.012; Witting N, 2001, NEUROLOGY, V57, P1817, DOI 10.1212/WNL.57.10.1817; Wolf SL, 2011, SUPPORT CARE CANC; Woolf C. J., 2006, TXB PAIN, P91; Xu JT, 2006, PAIN, V123, P306, DOI 10.1016/j.pain.2006.03.011	48	37	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96474	10.1371/journal.pone.0096474	http://dx.doi.org/10.1371/journal.pone.0096474			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24821182	Green Published, gold, Green Accepted			2022-12-27	WOS:000336653300018
J	Dugast, AS; Chan, Y; Hoffner, M; Licht, A; Nkolola, J; Li, HL; Streeck, H; Suscovich, TJ; Ghebremichael, M; Ackerman, ME; Barouch, DH; Alter, G				Dugast, Anne-Sophie; Chan, Ying; Hoffner, Michelle; Licht, Anna; Nkolola, Joseph; Li, Hualin; Streeck, Hendrik; Suscovich, Todd J.; Ghebremichael, Musie; Ackerman, Margaret E.; Barouch, Dan H.; Alter, Galit			Lack of Protection following Passive Transfer of Polyclonal Highly Functional Low-Dose Non-Neutralizing Antibodies	PLOS ONE			English	Article							DEPENDENT CELLULAR CYTOTOXICITY; IMMUNODEFICIENCY-VIRUS TYPE-1; NEUTRALIZING MONOCLONAL-ANTIBODIES; ACTIVE ANTIRETROVIRAL THERAPY; MUCOSAL SHIV CHALLENGE; RHESUS MACAQUES; FC-RECEPTOR; HIV-1-INFECTED INDIVIDUALS; MEDIATED CYTOTOXICITY; HIV-1 INFECTION	Recent immune correlates analysis from the RV144 vaccine trial has renewed interest in the role of non-neutralizing antibodies in mediating protection from infection. While neutralizing antibodies have proven difficult to induce through vaccination, extra-neutralizing antibodies, such as those that mediate antibody-dependent cellular cytotoxicity (ADCC), are associated with long-term control of infection. However, while several non-neutralizing monoclonal antibodies have been tested for their protective efficacy in vivo, no studies to date have tested the protective activity of naturally produced polyclonal antibodies from individuals harboring potent ADCC activity. Because ADCC-inducing antibodies are highly enriched in elite controllers (EC), we passively transferred highly functional non-neutralizing polyclonal antibodies, purified from an EC, to assess the potential impact of polyclonal non-neutralizing antibodies on a stringent SHIV-SF162P3 challenge in rhesus monkeys. Passive transfer of a low-dose of ADCC inducing antibodies did not protect from infection following SHIV-SF162P3 challenge. Passively administered antibody titers and gp120-specific, but not gp41-specific, ADCC and antibody induced phagocytosis (ADCP) were detected in the majority of the monkeys, but did not correlate with post infection viral control. Thus these data raise the possibility that gp120-specific ADCC activity alone may not be sufficient to control viremia post infection but that other specificities or Fc-effector profiles, alone or in combination, may have an impact on viral control and should be tested in future passive transfer experiments.	[Dugast, Anne-Sophie; Chan, Ying; Hoffner, Michelle; Licht, Anna; Suscovich, Todd J.; Ghebremichael, Musie; Barouch, Dan H.; Alter, Galit] Harvard Univ, Massachusetts Gen Hosp, Ragon Inst, Cambridge, MA 02138 USA; [Dugast, Anne-Sophie; Chan, Ying; Hoffner, Michelle; Licht, Anna; Suscovich, Todd J.; Ghebremichael, Musie; Barouch, Dan H.; Alter, Galit] MIT, Cambridge, MA 02139 USA; [Nkolola, Joseph; Li, Hualin; Barouch, Dan H.] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Ackerman, Margaret E.] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [Streeck, Hendrik] Henry Jackson Fdn, Mil HIV Res Program, Rockville, MD USA	Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Dartmouth College; Walter Reed Army Institute of Research (WRAIR)	Alter, G (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Ragon Inst, Cambridge, MA 02138 USA.	galter@partners.org	Barouch, Dan/Y-3918-2019; Dugast, AnneSophie/L-9541-2015		Gates Foundation [CAVD OPP1032817]; Harvard CFAR [P30 AI060354-02];  [AI080289];  [CHAVI 5U19AI067854-05];  [AI078526];  [AI095985];  [AI096040]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI078526, R37AI080289, R01AI080289, U19AI095985, P30AI060354, U19AI067854, U19AI096040] Funding Source: NIH RePORTER	Gates Foundation(Bill & Melinda Gates Foundation); Harvard CFAR; ; ; ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by AI080289, CHAVI 5U19AI067854-05, AI078526, AI095985, AI096040, Gates Foundation CAVD OPP1032817 and the Harvard CFAR P30 AI060354-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasa-Chapman MMI, 2005, J VIROL, V79, P2823, DOI 10.1128/JVI.79.5.2823-2830.2005; Ackerman ME, 2011, J IMMUNOL METHODS; Alsmadi O, 1997, J VIROL, V71, P925, DOI 10.1128/JVI.71.2.925-933.1997; Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Bailey JR, 2006, J VIROL, V80, P4758, DOI 10.1128/JVI.80.10.4758-4770.2006; Banks ND, 2002, AIDS RES HUM RETROV, V18, P1197, DOI 10.1089/08892220260387940; Binley JM, 2010, J VIROL, V84, P5637, DOI 10.1128/JVI.00105-10; Binley JM, 2000, J INFECT DIS, V182, P945, DOI 10.1086/315774; Burton DR, 2011, P NATL ACAD SCI USA, V108, P11181, DOI 10.1073/pnas.1103012108; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; DeVico AL, 2004, NAT REV MICROBIOL, V2, P401, DOI 10.1038/nrmicro878; Dugast AS, 2011, VIROLOGY, V415, P160, DOI 10.1016/j.virol.2011.03.012; Florese RH, 2006, J IMMUNOL, V177, P4028, DOI 10.4049/jimmunol.177.6.4028; Florese RH, 2009, J IMMUNOL, V182, P3718, DOI 10.4049/jimmunol.0803115; Forthal DN, 2001, AIDS RES HUM RETROV, V17, P553, DOI 10.1089/08892220151126661; Forthal DN, 2001, J VIROL, V75, P6953, DOI 10.1128/JVI.75.15.6953-6961.2001; Forthal DN, 1999, J INFECT DIS, V180, P1338, DOI 10.1086/314988; Gomez-Roman VR, 2006, J IMMUNOL METHODS, V308, P53, DOI 10.1016/j.jim.2005.09.018; Gomez-Roman VR, 2005, J IMMUNOL, V174, P2185, DOI 10.4049/jimmunol.174.4.2185; HASHIMOTO G, 1983, J INFECT DIS, V148, P785, DOI 10.1093/infdis/148.5.785; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Hidajat R, 2009, J VIROL, V83, P791, DOI 10.1128/JVI.01672-08; Hofmann-Lehmann R, 2001, J VIROL, V75, P7470, DOI 10.1128/JVI.75.16.7470-7480.2001; Holl V, 2006, J VIROL, V80, P6177, DOI 10.1128/JVI.02625-05; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kohl S, 2000, J INFECT DIS, V181, P335, DOI 10.1086/315208; Lambotte O, 2009, AIDS, V23, P897, DOI 10.1097/QAD.0b013e328329f97d; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Moog C, 2013, MUCOSAL IMMUNOL; Moore T, 2002, IMMUNOLOGY, V105, P213, DOI 10.1046/j.0019-2805.2001.01354.x; Ng CT, 2010, NAT MED, V16, P1117, DOI 10.1038/nm.2233; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Russo S, 2006, CURR HIV RES, V4, P177, DOI 10.2174/157016206776055011; Sarzotti-Kelsoe M, 2013, J IMMUNOL METHODS; Sholukh AM, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-8; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Tomomi Iwakura, 1927, J IMMUNOL, V3; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Xiao P, 2010, J VIROL, V84, P7161, DOI 10.1128/JVI.00410-10	48	51	51	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97229	10.1371/journal.pone.0097229	http://dx.doi.org/10.1371/journal.pone.0097229			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24820481	gold, Green Submitted, Green Published			2022-12-27	WOS:000336653300095
J	Galiano, D; Bernardo-Silva, J; de Freitas, TRO				Galiano, Daniel; Bernardo-Silva, Jorge; de Freitas, Thales R. O.			Genetic Pool Information Reflects Highly Suitable Areas: The Case of Two Parapatric Endangered Species of Tuco-tucos (Rodentia: Ctenomiydae)	PLOS ONE			English	Article							CTENOMYS-MINUTUS RODENTIA; GENUS CTENOMYS; CONSERVATION; POPULATION; MODELS; SIZE; DISTRIBUTIONS; PREDICTION; AUSTRALIS	Conservation of small mammals requires knowledge of the genetically and ecologically meaningful spatial scales at which species respond to habitat modifications. Conservation strategies can be improved through the use of ecological niche models and genetic data to classify areas of high environmental suitability. In this study, we applied a Maxent model integrated with genetic information (nucleotide diversity, haplotype diversity and Fu's Fs neutrality tests) to evaluate potential genetic pool populations with highly suitable areas for two parapatric endangered species of tuco-tucos (Ctenomys minutus and C. lami). Our results demonstrated that both species were largely influenced by vegetation and soil variables at a landscape scale and inhabit a highly specific niche. Ctenomys minutus was also influenced by the variable altitude; the species was associated with low altitudes (sea level). Our model of genetic data associated with environmental suitability indicate that the genetic pool data were associated with highly suitable areas for C. minutus. This pattern was not evident for C. lami, but this outcome could be a consequence of the restricted range of the species. The preservation of species requires not only detailed knowledge of their natural history and genetic structure but also information on the availability of suitable areas where species can survive, and such knowledge can aid significantly in conservation planning. This finding reinforces the use of these two techniques for planning conservation actions.	[Galiano, Daniel; de Freitas, Thales R. O.] Univ Fed Rio Grande do Sul, Programa Posgrad Biol Anim, Porto Alegre, RS, Brazil; [Bernardo-Silva, Jorge; de Freitas, Thales R. O.] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Galiano, D (corresponding author), Univ Fed Rio Grande do Sul, Programa Posgrad Biol Anim, Porto Alegre, RS, Brazil.	galiano3@hotmail.com	Freitas, Thales Renato Ochotorena de/G-1160-2012; Galiano, Daniel/ABV-4574-2022; Galiano, Daniel/O-1671-2013	Freitas, Thales Renato Ochotorena de/0000-0002-1019-9303; Galiano, Daniel/0000-0003-1428-8634	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Brazilian Ministry of Science and Technology	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Ministry of Science and Technology	Funding was provided by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazilian Ministry of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardo-Silva J, 2012, NAT CONSERVACAO, V10, P207, DOI 10.4322/natcon.2012.026; Bertrand R, 2012, GLOBAL CHANGE BIOL, V18, P2648, DOI 10.1111/j.1365-2486.2012.02679.x; COMPARATORE VM, 1992, Z SAUGETIERKD, V57, P47; Cutrera AP, 2010, J MAMMAL, V91, P1425, DOI 10.1644/10-MAMM-A-057.1; de Siqueira MF, 2009, J NAT CONSERV, V17, P25, DOI 10.1016/j.jnc.2008.11.001; DEFREITAS TRO, 1994, CYTOGENET CELL GENET, V67, P193, DOI 10.1159/000133821; DEFREITAS TRO, 1995, STUD NEOTROP FAUNA E, V30, P53, DOI 10.1080/01650529509360941; Diniz J, 2009, TREE GENET GENOMES, V5, P617, DOI 10.1007/s11295-009-0214-0; Diniz-Filho JAF, 2008, J BIOGEOGR, V35, P753, DOI 10.1111/j.1365-2699.2008.01912.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Esteves LS, 2002, J COASTAL RES, P273; Fernandes FA., 2007, Braz. J. Biol., V67, P839, DOI 10.1590/S1519-69842007000500006; Fernandez-Stolz GP, 2007, J MAMMAL, V88, P935, DOI 10.1644/06-MAMM-A-210R1.1; Fornel R, 2010, BIOL J LINN SOC, V101, P705, DOI 10.1111/j.1095-8312.2010.01496.x; Freitas T.R.O, 2007, ACTA THERIOL, V52, P171; Freitas TRO, 2001, STUD NEOTROP FAUNA E, V36, P1, DOI DOI 10.1076/SNFE.36.1.1.8882; Fu YX, 1997, GENETICS, V147, P915; Gava A, 2003, GENETICA, V119, P11, DOI 10.1023/A:1024465429856; Hesp PA, 2009, LECT NOTES EARTH SCI, V107, P93; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; IUCN, 2013, IUCN RED LIST THREAT; Kubiak BB, 2013, THESIS U RIO GRANDE; Lacey EA, 2000, LIFE UNDERGROUND BIO; Lopes CM, 2012, J HERED, V103, P672, DOI 10.1093/jhered/ess027; Lopes CM, 2013, HEREDITY, P1; MALIZIA AI, 1991, ACTA THERIOL, V36, P87, DOI 10.4098/AT.arch.91-5; Manning JA, 2004, J MAMMAL, V85, P87, DOI 10.1644/1545-1542(2004)085&lt;0087:SMSADW&gt;2.0.CO;2; Marco-Junior PD, 2009, MEGADIVERSIDADE, V5, P65; Marinho JR, 2006, ACTA THERIOL, V51, P53, DOI 10.1007/BF03192655; Massarini IA, 2005, CARYOLOGIA, V58, P21; MOREIRA DM, 1991, BIOCHEM GENET, V29, P601, DOI 10.1007/BF02426874; Parada A, 2011, J MAMMAL, V92, P671, DOI 10.1644/10-MAMM-A-121.1; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Razgour O, 2011, BIOL CONSERV, V144, P2922, DOI 10.1016/j.biocon.2011.08.010; Reig O.A., 1990, Progress in Clinical and Biological Research, V335, P71; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Tomazelli L.J., 2000, GEOLOGIA RIO GRANDE, P375; Tuomisto H, 2006, ECOGRAPHY, V29, P273, DOI 10.1111/j.2006.0906-7590.04390.x; Vassallo AI, 1998, J ZOOL, V244, P415, DOI 10.1111/j.1469-7998.1998.tb00046.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x	43	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97301	10.1371/journal.pone.0097301	http://dx.doi.org/10.1371/journal.pone.0097301			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819251	gold, Green Submitted, Green Published			2022-12-27	WOS:000336653300105
J	Magi, S; Saeki, Y; Kasamatsu, M; Tashiro, E; Imoto, M				Magi, Shigeyuki; Saeki, Yuya; Kasamatsu, Masato; Tashiro, Etsu; Imoto, Masaya			Chemical Genomic-Based Pathway Analyses for Epidermal Growth Factor-Mediated Signaling in Migrating Cancer Cells	PLOS ONE			English	Article							PROTEIN-KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; CADHERIN ADHESION; ACTIVATION; MOTILITY; RECEPTOR; EGFR; PHOSPHORYLATION; MECHANISMS; PAXILLIN	To explore the diversity and consistency of the signaling pathways that regulate tumor cell migration, we chose three human tumor cell lines that migrated after treatment with EGF. We then quantified the effect of fifteen inhibitors on the levels of expression or the phosphorylation levels of nine proteins that were induced by EGF stimulation in each of these cell lines. Based on the data obtained in this study and chemical-biological assumptions, we deduced cell migration pathways in each tumor cell line, and then compared them. As a result, we found that both the MEK/ERK and JNK/c-Jun pathways were activated in all three migrating cell lines. Moreover, GSK-3 and p38 were found to regulate PI3K/Akt pathway in only EC109 cells, and JNK was found to crosstalk with p38 and Fos related pathway in only TT cells. Taken together, our analytical system could easily distinguish between the common and cell type-specific pathways responsible for tumor cell migration.	[Magi, Shigeyuki; Saeki, Yuya; Kasamatsu, Masato; Tashiro, Etsu; Imoto, Masaya] Keio Univ, Fac Sci & Technol, Dept Biosci & Informat, Yokohama, Kanagawa 223, Japan	Keio University	Imoto, M (corresponding author), Keio Univ, Fac Sci & Technol, Dept Biosci & Informat, 3-14-1 Hiyoshi, Yokohama, Kanagawa 223, Japan.	imoto@bio.keio.ac.jp		Tashiro, Etsu/0000-0003-4533-623X	Ministry of Education, Culture, Sports, Science, and Technology, Japan; JSPS Fellows; Grants-in-Aid for Scientific Research [23102006, 26350974] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS Fellows(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Challenging Exploratory Research and JSPS Fellows, the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carlson SM, 2011, ACS CHEM BIOL, V6, P75, DOI 10.1021/cb1002834; Ching YP, 2007, CANCER RES, V67, P3601, DOI 10.1158/0008-5472.CAN-06-3994; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; Gan Y, 2010, ONCOGENE, V29, P4947, DOI 10.1038/onc.2010.240; Gavard J, 2004, J CELL SCI, V117, P257, DOI 10.1242/jcs.00857; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Ishikawa K, 2012, MOL BIOL CELL, V23, P1294, DOI 10.1091/mbc.E11-09-0780; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Kovacs EM, 2002, J BIOL CHEM, V277, P6708, DOI 10.1074/jbc.M109640200; Kraemer A, 2007, AM J PHYSIOL-CELL PH, V292, pC1061, DOI 10.1152/ajpcell.00073.2006; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Magi S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00823; Makrodouli E, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-118; Pece S, 1999, J BIOL CHEM, V274, P19347, DOI 10.1074/jbc.274.27.19347; Smit GDV, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000217; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang JH, 2010, MOL CANCER RES, V8, P266, DOI 10.1158/1541-7786.MCR-09-0221; Yue P, 2012, ONCOGENE, V31, P2309, DOI 10.1038/onc.2011.409	21	3	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96776	10.1371/journal.pone.0096776	http://dx.doi.org/10.1371/journal.pone.0096776			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24820097	Green Published, gold, Green Submitted			2022-12-27	WOS:000336653300030
J	Massah, S; Hollebakken, R; Labrecque, MP; Kolybaba, AM; Beischlag, TV; Prefontaine, GG				Massah, Shabnam; Hollebakken, Robert; Labrecque, Mark P.; Kolybaba, Addie M.; Beischlag, Timothy V.; Prefontaine, Gratien G.			Epigenetic Characterization of the Growth Hormone Gene Identifies SmcHD1 as a Regulator of Autosomal Gene Clusters	PLOS ONE			English	Article							LOCUS-CONTROL REGION; BECKWITH-WIEDEMANN-SYNDROME; CHROMOSOMES-HINGE DOMAIN; INACTIVE X-CHROMOSOME; PIT-1 BINDING-SITES; DNA; EXPRESSION; PROMOTER; METHYLATION; ACTIVATION	Regulatory elements for the mouse growth hormone (GH) gene are located distally in a putative locus control region (LCR) in addition to key elements in the promoter proximal region. The role of promoter DNA methylation for GH gene regulation is not well understood. Pit-1 is a POU transcription factor required for normal pituitary development and obligatory for GH gene expression. In mammals, Pit-1 mutations eliminate GH production resulting in a dwarf phenotype. In this study, dwarf mice illustrated that Pit-1 function was obligatory for GH promoter hypomethylation. By monitoring promoter methylation levels during developmental GH expression we found that the GH promoter became hypomethylated coincident with gene expression. We identified a promoter differentially methylated region (DMR) that was used to characterize a methylation-dependent DNA binding activity. Upon DNA affinity purification using the DMR and nuclear extracts, we identified structural maintenance of chromosomes hinge domain containing -1 (SmcHD1). To better understand the role of SmcHD1 in genome-wide gene expression, we performed microarray analysis and compared changes in gene expression upon reduced levels of SmcHD1 in human cells. Knock-down of SmcHD1 in human embryonic kidney (HEK293) cells revealed a disproportionate number of up-regulated genes were located on the X-chromosome, but also suggested regulation of genes on non-sex chromosomes. Among those, we identified several genes located in the protocadherin beta cluster. In addition, we found that imprinted genes in the H19/Igf2 cluster associated with Beckwith-Wiedemann and Silver-Russell syndromes (BWS & SRS) were dysregulated. For the first time using human cells, we showed that SmcHD1 is an important regulator of imprinted and clustered genes.	[Massah, Shabnam; Hollebakken, Robert; Labrecque, Mark P.; Beischlag, Timothy V.; Prefontaine, Gratien G.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Kolybaba, Addie M.] Univ Munich, Fac Biol, Martinsried, Germany	Simon Fraser University; University of Munich	Prefontaine, GG (corresponding author), Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada.	ggp1@sfu.ca	Labrecque, Mark/GPP-4575-2022	Labrecque, Mark/0000-0001-7887-7599	Natural Sciences and Engineering Research Council [372216]	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Natural Sciences and Engineering Research Council grant 372216 to Dr. Prefontaine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; Bohmdorfer G, 2011, PLANT J, V67, P420, DOI 10.1111/j.1365-313X.2011.04604.x; Bolt MW, 1997, ANAL BIOCHEM, V247, P185, DOI 10.1006/abio.1997.2061; Cooper WN, 2005, EUR J HUM GENET, V13, P1025, DOI 10.1038/sj.ejhg.5201463; Dominguez B, 2007, BIOCHEM BIOPH RES CO, V358, P59, DOI 10.1016/j.bbrc.2007.04.085; Duong Cuong V, 2012, Endocr Relat Cancer, V19, P805, DOI 10.1530/ERC-12-0251; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; ELLIOTT M, 1994, J MED GENET, V31, P560, DOI 10.1136/jmg.31.7.560; Fontemaggi G, 2001, MOL CELL BIOL, V21, P8461, DOI 10.1128/MCB.21.24.8461-8470.2001; GAIDO ML, 1989, BIOCHIM BIOPHYS ACTA, V1008, P234, DOI 10.1016/0167-4781(80)90014-7; Gendrel AV, 2013, MOL CELL BIOL, V33, P3150, DOI 10.1128/MCB.00145-13; Gendrel AV, 2012, DEV CELL, V23, P265, DOI 10.1016/j.devcel.2012.06.011; Gicquel C, 2005, NAT GENET, V37, P1003, DOI 10.1038/ng1629; Guo Y, 2012, P NATL ACAD SCI USA, V109, P21081, DOI 10.1073/pnas.1219280110; Harvey SH, 2002, GENOME BIOL, V3; Hirano K, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00090; Ho YG, 2006, MOL CELL, V23, P365, DOI 10.1016/j.molcel.2006.05.041; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; IRANMANESH A, 1991, J CLIN ENDOCR METAB, V73, P1081, DOI 10.1210/jcem-73-5-1081; Jacob KJ, 2013, CLIN GENET, V84, P326, DOI 10.1111/cge.12143; Kaneko R, 2006, J BIOL CHEM, V281, P30551, DOI 10.1074/jbc.M605677200; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; Kronenberg H, 2008, WILLIAMS TXB ENDOCRI, Vxix; Labrecque MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029545; Lemmers RJLF, 2012, NAT GENET, V44, P1370, DOI 10.1038/ng.2454; LEW D, 1993, GENE DEV, V7, P683, DOI 10.1101/gad.7.4.683; LIN CJ, 1992, NATURE, V360, P765, DOI 10.1038/360765a0; LIN SC, 1994, DEVELOPMENT, V120, P515; LIRA SA, 1988, P NATL ACAD SCI USA, V85, P4755, DOI 10.1073/pnas.85.13.4755; Lunyak VV, 2007, SCIENCE, V317, P248, DOI 10.1126/science.1140871; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Maher ER, 2000, J CLIN INVEST, V105, P247, DOI 10.1172/JCI9340; Mitsuhashi S, 2013, NEUROMUSCULAR DISORD, V23, P975, DOI 10.1016/j.nmd.2013.08.009; Mould AW, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-19; Ngo V, 1996, MOL CELL BIOL, V16, P3245; Nozawa RS, 2013, NAT STRUCT MOL BIOL, V20, P566, DOI 10.1038/nsmb.2532; Pebernard S, 2006, MOL CELL BIOL, V26, P1617, DOI 10.1128/MCB.26.5.1617-1630.2006; Postigo AA, 1997, EMBO J, V16, P3935, DOI 10.1093/emboj/16.13.3935; Prefontaine GG, 1998, MOL CELL BIOL, V18, P3416, DOI 10.1128/MCB.18.6.3416; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; RHODES SJ, 1994, CURR OPIN GENET DEV, V4, P709, DOI 10.1016/0959-437X(94)90138-S; Rump P, 2005, AM J MED GENET A, V136A, P95, DOI 10.1002/ajmg.a.30729; RUSSELL A, 1954, P ROY SOC MED, V47, P1040; Sacconi S, 2013, AM J HUM GENET, V93, P744, DOI 10.1016/j.ajhg.2013.08.004; Scully KM, 2000, SCIENCE, V290, P1127, DOI 10.1126/science.290.5494.1127; Scully KM, 2002, SCIENCE, V295, P2231, DOI 10.1126/science.1062736; Shewchuk BM, 1999, J BIOL CHEM, V274, P35725, DOI 10.1074/jbc.274.50.35725; Shewchuk BM, 2006, MOL CELL BIOL, V26, P6535, DOI 10.1128/MCB.00267-06; Smith EY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002422; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; THORBURN MJ, 1970, AM J DIS CHILD, V119, P316, DOI 10.1001/archpedi.1970.02100050318006; Toogood AA, 1998, CLIN ENDOCRINOL, V48, P569, DOI 10.1046/j.1365-2265.1998.00440.x; Toogood AA, 1996, J CLIN ENDOCR METAB, V81, P460, DOI 10.1210/jc.81.2.460; VANCE ML, 1990, NEW ENGL J MED, V323, P52; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Yaneva M, 2003, ANAL CHEM, V75, P6437, DOI 10.1021/ac034698l	57	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97535	10.1371/journal.pone.0097535	http://dx.doi.org/10.1371/journal.pone.0097535			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24818964	Green Submitted, gold, Green Published			2022-12-27	WOS:000336653300121
J	Zheng, L; Tang, WF; Shi, YJ; Chen, SC; Wang, X; Wang, LM; Shao, AZ; Ding, GW; Liu, C; Liu, RP; Yin, J; Gu, HY				Zheng, Liang; Tang, Weifeng; Shi, Yijun; Chen, Suocheng; Wang, Xu; Wang, Liming; Shao, Aizhong; Ding, Guowen; Liu, Chao; Liu, Ruiping; Yin, Jun; Gu, Haiyong			p21 rs3176352 G > C and p73 rs1801173 C > T Polymorphisms Are Associated with an Increased Risk of Esophageal Cancer in a Chinese Population	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; BREAST-CANCER; LUNG-CANCER; P53 POLYMORPHISMS; TP53 ARG72PRO; ACTIVATION; CYCLE; SUSCEPTIBILITY; P21(WAF1/CIP1); SUPPRESSION	Objective: Esophageal cancer was the fifth most commonly diagnosed cancer and the fourth leading cause of cancerrelated death in China in 2009. Genetic factors might play an important role in esophageal squamous cell carcinoma (ESCC) carcinogenesis. Designs and Methods: To evaluate the effect p21, p53, TP53BP1 and p73 single nucleotide polymorphisms (SNPs) on the risk of ESCC, we conducted a hospital based case-control study. A total of 629 ESCC cases and 686 controls were recruited. Their genotypes were determined using ligation detection reaction (LDR) method. Results: When the p21 rs3176352 GG homozygote genotype was used as the reference group, the CC genotype was associated with a significantly increased risk of ESCC. When the p73 rs1801173 CC homozygote genotype was used as the reference group, the CT genotype was associated with a significantly increased risk of ESCC. After Bonferroni correction, for p21 rs3176352 G > C, the pcorrect was still significant. For the other six SNPs, in all comparison models, no association between the polymorphisms and ESCC risk was observed. Conclusions: p21 rs3176352 G > C and p73 rs1801173 C > T SNPs are associated with increased risk of ESCC. To confirm the current findings, additional, larger studies and tissue-specific biological characterization are required.	[Zheng, Liang] Suzhou Univ, Peoples Hosp Changzhou 1, Dept Cardiothorac Surg, Changzhou, Jiangsu, Peoples R China; [Zheng, Liang] Suzhou Univ, Affiliated Hosp 3, Changzhou, Jiangsu, Peoples R China; [Tang, Weifeng; Shi, Yijun; Chen, Suocheng; Wang, Xu; Shao, Aizhong; Ding, Guowen; Liu, Chao; Yin, Jun; Gu, Haiyong] Jiangsu Univ, Affiliated Peoples Hosp, Dept Cardiothorac Surg, Zhenjiang, Jiangsu, Peoples R China; [Wang, Liming] Jiangsu Univ, Peoples Hosp Affiliated, Inst Canc, Dept Chemotherapy, Zhenjiang, Jiangsu, Peoples R China; [Liu, Ruiping] Nanjing Med Univ, Changzhou Peoples Hosp 2, Affiliated Hosp, Dept Orthoped, Changzhou, Jiangsu, Peoples R China	Jiangsu University; Jiangsu University; Nanjing Medical University	Yin, J (corresponding author), Jiangsu Univ, Affiliated Peoples Hosp, Dept Cardiothorac Surg, Zhenjiang, Jiangsu, Peoples R China.	yin912@126.com; haiyong_gu@hotmail.com			National Natural Science Foundation of China [81370001, 81371927, 81101889, 81000028]; Jiangsu Province Natural Science Foundation [BK2010333, BK2011481]; Social Development Foundation of Zhenjiang [SH2010017]; Changzhou Young Talents and ScienceTechnology Foundation of Health Bureau [QN201102]; Affiliated People's Hospital of Jiangsu University fund [Y200913]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Social Development Foundation of Zhenjiang; Changzhou Young Talents and ScienceTechnology Foundation of Health Bureau; Affiliated People's Hospital of Jiangsu University fund	This study was supported in part by National Natural Science Foundation of China (81370001, 81371927, 81101889, 81000028), Jiangsu Province Natural Science Foundation (BK2010333, BK2011481), Social Development Foundation of Zhenjiang (SH2010017) and Changzhou Young Talents and ScienceTechnology Foundation of Health Bureau (QN201102) and Affiliated People's Hospital of Jiangsu University fund (Y200913). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Altilia S, 2012, AGING-US, V4, P28, DOI 10.18632/aging.100425; Berrino F, 2007, LANCET ONCOL, V8, P773, DOI 10.1016/S1470-2045(07)70245-0; Chen WQ, 2013, J THORAC DIS, V5, P19, DOI 10.3978/j.issn.2072-1439.2013.01.04; Chen ZJ, 2011, NAT GENET, V43, P55, DOI 10.1038/ng.732; Dahabreh IJ, 2013, AM J EPIDEMIOL, V177, P1317, DOI 10.1093/aje/kws394; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Gartel AL, 1996, P SOC EXP BIOL MED, V213, P138; Ge H, 2007, DIS ESOPHAGUS, V20, P290, DOI 10.1111/j.1442-2050.2007.00672.x; Gu HY, 2012, MOL BIOL REP, V39, P9105, DOI 10.1007/s11033-012-1782-x; Harada K, 2000, ORAL ONCOL, V36, P3, DOI 10.1016/S1368-8375(99)00049-4; Iwabuchi K, 1998, J BIOL CHEM, V273, P26061, DOI 10.1074/jbc.273.40.26061; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kaul R, 2003, INT J CANCER, V103, P606, DOI 10.1002/ijc.10881; Keshava C, 2002, CANCER EPIDEM BIOMAR, V11, P127; LI R, 1994, NATURE, V371, P534, DOI 10.1038/371534a0; Liu L, 2011, J THORAC ONCOL, V6, P1793, DOI 10.1097/JTO.0b013e3182272273; Mai M, 1998, CANCER RES, V58, P2347; Rafnar T, 2011, CANCER RES, V71, P1356, DOI 10.1158/0008-5472.CAN-10-2852; Sinilnikova OM, 2009, BRIT J CANCER, V101, P1456, DOI 10.1038/sj.bjc.6605279; Soussi T, 2001, NAT REV CANCER, V1, P233, DOI 10.1038/35106009; Taghavi N, 2010, ARCH IRAN MED, V13, P235; Wang N, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-589; Wei JS, 2013, HUM IMMUNOL, V74, P1199, DOI 10.1016/j.humimm.2013.06.012; Weiss RH, 2003, CANCER LETT, V189, P39, DOI 10.1016/S0304-3835(02)00495-0; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; Xi YG, 2004, CARCINOGENESIS, V25, P2201, DOI 10.1093/carcin/bgh229; Yang WJ, 2010, ANN SURG ONCOL, V17, P1453, DOI 10.1245/s10434-009-0882-x	31	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96958	10.1371/journal.pone.0096958	http://dx.doi.org/10.1371/journal.pone.0096958			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24820515	Green Published, gold, Green Submitted			2022-12-27	WOS:000336653300055
J	Benning, L; Golub, ET; Anastos, K; French, AL; Cohen, M; Gilbert, D; Gillevet, P; Munyazesa, E; Landay, AL; Sikaroodi, M; Spear, GT				Benning, Lorie; Golub, Elizabeth T.; Anastos, Kathryn; French, Audrey L.; Cohen, Mardge; Gilbert, Douglas; Gillevet, Patrick; Munyazesa, Elisaphane; Landay, Alan L.; Sikaroodi, Masoumeh; Spear, Gregory T.			Comparison of Lower Genital Tract Microbiota in HIV-Infected and Uninfected Women from Rwanda and the US	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; BACTERIAL VAGINOSIS; MYCOPLASMA-GENITALIUM; VAGINAL MICROBIOME; H2O2-PRODUCING LACTOBACILLI; ASSOCIATION; IDENTIFICATION; DIVERSITY; INERS; FLORA	Introduction: Previous studies have shown that alterations of the bacterial microbiota in the lower female genital tract influence susceptibility to HIV infection and shedding. We assessed geographic differences in types of genital microbiota between HIV-infected and uninfected women from Rwanda and the United States. Methods: Genera of lower genital tract bacterial microbiota were identified by high-throughput pyrosequencing of the 16S rRNA gene from 46 US women (36 HIV-infected, 10 HIV-uninfected) and 40 Rwandan women (18 HIV-infected, 22 HIV-uninfected) with similar proportions of low (0-3) Nugent scores. Species of Lactobacillus were identified by assembling sequences along with reference sequences into phylogenetic trees. Prevalence of genera and Lactobacillus species were compared using Fisher's exact tests. Results: Overall the seven most prevalent genera were Lactobacillus (74%), Prevotella (56%), Gardnerella (55%), Atopobium (42%), Sneathia (37%), Megasphaera (30%), and Parvimonas (26%), observed at similar prevalences comparing Rwandan to US women, except for Megasphaera (20% vs. 39%, p = 0.06). Additionally, Rwandan women had higher frequencies of Mycoplasma (23% vs. 7%, p = 0.06) and Eggerthella (13% vs. 0%, p = 0.02), and lower frequencies of Lachnobacterium (8% vs. 35%, p<0.01) and Allisonella (5% vs. 30%, p<0.01), compared with US women. The prevalence of Mycoplasma was highest (p<0.05) in HIV-infected Rwandan women (39%), compared to HIV-infected US women (6%), HIV-uninfected Rwandan (9%) and US (10%) women. The most prevalent lactobacillus species in both Rwandan and US women was L. iners (58% vs. 76%, p = 0.11), followed by L. crispatus (28% vs. 30%, p = 0.82), L. jensenii (20% vs. 24%, p = 0.80), L. gasseri (20% vs. 11%, p = 0.37) and L. vaginalis (20% vs. 7%, p = 0.10). Discussion: We found similar prevalence of most major bacterial genera and Lactobacillus species in Rwandan and US women. Further work will be needed to establish whether observed differences differentially impact lower genital tract health or susceptibility to genital infections.	[Benning, Lorie; Golub, Elizabeth T.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Anastos, Kathryn] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Anastos, Kathryn] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Anastos, Kathryn] Montefiore Med Ctr, Bronx, NY 10467 USA; [French, Audrey L.; Cohen, Mardge] John H Stroger Jr Hosp Cook Cty, Ruth M Rothstein CORE Ctr, Chicago, IL USA; [French, Audrey L.; Cohen, Mardge] Rush Univ, Med Ctr, Dept Med, Chicago, IL 60612 USA; [Gilbert, Douglas; Landay, Alan L.; Spear, Gregory T.] Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA; [Gillevet, Patrick; Sikaroodi, Masoumeh] George Mason Univ, Microbiome Anal Ctr, Dept Environm Sci & Policy, Manassas, VA USA; [Munyazesa, Elisaphane] Rwanda Biomed Ctr Natl Reference Lab Div, Dept Biomed Serv, Kigali, Rwanda	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; John H Stroger Junior Hospital Cook County; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rush University; Rush University; George Mason University; Rwanda Biomedical Center	Benning, L (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	lbenning@jhu.edu			National Institute of Allergy and Infectious Diseases [UO1-AI-35004, UO1-AI-31834, UO1-AI-34994, UO1-AI-34989, UO1-AI-34993, UO1-AI-42590, P01 AI082971]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [UO1-HD-32632]; National Cancer Institute; National Institute on Drug Abuse; National Institute on Deafness and Other Communication Disorders; National Center for Research Resources (UCSF-CTSA) [UL1 TR000004]; AIDS International Training and Research Program (Fogarty International Center) [NIH D43-TW001403]; Center for AIDS Research of the Albert Einstein College of Medicine and Montefiore Medical Center; National Institutes of Health [NIH AI-51519]; National Institute of Diabetes and Digestive and Kidney Disease [DK54615]; Chicago Developmental Center for AIDS Research [P30 AI082151]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD032632] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW001403] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI042590, P30AI082151, U01AI035004, U01AI034989, U01AI034994, P01AI082971, P30AI051519, U01AI034993, U01AI031834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054615] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Center for Research Resources (UCSF-CTSA); AIDS International Training and Research Program (Fogarty International Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Center for AIDS Research of the Albert Einstein College of Medicine and Montefiore Medical Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Chicago Developmental Center for AIDS Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The WIHS is funded by the National Institute of Allergy and Infectious Diseases (UO1-AI-35004, UO1-AI-31834, UO1-AI-34994, UO1-AI-34989, UO1-AI-34993, UO1-AI-42590), and by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (UO1-HD-32632). The study is cofunded by the National Cancer Institute, the National Institute on Drug Abuse, and the National Institute on Deafness and Other Communication Disorders. Funding is also provided by the National Center for Research Resources (UCSF-CTSA Grant Number UL1 TR000004). The RWISA was supported by supplements from the National Institute of Allergy and Infectious Diseases to the Bronx/Manhattan Women's Interagency HIV Study (WIHS), which is funded by the National Institute of Allergy and Infectious Diseases (UO1-AI-35004). This work was also supported in part by the AIDS International Training and Research Program (Fogarty International Center, NIH D43-TW001403) and the Center for AIDS Research of the Albert Einstein College of Medicine and Montefiore Medical Center funded by the National Institutes of Health (NIH AI-51519) and by the National Institute of Diabetes and Digestive and Kidney Disease (DK54615). Additional funding for this project was provided by the National Institute of Allergy and Infectious Diseases P01 AI082971 and the Chicago Developmental Center for AIDS Research Grant Number P30 AI082151. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsel R., 1983, AM J MED, V14, P74, DOI DOI 10.1016/0002-9343(83)91112-9.PUBMED:6600371; [Anonymous], 2010, GLOB REP UNAIDS REP, p[181, 183, 202, 204]; Antonio MAD, 1999, J INFECT DIS, V180, P1950, DOI 10.1086/315109; Artinez RCRM, 2008, APPL ENVIRON MICROB, V74, P4539, DOI 10.1128/AEM.00284-08; Atashili J, 2008, AIDS, V22, P1493, DOI 10.1097/QAD.0b013e3283021a37; Bacon MC, 2005, CLIN DIAGN LAB IMMUN, V12, P1013, DOI 10.1128/CDLI.12.9.1013-1019.2005; Barkan SE, 1998, EPIDEMIOLOGY, V9, P117, DOI 10.1097/00001648-199803000-00004; Brotman RM, 2011, J CLIN INVEST, V121, P4610, DOI 10.1172/JCI57172; Coleman JS, 2007, AIDS, V21, P755, DOI 10.1097/QAD.0b013e328012b838; Cu-Uvin S, 2001, CLIN INFECT DIS, V33, P894, DOI 10.1086/322613; ESCHENBACH DA, 1989, J CLIN MICROBIOL, V27, P251, DOI 10.1128/JCM.27.2.251-256.1989; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Gatski M, 2011, INT J STD AIDS, V22, P155, DOI 10.1258/ijsa.2010.010320; Guentzel MN, 1996, MED MICROBIOLOGY; Gupta K, 1998, J INFECT DIS, V178, P446, DOI 10.1086/515635; Hale TL, 1996, MED MICROBIOLOGY, P22; HILLIER SL, 1993, CLIN INFECT DIS, V16, pS273, DOI 10.1093/clinids/16.Supplement_4.S273; HILLIER SL, 1992, OBSTET GYNECOL, V79, P369, DOI 10.1097/00006250-199203000-00008; Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078; Jakobsen TH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068484; Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P533, DOI 10.1111/j.1471-0528.2010.02840.x; Li JR, 2012, REPROD SCI, V19, P235, DOI 10.1177/1933719111418379; Ling ZX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-488; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Macklaim JM, 2011, P NATL ACAD SCI USA, V108, P4688, DOI 10.1073/pnas.1000086107; Manhart LE, 2008, J INFECT DIS, V197, P733, DOI 10.1086/526501; Marconi C, 2013, EUR J OBSTET GYN R B, V167, P205, DOI 10.1016/j.ejogrb.2012.12.003; Martin HL, 1999, J INFECT DIS, V180, P1863, DOI 10.1086/315127; Mavedzenge SN, 2012, AIDS, V26, P617, DOI 10.1097/QAD.0b013e32834ff690; Nicolle LE, 2013, CRIT CARE CLIN, V29, P699, DOI 10.1016/j.ccc.2013.03.014; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Pepin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025082; Perry A, 2011, EXPERT REV ANTI-INFE, V9, P1149, DOI [10.1586/ERI.11.137, 10.1586/eri.11.137]; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Schellenberg JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041217; Sha BE, 2005, J INFECT DIS, V191, P25, DOI 10.1086/426394; Singh DK, 2009, J INFECT DIS, V199, P1851, DOI 10.1086/599123; Spear GT, 2008, J INFECT DIS, V198, P1131, DOI 10.1086/591942; Spear GT, 2012, AIDS RES HUM RETROV, V28, P1244, DOI 10.1089/aid.2011.0382; Spear GT, 2011, APPL ENVIRON MICROB, V77, P378, DOI 10.1128/AEM.00973-10; Spear GT, 2010, AIDS RES HUM RETROV, V26, P193, DOI 10.1089/aid.2009.0166; Verstraelen H, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-116; Wiesenfeld HC, 2003, CLIN INFECT DIS, V36, P663, DOI 10.1086/367658	44	14	17	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96844	10.1371/journal.pone.0096844	http://dx.doi.org/10.1371/journal.pone.0096844			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24817204	gold, Green Published, Green Submitted			2022-12-27	WOS:000336838000070
J	Burns, ME; Vavrek, MJ				Burns, Michael E.; Vavrek, Matthew J.			Probable Ankylosaur Ossicles from the Middle Cenomanian Dunvegan Formation of Northwestern Alberta, Canada	PLOS ONE			English	Article							BRITISH-COLUMBIA; DERMAL ARMOR; DINOSAUR; OSTEODERMS; EVOLUTION; HISTOLOGY; SKELETON	A sample of six probable fragmentary ankylosaur ossicles, collected from Cenomanian deposits of the Dunvegan Formation along the Peace River, represent one of the first dinosaurian skeletal fossils reported from pre-Santonian deposits in Alberta. Specimens were identified as ankylosaur by means of a palaeohistological analysis. The primary tissue is composed of zonal interwoven structural fibre bundles with irregularly-shaped lacunae, unlike the elongate lacunae of the secondary lamellar bone. The locality represents the most northerly Cenomanian occurrence of ankylosaur skeletal remains. Further fieldwork in under-examined areas of the province carries potential for additional finds.	[Burns, Michael E.] Univ Alberta, Edmonton, AB, Canada; [Vavrek, Matthew J.] Pipestone Creek Dinosaur Initiat, Clairmont, AB, Canada	University of Alberta	Burns, ME (corresponding author), Univ Alberta, Edmonton, AB, Canada.	mburns@ualberta.ca	Burns, Michael E/GPC-8311-2022	Burns, Michael/0000-0002-9587-563X; Vavrek, Matthew/0000-0003-0186-812X	Department of Biological Sciences; Dinosaur Research Institute	Department of Biological Sciences; Dinosaur Research Institute	Funding to MEB was provided by the Department of Biological Sciences. Funding for fieldwork was provided by the Dinosaur Research Institute to MJV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell PR, 2008, ALCHERINGA, V32, P271, DOI 10.1080/03115510802096101; Blows WT, 2001, LIFE O PAST, P363; Burns ME, J VRETEBR P IN PRESS, V34; Burns ME, 2013, J MORPHOL, V274, P676, DOI 10.1002/jmor.20125; Cerda IA, 2011, LETHAIA, V44, P417, DOI 10.1111/j.1502-3931.2010.00252.x; Cerda IA, 2010, ACTA PALAEONTOL POL, V55, P389, DOI 10.4202/app.2009.1101; Chinsamy A, 2012, ANAT REC, V295, P610, DOI 10.1002/ar.22428; Cook TD, 2008, CAN J EARTH SCI, V45, P1185, DOI 10.1139/E08-064; Coy C, 1997, ENCY DINOSAURS, P90; Cumbaa SL, 1999, SUMMARY INVESTIGATIO, V1, P94; Currie PJ, 2005, LIFE O PAST, P3; de Ricqles A., 2001, PUBLICACION ESPECIAL, V7, P171; Fiorillo Anthony R., 2006, Journal of the Paleontological Society of Korea, V22, P15; Fiorillo Anthony R., 2001, Historical Biology, V15, P323, DOI 10.1080/0891296021000037327; FOX RC, 1984, CAN J EARTH SCI, V21, P258, DOI 10.1139/e84-026; Frakes LA, 1999, GEOL S AM S, P49; Hay MJ, 2007, CAN J EARTH SCI, V44, P775, DOI 10.1139/E07-002; Hayashi S, 2010, ACTA PALAEONTOL POL, V55, P213, DOI 10.4202/app.2009.0103; Hayashi S, 2009, J VERTEBR PALEONTOL, V29, P123, DOI 10.1080/02724634.2009.10010366; Henderson D, 2012, ALBERTA PALAEONTOLOG, V27, P7; Huber BT, 2002, GEOLOGY, V30, P123, DOI 10.1130/0091-7613(2002)030<0123:DSPROE>2.0.CO;2; Irving E, 1993, EVOLUTION W INTERIOR, P91; Martill DM, 2000, PALAEONTOLOGY, V43, P549, DOI 10.1111/j.0031-0239.2000.00139.x; McCarthy PJ, 1999, SEDIMENTOLOGY, V46, P861, DOI 10.1046/j.1365-3091.1999.00257.x; McCrea Richard T., 2014, Bulletin of the New Mexico Museum of Natural History and Science, P5; McCrea RT, 2001, LIFE O PAST, P413; Pasch AD, 1997, SHORT NOTES ALASKA G, V1997, P99; Pasch Anne D., 2001, P219; Plint AG, 2000, B CAN PETROL GEOL, V48, P43, DOI 10.2113/48.1.43; Ryan Michael J., 2001, P279; Rylaarsdam JR, 2006, CAN J EARTH SCI, V43, P631, DOI 10.1139/E06-014; Salisbury SW, 2001, CROCODILIAN BIOLOGY AND EVOLUTION, P85; Scheyer TM, 2004, J VERTEBR PALEONTOL, V24, P874, DOI 10.1671/0272-4634(2004)024[0874:HOAOIF]2.0.CO;2; Scheyer TM, 2007, ACTA PALAEONTOL POL, V52, P137; STOTT DF, 1982, GEOLOGICAL SURVEY CA, V328, P1; Tokaryk TT, 1997, J VERTEBR PALEONTOL, V17, P172, DOI 10.1080/02724634.1997.10010961; Tucker AD, 1997, MAR FRESHWATER RES, V48, P343, DOI 10.1071/MF96113; Upchurch Jr G.R., 1993, EVOLUTION W INTERIOR, P243; Vavrek MJ, ARCTIC IN PRESS; Vickaryous MK, 2008, J MORPHOL, V269, P398, DOI 10.1002/jmor.10575; Vickaryous MK, 2009, J ANAT, V214, P441, DOI 10.1111/j.1469-7580.2008.01043.x; WOLFE JA, 1987, PALAEOGEOGR PALAEOCL, V61, P33, DOI 10.1016/0031-0182(87)90040-X	42	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96075	10.1371/journal.pone.0096075	http://dx.doi.org/10.1371/journal.pone.0096075			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816807	Green Published, gold, Green Submitted			2022-12-27	WOS:000336838000022
J	O'Shea, MK; Fletcher, TE; Beeching, NJ; Dedicoat, M; Spence, D; McShane, H; Cunningham, AF; Wilson, D				O'Shea, Matthew K.; Fletcher, Thomas E.; Beeching, Nicholas J.; Dedicoat, Martin; Spence, David; McShane, Helen; Cunningham, Adam F.; Wilson, Duncan			Tuberculin Skin Testing and Treatment Modulates Interferon-Gamma Release Assay Results for Latent Tuberculosis in Migrants	PLOS ONE			English	Article							HEALTH-CARE WORKERS; QUANTIFERON-TB GOLD; CELL RESPONSES; INFECTION; DIAGNOSIS; ENUMERATION	Background: Identifying latent tuberculosis infection (LTBI) in people migrating from TB endemic regions to low incidence countries is an important control measure. However, no prospective longitudinal comparisons between diagnostic tests used in such migrant populations are available. Objectives: To compare commercial interferon (IFN)-gamma release assays (IGRAs) and the tuberculin skin test (TST) for diagnosing LTBI in a migrant population, and the influence of antecedent TST and LTBI treatment on IGRA performance. Materials and Methods: This cohort study, performed from February to September 2012, assessed longitudinal IGRA and TST responses in Nepalese military recruits recently arrived in the UK. Concomitant T-SPOT. TB, QFT-GIT and TST were performed on day 0, with IGRAs repeated 7 and 200 days later, following treatment for LTBI if necessary. Results: individuals by QFT-GIT. There was substantial agreement between TST and T-SPOT. TB positives at baseline (71.4% agreement; kappa = 0.62; 95% CI: 0.44-0.79), but only moderate concordance between positive IGRAs (38.1% agreement; kappa = 0.46; 95% CI: 0.25-0.67). When reassessed 7 days following TST, numbers of IGRA-positive individuals changed from 8 to 23 for QFT-GIT (p = 0.0074) and from 21 to 23 for T-SPOT. TB (p=0.87). This resulted in an increase in IGRA concordance to substantial (64.3% agreement; kappa = 0.73; 95% CI: 0.58-0.88). Thus, in total on day 0 and day 7 after testing, 29 out of 166 participants (17.5%) provided a positive IGRA and of these 13 were TST negative. Two hundred days after the study commenced and three months after treatment for LTBI was completed by those who were given chemoprophylaxis, 23 and 21 participants were positive by T-SPOT. TB or QFT-GIT respectively. When individual responses were examined longitudinally within this population 35% of the day 7 QFT-GIT-positive, and 19% T-SPOT. TB-positive individuals, were negative by IGRA. When the change in the levels of secreted IFN-gamma was examined after chemoprophylaxis c the median levels were found to have fallen dramatically by 77.3% from a pre-treatment median concentration of IFN-gamma 2.7 3 IU/ml to a post-treatment median concentration IFN-gamma 0.62 (p = 0.0002). Conclusions: This study suggests differences in the capacity of commercially available IGRAs to identify LTBI in the absence of antecedent TST and that IGRAs, in the time periods examined, may not be the optimal tests to determine the success of chemoprophylaxis for LTBI.	[O'Shea, Matthew K.; McShane, Helen] Univ Oxford, Nuffield Dept Med, Jenner Inst, Oxford, England; [O'Shea, Matthew K.; Cunningham, Adam F.] Univ Birmingham Edgbaston, MRC Ctr Immune Regulat, Sch Immun & Infect, Birmingham, W Midlands, England; [Fletcher, Thomas E.; Beeching, Nicholas J.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Dedicoat, Martin] Birmingham Heartlands Hosp, Dept Infect Dis & Trop Med, Birmingham B9 5ST, W Midlands, England; [Spence, David] Friarage Hosp, Dept Resp Med, Northallerton, N Yorkshire, England; [Wilson, Duncan] Joint Med Command, Royal Ctr Def Med Acad & Res, Birmingham, W Midlands, England	University of Oxford; Jenner Institute; University of Birmingham; Liverpool School of Tropical Medicine; University of Liverpool; Heart of England NHS Foundation Trust; University of Birmingham; Royal Centre for Defence Medicine	Cunningham, AF (corresponding author), Univ Birmingham Edgbaston, MRC Ctr Immune Regulat, Sch Immun & Infect, Birmingham, W Midlands, England.	a.f.cunningham@bham.ac.uk	Dedicoat, Martin/AFC-7815-2022; Beeching, Nicholas J/L-5363-2017	Fletcher, Tom/0000-0002-3712-415X; McShane, Helen/0000-0002-2126-5142; O'Shea, Matthew/0000-0001-6414-8088; Dedicoat, Martin/0000-0001-9833-4882; Beeching, Nicholas/0000-0002-7019-8791; Cunningham, Adam/0000-0003-0248-964X	UK Surgeon General; Drummond Foundation	UK Surgeon General; Drummond Foundation	Funding was received from the UK Surgeon General and the Drummond Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], TUB CLIN DIAGN MAN T; [Anonymous], CAN COMMUN DIS REP, V34, P1; Baker CA, 2009, AM J TROP MED HYG, V80, P628, DOI 10.4269/ajtmh.2009.80.628; Borsuk S, 2009, TUBERCULOSIS, V89, P423, DOI 10.1016/j.tube.2009.07.003; Carrara S, 2004, CLIN INFECT DIS, V38, P754, DOI 10.1086/381754; Chee CBE, 2007, AM J RESP CRIT CARE, V175, P282, DOI 10.1164/rccm.200608-1109OC; Chee CBE, 2013, RESPIROLOGY, V18, P205, DOI 10.1111/resp.12002; Chiappini E, 2012, CLIN THER, V34, P1041, DOI 10.1016/j.clinthera.2012.03.006; Dheda K, 2005, LANCET INFECT DIS, V5, P324, DOI 10.1016/S1473-3099(05)70119-5; Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110; Diel R, 2011, AM J RESP CRIT CARE, V183, P88, DOI 10.1164/rccm.201006-0974OC; Dyrhol-Riise AM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-57; Ewer K, 2006, AM J RESP CRIT CARE, V174, P831, DOI 10.1164/rccm.200511-1783OC; Franken WPJ, 2008, INT J TUBERC LUNG D, V12, P1286; Harari A, 2005, J IMMUNOL, V174, P1037, DOI 10.4049/jimmunol.174.2.1037; Health Protection Agency, 2012, TUB UK ANN REP TUB S; Igari H, 2007, INT J TUBERC LUNG D, V11, P788; Kang YA, 2005, JAMA-J AM MED ASSOC, V293, P2756, DOI 10.1001/jama.293.22.2756; Kim Chang Ho, 2013, Cytometry B Clin Cytom, DOI 10.1002/cytob.21110; Klenerman P, 2002, NAT REV IMMUNOL, V2, P263, DOI 10.1038/nri777; Lalvani A, 2004, CLIN INFECT DIS, V38, P757, DOI 10.1086/381763; Lalvani A, 2001, AM J RESP CRIT CARE, V163, P824, DOI 10.1164/ajrccm.163.4.2009100; Lalvani A, 2001, J INFECT DIS, V183, P469, DOI 10.1086/318081; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee SW, 2012, INFECTION, V40, P431, DOI 10.1007/s15010-012-0265-2; Leyten EMS, 2007, EUR RESPIR J, V29, P1212, DOI 10.1183/09031936.00117506; Mack U, 2009, EUR RESPIR J, V33, P956, DOI 10.1183/09031936.00120908; Mahomed H, 2006, INT J TUBERC LUNG D, V10, P310; Mancuso JD, 2012, AM J RESP CRIT CARE, V185, P427, DOI 10.1164/rccm.201107-1244OC; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; MENZIES RI, 2000, LUNG BIOL HEALTH DIS, V144, P279; Naseer A, 2007, EUR RESPIR J, V29, P1282, DOI 10.1183/09031936.00017807; O'Shea MK, 2014, J ROY ARMY MED CORPS, V7, P2014; Pai M, 2009, INT J TUBERC LUNG D, V13, P84; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2007, PLOS MED, V4, P980, DOI 10.1371/journal.pmed.0040208; Pai M, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-7; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; Pareek M, 2013, THORAX, V68, P230, DOI 10.1136/thoraxjnl-2011-201542; Pathan AA, 2000, EUR J IMMUNOL, V30, P2713, DOI 10.1002/1521-4141(200009)30:9<2713::AID-IMMU2713>3.0.CO;2-4; Pathan AA, 2001, J IMMUNOL, V167, P5217, DOI 10.4049/jimmunol.167.9.5217; Perry S, 2008, CLIN VACCINE IMMUNOL, V15, P425, DOI 10.1128/CVI.00398-07; Sauzullo I, 2011, TUBERCULOSIS, V91, P322, DOI 10.1016/j.tube.2011.05.004; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Theron G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037436; van Zyl-Smit RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008517; van Zyl-Smit RN, 2009, AM J RESP CRIT CARE, V180, P49, DOI 10.1164/rccm.200811-1704OC; Vilaplana C, 2008, SCAND J IMMUNOL, V67, P610, DOI 10.1111/j.1365-3083.2008.02103.x; Wilkinson KA, 2006, J INFECT DIS, V193, P354, DOI 10.1086/499311; World Health Organisation, 2014, GLOB HLTH OBS DAT RE	52	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97366	10.1371/journal.pone.0097366	http://dx.doi.org/10.1371/journal.pone.0097366			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816576	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000336838000133
J	Pravdin, SF; Dierckx, H; Katsnelson, LB; Solovyova, O; Markhasin, VS; Panfilov, AV				Pravdin, Sergey F.; Dierckx, Hans; Katsnelson, Leonid B.; Solovyova, Olga; Markhasin, Vladimir S.; Panfilov, Alexander V.			Electrical Wave Propagation in an Anisotropic Model of the Left Ventricle Based on Analytical Description of Cardiac Architecture	PLOS ONE			English	Article							MYOCARDIUM; ACTIVATION; MECHANISMS; VORTICES; REENTRY; HEART; FIBRILLATION; TERMINATION; GENERATION; THICKNESS	We develop a numerical approach based on our recent analytical model of fiber structure in the left ventricle of the human heart. A special curvilinear coordinate system is proposed to analytically include realistic ventricular shape and myofiber directions. With this anatomical model, electrophysiological simulations can be performed on a rectangular coordinate grid. We apply our method to study the effect of fiber rotation and electrical anisotropy of cardiac tissue (i.e., the ratio of the conductivity coefficients along and across the myocardial fibers) on wave propagation using the ten Tusscher-Panfilov (2006) ionic model for human ventricular cells. We show that fiber rotation increases the speed of cardiac activation and attenuates the effects of anisotropy. Our results show that the fiber rotation in the heart is an important factor underlying cardiac excitation. We also study scroll wave dynamics in our model and show the drift of a scroll wave filament whose velocity depends non-monotonically on the fiber rotation angle; the period of scroll wave rotation decreases with an increase of the fiber rotation angle; an increase in anisotropy may cause the breakup of a scroll wave, similar to the mother rotor mechanism of ventricular fibrillation.	[Pravdin, Sergey F.] Inst Math & Mech, Funct Approximat Theory Dept, Ekaterinburg, Russia; [Pravdin, Sergey F.; Katsnelson, Leonid B.; Solovyova, Olga; Markhasin, Vladimir S.] Inst Immunol & Physiol, Lab Math Physiol, Ekaterinburg, Russia; [Pravdin, Sergey F.; Dierckx, Hans; Panfilov, Alexander V.] Univ Ghent, Fac Sci, Dept Phys & Astron, B-9000 Ghent, Belgium; [Katsnelson, Leonid B.; Solovyova, Olga; Markhasin, Vladimir S.] Ural Fed Univ, Ekaterinburg, Russia; [Panfilov, Alexander V.] Moscow Inst Phys & Technol, Dolgoprudnyi, Moscow Region, Russia	Krasovskii Institute of Mathematics & Mechanics; Institute of Immunology & Physiology UB RAS; Ghent University; Ural Federal University; Moscow Institute of Physics & Technology	Pravdin, SF (corresponding author), Inst Math & Mech, Funct Approximat Theory Dept, Ekaterinburg, Russia.	sergey.pravdin@ugent.be; alexander.panfilov@ugent.be	Pravdin, Sergei F./O-8888-2016; Solovyova, Olga/T-8232-2017; Katsnelson, Leonid B/G-6752-2016; Dierckx, Hans/AAH-1714-2019; Panfilov, Alexander/G-8459-2016	Pravdin, Sergei F./0000-0003-4053-8895; Solovyova, Olga/0000-0003-4423-8734; Katsnelson, Leonid B/0000-0001-9553-9110; Panfilov, Alexander/0000-0003-2643-642X; Dierckx, Hans/0000-0003-0899-8082	Presidium of Urals Branch of the Russian Academy of Sciences [12-M-14-2009]; Flemish Community of Belgium [1F2B8M/JDW/2010-2011/10-BTL-RUS-01]; Ghent University [01SF1511]; UrFU [02.A03.21.0006]; program "State Support of the Leading Scientific Schools" [NS-4538.2014.1]; Russian Foundation for Basic Research [13-01-96048]; Government of the Sverdlovsk Region	Presidium of Urals Branch of the Russian Academy of Sciences; Flemish Community of Belgium; Ghent University(Ghent University); UrFU; program "State Support of the Leading Scientific Schools"; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Government of the Sverdlovsk Region	This work was supported by the Presidium of Urals Branch of the Russian Academy of Sciences (project 12-M-14-2009), the Flemish Community of Belgium (HD's fellowship and grant 1F2B8M/JDW/2010-2011/10-BTL-RUS-01), Ghent University (grant 01SF1511), the Agreement 211 between the Government of RF and UrFU #02.A03.21.0006, the program "State Support of the Leading Scientific Schools" (NS-4538.2014.1), the Russian Foundation for Basic Research (grant 13-01-96048) and the Government of the Sverdlovsk Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliev RR, 1996, CHAOS SOLITON FRACT, V7, P293, DOI 10.1016/0960-0779(95)00089-5; Andre F, 2012, J CARDIOVASCULAR S1, V14, P223; [Anonymous], 1973, GRAVITATION; Berenfeld O, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.061901; Caldwell BJ, 2009, CIRC-ARRHYTHMIA ELEC, V2, P433, DOI 10.1161/CIRCEP.108.830133; Carapella V, 2013, LECT NOTES COMPUT SC, V7945, P46, DOI 10.1007/978-3-642-38899-6_6; Castellanos A., 1990, CARDIAC ELECTROPHYSI, P666; Clayton RH, 2011, PROG BIOPHYS MOL BIO, V104, P22, DOI 10.1016/j.pbiomolbio.2010.05.008; CROSS MC, 1993, REV MOD PHYS, V65, P851, DOI 10.1103/RevModPhys.65.851; Davydov VA, 2004, PHYS LETT A, V325, P334, DOI 10.1016/j.physleta.2004.03.080; Dierckx H, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.012908; Dosdall DJ, 2008, AM J PHYSIOL-HEART C, V295, pH883, DOI 10.1152/ajpheart.00466.2008; Fenton F, 1998, CHAOS, V8, P20, DOI 10.1063/1.166311; Frindel Carole, 2007, Proceedings of the 29th Annual International Conference of the IEEE EMBS, P6007; Gilbert SH, 2012, IEEE ENG MED BIO, P4063, DOI 10.1109/EMBC.2012.6346859; Grandi E, 2010, J MOL CELL CARDIOL, V48, P112, DOI 10.1016/j.yjmcc.2009.09.019; HENRIQUEZ CS, 1993, CRIT REV BIOMED ENG, V21, P1; Holden A, 1997, COMPUTATIONAL BIOL H; Hoogendoorn C, 2013, IEEE T MED IMAGING, V32, P28, DOI 10.1109/TMI.2012.2230015; Jie X, 2010, CIRC RES, V106, P185, DOI 10.1161/CIRCRESAHA.109.210864; KAUL S, 1986, AM J ROENTGENOL, V146, P75, DOI 10.2214/ajr.146.1.75; Kawel N, 2012, CIRC-CARDIOVASC IMAG, V5, P500, DOI 10.1161/CIRCIMAGING.112.973560; Keener JP, 1996, BIOPHYS J, V71, P1335, DOI 10.1016/S0006-3495(96)79333-5; Keldermann RH, 2010, AM J PHYSIOL-HEART C, V299, pH134, DOI 10.1152/ajpheart.00862.2009; Kleber AG, 2004, PHYSIOL REV, V84, P431, DOI 10.1152/physrev.00025.2003; Nayak AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072950; Niederer SA, 2006, BIOPHYS J, V90, P1697, DOI 10.1529/biophysj.105.069534; NIELSEN PMF, 1991, AM J PHYSIOL, V260, pH1365, DOI 10.1152/ajpheart.1991.260.4.H1365; Noble D, 2002, SCIENCE, V295, P1678, DOI 10.1126/science.1069881; NOBLE D, 1962, J PHYSIOL-LONDON, V160, P317, DOI 10.1113/jphysiol.1962.sp006849; O'Hara T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002061; PANFILOV A, 1995, CHAOS SOLITON FRACT, V5, P681, DOI 10.1016/0960-0779(93)E0050-L; PANFILOV AV, 1993, J THEOR BIOL, V161, P271, DOI 10.1006/jtbi.1993.1055; PANFILOV AV, 1985, PHYSICA D, V17, P323, DOI 10.1016/0167-2789(85)90215-5; PANFILOV AV, 1990, PHYS LETT A, V147, P463, DOI 10.1016/0375-9601(90)90607-P; Panfilov AV, 1999, PHYS REV E, V59, pR6251, DOI 10.1103/PhysRevE.59.R6251; PANFILOV AV, 1991, PHYSICA D, V49, P107, DOI 10.1016/0167-2789(91)90200-S; PANFILOV AV, 1993, J CARDIOVASC ELECTR, V4, P412, DOI 10.1111/j.1540-8167.1993.tb01280.x; PANFILOV AV, 1990, PHYS LETT A, V151, P23, DOI 10.1016/0375-9601(90)90840-K; Pettigrew JB, 1860, P ROY SOC LONDON, V10, P433, DOI 10.1098/rspl.1859.0081; Pravdin SF, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-54; Qu ZL, 2000, BIOPHYS J, V78, P2761, DOI 10.1016/S0006-3495(00)76821-4; Ramrakha PS, 2012, OXFORD HDB CARDIOLOG; Reiser M. F., 2008, MAGNETIC RESONANCE T; Rice JJ, 2004, PROG BIOPHYS MOL BIO, V85, P179, DOI 10.1016/j.pbiomolbio.2004.01.011; Rodriguez B, 2005, CIRC RES, V97, P168, DOI 10.1161/01.RES.0000174429.00987.17; RUDENKO AN, 1983, STUD BIOPHYS, V98, P183; SAFFITZ JE, 1994, CIRC RES, V74, P1065, DOI 10.1161/01.RES.74.6.1065; Samie FH, 2001, CARDIOVASC RES, V50, P242, DOI 10.1016/S0008-6363(00)00289-3; Shajahan TK, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.011929; Sinha S, 2002, CHAOS, V12, P893, DOI 10.1063/1.1501176; Sridhar S, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.051908; Streeter D.D., 1979, HDB PHYSL, VVolume 1, P61; Sulman T, 2008, B MATH BIOL, V70, P910, DOI 10.1007/s11538-007-9285-y; TACCARDI B, 1994, CIRCULATION, V90, P3076, DOI 10.1161/01.CIR.90.6.3076; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; Ten Tusscher KHWJ, 2007, CIRC RES, V100, pE87, DOI 10.1161/CIRCRESAHA.107.150730; ter Keurs HEDJ, 2008, PROG BIOPHYS MOL BIO, V97, P312, DOI 10.1016/j.pbiomolbio.2008.02.013; Trayanova NA, 2013, WILEY INTERDISCIPLIN; Trew ML, 2011, ANN BIOMED ENG, V39, P235, DOI 10.1007/s10439-010-0163-7; Verschelde H, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.168104; Vigmond EJ, 2008, PROG BIOPHYS MOL BIO, V96, P3, DOI 10.1016/j.pbiomolbio.2007.07.012; Wellner M, 2002, P NATL ACAD SCI USA, V99, P8015, DOI 10.1073/pnas.112026199; Young R, 2010, P NATL ACAD SCI USA, V107, P14964; Zykov VS, 1996, PHYSICA D, V97, P322, DOI 10.1016/0167-2789(96)00145-5	66	24	26	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e93617	10.1371/journal.pone.0093617	http://dx.doi.org/10.1371/journal.pone.0093617			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24817308	Green Published, Green Submitted, gold			2022-12-27	WOS:000336838000004
J	Shim, HY; Park, JH; Kim, SY; Shin, DW; Shin, JY; Park, BY; Huh, JS; Shin, HY; Won, YJ; Seo, HG				Shim, Hye-Young; Park, Jong-Hyock; Kim, So-Young; Shin, Dong Wook; Shin, Ji-Yeon; Park, Bo Young; Huh, Jung-Sik; Shin, Hee-Young; Won, Young Joo; Seo, Hong Gwan			Discordance between Perceived and Actual Cancer Stage among Cancer Patients in Korea: A Nationwide Survey	PLOS ONE			English	Article							TRUTH-TELLING PRACTICE; BREAST-CANCER; BAD-NEWS; COMMUNICATION; PHYSICIANS; ATTITUDES; DISCLOSURE; DIAGNOSIS; WOMEN; CARE	Purpose: We assessed the accuracy of communication between doctors and patients by evaluating the consistency between patient perception of cancer stage and the medical records, and analyzed the most influential factors of incongruence among cancer patients at 10 cancer centers across Korea. Methods: Information was gathered from cancer patients at the National Cancer Center and nine regional cancer centers located in every province of Korea between 1 July 2008 and 31 August 2008. Data were analyzed using Pearson's chi(2) test and multivariate logistic regression analysis. Results: The stages of cancer reported by the 1,854 patients showed a low degree of congruence with the stages given in medical records (k = 0.35, P < 0.001). Only 57.1% of the patients had accurate knowledge of their cancer stage. In total, 18.5% underestimated their stage of disease, and the more advanced the cancer stage, the more likely they were to underestimate it, in order of local (14.2%), regional (23.7%), and distant (51.6%). Logistic regression analysis showed that congruence was lower in patients with cervical cancer (odds ratio [OR] = 0.51, 95% confidence interval [CI] = 0.30-0.87), recurrence (OR = 0.64, 95% CI = 0.50-0.83), and treatment at the National Cancer Center (OR = 0.53, 95% CI = 0.39-0.72). Conclusion: There are knowledge gaps between patients' perceived and actual stage of cancer. Patients with cervical cancer, recurrence, and who received treatment at a regional cancer center showed less understanding of their cancer stage.	[Shim, Hye-Young; Park, Jong-Hyock; Kim, So-Young; Park, Bo Young; Won, Young Joo; Seo, Hong Gwan] Natl Canc Ctr, Natl Canc Control Inst, Goyang, South Korea; [Park, Jong-Hyock; Kim, So-Young] Chungbuk Natl Univ, Grad Sch Hlth Sci Business Convergence, Coll Med, Cheongju, South Korea; [Shin, Dong Wook] Seoul Natl Univ Hosp, Seoul 110744, South Korea; [Shin, Dong Wook] Seoul Natl Univ, Canc Hosp, Seoul, South Korea; [Shin, Ji-Yeon] Eulji Univ, Sch Med, Dept Prevent Med, Taejon, South Korea; [Huh, Jung-Sik] Jeju Reg Canc Ctr, Cheju, South Korea; [Shin, Hee-Young] Jeonnam Reg Canc Ctr, Jeonnam, South Korea	National Cancer Center - Korea (NCC); Chungbuk National University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Eulji University	Park, JH (corresponding author), Natl Canc Ctr, Natl Canc Control Inst, Goyang, South Korea.	jonghyock@gmail.com			National Cancer Center, Republic of Korea [210150]	National Cancer Center, Republic of Korea	This study was supported by a grant from the National Cancer Center (Grant number 210150), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNAS GJ, 1994, NEW ENGL J MED, V330, P223, DOI 10.1056/NEJM199401203300324; Baile WF, 2002, J CLIN ONCOL, V20, P2189, DOI 10.1200/JCO.2002.08.004; Choi KH, 2011, SUPPORT CARE CANCER, V19, P1495, DOI 10.1007/s00520-010-0973-z; Chun IH, 2013, ASIAN ONCOL NURS, V13, P59, DOI 10.5388/aon.2013.13.2.59; Fallowfield LJ, 2002, PALLIATIVE MED, V16, P297, DOI 10.1191/0269216302pm575oa; Friedrichsen M, 2006, J PALLIAT MED, V9, P673, DOI 10.1089/jpm.2006.9.673; Frost MH, 2000, PSYCHO-ONCOLOGY, V9, P221; Gongal R, 2006, PALLIATIVE MED, V20, P471, DOI 10.1191/0269216306pm1154oa; Heo DS, 2009, J KOREAN MED ASSOC, V52, P865, DOI 10.5124/jkma.2009.52.9.865; Hu WY, 2002, CANCER NURS, V25, P486, DOI 10.1097/00002820-200212000-00014; Im EO, 2000, WESTERN J NURS RES, V22, P551, DOI 10.1177/01939450022044593; Jenkins V, 2001, BRIT J CANCER, V84, P48, DOI 10.1054/bjoc.2000.1573; Jiang Y, 2007, PSYCHO-ONCOLOGY, V16, P928, DOI 10.1002/pon.1156; Jiang Y, 2006, SUPPORT CARE CANCER, V14, P1119, DOI 10.1007/s00520-006-0071-4; Polacek GNLJ, 2007, PATIENT EDUC COUNS, V65, P158, DOI 10.1016/j.pec.2006.06.003; Kazdaglis G, 2010, EMHJ, V16; Kim MH, 2005, QUAL LIFE RES, V14, P1401, DOI 10.1007/s11136-004-5681-z; Klocker JG, 1997, ANN NY ACAD SCI, V809, P56, DOI 10.1111/j.1749-6632.1997.tb48068.x; Lee MK, 2013, PALLIATIVE MED, V27, P144, DOI 10.1177/0269216311429042; LeeJones C, 1997, PSYCHO-ONCOLOGY, V6, P95, DOI 10.1002/(SICI)1099-1611(199706)6:2<95::AID-PON250>3.0.CO;2-B; Li SD, 1997, ANN NY ACAD SCI, V809, P243, DOI 10.1111/j.1749-6632.1997.tb48087.x; Li XP, 2013, ASIAN PAC J CANCER P, V14, P4157, DOI 10.7314/APJCP.2013.14.7.4157; Liang WH, 2002, J CLIN ONCOL, V20, P1008, DOI 10.1200/JCO.20.4.1008; Mandelblatt JS, 1999, CANCER-AM CANCER SOC, V86, P2378, DOI 10.1002/(SICI)1097-0142(19991201)86:11<2378::AID-CNCR28>3.3.CO;2-C; Mitchell JL, 1998, CANCER PRACT, V6, P153, DOI 10.1046/j.1523-5394.1998.006003153.x; Mystakidou K, 1996, PALLIATIVE MED, V10, P195, DOI 10.1177/026921639601000303; NOVACK DH, 1979, JAMA-J AM MED ASSOC, V241, P897, DOI 10.1001/jama.241.9.897; Oh DY, 2004, CANCER-AM CANCER SOC, V100, P1961, DOI 10.1002/cncr.20184; Okamura H, 1998, JPN J CLIN ONCOL, V28, P1, DOI 10.1093/jjco/28.1.1; Ozdogan M, 2004, SUPPORT CARE CANCER, V12, P497, DOI 10.1007/s00520-004-0633-2; Ozdogan M, 2006, J PALLIAT MED, V9, P1114, DOI 10.1089/jpm.2006.9.1114; Rust C, 2011, SOC WORK HEALTH CARE, V50, P739, DOI 10.1080/00981389.2011.585703; Santoso JT, 2006, CANCER J, V12, P73, DOI 10.1097/00130404-200601000-00013; Shahidi J, 2010, EUR J CANCER CARE, V19, P589, DOI 10.1111/j.1365-2354.2009.01100.x; Shahidi J, 2007, AUSTRAL ASIAN J CANC, V6, P213; Shin DW, 2012, SUPPORT CARE CANCER, V20, P1965, DOI 10.1007/s00520-011-1299-1; Stead ML, 2003, BRIT J CANCER, V88, P666, DOI 10.1038/sj.bjc.6600799; Tan T. K. S., 1993, Singapore Medical Journal, V34, P202; Uchitomi Y, 1997, ANN NY ACAD SCI, V809, P290, DOI 10.1111/j.1749-6632.1997.tb48092.x; Wang SY, 2004, J PSYCHOSOM RES, V57, P53, DOI 10.1016/S0022-3999(03)00566-X; 박진노, 2004, [The Korean Journal of Hospice and Palliative Care, 한국호스피스완화의료학회지], V7, P169; Young JL, 2001, NIH PUB; Yun YH, 2004, J CLIN ONCOL, V22, P307, DOI 10.1200/JCO.2004.07.053; Yun YH, 1992, J KOREAN ACAD FAM ME, V13, P790	44	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e90483	10.1371/journal.pone.0090483	http://dx.doi.org/10.1371/journal.pone.0090483			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4LX	24817193	gold, Green Published, Green Submitted			2022-12-27	WOS:000336838000002
J	Zielinski, D; Markus, B; Sheikh, M; Gymrek, M; Chu, C; Zaks, M; Srinivasan, B; Hoffman, JD; Aizenbud, D; Erlich, Y				Zielinski, Dina; Markus, Barak; Sheikh, Mona; Gymrek, Melissa; Chu, Clement; Zaks, Marta; Srinivasan, Balaji; Hoffman, Jodi D.; Aizenbud, Dror; Erlich, Yaniv			OTX2 Duplication Is Implicated in Hemifacial Microsomia	PLOS ONE			English	Article							AURICULO-VERTEBRAL SPECTRUM; OCULOAURICULOVERTEBRAL SPECTRUM; GENE PRIORITIZATION; GOLDENHAR SEQUENCE; GENOME; COMPLEX; VARIANTS; MUTATION; FEATURES; DNA	Hemifacial microsomia (HFM) is the second most common facial anomaly after cleft lip and palate. The phenotype is highly variable and most cases are sporadic. We investigated the disorder in a large pedigree with five affected individuals spanning eight meioses. Whole-exome sequencing results indicated the absence of a pathogenic coding point mutation. A genome-wide survey of segmental variations identified a 1.3 Mb duplication of chromosome 14q22.3 in all affected individuals that was absent in more than 1000 chromosomes of ethnically matched controls. The duplication was absent in seven additional sporadic HFM cases, which is consistent with the known heterogeneity of the disorder. To find the critical gene in the duplicated region, we analyzed signatures of human craniofacial disease networks, mouse expression data, and predictions of dosage sensitivity. All of these approaches implicated OTX2 as the most likely causal gene. Moreover, OTX2 is a known oncogenic driver in medulloblastoma, a condition that was diagnosed in the proband during the course of the study. Our findings suggest a role for OTX2 dosage sensitivity in human craniofacial development and raise the possibility of a shared etiology between a subtype of hemifacial microsomia and medulloblastoma.	[Zielinski, Dina; Markus, Barak; Sheikh, Mona; Gymrek, Melissa; Erlich, Yaniv] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Gymrek, Melissa] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Gymrek, Melissa] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Gymrek, Melissa] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Gymrek, Melissa] Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA; [Chu, Clement; Srinivasan, Balaji] Counsyl, San Francisco, CA USA; [Zaks, Marta; Aizenbud, Dror] Rambam Hlth Care Campus, Haifa, Israel; [Hoffman, Jodi D.] Tufts Med Ctr, Div Genet, Boston, MA USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Rambam Health Care Campus; Tufts Medical Center	Erlich, Y (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	yaniv@wi.mit.edu		Zielinski, Dina/0000-0002-6188-9590; Gymrek, Melissa/0000-0002-6086-3903	Whitehead Institute	Whitehead Institute	The study was funded by Whitehead Institute internal funds and private donations from Andria and Paul Heafy, Cathy and Jim Stone, and Ron Casty. Two authors, Drs. Balaji Srinivasan and Clement Chu, are from Counsyl Inc, a for-profit company. Their role in the manuscript was generation of the sequencing data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Aizenbud D, 2013, J CRANIOMAXILLOFAC S; Akiyama K, 2010, J HUM GENET, V55, P656, DOI 10.1038/jhg.2010.82; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Blumenstiel Brendan, 2010, Curr Protoc Hum Genet, VChapter 18, DOI 10.1002/0471142905.hg1804s66; Bray SM, 2010, P NATL ACAD SCI USA, V107, P16222, DOI 10.1073/pnas.1004381107; Bunt J, 2012, INT J CANCER, V131, pE21, DOI 10.1002/ijc.26474; Chassaing N, 2012, J MED GENET, V49, P373, DOI 10.1136/jmedgenet-2012-100892; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; COHEN MM, 1989, CLEFT PALATE J, V26, P276; Dabir TA, 2006, CLIN DYSMORPHOL, V15, P25, DOI 10.1097/01.mcd.0000181606.63005.50; de Ravel TJL, 2001, CLIN DYSMORPHOL, V10, P263, DOI 10.1097/00019605-200110000-00005; Diaczok D, 2008, J CLIN ENDOCR METAB, V93, P4351, DOI 10.1210/jc.2008-1189; Erlich Y, 2011, GENOME RES, V21, P658, DOI 10.1101/gr.117143.110; Fossat N, 2006, EMBO REP, V7, P824, DOI 10.1038/sj.embor.7400751; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gorlin RJ., 2001, SYNDROMES HEAD NECK, DOI 10.17245/jdapm.2019.19.5.261; Gymrek M, 2012, GENOME RES, V22, P1154, DOI 10.1101/gr.135780.111; Hashimoto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023359; Hide T, 2002, DEVELOPMENT, V129, P4347; HODES ME, 1981, J CRAN GENET DEV BIO, V1, P49; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Huang XS, 2010, TOHOKU J EXP MED, V222, P311, DOI 10.1620/tjem.222.311; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Ballesta-Martinez MJ, 2013, AM J MED GENET A, V161, P2030, DOI 10.1002/ajmg.a.36007; Kallen K, 2004, AM J MED GENET A, V127A, P26, DOI 10.1002/ajmg.a.20643; KAYE CI, 1992, AM J MED GENET, V43, P913, DOI 10.1002/ajmg.1320430602; Keegan CE, 2001, GENET MED, V3, P310, DOI 10.1097/00125817-200107000-00007; Kelberman D, 2001, HUM GENET, V109, P638, DOI 10.1007/s00439-001-0626-x; Kiezun A, 2012, NAT GENET, V44, P623, DOI 10.1038/ng.2303; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; KOBRYNSKI L, 1993, AM J MED GENET, V46, P68, DOI 10.1002/ajmg.1320460111; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Lage K, 2008, P NATL ACAD SCI USA, V105, P20870, DOI 10.1073/pnas.0810772105; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Marth GT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r84; MATSUO I, 1995, GENE DEV, V9, P2646, DOI 10.1101/gad.9.21.2646; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McEntyre J, 2002, NCBI HDB; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miller RI, 2001, FETAL DIAGN THER, V16, P120, DOI 10.1159/000053894; Moreau Y, 2012, NAT REV GENET, V13, P523, DOI 10.1038/nrg3253; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Nolen LD, 2006, AM J MED GENET A, V140A, P1711, DOI 10.1002/ajmg.a.31335; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Northup JK, 2010, CLIN DYSMORPHOL, V19, P185, DOI 10.1097/MCD.0b013e3283359386; On ZS, 2008, AM J MED GENET A, V146A, P2480, DOI 10.1002/ajmg.a.32398; Oti M, 2007, CLIN GENET, V71, P1, DOI 10.1111/j.1399-0004.2006.00708.x; Pagon RA, 2009, GENEREVIEWS; POSWILLO D, 1988, DEVELOPMENT, V103, P207; PRIDJIAN G, 1995, AM J MED GENET, V59, P411, DOI 10.1002/ajmg.1320590402; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; RIMOIN D, 2006, EMERY RIMOINS PRINCI; ROLLNICK BR, 1983, AM J MED GENET, V15, P233, DOI 10.1002/ajmg.1320150207; Rooryck C, 2010, AM J MED GENET A, V152A, P1984, DOI 10.1002/ajmg.a.33491; Rozen S, 2000, Methods Mol Biol, V132, P365; Saccone SF, 2012, BIOINFORMATICS, V28, P1189, DOI 10.1093/bioinformatics/bts117; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; Vendramini-Pittoli S, 2009, CLIN DYSMORPHOL, V18, P67, DOI 10.1097/MCD.0b013e328323a7dd; Vermeesch JR, 2011, EUR J HUM GENET, V19, P1112, DOI 10.1038/ejhg.2011.83; Werler MM, 2004, CLEFT PALATE-CRAN J, V41, P494, DOI 10.1597/03-110.1	67	29	29	1	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96788	10.1371/journal.pone.0096788	http://dx.doi.org/10.1371/journal.pone.0096788			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816892	Green Published, Green Submitted, gold			2022-12-27	WOS:000336838000065
J	Dichamp, I; Abbas, W; Kumar, A; Di Martino, V; Herbein, G				Dichamp, Isabelle; Abbas, Wasim; Kumar, Amit; Di Martino, Vincent; Herbein, Georges			Cellular Activation and Intracellular HCV Load in Peripheral Blood Monocytes Isolated from HCV Monoinfected and HIV-HCV Coinfected Patients	PLOS ONE			English	Article							HEPATITIS-C VIRUS; NF-KAPPA-B; HUMAN-IMMUNODEFICIENCY-VIRUS; MONONUCLEAR-CELLS; MICROBIAL TRANSLOCATION; ANTIRETROVIRAL THERAPY; PROMONOCYTIC CELLS; TERMINAL KINASE; T-CELLS; INFECTION	Background: During HCV infection, the activation status of peripheral blood monocytes and its impact on HCV replication are poorly understood. We hypothesized that a modified activation of peripheral blood monocytes in HIV-HCV coinfected compared to HCV monoinfected patients may contribute to different monocytes reservoirs of HCV replication. Methods: We performed a case-control analysis involving HCV-infected patients with and without HIV coinfection. In peripheral blood mononuclear cells (PBMCs), peripheral blood lymphocytes (PBLs) and peripheral blood monocytes isolated from HCV monoinfected and HIV-HCV coinfected patients, intracellular HCV load and a marker of cellular activation, nuclear factor-kappaB (NF-kappa B) activation, were quantified using intracellular detection of HCV-core protein and electrophoretic mobility shift assay, respectively. Results: Intracellular HCV loads were higher in monocytes isolated from HIV-HCV coinfected patients than in those of monoinfected patients. Among PBMCs isolated from HIV-HCV coinfected patients, intracellular HCV loads were higher in monocytes compared to PBLs. Cellular activation as measured by NF-kappa B activation was higher in monocytes isolated from HIV-HCV coinfected patients than in those of monoinfected patients. Conclusions: Our results reveal the peripheral blood monocytes as an important extrahepatic reservoir for HCV in HIV-HCV coinfected patients and indicate a potential association between the activation state of monocytes and the size of the HCV reservoir in HIV-HCV coinfected patients.	[Dichamp, Isabelle; Abbas, Wasim; Kumar, Amit; Di Martino, Vincent; Herbein, Georges] Univ Franche Comte, Pathogens & Inflammat Dept, UPRES EA4266, SFR FED 4234, F-25030 Besancon, France; [Dichamp, Isabelle; Abbas, Wasim; Kumar, Amit; Herbein, Georges] CHRU Besancon, Dept Virol, Besancon, France; [Di Martino, Vincent] CHRU Besancon, Dept Hepatol, Besancon, France	Universite de Franche-Comte; Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; CHU Besancon	Herbein, G (corresponding author), Univ Franche Comte, Pathogens & Inflammat Dept, UPRES EA4266, SFR FED 4234, F-25030 Besancon, France.	georges.herbein@univ-fcomte.fr	Kumar, Amit/F-7708-2013	Kumar, Amit/0000-0002-7398-0498; Di Martino, Vincent/0000-0002-2022-690X	University of Franche-Comte (UFC); Region Franche-Comte [RECH-FON12-000013, 2012C-06102]; Higher Education Commission, Pakistan; Diasorin SA	University of Franche-Comte (UFC); Region Franche-Comte(Region Bourgogne-Franche-Comte); Higher Education Commission, Pakistan(Higher Education Commission of Pakistan); Diasorin SA	This work was supported by grants to G.H. from the University of Franche-Comte (UFC) and the Region Franche-Comte (RECH-FON12-000013). W. A. is a recipient of a doctoral scholarship from the Higher Education Commission, Pakistan. A. K. is a recipient of a postdoctoral fellowship of the Region Franche-Comte (2012C-06102). The authors thank Diasorin SA for its financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Ancuta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002516; Anthony DD, 2012, J INFECT DIS, V206, P969, DOI 10.1093/infdis/jis434; Arnaud N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010575; Bain C, 2001, GASTROENTEROLOGY, V120, P512, DOI 10.1053/gast.2001.21212; Balagopal A, 2008, GASTROENTEROLOGY, V135, P226, DOI 10.1053/j.gastro.2008.03.022; Blackard JT, 2007, J INFECT DIS, V195, P1765, DOI 10.1086/518251; Bronowicki JP, 1998, HEPATOLOGY, V28, P211, DOI 10.1002/hep.510280127; Chary A, 2012, J MED VIROL, V84, P431, DOI 10.1002/jmv.23210; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Chung H, 2010, J INFECT DIS, V202, P853, DOI 10.1086/655812; Coquillard G, 2009, J INFECT DIS, V200, P947, DOI 10.1086/605476; Di Martino V, 2001, HEPATOLOGY, V34, P1193, DOI 10.1053/jhep.2001.29201; Furione M, 2004, J CLIN MICROBIOL, V42, P3012, DOI 10.1128/JCM.42.7.3012-3016.2004; Garaigorta U, 2009, CELL HOST MICROBE, V6, P513, DOI 10.1016/j.chom.2009.11.004; Gordon S, 2012, J INNATE IMMUN, V4, P409, DOI 10.1159/000339280; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Guedj J, 2011, HEPATOLOGY, V53, P1801, DOI 10.1002/hep.24272; Herbein G, 1998, NATURE, V395, P189, DOI 10.1038/26026; Herbein G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-33; Heydtmann M, 2009, J VIROL, V83, P2796, DOI 10.1128/JVI.00996-08; Hiscott J, 2001, J CLIN INVEST, V107, P143, DOI 10.1172/JCI11918; Ito M, 2010, J INNATE IMMUN, V2, P607, DOI 10.1159/000317690; Joo MS, 2005, J VIROL, V79, P7648, DOI 10.1128/JVI.79.12.7648-7657.2005; Kanto T, 2006, INTERNAL MED, V45, P183, DOI 10.2169/internalmedicine.45.1530; Khan KA, 2013, J INNATE IMMUN, V5, P639, DOI 10.1159/000350517; Kottilil S, 2009, HEPATOLOGY, V50, P34, DOI 10.1002/hep.23055; LANFORD RE, 1995, J VIROL, V69, P8079, DOI 10.1128/JVI.69.12.8079-8083.1995; Laskus T, 2000, J INFECT DIS, V181, P442, DOI 10.1086/315283; Lin WY, 2011, J BIOL CHEM, V286, P2665, DOI 10.1074/jbc.M110.168286; Mahlknecht U, 2008, J LEUKOCYTE BIOL, V83, P718, DOI 10.1189/jlb.0607405; Marchetti G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032028; Mellor J, 1998, J GEN VIROL, V79, P705, DOI 10.1099/0022-1317-79-4-705; Naggie S, 2012, GASTROENTEROLOGY, V142, P1324, DOI 10.1053/j.gastro.2012.02.012; Navas S, 1998, J VIROL, V72, P1640, DOI 10.1128/JVI.72.2.1640-1646.1998; Radkowski M, 1998, TRANSPLANTATION, V66, P664, DOI 10.1097/00007890-199809150-00022; Rempel H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055776; Revie D, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-346; Rockstroh JK, 2005, J INFECT DIS, V192, P992, DOI 10.1086/432762; Ross RS, 2010, J CLIN MICROBIOL, V48, P1161, DOI 10.1128/JCM.01640-09; Schnuriger A, 2006, J CLIN MICROBIOL, V44, P1561, DOI 10.1128/JCM.44.4.1561-1563.2006; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shimizu YK, 1997, J VIROL, V71, P5769, DOI 10.1128/JVI.71.8.5769-5773.1997; Sulkowski MS, 2013, J INFECT DIS, V207, pS26, DOI 10.1093/infdis/jis764; Szabo G, 2005, IMMUNOBIOLOGY, V210, P237, DOI 10.1016/j.imbio.2005.05.018; Taylor LE, 2012, CLIN INFECT DIS, V55, pS33, DOI 10.1093/cid/cis367; Varin A, 2005, J BIOL CHEM, V280, P42557, DOI 10.1074/jbc.M502211200; Varin A, 2003, J BIOL CHEM, V278, P2219, DOI 10.1074/jbc.M209622200; Zhang JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017484; Zhang LM, 2013, VIROLOGY, V438, P28, DOI 10.1016/j.virol.2013.01.015	51	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96907	10.1371/journal.pone.0096907	http://dx.doi.org/10.1371/journal.pone.0096907			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809719	Green Published, gold, Green Submitted			2022-12-27	WOS:000338213300086
J	Gervain, J; Werker, JF; Geffen, MN				Gervain, Judit; Werker, Janet F.; Geffen, Maria N.			Category-Specific Processing of Scale-Invariant Sounds in Infancy	PLOS ONE			English	Article							LANGUAGE RECOGNITION; SELF-SIMILARITY; NATURAL IMAGES; STATISTICS; PERCEPTION; SPEECH; TIME	Increasing evidence suggests that the natural world has a special status for our sensory and cognitive functioning. The mammalian sensory system is hypothesized to have evolved to encode natural signals in an efficient manner. Exposure to natural stimuli, but not to artificial ones, improves learning and cognitive function. Scale-invariance, the property of exhibiting the same statistical structure at different spatial or temporal scales, is common to naturally occurring sounds. We recently developed a 3-parameter model to capture the essential characteristics of water sounds, and from this generated both scale-invariant and variable-scale sounds. In a previous study, we found that adults perceived a wide range of the artificial scale-invariant, but not the variable-scale, sounds as instances of natural sounds. Here, we explored the ontogenetic origins of these effects by investigating how young infants perceive and categorize scale-invariant acoustic stimuli. Even though they have several months of experience with natural water sounds, infants aged 5 months did not show a preference, in the first experiment, for the instances of the scale-invariant sounds rated as typical water-like sounds by adults over non-prototypical, but still scale-invariant instances. Scale-invariance might thus be a more relevant factor for the perception of natural signals than simple familiarity. In a second experiment, we thus directly compared infants' perception of scale-invariant and variable-scale sounds. When habituated to scale-invariant sounds, infants looked significantly longer to a change in sound category from scale-invariant to variable-scale sounds, whereas infants habituated to variable-scale sounds showed no such difference. These results suggest that infants were able to form a perceptual category of the scale-invariant, but not variable-scale sounds. These findings advance the efficient coding hypothesis, and suggest that the advantage for perceiving and learning about the natural world is evident from the first months of life.	[Gervain, Judit] CNRS, Lab Psychol Percept, Paris, France; [Gervain, Judit] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Werker, Janet F.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Geffen, Maria N.] Univ Penn, Dept Otorhinolaryngol HNS, Philadelphia, PA 19104 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of British Columbia; University of Pennsylvania	Geffen, MN (corresponding author), Univ Penn, Dept Otorhinolaryngol HNS, Philadelphia, PA 19104 USA.	mgeffen@med.upenn.edu		Gervain, Judit/0000-0002-2125-6369; Werker, Janet F./0000-0002-1168-9013	ANR [21373]; French Investissements d'Avenir - Labex EFL program [ANR-10-LABX-0083]; City of Paris; Natural Sciences and Engineering Research Council [81103]; Canadian Institutes for Advanced Research Funding; Burroughs Welcome Career Award at the Scientific Interface; Pennsylvania Lions Club Hearing Research Fellowship; Klingenstein Fellowship in Neurosciences; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC013660] Funding Source: NIH RePORTER	ANR(French National Research Agency (ANR)); French Investissements d'Avenir - Labex EFL program(French National Research Agency (ANR)); City of Paris(Region Ile-de-France); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes for Advanced Research Funding; Burroughs Welcome Career Award at the Scientific Interface(Burroughs Wellcome Fund); Pennsylvania Lions Club Hearing Research Fellowship; Klingenstein Fellowship in Neurosciences(Klingenstein Philanthropies); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The work was supported by an ANR Jeunes Chercheurs Jeunes Chercheuses Grant #21373, French Investissements d'Avenir - Labex EFL program (ANR-10-LABX-0083) and an Emergence(s) grant from the City of Paris to Judit Gervain, Natural Sciences and Engineering Research Council Grant #81103 and Canadian Institutes for Advanced Research Funding to Janet F. Werker, and Burroughs Welcome Career Award at the Scientific Interface, Pennsylvania Lions Club Hearing Research Fellowship and Klingenstein Fellowship in Neurosciences to Maria N. Geffen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Berman MG, 2008, PSYCHOL SCI, V19, P1207, DOI 10.1111/j.1467-9280.2008.02225.x; Bosch L, 1997, COGNITION, V65, P33, DOI 10.1016/S0010-0277(97)00040-1; Byers-Heinlein K, 2010, PSYCHOL SCI, V21, P343, DOI 10.1177/0956797609360758; Dehaene-Lambertz G, 2002, SCIENCE, V298, P2013, DOI 10.1126/science.1077066; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Geffen MN, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00015; Gervain J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2430; Kaplan S, 2010, PERSPECT PSYCHOL SCI, V5, P43, DOI 10.1177/1745691609356784; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; MANDELBROT B, 1967, SCIENCE, V156, P636, DOI 10.1126/science.156.3775.636; MEHLER J, 1988, COGNITION, V29, P143, DOI 10.1016/0010-0277(88)90035-2; MOON C, 1993, INFANT BEHAV DEV, V16, P495, DOI 10.1016/0163-6383(93)80007-U; NELSON DGK, 1995, INFANT BEHAV DEV, V18, P111; Oakes LM, 2010, J COGN DEV, V11, P255, DOI 10.1080/15248371003699977; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Pallier C, 1998, MEM COGNITION, V26, P844, DOI 10.3758/BF03211403; Pena M, 2003, P NATL ACAD SCI USA, V100, P11702, DOI 10.1073/pnas.1934290100; POLKA L, 1994, J EXP PSYCHOL HUMAN, V20, P421, DOI 10.1037/0096-1523.20.2.421; Quinn PC, 2000, PERCEPT PSYCHOPHYS, V62, P1625, DOI 10.3758/BF03212160; Robinson K, 1992, AUDITORY PHYSL PERCE, P429, DOI DOI 10.1016/B978-0-08-041847-6.50054-X; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Singh NC, 2003, J ACOUST SOC AM, V114, P3394, DOI 10.1121/1.1624067; Smith EC, 2006, NATURE, V439, P978, DOI 10.1038/nature04485; VOSS RF, 1975, NATURE, V258, P317, DOI 10.1038/258317a0; VOULOUMANOS A, 2007, DEVELOPMENTAL SCI, V10, P170; Vouloumanos A, 2007, DEVELOPMENTAL SCI, V10, P159, DOI 10.1111/j.1467-7687.2007.00549.x; Werner LA, 2011, AUDITORY DEVELOPMENT; Woolley SMN, 2005, NAT NEUROSCI, V8, P1371, DOI 10.1038/nn1536	30	13	13	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96278	10.1371/journal.pone.0096278	http://dx.doi.org/10.1371/journal.pone.0096278			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK1XT	24809801	gold, Green Published, Green Submitted			2022-12-27	WOS:000338213300027
J	Jiang, M; Han, YQ; Zhou, MG; Zhao, HZ; Xiao, X; Hou, YY; Gao, J; Bai, G; Luo, GA				Jiang, Min; Han, Yan-qi; Zhou, Meng-ge; Zhao, Hong-zhi; Xiao, Xue; Hou, Yuan-yuan; Gao, Jie; Bai, Gang; Luo, Guo-an			The Screening Research of Anti-Inflammatory Bioactive Markers from Different Flowering Phases of Flos Lonicerae Japonicae	PLOS ONE			English	Article							IDENTIFICATION; INFLAMMATION; INJECTION; MS	Flos Lonicerae Japonicae (FLJ) is an important cash crop in eastern Asia, and it is an anti-inflammatory Traditional Chinese Medicine. There are large variations in the quality of the marketed FLJ products. To find marker ingredients useful for quality control, a tandem technology integrating ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry (UPLC-Q/TOF), principal component analysis (PCA), heat map analysis and hierarchical cluster analysis coupled with a NF-kappa B luciferase reporter gene assay were used to identify the different ingredients from the green bud, white bud, flowering stage and leaf stages, as well as to screen the anti-inflammatory activity of FLJ compositions. As flowering progressed, the anti-inflammatory effects of FLJ gradually decreased; however, chlorogenic acid, swertiamarin and sweroside should be used to evaluate the quality of FLJ products.	[Jiang, Min; Han, Yan-qi; Zhou, Meng-ge; Zhao, Hong-zhi; Xiao, Xue; Hou, Yuan-yuan; Gao, Jie; Bai, Gang; Luo, Guo-an] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Jiang, Min; Han, Yan-qi; Zhou, Meng-ge; Zhao, Hong-zhi; Xiao, Xue; Hou, Yuan-yuan; Gao, Jie; Bai, Gang; Luo, Guo-an] Nankai Univ, Coll Pharm, Tianjin 300071, Peoples R China; [Jiang, Min; Han, Yan-qi; Zhou, Meng-ge; Zhao, Hong-zhi; Hou, Yuan-yuan; Gao, Jie; Bai, Gang] Nankai Univ, Tianjin Key Lab Mol Drug Res, Tianjin 300071, Peoples R China; [Luo, Guo-an] Tsinghua Univ, Dept Chem, Beijing 100084, Peoples R China	Nankai University; Nankai University; Nankai University; Tsinghua University	Bai, G (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	gangbai@nankai.edu.cn	赵, 洪芝/AAB-4771-2022; Jiang, Min/HGT-8781-2022		National Natural Science Foundation of China [81373506]; Key Program of Natural Science of Foundation of Tianjin, China [13JCZDJC31400]; Specialized Research Fund for the Doctor Program of Higher Education of China [20120031110042]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program of Natural Science of Foundation of Tianjin, China; Specialized Research Fund for the Doctor Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by a Grant from the National Natural Science Foundation of China (No. 81373506), the Key Program of Natural Science of Foundation of Tianjin, China (Nos. 13JCZDJC31400) and the Specialized Research Fund for the Doctor Program of Higher Education of China (Nos. 20120031110042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Ciarcia R, 2012, J CELL PHYSIOL, V227, P2798, DOI 10.1002/jcp.23029; Commission C.P., 2010, PHARM PEOPL REP CHIN; Fraige K, 2014, FOOD CHEM, V145, P395, DOI 10.1016/j.foodchem.2013.08.066; Jiang M, 2013, J ETHNOPHARMACOL, V147, P426, DOI 10.1016/j.jep.2013.03.032; Kim HR, 2010, INT IMMUNOPHARMACOL, V10, P1242, DOI 10.1016/j.intimp.2010.07.005; Krishnamoorthy S, 2006, CANCER METAST REV, V25, P481, DOI 10.1007/s10555-006-9016-0; Li MZ, 2010, MODERN BUSINESS, V9, P278; Li YJ, 2012, BIOMED CHROMATOGR, V26, P449, DOI 10.1002/bmc.1685; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Panaro MA, 2012, BR J NUTR, V17, P1; Park KI, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/828521; Peng LY, 2000, FITOTERAPIA, V71, P713, DOI 10.1016/S0367-326X(00)00212-4; Ryu KH, 2010, BIOSCI BIOTECH BIOCH, V74, P2022, DOI 10.1271/bbb.100279; Shang XF, 2011, J ETHNOPHARMACOL, V138, P1, DOI 10.1016/j.jep.2011.08.016; Shen WJ, 2012, BRAIN RES BULL, V88, P487, DOI 10.1016/j.brainresbull.2012.04.010; Tang D, 2008, J SEP SCI, V31, P3519, DOI 10.1002/jssc.200800173; Vaijanathappa J, 2009, PLANTA MED, V75, P12, DOI 10.1055/s-0028-1088333; Xing L, 2013, J ETHNOPHARMACOL, V148, P239, DOI 10.1016/j.jep.2013.04.019; Xu KJ, 2011, J PHARMACEUT BIOMED, V56, P1089, DOI 10.1016/j.jpba.2011.07.034; Xu YB, 2007, J ETHNOPHARMACOL, V111, P667, DOI 10.1016/j.jep.2007.01.017; Xu YX, 2010, INFLAMM RES, V59, P871, DOI 10.1007/s00011-010-0199-z; Yoo HJ, 2008, J PHARM PHARMACOL, V60, P779, DOI 10.1211/jpp.60.6.0014; Yue GGL, 2012, PHYTOTHER RES, V26, P915, DOI 10.1002/ptr.3659	24	24	29	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96214	10.1371/journal.pone.0096214	http://dx.doi.org/10.1371/journal.pone.0096214			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809338	Green Published, gold, Green Submitted			2022-12-27	WOS:000338213300021
J	Ma, DD; Cui, L; Gao, J; Yan, WJ; Liu, Y; Xu, SM; Wu, BL				Ma, Dandan; Cui, Li; Gao, Jie; Yan, Wenjuan; Liu, Ying; Xu, Shuaimei; Wu, Buling			Proteomic Analysis of Mesenchymal Stem Cells from Normal and Deep Carious Dental Pulp	PLOS ONE			English	Article							DEPENDENT ISOCITRATE DEHYDROGENASE; EXFOLIATED DECIDUOUS TEETH; PENTOSE-PHOSPHATE PATHWAY; GLUTAREDOXIN 3 PICOT; OXIDATIVE STRESS; PERIODONTAL-LIGAMENT; EPITHELIAL-CELLS; ALPHA-SUBUNIT; GROWTH-FACTOR; IN-VITRO	Dental pulp stem cells (DPSCs), precursor cells of odontoblasts, are ideal seed cells for tooth tissue engineering and regeneration. Our previous study has demonstrated that stem cells exist in dental pulp with deep caries and are called carious dental pulp stem cells (CDPSCs). The results indicated that CDPSCs had a higher proliferative and stronger osteogenic differentiation potential than DPSCs. However, the molecular mechanisms responsible for the biological differences between DPSCs and CDPSCs are poorly understood. The aim of this study was to define the molecular features of DPSCs and CDPSCs by comparing the proteomic profiles using two-dimensional fluorescence difference gel electrophoresis (2-D DIGE) in combination with matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS). Our results revealed that there were 18 protein spots differentially expressed between DPSCs and CDPSCs in a narrow pH range of 4 to 7. These differently expressed proteins are mostly involved in the regulation of cell proliferation, differentiation, cell cytoskeleton and motility. In addition, our results suggested that CDPSCs had a higher expression of antioxidative proteins that might protect CDPSCs from oxidative stress. This study explores some potential proteins responsible for the biological differences between DPSCs and CDPSCs and expands our understanding on the molecular mechanisms of mineralization of DPSCs in the formation of the dentin-pulp complex.	[Ma, Dandan; Cui, Li; Gao, Jie; Yan, Wenjuan; Liu, Ying; Xu, Shuaimei; Wu, Buling] Nanfang Hosp, Dept Stomatol, Guangzhou, Guangdong, Peoples R China; [Ma, Dandan; Cui, Li; Gao, Jie; Yan, Wenjuan; Liu, Ying; Xu, Shuaimei; Wu, Buling] Southern Med Univ, Coll Stomatol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Wu, BL (corresponding author), Nanfang Hosp, Dept Stomatol, Guangzhou, Guangdong, Peoples R China.	bulingwu1958@163.com		Cui, Li/0000-0001-9814-6945	National Natural Science Foundation of China (China) [81371137]	National Natural Science Foundation of China (China)(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (China, 81371137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2009, J BIOL CHEM, V284, P14939, DOI 10.1074/jbc.M900097200; Arthur A, 2008, STEM CELLS, V26, P1787, DOI 10.1634/stemcells.2007-0979; Bakin AV, 2004, MOL BIOL CELL, V15, P4682, DOI 10.1091/mbc.E04-04-0353; Banki K, 1998, J BIOL CHEM, V273, P11944, DOI 10.1074/jbc.273.19.11944; Banki K, 1996, J BIOL CHEM, V271, P32994, DOI 10.1074/jbc.271.51.32994; Bluteau G, 2008, EUR CELLS MATER, V16, P1; Bohman S, 2005, J BIOL CHEM, V280, P42397, DOI 10.1074/jbc.M506724200; Bronckaers A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071104; Celebi B, 2010, J PROTEOME RES, V9, P5217, DOI 10.1021/pr100506u; Cha H, 2008, J MOL CELL CARDIOL, V45, P796, DOI 10.1016/j.yjmcc.2008.09.124; Cha MK, 2009, CANCER EPIDEMIOL, V33, P281, DOI 10.1016/j.canep.2009.08.006; Chen CD, 1999, GENE DEV, V13, P593, DOI 10.1101/gad.13.5.593; Chen JS, 2011, EXP DIABETES RES, DOI 10.1155/2011/565647; Choi MY, 2007, EXP MOL MED, V39, P690, DOI 10.1038/emm.2007.75; Coghlin C, 2006, J PATHOL, V210, P351, DOI 10.1002/path.2056; Cooper JA, 2008, INT REV CEL MOL BIO, V267, P183, DOI 10.1016/S1937-6448(08)00604-7; Eleuterio E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071101; Fernandez-Salas E, 2002, MOL CELL BIOL, V22, P3610, DOI 10.1128/MCB.22.11.3610-3620.2002; Grantham J, 2006, EXP CELL RES, V312, P2309, DOI 10.1016/j.yexcr.2006.03.028; Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Guo DY, 2010, PROTEOMICS, V10, P3688, DOI 10.1002/pmic.201000306; Haunhorst P, 2013, MOL BIOL CELL, V24, P1895, DOI 10.1091/mbc.E12-09-0648; Haunhorst P, 2010, BIOCHEM BIOPH RES CO, V394, P372, DOI 10.1016/j.bbrc.2010.03.016; He GA, 2011, EUR J IMMUNOL, V41, P1221, DOI 10.1002/eji.201041266; Huang GTJ, 2010, TISSUE ENG PT A, V16, P605, DOI [10.1089/ten.tea.2009.0518, 10.1089/ten.TEA.2009.0518]; HUANG YC, 1990, BIOCHEMISTRY-US, V29, P8266, DOI 10.1021/bi00488a010; Huh TL, 1996, GENOMICS, V32, P295, DOI 10.1006/geno.1996.0120; Hummert TW, 2001, ENDOCRINE, V15, P93, DOI 10.1385/ENDO:15:1:093; Iguchi Y, 2009, J BIOL CHEM, V284, P22059, DOI 10.1074/jbc.M109.012195; Ivanovski S, 2006, ORAL DIS, V12, P358, DOI 10.1111/j.1601-0825.2006.01253.x; Jensen JM, 2000, J INVEST DERMATOL, V115, P708, DOI 10.1046/j.1523-1747.2000.00103.x; Jin SM, 2003, CELL MICROBIOL, V5, P165, DOI 10.1046/j.1462-5822.2003.00265.x; KIM YO, 1995, BIOCHEM J, V308, P63, DOI 10.1042/bj3080063; Kitamura A, 2001, BIOCHEM BIOPH RES CO, V287, P435, DOI 10.1006/bbrc.2001.5577; Kobayashi S, 1996, FEBS LETT, V386, P149, DOI 10.1016/0014-5793(96)00393-6; KRONE PH, 1994, BIOCHEM BIOPH RES CO, V204, P746, DOI 10.1006/bbrc.1994.2522; Kubota H, 2002, VITAM HORM, V65, P313, DOI 10.1016/S0083-6729(02)65069-1; Lin YF, 2009, CANCER RES, V69, P6879, DOI 10.1158/0008-5472.CAN-08-4700; Liu HB, 2011, J BONE MINER RES, V26, P2052, DOI 10.1002/jbmr.419; Luo DX, 2013, J BIOL CHEM, V288, P36733, DOI 10.1074/jbc.M113.514877; Ma DD, 2012, J ENDODONT, V38, P796, DOI 10.1016/j.joen.2012.02.014; Marttila M, 2012, BIOCHEM J, V442, P231, DOI 10.1042/BJ20111030; MIN HS, 1995, GENE DEV, V9, P2659, DOI 10.1101/gad.9.21.2659; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Mochida K, 2000, DEV BIOL, V227, P510, DOI 10.1006/dbio.2000.9911; Morsczeck C, 2005, MATRIX BIOL, V24, P155, DOI 10.1016/j.matbio.2004.12.004; Mrozik KM, 2010, STEM CELLS DEV, V19, P1485, DOI 10.1089/scd.2009.0446; Nakai A, 2012, PLANTA, V236, P427, DOI 10.1007/s00425-012-1614-1; Olsson MC, 2004, AM J PHYSIOL-HEART C, V287, pH2712, DOI 10.1152/ajpheart.01067.2003; Patil R, 2014, EXP CELL RES, V320, P92, DOI 10.1016/j.yexcr.2013.10.005; Gomes JAP, 2010, INVEST OPHTH VIS SCI, V51, P1408, DOI 10.1167/iovs.09-4029; Perl A, 2011, TRENDS MOL MED, V17, P395, DOI 10.1016/j.molmed.2011.01.014; Pivoriunas A, 2010, STEM CELLS DEV, V19, P1081, DOI 10.1089/scd.2009.0315; Pujol-Carrion N, 2006, J CELL SCI, V119, P4554, DOI 10.1242/jcs.03229; Qian YM, 2008, BIOCHEM J, V415, P123, DOI 10.1042/BJ20080722; Rivkin E, 2005, MOL REPROD DEV, V72, P259, DOI 10.1002/mrd.20335; Rubin CI, 2004, J CELL BIOCHEM, V93, P242, DOI 10.1002/jcb.20187; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Shimizu K, 2003, BIOCHEM BIOPH RES CO, V304, P766, DOI 10.1016/S0006-291X(03)00657-0; Sonoyama W, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000079; Soundar S, 2006, J BIOL CHEM, V281, P21073, DOI 10.1074/jbc.M602956200; SOUTHWICK FS, 1986, J BIOL CHEM, V261, P14191; Stevens A, 2008, STEM CELLS DEV, V17, P1175, DOI 10.1089/scd.2008.0012; Struys T, 2011, CELLS TISSUES ORGANS, V193, P366, DOI 10.1159/000321400; Suh KS, 2007, J CELL SCI, V120, P2631, DOI 10.1242/jcs.002741; SUN HQ, 1995, J CELL BIOL, V129, P147, DOI 10.1083/jcb.129.1.147; Sun XK, 2002, J DERMATOL SCI, V29, P195, DOI 10.1016/S0923-1811(02)00040-3; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Tung JJ, 2009, ANGIOGENESIS, V12, P209, DOI 10.1007/s10456-009-9139-3; Valle JRD, 2005, J VIROL, V79, P4557, DOI 10.1128/JVI.79.8.4557-4567.2005; Wei CC, 2005, J AM SOC NEPHROL, V16, P616, DOI 10.1681/ASN.2004080715; Witke W, 2001, J CELL BIOL, V154, P775, DOI 10.1083/jcb.200101113; Youmans KL, 2012, EXP NEUROL, V237, P90, DOI 10.1016/j.expneurol.2012.05.018; Zhang Y, 2008, BMB REP, V41, P765, DOI 10.5483/BMBRep.2008.41.11.765	75	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e97026	10.1371/journal.pone.0097026	http://dx.doi.org/10.1371/journal.pone.0097026			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809979	gold, Green Published, Green Submitted			2022-12-27	WOS:000338213300108
J	Specogna, AV; Turin, TC; Patten, SB; Hill, MD				Specogna, Adrian V.; Turin, Tanvir C.; Patten, Scott B.; Hill, Michael D.			Factors Associated with Early Deterioration after Spontaneous Intracerebral Hemorrhage: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							HEALTH-CARE PROFESSIONALS; TERM SURVIVAL; POPULATION; STROKE; GUIDELINES; MANAGEMENT; PREDICTORS; DEATH; RISK	Background and Purpose: Spontaneous intracerebral hemorrhage (ICH) is a devastating form of stroke with a poor prognosis overall. We conducted a systematic review and meta-analysis to identify and describe factors associated with early neurologic deterioration (END) after ICH. Methods: We sought to identify any factor which could be prognostic in the absence of an intervention. The Cochrane Library, EMBASE, the Global Health Library, and PubMed were searched for primary studies from the years 1966 to 2012 with no restrictions on language or study design. Studies of patients who received a surgical intervention or specific experimental therapies were excluded. END was defined as death, or worsening on a reliable outcome scale within seven days after onset. Results: 7,172 abstracts were reviewed, 1,579 full-text papers were obtained and screened. 14 studies were identified; including 2088 patients. Indices of ICH severity such as ICH volume (univariate combined OR per ml: 1.37, 95% CI: 1.12-1.68), presence of intraventricular hemorrhage (2.95, 95% CI: 1.57-5.55), glucose concentration (per mmol/l: 2.14, 95% CI: 1.03-4.47), fibrinogen concentration (per g/l: 1.83, 95% CI: 1.03-3.25), and d-dimer concentration at hospital admission (per mg/l: 4.19, 95% CI: 1.88-9.34) were significantly associated with END after random-effects analyses. Whereas commonly described risk factors for ICH progression such as blood pressure, history of hypertension, and ICH growth were not. Conclusions: This study summarizes the evidence to date on early ICH prognosis and highlights that the amount and distribution of the initial bleed at hospital admission may be the most important factors to consider when predicting early clinical outcomes.	[Specogna, Adrian V.; Turin, Tanvir C.; Patten, Scott B.] Univ Calgary, Fac Med, Dept Community Hlth Sci, Calgary, AB, Canada; [Hill, Michael D.] Univ Calgary, Fac Med, Dept Clin Neurosci, Calgary, AB, Canada	University of Calgary; University of Calgary	Specogna, AV (corresponding author), Univ Calgary, Fac Med, Dept Community Hlth Sci, Calgary, AB, Canada.	specogna@shaw.ca	Hill, Michael D/C-9073-2012; Patten, Scott/B-4434-2011; Turin, Tanvir C/L-7617-2016	Hill, Michael D/0000-0002-6269-1543; Patten, Scott/0000-0001-9871-4041; Turin, Tanvir C/0000-0002-7499-5050	University of Calgary; Alberta Heritage Foundation for Medical Research; Tomorrow's Research Cardiovascular Health Professional training program; Heart & Stroke Foundation of Alberta/NWT/NU; Alberta Innovates, Health Solutions	University of Calgary; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Tomorrow's Research Cardiovascular Health Professional training program; Heart & Stroke Foundation of Alberta/NWT/NU; Alberta Innovates, Health Solutions	This study was supported by the University of Calgary. Adrian Specogna has received salary support awards from by the Alberta Heritage Foundation for Medical Research, the University of Calgary, and the Tomorrow's Research Cardiovascular Health Professional training program. Scott Patten is a Senior Health Scholar with Alberta Innovates, Health Solutions. Michael Hill is supported by the Heart & Stroke Foundation of Alberta/NWT/NU and Alberta Innovates, Health Solutions. Tanvir Turin has no disclosures. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abilleira S, 2003, J NEUROSURG, V99, P65, DOI 10.3171/jns.2003.99.1.0065; Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; [Anonymous], 2011, STAT STAT SOFTW REL; Ariesen MJ, 2003, STROKE, V34, P2060, DOI 10.1161/01.STR.0000080678.09344.8D; Borenstein M., 2009, INTRO METAANALYSIS; Broderick JP, 1999, STROKE, V30, P905, DOI 10.1161/01.STR.30.4.905; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Bruce SS, 2011, NEUROCRIT CARE; Castellanos M, 2005, J NEUROL NEUROSUR PS, V76, P691, DOI 10.1136/jnnp.2004.044347; Creutzfeldt CJ, 2008, CRIT CARE MED, V36, P2214, DOI 10.1097/CCM.0b013e31817e2605; Delgado P, 2006, NEUROLOGY, V67, P94, DOI 10.1212/01.wnl.0000223349.97278.e0; Egger M, 2001, SYSTEMATIC REV HLTH, P487; Fogelholm R, 2005, J NEUROL NEUROSUR PS, V76, P1534, DOI 10.1136/jnnp.2004.055145; Fogelholm R, 2005, J NEUROL NEUROSUR PS, V76, P349, DOI 10.1136/jnnp.2003.034819; FRANKE CL, 1992, J NEUROL NEUROSUR PS, V55, P653, DOI 10.1136/jnnp.55.8.653; Hanger HC, 2008, J NEUROL, V255, P347, DOI 10.1007/s00415-008-0650-z; Hanley DF, 2009, STROKE, V40, P1533, DOI 10.1161/STROKEAHA.108.535419; Hobart J, 2007, J NEUROL, V254, P1119, DOI 10.1007/s00415-007-0535-6; Johkura K, 2011, J NEUROL SCI, V308, P165, DOI 10.1016/j.jns.2011.06.010; LAMPL Y, 1995, STROKE, V26, P2249, DOI 10.1161/01.STR.26.12.2249; Last JM, 2001, DICT EPIDEMIOLOGY, P196; MAYER SA, 1994, NEUROLOGY, V44, P1379, DOI 10.1212/WNL.44.8.1379; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Nuance, 2012, PDF CONV PROF; Ohwaki K, 2010, BR J NEUROSURG, V24; QURESHI AI, 1995, STROKE, V26, P1764, DOI 10.1161/01.STR.26.10.1764; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Rodriguez-Luna D, 2011, NEUROLOGY, V77, P1599, DOI 10.1212/WNL.0b013e3182343387; Sorimachi T, 2010, J CLIN NEUROSCI, V17, P1367, DOI 10.1016/j.jocn.2010.02.024; Stern JAC, 2009, METAANALYSIS STATA U, P257; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Sykora M, 2009, J NEUROL SCI, V284, P108, DOI 10.1016/j.jns.2009.04.028; Tan X, 2014, INTERN MED J, V44, P254, DOI 10.1111/imj.12352; Tetri S, 2008, J NEUROSURG, V108, P1172, DOI 10.3171/JNS/2008/108/6/1172; Tetri S, 2009, J NEUROSURG, V110, P411, DOI 10.3171/2008.8.JNS08445; Tuhrim S, 2008, NEW ENGL J MED, V358, P2174, DOI 10.1056/NEJMe0801856; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zhang X, 2012, PEPTIDES, V33, P336, DOI 10.1016/j.peptides.2012.01.011	40	46	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96743	10.1371/journal.pone.0096743	http://dx.doi.org/10.1371/journal.pone.0096743			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809990	gold, Green Published, Green Submitted			2022-12-27	WOS:000338213300068
J	Tabassum, F; Kumari, M; Rumley, A; Power, C; Strachan, DP; Lowe, G				Tabassum, Faiza; Kumari, Meena; Rumley, Ann; Power, Chris; Strachan, David P.; Lowe, Gordon			Lifecourse Social Position and D-Dimer; Findings from the 1958 British Birth Cohort	PLOS ONE			English	Article							FIBRIN D-DIMER; CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; TISSUE-PLASMINOGEN ACTIVATOR; VON-WILLEBRAND-FACTOR; RISK-FACTORS; SOCIOECONOMIC POSITION; HEMOSTATIC MARKERS; VENOUS THROMBOEMBOLISM; MYOCARDIAL-INFARCTION	The aim is to examine the association of lifecourse socioeconomic position (SEP) on circulating levels of D-dimer. Data from the 1958 British birth cohort were used, social class was determined at three stages of respondents' life: at birth, at 23 and at 42 years. A cumulative indicator score of SEP (CIS) was calculated ranging from 0 (always in the highest social class) to 9 (always in the lowest social class). In men and women, associations were observed between CIS and D-dimer (P<0.05). Thus, the respondents in more disadvantaged social classes had elevated levels of D-dimer compared to respondents in less disadvantaged social class. In multivariate analyses, the association of disadvantaged social position with D-dimer was largely explained by fibrinogen, C-reactive protein and von Willebrand Factor in women, and additionally by smoking, alcohol consumption and physical activity in men. Socioeconomic circumstances across the lifecourse at various stages also contribute independently to raised levels of D-dimer in middle age in women only. Risk exposure related to SEP accumulates across life and contributes to raised levels of D-dimer. The association of haemostatic markers and social differences in health may be mediated by inflammatory and other markers.	[Tabassum, Faiza] Univ Southampton, Fac Human & Social Sci, Sect Res Ctr 3, Southampton, Hants, England; [Tabassum, Faiza] UCL, Dept Infect & Populat Hlth, London, England; [Kumari, Meena] UCL, Dept Epidemiol & Publ Hlth, London, England; [Kumari, Meena] Univ Essex, ISER, Colchester CO4 3SQ, Essex, England; [Rumley, Ann; Lowe, Gordon] Univ Glasgow, Inst Cardiovasc & Med Sci, Royal Infirm, Glasgow, Lanark, Scotland; [Power, Chris] UCL, Inst Child Hlth, Ctr Pediat Epidemiol & Biostat, London, England; [Strachan, David P.] Univ London, Div Populat Hlth Sci & Educ, London, England	University of Southampton; University of London; University College London; University of London; University College London; University of Essex; Royal Infirmary of Edinburgh; University of Glasgow; University of London; University College London; University of London	Kumari, M (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	m.kumari@ucl.ac.uk			United Kingdom Medical Research Council under the Health of the Public initiative [G0000934]; ESRC [ES/H029745/1, ES/K005146/1] Funding Source: UKRI; MRC [G0000934] Funding Source: UKRI; Economic and Social Research Council [ES/H029745/1, ES/K005146/1] Funding Source: researchfish; Medical Research Council [G0000934] Funding Source: researchfish	United Kingdom Medical Research Council under the Health of the Public initiative(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The United Kingdom Medical Research Council funded the survey and statistical analysis in the 2002-2004 biomedical follow-up under the Health of the Public initiative (grant G0000934). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atherton K, 2008, J EPIDEMIOL COMMUN H, V62, P216, DOI 10.1136/jech.2006.058966; Ben-Shlomo Y, 2002, INT J EPIDEMIOL, V31, P285, DOI 10.1093/ije/31.2.285; Blane D, 1996, BMJ-BRIT MED J, V313, P1434, DOI 10.1136/bmj.313.7070.1434; Brunner E, 1996, LANCET, V347, P1008, DOI 10.1016/S0140-6736(96)90147-6; Carcaillon L, 2009, J THROMB HAEMOST, V7, P1972, DOI 10.1111/j.1538-7836.2009.03603.x; Cosmi Benilde, 2005, Semin Vasc Med, V5, P365, DOI 10.1055/s-2005-922481; Danesh J, 2001, CIRCULATION, V103, P2323; Eichinger S, 2003, JAMA-J AM MED ASSOC, V290, P1071, DOI 10.1001/jama.290.8.1071; Hallqvist J, 2004, SOC SCI MED, V58, P1555, DOI 10.1016/S0277-9536(03)00344-7; Jousilahti P, 2003, J EPIDEMIOL COMMUN H, V57, P730, DOI 10.1136/jech.57.9.730; Koster A, 2006, J GERONTOL A-BIOL, V61, P284, DOI 10.1093/gerona/61.3.284; Kuh D, 1997, LIFE COURSE APPROACH TO CHRONIC DISEASE EPIDEMIOLOGY, P15; Kumari M, 2000, ARTERIOSCL THROM VAS, V20, P1842, DOI 10.1161/01.ATV.20.7.1842; Lowe GDO, 2001, ARTERIOSCL THROM VAS, V21, P603, DOI 10.1161/01.ATV.21.4.603; Lowe GDO, 2004, ARTERIOSCL THROM VAS, V24, P1529, DOI 10.1161/01.ATV.0000135995.39488.6c; Lowe GDO, 1998, THROMB HAEMOSTASIS, V79, P129; Montebugnoli L, 2005, J CLIN PERIODONTOL, V32, P188, DOI 10.1111/j.1600-051X.2005.00641.x; Montebugnoli L, 2004, J CLIN PERIODONTOL, V31, P25, DOI 10.1111/j.0303-6979.2004.00432.x; Morange PE, 2006, ARTERIOSCL THROM VAS, V26, P2793, DOI 10.1161/01.ATV.0000249406.92992.0d; Palareti G, 2003, CIRCULATION, V108, P313, DOI 10.1161/01.CIR.0000079162.69615.0F; Pieper CF, 2000, J GERONTOL A-BIOL, V55, pM649, DOI 10.1093/gerona/55.11.M649; Power C, 2007, INT J EPIDEMIOL, V36, P532, DOI 10.1093/ije/dyl310; Quinn TJ, 2011, J THROMB HAEMOST, V9, P1475, DOI 10.1111/j.1538-7836.2011.04403.x; Ramsay S, 2008, ATHEROSCLEROSIS, V197, P654, DOI 10.1016/j.atherosclerosis.2007.02.022; ROSENGREN A, 1990, BRIT MED J, V300, P634, DOI 10.1136/bmj.300.6725.634; Rudnicka AR, 2007, CIRCULATION, V115, P996, DOI 10.1161/CIRCULATIONAHA.106.635169; Smith A, 2005, CIRCULATION, V112, P3080, DOI 10.1161/CIRCULATIONAHA.105.557132; Tabassum F, 2008, AM J EPIDEMIOL, V167, P1332, DOI 10.1093/aje/kwn055; Wannamethee SG, 2009, J THROMB HAEMOST, V7, P1605, DOI 10.1111/j.1538-7836.2009.03574.x; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Woodward M, 2007, J THROMB HAEMOST, V5, P1795, DOI 10.1111/j.1538-7836.2007.02677.x; Yarnell JWG, 2000, ARTERIOSCL THROM VAS, V20, P271, DOI 10.1161/01.ATV.20.1.271; Zoller B, 2012, THROMB RES, V129, P577, DOI 10.1016/j.thromres.2011.07.050	33	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e93277	10.1371/journal.pone.0093277	http://dx.doi.org/10.1371/journal.pone.0093277			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK1XT	24809471	Green Published, Green Accepted, gold			2022-12-27	WOS:000338213300003
J	Xi, Y; Shao, F; Bai, XY; Cai, GY; Lv, Y; Chen, XM				Xi, Yue; Shao, Feng; Bai, Xue-Yuan; Cai, Guangyan; Lv, Yang; Chen, Xiangmei			Changes in the Expression of the Toll-Like Receptor System in the Aging Rat Kidneys	PLOS ONE			English	Article							NF-KAPPA-B; INFLAMMATION; ACTIVATION; SENESCENCE; STRESS	Background: The mechanisms of kidney aging are not yet clear. Studies have shown that immunological inflammation is related to kidney aging. Toll-like receptors (TLRs) are one of the receptor types of the body's innate immune system. The function of the TLR system and the mechanisms by which it functions in renal aging remain unclear. In the present study, we, for the first time, systematically investigated the role of the TLR system and the inflammation responses activated by TLRs during kidney aging. Methods: We used western blot and immunohistochemistry to systematically analyze the changes in the expression and activation of the endogenous TLR ligands HSP70 and HMGB1, the TLRs (TLR1-TLR11), their downstream signaling pathway molecules MyD88 and Phospho-IRF-3, and the NF-kappa B signaling pathway molecules Phospho-IKKb, Phospho-I kappa B alpha (NF-kappa B inhibition factor a), NF-kappa Bp65, and Phospho-NF-kappa Bp65 (activated NF-kappa B p65) in the kidneys of 3 months old (youth group), 12 months old (middle age group), and 24 months old (elderly group) rats. We used RT-qPCR to detect the mRNA expression changes of the proinflammatory cytokines CCL3, CCL4, CCL5, CD80, TNF-alpha, and IL-12b in the rat renal tissues of the various age groups. Results: We found that during kidney aging, the HSP70 and HMGB1 expression levels were significantly increased, and the expression levels of TLR1, 2, 3, 4, 5, and 11 and their downstream signaling pathway molecules MyD88 and Phospho-IRF-3 were markedly elevated. Further studies have shown that in the aging kidneys, the expression levels of the NF-kappa B signaling pathway molecules Phospho-IKKb, Phospho-I kappa B alpha, NF-kappa Bp65, and Phospho-NF-kappa Bp65 were obviously increased, and those of the proinflammatory cytokines CCL3, CCL4, CCL5, CD80, TNF-alpha, and IL-12b were significantly upregulated. Conclusions: These results showed that the TLR system might play an important role during the kidney aging process maybe by activating the NF-kappa B signaling pathway and promoting the high expression of inflammation factors.	[Xi, Yue; Shao, Feng; Bai, Xue-Yuan; Cai, Guangyan; Lv, Yang; Chen, Xiangmei] Chinese Peoples Liberat Army Gen Hosp, Natl Clin Res Ctr Kidney Dis, Chinese PLA Inst Nephrol, State Key Lab Kidney Dis,Dept Nephrol,Hosp 301, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Bai, XY (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Natl Clin Res Ctr Kidney Dis, Chinese PLA Inst Nephrol, State Key Lab Kidney Dis,Dept Nephrol,Hosp 301, 2011DAV00088,2013BAI09B05, Beijing, Peoples R China.	xueyuan_bai@163.com; xmchen301@yeah.net	Lyu, Yang/AAJ-5175-2021	, Yang/0000-0002-4353-0082	National Basic Research Program of China [2011CBA01003]; National Key Scientific Program of China [2011CB964904]	National Basic Research Program of China(National Basic Research Program of China); National Key Scientific Program of China	This work was supported by a grant (No. 2011CBA01003) from the National Basic Research Program of China to X.Y.B. and a grant (No. 2011CB964904) from the National Key Scientific Program of China to X.Y.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KV, 2000, CURR OPIN IMMUNOL, V12, P13, DOI 10.1016/S0952-7915(99)00045-X; Baylis C, 2005, EXP GERONTOL, V40, P271, DOI 10.1016/j.exger.2005.01.008; Brown HJ, 2007, J AM SOC NEPHROL, V18, P1732, DOI 10.1681/ASN.2006060634; Cai WJ, 2008, AM J PATHOL, V173, P327, DOI 10.2353/ajpath.2008.080152; Chung HY, 2009, AGEING RES REV, V8, P18, DOI 10.1016/j.arr.2008.07.002; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9; Grosjean F., 2011, AGING HLTH, V7, P737; Judge S, 2005, FASEB J, V19, P419, DOI 10.1096/fj.04-2622fje; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; Lafyatis R, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2321; Lee EJ, 2006, ANAL BIOCHEM, V357, P299, DOI 10.1016/j.ab.2006.06.011; Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832; Li FL, 2010, AM J NEPHROL, V32, P179, DOI 10.1159/000317023; Lin M, 2012, J AM SOC NEPHROL, V23, P86, DOI 10.1681/ASN.2010111210; Mei CL, 2009, SEMIN NEPHROL, V29, P555, DOI 10.1016/j.semnephrol.2009.07.002; Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009; Robson MG, 2009, NEPHRON EXP NEPHROL, V113, pE1, DOI 10.1159/000228077; Salminen A, 2008, AGEING RES REV, V7, P83, DOI 10.1016/j.arr.2007.09.002; Sarkar D, 2006, CANCER LETT, V236, P13, DOI 10.1016/j.canlet.2005.04.009; Shimada M, 2012, NEPHROL DIAL TRANSPL, V27, P81, DOI 10.1093/ndt/gfr271; Smith KD, 2009, CURR OPIN NEPHROL HY, V18, P189, DOI 10.1097/MNH.0b013e32832a1d5f; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tsirpanlis G, 2009, BLOOD PURIFICAT, V28, P12, DOI 10.1159/000210032; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Zhou XJ, 2008, INT UROL NEPHROL, V40, P823, DOI 10.1007/s11255-008-9405-0	27	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96351	10.1371/journal.pone.0096351	http://dx.doi.org/10.1371/journal.pone.0096351			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810370	Green Published, gold, Green Submitted			2022-12-27	WOS:000338213300031
J	Hong, KU; Guo, YR; Li, QH; Cao, PX; Al-Maqtari, T; Vajravelu, BN; Du, JJ; Book, MJ; Zhu, XP; Nong, YB; Bhatnagar, A; Bolli, R				Hong, Kyung U.; Guo, Yiru; Li, Qian-Hong; Cao, Pengxiao; Al-Maqtari, Tareq; Vajravelu, Bathri N.; Du, Junjie; Book, Michael J.; Zhu, Xiaoping; Nong, Yibing; Bhatnagar, Aruni; Bolli, Roberto			c-kit plus Cardiac Stem Cells Alleviate Post-Myocardial Infarction Left Ventricular Dysfunction Despite Poor Engraftment and Negligible Retention in the Recipient Heart	PLOS ONE			English	Article							SEX-DETERMINING REGION; HUMAN Y-CHROMOSOME; REAL-TIME PCR; ISCHEMIC CARDIOMYOPATHY; MYOCARDIAL-INFARCTION; PROGENITOR CELLS; GENE; TRANSPLANTATION; SURVIVAL; REPAIR	Although transplantation of c-kit+ cardiac stem cells (CSCs) has been shown to alleviate left ventricular (LV) dysfunction induced by myocardial infarction (MI), the number of exogenous CSCs remaining in the recipient heart following transplantation and their mechanism of action remain unclear. We have previously developed a highly sensitive and accurate method to quantify the absolute number of male murine CSCs in female recipient organs after transplantation. In the present study, we used this method to monitor the number of donor CSCs in the recipient heart after intracoronary infusion. Female mice underwent a 60-min coronary occlusion followed by reperfusion; 2 days later, 100,000 c-kit+/linsyngeneic male mouse CSCs were infused intracoronarily. Only 12.7% of the male CSCs present in the heart immediately (5 min) after infusion were still present in the heart at 24 h, and their number declined rapidly thereafter. By 35 days after infusion, only,1,000 male CSCs were found in the heart. Significant numbers of male CSCs were found in the lungs and kidneys, but only in the first 24 h. The number of CSCs in the lungs increased between 5 min and 24 h after infusion, indicating recirculation of CSCs initially retained in other organs. Despite the low retention and rapid disappearance of CSCs from the recipient heart, intracoronary delivery of CSCs significantly improved LV function at 35 days (Millar catheter). These results suggest that direct differentiation of CSCs alone cannot account for the beneficial effects of CSCs on LV function; therefore, paracrine effects must be the major mechanism. The demonstration that functional improvement is dissociated from survival of transplanted cells has major implications for our understanding of cell therapy. In addition, this new quantitative method of stem cell measurement will be useful in testing approaches of enhancing CSC engraftment and survival after transplantation.	[Hong, Kyung U.; Guo, Yiru; Li, Qian-Hong; Cao, Pengxiao; Al-Maqtari, Tareq; Vajravelu, Bathri N.; Du, Junjie; Book, Michael J.; Zhu, Xiaoping; Nong, Yibing; Bhatnagar, Aruni; Bolli, Roberto] Univ Louisville, Dept Med, Inst Mol Cardiol, Louisville, KY 40292 USA; [Hong, Kyung U.; Cao, Pengxiao; Al-Maqtari, Tareq; Vajravelu, Bathri N.; Bhatnagar, Aruni; Bolli, Roberto] Univ Louisville, Dept Med, Diabet & Obes Ctr, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Bolli, R (corresponding author), Univ Louisville, Dept Med, Inst Mol Cardiol, Louisville, KY 40292 USA.	rbolli@louisville.edu	Vajravelu, Bathri/K-5504-2019; Guo, Yiru/L-2618-2015; Li, Qianhong/AAJ-7643-2020; Al-Maqtari, Tareq/AAO-7951-2021; Hong, Kyung Uk/G-7145-2011	Guo, Yiru/0000-0002-0614-9899; Hong, Kyung Uk/0000-0001-6700-9470; Nong, Yibing/0000-0001-7934-7821	NIH [R01 HL-55757, HL-70897, HL-76794, P01 HL-78825, 8P20GM103492-05]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076794, R01HL055757, R01HL070897, P01HL078825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103492] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by NIH (www.nih.gov) grants R01 HL-55757, HL-70897, HL-76794, P01 HL-78825, and 8P20GM103492-05. No additional funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Black RG, 2002, CIRC RES, V91, P165, DOI 10.1161/01.RES.0000028007.91385.EE; Bolli R, 2013, CIRCULATION, V128, P122, DOI 10.1161/CIRCULATIONAHA.112.001075; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Chai NN, 1998, GENOMICS, V49, P283, DOI 10.1006/geno.1998.5255; Cheng K, 2009, XENOTRANSPLANTATION, V16, P145, DOI 10.1111/j.1399-3089.2009.00526.x; Chugh AR, 2012, CIRCULATION, V126, pS54, DOI 10.1161/CIRCULATIONAHA.112.092627; Ellison GM, 2013, CELL, V154, P827, DOI 10.1016/j.cell.2013.07.039; Ferreira-Martins J, 2012, CIRC RES, V110, P701, DOI 10.1161/CIRCRESAHA.111.259507; Funkhouser AW, 2001, CELL TRANSPLANT, V10, P91; Georgakopoulos D, 1998, AM J PHYSIOL-HEART C, V274, pH1416, DOI 10.1152/ajpheart.1998.274.4.H1416; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; Guo Y, 1999, P NATL ACAD SCI USA, V96, P11507, DOI 10.1073/pnas.96.20.11507; Haider HK, 2008, J MOL CELL CARDIOL, V45, P554, DOI 10.1016/j.yjmcc.2008.05.004; Hong KU, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0346-0; Kajstura J, 2012, CIRC RES, V111, P894, DOI 10.1161/CIRCRESAHA.112.273649; Konstandin MH, 2013, CIRC RES, V113, P115, DOI 10.1161/CIRCRESAHA.113.301152; Laflamme MA, 2005, AM J PATHOL, V167, P663, DOI 10.1016/S0002-9440(10)62041-X; Lee ST, 2006, J NEUROSCI METH, V157, P225, DOI 10.1016/j.jneumeth.2006.04.019; Li QH, 2011, BASIC RES CARDIOL, V106, P849, DOI 10.1007/s00395-011-0180-1; Li QH, 2009, CIRCULATION, V120, P1222, DOI 10.1161/CIRCULATIONAHA.108.778688; MA K, 1993, CELL, V75, P1287, DOI 10.1016/0092-8674(93)90616-X; Magenta A, 2013, CIRC RES, V112, P1202, DOI 10.1161/CIRCRESAHA.113.301317; Reinecke H, 1999, CIRCULATION, V100, P193, DOI 10.1161/01.CIR.100.2.193; Robey TE, 2008, J MOL CELL CARDIOL, V45, P567, DOI 10.1016/j.yjmcc.2008.03.009; Sanada F, 2013, CIRC RES; Sanganalmath SK, 2013, CIRC RES, V113, P810, DOI 10.1161/CIRCRESAHA.113.300219; Schachinger V, 2008, CIRCULATION, V118, P1425, DOI 10.1161/CIRCULATIONAHA.108.777102; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Stein AB, 2007, BASIC RES CARDIOL, V102, P28, DOI 10.1007/s00395-006-0627-y; Tang XL, 2010, CIRCULATION, V121, P293, DOI 10.1161/CIRCULATIONAHA.109.871905; Tang YL, 2005, J AM COLL CARDIOL, V46, P1339, DOI 10.1016/j.jacc.2005.05.079; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Wang LJ, 2002, LIVER TRANSPLANT, V8, P822, DOI 10.1053/jlts.2002.34891; Yang B, 1999, AM J PHYSIOL-HEART C, V277, pH1906, DOI 10.1152/ajpheart.1999.277.5.H1906; Yaniz-Galende E, 2012, CIRC RES, V111, P1434, DOI 10.1161/CIRCRESAHA.111.263830	38	135	142	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96725	10.1371/journal.pone.0096725	http://dx.doi.org/10.1371/journal.pone.0096725			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806457	Green Published, gold, Green Submitted			2022-12-27	WOS:000335728900085
J	Carraro, L; Negri, P; Castelli, L; Pastore, M				Carraro, Luciana; Negri, Paolo; Castelli, Luigi; Pastore, Massimiliano			Implicit and Explicit Illusory Correlation as a Function of Political Ideology	PLOS ONE			English	Article							MODERATING ROLE; ATTITUDES; MODEL; PERSONALITY	Research has demonstrated that people who embrace different ideological orientations often show differences at the level of basic cognitive processes. For instance, conservatives (vs. liberals) display an automatic selective attention for negative (vs. positive) stimuli, and tend to more easily form illusory correlations between negative information and minority groups. In the present work, we further explored this latter effect by examining whether it only involves the formation of explicit attitudes or it extends to implicit attitudes. To this end, following the typical illusory correlation paradigm, participants were presented with members of two numerically different groups (majority and minority) each performing either a positive or negative behaviour. Negative behaviors were relatively infrequent, and the proportion of positive and negative behaviors within each group was the same. Next, explicit and implicit (i.e., IAT-measured) attitudes were assessed. Results showed that conservatives (vs. liberals) displayed stronger explicit as well as implicit illusory correlations effects, forming more negative attitudes toward the minority (vs. majority) group at both the explicit and implicit level.	[Carraro, Luciana; Castelli, Luigi; Pastore, Massimiliano] Univ Padua, Dept Dev & Socializat Psychol, Padua, Italy; [Negri, Paolo] Univ Padua, Dept Gen Psychol, Padua, Italy	University of Padua; University of Padua	Castelli, L (corresponding author), Univ Padua, Dept Dev & Socializat Psychol, Padua, Italy.	castelli.luigi@unipd.it		Carraro, Luciana/0000-0001-8100-4609; Castelli, Luigi/0000-0002-1472-4507	MIUR [RBFR128CR6]	MIUR(Ministry of Education, Universities and Research (MIUR))	This work has been financially supported by a research grant from MIUR (RBFR128CR6) awarded to the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorno Theodor W, 1950, AUTHORITARIAN PERSON; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Asendorpf JB, 2002, J PERS SOC PSYCHOL, V83, P380, DOI 10.1037//0022-3514.83.2.380; Caprara GV, 2006, POLIT PSYCHOL, V27, P1, DOI 10.1111/j.1467-9221.2006.00447.x; Caprara GV, 2004, AM PSYCHOL, V59, P581, DOI 10.1037/0003-066X.59.7.581; Carraro L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026456; Castelli L, 2011, J EXP SOC PSYCHOL, V47, P1013, DOI 10.1016/j.jesp.2011.03.016; Dodd MD, 2012, PHILOS T R SOC B, V367, P1589; Dovidio JF, 2002, J PERS SOC PSYCHOL, V82, P62, DOI 10.1037//0022-3514.82.1.62; FIEDLER K, 1991, J PERS SOC PSYCHOL, V60, P24, DOI 10.1037/0022-3514.60.1.24; Fiedler K., 2000, REV GEN PSYCHOL, V4, P25, DOI [10.1037/1089-2680.4.1.25, DOI 10.1037/1089-2680.4.1.25]; Friese M, 2008, EUR REV SOC PSYCHOL, V19, P285, DOI 10.1080/10463280802556958; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; HAMILTON DL, 1976, J EXP SOC PSYCHOL, V12, P392, DOI 10.1016/S0022-1031(76)80006-6; Hofmann W, 2008, GROUP PROCESS INTERG, V11, P69, DOI 10.1177/1368430207084847; Hofmann W, 2007, J EXP SOC PSYCHOL, V43, P497, DOI 10.1016/j.jesp.2006.05.004; Jost JT, 2006, AM PSYCHOL, V61, P651, DOI 10.1037/0003-066X.61.7.651; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Kanai R, 2011, CURR BIOL, V21, P677, DOI 10.1016/j.cub.2011.03.017; Kruschke JK, 1996, J EXP PSYCHOL LEARN, V22, P3, DOI 10.1037/0278-7393.22.1.3; Kruschke JK, 2003, CURR DIR PSYCHOL SCI, V12, P171, DOI 10.1111/1467-8721.01254; Kruschke JK, 2001, J EXP PSYCHOL LEARN, V27, P1385, DOI 10.1037//0278-7393.27.6.1385; McConnell AR, 2001, J EXP SOC PSYCHOL, V37, P435, DOI 10.1006/jesp.2000.1470; Oxley DR, 2008, SCIENCE, V321, P1667, DOI 10.1126/science.1157627; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Ratliff KA, 2010, J EXP SOC PSYCHOL, V46, P721, DOI 10.1016/j.jesp.2010.04.011; Rule NO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008733; Rydell RJ, 2006, J PERS SOC PSYCHOL, V91, P995, DOI 10.1037/0022-3514.91.6.995; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sherman JW, 2009, J PERS SOC PSYCHOL, V96, P305, DOI 10.1037/a0013778; Shook NJ, 2011, SOC PSYCHOL PERS SCI, V2, P650, DOI 10.1177/1948550611405219; Shook NJ, 2009, J EXP SOC PSYCHOL, V45, P995, DOI 10.1016/j.jesp.2009.04.003; Stroessner SJ, 2001, COGNITIVE SOCIAL PSYCHOLOGY, P247	34	7	7	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96312	10.1371/journal.pone.0096312	http://dx.doi.org/10.1371/journal.pone.0096312			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AI1ZC	24820311	gold, Green Published, Green Submitted			2022-12-27	WOS:000336653300014
J	Eticha, T; Mesfin, K				Eticha, Tadele Y.; Mesfin, Kalkidan			Self-Medication Practices in Mekelle, Ethiopia	PLOS ONE			English	Article								Background: Self-medication makes consumers more health conscious, reduces treatment burden on healthcare facilities and curtails the cost and time of obtaining access to treatment. However, it increases risks such as drug resistance, adverse drug reactions, incorrect diagnosis, drug interactions and polypharmacy. The purpose of this study was to assess the practices and factors associated with self-medication in Mekelle, Tigray region, Ethiopia. Methods: A cross-sectional study was undertaken in Mekelle from February to March 2013. A structured and pre-tested questionnaire was used for data collection to assess self-medication practices. Data were analyzed using of Statistical Package for Social Sciences (SPSS) version 20.0. Results: Among self-medicated study participants, 199(73.7%) were males and 71(26.3%) were females with mean age of 28.65 years. The most frequently reported illnesses or symptoms of illnesses that prompted self-medication of study participants were headache/fever (20.7%), gastrointestinal diseases (17.3%) and respiratory tract infections (15.9%) with the main reasons being mildness of the disease, prior experience and less expensive. The majority of drug consumers made their requests by telling their symptoms, by mentioning specific names of the drugs and by showing old samples. Analgesics/antipyretics, gastrointestinal drugs, respiratory drugs and oral rehydration salt were the most frequently requested categories of drugs. Pharmacists followed by other healthcare providers were the most frequently reported source of drug information for self-medication. Conclusions: The results of this study demonstrated that self-medication practices were common for a wide range of illnesses. Health professionals, especially community pharmacists need to educate people on the benefits and risks of selfmedication to encourage responsible self-medication.	[Eticha, Tadele Y.; Mesfin, Kalkidan] Mekelle Univ, Coll Hlth Sci, Dept Pharm, Mekelle, Ethiopia	Mekelle University	Eticha, T (corresponding author), Mekelle Univ, Coll Hlth Sci, Dept Pharm, Mekelle, Ethiopia.	td.eticha@gmail.com						Almasdy D, 2011, ARCH PHARM PRACT, V2, P95; Andualem T., 2004, ETHIOP J HEALTH SCI, V14, P1; Auta A, 2012, N AM J MED SCI, V4, P24, DOI 10.4103/1947-2714.92899; Belachew G., 2011, J APPL PHARM SCI, V1, P183; da Silva MGC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-339; Covington TR, 2006, AM J PHARM EDUC, V70, DOI 10.5688/aj7006137; Gaddam D, 2012, IJHP, V49, P79; Hughes CM, 2001, DRUG SAFETY, V24, P1027, DOI 10.2165/00002018-200124140-00002; Hussain A., 2008, S MED REV, V1, P14; Jain P, 2012, INDO GLOBAL J PHARM, V2, P21; Khade AM, 2012, INT J BASIC APP MED, V2, P254; Kumar N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072247; Patil A, 2013, INT J BASIC CLIN PHA, V2, P498, DOI [10.5455/2319-2003.ijbcp20130829, DOI 10.5455/2319-2003.IJBCP20130829]; Sapkota AR, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-610; Solomon Worku, 2003, Ethiopian Journal of Health Development, V17, P111; Sweileh WM, 2004, J AL AQSA U, V8, P1; Tamuno I., 2011, J BASIC APPL SCI RES, V1, P1319; World Health Organization, ROL PHARM SELF CAR S	18	44	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97464	10.1371/journal.pone.0097464	http://dx.doi.org/10.1371/journal.pone.0097464			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24820769	gold, Green Submitted, Green Published			2022-12-27	WOS:000336653300116
J	Hsiao, CL; Hsieh, AR; Lian, IB; Lin, YC; Wang, HM; Fann, CSJ				Hsiao, Ching-Lin; Hsieh, Ai-Ru; Lian, Ie-Bin; Lin, Ying-Chao; Wang, Hui-Min; Fann, Cathy S. J.			A Novel Method for Identification and Quantification of Consistently Differentially Methylated Regions	PLOS ONE			English	Article							CPG ISLAND HYPERMETHYLATION; DNA METHYLATION; PROFILES; PACKAGE; BIOMARKERS; METHYLOME; REVEALS; DENSITY; GENES	Advances in biotechnology have resulted in large- scale studies of DNA methylation. A differentially methylated region (DMR) is a genomic region with multiple adjacent CpG sites that exhibit different methylation statuses among multiple samples. Many so- called `` supervised'' methods have been established to identify DMRs between two or more comparison groups. Methods for the identification of DMRs without reference to phenotypic information are, however, less well studied. An alternative `` unsupervised'' approach was proposed, in which DMRs in studied samples were identified with consideration of nature dependence structure of methylation measurements between neighboring probes from tiling arrays. Through simulation study, we investigated effects of dependencies between neighboring probes on determining DMRs where a lot of spurious signals would be produced if the methylation data were analyzed independently of the probe. In contrast, our newly proposed method could successfully correct for this effect with a well- controlled false positive rate and a comparable sensitivity. By applying to two real datasets, we demonstrated that our method could provide a global picture of methylation variation in studied samples. R source codes to implement the proposed method were freely available at http://www.csjfann.ibms.sinica.edu.tw/eag/programlist/ICDMR/ICDMR.html.	[Hsiao, Ching-Lin; Hsieh, Ai-Ru; Lin, Ying-Chao; Wang, Hui-Min; Fann, Cathy S. J.] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Lian, Ie-Bin] Natl Changhua Univ Educ, Dept Math, Changhua, Taiwan	Academia Sinica - Taiwan; National Changhua University of Education	Fann, CSJ (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	csjfann@ibms.sinica.edu.tw	wang, huimin/HDM-8421-2022; Lian, Ie-Bin/AAE-3368-2021; Fann, Cathy SJ/F-9410-2010	Fann, Cathy SJ/0000-0001-9025-2276; HSIEH, AIRU/0000-0003-3900-9101; Lian, Ie-bin/0000-0003-3992-6049	National Science Council of Taiwan [NSC101-2811-B-001-041, NSC100-2811-B-001-071]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by National Science Council grants (NSC101-2811-B-001-041, NSC100-2811-B-001-071) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	[Anonymous], BREAST CANC RES; [Anonymous], MUTAT RES; Beck S, 2008, TRENDS GENET, V24, P231, DOI 10.1016/j.tig.2008.01.006; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Bera TK, 2006, CANCER RES, V66, P52, DOI 10.1158/0008-5472.CAN-05-3014; Bock C, 2012, NAT REV GENET, V13, P705, DOI 10.1038/nrg3273; Brzezianska E, 2013, MOL BIOL REP, V40, P309, DOI 10.1007/s11033-012-2063-4; Chavez L, 2010, GENOME RES, V20, P1441, DOI 10.1101/gr.110114.110; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Fernandez AF, 2012, GENOME RES, V22, P407, DOI 10.1101/gr.119867.110; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Fraley C, 2007, J STAT SOFTW, V18; Furrow RE, 2011, GENETICS, V189, P1377, DOI 10.1534/genetics.111.131912; Hayashi H, 2007, HUM GENET, V120, P701, DOI 10.1007/s00439-006-0254-6; Hill VK, 2011, CANCER RES, V71, P2988, DOI 10.1158/0008-5472.CAN-10-4026; Hinoue T, 2012, GENOME RES, V22, P271, DOI 10.1101/gr.117523.110; Holm K, BREAST CANC RES, V12, pR36; Houshdaran S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009359; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Kamalakaran S, 2011, MOL ONCOL, V5, P77, DOI 10.1016/j.molonc.2010.11.002; Kechris KJ, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1434; Kitamura E, 2007, GENOMICS, V89, P326, DOI 10.1016/j.ygeno.2006.11.006; Kobayashi Y, 2011, GENOME RES, V21, P1017, DOI 10.1101/gr.119487.110; Kuan Pei Fen, 2008, Pac Symp Biocomput, P515; Kuan PF, 2012, BIOMETRICS, V68, P774, DOI 10.1111/j.1541-0420.2011.01730.x; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Letelier P, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-11; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Lister R, 2009, GENOME RES, V19, P959, DOI 10.1101/gr.083451.108; Liu XP, 2011, BRAIN RES, V1391, P125, DOI 10.1016/j.brainres.2011.03.042; Lv J, 2012, NUCLEIC ACIDS RES, V40, pD1030, DOI 10.1093/nar/gkr1169; Mikeska T, 2012, EXPERT REV MOL DIAGN, V12, P473, DOI [10.1586/ERM.12.45, 10.1586/erm.12.45]; Milani L, 2010, BLOOD, V115, P1214, DOI 10.1182/blood-2009-04-214668; Ordway JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001314; Pai AA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001316; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Robinson MD, 2010, GENOME RES, V20, P1719, DOI 10.1101/gr.110601.110; Schilling E, 2007, GENOMICS, V90, P314, DOI 10.1016/j.ygeno.2007.04.011; Shaknovich R, 2010, BLOOD, V116, pE81, DOI 10.1182/blood-2010-05-285320; Shiota K, 2004, CYTOGENET GENOME RES, V105, P325, DOI 10.1159/000078205; Son CG, 2005, GENOME RES, V15, P443, DOI 10.1101/gr.3124505; Sun SY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-404; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Toedling J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-221; Tommasi S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010594; Toperoff G, 2012, HUM MOL GENET, V21, P371, DOI 10.1093/hmg/ddr472; van Vlodrop IJH, 2011, CLIN CANCER RES, V17, P4225, DOI 10.1158/1078-0432.CCR-10-3394; Wang D, 2012, BIOINFORMATICS, V28, P729, DOI 10.1093/bioinformatics/bts013; Wu GD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021034; Wu XW, 2010, CANCER RES, V70, P2718, DOI 10.1158/0008-5472.CAN-09-3631; Yanagawa N, 2007, LUNG CANCER, V58, P131, DOI 10.1016/j.lungcan.2007.05.011; Zhang Y, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr053; Zhang YY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000438; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237; Zhuang J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-59; Zilberman D, 2007, DEVELOPMENT, V134, P3959, DOI 10.1242/dev.001131	59	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97513	10.1371/journal.pone.0097513	http://dx.doi.org/10.1371/journal.pone.0097513			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24818602	gold, Green Published, Green Submitted			2022-12-27	WOS:000336653300119
J	Wu, QQ; Wu, FZ; Yang, WQ; Zhao, YY; He, W; Tan, B				Wu, Qiqian; Wu, Fuzhong; Yang, Wanqin; Zhao, Yeyi; He, Wei; Tan, Bo			Foliar Litter Nitrogen Dynamics as Affected by Forest Gap in the Alpine Forest of Eastern Tibet Plateau	PLOS ONE			English	Article							NUTRIENT RELEASE; LEAF-LITTER; ROCKY-MOUNTAINS; SOIL FERTILITY; FIR FOREST; DECOMPOSITION; CLIMATE; CARBON; TEMPERATURE; PHOSPHORUS	There is increasing attention on the effects of seasonal snowpack on wintertime litter decomposition, as well as the processes following it, in cold biomes. However, little information is available on how litter nitrogen (N) dynamics vary with snowpack variations created by tree crown canopies in alpine forests. Therefore, to understand the effects of seasonal snowpack on litter N dynamics during different critical stages, litterbags with fir (Abies faxoniana), birch (Betula albosinensis), larch (Larix mastersiana) and cypress (Sabina saltuaria) foliar litter were placed on the forest floor beneath snowpack created by forest gaps in the eastern Tibet Plateau. The litterbags were sampled at the onset of freezing, deep freezing, thawing and growing stages from October 2010 to October 2012. Mass loss and N concentrations in litter were measured. Over two years of decomposition, N release occurred mainly during the first year, especially during the first winter. Litter N release rates (both in the first year and during the entire two-year decomposition study period) were higher in the center of canopy gaps than under closed canopy, regardless of species. Litter N release rates in winter were also highest in the center of canopy gaps and lowest under closed canopy, regardless of species, however the reverse was found during the growing season. Compared with broadleaf litter, needle litter N release comparisons of gap center to closed canopy showed much stronger responses to the changes in snow cover in winter and availability of sunshine during the growing season. As the decomposition proceeded, decomposing litter quality, microbial biomass and environmental temperature were important factors related to litter N release rate. This suggests that if winter warm with climate change, reduced snow cover in winter might slow down litter N release in alpine forest.	[Wu, Qiqian; Wu, Fuzhong; Yang, Wanqin; Zhao, Yeyi; He, Wei; Tan, Bo] Sichuan Agr Univ, Inst Ecol Forestry, Chengdu, Sichuan, Peoples R China; [Wu, Qiqian] Northeast Forestry Univ, Ctr Ecol Res, Harbin, Heilongjiang, Peoples R China	Sichuan Agricultural University; Northeast Forestry University - China	Yang, WQ (corresponding author), Sichuan Agr Univ, Inst Ecol Forestry, Chengdu, Sichuan, Peoples R China.	scyangwq@163.com	WU, QIQIAN/B-7572-2017	WU, QIQIAN/0000-0002-4371-6303	National Natural Science Foundation of China [31170423, 31000213, 31270498]; Key Sci-tech Pillar Project of the "12th 5-year plan" of China [2011BAC09B05]; Sichuan Youth Sci-tech Foundation [2012JQ0008, 2012JQ0059]; China Postdoctoral Science Foundation [2012T50782]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Sci-tech Pillar Project of the "12th 5-year plan" of China; Sichuan Youth Sci-tech Foundation; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by National Natural Science Foundation of China(31170423, 31000213 and 31270498): http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list, and the Key Sci-tech Pillar Project of the "12th 5-year plan" of China (2011BAC09B05): http//www.most.gov.cn/, and Sichuan Youth Sci-tech Foundation (2012JQ0008 and 2012JQ0059): http://xmgl.scst.gov.cn/, and China Postdoctoral Science Foundation (2012T50782) http://jj. chinapostdoctor.org.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aber J. D., 2001, TERRESTRIAL ECOSYSTE; Aerts R, 2006, J ECOL, V94, P713, DOI 10.1111/j.1365-2745.2006.01142.x; Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Berg B, 2000, FOREST ECOL MANAG, V133, P13, DOI 10.1016/S0378-1127(99)00294-7; Berg B, 2000, CAN J FOREST RES, V30, P1136, DOI 10.1139/x00-044; Berg B., 2008, PLANT LITTER DECOMPO, DOI DOI 10.1007/978-3-540-74923-3; Bokhorst S, 2010, SOIL BIOL BIOCHEM, V42, P611, DOI 10.1016/j.soilbio.2009.12.011; BROOKES PC, 1982, SOIL BIOL BIOCHEM, V14, P319, DOI 10.1016/0038-0717(82)90001-3; Chapin F.S., 2002, PRINCIPLES TERRESTRI, DOI 10.1007/978-1-4419-9504-9; [邓仁菊 DENG Ren-Ju], 2009, [生态学报, Acta Ecologica Sinica], V29, P5730; EDMONDS RL, 1995, CAN J FOREST RES, V25, P1049, DOI 10.1139/x95-115; Garcia-Pausas J, 2004, SOIL BIOL BIOCHEM, V36, P989, DOI 10.1016/j.soilbio.2004.02.016; Gavazov KS, 2010, PLANT SOIL, V337, P19, DOI 10.1007/s11104-010-0477-0; Gong Z.T., 2007, PEDOGENESIS SOIL TAX; GOSZ JR, 1973, ECOL MONOGR, V43, P173, DOI 10.2307/1942193; Hobbie SE, 1996, BIOGEOCHEMISTRY, V35, P327, DOI 10.1007/BF02179958; HORNSBY DC, 1995, CAN J FOREST RES, V25, P1570, DOI 10.1139/x95-171; Kayastha R. B., 2003, BULL GLACIOL RES, V20, P7, DOI DOI 10.3189/s0022143000017846; Keane RE, 2008, CAN J FOREST RES, V38, P1431, DOI 10.1139/X08-003; Konestabo HS, 2007, APPL SOIL ECOL, V36, P136, DOI 10.1016/j.apsoil.2007.01.003; LISANEWORK N, 1994, FOREST ECOL MANAG, V65, P149, DOI 10.1016/0378-1127(94)90166-X; [刘利 Liu Li], 2010, [生态学报, Acta Ecologica Sinica], V30, P5687; Lu R.Q, 1999, METHODS SOIL AGROCHE, P18; Parton W, 2007, SCIENCE, V315, P361, DOI 10.1126/science.1134853; Ritter E, 2005, FOREST ECOL MANAG, V206, P15, DOI 10.1016/j.foreco.2004.08.011; Saccone P, 2013, PLANT SOIL, V363, P215, DOI 10.1007/s11104-012-1307-3; Sariyildiz T, 2003, SOIL BIOL BIOCHEM, V35, P391, DOI 10.1016/S0038-0717(02)00290-0; Singh KP, 1999, BIOL FERT SOILS, V29, P371, DOI 10.1007/s003740050567; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; STANTON ML, 1994, ARCTIC ALPINE RES, V26, P364, DOI 10.2307/1551798; Stieglitz M, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017337; Swift M. J., 1979, Decomposition in terrestrial ecosystems.; Tan Bo, 2011, Yingyong Shengtai Xuebao, V22, P2553; Tan B, 2011, ACTA AGR SCAND B-S P, V61, P670, DOI 10.1080/09064710.2010.541489; TAYLOR BR, 1989, ECOLOGY, V70, P97, DOI 10.2307/1938416; TOMASELLI M, 1991, VEGETATIO, V94, P177, DOI 10.1007/BF00032630; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wang A, 2012, CAN J MICROBIOL, V58, P572, DOI [10.1139/w2012-032, 10.1139/W2012-032]; Williams MW, 1998, ARCTIC ALPINE RES, V30, P26, DOI 10.2307/1551742; Wu FZ, 2010, ACTA OECOL, V36, P135, DOI 10.1016/j.actao.2009.11.002; Wu Qi-Qian, 2013, Chinese Journal of Plant Ecology, V37, P296, DOI 10.3724/SP.J.1258.2013.00029; Wu Qinggui, 2013, Chinese Journal of Applied and Environmental Biology, V19, P922, DOI 10.3724/SP.J.1145.2013.00922; Xia Lei, 2011, Chinese Journal of Plant Ecology, V35, P1127, DOI 10.3724/SP.J.1258.2011.01127; Xuluc-Tolosa FJ, 2003, FOREST ECOL MANAG, V174, P401, DOI 10.1016/S0378-1127(02)00059-2; [Yang Wanqin 杨万勤], 2007, [生态学报, Acta Ecologica Sinica], V27, P4157; ZHANG QH, 1995, ECOLOGY, V76, P2196, DOI 10.2307/1941693; Zhu JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062073; Zhu JX, 2012, SCAND J FOREST RES, V27, P586, DOI 10.1080/02827581.2012.670726	48	14	22	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97112	10.1371/journal.pone.0097112	http://dx.doi.org/10.1371/journal.pone.0097112			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24820771	gold, Green Submitted, Green Published			2022-12-27	WOS:000336653300076
J	Yamaguchi, S; Terasaka, S; Kobayashi, H; Asaoka, K; Motegi, H; Nishihara, H; Kanno, H; Onimaru, R; Ito, YM; Shirato, H; Houkin, K				Yamaguchi, Shigeru; Terasaka, Shunsuke; Kobayashi, Hiroyuki; Asaoka, Katsuyuki; Motegi, Hiroaki; Nishihara, Hiroshi; Kanno, Hiromi; Onimaru, Rikiya; Ito, Yoichi M.; Shirato, Hiroki; Houkin, Kiyohiro			Prognostic Factors for Survival in Patients with High-Grade Meningioma and Recurrence-Risk Stratification for Application of Radiotherapy	PLOS ONE			English	Article							MALIGNANT MENINGIOMAS; ATYPICAL MENINGIOMAS; ANAPLASTIC MENINGIOMAS; SINGLE INSTITUTION; RADIATION; THERAPY	Background: Radiotherapy for high-grade meningioma (HGM) is one of the essential treatment options for disease control. However, appropriate irradiation timing remains under debate. The object of this study is to discern which prognostic factors impact recurrence in HGM patients and to propose a risk-stratification system for the application of postoperative radiotherapy. Methods: We retrospectively reviewed 55 adult patients who were diagnosed with Grade II and III intracranial meningioma. Cox regression models were applied to the analysis for impact on early recurrence in HGM patients without postoperative radiotherapy. Results: Grade III malignancy (P = 0.0073) and transformed histology (P = 0.047) proved to be significantly poor prognostic factors of early recurrence by multivariate analysis. The other candidates for recurrence factors were Simpson Grade 3-5 resection, preoperative Karnofsky Performance status, <= 70%, and MIB-1 labeling index >= 15%. According to these prognostic factors, postoperative HGM patients could be stratified into three recurrence-risk groups. The prognoses were significantly different between each group, as the 3-year actual recurrence-free rates were 90% in low-risk group, 31% in intermediate-risk group, and 15% in high-risk group. Conclusion: We propose recurrence-risk stratification for postoperative HGM patients using clinically available factors. Our results suggest that the prognosis for patients with high-risk HGMs is dismal, whereas HGM patients belonging to the low-risk group could have favorable prognoses. This stratification provides us with the criteria necessary to determine whether to apply adjuvant radiotherapy to postoperative HGM patients, and to also help identify potentially curable HGMs without adjuvant radiotherapy.	[Yamaguchi, Shigeru; Terasaka, Shunsuke; Kobayashi, Hiroyuki; Motegi, Hiroaki; Houkin, Kiyohiro] Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Sapporo, Hokkaido, Japan; [Nishihara, Hiroshi; Kanno, Hiromi] Hokkaido Univ, Grad Sch Med, Dept Pathol, Sapporo, Hokkaido, Japan; [Onimaru, Rikiya; Shirato, Hiroki] Hokkaido Univ, Grad Sch Med, Dept Radiat Oncol, Sapporo, Hokkaido, Japan; [Ito, Yoichi M.] Hokkaido Univ, Grad Sch Med, Dept Biostat, Sapporo, Hokkaido, Japan; [Asaoka, Katsuyuki] Teine Keijinkai Hosp, Dept Neurosurg, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University; Teine Keijinkai Hospital	Terasaka, S (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Sapporo, Hokkaido, Japan.	terasas@med.hokudai.ac.jp	Yamaguchi, Shigeru/G-5419-2012; Shirato, Hiroki/A-7068-2010; Onimaru, Rikiya/C-9805-2012	Yamaguchi, Shigeru/0000-0003-3710-5888; Onimaru, Rikiya/0000-0002-4768-2358; Ito, Yoichi M./0000-0001-5073-0827; mao mu, yang huang/0000-0001-6153-5461				Adeberg S, 2012, INT J RADIAT ONCOL, V83, P859, DOI 10.1016/j.ijrobp.2011.08.010; Aghi MK, 2009, NEUROSURGERY, V64, P56, DOI 10.1227/01.NEU.0000330399.55586.63; Bush ML, 2011, NEURO-ONCOLOGY, V13, P983, DOI 10.1093/neuonc/nor072; Claus EB, 2005, NEUROSURGERY, V57, P1088, DOI 10.1227/01.NEU.0000188281.91351.B9; Durand A, 2009, J NEURO-ONCOL, V95, P367, DOI 10.1007/s11060-009-9934-0; Dziuk TW, 1998, J NEURO-ONCOL, V37, P177, DOI 10.1023/A:1005853720926; Kanno H, 2013, NEURO-ONCOLOGY, V15, P853, DOI 10.1093/neuonc/not028; Ko KW, 2007, J CLIN NEUROSCI, V14, P747, DOI 10.1016/j.jocn.2006.05.005; Krayenbuhl N, 2007, NEUROSURGERY, V61, P495, DOI 10.1227/01.NEU.0000280009.79813.DE; Mair R, 2011, J NEUROSURG, V115, P811, DOI 10.3171/2011.5.JNS11112; Motegi H, 2012, BRAIN TUMOR PATHOL, V29, P240, DOI 10.1007/s10014-012-0088-y; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Palma L, 1997, J NEUROSURG, V86, P793, DOI 10.3171/jns.1997.86.5.0793; Pasquier D, 2008, INT J RADIAT ONCOL, V71, P1388, DOI 10.1016/j.ijrobp.2007.12.020; Pearson BE, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/5/E3; Perry A, 1998, CANCER-AM CANCER SOC, V82, P2262, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2262::AID-CNCR23>3.3.CO;2-O; Preusser M, 2012, CANCER-AM CANCER SOC, V118, P5038, DOI 10.1002/cncr.27460; Rosenberg LA, 2009, INT J RADIAT ONCOL, V74, P427, DOI 10.1016/j.ijrobp.2008.08.018; SIMPSON D, 1957, J NEUROL NEUROSUR PS, V20, P22, DOI 10.1136/jnnp.20.1.22; Yang SY, 2008, J NEUROL NEUROSUR PS, V79, P574, DOI 10.1136/jnnp.2007.121582	20	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97108	10.1371/journal.pone.0097108	http://dx.doi.org/10.1371/journal.pone.0097108			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24820480	Green Published, gold			2022-12-27	WOS:000336653300075
J	Chen, DB; Wang, GN; Zeng, A; Fu, Y; Zhang, YC				Chen, Duan-Bing; Wang, Guan-Nan; Zeng, An; Fu, Yan; Zhang, Yi-Cheng			Optimizing Online Social Networks for Information Propagation	PLOS ONE			English	Article							RECOMMENDATION; BEHAVIOR	Online users nowadays are facing serious information overload problem. In recent years, recommender systems have been widely studied to help people find relevant information. Adaptive social recommendation is one of these systems in which the connections in the online social networks are optimized for the information propagation so that users can receive interesting news or stories from their leaders. Validation of such adaptive social recommendation methods in the literature assumes uniform distribution of users' activity frequency. In this paper, our empirical analysis shows that the distribution of online users' activity is actually heterogenous. Accordingly, we propose a more realistic multi-agent model in which users' activity frequency are drawn from a power-law distribution. We find that previous social recommendation methods lead to serious delay of information propagation since many users are connected to inactive leaders. To solve this problem, we design a new similarity measure which takes into account users' activity frequencies. With this similarity measure, the average delay is significantly shortened and the recommendation accuracy is largely improved.	[Chen, Duan-Bing; Wang, Guan-Nan; Fu, Yan; Zhang, Yi-Cheng] Univ Elect Sci & Technol China, Sch Comp Sci & Engn, Web Sci Ctr, Chengdu 610054, Peoples R China; [Chen, Duan-Bing; Zeng, An; Zhang, Yi-Cheng] Univ Fribourg, Dept Phys, CH-1700 Fribourg, Switzerland	University of Electronic Science & Technology of China; University of Fribourg	Zeng, A (corresponding author), Univ Fribourg, Dept Phys, CH-1700 Fribourg, Switzerland.	an.zeng@unifr.ch			National Natural Science Foundation of China [61103109, 61003231, 60973120]; Swiss National Science Foundation [200020-143272]; Huawei University-Enterprise Cooperation [YBCB2011057]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Huawei University-Enterprise Cooperation(Huawei Technologies)	This work was partially supported by the National Natural Science Foundation of China with Grant Nos. 61103109, 61003231 and 60973120, and by the Swiss National Science Foundation (Grant No. 200020-143272). DBC acknowledges the Huawei University-Enterprise Cooperation Project YBCB2011057 and the Tsinghua-Tencent Joint Laboratory for Internet Innovation Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adomavicius G, 2005, IEEE T KNOWL DATA EN, V17, P734, DOI 10.1109/TKDE.2005.99; Biancalana C, 2013, ACM T INTEL SYST TEC, V4, DOI 10.1145/2414425.2414435; Breese J, 1998, P 14 C UNC ART INT, P45; Chaoji V., 2012, WWW, P529, DOI DOI 10.1145/2187836.2187908; Chen DB, 2012, CHINESE PHYS LETT, V29, DOI 10.1088/0256-307X/29/4/048901; Chen DB, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2012-30899-9; Cimini G, 2011, EUR PHYS J B, V80, P201, DOI 10.1140/epjb/e2010-10716-5; Cimini G, 2013, ADV COMPLEX SYST, V16, DOI 10.1142/S0219525913500094; Cimini G, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.046108; De A, 2013, ARXIV13104579; Golbeck J, 2008, SCIENCE, V321, P1640, DOI 10.1126/science.1163357; Goncalves B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022656; Herlocker JL, 2004, ACM T INFORM SYST, V22, P5, DOI 10.1145/963770.963772; Kazienko P, 2011, IEEE T SYST MAN CY A, V41, P746, DOI 10.1109/TSMCA.2011.2132707; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lerman K, 2010, ICWSM, V10, P90, DOI DOI 10.1146/ANNUREV.AN.03.100174.001431; Linden G, 2003, IEEE INTERNET COMPUT, V7, P76, DOI 10.1109/MIC.2003.1167344; Lu LY, 2012, PHYS REP, V519, P1, DOI 10.1016/j.physrep.2012.02.006; Macskassy S. A., 2011, P 5 INT AAAI C WEBL, P209; Maslov S, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.248701; Medo M, 2009, EPL-EUROPHYS LETT, V88, DOI 10.1209/0295-5075/88/38005; Muchnik L, 2013, SCI REP-UK, V3, DOI 10.1038/srep01783; Niemann K, 2013, 19TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'13), P955; Quijano-Sanchez L, 2013, ACM T INTEL SYST TEC, V4, DOI 10.1145/2414425.2414433; Sinha RR., 2001, DELOS, P106; Wei D, 2011, PHYSICA A, V390, P2117, DOI 10.1016/j.physa.2011.02.005; Weng LL, 2013, 19TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'13), P356; Yu JF, 2010, PHYSICA A, V389, P3267, DOI 10.1016/j.physa.2010.03.043; Zhang CJ, 2012, PHYSICA A, V391, P1822, DOI 10.1016/j.physa.2011.09.038; Zhao ZD, 2012, EPL-EUROPHYS LETT, V100, DOI 10.1209/0295-5075/100/48004; Zhou T, 2008, EPL-EUROPHYS LETT, V82, DOI 10.1209/0295-5075/82/28002; Zhou T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020648; Zorrilla ME, 2012, BUSINESS INTELLIGENCE APPLICATIONS AND THE WEB: MODELS, SYSTEMS AND TECHNOLOGIES, P1, DOI 10.4018/978-1-61350-038-5	36	5	5	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96614	10.1371/journal.pone.0096614	http://dx.doi.org/10.1371/journal.pone.0096614			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816894	Green Published, gold			2022-12-27	WOS:000336838000045
J	Christie, NTM; Lee, AL; Fay, HG; Gray, AA; Kikis, EA				Christie, Nakeirah T. M.; Lee, Amy L.; Fay, Hannah G.; Gray, Amelia A.; Kikis, Elise A.			Novel Polyglutamine Model Uncouples Proteotoxicity from Aging	PLOS ONE			English	Article							MACHADO-JOSEPH-DISEASE; HEAT-SHOCK RESPONSE; CAENORHABDITIS-ELEGANS; MUTANT ATAXIN-3; PROTEIN HOMEOSTASIS; REPEAT LENGTH; AGGREGATION; EXPANSION; CONFORMATIONS; PROTEOSTASIS	Polyglutamine expansions in certain proteins are the genetic determinants for nine distinct progressive neurodegenerative disorders and resultant age-related dementia. In these cases, neurodegeneration is due to the aggregation propensity and resultant toxic properties of the polyglutamine-containing proteins. We are interested in elucidating the underlying mechanisms of toxicity of the protein ataxin-3, in which a polyglutamine expansion is the genetic determinant for Machado-Joseph Disease (MJD), also referred to as spinocerebellar ataxia 3 (SCA3). To this end, we have developed a novel model for ataxin-3 protein aggregation, by expressing a disease-related polyglutamine-containing fragment of ataxin-3 in the genetically tractable body wall muscle cells of the model system C. elegans. Here, we demonstrate that this ataxin-3 fragment aggregates in a polyQ length-dependent manner in C. elegans muscle cells and that this aggregation is associated with cellular dysfunction. However, surprisingly, this aggregation and resultant toxicity was not influenced by aging. This is in contrast to polyglutamine peptides alone whose aggregation/toxicity is highly dependent on age. Thus, the data presented here not only describe a new polyglutamine model, but also suggest that protein context likely influences the cellular interactions of the polyglutamine-containing protein and thereby modulates its toxic properties.	[Christie, Nakeirah T. M.; Lee, Amy L.; Fay, Hannah G.; Gray, Amelia A.; Kikis, Elise A.] Univ South, Dept Biol, Sewanee, TN 37375 USA	Sewanee: University of the South	Kikis, EA (corresponding author), Univ South, Dept Biol, Sewanee, TN 37375 USA.	eakikis@sewanee.edu			University of the South including the Office of the Dean of the College of Arts and Sciences	University of the South including the Office of the Dean of the College of Arts and Sciences	There was no external funding for this work. All funding was provided by start-up funds from the University of the South including the Office of the Dean of the College of Arts and Sciences, and Conduff. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; Berke SJS, 2004, J NEUROCHEM, V89, P908, DOI 10.1111/j.1471-4159.2004.02369.x; BRENNER S, 1974, GENETICS, V77, P71; Brignull HR, 2006, METHOD ENZYMOL, V412, P256, DOI 10.1016/S0076-6879(06)12016-9; Brignull HR, 2006, J NEUROSCI, V26, P7597, DOI 10.1523/JNEUROSCI.0990-06.2006; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chow MKM, 2004, J BIOL CHEM, V279, P47643, DOI 10.1074/jbc.M405799200; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Ellisdon AM, 2006, J BIOL CHEM, V281, P16888, DOI 10.1074/jbc.M601470200; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Gidalevitz T, 2010, CURR OPIN STRUC BIOL, V20, P23, DOI 10.1016/j.sbi.2009.11.001; Gidalevitz T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000399; Goti D, 2004, J NEUROSCI, V24, P10266, DOI 10.1523/JNEUROSCI.2734-04.2004; Gould VFC, 2007, NEUROBIOL DIS, V27, P362, DOI 10.1016/j.nbd.2007.06.005; Guisbert E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003466; Haacke A, 2007, J BIOL CHEM, V282, P18851, DOI 10.1074/jbc.M611914200; Hands SL, 2010, ACTA NEUROPATHOL, V120, P419, DOI 10.1007/s00401-010-0703-0; Horwich AL, 1997, CELL, V89, P499, DOI 10.1016/S0092-8674(00)80232-9; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Kikis EA, 2010, ADV EXP MED BIOL, V694, P138; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; Koch P, 2011, NATURE, V480, P543, DOI 10.1038/nature10671; Kopito RR, 2000, NAT CELL BIOL, V2, pE207, DOI 10.1038/35041139; Kuhlbrodt K, 2011, NAT CELL BIOL, V13, P273, DOI 10.1038/ncb2200; Masino L, 2003, FEBS LETT, V549, P21, DOI 10.1016/S0014-5793(03)00748-8; McLeod CJ, 2005, HUM MOL GENET, V14, P1041, DOI 10.1093/hmg/ddi096; Mitsui K, 2002, J NEUROSCI, V22, P9267; Mohri-Shiomi A, 2008, J BIOL CHEM, V283, P194, DOI 10.1074/jbc.M707956200; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Nagai Y, 2008, CURR PHARM DESIGN, V14, P3267, DOI 10.2174/138161208786404164; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Prahlad V, 2008, SCIENCE, V320, P811, DOI 10.1126/science.1156093; Silva MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002438; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; Takahashi T, 2008, HUM MOL GENET, V17, P345, DOI 10.1093/hmg/ddm311; Teixeira-Castro A, 2011, HUM MOL GENET, V20, P2996, DOI 10.1093/hmg/ddr203; van Oosten-Hawle P, 2013, CELL, V153, P1366, DOI 10.1016/j.cell.2013.05.015; Walters RH, 2009, J MOL BIOL, V393, P978, DOI 10.1016/j.jmb.2009.08.034	44	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96835	10.1371/journal.pone.0096835	http://dx.doi.org/10.1371/journal.pone.0096835			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24817148	Green Published, Green Submitted, gold			2022-12-27	WOS:000336838000069
J	Ocak, G; Drechsler, C; Vossen, CY; Vos, HL; Rosendaal, FR; Reitsma, PH; Hoffmann, MM; Marz, W; Ouwehand, WH; Krediet, RT; Boeschoten, EW; Dekker, FW; Wanner, C; Verduijn, M				Ocak, Gurbey; Drechsler, Christiane; Vossen, Carla Y.; Vos, Hans L.; Rosendaal, Frits R.; Reitsma, Pieter H.; Hoffmann, Michael M.; Maerz, Winfried; Ouwehand, Willem H.; Krediet, Raymond T.; Boeschoten, Elisabeth W.; Dekker, Friedo W.; Wanner, Christoph; Verduijn, Marion			Single Nucleotide Variants in the Protein C Pathway and Mortality in Dialysis Patients	PLOS ONE			English	Article							HUMAN BRAIN ENDOTHELIUM; FACTOR-V-LEIDEN; VENOUS THROMBOSIS; ACTIVATED RECEPTOR-1; VASCULAR ACCESS; SEVERE SEPSIS; GENE POLYMORPHISM; ORGAN DYSFUNCTION; ISCHEMIC-STROKE; RENAL-DISEASE	Background: The protein C pathway plays an important role in the maintenance of endothelial barrier function and in the inflammatory and coagulant processes that are characteristic of patients on dialysis. We investigated whether common single nucleotide variants (SNV) in genes encoding protein C pathway components were associated with all-cause 5 years mortality risk in dialysis patients. Methods: Single nucleotides variants in the factor V gene (F5 rs6025; factor V Leiden), the thrombomodulin gene (THBD rs1042580), the protein C gene (PROC rs1799808 and 1799809) and the endothelial protein C receptor gene (PROCR rs867186, rs2069951, and rs2069952) were genotyped in 1070 dialysis patients from the NEtherlands COoperative Study on the Adequacy of Dialysis (NECOSAD) cohort) and in 1243 dialysis patients from the German 4D cohort. Results: Factor V Leiden was associated with a 1.5-fold (95% CI 1.1-1.9) increased 5-year all-cause mortality risk and carriers of the AG/GG genotypes of the PROC rs1799809 had a 1.2-fold (95% CI 1.0-1.4) increased 5-year all-cause mortality risk. The other SNVs in THBD, PROC, and PROCR were not associated with 5-years mortality. Conclusion: Our study suggests that factor V Leiden and PROC rs1799809 contributes to an increased mortality risk in dialysis patients.	[Ocak, Gurbey; Vossen, Carla Y.; Rosendaal, Frits R.; Dekker, Friedo W.; Verduijn, Marion] Leiden Univ Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Drechsler, Christiane; Wanner, Christoph] Univ Hosp, Dept Med, Div Nephrol, Wurzburg, Germany; [Drechsler, Christiane; Wanner, Christoph] Univ Wurzburg, Comprehens Heart Failure Ctr, Wurzburg, Germany; [Drechsler, Christiane] Univ Wurzburg, Inst Clin Epidemiol & Biometry, Wurzburg, Germany; [Vos, Hans L.; Rosendaal, Frits R.; Reitsma, Pieter H.] Leiden Univ Med Ctr, Dept Thrombosis & Haemostasis, Leiden, Netherlands; [Vos, Hans L.; Rosendaal, Frits R.; Reitsma, Pieter H.] Leiden Univ Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [Hoffmann, Michael M.] Univ Med Ctr, Inst Clin Chem & Lab Med, Freiburg, Germany; [Maerz, Winfried] Heidelberg Univ, Dept Publ Hlth Social & Prevent Med, Mannheim, Germany; [Ouwehand, Willem H.] Univ Cambridge, Dept Hematol, Cambridge, England; [Ouwehand, Willem H.] Natl Hlth Serv Blood & Transplant, Cambridge, England; [Ouwehand, Willem H.] Wellcome Trust Sanger Inst, Dept Human Genet, Cambridge, England; [Krediet, Raymond T.] Univ Amsterdam, Acad Med Ctr, Dept Nephrol, NL-1105 AZ Amsterdam, Netherlands; [Boeschoten, Elisabeth W.] Hans Mak Inst, Naarden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); University of Wurzburg; University of Wurzburg; University of Wurzburg; Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); University of Freiburg; Ruprecht Karls University Heidelberg; University of Cambridge; NHS Blood & Transplant (NHSBT); Wellcome Trust Sanger Institute; University of Amsterdam; Academic Medical Center Amsterdam	Ocak, G (corresponding author), Leiden Univ Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands.	g.ocak@lumc.nl	Hoffmann, Michael M/D-4074-2015; Krediet, Raymond/GLT-2390-2022; Krediet, Raymond/AAP-3291-2021; Dekker, Friedo W/B-6452-2011; Rosendaal, Frits/Q-3842-2017	Hoffmann, Michael M/0000-0001-8459-6080; Krediet, Raymond/0000-0002-9851-8507; Dekker, Friedo W/0000-0002-2433-2494; Rosendaal, Frits/0000-0003-2558-7496; Ouwehand, Willem/0000-0002-7744-1790	Dutch Kidney Foundation; British Heart Foundation [RG/09/012/28096] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10214, RP-PG-0310-1002, NF-SI-0513-10151] Funding Source: researchfish	Dutch Kidney Foundation; British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	The NECOSAD was supported in part by unrestricted grants from the Dutch Kidney Foundation. No additional funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAART CF, 1993, LANCET, V341, P134, DOI 10.1016/0140-6736(93)90003-Y; Allon M, 2012, AM J KIDNEY DIS, V59, P682, DOI 10.1053/j.ajkd.2011.11.036; Auro K, 2007, PLOS GENET, V3, P1244, DOI 10.1371/journal.pgen.0030120; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Bezemer ID, 2008, JAMA-J AM MED ASSOC, V299, P1306, DOI 10.1001/jama.299.11.1306; BRANSON HE, 1983, LANCET, V2, P1165; Casserly LF, 2000, AM J KIDNEY DIS, V36, P405, DOI 10.1053/ajkd.2000.8983; Chen QX, 2008, HUM GENET, V123, P281, DOI 10.1007/s00439-008-0476-x; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; de Jager DJ, 2009, JAMA-J AM MED ASSOC, V302, P1782, DOI 10.1001/jama.2009.1488; De Willige SU, 2004, J THROMB HAEMOST, V2, P1305, DOI 10.1046/j.1538-7836.2004.00855.x; Domotor E, 2003, BLOOD, V101, P4797, DOI 10.1182/blood-2002-12-3680; Feldman HI, 1996, J AM SOC NEPHROL, V7, P523; Folsom AR, 1999, CIRCULATION, V100, P736, DOI 10.1161/01.CIR.100.7.736; Girndt M, 2007, SEMIN DIALYSIS, V20, P63, DOI 10.1111/j.1525-139X.2007.00243.x; Heijmans BT, 1998, THROMB HAEMOSTASIS, V80, P607; Ireland H, 2005, ATHEROSCLEROSIS, V183, P283, DOI 10.1016/j.atherosclerosis.2005.02.028; Joyce DE, 2001, J BIOL CHEM, V276, P11199, DOI 10.1074/jbc.C100017200; Kenet G, 2000, STROKE, V31, P1283, DOI 10.1161/01.STR.31.6.1283; Knoll GA, 2005, J AM SOC NEPHROL, V16, P1108, DOI 10.1681/ASN.2004110999; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Mosnier LO, 2003, BIOCHEM J, V373, P65, DOI 10.1042/BJ20030341; Pabinger I, 2012, J THROMB HAEMOST, V10, P217, DOI 10.1111/j.1538-7836.2011.04573.x; Pomp ER, 2009, THROMB HAEMOSTASIS, V101, P62, DOI 10.1160/TH08-08-0502; Reiner AP, 2008, J THROMB HAEMOST, V6, P1625, DOI 10.1111/j.1538-7836.2008.03118.x; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Saposnik B, 2004, BLOOD, V103, P1311, DOI 10.1182/blood-2003-07-2520; Smith NL, 2007, JAMA-J AM MED ASSOC, V297, P489, DOI 10.1001/jama.297.5.489; Tveit DP, 2002, AM J KIDNEY DIS, V39, P1011, DOI 10.1053/ajkd.2002.32774; van Dijk PCW, 2001, NEPHROL DIAL TRANSPL, V16, P1120, DOI 10.1093/ndt/16.6.1120; Verduijn M, 2011, NEPHRON CLIN PRACT, V119, pC236, DOI 10.1159/000326685; Walley KR, 2007, CRIT CARE MED, V35, P12, DOI 10.1097/01.CCM.0000249823.44726.4E; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Ye Z, 2006, LANCET, V367, P651, DOI 10.1016/S0140-6736(06)68263-9	35	5	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97251	10.1371/journal.pone.0097251	http://dx.doi.org/10.1371/journal.pone.0097251			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816905	Green Submitted, Green Published, gold			2022-12-27	WOS:000336838000123
J	Tang, WW; Li, L; Wu, LJ; Gong, JM; Zeng, XP				Tang, Wenwei; Li, Lei; Wu, Lujun; Gong, Jiemin; Zeng, Xinping			Glucose Biosensor Based on a Glassy Carbon Electrode Modified with Polythionine and Multiwalled Carbon Nanotubes	PLOS ONE			English	Article							LAYER-BY-LAYER; DIRECT ELECTROCHEMISTRY; GOLD NANOPARTICLES; OXIDASE; FILM; IMMOBILIZATION; ENZYME	A novel glucose biosensor was fabricated. The first layer of the biosensor was polythionine, which was formed by the electrochemical polymerisation of the thionine monomer on a glassy carbon electrode. The remaining layers were coated with chitosan-MWCNTs, GOx, and the chitosan-PTFE film in sequence. The MWCNTs embedded in FAD were like "conductive wires" connecting FAD with electrode, reduced the distance between them and were propitious to fast direct electron transfer. Combining with good electrical conductivity of PTH and MWCNTs, the current response was enlarged. The sensor was a parallel multi-component reaction system (PMRS) and excellent electrocatalytic performance for glucose could be obtained without a mediator. The glucose sensor had a working voltage of -0.42 V, an optimum working temperature of 25 degrees C, an optimum working pH of 7.0, and the best percentage of polytetrafluoroethylene emulsion (PTFE) in the outer composite film was 2%. Under the optimised conditions, the biosensor displayed a high sensitivity of 2.80 mu A mM(-1) cm(-2) and a low detection limit of 5 mu M (S/N = 3), with a response time of less than 15 s and a linear range of 0.04 mM to 2.5 mM. Furthermore, the fabricated biosensor had a good selectivity, reproducibility, and long-term stability, indicating that the novel CTS+PTFE/GOx/MWCNTs/PTH composite is a promising material for immobilization of biomolecules and fabrication of third generation biosensors.	[Tang, Wenwei; Wu, Lujun; Gong, Jiemin] Tongji Univ, Dept Chem, Shanghai 200092, Peoples R China; [Li, Lei; Zeng, Xinping] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China	Tongji University; Tongji University	Tang, WW (corresponding author), Tongji Univ, Dept Chem, Shanghai 200092, Peoples R China.	tangww@tongji.edu.cn; zengxp@tongji.edu.cn	LI, LI/GVS-5344-2022; li, li/HII-4157-2022; Li, Li/AEM-3636-2022		National Natural Science Foundation of China [21277098]; Natural Science Foundation of Shanghai [10ZR1432500]; Shanghai Municipal Commission of Economy and Informatization [20122846]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Shanghai Municipal Commission of Economy and Informatization	This work was supported by the National Natural Science Foundation of China (No. 21277098), the Natural Science Foundation of Shanghai (No. 10ZR1432500), the Shanghai Municipal Commission of Economy and Informatization (No. 20122846). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bard A. J., 2001, ELECTROCHEMICAL METH; BAULDREAY JM, 1983, ELECTROCHIM ACTA, V28, P1515, DOI 10.1016/0013-4686(83)85210-4; CLARK LC, 1962, ANN NY ACAD SCI, V102, P29, DOI 10.1111/j.1749-6632.1962.tb13623.x; Deng CY, 2010, BIOSENS BIOELECTRON, V26, P213, DOI 10.1016/j.bios.2010.06.013; Gao RF, 2009, ELECTROCHEM COMMUN, V11, P608, DOI 10.1016/j.elecom.2008.12.060; German N, 2010, MICROCHIM ACTA, V168, P221, DOI 10.1007/s00604-009-0270-z; Gooding JJ, 2003, J AM CHEM SOC, V125, P9006, DOI 10.1021/ja035722f; Guo CX, 2010, PHYS CHEM CHEM PHYS, V12, P12153, DOI 10.1039/c0cp00378f; KAMIN RA, 1980, ANAL CHEM, V52, P1198, DOI 10.1021/ac50058a010; Li QW, 2004, CARBON, V42, P287, DOI 10.1016/j.carbon.2003.10.030; Liu GZ, 2007, ELECTROCHEM COMMUN, V9, P2218, DOI 10.1016/j.elecom.2007.06.016; Liu XQ, 2008, BIOSENS BIOELECTRON, V23, P1887, DOI 10.1016/j.bios.2008.02.016; Liu Y, 2010, ELECTROANAL, V22, P1725, DOI 10.1002/elan.200900544; Manesh KM, 2008, BIOSENS BIOELECTRON, V23, P771, DOI 10.1016/j.bios.2007.08.016; Murthy ASN, 1998, ANAL CHIM ACTA, V363, P215, DOI 10.1016/S0003-2670(98)00083-X; Nenkova R, 2010, SENSOR ACTUAT B-CHEM, V148, P59, DOI 10.1016/j.snb.2010.05.034; Peng HP, 2011, BIOSENS BIOELECTRON, V26, P3005, DOI 10.1016/j.bios.2010.12.003; Shirsat MD, 2008, ELECTROANAL, V20, P150, DOI 10.1002/elan.200704028; Si P, 2011, ACS NANO, V5, P7617, DOI 10.1021/nn202714c; Wang QX, 2012, MICROCHIM ACTA, V176, P279, DOI 10.1007/s00604-011-0716-y; Wang Y, 2011, J MOL CATAL B-ENZYM, V71, P146, DOI 10.1016/j.molcatb.2011.04.011; Wang YL, 2011, BIOSENS BIOELECTRON, V30, P107, DOI 10.1016/j.bios.2011.08.038; Wang ZY, 2009, ANAL CHEM, V81, P1638, DOI 10.1021/ac802421h; WILSON R, 1992, BIOSENS BIOELECTRON, V7, P165, DOI 10.1016/0956-5663(92)87013-F; Wu S, 2007, ADV FUNCT MATER, V17, P585, DOI 10.1002/adfm.200600491; Wu XE, 2009, BIOELECTROCHEMISTRY, V77, P64, DOI 10.1016/j.bioelechem.2009.05.008; You CP, 2009, MICROCHIM ACTA, V167, P109, DOI 10.1007/s00604-009-0228-1; Zhang HF, 2011, SENSOR ACTUAT B-CHEM, V158, P23, DOI 10.1016/j.snb.2011.04.057; Zhang KY, 2010, MICROCHIM ACTA, V171, P139, DOI 10.1007/s00604-010-0409-y; Zhu ZH, 2011, BIOSENS BIOELECTRON, V26, P2119, DOI 10.1016/j.bios.2010.09.017	30	32	34	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e95030	10.1371/journal.pone.0095030	http://dx.doi.org/10.1371/journal.pone.0095030			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816121	gold, Green Published, Green Submitted			2022-12-27	WOS:000336838000011
J	Utsugi, C; Miyazono, S; Osada, K; Sasajima, H; Noguchi, T; Matsuda, M; Kashiwayanagi, M				Utsugi, Chizuru; Miyazono, Sadaharu; Osada, Kazumi; Sasajima, Hitoshi; Noguchi, Tomohiro; Matsuda, Mitsuyoshi; Kashiwayanagi, Makoto			Hard-Diet Feeding Recovers Neurogenesis in the Subventricular Zone and Olfactory Functions of Mice Impaired by Soft-Diet Feeding	PLOS ONE			English	Article							NEURAL STEM-CELLS; AGED SAMP8 MICE; ADULT NEUROGENESIS; PEDUNCULOPONTINE NUCLEUS; HIPPOCAMPAL NEUROGENESIS; PARIETAL CORTEX; SPATIAL MEMORY; DENTATE GYRUS; TOOTH LOSS; BULB	The subventricular zone (SVZ) generates an immense number of neurons even during adulthood. These neurons migrate to the olfactory bulb (OB) and differentiate into granule cells and periglomerular cells. The information broadcast by general odorants is received by the olfactory sensory neurons and transmitted to the OB. Recent studies have shown that a reduction of mastication impairs both neurogenesis in the hippocampus and brain functions. To examine these effects, we first measured the difference in Fos-immunoreactivity (Fos-ir) at the principal sensory trigeminal nucleus (Pr5), which receives intraoral touch information via the trigeminal nerve, when female adult mice ingested a hard or soft diet to explore whether soft-diet feeding could mimic impaired mastication. Ingestion of a hard diet induced greater expression of Fos-ir cells at the Pr5 than did a soft diet or no diet. Bromodeoxyuridine-immunoreactive (BrdU-ir) structures in sagittal sections of the SVZ and in the OB of mice fed a soft or hard diet were studied to explore the effects of changes in mastication on newly generated neurons. After 1 month, the density of BrdU-ir cells in the SVZ and OB was lower in the soft-diet-fed mice than in the hard-diet-fed mice. The odor preferences of individual female mice to butyric acid were tested in a Y-maze apparatus. Avoidance of butyric acid was reduced by the soft-diet feeding. We then explored the effects of the hard-diet feeding on olfactory functions and neurogenesis in the SVZ of mice impaired by soft-diet feeding. At 3 months of hard-diet feeding, avoidance of butyric acid was reversed and responses to odors and neurogenesis were recovered in the SVZ. The present results suggest that feeding with a hard diet improves neurogenesis in the SVZ, which in turn enhances olfactory function at the OB.	[Utsugi, Chizuru; Matsuda, Mitsuyoshi] Asahikawa Med Univ, Dept Oral & Maxillofacial Surg, Asahikawa, Hokkaido, Japan; [Utsugi, Chizuru; Miyazono, Sadaharu; Sasajima, Hitoshi; Noguchi, Tomohiro; Kashiwayanagi, Makoto] Asahikawa Med Univ, Dept Sensory Physiol, Asahikawa, Hokkaido, Japan; [Osada, Kazumi] Hlth Sci Univ Hokkaido, Sch Dent, Dept Oral Biol, Tohbetu, Japan	Asahikawa Medical College; Asahikawa Medical College	Kashiwayanagi, M (corresponding author), Asahikawa Med Univ, Dept Sensory Physiol, Asahikawa, Hokkaido, Japan.	yanagi@asahikawa-med.ac.jp	Noguchi, Tomohiro/B-6185-2011	Noguchi, Tomohiro/0000-0002-9354-9793	Asahikawa Medical University; Japan Society for the Promotion of Science [24770064]	Asahikawa Medical University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Asahikawa Medical University, and by a Japan Society for the Promotion of Science Grant (No. 24770064 to SM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JB, 2011, EUR J NEUROSCI, V33, P1160, DOI 10.1111/j.1460-9568.2011.07615.x; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Aoki H, 2005, GERONTOLOGY, V51, P369, DOI 10.1159/000088700; Bortolanza M, 2010, NEUROBIOL LEARN MEM, V94, P229, DOI 10.1016/j.nlm.2010.05.011; Bouab M, 2011, NEUROSCIENCE, V173, P135, DOI 10.1016/j.neuroscience.2010.11.032; Breton-Provencher V, 2009, J NEUROSCI, V29, P15245, DOI 10.1523/JNEUROSCI.3606-09.2009; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Carlen M, 2002, CURR BIOL, V12, P606, DOI 10.1016/S0960-9822(02)00771-6; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; DOTY RL, 1984, SCIENCE, V226, P1441, DOI 10.1126/science.6505700; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; Farkas T, 1999, NEUROSCIENCE, V90, P353, DOI 10.1016/S0306-4522(98)00451-5; Franklin K. B. J., 2008, MOUSE BRAIN; FUTAMI T, 1995, NEUROSCI RES, V21, P331, DOI 10.1016/0168-0102(94)00869-H; Galvao RP, 2008, J NEUROSCI, V28, P13368, DOI 10.1523/JNEUROSCI.2918-08.2008; Gheusi C, 2000, P NATL ACAD SCI USA, V97, P1823, DOI 10.1073/pnas.97.4.1823; Hitoshi S, 2007, J NEUROSCI RES, V85, P3574, DOI 10.1002/jnr.21455; Hoglinger GU, 2004, NAT NEUROSCI, V7, P726, DOI 10.1038/nn1265; Honda N, 2009, BIOL PHARM BULL, V32, P627, DOI 10.1248/bpb.32.627; Kandel E. R., 2013, PRINCIPLES NEURAL SC; Kato T, 1997, BEHAV BRAIN RES, V83, P239, DOI 10.1016/S0166-4328(97)86078-0; KAVALIERS M, 1994, BRAIN RES, V645, P325, DOI 10.1016/0006-8993(94)91667-5; Kavaliers M, 2001, HORM BEHAV, V40, P497, DOI 10.1006/hbeh.2001.1714; Kronenberg G, 2006, NEUROBIOL AGING, V27, P1505, DOI 10.1016/j.neurobiolaging.2005.09.016; Lazarini F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007017; Lexomboon D, 2012, J AM GERIATR SOC, V60, P1951, DOI 10.1111/j.1532-5415.2012.04154.x; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Lundstrom JN, 2011, ACS CHEM NEUROSCI, V2, P5, DOI 10.1021/cn1000843; Madronal N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011130; Marlatt MW, 2012, DEV NEUROBIOL, V72, P943, DOI 10.1002/dneu.22009; Martinez-Gonzalez C, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00022; Miura H, 2003, J ORAL REHABIL, V30, P808, DOI 10.1046/j.1365-2842.2003.01124.x; Moreno M, 2014, NEUROBIOL AGING, V35, P680, DOI 10.1016/j.neurobiolaging.2013.08.034; Moreno MM, 2009, P NATL ACAD SCI USA, V106, P17980, DOI 10.1073/pnas.0907063106; O'Keeffe GC, 2009, P NATL ACAD SCI USA, V106, P8754, DOI 10.1073/pnas.0803955106; Onozuka M, 2002, BEHAV BRAIN RES, V131, P125, DOI 10.1016/S0166-4328(01)00378-3; Onozuka M, 1999, BRAIN RES, V826, P148, DOI 10.1016/S0006-8993(99)01255-X; Osada K, 2011, CHEM SENSES, V36, P137, DOI 10.1093/chemse/bjq104; Patel RC, 2009, NEUROBIOL AGING, V30, P829, DOI 10.1016/j.neurobiolaging.2007.08.007; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Sakamoto M, 2011, P NATL ACAD SCI USA, V108, P8479, DOI 10.1073/pnas.1018782108; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; Stein PS, 2007, J AM DENT ASSOC, V138, P1314, DOI 10.14219/jada.archive.2007.0046; Tsutsui K, 2007, BIOMED RES-TOKYO, V28, P1, DOI 10.2220/biomedres.28.1; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; Watanabe K, 2002, BEHAV BRAIN RES, V128, P19, DOI 10.1016/S0166-4328(01)00268-6; Watson C, 2012, MOUSE NERVOUS SYSTEM, P1; Weijenberg RAF, 2011, NEUROSCI BIOBEHAV R, V35, P483, DOI 10.1016/j.neubiorev.2010.06.002; Yamamoto T, 2001, BRAIN RES, V902, P255, DOI 10.1016/S0006-8993(01)02410-6; Yamamoto Tetsu, 2009, Bull Tokyo Dent Coll, V50, P117; Yamamoto Tetsu, 2008, Bull Tokyo Dent Coll, V49, P185	53	31	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97309	10.1371/journal.pone.0097309	http://dx.doi.org/10.1371/journal.pone.0097309			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24817277	Green Published, Green Submitted, gold			2022-12-27	WOS:000336838000129
J	Yuan, YG; Tang, JJ; Leng, D; Hu, SJ; Yong, JWH; Chen, X				Yuan, Yongge; Tang, Jianjun; Leng, Dong; Hu, Shuijin; Yong, Jean W. H.; Chen, Xin			An Invasive Plant Promotes Its Arbuscular Mycorrhizal Symbioses and Competitiveness through Its Secondary Metabolites: Indirect Evidence from Activated Carbon	PLOS ONE			English	Article							SOLIDAGO-CANADENSIS; ROOT EXUDATE; SOIL; GROWTH; ALLELOPATHY; INHIBITION; COMMUNITY; FUNGI; TREE; L.	Secondary metabolites released by invasive plants can increase their competitive ability by affecting native plants, herbivores, and pathogens at the invaded land. Whether these secondary metabolites affect the invasive plant itself, directly or indirectly through microorganisms, however, has not been well documented. Here we tested whether activated carbon (AC), a well-known absorbent for secondary metabolites, affect arbuscular mycorrhizal (AM) symbioses and competitive ability in an invasive plant. We conducted three experiments (experiments 1-3) with the invasive forb Solidago canadensis and the native Kummerowia striata. Experiment 1 determined whether AC altered soil properties, levels of the main secondary metabolites in the soil, plant growth, and AMF communities associated with S. canadensis and K. striata. Experiment 2 determined whether AC affected colonization of S. canadensis by five AMF, which were added to sterilized soil. Experiment 3 determined the competitive ability of S. canadensis in the presence and absence of AMF and AC. In experiment 1, AC greatly decreased the concentrations of the main secondary metabolites in soil, and the changes in concentrations were closely related with the changes of AMF in S. canadensis roots. In experiment 2, AC inhibited the AMF Glomus versiforme and G. geosporum but promoted G. mosseae and G. diaphanum in the soil and also in S. canadensis roots. In experiment 3, AC reduced S. canadensis competitive ability in the presence but not in the absence of AMF. Our results provided indirect evidence that the secondary metabolites (which can be absorbed by AC) of the invasive plant S. canadensis may promote S. canadensis competitiveness by enhancing its own AMF symbionts.	[Yuan, Yongge; Tang, Jianjun; Leng, Dong; Chen, Xin] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Shuijin] N Carolina State Univ, Dept Plant Pathol, Raleigh, NC 27695 USA; [Yong, Jean W. H.] Singapore Univ Technol & Design, Singapore, Singapore	Zhejiang University; University of North Carolina; North Carolina State University; Singapore University of Technology & Design	Chen, X (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	chen-tang@zju.edu	Yong, Jean W. H./H-4671-2012; Yong, Jean/B-9976-2019	Yong, Jean W. H./0000-0003-3325-8254; Yong, Jean/0000-0003-3325-8254; Hu, Shuijin/0000-0002-3225-5126	Zhejiang Provincial Natural Science Foundation of China [Z5090089]; Research Fund for the Doctoral Program of Higher Education of China (RFDP) [20110101110077]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Research Fund for the Doctoral Program of Higher Education of China (RFDP)(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was supported by the Zhejiang Provincial Natural Science Foundation of China (No. Z5090089) and the Research Fund for the Doctoral Program of Higher Education of China (RFDP, No. 20110101110077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Alford ER, 2007, SOIL BIOL BIOCHEM, V39, P1812, DOI 10.1016/j.soilbio.2007.01.020; Barto EK, 2011, BIOL INVASIONS, V13, P2755, DOI 10.1007/s10530-011-9945-6; Besserer A, 2006, PLOS BIOL, V4, P1239, DOI 10.1371/journal.pbio.0040226; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Buee M, 2000, MOL PLANT MICROBE IN, V13, P693, DOI 10.1094/MPMI.2000.13.6.693; Callaway RM, 2008, ECOLOGY, V89, P1043, DOI 10.1890/07-0370.1; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Cantor A, 2011, BIOL INVASIONS, V13, P3015, DOI 10.1007/s10530-011-9986-x; Cappuccino N, 2006, BIOL LETTERS, V2, P189, DOI 10.1098/rsbl.2005.0433; Carey EV, 2004, PLANT ECOL, V172, P133, DOI 10.1023/B:VEGE.0000026031.14086.f1; Cipollini D, 2008, J CHEM ECOL, V34, P144, DOI 10.1007/s10886-008-9426-2; DeLuca TH, 2006, SOIL SCI SOC AM J, V70, P448, DOI 10.2136/sssaj2005.0096; Ens EJ, 2009, BIOL INVASIONS, V11, P275, DOI 10.1007/s10530-008-9232-3; Eppinga MB, 2006, OIKOS, V114, P168, DOI 10.1111/j.2006.0030-1299.14625.x; GERDEMANN J. W., 1963, TRANS BRIT MYCOL SOC, V46, P235; Giovannetti M., 1980, New Phytologist, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Gundale MJ, 2007, BIOL FERT SOILS, V43, P303, DOI 10.1007/s00374-006-0106-5; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; Hattenschwiler S, 2000, TRENDS ECOL EVOL, V15, P238, DOI 10.1016/S0169-5347(00)01861-9; Inderjit, 2003, PLANT SOIL, V256, P1, DOI 10.1023/A:1026242418333; Jin L, 2004, FUNCT PLANT BIOL, V31, P979, DOI 10.1071/FP04061; Kim YO, 2011, ECOL RES, V26, P87, DOI 10.1007/s11284-010-0762-7; Kourtev PS, 2002, ECOLOGY, V83, P3152, DOI 10.1890/0012-9658(2002)083[3152:EPSATM]2.0.CO;2; Lankau RA, 2011, OECOLOGIA, V165, P453, DOI 10.1007/s00442-010-1736-8; Lau JA, 2008, NEW PHYTOL, V178, P412, DOI 10.1111/j.1469-8137.2007.02360.x; Lehmann J, 2003, PLANT SOIL, V249, P343, DOI 10.1023/A:1022833116184; Liu SQ, 2013, ALLELOPATHY J, V31, P387; LODHI MAK, 1980, AM J BOT, V67, P1423, DOI 10.2307/2442870; MAHALL BE, 1992, ECOLOGY, V73, P2145, DOI 10.2307/1941462; Malmstrom CM, 2005, OECOLOGIA, V145, P153, DOI 10.1007/s00442-005-0099-z; Mangla S, 2008, J ECOL, V96, P58, DOI 10.1111/j.1365-2745.2007.01312.x; Marler MJ, 1999, ECOLOGY, V80, P1180, DOI 10.1890/0012-9658(1999)080[1180:MIECEO]2.0.CO;2; Matsubara Y, 2002, J JPN SOC HORTIC SCI, V71, P370, DOI 10.2503/jjshs.71.370; Mert-Turk F., 2006, J CELL MOL BIOL, V5, P13; Nagahashi G, 2000, MYCOL RES, V104, P1453, DOI 10.1017/S0953756200002860; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; Perry LG, 2005, J ECOL, V93, P1126, DOI 10.1111/j.1365-2745.2005.01044.x; Piotrowski JS, 2008, SOIL BIOL BIOCHEM, V40, P709, DOI 10.1016/j.soilbio.2007.10.005; Pringle A, 2009, ANNU REV ECOL EVOL S, V40, P699, DOI 10.1146/annurev.ecolsys.39.110707.173454; Reinhart KO, 2006, NEW PHYTOL, V170, P445, DOI 10.1111/j.1469-8137.2006.01715.x; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; Ridenour WM, 2001, OECOLOGIA, V126, P444, DOI 10.1007/s004420000533; Rillig MC, 2004, ECOL LETT, V7, P740, DOI 10.1111/j.1461-0248.2004.00620.x; Scervino JM, 2007, CAN J MICROBIOL, V53, P702, DOI 10.1139/W07-036; Scheublin TR, 2007, J ECOL, V95, P631, DOI 10.1111/j.1365-2745.2007.01244.x; Siemann E, 2003, ECOL APPL, V13, P1503, DOI 10.1890/03-5022; Siemann E, 2001, ECOL LETT, V4, P514, DOI 10.1046/j.1461-0248.2001.00274.x; Smith S., 1997, MYCORRHIZAL SYMBIOSI, V2nd Edn; Stinson KA, 2006, PLOS BIOL, V4, P727, DOI 10.1371/journal.pbio.0040140; Tang J.J., 2009, B SCI TECHNOLOGY, V25, P233; Thorpe AS, 2009, J ECOL, V97, P641, DOI 10.1111/j.1365-2745.2009.01520.x; Weber E, 1998, J BIOGEOGR, V25, P147, DOI 10.1046/j.1365-2699.1998.251119.x; Xu N, 2013, ALLELOPATHY J, V32, P243; [杨期和 YANG Qihe], 2005, [生态学杂志, Chinese Journal of Ecology], V24, P1459; Yu XJ, 2005, CHINESE SCI BULL, V50, P1105, DOI 10.1360/04WC0280; Yuan YG, 2013, J PLANT ECOL, V6, P253, DOI 10.1093/jpe/rts033; Zhang Q, 2007, ALLELOPATHY J, V20, P71; Zhang Q, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012380, 10.1371/journal.pone.0011063]; Zhang SS, 2011, APPL SOIL ECOL, V48, P280, DOI 10.1016/j.apsoil.2011.04.011	62	28	33	6	126	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97163	10.1371/journal.pone.0097163	http://dx.doi.org/10.1371/journal.pone.0097163			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24817325	Green Submitted, Green Published, gold			2022-12-27	WOS:000336838000110
J	Dardaei, L; Modica, L; Iotti, G; Blasi, F				Dardaei, Leila; Modica, Livia; Iotti, Giorgio; Blasi, Francesco			The Deficiency of Tumor Suppressor Prep1 Accelerates the Onset of Meis1-Hoxa9 Leukemogenesis	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; GENE-EXPRESSION; HOX GENES; DEFINITIVE HEMATOPOIESIS; FETAL LIVER; MEIS1; PBX1; MLL; PROGENITORS	Prep1 and Meis1 ortholog TALE transcription factors have opposing roles in tumorigenesis: Meis1 serves as an oncogene, Prep1 as a tumor suppressor. We now report that, Meis1 overexpression in primary Prep1-deficient (Prep1(i/i)) embryonic hematopoietic cells increases self-renewal potential of cells in vitro but not in vivo, whereas leukemia is instead obtained when Meis1 is combined with another oncogene, HoxA9. Prep1(i/i) Meis1-HoxA9-generated leukemic cells are less differentiated and grow more aggressively after the second passage in the mouse. These data indicate that Prep1 represents a barrier to the transforming activity of Meis1 in vitro, but its absence is not sufficient to induce early leukemogenesis. On the other hand, the Prep1(i/i) background appears to favor the insurgence of mutations that cause a more aggressive Meis1-HoxA9-generated leukemia. Indeed, the Prep1(i/i) leukemic cells upregulate the Polycomb protein Bmi-1 and expectedly down-regulate the Ink4a/Arf locus products. Finally, an important feature contributed by the Prep1(i/i) background is the post-transcriptional increase in Meis1 protein level.	[Dardaei, Leila; Modica, Livia; Iotti, Giorgio; Blasi, Francesco] Fdn Ist FIRC Oncol Mol IFOM, Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; IRCCS Istituti Fisioterapici Ospitalieri (IFO)	Blasi, F (corresponding author), Fdn Ist FIRC Oncol Mol IFOM, Milan, Italy.	francesco.blasi@ifom.eu		Migliaccio, Antimo/0000-0002-4197-2055; Blasi, Francesco/0000-0001-9406-1784	FUV (Fondazione Umberto Veronesi) fellowship; AIRC (Italian Association for Cancer Research); Cariplo; Italian Ministry of Health	FUV (Fondazione Umberto Veronesi) fellowship(Fondazione Umberto Veronesi); AIRC (Italian Association for Cancer Research)(Fondazione AIRC per la ricerca sul cancro); Cariplo(Fondazione Cariplo); Italian Ministry of Health(Ministry of Health, Italy)	Leila Dardaei was supported by FUV (Fondazione Umberto Veronesi) fellowship. This work was supported by grants from AIRC (Italian Association for Cancer Research), Cariplo, and the Italian Ministry of Health to FB. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Alharbi RA, 2013, LEUKEMIA, V27, P1000, DOI 10.1038/leu.2012.356; Argiropoulos B, 2010, BLOOD, V115, P4071, DOI 10.1182/blood-2009-06-225573; Azcoitia V, 2005, DEV BIOL, V280, P307, DOI 10.1016/j.ydbio.2005.01.004; Berthelsen J, 1998, EMBO J, V17, P1434, DOI 10.1093/emboj/17.5.1434; Borrow J, 1996, NAT GENET, V12, P159, DOI 10.1038/ng0296-159; Calvo KR, 2002, ONCOGENE, V21, P4247, DOI 10.1038/sj.onc.1205516; Dardaei L, 2014, P NATL ACAD SCI USA, V111, pE896, DOI 10.1073/pnas.1321200111; DiMartino JF, 2001, BLOOD, V98, P618, DOI 10.1182/blood.V98.3.618; Ferretti E, 2006, MOL CELL BIOL, V26, P5650, DOI 10.1128/MCB.00313-06; Ficara F, 2008, CELL STEM CELL, V2, P484, DOI 10.1016/j.stem.2008.03.004; Grier DG, 2005, J PATHOL, V205, P154, DOI 10.1002/path.1710; Hisa T, 2004, EMBO J, V23, P450, DOI 10.1038/sj.emboj.7600038; Iotti G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048353; Iotti G, 2011, P NATL ACAD SCI USA, V108, pE314, DOI 10.1073/pnas.1105216108; Jacobs Y, 1999, MOL CELL BIOL, V19, P5134, DOI 10.1128/mcb.19.7.5134; Kahlina K, 2004, J BIOL CHEM, V279, P44872, DOI 10.1074/jbc.M402467200; Kawagoe H, 1999, LEUKEMIA, V13, P687, DOI 10.1038/sj.leu.2401410; Keung YK, 1997, CANCER GENET CYTOGEN, V97, P94, DOI 10.1016/S0165-4608(96)00340-8; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Longobardi E, 2010, MOL ONCOL, V4, P126, DOI 10.1016/j.molonc.2010.01.001; Longobardi E, 2013, DEV DYNAMICS OFFICIA; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; MOSKOW JJ, 1995, MOL CELL BIOL, V15, P5434; Nakamura T, 1996, NAT GENET, V12, P149, DOI 10.1038/ng0296-149; Penkov D, 2005, MOL CELL BIOL, V25, P10768, DOI 10.1128/MCB.25.24.10768-10781.2005; Pineault N, 2002, EXP HEMATOL, V30, P49, DOI 10.1016/S0301-472X(01)00757-3; Rawat VPS, 2008, BLOOD, V111, P309, DOI 10.1182/blood-2007-04-085407; Serrano E, 2006, ACTA HAEMATOL-BASEL, V116, P77, DOI 10.1159/000093636; Thorsteinsdottir U, 2001, MOL CELL BIOL, V21, P224, DOI 10.1128/MCB.21.1.224-234.2001; van Gosliga D, 2007, EXP HEMATOL, V35, P1538, DOI 10.1016/j.exphem.2007.07.001; Wong P, 2007, GENE DEV, V21, P2762, DOI 10.1101/gad.1602107; Zeisig BB, 2004, MOL CELL BIOL, V24, P617, DOI 10.1128/MCB.24.2.617-628.2004	34	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96711	10.1371/journal.pone.0096711	http://dx.doi.org/10.1371/journal.pone.0096711			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809472	Green Submitted, Green Published, gold			2022-12-27	WOS:000338213300063
J	Yang, L; Jia, Z; Yang, L; Zhu, MM; Zhang, JC; Liu, J; Wu, P; Tian, WC; Li, J; Qi, Z; Tang, XD				Yang, Liang; Jia, Zhe; Yang, Lei; Zhu, Mengmeng; Zhang, Jincai; Liu, Jie; Wu, Ping; Tian, Wencong; Li, Jing; Qi, Zhi; Tang, Xiangdong			Exercise Protects against Chronic beta-Adrenergic Remodeling of the Heart by Activation of Endothelial Nitric Oxide Synthase	PLOS ONE			English	Article							FAILING HUMAN HEART; ATTENUATES CARDIAC-HYPERTROPHY; PATHOLOGICAL HYPERTROPHY; MYOCARDIAL-INFARCTION; HYPERTENSIVE-RATS; GENE-EXPRESSION; IN-VIVO; FAILURE; CELLS; DYSFUNCTION	Extensive data have shown that exercise training can provide cardio-protection against pathological cardiac hypertrophy. However, how long the heart can retain cardio-protective phenotype after the cessation of exercise is currently unknown. In this study, we investigated the time course of the loss of cardio-protection after cessation of exercise and the signaling molecules that are responsible for the possible sustained protection. Mice were made to run on a treadmill six times a week for 4 weeks and then rested for a period of 0, 1, 2 and 4 weeks followed by isoproterenol injection for 8 days. Morphological, echocardiographic and hemodynamic changes were measured, gene reactivation was determined by real-time PCR, and the expression and phosphorylation status of several cardio-protective signaling molecules were analyzed by Western-blot. HW/BW, HW/TL and LW/BW decreased significantly in exercise training (ER) mice. The less necrosis and lower fetal gene reactivation induced by isoproterenol injection were also found in ER mice. The echocardiographic and hemodynamic changes induced by beta-adrenergic overload were also attenuated in ER mice. The protective effects can be sustained for at least 2 weeks after the cessation of the training. Western-blot analysis showed that the alterations in the phosphorylation status of endothelial nitric oxide synthase (eNOS) (increase in serine 1177 and decrease in threonine 495) continued for 2 weeks after the cessation of the training whereas increases of the phosphorylation of Akt and mTOR disappeared. Further study showed that L-NG-Nitroarginine methyl ester (L-NAME) treatment abolished the cardio-protective effects of ER. Our findings demonstrate that stimulation of eNOS in mice through exercise training provides acute and sustained cardioprotection against cardiac hypertrophy.	[Yang, Liang; Zhang, Jincai; Liu, Jie; Tian, Wencong; Li, Jing; Tang, Xiangdong] Nankai Univ, Sch Med, Dept Pharmacol, Tianjin 300071, Peoples R China; [Jia, Zhe; Yang, Lei; Zhu, Mengmeng; Wu, Ping; Qi, Zhi] Nankai Univ, Sch Med, Dept Histol, Tianjin 300071, Peoples R China; [Jia, Zhe; Yang, Lei; Zhu, Mengmeng; Wu, Ping; Qi, Zhi] Nankai Univ, Sch Med, Dept Embryol, Tianjin 300071, Peoples R China	Nankai University; Nankai University; Nankai University	Li, J (corresponding author), Nankai Univ, Sch Med, Dept Pharmacol, Tianjin 300071, Peoples R China.	stellarli@nankai.edu.an; qizhi@nankai.edu.cn			National Natural Science Foundation of China [81102436, 81201206]; Natural Science Foundation of Tianjin [12JCQNJC08300, JCYBJC10000]; National Basic Research Program of China (973) [2010CB945001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin); National Basic Research Program of China (973)(National Basic Research Program of China)	This research was supported by the National Natural Science Foundation of China (81102436 to Liang Yang and 81201206 to Zhi Qi, http://www.nsfc.gov.cn/nsfc/cen/bsdt/jggb.html), the Natural Science Foundation of Tianjin (12JCQNJC08300 to Liang Yang and JCYBJC10000 to Zhi Qi, http://www.tstc.gov.cn/), the National Basic Research Program of China (973) (2010CB945001 to Xiangdong Tang and Jing Li, http://www.973.gov.cn/AreaAppl.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi T, 2011, CURR PHARM DESIGN, V17, P1818, DOI 10.2174/138161211796390976; Arimura K, 2001, AM J PHYSIOL-HEART C, V280, pH68, DOI 10.1152/ajpheart.2001.280.1.H68; Barouch LA, 2002, NATURE, V416, P337, DOI 10.1038/416337a; Boo YC, 2006, EXP MOL MED, V38, P453, DOI 10.1038/emm.2006.53; Calvert JW, 2011, CIRC RES, V108, P1448, DOI 10.1161/CIRCRESAHA.111.241117; Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; Cauwels A, 2006, J CLIN INVEST, V116, P2244, DOI 10.1172/JCI25426; Chung E, 2012, J APPL PHYSIOL, V112, P1564, DOI 10.1152/japplphysiol.00027.2012; Cotton JM, 2001, CIRCULATION, V104, P2318, DOI 10.1161/hc4401.098515; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Drexler H, 1998, J AM COLL CARDIOL, V32, P955, DOI 10.1016/S0735-1097(98)00336-2; Drexler H, 1999, CIRCULATION, V99, P2972, DOI 10.1161/01.CIR.99.23.2972; Fleming I, 2005, J CELL SCI, V118, P4103, DOI 10.1242/jcs.02541; Freimann S, 2005, J AM COLL CARDIOL, V45, P931, DOI 10.1016/j.jacc.2004.11.052; Giannuzzi P, 2003, CIRCULATION, V108, P554, DOI 10.1161/01.CIR.0000081780.38477.FA; HARDING P, 1995, HYPERTENSION, V25, P421, DOI 10.1161/01.HYP.25.3.421; Hare JM, 1998, CIRCULATION, V97, P161, DOI 10.1161/01.CIR.97.2.161; Hunter JJ, 1999, NEW ENGL J MED, V341, P1276, DOI 10.1056/NEJM199910213411706; Jones SP, 2003, P NATL ACAD SCI USA, V100, P4891, DOI 10.1073/pnas.0837428100; Kemi OJ, 2008, J CELL PHYSIOL, V214, P316, DOI 10.1002/jcp.21197; Krenek P, 2009, EUR J HEART FAIL, V11, P140, DOI 10.1093/eurjhf/hfn026; Kuboki K, 2000, CIRCULATION, V101, P676, DOI 10.1161/01.CIR.101.6.676; Leucker TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070088; Linz W, 1999, CARDIOVASC RES, V43, P549, DOI 10.1016/S0008-6363(99)00091-7; Matsuoka H, 1996, HYPERTENSION, V27, P14, DOI 10.1161/01.HYP.27.1.14; McMullen JR, 2003, P NATL ACAD SCI USA, V100, P12355, DOI 10.1073/pnas.1934654100; McMullen JR, 2007, P NATL ACAD SCI USA, V104, P612, DOI 10.1073/pnas.0606663104; Michael A, 2004, J BIOL CHEM, V279, P21383, DOI 10.1074/jbc.M401413200; Napoli C, 2004, P NATL ACAD SCI USA, V101, P8797, DOI 10.1073/pnas.0402734101; Narmoneva DA, 2004, CIRCULATION, V110, P962, DOI 10.1161/01.CIR.0000140667.37070.07; Ozaki M, 2002, CIRC J, V66, P851, DOI 10.1253/circj.66.851; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; Sanada S, 2003, HYPERTENSION, V41, P963, DOI 10.1161/01.HYP.0000062881.36813.7A; Sartoretto JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044627; Song XX, 2010, AM J PHYSIOL-CELL PH, V299, pC1256, DOI 10.1152/ajpcell.00338.2010; Wiemer G, 2001, HYPERTENSION, V38, P1367, DOI 10.1161/hy1101.096115; Yang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062373; Zhang QJ, 2009, J PHYSIOL-LONDON, V587, P3911, DOI 10.1113/jphysiol.2009.172916	38	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96892	10.1371/journal.pone.0096892	http://dx.doi.org/10.1371/journal.pone.0096892			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809512	Green Published, Green Submitted, gold			2022-12-27	WOS:000338213300084
J	Bates, D; Abraham, S; Campbell, M; Zehbe, I; Curiel, L				Bates, David; Abraham, Suraj; Campbell, Michael; Zehbe, Ingeborg; Curiel, Laura			Development and Characterization of an Antibody-Labeled Super-Paramagnetic Iron Oxide Contrast Agent Targeting Prostate Cancer Cells for Magnetic Resonance Imaging	PLOS ONE			English	Article							DTPA-MONOCLONAL ANTIBODY; HUMAN-PAPILLOMAVIRUS 16; MEMBRANE ANTIGEN; EXTRACELLULAR DOMAIN; NUDE-MICE; MULTIFUNCTIONAL NANOPARTICLES; SIGNAL-TRANSDUCTION; IN-VIVO; TUMOR; THERAPY	In this study we developed, characterized and validated in vitro a functional superparagmagnetic iron-oxide based magnetic resonance contrast agent by conjugating a commercially available iron oxide nanoparticle, Molday ION Rhodamine-B Carboxyl (MIRB), with a deimmunized mouse monoclonal antibody (muJ591) targeting prostate-specific membrane antigen (PSMA). This functional contrast agent is intended for the specific and non-invasive detection of prostate cancer cells that are PSMA positive, a marker implicated in prostate tumor progression and metastasis. The two-step carbodiimide reaction used to conjugate the antibody to the nanoparticle was efficient and we obtained an elemental iron content of 19586611 per antibody. Immunofluorescence microscopy and flow cytometry showed that the conjugated muJ591: MIRB complex specifically binds to PSMA-positive (LNCaP) cells. The muJ591: MIRB complex reduced cell adhesion and cell proliferation on LNCaP cells and caused apoptosis as tested by Annexin V assay, suggesting anti-tumorigenic characteristics. Measurements of the T2 relaxation time of the muJ591: MIRB complex using a 400 MHz Innova NMR and a multi-echo spin-echo sequence on a 3T MRI (Achieva, Philips) showed a significant T2 relaxation time reduction for the muJ591: MIRB complex, with a reduced T2 relaxation time as a function of the iron concentration. PSMA-positive cells treated with muJ591: MIRB showed a significantly shorter T2 relaxation time as obtained using a 3T MRI scanner. The reduction in T2 relaxation time for muJ591: MIRB, combined with its specificity against PSMA+LNCaP cells, suggest its potential as a biologically-specific MR contrast agent.	[Bates, David; Abraham, Suraj; Campbell, Michael; Zehbe, Ingeborg; Curiel, Laura] Thunder Bay Reg Res Inst, Thunder Bay, ON, Canada; [Bates, David; Zehbe, Ingeborg] Lakehead Univ, Dept Biol, Thunder Bay, ON P7B 5E1, Canada; [Campbell, Michael] Lakehead Univ, Dept Chem, Thunder Bay, ON P7B 5E1, Canada; [Curiel, Laura] Lakehead Univ, Dept Phys, Thunder Bay, ON P7B 5E1, Canada	Northern Ontario School of Medicine; Lakehead University; Lakehead University; Lakehead University	Curiel, L (corresponding author), Thunder Bay Reg Res Inst, Thunder Bay, ON, Canada.	lcuriel@lakeheadu.ca	Bates, David/AAE-7283-2019; Abraham, Suraj/AAL-5140-2020	Abraham, Suraj/0000-0001-6754-1811	Ontario Institute for Cancer Research [10NOV-446]; National Sciences and Engineering Research Council of Canada	Ontario Institute for Cancer Research; National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by the Ontario Institute for Cancer Research through a research grant (10NOV-446) and the National Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2011, J UROLOGY, V186, P687, DOI 10.1016/j.juro.2011.03.139; [Anonymous], CANADIAN CANC REGIST; Aoudjit Fawzi, 2012, Chemother Res Pract, V2012, P283181, DOI 10.1155/2012/283181; Artemov D, 2003, MAGNET RESON MED, V49, P403, DOI 10.1002/mrm.10406; Artemov D, 2003, J CELL BIOCHEM, V90, P518, DOI 10.1002/jcb.10660; Bander NH, 2006, NAT CLIN PRACT UROL, V3, P216, DOI 10.1038/ncpuro0452; Bander NH, 2003, SEMIN ONCOL, V30, P667, DOI 10.1016/S0093-7754(03)00358-0; Bander NH, 2003, J UROLOGY, V170, P1717, DOI 10.1097/01.ju.0000091655.77601.0c; Bander NH, 2005, J CLIN ONCOL, V23, P4591, DOI 10.1200/JCO.2005.05.160; Bayes M, 2007, Methods Find Exp Clin Pharmacol, V29, P547; BERNSTEIN MA, 2004, HDB MRI PULSE SEQUEN, P630; BULTE JWM, 1992, MAGNET RESON MED, V25, P148, DOI 10.1002/mrm.1910250115; Conway RE, 2006, MOL CELL BIOL, V26, P5310, DOI 10.1128/MCB.00084-06; Fang C, 2010, J CONTROL RELEASE, V146, P2, DOI 10.1016/j.jconrel.2010.05.013; GLEAVE ME, 1992, CANCER RES, V52, P1598; Gupta S, 2010, PROSTATE, V70, P1575, DOI 10.1002/pros.21193; Kircher MF, 2011, NAT REV CLIN ONCOL, V8, P677, DOI 10.1038/nrclinonc.2011.141; Konda SD, 2000, INVEST RADIOL, V35, P50, DOI 10.1097/00004424-200001000-00006; Koo H, 2011, ACCOUNTS CHEM RES, V44, P1018, DOI 10.1021/ar2000138; Lee DE, 2012, CHEM SOC REV, V41, P2656, DOI 10.1039/c2cs15261d; LIN MF, 1994, MOL CELL ENDOCRINOL, V99, pR21, DOI 10.1016/0303-7207(94)90025-6; Liu H, 1997, CANCER RES, V57, P3629; Lu Y, 2010, J PHYS CHEM C, V114, P17446, DOI 10.1021/jp105516f; Ma YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029170; MATSUMURA A, 1994, ACTA NEUROCHIR, P356; Matsuoka Takayuki, 2012, Kobe J Med Sci, V58, pE51; McFadden C, 2011, CONTRAST MEDIA MOL I, V6, P514, DOI 10.1002/cmmi.456; Nanus DM, 2003, J UROLOGY, V170, pS84, DOI 10.1097/01.ju.0000095151.97404.7c; Niccoli S, 2012, J VIROL, V86, P12384, DOI 10.1128/JVI.01512-12; Nogueira L, 2010, BJU INT, V105, P166, DOI 10.1111/j.1464-410X.2009.09088.x; Oosterwijk E, 2007, BJU INT, V99, P1301, DOI 10.1111/j.1464-410X.2007.06835.x; Peldschus K, 2010, MAGN RESON IMAGING, V28, P599, DOI 10.1016/j.mri.2009.12.017; Preziosi P, 2003, EUR RADIOL, V13, P925, DOI 10.1007/s00330-002-1703-9; Rajasekaran AK, 2005, AM J PHYSIOL-CELL PH, V288, pC975, DOI 10.1152/ajpcell.00506.2004; Richard C, 2010, ONCOGENE, V29, P3435, DOI 10.1038/onc.2010.93; Shahbazi-Gahrouei D., 2002, Australasian Physical and Engineering Sciences in Medicine, V25, P31, DOI 10.1007/BF03178372; Shahbazi-Gahrouei D, 2001, J MAGN RESON IMAGING, V14, P169, DOI 10.1002/jmri.1168; SHERRY AD, 1988, MAGNET RESON MED, V8, P180, DOI 10.1002/mrm.1910080208; Slack JK, 2001, ONCOGENE, V20, P1152, DOI 10.1038/sj.onc.1204208; Smith-Jones PM, 2000, CANCER RES, V60, P5237; Smith-Jones PM, 2003, J NUCL MED, V44, P610; Stewart AJ, 2005, J CLIN ONCOL, V23, P6556, DOI 10.1200/JCO.2005.20.966; Taylor RM, 2011, PROSTATE, V74, P689; Tu CQ, 2011, ANN BIOMED ENG, V39, P1335, DOI 10.1007/s10439-011-0270-0; Vallabhajosula S, 2004, PROSTATE, V58, P145, DOI 10.1002/pros.10281; Wang R, 2012, UROLOGY, V79, P449, DOI 10.1016/j.urology.2011.07.1383; Yu MK, 2012, THERANOSTICS, V2, P3, DOI 10.7150/thno.3463; Zhao M, 2001, NAT MED, V7, P1241, DOI 10.1038/nm1101-1241	48	32	33	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97220	10.1371/journal.pone.0097220	http://dx.doi.org/10.1371/journal.pone.0097220			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819929	Green Published, gold, Green Submitted			2022-12-27	WOS:000336653300091
J	Leineweber, C; Westerlund, H; Chungkham, HS; Lindqvist, R; Runesdotter, S; Tishelman, C				Leineweber, Constanze; Westerlund, Hugo; Chungkham, Holendro Singh; Lindqvist, Rikard; Runesdotter, Sara; Tishelman, Carol			Nurses' Practice Environment and Work-Family Conflict in Relation to Burn Out: A Multilevel Modelling Approach	PLOS ONE			English	Article							HOME INTERFERENCE; JOB DEMANDS; PHYSICIAN BURNOUT; REPORTED OUTCOMES; PATIENT SAFETY; MEDIATING ROLE; IMPACT; QUESTIONNAIRE; CONSEQUENCES; ANTECEDENTS	Objectives: To investigate associations between nurse work practice environment measured at department level and individual level work-family conflict on burnout, measured as emotional exhaustion, depersonalization and personal accomplishment among Swedish RNs. Methods: A multilevel model was fit with the individual RN at the 1st, and the hospital department at the 2nd level using cross-sectional RN survey data from the Swedish part of RN4CAST, an EU 7th framework project. The data analysed here is based on a national sample of 8,620 RNs from 369 departments in 53 hospitals. Results: Generally, RNs reported high values of personal accomplishment and lower values of emotional exhaustion and depersonalization. High work-family conflict increased the risk for emotional exhaustion, but for neither depersonalization nor personal accomplishment. On department level adequate staffing and good leadership and support for nurses reduced the risk for emotional exhaustion and depersonalization. Personal accomplishment was statistically significantly related to staff adequacy. Conclusions: The findings suggest that adequate staffing, good leadership, and support for nurses are crucial for RNs' mental health. Our findings also highlight the importance of hospital managers developing policies and practices to facilitate the successful combination of work with private life for employees.	[Leineweber, Constanze; Westerlund, Hugo; Chungkham, Holendro Singh] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden; [Leineweber, Constanze; Lindqvist, Rikard; Runesdotter, Sara; Tishelman, Carol] Karolinska Inst, Med Management Ctr, Dept Learning Informat Management & Eth, Stockholm, Sweden	Stockholm University; Karolinska Institutet	Leineweber, C (corresponding author), Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden.	constanze.leineweber@su.se	Leineweber, Constanze/Z-1330-2019; Tishelman, Carol/AAB-8936-2020; Westerlund, Hugo/A-3049-2012; Chungkham, Holendro Singh/G-6804-2012; Lindqvist, Rikard/AAZ-9034-2020; Leineweber, Constanze/G-7052-2012	Tishelman, Carol/0000-0003-4161-0342; Westerlund, Hugo/0000-0002-8806-5698; Chungkham, Holendro Singh/0000-0002-6016-8943; Lindqvist, Rikard/0000-0002-1913-8523; Leineweber, Constanze/0000-0001-8433-2405	Swedish Council for Working Life and Social Research (FAS) [2011-0403, 2009-1077 550, 2009-1758]; European Union [223468]; Swedish Association of Health Professionals; Stockholm County Council; Karolinska Institutet; Committee for Health and Caring Sciences (CfV); Strategic Research Program in Care Sciences (SFO-V) at Karolinska Institutet	Swedish Council for Working Life and Social Research (FAS)(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); European Union(European Commission); Swedish Association of Health Professionals; Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Committee for Health and Caring Sciences (CfV); Strategic Research Program in Care Sciences (SFO-V) at Karolinska Institutet	CL, RL and HSC are financed by two research projects and a centre of excellence grant from the Swedish Council for Working Life and Social Research (FAS # 2011-0403, #2009-1077 550 and #2009-1758). The authors have received funding from the European Union's Seventh Framework Program (FP7/2007-2013) under grant agreement no. 223468 and the Swedish Association of Health Professionals, the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet, Committee for Health and Caring Sciences (CfV) and Strategic Research Program in Care Sciences (SFO-V) at Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam S, 2008, J HEALTH PSYCHOL, V13, P847, DOI 10.1177/1359105308095055; Aiken LH, 2002, JAMA-J AM MED ASSOC, V288, P1987, DOI 10.1001/jama.288.16.1987; Aiken Linda H, 2012, BMJ, V344, pe1717, DOI 10.1136/bmj.e1717; Alarcon GM, 2011, J VOCAT BEHAV, V79, P549, DOI 10.1016/j.jvb.2011.03.007; Amstad FT, 2011, J OCCUP HEALTH PSYCH, V16, P151, DOI 10.1037/a0022170; Bowers L, 2011, SOC PSYCH PSYCH EPID, V46, P143, DOI 10.1007/s00127-010-0180-8; Brenninkmeijer V., 2003, Occupational and Environmental Medicine, V60, pi16, DOI 10.1136/oem.60.suppl_1.i16; Bruyneel L, 2009, J NURS SCHOLARSHIP, V41, P202, DOI 10.1111/j.1547-5069.2009.01272.x; Demerouti E, 2004, J VOCAT BEHAV, V64, P131, DOI 10.1016/S0001-8791(03)00030-7; Dierdorff EC, 2008, J APPL PSYCHOL, V93, P883, DOI 10.1037/0021-9010.93.4.883; Fuss I, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-353; Garrett Connie, 2008, AORN J, V87, P1191, DOI 10.1016/j.aorn.2008.01.022; Geurts S, 1999, SOC SCI MED, V48, P1135, DOI 10.1016/S0277-9536(98)00425-0; Geurts S. A., 2002, HDB WORK HLTH PSYCHO, P279, DOI [DOI 10.1002/0470013400.CH14, 10.1002/0470013400.ch14]; Gillet N, 2013, INT J NURS STUD, V50, P1359, DOI 10.1016/j.ijnurstu.2012.12.012; Goldstein H, 1995, MULTILEVEL STAT MODE, V2nd; Golembiewski RT, 1996, MONOGRAPHS ORG BEHAV, V21; Grzywacz JG, 2006, RES NURS HEALTH, V29, P414, DOI 10.1002/nur.20133; Hammer LB, 2009, J MANAGE, V35, P837, DOI 10.1177/0149206308328510; Kelly LA, 2011, J NURS ADMIN, V41, P428, DOI 10.1097/NNA.0b013e31822eddbc; KREFT IGG, 1995, MULTIVAR BEHAV RES, V30, P1, DOI 10.1207/s15327906mbr3001_1; Laschinger HKS, 2006, J NURS ADMIN, V36, P259; Lee J, 2011, PROF PSYCHOL-RES PR, V42, P252, DOI 10.1037/a0023319; Leineweber C, 2014, INT J NURS STUD, V51, P744, DOI 10.1016/j.ijnurstu.2013.09.010; Leiter MP, 2006, NURS RES, V55, P137, DOI 10.1097/00006199-200603000-00009; Leiter MP, 1993, PROFESSIONAL BURNOUT, P237, DOI DOI 10.1093/PUBMED/FDL064; Li BY, 2013, INT J NURS STUD, V50, P281, DOI 10.1016/j.ijnurstu.2012.07.001; Linzer M, 2001, AM J MED, V111, P170, DOI 10.1016/S0002-9343(01)00814-2; Maas C.J.M., 2005, METHODOLOGY, V1, P86, DOI [10.1027/1614-2241.1.3.86, DOI 10.1027/1614-2241.1.3.86]; Malqvist I, 2011, STYRFORMER ARBETSFOR; Maslach C, 1996, MASLACH BURNOUT INVE; Maslach C, 2008, J APPL PSYCHOL, V93, P498, DOI 10.1037/0021-9010.93.3.498; Montgomery AJ, 2006, STRESS HEALTH, V22, P203, DOI 10.1002/smi.1104; Nantsupawat A, 2011, J NURS SCHOLARSHIP, V43, P426, DOI 10.1111/j.1547-5069.2011.01419.x; Peeters M.C., 2005, INT J STRESS MANAGE, V12, P43, DOI DOI 10.1037/1072-5245.12.1.43; Peeters M. C. W., 2004, INT J STRESS MANAGE, V11, P305, DOI DOI 10.1037/1072-5245.11.4.305; R Core Team, 2021, R LANGUAGE ENV STAT; Schaufeli W.B., 2003, HDB WORK HLTH PSYCHO, V2, P282, DOI DOI 10.1002/0470013400.CH19; Schaufeli WB, 2004, J ORGAN BEHAV, V25, P293, DOI 10.1002/job.248; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Sermeus W, 2011, BMC NURS, V10, DOI 10.1186/1472-6955-10-6; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; Teng CI, 2010, INT J NURS STUD, V47, P1442, DOI 10.1016/j.ijnurstu.2010.04.005; THOMAS LT, 1995, J APPL PSYCHOL, V80, P6, DOI 10.1037/0021-9010.80.1.6; Toppinen-Tanner S, 2002, J ORGAN BEHAV, V23, P555, DOI 10.1002/job.155; Vahey D, 2004, MED CARE, V42; Van Bogaert P, 2013, INT J NURS STUD, V50, P357, DOI 10.1016/j.ijnurstu.2012.05.006; Van Bogaert P, 2010, J CLIN NURS, V19, P1664, DOI 10.1111/j.1365-2702.2009.03128.x; Van D.D., 2001, EUR J WORK ORGAN PSY, V10, P41, DOI [DOI 10.1080/13594320042000025, 10.1080/13594320042000025]; van der Heijden BIJM, 2008, J ADV NURS, V62, P572, DOI 10.1111/j.1365-2648.2008.04630.x; Wang Y, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-915; Zaslavsky AM, 2007, STAT MED, V26, P1885, DOI 10.1002/sim.2808	52	52	52	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96991	10.1371/journal.pone.0096991	http://dx.doi.org/10.1371/journal.pone.0096991			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI1ZC	24820972	Green Published, Green Submitted, gold			2022-12-27	WOS:000336653300057
J	Piccolo, R; Galasso, G; Capuano, E; De Luca, S; Esposito, G; Trimarco, B; Piscione, F				Piccolo, Raffaele; Galasso, Gennaro; Capuano, Ernesto; De Luca, Stefania; Esposito, Giovanni; Trimarco, Bruno; Piscione, Federico			Transradial versus Transfemoral Approach in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome. A Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; FEMORAL APPROACH; BLEEDING COMPLICATIONS; RADIAL APPROACH; ACCESS; IMPACT; MORTALITY; OUTCOMES; CATHETERIZATION; ANGIOPLASTY	Background: Transfemoral approach (TFA) remains the most common vascular access for percutaneous coronary intervention (PCI) in many countries. However, in the last years several randomized trials compared transradial approach (TRA) with TFA in patients with acute coronary syndrome (ACS), but only few studies were powered to estimate rare events. The aim of the current study was to clarify whether TRA is superior to TFA approach in patients with ACS undergoing percutaneous coronary intervention. A meta-analysis, meta-regression and trial sequential analysis of safety and efficacy of TRA in ACS setting was performed. Methods and Results: Medline, the Cochrane Library, Scopus, scientific session abstracts and relevant websites were searched. Data concerning the study design, patient characteristics, risk of bias, and outcomes were extracted. The primary endpoint was death. Secondary endpoints were: major bleeding and vascular complications. Outcomes were assessed within 30 days. Eleven randomized trials involving 9,202 patients were included. Compared with TFA, TRA significantly reduced the risk of death (odds ratio [OR] 0.70; 95% confidence interval [CI], 0.53-0.94; p = 0.016), but this finding was not confirmed in trial sequential analysis, indicating that sufficient evidence had not been yet reached. Furthermore, TRA compared with TFA reduced the risk of major bleeding (OR 0.60; 95% CI, 0.41-0.88; p = 0.008) and vascular complications (OR 0.35; 95% CI, 0.28-0.46; p<0.001); these findings were supported by trial sequential analyses. Conclusions: In patients with ACS undergoing PCI, a lower risk of death was observed with TRA. Nevertheless, the association between mortality and TRA in ACS setting should be interpreted with caution because it is based on insufficient evidence. However, because of the clinical relevance associated with major bleeding and vascular complications reduction, TRA should be recommended as first-choice vascular access in patients with ACS undergoing cardiac catheterization.	[Piccolo, Raffaele; Galasso, Gennaro; Capuano, Ernesto; De Luca, Stefania; Esposito, Giovanni; Trimarco, Bruno] Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy; [Piscione, Federico] Univ Salerno, Dept Med & Surg, I-84100 Salerno, Italy	University of Naples Federico II; University of Salerno	Galasso, G (corresponding author), Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy.	gengalas@unina.it	Trimarco, Bruno BT/K-7851-2016; Piccolo, Raffaele/AAA-7871-2019; Piccolo, Raffaele/U-4297-2017; Esposito, Giovanni/F-2880-2010	Trimarco, Bruno BT/0000-0002-0701-6449; Piccolo, Raffaele/0000-0002-3124-9912; Esposito, Giovanni/0000-0003-0565-7127; GALASSO, Gennaro/0000-0002-7265-7613; DE LUCA, STEFANIA/0000-0002-4607-529X; Karim, Md Rezaul/0000-0003-2702-4259				[Anonymous], EUROINTERVENTION; Baklanov DV, 2013, J AM COLL CARDIOL, V61, P420, DOI 10.1016/j.jacc.2012.10.032; Brasselet C, 2008, EUR HEART J, V29, P63, DOI 10.1093/eurheartj/ehm508; Brasselet C, 2007, HEART, V93, P1556, DOI 10.1136/hrt.2007.117309; Brok J, 2009, INT J EPIDEMIOL, V38, P287, DOI 10.1093/ije/dyn188; Buchler JR, 2008, J INTERV CARDIOL, V21, P50, DOI 10.1111/j.1540-8183.2007.00315.x; Cantor WJ, 2005, AM HEART J, V150, P543, DOI 10.1016/j.ahj.2004.10.043; Chatterjee S, 2012, ARCH INTERN MED, P1; Chhatriwalla AK, 2013, JAMA-J AM MED ASSOC, V309, P1022, DOI 10.1001/jama.2013.1556; Chodor P, 2011, KARDIOL POL, V69, P763; Chodor P, 2009, CARDIOL J, V16, P332; de Andrade PB, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-435; De Luca G, 2009, THROMB HAEMOSTASIS, V102, P428, DOI 10.1160/TH09-05-0287; Dechartres A, 2011, ANN INTERN MED, V155, P39, DOI 10.7326/0003-4819-155-1-201107050-00006; Doyle BJ, 2009, J AM COLL CARDIOL, V53, P2019, DOI 10.1016/j.jacc.2008.12.073; Doyle BJ, 2008, JACC-CARDIOVASC INTE, V1, P202, DOI 10.1016/j.jcin.2007.12.006; Eikelboom JW, 2006, CIRCULATION, V114, P774, DOI 10.1161/CIRCULATIONAHA.106.612812; Fox KAA, 2007, JAMA-J AM MED ASSOC, V297, P1892, DOI 10.1001/jama.297.17.1892; Gan L., 2009, J NANJING MED U INTE, V23, P270, DOI [10.1016/s1007-4376(09)60068-x, DOI 10.1016/S1007-4376(09)60068-X]; Genereux P, 2011, EUROINTERVENTION, V7, P905, DOI 10.4244/EIJV7I8A144; Gregory D, 2013, J INTERV CARDIOL, V26, P630, DOI 10.1111/joic.12070; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hou L, 2010, SAUDI MED J, V31, P158; Jang JS, 2012, EUROINTERVENTION, V8, P501, DOI 10.4244/EIJV8I4A78; Jolly SS, 2011, LANCET, V377, P1409, DOI 10.1016/S0140-6736(11)60404-2; Joyal D, 2012, AM J CARDIOL, V109, P813, DOI 10.1016/j.amjcard.2011.11.007; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Leonardi RA, 2012, AM J CARDIOL, V109, P1154, DOI 10.1016/j.amjcard.2011.11.048; Mann T, 1998, J AM COLL CARDIOL, V32, P572, DOI 10.1016/S0735-1097(98)00288-5; Mehran R, 2009, EUR HEART J, V30, P1457, DOI 10.1093/eurheartj/ehp110; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Nathan S, 2012, CURR CARDIOL REP, V14, P502, DOI 10.1007/s11886-012-0287-5; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Piccolo R, 2011, ATHEROSCLEROSIS, V217, P149, DOI 10.1016/j.atherosclerosis.2011.03.007; Rao SV, 2010, J AM COLL CARDIOL, V55, P2187, DOI 10.1016/j.jacc.2010.01.039; Rao SV, 2008, JACC-CARDIOVASC INTE, V1, P379, DOI 10.1016/j.jcin.2008.05.007; Romagnoli E, 2012, J AM COLL CARDIOL, V60, P2481, DOI 10.1016/j.jacc.2012.06.017; Saito S, 2003, CATHETER CARDIO INTE, V59, P26, DOI 10.1002/ccd.10493; Sciahbasi A, 2009, AM J CARDIOL, V103, P796, DOI 10.1016/j.amjcard.2008.11.049; Subherwal S, 2012, J AM COLL CARDIOL, V59, P1861, DOI 10.1016/j.jacc.2011.12.045; Thorlund K, 2009, INT J EPIDEMIOL, V38, P276, DOI 10.1093/ije/dyn179; Uhlemann M, 2012, JACC-CARDIOVASC INTE, V5, P36, DOI 10.1016/j.jcin.2011.08.011; Verheugt FWA, 2011, JACC-CARDIOVASC INTE, V4, P191, DOI 10.1016/j.jcin.2010.10.011; Vorobcsuk A, 2009, AM HEART J, V158, P814, DOI 10.1016/j.ahj.2009.08.022; Wang YB, 2012, J INVASIVE CARDIOL, V24, P412; Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013	47	31	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96127	10.1371/journal.pone.0096127	http://dx.doi.org/10.1371/journal.pone.0096127			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24820096	Green Published, Green Submitted, gold			2022-12-27	WOS:000336653300012
J	Tsubota, A; Mogushi, K; Aizaki, H; Miyaguchi, K; Nagatsuma, K; Matsudaira, H; Kushida, T; Furihata, T; Tanaka, H; Matsuura, T				Tsubota, Akihito; Mogushi, Kaoru; Aizaki, Hideki; Miyaguchi, Ken; Nagatsuma, Keisuke; Matsudaira, Hiroshi; Kushida, Tatsuya; Furihata, Tomomi; Tanaka, Hiroshi; Matsuura, Tomokazu			Involvement of MAP3K8 and miR-17-5p in Poor Virologic Response to Interferon-Based Combination Therapy for Chronic Hepatitis C	PLOS ONE			English	Article							GENOTYPE 1; MICRORNA EXPRESSION; GENETIC-VARIATION; PROTEIN-KINASE; VIRUS; RIBAVIRIN; IL28B; PEGINTERFERON; ASSOCIATION; PROGRESSION	Despite advances in chronic hepatitis C treatment, a proportion of patients respond poorly to treatment. This study aimed to explore hepatic mRNA and microRNA signatures involved in hepatitis C treatment resistance. Global hepatic mRNA and microRNA expression profiles were compared using microarray data between treatment responses. Quantitative real-time polymerase chain reaction validated the gene signatures from 130 patients who were infected with hepatitis C virus genotype 1b and treated with pegylated interferon-alpha and ribavirin combination therapy. The correlation between mRNA and microRNA was evaluated using in silico analysis and in vitro siRNA and microRNA inhibition/overexpression experiments. Multivariate regression analysis identified that the independent variables IL28B SNP rs8099917, hsa-miR-122-5p, hsa-miR-17-5p, and MAP3K8 were significantly associated with a poor virologic response. MAP3K8 and miR-17-5p expression were inversely correlated with treatment response. Furthermore, miR-17-5p repressed HCV production by targeting MAP3K8. Collectively, the data suggest that several molecules and the inverse correlation between mRNA and microRNA contributed to a host genetic refractory hepatitis C treatment response.	[Tsubota, Akihito; Nagatsuma, Keisuke; Matsudaira, Hiroshi] Jikei Univ, Sch Med, ICMR, Kashiwa, Chiba, Japan; [Tsubota, Akihito; Nagatsuma, Keisuke; Matsudaira, Hiroshi] Jikei Univ, Sch Med, Kashiwa Hosp, Div Gastroenterol & Hepatol, Kashiwa, Chiba, Japan; [Mogushi, Kaoru; Miyaguchi, Ken; Tanaka, Hiroshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Bioinformat, Bunkyo Ku, Tokyo, Japan; [Aizaki, Hideki] Natl Inst Infect Dis, Dept Virol 2, Shinjuku Ku, Tokyo 1628640, Japan; [Kushida, Tatsuya] Japan Sci & Technol Agcy, Natl Biosci Database Ctr, Chiyoda Ku, Tokyo, Japan; [Furihata, Tomomi] Chiba Univ, Grad Sch Pharmaceut Sci, Lab Pharmacol & Toxicol, Chiba, Japan; [Matsuura, Tomokazu] Jikei Univ, Sch Med, Dept Lab Med, Minato Ku, Tokyo, Japan	Jikei University; Jikei University; Tokyo Medical & Dental University (TMDU); National Institute of Infectious Diseases (NIID); Japan Science & Technology Agency (JST); Chiba University; Jikei University	Tsubota, A (corresponding author), Jikei Univ, Sch Med, ICMR, Kashiwa, Chiba, Japan.	atsubo@jikei.ac.jp	Furihata, Tomomi/J-9403-2017	Furihata, Tomomi/0000-0003-3614-9328; Mogushi, Kaoru/0000-0002-2618-8684; Kushida, Tatsuya/0000-0002-0784-4113	Ministry of Health, Labour and Welfare (Japan); Ministry of Education, Culture, Sports, Science and Technology (Japan); Clinical Research Funds from ICMR; Jikei University School of Medicine; Grants-in-Aid for Scientific Research [26870175, 24591001] Funding Source: KAKEN	Ministry of Health, Labour and Welfare (Japan)(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Clinical Research Funds from ICMR; Jikei University School of Medicine(Jikei University); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid from the Ministry of Health, Labour and Welfare (Japan), the Ministry of Education, Culture, Sports, Science and Technology (Japan), and Clinical Research Funds from ICMR, the Jikei University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albecka A, HEPTAOLOGY, V55, P998; Banerjee A, 2007, IMMUNOL CELL BIOL, V85, P420, DOI 10.1038/sj.icb.7100098; Bassendine MF, 2013, SEMIN IMMUNOPATHOL, V35, P87, DOI 10.1007/s00281-012-0356-2; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r127; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039; Feld JJ, 2007, HEPATOLOGY, V46, P1548, DOI 10.1002/hep.21853; Fellay J, 2010, NATURE, V464, P405, DOI 10.1038/nature08825; Gantke T, 2012, IMMUNOL REV, V246, P168, DOI 10.1111/j.1600-065X.2012.01104.x; Gao L, 2004, J VIROL, V78, P3480, DOI 10.1128/JVI.78.7.3480-3488.2004; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; George D, 2009, CURR TOP MED CHEM, V9, P611, DOI 10.2174/156802609789007345; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Hayashi N, 2012, J VIRAL HEPATITIS, V19, pE134, DOI 10.1111/j.1365-2893.2011.01528.x; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Hossain A, 2006, MOL CELL BIOL, V26, P8191, DOI 10.1128/MCB.00242-06; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kato T, 2007, J VIROL, V81, P4405, DOI 10.1128/JVI.02334-06; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kumada H, 2012, J HEPATOL, V56, P78, DOI 10.1016/j.jhep.2011.07.016; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Li JH, 2010, HEPATOLOGY, V51, P1904, DOI 10.1002/hep.23592; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Machida K, 2006, J VIROL, V80, P866, DOI 10.1128/JVI.80.2.866-874.2006; MIYOSHI J, 1991, MOL CELL BIOL, V11, P4088, DOI 10.1128/MCB.11.8.4088; Murakami Y, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-48; PATRIOTIS C, 1993, P NATL ACAD SCI USA, V90, P2251, DOI 10.1073/pnas.90.6.2251; Perugorria MJ, 2013, HEPATOLOGY, V57, P1238, DOI 10.1002/hep.26108; Sarasin-Filipowicz M, NAT MED, V15, P31; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Schaefer EAK, 2013, SEMIN LIVER DIS, V33, P358, DOI 10.1055/s-0033-1358524; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Serva A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052555; Syed GH, 2014, J VIROL, V88, P2519, DOI 10.1128/JVI.02727-13; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	43	8	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97078	10.1371/journal.pone.0097078	http://dx.doi.org/10.1371/journal.pone.0097078			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819603	gold, Green Published, Green Submitted			2022-12-27	WOS:000336653300068
J	Macdonald, D; Tessari, MA; Boogaard, I; Smith, M; Pulli, K; Szynol, A; Albertus, F; Lamers, MBAC; Dijkstra, S; Kordt, D; Reindl, W; Herrmann, F; McAllister, G; Fischer, DF; Munoz-Sanjuan, I				Macdonald, Douglas; Tessari, Michela A.; Boogaard, Ivette; Smith, Melanie; Pulli, Kristiina; Szynol, Agnieszka; Albertus, Faywell; Lamers, Marieke B. A. C.; Dijkstra, Sipke; Kordt, Daniel; Reindl, Wolfgang; Herrmann, Frank; McAllister, George; Fischer, David F.; Munoz-Sanjuan, Ignacio			Quantification Assays for Total and Polyglutamine-Expanded Huntingtin Proteins	PLOS ONE			English	Article							MUTANT HUNTINGTIN; DISEASE PATHOLOGY; MOUSE MODELS; CAG REPEATS; IN-VIVO; AGGREGATION; TOXICITY; BRAIN; EXPRESSION; VECTORS	The expansion of a CAG trinucleotide repeat in the huntingtin gene, which produces huntingtin protein with an expanded polyglutamine tract, is the cause of Huntington's disease (HD). Recent studies have reported that RNAi suppression of polyglutamine-expanded huntingtin (mutant HTT) in HD animal models can ameliorate disease phenotypes. A key requirement for such preclinical studies, as well as eventual clinical trials, aimed to reduce mutant HTT exposure is a robust method to measure HTT protein levels in select tissues. We have developed several sensitive and selective assays that measure either total human HTT or polyglutamine-expanded human HTT proteins on the electrochemiluminescence Meso Scale Discovery detection platform with an increased dynamic range over other methods. In addition, we have developed an assay to detect endogenous mouse and rat HTT proteins in pre-clinical models of HD to monitor effects on the wild type protein of both allele selective and non-selective interventions. We demonstrate the application of these assays to measure HTT protein in several HD in vitro cellular and in vivo animal model systems as well as in HD patient biosamples. Furthermore, we used purified recombinant HTT proteins as standards to quantitate the absolute amount of HTT protein in such biosamples.	[Macdonald, Douglas; Munoz-Sanjuan, Ignacio] CHDI Fdn, CHDI Management, Los Angeles, CA 90045 USA; [Tessari, Michela A.; Pulli, Kristiina] Galapagos BV, Leiden, Netherlands; [Smith, Melanie; Lamers, Marieke B. A. C.; McAllister, George] BioFocus, Saffron Walden, Essex, England; [Boogaard, Ivette; Szynol, Agnieszka; Albertus, Faywell; Dijkstra, Sipke; Fischer, David F.] BioFocus, Leiden, Netherlands; [Kordt, Daniel; Reindl, Wolfgang; Herrmann, Frank] Evotec AG, Hamburg, Germany	Galapagos NV; Evotec	Macdonald, D (corresponding author), CHDI Fdn, CHDI Management, Los Angeles, CA 90045 USA.	Douglas.Macdonald@chdifoundation.org	Pulli, Kristiina/O-9410-2016	Pulli, Kristiina/0000-0002-9517-1886; Fischer, David/0000-0002-6690-0197; Dijkstra, Sipke/0000-0003-2535-297X				Baldo B, 2012, CHEM BIOL, V19, P264, DOI 10.1016/j.chembiol.2011.12.020; Bates G, 2003, LANCET, V361, P1642, DOI 10.1016/S0140-6736(03)13304-1; Carroll JB, 2011, MOL THER, V19, P2178, DOI 10.1038/mt.2011.201; Cong SY, 2005, HYBRIDOMA, V24, P231, DOI 10.1089/hyb.2005.24.231; Davies SW, 1999, METHOD ENZYMOL, V309, P687; DiFiglia M, 2007, P NATL ACAD SCI USA, V104, P17204, DOI 10.1073/pnas.0708285104; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Duzdevich D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017119; Fu Q, 2010, CLIN CHEM, V56, P314, DOI 10.1373/clinchem.2009.135087; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Heikkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050717; Hu JX, 2009, NAT BIOTECHNOL, V27, P478, DOI 10.1038/nbt.1539; Huang B, 2008, J GENE MED, V10, P269, DOI 10.1002/jgm.1150; Huntington's Disease Collaborative Research Group, 1993, CELL, V72, P971, DOI DOI 10.1016/0092-8674(93)90585-E; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Kalchman MA, 1996, J BIOL CHEM, V271, P19385, DOI 10.1074/jbc.271.32.19385; Ko J, 2001, BRAIN RES BULL, V56, P319, DOI 10.1016/S0361-9230(01)00599-8; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Kugler S, 2003, VIROLOGY, V311, P89, DOI 10.1016/S0042-6822(03)00162-4; Li PW, 2007, NAT STRUCT MOL BIOL, V14, P381, DOI 10.1038/nsmb1234; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; McBride JL, 2011, MOL THER, V19, P2152, DOI 10.1038/mt.2011.219; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Menalled LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049838; Miller J, 2011, NAT CHEM BIOL, V7, P925, DOI [10.1038/nchembio.694, 10.1038/NCHEMBIO.694]; Paganetti P, 2009, CHEMBIOCHEM, V10, P1678, DOI 10.1002/cbic.200900131; Pardo R, 2006, J NEUROSCI, V26, P1635, DOI 10.1523/JNEUROSCI.3706-05.2006; Pyati R., 2007, ANNU REP PROG CHEM C, V103, P12; Sah DWY, 2011, J CLIN INVEST, V121, P500, DOI 10.1172/JCI45130; Sathasivam K, 2013, P NATL ACAD SCI USA, V110, P2366, DOI 10.1073/pnas.1221891110; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; Stanek LM, 2013, J HUNTINGTONS DIS, V2, P217, DOI 10.3233/JHD-130057; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Tabrizi SJ, 2009, LANCET NEUROL, V8, P791, DOI 10.1016/S1474-4422(09)70170-X; Weiss A, 2012, J CLIN INVEST, V122, P3731, DOI 10.1172/JCI64565; Weiss A, 2009, ANAL BIOCHEM, V395, P8, DOI 10.1016/j.ab.2009.08.001; Zhao YG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng006	42	39	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96854	10.1371/journal.pone.0096854	http://dx.doi.org/10.1371/journal.pone.0096854			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816435	Green Published, gold, Green Submitted			2022-12-27	WOS:000336838000072
J	Abeysinghe, HCS; Bokhari, L; Dusting, GJ; Roulston, CL				Abeysinghe, Hima C. S.; Bokhari, Laita; Dusting, Gregory J.; Roulston, Carli L.			Brain Remodelling following Endothelin-1 Induced Stroke in Conscious Rats	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; NEURAL STEM-CELLS; ADULT SUBVENTRICULAR ZONE; MICROGLIAL RESPONSE; ARTERY OCCLUSION; NEURONAL DAMAGE; RADIAL GLIA; LESION SIZE; TIME-COURSE; NEUROGENESIS	The extent of stroke damage in patients affects the range of subsequent pathophysiological responses that influence recovery. Here we investigate the effect of lesion size on development of new blood vessels as well as inflammation and scar formation and cellular responses within the subventricular zone (SVZ) following transient focal ischemia in rats (n = 34). Endothelin-1-induced stroke resulted in neurological deficits detected between 1 and 7 days (P<0.001), but significant recovery was observed beyond this time. MCID image analysis revealed varying degrees of damage in the ipsilateral cortex and striatum with infarct volumes ranging from 0.76-77 mm(3) after 14 days, where larger infarct volumes correlated with greater functional deficits up to 7 days (r = 0.53, P<0.05). Point counting of blood vessels within consistent sample regions revealed that increased vessel numbers correlated significantly with larger infarct volumes 14 days post-stroke in the core cortical infarct (r = 0.81, P<0.0001), core striatal infarct (r = 0.91, P<0.005) and surrounding border zones (r = 0.66, P<0.005; and r = 0.73, P<0.05). Cell proliferation within the SVZ also increased with infarct size (P<0.01) with a greater number of Nestin/GFAP positive cells observed extending towards the border zone in rats with larger infarcts. Lesion size correlated with both increased microglia and astrocyte activation, with severely diffuse astrocyte transition, the formation of the glial scar being more pronounced in rats with larger infarcts. Thus stroke severity affects cell proliferation within the SVZ in response to injury, which may ultimately make a further contribution to glial scar formation, an important factor to consider when developing treatment strategies that promote neurogenesis.	[Bokhari, Laita; Roulston, Carli L.] Univ Melbourne, Dept Med, Neurotrauma Res Team, Melbourne, Vic 3010, Australia; [Abeysinghe, Hima C. S.] Univ Melbourne, Dept Surg, Melbourne, Vic 3010, Australia; [Bokhari, Laita] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Dusting, Gregory J.] Royal Eye & Ear Hosp Melbourne, Ctr Eye Res, Cytoprotect Pharmacol Program, Melbourne, Vic, Australia; [Dusting, Gregory J.] Univ Melbourne, Fac Med, Dept Opthamol, Melbourne, Vic 3010, Australia	University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne	Abeysinghe, HCS (corresponding author), Univ Melbourne, Dept Surg, St Vincents Campus, Melbourne, Vic 3010, Australia.	himaa@student.unimelb.edu.au		Abeysinghe, Hima/0000-0002-7989-5972	National Heart Foundation Australia (NHF) [G07M3237]; Bethlehem Griffiths Foundation; National Health and Medical Research Council Australia (NHMRC) [628767];  [1003113]	National Heart Foundation Australia (NHF)(National Heart Foundation of Australia); Bethlehem Griffiths Foundation; National Health and Medical Research Council Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); 	This study was supported in part by grants from the National Heart Foundation Australia (NHF G07M3237, http://www.heartfoundation.org.au); The Bethlehem Griffiths Foundation (http://www.bethlehemgrf.com.au/); and the National Health and Medical Research Council Australia for project grant (NHMRC project grant 628767, http://www.nhmrc.gov.au/), and fellowship to Professor Dusting (No. 1003113). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arboix A, 2009, EXPERT REV NEUROTHER, V9, P179, DOI 10.1586/14737175.9.2.179; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bosomtwi A, 2008, J CEREBR BLOOD F MET, V28, P1978, DOI 10.1038/jcbfm.2008.85; Boyko M, 2011, BEHAV BRAIN RES, V223, P17, DOI 10.1016/j.bbr.2011.03.019; Brockhaus J, 1996, GLIA, V16, P81, DOI 10.1002/(SICI)1098-1136(199601)16:1<81::AID-GLIA9>3.0.CO;2-E; BROTT T, 1989, STROKE, V20, P871, DOI 10.1161/01.STR.20.7.871; Callaway JK, 2000, J NEUROSCI METH, V102, P53, DOI 10.1016/S0165-0270(00)00278-8; Callaway JK, 1999, STROKE, V30, P2704, DOI 10.1161/01.STR.30.12.2704; CHEN HH, 1994, STROKE, V25, P1651, DOI 10.1161/01.STR.25.8.1651; Chen JL, 2003, ANN NEUROL, V53, P743, DOI 10.1002/ana.10555; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; COLTON CA, 1987, FEBS LETT, V223, P284, DOI 10.1016/0014-5793(87)80305-8; Costa S, 2002, GLIA, V37, P105, DOI 10.1002/glia.10015; Counsell C, 2002, STROKE, V33, P1041, DOI 10.1161/hs0402.105909; Cramer SC, 2000, TRENDS NEUROSCI, V23, P265, DOI 10.1016/S0166-2236(00)01562-9; Cramer SC, 2007, STROKE, V38, P2108, DOI 10.1161/STROKEAHA.107.485631; Cramer SC, 2010, STROKE, V41, pS114, DOI 10.1161/STROKEAHA.110.595165; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; DERYCK M, 1989, STROKE, V20, P1383, DOI 10.1161/01.STR.20.10.1383; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; Garcia-Verdugo J, 1998, J NEUROBIOL, V36, P234, DOI 10.1002/(SICI)1097-4695(199808)36:2<234::AID-NEU10>3.0.CO;2-E; Gauthier LV, 2008, STROKE, V39, P1520, DOI 10.1161/STROKEAHA.107.502229; Goldstein LB, 1997, STROKE, V28, P307, DOI 10.1161/01.STR.28.2.307; Gonzalez FF, 2013, STROKE, V44, P753, DOI 10.1161/STROKEAHA.111.000104; Gregg C, 2003, J NEUROSCI, V23, P11587; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Henderson RD, 2000, STROKE, V31, P128, DOI 10.1161/01.STR.31.1.128; Huang IJ, 2001, RADIOLOGY, V221, P35, DOI 10.1148/radiol.2211001412; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; JONGBLOED L, 1986, STROKE, V17, P765, DOI 10.1161/01.STR.17.4.765; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kim YR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090000; Koenig IR, 2008, STROKE, V39, P1821, DOI 10.1161/STROKEAHA.107.505867; KRUPINSKI J, 1994, STROKE, V25, P1794, DOI 10.1161/01.STR.25.9.1794; Lansberg MG, 2012, LANCET NEUROL, V11, P860, DOI 10.1016/S1474-4422(12)70203-X; LEACH MJ, 1993, STROKE, V24, P1063, DOI 10.1161/01.STR.24.7.1063; Leira EC, 2008, CEREBROVASC DIS, V26, P573, DOI 10.1159/000165109; Leventhal C, 1999, MOL CELL NEUROSCI, V13, P450, DOI 10.1006/mcne.1999.0762; Liu XS, 2007, J CEREBR BLOOD F MET, V27, P564, DOI 10.1038/sj.jcbfm.9600371; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Lokmic Z, 2011, HISTOL HISTOPATHOL, V26, P781, DOI 10.14670/HH-26.781; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Marks L, 2001, HYPERTENSION, V38, P116, DOI 10.1161/01.HYP.38.1.116; McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Minger SL, 2007, REGEN MED, V2, P69, DOI 10.2217/17460751.2.1.69; Moss DW, 2001, EUR J NEUROSCI, V13, P529, DOI 10.1046/j.1460-9568.2001.01418.x; Nagai N, 2010, BRAIN RES, V1322, P109, DOI 10.1016/j.brainres.2010.01.077; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; OSBORNE KA, 1987, J NEUROL NEUROSUR PS, V50, P402, DOI 10.1136/jnnp.50.4.402; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Raivich G, 1999, ACTA NEUROCHIR SUPPL, V73, P21; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Rossi DJ, 2007, NAT NEUROSCI, V10, P1377, DOI 10.1038/nn2004; Roulston CL, 2008, EUR J PHARMACOL, V584, P100, DOI 10.1016/j.ejphar.2008.01.046; SAUNDERS DE, 1995, STROKE, V26, P1007, DOI 10.1161/01.STR.26.6.1007; Sbarbati A, 1996, ACTA NEUROPATHOL, V92, P56, DOI 10.1007/s004010050489; Schilling M, 2005, EXP NEUROL, V196, P290, DOI 10.1016/j.expneurol.2005.08.004; Schilling M, 2003, EXP NEUROL, V183, P25, DOI 10.1016/S0014-4886(03)00082-7; Schroeter M, 1999, NEUROSCIENCE, V89, P1367, DOI 10.1016/S0306-4522(98)00398-4; Schwamm LH, 1998, STROKE, V29, P2268, DOI 10.1161/01.STR.29.11.2268; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Szpak GM, 1999, FOLIA NEUROPATHOL, V37, P264; Tanaka R, 2003, NEUROSCIENCE, V117, P531, DOI 10.1016/S0306-4522(02)00954-5; Taylor CJ, 2013, BRAIN SCI, V3, P294, DOI 10.3390/brainsci3010294; Thored P, 2009, GLIA, V57, P835, DOI 10.1002/glia.20810; Walton NM, 2006, GLIA, V54, P815, DOI 10.1002/glia.20419; YAMAMOTO M, 1988, BRAIN RES, V452, P323, DOI 10.1016/0006-8993(88)90036-4; Yoo SW, 2008, EXP MOL MED, V40, P387, DOI 10.3858/emm.2008.40.4.387; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhang RL, 2002, STROKE, V33, P2675, DOI 10.1161/01.STR.0000034399.95249.59; Zhang RL, 2008, NEUROPHARMACOLOGY, V55, P345, DOI 10.1016/j.neuropharm.2008.05.027; Zhang RL, 2007, J CEREBR BLOOD F MET, V27, P1201, DOI 10.1038/sj.jcbfm.9600430; Zhang RL, 2006, J CEREBR BLOOD F MET, V26, P857, DOI 10.1038/sj.jcbfm.9600237	79	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e97007	10.1371/journal.pone.0097007	http://dx.doi.org/10.1371/journal.pone.0097007			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809543	Green Published, gold			2022-12-27	WOS:000338213300104
J	Laokri, S; Amoussouhui, A; Ouendo, EM; Hounnankan, AC; Anagonou, S; Gninafon, M; Kassa, F; Tawo, L; Dujardin, B				Laokri, Samia; Amoussouhui, Arnaud; Ouendo, Edgard M.; Hounnankan, Athanase Cossi; Anagonou, Severin; Gninafon, Martin; Kassa, Ferdinand; Tawo, Leon; Dujardin, Bruno			A Care Pathway Analysis of Tuberculosis Patients in Benin: Highlights on Direct Costs and Critical Stages for an Evidence-Based Decision-Making	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; DELAYS; DIAGNOSIS; POVERTY	Background: Free tuberculosis control fail to protect patients from substantial medical and non-medical expenditure, thus a greater degree of disaggregation of patient cost is needed to fully capture their context and inform policymaking. Methods: A retrospective cross-sectional study was conducted on a convenience sample of six health districts of Southern Benin. From August 2008 to February 2009, we recruited all smear-positive pulmonary tuberculosis patients treated under the national strategy in the selected districts. Direct out-of-pocket costs associated with tuberculosis, time delays, and care-seeking pattern were collected from symptom onset to end of treatment. Results: Population description and outcome data were reported for 245 patients of whom 153 completed their care pathway. For them, the median overall direct cost was USD 183 per patient. Payments to traditional healers, self-medication drugs, travel, and food expenditures contributed largely to this cost burden. Patient, provider, and treatment delays were also reported. Pre-diagnosis and intensive treatment stages were the most critical stages, with median expenditure of USD 43 per patient and accounting for 38% and 29% of the overall direct cost, respectively. However, financial barriers differed depending on whether the patient lived in urban or rural areas. Conclusions: This study delivers new evidence about bottlenecks encountered during the TB care pathway. Financial barriers to accessing the free-of-charge tuberculosis control strategy in Benin remain substantial for low-income households. Irregular time delays and hidden costs, often generated by multiple visits to various care providers, impair appropriate patient pathways. Particular attention should be paid to pre-diagnosis and intensive treatment. Cost assessment and combined targeted interventions embodied by a patient-centered approach on the specific critical stages would likely deliver better program outcomes.	[Laokri, Samia; Dujardin, Bruno] Univ Libre Bruxelles, Sch Publ Hlth, Res Ctr Hlth Policy & Syst Int Hlth, Brussels, Belgium; [Amoussouhui, Arnaud; Ouendo, Edgard M.; Hounnankan, Athanase Cossi] Inst Reg Sante Publ, Unite Rech, Ouidah, Benin; [Anagonou, Severin; Gninafon, Martin; Kassa, Ferdinand; Tawo, Leon] Programme Natl TB, Cotonou, Benin	Universite Libre de Bruxelles	Laokri, S (corresponding author), Univ Libre Bruxelles, Sch Publ Hlth, Res Ctr Hlth Policy & Syst Int Hlth, Brussels, Belgium.	slaokri@ulb.ac.be	Laokri, Samia/AFT-2884-2022	Laokri, Samia/0000-0002-9814-5405	Development and Cooperation-EuropAid Directorate-General of European Commission [Sante/2004/078-590]; Universite Libre de Bruxelles	Development and Cooperation-EuropAid Directorate-General of European Commission; Universite Libre de Bruxelles	The Development and Cooperation-EuropAid Directorate-General of European Commission (Projet Sante/2004/078-590) funded local staff training and data collection. A mini-ARC Grant from the Universite Libre de Bruxelles awarded to SL funded the analysis of data and writing of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barter DM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-980; Chard SE, 2009, MED ANTHROPOL Q, V23, P257, DOI 10.1111/j.1548-1387.2009.01059.x; El-Khoury M, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-49; FORESA Study team, 2005, RAPP ENQ SOC PRIS CH; Gninafon M, 2011, INT J TUBERC LUNG D, V15, P61; Hounnankan AC, 2009, RAPP EV FIN PROJ FOR; Lambert ML, 2005, TROP MED INT HEALTH, V10, P945, DOI 10.1111/j.1365-3156.2005.01485.x; Laokri S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056752; Laokri S, 2013, B WORLD HEALTH ORGAN, V91, P277, DOI 10.2471/BLT.12.110015; Lewin SA, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003267; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Mesfin MM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-173; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Ouendo EM, 2005, TROP MED INT HEALTH, V10, P179, DOI 10.1111/j.1365-3156.2004.01371.x; Sachdeva KS, 2012, INDIAN J MED RES, V135, P690; Samia Laokri, 2007, EVALUATION CHARGE EC; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; Trebucq A, 2010, INT J TUBERC LUNG D, V14, P434; Ukwaja KN, 2012, INT J TUBERC LUNG DI; Vassall A, 2013, LANCET GLOB HEALTH, V1, pE62, DOI 10.1016/S2214-109X(13)70044-5; WHO, 2011, WHO GLOBAL TUBERCULO; World Health Organization, 2008, GLOB TUB CONTR SURV; World Health Organization, WHO COUNTR HLTH PROF; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	24	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96912	10.1371/journal.pone.0096912	http://dx.doi.org/10.1371/journal.pone.0096912			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810007	Green Published, gold			2022-12-27	WOS:000338213300088
J	Carreras-Torres, R; Kundu, S; Zanetti, D; Esteban, E; Via, M; Moral, P				Carreras-Torres, Robert; Kundu, Suman; Zanetti, Daniela; Esteban, Esther; Via, Marc; Moral, Pedro			Genetic Risk Score of NOS Gene Variants Associated with Myocardial Infarction Correlates with Coronary Incidence across Europe	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; GENOME-WIDE ASSOCIATION; HEART-DISEASE MORTALITY; CARDIOVASCULAR-DISEASE; ARTERY-DISEASE; MONICA PROJECT; EVENT RATES; ATHEROSCLEROSIS RISK; MISSING HERITABILITY; SPATIAL-PATTERNS	Coronary artery disease (CAD) mortality and morbidity is present in the European continent in a four-fold gradient across populations, from the South (Spain and France) with the lowest CAD mortality, towards the North (Finland and UK). This observed gradient has not been fully explained by classical or single genetic risk factors, resulting in some cases in the so called Southern European or Mediterranean paradox. Here we approached population genetic risk estimates using genetic risk scores (GRS) constructed with single nucleotide polymorphisms (SNP) from nitric oxide synthases (NOS) genes. These SNPs appeared to be associated with myocardial infarction (MI) in 2165 cases and 2153 controls. The GRSs were computed in 34 general European populations. Although the contribution of these GRS was lower than 1% between cases and controls, the mean GRS per population was positively correlated with coronary incidence explaining 65-85% of the variation among populations (67% in women and 86% in men). This large contribution to CAD incidence variation among populations might be a result of colinearity with several other common genetic and environmental factors. These results are not consistent with the cardiovascular Mediterranean paradox for genetics and support a CAD genetic architecture mainly based on combinations of common genetic polymorphisms. Population genetic risk scores is a promising approach in public health interventions to develop lifestyle programs and prevent intermediate risk factors in certain subpopulations with specific genetic predisposition.	[Carreras-Torres, Robert; Zanetti, Daniela; Esteban, Esther; Moral, Pedro] Univ Barcelona, Dept Biol Anim Antropol, Barcelona, Spain; [Kundu, Suman] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Esteban, Esther; Moral, Pedro] Univ Barcelona, Inst Recerca Biodiversitat IRBio, Barcelona, Spain; [Via, Marc] Univ Barcelona, Dept Psiquiatria & Psicobiol Clin, Barcelona, Spain; [Via, Marc] Univ Barcelona, Inst Brain Cognit & Behav IR3C, Barcelona, Spain	University of Barcelona; Erasmus University Rotterdam; Erasmus MC; University of Barcelona; University of Barcelona; University of Barcelona	Moral, P (corresponding author), Univ Barcelona, Dept Biol Anim Antropol, Barcelona, Spain.	pmoral@ub.edu	Carreras-Torres, Robert/E-3887-2019; Moral, Pedro/K-9587-2014; Via, Marc/L-6511-2014; Kundu, Suman/I-2603-2019; Zanetti, Daniela/AAF-2297-2020; Esteban, M. Esther/K-9900-2014	Carreras-Torres, Robert/0000-0002-2925-734X; Moral, Pedro/0000-0001-5072-5892; Via, Marc/0000-0002-9966-9921; Kundu, Suman/0000-0002-6305-2559; Zanetti, Daniela/0000-0002-1225-1021; Esteban, M. Esther/0000-0002-2410-9700	Ministerio de Ciencia y Tecnologia [CGL2008-03955, CGL2011-27866]	Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research has been supported by the Ministerio de Ciencia y Tecnologia CGL2008-03955 and CGL2011-27866 projects to PM (http://www.idi.mineco.gob.es/); the Ministerio de Ciencia y Tecnologia Predoctoral Grant (BES-2009-016334) and Travel Grant (EEBB-2011-44310) to RCT ( http://www.idi.mineco.gob.es/); and the Beatriu de Pinos postdoctoral grant (2009 BP-B 00274) to MV (http://www10.gencat.cat/agaur_web/ AppJava/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; ARTAUDWILD SM, 1993, CIRCULATION, V88, P2771, DOI 10.1161/01.CIR.88.6.2771; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Barbujani G, 2004, ANNU REV GENOM HUM G, V5, P119, DOI 10.1146/annurev.genom.5.061903.180021; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Batsis JA, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-29; Bolton JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057310; Brautbar A, 2012, ATHEROSCLEROSIS, V223, P421, DOI 10.1016/j.atherosclerosis.2012.05.035; Bronte-Stewart B, 1956, POSTGRAD MED J, V35, P180; Casas JP, 2006, AM J EPIDEMIOL, V164, P921, DOI 10.1093/aje/kwj302; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Chikhi L, 1998, HUM BIOL, V70, P643; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Fu LY, 2009, J HYPERTENS, V27, P991, DOI 10.1097/HJH.0b013e3283294bec; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hughes MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040922; Ioannidis JPA, 2009, CIRC-CARDIOVASC GENE, V2, P7, DOI 10.1161/CIRCGENETICS.108.833392; Iwai N, 2004, J HYPERTENS, V22, P1119, DOI 10.1097/00004872-200406000-00012; Janssens ACJW, 2006, GENET MED, V8, P395, DOI 10.1097/01.gim.0000229689.18263.f4; Janssens ACJW, 2009, GENOME MED, V1, DOI 10.1186/gm20; Janssens ACJW, 2008, HUM MOL GENET, V17, pR166, DOI 10.1093/hmg/ddn250; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Keys A., 1980, 7 COUNTRIES MULTIVAR, P1; Kundu S, 2011, EUR J EPIDEMIOL, V26, P261, DOI 10.1007/s10654-011-9567-4; Kunnas TA, 2003, EUR J CLIN INVEST, V33, P1032, DOI 10.1111/j.1365-2362.2003.01271.x; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Lao O, 2008, ANN HUM GENET, V72, P48, DOI 10.1111/j.1469-1809.2007.00387.x; Li JY, 2010, CARDIOLOGY, V116, P271, DOI 10.1159/000316063; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Morris BJ, 2001, CLIN SCI, V100, P551, DOI 10.1042/CS20000223; Morrison AC, 2007, AM J EPIDEMIOL, V166, P28, DOI 10.1093/aje/kwm060; Mueller-Nordhorn J, 2008, EUR HEART J, V29, P1316, DOI 10.1093/eurheartj/ehm604; Mungrue IN, 2003, ACTA PHYSIOL SCAND, V179, P123, DOI 10.1046/j.1365-201X.2003.01182.x; Organization WH, 2016, GLOBAL STATUS REPORT; Paternoster L, 2010, CIRC-CARDIOVASC GENE, V3, P15, DOI 10.1161/CIRCGENETICS.108.834366; Paynter NP, 2010, JAMA-J AM MED ASSOC, V303, P631, DOI 10.1001/jama.2010.119; Pereira TV, 2007, J HYPERTENS, V25, P1763, DOI 10.1097/HJH.0b013e3281de740d; Prins BP, 2012, ATHEROSCLEROSIS, V225, P1, DOI 10.1016/j.atherosclerosis.2012.05.015; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Relethford JH, 2008, AM J PHYS ANTHROPOL, V136, P1, DOI 10.1002/ajpa.20789; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Ripatti S, 2010, LANCET, V376, P1393, DOI 10.1016/S0140-6736(10)61267-6; Robb GB, 2004, J BIOL CHEM, V279, P37982, DOI 10.1074/jbc.M400271200; Rosenberg MS, 2011, METHODS ECOL EVOL, V2, P229, DOI 10.1111/j.2041-210X.2010.00081.x; Ruidavets JB, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6077; SOKAL RR, 1989, AM J PHYS ANTHROPOL, V80, P267, DOI 10.1002/ajpa.1330800302; Stahl EA, 2012, NAT GENET, V44, P483, DOI 10.1038/ng.2232; Stengard JH, 1998, HUM GENET, V103, P234, DOI 10.1007/s004390050811; STEWART AW, 1994, INT J EPIDEMIOL, V23, P505; Thanassoulis G, 2012, CIRC-CARDIOVASC GENE, V5, P113, DOI 10.1161/CIRCGENETICS.111.961342; Thanassoulis G, 2010, CIRCULATION, V122, P2323, DOI 10.1161/CIRCULATIONAHA.109.909309; Thioulouse J, 1995, ENVIRON ECOL STAT, V2, P1, DOI 10.1007/BF00452928; Tunstall-Pedoe H, 1999, LANCET, V353, P1547, DOI 10.1016/S0140-6736(99)04021-0; TUNSTALLPEDOE H, 1988, BRIT MED J, V297, P1559, DOI 10.1136/bmj.297.6663.1559; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Vaarhorst AAM, 2012, CIRC-CARDIOVASC GENE, V5, P202, DOI 10.1161/CIRCGENETICS.111.960708; van der Net JB, 2009, AM HEART J, V158, P105, DOI 10.1016/j.ahj.2009.04.022; WHO, 2004, GLOB BURD DIS 2004; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Zhang K, 2012, THROMB RES, V130, P192, DOI 10.1016/j.thromres.2012.02.015; Zintzaras E, 2006, HYPERTENSION, V48, P700, DOI 10.1161/01.HYP.0000238124.91161.02	68	10	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96504	10.1371/journal.pone.0096504	http://dx.doi.org/10.1371/journal.pone.0096504			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806096	Green Published, gold, Green Submitted			2022-12-27	WOS:000335728900063
J	Sanderson, WC; Scherbov, S				Sanderson, Warren C.; Scherbov, Sergei			Measuring the Speed of Aging across Population Subgroups	PLOS ONE			English	Article							HANDGRIP STRENGTH; MORTALITY; COHORT; AGE	People in different subgroups age at different rates. Surveys containing biomarkers can be used to assess these subgroup differences. We illustrate this using hand-grip strength to produce an easily interpretable, physical-based measure that allows us to compare characteristic-based ages across educational subgroups in the United States. Hand-grip strength has been shown to be a good predictor of future mortality and morbidity, and therefore a useful indicator of population aging. Data from the Health and Retirement Survey (HRS) were used. Two education subgroups were distinguished, those with less than a high school diploma and those with more education. Regressions on hand-grip strength were run for each sex and race using age and education, their interactions and other covariates as independent variables. Ages of identical mean hand-grip strength across education groups were compared for people in the age range 60 to 80. The hand-grip strength of 65 year old white males with less education was the equivalent to that of 69.6 (68.2, 70.9) year old white men with more education, indicating that the more educated men had aged more slowly. This is a constant characteristic age, as defined in the Sanderson and Scherbov article "The characteristics approach to the measurement of population aging'' published 2013 in Population and Development Review. Sixty-five year old white females with less education had the same average hand-grip strength as 69.4 (68.2, 70.7) year old white women with more education. African-American women at ages 60 and 65 with more education also aged more slowly than their less educated counterparts. African American men with more education aged at about the same rate as those with less education. This paper expands the toolkit of those interested in population aging by showing how survey data can be used to measure the differential extent of aging across subpopulations.	[Sanderson, Warren C.] SUNY Stony Brook, Dept Econ, Stony Brook, NY 11794 USA; [Sanderson, Warren C.; Scherbov, Sergei] Int Inst Appl Syst Anal, World Populat Program, A-2361 Laxenburg, Austria; [Sanderson, Warren C.; Scherbov, Sergei] Int Inst Appl Syst Anal, Wittgenstein Ctr Demog & Global Human Capital, A-2361 Laxenburg, Austria; [Sanderson, Warren C.; Scherbov, Sergei] Austrian Acad Sci, VID OAW, Vienna Inst Demog, Laxenburg, Austria; [Sanderson, Warren C.; Scherbov, Sergei] Vienna Univ Econ & Business, WU, Laxenburg, Austria	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; International Institute for Applied Systems Analysis (IIASA); International Institute for Applied Systems Analysis (IIASA); Austrian Academy of Sciences	Sanderson, WC (corresponding author), SUNY Stony Brook, Dept Econ, Stony Brook, NY 11794 USA.	warren.sanderson@stonybrook.edu	Scherbov, Sergey/F-3158-2019; Sanderson, Warren/R-3398-2019	Scherbov, Sergey/0000-0001-5902-3790; Scherbov, Sergei/0000-0002-0881-1073; Sanderson, Warren/0000-0002-2205-948X	European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013); ERC [ERC2013-AdG 323947-Re-Ageing]	European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013); ERC(European Research Council (ERC)European Commission)	The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no ERC2013-AdG 323947-Re-Ageing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohannon Richard W, 2008, J Geriatr Phys Ther, V31, P3; Chen PJ, 2012, J AM MED DIR ASSOC, V13, P517, DOI 10.1016/j.jamda.2012.02.002; COOPER R, 2011, PLOS ONE, V0006; Cooper R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4467; Frederiksen H, 2002, GENET EPIDEMIOL, V23, P110, DOI 10.1002/gepi.1127; Klemera P, 2006, MECH AGEING DEV, V127, P240, DOI 10.1016/j.mad.2005.10.004; Levine ME, 2013, J GERONTOL A-BIOL, V68, P667, DOI 10.1093/gerona/gls233; Ling CHY, 2010, CAN MED ASSOC J, V182, P429, DOI 10.1503/cmaj.091278; Ortega FB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7279; Rantanen T, 2012, AGE, V34, P563, DOI 10.1007/s11357-011-9256-y; Sanderson WC, 2013, POPUL DEV REV, V39, P673, DOI 10.1111/j.1728-4457.2013.00633.x	11	32	34	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96289	10.1371/journal.pone.0096289	http://dx.doi.org/10.1371/journal.pone.0096289			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806337	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000335728900043
J	Sun, Y; Yin, QH; Fang, R; Yan, XX; Wang, Y; Bezerianos, A; Tang, HD; Miao, F; Sun, JF				Sun, Yu; Yin, Qihua; Fang, Rong; Yan, Xiaoxiao; Wang, Ying; Bezerianos, Anastasios; Tang, Huidong; Miao, Fei; Sun, Junfeng			Disrupted Functional Brain Connectivity and Its Association to Structural Connectivity in Amnestic Mild Cognitive Impairment and Alzheimer's Disease	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; RESTING-STATE NETWORKS; MODULAR ORGANIZATION; SMALL-WORLD; MATTER LOSS; TOPOLOGICAL PATTERNS; ANATOMICAL NETWORKS; COMMUNITY STRUCTURE; CORTICAL NETWORKS; DYNAMICS	Although anomalies in the topological architecture of whole-brain connectivity have been found to be associated with Alzheimer's disease (AD), our understanding about the progression of AD in a functional connectivity (FC) perspective is still rudimentary and few study has explored the function-structure relations in brain networks of AD patients. By using restingstate functional MRI (fMRI), this study firstly investigated organizational alternations in FC networks in 12 AD patients, 15 amnestic mild cognitive impairment (aMCI) patients, and 14 age-matched healthy aging subjects and found that all three groups exhibit economical small-world network properties. Nonetheless, we found a decline of the optimal architecture in the progression of AD, represented by a more localized modular organization with less efficient local information transfer. Our results also show that aMCI forms a boundary between normal aging and AD and represents a functional continuum between healthy aging and the earliest signs of dementia. Moreover, we revealed a dissociated relationship between the overall FC and structural connectivity (SC) in AD patients. In this study, diffusion tensor imaging tractography was used to map the structural network of the same individuals. The decreased FC-SC coupling may be indicative of more stringent and less dynamic brain function in AD patients. Our findings provided insightful implications for understanding the pathophysiological mechanisms of brain dysfunctions in aMCI and AD patients and demonstrated that functional disorders can be characterized by multimodal neuroimaging-based metrics.	[Sun, Yu; Bezerianos, Anastasios] Natl Univ Singapore, Ctr Life Sci, Singapore Inst Neurotechnol SINAPSE, Singapore 117548, Singapore; [Sun, Yu; Yan, Xiaoxiao; Sun, Junfeng] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Yin, Qihua; Miao, Fei] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Radiol, Shanghai 200030, Peoples R China; [Fang, Rong; Wang, Ying; Tang, Huidong] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Neurol, Shanghai 200030, Peoples R China	National University of Singapore; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Tang, HD (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Neurol, Shanghai 200030, Peoples R China.	tanghuidong@medmail.com.cn; mf11066@rjh.com.cn; jfsun@sjtu.edu.cn	Bezerianos, Tasos/AAC-2499-2022; Sun, Junfeng/D-1590-2010	Bezerianos, Tasos/0000-0002-8199-6000; Sun, Junfeng/0000-0002-7614-7127; SUN, Yu/0000-0002-6666-8586	National Basic Research Program of China (973 Program) [2011CB013304]; Med-X Research Fund of Shanghai Jiao Tong University [YG2012MS09]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Med-X Research Fund of Shanghai Jiao Tong University	This study was supported by National Basic Research Program of China (973 Program) (No. 2011CB013304) and Med-X Research Fund of Shanghai Jiao Tong University (No. YG2012MS09). The founders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Alexander-Bloch AF, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00147; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Bai F, 2012, J NEUROSCI, V32, P4307, DOI 10.1523/JNEUROSCI.5061-11.2012; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chen ZJ, 2008, CEREB CORTEX, V18, P2374, DOI 10.1093/cercor/bhn003; Chen ZJ, 2011, NEUROIMAGE, V56, P235, DOI 10.1016/j.neuroimage.2011.01.010; Cui ZX, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00042; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; de Haan W, 2012, NEUROIMAGE, V59, P3085, DOI 10.1016/j.neuroimage.2011.11.055; Del Sole A, 2008, EUR J NUCL MED MOL I, V35, P1357, DOI 10.1007/s00259-008-0773-6; Delbeuck X, 2003, NEUROPSYCHOL REV, V13, P79, DOI 10.1023/A:1023832305702; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Fan Y, 2011, NEUROIMAGE, V54, P1862, DOI 10.1016/j.neuroimage.2010.07.025; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fornito A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00022; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Frisoni GB, 2002, J NEUROL NEUROSUR PS, V73, P657, DOI 10.1136/jnnp.73.6.657; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; Gogtay N, 2008, P NATL ACAD SCI USA, V105, P15979, DOI 10.1073/pnas.0806485105; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Guo QH, 2009, ALZ DIS ASSOC DIS, V23, P253, DOI 10.1097/WAD.0b013e3181999e92; Guye M, 2008, CURR OPIN NEUROL, V21, P393, DOI 10.1097/WCO.0b013e3283065cfb; Han Y, 2011, NEUROIMAGE, V55, P287, DOI 10.1016/j.neuroimage.2010.11.059; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Hoptman MJ, 2010, SCHIZOPHR RES, V117, P13, DOI 10.1016/j.schres.2009.09.030; Karas GB, 2004, NEUROIMAGE, V23, P708, DOI 10.1016/j.neuroimage.2004.07.006; Kashtan N, 2005, P NATL ACAD SCI USA, V102, P13773, DOI 10.1073/pnas.0503610102; Koch MA, 2002, NEUROIMAGE, V16, P241, DOI 10.1006/nimg.2001.1052; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Liu ZY, 2012, PSYCHIAT RES-NEUROIM, V202, P118, DOI 10.1016/j.pscychresns.2012.03.002; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; MAJ M, 1993, ARCH CLIN NEUROPSYCH, V8, P123, DOI 10.1016/0887-6177(93)90030-5; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Meunier D., 2009, FRONT NEUROINFORM, V30, DOI [10.3389/neuro.11.037.2009, 10.3389/neuro.11.037.2009.eCollection2009]; Meunier D, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00200; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Passingham RE, 2002, NAT REV NEUROSCI, V3, P606, DOI 10.1038/nrn893; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Qi ZG, 2010, NEUROIMAGE, V50, P48, DOI 10.1016/j.neuroimage.2009.12.025; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Rombouts SARB, 2000, NEUROSCI LETT, V285, P231, DOI 10.1016/S0304-3940(00)01067-3; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rykhlevskaia E, 2008, PSYCHOPHYSIOLOGY, V45, P173, DOI 10.1111/j.1469-8986.2007.00621.x; Sanz-Arigita EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013788; Seo EH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053922, 10.1371/journal.pone.0076875]; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tagliazucchi E, 2013, NEUROIMAGE, V70, P327, DOI 10.1016/j.neuroimage.2012.12.073; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2013, JAMA PSYCHIAT, V70, P783, DOI 10.1001/jamapsychiatry.2013.1328; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; Wang JH, 2013, BIOL PSYCHIAT, V73, P472, DOI 10.1016/j.biopsych.2012.03.026; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu K, 2012, HUM BRAIN MAPP, V33, P552, DOI 10.1002/hbm.21232; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yao ZJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001006; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027	79	80	87	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96505	10.1371/journal.pone.0096505	http://dx.doi.org/10.1371/journal.pone.0096505			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806295	Green Published, gold, Green Submitted			2022-12-27	WOS:000335728900064
J	Zhang, QR; Yang, L; Qi, JL; Zhao, YQ; Zhu, TL; Liu, ZH; Liu, XF				Zhang, Qianru; Liao, Yang; Qi, Jianlin; Zhao, Yongqi; Zhu, Tianli; Liu, Zhaohui; Liu, Xufeng			A Visual ERP Study of Impulse Inhibition following a Zaleplon-Induced Nap after Sleep Deprivation	PLOS ONE			English	Article							RESPONSE-INHIBITION; TASK; PERFORMANCE; WAKEFULNESS; MAINTENANCE; POTENTIALS; COMPONENTS; ALERTNESS; COGNITION; CAFFEINE	The side effects of a zaleplon-induced nap as a countermeasure in the reduction of impulse inhibition function decline following 30 h of sleep deprivation (SD) were examined by event-related brain potentials. Sixteen adult participants performed a Go/NoGo task at five time points: (1) baseline; (2) after 30 h of SD; (3) upon sudden awakening, also called 2 h post-drug; (4) 4 h post-drug; and (5) 6 h post-drug. Behavior results show an increase in both reaction time and false alarm rates after SD and sudden awakening, and a marked decrease at 4 h and 6 h post-drug in zaleplon and placebo conditions. However, no difference was observed between the zaleplon condition and the placebo condition. In event-related potential (ERP) reults compared with results obtained under control conditions, NoGo-P3 latencies significantly increased, whereas the Nogo-P3 amplitude decreased after 30 h of SD and sudden awakening in both the zaleplon condition and the placebo condition. These results indicate that SD attenuates resource allocation and error monitoring for NoGo stimuli. In addition, NoGo-P3 latencies were longer in the zaleplon condition compared with the placebo condition at sudden awakening. Additionally, the NoGo-P3 latencies were shorter in the zaleplon condition than in the placebo condition at 4 h and 6 h post-drug. These results indicate that zaleplon at a dose of 10 mg/day may help subjects achieve a better recovery or maintain better impulse inhibition function, although the side effects of zaleplon last at least 2 h post-drug.	[Zhang, Qianru; Liao, Yang; Zhu, Tianli; Liu, Xufeng] Fourth Mil Med Univ, Dept Psychol, Xian 710032, Shaanxi, Peoples R China; [Zhang, Qianru; Liu, Zhaohui] Fourth Mil Med Univ, Dept Rehabil Physioltherapy, Tangdu Hosp, Xian 710032, Shaanxi, Peoples R China; [Qi, Jianlin] Air Force Gen Hosp, Dept Clin Psychol, Beijing, Peoples R China; [Zhao, Yongqi] Acad Mil Med Sci, Inst Basic Med Sci, Beijing, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force General Hospital PLA; Academy of Military Medical Sciences - China	Liu, ZH (corresponding author), Fourth Mil Med Univ, Dept Rehabil Physioltherapy, Tangdu Hosp, Xian 710032, Shaanxi, Peoples R China.	tdllkzy@fmmu.edu.cn; lllfmmu@fmmu.edu.cn	Liao, Yang/A-6479-2016	Liao, Yang/0000-0003-0969-235X	National Key Science and Technology Project of China [2008ZXJ09004-030]	National Key Science and Technology Project of China	This work was supported by the National Key Science and Technology Project of China, Grant No. 2008ZXJ09004-030. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bokura H, 2001, CLIN NEUROPHYSIOLOGY; BONNET MH, 1990, WORK STRESS, V4, P261, DOI 10.1080/02678379008256988; BONNET MH, 1991, SLEEP, V14, P307, DOI 10.1093/sleep/14.4.307; Bruin K. J., 2001, CLIN NEUROPHYSIOLOGY; Burle B, 2004, NEUROSCI LETT, V360, P77, DOI 10.1016/j.neulet.2004.02.034; Chuah YML, 2006, J NEUROSCI, V26, P7156, DOI 10.1523/JNEUROSCI.0906-06.2006; Costa G, 1997, CHRONOBIOL INT, V14, P89, DOI 10.3109/07420529709001147; De Valck E, 2001, J SLEEP RES, V10, P203, DOI 10.1046/j.1365-2869.2001.00260.x; Dinges D. F., 1990, ARE YOU AWAKE COGNIT, P159; DINGES DF, 1986, ELECTROEN CLIN NEURO, V64, P224, DOI 10.1016/0013-4694(86)90170-7; Drummond SPA, 2006, J SLEEP RES, V15, P261, DOI 10.1111/j.1365-2869.2006.00535.x; Drummond SPA, 2004, SLEEP, V27, P445; Elie R, 1999, J CLIN PSYCHIAT, V60, P536, DOI 10.4088/JCP.v60n0806; Falkenstein M, 2002, J PSYCHOPHYSIOL, V16, P167, DOI 10.1027//0269-8803.16.3.167; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Ficca G, 2010, SLEEP MED REV, V14, P249, DOI 10.1016/j.smrv.2009.09.005; Gottselig JM, 2006, J SLEEP RES, V15, P31, DOI 10.1111/j.1365-2869.2006.00497.x; Higuchi S, 2000, CHRONOBIOL INT, V17, P669, DOI 10.1081/CBI-100101073; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Hublin C, 2001, SLEEP, V24, P392, DOI 10.1093/sleep/24.4.392; HUMPHREY DG, 1994, HUM FACTORS, V36, P652, DOI 10.1177/001872089403600407; JODO E, 1992, ELECTROEN CLIN NEURO, V82, P477, DOI 10.1016/0013-4694(92)90054-L; Jones K, 2001, SLEEP MED REV, V5, P463, DOI 10.1053/smrv.2001.0203; Kok A, 1999, ACTA PSYCHOL, V101, P129, DOI 10.1016/S0001-6918(99)00003-7; Kopp B, 1996, PSYCHOPHYSIOLOGY, V33, P282, DOI 10.1111/j.1469-8986.1996.tb00425.x; MATSUMOTO K, 1994, ERGONOMICS, V37, P899, DOI 10.1080/00140139408963699; MORRIS AM, 1992, J OCCUP ENVIRON MED, V34, P1143; Naitoh P, 1982, J Hum Ergol (Tokyo), V11 Suppl, P259; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; Panjwani U, 2010, EUR J APPL PHYSIOL, V108, P549, DOI 10.1007/s00421-009-1222-3; PFEFFERBAUM A, 1985, ELECTROEN CLIN NEURO, V60, P423, DOI 10.1016/0013-4694(85)91017-X; Ray K, 2012, LIFE SCI; Shahid A, 2012, MORNINGNESS EVENINGN, P231; Takahashi M, 2003, SLEEP MED REV, V7, P227, DOI 10.1053/smrv.2002.0241; Takahashi M, 2000, SLEEP, V23, P813; Tietzel AJ, 2001, SLEEP J SLEEP RES SL; Whitmore JN, 2004, AVIAT SPACE ENVIR MD, V75, P29	37	5	5	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e95653	10.1371/journal.pone.0095653	http://dx.doi.org/10.1371/journal.pone.0095653			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806263	Green Published, Green Submitted, gold			2022-12-27	WOS:000335728900022
J	Oliver, RE; Islamovic, E; Obert, DE; Wise, ML; Herrin, LL; Hang, A; Harrison, SA; Ibrahim, A; Marshall, JM; Miclaus, KJ; Lazo, GR; Hu, GS; Jackson, EW				Oliver, Rebekah E.; Islamovic, Emir; Obert, Donald E.; Wise, Mitchell L.; Herrin, Lauri L.; Hang, An; Harrison, Stephen A.; Ibrahim, Amir; Marshall, Juliet M.; Miclaus, Kelci J.; Lazo, Gerard R.; Hu, Gongshe; Jackson, Eric W.			Comparative Systems Biology Reveals Allelic Variation Modulating Tocochromanol Profiles in Barley (Hordeum vulgare L.)	PLOS ONE			English	Article							RICH FRACTION TRF25; VITAMIN-E ACTION; GENETIC DISSECTION; ALPHA-TOCOPHEROL; MOLECULAR-BASIS; I-TASSER; TOCOTRIENOL; ANTIOXIDANT; BIOSYNTHESIS; QTL	Tocochromanols are recognized for nutritional content, plant stress response, and seed longevity. Here we present a systems biological approach to characterize and develop predictive assays for genes affecting tocochromanol variation in barley. Major QTL, detected in three regions of a SNP linkage map, affected multiple tocochromanol forms. Candidate genes were identified through barley/ rice orthology and sequenced in genotypes with disparate tocochromanol profiles. Gene-specific markers, designed based on observed polymorphism, mapped to the originating QTL, increasing R 2 values at the respective loci. Polymorphism within promoter regions corresponded to motifs known to influence gene expression. Quantitative PCR analysis revealed a trend of increased expression in tissues grown at cold temperatures. These results demonstrate utility of a novel method for rapid gene identification and characterization, and provide a resource for efficient development of barley lines with improved tocochromanol profiles.	[Oliver, Rebekah E.] N Dakota State Univ, Dept Plant Sci, Fargo, ND 58105 USA; [Oliver, Rebekah E.; Islamovic, Emir; Obert, Donald E.; Hang, An; Hu, Gongshe; Jackson, Eric W.] USDA ARS, Small Grains & Potato Germplasm Res Unit, Aberdeen, ID USA; [Obert, Donald E.] Limagrain Cereal Seeds, Indiana, PA USA; [Wise, Mitchell L.; Herrin, Lauri L.] USDA ARS, Cereal Crops Res Unit, Madison, WI USA; [Harrison, Stephen A.] Louisiana State Univ, Sch Plant Environm & Soil Sci, Baton Rouge, LA 70803 USA; [Ibrahim, Amir] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; [Marshall, Juliet M.] Univ Idaho Res & Extens, Dept Plant Soil & Entomol Sci, Idaho Falls, ID USA; [Miclaus, Kelci J.] SAS Inst Inc, JMP Genom Dev, Cary, NC USA; [Lazo, Gerard R.] USDA ARS, Western Reg Res Ctr, Albany, CA 94710 USA; [Jackson, Eric W.] Gen Mill Inc, Crop Biosci, Kannapolis, NC USA	North Dakota State University Fargo; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Louisiana State University System; Louisiana State University; Texas A&M University System; Texas A&M University College Station; Idaho; University of Idaho; SAS Institute Inc; United States Department of Agriculture (USDA)	Jackson, EW (corresponding author), Gen Mill Inc, Crop Biosci, Kannapolis, NC USA.	Rebekah.Oliver@ndsu.edu	Lazo, Gerard/A-8900-2009	Lazo, Gerard/0000-0002-9160-2052	United States Department of Agriculture - Agricultural Research Service CRIS project [301]	United States Department of Agriculture - Agricultural Research Service CRIS project	This work was supported by the United States Department of Agriculture - Agricultural Research Service CRIS project 301. SAS Institute Inc., provided support in the form of a salary for author KJM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the "Author Contributions'' section.	Adachi H, 2000, J GERONTOL A-BIOL, V55, pB280, DOI 10.1093/gerona/55.6.B280; [Anonymous], GENETICS; Azzi A, 2000, PROG LIPID RES, V39, P231, DOI 10.1016/S0163-7827(00)00006-0; Barnes P.J, 1983, DEV FOOD SCI, V5B, P1095; Bergman CJ, 2003, CEREAL CHEM, V80, P446, DOI 10.1094/CCHEM.2003.80.4.446; Cahoon EB, 2003, NAT BIOTECHNOL, V21, P1082, DOI 10.1038/nbt853; Chander S, 2008, MOL BREEDING, V22, P353, DOI 10.1007/s11032-008-9180-8; Chang PN, 2009, NUTR CANCER, V61, P357, DOI 10.1080/01635580802567166; Chiaromonte F, 2003, GENOME RES, V13, P2602, DOI 10.1101/gr.1169203; CHURCHILL GA, 1994, GENETICS, V138, P963; Collakova E, 2001, PLANT PHYSIOL, V127, P1113, DOI 10.1104/pp.010421; COONEY RV, 1993, P NATL ACAD SCI USA, V90, P1771, DOI 10.1073/pnas.90.5.1771; Cooper M, 2009, CURR OPIN PLANT BIOL, V12, P231, DOI 10.1016/j.pbi.2009.01.006; Dolde D, 1999, J AM OIL CHEM SOC, V76, P349, DOI 10.1007/s11746-999-0242-9; Drummond AJ, 2011, GENEIOUS V5 5; Dunn MA, 1998, PLANT MOL BIOL, V38, P551, DOI 10.1023/A:1006098132352; Falk J, 2004, PHYTOCHEMISTRY, V65, P2977, DOI 10.1016/j.phytochem.2004.08.047; Fratianni A, 2002, EUR FOOD RES TECHNOL, V215, P353, DOI 10.1007/s00217-002-0566-2; Havaux M, 2005, PLANT CELL, V17, P3451, DOI 10.1105/tpc.105.037036; Islamovic E, 2013, FIELD CROP RES, V154, P91, DOI 10.1016/j.fcr.2013.06.001; Islamovic E, 2013, MOL BREEDING, V31, P15, DOI 10.1007/s11032-012-9764-1; Jackson EW, 2008, CROP SCI, V48, P2141, DOI 10.2135/cropsci2007.11.0658; KamalEldin A, 1996, LIPIDS, V31, P671, DOI 10.1007/BF02522884; Khanna S, 2003, J BIOL CHEM, V278, P43508, DOI 10.1074/jbc.M307075200; Lampi AM, 2008, J AGR FOOD CHEM, V56, P9716, DOI 10.1021/jf801092a; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Liu RX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049836; Matringe M, 2008, PLANT PHYSIOL, V147, P764, DOI 10.1104/pp.108.117614; Matthaus B, 2003, J AM OIL CHEM SOC, V80, P1013, DOI 10.1007/s11746-003-0813-y; Munne-Bosch S, 2004, PLANTA, V218, P323, DOI 10.1007/s00425-003-1126-0; Munne-Bosch S, 2002, CRIT REV PLANT SCI, V21, P31, DOI 10.1016/S0735-2689(02)80037-5; NESARETNAM K, 1995, LIPIDS, V30, P1139, DOI 10.1007/BF02536615; Oliver RE, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-77; PETERSON DM, 1993, CEREAL CHEM, V70, P157, DOI 10.1006/jcrs.1993.1016; PETERSON DM, 1995, CEREAL CHEM, V72, P21; PIIRONEN V, 1986, CEREAL CHEM, V63, P78; Qureshi AA, 2002, ATHEROSCLEROSIS, V161, P199, DOI 10.1016/S0021-9150(01)00619-0; Qureshi AA, 2001, J NUTR BIOCHEM, V12, P318, DOI 10.1016/S0955-2863(01)00144-9; QURESHI AA, 1986, J BIOL CHEM, V261, P544; Rasool AHG, 2008, ARCH PHARM RES, V31, P1212, DOI 10.1007/s12272-001-1291-5; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sattler SE, 2004, PLANT CELL, V16, P1419, DOI 10.1105/tpc.021360; SCHULTZ G, 1985, PHYSIOL PLANTARUM, V64, P123, DOI 10.1111/j.1399-3054.1985.tb01222.x; Sen CK, 2006, LIFE SCI, V78, P2088, DOI 10.1016/j.lfs.2005.12.001; Sen CK, 2000, J BIOL CHEM, V275, P13049, DOI 10.1074/jbc.275.17.13049; SOLL J, 1979, BIOCHEM BIOPH RES CO, V91, P715, DOI 10.1016/0006-291X(79)91939-9; SOLL J, 1980, ARCH BIOCHEM BIOPHYS, V204, P544, DOI 10.1016/0003-9861(80)90066-1; Sookwong P, 2009, J AGR FOOD CHEM, V57, P4620, DOI 10.1021/jf900394t; Theriault A, 1999, CLIN BIOCHEM, V32, P309, DOI 10.1016/S0009-9120(99)00027-2; THOMPSON JN, 1979, J LIQ CHROMATOGR, V2, P327, DOI 10.1080/01483917908060067; Traber MG, 1996, ANNU REV NUTR, V16, P321, DOI 10.1146/annurev.nu.16.070196.001541; Trebst A, 2002, FEBS LETT, V516, P156, DOI 10.1016/S0014-5793(02)02526-7; van Eeuwijk FA, 2010, CURR OPIN PLANT BIOL, V13, P193, DOI 10.1016/j.pbi.2010.01.001; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang S., 2005, WINDOWS QTL CARTOGRA; Watters JL, 2009, CANCER RES, V69, P3833, DOI 10.1158/0008-5472.CAN-08-4640; Wong JC, 2003, CROP SCI, V43, P2257, DOI 10.2135/cropsci2003.2257; Yoshida Y, 2003, CHEM PHYS LIPIDS, V123, P63, DOI 10.1016/S0009-3084(02)00164-0; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702	59	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96276	10.1371/journal.pone.0096276	http://dx.doi.org/10.1371/journal.pone.0096276			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24820172	Green Published, Green Submitted, gold			2022-12-27	WOS:000336653300013
J	Bai, WQ; Xiao, YH; Zhao, J; Song, SQ; Hu, L; Zeng, JY; Li, XB; Hou, L; Luo, M; Li, DM; Pei, Y				Bai, Wen-Qin; Xiao, Yue-Hua; Zhao, Juan; Song, Shui-Qing; Hu, Lin; Zeng, Jian-Yan; Li, Xian-Bi; Hou, Lei; Luo, Ming; Li, De-Mou; Pei, Yan			Gibberellin Overproduction Promotes Sucrose Synthase Expression and Secondary Cell Wall Deposition in Cotton Fibers	PLOS ONE			English	Article							SEED DEVELOPMENT; CELLULOSE SYNTHESIS; BIOSYNTHESIS; INITIATION; ELONGATION; GROWTH; DIFFERENTIATION; OVEREXPRESSION; BINDING; GENE	Bioactive gibberellins (GAs) comprise an important class of natural plant growth regulators and play essential roles in cotton fiber development. To date, the molecular base of GAs' functions in fiber development is largely unclear. To address this question, the endogenous bioactive GA levels in cotton developing fibers were elevated by specifically up-regulating GA 20-oxidase and suppressing GA 2-oxidase via transgenic methods. Higher GA levels in transgenic cotton fibers significantly increased micronaire values, 1000-fiber weight, cell wall thickness and cellulose contents of mature fibers. Quantitative RTPCR and biochemical analysis revealed that the transcription of sucrose synthase gene GhSusA1 and sucrose synthase activities were significantly enhanced in GA overproducing transgenic fibers, compared to the wild-type cotton. In addition, exogenous application of bioactive GA could promote GhSusA1 expression in cultured fibers, as well as in cotton hypocotyls. Our results suggested that bioactive GAs promoted secondary cell wall deposition in cotton fibers by enhancing sucrose synthase expression.	[Bai, Wen-Qin; Xiao, Yue-Hua; Zhao, Juan; Song, Shui-Qing; Hu, Lin; Zeng, Jian-Yan; Li, Xian-Bi; Hou, Lei; Luo, Ming; Li, De-Mou; Pei, Yan] Southwest Univ, Biotechnol Res Ctr, Chongqing, Peoples R China	Southwest University - China	Pei, Y (corresponding author), Southwest Univ, Biotechnol Res Ctr, Chongqing, Peoples R China.	peiyan3@swu.edu.cn			National Natural Science Foundation of China [31130039, 31271769]; Ph.D. Programs Foundation of Southwest University, China [Kb2009007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Southwest University, China	This work was supported by the National Natural Science Foundation of China (31130039 to Y. P. and 31271769 to Y. H. X.) and Ph.D. Programs Foundation of Southwest University, China (Kb2009007 to W. Q. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basra AS, 1999, COTTON FIBERS: DEVELOPMENTAL BIOLOGY, QUALITY IMPROVEMENT, AND TEXTILE PROCESSING, P47; BEASLEY CA, 1973, SCIENCE, V179, P1003, DOI 10.1126/science.179.4077.1003; Bhattacharya A, 2012, PLANT CELL REP, V31, P945, DOI 10.1007/s00299-011-1214-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHOUREY PS, 1981, MOL GEN GENET, V184, P372, DOI 10.1007/BF00352507; Dayan J, 2010, PLANT BIOTECHNOL J, V8, P425, DOI 10.1111/j.1467-7652.2009.00480.x; Debeaujon I, 2003, PLANT CELL, V15, P2514, DOI 10.1105/tpc.014043; Eriksson ME, 2000, NAT BIOTECHNOL, V18, P784, DOI 10.1038/77355; Gou JQ, 2011, NEW PHYTOL, V192, P626, DOI 10.1111/j.1469-8137.2011.03837.x; Haigler CH, 2005, PHYSIOL PLANTARUM, V124, P285, DOI 10.1111/j.1399-3054.2005.00480.x; Haigler CH, 2001, PLANT MOL BIOL, V47, P29, DOI 10.1023/A:1010615027986; Hedden P, 2012, BIOCHEM J, V444, P11, DOI 10.1042/BJ20120245; Hou L, 2008, CHINESE SCI BULL, V53, P2639, DOI 10.1007/s11434-008-0290-9; Iqbal N, 2011, CURR SCI INDIA, V100, P998; Jiang YJ, 2012, PLANT BIOTECHNOL J, V10, P301, DOI 10.1111/j.1467-7652.2011.00662.x; Kim HJ, 2001, PLANT PHYSIOL, V127, P1361, DOI 10.1104/pp.010724; Kurek I, 2002, P NATL ACAD SCI USA, V99, P11109, DOI 10.1073/pnas.162077099; Luo M, 2007, PLANT J, V51, P419, DOI 10.1111/j.1365-313X.2007.03144.x; Magome H, 2013, P NATL ACAD SCI USA, V110, P1947, DOI 10.1073/pnas.1215788110; Nadeau CD, 2011, PLANT PHYSIOL, V156, P897, DOI 10.1104/pp.111.172577; NOLTE KD, 1995, PLANT PHYSIOL, V109, P1285, DOI 10.1104/pp.109.4.1285; Olszewski N, 2002, PLANT CELL, V14, pS61, DOI 10.1105/tpc.010476; Potikha TS, 1999, PLANT PHYSIOL, V119, P849, DOI 10.1104/pp.119.3.849; Qin YM, 2011, CURR OPIN PLANT BIOL, V14, P106, DOI 10.1016/j.pbi.2010.09.010; Ruan YL, 1998, PLANT PHYSIOL, V118, P399, DOI 10.1104/pp.118.2.399; Ruan YL, 2003, PLANT CELL, V15, P952, DOI 10.1105/tpc.010108; Ruan YL, 2007, FUNCT PLANT BIOL, V34, P1, DOI 10.1071/FP06234; Seagull R. W., 2004, Journal of Cotton Science, V8, P105; Singh B, 2009, PLANT CELL REP, V28, P1023, DOI 10.1007/s00299-009-0714-2; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; Vidal AM, 2001, PHYSIOL PLANTARUM, V112, P251, DOI 10.1034/j.1399-3054.2001.1120214.x; Wang HY, 2009, PLANT BIOTECHNOL J, V7, P13, DOI 10.1111/j.1467-7652.2008.00367.x; Xiao YH, 2006, BIOTECHNIQUES, V41, P548, DOI 10.2144/000112295; Xiao YH, 2010, J PLANT PHYSIOL, V167, P829, DOI 10.1016/j.jplph.2010.01.003; Xu SM, 2012, MOL PLANT, V5, P430, DOI 10.1093/mp/ssr090; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Zhang M, 2011, NAT BIOTECHNOL, V29, P453, DOI 10.1038/nbt.1843; Zhao D, 2010, CROP SCI, V50, P1537, DOI 10.2135/cropsci2009.09.0521; Zhu YQ, 2003, PLANT PHYSIOL, V133, P580, DOI 10.1104/pp.103.027052	39	44	53	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96537	10.1371/journal.pone.0096537	http://dx.doi.org/10.1371/journal.pone.0096537			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816840	gold, Green Submitted, Green Published			2022-12-27	WOS:000336838000043
J	Gini, R; Schuemie, MJ; Francesconi, P; Lapi, F; Cricelli, I; Pasqua, A; Gallina, P; Donato, D; Brugaletta, S; Donatini, A; Marini, A; Cricelli, C; Damiani, G; Bellentani, M; van der Lei, J; Sturkenboom, MCJM; Klazinga, NS				Gini, Rosa; Schuemie, Martijn J.; Francesconi, Paolo; Lapi, Francesco; Cricelli, Iacopo; Pasqua, Alessandro; Gallina, Pietro; Donato, Daniele; Brugaletta, Salvatore; Donatini, Andrea; Marini, Alessandro; Cricelli, Claudio; Damiani, Gianfranco; Bellentani, Mariadonata; van der Lei, Johan; Sturkenboom, Miriam C. J. M.; Klazinga, Niek S.			Can Italian Healthcare Administrative Databases Be Used to Compare Regions with Respect to Compliance with Standards of Care for Chronic Diseases?	PLOS ONE			English	Article							SERVICES RESEARCH; QUALITY MEASURES; PERFORMANCE; POPULATION; DELIVERY; OUTCOMES; RECORDS; EUROPE; SYSTEM	Background: Italy has a population of 60 million and a universal coverage single-payer healthcare system, which mandates collection of healthcare administrative data in a uniform fashion throughout the country. On the other hand, organization of the health system takes place at the regional level, and local initiatives generate natural experiments. This is happening in particular in primary care, due to the need to face the growing burden of chronic diseases. Health services research can compare and evaluate local initiatives on the basis of the common healthcare administrative data. However reliability of such data in this context needs to be assessed, especially when comparing different regions of the country. In this paper we investigated the validity of healthcare administrative databases to compute indicators of compliance with standards of care for diabetes, ischaemic heart disease (IHD) and heart failure (HF). Methods: We compared indicators estimated from healthcare administrative data collected by Local Health Authorities in five Italian regions with corresponding estimates from clinical data collected by General Practitioners (GPs). Four indicators of diagnostic follow-up (two for diabetes, one for IHD and one for HF) and four indicators of appropriate therapy (two each for IHD and HF) were considered. Results: Agreement between the two data sources was very good, except for indicators of laboratory diagnostic follow-up in one region and for the indicator of bioimaging diagnostic follow-up in all regions, where measurement with administrative data underestimated quality. Conclusion: According to evidence presented in this study, estimating compliance with standards of care for diabetes, ischaemic heart disease and heart failure from healthcare databases is likely to produce reliable results, even though completeness of data on diagnostic procedures should be assessed first. Performing studies comparing regions using such indicators as outcomes is a promising development with potential to improve quality governance in the Italian healthcare system.	[Gini, Rosa; Francesconi, Paolo] Agenzia Reg Sanita Toscana, Florence, Italy; [Gini, Rosa; Schuemie, Martijn J.; van der Lei, Johan; Sturkenboom, Miriam C. J. M.] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands; [Lapi, Francesco; Cricelli, Claudio] Soc Italiana Med Gen, Florence, Italy; [Cricelli, Iacopo; Pasqua, Alessandro] Genomedics, Florence, Italy; [Gallina, Pietro; Donato, Daniele] Unita Locale Socio Sanit Padova, Padua, Italy; [Brugaletta, Salvatore] Azienda Sanit Prov Ragusa, Ragusa, Italy; [Donatini, Andrea] Assessorato Polit Salute, Bologna, Italy; [Marini, Alessandro] Zona Terr Senigallia, Senigallia, Italy; [Damiani, Gianfranco] Univ Cattolica Sacro Cuore, Rome, Italy; [Bellentani, Mariadonata] Agenzia Nazl Serv Sanit Reg, Rome, Italy; [Klazinga, Niek S.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Amsterdam; Academic Medical Center Amsterdam	Gini, R (corresponding author), Agenzia Reg Sanita Toscana, Florence, Italy.	rosa.gini@ars.toscana.it	Brugaletta, Salvatore/AAJ-2090-2020; Damiani, Gianfranco/K-2782-2016; CRICELLI, Claudio/E-7607-2010	Damiani, Gianfranco/0000-0003-3028-6188; CRICELLI, Claudio/0000-0002-9607-5802; Sturkenboom, Miriam/0000-0003-1360-2388; Schuemie, Martijn/0000-0002-0817-5361; Gini, Rosa/0000-0002-6250-877X	"La Valutazione dei nuovi modelli organizzativi della Medicina Generale", VALORE - Italian Ministry of Health [art.12-bis, d. lgs. 502/1992]; "Integrazione dei contenuti informativi per la gestione sul territorio di pazienti con patologie complesse o con patologie croniche", MATRICE - Italian Ministry of Health in the framework of the MATTONI Program	"La Valutazione dei nuovi modelli organizzativi della Medicina Generale", VALORE - Italian Ministry of Health; "Integrazione dei contenuti informativi per la gestione sul territorio di pazienti con patologie complesse o con patologie croniche", MATRICE - Italian Ministry of Health in the framework of the MATTONI Program	This study was funded by the project named "La Valutazione dei nuovi modelli organizzativi della Medicina Generale", acronym VALORE, funded by the Italian Ministry of Health in the context of regular health research (art.12-bis, d. lgs. 502/1992) and by the project named "Integrazione dei contenuti informativi per la gestione sul territorio di pazienti con patologie complesse o con patologie croniche", acronym MATRICE, funded by the Italian Ministry of Health in the framework of the MATTONI Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality, 2001, GUID PREV QUAL IND H; Barnes KA, 2012, NEW ENGL J MED, V367, P891, DOI 10.1056/NEJMp1204487; Cebul RD, 2011, NEW ENGL J MED, V365, P825, DOI 10.1056/NEJMsa1102519; Costa G, 2011, EPIDEMIOLOGIA PRE S2, V35, P5; Ettelt S, 2011, J HEALTH SERV RES PO, V16, P48, DOI 10.1258/jhsrp.2011.011004; Filippi Alessandro, 2005, Ital Heart J, V6, P49; Francesconi P, 2011, EPIDEMIOL PREV, V35, P128; Gini R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-15; Green ME, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-214; Hansen J, 2011, J HEALTH SERV RES PO, V16, P16, DOI 10.1258/jhsrp.2011.011040; Jaakkimainen RL, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-44; Klazinga N, 2011, J HEALTH SERV RES PO, V16, P38, DOI 10.1258/jhsrp.2011.011042; Marvasti FF, 2012, NEW ENGL J MED, V367, P889, DOI 10.1056/NEJMp1206230; National Institute for Health and Care Excellence, NICE MEN IND; Profili S., 2009, HLTH SYST TRANSIT, V11, P1; Reed M, 2012, ANN INTERN MED, V157, P482, DOI 10.7326/0003-4819-157-7-201210020-00004; Rosano A, 2011, OUT OF POCKET PAYMEN; Saxena S, 2006, J ROY SOC MED, V99, P81, DOI 10.1258/jrsm.99.2.81; Schafer Willemijn, 2011, Qual Prim Care, V19, P77; Solberg LI, 2006, AM J MED QUAL, V21, P310, DOI 10.1177/1062860606289071; Starfield B, 2010, HEALTH AFFAIR, V29, P1030, DOI 10.1377/hlthaff.2010.0002; Tang PC, 2007, J AM MED INFORM ASSN, V14, P10, DOI 10.1197/jamia.M2198; The Organisation for Economic Co-operation and Development, 2013, STRENGTH HLTH INF IN; Visca M, 2013, HEALTH POLICY, V113, P188, DOI 10.1016/j.healthpol.2013.05.016	24	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e95419	10.1371/journal.pone.0095419	http://dx.doi.org/10.1371/journal.pone.0095419			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4LX	24816637	Green Published, gold			2022-12-27	WOS:000336838000015
J	Gurm, HS; Kooiman, J; LaLonde, T; Grines, C; Share, D; Seth, M				Gurm, Hitinder S.; Kooiman, Judith; LaLonde, Thomas; Grines, Cindy; Share, David; Seth, Milan			A Random Forest Based Risk Model for Reliable and Accurate Prediction of Receipt of Transfusion in Patients Undergoing Percutaneous Coronary Intervention	PLOS ONE			English	Article							BLOOD-TRANSFUSION; ROC CURVE; MORTALITY; OUTCOMES; ABILITY; MARKER; IMPACT; AREA	Background: Transfusion is a common complication of Percutaneous Coronary Intervention (PCI) and is associated with adverse short and long term outcomes. There is no risk model for identifying patients most likely to receive transfusion after PCI. The objective of our study was to develop and validate a tool for predicting receipt of blood transfusion in patients undergoing contemporary PCI. Methods: Random forest models were developed utilizing 45 pre-procedural clinical and laboratory variables to estimate the receipt of transfusion in patients undergoing PCI. The most influential variables were selected for inclusion in an abbreviated model. Model performance estimating transfusion was evaluated in an independent validation dataset using area under the ROC curve (AUC), with net reclassification improvement (NRI) used to compare full and reduced model prediction after grouping in low, intermediate, and high risk categories. The impact of procedural anticoagulation on observed versus predicted transfusion rates were assessed for the different risk categories. Results: Our study cohort was comprised of 103,294 PCI procedures performed at 46 hospitals between July 2009 through December 2012 in Michigan of which 72,328 (70%) were randomly selected for training the models, and 30,966 (30%) for validation. The models demonstrated excellent calibration and discrimination (AUC: full model = 0.888 (95% CI 0.877-0.899), reduced model AUC = 0.880 (95% CI, 0.868-0.892), p for difference 0.003, NRI = 2.77%, p = 0.007). Procedural anticoagulation and radial access significantly influenced transfusion rates in the intermediate and high risk patients but no clinically relevant impact was noted in low risk patients, who made up 70% of the total cohort. Conclusions: The risk of transfusion among patients undergoing PCI can be reliably calculated using a novel easy to use computational tool (https://bmc2.org/calculators/transfusion). This risk prediction algorithm may prove useful for both bed side clinical decision making and risk adjustment for assessment of quality.	[Gurm, Hitinder S.; Seth, Milan] Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [Kooiman, Judith] Leiden Univ Med Ctr, Dept Thrombosis & Hemostasis, Leiden, Netherlands; [Kooiman, Judith] Leiden Univ Med Ctr, Dept Nephrol, Leiden, Netherlands; [LaLonde, Thomas] St John Providence Hlth Syst, Dept Internal Med, Detroit, MI USA; [Grines, Cindy] Detroit Med Ctr, Dept Internal Med, Detroit, MI USA; [Share, David] Blue Cross Blue Shield Michigan, Detroit, MI USA	University of Michigan System; University of Michigan; Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); St. John Hospital & Medical Center; Detroit Medical Center	Gurm, HS (corresponding author), Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA.	hgurm@med.umich.edu		Gurm, Hitinder/0000-0002-1646-0218	Blue Cross Blue Shield of Michigan	Blue Cross Blue Shield of Michigan	The BMC2 registry is funded by Blue Cross Blue Shield of Michigan. The sponsor had no role in study design, review or the decision to submit the work for publication. There are no current funding sources for this specific study and no internal or external funding was used to support the work presented in this manuscript.	Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chia CC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003561; Cook NR, 2008, STAT MED, V27, P191, DOI 10.1002/sim.2987; Doyle BJ, 2009, J AM COLL CARDIOL, V53, P2019, DOI 10.1016/j.jacc.2008.12.073; Feit F, 2007, AM J CARDIOL, V100, P1364, DOI 10.1016/j.amjcard.2007.06.026; Gurm HS, 2008, J AM COLL CARDIOL, V51, P529, DOI 10.1016/j.jacc.2007.09.053; Gurm HS, 2013, J AM COLL CARDIOL, V61, P2242, DOI 10.1016/j.jacc.2013.03.026; Jani SM, 2007, CLIN CARDIOL, V30, P49, DOI 10.1002/clc.20236; Koch CG, 2006, ANN THORAC SURG, V81, P1650, DOI 10.1016/j.athoracsur.2005.12.037; Mehta SK, 2009, CIRC-CARDIOVASC INTE, V2, P222, DOI 10.1161/CIRCINTERVENTIONS.108.846741; Moscucci M, 2006, CIRCULATION, V113, P814, DOI 10.1161/CIRCULATIONAHA.105.541995; Ndrepepa G, 2008, J AM COLL CARDIOL, V51, P690, DOI 10.1016/j.jacc.2007.10.040; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004127; Rao SC, 2013, J AM COLL CARDIOL, V61, P1847, DOI 10.1016/j.jacc.2013.02.017; Rao SV, 2004, JAMA-J AM MED ASSOC, V292, P1555, DOI 10.1001/jama.292.13.1555; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Sherwood MW, 2012, CIRCULATION, V126; Shishehbor MH, 2009, JACC-CARDIOVASC INTE, V2, P46, DOI 10.1016/j.jcin.2008.09.011; Steg PG, 2011, EUR HEART J, V32, P1854, DOI 10.1093/eurheartj/ehr204; Touw WG, 2012, BRIEFINGS BIOINFORMA	21	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96385	10.1371/journal.pone.0096385	http://dx.doi.org/10.1371/journal.pone.0096385			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816645	Green Submitted, Green Published, gold			2022-12-27	WOS:000336838000035
J	Li, SM; Chen, R; Li, Y; Yang, ZR; Deng, QJ; Zhong, Z; Ong, ML; Zhan, SY				Li, Shi-Ming; Chen, Ru; Li, Yuan; Yang, Zhi-Rong; Deng, Qiu-Ju; Zhong, Zheng; Ong, Moh-Lim; Zhan, Si-Yan			Meta-Analysis of Randomized Controlled Trials Comparing Latanoprost with Timolol in the Treatment of Asian Populations with Chronic Angle-Closure Glaucoma	PLOS ONE			English	Article							TERM CLINICAL COURSE; PREVALENCE; CHINESE; EFFICACY; DISTRICT; 6-MONTH	Background: To evaluate the efficacy and safety of latanoprost compared with timolol in the treatment of Asian patients with chronic angle-closure glaucoma (CACG). Methods: Relevant trials were identified through systematic searches of Medline, EMBASE, PubMed, Cochrane Library, Google Scholar and several Chinese databases. The main outcome measures included absolute and relative reduction of intraocular pressure (IOP) at mean, peak and trough from baseline, ocular adverse effects and systemic adverse events. Results: Seven randomized controlled trials with 685 patients were included. In comparison with timolol, latanoprost reduced absolute IOP in CACG patients by more than 2.3 mmHg (95% CI, 1.8 similar to 2.9, P<0.01), 2.4 mmHg (95% CI, 1.9 similar to 2.9, P<0.01) and 2.5 mmHg (95% CI, 1.6 similar to 3.3, P<0.01) at mean, peak and trough, respectively. As for relative IOP, there is 9.0% (95% CI, 6.6 similar to 11.4, P<0.01), 9.7% (95% CI, 7.6 similar to 11.8, P<0.01), and 10.8% (95% CI, 7.4 similar to 14.3, P<0.01) greater reduction among latanoprost users than among timolol users. The differences were statistically significant at all time points (1, 2, 4, 8, 12, and 24 weeks). More ocular adverse effects (OR = 1.49, 95% CI, 1.05 similar to 2.10, P = 0.02) and less systemic adverse events (OR = 0.46, 95% CI, 0.25 similar to 0.84, P = 0.01) were observed in latanoprost group in comparison with timolol group. Conclusion: Compared with timolol, latanoprost was significantly more effective in lowering IOP of Asian patients with CACG, with higher risk of ocular adverse effects but lower risk of systemic adverse events, and might be a good substitute for CACG patients.	[Li, Shi-Ming] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China; [Chen, Ru; Yang, Zhi-Rong; Zhan, Si-Yan] Peking Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Beijing 100871, Peoples R China; [Li, Yuan; Zhong, Zheng] Pfizer China, Beijing, Peoples R China; [Deng, Qiu-Ju] Peking Univ, Dept Genet, Sch Oncol, Beijing Canc Hosp & Inst, Beijing 100871, Peoples R China; [Ong, Moh-Lim] Pfizer Global Pharmaceut, New York, NY USA	Capital Medical University; Peking University; Pfizer; Peking University; Pfizer	Zhan, SY (corresponding author), Peking Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Beijing 100871, Peoples R China.	siyan-zhan@bjmu.edu.cn			Pfizer China, Beijing	Pfizer China, Beijing(Pfizer)	This study was supported by Pfizer China, Beijing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams KR, 2005, STAT MED, V24, P3823, DOI 10.1002/sim.2423; Alsagoff Z, 2000, OPHTHALMOLOGY, V107, P2300, DOI 10.1016/S0161-6420(00)00385-7; Astin M, 1997, CURR EYE RES, V16, P886, DOI 10.1076/ceyr.16.9.886.5038; Aung T, 2000, OPHTHALMOLOGY, V107, P1178, DOI 10.1016/S0161-6420(00)00073-7; Bourne RRA, 2003, BRIT J OPHTHALMOL, V87, P1069, DOI 10.1136/bjo.87.9.1069; Camras CB, 1996, OPHTHALMOLOGY, V103, P138, DOI 10.1016/S0161-6420(96)30749-5; Cheng JW, 2009, J GLAUCOMA, V18, P652, DOI 10.1097/IJG.0b013e31819c49d4; Chew PTK, 2004, OPHTHALMOLOGY, V111, P427, DOI 10.1016/j.ophtha.2003.06.007; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FOLLMANN D, 1992, J CLIN EPIDEMIOL, V45, P769, DOI 10.1016/0895-4356(92)90054-Q; Foster PJ, 1996, ARCH OPHTHALMOL-CHIC, V114, P1235, DOI 10.1001/archopht.1996.01100140435011; Foster PJ, 2000, ARCH OPHTHALMOL-CHIC, V118, P1105, DOI 10.1001/archopht.118.8.1105; He MG, 2006, INVEST OPHTH VIS SCI, V47, P2782, DOI 10.1167/iovs.06-0051; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; [孔祥梅 Kong Xiangmei], 2005, [中国实用眼科杂志, Chinese Journal of Practical Ophtahalmology], V23, P475; Kook MS, 2005, J OCUL PHARMACOL TH, V21, P75, DOI 10.1089/jop.2005.21.75; Lazarus H M, 1989, Lens Eye Toxic Res, V6, P59; Liu YL, 2006, SHANDONG MED J, V46, P52; MCGALLIARD J N, 1990, Eye (London), V4, P823; PATEL SC, 1995, OPHTHALMIC SURG LAS, V26, P233; Perfetti S, 1998, ACTA OPHTHALMOL SCAN, V76, P52; Ritch R, 2002, J GLAUCOMA, V11, P239, DOI 10.1097/00061198-200206000-00013; ROBIN AL, 1982, ARCH OPHTHALMOL-CHIC, V100, P919, DOI 10.1001/archopht.1982.01030030927004; Rosman M, 2002, OPHTHALMOLOGY, V109, P2227, DOI 10.1016/S0161-6420(02)01275-7; Sihota R, 2004, ARCH OPHTHALMOL-CHIC, V122, P185, DOI 10.1001/archopht.122.2.185; van der Valk R, 2005, OPHTHALMOLOGY, V112, P1177, DOI 10.1016/j.ophtha.2005.01.042; Vijaya L, 2006, ARCH OPHTHALMOL-CHIC, V124, P403, DOI 10.1001/archopht.124.3.403; Wang Ningli, 2002, Zhonghua Yan Ke Za Zhi, V38, P712; Watson P, 1996, OPHTHALMOLOGY, V103, P126, DOI 10.1016/S0161-6420(96)30750-1; Yamamoto T, 2005, OPHTHALMOLOGY, V112, P1661, DOI 10.1016/j.ophtha.2005.05.012; Zhang WY, 2001, BRIT J OPHTHALMOL, V85, P983, DOI 10.1136/bjo.85.8.983; Zhao JL, 2013, J GLAUCOMA, V22, P591, DOI 10.1097/IJG.0b013e31825af33e	35	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96852	10.1371/journal.pone.0096852	http://dx.doi.org/10.1371/journal.pone.0096852			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816233	Green Published, Green Submitted, gold			2022-12-27	WOS:000336838000071
J	Miller, IS; Didier, S; Murray, DW; Turner, TH; Issaivanan, M; Ruggieri, R; Al-Abed, Y; Symons, M				Miller, Ian S.; Didier, Sebastien; Murray, David W.; Turner, Tia H.; Issaivanan, Magimairajan; Ruggieri, Rosamaria; Al-Abed, Yousef; Symons, Marc			Semapimod Sensitizes Glioblastoma Tumors to Ionizing Radiation by Targeting Microglia	PLOS ONE			English	Article							SEVERE CROHNS-DISEASE; TETRAVALENT GUANYLHYDRAZONE; MALIGNANT GLIOMA; NECROSIS-FACTOR; CELL INVASION; GROWTH; SUPPRESSION; CNI-1493; INHIBITION; ACTIVATION	Glioblastoma is the most malignant and lethal form of astrocytoma, with patients having a median survival time of approximately 15 months with current therapeutic modalities. It is therefore important to identify novel therapeutics. There is mounting evidence that microglia (specialized brain-resident macrophages) play a significant role in the development and progression of glioblastoma tumors. In this paper we show that microglia, in addition to stimulating glioblastoma cell invasion, also promote glioblastoma cell proliferation and resistance to ionizing radiation in vitro. We found that semapimod, a drug that selectively interferes with the function of macrophages and microglia, potently inhibits microglia-stimulated GL261 invasion, without affecting serum-stimulated glioblastoma cell invasion. Semapimod also inhibits microglia-stimulated resistance of glioblastoma cells to radiation, but has no significant effect on microglia-stimulated glioblastoma cell proliferation. We also found that intracranially administered semapimod strongly increases the survival of GL261 tumor-bearing animals in combination with radiation, but has no significant benefit in the absence of radiation. In conclusion, our observations indicate that semapimod sensitizes glioblastoma tumors to ionizing radiation by targeting microglia and/or infiltrating macrophages.	[Miller, Ian S.; Didier, Sebastien; Murray, David W.; Turner, Tia H.; Issaivanan, Magimairajan; Ruggieri, Rosamaria; Symons, Marc] Feinstein Inst Med Res North Shore LIJ, Ctr Oncol & Cell Biol, Manhasset, NY 11030 USA; [Al-Abed, Yousef] Feinstein Inst Med Res North Shore LIJ, Ctr Mol Innovat, Manhasset, NY USA	Northwell Health; Northwell Health	Symons, M (corresponding author), Feinstein Inst Med Res North Shore LIJ, Ctr Oncol & Cell Biol, Manhasset, NY 11030 USA.	msymons@nshs.edu		Miller, Ian/0000-0003-2118-6345; Turner, Tia/0000-0002-6284-4933	Voices Against Brain Cancer Foundation Project To Cure Foundation; Feinstein Institute for Medical Research; Bradley Zankel Foundation	Voices Against Brain Cancer Foundation Project To Cure Foundation; Feinstein Institute for Medical Research; Bradley Zankel Foundation	Voices Against Brain Cancer Foundation (www.voicesagainstbraincancer.org) Project To Cure Foundation (www.projecttocure.org). The Feinstein Institute for Medical Research (www.FeinsteinInstitute.org). Bradley Zankel Foundation (www.bradleyzankelfoundation.org). MI is Fr. PJ Mckenna St. Baldrick's scholar (www.stbaldricks.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins HB, 2001, CLIN CANCER RES, V7, P486; Bettinger I, 2002, ACTA NEUROPATHOL, V103, P351, DOI 10.1007/s00401-001-0472-x; Bianchi M, 1996, J EXP MED, V183, P927, DOI 10.1084/jem.183.3.927; BIANCHI M, 1995, MOL MED, V1, P254, DOI 10.1007/BF03401550; Bjork L, 1997, J INFECT DIS, V176, P1303; da Fonseca ACC, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/264124; Charles NA, 2012, GLIA, V60, P502, DOI 10.1002/glia.21264; Cohen PS, 1996, P NATL ACAD SCI USA, V93, P3967, DOI 10.1073/pnas.93.9.3967; Coniglio SJ, 2012, MOL MED, V18, P519, DOI 10.2119/molmed.2011.00217; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Dobrenis K, 1998, METHODS, V16, P320, DOI 10.1006/meth.1998.0688; Dotan I, 2010, GUT, V59, P760, DOI 10.1136/gut.2009.179994; Gabrusiewicz K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023902; Gursel DB, 2012, NEUROSURGERY, V70, pN17, DOI 10.1227/01.neu.0000414945.71472.7d; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hommes D, 2002, GASTROENTEROLOGY, V122, P7, DOI 10.1053/gast.2002.30770; Jacobs VL, 2012, NEURO-ONCOLOGY, V14, P119, DOI 10.1093/neuonc/nor194; Keunen O, 2011, P NATL ACAD SCI USA, V108, P3749, DOI 10.1073/pnas.1014480108; Komohara Y, 2008, J PATHOL, V216, P15, DOI 10.1002/path.2370; Kostianovsky AM, 2008, J IMMUNOL, V181, P5425, DOI 10.4049/jimmunol.181.8.5425; Li W, 2012, NEURO-ONCOLOGY, V14, P958, DOI 10.1093/neuonc/nos116; Lowenberg M, 2005, J IMMUNOL, V175, P2293, DOI 10.4049/jimmunol.175.4.2293; Lowenberg M, 2007, CURR OPIN DRUG DISC, V10, P560; Lu KV, 2012, CANCER CELL, V22, P21, DOI 10.1016/j.ccr.2012.05.037; Maes W, 2011, CANCER IMMUNOL IMMUN, V60, P153, DOI 10.1007/s00262-010-0946-6; Markovic DS, 2009, P NATL ACAD SCI USA, V106, P12530, DOI 10.1073/pnas.0804273106; Meng YR, 2010, CANCER RES, V70, P1534, DOI 10.1158/0008-5472.CAN-09-2995; Pyonteck SM, 2013, NAT MED; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Roggendorf W, 1996, ACTA NEUROPATHOL, V92, P288, DOI 10.1007/s004010050520; Ruffell B, 2012, TRENDS IMMUNOL, V33, P119, DOI 10.1016/j.it.2011.12.001; Squatrito M, 2011, CANCER RES, V71, P5945, DOI 10.1158/0008-5472.CAN-11-1245; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Wesolowska A, 2008, ONCOGENE, V27, P918, DOI 10.1038/sj.onc.1210683; Zhai HY, 2011, GLIA, V59, P472, DOI 10.1002/glia.21117; Zinser E, 2004, IMMUNOBIOLOGY, V209, P89, DOI 10.1016/j.imbio.2004.04.004	37	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e95885	10.1371/journal.pone.0095885	http://dx.doi.org/10.1371/journal.pone.0095885			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816734	Green Submitted, Green Published, gold			2022-12-27	WOS:000336838000018
J	Chen, MM; Crous-Bou, M; Setiawan, VW; Prescott, J; Olson, SH; Wentzensen, N; Black, A; Brinton, L; Chen, C; Chen, C; Cook, LS; Doherty, J; Friedenreich, CM; Hankinson, SE; Hartge, P; Henderson, BE; Hunter, DJ; Le Marchand, L; Liang, XL; Lissowska, J; Lu, LG; Orlow, I; Petruzella, S; Polidoro, S; Pooler, L; Rebbeck, TR; Risch, H; Sacerdote, C; Schumacher, F; Sheng, X; Shu, XO; Weiss, NS; Xia, L; Van den Berg, D; Yang, HP; Yu, H; Chanock, S; Haiman, C; Kraft, P; De Vivo, I				Chen, Maxine M.; Crous-Bou, Marta; Setiawan, Veronica W.; Prescott, Jennifer; Olson, Sara H.; Wentzensen, Nicolas; Black, Amanda; Brinton, Louise; Chen, Chu; Chen, Constance; Cook, Linda S.; Doherty, Jennifer; Friedenreich, Christine M.; Hankinson, Susan E.; Hartge, Patricia; Henderson, Brian E.; Hunter, David J.; Le Marchand, Loic; Liang, Xiaolin; Lissowska, Jolanta; Lu, Lingeng; Orlow, Irene; Petruzella, Stacey; Polidoro, Silvia; Pooler, Loreall; Rebbeck, Timothy R.; Risch, Harvey; Sacerdote, Carlotta; Schumacher, Frederick; Sheng, Xin; Shu, Xiao-ou; Weiss, Noel S.; Xia, Lucy; Van den Berg, David; Yang, Hannah P.; Yu, Herbert; Chanock, Stephen; Haiman, Christopher; Kraft, Peter; De Vivo, Immaculata			Exome-Wide Association Study of Endometrial Cancer in a Multiethnic Population	PLOS ONE			English	Article							PROTEIN-S; GENE-EXPRESSION; PROSTATE-CANCER; RISK; VARIANTS; OBESITY	Endometrial cancer (EC) contributes substantially to total burden of cancer morbidity and mortality in the United States. Family history is a known risk factor for EC, thus genetic factors may play a role in EC pathogenesis. Three previous genome-wide association studies (GWAS) have found only one locus associated with EC, suggesting that common variants with large effects may not contribute greatly to EC risk. Alternatively, we hypothesize that rare variants may contribute to EC risk. We conducted an exome-wide association study (EXWAS) of EC using the Infinium HumanExome BeadChip in order to identify rare variants associated with EC risk. We successfully genotyped 177,139 variants in a multiethnic population of 1,055 cases and 1,778 controls from four studies that were part of the Epidemiology of Endometrial Cancer Consortium (E2C2). No variants reached global significance in the study, suggesting that more power is needed to detect modest associations between rare genetic variants and risk of EC.	[Chen, Maxine M.; Crous-Bou, Marta; Chen, Constance; Hunter, David J.; Kraft, Peter; De Vivo, Immaculata] Harvard Univ, Sch Publ Hlth, Program Genet Epidemiol & Stat Genet, Boston, MA 02115 USA; [Crous-Bou, Marta; Prescott, Jennifer; Hankinson, Susan E.; De Vivo, Immaculata] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Crous-Bou, Marta; Prescott, Jennifer; Hankinson, Susan E.; De Vivo, Immaculata] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Setiawan, Veronica W.; Henderson, Brian E.; Pooler, Loreall; Sheng, Xin; Xia, Lucy; Van den Berg, David; Haiman, Christopher] Univ So Calif, Los Angeles, CA USA; [Olson, Sara H.; Liang, Xiaolin; Orlow, Irene; Petruzella, Stacey] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Wentzensen, Nicolas; Black, Amanda; Brinton, Louise; Yang, Hannah P.; Chanock, Stephen] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Chen, Chu] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Cook, Linda S.] Univ New Mexico, Albuquerque, NM 87131 USA; [Cook, Linda S.; Friedenreich, Christine M.] CancerControl Alberta, Alberta Hlth Serv, Calgary, AB, Canada; [Doherty, Jennifer] Dartmouth Coll, Geisel Sch Med, Hanover, NH 03755 USA; [Hankinson, Susan E.] Univ Massachusetts, Dept Biostat & Epidemiol, Amherst, MA 01003 USA; [Le Marchand, Loic] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA; [Lissowska, Jolanta] M Sklodowska Curie Canc Ctr, Dept Canc Epidemiol & Prevent, Warsaw, Poland; [Lissowska, Jolanta] Inst Oncol, Warsaw, Poland; [Lu, Lingeng; Risch, Harvey] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Polidoro, Silvia; Sacerdote, Carlotta] Ctr Canc Prevent CPO Piemonte, Turin, Italy; [Polidoro, Silvia; Sacerdote, Carlotta] Human Genet Fdn HuGeF, Turin, Italy; [Rebbeck, Timothy R.] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Schumacher, Frederick] Canc Prevent Inst Calif, Fremont, CA USA; [Shu, Xiao-ou] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Weiss, Noel S.] Univ Washington, Seattle, WA 98195 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Southern California; Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Fred Hutchinson Cancer Center; University of New Mexico; Alberta Health Services (AHS); University of Calgary; Dartmouth College; University of Massachusetts System; University of Massachusetts Amherst; Cancer Research Center of Hawaii; University of Hawaii System; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Yale University; University of Pennsylvania; Pennsylvania Medicine; Cancer Prevention Institute of California; Vanderbilt University; University of Washington; University of Washington Seattle	De Vivo, I (corresponding author), Harvard Univ, Sch Publ Hlth, Program Genet Epidemiol & Stat Genet, 665 Huntington Ave, Boston, MA 02115 USA.	nhidv@channing.harvard.edu	Lissowska, Jolanta/AAH-3252-2020; Van Den Berg, David J/G-8598-2017; Polidoro, Silvia/GYJ-3517-2022; Wentzensen, Nicolas/AAG-8522-2019; Rebbeck, Timothy/GLU-8348-2022; Schumacher, Fredrick/R-6043-2019; Crous-Bou, Marta/A-9499-2019; Brinton, Louise A/G-7486-2015	Lissowska, Jolanta/0000-0003-2695-5799; Van Den Berg, David J/0000-0002-5404-5218; Rebbeck, Timothy/0000-0002-4799-1900; Schumacher, Fredrick/0000-0002-3073-7463; Crous-Bou, Marta/0000-0003-1493-4288; Brinton, Louise A/0000-0003-3853-8562; De Vivo, Immaculata/0000-0002-7185-7402; Olson, Sara/0000-0003-0182-2754; Sacerdote, Carlotta/0000-0002-8008-5096; Setiawan, Veronica/0000-0001-9239-5692; Polidoro, Silvia/0000-0003-2968-0575; Friedenreich, Christine/0000-0002-4783-1966; Chen, Maxine/0000-0001-7138-6228; Orlow, Irene/0000-0001-6234-6961	NCI, NIH [1R01 CA134958, 2R01 CA082838, P01 CA087969, R01 CA49449, CA54281, CA128008, R01CA83918, P30-CA008748]; NCI [5T32CA009001-38]; Spanish Ministry of Health, Carlos III Health Institute; NIH [RO1 CA105212, RO1 CA 87538, RO1 CA75977, RO3 CA80636, NO1 HD23166, R35 CA39779, KO5 CA92002]; Fred Hutchinson Cancer Research Center; National Cancer Institute of Canada; Canadian Cancer Society; Canadian Institute for Health Research; Alberta Innovates-Health Solutions; Alberta Cancer Foundation through the Weekend to End Women's Cancers Breast Cancer Chair; Canada Research Chairs program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD023166] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA054281, R35CA039779, P30CA016359, K05CA092002, R01CA083918, R01CA075977, R03CA128008, R01CA054281, P01CA087969, ZIACP010126, R01CA082838, R01CA087538, R01CA049449, T32CA009001, R03CA080636, R01CA134958, R01CA105212, P30CA008748] Funding Source: NIH RePORTER	NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Spanish Ministry of Health, Carlos III Health Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fred Hutchinson Cancer Research Center; National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions; Alberta Cancer Foundation through the Weekend to End Women's Cancers Breast Cancer Chair; Canada Research Chairs program(Canada Research Chairs); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Nurses' Health Study (NHS) investigators are supported by the NCI, NIH Grants Number 1R01 CA134958, 2R01 CA082838, P01 CA087969, and R01 CA49449. MMC is supported by training grant 5T32CA009001-38 from the NCI. MCB is also supported by a Sara Borrell postdoctoral fellowship from the Spanish Ministry of Health, Carlos III Health Institute. The Multiethnic Cohort Study (MEC) is supported by the NCI, NHI Grants Number CA54281, CA128008, and 2R01 CA082838. The Fred Hutchinson Cancer Research Center (FHCRC) is supported by NCI, NIH Grant Number 2R01 CA082838, NIH RO1 CA105212, RO1 CA 87538, RO1 CA75977, RO3 CA80636, NO1 HD23166, R35 CA39779, KO5 CA92002 and funds from the Fred Hutchinson Cancer Research Center. The EDGE Study (Estrogen, Diet, Genetics, and Endometrial Cancer) is supported by NCI, NIH Grants Number 2R01 CA082838, R01CA83918 (Olson PI) and P30-CA008748 (Cancer Center Support Grant). The Alberta Health Services Study (AHS) was supported by operating grants obtained from the National Cancer Institute of Canada with funds from the Canadian Cancer Society and the Canadian Institute for Health Research. The AHS is also supported by NCI, NIH Grant Number 2R01 CA082838. Dr Christine Friedenreich is supported by career awards from Alberta Innovates-Health Solutions and the Alberta Cancer Foundation through the Weekend to End Women's Cancers Breast Cancer Chair. Dr Linda Cook was supported through the Canada Research Chairs program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2013, CANC FACTS FIG 2013; Andersen BD, 2001, THROMB HAEMOSTASIS, V86, P1392, DOI 10.1055/s-0037-1616741; Bergstrom A, 2001, INT J CANCER, V91, P421, DOI 10.1002/1097-0215(200002)9999:9999&lt;::AID-IJC1053&gt;3.0.CO;2-T; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; De Vivo I, 2014, HUM GENET, V133, P211, DOI 10.1007/s00439-013-1369-1; FitzGerald LM, 2013, CANCER EPIDEM BIOMAR, V22, P1520, DOI 10.1158/1055-9965.EPI-13-0345; Fortuny J, 2009, CANCER EPIDEM BIOMAR, V18, P1448, DOI 10.1158/1055-9965.EPI-08-0936; Friedenreich CM, 2010, CANCER CAUSE CONTROL, V21, P1105, DOI 10.1007/s10552-010-9538-1; GRADY D, 1995, OBSTET GYNECOL, V85, P304, DOI 10.1016/0029-7844(94)00383-O; Griffith OL, 2006, J CLIN ONCOL, V24, P5043, DOI 10.1200/JCO.2006.06.7330; Gruber SB, 1996, CANCER EPIDEM BIOMAR, V5, P411; Gylfe AE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003876; Haiman CA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003419; Hindorff LA, 2009, CATALOG PUBLISHED GE; Hughes Q, 2007, J THROMB HAEMOST, V5, P2243, DOI 10.1111/j.1538-7836.2007.02730.x; Huyghe JR, 2013, NAT GENET, V45, P197, DOI 10.1038/ng.2507; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kaaks R, 2002, CANCER EPIDEM BIOMAR, V11, P1531; Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Long JR, 2012, CANCER EPIDEM BIOMAR, V21, P980, DOI 10.1158/1055-9965.EPI-11-1160; Lucenteforte E, 2009, EUR J CANCER PREV, V18, P95, DOI 10.1097/CEJ.0b013e328305a0c9; Olson SH, 2009, CANCER CAUSE CONTROL, V20, P491, DOI 10.1007/s10552-008-9290-y; PERSSON I, 1989, BRIT MED J, V298, P147, DOI 10.1136/bmj.298.6667.147; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Saraon P, 2012, J BIOL CHEM, V287, P34019, DOI 10.1074/jbc.M112.384438; Schmandt RE, 2011, AM J OBSTET GYNECOL, V205, P518, DOI 10.1016/j.ajog.2011.05.042; Setiawan VW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030390; Spurdle AB, 2011, NAT GENET, V43, P451, DOI 10.1038/ng.812; Suzuki A, 2010, J BIOL CHEM, V285, P13444, DOI 10.1074/jbc.M109.062430; Thompson ER, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002894; VASEN HFA, 1994, ANTICANCER RES, V14, P1675; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	34	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e97045	10.1371/journal.pone.0097045	http://dx.doi.org/10.1371/journal.pone.0097045			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810602	Green Published, gold, Green Submitted			2022-12-27	WOS:000338213300113
J	Ebrahimi, M; Aghagolzadeh, P; Shamabadi, N; Tahmasebi, A; Alsharifi, M; Adelson, DL; Hemmatzadeh, F; Ebrahimie, E				Ebrahimi, Mansour; Aghagolzadeh, Parisa; Shamabadi, Narges; Tahmasebi, Ahmad; Alsharifi, Mohammed; Adelson, David L.; Hemmatzadeh, Farhid; Ebrahimie, Esmaeil			Understanding the Underlying Mechanism of HA-Subtyping in the Level of Physic-Chemical Characteristics of Protein	PLOS ONE			English	Article							SUPPORT VECTOR MACHINE; INFLUENZA-A VIRUSES; AMINO-ACID; ENZYME THERMOSTABILITY; FEATURE-SELECTION; BINDING PROTEINS; PREDICTION; FEATURES; CLASSIFICATION; HEMAGGLUTININ	The evolution of the influenza A virus to increase its host range is a major concern worldwide. Molecular mechanisms of increasing host range are largely unknown. Influenza surface proteins play determining roles in reorganization of host-sialic acid receptors and host range. In an attempt to uncover the physic-chemical attributes which govern HA subtyping, we performed a large scale functional analysis of over 7000 sequences of 16 different HA subtypes. Large number (896) of physic-chemical protein characteristics were calculated for each HA sequence. Then, 10 different attribute weighting algorithms were used to find the key characteristics distinguishing HA subtypes. Furthermore, to discover machine leaning models which can predict HA subtypes, various Decision Tree, Support Vector Machine, Naive Bayes, and Neural Network models were trained on calculated protein characteristics dataset as well as 10 trimmed datasets generated by attribute weighting algorithms. The prediction accuracies of the machine learning methods were evaluated by 10-fold cross validation. The results highlighted the frequency of Gln (selected by 80% of attribute weighting algorithms), percentage/frequency of Tyr, percentage of Cys, and frequencies of Try and Glu (selected by 70% of attribute weighting algorithms) as the key features that are associated with HA subtyping. Random Forest tree induction algorithm and RBF kernel function of SVM (scaled by grid search) showed high accuracy of 98% in clustering and predicting HA subtypes based on protein attributes. Decision tree models were successful in monitoring the short mutation/reassortment paths by which influenza virus can gain the key protein structure of another HA subtype and increase its host range in a short period of time with less energy consumption. Extracting and mining a large number of amino acid attributes of HA subtypes of influenza A virus through supervised algorithms represent a new avenue for understanding and predicting possible future structure of influenza pandemics.	[Ebrahimi, Mansour; Shamabadi, Narges] Univ Qom, Sch Basic Sci, Dept Biol, Qom, Iran; [Aghagolzadeh, Parisa] Univ Bern, Dept Nephrol Hypertens & Clin Pharmacol, Bern, Switzerland; [Tahmasebi, Ahmad] Shiraz Univ, Inst Biotechnol, Shiraz, Iran; [Alsharifi, Mohammed; Adelson, David L.; Ebrahimie, Esmaeil] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia; [Hemmatzadeh, Farhid] Univ Adelaide, Sch Anim & Vet Sci, Adelaide, SA, Australia	University of Bern; Shiraz University; University of Adelaide; University of Adelaide	Hemmatzadeh, F (corresponding author), Univ Adelaide, Sch Anim & Vet Sci, Adelaide, SA, Australia.	farhid.hemmatzadeh@adelaide.edu.au; esmaeil.ebrahimie@adelaide.edu.au	Adelson, David L/E-5506-2011; Ebrahimie, Esmaeil/AAN-2611-2020; Ebrahimi, Mansour/AAO-9096-2021	Adelson, David L/0000-0003-2404-5636; Ebrahimie, Esmaeil/0000-0002-4431-2861; Ebrahimi, Mansour/0000-0001-7011-2567; Aghagolzadeh, Parisa/0000-0002-1519-5790; Hemmatzadeh, Farhid/0000-0002-4572-8869	Australian Centre for International Agricultural Research, ACIAR [AH2006-050]	Australian Centre for International Agricultural Research, ACIAR(Australian Ctr Intl Agr Res)	This study has been granted through Australian Centre for International Agricultural Research, ACIAR (Project number: AH2006-050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeola OA, 2009, VET ITAL, V45, P383; Althouse BM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001258; [Anonymous], 2009, NATURE, DOI DOI 10.1038/nature07634; Ashrafi E, 2011, BIOINFORM BIOL INSIG, V5, P59, DOI 10.4137/BBI.S6206; ASHRAFI E, 2011, BIOINFORMAT IN PRESS; Attaluri PK., 2009, BIOT 2009, P21; Baseri S, 2011, ADV STUDIES BIOL, V3, P181; Baumgartner C, 2010, BIOINFORMATICS, V26, P1745, DOI 10.1093/bioinformatics/btq254; Bijanzadeh E, 2010, AUST J CROP SCI, V4, P402; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Byvatov E, 2003, J CHEM INF COMP SCI, V43, P1882, DOI 10.1021/ci0341161; Campitelli L, 1997, VIROLOGY, V232, P310, DOI 10.1006/viro.1997.8514; Cartwright Hugh M., 2008, V458, P1; Collier Nigel, 2011, J Biomed Semantics, V2 Suppl 5, pS9, DOI 10.1186/2041-1480-2-S5-S9; Cui G, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S7-S5; Deng L, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-426; Ding CHQ, 2001, BIOINFORMATICS, V17, P349, DOI 10.1093/bioinformatics/17.4.349; Driskell EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038067; Dugas AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056176; Ebrahimi M, 2011, IRAN J VET RES, V12, P205; Ebrahimi M, 2009, EXCLI J, V8, P218; Ebrahimi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023146; Ebrahimi M, 2010, J RES MED SCI, V15, P299; Ebrahimi M, 2010, CURR BIOINFORM, V5, P195, DOI 10.2174/157489310792006693; EBRAHIMIE E, 2010, J CELL MOL RES, V2, P15; Ebrahimie E, 2011, NATUREPRECEDINGS; Ebrahimie Esmaeil, 2011, Saline Syst, V7, P1, DOI 10.1186/1746-1448-7-1; Fouchier RAM, 2013, NATURE, V500, P150, DOI 10.1038/500150a; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gromiha MM, 2008, PROTEINS, V70, P1274, DOI 10.1002/prot.21616; Gromiha MM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-135; He JK, 2010, PROTEIN ENG DES SEL, V23, P935, DOI 10.1093/protein/gzq078; Hemmatzadeh F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056801; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Herfst S, 2012, J INFECT DIS, V205, P1628, DOI 10.1093/infdis/jis257; Hosseinzadeh F, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-238; Hosseinzadeh F, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040017, 10.1371/annotation/2b218d50-a9d5-45b2-80d0-0e806e530749]; Hu X, 2012, J BIOMED INFORM, V45, P913, DOI 10.1016/j.jbi.2012.03.001; Huang LT, 2006, COMPUT BIOL CHEM, V30, P408, DOI 10.1016/j.compbiolchem.2006.06.004; Huang LT, 2012, J COMPUT AID MOL DES, V26, P339, DOI 10.1007/s10822-012-9560-3; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Imai M, 2012, CURR OPIN VIROL, V2, P160, DOI 10.1016/j.coviro.2012.03.003; Ito Kimihito, 2011, Virus (Nagoya), V61, P3; Kumar M, 2011, J MOL RECOGNIT, V24, P303, DOI 10.1002/jmr.1061; Kuo CC, 2011, IEEE ENG MED BIO, P6281, DOI 10.1109/IEMBS.2011.6091550; Lakijadeh A., 2011, ADV STUDIES BIOL, V3, P63; Li ZB, 2012, ACCIDENT ANAL PREV, V45, P478, DOI 10.1016/j.aap.2011.08.016; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Lin HH, 2006, J LIPID RES, V47, P824, DOI 10.1194/jlr.M500530-JLR200; Liu Jang-Pin, 2006, Journal of Microbiology Immunology and Infection, V39, P4; Macas M, 2012, COMPUT METH PROG BIO, V108, P138, DOI 10.1016/j.cmpb.2012.02.006; Manly B.F.J., 1994, MULTIVARIATE STAT ME; Markowetz F, 2003, BIOMETRICAL J, V45, P377, DOI 10.1002/bimj.200390019; Martinez JG, 2011, AM STAT, V65, P223, DOI 10.1198/tas.2011.11052; McCarthy LC, 2012, AM J OPHTHALMOL, V154, P568, DOI 10.1016/j.ajo.2012.03.021; Miotto O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009025; Niu XH, 2012, PROTEIN PEPTIDE LETT, V19, P940, DOI 10.2174/092986612802084492; Nongpiur ME, 2013, OPHTHALMOLOGY, V120, P48, DOI 10.1016/j.ophtha.2012.07.005; Nunthaboot N, 2010, J CHEM INF MODEL, V50, P1410, DOI 10.1021/ci100038g; Ong SAK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-300; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; Pan CE, 2009, BIOCHEM BIOPH RES CO, V385, P402, DOI 10.1016/j.bbrc.2009.05.064; Patel A. K., 2012, DIG J NANOMATER BIOS, V5, P191; Qi J, 2004, J MOL EVOL, V58, P1, DOI 10.1007/s00239-003-2493-7; Qi J, 2004, J BIOINF COMPUT BIOL, V02, P1; Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251; Radman A, 2011, INT J MOL SCI, V12, P8415, DOI 10.3390/ijms12128415; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; Sahini L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009268; Sawagashira T, 2011, IEEE ENG MED BIO, P6208, DOI 10.1109/IEMBS.2011.6091533; SCHOLTISSEK C, 1985, VIROLOGY, V147, P287, DOI 10.1016/0042-6822(85)90131-X; Sherif FF, 2011, GENOMIC SIGNATURES A, P1; Shinya K, 2004, VIROLOGY, V320, P258, DOI 10.1016/j.virol.2003.11.030; Steinhauer DA, 2013, NATURE, V499, P412, DOI 10.1038/nature12455; Tahrokh E, 2011, GENES GENOM, V33, P565, DOI 10.1007/s13258-011-0057-6; Tamaki T, 2013, MED IMAGE ANAL, V17, P78, DOI 10.1016/j.media.2012.08.003; Tan T, 2012, IEEE T MED IMAGING; Tang ZQ, 2007, BIOINFORM BIOL INSIG, V1, P19; Tsilo LC, 2009, PROTEIN SECONDARY ST; Tsipouras MG, 2012, ARTIF INTELL MED, V55, P127, DOI 10.1016/j.artmed.2012.03.003; Vapnik V., 1995, NATURE STAT; Wang K, 2012, COMB CHEM HIGH THROU; Watanabe T, 2013, NATURE, V501, P551, DOI 10.1038/nature12392; Watanabe T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001218; WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0; Wen X, 2012, ARTIFICIAL NEURAL NE; Westerlund I, 2003, PROTEIN SCI, V12, P2360, DOI 10.1110/ps.0306003; Wu WM, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.2208; Wu XM, 2007, BIOINFORMATICS, V23, P1744, DOI 10.1093/bioinformatics/btm248; Wu ZQ, 2010, POULTRY SCI, V89, P1136, DOI 10.3382/ps.2010-00695; Xia XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037653; Xiong WJ, 2010, PROTEIN J, V29, P427, DOI 10.1007/s10930-010-9269-x; Zhao RH, 1998, J CHROMATOGR A, V828, P489, DOI 10.1016/S0021-9673(98)00589-5; Zhao XW, 2012, INT J MOL SCI, V13, P2196, DOI 10.3390/ijms13022196; Zhao YH, 2008, ADV SPACE RES, V41, P1955, DOI 10.1016/j.asr.2007.07.020; Zhou JF, 2013, NATURE, V499, P500, DOI 10.1038/nature12379; Zhu H., 2011, CURR TOP MICROBIOL I	98	17	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96984	10.1371/journal.pone.0096984	http://dx.doi.org/10.1371/journal.pone.0096984			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809455	Green Published, Green Submitted, gold			2022-12-27	WOS:000338213300102
J	Jia, YH; Sun, XW; Sun, JL; Pan, ZE; Wang, XW; He, SP; Xiao, SH; Shi, WJ; Zhou, ZL; Pang, BY; Wang, LR; Liu, JG; Ma, J; Du, XM; Zhu, J				Jia, Yinhua; Sun, Xiwei; Sun, Junling; Pan, Zhaoe; Wang, Xiwen; He, Shoupu; Xiao, Songhua; Shi, Weijun; Zhou, Zhongli; Pang, Baoyin; Wang, Liru; Liu, Jianguang; Ma, Jun; Du, Xiongming; Zhu, Jun			Association Mapping for Epistasis and Environmental Interaction of Yield Traits in 323 Cotton Cultivars under 9 Different Environments	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; QUANTITATIVE RESISTANCE; MISSING HERITABILITY; LEAF-BLIGHT; POPULATION; MAIZE; QTLS; LINES; FIBER	Improving yield is a major objective for cotton breeding schemes, and lint yield and its three component traits (boll number, boll weight and lint percentage) are complex traits controlled by multiple genes and various environments. Association mapping was performed to detect markers associated with these four traits using 651 simple sequence repeats (SSRs). A mixed linear model including epistasis and environmental interaction was used to screen the loci associated with these four yield traits by 323 accessions of Gossypium hirsutum L. evaluated in nine different environments. 251 significant loci were detected to be associated with lint yield and its three components, including 69 loci with individual effects and all involved in epistasis interactions. These significant loci explain similar to 62.05% of the phenotypic variance (ranging from 49.06% similar to 72.29% for these four traits). It was indicated by high contribution of environmental interaction to the phenotypic variance for lint yield and boll numbers, that genetic effects of SSR loci were susceptible to environment factors. Shared loci were also observed among these four traits, which may be used for simultaneous improvement in cotton breeding for yield traits. Furthermore, consistent and elite loci were screened with -Log(10) (P-value) >8.0 based on predicted effects of loci detected in different environments. There was one locus and 6 pairs of epistasis for lint yield, 4 loci and 10 epistasis for boll number, 15 loci and 2 epistasis for boll weight, and 2 loci and 5 epistasis for lint percentage, respectively. These results provided insights into the genetic basis of lint yield and its components and may be useful for marker-assisted breeding to improve cotton production.	[Jia, Yinhua; Sun, Junling; Pan, Zhaoe; Wang, Xiwen; He, Shoupu; Zhou, Zhongli; Pang, Baoyin; Wang, Liru; Du, Xiongming] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Key Lab Cotton Genet Improvement,Minist Agr, Anyang, Peoples R China; [Sun, Xiwei; Zhu, Jun] Zhejiang Univ, Key Lab Crop Germplasm Resource Zhejiang Prov, Hangzhou 310003, Zhejiang, Peoples R China; [Xiao, Songhua; Liu, Jianguang] Jiangsu Acad Agr Sci, Inst Ind Crops, Nanjing, Jiangsu, Peoples R China; [Shi, Weijun; Ma, Jun] Xinjiang Acad Agr Sci, Econ Crop Res Inst, Urumqi 1, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Ministry of Agriculture & Rural Affairs; Zhejiang University; Jiangsu Academy of Agricultural Sciences	Du, XM (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Key Lab Cotton Genet Improvement,Minist Agr, Anyang, Peoples R China.	duxm@cricaas.com.cn; jzhu@zju.edu.cn	Sun, Xiwei/HGD-7726-2022; Shoupu, He/AAR-5173-2021; Du, Xiongming/AAI-9999-2020; Zhu, Jun/B-9945-2009	Shoupu, He/0000-0001-8434-5484; 	National Science and Technology Support Program of China [2006BAD13B04]; National Basic Research Program of China [2010CB12600, 2011CB109306]	National Science and Technology Support Program of China; National Basic Research Program of China(National Basic Research Program of China)	This work has been funded by the National Science and Technology Support Program of China (2006BAD13B04), and National Basic Research Program of China (2010CB12600, 2011CB109306). The funders had no rule in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brachi B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-232; Campbell BT, 2005, EUPHYTICA, V144, P69, DOI 10.1007/s10681-005-4336-7; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Chen H, 2010, EUPHYTICA, V176, P321, DOI 10.1007/s10681-010-0204-1; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Culverhouse R, 2002, AM J HUM GENET, V70, P461, DOI 10.1086/338759; Godoy AS, 1999, EUPHYTICA, V105, P161, DOI 10.1023/A:1003438032096; He DH, 2005, EUPHYTICA, V144, P141, DOI 10.1007/s10681-005-5297-6; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Kump KL, 2011, NAT GENET, V43, P163, DOI 10.1038/ng.747; Lacape JM, 2013, FIELD CROP RES, V144, P256, DOI 10.1016/j.fcr.2013.01.001; Li H., 2012, NKS266, P1; Liu RZ, 2012, MOL BREEDING, V29, P297, DOI 10.1007/s11032-011-9547-0; Murcray CE, 2009, AM J EPIDEMIOL, V169, P219, DOI 10.1093/aje/kwn353; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Poland JA, 2011, P NATL ACAD SCI USA, V108, P6893, DOI 10.1073/pnas.1010894108; Shen XL, 2006, CROP SCI, V46, P61, DOI 10.2135/cropsci2005.0056; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; van Os J, 2009, AM J PSYCHIAT, V166, P964, DOI 10.1176/appi.ajp.2008.09060904; Yadava SK, 2012, THEOR APPL GENET, V125, P1553, DOI 10.1007/s00122-012-1934-3; Yu JW, 2013, THEOR APPL GENET, V126, P275, DOI 10.1007/s00122-012-1980-x; Zhang TZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057220; Ziegler A, 2008, BIOMETRICAL J, V50, P8, DOI 10.1002/bimj.200710398; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	24	31	34	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e95882	10.1371/journal.pone.0095882	http://dx.doi.org/10.1371/journal.pone.0095882			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810754	Green Published, Green Submitted, gold			2022-12-27	WOS:000338213300015
J	Kallman, T; De Mita, S; Larsson, H; Gyllenstrand, N; Heuertz, M; Parducci, L; Suyama, Y; Lagercrantz, U; Lascoux, M				Kallman, Thomas; De Mita, Stephane; Larsson, Hanna; Gyllenstrand, Niclas; Heuertz, Myriam; Parducci, Laura; Suyama, Yoshihisa; Lagercrantz, Ulf; Lascoux, Martin			Patterns of Nucleotide Diversity at Photoperiod Related Genes in Norway Spruce [Picea abies (L.) Karst.]	PLOS ONE			English	Article							PSEUDO-RESPONSE-REGULATOR; DEMOGRAPHIC HISTORY; CIRCADIAN CLOCK; LINKAGE DISEQUILIBRIUM; ARABIDOPSIS-THALIANA; MULTILOCUS PATTERNS; GLACIAL SURVIVAL; LOCAL ADAPTATION; CLINAL VARIATION; GROWTH RHYTHM	The ability of plants to track seasonal changes is largely dependent on genes assigned to the photoperiod pathway, and variation in those genes is thereby important for adaptation to local day length conditions. Extensive physiological data in several temperate conifer species suggest that populations are adapted to local light conditions, but data on the genes underlying this adaptation are more limited. Here we present nucleotide diversity data from 19 genes putatively involved in photoperiodic response in Norway spruce (Picea abies). Based on similarity to model plants the genes were grouped into three categories according to their presumed position in the photoperiod pathway: photoreceptors, circadian clock genes, and downstream targets. An HKA (Hudson, Kreitman and Aquade) test showed a significant excess of diversity at photoreceptor genes, but no departure from neutrality at circadian genes and downstream targets. Departures from neutrality were also tested with Tajima's D and Fay and Wu's H statistics under three demographic scenarios: the standard neutral model, a population expansion model, and a more complex population split model. Only one gene, the circadian clock gene PaPRR3 with a highly positive Tajima's D value, deviates significantly from all tested demographic scenarios. As the PaPRR3 gene harbours multiple non-synonymous variants it appears as an excellent candidate gene for control of photoperiod response in Norway spruce.	[Kallman, Thomas; Larsson, Hanna; Parducci, Laura; Lagercrantz, Ulf; Lascoux, Martin] Uppsala Univ, Evolutionary Biol Ctr, Dept Ecol & Genet, Uppsala, Sweden; [De Mita, Stephane] INRA Nancy, UMR Interact Arbres Microorganismes, Nancy, France; [Gyllenstrand, Niclas] Swedish Agr Univ, Dept Plant Biol & Forest Genet, Uppsala, Sweden; [Heuertz, Myriam] Forest Res Ctr INIA CIFOR Madrid, Madrid, Spain; [Suyama, Yoshihisa] Tohoku Univ, Grad Sch Agr Sci, Osaki, Japan	Uppsala University; INRAE; Universite de Lorraine; Swedish University of Agricultural Sciences; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Tohoku University	Kallman, T (corresponding author), Uppsala Univ, Evolutionary Biol Ctr, Dept Ecol & Genet, Uppsala, Sweden.	thomas.kallman@ebc.uu.se	Suyama, Yoshihisa/H-6115-2017; Parducci, Laura/B-8918-2012; Heuertz, Myriam/A-7831-2011; Parducci, Laura/H-9355-2019	Suyama, Yoshihisa/0000-0002-3136-5489; Parducci, Laura/0000-0003-1956-4757; Heuertz, Myriam/0000-0002-6322-3645; Parducci, Laura/0000-0003-1956-4757; Lascoux, Martin/0000-0003-1699-9042; Kallman, Thomas/0000-0003-0498-2665	Royal Swedish Academy of Agriculture and Forestry (ksla.se); Swedish Research Council for Environmental, Agricultural Sciences and Spatial Planning; TREESNIPS [QLRT-2001-01973]; EVOLTREE (Framework 6 program EU); NOVELTREE [EUI2008-40 03713]; Linktree and TipTree (Eranet Biodiversity); Nilsson-Ehle foundation	Royal Swedish Academy of Agriculture and Forestry (ksla.se); Swedish Research Council for Environmental, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); TREESNIPS; EVOLTREE (Framework 6 program EU); NOVELTREE; Linktree and TipTree (Eranet Biodiversity); Nilsson-Ehle foundation	Financial support were obtained from the Royal Swedish Academy of Agriculture and Forestry (ksla.se); the Swedish Research Council for Environmental, Agricultural Sciences and Spatial Planning; TREESNIPS, QLRT-2001-01973 (European commission); EVOLTREE (Framework 6 program EU); NOVELTREE, EUI2008-40 03713 (EU); Linktree and TipTree (Eranet Biodiversity); and Nilsson-Ehle foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren J, 2012, NEW PHYTOL, V194, P1112, DOI 10.1111/j.1469-8137.2012.04112.x; Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; Beales J, 2007, THEOR APPL GENET, V115, P721, DOI 10.1007/s00122-007-0603-4; Chen J, 2010, HEREDITY, V104, P3, DOI 10.1038/hdy.2009.88; Chen J, 2012, GENETICS, V191, P865, DOI 10.1534/genetics.112.140749; CLACK T, 1994, PLANT MOL BIOL, V25, P413, DOI 10.1007/BF00043870; De Mita S, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-27; Deng WW, 2011, P NATL ACAD SCI USA, V108, P6680, DOI 10.1073/pnas.1103175108; Ekberg I., 1979, HOLARCTIC ECOL, V2, P255, DOI [10.1111/j.1600-0587.1979.tb01297.x, DOI 10.1111/J.1600-0587.1979.TB01297.X]; ERIKSSON G, 1978, THEOR APPL GENET, V52, P3, DOI 10.1007/BF00273761; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fay JC, 2000, GENETICS, V155, P1405; Fournier-Level A, 2011, SCIENCE, V334, P86, DOI 10.1126/science.1209271; Fowler S, 1999, EMBO J, V18, P4679, DOI 10.1093/emboj/18.17.4679; Giesecke T, 2004, J BIOGEOGR, V31, P1523, DOI 10.1111/j.1365-2699.2004.01095.x; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gyllenstrand N, 2007, PLANT PHYSIOL, V144, P248, DOI 10.1104/pp.107.095802; Gyllenstrand N, 2014, PLANT CELL PHYSIOL, V55, P535, DOI 10.1093/pcp/pct199; Hall D, 2011, MOL ECOL, V20, P1463, DOI 10.1111/j.1365-294X.2011.05014.x; Heuertz M, 2006, GENETICS, V174, P2095, DOI 10.1534/genetics.106.065102; Hicks KA, 2001, PLANT CELL, V13, P1281, DOI 10.1105/tpc.13.6.1281; Holefors A, 2009, PLANT PHYSIOL BIOCH, V47, P105, DOI 10.1016/j.plaphy.2008.11.003; Holliday JA, 2008, NEW PHYTOL, V178, P103, DOI 10.1111/j.1469-8137.2007.02346.x; Holm K, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-109; Hudson RR, 2000, GENETICS, V155, P2011; HUDSON RR, 1987, GENETICS, V116, P153; Ingvarsson PK, 2008, GENETICS, V180, P329, DOI 10.1534/genetics.108.090431; Ingvarsson PK, 2005, GENETICS, V169, P945, DOI 10.1534/genetics.104.034959; Kallman T, 2009, THESIS UPPSALA U SWE; Karlgren A, 2013, PLANT PHYSIOL, V163, P792, DOI 10.1104/pp.113.224139; Karlgren A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060110; Karlgren A, 2011, PLANT PHYSIOL, V156, P1967, DOI 10.1104/pp.111.176206; Keller SR, 2012, MOL BIOL EVOL, V29, P3143, DOI 10.1093/molbev/mss121; Kujala ST, 2012, TREE GENETICS GENOME; LAGERCRANTZ U, 1990, EVOLUTION, V44, P38, DOI 10.1111/j.1558-5646.1990.tb04278.x; Lagercrantz U, 2009, J EXP BOT, V60, P2501, DOI 10.1093/jxb/erp139; Larsson H, 2013, G3-GENES GENOM GENET, V3, P795, DOI 10.1534/g3.112.005462; Li Y, 2010, MOL BIOL EVOL, V27, P1001, DOI 10.1093/molbev/msp301; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liesch R, 2005, TECHNICAL REPORT; Locke JCW, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100102; Ma XF, 2010, GENETICS, V186, P1033, DOI 10.1534/genetics.110.120873; Michael TP, 2003, SCIENCE, V302, P1049, DOI 10.1126/science.1082971; Namroud MC, 2010, J MOL EVOL, V70, P371, DOI 10.1007/s00239-010-9335-1; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nusinow DA, 2011, NATURE, V475, P398, DOI 10.1038/nature10182; Olsen KM, 2002, GENETICS, V160, P1641; Parducci L, 2012, SCIENCE, V335, P1083, DOI 10.1126/science.1216043; Pin PA, 2012, CURR BIOL, V22, P1095, DOI 10.1016/j.cub.2012.04.007; Pyhajarvi T, 2007, GENETICS, V177, P1713, DOI 10.1534/genetics.107.077099; Smith MK, 2007, J STAT SOFTW, V23; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Sperisen C, 2001, MOL ECOL, V10, P257, DOI 10.1046/j.1365-294X.2001.01180.x; St Onge KR, 2011, MOL ECOL, V20, P3306, DOI 10.1111/j.1365-294X.2011.05189.x; Stadler T, 2009, GENETICS, V182, P205, DOI 10.1534/genetics.108.094904; TAJIMA F, 1989, GENETICS, V123, P585; Tollefsrud MM, 2008, MOL ECOL, V17, P4134, DOI 10.1111/j.1365-294X.2008.03893.x; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Vendramin GG, 2000, GENOME, V43, P68, DOI 10.1139/gen-43-1-68; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Wright SI, 2004, GENETICS, V168, P1071, DOI 10.1534/genetics.104.026500	63	13	13	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e95306	10.1371/journal.pone.0095306	http://dx.doi.org/10.1371/journal.pone.0095306			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810273	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000338213300010
J	Lin, YS; Huang, WC; Chen, MS; Hsieh, TS				Lin, Yu-Shih; Huang, Wan-Chen; Chen, Mei-Shya; Hsieh, Tao-Shih			Toward Discovering New Anti-Cancer Agents Targeting Topoisomerase II alpha: A Facile Screening Strategy Adaptable to High Throughput Platform	PLOS ONE			English	Article							STRAND DNA CLEAVAGE; INTERFACIAL INHIBITION; DRUGS; ASSAY; ETOPOSIDE; GYRASE; MODEL	Topoisomerases are a family of vital enzymes capable of resolving topological problems in DNA during various genetic processes. Topoisomerase poisons, blocking reunion of cleaved DNA strands and stabilizing enzyme-mediated DNA cleavage complex, are clinically important antineoplastic and anti-microbial agents. However, the rapid rise of drug resistance that impedes the therapeutic efficacy of these life-saving drugs makes the discovering of new lead compounds ever more urgent. We report here a facile high throughput screening system for agents targeting human topoisomerase IIa (Top2 alpha). The assay is based on the measurement of fluorescence anisotropy of a 29 bp fluorophore-labeled oligonucleotide duplex. Since drug-stabilized Top2 alpha-bound DNA has a higher anisotropy compared with free DNA, this assay can work if one can use a dissociating agent to specifically disrupt the enzyme/DNA binary complexes but not the drug-stabilized ternary complexes. Here we demonstrate that NaClO4, a chaotropic agent, serves a critical role in our screening method to differentiate the drug-stabilized enzyme/DNA complexes from those that are not. With this strategy we screened a chemical library of 100,000 compounds and obtained 54 positive hits. We characterized three of them on this list and demonstrated their effects on the Top2 alpha-mediated reactions. Our results suggest that this new screening strategy can be useful in discovering additional candidates of anti-cancer agents.	[Lin, Yu-Shih; Huang, Wan-Chen; Chen, Mei-Shya; Hsieh, Tao-Shih] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Hsieh, Tao-Shih] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Academia Sinica - Taiwan; Duke University	Hsieh, TS (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan.	thsieh@duke.edu	Huang, Wan-Chen/N-2472-2019	Huang, Wan-Chen/0000-0002-7341-4373	National Research Program for Biopharmaceuticals (ChemBank); National Research Program for Biopharmaceuticals (High-Throughput Screening Resource Center) [NSC-101-2325-B-001-029]; NSC [NSC102-2325, NSC103-2811]	National Research Program for Biopharmaceuticals (ChemBank); National Research Program for Biopharmaceuticals (High-Throughput Screening Resource Center); NSC(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Research Program for Biopharmaceuticals (ChemBank and High-Throughput Screening Resource Center, NSC-101-2325-B-001-029), and NSC (NSC102-2325 and NSC103-2811). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bromberg KD, 2003, J BIOL CHEM, V278, P7406, DOI 10.1074/jbc.M212056200; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chen SH, 2013, ANNU REV BIOCHEM, V82, P139, DOI 10.1146/annurev-biochem-061809-100002; Cheng TJR, 2010, BIOORGAN MED CHEM, V18, P8512, DOI 10.1016/j.bmc.2010.10.036; Collin F, 2011, APPL MICROBIOL BIOT, V92, P479, DOI 10.1007/s00253-011-3557-z; CORBETT AH, 1992, J BIOL CHEM, V267, P683; Deweese JE, 2009, NUCLEIC ACIDS RES, V37, P738, DOI 10.1093/nar/gkn937; Forterre P, 2007, BIOCHIMIE, V89, P427, DOI 10.1016/j.biochi.2006.12.009; Fortune JM, 2000, PROG NUCLEIC ACID RE, V64, P221, DOI 10.1016/S0079-6603(00)64006-0; Jude KM, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt413; LEE MP, 1989, J BIOL CHEM, V264, P21779; LEE MP, 1992, NUCLEIC ACIDS RES, V20, P5027, DOI 10.1093/nar/20.19.5027; LEE MP, 1989, J BIOL CHEM, V264, P13510; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; LUND K, 1990, J BIOL CHEM, V265, P13856; Maxwell A, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gk1054; Mueller-Planitz F, 2006, J BIOL CHEM, V281, P23395, DOI 10.1074/jbc.M604119200; Nitiss JL, 1996, MOL PHARMACOL, V50, P1095; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Pommier Y, 2005, TRENDS PHARMACOL SCI, V26, P138, DOI 10.1016/j.tips.2005.01.008; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Pommier Y, 2009, CHEM REV, V109, P2894, DOI 10.1021/cr900097c; Roychoudhury S, 2003, J BIOMOL SCREEN, V8, P157, DOI 10.1177/1087057103252302; SANDER M, 1985, NUCLEIC ACIDS RES, V13, P1057, DOI 10.1093/nar/13.4.1057; SANDER M, 1983, J BIOL CHEM, V258, P8421; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Shapiro A, 2010, J BIOMOL SCREEN, V15, P1088, DOI 10.1177/1087057110378624; Shapiro AB, 2013, BIOCHEM PHARMACOL, V85, P1269, DOI 10.1016/j.bcp.2013.02.006; Taylor JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058010; Tse-Dinh Y. -C., 2007, Infectious Disorders - Drug Targets, V7, P3, DOI 10.2174/187152607780090748; Tse-Dinh YC, 2009, NUCLEIC ACIDS RES, V37, P731, DOI 10.1093/nar/gkn936; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; Wada S, 2005, CHEM BIODIVERS, V2, P689, DOI 10.1002/cbdv.200590045; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang JC, 2009, UNTANGLING DOUBLE HE; WASSERMAN RA, 1993, CANCER RES, V53, P3591; Wu CC, 2011, SCIENCE, V333, P459, DOI 10.1126/science.1204117; ZECHIEDRICH EL, 1989, BIOCHEMISTRY-US, V28, P6229, DOI 10.1021/bi00441a014; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	40	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e97008	10.1371/journal.pone.0097008	http://dx.doi.org/10.1371/journal.pone.0097008			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809695	Green Published, Green Submitted, gold			2022-12-27	WOS:000338213300105
J	Lin, YA; Zhang, CL; Lan, H; Gao, SB; Liu, HL; Liu, J; Cao, MJ; Pan, GT; Rong, TZ; Zhang, SZ				Lin, Yueai; Zhang, Chenlu; Lan, Hai; Gao, Shibin; Liu, Hailan; Liu, Jian; Cao, Moju; Pan, Guangtang; Rong, Tingzhao; Zhang, Suzhi			Validation of Potential Reference Genes for qPCR in Maize across Abiotic Stresses, Hormone Treatments, and Tissue Types	PLOS ONE			English	Article							REAL-TIME PCR; QUANTITATIVE RT-PCR; INTERNAL CONTROL GENES; TRANSCRIPTION FACTOR GENES; RELIABLE REFERENCE GENES; EXPRESSION NORMALIZATION; HOUSEKEEPING GENES; QRT-PCR; SELECTION; IDENTIFICATION	The reverse transcription quantitative polymerase chain reaction (RT-qPCR) is a powerful and widely used technique for the measurement of gene expression. Reference genes, which serve as endogenous controls ensure that the results are accurate and reproducible, are vital for data normalization. To bolster the literature on reference gene selection in maize, ten candidate reference genes, including eight traditionally used internal control genes and two potential candidate genes from our microarray datasets, were evaluated for expression level in maize across abiotic stresses (cold, heat, salinity, and PEG), phytohormone treatments (abscisic acid, salicylic acid, jasmonic acid, ethylene, and gibberellins), and different tissue types. Three analytical software packages, geNorm, NormFinder, and Bestkeeper, were used to assess the stability of reference gene expression. The results revealed that elongation factor 1 alpha (EF1 alpha), tubulin beta (beta-TUB), cyclophilin (CYP), and eukaryotic initiation factor 4A (EIF4A) were the most reliable reference genes for overall gene expression normalization in maize, while GRP (Glycine-rich RNA-binding protein), GLU1(beta-glucosidase), and UBQ9 (ubiquitin 9) were the least stable and most unsuitable genes. In addition, the suitability of EF1 alpha, beta-TUB, and their combination as reference genes was confirmed by validating the expression of WRKY50 in various samples. The current study indicates the appropriate reference genes for the urgent requirement of gene expression normalization in maize across certain abiotic stresses, hormones, and tissue types.	[Lin, Yueai; Zhang, Chenlu; Lan, Hai; Gao, Shibin; Liu, Hailan; Liu, Jian; Cao, Moju; Pan, Guangtang; Rong, Tingzhao; Zhang, Suzhi] Sichuan Agr Univ, Maize Res Inst, Key Lab Biol & Genet Breeding Maize Southwest Chi, Chengdu, Peoples R China	Sichuan Agricultural University	Zhang, SZ (corresponding author), Sichuan Agr Univ, Maize Res Inst, Key Lab Biol & Genet Breeding Maize Southwest Chi, Chengdu, Peoples R China.	suzhi1026@163.com	Cao, Moju/AAE-5424-2020		National Natural Science Foundation of China [30800687, 31071434]; Ph.D. Programs Foundation of Ministry of Education of China [1.20125103110011]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work is supported by grants from National Natural Science Foundation of China (No. 30800687 and No. 31071434)(http://www.nsfc.gov.cn/Portal0/default152.htm), Ph.D. Programs Foundation of Ministry of Education of China (1.20125103110011)(http://www.moe.gov.cn/publicfiles/business/htmlfiles/moe/moe_249/index.html), Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(http://fund.cscse.edu.cn/Login.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Bajguz A, 2009, PLANT PHYSIOL BIOCH, V47, P1, DOI 10.1016/j.plaphy.2008.10.002; Barsalobres-Cavallari CF, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-1; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Chandna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036918; Chang EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033278; Chen L, 2011, PLANTA, V234, P377, DOI 10.1007/s00425-011-1410-3; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Cruz F, 2009, MOL BREEDING, V23, P607, DOI 10.1007/s11032-009-9259-x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dombrowski JE, 2009, PLANT SCI, V176, P390, DOI 10.1016/j.plantsci.2008.12.005; ECKER JR, 1995, SCIENCE, V268, P667, DOI 10.1126/science.7732375; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Fernandez P, 2011, PLANT CELL REP, V30, P63, DOI 10.1007/s00299-010-0944-3; Gomez J, 1988, GENE INDUCED PLANT H; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hartung W, 2002, J EXP BOT, V53, P27, DOI 10.1093/jexbot/53.366.27; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Huis R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-71; Iskandar HM, 2004, PLANT MOL BIOL REP, V22, P325, DOI 10.1007/BF02772676; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Journot-Catalino N, 2006, PLANT CELL, V18, P3289, DOI 10.1105/tpc.106.044149; Kim BR, 2003, BIOTECHNOL LETT, V25, P1869, DOI 10.1023/A:1026298032009; Langnaese K, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-53; Lee JM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-8; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; Libault M, 2007, MOL PLANT MICROBE IN, V20, P900, DOI 10.1094/MPMI-20-8-0900; Lin YL, 2010, PLANT SCI, V178, P359, DOI 10.1016/j.plantsci.2010.02.005; Liu DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046451; Long XY, 2010, PLANT MOL BIOL, V74, P307, DOI 10.1007/s11103-010-9666-8; Lovdal T, 2009, ANAL BIOCHEM, V387, P238, DOI 10.1016/j.ab.2009.01.024; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Manoli A, 2012, J PLANT PHYSIOL, V169, P807, DOI 10.1016/j.jplph.2012.01.019; Marum L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035113; Mascia T, 2010, MOL PLANT PATHOL, V11, P805, DOI [10.1111/j.1364-3703.2010.00646.x, 10.1111/j.1365-3059.2009.02239.x]; Migocka M, 2011, MOL BREEDING, V28, P343, DOI 10.1007/s11032-010-9487-0; Narsai R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-56; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Ramamoorthy R, 2008, PLANT CELL PHYSIOL, V49, P865, DOI 10.1093/pcp/pcn061; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Schmidt GW, 2010, MOL GENET GENOMICS, V283, P233, DOI 10.1007/s00438-010-0511-1; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Sembdner G., 1994, SIGNALS SIGNAL TRANS, P223, DOI [10.1007/978-94-011-0239-1_13, DOI 10.1007/978-94-011-0239-1_13]; Silveira ED, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-84; Spinsanti G, 2008, AQUAT TOXICOL, V87, P178, DOI 10.1016/j.aquatox.2008.01.018; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Tu LL, 2007, CHINESE SCI BULL, V52, P3110, DOI 10.1007/s11434-007-0461-0; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Xu XP, 2006, PLANT CELL, V18, P1310, DOI 10.1105/tpc.105.037523; Xu YY, 2012, BIOCHEM BIOPH RES CO, V424, P398, DOI 10.1016/j.bbrc.2012.06.119; Yang B, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-68; Zhong HY, 2011, PLANT CELL REP, V30, P641, DOI 10.1007/s00299-010-0992-8; Zhou QY, 2008, PLANT BIOTECHNOL J, V6, P486, DOI 10.1111/j.1467-7652.2008.00336.x; Zhu HT, 2012, MOL BIOTECHNOL, V50, P49, DOI 10.1007/s12033-011-9414-6; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044405	62	116	123	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e95445	10.1371/journal.pone.0095445	http://dx.doi.org/10.1371/journal.pone.0095445			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810581	gold, Green Published, Green Submitted			2022-12-27	WOS:000338213300012
J	Mandelblat-Cerf, Y; Fee, MS				Mandelblat-Cerf, Yael; Fee, Michale S.			An Automated Procedure for Evaluating Song Imitation	PLOS ONE			English	Article							MALE ZEBRA FINCHES; BASAL GANGLIA; FOREBRAIN CIRCUIT; HYPOTHESIS; MECHANISMS; BIRDSONG; SPEECH; COULD	Songbirds have emerged as an excellent model system to understand the neural basis of vocal and motor learning. Like humans, songbirds learn to imitate the vocalizations of their parents or other conspecific "tutors.'' Young songbirds learn by comparing their own vocalizations to the memory of their tutor song, slowly improving until over the course of several weeks they can achieve an excellent imitation of the tutor. Because of the slow progression of vocal learning, and the large amounts of singing generated, automated algorithms for quantifying vocal imitation have become increasingly important for studying the mechanisms underlying this process. However, methodologies for quantifying song imitation are complicated by the highly variable songs of either juvenile birds or those that learn poorly because of experimental manipulations. Here we present a method for the evaluation of song imitation that incorporates two innovations: First, an automated procedure for selecting pupil song segments, and, second, a new algorithm, implemented in Matlab, for computing both song acoustic and sequence similarity. We tested our procedure using zebra finch song and determined a set of acoustic features for which the algorithm optimally differentiates between similar and non-similar songs.	[Mandelblat-Cerf, Yael; Fee, Michale S.] MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Fee, MS (corresponding author), MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, E25-618, Cambridge, MA 02139 USA.	fee@mit.edu		Fee, Michale/0000-0001-7539-1745	National Institutes of Health [R01 MH067105]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding for this work was provided by the National Institutes of Health (R01 MH067105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronov D, 2008, SCIENCE, V320, P630, DOI 10.1126/science.1155140; BAPTISTA LF, 1984, ANIM BEHAV, V32, P172, DOI 10.1016/S0003-3472(84)80335-8; Bottjer SW, 2010, NAT NEUROSCI, V13, P153, DOI 10.1038/nn.2472; CHEVEIGNE A, 2002, J ACOUST SOC AM, V111, P1917; CHILDERS DG, 1977, P IEEE, V65, P1428, DOI 10.1109/PROC.1977.10747; Doupe AJ, 2005, TRENDS NEUROSCI, V28, P353, DOI 10.1016/j.tins.2005.05.005; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Doya K, 1995, NOVEL REINFORCEMENT, P101; Fee MS, 2011, NEUROSCIENCE, V198, P152, DOI 10.1016/j.neuroscience.2011.09.069; Feher O, 2009, NATURE, V459, P564, DOI 10.1038/nature07994; Hanuschkin A, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00106; Ho C, 1998, P JOINT S NEUR COMP, V5, P76; Hoffmann LA, 2012, JOVE-J VIS EXP, V26, P50027; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; Lombardino AJ, 2000, J NEUROSCI, V20, P5054; MARLER P, 1970, AM SCI, V58, P669; NOTTEBOHM F, 1993, NETH J ZOOL, V43, P193, DOI 10.1163/156854293X00296; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Prather JF, 2008, NATURE, V451, P305, DOI 10.1038/nature06492; Ravbar P, 2012, J NEUROSCI, V32, P3422, DOI 10.1523/JNEUROSCI.3740-11.2012; Richard HRH, 2013, VOCAL LEARNING INVER, P547; Roberts TF, 2012, NAT NEUROSCI, V15, P1454, DOI 10.1038/nn.3206; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Tchernichovski O, 1998, P NATL ACAD SCI USA, V95, P8951, DOI 10.1073/pnas.95.15.8951; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Tschida K, 2012, CURR OPIN NEUROBIOL, V22, P320, DOI 10.1016/j.conb.2011.11.006; WILLIAMS H, 1990, ANIM BEHAV, V39, P745, DOI 10.1016/S0003-3472(05)80386-0	30	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96484	10.1371/journal.pone.0096484	http://dx.doi.org/10.1371/journal.pone.0096484			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809510	Green Submitted, Green Published, gold			2022-12-27	WOS:000338213300044
J	Menzel, U; Greiff, V; Khan, TA; Haessler, U; Hellmann, I; Friedensohn, S; Cook, SC; Pogson, M; Reddy, ST				Menzel, Ulrike; Greiff, Victor; Khan, Tarik A.; Haessler, Ulrike; Hellmann, Ina; Friedensohn, Simon; Cook, Skylar C.; Pogson, Mark; Reddy, Sai T.			Comprehensive Evaluation and Optimization of Amplicon Library Preparation Methods for High-Throughput Antibody Sequencing	PLOS ONE			English	Article							B-CELL POPULATIONS; MONOCLONAL-ANTIBODIES; GENE REPERTOIRE; MESSENGER-RNA; PHAGE DISPLAY; T-CELLS; MEMORY; AMPLIFICATION; DIVERSITY; BIAS	High-throughput sequencing (HTS) of antibody repertoire libraries has become a powerful tool in the field of systems immunology. However, numerous sources of bias in HTS workflows may affect the obtained antibody repertoire data. A crucial step in antibody library preparation is the addition of short platform-specific nucleotide adapter sequences. As of yet, the impact of the method of adapter addition on experimental library preparation and the resulting antibody repertoire HTS datasets has not been thoroughly investigated. Therefore, we compared three standard library preparation methods by performing Illumina HTS on antibody variable heavy genes from murine antibody-secreting cells. Clonal overlap and rank statistics demonstrated that the investigated methods produced equivalent HTS datasets. PCR-based methods were experimentally superior to ligation with respect to speed, efficiency, and practicality. Finally, using a two-step PCR based method we established a protocol for antibody repertoire library generation, beginning from inputs as low as 1 ng of total RNA. In summary, this study represents a major advance towards a standardized experimental framework for antibody HTS, thus opening up the potential for systems-based, cross-experiment meta-analyses of antibody repertoires.	[Menzel, Ulrike; Greiff, Victor; Khan, Tarik A.; Haessler, Ulrike; Hellmann, Ina; Friedensohn, Simon; Cook, Skylar C.; Pogson, Mark; Reddy, Sai T.] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Reddy, ST (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland.	sai.reddy@bsse.ethz.ch	Greiff, Victor/I-7686-2019; Reddy, Sai/B-4190-2012	Greiff, Victor/0000-0003-2622-5032; Reddy, Sai/0000-0002-9177-0857; Pogson, Mark/0000-0002-2383-4804; Lischetti, Ulrike/0000-0002-9956-3043; Khan, Tarik/0000-0003-2253-396X	Misrock Foundation; Swiss National Science Foundation; Whitaker Foundation; ETH Zurich Fellowship	Misrock Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Whitaker Foundation; ETH Zurich Fellowship	This work was supported by the The Misrock Foundation (www.misrockfoundation.com) [to STR]; Swiss National Science Foundation [SystemsX.ch RTD project AntibodyX, Marie Heim-Vogtlin fellowship to UH]; Whitaker Foundation [to TAK]; and ETH Zurich Fellowship [to MP]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ademokun A, 2011, AGING CELL, V10, P922, DOI 10.1111/j.1474-9726.2011.00732.x; Adiconis X, 2013, NAT METHODS, V10, P623, DOI 10.1038/nmeth.2483; Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Alon S, 2011, GENOME RES, V21, P1506, DOI 10.1101/gr.121715.111; BACHMANN MF, 1994, J IMMUNOL, V152, P4235; Bashford-Rogers RJM, 2013, GENOME RES, V23, P1874, DOI 10.1101/gr.154815.113; Benichou J, 2012, IMMUNOLOGY, V135, P183, DOI 10.1111/j.1365-2567.2011.03527.x; Carlson CS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3680; Carr D., 2013, HEXBIN HEXAGONAL BIN; Chardes T, 1999, FEBS LETT, V452, P386, DOI 10.1016/S0014-5793(99)00649-3; Cheung WC, 2012, NAT BIOTECHNOL, V30, P447, DOI 10.1038/nbt.2167; Estorninho M, 2013, J IMMUNOL, V191, P5430, DOI 10.4049/jimmunol.1300622; Georgiou G, 2014, NAT BIOTECHNOL, V32, P158, DOI 10.1038/nbt.2782; Greiff V, QUANTITATIVE A UNPUB; Hofer T, 2006, IMMUNOL REV, V211, P295, DOI 10.1111/j.0105-2896.2006.00380.x; Kidd BA, 2014, NAT IMMUNOL, V15, P118, DOI 10.1038/ni.2787; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/nmeth.1778, 10.1038/NMETH.1778]; Krebber A, 1997, J IMMUNOL METHODS, V201, P35, DOI 10.1016/S0022-1759(96)00208-6; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Li S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3333; Lou DI, 2013, P NATL ACAD SCI USA, V110, P19872, DOI 10.1073/pnas.1319590110; Lu J, 2014, MOL IMMUNOL, V57, P274, DOI 10.1016/j.molimm.2013.09.008; Lundberg DS, 2013, NAT METHODS, V10, P999, DOI 10.1038/nmeth.2634; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Mazor Y, 2007, NAT BIOTECHNOL, V25, P563, DOI 10.1038/nbt1296; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; Newell EW, 2014, NAT BIOTECHNOL, V32, P149, DOI 10.1038/nbt.2783; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Raabe CA, 2014, NUCLEIC ACIDS RES, V42, P1414, DOI 10.1093/nar/gkt1021; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Reddy ST, 2011, CURR OPIN BIOTECH, V22, P584, DOI 10.1016/j.copbio.2011.04.015; Reddy ST, 2010, NAT BIOTECHNOL, V28, P965, DOI 10.1038/nbt.1673; Robasky K, 2014, NAT REV GENET, V15, P56, DOI 10.1038/nrg3655; Saggy I, 2012, PROTEIN ENG DES SEL, V25, P539, DOI 10.1093/protein/gzs060; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Shiroguchi K, 2012, P NATL ACAD SCI USA, V109, P1347, DOI 10.1073/pnas.1118018109; 't Hoen PAC, 2013, NAT BIOTECHNOL, V31, P1015, DOI 10.1038/nbt.2702; Team R.C, R LANG ENV STAT COMP; Van Nieuwerburgh F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026969; Vollmers C, 2013, P NATL ACAD SCI USA, V110, P13463, DOI 10.1073/pnas.1312146110; Wang CL, 2010, P NATL ACAD SCI USA, V107, P1518, DOI 10.1073/pnas.0913939107; Warren RL, 2011, GENOME RES, V21, P790, DOI 10.1101/gr.115428.110; Weinstein JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067624; Weinstein JA, 2009, SCIENCE, V324, P807, DOI 10.1126/science.1170020; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wine Y, 2013, P NATL ACAD SCI USA, V110, P2993, DOI 10.1073/pnas.1213737110	51	37	40	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96727	10.1371/journal.pone.0096727	http://dx.doi.org/10.1371/journal.pone.0096727			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809667	Green Published, Green Submitted, gold			2022-12-27	WOS:000338213300065
J	Soler-Toscano, F; Zenil, H; Delahaye, JP; Gauvrit, N				Soler-Toscano, Fernando; Zenil, Hector; Delahaye, Jean-Paul; Gauvrit, Nicolas			Calculating Kolmogorov Complexity from the Output Frequency Distributions of Small Turing Machines	PLOS ONE			English	Article							COMPRESSION; PROGRAMS	Drawing on various notions from theoretical computer science, we present a novel numerical approach, motivated by the notion of algorithmic probability, to the problem of approximating the Kolmogorov-Chaitin complexity of short strings. The method is an alternative to the traditional lossless compression algorithms, which it may complement, the two being serviceable for different string lengths. We provide a thorough analysis for all Sigma(11)(n-1) 2(n) binary strings of length n<12 and for most strings of length 12 <= n <= 16 by running all similar to 2.5 x 10(13) Turing machines with 5 states and 2 symbols (8 x 22(9) with reduction techniques) using the most standard formalism of Turing machines, used in for example the Busy Beaver problem. We address the question of stability and error estimation, the sensitivity of the continued application of the method for wider coverage and better accuracy, and provide statistical evidence suggesting robustness. As with compression algorithms, this work promises to deliver a range of applications, and to provide insight into the question of complexity calculation of finite (and short) strings. Additional material can be found at the Algorithmic Nature Group website at http://www.algorithmicnature.org. An Online Algorithmic Complexity Calculator implementing this technique and making the data available to the research community is accessible at http://www.complexitycalculator.com.	[Soler-Toscano, Fernando] Univ Seville, Grp Log Lenguaje & Informac, Seville, Spain; [Zenil, Hector] Karolinska Inst, Unit Computat Med, Stockholm, Sweden; [Delahaye, Jean-Paul] Univ Lille 1, Lab Informat Fondamentale Lille, Lille, France; [Gauvrit, Nicolas] Ecole Prat Hautes Etud, Paris, France; [Soler-Toscano, Fernando; Zenil, Hector; Delahaye, Jean-Paul; Gauvrit, Nicolas] LABORES, Algorithm Nat Grp, Paris, France	University of Sevilla; Karolinska Institutet; Universite de Lille - ISITE; Universite de Lille; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE)	Zenil, H (corresponding author), Karolinska Inst, Unit Computat Med, Stockholm, Sweden.	hector.zenil@algorithmicnaturelab.org	Soler-Toscano, Fernando/L-2478-2014	Soler-Toscano, Fernando/0000-0003-1953-4136				BRADY AH, 1983, MATH COMPUT, V40, P647, DOI 10.2307/2007539; Brandouy O, 2014, RES INT BUS FINANC, V30, P336, DOI 10.1016/j.ribaf.2012.08.001; CALUDE C, 2002, INFORM RANDOMNESS; Calude CS, 2008, ADV APPL MATH, V40, P295, DOI 10.1016/j.aam.2007.01.001; Calude CS, 2002, EXP MATH, V11, P361, DOI 10.1080/10586458.2002.10504481; CHAITIN GJ, 1969, J ACM, V16, P145, DOI 10.1145/321495.321506; Chaitin GJ, 2011, THESIS U LILLE 1 FRA; CHAITIN Gregory J., 2003, PHILOS PROGRAM SIZE; Cilibrasi R, 2005, IEEE T INFORM THEORY, V51, P1523, DOI 10.1109/TIT.2005.844059; Cover TM, 2006, INFORM THEORY; Delahaye J-P., 2007, RANDOMNESS COMPLEXIT; Delahaye J-P, 2007, ARXIV08043459; Delahaye JP, 2012, APPL MATH COMPUT, V219, P63, DOI 10.1016/j.amc.2011.10.006; Downey RG, 2010, THEOR APPL COMPUT, P401, DOI 10.1007/978-0-387-68441-3; Gauvrit N, 2011, BEHAV RES M IN PRESS; Kirchherr W, 1997, MATH INTELL, V19, P7, DOI 10.1007/BF03024407; Kolmogorov A. N., 1968, International Journal of Computer Mathematics, V2, P157, DOI 10.1080/00207166808803030; Levin L. A., 1974, Problems of Information Transmission, V10, P206; Li M., 2008, INTRO KOLMOGOROV COM; RADO T, 1962, AT&T TECH J, V41, P877, DOI 10.1002/j.1538-7305.1962.tb00480.x; Rivals E, 1996, BIOCHIMIE, V78, P315, DOI 10.1016/0300-9084(96)84763-8; Soler-Toscano F, 2013, COMPUTABILITY, V2, P125, DOI 10.3233/COM-13019; SOLOMONOFF RJ, 1964, INFORM CONTROL, V7, P1, DOI 10.1016/S0019-9958(64)90223-2; Zenil H, 2011, J EC SURVEYS, V25, P463; Zenil H., 2011, THESIS U LILLE 1; Zenil H, 2014, PHYSICA A IN PRESS; Zenil H, 2013, ARXIV12126745CSCC; Zenil H., 2010, INFORM COMPUTATION; Zenil H, RANDOMNESS COMPUTATI; Zenil H, 2013, INT J BIFURCAT CHAOS, V23, DOI 10.1142/S0218127413501599; Zenil H, 2012, COMPLEXITY, V17, P26, DOI 10.1002/cplx.20388; Zenil H, 2010, COMPLEX SYST, V19, P1	33	73	73	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96223	10.1371/journal.pone.0096223	http://dx.doi.org/10.1371/journal.pone.0096223			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809449	Green Submitted, Green Published, gold			2022-12-27	WOS:000338213300022
J	Welch, TDJ; Ting, LH				Welch, Torrence D. J.; Ting, Lena H.			Mechanisms of Motor Adaptation in Reactive Balance Control	PLOS ONE			English	Article							HUMAN POSTURAL RESPONSES; REACHING MOVEMENTS; MUSCLE SYNERGIES; SENSORIMOTOR FEEDBACK; LOCOMOTOR ADAPTATION; IMPEDANCE CONTROL; ERROR-CORRECTION; INTERNAL-MODEL; CENTRAL SET; DYNAMICS	Balance control must be rapidly modified to provide stability in the face of environmental challenges. Although changes in reactive balance over repeated perturbations have been observed previously, only anticipatory postural adjustments preceding voluntary movements have been studied in the framework of motor adaptation and learning theory. Here, we hypothesized that adaptation occurs in task-level balance control during responses to perturbations due to central changes in the control of both anticipatory and reactive components of balance. Our adaptation paradigm consisted of a Training set of forward support-surface perturbations, a Reversal set of novel countermanding perturbations that reversed direction, and a Washout set identical to the Training set. Adaptation was characterized by a change in a motor variable from the beginning to the end of each set, the presence of aftereffects at the beginning of the Washout set when the novel perturbations were removed, and a return of the variable at the end of the Washout to a level comparable to the end of the Training set. Task-level balance performance was characterized by peak center of mass (CoM) excursion and velocity, which showed adaptive changes with repetitive trials. Only small changes in anticipatory postural control, characterized by body lean and background muscle activity were observed. Adaptation was found in the evoked long-latency muscular response, and also in the sensorimotor transformation mediating that response. Finally, in each set, temporal patterns of muscle activity converged towards an optimum predicted by a trade-off between maximizing motor performance and minimizing muscle activity. Our results suggest that adaptation in balance, as well as other motor tasks, is mediated by altering central sensitivity to perturbations and may be driven by energetic considerations.	[Ting, Lena H.] Emory Univ, WH Coulter Dept Biomed Engn, Atlanta, GA 30322 USA; Georgia Inst Technol, Atlanta, GA 30332 USA	Emory University; University System of Georgia; Georgia Institute of Technology	Ting, LH (corresponding author), Emory Univ, WH Coulter Dept Biomed Engn, Atlanta, GA 30322 USA.	lting@emory.edu	Ting, Lena H/I-9311-2014		National Institutes of Health [HD046922-01S1, NS053822]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053822] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by grants from the National Institutes of Health (HD046922-01S1, NS053822). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AA, 2009, J NEUROPHYSIOL, V102, P2816, DOI 10.1152/jn.00532.2009; Bernstein N, 1967, COORDINATION REGULAT; Bingham JT, 2011, J NEUROPHYSIOL, V106, P437, DOI 10.1152/jn.00010.2011; Bunderson N.E., 2008, J BIOMECH; Burdet E, 2001, NATURE, V414, P446, DOI 10.1038/35106566; Carpenter MG, 1999, EXP BRAIN RES, V129, P93, DOI 10.1007/s002210050940; Chong RKY, 1999, EXP BRAIN RES, V124, P513, DOI 10.1007/s002210050647; Conditt MA, 1997, J NEUROPHYSIOL, V78, P554, DOI 10.1152/jn.1997.78.1.554; Crevecoeur F, 2013, J NEUROPHYSIOL, V110, P1323, DOI 10.1152/jn.00216.2013; Crevecoeur F, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003177; Criscimagna-Hemminger SE, 2003, J NEUROPHYSIOL, V89, P168, DOI 10.1152/jn.00622.2002; Finley JM, 2013, J PHYSIOL-LONDON, V591, P1081, DOI 10.1113/jphysiol.2012.245506; Flanagan JR, 1997, J NEUROSCI, V17, P1519; Franklin DW, 2008, J NEUROSCI, V28, P11165, DOI 10.1523/JNEUROSCI.3099-08.2008; Franklin DW, 2004, J NEUROPHYSIOL, V92, P3097, DOI 10.1152/jn.00364.2004; Fransson PA, 2003, IEEE T BIO-MED ENG, V50, P1310, DOI 10.1109/TBME.2003.819851; Fransson PA, 2000, GAIT POSTURE, V12, P14, DOI 10.1016/S0966-6362(00)00052-7; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; Ganesh G, 2010, J NEUROPHYSIOL, V104, P382, DOI 10.1152/jn.01058.2009; Goodbody SJ, 1998, J NEUROPHYSIOL, V79, P1825, DOI 10.1152/jn.1998.79.4.1825; Hall LM, 2010, J NEUROPHYSIOL, V103, P968, DOI 10.1152/jn.00479.2009; Hanes DP, 1999, VISION RES, V39, P2777, DOI 10.1016/S0042-6989(99)00011-5; Hof AL, 2005, J BIOMECH, V38, P1, DOI 10.1016/j.jbiomech.2004.03.025; Horak F, 1996, HDB PHYSIOL 12, V12, P255; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; HORAK FB, 1994, J NEUROPHYSIOL, V72, P479, DOI 10.1152/jn.1994.72.2.479; Horak FB, 1996, ACQUISITION OF MOTOR BEHAVIOR IN VERTEBRATES, P57; HORAK FB, 1989, J NEUROPHYSIOL, V62, P841, DOI 10.1152/jn.1989.62.4.841; Huang HJ, 2012, J NEUROSCI, V32, P2182, DOI 10.1523/JNEUROSCI.4003-11.2012; KESHNER EA, 1987, EXP BRAIN RES, V69, P77; KUO AD, 1993, PROG BRAIN RES, V97, P349; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; Lockhart DB, 2007, NAT NEUROSCI, V10, P1329, DOI 10.1038/nn1986; Malone LA, 2012, J NEUROPHYSIOL, V108, P672, DOI 10.1152/jn.00391.2011; Martin TA, 1996, BRAIN, V119, P1199, DOI 10.1093/brain/119.4.1199; MIALL RC, 1993, J MOTOR BEHAV, V25, P203, DOI 10.1080/00222895.1993.9942050; Morton SM, 2001, EXP BRAIN RES, V141, P438, DOI 10.1007/s002210100889; NASHNER LM, 1976, EXP BRAIN RES, V26, P59; Nijhuis LBO, 2010, J NEUROPHYSIOL, V104, P2704, DOI 10.1152/jn.01080.2009; Safavynia SA, 2013, J NEUROPHYSIOL, V110, P1278, DOI 10.1152/jn.00609.2012; Safavynia SA, 2013, J NEUROPHYSIOL, V109, P31, DOI 10.1152/jn.00684.2012; Sainburg RL, 1999, J NEUROPHYSIOL, V81, P1045, DOI 10.1152/jn.1999.81.3.1045; Scholz JP, 2007, EXP BRAIN RES, V180, P163, DOI 10.1007/s00221-006-0848-1; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 2000, J NEUROSCI, V20, P7807; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Takahashi CD, 2001, J NEUROPHYSIOL, V86, P1047, DOI 10.1152/jn.2001.86.2.1047; Taylor JA, 2007, J NEUROPHYSIOL, V98, P317, DOI 10.1152/jn.01070.2006; Thoroughman KA, 1999, J NEUROSCI, V19, P8573; Timmann D, 1997, BRAIN, V120, P327, DOI 10.1093/brain/120.2.327; Ting LH, 2009, CHAOS, V19, DOI 10.1063/1.3142245; Tokuno CD, 2006, EXP BRAIN RES; Torres-Oviedo G, 2007, J NEUROPHYSIOL, V98, P2144, DOI 10.1152/jn.01360.2006; Torres-Oviedo G, 2006, J NEUROPHYSIOL, V96, P1530, DOI 10.1152/jn.00810.2005; Torres-Oviedo G, 2011, PROG BRAIN RES, V191, P65, DOI 10.1016/B978-0-444-53752-2.00013-8; Torres-Oviedo G, 2010, J NEUROPHYSIOL, V103, P3084, DOI 10.1152/jn.00960.2009; Trumbower RD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005411; Welch TDJ, 2008, J NEUROPHYSIOL, V99, P1032, DOI 10.1152/jn.01110.2007; Welch TDJ, 2009, J NEUROPHYSIOL, V101, P3294, DOI 10.1152/jn.90775.2008; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd; Zar JH, 1999, BIOSTATISTICAL ANAL	62	70	72	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96440	10.1371/journal.pone.0096440	http://dx.doi.org/10.1371/journal.pone.0096440			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810991	Green Published, Green Submitted, gold			2022-12-27	WOS:000338213300037
J	Zhang, JL; Zhou, Y; Zhou, GS; Xiao, CW				Zhang, Jingli; Zhou, Yong; Zhou, Guangsheng; Xiao, Chunwang			Composition and Structure of Pinus koraiensis Mixed Forest Respond to Spatial Climatic Changes	PLOS ONE			English	Article							MIDDAY STOMATAL CLOSURE; SUCCESSION; REGENERATION; CONDUCTANCE; TEMPERATURE; POPULATIONS; GRASSES; IMPACTS; LEAVES; STAND	Background: Although some studies have indicated that climate changes can affect Pinus koraiensis mixed forest, the responses of composition and structure of Pinus koraiensis mixed forests to climatic changes are unknown and the key climatic factors controlling the composition and structure of Pinus koraiensis mixed forest are uncertain. Methodology/principal findings: Field survey was conducted in the natural Pinus koraiensis mixed forests along a latitudinal gradient and an elevational gradient in Northeast China. In order to build the mathematical models for simulating the relationships of compositional and structural attributes of the Pinus koraiensis mixed forest with climatic and non-climatic factors, stepwise linear regression analyses were performed, incorporating 14 dependent variables and the linear and quadratic components of 9 factors. All the selected new models were computed under the +2 degrees C and +10% precipitation and +4 degrees C and +10% precipitation scenarios. The Max Temperature of Warmest Month, Mean Temperature of Warmest Quarter and Precipitation of Wettest Month were observed to be key climatic factors controlling the stand densities and total basal areas of Pinus koraiensis mixed forest. Increased summer temperatures and precipitations strongly enhanced the stand densities and total basal areas of broadleaf trees but had little effect on Pinus koraiensis under the +2 degrees C and +10% precipitation scenario and +4 degrees C and +10% precipitation scenario. Conclusions/significance: These results show that the Max Temperature of Warmest Month, Mean Temperature of Warmest Quarter and Precipitation of Wettest Month are key climatic factors which shape the composition and structure of Pinus koraiensis mixed forest. Although the Pinus koraiensis would persist, the current forests dominated by Pinus koraiensis in the region would all shift and become broadleaf-dominated forests due to the dramatic increase of broadleaf trees under the future global warming and increased precipitation.	[Zhang, Jingli; Zhou, Yong; Zhou, Guangsheng; Xiao, Chunwang] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Zhang, Jingli; Zhou, Yong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhou, Guangsheng] Chinese Acad Meteorol Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Meteorological Sciences (CAMS)	Xiao, CW (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	cwxiao@ibcas.ac.cn	Zhou, Yong/H-9048-2019; Zhou, Yong/B-9795-2017	Zhou, Yong/0000-0003-2546-8462; Zhou, Yong/0000-0003-2546-8462	National Basic Research Program of China (973 program) [2010CB951303]; National Natural Science Foundation of China [31370462]; State Key Laboratory of Vegetation and Environmental Change, Institute of Botany, Chinese Academy of Sciences	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Vegetation and Environmental Change, Institute of Botany, Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was financially supported by the National Basic Research Program of China (973 program, no. 2010CB951303), the National Natural Science Foundation of China (No. 31370462), and the State Key Laboratory of Vegetation and Environmental Change, Institute of Botany, Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archambault L, 1998, FOREST ECOL MANAG, V102, P61, DOI 10.1016/S0378-1127(97)00109-6; BERGERON Y, 1989, VEGETATIO, V79, P51, DOI 10.1007/BF00044848; Chen XW, 2003, PLANT ECOL, V164, P65, DOI 10.1023/A:1021241818362; Day ME, 2000, TREE PHYSIOL, V20, P57; del Rio M, 2001, FOREST ECOL MANAG, V142, P79, DOI 10.1016/S0378-1127(00)00341-8; Edenhofer O., 2014, CONTRIBUTION WORKING; Editorial Committee of Chinese forest, 1997, CHIN FOR, P450; Epstein HE, 1996, J VEG SCI, V7, P777, DOI 10.2307/3236456; Ewers BE, 2001, TREE PHYSIOL, V21, P841, DOI 10.1093/treephys/21.12-13.841; Fu L.G., 1999, FLORA CHINA, V4; Guo Li-ping, 2011, Yingyong Shengtai Xuebao, V22, P866; He HS, 2005, J BIOGEOGR, V32, P2043, DOI 10.1111/j.1365-2699.2005.01353.x; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; KINNAIRD JW, 1974, J ECOL, V62, P467, DOI 10.2307/2258992; Komarova TA, 2007, FOR SCI TECHNOL, V3, P17, DOI 10.1080/21580103.2007.9656314; MARSHALL JD, 1984, CAN J FOREST RES, V14, P905, DOI 10.1139/x84-161; NAKASHIZUKA T, 1989, ECOLOGY, V70, P1273, DOI 10.2307/1938186; Piao SL, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002888; Rehfeldt GE, 2002, GLOBAL CHANGE BIOL, V8, P912, DOI 10.1046/j.1365-2486.2002.00516.x; RUBIN J., 1964, SOIL SCI SOC AMER PROC, V28, P1; Sandford AP, 1986, TREE PHYSIOL, V2, P89, DOI 10.1093/treephys/2.1-2-3.89; SCHAETZL RJ, 1989, VEGETATIO, V79, P165; SCHAETZL RJ, 1989, CAN J FOREST RES, V19, P1, DOI 10.1139/x89-001; Schulze ED, 2005, OECOLOGIA, V146, P77, DOI 10.1007/s00442-005-0173-6; Seiwa K, 1997, SEED SCI RES, V7, P195, DOI 10.1017/S0960258500003536; Shao GF, 1996, CLIMATIC CHANGE, V34, P263; Son YH, 2001, BIORESOURCE TECHNOL, V78, P251, DOI 10.1016/S0960-8524(01)00012-8; TEERI JA, 1976, OECOLOGIA, V23, P1, DOI 10.1007/BF00351210; TENHUNEN JD, 1984, PLANTA, V162, P193, DOI 10.1007/BF00397440; TENHUNEN JD, 1980, OECOLOGIA, V47, P365, DOI 10.1007/BF00398530; Wang T, 2006, GLOBAL CHANGE BIOL, V12, P2404, DOI 10.1111/j.1365-2486.2006.01271.x; Wang TL, 2010, ECOL APPL, V20, P153, DOI 10.1890/08-2257.1; Way DA, 2010, TREE PHYSIOL, V30, P669, DOI 10.1093/treephys/tpq015; Williams RJ, 1996, J BIOGEOGR, V23, P747, DOI 10.1111/j.1365-2699.1996.tb00036.x; Xu CH, 2012, ATMOS OCEAN SCI LETT, V5, P527, DOI 10.1080/16742834.2012.11447042; Xu DY, 2001, ENVIRON INT, V27, P201, DOI 10.1016/S0160-4120(01)00083-6; Zhou L, 2011, ANN FOREST SCI, V68, P953, DOI 10.1007/s13595-011-0101-3; Zhou YL, 1997, GEOGRAPHY VEGETATION, P2	38	8	10	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e97192	10.1371/journal.pone.0097192	http://dx.doi.org/10.1371/journal.pone.0097192			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810605	gold, Green Published, Green Submitted			2022-12-27	WOS:000338213300133
J	Zukal, J; Bandouchova, H; Bartonicka, T; Berkova, H; Brack, V; Brichta, J; Dolinay, M; Jaron, KS; Kovacova, V; Kovarik, M; Martinkova, N; Ondracek, K; Rehak, Z; Turner, GG; Pikula, J				Zukal, Jan; Bandouchova, Hana; Bartonicka, Tomas; Berkova, Hana; Brack, Virgil; Brichta, Jiri; Dolinay, Matej; Jaron, Kamil S.; Kovacova, Veronika; Kovarik, Miroslav; Martinkova, Natalia; Ondracek, Karel; Rehak, Zdenek; Turner, Gregory G.; Pikula, Jiri			White-Nose Syndrome Fungus: A Generalist Pathogen of Hibernating Bats	PLOS ONE			English	Article							GEOMYCES-DESTRUCTANS; EMERGING DISEASE; MYOTIS-MYOTIS; HIBERNACULA; PERSISTENCE; DIVERSITY; PATHOLOGY; SELECTION; SUGGESTS	Host traits and phylogeny can determine infection risk by driving pathogen transmission and its ability to infect new hosts. Predicting such risks is critical when designing disease mitigation strategies, and especially as regards wildlife, where intensive management is often advocated or prevented by economic and/ or practical reasons. We investigated Pseudogymnoascus [Geomyces] destructans infection, the cause of white-nose syndrome (WNS), in relation to chiropteran ecology, behaviour and phylogenetics. While this fungus has caused devastating declines in North American bat populations, there have been no apparent population changes attributable to the disease in Europe. We screened 276 bats of 15 species from hibernacula in the Czech Republic over 2012 and 2013, and provided histopathological evidence for 11 European species positive for WNS. With the exception of Myotis myotis, the other ten species are all new reports for WNS in Europe. Of these, M. emarginatus, Eptesicus nilssonii, Rhinolophus hipposideros, Barbastella barbastellus and Plecotus auritus are new to the list of P. destructans-infected bat species. While the infected species are all statistically phylogenetically related, WNS affects bats from two suborders. These are ecologically diverse and adopt a wide range of hibernating strategies. Occurrence of WNS in distantly related bat species with diverse ecology suggests that the pathogen may be a generalist and that all bats hibernating within the distribution range of P. destructans may be at risk of infection.	[Zukal, Jan; Berkova, Hana; Martinkova, Natalia] Acad Sci Czech Republ, Inst Vertebrate Biol, Brno, Czech Republic; [Zukal, Jan; Bartonicka, Tomas; Dolinay, Matej; Rehak, Zdenek] Masaryk Univ, Dept Bot & Zool, Brno, Czech Republic; [Bandouchova, Hana; Brichta, Jiri; Kovacova, Veronika; Ondracek, Karel; Pikula, Jiri] Univ Vet & Pharmaceut Sci, Dept Ecol & Dis Game Fish & Bees, Brno, Czech Republic; [Brack, Virgil] Environm Solut & Innovations Inc, Cincinnati, OH USA; [Jaron, Kamil S.; Martinkova, Natalia] Masaryk Univ, Inst Biostat & Anal, Brno, Czech Republic; [Kovacova, Veronika] Nat Conservat Agcy Czech Republ, Adm Moravian Karst Protected Landscape Area, Blansko, Czech Republic; [Turner, Gregory G.] Penn Game Commiss, Harrisburg, PA USA	Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences; Masaryk University Brno; University of Veterinary Sciences Brno; Institute of Biostatistics & Analyses; Masaryk University Brno	Pikula, J (corresponding author), Univ Vet & Pharmaceut Sci, Dept Ecol & Dis Game Fish & Bees, Brno, Czech Republic.	pikulaj@vfu.cz	Martínková, Natália/C-2939-2008; Bandouchova, Hana/AAI-1213-2020; Pikula, Jiri/V-8620-2018; Berkova, Hana/G-1108-2014; Zukal, Jan/G-1180-2014; Kovacova, Veronika/V-1815-2019; Bartonička, Tomáš/J-2756-2014; Jaron, Kamil S/AAV-3720-2021	Martínková, Natália/0000-0003-4556-4363; Pikula, Jiri/0000-0001-8747-9365; Zukal, Jan/0000-0003-4967-6880; Kovacova, Veronika/0000-0001-9362-125X; Bandouchova, Hana/0000-0003-0373-7940	Grant Agency of the Czech Republic [P506/12/1064]; National Speleological Society of the USA	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); National Speleological Society of the USA	This study was supported by the Grant Agency of the Czech Republic (Project No. P506/12/1064) and by the National Speleological Society of the USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blehert DS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002779; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Boyles JG, 2011, SCIENCE, V332, P41, DOI 10.1126/science.1201366; Cryan PM, 2013, J WILDLIFE DIS, V49, P398, DOI 10.7589/2012-04-121; Cryan PM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-135; Eskew EA, 2013, EMERG INFECT DIS, V19, P379, DOI 10.3201/eid1093.120707; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Foley J, 2011, CONSERV BIOL, V25, P223, DOI 10.1111/j.1523-1739.2010.01638.x; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; HORACEK I., 2000, P 8 EBRS, V1, P11; Irwin NR, 2012, MOL ECOL, V21, P4137, DOI 10.1111/j.1365-294X.2012.05663.x; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Kubatova Alena, 2011, Czech Mycology, V63, P65; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Langwig KE, 2012, ECOL LETT, V15, P1050, DOI 10.1111/j.1461-0248.2012.01829.x; Lorch JM, 2013, APPL ENVIRON MICROB, V79, P1293, DOI 10.1128/AEM.02939-12; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Lorch JM, 2010, J VET DIAGN INVEST, V22, P224, DOI 10.1177/104063871002200208; Maher SP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2301; Martinkova N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013853; Meteyer CU, 2012, VIRULENCE, V3, P583, DOI 10.4161/viru.22330; Meteyer CU, 2009, J VET DIAGN INVEST, V21, P411, DOI 10.1177/104063870902100401; Minnis AM, 2013, FUNGAL BIOL-UK, V117, P638, DOI 10.1016/j.funbio.2013.07.001; Muller LK, 2013, MYCOLOGIA, V105, P253, DOI 10.3852/12-242; Orme D., 2018, R PACKAGE VERSION, V5, P1; Ostfeld RS, 2012, ANNU REV ECOL EVOL S, V43, P157, DOI 10.1146/annurev-ecolsys-102710-145022; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pattengale ND, 2010, J COMPUT BIOL, V17, P337, DOI 10.1089/cmb.2009.0179; Pikula J, 2012, J WILDLIFE DIS, V48, P207, DOI 10.7589/0090-3558-48.1.207; Puechmaille SJ, 2011, TRENDS ECOL EVOL, V26, P570, DOI 10.1016/j.tree.2011.06.013; Puechmaille SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019167; Puechmaille SJ, 2010, EMERG INFECT DIS, V16, P290, DOI 10.3201/eid1602.091391; R Core Team, R LANG ENV STAT COMP; Reichard JD, 2009, ACTA CHIROPTEROL, V11, P457, DOI 10.3161/150811009X485684; Simmons N., 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Simonovicova A, 2011, BIOLOGIA, V66, P562, DOI 10.2478/s11756-011-0041-2; Turner GG, 2014, J WILDLIFE DIS, V50, P566, DOI 10.7589/2014-03-058; Turner Gregory G., 2009, Bat Research News, V50, P47; U.S. Geological Survey, 2012, WHIT NOS SYNDR THREA; Verant ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046280; Warnecke L, 2012, P NATL ACAD SCI USA, V109, P6999, DOI 10.1073/pnas.1200374109; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb PI, 1996, CAN J ZOOL, V74, P761, DOI 10.1139/z96-087; Wibbelt G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074105; Wibbelt G, 2010, EMERG INFECT DIS, V16, P1237, DOI 10.3201/eid1608.100002; Wilder AP, 2011, BIOL LETTERS, V7, P950, DOI 10.1098/rsbl.2011.0355; Woolhouse MEJ, 2001, SCIENCE, V292, P1109, DOI 10.1126/science.1059026; Zukal J, 2005, MAMM BIOL, V70, P271, DOI 10.1016/j.mambio.2005.03.003	50	55	58	2	173	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97224	10.1371/journal.pone.0097224	http://dx.doi.org/10.1371/journal.pone.0097224			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24820101	gold, Green Published			2022-12-27	WOS:000336653300092
J	Guo, YF; Zhang, WH; Ren, SQ; Yang, L; Lu, DH; Zeng, ZL; Liu, YH; Jiang, HX				Guo, Yu-Fang; Zhang, Wen-Hui; Ren, Si-Qi; Yang, Lin; Lu, Dian-Hong; Zeng, Zhen-Ling; Liu, Ya-Hong; Jiang, Hong-Xia			IncA/C Plasmid-Mediated Spread of CMY-2 in Multidrug-Resistant Escherichia coli from Food Animals in China	PLOS ONE			English	Article							AMPC BETA-LACTAMASES; ENTERICA SEROTYPE NEWPORT; MOLECULAR CHARACTERIZATION; KLEBSIELLA-PNEUMONIAE; UNITED-STATES; CTX-M; PREVALENCE; GENES; OQXAB; ENTEROBACTERIACEAE	Objectives: To obtain a broad molecular epidemiological characterization of plasmid-mediated AmpC beta-lactamase CMY-2 in Escherichia coli isolates from food animals in China. Methods: A total of 1083 E. coli isolates from feces, viscera, blood, drinking water, and sub-surface soil were examined for the presence of CMY-2 beta-lactamases. CMY-2-producing isolates were characterized as follows: the bla(CMY-2) genotype was determined using PCR and sequencing, characterization of the bla(CMY-2) genetic environment, plasmid sizing using S1 nuclease pulsed-field gel electrophoresis (PFGE), PCR-based replicon typing, phylogenetic grouping, XbaI-PFGE, and multilocus sequence typing (MLST). Results: All 31 CMY-2 producers were only detected in feces, and presented with multidrug resistant phenotypes. All CMY-2 strains also co-harbored genes conferring resistance to other antimicrobials, including extended spectrum beta-lactamases genes (bla(CTX-M-14) or bla(CTX-M-55)), plasmid-mediated quinolone resistance determinants (qnr, oqxA, and aac-(6')-Ib-cr), floR and rmtB. The co-transferring of bla(CMY-2) with qnrS1 and floR (alone and together) was mainly driven by the Inc A/C type plasmid, with sizes of 160 or 200 kb. Gene cassette arrays inserted in the class 1 or class 2 integron were amplified among 12 CMY-2 producers. CMY-2 producers belonged to avirulent groups B1 (n = 12) and A (n = 11), and virulent group D (n = 8). There was a good correlation between phylogenetic groups and sequence types (ST). Twenty-four STs were identified, of which the ST complexes (STC) 101/B1 (n = 6), STC10/A (n = 5), and STC155/B1 (n = 3) were dominant. Conclusions: CMY-2 is the dominant AmpC b-lactamase in food animals and is associated with a transferable replicon IncA/C plasmid in the STC101, STC10, and STC155 strains.	[Guo, Yu-Fang; Zhang, Wen-Hui; Ren, Si-Qi; Yang, Lin; Zeng, Zhen-Ling; Liu, Ya-Hong; Jiang, Hong-Xia] SCAU, Guangdong Prov Key Lab Vet Pharmaceut Dev & Safet, Coll Vet Med, Guangzhou, Guangdong, Peoples R China; [Lu, Dian-Hong] Guangdong Acad Agr Sci, Inst Vet Med, Lab Clin Microbiol, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; Guangdong Academy of Agricultural Sciences	Jiang, HX (corresponding author), SCAU, Guangdong Prov Key Lab Vet Pharmaceut Dev & Safet, Coll Vet Med, Guangzhou, Guangdong, Peoples R China.	hxjiang@scau.edu.cn			National Natural Science Foundation of China [U1201214]; 973 Program [2013CB127203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China)	This work was supported in part by the National Natural Science Foundation of China (U1201214) and 973 Program (2013CB127203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaine SD, 2005, ANTIMICROB AGENTS CH, V49, P4061, DOI 10.1128/AAC.49.10.4061-4067.2005; Alvarez M, 2004, ANTIMICROB AGENTS CH, V48, P533, DOI 10.1128/AAC.48.2.533-537.2004; [Anonymous], 2010, M100S20 CLIN LAB STA; BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; Carattoli A, 2005, ANTIMICROB AGENTS CH, V49, P833, DOI 10.1128/AAC.49.2.833-835.2005; Carattoli A, 2013, INT J MED MICROBIOL, V303, P298, DOI 10.1016/j.ijmm.2013.02.001; Chen S, 2004, APPL ENVIRON MICROB, V70, P1, DOI 10.1128/AEM.70.1.1-7.2004; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clinical and Laboratory Standards Institute, 2008, M31A3 CLIN LAB STAND; Deng YT, 2011, ANTIMICROB AGENTS CH, V55, P4926, DOI 10.1128/AAC.00133-11; Egorova S, 2008, EMERG INFECT DIS, V14, P954, DOI 10.3201/eid1406.071168; Gupta A, 2003, J INFECT DIS, V188, P1707, DOI 10.1086/379668; Hansen LH, 2005, MICROB DRUG RESIST, V11, P378, DOI 10.1089/mdr.2005.11.378; Hiroi M, 2012, J VET MED SCI, V74, P189, DOI 10.1292/jvms.11-0372; Hornsey M, 2011, ANTIMICROB AGENTS CH, V55, P5952, DOI 10.1128/AAC.05108-11; Izdebski R, 2013, ANTIMICROB AGENTS CH, V57, P309, DOI 10.1128/AAC.01656-12; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Jiang HX, 2011, VET J, V187, P99, DOI 10.1016/j.tvjl.2009.10.017; Li L, 2013, J ANTIMICROB CHEMOTH, V68, P2263, DOI 10.1093/jac/dkt209; Li L, 2010, VET MICROBIOL, V144, P505, DOI 10.1016/j.vetmic.2010.02.005; Li XZ, 2007, VET MICROBIOL, V121, P197, DOI 10.1016/j.vetmic.2007.01.015; Li Y, 2008, J CLIN MICROBIOL, V46, P1317, DOI 10.1128/JCM.00073-07; Liebana E, 2013, CLIN INFECT DIS, V56, P1030, DOI 10.1093/cid/cis1043; Liu JH, 2007, INT J ANTIMICROB AG, V29, P576, DOI 10.1016/j.ijantimicag.2006.12.015; Mata C, 2012, J ANTIMICROB CHEMOTH, V67, P115, DOI 10.1093/jac/dkr412; Mataseje LF, 2010, DIAGN MICR INFEC DIS, V67, P387, DOI 10.1016/j.diagmicrobio.2010.02.027; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462; Meunier D, 2010, J MED MICROBIOL, V59, P467, DOI 10.1099/jmm.0.016162-0; Mulvey MR, 2009, VET MICROBIOL, V134, P279, DOI 10.1016/j.vetmic.2008.08.018; Mulvey MR, 2005, ANTIMICROB AGENTS CH, V49, P358, DOI 10.1128/AAC.49.1.358-365.2005; Mushtaq S, 2011, J ANTIMICROB CHEMOTH, V66, P2002, DOI 10.1093/jac/dkr226; Park KS, 2012, ANN CLIN LAB SCI, V42, P191; Pitout JDD, 2003, J CLIN MICROBIOL, V41, P4578, DOI 10.1128/JCM.41.10.4578-4582.2003; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Smet A, 2008, ANTIMICROB AGENTS CH, V52, P1238, DOI 10.1128/AAC.01285-07; Tamang MD, 2012, ANTIMICROB AGENTS CH, V56, P2705, DOI 10.1128/AAC.05598-11; Trott D, 2013, CURR PHARM DESIGN, V19, P239, DOI 10.2174/138161213804070339; van der Bij AK, 2011, ANTIMICROB AGENTS CH, V55, P3576, DOI 10.1128/AAC.00074-11; Wiesner M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-131; Winokur PL, 2001, ANTIMICROB AGENTS CH, V45, P2716, DOI 10.1128/AAC.45.10.2716-2722.2001; Woodford N, 2007, J ANTIMICROB CHEMOTH, V59, P102, DOI 10.1093/jac/dkl456; Xia LN, 2011, FOODBORNE PATHOG DIS, V8, P1241, DOI 10.1089/fpd.2011.0868; Yan JJ, 2004, ANTIMICROB AGENTS CH, V48, P1353, DOI 10.1128/AAC.48.4.1353-1356.2004; Zhao JJ, 2010, ANTIMICROB AGENTS CH, V54, P4219, DOI 10.1128/AAC.00139-10; Zheng HQ, 2012, INT J ANTIMICROB AG, V39, P305, DOI 10.1016/j.ijantimicag.2011.12.001; Zhuo C, 2009, CHIN J INFECT CHEMOT, V9, P185	46	30	32	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96738	10.1371/journal.pone.0096738	http://dx.doi.org/10.1371/journal.pone.0096738			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816748	Green Published, Green Submitted, gold			2022-12-27	WOS:000336838000058
J	Jakobsen, RB; Ostrup, E; Zhang, XL; Mikkelsen, TS; Brinchmann, JE				Jakobsen, Rune B.; Ostrup, Esben; Zhang, Xiaolan; Mikkelsen, Tarjei S.; Brinchmann, Jan E.			Analysis of the Effects of Five Factors Relevant to In Vitro Chondrogenesis of Human Mesenchymal Stem Cells Using Factorial Design and High Throughput mRNA-Profiling	PLOS ONE			English	Article							BONE-MARROW; GENE-EXPRESSION; ARTICULAR-CARTILAGE; GROWTH-FACTORS; TGF-BETA; DIFFERENTIATION; OPTIMIZATION; CHONDROCYTES; TISSUES; PROLIFERATION	The in vitro process of chondrogenic differentiation of mesenchymal stem cells for tissue engineering has been shown to require three-dimensional culture along with the addition of differentiation factors to the culture medium. In general, this leads to a phenotype lacking some of the cardinal features of native articular chondrocytes and their extracellular matrix. The factors used vary, but regularly include members of the transforming growth factor beta superfamily and dexamethasone, sometimes in conjunction with fibroblast growth factor 2 and insulin-like growth factor 1, however the use of soluble factors to induce chondrogenesis has largely been studied on a single factor basis. In the present study we combined a factorial quality-by-design experiment with high-throughput mRNA profiling of a customized chondrogenesis related gene set as a tool to study in vitro chondrogenesis of human bone marrow derived mesenchymal stem cells in alginate. 48 different conditions of transforming growth factor beta 1, 2 and 3, bone morphogenetic protein 2, 4 and 6, dexamethasone, insulin-like growth factor 1, fibroblast growth factor 2 and cell seeding density were included in the experiment. The analysis revealed that the best of the tested differentiation cocktails included transforming growth factor beta 1 and dexamethasone. Dexamethasone acted in synergy with transforming growth factor beta 1 by increasing many chondrogenic markers while directly downregulating expression of the pro-osteogenic gene osteocalcin. However, all factors beneficial to the expression of desirable hyaline cartilage markers also induced undesirable molecules, indicating that perfect chondrogenic differentiation is not achievable with the current differentiation protocols.	[Jakobsen, Rune B.; Ostrup, Esben; Brinchmann, Jan E.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Norwegian Ctr Stem Cell Res, N-0027 Oslo, Norway; [Jakobsen, Rune B.; Brinchmann, Jan E.] Univ Oslo, Dept Biochem, Inst Basic Med Sci, Fac Med, Oslo 3, Norway; [Ostrup, Esben] Univ Oslo, Inst Clin Dent, Dept Biomat, Oslo, Norway; [Zhang, Xiaolan; Mikkelsen, Tarjei S.] Broad Inst, Cambridge, MA USA; [Mikkelsen, Tarjei S.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Mikkelsen, Tarjei S.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Brinchmann, Jan E.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Inst Immunol, N-0027 Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; University of Oslo; National Hospital Norway	Brinchmann, JE (corresponding author), Univ Oslo, Rikshosp, Oslo Univ Hosp, Norwegian Ctr Stem Cell Res, N-0027 Oslo, Norway.	jan.brinchmann@rr-research.no	Mikkelsen, Tarjei S/A-1306-2007	Mikkelsen, Tarjei S/0000-0002-8133-3135; Ostrup, Esben/0000-0001-8387-4317	University of Oslo; Broad Institute; Harvard Stem Cell Institute	University of Oslo; Broad Institute; Harvard Stem Cell Institute	The research was supported by funds from the University of Oslo (www.uio.no) as part of a PhD-grant for the first author (RBJ). NanoString probe design and profiling were supported by funds from the Broad Institute (www.broadinstitute.org) and the Harvard Stem Cell Institute (www.hsci.harvard.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bahney CS, 2011, FASEB J, V25, P1486, DOI 10.1096/fj.10-165514; Barrilleaux B, 2006, TISSUE ENG, V12, P3007, DOI 10.1089/ten.2006.12.3007; Benders KEM, 2013, TRENDS BIOTECHNOL, V31, P169, DOI 10.1016/j.tibtech.2012.12.004; Bergkvist A, 2010, METHODS, V50, P323, DOI 10.1016/j.ymeth.2010.01.009; Binette F, 1998, J ORTHOP RES, V16, P207, DOI 10.1002/jor.1100160208; Bock HC, 2001, OSTEOARTHR CARTILAGE, V9, P654, DOI 10.1053/joca.2001.0420; BodeLesniewska B, 1996, J HISTOCHEM CYTOCHEM, V44, P303, DOI 10.1177/44.4.8601689; Boulland JL, 2013, STEM CELLS DEV, V22, P1042, DOI 10.1089/scd.2012.0560; Buckley CT, 2012, J MECH BEHAV BIOMED, V11, P102, DOI 10.1016/j.jmbbm.2011.09.004; Buxton AN, 2010, TISSUE ENG A; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chen YT, 2011, TISSUE ENG PART C-ME, V17, P1211, DOI 10.1089/ten.tec.2011.0092; Craft AM, 2013, DEVELOPMENT, V140, P2597, DOI 10.1242/dev.087890; Decaris ML, 2011, ANN BIOMED ENG, V39, P1174, DOI 10.1007/s10439-010-0217-x; Dehne T, 2010, GENE, V462, P8, DOI 10.1016/j.gene.2010.04.006; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Enochson L, 2012, BIORESEARCH OPEN ACC, V1, P306, DOI 10.1089/biores.2012.0277; Fernandes AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062994; FRENZ DA, 1994, DEVELOPMENT, V120, P415; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Handorf AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022887; Hardingham TE, 2006, J ANAT, V209, P469, DOI 10.1111/j.1469-7580.2006.00630.x; Herlofsen SR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-105; Herlofsen SR, 2011, TISSUE ENG PT A, V17, P1003, DOI [10.1089/ten.TEA.2010.0499, 10.1089/ten.tea.2010.0499]; Higashikawa A, 2009, ARTHRITIS RHEUM-US, V60, P166, DOI 10.1002/art.24243; Hildner F, 2010, J BIOMED MATER RES A, V94A, P978, DOI 10.1002/jbm.a.32761; HOLTZER H, 1960, P NATL ACAD SCI USA, V46, P1533, DOI 10.1073/pnas.46.12.1533; Huang WS, 2002, J CELL BIOCHEM, V85, P295, DOI 10.1002/jcb.10138; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Hunt MM, 2013, TISSUE ENG C; Jay GD, 2007, P NATL ACAD SCI USA, V104, P6194, DOI 10.1073/pnas.0608558104; Johnson DJ, 2012, SCIENCE, V338, DOI 10.1126/science.1225996; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Karlsen TA, 2011, TISSUE ENG PART C-ME, V17, P219, DOI [10.1089/ten.tec.2010.0200, 10.1089/ten.TEC.2010.0200]; Kawamura K, 2005, EXP HEMATOL, V33, P865, DOI 10.1016/j.exphem.2005.05.010; Keller B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016421; Kuroda Y, 2010, P NATL ACAD SCI USA, V107, P8639, DOI 10.1073/pnas.0911647107; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Liu G, 2007, J BIOL CHEM, V282, P20407, DOI 10.1074/jbc.M608383200; Longobardi L, 2006, J BONE MINER RES, V21, P626, DOI 10.1359/JBMR.051213; LUYTEN FP, 1988, ARCH BIOCHEM BIOPHYS, V267, P416, DOI 10.1016/0003-9861(88)90047-1; Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415; Malkov Vladislav A, 2009, BMC Res Notes, V2, P80, DOI 10.1186/1756-0500-2-80; Mandenius CF, 2008, BIOTECHNOL PROGR, V24, P1191, DOI 10.1002/btpr.67; NanoString Technologies I, 2012, NCOUNTER EXPR DAT AN; Okamoto O, 2006, CONNECT TISSUE RES, V47, P177, DOI 10.1080/03008200600846564; Olderoy MO, 2014, PLOS O IN PRESS 0313; Oldershaw RA, 2008, STEM CELLS, V26, P666, DOI 10.1634/stemcells.2007-0806; Oldershaw RA, 2010, BONE, V46, P286, DOI 10.1016/j.bone.2009.04.242; Park JR, 2008, CELL PROLIFERAT, V41, P859, DOI 10.1111/j.1365-2184.2008.00565.x; Puetzer JL, 2010, TISSUE ENG PART B-RE, V16, P435, DOI [10.1089/ten.teb.2009.0705, 10.1089/ten.TEB.2009.0705]; Roughley PJ, 2006, EUR CELLS MATER, V12, P92, DOI 10.22203/eCM.v012a11; Schmitt B, 2003, DIFFERENTIATION, V71, P567, DOI 10.1111/j.1432-0436.2003.07109003.x; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Seibel M.J., 2006, DYNAMICS BONE CARTIL; Sekiya I, 2005, CELL TISSUE RES, V320, P269, DOI 10.1007/s00441-004-1075-3; Sekiya I, 2002, P NATL ACAD SCI USA, V99, P4397, DOI 10.1073/pnas.052716199; Sekiya I, 2001, BIOCHEM BIOPH RES CO, V284, P411, DOI 10.1006/bbrc.2001.4898; Shahdadfar A, 2005, STEM CELLS, V23, P1357, DOI 10.1634/stemcells.2005-0094; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Solchaga LA, 2010, TISSUE ENG PT A, V16, P1009, DOI [10.1089/ten.tea.2009.0100, 10.1089/ten.TEA.2009.0100]; Steinert AF, 2012, STEM CELL TRANSL MED, V1, P237, DOI 10.5966/sctm.2011-0036; Tuan RS, 2013, NAT REV RHEUMATOL, V9, P74, DOI 10.1038/nrrheum.2012.235; van Kleffens M, 1998, MOL CELL ENDOCRINOL, V138, P151, DOI 10.1016/S0303-7207(98)00007-0; Wakitani S, 2004, CELL TRANSPLANT, V13, P595, DOI 10.3727/000000004783983747; Weiss S, 2010, J CELL PHYSIOL, V223, P84, DOI 10.1002/jcp.22013; Worster AA, 2001, J ORTHOPAED RES, V19, P738, DOI 10.1016/S0736-0266(00)00054-1; Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004; Zhu FC, 2012, J CELL PHYSIOL, V227, P2677, DOI 10.1002/jcp.23010; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	73	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96615	10.1371/journal.pone.0096615	http://dx.doi.org/10.1371/journal.pone.0096615			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816923	Green Published, Green Submitted, gold			2022-12-27	WOS:000336838000046
J	Kiso, H; Takahashi, K; Saito, K; Togo, Y; Tsukamoto, H; Huang, BY; Sugai, M; Shimizu, A; Tabata, Y; Economides, AN; Slavkin, HC; Bessho, K				Kiso, Honoka; Takahashi, Katsu; Saito, Kazuyuki; Togo, Yumiko; Tsukamoto, Hiroko; Huang, Boyen; Sugai, Manabu; Shimizu, Akira; Tabata, Yasuhiko; Economides, Aris N.; Slavkin, Harold C.; Bessho, Kazuhisa			Interactions between BMP-7 and USAG-1 (Uterine Sensitization-Associated Gene-1) Regulate Supernumerary Organ Formations	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-7; TOOTH MORPHOGENESIS; DENTAL MESENCHYME; CELL-DEATH; MOUSE; EXPRESSION; KIDNEY; TEETH; ANTAGONIST; RECEPTOR	Bone morphogenetic proteins (BMPs) are highly conserved signaling molecules that are part of the transforming growth factor (TGF)-beta superfamily, and function in the patterning and morphogenesis of many organs including development of the dentition. The functions of the BMPs are controlled by certain classes of molecules that are recognized as BMP antagonists that inhibit BMP binding to their cognate receptors. In this study we tested the hypothesis that USAG-1 (uterine sensitization-associated gene-1) suppresses deciduous incisors by inhibition of BMP-7 function. We learned that USAG-1 and BMP-7 were expressed within odontogenic epithelium as well as mesenchyme during the late bud and early cap stages of tooth development. USAG-1 is a BMP antagonist, and also modulates Wnt signaling. USAG-1 abrogation rescued apoptotic elimination of odontogenic mesenchymal cells. BMP signaling in the rudimentary maxillary incisor, assessed by expressions of Msx1 and Dlx2 and the phosphorylation of Smad protein, was significantly enhanced. Using explant culture and subsequent subrenal capsule transplantation of E15 USAG-1 mutant maxillary incisor tooth primordia supplemented with BMP-7 demonstrated in USAG-1(+/-) as well as USAG-1(-/-) rescue and supernumerary tooth development. Based upon these results, we conclude that USAG-1 functions as an antagonist of BMP-7 in this model system. These results further suggest that the phenotypes of USAG-1 and BMP-7 mutant mice reported provide opportunities for regenerative medicine and dentistry.	[Kiso, Honoka; Takahashi, Katsu; Saito, Kazuyuki; Togo, Yumiko; Tsukamoto, Hiroko; Bessho, Kazuhisa] Kyoto Univ, Dept Oral & Maxillofacial Surg, Grad Sch Med, Sakyo Ku, Kyoto, Japan; [Huang, Boyen] James Cook Univ, Dept Paediat Dent, Sch Med & Dent, Cairns, Australia; [Sugai, Manabu] Kyoto Univ Hosp, Translat Res Ctr, Sakyo Ku, Kyoto 606, Japan; [Shimizu, Akira] Osaka Univ, Host Def Lab, World Premier Int Immunol Frontier Res Ctr, Suita, Osaka, Japan; [Tabata, Yasuhiko] Kyoto Univ, Dept Biomat, Inst Frontier Med Sci, Kyoto, Japan; [Economides, Aris N.] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; [Slavkin, Harold C.] Univ So Calif, Ctr Craniofacial Mol Biol, Div Biomed Sci, Ostrow Sch Dent, Los Angeles, CA 90033 USA	Kyoto University; James Cook University; Kyoto University; Osaka University; Kyoto University; Regeneron; University of Southern California	Takahashi, K (corresponding author), Kyoto Univ, Dept Oral & Maxillofacial Surg, Grad Sch Med, Sakyo Ku, Shogoin Kawahara Cho, Kyoto, Japan.	takahask@kuhp.kyoto-u.ac.jp	Huang, Boyen/GRE-5912-2022; Huang, Boyen/I-7768-2014; Huang, Boyen/AAR-3348-2020	Huang, Boyen/0000-0002-1246-7447; Huang, Boyen/0000-0002-1246-7447; Huang, Boyen/0000-0002-1246-7447; Sugai, Manabu/0000-0003-1668-7647; Economides, Aris/0000-0002-6508-8942	A-STEP (Adaptable & Seamless Technology Transfer Program through Target-driven RD) FS stage [AS231Z01061G, AS242Z02645Q];  [22592213];  [25463081]; Grants-in-Aid for Scientific Research [25463081, 24390073, 25293069] Funding Source: KAKEN	A-STEP (Adaptable & Seamless Technology Transfer Program through Target-driven RD) FS stage; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research(C): 22592213 and 25463081 and A-STEP (Adaptable & Seamless Technology Transfer Program through Target-driven R&D) FS stage: AS231Z01061G and AS242Z02645Q. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens H, 1913, ANAT HEFTE, V48, P167; Andl T, 2004, DEVELOPMENT, V131, P2257, DOI 10.1242/dev.01125; Aoki K, 2003, NAT GENET, V35, P323, DOI 10.1038/ng1265; Bei M, 2000, DEVELOPMENT, V127, P4711; Brown A, 2006, BIODRUGS, V20, P243, DOI 10.2165/00063030-200620040-00005; Charles C, 2011, DEVELOPMENT, V138, P4063, DOI 10.1242/dev.069195; DANFORTH CH, 1958, GENETICS, V43, P139; Darwin C., 1871, P423; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; FITZGERALD LR, 1973, ARCH ORAL BIOL, V18, P381, DOI 10.1016/0003-9969(73)90162-3; Fujimori S, 2010, DEV BIOL, V348, P97, DOI 10.1016/j.ydbio.2010.09.009; Fujita K, 1958, J STOMATOL SOC JPN, V25, P97; Ganan Y, 1996, DEVELOPMENT, V122, P2349; Godin RE, 1998, DEVELOPMENT, V125, P3473; Graham A, 1996, MOL CELL NEUROSCI, V8, P76, DOI 10.1006/mcne.1996.0046; GRAHAM A, 1994, NATURE, V372, P684, DOI 10.1038/372684a0; Hovorakova M, 2011, J EXP ZOOL PART B, V316B, P347, DOI 10.1002/jez.b.21408; Huang B, 2013, ORAL DIS, V19, P144, DOI 10.1111/j.1601-0825.2012.01963.x; Jarvinen E, 2006, P NATL ACAD SCI USA, V103, P18627, DOI 10.1073/pnas.0607289103; KAUFMAN MH, 1995, J ANAT, V186, P607; Keranen SVE, 1999, DEV GENES EVOL, V209, P495, DOI 10.1007/s004270050282; Klein OD, 2006, DEV CELL, V11, P181, DOI 10.1016/j.devcel.2006.05.014; Klopcic B, 2007, EUR J CELL BIOL, V86, P781, DOI 10.1016/j.ejcb.2007.03.005; KOLLAR EJ, 1972, AM ZOOL, V12, P125; Kollar EJ, 1972, DEV ASPECTS ORAL BIO, P125; Lagronova-Churava S, 2013, J EXP ZOOL PART B, V320B, P307, DOI 10.1002/jez.b.22502; Li TT, 2004, CURR OPIN NEPHROL HY, V13, P417, DOI 10.1097/01.mnh.0000133974.24935.fe; Liu F, 2010, J DENT RES, V89, P909, DOI 10.1177/0022034510370090; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; Maas R, 1997, CRIT REV ORAL BIOL M, V8, P4, DOI 10.1177/10454411970080010101; Millen KJ, EPSTEINS INBORN ERRO, V3rd, DOI [10.1093/med/9780199934522.003.0137, DOI 10.1093/MED/9780199934522.003.0137]; Mitsiadis TA, 2003, DEVELOPMENT, V130, P4451, DOI 10.1242/dev.00631; Mitsiadis TA, 2008, DEV BIOL, V313, P887, DOI 10.1016/j.ydbio.2007.10.055; Miyazaki Y, 2003, KIDNEY INT, V63, P835, DOI 10.1046/j.1523-1755.2003.00834.x; Munne PM, 2010, EVOL DEV, V12, P383, DOI 10.1111/j.1525-142X.2010.00425.x; Munne PM, 2009, DEVELOPMENT, V136, P393, DOI 10.1242/dev.025064; Murashima-Suginami A, 2008, BIOCHEM BIOPH RES CO, V369, P1012, DOI 10.1016/j.bbrc.2008.02.135; Murashima-Suginami A, 2007, BIOCHEM BIOPH RES CO, V359, P549, DOI 10.1016/j.bbrc.2007.05.148; Mustonen T, 2003, DEV BIOL, V259, P123, DOI 10.1016/S0012-1606(03)00157-X; Nadiri A, 2004, J HISTOCHEM CYTOCHEM, V52, P103, DOI 10.1177/002215540405200110; Nakamura T, 2008, J BIOL CHEM, V283, P4825, DOI 10.1074/jbc.M708388200; Ohazama A, 2008, INBORN ERRORS DEV MO, P245; Ohazama A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004092; Ohazama A, 2009, DEVELOPMENT, V136, P897, DOI 10.1242/dev.027979; Ooe T, 1969, Okajimas Folia Anat Jpn, V46, P243; Peterkova R, 2005, ARCH ORAL BIOL, V50, P219, DOI 10.1016/j.archoralbio.2004.10.020; Peterkova R, 2002, CONNECT TISSUE RES, V43, P120, DOI 10.1080/03008200290000745; Peterkova R, 2000, J CRAN GENET DEV BIO, V20, P158; Pispa J, 2004, DEV DYNAM, V231, P432, DOI 10.1002/dvdy.20138; Plikus MV, 2005, EVOL DEV, V7, P440, DOI 10.1111/j.1525-142X.2005.05048.x; Prochazka J, 2010, P NATL ACAD SCI USA, V107, P15497, DOI 10.1073/pnas.1002784107; Rose C., 1895, OESTERR UNG VJSCHR Z, V2, P45; Sakata-Goto T, 2012, BONE, V50, P69, DOI 10.1016/j.bone.2011.09.049; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; Schneider M, 2008, J MOL MED, V86, P507, DOI 10.1007/s00109-007-0301-3; Schulze C., 1970, THOMAS ORAL PATHOLOG, P112; Slavkin HC, 1972, DEVELOPMENTAL ASPECT, P165; Slavkin HC, 1979, DEV CRANIOFACIAL BIO; Slavkin HC, 2012, BIRTH DISCIPLINE CRA; SOFAER JA, 1969, J EMBRYOL EXP MORPH, V22, P181; Tabata Y, 1998, ADV DRUG DELIVER REV, V31, P287, DOI 10.1016/S0169-409X(97)00125-7; Tabata Y, 1999, BIOMATERIALS, V20, P2169, DOI 10.1016/S0142-9612(99)00121-0; Takahashi K, 1998, DEVELOPMENT, V125, P1627; Takahashi K, 2013, GENE THERAPY TOOLS P, DOI [10.5772/52529., DOI 10.5772/52529]; Tanaka M, 2008, KIDNEY INT, V73, P181, DOI 10.1038/sj.ki.5002626; Thesleff I, 1996, ANAT REC, V245, P151; Thomas BL, 2000, DEVELOPMENT, V127, P217; Thomas BL, 1997, DEVELOPMENT, V124, P4811; Tucker AS, 2004, DEV BIOL, V268, P185, DOI 10.1016/j.ydbio.2003.12.019; VAINIO S, 1993, CELL, V75, P45, DOI 10.1016/S0092-8674(05)80083-2; Wang XP, 2009, DEVELOPMENT, V136, P1939, DOI 10.1242/dev.033803; Wang YH, 1999, DEV DYNAM, V216, P320, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<320::AID-DVDY2>3.0.CO;2-H; Wawersik S, 1999, DEV BIOL, V207, P176, DOI 10.1006/dbio.1998.9153; Yamamoto H, 2005, ARCH ORAL BIOL, V50, P189, DOI 10.1016/j.archoralbio.2004.11.010; Yanagita M, 2006, J CLIN INVEST, V116, P70, DOI 10.1172/JCI25445; Yanagita M, 2005, CYTOKINE GROWTH F R, V16, P309, DOI 10.1016/j.cytogfr.2005.02.007; Yanagita M, 2004, BIOCHEM BIOPH RES CO, V316, P490, DOI 10.1016/j.bbrc.2004.02.075; Yusof W Z, 1990, J Can Dent Assoc, V56, P147; Zhang QH, 2003, DEV DYNAM, V227, P78, DOI 10.1002/dvdy.10289; Zhang ZY, 2009, SCIENCE, V323, P1232, DOI 10.1126/science.1167418; ZHOU PB, 1995, GENE DEV, V9, P700, DOI 10.1101/gad.9.6.700; Zouvelou V, 2009, J EXP ZOOL PART B, V312B, P361, DOI 10.1002/jez.b.21262; Zuzarte-Luis V, 2005, SEMIN CELL DEV BIOL, V16, P261, DOI 10.1016/j.semcdb.2004.12.004	83	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96938	10.1371/journal.pone.0096938	http://dx.doi.org/10.1371/journal.pone.0096938			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816837	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000336838000082
J	Mouthaan, J; Sijbrandij, M; Reitsma, JB; Gersons, BPR; Olff, M				Mouthaan, Joanne; Sijbrandij, Marit; Reitsma, Johannes B.; Gersons, Berthold P. R.; Olff, Miranda			Comparing Screening Instruments to Predict Posttraumatic Stress Disorder	PLOS ONE			English	Article							ADMINISTERED PTSD SCALE; DAVIDSON TRAUMA SCALE; PSYCHOMETRIC PROPERTIES; EVENT SCALE; ANXIETY DISORDERS; SELF-REPORT; IES-R; VALIDATION; IMPACT; DEPRESSION	Background: Following traumatic exposure, a proportion of trauma victims develops posttraumatic stress disorder (PTSD). Early PTSD risk screening requires sensitive instruments to identify everyone at risk for developing PTSD in need of diagnostic follow-up. Aims: This study compares the accuracy of the 4-item SPAN, 10-item Trauma Screening Questionnaire (TSQ) and 22-item Impact of Event Scale-Revised (IES-R) in predicting chronic PTSD at a minimum sensitivity of 80%. Method: Injury patients admitted to a level-I trauma centre (N = 311) completed the instruments at a median of 23 days and were clinically assessed for PTSD at 6 months. Areas under the curve and specificities at 80% sensitivity were compared between instruments. Results: Areas under the curve in all instruments were adequate (SPAN: 0.83; TSQ: 0.82; IES-R: 0.83) with no significant differences. At 80% sensitivity, specificities were 64% for SPAN, 59% for TSQ and 72% for IES-R. Conclusion: The SPAN, TSQ and IES-R show similar accuracy in early detection of individuals at risk for PTSD, despite differences in number of items. The modest specificities and low positive predictive values found for all instruments could lead to relatively many false positive cases, when applied in clinical practice.	[Mouthaan, Joanne; Gersons, Berthold P. R.; Olff, Miranda] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Ctr Anxiety Disorders, NL-1105 AZ Amsterdam, Netherlands; [Sijbrandij, Marit] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Sijbrandij, Marit] EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Reitsma, Johannes B.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [Gersons, Berthold P. R.; Olff, Miranda] Arq Psychotrauma Expert Grp, Diemen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Arq Psychotrauma Expert Group	Olff, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Ctr Anxiety Disorders, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.olff@amc.uva.nl	Sijbrandij, Marit/N-6131-2018; Olff, Miranda/S-6235-2019	Sijbrandij, Marit/0000-0001-5430-9810; Mouthaan, Joanne/0000-0003-2491-7457; Reitsma, Johannes/0000-0003-4026-4345; Olff, Miranda/0000-0003-1016-9515	Netherlands Organization for Health Research and Development (ZonMw) [62300038]; Stichting Achmea Slachtoffer en Samenleving (SASS); Aid to Victims, Zeist, the Netherlands	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Stichting Achmea Slachtoffer en Samenleving (SASS); Aid to Victims, Zeist, the Netherlands	The study was supported by the Netherlands Organization for Health Research and Development (ZonMw), grant # 62300038, and Stichting Achmea Slachtoffer en Samenleving (SASS), Aid to Victims, Zeist, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins JW, 2008, J ANXIETY DISORD, V22, P1393, DOI 10.1016/j.janxdis.2008.02.002; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Asukai N, 2002, J NERV MENT DIS, V190, P175, DOI 10.1097/00005053-200203000-00006; BALDESSARINI RJ, 1983, ARCH GEN PSYCHIAT, V40, P569; Bienvenu OJ, 2013, CHEST, V144, P24, DOI 10.1378/chest.12-0908; Bisson JI, 2010, CLIN EVID, V2, P1, DOI DOI 10.3402/EJPT.V1I0.5541; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bossuyt PM, 2006, BRIT MED J, V332, P1089, DOI 10.1136/bmj.332.7549.1089; Brewin CR, 2008, J TRAUMA STRESS, V21, P3, DOI 10.1002/jts.20310; Brewin CR, 2010, J TRAUMA STRESS, V23, P393, DOI 10.1002/jts.20529; Brewin CR, 2002, BRIT J PSYCHIAT, V181, P158, DOI 10.1192/bjp.181.2.158; Chen CH, 2003, COMPR PSYCHIAT, V44, P78, DOI 10.1053/comp.2003.50013; Chen CS, 2011, KAOHSIUNG J MED SCI, V27, P560, DOI 10.1016/j.kjms.2011.06.033; Creamer M, 2003, BEHAV RES THER, V41, P1489, DOI 10.1016/j.brat.2003.07.010; Cuijpers P, 2009, PSYCHIAT RES, V168, P250, DOI 10.1016/j.psychres.2008.05.012; Davidson J R, 1997, Depress Anxiety, V5, P127, DOI 10.1002/(SICI)1520-6394(1997)5:3<127::AID-DA3>3.0.CO;2-B; de Vries GJ, 2009, J TRAUMA STRESS, V22, P259, DOI 10.1002/jts.20429; Dekkers AMM, 2010, COMMUNITY MENT HLT J, V46, P20, DOI 10.1007/s10597-009-9195-6; Donker T, 2010, J AFFECT DISORDERS, V122, P253, DOI 10.1016/j.jad.2009.07.013; Edwards PJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000008.pub4; FOA EB, 1993, J TRAUMA STRESS, V6, P459, DOI 10.1007/BF00974317; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HOVENS JE, 1994, J CLIN PSYCHOL, V50, P325, DOI 10.1002/1097-4679(199405)50:3<325::AID-JCLP2270500304>3.0.CO;2-M; Meltzer-Brody S, 1999, PSYCHIAT RES, V88, P63, DOI 10.1016/S0165-1781(99)00070-0; Mouthaan J, 2011, EUR J PSYCHOTRAUMATO, V2, DOI 10.3402/ejpt.v2i0.8294; Mouthaan J, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2460; Neria Y, 2008, PSYCHOL MED, V38, P467, DOI 10.1017/S0033291707001353; O'Donnell ML, 2008, CLIN PSYCHOL REV, V28, P387, DOI 10.1016/j.cpr.2007.07.008; O'Donnell ML, 2012, J TRAUMA STRESS, V25, P125, DOI 10.1002/jts.21677; O'Donnell ML, 2008, J CONSULT CLIN PSYCH, V76, P923, DOI 10.1037/a0012918; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P507, DOI 10.1176/appi.ajp.161.3.507; Peden M, 2002, INJURY CHART BOOK GR; Rash CJ, 2008, ADDICT BEHAV, V33, P1039, DOI 10.1016/j.addbeh.2008.04.006; Roberts NP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006869.pub2; Seo HJ, 2011, YONSEI MED J, V52, P673, DOI 10.3349/ymj.2011.52.4.673; Shalev AY, 1997, BRIT J PSYCHIAT, V170, P558, DOI 10.1192/bjp.170.6.558; Sijbrandij M, 2013, COCHRANE DATABASE SY; Sijbrandij M, 2007, AM J PSYCHIAT, V164, P82, DOI 10.1176/appi.ajp.164.1.82; Sijbrandij M, 2006, BRIT J PSYCHIAT, V189, P150, DOI 10.1192/bjp.bp.105.021121; Sijbrandij M, 2008, DEPRESS ANXIETY, V25, P1038, DOI 10.1002/da.20441; Smits N, 2007, INT J METH PSYCH RES, V16, P219, DOI 10.1002/mpr.230; TEASDALE G, 1974, LANCET, V2, P81; van Ballegooijen W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038480; Walters JTR, 2007, PSYCHOL MED, V37, P143, DOI 10.1017/S0033291706008658; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Weiss D.S., 1997, ASSESSING PSYCHOL TR, P399, DOI DOI 10.1037/T12199-000; Zatzick DF, 2002, ARCH SURG-CHICAGO, V137, P200, DOI 10.1001/archsurg.137.2.200; Zlotnick C, 1996, J NERV MENT DIS, V184, P255, DOI 10.1097/00005053-199604000-00010	49	43	43	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97183	10.1371/journal.pone.0097183	http://dx.doi.org/10.1371/journal.pone.0097183			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4LX	24816642	Green Published, gold, Green Submitted			2022-12-27	WOS:000336838000114
J	Garbarino, S; Magnavita, N				Garbarino, Sergio; Magnavita, Nicola			Obstructive Sleep Apnea Syndrome (OSAS), Metabolic Syndrome and Mental Health in Small Enterprise Workers. Feasibility of an Action for Health	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; ENDOTHELIAL FUNCTION; CARDIOVASCULAR RISK; ITALIAN VERSION; OBESITY; DEPRESSION; IMPAIRMENT; ANXIETY; SCALE; QUESTIONNAIRE	Objective: To determine the frequency of obstructive sleep apnea syndrome (OSAS), metabolic syndrome and common mental disorders in the working population of 11 small enterprises and the feasibility of a program of action for health. Method: The clinical risk of OSAS, the prevalence of metabolic syndrome, and the level of psychological disorders were assessed during routine medical examination at the workplace in 2012. The response to medical advice was assessed in 2013. Results: 12.3% of the workers were suspected of being affected by OSAS. One or more components of metabolic syndrome were present in 24.5% of cases. OSAS in "healthy" workers was significantly associated with the presence of one or more components of metabolic syndrome (OR = 3.83; 95% CI 1.45-10.13) and with a psychological disorders score in the highest quartile (OR = 4.67; 95% CI = 1.72-12.64). Workers with suspected OSAS were reluctant to follow advice about undergoing further tests under the NHS. However, in some cases, confirmation of the OSAS diagnosis and subsequent treatment led to an improvement in metabolic condition. Conclusion: Although participation in treatment was limited, anecdotal cases support the idea that prevention of obstructive sleep apnea in the workplace might be useful for workers' health.	[Garbarino, Sergio] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet & Maternal, Genoa, Italy; [Garbarino, Sergio] Univ Genoa, Dept Hlth Sci, Genoa, Italy; [Magnavita, Nicola] Univ Cattolica Sacro Cuore, Sect Occupat & Environm Med, Dept Publ Hlth, Rome, Italy	University of Genoa; University of Genoa; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Magnavita, N (corresponding author), Univ Cattolica Sacro Cuore, Sect Occupat & Environm Med, Dept Publ Hlth, Rome, Italy.	nicolamagnavita@gmail.com	Garbarino, Sergio/X-5368-2018; Magnavita, Nicola/J-6074-2014; Garbarino, Sergio/AAV-4629-2021	Garbarino, Sergio/0000-0002-8508-552X; Magnavita, Nicola/0000-0002-0988-7344; Garbarino, Sergio/0000-0002-8508-552X				Akishita M, 2011, J AM GERIATR SOC, V59, P1565, DOI 10.1111/j.1532-5415.2011.03526.x; Andrews JG, 2004, CLIN PSYCHOL REV, V24, P1031, DOI 10.1016/j.cpr.2004.08.002; Asghari A, 2012, EUR ARCH OTO-RHINO-L, V269, P2549, DOI 10.1007/s00405-012-1942-6; Bonde JPE, 2013, SCAND J WORK ENV HEA, V39, P217, DOI 10.5271/sjweh.3362; Capone GT, 2013, AM J MED GENET A, V161, P2188, DOI 10.1002/ajmg.a.36052; Carratu P, 2007, Monaldi Arch Chest Dis, V67, P6; Copertaro A, 2009, EPIDEMIOL PREV, V33, P227; Costa G, 2013, MED LAV, V104, P251; Dorkova Z, 2008, CHEST, V134, P686, DOI 10.1378/chest.08-0556; Drager LF, 2013, J AM COLL CARDIOL, V62, P569, DOI 10.1016/j.jacc.2013.05.045; Federation ID, 2006, IDF CONS WORLDW DEF; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Fusetti M, 2012, ACTA OTORHINOLARYNGO, V32, P320; Garbarino S, 2002, SLEEP, V25, P648; Garbarino S, 2014, SLEEPINESS HUMAN IMP; Goldberg D.P, 1972, DETECTION PSYCHIAT I; Grassi G, 2010, J HYPERTENS, V28, P1313, DOI 10.1097/HJH.0b013e328337a9fd; Guglielmi O, 2011, REV NEUROLOGIA, V52, P515, DOI 10.33588/rn.5209.2010470; Hoyos CM, 2012, THORAX, V67, P1081, DOI 10.1136/thoraxjnl-2011-201420; Jackson C, 2007, OCCUP MED-OXFORD, V57, P79, DOI 10.1093/occmed/kql169; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kato M, 2000, CIRCULATION, V102, P2607; Kinoshita LM, 2012, SLEEP BREATH, V16, P1201, DOI 10.1007/s11325-011-0632-8; Kraiczi H, 2001, CHEST, V119, P1085, DOI 10.1378/chest.119.4.1085; Kumor Marta, 2013, Pneumonol Alergol Pol, V81, P417; Lal C, 2012, CHEST, V141, P1601, DOI 10.1378/chest.11-2214; Macey PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010211; Maggi S, 2006, J GERONTOL A-BIOL, V61, P505, DOI 10.1093/gerona/61.5.505; MALLAMPATI SR, 1985, CAN ANAESTH SOC J, V32, P429, DOI 10.1007/BF03011357; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Namtvedt SK, 2013, HEART, V99, P30, DOI 10.1136/heartjnl-2012-303009; Nuckton TJ, 2006, SLEEP, V29, P903, DOI 10.1093/sleep/29.7.903; Oksanen T, 2013, SCAND J WORK ENV HEA, V39, P276, DOI 10.5271/sjweh.3332; PICCINELLI M, 1993, COMPR PSYCHIAT, V34, P198, DOI 10.1016/0010-440X(93)90048-9; Polak J, 2013, SLEEP, V36, P1483, DOI 10.5665/sleep.3040; Punjabi NM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000132; RICKETTS RM, 1972, AMER J ORTHODONTICS, V61, P1, DOI 10.1016/0002-9416(72)90172-8; Saunamaeki T, 2007, ACTA NEUROL SCAND, V116, P277, DOI 10.1111/j.1600-0404.2007.00901.x; Sharma SK, 2011, NEW ENGL J MED, V365, P2277, DOI 10.1056/NEJMoa1103944; Sivam S, 2012, EUR RESPIR J, V40, P913, DOI 10.1183/09031936.00177011; Sivertsen B, 2008, EUR RESPIR J, V32, P1497, DOI 10.1183/09031936.00044908; Sjosten N, 2009, RESP MED, V103, P1047, DOI 10.1016/j.rmed.2009.01.014; Trombetta IC, 2010, SLEEP, V33, P1193, DOI 10.1093/sleep/33.9.1193; Vignatelli L, 2003, NEUROL SCI, V23, P295, DOI 10.1007/s100720300004; Winston M, 2000, SOC PSYCH PSYCH EPID, V35, P569, DOI 10.1007/s001270050281; Ye J, 2009, INT J OBESITY, V33, P54, DOI 10.1038/ijo.2008.229; Young T, 2008, SLEEP, V31, P1071; Zamarron C, 2008, EUR J INTERN MED, V19, P390, DOI 10.1016/j.ejim.2007.12.006	49	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e97188	10.1371/journal.pone.0097188	http://dx.doi.org/10.1371/journal.pone.0097188			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810290	Green Published, Green Submitted, gold			2022-12-27	WOS:000338213300130
J	Lawson, DJ; Oak, N				Lawson, Daniel John; Oak, Neeraj			Apparent Strength Conceals Instability in a Model for the Collapse of Historical States	PLOS ONE			English	Article							CLIMATE-CHANGE; WORLD; REVOLUTION; CAMBODIA; SOCIETY; COMPLEX; ANGKOR; EMPIRE; RISE; EAST	An explanation for the political processes leading to the sudden collapse of empires and states would be useful for understanding both historical and contemporary political events. We examine political disintegration across eras, cultures and geographical scale to form a simple hypothesis that can be expressed verbally yet formulated mathematically. Factions within a state make choices described by game-theory about whether to accept the political status quo, or to attempt to better their circumstances through costly rebellion. In lieu of precise data we verify our model using sensitivity analysis. We find that a small amount of dissatisfaction is typically harmless to the state, but can trigger sudden collapse when there is a sufficient buildup of political inequality. Contrary to intuition, a state is predicted to be least stable when its leadership is at the height of its political power and thus most able to exert its influence through external warfare, lavish expense or autocratic decree.	[Lawson, Daniel John] Univ Bristol, Sch Math, Heilbronn Inst, Bristol, Avon, England; [Oak, Neeraj] Univ Bristol, Bristol Ctr Complex Sci, Bristol, Avon, England	University of Bristol; University of Bristol	Lawson, DJ (corresponding author), Univ Bristol, Sch Math, Heilbronn Inst, Bristol, Avon, England.	dan.lawson@bristol.ac.uk	Lawson, Daniel/A-8550-2011	Lawson, Daniel/0000-0002-5311-6213	Heilbronn Institute for Mathematical Research; Bristol Centre for Complexity Sciences	Heilbronn Institute for Mathematical Research; Bristol Centre for Complexity Sciences	DJL was funded by the Heilbronn Institute for Mathematical Research and NO by Bristol Centre for Complexity Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, HIST DYNAMICS WHY ST, DOI DOI 10.23943/PRINCETON/9780691180779.001.0001; [Anonymous], 1986, WEBERIAN SOCIOLOGICA; [Anonymous], 1990, COLLAPSE COMPLEX SOC; [Anonymous], 1998, GROWTH INEQUALITY GL; Ascher Abraham, 1988, REVOLUTION 1905 RUSS; Auzepy MF, 2008, CAMBRIDGE HIST BYZAN; Axelrod R., 2006, EVOLUTION COOPERATIO; Baggaley AW, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.016105; BALDWIN DA, 1979, WORLD POLIT, V31, P161, DOI 10.2307/2009941; BERNARD L, 1964, FR HIST STUD, V3, P454, DOI 10.2307/286151; Bickerman E, 1983, CAMBRIDGE HIST IRAN, V3; Blaydes L, 2013, AM POLIT SCI REV, V107, P16, DOI 10.1017/S0003055412000561; Boyd R, 2011, BEHAV ECOL SOCIOBIOL, V65, P431, DOI 10.1007/s00265-010-1100-3; Boyle J, 1968, CAMBRIDGE HIST ONLIN, V5; Breisach Ernst, 2007, HISTORIOGRAPHY ANCIE; Buckley BM, 2010, P NATL ACAD SCI USA, V107, P6748, DOI 10.1073/pnas.0910827107; Bury J., 1924, CAMBRIDGE ANCIENT HI, V2; Butzer KW, 2012, P NATL ACAD SCI USA, V109, P3632, DOI 10.1073/pnas.1114845109; Caesar GJ, 1997, CIVIL WAR, P76; Campante FR, 2012, J ECON PERSPECT, V26, P167, DOI 10.1257/jep.26.2.167; Coe M. D., 2003, ANGKOR KHMER CIVILIS; Collier P., 2000, EC CAUSES CIVIL CONF; Collins R., 1978, RES SOCIAL MOVEMENTS, V1, P1; Cullen HM, 2000, GEOLOGY, V28, P379, DOI 10.1130/0091-7613(2000)28<379:CCATCO>2.0.CO;2; Currie TE, 2010, NATURE, V467, P801, DOI 10.1038/nature09461; Diamond J., 2011, COLLAPSE SOC CHOOSE; Dillon Matthew, 2005, ANCIENT ROME EARLY R; Dugmore AJ, 2012, P NATL ACAD SCI USA, V109, P3658, DOI 10.1073/pnas.1115292109; Durant W, 1944, STORY CIVILISATION C; EISENSTADT SN, 1964, AM SOCIOL REV, V29, P235, DOI 10.2307/2092126; Evans D, 2007, P NATL ACAD SCI USA, V104, P14277, DOI 10.1073/pnas.0702525104; Gardner Brian, 1971, E INDIA CO HIST; Gause FG, 2011, FOREIGN AFF, V90, P81; Gavrilets S, 2010, CLIODYNAMICS J THEOR, V1, P58; GIBBON E., 1776, HIST DECLINE FALL RO, VI; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Grant M, 1996, ANTONINES ROMAN EMPI; Gregory Timothy E., 2005, HIST BYZANTIUM; Hammond N. G. L., 1988, CAMBRIDGE ANCIENT HI, V4; Herrin J., 2007, BYZANTIUM SURPRISING; HIGHAM C., 2004, CIVILIZATION ANGKOR; Hollister CW, 1961, J CABRILLO HIST ASS, V1, P1; Hunt Edwin S, 1994, MEDIEVAL SUPER CO ST; Johnstone S, 2011, SURVIVAL, V53, P11, DOI 10.1080/00396338.2011.571006; Jones B, 1992, ROMAN IMPERIAL BIOGR; Khaldun I, 1958, MUQADIMMAH INTRO HIS; Knappett C, 2008, ANTIQUITY, V82, P1009, DOI 10.1017/S0003598X0009774X; Laiou AE, 2008, CAMBRIDGE HIST BYZAN; Marohasy Jennifer, 2005, ENERGY ENV, V16, P457; McCormick M, 2012, J INTERDISCIPL HIST, V43, P169, DOI 10.1162/JINH_a_00379; Polunov Alexander, 2003, RUSSIA 19 CENTURY AU; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Saltelli A., 2000, SENSITIVITY ANAL, V134; Scullard HH, 2010, GRACCHI NERO HIST RO; Steinberg S. H., 1964, GERMAN HANSA; Treadgold, 1982, BYZANTINE STATE FINA; Trotsky L, 1972, PELICAN BOOKS; Turchin P, 2012, CLIODYNAMICS, V3, P2; Turchin P, 2003, HIST DYNAMICS; Turchin P, 2013, P NATL ACAD SCI USA, V110, P16384, DOI 10.1073/pnas.1308825110; TVERSKY A, 1973, COGNITIVE PSYCHOL, V5, P207, DOI 10.1016/0010-0285(73)90033-9; von Fritz Kurt, 1957, CLASSICAL PHILOL, V52, P73; Waterfield Robin, 2011, DIVIDING SPOILS WAR; Weiss H, 2001, SCIENCE, V291, P609, DOI 10.1126/science.1058775; Zhang DD, 2007, P NATL ACAD SCI USA, V104, P19214, DOI 10.1073/pnas.0703073104	65	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96523	10.1371/journal.pone.0096523	http://dx.doi.org/10.1371/journal.pone.0096523			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AK1XT	24810228	gold, Green Published, Green Submitted			2022-12-27	WOS:000338213300049
J	Blanton, H; Snyder, LB; Strauts, E; Larson, JG				Blanton, Hart; Snyder, Leslie B.; Strauts, Erin; Larson, Joy G.			Effect of Graphic Cigarette Warnings on Smoking Intentions in Young Adults	PLOS ONE			English	Article							PICTORIAL HEALTH WARNINGS; PSYCHOLOGICAL REACTANCE; SENSATION-SEEKING; FEAR APPEALS; UNITED-STATES; LABELS; SMOKERS; BEHAVIOR; TOBACCO; ADOLESCENTS	Introduction:Graphic warnings (GWs) on cigarette packs are widely used internationally and perhaps will be in the US but their impact is not well understood. This study tested support for competing hypotheses in different subgroups of young adults defined by their history of cigarette smoking and individual difference variables (e.g., psychological reactance). One hypothesis predicted adaptive responding (GWs would lower smoking-related intentions) and another predicted defensive responding (GWs would raise smoking-related intentions). Methods: Participants were an online sample of 1,169 Americans ages 18-24, who were randomly assigned either to view nine GWs designed by the FDA or to a no-label control. Both the intention to smoke in the future and the intention to quit smoking (among smokers) were assessed before and after message exposure. Results: GWs lowered intention to smoke in the future among those with a moderate lifetime smoking history (between 1 and 100 cigarettes), and they increased intention to quit smoking among those with a heavy lifetime smoking history (more than 100 cigarettes). Both effects were limited to individuals who had smoked in some but not all of the prior 30 days (i.e., occasional smokers). No evidence of defensive "boomerang effects'' on intention was observed in any subgroup. Conclusion: Graphic warnings can reduce interest in smoking among occasional smokers, a finding that supports the adaptive-change hypothesis. GWs that target occasional smokers might be more effective at reducing cigarette smoking in young adults.	[Blanton, Hart; Strauts, Erin] Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA; [Snyder, Leslie B.] Univ Connecticut, Dept Commun Sci, Storrs, CT 06268 USA; [Larson, Joy G.] Univ Connecticut, Ctr Hlth Intervent & Prevent, Storrs, CT USA	University of Connecticut; University of Connecticut; University of Connecticut	Blanton, H (corresponding author), Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA.	hart.blanton@uconn.edu			National Cancer Institute [1P50CA148596-01]; College of Liberal Arts and Sciences at the University of Connecticut; NATIONAL CANCER INSTITUTE [P50CA148596] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); College of Liberal Arts and Sciences at the University of Connecticut; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by a supplement to funding from the National Cancer Institute (1P50CA148596-01) and by the College of Liberal Arts and Sciences at the University of Connecticut. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarracin D, 2003, PERS SOC PSYCHOL B, V29, P834, DOI 10.1177/0146167203029007003; Andrews CL, 2012, GRAPHIC TOBACCO WARN; Azagba S, 2013, NICOTINE TOB RES, V15, P708, DOI 10.1093/ntr/nts194; BENSLEY LS, 1991, J APPL SOC PSYCHOL, V21, P1111, DOI 10.1111/j.1559-1816.1991.tb00461.x; Blanton H, 2013, J HEALTH COMMUN, V18, P1279, DOI 10.1080/10810730.2013.778359; Bledsoe LK, 2006, ADDICT BEHAV, V31, P1271, DOI 10.1016/j.addbeh.2005.08.012; Borland R, 2009, TOB CONTROL, V18, P358, DOI 10.1136/tc.2008.028043; Brehm J.W., 1966, THEORY PSYCHOL REACT; Brown AE, 2011, ADDICT BEHAV, V36, P1199, DOI 10.1016/j.addbeh.2011.07.024; Brown S, 2009, PSYCHOL HEALTH, V24, P517, DOI 10.1080/08870440801911130; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Chang FC, 2011, HEALTH EDUC RES, V26, P179, DOI 10.1093/her/cyq073; Cho HY, 2007, J COMMUN, V57, P293, DOI 10.1111/j.1460-2466.2007.00344.x; Edwards SA, 2010, NICOTINE TOB RES, V12, P1195, DOI 10.1093/ntr/ntq168; Erceg-Hurn DM, 2011, J APPL SOC PSYCHOL, V41, P219, DOI 10.1111/j.1559-1816.2010.00710.x; Fathelrahman AI, 2009, NICOTINE TOB RES, V11, P248, DOI 10.1093/ntr/ntn029; Fiore MC, 1997, ANN BEHAV MED, V19, P213, DOI 10.1007/BF02892286; Fishbein M., 2010, PREDICTING CHANGING, DOI 10.4324/9780203838020; FRANKEN RE, 1992, PERS INDIV DIFFER, V13, P31, DOI 10.1016/0191-8869(92)90214-A; Freeman MA, 2001, HEALTH PSYCHOL, V20, P424, DOI 10.1037//0278-6133.20.6.424; Gibbons FX, 1998, J PERS SOC PSYCHOL, V74, P1164, DOI 10.1037/0022-3514.74.5.1164; Golmier I, 2007, PSYCHOL REP, V100, P3, DOI 10.2466/PR0.100.1.3-18; Goodall C, 2008, HEALTH COMMUN, V23, P117, DOI 10.1080/10410230801967825; Hammond D, 2006, TOB CONTROL, V15, P19, DOI 10.1136/tc.2005.012294; Hammond D, 2004, AM J PUBLIC HEALTH, V94, P1442, DOI 10.2105/AJPH.94.8.1442; Hammond D, 2013, NICOTINE TOB RES, V15, P93, DOI 10.1093/ntr/nts094; Hammond D, 2011, TOB CONTROL, V20, P327, DOI 10.1136/tc.2010.037630; Jaccard J., 1990, INTERACTION EFFECTS; Jaccard J., 1998, INTERACTION EFFECTS; Kees J, 2010, J PUBLIC POLICY MARK, V29, P265, DOI 10.1509/jppm.29.2.265; Keller PA, 1999, J APPL PSYCHOL, V84, P403, DOI 10.1037/0021-9010.84.3.403; Keller PA, 1999, J EXP PSYCHOL-APPL, V5, P302, DOI 10.1037/1076-898X.5.3.302; Kessels LTE, 2010, HEALTH PSYCHOL, V29, P346, DOI 10.1037/a0019372; Kraemer JD, 2013, AM J PREV MED, V45, P334, DOI 10.1016/j.amepre.2013.05.004; LIBERMAN A, 1992, PERS SOC PSYCHOL B, V18, P669, DOI 10.1177/0146167292186002; Lissek S, 2005, EMOTION, V5, P396, DOI 10.1037/1528-3542.5.4.396; MACKINNON DP, 1993, HEALTH PSYCHOL, V12, P147, DOI 10.1037/0278-6133.12.2.147; Malouff JM, 2013, AM J ADDICTION, V22, P388, DOI 10.1111/j.1521-0391.2013.12040.x; McCool J, 2012, SOC SCI MED, V74, P1269, DOI 10.1016/j.socscimed.2011.12.043; McDermott L, 2007, TOB CONTROL, V16, P248, DOI 10.1136/tc.2006.018416; Nguyen QB, 2009, NICOTINE TOB RES, V11, P164, DOI 10.1093/ntr/ntp012; Nolan JM, 2008, PERS SOC PSYCHOL B, V34, P913, DOI 10.1177/0146167208316691; Nonnemaker J, 2010, EXPT STUDY GRAPHIC C; Pepper JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065533; Peters E, 2007, NICOTINE TOB RES, V9, P473, DOI 10.1080/14622200701239639; Pomery EA, 2009, PERS SOC PSYCHOL B, V35, P894, DOI 10.1177/0146167209335166; PRINTZ C, 2011, CANCER-AM CANCER SOC, V117, P5249, DOI DOI 10.1002/CNCR.26673; Rains SA, 2007, HUM COMMUN RES, V33, P241, DOI 10.1111/j.1468-2958.2007.00298.x; ROGERS RW, 1976, J PERS SOC PSYCHOL, V34, P54, DOI 10.1037/0022-3514.34.1.54; Rosenberg M, 1989, SOC ADOLESCENT SELF; Ruiter RAC, 2005, EUR J PUBLIC HEALTH, V15, P329, DOI 10.1093/eurpub/cki095; Sabbane LI, 2009, J CONSUM AFF, V43, P332, DOI 10.1111/j.1745-6606.2009.01142.x; Schroeder SA, 2012, J CANCER EDUC, V27, P5, DOI 10.1007/s13187-012-0327-2; Smith GE, 1997, HEALTH PSYCHOL, V16, P137, DOI 10.1037/0278-6133.16.2.137; Strasser AA, 2012, AM J PREV MED, V43, P41, DOI 10.1016/j.amepre.2012.02.026; Substance Abuse and Mental Health Services Administration, 2010, NSDUH SER; Thrasher JF, 2011, HEALTH POLICY, V102, P41, DOI 10.1016/j.healthpol.2011.06.003; U.S. Census Bureau, 2011, AM COMM SURV; U.S. Census Census Bureau, 2013, POP EST; US Department of Health and Human Services, 2012, PREV TOB UYOUTH YO; White V, 2008, ADDICTION, V103, P1562, DOI 10.1111/j.1360-0443.2008.02294.x; WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276; Wu DW, 2012, LANCET, V380, P871, DOI 10.1016/S0140-6736(12)61482-2; Zuckerman M, 2007, PERS INDIV DIFFER, V43, P1303, DOI 10.1016/j.paid.2007.03.021	64	26	26	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96315	10.1371/journal.pone.0096315	http://dx.doi.org/10.1371/journal.pone.0096315			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG9HB	24806481	Green Published, Green Submitted, gold			2022-12-27	WOS:000335728900046
J	Sancilio, S; di Giacomo, V; Di Giulio, M; Gallorini, M; Marsich, E; Travan, A; Tarusha, L; Cellini, L; Cataldi, A				Sancilio, Silvia; di Giacomo, Viviana; Di Giulio, Mara; Gallorini, Marialucia; Marsich, Eleonora; Travan, Andrea; Tarusha, Lorena; Cellini, Luigina; Cataldi, Amelia			Biological Responses of Human Gingival Fibroblasts (HGFs) in an Innovative Co-Culture Model with Streptococcus mitis to Thermosets Coated with a Silver Polysaccharide Antimicrobial System	PLOS ONE			English	Article							2-HYDROXYETHYL METHACRYLATE; BINDING	This study sought to evaluate the in vitro biological response of human gingival fibroblasts (HGFs) co-coltured with Streptococcus mitis to bisphenol A glycidylmethacrylate/triethylene glycol dimethacrylate (BisGMA/TEGDMA) thermosets coated with Chitlac-nAg, a nanocomposite system with antimicrobial properties. To avoid bacterial adhesion to dental devices and to reduce cytotoxicity against eukaryotic cells, we coated BisGMA/TEGDMA methacrylic thermosets with a new material, Chitlac-nAg, formed by stabilizing silver nanoparticles, which have well-known antimicrobial properties, with a polyelectrolyte solution containing Chitlac. Cytotoxicity, cell morphology, cell migration and inflammatory interleukine-6 (IL-6) and prostaglandin E-2 (PGE(2)) secretion were evaluated. Our results showed that the cytotoxicity exerted on HGFs by our nanocomposite material was absent in our co-culture model, where fibroblasts are able to adhere and migrate. After 24 h thermosets coated with Chitlac as well as those coated with Chitlac-nAg exerted a minimal cytotoxic effect on HGFs, while after 48 h LDH release rises up 20%. Moreover the presence of S. mitis reduced this release in a greater amount with Chitlac-nAg coated thermosets. The secretion of IL-6 was significant in both Chitlac and Chitlac-nAg coated thermosets, but PGE2 production was minimal, suggesting that the IL-6 production was not related to an inflammatory response. Co-culture and the addiction of saliva did not influence IL-6 and PGE2 secretion. Data obtained in the present work suggest that Chitlac nAg coated thermosets could significantly improve the success rates of restorative dentistry, since they limit bacterial adhesion and are not toxic to HGFs.	[Sancilio, Silvia; di Giacomo, Viviana; Di Giulio, Mara; Gallorini, Marialucia; Cellini, Luigina; Cataldi, Amelia] Univ G dAnnunzio, Dept Pharm, Chieti, Italy; [Marsich, Eleonora] Univ Trieste, Trieste, Italy; [Travan, Andrea; Tarusha, Lorena] Univ Trieste, Dept Life Sci, Trieste, Italy	G d'Annunzio University of Chieti-Pescara; University of Trieste; University of Trieste	di Giacomo, V (corresponding author), Univ G dAnnunzio, Dept Pharm, Chieti, Italy.	v.digiacomo@unich.it		MARSICH, ELEONORA/0000-0002-0700-4464; Cellini, Luigina/0000-0003-4068-9124; TRAVAN, Andrea/0000-0002-7454-6415; CATALDI, Amelia/0000-0002-4989-6210; DI GIULIO, MARA/0000-0002-8375-9404; Gallorini, Marialucia/0000-0002-2283-4159; DI GIACOMO, Viviana/0000-0003-3332-993X	FIRB project	FIRB project	This work was supported by a number of sources: first, a FIRB project, -"Accordi di Programma 2010'', directed by Prof. Cataldi (Cod. RBAPI095), on 'Processi degenerativi dei tessuti mineralizzati del cavo orale, impieghi di biomateriali e controllo delle interazioni con microrganismi dell'ambiente', second Prof. Cataldi's 2009 PRIN grant entitled ` Ruolo delle protein chinasi C (PKC) nei processi di interazione/integrazione tra biomateriale dentale/tessuto ospite/flora microbica della cavita' orale', third, an "ex 60%'' grant held by Prof. Cataldi and fourth, an "ex 60%'' grant held by Dr. Viviana di Giacomo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek KJ, 2013, ARCH ORAL BIOL, V58, P1282, DOI 10.1016/j.archoralbio.2013.07.007; Ballo AM, 2008, J MATER SCI-MATER M, V19, P3169, DOI 10.1007/s10856-008-3453-y; Belibasakis GN, 2011, FEMS IMMUNOL MED MIC, V63, P381, DOI 10.1111/j.1574-695X.2011.00863.x; Camporeale A, 2012, FRONT BIOSCI-LANDMRK, V17, P2306, DOI 10.2741/4054; Carpenter GH, 2013, ANNU REV FOOD SCI T, V4, P267, DOI 10.1146/annurev-food-030212-182700; Cataldi A, 2013, J BIOMED MATER RES A, V101, P378, DOI 10.1002/jbm.a.34337; de Jong HK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002933; di Giacomo V, 2013, INT ENDOD J, V46, P1164, DOI 10.1111/iej.12113; Di Giulio M, 2013, J MATER SCI-MATER M, V24, P1977, DOI 10.1007/s10856-013-4949-7; Di Giulio M, 2013, INT J MOL SCI, V14, P13615, DOI 10.3390/ijms140713615; Di Giulio M, 2012, APMIS, V120, P139, DOI 10.1111/j.1600-0463.2011.02828.x; Di Nisio C, 2013, INT ENDOD J, V46, P466, DOI 10.1111/iej.12012; Dickinson BC, 2011, MOL ORAL MICROBIOL, V26, P210, DOI 10.1111/j.2041-1014.2011.00609.x; Durner J, 2012, DENT MATER, V28, P818, DOI 10.1016/j.dental.2012.04.031; Engels-Deutsch M, 2011, ARCH ORAL BIOL, V56, P22, DOI 10.1016/j.archoralbio.2010.08.010; Ghanaati S, 2010, EUR J MED RES, V15, P483, DOI 10.1186/2047-783X-15-11-483; Heo SM, 2013, INFECT IMMUN, V81, P1364, DOI 10.1128/IAI.00825-12; Hsin YH, 2008, TOXICOL LETT, V179, P130, DOI 10.1016/j.toxlet.2008.04.015; Hsu SH, 2012, TISSUE ENG PT A, V18, P67, DOI [10.1089/ten.tea.2011.0157, 10.1089/ten.TEA.2011.0157]; Jayaramudu T, 2013, CARBOHYD POLYM, V95, P188, DOI 10.1016/j.carbpol.2013.02.075; Krifka S, 2013, BIOMATERIALS, V34, P4555, DOI 10.1016/j.biomaterials.2013.03.019; Marcotte H, 1998, MICROBIOL MOL BIOL R, V62, P71, DOI 10.1128/MMBR.62.1.71-109.1998; Marsich E, 2013, ACTA BIOMATER, V9, P5088, DOI 10.1016/j.actbio.2012.10.002; Melo MAS, 2013, J BIOMED MATER RES B, V101B, P620, DOI 10.1002/jbm.b.32864; Mitchell J, 2011, MOL ORAL MICROBIOL, V26, P89, DOI 10.1111/j.2041-1014.2010.00601.x; Rizzello L, 2013, NANOMEDICINE-UK, V8, P807, DOI [10.2217/NNM.13.63, 10.2217/nnm.13.63]; Travan A, 2012, BIOMACROMOLECULES, V13, P1564, DOI 10.1021/bm3002683; Travan A, 2011, ACTA BIOMATER, V7, P337, DOI 10.1016/j.actbio.2010.07.024; Travan A, 2010, BIOMACROMOLECULES, V11, P583, DOI 10.1021/bm9011419; Travan A, 2009, BIOMACROMOLECULES, V10, P1429, DOI 10.1021/bm900039x; Vorrasi J, 2010, MOL ORAL MICROBIOL, V25, P150, DOI 10.1111/j.2041-1014.2009.00554.x; Ye P, 2013, MICROB PATHOGENESIS, V56, P53, DOI 10.1016/j.micpath.2012.11.004; Yuan K, 2012, IMPLANT DENT, V21, P3, DOI 10.1097/ID.0b013e3182425c62; Zara S, 2011, INT ENDOD J, V44, P1145, DOI 10.1111/j.1365-2591.2011.01935.x; Zhou YZ, 2013, SMALL, V9, P3445, DOI 10.1002/smll.201202455; Zimmerli W, 2011, SEMIN IMMUNOPATHOL, V33, P295, DOI 10.1007/s00281-011-0275-7	36	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96520	10.1371/journal.pone.0096520	http://dx.doi.org/10.1371/journal.pone.0096520			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806464	Green Published, Green Submitted, gold			2022-12-27	WOS:000335728900067
J	Wallace, DL; Aarts, E; Dang, LC; Greer, SM; Jagust, WJ; D'Esposito, M				Wallace, Deanna L.; Aarts, Esther; Dang, Linh C.; Greer, Stephanie M.; Jagust, William J.; D'Esposito, Mark			Dorsal Striatal Dopamine, Food Preference and Health Perception in Humans	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; SYNTHESIS CAPACITY; OBESITY; BRAIN; SENSITIVITY; VMPFC	To date, few studies have explored the neurochemical mechanisms supporting individual differences in food preference in humans. Here we investigate how dorsal striatal dopamine, as measured by the positron emission tomography (PET) tracer [F-18] fluorometatyrosine (FMT), correlates with food-related decision-making, as well as body mass index (BMI) in 16 healthy-weight to moderately obese individuals. We find that lower PET FMT dopamine synthesis binding potential correlates with higher BMI, greater preference for perceived "healthy'' foods, but also greater healthiness ratings for food items. These findings further substantiate the role of dorsal striatal dopamine in food-related behaviors and shed light on the complexity of individual differences in food preference.	[Wallace, Deanna L.; Aarts, Esther; Dang, Linh C.; Greer, Stephanie M.; Jagust, William J.; D'Esposito, Mark] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Aarts, Esther] Radboud Univ Nijmegen, Ctr Cognit Neuroimaging, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Dang, Linh C.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA	University of California System; University of California Berkeley; Radboud University Nijmegen; Vanderbilt University	Wallace, DL (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	deanna_wallace@berkeley.edu	Aarts, Esther/J-2254-2012; Jagust, William/ABE-6426-2020	Aarts, Esther/0000-0001-6360-6200; 	NIH [DA20600, AG044292, F32DA276840]; Tanita Healthy Weight Community Fellowship; NATIONAL INSTITUTE ON AGING [R01AG044292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020600] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tanita Healthy Weight Community Fellowship; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was generously funded by NIH grants DA20600, AG044292 and F32DA276840, and the Tanita Healthy Weight Community Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barratt W, 2006, BARRATT SIMPLIFIED M; Berridge KC, 2009, PHYSIOL BEHAV, V97, P537, DOI 10.1016/j.physbeh.2009.02.044; Cools R, 2008, J NEUROSCI, V28, P1208, DOI 10.1523/JNEUROSCI.4475-07.2008; Cools R, 2009, J NEUROSCI, V29, P1538, DOI 10.1523/JNEUROSCI.4467-08.2009; DeJesus OT, 1997, J NUCL MED, V38, P630; Dunn JP, 2012, DIABETES CARE, V35, P1105, DOI 10.2337/dc11-2250; Eberling JL, 2008, FRONT HUM NEUROSCI, V1, DOI 10.3389/neuro.09.009.2007; Goto Y, 2007, NEUROPHARMACOLOGY, V53, P583, DOI 10.1016/j.neuropharm.2007.07.007; Gravel K, 2012, APPETITE, V59, P877, DOI 10.1016/j.appet.2012.08.028; Hare TA, 2011, J NEUROSCI, V31, P11077, DOI 10.1523/JNEUROSCI.6383-10.2011; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Jordan S, 1997, BRAIN RES, V750, P264, DOI 10.1016/S0006-8993(96)01366-2; Katan MB, 2010, JAMA-J AM MED ASSOC, V303, P65, DOI 10.1001/jama.2009.1912; Laakso A, 2002, BIOL PSYCHIAT, V52, P759, DOI 10.1016/S0006-3223(02)01369-0; Logan J, 2000, NUCL MED BIOL, V27, P661, DOI 10.1016/S0969-8051(00)00137-2; Mawlawi O, 2001, J CEREBR BLOOD F MET, V21, P1034, DOI 10.1097/00004647-200109000-00002; Mengarelli F, 2013, CEREB CORTEX; Parker BA, 2004, EUR J CLIN NUTR, V58, P212, DOI 10.1038/sj.ejcn.1601768; PATLAK CS, 1985, J CEREBR BLOOD F MET, V5, P584, DOI 10.1038/jcbfm.1985.87; Provencher V, 2009, APPETITE, V52, P340, DOI 10.1016/j.appet.2008.11.005; Snow BJ, 1996, ADV NEUROL, V69, P449; Stice E, 2011, J NEUROSCI, V31, P4360, DOI 10.1523/JNEUROSCI.6604-10.2011; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Szczypka MS, 2001, NEURON, V30, P819, DOI 10.1016/S0896-6273(01)00319-1; Thanos PK, 2008, SYNAPSE, V62, P50, DOI 10.1002/syn.20468; VanBrocklin HF, 2004, APPL RADIAT ISOTOPES, V61, P1289, DOI 10.1016/j.apradiso.2004.04.008; VINGERHOETS FJG, 1994, ANN NEUROL, V36, P765, DOI 10.1002/ana.410360513; Volkow ND, 2011, TRENDS COGN SCI, V15, P37, DOI 10.1016/j.tics.2010.11.001; Wallace DL, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00032; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Wilcox CE, 2010, J OBES, V2010, DOI 10.1155/2010/909348; Ziauddeen H, 2012, NAT REV NEUROSCI, V13, P279, DOI 10.1038/nrn3212	33	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96319	10.1371/journal.pone.0096319	http://dx.doi.org/10.1371/journal.pone.0096319			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806534	Green Submitted, gold, Green Published			2022-12-27	WOS:000335728900048
J	Mohammedi, K; Bellili-Munoz, N; Driss, F; Roussel, R; Seta, N; Fumeron, F; Hadjadj, S; Marre, M; Velho, G				Mohammedi, Kamel; Bellili-Munoz, Naima; Driss, Fathi; Roussel, Ronan; Seta, Nathalie; Fumeron, Frederic; Hadjadj, Samy; Marre, Michel; Velho, Gilberto			Manganese Superoxide Dismutase (SOD2) Polymorphisms, Plasma Advanced Oxidation Protein Products (AOPP) Concentration and Risk of Kidney Complications in Subjects with Type 1 Diabetes	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; ALLELIC VARIATIONS; NADPH OXIDASE; RENAL-DISEASE; NEPHROPATHY; STRESS; GENE; ASSOCIATION; DYSFUNCTION; POPULATION	Aims: Oxidative stress is involved in the pathophysiology of diabetic nephropathy. Manganese superoxide dismutase (SOD2) catalyses the dismutation of superoxide, regulates the metabolism of reactive oxygen species in the mitochondria and is highly expressed in the kidney. Plasma concentration of advanced oxidation protein products (AOPP), a marker of oxidative stress, was found to be increased in patients with kidney disease. We investigated associations of SOD2 allelic variations, plasma SOD activity and AOPP concentration with diabetic nephropathy in type 1 diabetic subjects. Methods: Eight SNPs in the SOD2 region were analysed in 1285 Caucasian subjects with type 1 diabetes from the SURGENE prospective study (n = 340; 10-year follow-up), GENESIS (n = 501) and GENEDIAB (n = 444) cross-sectional studies. Baseline plasma concentration of AOPP and SOD activity were measured in GENEDIAB participants. Hazard ratio (HR) and odds ratio (OR) were determined for incidence and prevalence of nephropathy. Analyses were adjusted or stratified by retinopathy stages. Results: In the SURGENE cohort, the T-allele of rs4880 (V16A) was associated with the incidence of renal events (new cases, or the progression to a more severe stage of nephropathy; HR 1.99, 95% CI 1.24-3.12, p = 0.004) and with the decline in estimated glomerular filtration rate (eGFR) during follow-up. Similar associations were observed for rs2758329 and rs8031. Associations were replicated in GENESIS/GENEDIAB cohorts, in the subset of participants without proliferative retinopathy, and were confirmed by haplotype analyses. Risk allele and haplotype were also associated with higher plasma AOPP concentration and lower SOD activity. Conclusions: SOD2 allelic variations were associated with the incidence and the progression of diabetic nephropathy, with a faster decline in eGFR and with plasma AOPP concentration and SOD activity in subjects with type 1 diabetes. These results are consistent with a role for SOD2 in the protection against oxidative stress and kidney disease in type 1 diabetes.	[Mohammedi, Kamel; Bellili-Munoz, Naima; Roussel, Ronan; Fumeron, Frederic; Marre, Michel; Velho, Gilberto] INSERM, Res Unit 1138, Paris, France; [Mohammedi, Kamel; Roussel, Ronan; Marre, Michel] Hop Xavier Bichat, AP HP, Dept Diabetol Endocrinol & Nutr, Paris, France; [Driss, Fathi] INSERM, Res Unit 773, Paris, France; [Driss, Fathi; Seta, Nathalie] Hop Xavier Bichat, AP HP, Dept Biochem, Paris, France; [Roussel, Ronan; Fumeron, Frederic; Marre, Michel] Univ Paris Diderot, UFR Med, Sorbonne Paris Cite, Paris, France; [Seta, Nathalie] Univ Paris Diderot, UFR Pharm, Sorbonne Paris Cite, Paris, France; [Hadjadj, Samy] Ctr Hosp Univ Poitiers, Dept Endocrinol & Diabetol, Poitiers, France; [Hadjadj, Samy] INSERM, Res Unit 1082, Paris, France; [Hadjadj, Samy] INSERM, CIC 0802, Paris, France; [Hadjadj, Samy] Univ Poitiers, UFR Med & Pharm, Poitiers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CHU Poitiers; Universite de Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers	Velho, G (corresponding author), INSERM, Res Unit 1138, Paris, France.	gilberto.velho@inserm.fr	Seta, Nathalie S/F-1824-2018; Velho, Gilberto/Q-6724-2017; Fumeron, Frederic/AAC-6882-2019; Mohammedi, Kamel/AAG-3129-2019	Seta, Nathalie S/0000-0002-9240-8630; Velho, Gilberto/0000-0001-8811-363X; Fumeron, Frederic/0000-0002-7916-4619; Marre, Michel/0000-0002-3071-1837; Mohammedi, Kamel/0000-0001-6139-1197	Association Diabete Risque Vasculaire (ADRV); Association L'Aide Aux Jeunes Diabetiques (AJD), France	Association Diabete Risque Vasculaire (ADRV); Association L'Aide Aux Jeunes Diabetiques (AJD), France	This work was supported by grants from Association Diabete Risque Vasculaire (ADRV), and Association L'Aide Aux Jeunes Diabetiques (AJD), France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastaki M, 2006, PHARMACOGENET GENOM, V16, P279, DOI 10.1097/01.fpc.0000199498.08725.9c; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Ceriello A, 2000, DIABETES, V49, P2170, DOI 10.2337/diabetes.49.12.2170; De Cavanagh EMV, 2000, AM J PHYSIOL-REG I, V278, pR572, DOI 10.1152/ajpregu.2000.278.3.R572; Diabet Control Complications Trial Res Grp, 1997, DIABETES, V46, P1829; Etoh T, 2003, DIABETOLOGIA, V46, P1428, DOI 10.1007/s00125-003-1205-6; Ewens KG, 2005, DIABETES, V54, P3305, DOI 10.2337/diabetes.54.11.3305; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; GUIDOT DM, 1993, J BIOL CHEM, V268, P26699; Hadjadj S, 2001, J AM SOC NEPHROL, V12, P541, DOI 10.1681/ASN.V123541; Hadjadj S, 2004, DIABETES CARE, V27, P2661, DOI 10.2337/diacare.27.11.2661; Hovnik T, 2009, DIABETES CARE, V32, P2258, DOI 10.2337/dc09-0852; Jones CA, 2005, KIDNEY INT, V67, P1684, DOI 10.1111/j.1523-1755.2005.00265.x; Kangas-Kontio T, 2009, BRIT J OPHTHALMOL, V93, P1401, DOI 10.1136/bjo.2009.159012; Kitada M, 2011, DIABETES, V60, P634, DOI 10.2337/db10-0386; Kohner EM, 1991, TXB DIABETES MELLITU, V2, P575; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; MARKLUND SL, 1984, BIOCHEM J, V222, P649, DOI 10.1042/bj2220649; MARKLUND SL, 1982, CLIN CHIM ACTA, V126, P41, DOI 10.1016/0009-8981(82)90360-6; Marre M, 1997, J CLIN INVEST, V99, P1585, DOI 10.1172/JCI119321; Martin-Gallan P, 2003, FREE RADICAL BIO MED, V34, P1563, DOI 10.1016/S0891-5849(03)00185-0; Mohammedi K, 2013, DIABETOLOGIA, V56, P2733, DOI 10.1007/s00125-013-3057-z; Mohammedi K, 2011, MOL GENET METAB, V104, P654, DOI 10.1016/j.ymgme.2011.08.033; Mollsten A, 2009, DIABETOLOGIA, V52, P2590, DOI 10.1007/s00125-009-1550-1; Mollsten A, 2007, DIABETES, V56, P265, DOI 10.2337/db06-0698; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Orchard TJ, 2010, DIABETOLOGIA, V53, P2312, DOI 10.1007/s00125-010-1860-3; Piwowar A, 2008, DIABETES-METAB RES, V24, P549, DOI 10.1002/dmrr.885; Piwowar A, 2010, CLIN INVEST MED, V33, pE109, DOI 10.25011/cim.v33i2.12349; Portero-Otin M, 2008, BIOCHEM BIOPH RES CO, V368, P528, DOI 10.1016/j.bbrc.2008.01.101; Rodriguez-Iturbe B, 2007, J APPL PHYSIOL, V102, P255, DOI 10.1152/japplphysiol.00513.2006; Sedeek M, 2010, AM J PHYSIOL-RENAL, V299, pF1348, DOI 10.1152/ajprenal.00028.2010; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shi XY, 2008, ENDOCRINOLOGY, V149, P1829, DOI 10.1210/en.2007-1544; Sutton A, 2005, PHARMACOGENET GENOM, V15, P311, DOI 10.1097/01213011-200505000-00006; Sutton A, 2003, PHARMACOGENETICS, V13, P145, DOI 10.1097/00008571-200303000-00004; Tian C, 2011, DIABETOLOGIA, V54, P803, DOI 10.1007/s00125-010-2004-5; Tregouet DA, 2004, ANN HUM GENET, V68, P165, DOI 10.1046/j.1529-8817.2003.00085.x; Wei XF, 2009, AM J PHYSIOL-RENAL, V296, pF427, DOI 10.1152/ajprenal.90536.2008; WitkoSarsat V, 1996, KIDNEY INT, V49, P1304, DOI 10.1038/ki.1996.186; Young IS, 2001, J CLIN PATHOL, V54, P176, DOI 10.1136/jcp.54.3.176	43	26	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96916	10.1371/journal.pone.0096916	http://dx.doi.org/10.1371/journal.pone.0096916			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819633	Green Published, Green Submitted, gold			2022-12-27	WOS:000336653300049
J	Narjoz, C; Favre, A; McMullen, J; Kiehl, P; Montemurro, M; Figg, WD; Beaune, P; de Waziers, I; Rochat, B				Narjoz, Celine; Favre, Amelie; McMullen, Justin; Kiehl, Philippe; Montemurro, Michael; Figg, William D.; Beaune, Philippe; de Waziers, Isabelle; Rochat, Bertrand			Important Role of CYP2J2 in Protein Kinase Inhibitor Degradation: A Possible Role in Intratumor Drug Disposition and Resistance	PLOS ONE			English	Article							CYTOCHROME-P450 2J2; ANTICANCER AGENTS; MOLECULAR-MECHANISMS; MASS-SPECTROMETRY; OVARIAN-CANCER; LUNG-CANCER; IMATINIB; METABOLISM; EXPRESSION; IDENTIFICATION	We have investigated in vitro the metabolic capability of 3 extrahepatic cytochromes P-450, CYP1A1, 1B1 and 2J2, known to be over-expressed in various tumors, to biotransform 5 tyrosine kinase inhibitors (TKI): dasatinib, imatinib, nilotinib, sorafenib and sunitinib. Moreover, mRNA expression of CYP1A1, 1B1, 2J2 and 3A4 in 6 hepatocellular and 14 renal cell carcinoma tumor tissues and their surrounding healthy tissues, was determined. Our results show that CYP1A1, 1B1 and especially 2J2 can rapidly biotransform the studied TKIs with a metabolic efficiency similar to that of CYP3A4. The mRNA expression of CYP1A1, 1B1, 2J2 and 3A4 in tumor biopsies has shown i) the strong variability of CYP expression and ii) distinct outliers showing high expression levels (esp. CYP2J2) that are compatible with high intratumoral CYP activity and tumor-specific TKI degradation. CYP2J2 inhibition could be a novel clinical strategy to specifically increase the intratumoral rather than plasma TKI levels, improving TKI efficacy and extending the duration before relapse. Such an approach would be akin to beta-lactamase inhibition, a classical strategy to avoid antibiotic degradation and resistance.	[Narjoz, Celine; Beaune, Philippe; de Waziers, Isabelle] Univ Paris 05, INSERM UMR S U775, Sorbonne Paris Cite, Paris, France; [Narjoz, Celine; Beaune, Philippe] Hop Europeen Georges Pompidou, Serv Biochim, Unite Fonct Pharmacogenet & Oncol Mol, Paris, France; [Favre, Amelie; McMullen, Justin; Kiehl, Philippe; Rochat, Bertrand] CHU Vaudois, Quantitat Mass Spectrometry Facil, Lausanne, Switzerland; [Montemurro, Michael] Univ Zurich Hosp, CH-8091 Zurich, Switzerland; [Figg, William D.] NCI, Genitourinary Malignancies Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Zurich; University Zurich Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Rochat, B (corresponding author), CHU Vaudois, Quantitat Mass Spectrometry Facil, Lausanne, Switzerland.	bertrand.rochat@chuv.ch	De Waziers, Isabelle/N-5453-2018; Figg, William D/M-2411-2016; Montemurro, Michael/GQH-8271-2022	de Waziers, Isabelle/0000-0002-7859-3315; Figg, William/0000-0003-2428-5613; NARJOZ, Celine/0000-0001-6959-3527; Beaune, Philippe/0000-0002-6569-9014	NATIONAL CANCER INSTITUTE [ZICSC006537, ZIABC010627] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; [Anonymous], CANC RES; Belloc C, 1996, TOXICOLOGY, V106, P207, DOI 10.1016/0300-483X(95)03178-I; Bieche I, 2007, PHARMACOGENET GENOM, V17, P731, DOI 10.1097/FPC.0b013e32810f2e58; Chen C, 2011, J PHARMACOL EXP THER, V336, P344, DOI 10.1124/jpet.110.174805; Dean M, 2005, ANNU REV GENOM HUM G, V6, P123, DOI 10.1146/annurev.genom.6.080604.162122; Downie D, 2005, CLIN CANCER RES, V11, P7369, DOI 10.1158/1078-0432.CCR-05-0466; Falasca M, 2012, EXPERT OPIN INV DRUG, V21, P657, DOI 10.1517/13543784.2012.679339; Fujimura T, 2009, UROLOGY, V74, P391, DOI 10.1016/j.urology.2009.02.033; Ghassabian S, 2012, BIOCHEM PHARMACOL, V84, P215, DOI 10.1016/j.bcp.2012.04.001; Girault I, 2005, DRUG METAB DISPOS, V33, P1803, DOI 10.1124/dmd.105.005173; GONZALEZ FJ, 1990, TRENDS GENET, V6, P182, DOI 10.1016/0168-9525(90)90174-5; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Haas S, 2009, PATHOL RES PRACT, V205, P716, DOI 10.1016/j.prp.2009.06.003; Haouala A, 2009, J CHROMATOGR B, V877, P1982, DOI 10.1016/j.jchromb.2009.04.045; Jiang JG, 2005, CANCER RES, V65, P4707, DOI 10.1158/0008-5472.CAN-04-4173; Jiang JG, 2009, CHIN J CANC, V28, P93; Kamath AV, 2008, CANCER CHEMOTH PHARM, V61, P365, DOI 10.1007/s00280-007-0478-8; Kantarjian HM, 2003, BLOOD, V101, P473, DOI 10.1182/blood-2002-05-1451; Lee CA, 2012, DRUG METAB DISPOS, V40, P943, DOI 10.1124/dmd.111.043505; Lee CA, 2010, DRUG METAB DISPOS, V38, P347, DOI 10.1124/dmd.109.030270; Leung YK, 2005, CANCER RES, V65, P3726, DOI 10.1158/0008-5472.CAN-04-3771; Li J, 2007, CLIN CANCER RES, V13, P3731, DOI 10.1158/1078-0432.CCR-07-0088; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Ma J, 2007, MOL CANCER THER, V6, P2879, DOI 10.1158/1535-7163.MCT-07-0297; Marull M, 2006, J MASS SPECTROM, V41, P390, DOI 10.1002/jms.1002; Nguyen TA, 2008, MOL PHARMACOL, V73, P1122, DOI 10.1124/mol.107.042861; Oyama T, 2008, FRONT BIOSCI, V13, P5787; Rebucci M, 2013, BIOCHEM PHARMACOL, V85, P1219, DOI 10.1016/j.bcp.2013.02.017; Ren S, 2013, DRUG METAB DISPOS, V41, P60, DOI 10.1124/dmd.112.048264; Rochat B, 2005, CLIN PHARMACOKINET, V44, P349, DOI 10.2165/00003088-200544040-00002; Rochat B, 2009, CURR CANCER DRUG TAR, V9, P652, DOI 10.2174/156800909789056999; Rochat B, 2001, J PHARMACOL EXP THER, V296, P537; Rochat B, 2008, J MASS SPECTROM, V43, P736, DOI 10.1002/jms.1369; Rochat B, 2008, BIOPHARM DRUG DISPOS, V29, P103, DOI 10.1002/bdd.598; Scappini B, 2004, CANCER-AM CANCER SOC, V100, P1459, DOI 10.1002/cncr.20131; Sugiyama M, 2011, DRUG METAB DISPOS, V39, P757, DOI 10.1124/dmd.110.037853; van Erp NP, 2009, CANCER TREAT REV, V35, P692, DOI 10.1016/j.ctrv.2009.08.004; Wang LF, 2008, DRUG METAB DISPOS, V36, P1828, DOI 10.1124/dmd.107.020255; Widmer N, 2006, BRIT J CLIN PHARMACO, V62, P97, DOI 10.1111/j.1365-2125.2006.02719.x; Yabuki N, 2007, CANCER GENET CYTOGEN, V173, P1, DOI 10.1016/j.cancergencyto.2006.07.020; Zhang W, 2006, J PATHOL, V209, P213, DOI 10.1002/path.1955	43	22	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e95532	10.1371/journal.pone.0095532	http://dx.doi.org/10.1371/journal.pone.0095532			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819355	gold, Green Published, Green Submitted			2022-12-27	WOS:000336653300006
J	Wang, YT; Jiang, ZY; Fu, LL; Lu, Y; Men, YF				Wang, Yaotao; Jiang, Zhiyong; Fu, Lianlian; Lu, Ying; Men, Yongfeng			Lamellar Thickness and Stretching Temperature Dependency of Cavitation in Semicrystalline Polymers	PLOS ONE			English	Article							X-RAY-SCATTERING; HIGH-DENSITY POLYETHYLENE; TENSILE DEFORMATION-BEHAVIOR; SMALL-ANGLE; PLASTIC-DEFORMATION; MICROINDENTATION HARDNESS; ISOTACTIC POLY(1-BUTENE); STRUCTURAL EVOLUTION; BETA-POLYPROPYLENE; MECHANISMS	Polybutene-1 (PB-1), a typical semicrystalline polymer, in its stable form I shows a peculiar temperature dependent strain-whitening behavior when being stretched at temperatures in between room temperature and melting temperature of the crystallites where the extent of strain-whitening weakens with the increasing of stretching temperature reaching a minima value followed by an increase at higher stretching temperatures. Correspondingly, a stronger strain-hardening phenomenon was observed at higher temperatures. The strain-whitening phenomenon in semicrystalline polymers has its origin of cavitation process during stretching. In this work, the effect of crystalline lamellar thickness and stretching temperature on the cavitation process in PB-1 has been investigated by means of combined synchrotron ultrasmall-angle and wide-angle X-ray scattering techniques. Three modes of cavitation during the stretching process can be identified, namely "no cavitation" for the quenched sample with the thinnest lamellae where only shear yielding occurred, "cavitation with reorientation" for the samples stretched at lower temperatures and samples with thicker lamellae, and "cavitation without reorientation" for samples with thinner lamellae stretched at higher temperatures. The mode "cavitation with reorientation" occurs before yield point where the plate-like cavities start to be generated within the lamellar stacks with normal perpendicular to the stretching direction due to the blocky substructure of the crystalline lamellae and reorient gradually to the stretching direction after strain-hardening. The mode of "cavitation without reorientation" appears after yield point where ellipsoidal shaped cavities are generated in those lamellae stacks with normal parallel to the stretching direction followed by an improvement of their orientation at larger strains. X-ray diffraction results reveal a much improved crystalline orientation for samples with thinner lamellae stretched at higher temperatures. The observed behavior of microscopic structural evolution in PB-1 stretched at different temperatures explains above mentioned changes in macroscopic strain-whitening phenomenon with increasing in stretching temperature and stress-strain curves.	[Wang, Yaotao; Jiang, Zhiyong; Fu, Lianlian; Lu, Ying; Men, Yongfeng] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Polymer Phys & Chem, Univ Chinese Acad Sci, Changchun 130022, Peoples R China	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; University of Chinese Academy of Sciences, CAS	Men, YF (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Polymer Phys & Chem, Univ Chinese Acad Sci, Changchun 130022, Peoples R China.	men@ciac.ac.cn		Men, Yongfeng/0000-0003-3277-2227	National Natural Science Foundation of China [21134006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (21134006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addiego F, 2006, POLYMER, V47, P4387, DOI 10.1016/j.polymer.2006.03.093; Al-Hussein M, 2002, MACROMOLECULES, V35, P8515, DOI 10.1021/ma020831k; Azzurri F, 2003, POLYMER, V44, P1641, DOI 10.1016/S0032-3861(02)00864-9; Azzurri F, 2002, MACROMOLECULES, V35, P9069, DOI 10.1021/ma021005e; Bao RY, 2013, POLYMER, V54, P1259, DOI 10.1016/j.polymer.2012.12.050; Bartczak Z, 2005, POLYMER, V46, P6050, DOI 10.1016/j.polymer.2005.04.092; BOOR J, 1963, J POLYM SCI PART A, V1, P59, DOI 10.1002/pol.1963.100010106; BOSE S, 1978, J APPL PHYS, V49, P2916, DOI 10.1063/1.325177; BOWDEN PB, 1974, J MATER SCI, V9, P2034, DOI 10.1007/BF00540553; BUTLER MF, 1995, MACROMOLECULES, V28, P6383, DOI 10.1021/ma00123a001; Butler MF, 1998, POLYMER, V39, P39, DOI 10.1016/S0032-3861(97)00226-7; CHU F, 1994, POLYMER, V35, P3442, DOI 10.1016/0032-3861(94)90906-7; Deblieck RAC, 2011, POLYMER, V52, P2979, DOI 10.1016/j.polymer.2011.03.055; Dijkstra PTS, 2002, POLYM ENG SCI, V42, P152, DOI 10.1002/pen.10936; FLORY PJ, 1978, NATURE, V272, P226, DOI 10.1038/272226a0; FRIEDRICH K, 1983, ADV POLYM SCI, V52-3, P225; Galeski A, 2003, PROG POLYM SCI, V28, P1643, DOI 10.1016/j.progpolymsci.2003.09.003; GALESKI A, 1992, MACROMOLECULES, V25, P5705, DOI 10.1021/ma00047a023; Galeski A, 2010, MACROMOL SYMP, V298, P1, DOI 10.1002/masy.201000076; GEDDE UW, 1994, POLYM ENG SCI, V34, P1773, DOI 10.1002/pen.760342402; GOHIL RM, 1982, J MACROMOL SCI PHYS, VB21, P189, DOI 10.1080/00222348208204934; GSELL C, 1994, MAT SCI ENG A-STRUCT, V175, P183, DOI 10.1016/0921-5093(94)91058-8; HAMZEH FM, 1974, J APPL PHYS, V45, P3189, DOI 10.1063/1.1663746; Heck B, 1999, NEW J PHYS, V1, DOI 10.1088/1367-2630/1/1/317; Hermanns P., 1939, KOLLOID Z, V88, P68; Hiss R, 1999, MACROMOLECULES, V32, P4390, DOI 10.1021/ma981776b; Humbert S, 2010, MACROMOLECULES, V43, P7212, DOI 10.1021/ma101042d; Jiang ZY, 2007, MACROMOLECULES, V40, P7263, DOI 10.1021/ma0627572; Jiang ZY, 2009, POLYMER, V50, P4101, DOI 10.1016/j.polymer.2009.06.063; JUSKA T, 1982, POLYM ENG SCI, V22, P766, DOI 10.1002/pen.760221207; Li JX, 1998, POLYMER, V39, P6935, DOI 10.1016/S0032-3861(98)00144-X; Li XH, 2008, MACROMOLECULES, V41, P4371, DOI 10.1021/ma702834y; Liu Y, 1997, POLYMER, V38, P2797, DOI 10.1016/S0032-3861(97)85617-0; LIU Y, 1994, J POLYM SCI POL PHYS, V32, P2037, DOI 10.1002/polb.1994.090321210; Lorenz-Haas C, 2003, PHYS CHEM CHEM PHYS, V5, P1235, DOI 10.1039/b210684a; LUCIANI L, 1988, PROG POLYM SCI, V13, P37, DOI 10.1016/0079-6700(88)90010-X; Lv RH, 2008, J POLYM SCI POL PHYS, V46, P1202, DOI 10.1002/polb.21453; MEINEL G, 1970, KOLLOID Z Z POLYM, V242, P1151, DOI 10.1007/BF02084721; Men Y, 2002, POLYMER, V43, P2761, DOI 10.1016/S0032-3861(02)00082-4; Men YF, 2004, MACROMOLECULES, V37, P9481, DOI 10.1021/ma048274k; Men YF, 2005, J POLYM SCI POL PHYS, V43, P87, DOI 10.1002/polb.20310; Men YF, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.095502; Men YF, 2003, MACROMOLECULES, V36, P4689, DOI 10.1021/ma0344902; Na B, 2007, J APPL POLYM SCI, V105, P3274, DOI 10.1002/app.26594; Narisawa I., 1990, ADV POLYM SCI, V91, P353; Nathani H, 2004, ACTA MATER, V52, P3217, DOI 10.1016/j.actamat.2004.03.021; NATTA G, 1955, J AM CHEM SOC, V77, P1708, DOI 10.1021/ja01611a109; Pawlak A, 2005, MACROMOLECULES, V38, P9688, DOI 10.1021/ma050842o; Pawlak A, 2008, MACROMOLECULES, V41, P2839, DOI 10.1021/ma0715122; Pawlak A, 2007, POLYMER, V48, P1397, DOI 10.1016/j.polymer.2006.12.054; Pawlak A, 2010, POLYMER, V51, P5771, DOI 10.1016/j.polymer.2010.10.003; Pawlak A, 2010, J POLYM SCI POL PHYS, V48, P1271, DOI 10.1002/polb.22020; PETERLIN A, 1971, J MATER SCI, V6, P490, DOI 10.1007/BF00550305; Polanyi N, 1921, Z PHYS, V7, P149; POPLI R, 1987, J POLYM SCI POL PHYS, V25, P441, DOI 10.1002/polb.1987.090250301; Porod G., 1982, SMALL ANGLE XRAY SCA, P35; POWERS J, 1965, J RES NBS A PHYS CH, VA 69, P335, DOI 10.6028/jres.069A.034; Roth SV, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2336195; Rozanski A, 2011, MACROMOLECULES, V44, P7273, DOI 10.1021/ma201090z; RULAND W, 1969, J POLYM SCI POL SYM, P143; Schneider K, 2006, MACROMOL SYMP, V236, P241, DOI 10.1002/masy.200650430; Schultz J, 1974, POLYM MAT SCI; SEGUELA R, 1990, J MATER SCI LETT, V9, P46, DOI 10.1007/BF00722865; Strobl G, 2000, EUR PHYS J E, V3, P165, DOI 10.1007/s101890070030; Strobl G., 1997, PHYS POLYM; Thomas C, 2007, POLYMER, V48, P6041, DOI 10.1016/j.polymer.2007.07.062; Wang YT, 2013, MACROMOLECULES, V46, P518, DOI 10.1021/ma302389j; WU W, 1992, POLYMER, V33, P4137, DOI 10.1016/0032-3861(92)90617-6; YANG YC, 1985, MAKROMOL CHEM, V186, P1961; YOUNG RJ, 1973, J MATER SCI, V8, P23, DOI 10.1007/BF00755579; Zhang XC, 2000, POLYMER, V41, P3797, DOI 10.1016/S0032-3861(99)00594-7; Zhang XQ, 2012, POLYMER, V53, P648, DOI 10.1016/j.polymer.2011.12.002	72	41	41	5	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97234	10.1371/journal.pone.0097234	http://dx.doi.org/10.1371/journal.pone.0097234			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24820772	Green Published, gold, Green Submitted			2022-12-27	WOS:000336653300096
J	Zielinski, P; Dudek, K; Stuglik, MT; Liana, M; Babik, W				Zielinski, Piotr; Dudek, Katarzyna; Stuglik, Michal Tadeusz; Liana, Marcin; Babik, Wieslaw			Single Sucleotide Polymorphisms Reveal Genetic Structuring of the Carpathian Newt and Provide Evidence of Interspecific Gene Flow in the Nuclear Genome	PLOS ONE			English	Article							POPULATION SUBDIVISION; GEOGRAPHIC STRUCTURE; ASCERTAINMENT BIAS; BAYESIAN METHODS; DIVERGENCE; SPECIATION; SCALE; INTROGRESSION; MARKERS; HYBRIDIZATION	Genetic variation within species is commonly structured in a hierarchical manner which may result from superimposition of processes acting at different spatial and temporal scales. In organisms of limited dispersal ability, signatures of past subdivision are detectable for a long time. Studies of contemporary genetic structure in such taxa inform about the history of isolation, range changes and local admixture resulting from geographically restricted hybridization with related species. Here we use a set of 139 transcriptome-derived, unlinked nuclear single nucleotide polymorphisms (SNP) to assess the genetic structure of the Carpathian newt (Lissotriton montandoni, Lm) and introgression from its congener, the smooth newt (L. vulgaris, Lv). Two substantially differentiated groups of Lm populations likely originated from separate refugia, both located in the Eastern Carpathians. The colonization of the present range in north-western and south-western directions was accompanied by a modest loss of variation; admixture between the two groups has occurred in the middle of the Eastern Carpathians. Local, apparently recent introgression of Lv alleles into several Lm populations was detected, demonstrating increased power for admixture detection in comparison to a previous study based on a limited number of microsatellite markers. The level of introgression was higher in Lm populations classified as admixed than in syntopic populations. We discuss the possible causes and propose further tests to distinguish between alternatives. Several outlier loci were identified in tests of interspecific differentiation, suggesting genomic heterogeneity of gene flow between species.	[Zielinski, Piotr; Dudek, Katarzyna; Stuglik, Michal Tadeusz; Babik, Wieslaw] Jagiellonian Univ, Inst Environm Sci, Krakow, Poland; [Liana, Marcin] Jagiellonian Univ, Inst Zool, Dept Comparat Anat, Krakow, Poland	Jagiellonian University; Jagiellonian University	Zielinski, P (corresponding author), Jagiellonian Univ, Inst Environm Sci, Krakow, Poland.	piotr.zielinski@uj.edu.pl		Babik, Wieslaw/0000-0002-1698-6615; Dudek, Katarzyna/0000-0002-9810-2536; Zielinski, Piotr/0000-0002-8533-6800	Polish National Science Center [8171/B/P01/2011/40]; Jagiellonian University [DS/WBiNoZ/INoS/762/13]; National Multidisciplinary Laboratory of Functional Nanomaterials NanoFun [POIG. 02.02.00-00-025/09]	Polish National Science Center; Jagiellonian University; National Multidisciplinary Laboratory of Functional Nanomaterials NanoFun	The work was supported by the Polish National Science Center grant nr 8171/B/P01/2011/40 to WB and by the Jagiellonian University grant DS/WBiNoZ/INoS/762/13. MTS is the recipient of DOCTUS stipend. The GoldenGate Genotyping (Illumina) was performed in Genome Analysis Laboratory (Laboratory of High Throughput Technologies, IBMiB, Faculty of Biology UAM, Poznan), funded by National Multidisciplinary Laboratory of Functional Nanomaterials NanoFun nr POIG. 02.02.00-00-025/09 (Innovative Economy Operational Programme, Priority Axis 2: R& D Infrastructure, Action 2.2: Support of Formation of Common Research Infrastructure of Scientific Units). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboim MA, 2010, J EVOLUTION BIOL, V23, P817, DOI 10.1111/j.1420-9101.2010.01953.x; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Babik W, 2005, MOL ECOL, V14, P2475, DOI 10.1111/j.1365-294X.2005.02605.x; Babik W, 2003, MOL ECOL, V12, P1913, DOI 10.1046/j.1365-294X.2003.01880.x; Bayger JA, 1937, KLUCZ OZNACZANIA PLA; Beaumont MA, 2005, TRENDS ECOL EVOL, V20, P435, DOI 10.1016/j.tree.2005.05.017; Beaumont MA, 2010, ANNU REV ECOL EVOL S, V41, P379, DOI 10.1146/annurev-ecolsys-102209-144621; Bebbee TJC., 1996, ECOLOGY CONSERVATION, P214; Bierne N, 2011, MOL ECOL, V20, P2044, DOI 10.1111/j.1365-294X.2011.05080.x; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Brumfield RT, 2003, TRENDS ECOL EVOL, V18, P249, DOI 10.1016/S0169-5347(03)00018-1; Cabe PR, 2007, HEREDITY, V98, P53, DOI 10.1038/sj.hdy.6800905; Charlesworth B, 2003, ANNU REV ECOL EVOL S, V34, P99, DOI 10.1146/annurev.ecolsys.34.011802.132359; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Corbett-Detig RB, 2013, NATURE, V504, P135, DOI 10.1038/nature12678; Currat M, 2008, EVOLUTION, V62, P1908, DOI 10.1111/j.1558-5646.2008.00413.x; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Dowling TE, 1997, EVOLUTION, V51, P1574, DOI 10.1111/j.1558-5646.1997.tb01480.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fan JB, 2006, NAT REV GENET, V7, P632, DOI 10.1038/nrg1901; Flaxman SM, 2013, EVOLUTION, V67, P2577, DOI 10.1111/evo.12055; Foll M, 2006, GENETICS, V174, P875, DOI 10.1534/genetics.106.059451; Francois O, 2010, MOL ECOL RESOUR, V10, P773, DOI 10.1111/j.1755-0998.2010.02868.x; Frankham R., 2010, INTRO CONSERVATION G, DOI DOI 10.1017/CBO9780511809002; Frantz AC, 2009, J APPL ECOL, V46, P493, DOI 10.1111/j.1365-2664.2008.01606.x; Frean M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0211; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haasl RJ, 2011, HEREDITY, V106, P158, DOI 10.1038/hdy.2010.21; Helfer V, 2012, MOL ECOL, V21, P4706, DOI 10.1111/j.1365-294X.2012.05742.x; Helyar SJ, 2011, MOL ECOL RESOUR, V11, P123, DOI 10.1111/j.1755-0998.2010.02943.x; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 2011, GENETICA, V139, P617, DOI 10.1007/s10709-011-9547-3; Hickerson MJ, 2010, MOL PHYLOGENET EVOL, V54, P291, DOI 10.1016/j.ympev.2009.09.016; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.1111/j.1558-5646.1999.tb04571.x; Ingvarsson PK, 2004, GENET RES, V83, P31, DOI 10.1017/S0016672303006529; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kisel Y, 2010, AM NAT, V175, P316, DOI 10.1086/650369; Landguth EL, 2010, MOL ECOL, V19, P4179, DOI 10.1111/j.1365-294X.2010.04808.x; Landguth EL, 2012, MOL ECOL RESOUR, V12, P276, DOI 10.1111/j.1755-0998.2011.03077.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LATTER BDH, 1972, GENETICS, V70, P475; Lawniczak MKN, 2010, SCIENCE, V330, P512, DOI 10.1126/science.1195755; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Litvinchuk Spartak N., 2003, Alytes (Paris), V20, P161; Manel S, 2013, TRENDS ECOL EVOL, V28, P614, DOI 10.1016/j.tree.2013.05.012; Mullen LB, 2010, MOL ECOL, V19, P898, DOI 10.1111/j.1365-294X.2010.04541.x; Nadachowska K, 2009, MOL BIOL EVOL, V26, P829, DOI 10.1093/molbev/msp004; Nadachowska-Brzyska K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003942; Nadachowska-Brzyska K, 2012, MOL ECOL, V21, P887, DOI 10.1111/j.1365-294X.2011.05347.x; Nadeau NJ, 2012, PHILOS T R SOC B, V367, P343, DOI 10.1098/rstb.2011.0198; Narum SR, 2011, MOL ECOL RESOUR, V11, P184, DOI 10.1111/j.1755-0998.2011.02987.x; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Nolte AW, 2009, MOL ECOL, V18, P2615, DOI 10.1111/j.1365-294X.2009.04208.x; Noor MAF, 2009, HEREDITY, V103, P439, DOI 10.1038/hdy.2009.151; Nosil P, 2012, PHILOS T R SOC B, V367, P332, DOI 10.1098/rstb.2011.0263; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Paschou P, 2007, PLOS GENET, V3, P1672, DOI 10.1371/journal.pgen.0030160; Pritchard JK, 2000, GENETICS, V155, P945; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Rafinski J, 2001, FOLIA BIOL-KRAKOW, V49, P239; Ronikier M, 2011, TAXON, V60, P373, DOI 10.1002/tax.602008; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenblum EB, 2007, J HERED, V98, P331, DOI 10.1093/jhered/esm031; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Roux C, 2013, MOL BIOL EVOL, V30, P1574, DOI 10.1093/molbev/mst066; Savage WK, 2010, MOL ECOL, V19, P3301, DOI 10.1111/j.1365-294X.2010.04718.x; SLATKIN M, 1991, GENETICS, V127, P627; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Smith MA, 2005, ECOGRAPHY, V28, P110; Sommer RS, 2006, MAMMAL REV, V36, P251, DOI 10.1111/j.1365-2907.2006.00093.x; Sotiropoulos K, 2013, CONSERV GENET, V14, P385, DOI 10.1007/s10592-013-0452-4; Sousa V, 2013, NAT REV GENET, V14, P404, DOI 10.1038/nrg3446; Stadler T, 2009, GENETICS, V182, P205, DOI 10.1534/genetics.108.094904; Steele CA, 2009, MOL ECOL, V18, P1629, DOI 10.1111/j.1365-294X.2009.04135.x; Stewart JR, 2009, J EVOLUTION BIOL, V22, P2363, DOI 10.1111/j.1420-9101.2009.01859.x; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Storz JF, 2005, MOL ECOL, V14, P671, DOI 10.1111/j.1365-294X.2005.02437.x; Stuglik MT, 2014, ECOL EVOL, V4, P623, DOI 10.1002/ece3.965; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; Teeter KC, 2010, EVOLUTION, V64, P472, DOI 10.1111/j.1558-5646.2009.00846.x; Tzedakis PC, 2013, TRENDS ECOL EVOL, V28, P696, DOI 10.1016/j.tree.2013.09.001; Unger SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074180; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; Vences Miguel, 2007, Amphibian Biology, V7, P2613; Via S, 2012, PHILOS T R SOC B, V367, P451, DOI 10.1098/rstb.2011.0260; Wakeley J, 2001, THEOR POPUL BIOL, V59, P133, DOI 10.1006/tpbi.2000.1495; Wu CI, 2004, NAT REV GENET, V5, P114, DOI 10.1038/nrg1269; Zielinski P, 2014, MOL ECOL RESOUR, V14, P352, DOI 10.1111/1755-0998.12171; Zielinski P, 2013, MOL ECOL, V22, P1884, DOI 10.1111/mec.12225	101	20	20	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97431	10.1371/journal.pone.0097431	http://dx.doi.org/10.1371/journal.pone.0097431			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24820116	gold, Green Published			2022-12-27	WOS:000336653300112
J	Smith, IM; Christensen, JE; Arneborg, N; Jespersen, L				Smith, Ida M.; Christensen, Jeffrey E.; Arneborg, Nils; Jespersen, Lene			Yeast Modulation of Human Dendritic Cell Cytokine Secretion: An In Vitro Study	PLOS ONE			English	Article							SACCHAROMYCES-BOULARDII; GUT MICROBIOTA; T-CELLS; GASTROINTESTINAL-TRACT; MONONUCLEAR-CELLS; EPITHELIAL-CELLS; IMMUNE-RESPONSE; CACO-2 CELLS; LACTOBACILLI; STRAINS	Probiotics are live microorganisms which when administered in adequate amounts confer a health benefit on the host. The concept of individual microorganisms influencing the makeup of T cell subsets via interactions with intestinal dendritic cells (DCs) appears to constitute the foundation for immunoregulatory effects of probiotics, and several studies have reported probiotic strains resulting in reduction of intestinal inflammation through modulation of DC function. Consequent to a focus on Saccharomyces boulardii as the fundamental probiotic yeast, very little is known about hundreds of non-Saccharomyces yeasts in terms of their interaction with the human gastrointestinal immune system. The aim of the present study was to evaluate 170 yeast strains representing 75 diverse species for modulation of inflammatory cytokine secretion by human DCs in vitro, as compared to cytokine responses induced by a S. boulardii reference strain with probiotic properties documented in clinical trials. Furthermore, we investigated whether cytokine inducing interactions between yeasts and human DCs are dependent upon yeast viability or rather a product of membrane interactions regardless of yeast metabolic function. We demonstrate high diversity in yeast induced cytokine profiles and employ multivariate data analysis to reveal distinct clustering of yeasts inducing similar cytokine profiles in DCs, highlighting clear species distinction within specific yeast genera. The observed differences in induced DC cytokine profiles add to the currently very limited knowledge of the cross-talk between yeasts and human immune cells and provide a foundation for selecting yeast strains for further characterization and development toward potentially novel yeast probiotics. Additionally, we present data to support a hypothesis that the interaction between yeasts and human DCs does not solely depend on yeast viability, a concept which may suggest a need for further classifications beyond the current definition of a probiotic.	[Smith, Ida M.; Christensen, Jeffrey E.] Chr Hansen AS, Hlth & Nutr Div Discovery, Horsholm, Denmark; [Smith, Ida M.; Arneborg, Nils; Jespersen, Lene] Univ Copenhagen, Dept Food Sci, Frederiksberg, Denmark	Chr Hansen; University of Copenhagen	Jespersen, L (corresponding author), Univ Copenhagen, Dept Food Sci, Frederiksberg, Denmark.	lj@food.ku.dk	Jespersen, Lene/E-1717-2015; Jespersen, Lene/AAA-4230-2021; Arneborg, Nils/M-6506-2014	Jespersen, Lene/0000-0002-2555-5948; Jespersen, Lene/0000-0002-2555-5948; Arneborg, Nils/0000-0002-4323-5446; Christensen, Jeffrey E./0000-0001-7357-7677	EU [PITN-GA-2010-264717]	EU(European Commission)	The research leading to these results was funded by the EU's Seventh Framework Programme (FP7) under grant agreement PITN-GA-2010-264717, in the form of a research fellowship for IMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba N, 2008, J LEUKOCYTE BIOL, V84, P468, DOI 10.1189/jlb.0108017; Baba N, 2009, IMMUNOLOGY, V128, pe523, DOI 10.1111/j.1365-2567.2008.03022.x; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Carson RT, 1999, J IMMUNOL METHODS, V227, P41, DOI 10.1016/S0022-1759(99)00069-1; Chen XH, 2006, J BIOL CHEM, V281, P24449, DOI 10.1074/jbc.M605200200; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Collins JD, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1944; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Dahan S, 2003, INFECT IMMUN, V71, P766, DOI 10.1128/IAI.71.2.766-773.2003; Dalmasso G, 2006, GASTROENTEROLOGY, V131, P1812, DOI 10.1053/j.gastro.2006.10.001; Di Giacinto C, 2005, J IMMUNOL, V174, P3237, DOI 10.4049/jimmunol.174.6.3237; Dinleyici EC, 2012, EXPERT OPIN BIOL TH, V12, P395, DOI 10.1517/14712598.2012.664129; Donkor ON, 2012, CLIN EXP IMMUNOL, V167, P282, DOI 10.1111/j.1365-2249.2011.04496.x; FAO/WHO, 2002, GUIDELINES EVALUATIO, P1; Foligne B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000313; Foligne B, 2010, WORLD J GASTROENTERO, V16, P2134, DOI 10.3748/wjg.v16.i17.2134; Gad M, 2011, FEMS IMMUNOL MED MIC, V63, P93, DOI 10.1111/j.1574-695X.2011.00835.x; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Hatoum R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00421; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Jawhara S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040648; Jeon Seong Gyu, 2012, PLoS Pathog, V8, pe1002714, DOI 10.1371/journal.ppat.1002714; Konieczna P, 2012, GUT, V61, P354, DOI 10.1136/gutjnl-2011-300936; Kourelis A, 2010, J APPL MICROBIOL, V109, P260, DOI 10.1111/j.1365-2672.2009.04651.x; Kumura H, 2004, J DAIRY SCI, V87, P4050, DOI 10.3168/jds.S0022-0302(04)73546-8; Kwon HK, 2010, P NATL ACAD SCI USA, V107, P2159, DOI 10.1073/pnas.0904055107; Lee SK, 2009, DIGEST DIS SCI, V54, P255, DOI 10.1007/s10620-008-0357-0; Maccaferri S, 2012, APPL ENVIRON MICROB, V78, P956, DOI 10.1128/AEM.06385-11; Macey BM, 2006, MAR BIOTECHNOL, V8, P246, DOI 10.1007/s10126-005-0113-9; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Mann ER, 2013, IMMUNOL LETT; Martins FS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008925; Martins FS, 2005, J GEN APPL MICROBIOL, V51, P83, DOI 10.2323/jgam.51.83; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; McFarland LV, 2010, WORLD J GASTROENTERO, V16, P2202, DOI 10.3748/wjg.v16.i18.2202; Pedersen LL, 2012, INT J FOOD MICROBIOL, V159, P144, DOI 10.1016/j.ijfoodmicro.2012.08.016; Plantinga TS, 2012, CYTOKINE, V59, P159, DOI 10.1016/j.cyto.2012.03.020; Pothoulakis C, 2009, ALIMENT PHARM THER, V30, P826, DOI 10.1111/j.1365-2036.2009.04102.x; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Reyes-Becerril M, 2008, FISH SHELLFISH IMMUN, V25, P731, DOI 10.1016/j.fsi.2008.02.010; Romanin D, 2010, INT J FOOD MICROBIOL, V140, P102, DOI 10.1016/j.ijfoodmicro.2010.04.014; Ruiz PA, 2005, IMMUNOLOGY, V115, P441, DOI 10.1111/j.1365-2567.2005.02176.x; Saegusa S, 2007, BIOSCI BIOTECH BIOCH, V71, P2428, DOI 10.1271/bbb.70172; Scanlan PD, 2008, ISME J, V2, P1183, DOI 10.1038/ismej.2008.76; Smelt MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047244; Sougioultzis S, 2006, BIOCHEM BIOPH RES CO, V343, P69, DOI 10.1016/j.bbrc.2006.02.080; Suzuki M, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P361, DOI 10.1016/B978-0-444-52149-1.00024-0; Thomas S, 2009, CLIN EXP IMMUNOL, V156, P78, DOI 10.1111/j.1365-2249.2009.03878.x; Thomas S, 2011, AM J PHYSL GASTROINT; van der Aa Kuhle A, 2003, SYST APPL MICROBIOL, V26, P564; Vaughan-Martini A, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P733, DOI 10.1016/B978-0-444-52149-1.00061-6; Vignali DAA, 2000, J IMMUNOL METHODS, V243, P243, DOI 10.1016/S0022-1759(00)00238-6; Wall R, 2012, AM J CLIN NUTR, V95, P1278, DOI 10.3945/ajcn.111.026435; Weiss G, 2011, CYTOKINE, V56, P520, DOI 10.1016/j.cyto.2011.07.024; Weiss G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011065; Wells JM, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S17; Zanello G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018573; Zeuthen LH, 2008, IMMUNOLOGY, V124, P489, DOI 10.1111/j.1365-2567.2007.02800.x; Zeuthen LH, 2008, IMMUNOLOGY, V123, P197, DOI 10.1111/j.1365-2567.2007.02687.x	62	22	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96595	10.1371/journal.pone.0096595	http://dx.doi.org/10.1371/journal.pone.0096595			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816850	gold, Green Published, Green Submitted			2022-12-27	WOS:000336838000044
J	You, WH; Fan, SF; Yu, D; Xie, D; Liu, CH				You, Wenhua; Fan, Shufeng; Yu, Dan; Xie, Dong; Liu, Chunhua			An Invasive Clonal Plant Benefits from Clonal Integration More than a Co-Occurring Native Plant in Nutrient-Patchy and Competitive Environments	PLOS ONE			English	Article							DIVISION-OF-LABOR; EXTENSIVE PHYSIOLOGICAL INTEGRATION; ALTERNANTHERA-PHILOXEROIDES; PHOTOSYNTHETIC EFFICIENCY; FRAGARIA-CHILOENSIS; BIOMASS ALLOCATION; ALLIGATOR WEED; AFFECTS GROWTH; HERB; WATER	Many notorious invasive plants are clonal, however, little is known about the different roles of clonal integration effects between invasive and native plants. Here, we hypothesize that clonal integration affect growth, photosynthetic performance, biomass allocation and thus competitive ability of invasive and native clonal plants, and invasive clonal plants benefit from clonal integration more than co-occurring native plants in heterogeneous habitats. To test these hypotheses, two stoloniferous clonal plants, Alternanthera philoxeroides (invasive), Jussiaea repens (native) were studied in China. The apical parts of both species were grown either with or without neighboring vegetation and the basal parts without competitors were in nutrient-rich or -poor habitats, with stolon connections were either severed or kept intact. Competition significantly reduced growth and photosynthetic performance of the apical ramets in both species, but not the biomass of neighboring vegetation. Without competition, clonal integration greatly improved the growth and photosynthetic performance of both species, especially when the basal parts were in nutrient-rich habitats. When grown with neighboring vegetation, growth of J. repens and photosynthetic performance of both species were significantly enhanced by clonal integration with the basal parts in both nutrient-rich and -poor habitats, while growth and relative neighbor effect (RNE) of A. philoxeroides were greatly improved by clonal integration only when the basal parts were in nutrient-rich habitats. Moreover, clonal integration increased A. philoxeroides's biomass allocation to roots without competition, but decreased it with competition, especially when the basal ramets were in nutrient-rich sections. Effects of clonal integration on biomass allocation of J. repens was similar to that of A. philoxeroides but with less significance. These results supported our hypothesis that invasive clonal plants A. philoxeroides benefits from clonal integration more than co-occurring native J. repens, suggesting that the invasiveness of A. philoxeroides may be closely related to clonal integration in heterogeneous environments.	[You, Wenhua; Fan, Shufeng; Yu, Dan; Xie, Dong; Liu, Chunhua] Wuhan Univ, Coll Life Sci, Natl Field Stn Lake Ecosyst Liangzi Lake, Wuhan 430072, Peoples R China	Wuhan University	Yu, D (corresponding author), Wuhan Univ, Coll Life Sci, Natl Field Stn Lake Ecosyst Liangzi Lake, Wuhan 430072, Peoples R China.	yudan01@public.wh.hb.cn; liuchh@163.com		Fan, Shufeng/0000-0002-5930-2631	National Natural Science Foundation of China [30930011, 31170339]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (30930011 and 31170339). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPERT P, 1986, OECOLOGIA, V70, P227, DOI 10.1007/BF00379244; Alpert P, 2003, J ECOL, V91, P27, DOI 10.1046/j.1365-2745.2003.00737.x; BIRCH CPD, 1994, J ECOL, V82, P653, DOI 10.2307/2261272; BJORKMAN O, 1987, PLANTA, V170, P489, DOI 10.1007/BF00402983; Brezina S, 2006, FLORA, V201, P461, DOI 10.1016/j.flora.2005.10.003; Chidumayo EN, 2006, EVOL ECOL, V20, P59, DOI 10.1007/s10682-005-3873-9; D'Hertefeldt T, 1999, J ECOL, V87, P258, DOI 10.1046/j.1365-2745.1999.00345.x; D'Hertefeldt T, 2002, NEW PHYTOL, V156, P469, DOI 10.1046/j.1469-8137.2002.00529.x; Day KJ, 2003, FUNCT ECOL, V17, P454, DOI 10.1046/j.1365-2435.2003.00758.x; de Kroon H, 1998, OECOLOGIA, V116, P38, DOI 10.1007/s004420050561; DEKROON H, 1992, OIKOS, V63, P410, DOI 10.2307/3544967; Gunasekera L, 2001, J AQUAT PLANT MANAGE, V39, P17; HARTNETT DC, 1983, ECOLOGY, V64, P779, DOI 10.2307/1937201; HARTNETT DC, 1985, J ECOL, V73, P415, DOI 10.2307/2260484; Herben T, 2004, EVOL ECOL, V18, P493, DOI 10.1007/s10682-004-5141-9; HUTCHINGS MJ, 1994, ADV ECOL RES, V25, P159, DOI 10.1016/S0065-2504(08)60215-9; Hutchings MJ, 1997, TRENDS ECOL EVOL, V12, P390, DOI 10.1016/S0169-5347(97)87382-X; Ikegami M, 2008, ECOL MODEL, V213, P156, DOI 10.1016/j.ecolmodel.2007.11.016; Jonsdottir IS, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P109; JULIEN MH, 1995, J AQUAT PLANT MANAGE, V33, P55; Kikvidze Z, 2006, J VEG SCI, V17, P77, DOI 10.1111/j.1654-1103.2006.tb02425.x; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Li M, 2008, AQUAT BOT, V88, P347, DOI 10.1016/j.aquabot.2008.01.002; Liu J, 2006, BIOL INVASIONS, V8, P1461, DOI 10.1007/s10530-005-5838-x; [马瑞燕 Ma Ruiyan], 2005, [应用与环境生物学报, Chinese Journal of Applied and Environmental Biology], V11, P246; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Maurer DA, 2002, OECOLOGIA, V131, P279, DOI 10.1007/s00442-002-0886-8; Moola FM, 2009, PLANT ECOL, V201, P319, DOI 10.1007/s11258-008-9496-9; Nilsson J, 2008, EVOL ECOL, V22, P437, DOI 10.1007/s10682-007-9199-z; Otfinowski R, 2008, PLANT ECOL, V199, P235, DOI 10.1007/s11258-008-9428-8; Peltzer DA, 2002, AM J BOT, V89, P494, DOI 10.3732/ajb.89.3.494; Pennings SC, 2000, ECOLOGY, V81, P709; Price EAC, 1996, OIKOS, V75, P279, DOI 10.2307/3546251; Roiloa SR, 2006, ANN BOT-LONDON, V98, P1043, DOI 10.1093/aob/mcl185; Roiloa SR, 2007, ENVIRON EXP BOT, V61, P1, DOI 10.1016/j.envexpbot.2007.02.006; Roiloa SR, 2007, J ECOL, V95, P397, DOI 10.1111/j.1365-2745.2007.01216.x; Roiloa SR, 2014, J PLANT ECOL, V7, P413, DOI 10.1093/jpe/rtt045; Roiloa SR, 2013, BIOL INVASIONS, V15, P1895, DOI 10.1007/s10530-013-0417-z; Roiloa SR, 2010, BIOL INVASIONS, V12, P1815, DOI 10.1007/s10530-009-9592-3; SCHMID B, 1987, ECOLOGY, V68, P2016, DOI 10.2307/1939892; Schreiber U., 1998, P320; Sosnova M, 2011, AQUAT BOT, V95, P88, DOI 10.1016/j.aquabot.2011.04.001; Stuefer JF, 1996, FUNCT ECOL, V10, P328, DOI 10.2307/2390280; Wang BR, 2005, AQUAT BOT, V81, P277, DOI 10.1016/j.aquabot.2005.01.004; Wang N, 2008, ANN BOT-LONDON, V101, P671, DOI 10.1093/aob/mcn005; [王宁 Wang Ning], 2010, [生态环境学报, Ecology and Environmental Sciences], V19, P2302; WATSON MA, 1986, TRENDS ECOL EVOL, V1, P119, DOI 10.1016/0169-5347(86)90005-4; Wilsey B, 2002, PLANT ECOL, V159, P15, DOI 10.1023/A:1015556816307; Xiao KY, 2011, AQUAT BOT, V95, P249, DOI 10.1016/j.aquabot.2011.07.002; You WH, 2013, HYDROBIOLOGIA, V718, P27, DOI 10.1007/s10750-013-1596-4; Yu FH, 2008, ANN BOT-LONDON, V102, P571, DOI 10.1093/aob/mcn119; Yu FH, 2009, AM J BOT, V96, P1983, DOI 10.3732/ajb.0800426; Yu FH, 2001, EVOL ECOL, V15, P303, DOI 10.1023/A:1016032831038; Yurkonis KA, 2005, J ECOL, V93, P1053, DOI 10.1111/j.1365-2745.2005.01029.x	54	52	61	8	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97246	10.1371/journal.pone.0097246	http://dx.doi.org/10.1371/journal.pone.0097246			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816849	gold, Green Submitted, Green Published			2022-12-27	WOS:000336838000122
J	Das, S; Bedja, D; Campbell, N; Dunkerly, B; Chenna, V; Maitra, A; Steenbergen, C				Das, Samarjit; Bedja, Djahida; Campbell, Nathaniel; Dunkerly, Brittany; Chenna, Venugopal; Maitra, Anirban; Steenbergen, Charles			miR-181c Regulates the Mitochondrial Genome, Bioenergetics, and Propensity for Heart Failure In Vivo	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; PERMEABILITY TRANSITION PORE; ADENINE-NUCLEOTIDE TRANSPORT; ISCHEMIA; DYSFUNCTION; MICRORNAS; CALCIUM; DISEASE; CARDIOPROTECTION; PHOSPHORYLATION	MicroRNAs (miRNAs) are small non-coding RNAs, which inhibit the stability and/or translation of a mRNA. miRNAs have been found to play a powerful role in various cardiovascular diseases. Recently, we have demonstrated that a microRNA (miR-181c) can be encoded in the nucleus, processed to the mature form in the cytosol, translocated into the mitochondria, and ultimately can regulate mitochondrial gene expression. However the in vivo impact of miR-181c is unknown. Here we report an in-vivo method for administration of miR-181c in rats, which leads to reduced exercise capacity and signs of heart failure, by targeting the 39- end of mt-COX1 (cytochrome c oxidase subunit 1). We cloned miR-181c and packaged it in lipid-based nanoparticles for systemic delivery. The plasmid DNA complexed nanovector shows no apparent toxicity. We find that the mRNA levels of mitochondrial complex IV genes in the heart, but not any other mitochondrial genes, are significantly altered with miR-181c overexpression, suggesting selective mitochondrial complex IV remodeling due to miR-181c targeting mt-COX1. Isolated heart mitochondrial studies showed significantly altered O-2-consumption, ROS production, matrix calcium, and mitochondrial membrane potential in miR-181c-treated animals. For the first time, this study shows that miRNA delivered to the heart in-vivo can lead to cardiac dysfunction by regulating mitochondrial genes.	[Das, Samarjit; Campbell, Nathaniel; Dunkerly, Brittany; Maitra, Anirban; Steenbergen, Charles] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21218 USA; [Bedja, Djahida] Johns Hopkins Univ, Dept Cardiol, Baltimore, MD USA; [Bedja, Djahida] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia; [Dunkerly, Brittany] Notre Dame Maryland Univ, Baltimore, MD USA; [Chenna, Venugopal; Maitra, Anirban] Dept Pathol, Houston, TX USA; [Chenna, Venugopal; Maitra, Anirban] Dept Translat Mol Pathol, Houston, TX USA; [Maitra, Anirban] Johns Hopkins Univ, Dept Oncol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Macquarie University; Johns Hopkins University	Steenbergen, C (corresponding author), Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21218 USA.	csteenb1@jhmi.edu		Dunkerly-Eyring, Brittany/0000-0003-4684-5861; Campbell, Nathaniel/0000-0002-0355-0708	National Institutes of Health [R01HL39752, U54CA151838]; Scientist Development Grant from the American Heart Association [14SDG18890049]; Sister Alma McNicholas Fund from the Notre Dame of Maryland University; NATIONAL CANCER INSTITUTE [U54CA151838] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scientist Development Grant from the American Heart Association(American Heart Association); Sister Alma McNicholas Fund from the Notre Dame of Maryland University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health, R01HL39752 (CS) and U54CA151838 (AM), and a Scientist Development Grant from the American Heart Association 14SDG18890049 (SD). BD gratefully acknowledges her support from the Sister Alma McNicholas Fund from the Notre Dame of Maryland University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL EL, 1993, PHYSIOL BEHAV, V54, P309, DOI 10.1016/0031-9384(93)90116-W; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; AMBROSIO G, 1993, J BIOL CHEM, V268, P18532; Balaban RS, 2009, BBA-BIOENERGETICS, V1787, P1334, DOI 10.1016/j.bbabio.2009.05.011; Bandiera S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020746; Barrey E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020220; Begriche K, 2013, HEPATOLOGY, V58, P1497, DOI 10.1002/hep.26226; Bian Z, 2010, CELL RES, V20, P1076, DOI 10.1038/cr.2010.119; BOLLI R, 1995, J CLIN INVEST, V96, P1066, DOI 10.1172/JCI118093; Bolli R, 1999, PHYSIOL REV, V79, P609, DOI 10.1152/physrev.1999.79.2.609; Brookes P, 2002, FREE RADICAL BIO MED, V32, P370, DOI 10.1016/S0891-5849(01)00805-X; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen JQ, 2009, BBA-MOL CELL RES, V1793, P1540, DOI 10.1016/j.bbamcr.2009.06.001; Das S, 2008, CIRC RES, V103, P983, DOI 10.1161/CIRCRESAHA.108.178970; Das S, 2012, CIRC RES, V110, P1596, DOI 10.1161/CIRCRESAHA.112.267732; Das S, 2012, J MOL CELL CARDIOL, V52, P448, DOI 10.1016/j.yjmcc.2011.09.007; Dorn GW, 2012, CIRC RES, V110, P958, DOI 10.1161/CIRCRESAHA.111.260752; Florens L, 2001, BIOCHEMISTRY-US, V40, P7491, DOI 10.1021/bi0101188; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909; Ragone MI, 2009, J CARDIOVASC PHARM, V54, P213, DOI 10.1097/FJC.0b013e3181b04ce3; KITAKAZE M, 1988, CIRCULATION, V77, P685, DOI 10.1161/01.CIR.77.3.685; Komary Z, 2010, BBA-BIOENERGETICS, V1797, P922, DOI 10.1016/j.bbabio.2010.03.010; Kren BT, 2009, RNA BIOL, V6, P65, DOI 10.4161/rna.6.1.7534; Lam MPY, 2012, J PROTEOMICS, V75, P4602, DOI 10.1016/j.jprot.2012.02.014; Latronico MVG, 2012, CIRC RES, V110, P1540, DOI 10.1161/CIRCRESAHA.112.271312; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Mick DU, 2011, NAT REV MOL CELL BIO, V12, P14, DOI 10.1038/nrm3029; Moens AL, 2008, CIRCULATION, V117, P1810, DOI 10.1161/CIRCULATIONAHA.107.725481; Nguyen TT, 2011, J BIOL CHEM, V286, P40184, DOI 10.1074/jbc.M111.243469; Parks RJ, 2018, METHODS MOL BIOL, V1782, P187, DOI [10.1007/978-1-61779-382-0_15, 10.1007/978-1-4939-7831-1_11]; Pramanik D, 2011, MOL CANCER THER, V10, P1470, DOI 10.1158/1535-7163.MCT-11-0152; Sripada L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044873; Steenbergen C, 2009, BASIC RES CARDIOL, V104, P149, DOI 10.1007/s00395-009-0002-x; van Rooij E, 2008, CIRC RES, V103, P919, DOI 10.1161/CIRCRESAHA.108.183426	35	102	108	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96820	10.1371/journal.pone.0096820	http://dx.doi.org/10.1371/journal.pone.0096820			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810628	Green Published, gold, Green Submitted			2022-12-27	WOS:000338213300075
J	Niklasson, L; Sundh, H; Olsen, RE; Jutfelt, F; Skjodt, K; Nilsen, TO; Sundell, KS				Niklasson, Lars; Sundh, Henrik; Olsen, Rolf-Erik; Jutfelt, Fredrik; Skjodt, Karsten; Nilsen, Tom O.; Sundell, Kristina Snuttan			Effects of Cortisol on the Intestinal Mucosal Immune Response during Cohabitant Challenge with IPNV in Atlantic Salmon (Salmo salar)	PLOS ONE			English	Article							INFECTIOUS PANCREATIC NECROSIS; ACUTE STRESS ALTERS; POST-SMOLTS; RAINBOW-TROUT; ANTIVIRAL ACTIVITY; VIRUS CHALLENGE; REFERENCE GENES; RT-PCR; EXPRESSION; L.	Infectious pancreatic necrosis virus (IPNV) causes high incidence of disease in salmonids during the first period after SW transfer. During this period as well as during periods of stress, cortisol levels increase and indications of a relationship between IPNV susceptibility and cortisol have been suggested. The intestine is an entry route and a target tissue for IPNV displaying severe enteritis and sloughing of the mucosa in infected fish. The mechanisms behind effects of the virus on the intestinal tissue and the impact of cortisol on the effect remain unclear. In the present study, Atlantic salmon post smolts treated with or without slow release cortisol implants were subjected to a cohabitant IPNV challenge. Analysis of genes and proteins related to the innate and acquired immune responses against virus was performed 6 days post-challenge using qPCR and immunohistochemistry. An increased mRNA expression of anti-viral cytokine interferon type I was observed in the proximal intestine and head kidney as a response to the viral challenge and this effect was suppressed by cortisol. No effect was seen in the distal intestine. T-cell marker CD3 as well as MHC-I in both intestinal regions and in the head kidney was down regulated at the mRNA level. Number of CD8 alpha lymphocytes decreased in the proximal intestine in response to cortisol. On the other hand, mRNA expression of Mx and IL-1 beta increased in the proximal intestine and head kidney in IPNV challenged fish in the presence of cortisol suggesting that the immune activation shifts in timing and response pathway during simulated stress. The present study clearly demonstrates that IPNV infection results in a differentiated epithelial immune response in the different intestinal regions of the Atlantic salmon. It also reveals that the epithelial immune response differs from the systemic, but that both are modulated by the stress hormone cortisol.	[Niklasson, Lars; Sundh, Henrik; Jutfelt, Fredrik; Sundell, Kristina Snuttan] Univ Gothenburg, Dept Biol & Environm Sci, Fish Endocrinol Lab, Gothenburg, Sweden; [Olsen, Rolf-Erik] Inst Marine Res, Dept Anim Welf, Matredal, Norway; [Skjodt, Karsten] Univ Southern Denmark, Dept Canc & Inflammat, Odense, Denmark; [Nilsen, Tom O.] Univ Bergen, Dept Biol, Bergen, Norway	University of Gothenburg; Institute of Marine Research - Norway; University of Southern Denmark; University of Bergen	Niklasson, L (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci, Fish Endocrinol Lab, Gothenburg, Sweden.	lars.niklasson@bioenv.gu.se	Sundell, Kristina/F-8884-2016; Sundh, Henrik/C-2477-2008; Jutfelt, Fredrik/B-6988-2014	Sundell, Kristina/0000-0002-7643-2083; Sundh, Henrik/0000-0002-1459-5450; Jutfelt, Fredrik/0000-0001-9838-3991; Olsen, Rolf/0000-0001-7523-3165; Olsen, Rolf Erik/0000-0002-6633-5837; Skjodt, Karsten/0000-0002-9161-8185	Helge Ax:son Johnsons Foundation; Wilhelm & Martina Lundgrens Foundation; Adlerbertska Scientific Foundation; EU project LIFECYCLE; EU project AQUAMAX; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning	Helge Ax:son Johnsons Foundation; Wilhelm & Martina Lundgrens Foundation; Adlerbertska Scientific Foundation; EU project LIFECYCLE; EU project AQUAMAX; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas)	This work was funded by Helge Ax:son Johnsons Foundation (http://www.haxsonj.se/), Wilhelm & Martina Lundgrens Foundation (http://www.wmlundgren.se/), Adlerbertska Scientific Foundation (http://www.gu.se/forskning/stipendier/gustipendier/adlerbertska_forskningsstiftelsen/), the EU project LIFECYCLE: "Essential biological functions related to the most relevant stages of aquaculture fish life-history'' FP 7 (http://www.lifecycle-fp7.eu/), the EU project AQUAMAX; "Sustainable aquafeeds to maximize the health benefits of farmed fish for consumers'' FP 6 (eatip.ttime.be/shortcut.asp?FILE=878), and the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (http://www.formas.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts JL, 2004, BIOTECHNIQUES, V36, P84, DOI 10.2144/04361ST04; Barton B.A., 1991, Annual Review of Fish Diseases, V1, P3, DOI 10.1016/0959-8030(91)90019-G; Bowden TJ, 2003, J FISH DIS, V26, P309, DOI 10.1046/j.1365-2761.2003.00456.x; Bowden TJ, 2002, J FISH DIS, V25, P555, DOI 10.1046/j.1365-2761.2002.00402.x; Collet B, 2009, VET IMMUNOL IMMUNOP, V130, P92, DOI 10.1016/j.vetimm.2008.12.022; Das BK, 2007, FISH SHELLFISH IMMUN, V23, P514, DOI 10.1016/j.fsi.2006.10.010; Das BK, 2009, FISH SHELLFISH IMMUN, V26, P40, DOI 10.1016/j.fsi.2008.03.009; DOBOS P, 1977, J VIROL, V22, P150, DOI 10.1128/JVI.22.1.150-159.1977; Evensen O., 2008, ENCY VIROLOGY, P83, DOI DOI 10.1016/B978-012374410-4.00772-X; Fridell F, 2007, AQUACULTURE, V270, P23, DOI 10.1016/j.aquaculture.2007.04.081; Gadan K, 2012, FISH SHELLFISH IMMUN, V32, P637, DOI 10.1016/j.fsi.2012.01.004; Gadan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054656; Hansen T, 1998, OPPDRETT LAKSESMOLT; Harris J, 2000, VET IMMUNOL IMMUNOP, V77, P163, DOI 10.1016/S0165-2427(00)00235-X; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hershberg RM, 2000, IMMUNOL TODAY, V21, P123, DOI 10.1016/S0167-5699(99)01575-3; Hetland DL, 2010, FISH SHELLFISH IMMUN, V28, P30, DOI 10.1016/j.fsi.2009.09.011; Hill B. J., 1995, Annual Review of Fish Diseases, V5, P55, DOI 10.1016/0959-8030(95)00011-9; Hoar W.S., 1988, P275; Hong S, 2009, COMP BIOCHEM PHYS B, V153, P275, DOI 10.1016/j.cbpb.2009.03.008; Ingerslev HC, 2009, SCAND J IMMUNOL, V69, P90, DOI 10.1111/j.1365-3083.2008.02201.x; Ingerslev HC, 2006, FISH SHELLFISH IMMUN, V20, P450, DOI 10.1016/j.fsi.2005.06.002; Jager KJ, 2008, KIDNEY INT, V74, P560, DOI 10.1038/ki.2008.217; Kajita Y., 1992, Fish & Shellfish Immunology, V2, P155, DOI 10.1016/S1050-4648(05)80044-0; Kvamme BO, 2013, FISH SHELLFISH IMMUN, V34, P55, DOI 10.1016/j.fsi.2012.10.006; Larsen R, 2004, J VIROL, V78, P7938, DOI 10.1128/JVI.78.15.7938-7944.2004; Lee SH, 2002, GENOME RES, V12, P527, DOI 10.1101/gr.20102; Liu Y, 2008, DEV COMP IMMUNOL, V32, P26, DOI 10.1016/j.dci.2007.03.015; Lovoll M, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-8; M'Gonigle RH., 1941, T AM FISH SOC, V70, P297, DOI DOI 10.1577/1548-8659(1940)70[297:ACEOSF]2.0.CO;2; MARC AM, 1995, J FISH BIOL, V46, P1065, DOI 10.1006/jfbi.1995.0101; MAULE AG, 1987, CAN J FISH AQUAT SCI, V44, P161, DOI 10.1139/f87-021; McBeath AJA, 2007, FISH SHELLFISH IMMUN, V22, P230, DOI 10.1016/j.fsi.2006.05.004; McCormick SD, 2001, AM ZOOL, V41, P781, DOI 10.1668/0003-1569(2001)041[0781:ECOOIT]2.0.CO;2; MCKNIGHT IJ, 1976, BRIT VET J, V132, P76, DOI 10.1016/S0007-1935(17)34791-7; Metz JR, 2006, J ENDOCRINOL, V191, P25, DOI 10.1677/joe.1.06640; Miron N, 2012, CLIN EXP IMMUNOL, V167, P405, DOI 10.1111/j.1365-2249.2011.04523.x; Moore LJ, 2005, MOL IMMUNOL, V42, P1225, DOI 10.1016/j.molimm.2004.11.017; MUIR WD, 1994, AQUACULTURE, V127, P69, DOI 10.1016/0044-8486(94)90193-7; Munang'andu HM, 2013, VACCINE, V31, P1956, DOI 10.1016/j.vaccine.2013.02.008; NAGAE M, 1994, FISH PHYSIOL BIOCHEM, V13, P41, DOI 10.1007/BF00004118; Niklasson L, 2011, FISH SHELLFISH IMMUN, V31, P1072, DOI 10.1016/j.fsi.2011.09.011; Olsen RE, 2005, AQUACULTURE, V250, P480, DOI 10.1016/j.aquaculture.2005.03.014; Olsen RE, 2002, FISH PHYSIOL BIOCHEM, V26, P211, DOI 10.1023/A:1026217719534; Olsvik PA, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-21; Ozaki A, 2001, MOL GENET GENOMICS, V265, P23, DOI 10.1007/s004380000392; Parkin J, 2001, LANCET, V357, P1777, DOI 10.1016/S0140-6736(00)04904-7; Racicot K, 2012, AM J REPROD IMMUNOL, V67, P498, DOI 10.1111/j.1600-0897.2012.01109.x; Reyes-Cerpa S, 2012, FISH SHELLFISH IMMUN, V32, P291, DOI 10.1016/j.fsi.2011.11.018; Roberts RJ, 2005, J FISH DIS, V28, P383, DOI 10.1111/j.1365-2761.2005.00642.x; Robertsen B, 2006, FISH SHELLFISH IMMUN, V20, P172, DOI 10.1016/j.fsi.2005.01.010; Ronneseth A, 2007, AQUACULTURE, V271, P100, DOI 10.1016/j.aquaculture.2007.03.021; Sagstad A, 2007, J FISH DIS, V30, P201, DOI 10.1111/j.1365-2761.2007.00808.x; Saint-Jean SR, 2006, VET IMMUNOL IMMUNOP, V110, P1, DOI 10.1016/j.vetimm.2005.08.023; Santi N, 2004, VIROLOGY, V322, P31, DOI 10.1016/j.virol.2003.12.016; Schreck Carl B., 1996, Fish Physiology, V15, P311; Skjesol A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-396; Skjesol A, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-17; Skjesol A, 2009, VIRUS RES, V143, P53, DOI 10.1016/j.virusres.2009.03.004; Smail DA, 1995, J FISH DIS, V18, P631, DOI 10.1111/j.1365-2761.1995.tb00369.x; SPECKER JL, 1994, AQUACULTURE, V121, P181, DOI 10.1016/0044-8486(94)90019-1; Stefansson SO, 2012, AQUACULTURE, V362, P127, DOI 10.1016/j.aquaculture.2011.07.002; Sun BJ, 2011, J VIROL, V85, P9188, DOI 10.1128/JVI.00319-11; Sundell K, 2003, AQUACULTURE, V222, P265, DOI 10.1016/S0044-8486(03)00127-3; Sundh H, 2009, J FISH DIS, V32, P687, DOI 10.1111/j.1365-2761.2009.01047.x; Sundh H, 2011, AQUACULTURE, V321, P85, DOI 10.1016/j.aquaculture.2011.08.011; Sundh Henrik, 2010, BMC Physiology, V10, P22, DOI 10.1186/1472-6793-10-22; TATE H, 1990, JPN J VET SCI, V52, P931; Tatner Mary F., 1996, Fish Physiology, V15, P255; Toyokawa K, 2007, AM J REPROD IMMUNOL, V57, P23, DOI 10.1111/j.1600-0897.2006.00439.x; WOLF K, 1971, ARCH GES VIRUSFORSCH, V34, P144, DOI 10.1007/BF01241716; Yada T, 2002, INT REV CYTOL, V220, P35	72	19	19	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e94288	10.1371/journal.pone.0094288	http://dx.doi.org/10.1371/journal.pone.0094288			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809845	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000338213300007
J	Rothgerber, H				Rothgerber, Hank			Horizontal Hostility among Non-Meat Eaters	PLOS ONE			English	Article							VEGETARIAN; MEAT; ATTITUDES; MINORITY; DIETS	The present study examined intergroup judgments made between four groups of non-meat eaters: health vegetarians; ethical vegetarians; health vegans, and ethical vegans. Consistent with hypotheses based on horizontal hostility and the need to maintain ingroup distinctiveness, ethical vegetarians gave unfavorable evaluations to health vegetarians relative to vegans, especially when the mainstream omnivore group was made salient. Contrary to expectations, vegans gave relatively more favorable evaluations to ethical vegetarians than health vegetarians when mainstream salience was low. This was especially true for vegans who were motivated primarily by ethical concerns. When mainstream salience was high, vegans did not distinguish between the vegetarian subgroups. Results suggest that one's motives for abstaining from meat often play a larger role in this type of intergroup perceptions than one's dietary practices.	Bellarmine Univ, Dept Psychol, Louisville, KY 40205 USA	Bellarmine University	Rothgerber, H (corresponding author), Bellarmine Univ, Dept Psychol, Louisville, KY 40205 USA.	hrothgerber@bellarmine.edu						[Anonymous], 2007, VEG J; Caro Mark, 2009, FOIE GRAS WARS; Corliss Richard, 2002, Time, V160, P48; Cunningham J., 2009, VEGETARIAN J, V29; Fox N, 2008, APPETITE, V50, P422, DOI 10.1016/j.appet.2007.09.007; Hamilton M., 2006, Food, Culture & Society, V9, P155, DOI 10.2752/155280106778606053; Herzog Jr H. A., 1991, ANTHROZO, V4, p184?191, DOI [10.2752/089279391787057170, DOI 10.2752/089279391787057170]; Jabs J, 1998, J NUTR EDUC, V30, P196, DOI 10.1016/S0022-3182(98)70319-X; Jetten J, 2004, J PERS SOC PSYCHOL, V86, P862, DOI 10.1037/0022-3514.86.6.862; Lindeman M, 2001, APPETITE, V37, P175, DOI 10.1006/appe.2001.0437; Maurer Donna, 2010, VEGETARIANISM MOVEME; MOSCOVICI S, 1969, SOCIOMETRY, V32, P365, DOI 10.2307/2786541; Potts A, 2010, FEM PSYCHOL, V20, P53, DOI 10.1177/0959353509351181; Povey R, 2001, APPETITE, V37, P15, DOI 10.1006/appe.2001.0406; Rothgerber H, 1997, J PERS SOC PSYCHOL, V73, P1191, DOI 10.1037/0022-3514.73.6.1191; Rothgerber H, 2014, APPETITE, V72, P98, DOI 10.1016/j.appet.2013.10.002; Rothgerber H, 2013, APPETITE, V68, P76, DOI 10.1016/j.appet.2013.04.012; Rozin P, 1997, PSYCHOL SCI, V8, P67, DOI 10.1111/j.1467-9280.1997.tb00685.x; Ruby MB, 2012, APPETITE, V58, P141, DOI 10.1016/j.appet.2011.09.019; Ruby Matthew Byron, 2008, THESIS; TAJFEL H., 1986, DIFFERENTIATION SOCI, P7, DOI [10.4324/9780203505984-16, DOI 10.4324/9780203505984-16]; White JB, 1999, J SOC ISSUES, V55, P537, DOI 10.1111/0022-4537.00132; White JB, 2006, GROUP PROCESS INTERG, V9, P339, DOI 10.1177/1368430206064638; WILDER DA, 1988, J PERS SOC PSYCHOL, V54, P62, DOI 10.1037/0022-3514.54.1.62	24	18	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96457	10.1371/journal.pone.0096457	http://dx.doi.org/10.1371/journal.pone.0096457			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK1XT	24809342	gold, Green Submitted, Green Published			2022-12-27	WOS:000338213300041
J	Asaithambi, A; Ay, M; Jin, HJ; Gosh, A; Anantharam, V; Kanthasamy, A; Kanthasamy, AG				Asaithambi, Arunkumar; Ay, Muhammet; Jin, Huajun; Gosh, Anamitra; Anantharam, Vellareddy; Kanthasamy, Arthi; Kanthasamy, Anumantha G.			Protein Kinase D1 (PKD1) Phosphorylation Promotes Dopaminergic Neuronal Survival during 6-OHDA-Induced Oxidative Stress	PLOS ONE			English	Article							NF-KAPPA-B; D-DEPENDENT ACTIVATION; CELL-CULTURE MODEL; C-DELTA; PROTEOLYTIC ACTIVATION; PARKINSONS-DISEASE; TYROSINE PHOSPHORYLATION; DISTINCT MECHANISMS; NUCLEAR EXPORT; CLEAVAGE SITE	Oxidative stress is a major pathophysiological mediator of degenerative processes in many neurodegenerative diseases including Parkinson's disease (PD). Aberrant cell signaling governed by protein phosphorylation has been linked to oxidative damage of dopaminergic neurons in PD. Although several studies have associated activation of certain protein kinases with apoptotic cell death in PD, very little is known about protein kinase regulation of cell survival and protection against oxidative damage and degeneration in dopaminergic neurons. Here, we characterized the PKD1-mediated protective pathway against oxidative damage in cell culture models of PD. Dopaminergic neurotoxicant 6-hydroxy dopamine (6-OHDA) was used to induce oxidative stress in the N27 dopaminergic cell model and in primary mesencephalic neurons. Our results indicated that 6-OHDA induced the PKD1 activation loop (PKD1S744/S748) phosphorylation during early stages of oxidative stress and that PKD1 activation preceded cell death. We also found that 6-OHDA rapidly increased phosphorylation of the C-terminal S916 in PKD1, which is required for PKD1 activation loop (PKD1S744/748) phosphorylation. Interestingly, negative modulation of PKD1 activation by RNAi knockdown or by the pharmacological inhibition of PKD1 by kbNB- 14270 augmented 6-OHDA-induced apoptosis, while positive modulation of PKD1 by the overexpression of full length PKD1 (PKD1(WT)) or constitutively active PKD1 (PKD1(S744E/S748E)) attenuated 6-OHDA-induced apoptosis, suggesting an anti-apoptotic role for PKD1 during oxidative neuronal injury. Collectively, our results demonstrate that PKD1 signaling plays a cell survival role during early stages of oxidative stress in dopaminergic neurons and therefore, positive modulation of the PKD1-mediated signal transduction pathway can provide a novel neuroprotective strategy against PD.	[Asaithambi, Arunkumar; Ay, Muhammet; Jin, Huajun; Gosh, Anamitra; Anantharam, Vellareddy; Kanthasamy, Arthi; Kanthasamy, Anumantha G.] Iowa State Univ, Dept Biomed Sci, Ames, IA 50011 USA	Iowa State University	Kanthasamy, AG (corresponding author), Iowa State Univ, Dept Biomed Sci, Ames, IA 50011 USA.	akanthas@iastate.edu		Kanthasamy, Arthi/0000-0003-4654-9907; Ay, Muhammet/0000-0003-1179-593X; Kanthasamy, Anumantha/0000-0002-6454-4264	National Institutes of Health (NIH) [NS 074443, ES10586]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074443] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) [Grants NS 074443, and ES10586]. The W. Eugene and Linda Lloyd Endowed Chair to A.G.K. is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantharam V, 2002, J NEUROSCI, V22, P1738, DOI 10.1523/JNEUROSCI.22-05-01738.2002; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Asaithambi A, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-43; Brandlin I, 2002, J BIOL CHEM, V277, P6490, DOI 10.1074/jbc.M106083200; Cassarino DS, 1999, BBA-MOL BASIS DIS, V1453, P49, DOI 10.1016/S0925-4439(98)00083-0; Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Dranka BP, 2012, J NEUROCHEM, V122, P941, DOI 10.1111/j.1471-4159.2012.07836.x; Elkon H, 2001, CELL MOL NEUROBIOL, V21, P771, DOI 10.1023/A:1015160323009; Friling S, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-146; Ghosh A, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M112.444224; Gomez-Lazaro M, 2008, FREE RADICAL BIO MED, V44, P1960, DOI 10.1016/j.freeradbiomed.2008.03.009; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Hanrott K, 2006, J BIOL CHEM, V281, P5373, DOI 10.1074/jbc.M511560200; Harischandra DS, 2014, PRION, V8, P142, DOI 10.4161/pri.28369; Haussermann S, 1999, FEBS LETT, V462, P442, DOI 10.1016/S0014-5793(99)01577-X; Jaggi M, 2007, FRONT BIOSCI-LANDMRK, V12, P3757, DOI 10.2741/2349; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Jin H., 2013, BIOCH BIOPHYS ACTA; Jin HJ, 2011, J BIOL CHEM, V286, P19840, DOI 10.1074/jbc.M110.203687; Jin HJ, 2011, J NEUROSCI, V31, P2035, DOI 10.1523/JNEUROSCI.5634-10.2011; Kanthasamy AG, 2006, FREE RADICAL BIO MED, V41, P1578, DOI 10.1016/j.freeradbiomed.2006.08.016; Kanthasamy K, 2011, CURR NEUROPHARMACOL, V9, P49, DOI 10.2174/157015911795017353; Kaul S, 2005, J BIOL CHEM, V280, P28721, DOI 10.1074/jbc.M501092200; Latchoumycandane C, 2011, TOXICOL APPL PHARM, V256, P314, DOI 10.1016/j.taap.2011.07.021; Lin M, 2012, NEUROSCIENCE, V210, P308, DOI 10.1016/j.neuroscience.2012.03.004; Lopert P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050683; Lotharius J, 1999, J NEUROSCI, V19, P1284; Malkus KA, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-24; Martin DP, 2011, NEUROTOXICOLOGY, V32, P554, DOI 10.1016/j.neuro.2011.07.008; Matthews SA, 2006, MOL CELL BIOL, V26, P1569, DOI 10.1128/MCB.26.4.1569-1577.2006; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; Ortiz-Ortiz MA, 2009, NEUROTOXICOLOGY, V30, P1008, DOI 10.1016/j.neuro.2009.07.016; Parra M, 2005, J BIOL CHEM, V280, P13762, DOI 10.1074/jbc.M413396200; Peng J, 2004, J BIOL CHEM, V279, P32626, DOI 10.1074/jbc.M404596200; Philpott KL, 2008, CNS NEUROL DISORD-DR, V7, P83, DOI 10.2174/187152708783885129; Prasad KN, 1998, MOL GENET METAB, V65, P1, DOI 10.1006/mgme.1998.2726; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Przedborski S, 2005, PARKINSONISM RELAT D, V11, pS3, DOI 10.1016/j.parkreldis.2004.10.012; Przedborski S, 2003, ANN NY ACAD SCI, V991, P189; Rey O, 2001, J BIOL CHEM, V276, P49228, DOI 10.1074/jbc.M109395200; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; Rybin VO, 2009, J BIOL CHEM, V284, P2332, DOI 10.1074/jbc.M806381200; Shivalingappa PC, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/424285; Sidorenko SP, 1996, IMMUNITY, V5, P353, DOI 10.1016/S1074-7613(00)80261-7; Song J, 2009, BIOCHEM BIOPH RES CO, V378, P610, DOI 10.1016/j.bbrc.2008.11.106; Stafford MJ, 2003, BLOOD, V101, P1392, DOI 10.1182/blood-2002-08-2384; Storz P, 2004, MOL PHARMACOL, V66, P870, DOI 10.1124/mol.104.000687; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Storz P, 2003, J BIOL CHEM, V278, P17969, DOI 10.1074/jbc.M213224200; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Storz P, 2005, MOL CELL BIOL, V25, P8520, DOI 10.1128/MCB.25.19.8520-8530.2005; Storz P, 2007, TRENDS CELL BIOL, V17, P13, DOI 10.1016/j.tcb.2006.11.003; Subramaniam S, 2010, FEBS J, V277, P22, DOI 10.1111/j.1742-4658.2009.07367.x; Sundram V, 2011, MOL CANCER RES, V9, P985, DOI 10.1158/1541-7786.MCR-10-0365; Tan MQ, 2003, J BIOL CHEM, V278, P2824, DOI 10.1074/jbc.M211523200; Van Lint J, 1998, J BIOL CHEM, V273, P7038, DOI 10.1074/jbc.273.12.7038; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Waldron RT, 2003, J BIOL CHEM, V278, P154, DOI 10.1074/jbc.M208075200; Xu Q, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/431068; Yang YJ, 2004, MOL CELL NEUROSCI, V25, P406, DOI 10.1016/j.mcn.2003.11.011; Yuan JZ, 2002, BIOCHEM BIOPH RES CO, V291, P444, DOI 10.1006/bbrc.2002.6469; Zhang DH, 2007, J NEUROSCI, V27, P5349, DOI 10.1523/JNEUROSCI.4107-06.2007; Zhang L, 2010, BRAIN RES, V1357, P157, DOI 10.1016/j.brainres.2010.08.007; Zhukova E, 2001, J BIOL CHEM, V276, P40298, DOI 10.1074/jbc.M106512200	67	18	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96947	10.1371/journal.pone.0096947	http://dx.doi.org/10.1371/journal.pone.0096947			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806360	Green Published, Green Submitted, gold			2022-12-27	WOS:000335728900120
J	Ventura, J; Bagaria, G; Sans-Fuentes, MA; Perez-Hernandez, R				Ventura, Jacint; Bagaria, Guillem; Assumpcio Sans-Fuentes, Maria; Perez-Hernandez, Roger			Common Distribution Patterns of Marsupials Related to Physiographical Diversity in Venezuela	PLOS ONE			English	Article							PTERIDOPHYTES; DIDELPHIDAE; MAMMALS	The aim of this study is to identify significant biotic regions (groups of areas with similar biotas) and biotic elements (groups of taxa with similar distributions) for the marsupial fauna in a part of northern South America using physiographical areas as Operational Geographical Units (OGUs). We considered Venezuela a good model to elucidate this issue because of its high diversity in landscapes and the relatively vast amount of information available on the geographical distribution of marsupial species. Based on the presence-absence of 33 species in 15 physiographical sub-regions (OGUs) we identified Operational Biogeographical Units (OBUs) and chorotypes using a quantitative analysis that tested statistical significance of the resulting groups. Altitudinal and/or climatic trends in the OBUs and chorotypes were studied using a redundancy analysis. The classification method revealed four OBUs. Strong biotic boundaries separated: i) the xerophytic zone of the Continental coast (OBU I); ii) the sub-regions north of the Orinoco River (OBU III and IV); and those south to the river (OBU II). Eleven chorotypes were identified, four of which included a single species with a restricted geographic distribution. As for the other chorotypes, three main common distribution patterns have been inferred: i) species from the Llanos and/or distributed south of the Orinoco River; ii) species exclusively from the Andes; and iii) species that either occur exclusively north of the Orinoco River or that show a wide distribution throughout Venezuela. Mean altitude, evapotranspiration and precipitation of the driest month, and temperature range allowed us to characterize environmentally most of the OBUs and chorotypes obtained.	[Ventura, Jacint; Bagaria, Guillem] Univ Autonoma Barcelona, Fac Biociencies, Dept Biol Anim Biol Vegetal & Ecol, Cerdanyola Del Valles, Spain; [Bagaria, Guillem] CREAF, Cerdanyola Del Valles, Spain; [Assumpcio Sans-Fuentes, Maria] Univ Arizona, Sch Geog & Dev, Tucson, AZ USA; [Assumpcio Sans-Fuentes, Maria] Univ Barcelona, Fac Farm, Dept Fisiol Anim, E-08028 Barcelona, Spain; [Perez-Hernandez, Roger] Cent Univ Venezuela, Fac Ciencias, Inst Zool & Ecol Trop, Caracas, Venezuela	Autonomous University of Barcelona; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); University of Arizona; University of Barcelona; University of Central Venezuela	Ventura, J (corresponding author), Univ Autonoma Barcelona, Fac Biociencies, Dept Biol Anim Biol Vegetal & Ecol, Cerdanyola Del Valles, Spain.	jacint.ventura.queija@uab.es	Bagaria, Guillem/D-3831-2014; Bagaria, Guillem/Q-5869-2019	Bagaria, Guillem/0000-0001-6465-2866; 	Spanish Ministerio de Educacion y Cultura (Programa de Cooperacion Cientifica con Iberoamerica, A) Proyectos de Investigacion Conjunta)	Spanish Ministerio de Educacion y Cultura (Programa de Cooperacion Cientifica con Iberoamerica, A) Proyectos de Investigacion Conjunta)	The study was funded by the Spanish Ministerio de Educacion y Cultura (Programa de Cooperacion Cientifica con Iberoamerica, A) Proyectos de Investigacion Conjunta). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera Meneses M, 2007, GEOVENEZUELA 2CARACA, P576; Aguilera Meneses M, 2011, MAPA UNIDADES ZOOGEO; Alvarez Bernal F, 1983, ATLAS CLIMATOLGOICO; Anderson RP, 2012, STUD NEOTROP FAUNA E, V47, P157, DOI 10.1080/01650521.2012.745295; Azocar A., 2003, BIODIVERSIDAD VENEZU, VII, P716; Baez JC, 2004, PHYCOLOGIA, V43, P404, DOI 10.2216/i0031-8884-43-4-404.1; BARONIURBANI C, 1976, SYST ZOOL, V25, P251, DOI 10.2307/2412493; Barrio Amoros Cesar Luis, 1998, Acta Biologica Venezuelica, V18, P1; Barrio-Amoros C.L., 2004, REV ECOLOG PRIME IA, V9, P1; BIRKS HJB, 1987, ANN ZOOL FENN, V24, P165; Bisbal FJ, 2010, MEM FUND LA SALLE CI, V172, P69; Pefaur Jaime E., 2000, Amphibian and Reptile Conservation, V2, P42; Creighton GK, 2007, MAMMALS S AM, V1, P43, DOI [10.7208/chicago/9780226282428.001.0001, DOI 10.7208/CHICAGO/9780226282428.001.0001]; Creighton GK, 2007, MAMMALS S AM, V1, P51; CRICK RE, 1980, J PALEONTOL, V54, P1218; CROVELLO TJ, 1981, TAXON, V30, P563, DOI 10.2307/1219938; deGamero MLD, 1996, PALAEOGEOGR PALAEOCL, V123, P385, DOI 10.1016/0031-0182(96)00115-0; DOADRIO I, 1988, Bonner Zoologische Beitraege, V39, P113; Duarte Miguel A., 1992, Acta Cientifica Venezolana, V43, P240; Feer F, 1997, NEOTROPICAL RAINFORE; Gardner AL, 2007, MAMMALS S AM, P61; Gardner Alfred L., 1993, P15; Gutierrez EE, 2011, MAMMALIA, V75, P381, DOI 10.1515/MAMM.2011.051; HANDLEY C O JR, 1976, Brigham Young University Science Bulletin Biological Series, V20, P1; Handley C.O. Jr, 1979, P65; Hearn Jr P., 2000, GLOBAL GIS DATABASE; HERSHKOVITZ P, 1992, FIELDIANA ZOOLOGY, V70, P1; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; HUBER O, 1997, VERTEBRADOS ACTUALES, P279; Huber O., 2007, GEOVENEZUELA MEDIO F, V2, P538; Jansa SA, 2014, EVOLUTION, V68, P684, DOI 10.1111/evo.12290; Jurasinski G., 2012, SIMBA COLLECTION FUN; LAMARCA E, 2003, BIODIVERSIDAD VENEZU, V2, P582; Legorburu MJ, 1995, BALANCE AMBIENTAL VE; Linares O, 1997, MAMMALIA, V61, P255; Linares O., 1998, MAMIFEROS VENEZUELA; Marquez AL, 2001, ECOGRAPHY, V24, P659, DOI 10.1034/j.1600-0587.2001.240605.x; Marquez AL, 1997, J BIOGEOGR, V24, P613, DOI 10.1111/j.1365-2699.1997.tb00073.x; Mayr E., 1967, Bulletin of the American Museum of Natural History, V136, P269; MCCOY ED, 1986, ECOLOGY, V67, P749, DOI 10.2307/1937698; Mittermeier RA, 1997, MEGADIVERSITY EARTHS; Ochoa J, 2003, BIODIVERSIDAD VENEZU, P650; Ochoa J.G., 2008, MEM SOC CIENC NAT, V170, P5; OJASTI J, 1972, Memoria de la Sociedad de Ciencias Naturales La Salle, V32, P159; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Olivero J, 2013, SYST BIOL, V62, P1, DOI 10.1093/sysbio/sys061; Palomo L. Javier, 1994, Polish Ecological Studies, V20, P497; Perez-Hernandez R., 1989, P363; Perez-Hernandez R, 1994, MARUSUPIALES VENEZUE; Pine RH, 2007, MAMMALS S AM, P82107; R Development Core Team, 2012, R LANG ENV STAT COMP; Real R., 1992, Donana Acta Vertebrata, V19, P53; Real R., 1996, Donana Acta Vertebrata, V23, P123; REIG OA, 1977, BIOL J LINN SOC, V9, P191, DOI 10.1111/j.1095-8312.1977.tb00265.x; Rivas GA, 2012, ZOOTAXA, P3; Sanchez HJ, 2012, M FUND SALLE CIENCIA, V173, P173; Sans-Fuentes MA, 2000, J BIOGEOGR, V27, P755, DOI 10.1046/j.1365-2699.2000.00421.x; Senaris JC, 2009, ANFIBIOS VENEZUELA E, P41; Soriano P., 2003, BIODIVERSIDAD VENEZU, VII, P696; Soriano PJ, 1999, INTERCIENCIA, V24, P17; Stein BR, 2007, MAMMALS S AM MARSUPI, P14; Urbani F., 2011, BIOLLANIA EDICION ES, V10, P27; Van der Hammen T., 1986, HIGH ALTITUDE TROPIC; Ventura J, 1998, J MAMMAL, V79, P104, DOI 10.2307/1382845; Voss RS, 2013, AM MUS NOVIT, P1; Voss RS, 2001, B AM MUS NAT HIST, P3; WALTER H, 1971, BOL SOC VEN CIENC NA, V29, P211; Woodman N, 2007, MAMMALS S AM	68	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96714	10.1371/journal.pone.0096714	http://dx.doi.org/10.1371/journal.pone.0096714			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806452	Green Published, gold, Green Submitted			2022-12-27	WOS:000335728900084
J	Yavagal, DR; Lin, BW; Raval, AP; Garza, PS; Dong, CH; Zhao, WZ; Rangel, EB; McNiece, I; Rundek, T; Sacco, RL; Perez-Pinzon, M; Hare, JM				Yavagal, Dileep R.; Lin, Baowan; Raval, Ami P.; Garza, Philip S.; Dong, Chuanhui; Zhao, Weizhao; Rangel, Erika B.; McNiece, Ian; Rundek, Tatjana; Sacco, Ralph L.; Perez-Pinzon, Miguel; Hare, Joshua M.			Efficacy and Dose-Dependent Safety of Intra-Arterial Delivery of Mesenchymal Stem Cells in a Rodent Stroke Model	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; MARROW STROMAL CELLS; MYOCARDIAL-INFARCTION; THERAPEUTIC BENEFIT; ARTERY OCCLUSION; PROGENITOR CELLS; TRANSPLANTATION; RAT; NEUROPROTECTION; INJECTION	Intra-arterial (IA) delivery of mesenchymal stem cells (MSCs) for acute ischemic stroke is attractive for clinical translation. However, studies using rat model of stroke have demonstrated that IA MSCs delivery can decrease middle cerebral artery (MCA) flow, which may limit its clinical translation. The goal of this study is to identify a dose of IA MSCs (maximum tolerated dose; MTD) that does not compromise MCA flow and evaluate its efficacy and optimal timing in a rat model of reversible middle cerebral artery occlusion (rMCAo). We sought to determine if there is a difference in efficacy of acute (1 h) versus sub-acute (24 h) IA MSCs treatment after rMCAo. Adult female Sprague-Dawley rats underwent rMCAo (90 min) and an hour later a single dose of MSCs (at de-escalating doses 1 x10(6), 5 x 10(5), 2 x 10(5), 1 x 10(5) and 5 x 10(4)) was given using IA route. MSCs were suspended in phosphate buffered saline (PBS) and PBS alone was used for control experiments. We measured the percent change in mean laser Doppler flow signal over the ipsilateral MCA in de-escalating doses groups to determine MTD. The results demonstrated that the lowering of IA MSC dose to 1 x 10(5) and below did not compromise MCA flow and hence an IA MSC dose of 1 x 10(5) considered as MTD. Subsequently, 1 h and 24 h after rMCAo, rats were treated with IA MSCs or PBS. The 24 h delivery of IA MSCs significantly improved neurodeficit score and reduced the mean infarct volume at one month as compared to control, but not the 1 h delivery. Overall, this study suggests that the IA delivery of MSCs can be performed safely and efficaciously at the MTD of 1 x 10(5) delivered at 24 hours in rodent model of stroke.	[Yavagal, Dileep R.; Lin, Baowan; Raval, Ami P.; Garza, Philip S.; Perez-Pinzon, Miguel] Univ Miami, Leonard M Miller Sch Med, Cerebral Vasc Dis Res Labs, Miami, FL 33136 USA; [Yavagal, Dileep R.; Raval, Ami P.; Dong, Chuanhui; Zhao, Weizhao; Rundek, Tatjana; Sacco, Ralph L.; Perez-Pinzon, Miguel] Univ Miami, Dept Neurol, Leonard M Miller Sch Med, Miami, FL USA; [Yavagal, Dileep R.; Rangel, Erika B.; McNiece, Ian; Hare, Joshua M.] Univ Miami, Leonard M Miller Sch Med, Interdisciplinary Stem Cell Inst, Miami, FL USA; [Hare, Joshua M.] Univ Miami, Dept Med, Leonard M Miller Sch Med, Miami, FL USA	University of Miami; University of Miami; University of Miami; University of Miami	Yavagal, DR (corresponding author), Univ Miami, Leonard M Miller Sch Med, Cerebral Vasc Dis Res Labs, Miami, FL 33136 USA.	dyavagal@med.miami.edu	Sacco, Ralph/Y-9278-2019; Rangel, Erika/H-3066-2013	Rangel, Erika/0000-0003-0982-2484; Lin, Binshan/0000-0002-8481-302X	Department of Neurology, University of Miami (DRY); James and Esther King Biomedical Research Program; Florida Department of Health [2KN09]; University of Miami intramural grant:Interdepartmental Research Development Initiative; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000460] Funding Source: NIH RePORTER	Department of Neurology, University of Miami (DRY); James and Esther King Biomedical Research Program; Florida Department of Health; University of Miami intramural grant:Interdepartmental Research Development Initiative; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by Department of Neurology, University of Miami (DRY); James and Esther King Biomedical Research Program, Florida Department of Health Grant # 2KN09 (DRY); University of Miami intramural grant: Interdepartmental Research Development Initiative grant 2009-2010 (DRY) and the Anderson Family Gift 2010-2011, 2012-2014 (DRY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Belayev L, 1999, BRAIN RES, V833, P181, DOI 10.1016/S0006-8993(99)01528-0; Bhatia Rinky, 2005, Congest Heart Fail, V11, P87, DOI 10.1111/j.1527-5299.2005.03618.x; Bliss T, 2007, STROKE, V38, P817, DOI 10.1161/01.STR.0000247888.25985.62; Blum A, 2012, ATHEROSCLEROSIS, V223, P269, DOI 10.1016/j.atherosclerosis.2012.03.017; Brenneman M, 2010, J CEREBR BLOOD F MET, V30, P140, DOI 10.1038/jcbfm.2009.198; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; Cloft HJ, 2009, AM J NEURORADIOL, V30, P453, DOI 10.3174/ajnr.A1462; del Zoppo GJ, 2009, STROKE, V40, P2945, DOI 10.1161/STROKEAHA.109.192535; del Zoppo Gregory J., 2009, V25, P34, DOI 10.1159/000209471; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Friedrich MAG, 2012, CELL TRANSPLANT, V21, pS13, DOI 10.3727/096368912X612512; Guzman R, 2008, STROKE, V39, P1300, DOI 10.1161/STROKEAHA.107.500470; Ikeda N, 2005, STROKE, V36, P2725, DOI 10.1161/01.STR.0000190006.88896.d3; Janowski M, 2013, J CEREBR BLOOD F MET, V33, P921, DOI 10.1038/jcbfm.2013.32; Kamiya N, 2008, LIFE SCI, V83, P433, DOI 10.1016/j.lfs.2008.07.018; Ley JJ, 2005, J PHARMACOL EXP THER, V313, P1090, DOI 10.1124/jpet.105.083386; Li L, 2010, J CEREBR BLOOD F MET, V30, P653, DOI 10.1038/jcbfm.2009.238; Li Y, 2001, NEUROLOGY, V56, P1666, DOI 10.1212/WNL.56.12.1666; Lin BW, 2000, BRAIN RES, V865, P237, DOI 10.1016/S0006-8993(00)02228-9; Liu X, 2013, PROG NEUROBIOL; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Mimura T, 2005, J NEUROPATH EXP NEUR, V64, P1108, DOI 10.1097/01.jnen.0000190068.03009.b5; Minnerup Jens, 2010, Exp Transl Stroke Med, V2, P3, DOI 10.1186/2040-7378-2-3; Pendharkar AV, 2010, STROKE, V41, P2064, DOI 10.1161/STROKEAHA.109.575993; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Raval AP, 2009, NEUROSCIENCE, V160, P307, DOI 10.1016/j.neuroscience.2009.02.065; Rosenblum S, 2012, STROKE, V43, P1624, DOI 10.1161/STROKEAHA.111.637884; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Uccelli A, 2006, EUR J IMMUNOL, V36, P2566, DOI 10.1002/eji.200636416; Walczak P, 2008, STROKE, V39, P1569, DOI 10.1161/STROKEAHA.107.502047; Wechsler L, 2009, STROKE, V40, P510, DOI 10.1161/STROKEAHA.108.526863; Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147; Williams BA, 2008, GERONTOLOGY, V54, P300, DOI 10.1159/000156223; Woitzik J, 2007, J NEUROSURG, V106, P872, DOI 10.3171/jns.2007.106.5.872; Zhang L, 2012, BRAIN RES, V1489, P104, DOI 10.1016/j.brainres.2012.10.017	40	59	60	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e93735	10.1371/journal.pone.0093735	http://dx.doi.org/10.1371/journal.pone.0093735			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24807059	Green Submitted, Green Published, gold			2022-12-27	WOS:000335728900007
J	Catalli, A; Karpov, V; Erdos, LE; Tancowny, BP; Schleimer, RP; Kulka, M				Catalli, Adriana; Karpov, Victor; Erdos, Levente E.; Tancowny, Brian P.; Schleimer, Robert P.; Kulka, Marianna			Stimulus-Selective Regulation of Human Mast Cell Gene Expression, Degranulation and Leukotriene Production by Fluticasone and Salmeterol	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; FC-EPSILON-RI; SUBSTANCE-P; FUNCTIONAL DESENSITIZATION; ANTIMICROBIAL PEPTIDES; INDEPENDENT ACTIVATION; HISTAMINE-RELEASE; RBL-2H3 CELLS; DEXAMETHASONE; RECEPTORS	Despite the fact that glucocorticoids and long acting beta agonists are effective treatments for asthma, their effects on human mast cells (MC) appear to be modest. Although MC are one of the major effector cells in the underlying inflammatory reactions associated with asthma, their regulation by these drugs is not yet fully understood and, in some cases, controversial. Using a human immortalized MC line (LAD2), we studied the effects of fluticasone propionate (FP) and salmeterol (SM), on the release of early and late phase mediators. LAD2 cells were pretreated with FP (100 nM), SM (1 mu M), alone and in combination, at various incubation times and subsequently stimulated with agonists substance P, C3a and IgE/anti-IgE. Degranulation was measured by the release of beta-hexosaminidase. Cytokine and chemokine expression were measured using quantitative PCR, ELISA and cytometric bead array (CBA) assays. The combination of FP and SM synergistically inhibited degranulation of MC stimulated with substance P (33% inhibition compared to control, n = 3, P<.05). Degranulation was inhibited by FP alone, but not SM, when MC were stimulated with C3a (48% inhibition, n = 3, P<.05). As previously reported, FP and SM did not inhibit degranulation when MC were stimulated with IgE/anti-IgE. FP and SM in combination inhibited substance P-induced release of tumor necrosis factor (TNF), CCL2, and CXCL8 (98%, 99% and 92% inhibition, respectively, n = 4, P<.05). Fluticasone and salmeterol synergistically inhibited mediator production by human MC stimulated with the neuropeptide substance P. This synergistic effect on mast cell signaling may be relevant to the therapeutic benefit of combination therapy in asthma.	[Catalli, Adriana; Karpov, Victor; Kulka, Marianna] Natl Inst Nanotechnol, Natl Res Council, Edmonton, AB, Canada; [Kulka, Marianna] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Erdos, Levente E.; Tancowny, Brian P.; Schleimer, Robert P.] Northwestern Univ, Feinberg Sch Med, Div Allergy Immunol, Chicago, IL 60611 USA	National Research Council Canada; University of Alberta; Northwestern University; Feinberg School of Medicine	Kulka, M (corresponding author), Natl Inst Nanotechnol, Natl Res Council, Edmonton, AB, Canada.	marianna.kulka@nrc-cnrc.gc.ca		Karpov, Victor/0000-0003-2558-8368	GlaxoSmithKline; American Academy of Allergy, Asthma and Immunology; National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL068546] Funding Source: NIH RePORTER	GlaxoSmithKline(GlaxoSmithKline); American Academy of Allergy, Asthma and Immunology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by grants from GlaxoSmithKline, the American Academy of Allergy, Asthma and Immunology and the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock IM, 2003, CURR ALLERGY ASTHM R, V3, P249, DOI 10.1007/s11882-003-0047-0; Andrade MVM, 2004, J IMMUNOL, V172, P7254, DOI 10.4049/jimmunol.172.12.7254; [Anonymous], BLOOD; Borger P, 2002, J ALLERGY CLIN IMMUN, V110, P841, DOI 10.1067/mai.2002.130047; Boyce JA, 2009, J ALLERGY CLIN IMMUN, V123, P569, DOI 10.1016/j.jaci.2009.01.041; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; CHONG LK, 1995, AM J RESP CELL MOL, V13, P540, DOI 10.1165/ajrcmb.13.5.7576689; Chong LK, 1997, BRIT J PHARMACOL, V121, P717, DOI 10.1038/sj.bjp.0701185; Chung K Fan, 2004, Treat Respir Med, V3, P279, DOI 10.2165/00151829-200403050-00002; CHURCH MK, 1987, BRIT J PHARMACOL, V90, P421, DOI 10.1111/j.1476-5381.1987.tb08972.x; COHAN VL, 1989, AM REV RESPIR DIS, V140, P951, DOI 10.1164/ajrccm/140.4.951; COLLADOESCOBAR D, 1990, J IMMUNOL, V144, P3449; Eickelberg O, 1999, J BIOL CHEM, V274, P1005, DOI 10.1074/jbc.274.2.1005; Fenton C, 2004, DRUGS, V64, P1975, DOI 10.2165/00003495-200464170-00014; Fitzgerald Dominic A, 2006, Treat Respir Med, V5, P407, DOI 10.2165/00151829-200605060-00006; Goldsmith DR, 2004, DRUGS, V64, P1597, DOI 10.2165/00003495-200464140-00006; Heib V, 2008, BRIT J HAEMATOL, V142, P683, DOI 10.1111/j.1365-2141.2008.07244.x; Heise CE, 2000, J BIOL CHEM, V275, P30531, DOI 10.1074/jbc.M003490200; Kang HS, 2004, ARCH IMMUNOL THER EX, V52, P338; Kato A, 2009, J IMMUNOL, V182, P7233, DOI 10.4049/jimmunol.0801375; Kim CK, 2006, ACTA PAEDIATR, V95, P479, DOI 10.1080/08035250600554268; KincyCain T, 1997, J IMMUNOL, V158, P2334; Kirshenbaum AS, 1999, BLOOD, V94, P2333, DOI 10.1182/blood.V94.7.2333.419k30_2333_2342; Kirshenbaum AS, 2003, LEUKEMIA RES, V27, P677, DOI 10.1016/S0145-2126(02)00343-0; Kulka M, 2008, IMMUNOLOGY, V123, P398, DOI 10.1111/j.1365-2567.2007.02705.x; Li M, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-79; Lynch KR, 1999, NATURE, V399, P789; Mau SE, 1997, J NEUROCHEM, V69, P762; Mehrotra AK, 2009, CURR MOL MED, V9, P384, DOI 10.2174/156652409787847209; NAGAI H, 1992, AGENTS ACTIONS, V35, P143, DOI 10.1007/BF01997492; Nagata T, 2008, BIOL PHARM BULL, V31, P464, DOI 10.1248/bpb.31.464; Nayak A, 2007, DRUGS, V67, P887, DOI 10.2165/00003495-200767060-00005; PEACHELL PT, 1988, J IMMUNOL, V140, P571; Ramalho R, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-41; RAMKUMAR V, 1995, J IMMUNOL, V154, P5436; Schild H, 1937, Q J EXP PHYSIOL, V26, P165; SCHLEIMER RP, 1983, J CLIN INVEST, V71, P1830, DOI 10.1172/JCI110938; Schleimer RP, 2003, MIDDLETONS ALLERGY P, P870; Smith K, 2009, J ASTHMA, V46, P234, DOI 10.1080/02770900802627294; Smith SJ, 2002, CLIN EXP ALLERGY, V32, P906, DOI 10.1046/j.1365-2745.2002.01418.x; Tatemoto K, 2006, BIOCHEM BIOPH RES CO, V349, P1322, DOI 10.1016/j.bbrc.2006.08.177; Thangam EB, 2005, FASEB J, V19, P798, DOI 10.1096/fj.04-2797fje; Tossi A, 2005, CURR PROTEIN PEPT SC, V6, P1, DOI 10.2174/1389203053027539; Tuluc F, 2009, TRENDS IMMUNOL, V30, P271, DOI 10.1016/j.it.2009.03.006; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WALSH DT, 1995, BRIT J PHARMACOL, V114, P1343, DOI 10.1111/j.1476-5381.1995.tb13354.x; Yeager MP, 2004, ACTA ANAESTH SCAND, V48, P799, DOI 10.1111/j.1399-6576.2004.00434.x; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	48	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96891	10.1371/journal.pone.0096891	http://dx.doi.org/10.1371/journal.pone.0096891			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819142	gold, Green Published, Green Submitted			2022-12-27	WOS:000336653300043
J	Di Giorgio, A; Smith, RM; Fazio, L; D'Ambrosio, E; Gelao, B; Tomasicchio, A; Selvaggi, P; Taurisano, P; Quarto, T; Masellis, R; Rampino, A; Caforio, G; Popolizio, T; Blasi, G; Sadee, W; Bertolino, A				Di Giorgio, Annabella; Smith, Ryan M.; Fazio, Leonardo; D'Ambrosio, Enrico; Gelao, Barbara; Tomasicchio, Aldo; Selvaggi, Pierluigi; Taurisano, Paolo; Quarto, Tiziana; Masellis, Rita; Rampino, Antonio; Caforio, Grazia; Popolizio, Teresa; Blasi, Giuseppe; Sadee, Wolfgang; Bertolino, Alessandro			DRD2/CHRNA5 Interaction on Prefrontal Biology and Physiology during Working Memory	PLOS ONE			English	Article							RADIAL-ARM MAZE; NICOTINIC ACETYLCHOLINE-RECEPTORS; CATECHOL-O-METHYLTRANSFERASE; SUBUNIT MESSENGER-RNA; DRD2 SNP RS1076560; CHOLINERGIC MODULATION; DOPAMINERGIC MODULATION; PARKINSONS-DISEASE; COGNITIVE FUNCTION; CANDIDATE GENES	Background: Prefrontal behavior and activity in humans are heritable. Studies in animals demonstrate an interaction between dopamine D2 receptors and nicotinic acetylcholine receptors on prefrontal behavior but evidence in humans is weak. Therefore, we hypothesize that genetic variation regulating dopamine D2 and nicotinic acetylcholine receptor signaling impact prefrontal cortex activity and related cognition. To test this hypothesis in humans, we explored the interaction between functional genetic variants in the D2 receptor gene (DRD2, rs1076560) and in the nicotinic receptor alpha 5 gene (CHRNA5, rs16969968) on both dorsolateral prefrontal cortex mediated behavior and physiology during working memory and on prefrontal gray matter volume. Methods: A large sample of healthy subjects was compared for genotypic differences for DRD2 rs1076560 (G>T) and CHNRA5 rs16969968 (G>A) on prefrontal phenotypes, including cognitive performance at the N-Back task, prefrontal physiology with BOLD fMRI during performance of the 2-Back working memory task, and prefrontal morphometry with structural MRI. Results: We found that DRD2 rs1076560 and CHNRA5 rs16969968 interact to modulate cognitive function, prefrontal physiology during working memory, and prefrontal gray matter volume. More specifically, CHRNA5-AA/DRD2-GT subjects had greater behavioral performance, more efficient prefrontal cortex activity at 2-Back working memory task, and greater prefrontal gray matter volume than the other genotype groups. Conclusions: The present data extend previous studies in animals and enhance our understanding of dopamine and acetylcholine signaling in the human prefrontal cortex, demonstrating interactions elicited by working memory that are modulated by genetic variants in DRD2 and CHRNA5.	[Di Giorgio, Annabella; Popolizio, Teresa; Bertolino, Alessandro] IRCCSS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy; [Smith, Ryan M.; Sadee, Wolfgang] Ohio State Univ, Ctr Pharmacogen, Dept Pharmacol, Columbus, OH 43210 USA; [Fazio, Leonardo; D'Ambrosio, Enrico; Gelao, Barbara; Tomasicchio, Aldo; Selvaggi, Pierluigi; Taurisano, Paolo; Quarto, Tiziana; Masellis, Rita; Rampino, Antonio; Caforio, Grazia; Blasi, Giuseppe; Bertolino, Alessandro] Aldo Moro Univ, Dept Basic Med Sci Neurosci & Sense Organs, Grp Psychiat Neurosci, Bari, Italy; [Quarto, Tiziana] Univ Helsinki, Dept Behav Sci, Cognit Brain Res Unit, Helsinki, Finland; [Bertolino, Alessandro] F Hoffman La Roche Ltd, NORD DTA, pRED, Basel, Switzerland	IRCCS Casa Sollievo Della Sofferenza; University System of Ohio; Ohio State University; Universita degli Studi di Bari Aldo Moro; University of Helsinki; Roche Holding	Smith, RM (corresponding author), Ohio State Univ, Ctr Pharmacogen, Dept Pharmacol, Columbus, OH 43210 USA.	ryan.smith2@osumc.edu; alessandro.bertolino@uniba.it	Selvaggi, Pierluigi/AAB-2481-2019; Blasi, Giuseppe/HHS-5404-2022; Di Giorgio, Annabella/D-7353-2017; Bertolino, Alessandro/O-6352-2016; Taurisano, Paolo/U-1828-2017; Rampino, Antonio/Q-4465-2016; Di Giorgio, Annabella/AAI-5367-2020; Di Giorgio, Annabella/AAS-1137-2020; D'Ambrosio, Enrico/K-1942-2015; Taurisano, Paolo/AID-5342-2022	Selvaggi, Pierluigi/0000-0001-9069-0700; Di Giorgio, Annabella/0000-0001-7876-3495; Bertolino, Alessandro/0000-0002-1251-1380; Taurisano, Paolo/0000-0001-6140-9326; Rampino, Antonio/0000-0002-9654-3266; Di Giorgio, Annabella/0000-0001-7876-3495; D'Ambrosio, Enrico/0000-0001-9774-3860; Taurisano, Paolo/0000-0001-6140-9326; Blasi, Giuseppe/0000-0003-0878-1131	US National Institutes of Health, General Medical Sciences [U01 GM092655]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092655] Funding Source: NIH RePORTER	US National Institutes of Health, General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was in part supported by a grant from the US National Institutes of Health, General Medical Sciences, U01 GM092655. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ando J, 2001, BEHAV GENET, V31, P615, DOI 10.1023/A:1013353613591; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bailey CDC, 2012, BIOL PSYCHIAT, V71, P120, DOI 10.1016/j.biopsych.2011.09.011; Bailey CDC, 2010, J NEUROSCI, V30, P9241, DOI 10.1523/JNEUROSCI.2258-10.2010; Bertolino A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009348; Bertolino A, 2009, BRAIN, V132, P417, DOI 10.1093/brain/awn248; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; Blasi G, 2011, P NATL ACAD SCI USA, V108, P1158, DOI 10.1073/pnas.1013535108; Blokland GAM, 2011, J NEUROSCI, V31, P10882, DOI 10.1523/JNEUROSCI.5334-10.2011; Calabresi P, 2006, LANCET NEUROL, V5, P974, DOI 10.1016/S1474-4422(06)70600-7; Callicott JH, 2003, AM J PSYCHIAT, V160, P709, DOI 10.1176/appi.ajp.160.4.709; Centonze D, 2004, NEUROSCIENCE, V129, P157, DOI 10.1016/j.neuroscience.2004.07.043; Chan WK, 2007, NEUROPHARMACOLOGY, V52, P1641, DOI 10.1016/j.neuropharm.2007.03.008; Chudasama Y, 2004, LEARN MEMORY, V11, P78, DOI 10.1101/lm.70904; Clarke TK, 2014, ANN HUM GENET, V78, P33, DOI 10.1111/ahg.12046; Connor JP, 2007, ADDICT BEHAV, V32, P310, DOI 10.1016/j.addbeh.2006.04.006; Croxson PL, 2011, NAT NEUROSCI, V14, P1510, DOI 10.1038/nn.2971; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Exley R, 2012, J NEUROSCI, V32, P2352, DOI 10.1523/JNEUROSCI.4985-11.2012; Falcone M, 2013, NEUROPSYCHOPHARMACOL, V38, P2327, DOI 10.1038/npp.2013.152; First M.B., 1996, GUIDE STRUCTURED CLI; GoldmanRakic PS, 1995, ANN NY ACAD SCI, V769, P71, DOI 10.1111/j.1749-6632.1995.tb38132.x; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Gotti C, 2009, BIOCHEM PHARMACOL, V78, P703, DOI 10.1016/j.bcp.2009.05.024; GRANON S, 1995, PSYCHOPHARMACOLOGY, V119, P139, DOI 10.1007/BF02246154; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Hong LE, 2011, GENES BRAIN BEHAV, V10, P530, DOI 10.1111/j.1601-183X.2011.00689.x; Hong LE, 2010, P NATL ACAD SCI USA, V107, P13509, DOI 10.1073/pnas.1004745107; Howe MN, 2001, INT PSYCHOGERIATR, V13, P465, DOI 10.1017/S1041610201007888; Jackson KJ, 2013, PSYCHIAT GENET, V23, P20, DOI 10.1097/YPG.0b013e32835bd5f1; Kassam SM, 2008, J NEUROSCI, V28, P8756, DOI 10.1523/JNEUROSCI.2645-08.2008; KRISTT DA, 1979, ANAT EMBRYOL, V157, P217, DOI 10.1007/BF00305161; Kuehn BM, 2006, JAMA-J AM MED ASSOC, V295, P483, DOI 10.1001/jama.295.5.483; Kuryatov A, 2011, MOL PHARMACOL, V79, P119, DOI 10.1124/mol.110.066357; Lambe EK, 2000, J NEUROSCI, V20, P8780; LEVIN ED, 1991, BRAIN RES BULL, V27, P125, DOI 10.1016/0361-9230(91)90293-S; LEVIN ED, 1989, BEHAV NEURAL BIOL, V51, P270, DOI 10.1016/S0163-1047(89)90917-5; Levin ED, 2006, PSYCHOPHARMACOLOGY, V184, P523, DOI 10.1007/s00213-005-0164-7; Levin ED, 1998, PSYCHOPHARMACOLOGY, V138, P217, DOI 10.1007/s002130050667; LEVIN ED, 1989, PHARMACOL BIOCHEM BE, V33, P919, DOI 10.1016/0091-3057(89)90494-2; LEVIN ED, 1995, PHARMACOL BIOCHEM BE, V51, P369, DOI 10.1016/0091-3057(94)00406-9; LEVIN ED, 1987, BEHAV NEURAL BIOL, V48, P206, DOI 10.1016/S0163-1047(87)90752-7; Levitt P, 1997, TRENDS NEUROSCI, V20, P269, DOI 10.1016/S0166-2236(96)01028-4; LIPTON SA, 1988, SCIENCE, V239, P1293, DOI 10.1126/science.3344435; Loughead J, 2010, BIOL PSYCHIAT, V67, P715, DOI 10.1016/j.biopsych.2010.01.016; Luciano M, 2001, BEHAV GENET, V31, P581, DOI 10.1023/A:1013397428612; Markett SA, 2010, J COGNITIVE NEUROSCI, V22, P1944, DOI 10.1162/jocn.2009.21354; MARKS MJ, 1992, J NEUROSCI, V12, P2765; Mattay VS, 2002, ANN NEUROL, V51, P156, DOI 10.1002/ana.10078; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; MCGURK SR, 1989, PSYCHOPHARMACOLOGY, V99, P371, DOI 10.1007/BF00445560; Mechawar N, 2001, NEUROSCIENCE, V108, P555, DOI 10.1016/S0306-4522(01)00389-X; Moyer RA, 2011, NEUROPSYCHOPHARMACOL, V36, P753, DOI 10.1038/npp.2010.208; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Papaleo F, 2013, MOL PSYCHIAT; Pickel VM, 2002, SYNAPSE, V45, P113, DOI 10.1002/syn.10092; Polderman TJC, 2006, ACTA NEUROL BELG, V106, P191; Poorthuis RB, 2013, CEREB CORTEX, V23, P148, DOI 10.1093/cercor/bhr390; PUGH PC, 1994, J NEUROSCI, V14, P889; RamirezLatorre J, 1996, NATURE, V380, P347, DOI 10.1038/380347a0; Robbins TW, 2007, CEREB CORTEX, V17, pI151, DOI 10.1093/cercor/bhm066; Saccone NL, 2009, AM J MED GENET B, V150B, P453, DOI 10.1002/ajmg.b.30828; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Salas R, 2003, MOL PHARMACOL, V63, P1059, DOI 10.1124/mol.63.5.1059; Sasabe T, 2007, NEUROSCI LETT, V412, P139, DOI 10.1016/j.neulet.2006.10.064; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Sherren N, 2005, NEUROSCIENCE, V136, P445, DOI 10.1016/j.neuroscience.2005.08.053; Sihver W, 1998, NEUROSCIENCE, V85, P1121, DOI 10.1016/S0306-4522(97)00652-0; Smith RM, 2011, EUR J HUM GENET, V19, P76, DOI 10.1038/ejhg.2010.120; Spinelli S, 2006, NEUROPHARMACOLOGY, V51, P238, DOI 10.1016/j.neuropharm.2006.03.012; Sullivan D, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.146; Tan HY, 2008, J CLIN INVEST, V118, P2200, DOI [10.1172/JCI3472S, 10.1172/JCI34725]; Tan HY, 2007, P NATL ACAD SCI USA, V104, P12536, DOI 10.1073/pnas.0610125104; Threlfell S, 2012, NEURON, V75, P58, DOI 10.1016/j.neuron.2012.04.038; Tritsch NX, 2012, NEURON, V76, P33, DOI 10.1016/j.neuron.2012.09.023; Usiello A, 2000, NATURE, V408, P199, DOI 10.1038/35041572; Voisey J, 2012, PSYCHIAT RES, V196, P285, DOI 10.1016/j.psychres.2011.09.024; WADA E, 1990, BRAIN RES, V526, P45, DOI 10.1016/0006-8993(90)90248-A; Wang JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080204; Wang M, 2004, SCIENCE, V303, P853, DOI 10.1126/science.1091162; Wang TY, 2013, BEHAV BRAIN RES, V250, P285, DOI 10.1016/j.bbr.2013.05.015; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670; Wei JX, 2012, ADDICT BEHAV, V37, P622, DOI 10.1016/j.addbeh.2012.01.009; Winterer G, 2010, AM J MED GENET B, V153B, P1448, DOI 10.1002/ajmg.b.31126; Winzer-Serhan UH, 2005, J COMP NEUROL, V481, P19, DOI 10.1002/cne.20357; Woodruff-Pak DS, 2003, BEHAV BRAIN RES, V143, P159, DOI 10.1016/S0166-4328(03)00039-1; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P20552, DOI 10.1073/pnas.0707106104; Zhou X, 2011, J NEUROPHYSIOL, V106, P2180, DOI 10.1152/jn.00148.2011; Zoli M, 2002, J NEUROSCI, V22, P8785	92	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e95997	10.1371/journal.pone.0095997	http://dx.doi.org/10.1371/journal.pone.0095997			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819610	Green Published, Green Submitted, gold			2022-12-27	WOS:000336653300009
J	Liao, H; Zeng, A; Xiao, R; Ren, ZM; Chen, DB; Zhang, YC				Liao, Hao; Zeng, An; Xiao, Rui; Ren, Zhuo-Ming; Chen, Duan-Bing; Zhang, Yi-Cheng			Ranking Reputation and Quality in Online Rating Systems	PLOS ONE			English	Article							INFORMATION; COEFFICIENT	How to design an accurate and robust ranking algorithm is a fundamental problem with wide applications in many real systems. It is especially significant in online rating systems due to the existence of some spammers. In the literature, many well-performed iterative ranking methods have been proposed. These methods can effectively recognize the unreliable users and reduce their weight in judging the quality of objects, and finally lead to a more accurate evaluation of the online products. In this paper, we design an iterative ranking method with high performance in both accuracy and robustness. More specifically, a reputation redistribution process is introduced to enhance the influence of highly reputed users and two penalty factors enable the algorithm resistance to malicious behaviors. Validation of our method is performed in both artificial and real user-object bipartite networks.	[Liao, Hao; Zeng, An; Xiao, Rui; Ren, Zhuo-Ming; Chen, Duan-Bing; Zhang, Yi-Cheng] Univ Fribourg, Dept Phys, CH-1700 Fribourg, Switzerland; [Ren, Zhuo-Ming] Univ Shanghai Sci & Technol, Res Ctr Complex Syst Sci, Shanghai, Peoples R China; [Chen, Duan-Bing] Univ Elect Sci & Technol China, Web Sci Ctr, Chengdu 610054, Peoples R China	University of Fribourg; University of Shanghai for Science & Technology; University of Electronic Science & Technology of China	Zeng, A (corresponding author), Univ Fribourg, Dept Phys, CH-1700 Fribourg, Switzerland.	an.zeng@unifr.ch	REN, Zhuo-Ming/M-9158-2014		EU [611272]; Swiss National Science Foundation [200020-143272]; Tsinghua-Tencent Joint Laboratory for Internet Innovation Technology; Huawei University-Enterprise Cooperation Project [YBCB2011057]	EU(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Tsinghua-Tencent Joint Laboratory for Internet Innovation Technology; Huawei University-Enterprise Cooperation Project(Huawei Technologies)	This work was partially supported by the EU FP7 Grant 611272 (project GROWTHCOM) and by the Swiss National Science Foundation (grant no. 200020-143272). D.-B. Chen acknowledges support from the Tsinghua-Tencent Joint Laboratory for Internet Innovation Technology, and the Huawei University-Enterprise Cooperation Project YBCB2011057. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; ALTMAN NS, 1992, AM STAT, V46, P175, DOI 10.2307/2685209; [Anonymous], FDN INTELLIGENT SYST; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Benevenuto F, 2009, PROCEEDINGS 32ND ANNUAL INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P620, DOI 10.1145/1571941.1572047; Dellarocas C., 2000, EC'00. Proceedings of the 2nd ACM Conference on Electronic Commerce, P150, DOI 10.1145/352871.352889; GOLDBERG D, 1992, COMMUN ACM, V35, P61, DOI 10.1145/138859.138867; Grier C, 2010, PROCEEDINGS OF THE 17TH ACM CONFERENCE ON COMPUTER AND COMMUNICATIONS SECURITY (CCS'10), P27, DOI 10.1145/1866307.1866311; Guttman RH, 1998, KNOWL ENG REV, V13, P147, DOI 10.1017/S0269888998002082; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Herlocker JL, 2004, ACM T INFORM SYST, V22, P5, DOI 10.1145/963770.963772; Josang A, 2007, DECIS SUPPORT SYST, V43, P618, DOI 10.1016/j.dss.2005.05.019; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Laureti P, 2006, EUROPHYS LETT, V75, P1006, DOI 10.1209/epl/i2006-10204-8; Lee K, 2010, SIGIR 2010: PROCEEDINGS OF THE 33RD ANNUAL INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH DEVELOPMENT IN INFORMATION RETRIEVAL, P435, DOI 10.1145/1835449.1835522; Liao H, 2013, 13113064 ARXIV; Lim E.-P., 2010, P 19 ACM INT C INF K, DOI [10.1145/1871437.1871557, DOI 10.1145/1871437.1871557]; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Lu LY, 2012, PHYS REP, V519, P1, DOI 10.1016/j.physrep.2012.02.006; Masum H, 2004, 1 MONDAY, V9, P7; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Pan WK, 2013, P 26 AAAI C ART INT, P39; Resnick P, 2000, COMMUN ACM, V43, P45, DOI 10.1145/355112.355122; Shang MS, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/48006; Tacchella A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00723; Wang G, 2011, ICDM, V2011, P1242, DOI DOI 10.1109/ICDM.2011.124; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yu YK, 2006, PHYSICA A, V371, P732, DOI 10.1016/j.physa.2006.04.057; Zeng A, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.036101; Zeng A, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/18005; Zhang QM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062624; Zhou YB, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/3/033033; Zhou YB, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/48002	34	33	35	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97146	10.1371/journal.pone.0097146	http://dx.doi.org/10.1371/journal.pone.0097146			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819119	Green Published, gold, Green Submitted			2022-12-27	WOS:000336653300083
J	Liu, J; Song, WQ; Yuan, T; Xu, ZL; Jia, WT; Zhang, CQ				Liu, Ji; Song, Wenqi; Yuan, Ting; Xu, Zhengliang; Jia, Weitao; Zhang, Changqing			A Comparison between Platelet-Rich Plasma (PRP) and Hyaluronate Acid on the Healing of Cartilage Defects	PLOS ONE			English	Article							FIBRIN L-PRF; DEGENERATIVE PATHOLOGY; ARTICULAR-CARTILAGE; GROWTH-FACTORS; P-PRP; OSTEOARTHRITIS; INJECTION; CELLS; GRADIENTS; SCAFFOLDS	Platelet-rich plasma (PRP) has offered great promise for the treatment of cartilage degradation, and has been proved to have positive effects on the restoration of cartilage lesions. But no comparative work has been done between PRP and hyaluronate acid (HA) concerning their restoring effect on cartilage defect, especially by means of animal experiments and histologic assessments. The purpose of the study was to compare the therapeutic effects of P-PRP and HA on osteoarthritis in rabbit knees. Thirty rabbits were used to establish the animal models by creating a cartilage defect of 5 mm in diameter on the condyles of the femurs, and were randomly divided into three groups: the P-PRP group, HA group and the control group. Then each group was treated with P-PRP, HA or saline solution, respectively. Six and twelve weeks later the rabbits were sacrificed and the samples were collected. The platelet number, the concentrations of growth factors of P-PRP and whole blood, and the IL-1 beta concentration in the joint fluid were investigated, and the histological assessment of the cartilage were performed according to Mankin's scoring system. Micro-CT was also used to evaluate the restoration of subchondral bone. The platelet concentration in P-PRP is 6.8 fold of that in the whole blood. The IL-1b level in the P-PRP group was lower than in the HA group (p < 0.01) and in the control group (p < 0.01). The restoration of the defected cartilage as well as the subchondral bone was better in the P-PRP group than in the HA group or the control group (P < 0.05). Our data showed that P-PRP is better than HA in promoting the restoration of the cartilage and alleviating the arthritis caused by cartilage damage.	[Liu, Ji; Song, Wenqi; Yuan, Ting; Xu, Zhengliang; Jia, Weitao; Zhang, Changqing] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 6, Dept Orthopaed Surg, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Zhang, CQ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 6, Dept Orthopaed Surg, Shanghai 200030, Peoples R China.	Zhangcq@sjtu.edu.cn		zhang, changqing/0000-0002-7408-4126	National Natural Science Foundation of China [81000811, 81371962]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the National Natural Science Foundation of China (Grants no. 81000811 and 81371962). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeda K, 2006, OSTEOARTHR CARTILAGE, V14, P1272, DOI 10.1016/j.joca.2006.05.008; Bendinelli P, 2010, J CELL PHYSIOL, V225, P757, DOI 10.1002/jcp.22274; Chang KV, 2014, ARCH PHYS MED REHAB, V95, P562, DOI 10.1016/j.apmr.2013.11.006; Dhollander AAM, 2011, KNEE SURG SPORT TR A, V19, P536, DOI 10.1007/s00167-010-1337-4; Ehrenfest DMD, 2012, CURR PHARM BIOTECHNO, V13, P1145; Ehrenfest DMD, 2009, TRENDS BIOTECHNOL, V27, P158, DOI 10.1016/j.tibtech.2008.11.009; Filardo G, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-229; Grigolo B.., 2011, J ORTHOPEDICS, V3, P17; Haleem AM, 2010, CARTILAGE, V1, P253, DOI 10.1177/1947603510366027; Kon E, 2011, ARTHROSCOPY, V27, P1490, DOI 10.1016/j.arthro.2011.05.011; Kon E, 2010, KNEE SURG SPORT TR A, V18, P472, DOI 10.1007/s00167-009-0940-8; Kruger JP, 2012, J ORTHOP RES, V30, P845, DOI 10.1002/jor.22005; Landesberg R, 2000, J ORAL MAXIL SURG, V58, P297, DOI 10.1016/S0278-2391(00)90058-2; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; Milano G, 2010, OSTEOARTHR CARTILAGE, V18, P971, DOI 10.1016/j.joca.2010.03.013; Mohan N, 2011, TISSUE ENG PT A, V17, P2845, DOI 10.1089/ten.tea.2011.0135; Peyron JG, 1977, PATHOL BIOL PARIS, V22, P731; Ramonda R, 2013, EUR J INTERN MED, V24, P11, DOI 10.1016/j.ejim.2012.10.002; Say F, 2013, ACTA CHIR ORTHOP TR, V80, P278; Sun Y, 2010, INT ORTHOP, V34, P589, DOI 10.1007/s00264-009-0793-2; Wang XQ, 2009, J CONTROL RELEASE, V134, P81, DOI 10.1016/j.jconrel.2008.10.021; Zumstein MA, 2011, OPER TECHN SPORT MED, V19, P190, DOI 10.1053/j.otsm.2011.01.001	22	30	31	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97293	10.1371/journal.pone.0097293	http://dx.doi.org/10.1371/journal.pone.0097293			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819118	Green Submitted, Green Published, gold			2022-12-27	WOS:000336653300103
J	Liu, Q; Cai, XW; Wu, B; Zhu, ZF; Chen, HQ; Fu, XL				Liu, Qi; Cai, Xu-Wei; Wu, Bin; Zhu, Zheng-Fei; Chen, Hai-Quan; Fu, Xiao-Long			Patterns of Failure after Radical Surgery among Patients with Thoracic Esophageal Squamous Cell Carcinoma: Implications for the Clinical Target Volume Design of Postoperative Radiotherapy	PLOS ONE			English	Article							LYMPH-NODE DISSECTION; RECURRENCE PATTERN; CURATIVE RESECTION; RADIATION-THERAPY; CANCER; SURVIVAL; CHEMORADIOTHERAPY; NUMBER; IMPACT; LOCATION	Background: This study evaluated patterns of treatment failure (especially locoregional failure; LRF) after radical esophagectomy and proposes a clinical target volume (CTV) for postoperative radiotherapy (PORT) among patients with thoracic esophageal squamous cell carcinoma (SCC). Methods: All patients who were followed up in our center after radical esophagectomy between 2007 and 2011 were retrospectively enrolled. The patterns of first discovered failure were assessed, and LRFs (including anastomotic and regional lymph node recurrences) were evaluated to determine whether our proposed PORT CTV encompassed these areas. The clinicopathologic factors predictive of lymphatic recurrence type were analyzed. Results: Of the 414 patients who underwent surgery and were followed up over the study, 207 experienced recurrent or metastatic diseases. The median time to progression was 11.0 months. Of the 173 patients with locoregional recurrence, nodal failure recurred in 160; supraclavicular and superior mediastinal lymph nodes had the highest metastasis rates. All 233 recurrent sites across the 160 patients were located in a standard CTV area, including the bilateral supraclavicular areas, the entire mediastinum, and the left gastric lymphatic drainage region. A total of 203 sites (87.2%) were located in either the bilateral supraclavicular areas or the entire mediastinum, and 185 sites (79.4%) were located in either the bilateral supraclavicular areas or the upper mediastinum. A multivariate analysis revealed the lymph node metastatic ratio (LNMR) and tumor differentiation were risk factors for nodal failure. Conclusions: Locoregional recurrence (especially lymph node recurrence) was the most common and potentially preventable type of initial treatment failure after curative surgery among patients with thoracic esophageal SCC. The proposed PORT CTV covered most LRF sites. The lymphatic drainage regions for PORT are selective, and the supraclavicular and superior mediastinal areas should be considered. However, the value of PORT and the extent of CTV should be investigated in further prospective studies.	[Liu, Qi; Cai, Xu-Wei; Zhu, Zheng-Fei; Fu, Xiao-Long] Fudan Univ, Shanghai Canc Ctr, Dept Radiat Oncol, Shanghai 200433, Peoples R China; [Liu, Qi; Cai, Xu-Wei; Wu, Bin; Zhu, Zheng-Fei; Chen, Hai-Quan; Fu, Xiao-Long] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Chen, Hai-Quan] Fudan Univ, Shanghai Canc Ctr, Dept Thorac Surg, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Fu, XL (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Radiat Oncol, Shanghai 200433, Peoples R China.	xlfu1964@hotmail.com						Bhansali MS, 1997, WORLD J SURG, V21, P275, DOI 10.1007/s002689900228; Cai WJ, 2010, RADIOTHER ONCOL, V96, P104, DOI 10.1016/j.radonc.2010.04.029; Chen G, 2007, WORLD J SURG, V31, P1107, DOI 10.1007/s00268-006-0551-1; Chen JQ, 2012, INT J RADIAT ONCOL, V82, P475, DOI 10.1016/j.ijrobp.2010.08.037; Chen JQ, 2009, EUR J CARDIO-THORAC, V36, P480, DOI 10.1016/j.ejcts.2009.03.056; FOK M, 1993, SURGERY, V113, P138; Huang W, 2010, RADIOTHER ONCOL, V95, P229, DOI 10.1016/j.radonc.2010.01.006; Japanese Society for Esophageal Disease, 2001, GUID CLIN PATH STUD; Kimura H, 1999, DIS ESOPHAGUS, V12, P205; Lee SJ, 2005, CLIN RADIOL, V60, P547, DOI 10.1016/j.crad.2004.09.002; Li CL, 2013, ONCOL LETT, V5, P355, DOI 10.3892/ol.2012.946; Lu JC, 2008, DIS ESOPHAGUS, V21, P502, DOI 10.1111/j.1442-2050.2007.00797.x; Mirinezhad SK, 2013, ASIAN PAC J CANCER P, V14, P1677, DOI 10.7314/APJCP.2013.14.3.1677; Nakagawa S, 2004, J AM COLL SURGEONS, V198, P205, DOI 10.1016/j.jamcollsurg.2003.10.005; Qiao XY, 2008, INT J RADIAT ONCOL, V70, P396, DOI 10.1016/j.ijrobp.2007.06.031; Rice TW, 2003, J THORAC CARDIOV SUR, V126, P1590, DOI 10.1016/S0022-5223(03)01025-0; Schreiber D, 2010, J THORAC ONCOL, V5, P244, DOI 10.1097/JTO.0b013e3181c5e34f; Shridhar Ravi, 2013, J Gastrointest Cancer, V44, P375, DOI 10.1007/s12029-013-9511-9; Tachibana M, 2006, LANGENBECK ARCH SURG, V391, P304, DOI 10.1007/s00423-006-0063-3; TENIERE P, 1991, SURG GYNECOL OBSTET, V173, P123; van Hagen P, 2013, BRIT J SURG, V100, P267, DOI 10.1002/bjs.8968; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Xiao ZF, 2005, INT J RADIAT ONCOL, V62, P82, DOI 10.1016/j.ijrobp.2004.08.046; Xu YP, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-116; Yu E, 2009, CURR ONCOL, V16, P258; ZIEREN HU, 1995, WORLD J SURG, V19, P444, DOI 10.1007/BF00299187	26	65	94	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97225	10.1371/journal.pone.0097225	http://dx.doi.org/10.1371/journal.pone.0097225			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24820177	Green Submitted, Green Published, gold			2022-12-27	WOS:000336653300093
J	Wang, YH; Zhang, CL; Fang, XT; Zhao, YL; Chen, XH; Sun, JJ; Zhou, Y; Wang, JJ; Wang, YG; Lan, XY; Chen, H				Wang, Yanhong; Zhang, Chunlei; Fang, Xingtang; Zhao, Yulong; Chen, Xiaohui; Sun, Jiajie; Zhou, Yang; Wang, Jianjin; Wang, Yongan; Lan, Xianyong; Chen, Hong			Identification and Profiling of microRNAs and Their Target Genes from Developing Caprine Skeletal Muscle	PLOS ONE			English	Article							MATERNAL NUTRIENT RESTRICTION; EXPRESSION; DIFFERENTIATION; PROLIFERATION; PREDICTION; MIR-206; GROWTH; BIOGENESIS; MYOGENESIS; DISCOVERY	Goat is an important agricultural animal for meat production. Functional studies have demonstrated that microRNAs (miRNAs) regulate gene expression at the post-transcriptional level and play an important role in various biological processes. Although studies on miRNAs expression profiles have been performed in various animals, relatively limited information about goat muscle miRNAs has been reported. To investigate the miRNAs involved in regulating different periods of skeletal muscle development, we herein performed a comprehensive research for expression profiles of caprine miRNAs during two developmental stages of skeletal muscles: fetal stage and six month-old stage. As a result, 15,627,457 and 15,593,721 clean reads were obtained from the fetal goat library (FC) and the six month old goat library (SMC), respectively. 464 known miRNAs and 83 novel miRNA candidates were identified. Furthermore, by comparing the miRNA profile, 336 differentially expressed miRNAs were identified and then the potential targets of the differentially expressed miRNAs were predicted. To understand the regulatory network of miRNAs during muscle development, the mRNA expression profiles for the two development stages were characterized and 7322 differentially expressed genes (DEGs) were identified. Then the potential targets of miRNAs were compared to the DEGs, the intersection of the two gene sets were screened out and called differentially expressed targets (DE-targets), which were involved in 231 pathways. Ten of the 231 pathways that have smallest P-value were shown as network figures. Based on the analysis of pathways and networks, we found that miR-424-5p and miR-29a might have important regulatory effect on muscle development, which needed to be further studied. This study provided the first global view of the miRNAs in caprine muscle tissues. Our results help elucidation of complex regulatory networks between miRNAs and mRNAs and for the study of muscle development.	[Wang, Yanhong; Sun, Jiajie; Zhou, Yang; Lan, Xianyong; Chen, Hong] Northwest A& F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China; [Wang, Yanhong; Zhang, Chunlei; Fang, Xingtang; Zhao, Yulong; Chen, Xiaohui; Wang, Jianjin; Wang, Yongan] Jiangsu Normal Univ, Inst Cellular & Mol Biol, Xuzhou, Jiangsu, Peoples R China	Northwest A&F University - China; Jiangsu Normal University	Chen, H (corresponding author), Northwest A& F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China.	chenhong1212@263.net	wang, yan/GSE-6489-2022; wang, yi/GVT-8516-2022; Wang, Yanbo/HFZ-8018-2022		Research Fund for the Doctor Program of Higher Education of China [20120204110007]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); College Industrialization Project of Jiangsu Province [JHB2012-32]; Agricultural Science and Technology Innovation Projects of Shaanxi Province [2012NKC01-13]; Science and Technology Planning Project of Xuzhou City [XF12C052]	Research Fund for the Doctor Program of Higher Education of China; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); College Industrialization Project of Jiangsu Province; Agricultural Science and Technology Innovation Projects of Shaanxi Province; Science and Technology Planning Project of Xuzhou City	This study was supported by Research Fund for the Doctor Program of Higher Education of China (No. 20120204110007), A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), the College Industrialization Project of Jiangsu Province(No. JHB2012-32), Agricultural Science and Technology Innovation Projects of Shaanxi Province (No. 2012NKC01-13), Science and Technology Planning Project of Xuzhou City(No. XF12C052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Sini R, 2009, J SURG ONCOL, V99, P135, DOI 10.1002/jso.21213; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; [Anonymous], DROP; Arhondakis S, 2004, GENE, V325, P165, DOI 10.1016/j.gene.2003.10.009; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benjamini Y, 2001, ANN STAT, V29, P1165; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Caiment F, 2010, GENOME RES, V20, P1651, DOI 10.1101/gr.108787.110; Callis TE, 2008, EXP BIOL MED, V233, P131, DOI 10.3181/0709-MR-237; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Chen X, 2010, CELL RES, V20, P1128, DOI 10.1038/cr.2010.80; Crippa S, 2011, J CELL BIOL, V193, P1197, DOI 10.1083/jcb.201011099; Crist CG, 2009, P NATL ACAD SCI USA, V106, P13383, DOI 10.1073/pnas.0900210106; Cui Y, 2011, PLOS ONE; D'Onofrio G, 2007, FEBS LETT, V581, P5819, DOI 10.1016/j.febslet.2007.11.052; Davis E, 2004, CURR BIOL, V14, P1858, DOI 10.1016/j.cub.2004.09.079; Dey BK, 2011, MOL CELL BIOL, V31, P203, DOI 10.1128/MCB.01009-10; Feng Y, 2011, CELL BIOCHEM FUNCT, V29, P378, DOI 10.1002/cbf.1760; Gu LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086150; Guller I, 2010, J PHYSIOL-LONDON, V588, P4075, DOI 10.1113/jphysiol.2010.194175; Hocquette JF, 2010, ANIMAL, V4, P1797, DOI 10.1017/S1751731110001448; Hua WP, 2011, GENOMICS, V98, P272, DOI 10.1016/j.ygeno.2011.03.012; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang Pan, 2010, Journal of Agricultural Biotechnology, V18, P1149; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Ji ZB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049463; Jiang P, 2007, NUCLEIC ACIDS RES, V35, pW339, DOI 10.1093/nar/gkm368; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kudla G, 2006, PLOS BIOL, V4, P933, DOI 10.1371/journal.pbio.0040180; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li TT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-186; Li ZM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041658, 10.1371/journal.pone.0053176]; Ling YH, 2013, GENET MOL RES, V12, P1951, DOI 10.4238/2013.June.13.4; Lu LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027596; McCarthy JJ, 2007, J APPL PHYSIOL, V102, P306, DOI 10.1152/japplphysiol.00932.2006; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Muroya S, 2013, J ANIM SCI, V91, P90, DOI 10.2527/jas.2012-5371; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Pogue AI, 2010, NEUROSCI LETT, V476, P18, DOI 10.1016/j.neulet.2010.03.054; Qin LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072418; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Small EM, 2010, P NATL ACAD SCI USA, V107, P4218, DOI 10.1073/pnas.1000300107; Song Lin, 2006, Birth Defects Research, V78, P140, DOI 10.1002/bdrc.20070; Sun JJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-42; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; van Rooij E, 2008, TRENDS GENET, V24, P159, DOI 10.1016/j.tig.2008.01.007; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Wang L, 2012, EXP CELL RES, V318, P2324, DOI 10.1016/j.yexcr.2012.06.018; Wang XNH, 2011, J AM SOC NEPHROL, V22, P2068, DOI 10.1681/ASN.2010121278; Wong CF, 2008, J BIOL CHEM, V283, P9836, DOI 10.1074/jbc.M709614200; Xie ZX, 2005, PLANT PHYSIOL, V138, P2145, DOI 10.1104/pp.105.062943; Yan XC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030925; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P152, DOI 10.1093/nar/gkl1032; Zhang BH, 2009, GENE, V443, P100, DOI 10.1016/j.gene.2009.04.027; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058905; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006; Zhu MJ, 2006, J PHYSIOL-LONDON, V575, P241, DOI 10.1113/jphysiol.2006.112110; Zhu MJ, 2004, BIOL REPROD, V71, P1968, DOI 10.1095/biolreprod.104.034561	77	16	19	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96857	10.1371/journal.pone.0096857	http://dx.doi.org/10.1371/journal.pone.0096857			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24818606	Green Published, Green Submitted, gold			2022-12-27	WOS:000336653300039
J	Folgado, H; Duarte, R; Fernandes, O; Sampaio, J				Folgado, Hugo; Duarte, Ricardo; Fernandes, Orlando; Sampaio, Jaime			Competing with Lower Level Opponents Decreases Intra-Team Movement Synchronization and Time-Motion Demands during Pre-Season Soccer Matches	PLOS ONE			English	Article							SEASONAL-VARIATION; PERFORMANCE; COORDINATION; OPPOSITION; DYNAMICS; VARIABLES; LOCATION; BEHAVIOR; QUALITY; FITNESS	This study aimed to quantify the time-motion demands and intra-team movement synchronization during the pre-season matches of a professional soccer team according to the opposition level. Positional data from 20 players were captured during the first half of six pre-season matches of a Portuguese first league team. Time-motion demands were measured by the total distance covered and distance covered at different speed categories. Intra-team coordination was measured by calculating the relative phase of all pairs of outfield players. Afterwards, the percentage of time spent in the -30 degrees to 30 degrees bin (near-in-phase mode of coordination) was calculated for each dyad as a measure of space-time movement synchronization. Movement synchronization data were analyzed for the whole team, according to each dyad average speed and by groups of similar dyadic synchronization tendencies. Then, these data were compared according to the opponent team level (first league; second league; amateurs). Time-motion demands showed no differences in total distance covered per opposition levels, while matches opposing teams of superior level revealed more distance covered at very high intensity. Competing against superior level teams implied more time in synchronized behavior for the overall displacements and displacements at higher intensities. These findings suggest that playing against higher-level opponents (1st league teams) increased time-motion demands at high intensities in tandem with intra-team movement synchronization tendencies.	[Folgado, Hugo; Fernandes, Orlando] Univ Evora, Dept Sport & Hlth, Evora, Portugal; [Duarte, Ricardo] Univ Lisbon, Fac Motricidade Humana, Interdisciplinary Ctr Study Human Performance CIP, P-1699 Lisbon, Portugal; [Folgado, Hugo; Sampaio, Jaime] Univ Tras Os Montes & Alto Douro, Res Ctr Sports Sci Hlth & Human Dev CIDESD, Vila Real, Portugal	University of Evora; Universidade de Lisboa; University of Tras-os-Montes & Alto Douro	Folgado, H (corresponding author), Univ Evora, Dept Sport & Hlth, Evora, Portugal.	hfolgado@uevora.pt	Folgado, Hugo/D-4501-2013; Sampaio, Jaime/B-7392-2008; Duarte, Ricardo/G-4747-2013	Folgado, Hugo/0000-0002-9432-1950; Sampaio, Jaime/0000-0003-2335-9991; Fernandes, Orlando de Jesus/0000-0001-7273-8774; Duarte, Ricardo/0000-0002-2122-7728				Bangsbo J, 2006, J SPORT SCI, V24, P665, DOI 10.1080/02640410500482529; Bourbousson J, 2010, J SPORT SCI, V28, P339, DOI 10.1080/02640410903503632; Caldwell BP, 2009, J STRENGTH COND RES, V23, P1370, DOI 10.1519/JSC.0b013e3181a4e82f; Carling C, 2013, SPORTS MED, V43, P655, DOI 10.1007/s40279-013-0055-8; Carling C, 2012, J SPORT SCI, V30, P325, DOI 10.1080/02640414.2011.652655; Carling C, 2011, EUR J SPORT SCI, V11, P155, DOI 10.1080/17461391.2010.499972; Casajus JA, 2001, J SPORT MED PHYS FIT, V41, P463; Coutts AJ, 2010, J SCI MED SPORT, V13, P133, DOI 10.1016/j.jsams.2008.09.015; Davids K, 2003, SPORTS MED, V33, P245, DOI 10.2165/00007256-200333040-00001; Davids K, 2005, SCI FOOTBALL P 5 WOR, VV, P537; Del Re, 2013, COMPUTEES COMPUTE EF; Duarte R, 2013, HUM MOVEMENT SCI, V32, P555, DOI 10.1016/j.humov.2013.01.011; Duarte R, 2012, HUM MOVEMENT SCI, V31, P1639, DOI 10.1016/j.humov.2012.03.001; Duarte R, 2012, SPORTS MED, V42, P633, DOI 10.2165/11632450-000000000-00000; Faude O, 2012, J SPORT SCI, V30, P625, DOI 10.1080/02640414.2012.665940; Folgado H, 2014, EUR J SPORT SCI, V14, pS487, DOI 10.1080/17461391.2012.730060; Glazier PS, 2010, SPORTS MED, V40, P625, DOI 10.2165/11534970-000000000-00000; Grehaigne JF, 1999, J TEACH PHYS EDUC, V18, P159, DOI 10.1123/jtpe.18.2.159; Lago C, 2010, EUR J SPORT SCI, V10, P103, DOI 10.1080/17461390903273994; Lago C, 2009, J SPORT SCI, V27, P1463, DOI 10.1080/02640410903131681; McGarry T, 2002, J SPORT SCI, V20, P771, DOI 10.1080/026404102320675620; Mohr M, 2003, J SPORT SCI, V21, P519, DOI 10.1080/0264041031000071182; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Palacios, 2006, DEG2UTM MATLAB CENTR; Palut Y, 2005, J SPORT SCI, V23, P1021, DOI 10.1080/02640410400021682; Passos P, 2011, J MOTOR BEHAV, V43, P155, DOI 10.1080/00222895.2011.552078; Rampinini E, 2007, INT J SPORTS MED, V28, P1018, DOI 10.1055/s-2007-965158; Sampaio J, 2012, INT J SPORTS MED, V33, P395, DOI 10.1055/s-0031-1301320; Sampaio JE, 2014, J SCI MED SPORT, V17, P229, DOI 10.1016/j.jsams.2013.04.005; Taylor JB, 2008, J SPORT SCI, V26, P885, DOI 10.1080/02640410701836887; Travassos B, 2012, HUM MOVEMENT SCI, V31, P932, DOI 10.1016/j.humov.2011.10.004; Travassos B, 2011, HUM MOVEMENT SCI, V30, P1245, DOI 10.1016/j.humov.2011.04.003; Travassos B., 2010, OPEN SPORTS SCI J, V3, P56, DOI DOI 10.2174/1875399X01003010056; Travassos B, 2012, J SPORT SCI, V30, P1447, DOI 10.1080/02640414.2012.712716	34	109	112	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97145	10.1371/journal.pone.0097145	http://dx.doi.org/10.1371/journal.pone.0097145			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4LX	24817186	Green Published, Green Submitted, gold			2022-12-27	WOS:000336838000107
J	Oguz, C; Palmisano, A; Laomettachit, T; Watson, LT; Baumann, WT; Tyson, JJ				Oguz, Cihan; Palmisano, Alida; Laomettachit, Teeraphan; Watson, Layne T.; Baumann, William T.; Tyson, John J.			A Stochastic Model Correctly Predicts Changes in Budding Yeast Cell Cycle Dynamics upon Periodic Expression of CLN2	PLOS ONE			English	Article							SIZE CONTROL; SYNCHRONIZATION; VARIABILITY; GROWTH	In this study, we focus on a recent stochastic budding yeast cell cycle model. First, we estimate the model parameters using extensive data sets: phenotypes of 110 genetic strains, single cell statistics of wild type and cln3 strains. Optimization of stochastic model parameters is achieved by an automated algorithm we recently used for a deterministic cell cycle model. Next, in order to test the predictive ability of the stochastic model, we focus on a recent experimental study in which forced periodic expression of CLN2 cyclin (driven by MET3 promoter in cln3 background) has been used to synchronize budding yeast cell colonies. We demonstrate that the model correctly predicts the experimentally observed synchronization levels and cell cycle statistics of mother and daughter cells under various experimental conditions (numerical data that is not enforced in parameter optimization), in addition to correctly predicting the qualitative changes in size control due to forced CLN2 expression. Our model also generates a novel prediction: under frequent CLN2 expression pulses, G1 phase duration is bimodal among small-born cells. These cells originate from daughters with extended budded periods due to size control during the budded period. This novel prediction and the experimental trends captured by the model illustrate the interplay between cell cycle dynamics, synchronization of cell colonies, and size control in budding yeast.	[Oguz, Cihan; Palmisano, Alida; Tyson, John J.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA; [Palmisano, Alida; Watson, Layne T.] Virginia Tech, Dept Comp Sci, Blacksburg, VA USA; [Laomettachit, Teeraphan] King Mongkuts Univ Technol Thonburi, Sch Bioresources & Technol, Bioinformat & Syst Biol Program, Bangkok, Thailand; [Baumann, William T.] Virginia Tech, Dept Elect & Comp Engn, Blacksburg, VA USA; [Watson, Layne T.] Virginia Tech, Dept Math, Blacksburg, VA 24061 USA; [Watson, Layne T.] Virginia Tech, Dept Aerosp & Ocean Engn, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; King Mongkuts University of Technology Thonburi; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Oguz, C (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.	cihanoguzvt@gmail.com	Tyson, John J/A-2942-2014; Oguz, Cihan/H-2727-2019; Palmisano, Alida/C-2254-2015	Tyson, John J/0000-0001-7560-6013; Palmisano, Alida/0000-0002-1859-3719; Oguz, Cihan/0000-0002-2860-3546; Laomettachit, Teeraphan/0000-0003-3194-1391	National Institute of General Medical Sciences of the National Institutes of Health [R01 GM078989-07]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078989] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under award number R01 GM078989-07 to JJT and WTB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberghina L, 1998, J BACTERIOL, V180, P3864, DOI 10.1128/JB.180.15.3864-3872.1998; Avraham N, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.13; Bi EF, 2012, GENETICS, V191, P347, DOI 10.1534/genetics.111.132886; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; Charvin G, 2009, P NATL ACAD SCI USA, V106, P6632, DOI 10.1073/pnas.0809227106; Charvin G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001468; Cross FR, 2002, MOL BIOL CELL, V13, P52, DOI 10.1091/mbc.01-05-0265; Davis PK, 2001, BIOTECHNIQUES, V30, P1322, DOI 10.2144/01306rv01; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; Futcher Bruce, 1999, Methods in Cell Science, V21, P79, DOI 10.1023/A:1009872403440; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Jackman J, 2001, CURR PROTOC CELL BIO; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; Kugler P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043001; Laomettachit T, 2011, THESIS VIRGINIA I TE; Li B, 2013, QUANT BIOL, V1, P131, DOI DOI 10.1007/978-1-4939-8882-2_10; LORD PG, 1981, J CELL SCI, V50, P361; Manukyan A, 2011, METHODS MOL BIOL, V761, P173, DOI 10.1007/978-1-61779-182-6_12; Novak B, 1997, P NATL ACAD SCI USA, V94, P9147, DOI 10.1073/pnas.94.17.9147; Nurse P., 1981, CELL CYCLE, P85; Oguz C, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-53; Poovathingal SK, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-414; Turner JJ, 2012, CURR BIOL, V22, pR350, DOI 10.1016/j.cub.2012.02.041; Wang P, 2008, P 2008 SPRING SIM MU, P385	24	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96726	10.1371/journal.pone.0096726	http://dx.doi.org/10.1371/journal.pone.0096726			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816736	Green Published, Green Submitted, gold			2022-12-27	WOS:000336838000057
J	Wang, C; Guo, Y; Wang, J; Min, ZQ				Wang, Chong; Guo, Yu; Wang, Jing; Min, Zhiqun			The Suppressive Role of SOX7 in Hepatocarcinogenesis	PLOS ONE			English	Article							BETA-CATENIN GENE; HEPATOCELLULAR-CARCINOMA; EXPRESSION; PROGRESSION; CANCER	SOX7 is a transcription factor mediating various developmental processes. However, its role in hepatocellular carcinoma (HCC) remains unclear. Here, we assessed the role of SOX7 in hepatocarcinogenesis. We found HCC samples exhibited lower levels of SOX7 mRNA and protein expression than non-tumor samples, and the expression of SOX7 was negatively correlated with tumor size. SOX7 expression was also reduced in four HCC cell lines (SMMC-7721, Hep3B, HepG2 and Huh 7). Overexpression of SOX7 could inhibit HCC cell growth, with G1 to S phase arrest. In SOX7-overexpression cells, cyclin D1 and c-myc, two cell cycle promoters, were down-regulated. Moreover, ectopic expression of cyclin D1 or c-myc could override G1 to S pahse arrest induced by SOX7. Furthermore, overexpression of SOX7 suppressed tumor formation with down-regulation of cyclin D1 and c-myc in vivo. The expression of Ki-67, a proliferation marker, was also reduced in SOX7-overexpression tumors. Taken together, our study suggests that SOX7 plays an important inhibitory role in hepatocarcinogenesis, and might be a novel target for HCC therapy.	[Wang, Chong] Xiamen Univ, Coll Med, Dept Basic Med Sci, Xiamen, Fujian, Peoples R China; [Guo, Yu] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Hepat Surg, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Jing] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gynaecol & Obstet, Guangzhou 510275, Guangdong, Peoples R China; [Min, Zhiqun] Guangzhou Med Univ, Affiliated Hosp 2, Clin Lab Ctr Mol Med, Guangzhou, Guangdong, Peoples R China	Xiamen University; Sun Yat Sen University; Sun Yat Sen University; Guangzhou Medical University	Wang, C (corresponding author), Xiamen Univ, Coll Med, Dept Basic Med Sci, Xiamen, Fujian, Peoples R China.	wangchong@xmu.edu.cn		Guo, Yu/0000-0002-8886-0106	National Natural Science Foundation of China [81302550]; Natural Science Foundation of Guangdong Province [S2012040006483]; Science and Technology Planning Project of Guangdong Province [2012B031800031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province	Funding provide by National Natural Science Foundation of China (81302550) http://www.nsfc.gov.cn/, The Natural Science Foundation of Guangdong Province (S2012040006483)http://gdsf.gdstc.gov.cn/ and the Science and Technology Planning Project of Guangdong Province (2012B031800031) http://pro.gdstc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cui J, 2003, J GASTROEN HEPATOL, V18, P280, DOI 10.1046/j.1440-1746.2003.02973.x; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; EMI M, 1993, GENE CHROMOSOME CANC, V7, P152, DOI 10.1002/gcc.2870070307; HARLEY VR, 1994, NUCLEIC ACIDS RES, V22, P1500, DOI 10.1093/nar/22.8.1500; Hayano T, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-17; Herencia C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034656; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Katoh M, 2002, INT J MOL MED, V9, P363; Miyoshi Y, 1998, CANCER RES, V58, P2524; Pineau P, 1999, ONCOGENE, V18, P3127, DOI 10.1038/sj.onc.1202648; Shiraha H, 2013, INT J ONCOL, V42, P1133, DOI 10.3892/ijo.2013.1829; Stovall DB, 2014, HISTOL HISTOPATHOL, V29, P439, DOI 10.14670/HH-29.10.439; Stovall DB, 2013, AM J PATHOL, V183, P1645, DOI 10.1016/j.ajpath.2013.07.025; Takash W, 2001, NUCLEIC ACIDS RES, V29, P4274, DOI 10.1093/nar/29.21.4274; White BD, 2012, GASTROENTEROLOGY, V142, P219, DOI 10.1053/j.gastro.2011.12.001; Wu GG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088796; Ye XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055615; Zhang Y, 2009, CANCER LETT, V277, P29, DOI 10.1016/j.canlet.2008.11.014; Zhong WD, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-248; Zimonjic DB, 2012, INT J ONCOL, V41, P393, DOI 10.3892/ijo.2012.1474	22	23	26	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97433	10.1371/journal.pone.0097433	http://dx.doi.org/10.1371/journal.pone.0097433			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816720	Green Submitted, Green Published, gold			2022-12-27	WOS:000336838000136
J	Zheng, X; Hu, Y; Yuan, Y; Zhao, YF				Zheng, Xi; Hu, Yang; Yuan, Yong; Zhao, Yong-Fan			Retrospective Cohort Analysis of Chest Injury Characteristics and Concurrent Injuries in Patients Admitted to Hospital in the Wenchuan and Lushan Earthquakes in Sichuan, China	PLOS ONE			English	Article							SEVERITY SCORE; PROFILE; TRAUMA	Background: The aim of this study was to compare retrospectively the characteristics of chest injuries and frequencies of other, concurrent injuries in patients after earthquakes of different seismic intensity. Methods: We compared the cause, type, and body location of chest injuries as well as the frequencies of other, concurrent injuries in patients admitted to our hospital after the Wenchuan and Lushan earthquakes in Sichuan, China. We explored possible relationships between seismic intensity and the causes and types of injuries, and we assessed the ability of the Injury Severity Score, New Injury Severity Score, and Chest Injury Index to predict respiratory failure in chest injury patients. Results: The incidence of chest injuries was 9.9% in the stronger Wenchuan earthquake and 22.2% in the less intensive Lushan earthquake. The most frequent cause of chest injuries in both earthquakes was being accidentally struck. Injuries due to falls were less prevalent in the stronger Wenchuan earthquake, while injuries due to burial were more prevalent. The distribution of types of chest injury did not vary significantly between the two earthquakes, with rib fractures and pulmonary contusions the most frequent types. Spinal and head injuries concurrent with chest injuries were more prevalent in the less violent Lushan earthquake. All three trauma scoring systems showed poor ability to predict respiratory failure in patients with earthquake-related chest injuries. Conclusions: Previous studies may have underestimated the incidence of chest injury in violent earthquakes. The distributions of types of chest injury did not differ between these two earthquakes of different seismic intensity. Earthquake severity and interval between rescue and treatment may influence the prevalence and types of injuries that co-occur with the chest injury. Trauma evaluation scores on their own are inadequate predictors of respiratory failure in patients with earthquake-related chest injuries.	[Zheng, Xi; Hu, Yang; Yuan, Yong; Zhao, Yong-Fan] Sichuan Univ, West China Hosp, Dept Thorac Surg, Chengdu 610064, Sichuan Provinc, Peoples R China	Sichuan University	Zhao, YF (corresponding author), Sichuan Univ, West China Hosp, Dept Thorac Surg, Chengdu 610064, Sichuan Provinc, Peoples R China.	doctorzhaoyongfan@hotmail.com	Yuan, Yuan/GVS-5120-2022					Al-Koudmani I, 2012, J CARDIOTHORAC SURG, V7, DOI 10.1186/1749-8090-7-35; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; CONN J H, 1963, J Trauma, V3, P22, DOI 10.1097/00005373-196301000-00003; Demirhan Recep, 2009, Interact Cardiovasc Thorac Surg, V9, P450, DOI 10.1510/icvts.2009.206599; Doocy S, 2013, PLOS CURR, V5; GAILLARD M, 1990, J TRAUMA, V30, P93, DOI 10.1097/00005373-199001000-00015; Ghodsi Seyed Mohammad, 2006, Chin J Traumatol, V9, P345; Honma M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00749; Hu J, 2010, SURG TODAY, V40, P729, DOI 10.1007/s00595-009-4130-6; Hu Y, 2010, WORLD J SURG, V34, P728, DOI 10.1007/s00268-010-0427-2; Kimura A, 2012, WORLD J SURG, V36, P813, DOI 10.1007/s00268-012-1498-z; LeMier M, 2001, Inj Prev, V7, P334, DOI 10.1136/ip.7.4.334; Liman ST, 2003, EUR J CARDIO-THORAC, V23, P374, DOI 10.1016/S1010-7940(02)00813-8; LOCICERO J, 1989, SURG CLIN N AM, V69, P15; Mulvey JM, 2008, INJURY, V39, P554, DOI 10.1016/j.injury.2007.07.025; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Ozdogan S, 2001, CHEST, V120, P1163, DOI 10.1378/chest.120.4.1163; Ratnapradipa D, 2012, J ENVIRON HEALTH, V74, P42; Sato K, 2013, RESPIR INVESTIG, V51, P24, DOI 10.1016/j.resinv.2012.11.002; SHORR RM, 1987, ANN SURG, V206, P200, DOI 10.1097/00000658-198708000-00013; Toker A, 2002, SURG TODAY, V32, P769, DOI 10.1007/s005950200147; Veysi VT, 2009, INT ORTHOP, V33, P1425, DOI 10.1007/s00264-009-0746-9; Wen YS, 2000, AM J EMERG MED, V18, P825; Whitman Rv, 1997, EARTHQ SPECTRA, V13, P643, DOI [10.1193/1.1585973, DOI 10.1193/1.1585973]; Xie Juan, 2008, J Evid Based Med, V1, P20, DOI 10.1111/j.1756-5391.2008.00010.x; Xu C, 2013, NAT HAZARDS, V69, P1459, DOI 10.1007/s11069-013-0757-0; Yoshimura N, 1996, CHEST, V110, P759, DOI 10.1378/chest.110.3.759; Zheng Y, 2013, SCI CHINA EARTH SCI, V56, P1158, DOI 10.1007/s11430-013-4641-2	28	1	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97354	10.1371/journal.pone.0097354	http://dx.doi.org/10.1371/journal.pone.0097354			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816485	Green Published, gold, Green Submitted			2022-12-27	WOS:000336838000132
J	Kelemen, LE; Brenton, JD; Parkinson, C; Whitaker, HC; Piskorz, AM; Csizmadi, I; Robson, PJ				Kelemen, Linda E.; Brenton, James D.; Parkinson, Christine; Whitaker, Hayley C.; Piskorz, Anna M.; Csizmadi, Ilona; Robson, Paula J.			Conditions Associated with Circulating Tumor-Associated Folate Receptor 1 Protein in Healthy Men and Women	PLOS ONE			English	Article							OVARIAN-CANCER PATIENTS; BINDING-PROTEIN; ALPHA EXPRESSION; ESTROGEN-RECEPTOR; BREAST-CANCER; RETINOIC ACID; CELLS; SERUM; GENE; MODULATION	Background: Serum concentrations of the tumor-associated folate receptor 1 (FOLR1) protein may be a marker for early cancer detection, yet concentrations have also been detected in cancer-free women. We investigated the conditions associated with circulating FOLR1 protein in healthy individuals and sought to clarify the range of normal serum values. Methods: Sera of cancer-free men and women (N = 60) enrolled in a population-based cohort study in Alberta, Canada were analyzed for FOLR1 protein using an electrochemical luminescence immunoassay. Dietary, lifestyle, medical and reproductive history information was collected by questionnaires. Differences in serum FOLR1 concentrations between groups were assessed by non-parametric tests, and predictors of serum FOLR1 concentrations were estimated using multivariable linear regression. Results: Median serum FOLR1 concentration was higher in women (491 pg/ml, range = 327-693 pg/ml) than in men (404 pg/ml, range = 340-682 pg/ml), P = 0.001. FOLR1 concentration was also positively associated with vitamin A intake (P = 0.02), and showed positive trends with age and with oral contraceptive hormone use among women and an inverse trend with body mass index. All variables examined explained almost half of the variation in serum FOLR1 (model R-2 = 0.44, P = 0.04); however, the retention of gender (P = 0.003) and vitamin A intake (P = 0.03) together explained 20% (P = 0.001) of serum FOLR1 variation. No other predictor was significant at P<0.05. Conclusions: The positive association between serum FOLR1 concentration and female gender independent of an age effect suggests caution against statements to exploit serum FOLR1 for early cancer detection without further understanding the biological underpinnings of these observations. Serum FOLR1 concentrations may be influenced by the steroid retinoic acid (vitamin A) but do not appear to be associated with folate nutritional status. These findings require confirmation in larger independent studies.	[Kelemen, Linda E.; Csizmadi, Ilona] Alberta Hlth Serv, Dept Populat Hlth Res, Calgary, AB, Canada; [Kelemen, Linda E.] Univ Calgary, Dept Med Genet, Calgary, AB, Canada; [Brenton, James D.; Parkinson, Christine; Whitaker, Hayley C.; Piskorz, Anna M.] Univ Cambridge, Li Ka Shing Ctr, Canc Res United Kingdom Cambridge Inst, Cambridge, England; [Brenton, James D.; Whitaker, Hayley C.] Univ Cambridge, Hutchison Med Res Council Res Ctr, Dept Oncol, Cambridge, England; [Brenton, James D.] Cambridge Biomed Res Ctr, Natl Inst Hlth Res, Cambridge, England; [Brenton, James D.] Cambridge Expt Canc Med Ctr, Cambridge, England; [Csizmadi, Ilona] Univ Calgary, Dept Oncol, Calgary, AB, Canada; [Csizmadi, Ilona] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Robson, Paula J.] Alberta Hlth Serv, Edmonton, AB, Canada; [Robson, Paula J.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada	Alberta Health Services (AHS); University of Calgary; University of Calgary; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; University of Cambridge; University of Calgary; University of Calgary; Alberta Health Services (AHS); University of Alberta	Kelemen, LE (corresponding author), Alberta Hlth Serv, Dept Populat Hlth Res, Calgary, AB, Canada.	lkelemen@post.harvard.edu	Robson, Paula J/Q-3351-2017; Brenton, James D/B-3174-2008	Robson, Paula J/0000-0003-4640-1371; Brenton, James D/0000-0002-5738-6683; Csizmadi, Ilona/0000-0002-4895-1310	Canadian Institutes of Health Research [MSH-87734]; Alberta Cancer Foundation; Alberta Cancer Prevention Legacy Fund (Government of Alberta); Canadian Partnership Against Cancer; Cancer Research UK [15601] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Foundation; Alberta Cancer Prevention Legacy Fund (Government of Alberta); Canadian Partnership Against Cancer; Cancer Research UK(Cancer Research UK)	LEK was supported by a Canadian Institutes of Health Research Investigator award MSH-87734. The Tomorrow Project is hosted by Alberta Health Services, and is supported by the Alberta Cancer Foundation, the Alberta Cancer Prevention Legacy Fund (Government of Alberta), and the Canadian Partnership Against Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1982, NUTR REV, V40, P234; Basal E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006292; Bolton JA, 1999, GENE, V230, P215, DOI 10.1016/S0378-1119(99)00081-5; BROWN D, 1992, J AM SOC NEPHROL, V3, P895; Bryant Heather, 2006, Chronic Dis Can, V27, P51; CAMPBELL IG, 1991, CANCER RES, V51, P5329; COLMAN N, 1976, BLOOD, V48, P911; COSTA MD, 1974, J LAB CLIN MED, V83, P207; Csizmadi I, 2007, PUBLIC HEALTH NUTR, V10, P88, DOI 10.1017/S1368980007184287; Elwood PC, 1997, BIOCHEMISTRY-US, V36, P1467, DOI 10.1021/bi962070h; Food and Drug Administration, 1996, FED REGISTER, V61, P8781; Food standards Australia New Zealand, FIN ASS REP PROP P29; He W, 2008, INT J CANCER, V123, P1968, DOI 10.1002/ijc.23717; Healey CS, 2000, CARCINOGENESIS, V21, P189, DOI 10.1093/carcin/21.2.189; Health Canada, 1998, CANADA GAZETTE 2, V132, P3026; HENDERSON GB, 1990, ANNU REV NUTR, V10, P319, DOI [10.1146/annurev.nutr.10.1.319, 10.1146/annurev.nu.10.070190.001535]; Institute of Medicine, 2001, DIET REF INT VIT A V; KANE MA, 1988, J CLIN INVEST, V81, P1398, DOI 10.1172/JCI113469; Kelemen LE, 2005, CANCER EPIDEM BIOMAR, V14, P2168, DOI 10.1158/1055-9965.EPI-05-0260; Kelemen LE, 2006, INT J CANCER, V119, P243, DOI 10.1002/ijc.21712; Kelley KMM, 2003, CANCER RES, V63, P2820; Leamon CP, 2004, ADV DRUG DELIVER REV, V56, P1127, DOI 10.1016/j.addr.2004.01.008; Leung F, 2013, CLIN BIOCHEM, V46, P1462, DOI 10.1016/j.clinbiochem.2013.03.010; Li H, 2010, INT J PHARMACEUT, V402, P57, DOI 10.1016/j.ijpharm.2010.09.019; LUHRS CA, 1992, J CLIN INVEST, V90, P840, DOI 10.1172/JCI115959; LUHRS CA, 1987, P NATL ACAD SCI USA, V84, P6546, DOI 10.1073/pnas.84.18.6546; MARKKANEN T, 1974, INT J VITAM NUTR RES, V44, P81; MATSUE H, 1992, P NATL ACAD SCI USA, V89, P6006, DOI 10.1073/pnas.89.13.6006; Naumann RW, 2013, J CLIN ONCOL, V31, P4400, DOI 10.1200/JCO.2013.49.7685; O'Shannessy DJ, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-29; Radimer K, 2004, AM J EPIDEMIOL, V160, P339, DOI 10.1093/aje/kwh207; ROCHMAN H, 1985, CANCER DETECT PREV, V8, P71; SAIKAWA Y, 1995, BIOCHEMISTRY-US, V34, P9951, DOI 10.1021/bi00031a018; Tran T, 2005, CANCER RES, V65, P4431, DOI 10.1158/0008-5472.CAN-04-2890; van Dam GM, 2011, NAT MED, V17, P1315, DOI 10.1038/nm.2472; Walters CL, 2013, GYNECOL ONCOL, V131, P493, DOI 10.1016/j.ygyno.2013.07.080; WAXMAN S, 1973, BLOOD, V42, P281, DOI 10.1182/blood.V42.2.281.281; Xia W, 2010, J MED CHEM, V53, P6811, DOI 10.1021/jm100509v; Xu Y, 2010, TUMOR BIOL, V31, P589, DOI 10.1007/s13277-010-0074-0	39	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96542	10.1371/journal.pone.0096542	http://dx.doi.org/10.1371/journal.pone.0096542			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810481	Green Published, Green Submitted, gold			2022-12-27	WOS:000338213300051
J	Reyes-Prieto, A; Barquera, B; Juarez, O				Reyes-Prieto, Adrian; Barquera, Blanca; Juarez, Oscar			Origin and Evolution of the Sodium -Pumping NADH: Ubiquinone Oxidoreductase	PLOS ONE			English	Article							NA+-TRANSLOCATING NADH; DESULFOVIBRIO-VULGARIS HILDENBOROUGH; FERREDOXIN NAD(+) OXIDOREDUCTASE; VIRULENCE GENE-EXPRESSION; POTENTIAL COUPLING SITE; VIBRIO-CHOLERAE; NADHQUINONE OXIDOREDUCTASE; QUINONE OXIDOREDUCTASE; BINDING-SITE; RHODOBACTER-CAPSULATUS	The sodium -pumping NADH: ubiquinone oxidoreductase (Na+-NQR) is the main ion pump and the primary entry site for electrons into the respiratory chain of many different types of pathogenic bacteria. This enzymatic complex creates a transmembrane gradient of sodium that is used by the cell to sustain ionic homeostasis, nutrient transport, ATP synthesis, flagellum rotation and other essential processes. Comparative genomics data demonstrate that the nqr operon, which encodes all Na+-NQR subunits, is found in a large variety of bacterial lineages with different habitats and metabolic strategies. Here we studied the distribution, origin and evolution of this enzymatic complex. The molecular phylogenetic analyses and the organizations of the nqr operon indicate that Na+-NQR evolved within the Chlorobi/Bacteroidetes group, after the duplication and subsequent neofunctionalization of the operon that encodes the homolog RNF complex. Subsequently, the nqr operon dispersed through multiple horizontal transfer events to other bacterial lineages such as Chlamydiae, Planctomyces and alpha, beta, gamma and delta -proteobacteria. Considering the biochemical properties of the Na+-NQR complex and its physiological role in different bacteria, we propose a detailed scenario to explain the molecular mechanisms that gave rise to its novel redox-dependent sodium -pumping activity. Our model postulates that the evolution of the Na+-NQR complex involved a functional divergence from its RNF homolog, following the duplication of the rnf operon, the loss of the rnfB gene and the recruitment of the reductase subunit of an aromatic monooxygenase.	[Reyes-Prieto, Adrian] Univ New Brunswick, Canadian Inst Adv Res, Fredericton, NB, Canada; [Reyes-Prieto, Adrian] Univ New Brunswick, Dept Biol, Fredericton, NB, Canada; [Barquera, Blanca; Juarez, Oscar] Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA	Canadian Institute for Advanced Research (CIFAR); University of New Brunswick; University of New Brunswick; Rensselaer Polytechnic Institute	Juarez, O (corresponding author), Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA.	juareo@rpi.edu		Juarez, Oscar/0000-0002-2915-8413	NSF [MCB 1052234]; NSERC [402421-2011 CFI-LOF 28276]; NBIF [RIF2012-006]	NSF(National Science Foundation (NSF)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NBIF	This work was partially supported by NSF Grant MCB 1052234 (OJ and BB), and NSERC Discovery 402421-2011 CFI-LOF 28276 and NBIF RIF2012-006 (ARP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anbar AD, 2008, SCIENCE, V322, P1481, DOI 10.1126/science.1163100; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Backiel J, 2008, BIOCHEMISTRY-US, V47, P11273, DOI 10.1021/bi800920j; Barquera B, 2004, BIOCHEMISTRY-US, V43, P12322, DOI 10.1021/bi048689y; Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; Barquera B, 2003, J AM CHEM SOC, V125, P265, DOI 10.1021/ja0207201; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Bertsova YV, 2004, FEBS LETT, V563, P207, DOI 10.1016/S0014-5793(04)00312-6; Biegel E, 2011, CELL MOL LIFE SCI, V68, P613, DOI 10.1007/s00018-010-0555-8; Biegel E, 2010, P NATL ACAD SCI USA, V107, P18138, DOI 10.1073/pnas.1010318107; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6299, DOI 10.1021/bi900525v; Bogachev AV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P143, DOI 10.1007/s10541-005-0093-4; Breinlinger EC, 1997, J AM CHEM SOC, V119, P1165, DOI 10.1021/ja9612110; Bruggemann H, 2003, P NATL ACAD SCI USA, V100, P1316, DOI 10.1073/pnas.0335853100; Pereira IAC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00069; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Casutt MS, 2011, J BIOL CHEM, V286, P40075, DOI 10.1074/jbc.M111.224980; Casutt MS, 2010, J BIOL CHEM, V285, P27088, DOI 10.1074/jbc.M109.071126; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; COLLINS MD, 1981, MICROBIOL REV, V45, P316, DOI 10.1128/MMBR.45.2.316-354.1981; Cramer WA, 2011, BBA-BIOENERGETICS, V1807, P788, DOI 10.1016/j.bbabio.2011.02.006; Crossman LC, 2013, ISME J, V7, P148, DOI 10.1038/ismej.2012.90; Doolittle R. F., 1986, URFS ORFS PRIMER ANA; Duffy EB, 2006, J BACTERIOL, V188, P8343, DOI 10.1128/JB.01383-06; Frigaard NU, 1997, ARCH MICROBIOL, V167, P343, DOI 10.1007/s002030050453; FUCHS G, 1980, ARCH MICROBIOL, V128, P64, DOI 10.1007/BF00422307; Fuerst JA, 2011, NAT REV MICROBIOL, V9, P403, DOI 10.1038/nrmicro2578; Gifford CM, 2000, NUCLEIC ACIDS RES, V28, P762, DOI 10.1093/nar/28.3.762; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Hase CC, 1999, P NATL ACAD SCI USA, V96, P3183, DOI 10.1073/pnas.96.6.3183; Hase CC, 1998, P NATL ACAD SCI USA, V95, P730, DOI 10.1073/pnas.95.2.730; Hase CC, 2001, MICROBIOL MOL BIOL R, V65, P353, DOI 10.1128/MMBR.65.3.353-370.2001; Hase CC, 2001, BBA-BIOENERGETICS, V1505, P169, DOI 10.1016/S0005-2728(00)00286-3; Hayashi M, 2001, BBA-BIOENERGETICS, V1505, P37, DOI 10.1016/S0005-2728(00)00275-9; Hayashi M, 2001, FEBS LETT, V488, P5, DOI 10.1016/S0014-5793(00)02404-2; Hayashi M, 1996, FEBS LETT, V381, P174, DOI 10.1016/0014-5793(96)00114-7; Hess V, 2013, J BIOL CHEM, V288, P31496, DOI 10.1074/jbc.M113.510255; Hsiao CL, 2013, NAT CHEM, V5, P525, DOI [10.1038/NCHEM.1649, 10.1038/nchem.1649]; Imkamp F, 2007, J BACTERIOL, V189, P8145, DOI 10.1128/JB.01017-07; Jayamani E, 2008, UNIQUE WAY ENERGY CO; Jeong HS, 2000, J BACTERIOL, V182, P1208, DOI 10.1128/JB.182.5.1208-1214.2000; Jouanneau Y, 1998, EUR J BIOCHEM, V251, P54, DOI 10.1046/j.1432-1327.1998.2510054.x; Juarez O, 2008, J BIOL CHEM, V283, P33162, DOI 10.1074/jbc.M806913200; Juarez O, 2012, BBA-BIOENERGETICS, V1817, P1823, DOI 10.1016/j.bbabio.2012.03.017; Juarez O, 2012, J BIOL CHEM, V287, P25678, DOI 10.1074/jbc.M112.366088; Juarez O, 2011, J BIOL CHEM, V286, P26383, DOI 10.1074/jbc.M111.257873; Juarez O, 2010, P NATL ACAD SCI USA, V107, P12505, DOI 10.1073/pnas.1002866107; Juarez O, 2009, BIOCHEMISTRY-US, V48, P9516, DOI 10.1021/bi900845y; Juarez O, 2009, J BIOL CHEM, V284, P8963, DOI 10.1074/jbc.M809395200; Kalman S, 1999, NAT GENET, V21, P385, DOI 10.1038/7716; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KERGER BD, 1988, ARCH MICROBIOL, V149, P255, DOI 10.1007/BF00422014; Kim YC, 2007, P NATL ACAD SCI USA, V104, P2169, DOI 10.1073/pnas.0611114104; Kjaer B, 1998, BIOCHEMISTRY-US, V37, P3237, DOI 10.1021/bi973121t; Koehl P, 2002, J MOL BIOL, V323, P551, DOI 10.1016/S0022-2836(02)00971-3; Kopke M, 2010, P NATL ACAD SCI USA, V107, P13087, DOI 10.1073/pnas.1004716107; Koo MS, 2003, EMBO J, V22, P2614, DOI 10.1093/emboj/cdg252; Kumagai H, 1997, BIOCHEMISTRY-US, V36, P5509, DOI 10.1021/bi970014q; Lambden PR, 2006, MICROBIOL-SGM, V152, P2573, DOI 10.1099/mic.0.29032-0; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Liu SS, 2010, ANN NY ACAD SCI, V1201, P84, DOI 10.1111/j.1749-6632.2010.05632.x; MACY JM, 1979, ANNU REV MICROBIOL, V33, P561, DOI 10.1146/annurev.mi.33.100179.003021; McClarty G, 1999, CHLAMYDIA, P69; MOULDER JW, 1993, INFECT AGENT DIS, V2, P87; Muller V, 2008, ANN NY ACAD SCI, V1125, P137, DOI 10.1196/annals.1419.011; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nakajo K, 2006, ORAL MICROBIOL IMMUN, V21, P283, DOI 10.1111/j.1399-302X.2006.00289.x; Nedielkov R, 2013, J BIOL CHEM, V288, P30597, DOI 10.1074/jbc.M112.435750; Neehaubl Y, 2013, BIOCHEMISTRY-US, V52, P3085, DOI 10.1021/bi4000386; Neehaul Y, 2012, BIOCHEMISTRY-US, V51, P4072, DOI 10.1021/bi300343u; Pessione E, 1999, EUR J BIOCHEM, V265, P549, DOI 10.1046/j.1432-1327.1999.00720.x; Quinn MJ, 2012, MICROBIOL-SGM, V158, P1094, DOI 10.1099/mic.0.056119-0; RICH PR, 1995, FEBS LETT, V375, P5, DOI 10.1016/0014-5793(95)01164-A; Rohlin L, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-62; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; SCHAUDER R, 1987, ARCH MICROBIOL, V148, P218, DOI 10.1007/BF00414815; Schlegel K, 2012, FEBS J, V279, P4444, DOI 10.1111/febs.12031; SCHMEHL M, 1993, MOL GEN GENET, V241, P602, DOI 10.1007/BF00279903; Seedorf H, 2008, P NATL ACAD SCI USA, V105, P2128, DOI 10.1073/pnas.0711093105; Shea ME, 2013, J BIOL CHEM, V288, P31241, DOI 10.1074/jbc.M113.510776; SKULACHEV VP, 1989, J BIOENERG BIOMEMBR, V21, P635, DOI 10.1007/BF00762683; Sorokin DY, 2008, EXTREMOPHILES, V12, P431, DOI 10.1007/s00792-008-0148-8; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Strittmatter AW, 2009, ENVIRON MICROBIOL, V11, P1038, DOI 10.1111/j.1462-2920.2008.01825.x; VARADARAJAN R, 1989, SCIENCE, V243, P69, DOI 10.1126/science.2563171; Verkhovsky MI, 2010, BBA-BIOENERGETICS, V1797, P738, DOI 10.1016/j.bbabio.2009.12.020; WEISBURG WG, 1986, J BACTERIOL, V167, P570, DOI 10.1128/jb.167.2.570-574.1986; Wikstrom M, 2006, BBA-BIOENERGETICS, V1757, P1047, DOI 10.1016/j.bbabio.2006.01.010; Williams KP, 2010, J BACTERIOL, V192, P2305, DOI 10.1128/JB.01480-09; Wunsch P, 2005, J BACTERIOL, V187, P1992, DOI 10.1128/JB.187.6.1992-2001.2005; Xu Q, 2003, P NATL ACAD SCI USA, V100, P1286, DOI 10.1073/pnas.0337479100; YAGI T, 1991, J BIOENERG BIOMEMBR, V23, P211, DOI 10.1007/BF00762218; Zhou WD, 1999, BIOCHEMISTRY-US, V38, P16246, DOI 10.1021/bi991664s; Zhou ZM, 1996, BIOCHEMISTRY-US, V35, P15980, DOI 10.1021/bi962124n; Zhou ZM, 1996, BIOCHEMISTRY-US, V35, P12443, DOI 10.1021/bi9610865	98	59	61	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96696	10.1371/journal.pone.0096696	http://dx.doi.org/10.1371/journal.pone.0096696			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809444	Green Submitted, gold, Green Published			2022-12-27	WOS:000338213300062
J	Schillinger, K; Mesoudi, A; Lycett, SJ				Schillinger, Kerstin; Mesoudi, Alex; Lycett, Stephen J.			Considering the Role of Time Budgets on Copy-Error Rates in Material Culture Traditions: An Experimental Assessment	PLOS ONE			English	Article							SEX-DIFFERENCES; TRANSMISSION; EVOLUTION; TECHNOLOGY; PERSPECTIVE; HANDEDNESS; SYMMETRY; BASKETRY; ORIGIN; SHAPE	Ethnographic research highlights that there are constraints placed on the time available to produce cultural artefacts in differing circumstances. Given that copying error, or cultural 'mutation', can have important implications for the evolutionary processes involved in material culture change, it is essential to explore empirically how such 'time constraints' affect patterns of artefactual variation. Here, we report an experiment that systematically tests whether, and how, varying time constraints affect shape copying error rates. A total of 90 participants copied the shape of a 3D 'target handaxe form' using a standardized foam block and a plastic knife. Three distinct 'time conditions' were examined, whereupon participants had either 20, 15, or 10 minutes to complete the task. One aim of this study was to determine whether reducing production time produced a proportional increase in copy error rates across all conditions, or whether the concept of a task specific 'threshold' might be a more appropriate manner to model the effect of time budgets on copy-error rates. We found that mean levels of shape copying error increased when production time was reduced. However, there were no statistically significant differences between the 20 minute and 15 minute conditions. Significant differences were only obtained between conditions when production time was reduced to 10 minutes. Hence, our results more strongly support the hypothesis that the effects of time constraints on copying error are best modelled according to a 'threshold' effect, below which mutation rates increase more markedly. Our results also suggest that 'time budgets' available in the past will have generated varying patterns of shape variation, potentially affecting spatial and temporal trends seen in the archaeological record. Hence, 'time-budgeting' factors need to be given greater consideration in evolutionary models of material culture change.	[Schillinger, Kerstin; Lycett, Stephen J.] Univ Kent, Dept Anthropol, Canterbury, Kent, England; [Mesoudi, Alex] Univ Durham, Dept Anthropol, Durham, England; [Mesoudi, Alex] Univ Durham, Ctr Coevolut Biol & Culture, Durham, England	University of Kent; Durham University; Durham University	Schillinger, K (corresponding author), Univ Kent, Dept Anthropol, Canterbury, Kent, England.	kerstin.schillinger@gmail.com	Mesoudi, Alex/K-4410-2012	Mesoudi, Alex/0000-0002-7740-1625	Leverhulme Trust [F/07 476/AR]	Leverhulme Trust(Leverhulme Trust)	This work was funded by the Leverhulme Trust (Research Project Grant F/07 476/AR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, PROJECTILE TECHNOLOG; Arnold P.J., 1991, LATIN AM ANTI, V2, P363, DOI DOI 10.2307/971784; Ashburner M., 2004, DROSOPHILA LAB HDB; Bentley RA, 2004, P ROY SOC B-BIOL SCI, V271, P1443, DOI 10.1098/rspb.2004.2746; Bettinger RL, 2006, J ARCHAEOL SCI, V33, P538, DOI 10.1016/j.jas.2005.09.009; Bettinger RL, 1999, AM ANTIQUITY, V64, P231, DOI 10.2307/2694276; Beyene Y, 2013, P NATL ACAD SCI USA, V110, P1584, DOI 10.1073/pnas.1221285110; BINFORD LR, 1979, J ANTHROPOL RES, V35, P255, DOI 10.1086/jar.35.3.3629902; BINFORD LR, 1978, AM ANTIQUITY, V43, P330, DOI 10.2307/279390; Buchanan B, 2010, NEW PERSPECTIVES ON OLD STONES: ANALYTICAL APPROACHES TO PALEOLITHIC TECHNOLOGIES, P255, DOI 10.1007/978-1-4419-6861-6_11; Callow P, 1976, THESIS U CAMBRIDGE C; Clark J. D., 1994, INTEGRATIVE PATHS PA, P451; Clarke D.L., 1968, ANAL ARCHAEOLOGY; CORBALLIS MC, 1989, PSYCHOL REV, V96, P492, DOI 10.1037/0033-295X.96.3.492; Costa AG, 2010, NEW PERSPECTIVES ON OLD STONES: ANALYTICAL APPROACHES TO PALEOLITHIC TECHNOLOGIES, P23, DOI 10.1007/978-1-4419-6861-6_2; Deetz James, 1967, INVITATION ARCHAEOLO; Dytham C, 2003, CHOOSING USING STAT; Edwards SW, 2001, KALAMBO FALLS PREHIS, VIII, P605; Eerkens JW, 2000, CURR ANTHROPOL, V41, P663, DOI 10.1086/317394; Eerkens JW, 2005, J ANTHROPOL ARCHAEOL, V24, P316, DOI 10.1016/j.jaa.2005.08.001; Eerkens JW, 2001, AM ANTIQUITY, V66, P493, DOI 10.2307/2694247; FALSETTI AB, 1993, INT J PRIMATOL, V14, P551, DOI 10.1007/BF02215447; Gowlett J.A.J., 2006, AXE AGE ACHEULIAN TO, P203; Gowlett JAJ, 2011, CASTING NET WIDE PAP, P93; Greenspan R.J., 2004, FLY PUSHING THEORY P; Halpern D., 2013, SEX DIFFERENCES COGN, V4th; Hamilton MJ, 2009, J ANTHROPOL ARCHAEOL, V28, P55, DOI 10.1016/j.jaa.2008.10.005; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Holm DG, 1976, GENET BIOL DROSOPHIL, P529; Jordan P, 2003, J ANTHROPOL ARCHAEOL, V22, P42, DOI 10.1016/S0278-4165(03)00004-7; Jungers WL, 1995, YEARB PHYS ANTHROPOL, V38, P137; Kempe M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048333; Layton R, 2010, J CULTURAL SCI, V3, P1; Lepre CJ, 2011, NATURE, V477, P82, DOI 10.1038/nature10372; Linn MC, 1986, PSYCHOL GENDER ADV M, P67; Lycett SJ, 2006, J ARCHAEOL SCI, V33, P847, DOI 10.1016/j.jas.2005.10.014; Lycett SJ, 2011, J EVOLUTIONARY PSYCH, V9, P143, DOI [DOI 10.1016/J.JAA.2007.07.003, DOI 10.1556/JEP.9.2011.23.1]; Lycett SJ, 2014, J ARCHAEOLOGICAL MET; Lycett SJ, 2008, WORLD ARCHAEOL, V40, P295, DOI 10.1080/00438240802260970; Lycett SJ, 2008, J ARCHAEOL SCI, V35, P2640, DOI 10.1016/j.jas.2008.05.002; Lycett SJ, 2010, NEW PERSPECTIVES ON OLD STONES: ANALYTICAL APPROACHES TO PALEOLITHIC TECHNOLOGIES, P207, DOI 10.1007/978-1-4419-6861-6_9; Lyman RL, 2008, J ARCHAEOL SCI, V35, P2805, DOI 10.1016/j.jas.2008.05.008; Mesoudi A, 2004, EVOLUTION, V58, P1; Mesoudi A., 2011, CULTURAL EVOLUTION D; Mesoudi A, 2008, AM ANTIQUITY, V73, P3, DOI 10.2307/25470456; NEIMAN FD, 1995, AM ANTIQUITY, V60, P7, DOI 10.2307/282074; NEWCOMER MH, 1971, WORLD ARCHAEOL, V3, P85, DOI 10.1080/00438243.1971.9979493; O'Neale LM, 1947, AM ANTIQUITY, V12, P239, DOI 10.2307/275053; OBrien M, 2010, INNOVATION CULTURAL; OBRIEN MJ, 2003, STYLE FUNCTION TRANS, P1; OBrien MJ, 2000, APPL EVOLUTIONARY AR; Orton C., 1993, POTTERY ARCHAEOLOGY; Puri R. K., 2013, UNDERSTANDING CULTUR, P266; Randall-MacIver D, 1905, J R ANTHROPOL INST G, V35, P20, DOI 10.2307/2843113; Rasic R., 2001, LITHIC DEBITAGE CONT, P61; Raymond M, 1996, P ROY SOC B-BIOL SCI, V263, P1627, DOI 10.1098/rspb.1996.0238; Ridley M., 2004, EVOLUTION; Robert M, 2003, MEM COGNITION, V31, P1136, DOI 10.3758/BF03196134; Roche H, 2005, STONE KNAPPING NECES, P35; Rogers DS, 2009, P ROY SOC B-BIOL SCI, V276, P3835, DOI 10.1098/rspb.2009.1088; Rohlf F.R., 2010, TPSDIG2 V2 16; Schick K. D., 1993, MAKING SILENT STONES; Schillinger K, 2014, AM ANTIQUITY, V79, P128, DOI 10.7183/0002-7316.79.1.128; Shennan SJ, 2001, AM ANTIQUITY, V66, P577, DOI 10.2307/2694174; Shennan S, 2011, PHILOS T R SOC B, V366, P1070, DOI 10.1098/rstb.2010.0380; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; SMITH FT, 1978, AFR ARTS, V12, P78, DOI 10.2307/3335387; Sokal R.R., 2012, BIOMETRY; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Torrence Robin., 1983, HUNTER GATHERER EC P, P11, DOI DOI 10.1073/PNAS.0913047107; TOTH N, 1985, J HUM EVOL, V14, P607, DOI 10.1016/S0047-2484(85)80087-7; Ugan A, 2003, J ARCHAEOL SCI, V30, P1315, DOI 10.1016/S0305-4403(03)00022-0; VOYER D, 1995, PSYCHOL BULL, V117, P250, DOI 10.1037/0033-2909.117.2.250; Weltfish G, 1932, AM ANTHROPOL, V34, P108, DOI 10.1525/aa.1932.34.1.02a00070; Whittaker J.C., 1994, FLINTKNAPPING MAKING; Winter-Livneh R, 2013, J ARCHAEOL SCI, V40, P1340, DOI 10.1016/j.jas.2012.10.007; Wynn TG, 1996, YEARB PHYS ANTHROPOL, V39, P11	77	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e97157	10.1371/journal.pone.0097157	http://dx.doi.org/10.1371/journal.pone.0097157			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK1XT	24809848	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000338213300127
J	du Toit, E; van Schalkwyk, C; Dunbar, R; Jennings, K; Yang, B; Coetzee, D; Beyers, N				du Toit, Elizabeth; van Schalkwyk, Cari; Dunbar, Rory; Jennings, Karen; Yang, Blia; Coetzee, David; Beyers, Nulda			Missed Opportunities for Retention in Pre-ART Care in Cape Town, South Africa	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; HIV DIAGNOSIS; FOLLOW-UP; MORTALITY; OUTCOMES; SERVICE; TB	Background: Few studies have evaluated access to and retention in pre-ART care. Objectives: To evaluate the proportion of People Living With HIV (PLWH) in pre-ART and ART care and factors associated with retention in pre-ART and ART care from a community cohort. Methods: A cross sectional survey was conducted from February - April 2011. Self reported HIV positive, negative or participants of unknown status completed a questionnaire on their HIV testing history, access to pre-ART and retention in pre-ART and ART care. Results: 872 randomly selected adults who reported being HIV positive in the ZAMSTAR 2010 prevalence survey were included and revisited. 579 (66%) reconfirmed their positive status and were included in this analysis. 380 (66%) had initiated ART with 357 of these (94%) retained in ART care. 199 (34%) had never initiated ART of whom 186 (93%) accessed pre-ART care, and 86 (43%) were retained in pre-ART care. In a univariable analysis none of the factors analysed were significantly associated with retention in care in the pre-ART group. Due to the high retention in ART care, factors associated with retention in ART care, were not analysed further. Conclusion: Retention in ART care was high; however it was low in pre-ART care. The opportunity exists, if care is better integrated, to engage with clients in primary health care facilities to bring them back to, and retain them in, pre-ART care.	[du Toit, Elizabeth; Dunbar, Rory; Yang, Blia; Beyers, Nulda] Univ Stellenbosch, Dept Paediat & Child Hlth, Desmond Tutu TB Ctr, Parow, South Africa; [van Schalkwyk, Cari] Univ Stellenbosch, Natl Res Fdn, Ctr Excellence Epidemiol Modelling & Anal SACEMA, South African Dept Sci & Technol, ZA-7600 Stellenbosch, South Africa; [Jennings, Karen] City Cape Town Hlth Directorate, Cape Town, South Africa; [Coetzee, David] Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa	Stellenbosch University; National Research Foundation - South Africa; Stellenbosch University; University of Cape Town	du Toit, E (corresponding author), Univ Stellenbosch, Dept Paediat & Child Hlth, Desmond Tutu TB Ctr, Parow, South Africa.	elizabethd@sun.ac.za		van Schalkwyk, Cari/0000-0001-5154-1390	United States Agency for International Development (USAID) Cooperative Agreement [GHN-A-00-08-00004-00]	United States Agency for International Development (USAID) Cooperative Agreement(United States Agency for International Development (USAID))	This research was supported by a United States Agency for International Development (USAID) Cooperative Agreement (TREAT TB - Agreement No. GHN-A-00-08-00004-00). The contents are the responsibility of the author(s) and do not necessarily reflect the views of USAID. Funders URL:www.usaid.gov/south-africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actuarial Society of South Africa, 2011, ASSA 2008 AIDS DEM M; Amuron B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-290; Ayles H, 2013, LANCET; Ayles HM, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-63; Brinkhof MW, B WHO; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; FORD N, 2006, SOUTH AFR J HIV  DEC, P17; Fried J, 2012, SEX TRANSM INFECT, V88, P147, DOI 10.1136/sextrans-2011-050140; IeDEA and ART Cohort Collaborations, 2014, J Acquir Immune Defic Syndr, V65, pe8, DOI 10.1097/QAI.0b013e3182a39979; Ingle SM, 2010, SAMJ S AFR MED J, V100, P675, DOI 10.7196/SAMJ.3952; Jarvis JN, 2010, AIDS, V24, P1233, DOI 10.1097/QAD.0b013e3283383aeb; Kranzer K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013801; Larson BA, 2010, TROP MED INT HEALTH, V15, P43, DOI 10.1111/j.1365-3156.2010.02511.x; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lessells RJ, 2011, J ACQ IMMUN DEF SYND, V56, P1, DOI 10.1097/QAI.0b013e3182075ae2; Losina E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009538; Loveday M, 2011, TROP MED INT HEALTH, V16, P431, DOI 10.1111/j.1365-3156.2010.02721.x; Marston Barbara J, 2007, J Int Assoc Physicians AIDS Care (Chic), V6, P106, DOI 10.1177/1545109707300688; Pepper DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019484; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Scott V, 2011, TROP MED INT HEALTH, V16, P1384, DOI 10.1111/j.1365-3156.2011.02842.x; South Africa National Department of Health, 2010, CLIN GUID MAN HIV AI; South African National Department of Health, 2013, NAT STRAT PLAN HIV S; South African National Department of Health, 2013, S AFR ANT TREATM GUI	24	6	6	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96867	10.1371/journal.pone.0096867	http://dx.doi.org/10.1371/journal.pone.0096867			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806474	Green Published, gold			2022-12-27	WOS:000335728900108
J	Scholmerich, VLN; Erdem, O; Borsboom, G; Ghorashi, H; Groenewegen, P; Steegers, EAP; Kawachi, I; Denktas, S				Schoelmerich, Vera L. N.; Erdem, Ozcan; Borsboom, Gerard; Ghorashi, Halleh; Groenewegen, Peter; Steegers, Eric A. P.; Kawachi, Ichiro; Denktas, Semiha			The Association of Neighborhood Social Capital and Ethnic (Minority) Density with Pregnancy Outcomes in the Netherlands	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; FETAL-GROWTH RESTRICTION; PRETERM BIRTH; PUBLIC-HEALTH; VIOLENT CRIME; DEPRIVATION; POPULATION; CONSEQUENCES; INEQUALITIES; DISPARITIES	Background: Perinatal morbidity rates are relatively high in the Netherlands, and significant inequalities in perinatal morbidity and mortality can be found across neighborhoods. In socioeconomically deprived areas, 'Western' women are particularly at risk for adverse birth outcomes. Almost all studies to date have explained the disparities in terms of individual determinants of birth outcomes. This study examines the influence of neighborhood contextual characteristics on birth weight (adjusted for gestational age) and preterm birth. We focused on the influence of neighborhood social capital measured as informal socializing and social connections between neighbors -as well as ethnic (minority) density. Methods: Data on birth weight and prematurity were obtained from the Perinatal Registration Netherlands 2000-2008 dataset, containing 97% of all pregnancies. Neighborhood-level measurements were obtained from three different sources, comprising both survey and registration data. We included 3.422 neighborhoods and 1.527.565 pregnancies for the birth weight analysis and 1.549.285 pregnancies for the premature birth analysis. Linear and logistic multilevel regression was performed to assess the associations of individual and neighborhood level variables with birth weight and preterm birth. Results: We found modest but significant neighborhood effects on birth weight and preterm births. The effect of ethnic (minority) density was stronger than that of neighborhood social capital. Moreover, ethnic (minority) density was associated with higher birth weight for infants of non-Western ethnic minority women compared to Western women (15 grams; 95% CI: 12,4/17,5) as well as reduced risk for prematurity (OR 0.97; CI 0,95/0,99). Conclusions: Our results indicate that neighborhood contexts are associated with birth weight and preterm birth in the Netherlands. Moreover, ethnic (minority) density seems to be a protective factor for non-Western ethnic minority women, but not for Western women. This helps explain the increased risk of Western women in deprived neighborhoods for adverse birth outcomes found in previous studies.	[Schoelmerich, Vera L. N.; Steegers, Eric A. P.; Denktas, Semiha] Erasmus Univ, Med Ctr, Dept Obstet & Gynecol, Div Obstet & Prenatal Med, Rotterdam, Netherlands; [Schoelmerich, Vera L. N.; Groenewegen, Peter] Vrije Univ Amsterdam, Dept Org Sci, Amsterdam, Netherlands; [Schoelmerich, Vera L. N.; Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Erdem, Ozcan] Municipal Rotterdam, Res & Business Intelligence, Rotterdam, Netherlands; [Erdem, Ozcan; Borsboom, Gerard] Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Ghorashi, Halleh] Vrije Univ Amsterdam, Dept Sociol, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; Harvard University; Harvard T.H. Chan School of Public Health; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam	Scholmerich, VLN (corresponding author), Erasmus Univ, Med Ctr, Dept Obstet & Gynecol, Div Obstet & Prenatal Med, Rotterdam, Netherlands.	vera.schoelmerich@cantab.net	Denktas, Semiha/AAE-2349-2021; Groenewegen, Peter/O-1539-2019; Groenewegen, Peter/B-1959-2012	Denktas, Semiha/0000-0003-1617-2379; Groenewegen, Peter/0000-0003-4006-1601; Groenewegen, Peter/0000-0003-4006-1601; Ghorashi, Halleh/0000-0003-0157-7525				Agyemang C, 2009, J EPIDEMIOL COMMUN H, V63, P755, DOI 10.1136/jech.2008.080408; Auger N, 2008, PAEDIATR PERINAT EP, V22, P467, DOI 10.1111/j.1365-3016.2008.00959.x; Barker DJP, 2006, CLIN OBSTET GYNECOL, V49, P270, DOI 10.1097/00003081-200606000-00009; Berkman LF, 2000, SOCIAL EPIDEMIOLOGY, V2000, P174; Buka SL, 2003, AM J EPIDEMIOL, V157, P1, DOI 10.1093/aje/kwf170; Coleman J., 1994, FDN SOCIAL THEORY; Collins James W. Jr., 1997, Ethnicity and Disease, V7, P184; de Graaf JP, 2010, BJOG-INT J OBSTET GY, V117, P1098, DOI 10.1111/j.1471-0528.2010.02611.x; de Graaf JP, 2013, CURR OPIN OBSTET GYN, V25, P98, DOI 10.1097/GCO.0b013e32835ec9b0; de Graaf JP, 2012, J MATERN-FETAL NEO M, P1; Dole N, 2003, AM J EPIDEMIOL, V157, P14, DOI 10.1093/aje/kwf176; Euro-Peristat, 2013, EUR PER HLTH REP HLT; Goedhart G, 2008, BJOG-INT J OBSTET GY, V115, P710, DOI 10.1111/j.1471-0528.2008.01682.x; Grady SC, 2006, SOC SCI MED, V63, P3013, DOI 10.1016/j.socscimed.2006.08.017; Harpham T, 2002, HEALTH POLICY PLANN, V17, P106, DOI 10.1093/heapol/17.1.106; Hox JJ, 2010, MULTILEVEL ANAL TECH, V2nd; Jaddoe VWV, 2008, PAEDIATR PERINAT EP, V22, P162, DOI 10.1111/j.1365-3016.2007.00916.x; Kawachi I, 2010, HDB MED SOCIOLOGY, V2010, P18; Kramer MS, 2000, PAEDIATR PERINAT EP, V14, P194, DOI 10.1046/j.1365-3016.2000.00266.x; Lin N., 2002, SOCIAL CAPITAL THEOR, V19; Lochner KA, 2003, SOC SCI MED, V56, P1797, DOI 10.1016/S0277-9536(02)00177-6; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; Masi CM, 2007, SOC SCI MED, V65, P2440, DOI 10.1016/j.socscimed.2007.07.014; McKenzie K, 2002, BRIT J PSYCHIAT, V181, P280, DOI 10.1192/bjp.181.4.280; Messer LC, 2008, SOC SCI MED, V67, P1247, DOI 10.1016/j.socscimed.2008.06.009; Mohnen SM, 2011, SOC SCI MED, V72, P660, DOI 10.1016/j.socscimed.2010.12.004; Mook-Kanamori DO, 2010, JAMA-J AM MED ASSOC, V303, P527, DOI 10.1001/jama.2010.78; Moore S, 2006, J EPIDEMIOL COMMUN H, V60, P729, DOI 10.1136/jech.2005.041848; Morenoff JD, 2003, AM J SOCIOL, V108, P976, DOI 10.1086/374405; Moster D, 2008, NEW ENGL J MED, V359, P262, DOI 10.1056/NEJMoa0706475; Mujahid MS, 2007, AM J EPIDEMIOL, V165, P858, DOI 10.1093/aje/kwm040; O'Campo P, 2008, AM J EPIDEMIOL, V167, P155, DOI 10.1093/aje/kwm277; Pearl M, 2001, J INFORM, V91; Pickett KE, 2008, ETHNIC HEALTH, V13, P321, DOI 10.1080/13557850701882928; Pickett KE, 2002, ANN EPIDEMIOL, V12, P410, DOI 10.1016/S1047-2797(01)00249-6; Poeran J, 2013, SOCIAL SCI MED; Poeran J, 2011, J MATERN-FETAL NEO M, V24, P643, DOI 10.3109/14767058.2010.511341; Poortinga W, 2006, SOC SCI MED, V63, P255, DOI 10.1016/j.socscimed.2005.11.039; Proctor A, 2011, SOC SCI MED, V72, P1838, DOI 10.1016/j.socscimed.2011.03.043; Putnam R., 1993, AM PROSPECT, V13, P35, DOI DOI 10.1287/mnsc.1120.1644; Raudenbush SW, 1999, SOCIOL METHODOL, V29, P1, DOI 10.1111/0081-1750.00059; Reitsma J B, 2003, Ned Tijdschr Geneeskd, V147, P2286; Roberts EM, 1997, AM J PUBLIC HEALTH, V87, P597, DOI 10.2105/AJPH.87.4.597; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Snijders T., 1999, MULTILEVEL MODELING; Szreter S, 2004, INT J EPIDEMIOL, V33, P650, DOI 10.1093/ije/dyh013; van Hooijdonk C, 2008, INT J EPIDEMIOL, V37, P1384, DOI 10.1093/ije/dyn181; Van Huijsduijnen JH, 2007, WOON 2006 ONDERZOEKS; van Lenthe FJ, 2002, INT J OBESITY, V26, P234, DOI 10.1038/sj.ijo.0801841	49	17	17	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e95873	10.1371/journal.pone.0095873	http://dx.doi.org/10.1371/journal.pone.0095873			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG9HB	24806505	Green Published, gold, Green Submitted			2022-12-27	WOS:000335728900026
J	Voglmayr, H; Montes-Borrego, M; Landa, BB				Voglmayr, Hermann; Montes-Borrego, Miguel; Landa, Blanca B.			Disentangling Peronospora on Papaver: Phylogenetics, Taxonomy, Nomenclature and Host Range of Downy Mildew of Opium Poppy (Papaver somniferum) and Related Species	PLOS ONE			English	Article							RIBOSOMAL DNA; HERBARIUM SPECIMENS; ARBORESCENS; PATHOGENS; FUNGI	Based on sequence data from ITS rDNA, cox1 and cox2, six Peronospora species are recognised as phylogenetically distinct on various Papaver species. The host ranges of the four already described species P. arborescens, P. argemones, P. cristata and P. meconopsidis are clarified. Based on sequence data and morphology, two new species, P. apula and P. somniferi, are described from Papaver apulum and P. somniferum, respectively. The second Peronospora species parasitizing Papaver somniferum, that was only recently recorded as Peronospora cristata from Tasmania, is shown to represent a distinct taxon, P. meconopsidis, originally described from Meconopsis cambrica. It is shown that P. meconopsidis on Papaver somniferum is also present and widespread in Europe and Asia, but has been overlooked due to confusion with P. somniferi and due to less prominent, localized disease symptoms. Oospores are reported for the first time for P. meconopsidis from Asian collections on Papaver somniferum. Morphological descriptions, illustrations and a key are provided for all described Peronospora species on Papaver. cox1 and cox2 sequence data are confirmed as equally good barcoding loci for reliable Peronospora species identification, whereas ITS rDNA does sometimes not resolve species boundaries. Molecular phylogenetic data reveal high host specificity of Peronospora on Papaver, which has the important phytopathological implication that wild Papaver spp. cannot play any role as primary inoculum source for downy mildew epidemics in cultivated opium poppy crops.	[Voglmayr, Hermann] Univ Vienna, Dept Bot & Biodivers Res, Div Systemat & Evolutionary Bot, Vienna, Austria; [Voglmayr, Hermann] BOKU Univ Nat Resources & Life Sci, Dept Forest & Soil Sci, Inst Forest Entomol Forest Pathol & Forest Protec, Vienna, Austria; [Montes-Borrego, Miguel; Landa, Blanca B.] CSIC, Inst Sustainable Agr IAS, Dept Crop Protect, Cordoba, Spain	University of Vienna; University of Natural Resources & Life Sciences, Vienna; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS)	Voglmayr, H (corresponding author), Univ Vienna, Dept Bot & Biodivers Res, Div Systemat & Evolutionary Bot, Vienna, Austria.	hermann.voglmayr@univie.ac.at	Landa, Blanca B/K-9629-2014; Voglmayr, Hermann/B-1484-2013; Montes Borrego, Miguel/K-9585-2014	Landa, Blanca B/0000-0002-9511-3731; Voglmayr, Hermann/0000-0001-7666-993X; Montes Borrego, Miguel/0000-0001-6346-2788	Austrian Science Fund (FWF) [P22739-B20]; Incentivos a Proyectos de Excelencia, CICE-Junta de Andalucia [P10-AGR-6497]; FEDER (EU); Austrian Science Fund (FWF) [P 22739] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Incentivos a Proyectos de Excelencia, CICE-Junta de Andalucia; FEDER (EU)(European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Financial support by the Austrian Science Fund (FWF, project P22739-B20, http://www.fwf.ac.at/) to HV and by Incentivos a Proyectos de Excelencia (P10-AGR-6497), CICE-Junta de Andalucia and FEDER (EU) to MMB is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCOCK N. L., 1933, NEW FLORA AND SILVA, V5, P279; Behr L, 1956, J PHYTOPATHOL, V27, P289; Berkeley M.J., 1846, J HORTICULT SOC LOND, V1, P9; Bonants P, 1997, EUR J PLANT PATHOL, V103, P345, DOI 10.1023/A:1008640227432; Carolan JC, 2006, ANN BOT-LONDON, V98, P141, DOI 10.1093/aob/mcl079; Choi YJ, 2007, MYCOL RES, V111, P381, DOI 10.1016/j.mycres.2007.02.003; Choi YJ, 2011, MYCOPATHOLOGIA, V171, P151, DOI 10.1007/s11046-010-9340-3; Choi YJ, 2011, FUNGAL BIOL-UK, V115, P102, DOI 10.1016/j.funbio.2010.10.010; Choi YJ, 2009, MYCOL RES, V113, P1340, DOI 10.1016/j.mycres.2009.08.010; Constantinescu O., 1991, THUNBERGIA, V15, P1; Cotterill PJ, 1998, AUSTRALAS PLANT PATH, V27, P263, DOI 10.1071/AP98030; COTTON A. D., 1929, GARD CHRON [LONDON], V85, P143; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FRANCIS SM, 1981, CMI DESCRIPTIONS PAT, V686, P1; Garcia-Blazquez G, 2008, MYCOL RES, V112, P502, DOI 10.1016/j.mycres.2007.10.007; GAUMANN E, 1923, BEITR KRYPTOGAMENFL, V5, P1; Goker M, 2007, FUNGAL GENET BIOL, V44, P105, DOI 10.1016/j.fgb.2006.07.005; Goker M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006319; Goker M., 2004, Mycological Progress, V3, P83, DOI 10.1007/s11557-006-0079-7; GUSTAVSSON A, 1991, AN JARDIN BOT MADRID, V49, P3; Gustavsson A., 1959, OPERA BOT, V3, P1; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hudspeth DSS, 2000, MYCOLOGIA, V92, P674, DOI 10.2307/3761425; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kapoor L, 1995, OPIUM POPPY BOT CHEM; Kochman J, 1970, GRZYBY MYCOTA; Landa BB, 2005, PLANT DIS, V89, P338, DOI 10.1094/PD-89-0338B; Landa BB, 2007, PHYTOPATHOLOGY, V97, P1380, DOI 10.1094/PHYTO-97-11-1380; Maiti S., 1986, Indian Journal of Mycological Research, V24, P21; MAYOR E., 1949, BER SCHWEIZ BOT GES, V59, P268; Mayor E, 1958, MEMOIRES SOC NEUCHAT, V9, P1; MONCALVO JM, 1995, MYCOLOGIA, V87, P223, DOI 10.2307/3760908; Montes-Borrego M, 2008, PLANT DIS, V92, P834, DOI 10.1094/PDIS-92-5-0834B; Montes-Borrego M, 2009, PLANT PATHOL, V58, P1092, DOI 10.1111/j.1365-3059.2009.02141.x; Montes-Borrego M, 2009, PHYTOPATHOLOGY, V99, P73, DOI 10.1094/PHYTO-99-1-0073; MUSKETT AE, 1984, P ROY IRISH ACAD B, V84, P83; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; REID DA, 1969, T BRIT MYCOL SOC, V52, P19, DOI 10.1016/S0007-1536(69)80156-7; Riethmuller A, 2002, MYCOLOGIA, V94, P834, DOI 10.2307/3761698; Robideau GP, 2011, MOL ECOL RESOUR, V11, P1002, DOI 10.1111/j.1755-0998.2011.03041.x; Rouxel M, 2013, NEW PHYTOL, V197, P251, DOI 10.1111/nph.12016; Runge F, 2011, EUR J PLANT PATHOL, V129, P135, DOI 10.1007/s10658-010-9714-x; SAVULESCU TR, 1948, SVDOWIA, V2, P255; Schroder S, 2011, ORG DIVERS EVOL, V11, P3, DOI 10.1007/s13127-010-0035-x; Scott JB, 2004, MYCOL RES, V108, P198, DOI 10.1017/S095375620300916X; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Telle S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003584; Thiers B., 2022, INDEX HERBARIORUM GL; Thines M, 2013, MYCOL PROG, V12, P321, DOI 10.1007/s11557-012-0837-7; Thines M, 2011, MYCOL PROG, V10, P415, DOI 10.1007/s11557-010-0712-3; Thines M, 2010, EUR J PLANT PATHOL, V128, P81, DOI 10.1007/s10658-010-9632-y; Thines M, 2009, MYCOL RES, V113, P532, DOI 10.1016/j.mycres.2008.12.005; Tranzschel W, 1902, T BOT MUZ IMP AKAD N, V1, P47; Voglmayr H, 2003, MYCOL RES, V107, P1132, DOI 10.1017/S0953756203008438; Voglmayr H, 2008, MYCOL RES, V112, P885, DOI 10.1016/j.mycres.2008.01.020; Voglmayr H, 2008, EUR J PLANT PATHOL, V122, P3, DOI 10.1007/s10658-008-9341-y; Voglmayr H, 2014, MYCOL PROG, V13, P131, DOI 10.1007/s11557-013-0900-z; Voglmayr H, 2011, MYCOL PROG, V10, P283, DOI 10.1007/s11557-010-0699-9; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; YOSSIFOVlTCH M., 1929, Revue de pathologie vegetale et d'entomologie agricole de France, V16	63	33	38	11	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96838	10.1371/journal.pone.0096838	http://dx.doi.org/10.1371/journal.pone.0096838			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806292	Green Published, Green Submitted, gold			2022-12-27	WOS:000335728900104
J	Wang, P; Huang, L; Jiang, H; Tian, J; Chu, XY; Wu, NF				Wang, Ping; Huang, Lu; Jiang, Hu; Tian, Jian; Chu, Xiaoyu; Wu, Ningfeng			Improving the Secretion of a Methyl Parathion Hydrolase in Pichia pastoris by Modifying Its N-Terminal Sequence	PLOS ONE			English	Article							PROTEIN DISULFIDE-ISOMERASE; HIGH-LEVEL EXPRESSION; ORGANOPHOSPHORUS HYDROLASE; BIOCHEMICAL-CHARACTERIZATION; FUNCTIONAL EXPRESSION; CODON OPTIMIZATION; GENE; LIPASE; BIOREMEDIATION; GLYCOSYLATION	Pichia pastoris is commonly used to express and secrete target proteins, although not all recombinant proteins can be successfully produced. In this study, we used methyl parathion hydrolase (MPH) from Ochrobactrum sp. M231 as a model to study the importance of the N-terminus of the protein for its secretion. While MPH can be efficiently expressed intracellularly in P. pastoris, it is not secreted into the extracellular environment. Three MPH mutants (N-66-MPH, D-10-MPH, and N-9-MPH) were constructed through modification of its N-terminus, and the secretion of each by P. pastoris was improved when compared to wild-type MPH. The level of secreted D-10-MPH was increased to 0.21 U/mL, while that of N-9-MPH was enhanced to 0.16 U/mL. Although N-66-MPH was not enzymatically active, it was secreted efficiently, and was identified by SDS-PAGE. These results demonstrate that the secretion of heterologous proteins in P. pastoris may be improved by modifying their N-terminal structures.	[Wang, Ping; Jiang, Hu; Tian, Jian; Chu, Xiaoyu; Wu, Ningfeng] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China; [Huang, Lu] Chinese Acad Agr Sci, Key Lab Feed Biotechnol, Minist Agr, Feed Res Inst, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Tian, J (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China.	tianjian@caas.cn	Tian, Jian/D-1052-2011; , 田健/AAX-7731-2020	Tian, Jian/0000-0002-9997-6518; , 田健/0000-0002-9997-6518	National High Technology Research and Development Program of China (863 Program) [2013AA102804]; National Natural Science Foundation of China (NSFC) [30900839]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the National High Technology Research and Development Program of China (863 Program, 2013AA102804) and the National Natural Science Foundation of China (NSFC, Grant no. 30900839). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad S, 2010, BIOTECHNOL J, V5, P413, DOI 10.1002/biot.200900233; Bollok M, 2005, APPL BIOCHEM BIOTECH, V126, P61, DOI 10.1007/s12010-005-0006-4; Calik P, 2010, J CHEM TECHNOL BIOT, V85, P1628, DOI 10.1002/jctb.2474; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; Chang SW, 2006, J AGR FOOD CHEM, V54, P5831, DOI 10.1021/jf060835e; Chang SW, 2011, J AGR FOOD CHEM, V59, P6710, DOI 10.1021/jf200537w; Chang SW, 2006, J AGR FOOD CHEM, V54, P815, DOI 10.1021/jf052183k; Chu XY, 2006, PROTEIN EXPRES PURIF, V49, P9, DOI 10.1016/j.pep.2006.03.013; Chu XY, 2010, APPL MICROBIOL BIOT, V88, P125, DOI 10.1007/s00253-010-2738-5; Dong YJ, 2005, J MOL BIOL, V353, P655, DOI 10.1016/j.jmb.2005.08.057; Gao MJ, 2012, BIOPROC BIOSYST ENG, V35, P1125, DOI 10.1007/s00449-012-0697-1; Heinzelman P, 2009, P NATL ACAD SCI USA, V106, P5610, DOI 10.1073/pnas.0901417106; Higgins DR, 1998, METH MOL B, V103, P1; Huang L, 2012, BIOTECHNOL LETT, V34, P1115, DOI 10.1007/s10529-012-0882-y; Inan Mehmet, 2007, V389, P65; Kapoor M, 2011, INT BIODETER BIODEGR, V65, P896, DOI 10.1016/j.ibiod.2010.12.017; Kim SJ, 2009, J MICROBIOL BIOTECHN, V19, P966, DOI 10.4014/jmb.0901.018; Kjeldsen T, 1999, BIOTECHNOL APPL BIOC, V29, P79; Levary DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018342; Li ZG, 2010, PROTEIN EXPRES PURIF, V72, P113, DOI 10.1016/j.pep.2010.03.004; Li ZG, 2009, PROTEIN EXPRES PURIF, V67, P175, DOI 10.1016/j.pep.2009.06.001; Macauley-Patrick S, 2005, YEAST, V22, P249, DOI 10.1002/yea.1208; Marx H, 2009, FEMS YEAST RES, V9, P1260, DOI 10.1111/j.1567-1364.2009.00561.x; Muraki M, 2006, PROTEIN EXPRES PURIF, V50, P137, DOI 10.1016/j.pep.2006.08.006; Pepeliaev S, 2011, J BIOTECHNOL, V156, P67, DOI 10.1016/j.jbiotec.2011.08.017; Raynes JK, 2011, BIOTECHNOL PROGR, V27, P360, DOI 10.1002/btpr.518; Sakaguchi M, 1997, CURR OPIN BIOTECH, V8, P595, DOI 10.1016/S0958-1669(97)80035-3; Sirotkina M, 2012, INT BIODETER BIODEGR, V68, P18, DOI 10.1016/j.ibiod.2011.12.004; Tian J, 2013, APPL MICROBIOL BIOT, V97, P2997, DOI 10.1007/s00253-012-4411-7; Tian JA, 2010, FEBS J, V277, P4901, DOI 10.1111/j.1742-4658.2010.07895.x; Tsai CW, 2006, J BIOTECHNOL, V121, P458, DOI 10.1016/j.jbiotec.2005.08.025; Wang XX, 2008, BIOCHEM BIOPH RES CO, V365, P453, DOI 10.1016/j.bbrc.2007.10.193; Wu D, 2011, BIOTECHNOL BIOPROC E, V16, P305, DOI 10.1007/s12257-009-3021-4; Xiao W, 2008, J AGR SCI TECHNOL, P99; Xiong AS, 2003, ACTA BIOCH BIOPH SIN, V35, P154; Yang C, 2010, APPL ENVIRON MICROB, V76, P434, DOI 10.1128/AEM.02162-09; Yang JK, 2010, J MOL CATAL B-ENZYM, V63, P164, DOI 10.1016/j.molcatb.2010.01.011; Yu HJ, 2009, CURR MICROBIOL, V59, P573, DOI 10.1007/s00284-009-9484-x; Zhang JH, 2011, BIOTECHNOL BIOPROC E, V16, P1196, DOI 10.1007/s12257-011-0136-1; Zhang XZ, 2005, APPL ENVIRON MICROB, V71, P4101, DOI 10.1128/AEM.71.7.4101-4103.2005	40	4	5	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96974	10.1371/journal.pone.0096974	http://dx.doi.org/10.1371/journal.pone.0096974			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806460	Green Published, Green Submitted, gold			2022-12-27	WOS:000335728900122
J	Hur, KH; Macdonald, PJ; Berk, S; Angert, CI; Chen, Y; Mueller, JD				Hur, Kwang-Ho; Macdonald, Patrick J.; Berk, Serkan; Angert, C. Isaac; Chen, Yan; Mueller, Joachim D.			Quantitative Measurement of Brightness from Living Cells in the Presence of Photodepletion	PLOS ONE			English	Article							FLUORESCENCE FLUCTUATION SPECTROSCOPY; PHOTON-COUNTING HISTOGRAM; PROTEIN INTERACTIONS; OLIGOMERIZATION; STOICHIOMETRY; COMPLEXES; EGFP	The brightness of fluorescently labeled proteins provides an excellent marker for identifying protein interactions in living cells. Quantitative interpretation of brightness, however, hinges on a detailed understanding of the processes that affect the signal fluctuation of the fluorescent label. Here, we focus on the cumulative influence of photobleaching on brightness measurements in cells. Photobleaching within the finite volume of the cell leads to a depletion of the population of fluorescently labeled proteins with time. The process of photodepletion reduces the fluorescence signal which biases the analysis of brightness data. Our data show that even small reductions in the signal can introduce significant bias into the analysis of the data. We develop a model that quantifies the bias and introduce an analysis method that accurately determines brightness in the presence of photodepletion as verified by experiments with mammalian and yeast cells. In addition, photodepletion experiments with the fluorescent protein EGFP reveal the presence of a photoconversion process, which leads to a marked decrease in the brightness of the EGFP protein. We also identify conditions where the effect of EGFP's photoconversion on brightness experiments can be safely ignored.	[Hur, Kwang-Ho; Angert, C. Isaac; Chen, Yan; Mueller, Joachim D.] Univ Minnesota, Sch Phys & Astron, Minneapolis, MN 55455 USA; [Macdonald, Patrick J.; Berk, Serkan] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Mueller, JD (corresponding author), Univ Minnesota, Sch Phys & Astron, Minneapolis, MN 55455 USA.	mueller@physics.umn.edu		Mueller, Joachim/0000-0002-8822-5313; Macdonald, Patrick/0000-0002-4641-954X	National Institutes of Health [R01GM064589]; National Science Foundation [PHY-0346782]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064589] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by the National Institutes of Health (R01GM064589) and the National Science Foundation (PHY-0346782). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacia K, 2006, NAT METHODS, V3, P83, DOI 10.1038/NMETH822; BERLAND KM, 1995, BIOPHYS J, V68, P694, DOI 10.1016/S0006-3495(95)80230-4; Bogdanov AM, 2009, NAT CHEM BIOL, V5, P459, DOI 10.1038/nchembio.174; Caccia M, 2005, APPL SPECTROSC, V59, P227, DOI 10.1366/0003702053084981; Chen Y, 2003, P NATL ACAD SCI USA, V100, P15492, DOI 10.1073/pnas.2533045100; Chen Y, 1999, BIOPHYS J, V77, P553, DOI 10.1016/S0006-3495(99)76912-2; Chen Y, 2002, BIOPHYS J, V82, P133, DOI 10.1016/S0006-3495(02)75380-0; Chen Y, 2007, P NATL ACAD SCI USA, V104, P3147, DOI 10.1073/pnas.0606557104; Delon A, 2004, J FLUORESC, V14, P255, DOI 10.1023/B:JOFL.0000024557.73246.f9; Didier P, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.090602; Digman MA, 2009, P NATL ACAD SCI USA, V106, P2170, DOI 10.1073/pnas.0806036106; Drummond DR, 2002, J MICROSC-OXFORD, V206, P161, DOI 10.1046/j.1365-2818.2002.01024.x; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Ha T, 2012, ANNU REV PHYS CHEM, V63, P595, DOI 10.1146/annurev-physchem-032210-103340; Hillesheim LN, 2006, BIOPHYS J, V91, P4273, DOI 10.1529/biophysj.106.085845; Hillesheim LN, 2003, BIOPHYS J, V85, P1948, DOI 10.1016/S0006-3495(03)74622-0; Jain A, 2011, NATURE, V473, P484, DOI 10.1038/nature10016; Kask P, 1999, P NATL ACAD SCI USA, V96, P13756, DOI 10.1073/pnas.96.24.13756; Macdonald PJ, 2012, ANAL BIOCHEM, V421, P291, DOI 10.1016/j.ab.2011.10.040; Macdonald PJ, 2010, BIOPHYS J, V99, P979, DOI 10.1016/j.bpj.2010.05.017; Muller JD, 2004, BIOPHYS J, V86, P3981, DOI 10.1529/biophysj.103.037887; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Peterman EJG, 1999, J PHYS CHEM A, V103, P10553, DOI 10.1021/jp991968o; QIAN H, 1990, BIOPHYS J, V57, P375, DOI 10.1016/S0006-3495(90)82539-X; QIAN H, 1990, P NATL ACAD SCI USA, V87, P5479, DOI 10.1073/pnas.87.14.5479; Ries J, 2012, BIOESSAYS, V34, P361, DOI 10.1002/bies.201100111; Saffarian S, 2007, BIOPHYS J, V93, P1021, DOI 10.1529/biophysj.107.105494; Saha R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01580; Slaughter BD, 2007, P NATL ACAD SCI USA, V104, P20320, DOI 10.1073/pnas.0710336105; Slaughter BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001931; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Wu B, 2006, BIOPHYS J, V91, P2687, DOI 10.1529/biophysj.106.086181; Wu B, 2010, P NATL ACAD SCI USA, V107, P4117, DOI 10.1073/pnas.0905670107; Wu B, 2009, BIOPHYS J, V96, P2391, DOI 10.1016/j.bpj.2008.12.3902; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	35	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97440	10.1371/journal.pone.0097440	http://dx.doi.org/10.1371/journal.pone.0097440			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24820174	Green Published, Green Submitted, gold			2022-12-27	WOS:000336653300113
J	Mukhopadhyay, I; Kulkarni, A; Aranake, S; Karnik, P; Shetty, M; Thorat, S; Ghosh, I; Wale, D; Bhosale, V; Khairatkar-Joshi, N				Mukhopadhyay, Indranil; Kulkarni, Abhay; Aranake, Sarika; Karnik, Pallavi; Shetty, Mahesh; Thorat, Sandeep; Ghosh, Indraneel; Wale, Dinesh; Bhosale, Vikram; Khairatkar-Joshi, Neelima			Transient Receptor Potential Ankyrin 1 Receptor Activation In Vitro and In Vivo by Pro-tussive Agents: GRC 17536 as a Promising Anti-Tussive Therapeutic	PLOS ONE			English	Article							CIGARETTE-SMOKE; SENSORY NEURONS; ALPHA,BETA-UNSATURATED ALDEHYDES; CHRONIC COUGH; GUINEA-PIGS; CELL-LINE; TRPA1; INFLAMMATION; DISEASE; TARGET	Cough is a protective reflex action that helps clear the respiratory tract which is continuously exposed to airborne environmental irritants. However, chronic cough presents itself as a disease in its own right and despite its global occurrence; the molecular mechanisms responsible for cough are not completely understood. Transient receptor potential ankyrin1 (TRPA1) is robustly expressed in the neuronal as well as non-neuronal cells of the respiratory tract and is a sensor of a wide range of environmental irritants. It is fast getting acceptance as a key biological sensor of a variety of pro-tussive agents often implicated in miscellaneous chronic cough conditions. In the present study, we demonstrate in vitro direct functional activation of TRPA1 receptor by citric acid which is routinely used to evoke cough in preclinical and clinical studies. We also show for the first time that a potent and selective TRPA1 antagonist GRC 17536 inhibits citric acid induced cellular Ca+2 influx in TRPA1 expressing cells and the citric acid induced cough response in guinea pigs. Hence our data provides a mechanistic link between TRPA1 receptor activation in vitro and cough response induced in vivo by citric acid. Furthermore, we also show evidence for TRPA1 activation in vitro by the TLR4, TLR7 and TLR8 ligands which are implicated in bacterial/respiratory virus pathogenesis often resulting in chronic cough. In conclusion, this study highlights the potential utility of TRPA1 antagonist such as GRC 17536 in the treatment of miscellaneous chronic cough conditions arising due to diverse causes but commonly driven via TRPA1.	[Mukhopadhyay, Indranil; Kulkarni, Abhay; Aranake, Sarika; Karnik, Pallavi; Shetty, Mahesh; Thorat, Sandeep; Ghosh, Indraneel; Wale, Dinesh; Bhosale, Vikram; Khairatkar-Joshi, Neelima] Glenmark Pharmaceut Ltd, Glenmark Res Ctr, Biol Res, Navi Mumbai, Maharashtra, India	Glenmark Pharmaceuticals Limited	Khairatkar-Joshi, N (corresponding author), Glenmark Pharmaceut Ltd, Glenmark Res Ctr, Biol Res, Navi Mumbai, Maharashtra, India.	neelima_joshi@glenmarkpharma.com	Kulkarni, Abhay/GLS-0204-2022		Glenmark Pharmaceuticals Ltd.	Glenmark Pharmaceuticals Ltd.	The work was funded by Glenmark Pharmaceuticals Ltd. and its subsidiary. The funder is a legal entity and not a natural person, and hence has no role in the design, data collection, analysis or preparation of the manuscript.	Akopian AN, 2007, J PHYSIOL-LONDON, V583, P175, DOI 10.1113/jphysiol.2007.133231; Andre E, 2009, BRIT J PHARMACOL, V158, P1621, DOI 10.1111/j.1476-5381.2009.00438.x; Andre E, 2008, J CLIN INVEST, V118, P2574, DOI 10.1172/JCI34886; Bautista DM, 2013, ANNU REV PHYSIOL, V75, P181, DOI 10.1146/annurev-physiol-030212-183811; Becker J, 2011, J BIOTECHNOL, V156, P227, DOI 10.1016/j.jbiotec.2011.09.014; Belvisi MG, 2008, BRIT J PHARMACOL, V155, P547, DOI 10.1038/bjp.2008.298; Belvisi MG, 2011, CHEST, V140, P1040, DOI 10.1378/chest.10-3327; Belvisi MG, 2004, THORAX, V59, P438, DOI 10.1136/thx.2003.013490; Bessac BF, 2008, J CLIN INVEST, V118, P1899, DOI 10.1172/JCI34192; Bezemer GFG, 2012, PHARMACOL REV, V64, P337, DOI 10.1124/pr.111.004622; Birrell MA, 2009, AM J RESP CRIT CARE, V180, P1042, DOI 10.1164/rccm.200905-0665OC; Buckley J, 2011, THORAX, V66, P1029, DOI 10.1136/thx.2010.158568; Canning BJ, 2006, AM J PHYSIOL-REG I, V291, pR454, DOI 10.1152/ajpregu.00862.2005; Canning BJ, 2010, OTOLARYNG CLIN N AM, V43, P15, DOI 10.1016/j.otc.2009.11.012; Canning BJ, 2009, PULM PHARMACOL THER, V22, P75, DOI 10.1016/j.pupt.2009.01.003; Cherfils-Vicini J, 2010, J CLIN INVEST, V120, P1285, DOI 10.1172/JCI36551; Chung KF, 2003, IDRUGS, V6, P781; Chung KF, 2008, LANCET, V371, P1364, DOI 10.1016/S0140-6736(08)60595-4; Dicpinigaitis PV, 2011, BRIT J PHARMACOL, V163, P116, DOI 10.1111/j.1476-5381.2010.01198.x; Facchinetti F., 2010, OPEN DRUG DISCOV J, V2, P71, DOI [10.2174/1877381801002030071, DOI 10.2174/1877381801002030071]; Facchinetti F, 2007, AM J RESP CELL MOL, V37, P617, DOI 10.1165/rcmb.2007-0130OC; Gu QH, 2010, J APPL PHYSIOL, V108, P891, DOI 10.1152/japplphysiol.01371.2009; Hasday JD, 1999, CHEST, V115, P829, DOI 10.1378/chest.115.3.829; Lavinka Pamela Colleen, 2013, Cough, V9, P8, DOI 10.1186/1745-9974-9-8; Mazzone SB, 2005, J PHYSIOL-LONDON, V569, P559, DOI 10.1113/jphysiol.2005.093153; Mazzone Stuart B, 2005, Cough, V1, P2, DOI 10.1186/1745-9974-1-2; McCartney SA, 2009, IMMUNOL REV, V227, P87, DOI 10.1111/j.1600-065X.2008.00726.x; McMahon SB, 2006, CELL, V124, P1123, DOI 10.1016/j.cell.2006.03.006; Moller-Larsen S, 2008, THORAX, V63, P1064, DOI 10.1136/thx.2007.094128; Morice AH, 2011, CURR RESPIR MED REV, V7, P10, DOI 10.2174/157339811794109246; Mukhopadhyay I, 2011, J RECEPT SIG TRANSD, V31, P350, DOI 10.3109/10799893.2011.602413; Nassenstein C, 2008, J PHYSIOL-LONDON, V586, P1595, DOI 10.1113/jphysiol.2007.148379; Nassini R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042454; Qi J, 2011, J IMMUNOL, V186, P6417, DOI 10.4049/jimmunol.1001241; Raisinghani M, 2011, AM J PHYSIOL-CELL PH, V301, pC587, DOI 10.1152/ajpcell.00465.2010; Reilly CA, 2003, TOXICOL SCI, V73, P170, DOI 10.1093/toxsci/kfg044; Schroeder K, 2002, BRIT MED J, V324, P329, DOI 10.1136/bmj.324.7333.329; Shapiro D, 2013, CHEM RES TOXICOL, V26, P750, DOI 10.1021/tx400024h; Silva-Carvalho L, 1998, J NEUROPHYSIOL, V79, P2374, DOI 10.1152/jn.1998.79.5.2374; Taylor-Clark TE, 2009, AM J RESP CELL MOL, V40, P756, DOI 10.1165/rcmb.2008-0292OC; Wang YYY, 2011, J GEN PHYSIOL, V137, P493, DOI 10.1085/jgp.201110615; Wang YYY, 2010, J NEUROSCI, V30, P12958, DOI 10.1523/JNEUROSCI.2715-10.2010; Wright Caroline E, 2010, Cough, V6, P8, DOI 10.1186/1745-9974-6-8; Xia R, 2011, ADV EXP MED BIOL, V704, P637, DOI 10.1007/978-94-007-0265-3_34; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Zhang L, 2013, J VIROL, V10, P135	46	42	44	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97005	10.1371/journal.pone.0097005	http://dx.doi.org/10.1371/journal.pone.0097005			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819048	Green Submitted, gold, Green Published			2022-12-27	WOS:000336653300062
J	Vazquez-Marrufo, M; Galvao-Carmona, A; Gonzalez-Rosa, JJ; Hidalgo-Munoz, AR; Borges, M; Ruiz-Pena, JL; Izquierdo, G				Vazquez-Marrufo, Manuel; Galvao-Carmona, Alejandro; Gonzalez-Rosa, Javier J.; Hidalgo-Munoz, Antonio R.; Borges, Monica; Luis Ruiz-Pena, Juan; Izquierdo, Guillermo			Neural Correlates of Alerting and Orienting Impairment in Multiple Sclerosis Patients	PLOS ONE			English	Article							COGNITIVE IMPAIRMENT; NETWORK DYSFUNCTION; PASAT PERFORMANCE; ATTENTION; AMPLITUDE; POTENTIALS; READINESS; SPEED; ERP	Background: A considerable percentage of multiple sclerosis patients have attentional impairment, but understanding its neurophysiological basis remains a challenge. The Attention Network Test allows 3 attentional networks to be studied. Previous behavioural studies using this test have shown that the alerting network is impaired in multiple sclerosis. The aim of this study was to identify neurophysiological indexes of the attention impairment in relapsing-remitting multiple sclerosis patients using this test. Results: After general slowing had been removed in patients group to isolate the effects of each condition, some behavioral differences between them were obtained. About Contingent Negative Variation, a statistically significant decrement were found in the amplitude for Central and Spatial Cue Conditions for patient group (p<0.05). ANOVAs showed for the patient group a significant latency delay for P1 and N1 components (p<0.05) and a decrease of P3 amplitude for congruent and incongruent stimuli (p <0.01). With regard to correlation analysis, PASAT-3s and SDMT showed significant correlations with behavioral measures of the Attention Network Test (p<0.01) and an ERP parameter (CNV amplitude). Conclusions: Behavioral data are highly correlated with the neuropsychological scores and show that the alerting and orienting mechanisms in the patient group were impaired. Reduced amplitude for the Contingent Negative Variation in the patient group suggests that this component could be a physiological marker related to the alerting and orienting impairment in relapsing-remitting multiple sclerosis. P1 and N1 delayed latencies are evidence of the demyelination process that causes impairment in the first steps of the visual sensory processing. Lastly, P3 amplitude shows a general decrease for the pathological group probably indexing a more central impairment. These results suggest that the Attention Network Test give evidence of multiple levels of attention impairment, which could help in the assessment and treatment of relapsing-remitting multiple sclerosis patients.	[Vazquez-Marrufo, Manuel; Galvao-Carmona, Alejandro; Hidalgo-Munoz, Antonio R.] Univ Seville, Fac Psychol, Dept Expt Psychol, Seville, Spain; [Borges, Monica; Luis Ruiz-Pena, Juan; Izquierdo, Guillermo] Virgen Macarena Hosp, Multiple Sclerosis Unit, Seville, Spain; [Gonzalez-Rosa, Javier J.] Tech Univ Madrid UPM, CTB, Lab Clin Neurosci, Madrid, Spain	University of Sevilla; Hospital Universitario Virgen Macarena; Universidad Politecnica de Madrid; Centro de Tecnologia Biomedica (CTB)	Vazquez-Marrufo, M (corresponding author), Univ Seville, Fac Psychol, Dept Expt Psychol, Seville, Spain.	marrufo@us.es	Gonzalez-Rosa, Javier J./AAK-6791-2021; Gonzalez-Rosa, Javier J./K-1291-2014; peña, juan luis ruiz/Z-6168-2019; Hidalgo-Muñoz, Antonio R./ABG-5286-2020; Galvao-Carmona, Alejandro/A-1725-2015; Marrufo, Manuel Vazquez/Y-8460-2019	Gonzalez-Rosa, Javier J./0000-0002-5609-1103; Gonzalez-Rosa, Javier J./0000-0002-5609-1103; peña, juan luis ruiz/0000-0003-3956-1131; Galvao-Carmona, Alejandro/0000-0002-5126-1273; Marrufo, Manuel Vazquez/0000-0002-0456-7165; Hidalgo-Munoz, Antonio R/0000-0002-0457-5114; Borges Guerra, Monica/0000-0002-4258-2390	Plan Nacional I+D+i (Ministerio de Economia y Competitividad, Government of Spain) [PSI2010-16825]; Asociacion Neuroinvest and Asociacion Sanitaria Virgen Macarena	Plan Nacional I+D+i (Ministerio de Economia y Competitividad, Government of Spain); Asociacion Neuroinvest and Asociacion Sanitaria Virgen Macarena	This study was supported by Plan Nacional I+D+i (Ministerio de Economia y Competitividad, Government of Spain, PSI2010-16825); Asociacion Neuroinvest and Asociacion Sanitaria Virgen Macarena. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnettt PA, 2011, EXPERT REV NEUROTHER, V11, P411, DOI 10.1586/ERN.11.12; Baker KS, 2011, NEUROPSYCHOLOGIA, V49, P3303, DOI 10.1016/j.neuropsychologia.2011.08.003; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Benedict RHB, 2011, NAT REV NEUROL, V7, P332, DOI 10.1038/nrneurol.2011.61; Callejas A, 2005, EXP BRAIN RES, V167, P27, DOI 10.1007/s00221-005-2365-z; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Crivelli L, 2012, J INT NEUROPSYCH SOC, V18, P757, DOI 10.1017/S1355617712000410; De Sonneville LMJ, 2002, NEUROPSYCHOLOGIA, V40, P1751, DOI 10.1016/S0028-3932(02)00041-6; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fernandez-Duque D, 2006, NEUROPSYCHOLOGY, V20, P133, DOI 10.1037/0894-4105.20.2.133; FernandezDuque D, 1997, NEUROPSYCHOLOGIA, V35, P477, DOI 10.1016/S0028-3932(96)00103-0; Filippi M, 2012, RADIOLOGY, V262, P932, DOI 10.1148/radiol.11111299; Gomez CM, 2003, NEUROIMAGE, V20, P216, DOI 10.1016/S1053-8119(03)00295-7; Gomez CM, 2001, BRAIN TOPOGR, V13, P149, DOI 10.1023/A:1007816201345; Gonzalez-Rosa JJ, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-39; Gonzalez-Rosa JJ, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-64; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Kail R, 1998, J CLIN EXP NEUROPSYC, V20, P98, DOI 10.1076/jcen.20.1.98.1483; Kiiski H, 2011, J NEUROL SCI, V305, P45, DOI 10.1016/j.jns.2011.03.018; Kiiski H, 2011, EUR J NEUROL, V18, P792, DOI 10.1111/j.1468-1331.2010.03172.x; Kratz O, 2011, INT J PSYCHOPHYSIOL, V81, P82, DOI 10.1016/j.ijpsycho.2011.05.008; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Leocani L, 2010, NEUROL SCI, V31, P249, DOI 10.1007/s10072-010-0398-y; Lori S, 2011, NEUROL SCI, V32, P1043, DOI 10.1007/s10072-011-0602-8; Magnano I, 2006, J NEUROL SCI, V245, P117, DOI 10.1016/j.jns.2005.08.027; McConnell MM, 2011, ATTEN PERCEPT PSYCHO, V73, P1096, DOI 10.3758/s13414-010-0085-3; Missonnier P, 2013, NEURODEGENER DIS, V12, P59, DOI 10.1159/000338815; Neuhaus AH, 2010, SCHIZOPHR RES, V124, P119, DOI 10.1016/j.schres.2010.08.014; Neuhaus AH, 2010, INT J PSYCHOPHYSIOL, V76, P72, DOI 10.1016/j.ijpsycho.2010.02.005; Omisade Antonina, 2012, Int J MS Care, V14, P84, DOI 10.7224/1537-2073-14.2.84; Paul RH, 1998, MULT SCLER, V4, P433, DOI 10.1191/135245898678919438; POLICH J, 1986, PSYCHOPHYSIOLOGY, V23, P590, DOI 10.1111/j.1469-8986.1986.tb00677.x; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Prakash RS, 2008, MULT SCLER J, V14, P1250, DOI 10.1177/1352458508095004; Rohrbaugh J.W., 1983, TUTORIALS ERP RES EN, P269, DOI 10.1016/S0166-4115(08)62044-0; Rossi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044826; Sepulcre J, 2006, MULT SCLER J, V12, P187, DOI 10.1191/1352458506ms1258oa; Smith A, 1982, SYMBOL DIGITS MODALI; Smith A., 1968, LEARNING DISORDERS, P83, DOI DOI 10.1080/13803390591004428; TECCE JJ, 1972, PSYCHOL BULL, V77, P73, DOI 10.1037/h0032177; Tombaugh TN, 2006, ARCH CLIN NEUROPSYCH, V21, P53, DOI 10.1016/j.acn.2005.07.006; Tur C, 2011, MULT SCLER J, V17, P1324, DOI 10.1177/1352458511410341; Urbanek C, 2010, MULT SCLER J, V16, P93, DOI 10.1177/1352458509350308; VAEZMOUSAVI SM, 1993, INT J PSYCHOPHYSIOL, V15, P105, DOI 10.1016/0167-8760(93)90068-Z; Whelan R, 2010, CLIN NEUROPHYSIOL, V121, P1420, DOI 10.1016/j.clinph.2010.03.019; Wojtowicz M, 2013, J INT NEUROPSYCH SOC, V19, P551, DOI 10.1017/S1355617713000027; Yin XT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050590	50	25	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97226	10.1371/journal.pone.0097226	http://dx.doi.org/10.1371/journal.pone.0097226			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24820333	Green Published, gold			2022-12-27	WOS:000336653300094
J	Alwarfaly, S; Abdulsid, A; Hanretty, K; Lyall, F				Alwarfaly, Samy; Abdulsid, Akrem; Hanretty, Kevin; Lyall, Fiona			Paraoxonase 2 Protein Is Spatially Expressed in the Human Placenta and Selectively Reduced in Labour	PLOS ONE			English	Article							OXIDATIVE STRESS; GENE-EXPRESSION; DENSITY-LIPOPROTEIN; BIOLOGICAL-ACTIVITY; SERUM PARAOXONASE; BLOOD-FLOW; ATHEROSCLEROSIS; PON1; TERM; CELLS	Humans parturition involves interaction of hormonal, neurological, mechanical stretch and inflammatory pathways and the placenta plays a crucial role. The paraoxonases (PONs 1-3) protect against oxidative damage and lipid peroxidation, modulation of endoplasmic reticulum stress and regulation of apoptosis. Nothing is known about the role of PON2 in the placenta and labour. Since PON2 plays a role in oxidative stress and inflammation, both features of labour, we hypothesised that placental PON2 expression would alter during labour. PON2 was examined in placentas obtained from women who delivered by cesarean section and were not in labour and compared to the equivalent zone of placentas obtained from women who delivered vaginally following an uncomplicated labour. Samples were obtained from 12 sites within each placenta: 4 equally spaced apart pieces were sampled from the inner, middle and outer placental regions. PON2 expression was investigated by Western blotting and real time PCR. Two PON2 forms, one at 62 kDa and one at 43 kDa were found in all samples. No difference in protein expression of either isoform was found between the three sites in either the labour or non-labour group. At the middle site there was a highly significant decrease in PON2 expression in the labour group when compared to the non-labour group for both the 62 kDa form (p = 0.02) and the 43 kDa form (p = 0.006). No spatial differences were found within placentas at the mRNA level in either labour or non-labour. There was, paradoxically, an increase in PON2 mRNA in the labour group at the middle site only. This is the first report to describe changes in PON2 in the placenta in labour. The physiological and pathological significance of these remains to be elucidated but since PON2 is anti-inflammatory further studies are warranted to understand its role.	[Alwarfaly, Samy; Abdulsid, Akrem; Lyall, Fiona] Univ Glasgow, Inst Med Genet, Sch Med, Yorkhill Hosp, Glasgow, Lanark, Scotland; [Hanretty, Kevin] So Gen Hosp, Matern Hosp, Glasgow G51 4TF, Lanark, Scotland	University of Glasgow; University of Glasgow	Lyall, F (corresponding author), Univ Glasgow, Inst Med Genet, Sch Med, Yorkhill Hosp, Glasgow, Lanark, Scotland.	fiona.lyall@glasgow.ac.uk			Libyan Cultural Affairs	Libyan Cultural Affairs	This work was supported by a scholarship to S. Alwarfaly from the Funded by the Libyan Cultural Affairs-administered By University of Glasgow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulsid A, 2014, J REPROD IMMUNOL, V101, P89, DOI 10.1016/j.jri.2013.09.002; Abdulsid A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071127; Abdulsid A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054540; Allport VC, 2001, MOL HUM REPROD, V7, P581, DOI 10.1093/molehr/7.6.581; Altenhofer S, 2010, J BIOL CHEM, V285, P24398, DOI 10.1074/jbc.M110.118604; Aviram M, 2000, CIRCULATION, V101, P2510, DOI 10.1161/01.CIR.101.21.2510; Aviram M, 2004, FREE RADICAL BIO MED, V37, P1304, DOI 10.1016/j.freeradbiomed.2004.06.030; BORELL U, 1965, AM J OBSTET GYNECOL, V93, P44, DOI 10.1016/0002-9378(65)90293-0; BRAR HS, 1988, AM J OBSTET GYNECOL, V158, P952, DOI 10.1016/0002-9378(88)90100-7; Burdon C, 2007, PLACENTA, V28, P724, DOI 10.1016/j.placenta.2006.12.001; Camps J, 2009, CRIT REV CL LAB SCI, V46, P83, DOI 10.1080/10408360802610878; Challis JRG, 2000, ENDOCR REV, V21, P514, DOI 10.1210/er.21.5.514; Chen DF, 2004, EPIDEMIOLOGY, V15, P466, DOI 10.1097/01.ede.0000129509.59912.b2; Cindrova-Davies T, 2007, AM J PATHOL, V171, P1168, DOI 10.2353/ajpath.2007.070528; Deakin S, 2002, J BIOL CHEM, V277, P4301, DOI 10.1074/jbc.M107440200; Devarajan A, 2011, ANTIOXID REDOX SIGN, V14, P341, DOI 10.1089/ars.2010.3430; Draganov DI, 2005, J LIPID RES, V46, P1239, DOI 10.1194/jlr.M400511-JLR200; Draganov DI, 2004, N-S ARCH PHARMACOL, V369, P78, DOI 10.1007/s00210-003-0833-1; Dwarakanath RS, 2004, J MOL CELL CARDIOL, V36, P585, DOI 10.1016/j.yjmcc.2004.02.007; Elliott CL, 1998, AM J OBSTET GYNECOL, V179, P215, DOI 10.1016/S0002-9378(98)70275-3; Fuhrman B, 2008, ARTERIOSCL THROM VAS, V28, P1361, DOI 10.1161/ATVBAHA.108.166041; Furlong CE, 2008, PROTEINS CELL REGUL, V6, P3, DOI 10.1007/978-1-4020-6561-3_1; Horke S, 2007, CIRCULATION, V115, P2055, DOI 10.1161/CIRCULATIONAHA.106.681700; Horke S, 2010, BIOCHEM J, V426, P73, DOI 10.1042/BJ20091414; Jakubowski H, 2000, J BIOL CHEM, V275, P3957, DOI 10.1074/jbc.275.6.3957; Jaouad L, 2006, ATHEROSCLEROSIS, V185, P191, DOI 10.1016/j.atherosclerosis.2005.06.012; Keelan JA, 2003, PLACENTA, V24, pS33, DOI 10.1053/plac.2002.0948; Lee KJ, 2010, PLACENTA, V31, P698, DOI 10.1016/j.placenta.2010.05.006; Lim R, 2012, PLACENTA, V33, P52, DOI 10.1016/j.placenta.2011.10.004; MacIntyre DA, 2012, J MATERN-FETAL NEO M, V25, P17, DOI 10.3109/14767058.2012.666114; Mackness B, 1997, ARTERIOSCL THROM VAS, V17, P1233, DOI 10.1161/01.ATV.17.7.1233; Mackness B, 2010, IUBMB LIFE, V62, P480, DOI 10.1002/iub.347; MACKNESS MI, 1991, FEBS LETT, V286, P152, DOI 10.1016/0014-5793(91)80962-3; MACKNESS MI, 1993, ATHEROSCLEROSIS, V104, P129, DOI 10.1016/0021-9150(93)90183-U; Many A, 1997, PLACENTA, V18, P725, DOI 10.1016/S0143-4004(97)90015-1; Martinelli N, 2013, ADV CLIN CHEM, V59, P65, DOI 10.1016/B978-0-12-405211-6.00003-6; MCCORD JM, 1993, CLIN BIOCHEM, V26, P351, DOI 10.1016/0009-9120(93)90111-I; Meilin E, 2010, ATHEROSCLEROSIS, V208, P390, DOI 10.1016/j.atherosclerosis.2009.07.057; Ng CJ, 2006, J BIOL CHEM, V281, P29491, DOI 10.1074/jbc.M605379200; Ng CJ, 2001, J BIOL CHEM, V276, P44444, DOI 10.1074/jbc.M105660200; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Peng HH, 2011, KAOHSIUNG J MED SCI, V27, P494, DOI 10.1016/j.kjms.2011.06.012; Petraglia F, 2010, ENDOCR REV, V31, P783, DOI 10.1210/er.2009-0019; PrimoParmo SL, 1996, GENOMICS, V33, P498, DOI 10.1006/geno.1996.0225; Ramsey EM, 1980, ANATOMY PHYSL RADIOL; Reddy ST, 2001, ARTERIOSCL THROM VAS, V21, P542, DOI 10.1161/01.ATV.21.4.542; Rothem L, 2007, FREE RADICAL BIO MED, V43, P730, DOI 10.1016/j.freeradbiomed.2007.05.003; Shih DM, 2007, CIRC RES, V100, P1200, DOI 10.1161/01.RES.0000264499.48737.69; Shih DM, 2009, CURR OPIN LIPIDOL, V20, P288, DOI 10.1097/MOL.0b013e32832ca1ee; Shih DM, 1998, NATURE, V394, P284, DOI 10.1038/28406; Shiner M, 2004, FREE RADICAL BIO MED, V37, P2052, DOI 10.1016/j.freeradbiomed.2004.09.003; Sierksma A, 2002, ALCOHOL CLIN EXP RES, V26, P1430, DOI 10.1097/01.ALC.0000030639.57507.60; Sitras V, 2008, MOL HUM REPROD, V14, P61, DOI 10.1093/molehr/gam083; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Stoltz DA, 2007, AM J PHYSIOL-LUNG C, V292, pL852, DOI 10.1152/ajplung.00370.2006; Teiber JF, 2008, INFECT IMMUN, V76, P2512, DOI 10.1128/IAI.01606-07; Watson AD, 1995, J CLIN INVEST, V96, P2882, DOI 10.1172/JCI118359; Witte I, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2010.91; Xu Y, 2005, MOL PHARMACEUT, V2, P481, DOI 10.1021/mp0500519; YANG Y, 2012, FREE RADIC BIOL MED, V83, P53; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec	62	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96754	10.1371/journal.pone.0096754	http://dx.doi.org/10.1371/journal.pone.0096754			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816800	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000336838000060
J	Pueyo, MT; Mutafci, BA; Soto-Arriaza, MA; Di Mascio, P; Carmona-Ribeiro, AM				Pueyo, Manuel T.; Mutafci, Bruna A.; Soto-Arriaza, Marco A.; Di Mascio, Paolo; Carmona-Ribeiro, Ana M.			The Self-Assembly of a Cyclic Lipopeptides Mixture Secreted by a B. megaterium Strain and Its Implications on Activity against a Sensitive Bacillus Species	PLOS ONE			English	Article							MASS-SPECTROMETRY; SURFACTIN; ANTHRACIS; SOIL; PSEUDOMONAS; INDUCTION; APOPTOSIS; DNA	Cyclic lipopeptides are produced by a soil Bacillus megaterium strain and several other Bacillus species. In this work, they are detected both in the Bacillus intact cells and the cells culture medium by MALDI-TOF mass spectrometry. The cyclic lipopeptides self-assemble in water media producing negatively charged and large aggregates (300-800 nm of mean hydrodynamic radius) as evaluated by dynamic light scattering and zeta-potential analysis. The aggregate size depends on pH and ionic strength. However, it is not affected by changes in the osmolarity of the outer medium suggesting the absence of an internal aqueous compartment despite the occurrence of low molecular weight phospholipids in their composition as determined from inorganic phosphorus analysis. The activity against a sensitive Bacillus cereus strain was evaluated from inhibition halos and B. cereus lysis. Essential features determining the antibiotic activity on susceptible Bacillus cereus cells are the preserved cyclic moiety conferring cyclic lipopeptides resistance to proteases and the medium pH. The aggregates are inactive per se at the pH of the culture medium which is around 6 or below. The knock out of the sensitive cells only takes place when the aggregates are disassembled due to a high negative charge at pH above 6.	[Pueyo, Manuel T.; Mutafci, Bruna A.; Di Mascio, Paolo; Carmona-Ribeiro, Ana M.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Soto-Arriaza, Marco A.] Pontificia Univ Catolica Chile, Dept Quim Fis, Santiago, Chile	Universidade de Sao Paulo; Pontificia Universidad Catolica de Chile	Pueyo, MT (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil.	matpueyo@iq.usp.br; amcr@usp.br	Carmona-Ribeiro, Ana M./B-4768-2016; Di Mascio, Paolo/D-1264-2014; Carmona-Ribeiro, Ana M/A-6235-2008; Soto-Arriaza, Marco/J-8918-2017	Carmona-Ribeiro, Ana M./0000-0001-8500-2707; Di Mascio, Paolo/0000-0003-4125-8350; Carmona-Ribeiro, Ana M/0000-0001-8500-2707; Soto-Arriaza, Marco/0000-0003-4502-6960	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP [2006/56530-4, 2008/05866, 2011/00046-5, 2012/12663-1, 2013/07937-8]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Programa de Apoio aos Nucleos de Excelencia (PRONEX/FINEP); Pro-Reitoria de Pesquisa da Universidade de Sao Paulo (PRPUSP); Instituto do Milenio-Redoxoma [420011/2005-6]; INCT Redoxoma (FAPESP/CNPq/CAPES) [573530/2008-4]; NAP Redoxoma (PRPUSP) [2011.1.9352.1.8]; MCT/CNPq [60/2008]; Projetos Conjuntos de P&D&I - Americas CNPq/CONICYT(Chile) [490735/2008-8]; CNPq	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Programa de Apoio aos Nucleos de Excelencia (PRONEX/FINEP); Pro-Reitoria de Pesquisa da Universidade de Sao Paulo (PRPUSP); Instituto do Milenio-Redoxoma; INCT Redoxoma (FAPESP/CNPq/CAPES); NAP Redoxoma (PRPUSP); MCT/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Projetos Conjuntos de P&D&I - Americas CNPq/CONICYT(Chile); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP (grants 2006/56530-4; 2008/05866; 2011/00046-5; 2012/12663-1; 2013/07937-8), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Programa de Apoio aos Nucleos de Excelencia (PRONEX/FINEP), Pro-Reitoria de Pesquisa da Universidade de Sao Paulo (PRPUSP), Instituto do Milenio-Redoxoma (420011/2005-6), INCT Redoxoma (FAPESP/CNPq/CAPES 573530/2008-4), NAP Redoxoma (PRPUSP 2011.1.9352.1.8) and MCT/CNPq no. 60/2008 -Projetos Conjuntos de P&D&I - Americas CNPq/CONICYT(Chile) 490735/2008-8. BAM thanks CNPq for a trainee technician fellowship. PDM and AMC-R thank CNPq for their productivity in research fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banat IM, 2010, APPL MICROBIOL BIOT, V87, P427, DOI 10.1007/s00253-010-2589-0; Brand GD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045848; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; Carmona-Ribeiro Ana Maria, 2011, Biomimetic Based Applications, P227; Carmona-Ribeiro Ana Maria, 2012, Methods Mol Biol, V906, P283, DOI 10.1007/978-1-61779-953-2_22; Carvalho CA, 2012, BBA-BIOMEMBRANES, V1818, P3064, DOI 10.1016/j.bbamem.2012.08.008; Chikerema SM, 2012, J APPL MICROBIOL, V113, P1389, DOI 10.1111/jam.12006; Draganov DI, 2005, J LIPID RES, V46, P1239, DOI 10.1194/jlr.M400511-JLR200; Findlay B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054280; Grabowski E., 1983, MEASUREMENT SUSPENDE, P199; Han CS, 2006, J BACTERIOL, V188, P3382, DOI 10.1128/JB.188.9.3382-3390.2006; Helgason E, 2000, APPL ENVIRON MICROB, V66, P2627, DOI 10.1128/AEM.66.6.2627-2630.2000; Hoefler BC, 2012, P NATL ACAD SCI USA, V109, P13082, DOI 10.1073/pnas.1205586109; Hong HA, 2009, RES MICROBIOL, V160, P134, DOI 10.1016/j.resmic.2008.11.002; Isom DG, 2011, P NATL ACAD SCI USA, V108, P5260, DOI 10.1073/pnas.1010750108; Jacques P, 2011, MICROBIOL MONOGR, V20, P57, DOI 10.1007/978-3-642-14490-5_3; Janek T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057991; Kikuchi IS, 2000, J PHYS CHEM B, V104, P2829, DOI 10.1021/jp9935891; Kim SY, 2007, FEBS LETT, V581, P865, DOI 10.1016/j.febslet.2007.01.059; Kolsto AB, 2009, ANNU REV MICROBIOL, V63, P451, DOI 10.1146/annurev.micro.091208.073255; Leenders F, 1999, RAPID COMMUN MASS SP, V13, P943; Maeda H, 1997, J PHYS CHEM B, V101, P7378, DOI 10.1021/jp9633815; MAGETDANA R, 1994, TOXICOLOGY, V87, P151, DOI 10.1016/0300-483X(94)90159-7; Pueyo M, 2009, MICROB ECOL, V57, P367, DOI 10.1007/s00248-008-9464-x; Raaijmakers JM, 2006, MOL PLANT MICROBE IN, V19, P699, DOI 10.1094/MPMI-19-0699; Raaijmakers JM, 2010, FEMS MICROBIOL REV, V34, P1037, DOI 10.1111/j.1574-6976.2010.00221.x; RIBEIRO AMC, 1983, BIOCHIM BIOPHYS ACTA, V733, P172; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81; Sonenshein AL, 2002, BACILLUS SUBTILIS IT, P3, DOI [10.1128/9781555817992.ch1, DOI 10.1128/9781555817992.CH1]; Wang CL, 2007, PEPTIDES, V28, P1344, DOI 10.1016/j.peptides.2007.06.014; WILSON JB, 1964, J BACTERIOL, V87, P237, DOI 10.1128/JB.87.1.237-238.1964; Zhang Y, 2003, BBA-BIOMEMBRANES, V1614, P182, DOI 10.1016/S0005-2736(03)00177-9	34	6	6	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97261	10.1371/journal.pone.0097261	http://dx.doi.org/10.1371/journal.pone.0097261			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816927	Green Published, Green Submitted, gold			2022-12-27	WOS:000336838000124
J	Wang, LK; Hsiao, TH; Hong, TM; Chen, HY; Kao, SH; Wang, WL; Yu, SL; Lin, CW; Yang, PC				Wang, Lu-Kai; Hsiao, Tzu-Hung; Hong, Tse-Ming; Chen, Hsuan-Yu; Kao, Shih-Han; Wang, Wen-Lung; Yu, Sung-Liang; Lin, Ching-Wen; Yang, Pan-Chyr			MicroRNA-133a Suppresses Multiple Oncogenic Membrane Receptors and Cell Invasion in Non-Small Cell Lung Carcinoma	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CANCER CELLS; SIGNALING PATHWAYS; PROSTATE-CANCER; MIR-133A; EXPRESSION; MIGRATION; TARGET; PROLIFERATION; MALIGNANCY	Non-small cell lung cancers (NSCLCs) cause high mortality worldwide, and the cancer progression can be activated by several genetic events causing receptor dysregulation, including mutation or amplification. MicroRNAs are a group of small non-coding RNA molecules that function in gene silencing and have emerged as the fine-tuning regulators during cancer progression. MiR-133a is known as a key regulator in skeletal and cardiac myogenesis, and it acts as a tumor suppressor in various cancers. This study demonstrates that miR-133a expression negatively correlates with cell invasiveness in both transformed normal bronchial epithelial cells and lung cancer cell lines. The oncogenic receptors in lung cancer cells, including insulin-like growth factor 1 receptor (IGF-1R), TGF-beta receptor type-1 (TGFBR1), and epidermal growth factor receptor (EGFR), are direct targets of miR-133a. MiR-133a can inhibit cell invasiveness and cell growth through suppressing the expressions of IGF-1R, TGFBR1 and EGFR, which then influences the downstream signaling in lung cancer cell lines. The cell invasive ability is suppressed in IGF-1R- and TGFBR1-repressed cells and this phenomenon is mediated through AKT signaling in highly invasive cell lines. In addition, by using the in vivo animal model, we find that ectopically-expressing miR-133a dramatically suppresses the metastatic ability of lung cancer cells. Accordingly, patients with NSCLCs who have higher expression levels of miR-133a have longer survival rates compared with those who have lower miR-133a expression levels. In summary, we identified the tumor suppressor role of miR-133a in lung cancer outcome prognosis, and we demonstrated that it targets several membrane receptors, which generally produce an activating signaling network during the progression of lung cancer.	[Wang, Lu-Kai; Yang, Pan-Chyr] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Hsiao, Tzu-Hung; Kao, Shih-Han; Yang, Pan-Chyr] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan; [Hong, Tse-Ming] Natl Cheng Kung Univ, Inst Clin Med, Tainan 70101, Taiwan; [Chen, Hsuan-Yu] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Yu, Sung-Liang] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Wang, Wen-Lung; Lin, Ching-Wen; Yang, Pan-Chyr] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Yu, Sung-Liang; Yang, Pan-Chyr] Natl Taiwan Univ, Coll Med, NTU Ctr Genom Med, Taipei 10764, Taiwan	National Defense Medical Center; National Taiwan University; National Cheng Kung University; Academia Sinica - Taiwan; National Taiwan University; Academia Sinica - Taiwan; National Taiwan University	Lin, CW (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	b8921022anita@gmail.com	Ching-Wen, Lin/ABB-1997-2020; Chen, Hsuan-Yu/AAE-8428-2019	YANG, PAN-CHYR/0000-0001-6330-6048; YU, SUNG-LIANG/0000-0003-4535-9036	National Science Council [NSC101-2321-B-002-068-, NSC102-2321-B-002-053-, NSC102-2325-B-006-016-, NSC99-2628-B-006-031-MY3, NSC102-2911-I-002-303]	National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council (NSC101-2321-B-002-068-, NSC102-2321-B-002-053-, NSC102-2325-B-006-016-, and NSC99-2628-B-006-031-MY3, NSC102-2911-I-002-303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Y, 2001, AM J RESP CELL MOL, V25, P542, DOI 10.1165/ajrcmb.25.5.4298; Cheung M, 2013, CURR CANCER DRUG TAR, V13, P234, DOI 10.2174/1568009611313030002; Choi EJ, 2010, MOL CANCER RES, V8, P1027, DOI 10.1158/1541-7786.MCR-09-0507; Chong CR, 2013, NAT MED, V19, P1389, DOI 10.1038/nm.3388; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Cooper WA, 2013, J THORAC DIS, V5, pS479, DOI 10.3978/j.issn.2072-1439.2013.08.03; Cui WJ, 2013, FEBS J, V280, P3962, DOI 10.1111/febs.12398; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Hoffman PC, 2000, LANCET, V355, P479, DOI 10.1016/S0140-6736(00)82038-3; Hsu YC, 2009, CLIN CANCER RES, V15, P7309, DOI 10.1158/1078-0432.CCR-09-1572; Kaklamani Virginia G, 2004, Expert Rev Anticancer Ther, V4, P649, DOI 10.1586/14737140.4.4.649; Kano M, 2010, INT J CANCER, V127, P2804, DOI 10.1002/ijc.25284; Kojima S, 2012, BRIT J CANCER, V106, P405, DOI 10.1038/bjc.2011.462; Koutsoulidou A, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-34; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lin C.-W., 2013, NAT COMMUN, V4; Ling H, 2013, NAT REV DRUG DISCOV, V12, P847, DOI 10.1038/nrd4140; Meng XN, 2009, BRIT J CANCER, V101, P327, DOI 10.1038/sj.bjc.6605154; Mitsudomi T, 2013, NAT REV CLIN ONCOL, V10, P235, DOI 10.1038/nrclinonc.2013.22; Moriya Y, 2012, J HUM GENET, V57, P38, DOI 10.1038/jhg.2011.126; Nohata N, 2011, INT J ONCOL, V38, P209, DOI 10.3892/ijo_00000840; Peng Y, 2013, P NATL ACAD SCI USA, V110, P15043, DOI 10.1073/pnas.1307107110; Reck M, 2013, LANCET, V382, P709, DOI 10.1016/S0140-6736(13)61502-0; Rosell R, 2013, LANCET, V382, P720, DOI 10.1016/S0140-6736(13)61715-8; Santibanez JF, 2011, CLIN SCI, V121, P233, DOI 10.1042/CS20110086; Scagliotti GV, 2012, CANCER TREAT REV, V38, P292, DOI 10.1016/j.ctrv.2011.07.008; Seccareccia E, 2012, GROWTH HORM IGF RES, V22, P193, DOI 10.1016/j.ghir.2012.09.003; Shi Y, 2014, J THORAC ONCOL, V9, P154, DOI 10.1097/JTO.0000000000000033; Singh Inderpal, 2013, Front Biosci (Schol Ed), V5, P231; Tai CJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-95; Tao J, 2012, ONCOL REP, V27, P1967, DOI 10.3892/or.2012.1711; Tufman A, 2013, THERANOSTICS, V3, P942, DOI 10.7150/thno.6615; Uchida Y, 2013, UROL ONCOL-SEMIN ORI, V31, P115, DOI 10.1016/j.urolonc.2010.09.017; Voortman J, 2010, CANCER RES, V70, P8288, DOI 10.1158/0008-5472.CAN-10-1348; Wen DC, 2013, TUMOR BIOL, V34, P793, DOI 10.1007/s13277-012-0609-7; Wu WJ, 2013, CLIN CANCER RES, V19, P5699, DOI 10.1158/1078-0432.CCR-13-1758; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008	37	139	144	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96765	10.1371/journal.pone.0096765	http://dx.doi.org/10.1371/journal.pone.0096765			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816813	Green Published, gold, Green Submitted			2022-12-27	WOS:000336838000062
J	Keyamura, Y; Nagano, C; Kohashi, M; Niimi, M; Nozako, M; Koyama, T; Yasufuku, R; Imaizumi, A; Itabe, H; Yoshikawa, T				Keyamura, Yuka; Nagano, Chifumi; Kohashi, Masayuki; Niimi, Manabu; Nozako, Masanori; Koyama, Takashi; Yasufuku, Reiko; Imaizumi, Ayako; Itabe, Hiroyuki; Yoshikawa, Tomohiro			Add-On Effect of Probucol in Atherosclerotic, Cholesterol-Fed Rabbits Treated with Atorvastatin	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA; RANDOMIZED-TRIALS; OXIDATIVE STRESS; DEFICIENT MICE; LDL; PROGRESSION; PARTICIPANTS; METAANALYSIS; PRAVASTATIN	Objective: Lowering the blood concentration of low-density lipoprotein (LDL) cholesterol is the primary strategy employed in treating atherosclerotic disorders; however, most commonly prescribed statins prevent cardiovascular events in just 30% to 40% of treated patients. Therefore, additional treatment is required for patients in whom statins have been ineffective. In this study of atherosclerosis in rabbits, we examined the effect of probucol, a lipid-lowering drug with potent antioxidative effects, added to treatment with atorvastatin. Methods and Results: Atherosclerosis was induced by feeding rabbits chow containing 0.5% cholesterol for 8 weeks. Probucol 0.1%, atorvastatin 0.001%, and atorvastatin 0.003% were administered solely or in combination for 6 weeks, beginning 2 weeks after the start of atherosclerosis induction. Atorvastatin decreased the plasma concentration of non-high-density lipoprotein cholesterol (non-HDLC) dose-dependently; atorvastatin 0.003% decreased the plasma concentration of non-HDLC by 25% and the area of atherosclerotic lesions by 21%. Probucol decreased the plasma concentration of non-HDLC to the same extent as atorvastatin (i.e., by 22%) and the area of atherosclerotic lesions by 41%. Probucol with 0.003% atorvastatin decreased the plasma concentration of non-HDLC by 38% and the area of atherosclerotic lesions by 61%. Co-administration of probucol with atorvastatin did not affect the antioxidative effects of probucol, which were not evident on treatment with atorvastatin alone, such as prevention of in vitro LDL-oxidation, increase in paraoxonase-1 activity of HDL, and decreases in plasma and plaque levels of oxidized-LDL in vivo. Conclusions: Probucol has significant add-on anti-atherosclerotic effects when combined with atorvastatin treatment; suggesting that this combination might be beneficial for treatment of atherosclerosis.	[Keyamura, Yuka; Nagano, Chifumi; Kohashi, Masayuki; Niimi, Manabu; Nozako, Masanori; Koyama, Takashi; Yasufuku, Reiko; Imaizumi, Ayako; Yoshikawa, Tomohiro] Otsuka Pharmaceut Co Ltd, Free Rad Res Project, Tokushima 77101, Japan; [Keyamura, Yuka; Itabe, Hiroyuki] Showa Univ, Sch Pharm, Div Biol Chem, Dept Mol Biol, Tokyo, Japan	Otsuka Pharmaceutical; Showa University	Yoshikawa, T (corresponding author), Otsuka Pharmaceut Co Ltd, Free Rad Res Project, Tokushima 77101, Japan.	yoshikawa.tomohiro.a@otsuka.jp	板部板部, 洋之/ABC-7746-2020; Niimi, Manabu/AAU-5428-2020	Niimi, Manabu/0000-0002-3694-5642	Otsuka Pharmaceutical Co., Ltd.	Otsuka Pharmaceutical Co., Ltd.(Otsuka Pharmaceutical)	The authors, YK, CN, MK, MN, MN, TK, RY, AI, TY received funding from Otsuka Pharmaceutical Co., Ltd. We have carefully reviewed our statements relating to the author contributions, and ensured that we have specifically and accurately indicated the roles that these authors had in our study. The funder provided support in the form of salaries for authors, YK, CN, MK, MNi, MNo, TK, RY, AI, TY, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "Author contributions" section.	Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Brasen JH, 1998, VIRCHOWS ARCH, V432, P557, DOI 10.1007/s004280050205; Ge CJ, 2012, CHINESE MED J-PEKING, V125, P2472, DOI 10.3760/cma.j.issn.0366-6999.2012.14.014; Hansel B, 2004, J CLIN ENDOCR METAB, V89, P4963, DOI 10.1210/jc.2004-0305; Hatch F T, 1968, Adv Lipid Res, V6, P1; Inagaki M, 2012, J ATHEROSCLER THROMB, V19, P643, DOI 10.5551/jat.12807; ITABE H, 1994, J BIOL CHEM, V269, P15274; Itabe H, 2009, CLIN REV ALLERG IMMU, V37, P4, DOI 10.1007/s12016-008-8095-9; Itoh S, 2002, CIRCULATION, V105, P2288, DOI 10.1161/01.CIR.0000015607.33345.1F; Kasai T, 2012, ATHEROSCLEROSIS, V220, P463, DOI 10.1016/j.atherosclerosis.2011.09.051; Kastelein JJP, 2008, NEW ENGL J MED, V358, P1431, DOI 10.1056/NEJMoa0800742; Kato R, 2009, ARTERIOSCL THROM VAS, V29, P33, DOI 10.1161/ATVBAHA.108.164723; KITA T, 1987, P NATL ACAD SCI USA, V84, P5928, DOI 10.1073/pnas.84.16.5928; Moghadasian MH, 1999, CIRCULATION, V99, P1733, DOI 10.1161/01.CIR.99.13.1733; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Niimi M, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-166; PARTHASARATHY S, 1986, J CLIN INVEST, V77, P641, DOI 10.1172/JCI112349; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; SASAHARA M, 1994, J CLIN INVEST, V94, P155, DOI 10.1172/JCI117301; Sawayama Y, 2002, J AM COLL CARDIOL, V39, P610, DOI 10.1016/S0735-1097(01)01783-1; Schmitz G, 2010, ATHEROSCLEROSIS, V208, P10, DOI 10.1016/j.atherosclerosis.2009.05.029; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Steinberg G, 1986, AM J CARDIOL, V57, p16H; Takeshita S, 2000, J Atheroscler Thromb, V7, P238; TAWARA K, 1986, JPN J PHARMACOL, V40, P123, DOI 10.1254/jjp.40.123; WALLDIUS G, 1994, AM J CARDIOL, V74, P875, DOI 10.1016/0002-9149(94)90579-7; WITZTUM JL, 1991, J CLIN INVEST, V88, P1785, DOI 10.1172/JCI115499; Wu BJ, 2006, J EXP MED, V203, P1117, DOI 10.1084/jem.20052321; Xu ZY, 2009, ATHEROSCLEROSIS, V206, P427, DOI 10.1016/j.atherosclerosis.2009.03.023; Yamashita S, 2009, ATHEROSCLEROSIS, V207, P16, DOI 10.1016/j.atherosclerosis.2009.04.002; Yamashita S, 2008, J ATHEROSCLER THROMB, V15, P292, DOI 10.5551/jat.E610; Yoshikawa T, 2008, HORM METAB RES, V40, P473, DOI 10.1055/s-2008-1065348; Yoshikawa T, 2001, HORM METAB RES, V33, P472, DOI 10.1055/s-2001-16940; Yu Q, 2012, HISTOL HISTOPATHOL, V27, P529, DOI 10.14670/HH-27.529; Zhou Q, 2010, CIRC J, V74, P818, DOI 10.1253/circj.CJ-10-0110	36	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96929	10.1371/journal.pone.0096929	http://dx.doi.org/10.1371/journal.pone.0096929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810608	Green Submitted, Green Published, gold			2022-12-27	WOS:000338213300094
J	de Cerqueira, CCS; Hunemeier, T; Gomez-Valdes, J; Ramallo, V; Volasko-Krause, CD; Barbosa, AAL; Vargas-Pinilla, P; Dornelles, RC; Longo, D; Rothhammer, F; Bedoya, G; Canizales-Quinteros, S; Acuna-Alonzo, V; Gallo, C; Poletti, G; Gonzalez-Jose, R; Salzano, FM; Callegari-Jacques, SM; Schuler-Faccini, L; Ruiz-Linares, A; Bortolini, MC				Silva de Cerqueira, Caio Cesar; Huenemeier, Tabita; Gomez-Valdes, Jorge; Ramallo, Virginia; Daiana Volasko-Krause, Carla; Leal Barbosa, Ana Angelica; Vargas-Pinilla, Pedro; Ciconet Dornelles, Rodrigo; Longo, Danae; Rothhammer, Francisco; Bedoya, Gabriel; Canizales-Quinteros, Samuel; Acuna-Alonzo, Victor; Gallo, Carla; Poletti, Giovanni; Gonzalez-Jose, Rolando; Mauro Salzano, Francisco; Maria Callegari-Jacques, Sidia; Schuler-Faccini, Lavinia; Ruiz-Linares, Andres; Catira Bortolini, Maria		CANDELA Consortium Anal Diversity	Implications of the Admixture Process in Skin Color Molecular Assessment	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HUMAN PIGMENTATION VARIATION; EYE COLOR; GENE; POLYMORPHISMS; EVOLUTION; POPULATIONS; PHENOTYPE; ANCESTRY; PROTEIN	The understanding of the complex genotype-phenotype architecture of human pigmentation has clear implications for the evolutionary history of humans, as well as for medical and forensic practices. Although dozens of genes have previously been associated with human skin color, knowledge about this trait remains incomplete. In particular, studies focusing on populations outside the European-North American axis are rare, and, until now, admixed populations have seldom been considered. The present study was designed to help fill this gap. Our objective was to evaluate possible associations of 18 single nucleotide polymorphisms (SNPs), located within nine genes, and one pseudogene with the Melanin Index (MI) in two admixed Brazilian populations (Gaucho, N = 352; Baiano, N = 148) with different histories of geographic and ethnic colonization. Of the total sample, four markers were found to be significantly associated with skin color, but only two (SLC24A5 rs1426654, and SLC45A2 rs16891982) were consistently associated with MI in both samples (Gaucho and Baiano). Therefore, only these 2 SNPs should be preliminarily considered to have forensic significance because they consistently showed the association independently of the admixture level of the populations studied. We do not discard that the other two markers (HERC2 rs1129038 and TYR rs1126809) might be also relevant to admixed samples, but additional studies are necessary to confirm the real importance of these markers for skin pigmentation. Finally, our study shows associations of some SNPs with MI in a modern Brazilian admixed sample, with possible applications in forensic genetics. Some classical genetic markers in Euro-North American populations are not associated with MI in our sample. Our results point out the relevance of considering population differences in selecting an appropriate set of SNPs as phenotype predictors in forensic practice.	[Silva de Cerqueira, Caio Cesar; Huenemeier, Tabita; Ramallo, Virginia; Daiana Volasko-Krause, Carla; Vargas-Pinilla, Pedro; Ciconet Dornelles, Rodrigo; Maria Callegari-Jacques, Sidia; Schuler-Faccini, Lavinia; Catira Bortolini, Maria] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil; [Gomez-Valdes, Jorge] Univ Nacl Autonoma Mexico, Fac Med, Dept Anat, Lab Antropol Fis, Mexico City 04510, DF, Mexico; [Leal Barbosa, Ana Angelica] Univ Estadual Sudoeste Bahia, Dept Ciencias Biol, Jequie, Brazil; [Longo, Danae] Inst Fed Educ Ciencia & Tecnol Farroupilha, Alegrete, Brazil; [Rothhammer, Francisco] Univ Chile, Fac Med, Univ Tarapaca, Inst Alta Invest, Arica, Chile; [Rothhammer, Francisco] Ctr Invest Hombre El Desierto, Arica, Chile; [Bedoya, Gabriel] Univ Antioquia, Medellin, Colombia; [Canizales-Quinteros, Samuel] Univ Nacl Autonoma Mexico, Fac Quim, Unidad Genom Poblaciones Aplicada Salud, Mexico City 04510, DF, Mexico; [Canizales-Quinteros, Samuel] Inst Nacl Med Genom, Mexico City, DF, Mexico; [Acuna-Alonzo, Victor] Escuela Nacl Antropol & Hist, Mol Genet Lab, Mexico City, DF, Mexico; [Gallo, Carla; Poletti, Giovanni] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Lab Invest & Desarrollo, Lima, Peru; [Gonzalez-Jose, Rolando] Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patago, Puerto Madryn, Argentina; [Mauro Salzano, Francisco; Maria Callegari-Jacques, Sidia] Univ Fed Rio Grande do Sul, Dept Estatist, Porto Alegre, RS, Brazil; [Schuler-Faccini, Lavinia] INAGEMP Inst Nacl Genet Med Populac, Porto Alegre, RS, Brazil; [Ruiz-Linares, Andres] UCL, Dept Genet Evolut & Environm, London, England; [Ruiz-Linares, Andres] UCL, UCL Genet Inst, London, England	Universidade Federal do Rio Grande do Sul; Universidad Nacional Autonoma de Mexico; Universidade Estadual do Sudoeste da Bahia; Instituto Federal Farroupilha; Universidad de Chile; Universidad de Tarapaca; Universidad de Antioquia; Instituto Nacional de Medicina Genomica; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Medicina Genomica; Universidad Peruana Cayetano Heredia; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidade Federal do Rio Grande do Sul; University of London; University College London; University of London; University College London	Bortolini, MC (corresponding author), Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil.	maria.bortolini@ufrgs.br	Salzano, Francisco M/L-7916-2015; Callegari-Jacques, Sidia M/H-1774-2016; SCHULER-FACCINI, LAVINIA/C-8309-2013; Gallo, Carla/Q-4296-2019; SCHULER-FACCINI, LAVINIA/K-2927-2016; Hünemeier, Tábita/F-4181-2011; Ruiz-Linares, Andres/AAR-1104-2021; Vargas Pinilla, Pedro/O-7901-2018	SCHULER-FACCINI, LAVINIA/0000-0002-2428-0460; SCHULER-FACCINI, LAVINIA/0000-0002-2428-0460; Ruiz-Linares, Andres/0000-0001-8372-1011; Vargas Pinilla, Pedro/0000-0003-4622-0941; CALLEGARI JACQUES, SIDIA M./0000-0002-2489-2539; BARBOSA, ANA ANGELICA LEAL BARBOSA/0000-0002-0370-202X; Gonzalez-Jose, Rolando/0000-0002-8128-9381; Hunemeier, Tabita/0000-0002-3156-2079; Gallo, Carla/0000-0001-8348-0473	Brazil: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [400554/2012-7]; Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul, (FAPERGS) [PqG 11/1426-0]; UK: Leverhulme Trust and Biotechnology and Biological Sciences Research Council of the United Kingdom	Brazil: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul, (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); UK: Leverhulme Trust and Biotechnology and Biological Sciences Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding provided by the following: Brazil: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; (400554/2012-7, PVE - Ciencia sem Fronteiras), the Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul, (FAPERGS; PRONEX and PqG 11/1426-0; UK: Leverhulme Trust and Biotechnology and Biological Sciences Research Council of the United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON JH, 2001, COMPUTER PROGRAMS EP; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Amos CI, 2011, HUM MOL GENET, V20, P5012, DOI 10.1093/hmg/ddr415; Beleza S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003372; Beleza S, 2013, MOL BIOL EVOL, V30, P24, DOI 10.1093/molbev/mss207; Bortolini MC, 1999, AM J HUM BIOL, V11, P551, DOI 10.1002/(SICI)1520-6300(1999)11:4<551::AID-AJHB15>3.0.CO;2-Z; Cerqueira C. C. S., 2011, FORENSIC SCI, P85; Cerqueira CCS, 2012, AM J HUM BIOL, V24, P705, DOI 10.1002/ajhb.22263; Cheli Y, 2009, J BIOL CHEM, V284, P18699, DOI 10.1074/jbc.M109.005819; Cook AL, 2009, J INVEST DERMATOL, V129, P392, DOI 10.1038/jid.2008.211; Edwards M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000867; Eiberg H, 2008, HUM GENET, V123, P177, DOI 10.1007/s00439-007-0460-x; Fernandez L, 2008, HUM MUTAT, V29, P1161, DOI 10.1002/humu.20804; Gerstenblith MR, 2010, PIGM CELL MELANOMA R, V23, P587, DOI 10.1111/j.1755-148X.2010.00730.x; Ginger RS, 2008, J BIOL CHEM, V283, P5486, DOI 10.1074/jbc.M707521200; Graf J, 2005, HUM MUTAT, V25, P278, DOI 10.1002/humu.20143; Guedj M, 2008, HUM MUTAT, V29, P1154, DOI 10.1002/humu.20823; Guerreiro V, 2009, GENET MOL BIOL, V32, P1, DOI 10.1590/S1415-47572009005000001; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; Hida T, 2009, PIGM CELL MELANOMA R, V22, P623, DOI 10.1111/j.1755-148X.2009.00582.x; Hunemeier T, 2007, AM J PHYS ANTHROPOL, V133, P854, DOI 10.1002/ajpa.20604; Jablonski NG, 2012, J ROY COLL PHYS EDIN, V42, P58, DOI 10.4997/JRCPE.2012.114; Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403; Jablonski NG, 2012, PHILOS T R SOC B, V367, P785, DOI 10.1098/rstb.2011.0308; Jablonski NG, 2010, P NATL ACAD SCI USA, V107, P8962, DOI 10.1073/pnas.0914628107; Kayser M, 2011, NAT REV GENET, V12, P179, DOI 10.1038/nrg2952; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; Liu F, 2013, SEMIN CELL DEV BIOL, V24, P562, DOI 10.1016/j.semcdb.2013.03.013; Marrero AR, 2007, AM J PHYS ANTHROPOL, V132, P301, DOI 10.1002/ajpa.20515; McEvoy B, 2006, HUM MOL GENET, V15, pR176, DOI 10.1093/hmg/ddl217; Nan H, 2009, J INVEST DERMATOL, V129, P2250, DOI 10.1038/jid.2009.62; Neitzke-Montinelli V, 2012, AM J HUM BIOL, V24, P853, DOI 10.1002/ajhb.22301; Norton HL, 2007, MOL BIOL EVOL, V24, P710, DOI 10.1093/molbev/msl203; Ott J, 1988, PROGRAM HWE UTILITY; Paik SH, 2012, EXP MOL MED, V44, P241, DOI 10.3858/emm.2012.44.3.020; Parra EJ, 2007, YEARB PHYS ANTHROPOL, V50, P85, DOI 10.1002/ajpa.20727; Priore MD, 2004, ANCESTRAIS INTRO HIS; Quillen EE, 2012, HUM GENET, V131, P1073, DOI 10.1007/s00439-011-1135-1; Quillen Ellen E, 2011, J Invest Dermatol, V131, pE5, DOI 10.1038/skinbio.2011.3; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Rodrigues Nina., 2008, AFRICANOS BRASIL; Ruiz-Linares A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004572; Salzano FM, 2002, EVOLUTION GENETICS L; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Spichenok O, 2011, FORENSIC SCI INT-GEN, V5, P472, DOI 10.1016/j.fsigen.2010.10.005; Stokowski RP, 2007, AM J HUM GENET, V81, P1119, DOI 10.1086/522235; Sturm RA, 2001, GENE, V277, P49, DOI 10.1016/S0378-1119(01)00694-1; Sturm RA, 2008, AM J HUM GENET, V82, P424, DOI 10.1016/j.ajhg.2007.11.005; Sturm RA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-248; Sturm RA, 2009, HUM MOL GENET, V18, pR9, DOI 10.1093/hmg/ddp003; Valenzuela RK, 2010, J FORENSIC SCI, V55, P315, DOI 10.1111/j.1556-4029.2009.01317.x; Visser M, 2012, GENOME RES, V22, P446, DOI 10.1101/gr.128652.111; Walsh S, 2013, FORENSIC SCI INT-GEN, V7, P98, DOI 10.1016/j.fsigen.2012.07.005; Walsh S, 2011, FORENSIC SCI INT-GEN, V5, P170, DOI 10.1016/j.fsigen.2010.02.004	55	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96886	10.1371/journal.pone.0096886	http://dx.doi.org/10.1371/journal.pone.0096886			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24809478	Green Submitted, Green Published, gold			2022-12-27	WOS:000338213300083
J	Wang, SH; Wang, JY; Lin, PY; Lin, KH; Ko, CJ; Hsieh, CE; Lin, HC; Chen, YL				Wang, Szu-Han; Wang, Jiun-Yi; Lin, Ping-Yi; Lin, Kuo-Hua; Ko, Chih-Jan; Hsieh, Chia-En; Lin, Hui-Chuan; Chen, Yao-Li			Predisposing Risk Factors for Delirium in Living Donor Liver Transplantation Patients in Intensive Care Units	PLOS ONE			English	Article							MECHANICALLY VENTILATED PATIENTS; POSTOPERATIVE DELIRIUM; HEPATIC-ENCEPHALOPATHY; RELIABILITY; MORTALITY; VALIDITY; SURGERY	Background: Delirium is one of the main causes of increased length of intensive care unit (ICU) stay among patients who have undergone living donor liver transplantation (LDLT). We aimed to evaluate risk factors for delirium after LDLT as well as to investigate whether delirium impacts the length of ICU and hospital stay. Methods: Seventy-eight patients who underwent LDLT during the period January 2010 to December 2012 at a single medical center were enrolled. The Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) scale was used to diagnose delirium. Preoperative, postoperative, and hematologic factors were included as potential risk factors for developing delirium. Results: During the study period, delirium was diagnosed in 37 (47.4%) patients after LDLT. The mean onset of symptoms occurred 7.0 +/- 5.5 days after surgery and the mean duration of symptoms was 5.0 +/- 2.6 days. The length of stay in the ICU for patients with delirium (39.8 +/- 28.1 days) was significantly longer than that for patients without delirium (29.3 +/- 19.0 days) (p < 0.05). Risk factors associated with delirium included history of alcohol abuse [odds ratio (OR) = 6.40, 95% confidence interval (CI): 1.85-22.06], preoperative hepatic encephalopathy (OR = 4.45, 95% CI: 1.36-14.51), APACHE II score >= 16 (OR = 1.73, 95% CI: 1.71-2.56), and duration of endotracheal intubation >= 5 days (OR = 1.81, 95% CI: 1.52-2.23). Conclusions: History of alcohol abuse, preoperative hepatic encephalopathy, APACHE II scores >= 16 and endotracheal intubation >= 5 days were predictive of developing delirium in the ICU following liver transplantation surgery and were associated with increased length of ICU and hospital stay.	[Wang, Szu-Han; Hsieh, Chia-En] Changhua Christian Hosp, Organ Transplant Ctr, Changhua, Taiwan; [Wang, Jiun-Yi] Asia Univ, Dept Hlth Care Adm, Taichung, Taiwan; [Lin, Ping-Yi] Changhua Christian Hosp, Transplant Med & Surg Res Ctr, Changhua, Taiwan; [Lin, Hui-Chuan] Hung Kuang Univ, Dept Senior Citizen Welf & Business, Taichung, Taiwan; [Lin, Kuo-Hua; Ko, Chih-Jan; Chen, Yao-Li] Changhua Christian Hosp, Dept Gen Surg, Changhua, Taiwan; [Chen, Yao-Li] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chen, Yao-Li] Kaohsiung Med Univ, Sch Med, Kaohsiung, Taiwan	Changhua Christian Hospital; Asia University Taiwan; Changhua Christian Hospital; Hungkuang University; Changhua Christian Hospital; Chung Shan Medical University; Kaohsiung Medical University	Lin, HC (corresponding author), Hung Kuang Univ, Dept Senior Citizen Welf & Business, Taichung, Taiwan.	jenny9286@sunrise.hk.edu.tw; 31560@cch.org.tw						Bajaj JS, 2007, AM J GASTROENTEROL, V102, P754, DOI 10.1111/j.1572-0241.2007.01048.x; Bohner H, 2003, ANN SURG, V238, P149, DOI 10.1097/00000658-200307000-00019; Bruce AJ, 2007, INT PSYCHOGERIATR, V19, P197, DOI 10.1017/S104161020600425X; Chiu NM, 2009, PSYCHIAT CLIN NEUROS, V63, P471, DOI 10.1111/j.1440-1819.2009.01987.x; Dhar R, 2008, NEUROCRIT CARE, V8, P253, DOI 10.1007/s12028-007-9020-4; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Groen JA, 2012, J CARDIAC SURG, V27, P589, DOI 10.1111/j.1540-8191.2012.01508.x; Jochum T, 2011, OPEN CRITICAL CARE M, V4, P47; Jowsey S G, 2001, J Psychiatr Pract, V7, P404, DOI 10.1097/00131746-200111000-00006; Lescot T, 2013, CAN J GASTROENTEROL, V27, P207, DOI 10.1155/2013/289185; Marcantonio ER, 1998, AM J MED, V105, P380, DOI 10.1016/S0002-9343(98)00292-7; Olin K, 2005, BRIT J SURG, V92, P1559, DOI 10.1002/bjs.5053; Pisani MA, 2007, ARCH INTERN MED, V167, P1629, DOI 10.1001/archinte.167.15.1629; Platz KP, 2000, TRANSPL INT, V13, P127; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Shehabi Y, 2010, CRIT CARE MED, V38, P2311, DOI 10.1097/CCM.0b013e3181f85759; Telles-Correia Diogo, 2006, Acta Med Port, V19, P165; Thomason JWW, 2005, CRIT CARE, V9, pR375, DOI 10.1186/cc3729; Vasilevskis EE, 2011, J AM GERIATR SOC, V59, pS249, DOI 10.1111/j.1532-5415.2011.03673.x; Yoshimura Y, 2004, WORLD J SURG, V28, P982, DOI 10.1007/s00268-004-7344-1	22	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96676	10.1371/journal.pone.0096676	http://dx.doi.org/10.1371/journal.pone.0096676			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24811254	Green Published, gold, Green Submitted			2022-12-27	WOS:000338213300060
J	Zeng, SH; Liu, YL; Wu, M; Liu, XM; Shen, XF; Liu, CZ; Wang, Y				Zeng, Shaohua; Liu, Yongliang; Wu, Min; Liu, Xiaomin; Shen, Xiaofei; Liu, Chunzhao; Wang, Ying			Identification and Validation of Reference Genes for Quantitative Real-Time PCR Normalization and Its Applications in Lycium	PLOS ONE			English	Article							RT-PCR; HOUSEKEEPING GENES; POLYGALACTURONASE GENE; REGULATORY REGIONS; EXPRESSION; SELECTION; RNA; TRANSCRIPTION; FLAVONOIDS; MODEL	Lycium barbarum and L. ruthenicum are extensively used as traditional Chinese medicinal plants. Next generation sequencing technology provides a powerful tool for analyzing transcriptomic profiles of gene expression in non-model species. Such gene expression can then be confirmed with quantitative real-time polymerase chain reaction (qRT-PCR). Therefore, use of systematically identified suitable reference genes is a prerequisite for obtaining reliable gene expression data. Here, we calculated the expression stability of 18 candidate reference genes across samples from different tissues and grown under salt stress using geNorm and NormFinder procedures. The geNorm-determined rank of reference genes was similar to those defined by NormFinder with some differences. Both procedures confirmed that the single most stable reference gene was ACNTIN1 for L. barbarum fruits, H2B1 for L. barbarum roots, and EF1 alpha for L. ruthenicum fruits. PGK3, H2B2, and PGK3 were identified as the best stable reference genes for salt-treated L. ruthenicum leaves, roots, and stems, respectively. H2B1 and GAPDH1+PGK1 for L. ruthenicum and SAMDC2+H2B1 for L. barbarum were the best single and/or combined reference genes across all samples. Finally, expression of salt-responsive gene NAC, fruit ripening candidate gene LrPG, and anthocyanin genes were investigated to confirm the validity of the selected reference genes. Suitable reference genes identified in this study provide a foundation for accurately assessing gene expression and further better understanding of novel gene function to elucidate molecular mechanisms behind particular biological/physiological processes in Lycium.	[Zeng, Shaohua; Wu, Min; Liu, Xiaomin; Wang, Ying] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Liu, Yongliang; Shen, Xiaofei; Wang, Ying] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Pant Germplasm Enhancement & Specialty Ag, Wuhan, Hubei, Peoples R China; [Liu, Chunzhao] Chinese Acad Sci, Inst Proc Engn, Natl Key Lab Biochem Engn, Beijing, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; Institute of Process Engineering, CAS	Wang, Y (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China.	yingwang@wbgcas.cn	Liu, Yongliang/AAN-6097-2020; Liu, Yongliang/AAP-5477-2020		National Natural Science Foundation of China [31100223]; Scientific Research Equipment Project of Chinese Academy of Sciences [YZ201227]; Key Laboratory of Plant Resources Conservation and Sustainable Utilization	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Equipment Project of Chinese Academy of Sciences; Key Laboratory of Plant Resources Conservation and Sustainable Utilization	This work was supported by National Natural Science Foundation of China (Grant no.31100223), Scientific Research Equipment Project of Chinese Academy of Sciences (YZ201227), and Key Laboratory of Plant Resources Conservation and Sustainable Utilization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amagase H, 2011, FOOD RES INT, V44, P1702, DOI 10.1016/j.foodres.2011.03.027; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; BIRD CR, 1988, PLANT MOL BIOL, V11, P651, DOI 10.1007/BF00017465; Borges A, 2012, PLANT CELL REP, V31, P827, DOI 10.1007/s00299-011-1204-x; Chan HC, 2007, EXP NEUROL, V203, P269, DOI 10.1016/j.expneurol.2006.05.031; Chen L, 2011, PLANTA, V234, P377, DOI 10.1007/s00425-011-1410-3; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; DEIKMAN J, 1992, PLANT PHYSIOL, V100, P2013, DOI 10.1104/pp.100.4.2013; DELLAPENNA D, 1989, PLANT PHYSIOL, V90, P1372, DOI 10.1104/pp.90.4.1372; Dixon RA, 1999, TRENDS PLANT SCI, V4, P394, DOI 10.1016/S1360-1385(99)01471-5; Dombrowski JE, 2009, PLANT SCI, V176, P390, DOI 10.1016/j.plantsci.2008.12.005; Dong JZ, 2009, PLANT FOOD HUM NUTR, V64, P199, DOI 10.1007/s11130-009-0128-x; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; Gu CS, 2011, MOL BIOTECHNOL, V49, P192, DOI 10.1007/s12033-011-9394-6; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Huis R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-71; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Li SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016380; LINCOLN JE, 1988, MOL GEN GENET, V212, P71, DOI 10.1007/BF00322446; Liu Z, 2013, PLANT CELL TISS ORG, V113, P469, DOI 10.1007/s11240-013-0288-0; Lovdal T, 2009, ANAL BIOCHEM, V387, P238, DOI 10.1016/j.ab.2009.01.024; MONTGOMERY J, 1993, PLANT CELL, V5, P1049, DOI 10.1105/tpc.5.9.1049; Narsai R, 2010, BMC PLANT BIOL, V10; NICHOLASS FJ, 1995, PLANT MOL BIOL, V28, P423, DOI 10.1007/BF00020391; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Ouyang B, 2007, J EXP BOT, V58, P507, DOI 10.1093/jxb/erl258; Potterat O, 2010, PLANTA MED, V76, P7, DOI 10.1055/s-0029-1186218; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; TUCKER GA, 1982, PLANTA, V155, P64, DOI 10.1007/BF00402933; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walker NJ, 2002, SCIENCE, V296, P557, DOI 10.1126/science.296.5567.557; Wang LJ, 2013, PLANT PHYSIOL BIOCH, V70, P304, DOI 10.1016/j.plaphy.2013.05.038; Yao X, 2011, CHEM BIODIVERS, V8, P976, DOI 10.1002/cbdv.201000018; Zeng SH, 2014, PHYSIOL PLANTARUM, V150, P505, DOI 10.1111/ppl.12131; Zheng J, 2011, FOOD CHEM, V126, P859, DOI 10.1016/j.foodchem.2010.11.052; Zhong HY, 2011, PLANT CELL REP, V30, P641, DOI 10.1007/s00299-010-0992-8	41	31	35	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e97039	10.1371/journal.pone.0097039	http://dx.doi.org/10.1371/journal.pone.0097039			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810586	gold, Green Published, Green Submitted			2022-12-27	WOS:000338213300112
J	Assi, H; Espinosa, J; Suprise, S; Sofroniew, M; Doherty, R; Zamler, D; Lowenstein, PR; Castro, MG				Assi, Hikmat; Espinosa, Jaclyn; Suprise, Sarah; Sofroniew, Michael; Doherty, Robert; Zamler, Daniel; Lowenstein, Pedro R.; Castro, Maria G.			Assessing the Role of STAT3 in DC Differentiation and Autologous DC Immunotherapy in Mouse Models of GBM	PLOS ONE			English	Article							DENDRITIC CELL VACCINATION; TUMOR MICROENVIRONMENT; IMMUNE-RESPONSES; CANCER-CELLS; EXPRESSION; BRAIN; GLIOBLASTOMA; APOPTOSIS; ACTIVATION; INHIBITION	Cellular microenvironments, particularly those found in tumors, elicit a tolerogenic DC phenotype which can attenuate immune responses. Central to this process is the STAT3-mediated signaling cascade. As a transcription factor and oncogene, STAT3 promotes the expression of genes which allow tumor cells to proliferate, migrate and evade apoptosis. More importantly, activation of STAT3 in tumor infiltrating immune cells has been shown to be responsible, in part, for their immune-suppressed phenotype. The ability of STAT3 to orchestrate a diverse set of immunosuppressive instructions has made it an attractive target for cancer vaccines. Using a conditional hematopoietic knockout mouse model of STAT3, we evaluated the impact of STAT3 gene ablation on the differentiation of dendritic cells from bone marrow precursors. We also assessed the impact of STAT3 deletion on phagocytosis, maturation, cytokine secretion and antigen presentation by GMCSF derived DCs in vitro. In addition to in vitro studies, we compared the therapeutic efficacy of DC vaccination using STAT3 deficient DCs to wild type counterparts in an intracranial mouse model of GBM. Our results indicated the following pleiotropic functions of STAT3: hematopoietic cells which lacked STAT3 were unresponsive to Flt3L and failed to differentiate as DCs. In contrast, STAT3 was not required for GM-CSF induced DC differentiation as both wild type and STAT3 null bone marrow cells gave rise to similar number of DCs. STAT3 also appeared to regulate the response of GM-CSF derived DCs to CpG. STAT3 null DCs expressed high levels of MHC-II, secreted more IL-12p70, IL-10, and TNF alpha were better antigen presenters in vitro. Although STAT3 deficient DCs displayed an enhanced activated phenotype in culture, they elicited comparable therapeutic efficacy in vivo compared to their wild type counterparts when utilized in vaccination paradigms in mice bearing intracranial glioma tumors.	[Assi, Hikmat; Espinosa, Jaclyn; Suprise, Sarah; Doherty, Robert; Zamler, Daniel; Lowenstein, Pedro R.; Castro, Maria G.] Univ Michigan, Sch Med, Dept Neurosurg, Ann Arbor, MI 48109 USA; [Assi, Hikmat; Espinosa, Jaclyn; Suprise, Sarah; Doherty, Robert; Zamler, Daniel; Lowenstein, Pedro R.; Castro, Maria G.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI USA; [Assi, Hikmat] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Sofroniew, Michael] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Castro, MG (corresponding author), Univ Michigan, Sch Med, Dept Neurosurg, Ann Arbor, MI 48109 USA.	mariacas@umich.edu	Castro, Maria/ABC-5182-2021; Sofroniew, Michael/ABE-8857-2020	Castro, Maria/0000-0003-2237-2756; Zamler, Daniel/0000-0003-0375-8119; Doherty, Robert/0000-0001-9307-7995	National Institutes of Health/National Institute of Neurological Disorders & Stroke (NIH/NINDS) [U01-NS052465, U01-NS052465-S1, R01-NS074387, R01-NS057711]; MICHR [R01-NS054193, R01-NS061107, R01-NS082311, R21-NS084275]; Department of Neurosurgery, University of Michigan School of Medicine; Michigan Institute for Clinical and Health Research [NIH UL1-TR000433, MICHR U040007]; University of Michigan Cancer Biology Training Grant, NIH/NCI (National Cancer Institute) [T32-CA009676]; University of Michigan Training in Clinical and Basic Neuroscience [T32-NS007222]; University of Michigan Medical Scientist Training Program, NIH/NIGMS (National Institute of General Medicine Sciences) [T32-GM007863]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082311, R01NS061107, U01NS052465, T32NS007222, R01NS057711, R21NS084275, R01NS054193, R01NS074387] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Neurological Disorders & Stroke (NIH/NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MICHR; Department of Neurosurgery, University of Michigan School of Medicine; Michigan Institute for Clinical and Health Research; University of Michigan Cancer Biology Training Grant, NIH/NCI (National Cancer Institute); University of Michigan Training in Clinical and Basic Neuroscience; University of Michigan Medical Scientist Training Program, NIH/NIGMS (National Institute of General Medicine Sciences); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health/National Institute of Neurological Disorders & Stroke (NIH/NINDS) Grants U01-NS052465, U01-NS052465- S1, R01-NS074387, R01-NS057711, and MICHR Pilot R12 to M.G.C.; NIH/NINDS Grants R01-NS054193, R01-NS061107, R01-NS082311, and R21-NS084275 to P.R.L.; the Department of Neurosurgery, University of Michigan School of Medicine; the Michigan Institute for Clinical and Health Research, NIH UL1-TR000433 and MICHR U040007; University of Michigan Cancer Biology Training Grant, NIH/NCI (National Cancer Institute) T32-CA009676; University of Michigan Training in Clinical and Basic Neuroscience, NIH/NINDS T32-NS007222; and the University of Michigan Medical Scientist Training Program, NIH/NIGMS (National Institute of General Medicine Sciences) T32-GM007863. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Ghazal M, 2008, CLIN CANCER RES, V14, P8228, DOI 10.1158/1078-0432.CCR-08-1329; Alonzi T, 2004, CYTOKINE, V26, P45, DOI 10.1016/j.cyto.2003.12.002; Assi H CM, 2013, ANIMAL MODELS BRAIN; AUSMAN JI, 1970, CANCER RES, V30, P2394; Bloch O, 2013, CLIN CANCER RES, V19, P3165, DOI 10.1158/1078-0432.CCR-12-3314; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Cho DY, 2012, WORLD NEUROSURG, V77, P736, DOI 10.1016/j.wneu.2011.08.020; Cui W, 2011, IMMUNITY, V35, P792; Curtin JF, 2006, J IMMUNOL, V176, P3566, DOI 10.4049/jimmunol.176.6.3566; Curtin JF, 2009, PLOS MED, V6, P83, DOI 10.1371/journal.pmed.1000010; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Epling-Burnette PK, 2001, J CLIN INVEST, V107, P351, DOI 10.1172/JCI9940; Fecci PE, 2006, CANCER RES, V66, P3294, DOI 10.1158/0008-5472.CAN-05-3773; He JL, 2004, J BIOL CHEM, V279, P4705, DOI 10.1074/jbc.M311183200; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Higano CS, 2010, NAT REV DRUG DISCOV, V9, P513, DOI 10.1038/nrd3220; Iwata-Kajihara T, 2011, J IMMUNOL, V187, P27, DOI 10.4049/jimmunol.1002067; Kim JE, 2013, PHARMACOL RES, V71, P23, DOI 10.1016/j.phrs.2013.02.001; Kitamura H, 2005, IMMUNITY, V23, P491, DOI 10.1016/j.immuni.2005.09.010; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Kortylewski M, 2009, NAT BIOTECHNOL, V27, P925, DOI 10.1038/nbt.1564; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Laouar Y, 2003, IMMUNITY, V19, P903, DOI 10.1016/S1074-7613(03)00332-7; Larocque D, 2010, P NATL ACAD SCI USA, V107, P14443, DOI 10.1073/pnas.0913496107; Li GH, 2009, J NEURO-ONCOL, V91, P165, DOI 10.1007/s11060-008-9696-0; Liau LM, 2005, CLIN CANCER RES, V11, P5515, DOI 10.1158/1078-0432.CCR-05-0464; Liu L, 2006, ONCOGENE, V25, P4904, DOI 10.1038/sj.onc.1209501; Lowenstein PR, 2002, TRENDS IMMUNOL, V23, P70, DOI 10.1016/S1471-4906(01)02151-2; Lowenstein PR, 2002, TRENDS IMMUNOL, V23, P23, DOI 10.1016/S1471-4906(01)02063-4; Mora LB, 2002, CANCER RES, V62, P6659; Morikawa T, 2011, CLIN CANCER RES, V17, P1452, DOI 10.1158/1078-0432.CCR-10-2694; Nefedova Y, 2004, J IMMUNOL, V172, P464, DOI 10.4049/jimmunol.172.1.464; Raychaudhuri B, 2011, NEURO-ONCOLOGY, V13, P591, DOI 10.1093/neuonc/nor042; Ribas A, 2009, CLIN CANCER RES, V15, P6267, DOI 10.1158/1078-0432.CCR-09-1254; Saha A, 2010, SCAND J IMMUNOL, V71, P70, DOI 10.1111/j.1365-3083.2009.02355.x; SHERMAN LA, 1993, ANNU REV IMMUNOL, V11, P385, DOI 10.1146/annurev.immunol.11.1.385; Soldati R, 2012, INT J CANCER, V131, P1131, DOI 10.1002/ijc.26498; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Zhao X, 2012, ASIAN PAC J CANCER P, V13, P2873, DOI 10.7314/APJCP.2012.13.6.2873; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	42	10	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96318	10.1371/journal.pone.0096318	http://dx.doi.org/10.1371/journal.pone.0096318			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806510	Green Published, Green Submitted, gold			2022-12-27	WOS:000335728900047
J	Ferguson, E; Maltby, J; Bibby, PA; Lawrence, C				Ferguson, Eamonn; Maltby, John; Bibby, Peter A.; Lawrence, Claire			Fast to Forgive, Slow to Retaliate: Intuitive Responses in the Ultimatum Game Depend on the Degree of Unfairness	PLOS ONE			English	Article							DECISION-MAKING; RECIPROCITY; PERSONALITY; COOPERATION; EVOLUTION; FAIRNESS; DONORS	Evolutionary accounts have difficulty explaining why people cooperate with anonymous strangers they will never meet. Recently models, focusing on emotional processing, have been proposed as a potential explanation, with attention focusing on a dual systems approach based on system 1 (fast, intuitive, automatic, effortless, and emotional) and system 2 (slow, reflective, effortful, proactive and unemotional). Evidence shows that when cooperation is salient, people are fast (system 1) to cooperate, but with longer delays (system 2) they show greed. This is interpreted within the framework of the social heuristic hypothesis (SHH), whereby people overgeneralize potentially advantageous intuitively learnt and internalization social norms to 'atypical' situations. We extend this to explore intuitive reactions to unfairness by integrating the SHH with the 'fast to forgive, slow to anger' (FFSA) heuristic. This suggests that it is advantageous to be prosocial when facing uncertainty. We propose that whether or not someone intuitively shows prosociality (cooperation) or retaliation is moderated by the degree (certainty) of unfairness. People should intuitively cooperate when facing mild levels of unfairness (fast to forgive) but when given longer to decide about another's mild level of unfairness should retaliate (slow to anger). However, when facing severe levels of unfairness, the intuitive response is always retaliation. We test this using a series of one-shot ultimatum games and manipulate level of offer unfairness (50:50 60:40, 70:30, 80:20, 90:10) and enforced time delays prior to responding (1s, 2s, 8s, 15s). We also measure decision times to make responses after the time delays. The results show that when facing mildly unfair offers (60:40) people are fast (intuitive) to cooperate but with longer delays reject these mildly unfair offers: 'fast to forgive, and slow to retaliate'. However, for severely unfair offers (90:10) the intuitive and fast response is to always reject.	[Ferguson, Eamonn; Bibby, Peter A.; Lawrence, Claire] Univ Nottingham, Sch Psychol, PSPH Grp, Nottingham NG7 2RD, England; [Maltby, John] Univ Leicester, Sch Psychol, Leicester, Leics, England	University of Nottingham; University of Leicester	Ferguson, E (corresponding author), Univ Nottingham, Sch Psychol, PSPH Grp, Nottingham NG7 2RD, England.	eamonn.ferguson@nottingham.ac.uk	Maltby, John/S-4021-2019; Maltby, John/A-9338-2012; Lawrence, Claire/P-1058-2018	Maltby, John/0000-0002-0621-9359; Maltby, John/0000-0002-0621-9359; Lawrence, Claire/0000-0001-6787-9716; Ferguson, Eamonn/0000-0002-7678-1451	schools of Psychology at the Universities of Leicester and Nottingham	schools of Psychology at the Universities of Leicester and Nottingham	The study was funded by the schools of Psychology at the Universities of Leicester and Nottingham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardsley N., 2000, Experimental Economics, V3, P215, DOI 10.1007/BF01669773; Bosman R, 2001, EMOTIONS REJECTION C; Buss DM, 2008, GROUP DYN-THEOR RES, V12, P53, DOI 10.1037/1089-2699.12.1.53; Cappelletti D, 2008, JENA EC RES PAPERS; Delton AW, 2011, P NATL ACAD SCI USA, V108, P13335, DOI 10.1073/pnas.1102131108; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Ferguson E, 2012, TRANSFUSION, V52, P2189, DOI 10.1111/j.1537-2995.2011.03557.x; Ferguson E, 2011, PERS INDIV DIFFER, V51, P201, DOI 10.1016/j.paid.2011.03.030; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; Fudenberg D, 2012, AM ECON REV, V102, P720, DOI 10.1257/aer.102.2.720; Grimm V, 2011, ECON LETT, V111, P113, DOI 10.1016/j.econlet.2011.01.025; Hayes A. F, 2013, INTRO MEDIATION MODE, DOI [10.1111/jedm.12050, DOI 10.1111/JEDM.12050]; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Kahneman D., 2011, THINKING, P512; King-Casas B, 2008, SCIENCE, V321, P806, DOI 10.1126/science.1156902; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Milinski M, 2002, P ROY SOC B-BIOL SCI, V269, P881, DOI 10.1098/rspb.2002.1964; Muthen LK, 1998, MPLUS USERS GUIDE, P750; Neo WS, 2013, J ECON PSYCHOL, V34, P20, DOI 10.1016/j.joep.2012.11.001; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Oechssler J, 2006, COOLING OFF IN THE U; Osumi T, 2010, PERS INDIV DIFFER, V49, P451, DOI 10.1016/j.paid.2010.04.016; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Rand DG, 2012, NATURE, V489, P427, DOI 10.1038/nature11467; Rand DG, 2014, NATURE COMM IN PRESS; ROSE SA, 1974, CHILD DEV, V45, P499, DOI 10.2307/1127977; Rubinstein A, 2007, ECON J, V117, P1243, DOI 10.1111/j.1468-0297.2007.02081.x; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Sutter M, 2003, ECON LETT, V81, P341, DOI 10.1016/S0165-1765(03)00215-5; Tomasello M, 2012, TRENDS COGN SCI, V16, P580, DOI 10.1016/j.tics.2012.10.006; Wu Y, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00131; Zaki J, 2013, CURR DIR PSYCHOL SCI, V22, P466, DOI 10.1177/0963721413492764; [No title captured]; [No title captured]	35	13	13	6	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96344	10.1371/journal.pone.0096344	http://dx.doi.org/10.1371/journal.pone.0096344			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI1ZC	24820479	Green Published, Green Submitted, gold			2022-12-27	WOS:000336653300015
J	Gupta, AK; Giaglis, S; Hasler, P; Hahn, S				Gupta, Anurag Kumar; Giaglis, Stavros; Hasler, Paul; Hahn, Sinuhe			Efficient Neutrophil Extracellular Trap Induction Requires Mobilization of Both Intracellular and Extracellular Calcium Pools and Is Modulated by Cyclosporine A	PLOS ONE			English	Article							HISTONE DEIMINATION; MAMMALIAN TARGET; INHIBITION; CALCINEURIN; DNA; MYELOPEROXIDASE; ACTIVATION; RELEASE; CELLS; IL-8	Excessive or aberrant generation of neutrophil extracellular traps (NETs) has recently become implicated in the underlying aetiology of a number of human pathologies including preeclampsia, systemic lupus erythromatosus, rheumatoid arthritis, auto-antibody induced small vessel vasculitis, coagulopathies such as deep vein thrombosis or pulmonary complications. These results imply that effective pharmacological therapeutic strategies will need to be developed to counter overt NETosis in these and other inflammatory disorders. As calcium flux is implicated in the generation of reactive oxygen species and histone citrullination, two key events in NETosis, we analysed the roles of both extra- and intracellular calcium pools and their modulation by pharmacological agents in the NETotic process in detail. Interleukin-8 (IL-8) was used as a physiological stimulus of NETosis. Our data demonstrate that efficient induction of NETosis requires mobilisation of both extracellular and intracellular calcium pools. Since modulation of the calcineurin pathway by cyclosporine A has been described in neutrophils, we investigated its influence on NETosis. Our data indicate that IL-8 induced NETosis is reduced by ascomycin and cyclosporine A, antagonists of the calcineurin pathway, but not following treatment with rapamycin, which utilizes the mTOR pathway. The action of the G protein coupled receptor phospholipase C pathway appears to be essential for the induction of NETs by IL-8, as NETosis was diminished by treatment with either pertussis toxin, a G-protein inhibitor, the phospholipase C inhibitor, U73122, or staurosporine, an inhibitor of protein kinase C. The data regarding the calcineurin antagonists, ascomycin and cyclosporine A, open the possibility to therapeutically supress or modulate NETosis. They also provide new insight into the mechanism whereby such immune suppressive drugs render transplant patients susceptible to opportunistic fungal infections.	[Gupta, Anurag Kumar; Giaglis, Stavros; Hahn, Sinuhe] Univ Basel Hosp, Dept Biomed, Lab Prenatal Med, CH-4031 Basel, Switzerland; [Giaglis, Stavros; Hasler, Paul] Cantonal Hosp Aarau, Dept Rheumatol, Aarau, Switzerland	University of Basel; Kantonsspital Aarau AG (KSA)	Hahn, S (corresponding author), Univ Basel Hosp, Dept Biomed, Lab Prenatal Med, CH-4031 Basel, Switzerland.	sinuhe.hahn@usb.ch	Giaglis, Stavros/GSO-0043-2022	Giaglis, Stavros/0000-0003-2216-9539; Gupta, Anurag/0000-0001-6850-3489	EU FP7 SAFE Network [LSHB-CT-2004-503243]; University Hospital Basel and Cantonal Hospital Aarau	EU FP7 SAFE Network; University Hospital Basel and Cantonal Hospital Aarau	This work was supported by EU FP7 SAFE Network (LSHB-CT-2004-503243) and funds from the University Hospital Basel and Cantonal Hospital Aarau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba G, 2012, J ENDOCRINOL, V214, P399, DOI 10.1530/JOE-12-0106; Ayala VI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019016; BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265; Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531; Brechard S, 2005, CELL CALCIUM, V37, P531, DOI 10.1016/j.ceca.2005.01.019; Brechard S, 2008, J LEUKOCYTE BIOL, V84, P1223, DOI 10.1189/jlb.0807553; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00413; Carballo M, 1999, J BIOL CHEM, V274, P93, DOI 10.1074/jbc.274.1.93; Carmona-Rivera C, 2014, ANN RHEUM DIS; Cheng OZ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00001; Fields TA, 1997, BIOCHEM J, V321, P561, DOI 10.1042/bj3210561; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Fuchs TA, 2012, ARTERIOSCL THROM VAS, V32, P1777, DOI 10.1161/ATVBAHA.111.242859; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Bass JIF, 2010, J IMMUNOL, V184, P6386, DOI 10.4049/jimmunol.0901640; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Gray RD, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-12; Greenblatt MB, 2010, J EXP MED, V207, P923, DOI 10.1084/jem.20092531; Gremese E, 2004, CLIN EXP RHEUMATOL, V22, pS101; Gupta AK, 2005, HUM IMMUNOL, V66, P1146, DOI 10.1016/j.humimm.2005.11.003; Gupta AK, 2010, FEBS LETT, V584, P3193, DOI 10.1016/j.febslet.2010.06.006; Hahn S, 2013, SEMIN IMMUNOPATHOL; Hahn S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00362; Hakkim A, 2011, NAT CHEM BIOL, V7, P75, DOI 10.1038/NCHEMBIO.496; Hauser CJ, 1999, SHOCK, V12, P428, DOI 10.1097/00024382-199912000-00003; Hauser CJ, 2001, J LEUKOCYTE BIOL, V69, P63; Hendey B, 1996, BLOOD, V87, P2038; HENDEY B, 1992, SCIENCE, V258, P296, DOI 10.1126/science.1384129; Ina K, 2002, INFLAMM BOWEL DIS, V8, P1, DOI 10.1097/00054725-200201000-00001; Itakura A, 2013, AM J PHYSIOL-CELL PH, V305, pC348, DOI 10.1152/ajpcell.00108.2013; Joshi MB, 2013, FEBS LETT, V587, P2241, DOI 10.1016/j.febslet.2013.05.053; Kaplan MJ, 2012, J IMMUNOL, V189, P2689, DOI 10.4049/jimmunol.1201719; Keshari RS, 2013, J CELL BIOCHEM, V114, P532, DOI 10.1002/jcb.24391; Keshari RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048111; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Khandpur R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005580; Kitahara K, 2007, CURR OPIN RHEUMATOL, V19, P238, DOI 10.1097/BOR.0b013e328099af80; Kuhns D, 1998, J IMMUNOL, V161, P4332; Lin AM, 2011, J IMMUNOL, V187, P490, DOI 10.4049/jimmunol.1100123; Martinod K, 2013, P NATL ACAD SCI USA, V110, P8674, DOI 10.1073/pnas.1301059110; McInturff AM, 2012, BLOOD, V120, P3118, DOI 10.1182/blood-2012-01-405993; Metzler KD, 2011, BLOOD, V117, P953, DOI 10.1182/blood-2010-06-290171; MINTA A, 1989, J BIOL CHEM, V264, P8171; Neeli I, 2008, J IMMUNOL, V180, P1895, DOI 10.4049/jimmunol.180.3.1895; Neeli I, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00038; Neeli I, 2009, J INNATE IMMUN, V1, P194, DOI 10.1159/000206974; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Parker H, 2012, J LEUKOCYTE BIOL, V92, P841, DOI 10.1189/jlb.1211601; Pilsczek FH, 2010, J IMMUNOL, V185, P7413, DOI 10.4049/jimmunol.1000675; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; Schorr W, 1999, EUR J IMMUNOL, V29, P897, DOI 10.1002/(SICI)1521-4141(199903)29:03<897::AID-IMMU897>3.3.CO;2-X; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; SPANGRUDE GJ, 1985, J IMMUNOL, V135, P4135; Spisani S, 2001, RHEUMATOLOGY, V40, P794, DOI 10.1093/rheumatology/40.7.794; Thornton RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053837; Tintinger GR, 2013, SEMIN IMMUNOPATHOL, V35, P395, DOI 10.1007/s00281-013-0366-8; Tintinger GR, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-29; Vandewalle A, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-8; Vega A, 2007, J CELL SCI, V120, P2328, DOI 10.1242/jcs.000331; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Wang YJ, 2012, J BIOL CHEM, V287, P25941, DOI 10.1074/jbc.M112.375725; WENZELSEIFERT K, 1991, J IMMUNOL, V147, P1940; Yan PK, 2006, J IMMUNOL, V177, P7050, DOI 10.4049/jimmunol.177.10.7050; Zurita E, 2013, INFECT IMMUN, V81, P2371, DOI 10.1128/IAI.00336-13	65	149	152	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97088	10.1371/journal.pone.0097088	http://dx.doi.org/10.1371/journal.pone.0097088			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819773	gold, Green Published, Green Submitted			2022-12-27	WOS:000336653300070
J	Mu, YN; Li, MY; Ding, F; Ding, Y; Ao, JQ; Hu, SNA; Chen, XH				Mu, Yinnan; Li, Mingyu; Ding, Feng; Ding, Yang; Ao, Jingqun; Hu, Songnian; Chen, Xinhua			De Novo Characterization of the Spleen Transcriptome of the Large Yellow Croaker (Pseudosciaena crocea) and Analysis of the Immune Relevant Genes and Pathways Involved in the Antiviral Response	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; POLY-I-C; DAVID BIOINFORMATICS RESOURCES; CELL ANTIGEN RECEPTOR; DOUBLE-STRANDED-RNA; POLYRIBOCYTIDYLIC ACID; PROFILING ANALYSIS; BONY FISH; EXPRESSION; IFN	The large yellow croaker (Pseudosciaena crocea) is an economically important marine fish in China. To understand the molecular basis for antiviral defense in this species, we used Illumia paired-end sequencing to characterize the spleen transcriptome of polyriboinosinic:polyribocytidylic acid [poly(I:C)]-induced large yellow croakers. The library produced 56,355,728 reads and assembled into 108,237 contigs. As a result, 15,192 unigenes were found from this transcriptome. Gene ontology analysis showed that 4,759 genes were involved in three major functional categories:biological process, cellular component, and molecular function. We further ascertained that numerous consensus sequences were homologous to known immune-relevant genes. Kyoto Encyclopedia of Genes and Genomes orthology mapping annotated 5,389 unigenes and identified numerous immune-relevant pathways. These immune-relevant genes and pathways revealed major antiviral immunity effectors, including but not limited to:pattern recognition receptors, adaptors and signal transducers, the interferons and interferon-stimulated genes, inflammatory cytokines and receptors, complement components, and B-cell and T-cell antigen activation molecules. Moreover, the partial genes of Toll-like receptor signaling pathway, RIG-I-like receptors signaling pathway, Janus kinase-Signal Transducer and Activator of Transcription (JAK-STAT) signaling pathway, and T-cell receptor (TCR) signaling pathway were found to be changed after poly(I:C) induction by real-time polymerase chain reaction (PCR) analysis, suggesting that these signaling pathways may be regulated by poly(I:C), a viral mimic. Overall, the antivirus-related genes and signaling pathways that were identified in response to poly(I:C) challenge provide valuable leads for further investigation of the antiviral defense mechanism in the large yellow croaker.	[Mu, Yinnan; Li, Mingyu; Ding, Yang; Ao, Jingqun; Chen, Xinhua] State Ocean Adm, Inst Oceanog 3, Key Lab Marine Biogenet & Resources, Xiamen, Peoples R China; [Ao, Jingqun; Chen, Xinhua] State Ocean Adm, Inst Oceanog 3, Collaborat Innovat Ctr Deep Sea Biol, Xiamen, Peoples R China; [Ding, Feng; Hu, Songnian] Chinese Acad Sci, Beijing Inst Gen, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Ding, Feng] King Abdullah Univ Sci & Technol, Biol & Environm Sci & Engn Div, Thuwal, Saudi Arabia	State Oceanic Administration; State Oceanic Administration; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; King Abdullah University of Science & Technology	Hu, SNA (corresponding author), Chinese Acad Sci, Beijing Inst Gen, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China.	husn@big.ac.cn; Chenxinh@tom.com	Hu, Songnian/C-6509-2013	Hu, Songnian/0000-0003-3966-3111; Li, Mingyu/0000-0003-1217-2929; Ding, Feng/0000-0001-8237-4062	National Basic Research Program of China [2012CB114402]; National Natural Science Foundation of China [31125027, 31372556]; Nation '863' Project [2012AA092202]; Xiamen south ocean research center [13GZP002NF08]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nation '863' Project(National High Technology Research and Development Program of China); Xiamen south ocean research center	The work was supported by grants from the National Basic Research Program of China (2012CB114402), National Natural Science Foundation of China (31125027 and 31372556), Nation ' 863 ' Project (2012AA092202), and fund of Xiamen south ocean research center (13GZP002NF08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanes H, 2011, GENOME RES, V21, P1328, DOI 10.1101/gr.116012.110; Altmann SM, 2003, J VIROL, V77, P1992, DOI 10.1128/JVI.77.3.1992-2002.2003; Alvarez-Pellitero P, 2008, VET IMMUNOL IMMUNOP, V126, P171, DOI 10.1016/j.vetimm.2008.07.013; Brodersen DE, 2005, FEBS J, V272, P2098, DOI 10.1111/j.1742-4658.2005.04651.x; Casani D, 2009, MOL IMMUNOL, V46, P943, DOI 10.1016/j.molimm.2008.09.016; Chen XH, 2003, J FISH DIS, V26, P615, DOI 10.1046/j.1365-2761.2003.00494.x; Demoulins T, 2009, VIROLOGY, V386, P225, DOI 10.1016/j.virol.2009.01.024; Fernandez-Trujillo A, 2008, FISH SHELLFISH IMMUN, V24, P279, DOI 10.1016/j.fsi.2007.11.008; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Gosu V, 2012, MOLECULES, V17, P13503, DOI 10.3390/molecules171113503; Han XW, 2009, P NATL ACAD SCI USA, V106, P12741, DOI 10.1073/pnas.0902417106; Hanriot L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-418; Hansen JD, 2011, DEV COMP IMMUNOL, V35, P886, DOI 10.1016/j.dci.2011.01.008; Hasler P, 2001, FASEB J, V15, P2085, DOI 10.1096/fj.00-0860rev; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang YH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-556; Imada K, 2000, MOL IMMUNOL, V37, P1, DOI 10.1016/S0161-5890(00)00018-3; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Kumar H, 2009, BIOCHEM J, V420, P1, DOI 10.1042/BJ20090272; Lee KY, 2012, J BIOL CHEM, V287, P11891, DOI 10.1074/jbc.M111.338467; Lin J, 2001, J CELL SCI, V114, P243; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005; Matsuo A, 2008, J IMMUNOL, V181, P3474, DOI 10.4049/jimmunol.181.5.3474; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Mu YN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-506; Mukhopadhyay R, 2008, MOL CELL, V32, P371, DOI 10.1016/j.molcel.2008.09.019; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Palti Y, 2011, DEV COMP IMMUNOL, V35, P1263, DOI 10.1016/j.dci.2011.03.006; Pereiro P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035369; Plant KP, 2005, DEV COMP IMMUNOL, V29, P627, DOI 10.1016/j.dci.2004.09.008; Pratt JC, 2000, J IMMUNOL, V165, P4158, DOI 10.4049/jimmunol.165.8.4158; Rebl A, 2010, VET IMMUNOL IMMUNOP, V134, P139, DOI 10.1016/j.vetimm.2009.09.021; Rise ML, 2008, DEV COMP IMMUNOL, V32, P916, DOI 10.1016/j.dci.2008.01.002; Robertsen B, 2003, J INTERF CYTOK RES, V23, P601, DOI 10.1089/107999003322485107; Shi BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044900; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; SIU G, 1984, CELL, V37, P393, DOI 10.1016/0092-8674(84)90369-6; Swiecki M, 2011, J LEUKOCYTE BIOL, V90, P691, DOI 10.1189/jlb.0311166; TURNER GJ, 1992, PROTEINS, V14, P333, DOI 10.1002/prot.340140303; Wang WB, 2011, J IMMUNOL, V187, P2578, DOI 10.4049/jimmunol.1004128; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Xiang LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-472; Zhang X, 2013, ONCOGENE, V32, P2782, DOI 10.1038/onc.2012.289; Zheng WB, 2006, FISH SHELLFISH IMMUN, V21, P414, DOI 10.1016/j.fsi.2006.01.006; Zou J, 2007, J IMMUNOL, V179, P3859, DOI 10.4049/jimmunol.179.6.3859; Zou J, 2011, DEV COMP IMMUNOL, V35, P1376, DOI 10.1016/j.dci.2011.07.001; Zou J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-85	52	76	83	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97471	10.1371/journal.pone.0097471	http://dx.doi.org/10.1371/journal.pone.0097471			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24820969	Green Submitted, Green Published, gold			2022-12-27	WOS:000336653300117
J	Shen, L; Yin, ZH; Wu, W; Ren, YW; Li, XL; Zhou, BS				Shen, Li; Yin, Zhihua; Wu, Wei; Ren, Yangwu; Li, Xuelian; Zhou, Baosen			Single Nucleotide Polymorphism in ATM Gene, Cooking Oil Fumes and Lung Adenocarcinoma Susceptibility in Chinese Female Non-Smokers: A Case-Control Study	PLOS ONE			English	Article							ATAXIA-TELANGIECTASIA GENE; CANCER RISK; TRANSCRIPTION FACTOR; DNA-DAMAGE; PROMOTER POLYMORPHISM; WOMEN; BINDING; REPAIR; ASSOCIATION; IDENTIFICATION	Background: The ataxia-telangiectasia mutated (ATM) gene plays an important role in the DNA double-strand breaks repair pathway. Single nucleotide polymorphisms (SNPs) of DNA repair genes are suspected to influence the risk of lung cancer. This study aimed to investigate the association between the ATM -111G>A (rs189037) polymorphism, environmental risk factors and the risk of lung adenocarcinoma in Chinese female non-smokers. Methods: A hospital-based case-control study of 487 lung cancer patients and 516 matched cancer-free controls was conducted. Information concerning demographic and environmental risk factors was obtained for each case and control by a trained interviewer. After informed consent was obtained, 10 ml venous blood was collected from each subject for biomarker testing. Single nucleotide polymorphism was determined by using TaqMan method. Results: This study showed that the individuals with ATM rs189037 AA genotype were at an increased risk for lung adenocarcinoma compared with those carrying the GA or GG genotype (adjusted odds ratios (OR) 1.44, 95% confidence interval (CI) 1.02-2.02, P = 0.039). The stratified analysis suggested that increased risk associated with ATM rs189037 AA genotype in individuals who never or seldom were exposed to cooking oil fumes (adjusted OR 1.89, 95% CI 1.03-3.49, P = 0.040). Conclusions: ATM rs189037 might be associated with the risk of lung adenocarcinoma in Chinese non-smoking females. Furthermore, ATM rs189037 AA genotype might be a risk factor of lung adenocarcinoma among female non-smokers without cooking oil fume exposure.	[Shen, Li; Yin, Zhihua; Wu, Wei; Ren, Yangwu; Li, Xuelian; Zhou, Baosen] China Med Univ, Sch Publ Hlth, Dept Epidemiol, Shenyang, Liaoning Provin, Peoples R China; [Shen, Li; Yin, Zhihua; Wu, Wei; Ren, Yangwu; Li, Xuelian; Zhou, Baosen] Univ Liaoning Prov, Key Lab Canc Etiol & Intervent, Shenyang, Peoples R China	China Medical University	Zhou, BS (corresponding author), China Med Univ, Sch Publ Hlth, Dept Epidemiol, Shenyang, Liaoning Provin, Peoples R China.	bszhou@mail.cmu.edu.cn			National Natural Science Foundation of China [81272293, 81102194]; China Medical Board [00726]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Medical Board	This study was supported by grant no. 81272293 from National Natural Science Foundation of China, grant no. 81102194 from National Natural Science Foundation of China, and grant no. 00726 from China Medical Board. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bau DT, 2010, LARYNGOSCOPE, V120, P2417, DOI 10.1002/lary.21009; Belani CP, 2007, LUNG CANCER, V55, P15, DOI 10.1016/j.lungcan.2006.09.008; Chen H, 1992, Biomed Environ Sci, V5, P229; Chen T, 2010, MECH AGEING DEV, V131, P636, DOI 10.1016/j.mad.2010.08.009; Chiang TA, 1999, ENVIRON RES, V81, P18, DOI 10.1006/enrs.1998.3876; Frey UH, 2008, PHARMACOGENET GENOM, V18, P141, DOI 10.1097/FPC.0b013e3282f49964; GAO YT, 1987, INT J CANCER, V40, P604, DOI 10.1002/ijc.2910400505; Gilad S, 1998, AM J HUM GENET, V62, P551, DOI 10.1086/301755; Hsia TC, 2013, ANTICANCER RES, V33, P4067; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kim JH, 2006, HUM MOL GENET, V15, P1181, DOI 10.1093/hmg/ddl033; Ko YC, 2000, AM J EPIDEMIOL, V151, P140, DOI 10.1093/oxfordjournals.aje.a010181; Kurz EU, 2004, DNA REPAIR, V3, P889, DOI 10.1016/j.dnarep.2004.03.029; Lavin MF, 2007, CELL CYCLE, V6, P931, DOI 10.4161/cc.6.8.4180; Lo YL, 2010, LUNG CANCER, V69, P148, DOI 10.1016/j.lungcan.2009.11.007; MATTSON ME, 1987, AM J PUBLIC HEALTH, V77, P425, DOI 10.2105/AJPH.77.4.425; Menzaghi C, 2006, J AM SOC NEPHROL, V17, pS115, DOI 10.1681/ASN.2005121340; Petrini JHJ, 2003, TRENDS CELL BIOL, V13, P458, DOI 10.1016/S0962-8924(03)00170-3; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Schultz J, 2009, MOL CARCINOGEN, V48, P14, DOI 10.1002/mc.20452; Seow A, 2000, CANCER EPIDEM BIOMAR, V9, P1215; Shi Hailong, 2005, Zhongguo Fei Ai Za Zhi, V8, P279, DOI 10.3779/j.issn.1009-3419.2005.04.06; Spitz MR, 2003, CANCER EPIDEM BIOMAR, V12, P689; Taulan M, 2007, BIOCHEM BIOPH RES CO, V361, P775, DOI 10.1016/j.bbrc.2007.07.091; Teraoka SN, 1999, AM J HUM GENET, V64, P1617, DOI 10.1086/302418; Thomas L, 2005, CHEST, V128, P370, DOI 10.1378/chest.128.1.370; Wang CH, 2011, CHINESE J PHYSIOL, V54, P413, DOI 10.4077/CJP.2011.AMM106; Wang Hong-mei, 2011, Nan Fang Yi Ke Da Xue Xue Bao, V31, P1863; Wang HC, 2010, ANTICANCER RES, V30, P5217; Wei QY, 1996, CANCER RES, V56, P4103; Xu L, 2012, J CLIN ENDOCR METAB, V97, P1913, DOI 10.1210/jc.2011-3299; Yang SC, 2000, CHEM RES TOXICOL, V13, P1046, DOI 10.1021/tx0000419; Zang EA, 1996, JNCI-J NATL CANCER I, V88, P183, DOI 10.1093/jnci/88.3-4.183; Zhang L, 2010, INT J RADIAT ONCOL, V77, P1360, DOI 10.1016/j.ijrobp.2009.07.1675; Zhao P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-234; Zhong LJ, 1999, EPIDEMIOLOGY, V10, P488, DOI 10.1097/00001648-199909000-00005	38	21	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96911	10.1371/journal.pone.0096911	http://dx.doi.org/10.1371/journal.pone.0096911			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819391	Green Published, Green Submitted, gold			2022-12-27	WOS:000336653300046
J	Tertil, M; Skrzypek, K; Florczyk, U; Weglarczyk, K; Was, H; Collet, G; Guichard, A; Gil, T; Kuzdzal, J; Jozkowicz, A; Kieda, C; Pichon, C; Dulak, J				Tertil, Magdalena; Skrzypek, Klaudia; Florczyk, Urszula; Weglarczyk, Kazimierz; Was, Halina; Collet, Guillaume; Guichard, Alan; Gil, Tomasz; Kuzdzal, Jaroslaw; Jozkowicz, Alicja; Kieda, Claudine; Pichon, Chantal; Dulak, Jozef			Regulation and Novel Action of Thymidine Phosphorylase in Non-Small Cell Lung Cancer: Crosstalk with Nrf2 and HO-1	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HEME OXYGENASE-1; IL-8 EXPRESSION; PROMOTES ANGIOGENESIS; MOLECULAR-MECHANISMS; TUMOR-CELLS; A549 CELLS; IN-VITRO; CARCINOMA; PROLIFERATION	Proangiogenic enzyme thymidine phosphorylase (TP) is a promising target for anticancer therapy, yet its action in non-small cell lung carcinoma (NSCLC) is not fully understood. To elucidate its role in NSCLC tumor growth, NCI-H292 lung mucoepidermoid carcinoma cells and endothelial cells were engineered to overexpress TP by viral vector transduction. NSCLC cells with altered expression of transcription factor Nrf2 or its target gene heme oxygenase-1 (HO-1) were used to study the regulation of TP and the findings from pre-clinical models were related to gene expression data from clinical NSCLC specimens. Overexpression of Nrf2 or HO-1 resulted in upregulation of TP in NCI-H292 cells, an effect mimicked by treatment with an antioxidant N-acetylcysteine and partially reversed by HO-1 knockdown. Overexpression of TP attenuated cell prolifera\tion and migration in vitro, but simultaneously enhanced angiogenic potential of cancer cells supplemented with thymidine. The latter was also observed for SK-MES-1 squamous cell carcinoma and NCI-H460 large cell carcinoma cells. TP-overexpressing NCI-H292 tumors in vivo exhibited better oxygenation and higher expression of IL-8, IL-1 beta and IL-6. TP overexpression in endothelial cells augmented their angiogenic properties which was associated with enhanced generation of HO-1 and VEGF. Correlation of TP with the expression of HO-1 and inflammatory cytokines was confirmed in clinical samples of NSCLC. Altogether, the increased expression of IL-1 beta and IL-6 together with proangiogenic effects of TP-expressing NSCLC on endothelium can contribute to tumor growth, implying TP as a target for antiangiogenesis in NSCLC.	[Tertil, Magdalena; Skrzypek, Klaudia; Florczyk, Urszula; Was, Halina; Jozkowicz, Alicja; Dulak, Jozef] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Med Biotechnol, Krakow, Poland; [Tertil, Magdalena; Skrzypek, Klaudia; Weglarczyk, Kazimierz; Collet, Guillaume; Guichard, Alan; Kieda, Claudine; Pichon, Chantal] CNRS UPR4301, Ctr Biophys Mol, Orleans, France; [Tertil, Magdalena] Polish Acad Sci, Inst Pharmacol, Dept Mol Neuropharmacol, Krakow, Poland; [Gil, Tomasz; Kuzdzal, Jaroslaw] Jagiellonian Univ, John Paul Hosp 2, Coll Med, Dept Thorac Surg, Krakow, Poland	Jagiellonian University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Polish Academy of Sciences; Jagiellonian University; Collegium Medicum Jagiellonian University	Dulak, J (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Med Biotechnol, Krakow, Poland.	jozef.dulak@uj.edu.pl	Skrzypek, Klaudia/U-6462-2018; Kieda, Claudine/U-1361-2019	Skrzypek, Klaudia/0000-0002-3997-924X; Tertil, Magdalena/0000-0001-9841-3572; Was, Halina/0000-0003-2743-0337; Collet, Guillaume/0000-0002-0355-563X; Guichard, Alan/0000-0001-8623-9570	National Science Centre (NCN) [311/N-COST/2008/0, 347/N-INCA/2008/0, N N301 314837]; Conseil Regional du Centre; European Union; Polish Ministry of Science and Higher Education [POIG.02.01.00-12-064/08, 02.02.00-00-014/08, 01.01.02-00-109/09, 01.01.02-00-069/09]	National Science Centre (NCN)(National Science Centre, Poland); Conseil Regional du Centre(Region Centre-Val de Loire); European Union(European Commission); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	Supported by the grants No 311/N-COST/2008/0, 347/N-INCA/2008/0 and N N301 314837 from the National Science Centre (NCN). Alicja Jozkowicz was an International Senior Research Fellow from Wellcome Trust. M. Tertil and K. Skrzypek were supported by Conseil Regional du Centre, stipend for co-tutorial PhD thesis. The Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University is a beneficiary of the structural funds from the European Union and the Polish Ministry of Science and Higher Education (grants No: POIG.02.01.00-12-064/08, 02.02.00-00-014/08, 01.01.02-00-109/09 and 01.01.02-00-069/09). analysis, decision to publish, or preparation of the manuscript. Research conducted in the scope of the MiR-TANGo International Associated Laboratory (LIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama S, 2004, CANCER SCI, V95, P851, DOI 10.1111/j.1349-7006.2004.tb02193.x; Bayliss TJ, 2011, EXPERT OPIN BIOL TH, V11, P1663, DOI 10.1517/14712598.2011.627850; Bijnsdorp IV, 2011, BRIT J CANCER, V104, P1185, DOI 10.1038/bjc.2011.74; Bronckaers A, 2009, MED RES REV, V29, P903, DOI 10.1002/med.20159; Brown NS, 2000, CANCER RES, V60, P6298; Calkins MJ, 2005, P NATL ACAD SCI USA, V102, P244, DOI 10.1073/pnas.0408487101; Carmi Y, 2011, J IMMUNOL, V186, P3462, DOI 10.4049/jimmunol.1002901; Deshane J, 2007, J EXP MED, V204, P605, DOI 10.1084/jem.20061609; Florczyk U, 2011, FREE RADICAL BIO MED, V51, P1882, DOI 10.1016/j.freeradbiomed.2011.08.023; Florczyk Urszula, 2010, Postepy Biochem, V56, P147; Frick M, 2003, ATHEROSCLEROSIS, V170, P229, DOI 10.1016/S0021-9150(03)00299-5; Grochot-Przeczek A, 2012, CLIN SCI, V122, P93, DOI 10.1042/CS20110147; HARADA S, 1994, J CLIN INVEST, V93, P2490, DOI 10.1172/JCI117258; Homma S, 2009, CLIN CANCER RES, V15, P3423, DOI 10.1158/1078-0432.CCR-08-2822; Hotchkiss KA, 2003, J BIOL CHEM, V278, P19272, DOI 10.1074/jbc.M212670200; Jozkowicz A, 2003, ANTIOXID REDOX SIGN, V5, P155, DOI 10.1089/152308603764816514; Kim HR, 2008, LUNG CANCER, V60, P47, DOI 10.1016/j.lungcan.2007.09.021; Kozakowska M, 2012, ANTIOXID REDOX SIGN, V16, P113, DOI 10.1089/ars.2011.3964; Kusabe T, 2005, RHEUMATOL INT, V25, P625, DOI 10.1007/s00296-005-0624-8; Li W, 2005, ARTERIOSCL THROM VAS, V25, P1370, DOI 10.1161/01.ATV.0000168914.85107.64; Liekens S, 2007, BIOCHEM PHARMACOL, V74, P1555, DOI 10.1016/j.bcp.2007.05.008; Lin HH, 2011, J BIOL CHEM, V286, P3829, DOI 10.1074/jbc.M110.168831; Lin Q, 2012, ONCOL LETT, V3, P761, DOI 10.3892/ol.2012.575; Loboda A, 2008, ANTIOXID REDOX SIGN, V10, P1767, DOI 10.1089/ars.2008.2043; Loboda A, 2008, LUNG CANCER, V60, P1, DOI 10.1016/j.lungcan.2007.10.024; Loboda A, 2009, ANTIOXID REDOX SIGN, V11, P1501, DOI [10.1089/ars.2008.2211, 10.1089/ARS.2008.2211]; Lu HY, 2009, CLIN CANCER RES, V15, P5136, DOI 10.1158/1078-0432.CCR-08-3203; Miyake M, 2011, ONCOL REP, V25, P653, DOI 10.3892/or.2010.1125; Nakajima Y, 2004, CANCER RES, V64, P1794, DOI 10.1158/0008-5472.CAN-03-2597; Namiki A, 1995, J BIOL CHEM, V270, P31189, DOI 10.1074/jbc.270.52.31189; O'Byrne KJ, 2000, BRIT J CANCER, V82, P1427, DOI 10.1054/bjoc.1999.1129; Ravichandran K, 2011, INDIAN J EXP BIOL, V49, P840; Saito S, 2003, J GASTROENTEROL, V38, P229, DOI 10.1007/s005350300041; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Schmid-Bindert G, 2013, TARGET ONCOL, V8, P15, DOI 10.1007/s11523-013-0261-1; Seike T, 2011, CLIN EXP METASTAS, V28, P13, DOI 10.1007/s10585-010-9354-8; Sengupta S, 2003, BRIT J PHARMACOL, V139, P219, DOI 10.1038/sj.bjp.0705216; Skrzypek K, 2013, ANTIOXID REDOX SIGN, V19, P644, DOI 10.1089/ars.2013.5184; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Torisu-Itakura H, 2000, JPN J CANCER RES, V91, P906, DOI 10.1111/j.1349-7006.2000.tb01033.x; Tsai MS, 2011, MOL PHARMACOL, V80, P136, DOI 10.1124/mol.111.071316; Was H, 2006, AM J PATHOL, V169, P2181, DOI 10.2353/ajpath.2006.051365; Was H, 2010, CURR DRUG TARGETS, V11, P1551, DOI 10.2174/1389450111009011551; Zhang XL, 2005, EUR J IMMUNOL, V35, P3258, DOI 10.1002/eji.200526116	44	22	22	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97070	10.1371/journal.pone.0097070	http://dx.doi.org/10.1371/journal.pone.0097070			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819505	Green Published, Green Submitted, gold			2022-12-27	WOS:000336653300067
J	Wang, J; Ma, HC; Ge, XX; Zhang, J; Teng, KL; Sun, ZZ; Zhong, J				Wang, Jian; Ma, Hongchu; Ge, Xiaoxuan; Zhang, Jie; Teng, Kunling; Sun, Zhizeng; Zhong, Jin			Bovicin HJ50-Like Lantibiotics, a Novel Subgroup of Lantibiotics Featured by an Indispensable Disulfide Bridge	PLOS ONE			English	Article							POTENT ANTIMICROBIAL ACTIVITY; IIA BACTERIOCINS; AMINO-ACIDS; LIPID II; PEPTIDES; BIOSYNTHESIS; HJ50; IDENTIFICATION; LACTICIN-481; PROTEINS	Lantibiotics are ribosomally-synthesized and posttranslationally modified peptides with potent antimicrobial activities. Discovery of novel lantibiotics has been greatly accelerated with the soaring release of genomic information of microorganisms. As a unique class II lantibiotic, bovicin HJ50 is produced by Streptococcus bovis HJ50 and contains one rare disulfide bridge. By using its precursor BovA as a drive sequence, 16 BovA-like peptides were revealed in a wide variety of species. From them, three representative novel lan loci from Clostridium perfringens D str. JGS1721, Bacillus cereus As 1.348 and B. thuringiensis As 1.013 were identified by PCR screening. The corresponding mature lantibiotics designated perecin, cerecin and thuricin were obtained and structurally elucidated to be bovicin HJ50-like lantibiotics especially by containing a conserved disulfide bridge. The disulfide bridge was substantiated to be essential for the function of bovicin HJ50-like lantibiotics as its disruption eliminated their antimicrobial activities. Further analysis indicated that the disulfide bridge played a crucial role in maintaining the hydrophobicity of bovicin HJ50, which might facilitate it to exert antimicrobial function. This study unveiled a novel subgroup of disulfide-containing lantibiotics from bacteria of different niches and further demonstrated the indispensable role of disulfide bridge in these novel bovicin HJ50-like lantibiotics.	[Wang, Jian; Ma, Hongchu; Ge, Xiaoxuan; Zhang, Jie; Teng, Kunling; Sun, Zhizeng; Zhong, Jin] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China; [Wang, Jian; Ma, Hongchu; Ge, Xiaoxuan; Zhang, Jie] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhong, J (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China.	zhongj@im.ac.cn	Wang, Jian/ABG-9051-2021	Wang, Jian/0000-0002-6785-7899; Sun, Zhizeng/0000-0002-0033-5885	National Natural Science Foundation of China [31070041, 31200046]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-J-6, KSCX2-EW-Q-14, KSCX2-EW-G-14]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences)	This research was supported by the National Natural Science Foundation of China (31070041, 31200046), and the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-J-6, KSCX2-EW-Q-14, and KSCX2-EW-G-14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Begley M, 2009, APPL ENVIRON MICROB, V75, P5451, DOI 10.1128/AEM.00730-09; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Derksen DJ, 2008, CHEMBIOCHEM, V9, P1898, DOI 10.1002/cbic.200800272; Fimland G, 2005, J PEPT SCI, V11, P688, DOI 10.1002/psc.699; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Georgalaki M, 2013, FOOD MICROBIOL, V33, P124, DOI 10.1016/j.fm.2012.09.008; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hechard Y, 2002, BIOCHIMIE, V84, P545, DOI 10.1016/S0300-9084(02)01417-7; Holo H, 2001, MICROBIOL-SGM, V147, P643, DOI 10.1099/00221287-147-3-643; Islam MR, 2012, J AM CHEM SOC, V134, P3687, DOI 10.1021/ja300007h; Kabuki T, 2009, J APPL MICROBIOL, V106, P853, DOI 10.1111/j.1365-2672.2008.04059.x; Knerr PJ, 2012, ACS CHEM BIOL, V7, P1791, DOI 10.1021/cb300372b; Levengood MR, 2009, J AM CHEM SOC, V131, P12024, DOI 10.1021/ja903239s; Lin YH, 2011, MICROBIOL RES, V166, P146, DOI 10.1016/j.micres.2010.05.001; Liu G, 2009, MICROBIOL-SGM, V155, P584, DOI 10.1099/mic.0.022707-0; Marsh AJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-679; McClerren AL, 2006, P NATL ACAD SCI USA, V103, P17243, DOI 10.1073/pnas.0606088103; Meindl K, 2010, ANGEW CHEM INT EDIT, V49, P1151, DOI 10.1002/anie.200905773; Okesli A, 2011, J AM CHEM SOC, V133, P13753, DOI 10.1021/ja205783f; Patton GC, 2008, BIOCHEMISTRY-US, V47, P7342, DOI 10.1021/bi800277d; Rink R, 2005, BIOCHEMISTRY-US, V44, P8873, DOI 10.1021/bi050081h; Sambrook J, 1989, MOL CLONING; Sawa N, 2012, APPL ENVIRON MICROB, V78, P900, DOI 10.1128/AEM.06497-11; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; Schroeder BO, 2011, NATURE, V469, P419, DOI 10.1038/nature09674; Shi YX, 2011, J AM CHEM SOC, V133, P2338, DOI 10.1021/ja109044r; Sit CS, 2011, ACCOUNTS CHEM RES, V44, P261, DOI 10.1021/ar1001395; Sun ZZ, 2009, ANTIMICROB AGENTS CH, V53, P1964, DOI 10.1128/AAC.01382-08; Teng KL, 2014, J BIOL CHEM, V289, P9823, DOI 10.1074/jbc.M113.513150; Tulumello DV, 2009, BIOCHEMISTRY-US, V48, P12096, DOI 10.1021/bi9013819; van Heel AJ, 2013, NUCLEIC ACIDS RES, V41, pW448, DOI 10.1093/nar/gkt391; Wang J, 2014, APPL ENVIRON MICROB, V80, P2633, DOI 10.1128/AEM.03751-13; Wang J, 2014, APPL ENVIRON MICROB, V80, P1062, DOI 10.1128/AEM.03213-13; Willey JM, 2007, ANNU REV MICROBIOL, V61, P477, DOI 10.1146/annurev.micro.61.080706.093501; Xiao HJ, 2004, MICROBIOL-SGM, V150, P103, DOI 10.1099/mic.0.26437-0; Xie LL, 2004, SCIENCE, V303, P679, DOI 10.1126/science.1092600; Yount NY, 2004, P NATL ACAD SCI USA, V101, P7363, DOI 10.1073/pnas.0401567101	40	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e97121	10.1371/journal.pone.0097121	http://dx.doi.org/10.1371/journal.pone.0097121			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24821187	gold, Green Published, Green Submitted			2022-12-27	WOS:000336653300078
J	Wang, W; Scheffler, K; Esbensen, Y; Strand, JM; Stewart, JB; Bjoras, M; Eide, L				Wang, Wei; Scheffler, Katja; Esbensen, Ying; Strand, Janne M.; Stewart, James B.; Bjoras, Magnar; Eide, Lars			Addressing RNA Integrity to Determine the Impact of Mitochondrial DNA Mutations on Brain Mitochondrial Function with Age	PLOS ONE			English	Article							MTDNA MUTATOR MICE; POINT MUTATIONS; DELETIONS; POLYMERASE	Mitochondrial DNA (mtDNA) mutations can result in mitochondrial dysfunction, but emerging experimental data question the fundamental role of mtDNA mutagenesis in age-associated mitochondrial impairment. The multicopy nature of mtDNA renders the impact of a given mtDNA mutation unpredictable. In this study, we compared mtDNA stability and mtRNA integrity during normal aging. Seven distinct sites in mouse brain mtDNA and corresponding mtRNA were analyzed. Accumulation of mtDNA mutations during aging was highly site-specific. The variation in mutation frequencies overrode the age-mediated increase by more than 100-fold and aging generally did not influence mtDNA mutagenesis. Errors introduced by mtRNA polymerase were also site-dependent and up to two hundred-fold more frequent than mtDNA mutations, and independent of mtDNA mutation frequency. We therefore conclude that mitochondrial transcription fidelity limits the impact of mtDNA mutations.	[Wang, Wei; Scheffler, Katja; Strand, Janne M.; Bjoras, Magnar; Eide, Lars] Univ Oslo, Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Wang, Wei; Scheffler, Katja; Strand, Janne M.; Bjoras, Magnar] Univ Oslo, Oslo Univ Hosp, Dept Microbiol, Oslo, Norway; [Esbensen, Ying] Akershus Univ Hosp, Dept Clin Mol Biol, Lorenskog, Norway; [Esbensen, Ying] Akershus Univ Hosp, Div Med,Univ, Lab Sci EpiGen, Lorenskog, Norway; [Esbensen, Ying] Univ Oslo, Lorenskog, Norway; [Stewart, James B.] Max Planck Inst Biol Ageing, Cologne, Germany	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; Max Planck Society	Eide, L (corresponding author), Univ Oslo, Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway.	lars.eide@medisin.uio.no	Scheffler, Katja/GPP-7023-2022; Stewart, James B/C-9633-2011; Bjørås, Magnar/N-9286-2017	Stewart, James B/0000-0002-2902-4968; Scheffler, Katja/0000-0002-1734-7807	Norwegian Research Council	Norwegian Research Council(Research Council of NorwayEuropean Commission)	The work has been supported by the Norwegian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameur A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002028; Campbell GR, 2012, ACTA NEUROPATHOL, V124, P209, DOI 10.1007/s00401-012-1001-9; Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010; Ericson NG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002689; Halsne R, 2012, DNA REPAIR, V11, P278, DOI 10.1016/j.dnarep.2011.12.001; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Kennedy SR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003794; Kraytsberg Y, 2009, AGING CELL, V8, P502, DOI 10.1111/j.1474-9726.2009.00484.x; Kuhn CD, 2007, CELL, V131, P1260, DOI 10.1016/j.cell.2007.10.051; LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4; McDonald DGM, 2002, AM J MED GENET, V111, P191, DOI 10.1002/ajmg.10522; Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976; Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863; Ricchetti M, 2004, PLOS BIOL, V2, P1313, DOI 10.1371/journal.pbio.0020273; Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95; Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988; Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258; Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com	21	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96940	10.1371/journal.pone.0096940	http://dx.doi.org/10.1371/journal.pone.0096940			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	24819950	Green Published, gold, Green Submitted			2022-12-27	WOS:000336653300051
J	Cadiz-Rivera, B; Fromm, G; de Vries, C; Fields, J; McGrath, KE; Fiering, S; Bulger, M				Cadiz-Rivera, Brenda; Fromm, George; de Vries, Christina; Fields, Jennifer; McGrath, Kathleen E.; Fiering, Steven; Bulger, Michael			The Chromatin "Landscape" of a Murine Adult beta-Globin Gene Is Unaffected by Deletion of Either the Gene Promoter or a Downstream Enhancer	PLOS ONE			English	Article							LOCUS-CONTROL REGION; HYPERSENSITIVE SITES; ERYTHROID-CELLS; TRANSCRIPTION; EXPRESSION; SENSITIVITY; ACTIVATION; LINKING; PATTERN; MICE	In mammals, the complex tissue-and developmental-specific expression of genes within the beta-globin cluster is known to be subject to control by the gene promoters, by a locus control region (LCR) located upstream of the cluster, and by sequence elements located across the intergenic regions. Despite extensive investigation, however, the complement of sequences that is required for normal regulation of chromatin structure and gene expression within the cluster is not fully defined. To further elucidate regulation of the adult beta-globin genes, we investigate the effects of two deletions engineered within the endogenous murine beta-globin locus. First, we find that deletion of the beta 2-globin gene promoter, while eliminating b2-globin gene expression, results in no additional effects on chromatin structure or gene expression within the cluster. Notably, our observations are not consistent with competition among the beta-globin genes for LCR activity. Second, we characterize a novel enhancer located 3' of the beta 2-globin gene, but find that deletion of this sequence has no effect whatsoever on gene expression or chromatin structure. This observation highlights the difficulty in assigning function to enhancer sequences identified by the chromatin "landscape" or even by functional assays.	[Cadiz-Rivera, Brenda; Fromm, George; de Vries, Christina; McGrath, Kathleen E.; Bulger, Michael] Univ Rochester, Med Ctr, Dept Psychiat, Rochester, NY 14642 USA; [Cadiz-Rivera, Brenda; Fromm, George; de Vries, Christina; McGrath, Kathleen E.; Bulger, Michael] Ctr Pediat Biomed Res, Rochester, NY USA; [Fromm, George] NIEHS, NIH, Res Triangle Pk, NC 27709 USA; [Fields, Jennifer; Fiering, Steven] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Microbiol & Immunol, Hanover, NH 03756 USA	University of Rochester; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Dartmouth College	Bulger, M (corresponding author), Univ Rochester, Med Ctr, Dept Psychiat, Rochester, NY 14642 USA.	michael_bulger@urmc.rochester.edu	Fromm, George/GYA-1316-2022	Fromm, George/0000-0002-7049-0274	National Institutes of Health (NIH) [R01-DK070687-06A1]; Institutional Ruth L. Kirschstein National Research Service Award [GM068411]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM068411] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) R01-DK070687-06A1. G. F. and B.C.-R. were supported in part by grant number GM068411 from Institutional Ruth L. Kirschstein National Research Service Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender MA, 2000, MOL CELL, V5, P387, DOI 10.1016/S1097-2765(00)80433-5; Bulger M, 2003, MOL CELL BIOL, V23, P5234, DOI 10.1128/MCB.23.15.5234-5244.2003; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Chakalova L, 2005, BLOOD, V105, P2154, DOI 10.1182/blood-2003-11-4069; CHOI ORB, 1988, CELL, V55, P17, DOI 10.1016/0092-8674(88)90005-0; ELGIN SCR, 1988, J BIOL CHEM, V263, P19259; Engel JD, 2000, CELL, V100, P499, DOI 10.1016/S0092-8674(00)80686-8; Forsberg EC, 2000, P NATL ACAD SCI USA, V97, P14494, DOI 10.1073/pnas.97.26.14494; Fromm G, 2011, BLOOD, V117, P5207, DOI 10.1182/blood-2010-08-302018; Fromm G, 2009, BLOOD, V114, P3479, DOI 10.1182/blood-2009-03-210690; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Hu X, 2003, P NATL ACAD SCI USA, V100, P1111, DOI 10.1073/pnas.0337404100; Hu X, 2007, BLOOD, V109, P2210, DOI 10.1182/blood-2006-06-029868; Johnson KD, 2001, MOL CELL, V8, P465, DOI 10.1016/S1097-2765(01)00309-4; Kingsley PD, 2006, BLOOD, V107, P1665, DOI 10.1182/blood-2005-08-3097; Levine M, 2010, CURR BIOL, V20, pR754, DOI 10.1016/j.cub.2010.06.070; McGrath KE, 2011, BLOOD, V117, P4600, DOI 10.1182/blood-2010-12-325357; OHTA Y, 1976, P NATL ACAD SCI USA, V73, P1232, DOI 10.1073/pnas.73.4.1232; Palis J, 2008, CURR OPIN HEMATOL, V15, P155, DOI 10.1097/MOH.0b013e3282f97ae1; Reik A, 1998, MOL CELL BIOL, V18, P5992, DOI 10.1128/MCB.18.10.5992; Sankaran VG, 2011, NEW ENGL J MED, V365, P807, DOI 10.1056/NEJMoa1103070; Sawado T, 2003, GENE DEV, V17, P1009, DOI 10.1101/gad.1072303; Schubeler D, 2001, P NATL ACAD SCI USA, V98, P11432, DOI 10.1073/pnas.201394698; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080	27	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e92947	10.1371/journal.pone.0092947	http://dx.doi.org/10.1371/journal.pone.0092947			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24817273	Green Submitted, gold, Green Published			2022-12-27	WOS:000336838000003
J	Huo, L; Dang, YH; Lv, JQ; Xing, HQ; Li, F				Huo, Li; Dang, Yonghong; Lv, Jingqiao; Xing, Haiqun; Li, Fang			Application of Dual Phase Imaging of C-11-Acetate Positron Emission Tomography on Differential Diagnosis of Small Hepatic Lesions	PLOS ONE			English	Article							FOCAL NODULAR HYPERPLASIA; HEPATOCELLULAR-CARCINOMA; C-11 ACETATE; LIVER; ADENOMA; PET/CT; HEMANGIOMAS; MANAGEMENT; FDG	Objective: Previously we observed that dual phase C-11-acetate positron emission tomography (AC-PET) could be employed for differential diagnosis of liver malignancies. In this study, we prospectively evaluated the effect of dual phase AC-PET on differential diagnosis of primary hepatic lesions of 1-3 cm in size. Methods: 33 patients having primary hepatic lesions with size of 1-3 cm in diameter undertook dual phase AC-PET scans. Procedure included an early upper-abdomen scan immediately after tracer injection and a conventional scan in 11-18 min. The standardized uptake value (SUV) was calculated for tumor (SUVT) and normal tissue (SUVB), from which C-11-acetate uptake ratio (as lesion against normal liver tissue, SUVT/SUVB) in early imaging (R1), conventional imaging (R2), and variance between R2 and R1 (Delta R) were derived. Diagnoses based on AC-PET data and histology were compared. Statistical analysis was performed with SPSS 19.0. Results: 20 patients were found to have HCC and 13 patients had benign tumors. Using Delta R>0 as criterion for malignancy, the accuracy and specificity were significantly increased comparing with conventional method. The area under ROC curve (AUC) for R1, R2, and Delta R were 0.417, 0.683 and 0.831 respectively. Differential diagnosis between well-differentiated HCCs and benign lesions of FNHs and hemangiomas achieved 100% correct. Strong positive correlation was also found between R1 and R2 in HCC (r(2) = 0.55, P<0.001). Conclusions: Dual phase AC-PET scan is a useful procedure for differential diagnosis of well-differentiated hepatocellular carcinoma and benign lesions. The dynamic changes of C-11-acetate uptake in dual phase imaging provided key information for final diagnosis.	[Huo, Li; Dang, Yonghong; Lv, Jingqiao; Xing, Haiqun; Li, Fang] Beijing Union Med Coll Hosp, PET Ctr, Dept Nucl Med, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Li, F (corresponding author), Beijing Union Med Coll Hosp, PET Ctr, Dept Nucl Med, Beijing, Peoples R China.	lifang@pumch.cn			National Natural Science Foundation of China [81071188]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (grant number 81071188). The authors thank Dr. Chien Chou for her guidance of this research work. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Byam J, 2013, HEPATOBILIARY SURG N, V2, P9; Chen SR, 2004, IEEE T MED IMAGING, V23, P426, DOI 10.1109/TMI.2004.824229; Cherqui D, 1995, HEPATOLOGY, V22, P1674, DOI 10.1016/0270-9139(95)90190-6; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Ho CL, 2003, J NUCL MED, V44, P213; Huo L, 2009, CLIN NUCL MED, V34, P874, DOI 10.1097/RLU.0b013e3181bed06e; Hussain SM, 2006, EUR RADIOL, V16, P1873, DOI 10.1007/s00330-006-0292-4; Hwang KH, 2009, APPL RADIAT ISOTOPES, V67, P1195, DOI 10.1016/j.apradiso.2009.02.011; Jarnagin WR, 2010, ANN SURG ONCOL, V17, P1226, DOI 10.1245/s10434-010-0978-3; Kim T, 2001, RADIOLOGY, V219, P699, DOI 10.1148/radiology.219.3.r01jn45699; Kurtaran A, 2000, LIVER, V20, P487, DOI 10.1034/j.1600-0676.2000.020006487.x; Larsson P, 2012, MOL IMAGING RADIONUC, V21, P6, DOI 10.4274/Mirt.87; Lecler A, 2011, CLIN RES HEPATOL GAS, V35, P159, DOI 10.1016/j.clinre.2010.10.006; Magini G, 2009, CLIN NUCL MED, V34, P659, DOI 10.1097/RLU.0b013e3181b53488; Mitterhauser M, 2004, APPL RADIAT ISOTOPES, V61, P1147, DOI 10.1016/j.apradiso.2004.03.060; Park JW, 2008, J NUCL MED, V49, P1912, DOI 10.2967/jnumed.108.055087; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Salem N, 2009, Q J NUCL MED MOL IM, V53, P144; Shiomi S, 1999, ANN NUCL MED, V13, P427, DOI 10.1007/BF03164939; Vilgrain V, 2000, RADIOGRAPHICS, V20, P379, DOI 10.1148/radiographics.20.2.g00mc01379; Yamamoto T, 2001, JPN J CANCER RES, V92, P1207, DOI 10.1111/j.1349-7006.2001.tb02141.x; Yang ZF, 2008, ANAT REC, V291, P721, DOI 10.1002/ar.20668; Yoshii Y, 2009, NUCL MED BIOL, V36, P771, DOI 10.1016/j.nucmedbio.2009.05.006	23	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96517	10.1371/journal.pone.0096517	http://dx.doi.org/10.1371/journal.pone.0096517			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816814	Green Submitted, Green Published, gold			2022-12-27	WOS:000336838000042
J	Tinago, W; Coghlan, E; Macken, A; McAndrews, J; Doak, B; Prior-Fuller, C; Lambert, JS; Sheehan, GJ; Mallon, PWG				Tinago, Willard; Coghlan, Elizabeth; Macken, Alan; McAndrews, Julie; Doak, Brenda; Prior-Fuller, Charlotte; Lambert, John S.; Sheehan, Gerard J.; Mallon, Patrick W. G.		Mater Immunology Study Grp	Clinical, Immunological and Treatment-Related Factors Associated with Normalised CD4+/CD8+T-Cell Ratio: Effect of Naive and Memory T-Cell Subsets	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; ACTIVE ANTIRETROVIRAL THERAPY; VIRAL SUPPRESSION; CD4/CD8 RATIO; CD4(+); LYMPHOCYTES; CHILDREN; RECOVERY; ADULTS; HOMEOSTASIS	Background: Although effective antiretroviral therapy(ART) increases CD4+ T-cell count, responses to ART vary considerably and only a minority of patients normalise their CD4+/CD8+ ratio. Although retention of naive CD4+ T-cells is thought to predict better immune responses, relationships between CD4+ and CD8+ T-cell subsets and CD4+/CD8+ ratio have not been well described. Methods: A cross-sectional study in a cohort of ambulatory HIV+ patients. We used flow cytometry on fresh blood to determine expanded CD4+ and CD8+ T-cell subsets; CD45RO+CD62L+(central memory), CD45RO+CD62L-(effector memory) and CD45RO-CD62L+(naive) alongside routine T-cell subsets(absolute, percentage CD4+ and CD8+ counts), HIVRNA and collected demographic and treatment data. Relationship between CD4+/CD8+ T-cell ratio and expanded T-cell subsets was determined using linear regression analysis. Results are median[IQR] and regression coefficients unless stated. Results: We recruited 190 subjects, age 42(36-48) years, 65% male, 65.3% Caucasian, 91% on ART(52.6% on protease inhibitors), 78.4% with HIVRNA<40cps/ml and median ART duration 6.8(2.6-10.2) years. Nadir and current CD4+ counts were 200(112-309) and 465(335-607) cells/mm(3) respectively. Median CD4+/CD8+ ratio was 0.6(0.4-1.0), with 26.3% of subjects achieving CD4+/CD8+ ratio>1. Of the expanded CD4+ T-cell subsets, 27.3(18.0-38.3)% were naive, 36.8(29.0-40.0)% central memory and 27.4(20.0-38.5)% effector memory. Of the CD8+ T-cells subsets, 16.5(10.2-25.5)% were naive, 19.9(12.7-26.6)% central memory and 41.0(31.8-52.5)% effector memory. In the multivariable adjusted analysis, total cumulative-ART exposure(+0.15, p = 0.007), higher nadir CD4+ count(+0.011, p<0.001) and higher % CD8+ naive T-cells(+ 0.0085, p<0.001) were associated with higher CD4+/CD8+ ratio, higher absolute CD8+ T-cell(-0.0044, p<0.001) and higher % CD4+ effector memory T-cells(-0.004, p = 0.0036) were associated with lower CD4+/CD8+ ratio. Those with CD4+/CD8+ ratio>1 had significantly higher median % CD8+ naive T-cells; 25.4(14.0-36.0)% versus 14.4(9.4-21.6)%, p<0.0001, but significantly lower absolute CD8+ count; 464(384.5-567) versus 765(603-1084) cells/mm(3), p<0.001. Conclusions: Study suggests important role for naive CD8+ T-cell populations in normalisation of the immune response to HIV-infection. How these findings relate to persistent immune activation on ART requires further study.	[Tinago, Willard; Coghlan, Elizabeth; Macken, Alan; Lambert, John S.; Sheehan, Gerard J.; Mallon, Patrick W. G.] Univ Coll Dublin, HIV Mol Res Grp, Sch Med & Med Sci, Dublin 2, Ireland; [Tinago, Willard] Univ Zimbabwe, Dept Community Med, Harare, Zimbabwe; [McAndrews, Julie; Doak, Brenda; Prior-Fuller, Charlotte] Mater Misericordiae Univ Hosp, Dept Immunol, Dublin, Ireland; [Lambert, John S.; Sheehan, Gerard J.; Mallon, Patrick W. G.] Mater Misericordiae Univ Hosp, Dept Infect Dis, Dublin, Ireland	University College Dublin; University of Zimbabwe; Mater Misericordiae University Hospital; University College Dublin; Mater Misericordiae University Hospital; University College Dublin	Tinago, W (corresponding author), Univ Coll Dublin, HIV Mol Res Grp, Sch Med & Med Sci, Dublin 2, Ireland.	willard.tinago@ucdconnect.ie		lambert, john/0000-0001-5404-2415; Tinago, Willard/0000-0001-6858-9606	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	Work was supported by an unrestricted fund from GlaxoSmithKline. http://www.gsk.ie/gsk_at_a_glance/glaxosmithkline_dublin.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Larran A, 2002, CYTOMETRY, V50, P249, DOI 10.1002/cyto.10129; Amadori A, 1995, NAT MED, V1, P1240; Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; Buggert M, 2014, J IMMUNOL; Castagna A, 2010, ANTIVIR THER, V15, P165, DOI 10.3851/IMP1513; Catalfamo M, 2011, J IMMUNOL, V186, P2106, DOI 10.4049/jimmunol.1002000; Condotta SA, 2013, J IMMUNOL, V190, P1991, DOI 10.4049/jimmunol.1202379; Cotter AG, 2013, CURR OPIN HIV AIDS; Douek DC, 2000, J INFECT DIS, V181, P1479, DOI 10.1086/315398; Hazenberg MD, 2000, NAT IMMUNOL, V1, P285, DOI 10.1038/79724; Hearps AC, 2011, SEX HEALTH, V8, P453, DOI 10.1071/SH11028; Hel Z, 2006, TRENDS IMMUNOL, V27, P274, DOI 10.1016/j.it.2006.04.007; Katlama C, 2013, LANCET, V381, P2109, DOI 10.1016/S0140-6736(13)60104-X; Kovacs JA, 2001, J EXP MED, V194, P1731, DOI 10.1084/jem.194.12.1731; La Gruta NL, 2013, CURR OPIN VIROL, V3, P447, DOI 10.1016/j.coviro.2013.06.011; La Gruta NL, 2010, J CLIN INVEST, V120, P1885, DOI 10.1172/JCI41538; Lancioni CL, 2011, J INFECT DIS, V203, P992, DOI 10.1093/infdis/jiq141; Lempicki RA, 2000, P NATL ACAD SCI USA, V97, P13778, DOI 10.1073/pnas.250472097; Leung V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077665; MARGOLICK JB, 1995, NAT MED, V1, P674, DOI 10.1038/nm0795-674; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Menendez P, 1998, CYTOMETRY, V34, P264, DOI 10.1002/(SICI)1097-0320(19981215)34:6<264::AID-CYTO4>3.0.CO;2-P; Pitcher CJ, 1999, NAT MED, V5, P518, DOI 10.1038/8400; RABIN RL, 1995, J CLIN INVEST, V95, P2054, DOI 10.1172/JCI117891; Rodger AJ, 2013, AIDS, V27, P973, DOI 10.1097/QAD.0b013e32835cae9c; ROEDERER M, 1995, J CLIN INVEST, V95, P2061, DOI 10.1172/JCI117892; Sachsenberg N, 1998, J EXP MED, V187, P1295, DOI 10.1084/jem.187.8.1295; Sainz T, 2013, AIDS, V27, P1513, DOI 10.1097/QAD.0b013e32835faa72; Serrano-Villar S, 2014, HIV MED, V15, P40, DOI 10.1111/hiv.12081; Serrano-Villar S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085798; Serrano-Villar S, 2013, J INFECTION, V66, P57, DOI 10.1016/j.jinf.2012.09.013; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Yamaoka M, 2004, RADIAT RES, V161, P290, DOI 10.1667/RR3143	33	44	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97011	10.1371/journal.pone.0097011	http://dx.doi.org/10.1371/journal.pone.0097011			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816636	Green Published, gold, Green Submitted			2022-12-27	WOS:000336838000094
J	Ajabnoor, GM; Bahijri, S; Borai, A; Abdulkhaliq, AA; Al-Aama, JY; Chrousos, GP				Ajabnoor, Ghada M.; Bahijri, Suhad; Borai, Anwar; Abdulkhaliq, Altaf A.; Al-Aama, Jumana Y.; Chrousos, George P.			Health Impact of Fasting in Saudi Arabia during Ramadan: Association with Disturbed Circadian Rhythm and Metabolic and Sleeping Patterns	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; GLUCOSE-METABOLISM; INSULIN-RESISTANCE; PROTEIN-SYNTHESIS; CALORIC RESTRICTION; DIABETES-MELLITUS; MARKED INCREASE; GROWTH-HORMONE; PLASMA LEPTIN; BODY-WEIGHT	Background: Muslims go through strict Ramadan fasting from dawn till sunset for one month yearly. These practices are associated with disturbed feeding and sleep patterns. We recently demonstrated that, during Ramadan, circadian cortisol rhythm of Saudis is abolished, exposing these subjects to continuously increased cortisol levels. Hypothesis: Secretory patterns of other hormones and metabolic parameters associated with cortisol, and insulin resistance, might be affected during Ramadan. Protocol: Ramadan practitioners (18 males, 5 females; mean age +/- SEM = 23.16 +/- 1.2 years) were evaluated before and two weeks into Ramadan. Blood was collected for measurements of endocrine and metabolic parameters at 9 am (+/- 1 hour) and again twelve hours later. Results: In Ramadan, glucose concentration was kept within normal range, with a significant increase in the morning. Mean morning concentration of leptin was significantly higher than pre-Ramadan values (p = 0.001), in contrast to that of adiponectin, which was significantly lower (p<0.001). These changes were associated with increased insulin resistance in morning and evening. Concentrations of hsCRP were lower during Ramadan than those during regular living conditions, however, normal circadian fluctuation was abolished (p = 0.49). Even though means of liver enzymes, total bilirubin, total protein and albumin were all decreased during Ramadan, statistically lower means were only noted for GGT, total protein, and albumin (p = 0.018, 0.002 and 0.001 respectively). Discussion: Saudi Ramadan practitioners have altered adipokine patterns, typical of insulin resistance. The noted decreases of hsCRP, liver enzymes, total protein, and albumin, are most likely a result of fasting, while loss of circadian rhythmicity of hsCRP is probably due to loss of circadian cortisol rhythm. Conclusions: Modern Ramadan practices in Saudi Arabia, which are associated with evening hypercortisolism, are also characterized by altered adipokines patterns, and an abolished hsCRP circadian rhythm, all likely to increase cardiometabolic risk.	[Ajabnoor, Ghada M.; Bahijri, Suhad] King Abdulaziz Univ, Fac Med, Dept Clin Biochem, Jeddah 21413, Saudi Arabia; [Ajabnoor, Ghada M.; Bahijri, Suhad; Borai, Anwar; Abdulkhaliq, Altaf A.; Al-Aama, Jumana Y.; Chrousos, George P.] King Abdulaziz Univ, King Fahd Med Res Ctr, Saudi Diabet Study Res Grp, Jeddah 21413, Saudi Arabia; [Borai, Anwar] King Saud Bin Abdulaziz Univ Hlth Sci KSAU HS, Coll Med, King Abdullah Int Med Res Ctr KAIMRC, Jeddah, Saudi Arabia; [Abdulkhaliq, Altaf A.] Umm Al Qura Univ, Fac Med, Dept Clin Biochem, Mecca, Saudi Arabia; [Al-Aama, Jumana Y.] King Abdulaziz Univ, Fac Med, Dept Med Genet, Jeddah 21413, Saudi Arabia; [Al-Aama, Jumana Y.] King Abdulaziz Univ, Princess Al Jawhara Al Brahim Ctr Excellence Res, Jeddah 21413, Saudi Arabia; [Chrousos, George P.] Univ Athens, Sch Med, Dept Pediat 1, Aghia Sophia Childrens Hosp, GR-11527 Athens, Greece	King Abdulaziz University; King Abdulaziz University; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); Umm Al Qura University; King Abdulaziz University; King Abdulaziz University; Athens Medical School; National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital	Ajabnoor, GM (corresponding author), King Abdulaziz Univ, Fac Med, Dept Clin Biochem, Jeddah 21413, Saudi Arabia.	gmaan2002@yahoo.com	Al-aama, Jumana/AAA-8653-2021; Bahijri, Suhad M/AAF-4141-2020; ajabnoor, ghada M.A/H-5128-2012	Bahijri, Suhad M/0000-0001-6674-5409; ajabnoor, ghada M.A/0000-0001-9096-1531; ABDULKHALIQ, ALTAF A./0000-0002-8148-1103	deanship of research at King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia [HiCi/1432-6-2]	deanship of research at King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia	This project was supported by the deanship of research at King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia under grant number (HiCi/1432-6-2) as part of a main research study conducted by the "Saudi Diabetes Study Research Group''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlouni A, 1997, ANN NUTR METAB, V41, P242, DOI 10.1159/000177999; Adlouni A, 1998, CLIN CHIM ACTA, V271, P179, DOI 10.1016/S0009-8981(97)00245-3; Al Hourani HM, 2009, EFFECTS RAMADAN FAST; Anson RM, 2003, P NATL ACAD SCI USA, V100, P6216, DOI 10.1073/pnas.1035720100; Antuna-Puente B, 2008, DIABETES METAB, V34, P2, DOI 10.1016/j.diabet.2007.09.004; Bahijri S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060917, 10.1371/annotation/8d92315c-9944-4470-9bbb-806a26b0809b]; BOYLE PJ, 1994, J CLIN INVEST, V93, P529, DOI 10.1172/JCI117003; BRANDENBERGER G, 1994, J HYPERTENS, V12, P277; Chandalia HB, 1987, PRAC DIABETES INT, V4, P287, DOI DOI 10.1002/PDI.1960040610; Charmandari E, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003595; Chennaoui M, 2009, APPL PHYSIOL NUTR ME, V34, P587, DOI 10.1139/H09-014; ELATI J, 1995, AM J CLIN NUTR, V62, P302, DOI 10.1093/ajcn/62.2.302; Elimam A, 1998, EUR J ENDOCRINOL, V139, P615, DOI 10.1530/eje.0.1390615; Eng J, 2003, RADIOLOGY, V227, P309, DOI 10.1148/radiol.2272012051; FEDAIL SS, 1982, AM J CLIN NUTR, V36, P350, DOI 10.1093/ajcn/36.2.350; Ferrie JE, 2007, SLEEP, V30, P1659, DOI 10.1093/sleep/30.12.1659; FROST G, 1987, HUM NUTR-APPL NUTR, V41A, P47; GARLICK PJ, 1994, AM J PHYSIOL, V266, pE287, DOI 10.1152/ajpendo.1994.266.3.E287; Gavrila A, 2003, J CLIN ENDOCR METAB, V88, P2838, DOI 10.1210/jc.2002-021721; GOODRICK CL, 1990, MECH AGEING DEV, V55, P69, DOI 10.1016/0047-6374(90)90107-Q; GUMAA KA, 1978, BRIT J NUTR, V40, P573, DOI 10.1079/BJN19780161; Heilbronn LK, 2003, AM J CLIN NUTR, V78, P361, DOI 10.1093/ajcn/78.3.361; HO KY, 1988, J CLIN INVEST, V81, P968, DOI 10.1172/JCI113450; Jauch-Chara K, 2007, DIABETIC MED, V24, P684, DOI 10.1111/j.1464-5491.2007.02116.x; Kanaley JA, 2008, CURR OPIN CLIN NUTR, V11, P50, DOI 10.1097/MCO.0b013e3282f2b0ad; Kocc M, 2011, TURK KARDIYOL DERN A, V39, P568, DOI 10.5543/tkda.2011.01649; la Fleur SE, 2001, DIABETES, V50, P1237, DOI 10.2337/diabetes.50.6.1237; Laposky AD, 2008, FEBS LETT, V582, P142, DOI 10.1016/j.febslet.2007.06.079; Licinio J, 1998, J CLIN ENDOCR METAB, V83, P4140, DOI 10.1210/jc.83.11.4140; Licinio J, 1997, NAT MED, V3, P575, DOI 10.1038/nm0597-575; MAISLOS M, 1993, AM J CLIN NUTR, V57, P640, DOI 10.1093/ajcn/57.5.640; Martino TA, 2008, AM J PHYSIOL-REG I, V294, pR1675, DOI 10.1152/ajpregu.00829.2007; Mattson MP, 2002, PHYSIOL REV, V82, P637, DOI 10.1152/physrev.00004.2002; Mattson MP, 2005, J NUTR BIOCHEM, V16, P129, DOI 10.1016/j.jnutbio.2004.12.007; Meier-Ewert HK, 2004, J AM COLL CARDIOL, V43, P678, DOI 10.1016/j.jacc.2003.07.050; Nader N, 2010, TRENDS ENDOCRIN MET, V21, P277, DOI 10.1016/j.tem.2009.12.011; Nematy M, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-69; Nofzinger EA, 2002, BRAIN, V125, P1105, DOI 10.1093/brain/awf103; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Plat L, 1999, J CLIN ENDOCR METAB, V84, P3082, DOI 10.1210/jc.84.9.3082; Plat L, 1996, AM J PHYSIOL-ENDOC M, V270, pE36, DOI 10.1152/ajpendo.1996.270.1.E36; POCKNEE RC, 1978, J NUTR, V108, P1266, DOI 10.1093/jn/108.8.1266; Purnell JQ, 1999, J CLIN ENDOCR METAB, V84, P3125, DOI 10.1210/jc.84.9.3125; Ruiter M, 2003, DIABETES, V52, P1709, DOI 10.2337/diabetes.52.7.1709; Salti I, 2004, DIABETES CARE, V27, P2306, DOI 10.2337/diacare.27.10.2306; Scheen AJ, 1996, AM J PHYSIOL-ENDOC M, V271, pE261, DOI 10.1152/ajpendo.1996.271.2.E261; Schoeller DA, 1997, J CLIN INVEST, V100, P1882, DOI 10.1172/JCI119717; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Sinha MK, 1996, J CLIN INVEST, V97, P1344, DOI 10.1172/JCI118551; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Spiegel K, 2005, J APPL PHYSIOL, V99, P2008, DOI 10.1152/japplphysiol.00660.2005; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Spiegel K, 2004, J CLIN ENDOCR METAB, V89, P5762, DOI 10.1210/jc.2004-1003; Turek FW, 2008, AM J PHYSIOL-REG I, V294, pR1672, DOI 10.1152/ajpregu.00160.2008; Turek FW, 2005, SLEEP, V28, P548, DOI 10.1093/sleep/28.5.548; Turek FW DC, 2005, PRINCIPLES PRACTICE, P318; van Leeuwen WMA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004589; VanCauter E, 1997, ENDOCR REV, V18, P716, DOI 10.1210/er.18.5.716; WATERLOW JC, 1995, ANNU REV NUTR, V15, P57, DOI 10.1146/annurev.nu.15.070195.000421; WATERLOW JC, 1986, ANNU REV NUTR, V6, P495, DOI 10.1146/annurev.nu.06.070186.002431; Wolk R, 2005, CURR PROB CARDIOLOGY, V30, P625, DOI 10.1016/j.cpcardiol.2005.07.002; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yuan CL, 2008, AM J PHYSIOL-ENDOC M, V295, pE216, DOI 10.1152/ajpendo.00545.2007; Zimmet PZ, 1998, INT J OBESITY, V22, P171, DOI 10.1038/sj.ijo.0800559	64	41	41	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96500	10.1371/journal.pone.0096500	http://dx.doi.org/10.1371/journal.pone.0096500			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810091	Green Published, gold, Green Submitted			2022-12-27	WOS:000338213300048
J	Fetherman, ER; Winkelman, DL; Baerwald, MR; Schisler, GJ				Fetherman, Eric R.; Winkelman, Dana L.; Baerwald, Melinda R.; Schisler, George J.			Survival and Reproduction of Myxobolus cerebralis-Resistant Rainbow Trout Introduced to the Colorado River and Increased Resistance of Age-0 Progeny	PLOS ONE			English	Article							WHIRLING DISEASE-RESISTANT; SUSCEPTIBLE STRAINS; ATLANTIC SALMON; REESTABLISHMENT; POPULATION; MORBIDITY; MORTALITY; SELECTION; PARASITE; GROWTH	Myxobolus cerebralis caused severe declines in rainbow trout populations across Colorado following its introduction in the 1980s. One promising approach for the recovery of Colorado's rainbow trout populations has been the production of rainbow trout that are genetically resistant to the parasite. We introduced one of these resistant crosses, known as the GRxCRR (cross between the German Rainbow [GR] and Colorado River Rainbow [CRR] trout strains), to the upper Colorado River. The abundance, survival, and growth of the stocked GRxCRR population was examined to determine if GRxCRRs had contributed offspring to the age-0 population, and determine whether these offspring displayed increased resistance and survival characteristics compared to their wild CRR counterparts. Apparent survival of the introduced GRxCRR over the entire study period was estimated to be 0.007 (+/- 0.001). Despite low survival of the GRxCRRs, age-0 progeny of the GRxCRR were encountered in years 2008 through 2011. Genetic assignments revealed a shift in the genetic composition of the rainbow trout fry population over time, with CRR fish comprising the entirety of the fry population in 2007, and GR-cross fish comprising nearly 80% of the fry population in 2011. A decrease in average infection severity (myxospores fish(-1)) was observed concurrent with the shift in the genetic composition of the rainbow trout fry population, decreasing from an average of 47,708 (+/- 8,950) myxospores fish(-1) in 2009 to 2,672 (+/- 4,379) myxospores fish(-1) in 2011. Results from this experiment suggest that the GRxCRR can survive and reproduce in rivers with a high prevalence of M. cerebralis. In addition, reduced myxospore burdens in age-0 fish indicated that stocking this cross may ultimately lead to an overall reduction in infection prevalence and severity in the salmonid populations of the upper Colorado River.	[Fetherman, Eric R.; Schisler, George J.] Colorado Pk & Wildlife, Ft Collins, CO 80521 USA; [Winkelman, Dana L.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Colorado Cooperat Fish & Wildlife Res Unit, US Geol Survey, Ft Collins, CO 80523 USA; [Baerwald, Melinda R.] Univ Calif Davis, Dept Anim Sci, Genom Variat Lab, Davis, CA 95616 USA	Colorado State University; United States Department of the Interior; United States Geological Survey; University of California System; University of California Davis	Fetherman, ER (corresponding author), Colorado Pk & Wildlife, Ft Collins, CO 80521 USA.	Eric.Fetherman@state.co.us	Fetherman, Eric/AAZ-7045-2020	Fetherman, Eric/0000-0003-4792-7148; Baerwald, Melinda/0000-0001-7462-5212; Schisler, George/0000-0001-6948-6991	Federal Aid in Sport Fish Restoration program [F-394R]	Federal Aid in Sport Fish Restoration program	This work was funded by the Federal Aid in Sport Fish Restoration program, project F-394R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D. R., 2008, MODEL BASED INFERENC; Anderson EC, 2002, GENETICS, V160, P1217; Arismendi I., 2012, HYDROBIOLOGIA, P1, DOI DOI 10.1007/S10750-012-1327-2; Baerwald MR, 2011, HEREDITY, V106, P920, DOI 10.1038/hdy.2010.137; BAILEY NTJ, 1951, BIOMETRIKA, V38, P293, DOI 10.2307/2332575; Bosch WJ, 2007, N AM J FISH MANAGE, V27, P198, DOI 10.1577/M05-044.1; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Busacker G.P., 1990, P363; Carmona-Catot G, 2012, REV FISH BIOL FISHER, V22, P325, DOI 10.1007/s11160-011-9230-x; El-Matbouli M, 2006, WAR WHIRLDS, P22; FABENS AJ, 1965, GROWTH, V29, P265; Fetherman ER, 2012, FEDERAL AID FISH WIL; Fetherman ER, 2012, DIS AQUAT ORGAN, V102, P97, DOI 10.3354/dao02543; Fetherman ER, 2011, J AQUAT ANIM HEALTH, V23, P169, DOI 10.1080/08997659.2011.630273; Flagg TA, 2004, AM FISH S S, V44, P387; Fraser DJ, 2008, EVOL APPL, V1, P535, DOI 10.1111/j.1752-4571.2008.00036.x; GATZ AJ, 1987, OECOLOGIA, V74, P7, DOI 10.1007/BF00377339; Granath WO, 2007, J PARASITOL, V93, P104, DOI 10.1645/GE-948R.1; Halverson A., 2010, ENTIRELY SYNTHETIC F; Harig AL, 2002, ECOL APPL, V12, P535, DOI 10.1890/1051-0761(2002)012[0535:MHRFET]2.0.CO;2; Hedrick RP, 2003, DIS AQUAT ORGAN, V55, P37, DOI 10.3354/dao055037; Hesthagen T, 2003, FISHERIES MANAG ECOL, V10, P87, DOI 10.1046/j.1365-2400.2003.00326.x; HICKS BJ, 1991, WATER RESOUR BULL, V27, P217; Isely J. Jeffery, 2007, P187; MARKIW ME, 1974, J FISH RES BOARD CAN, V31, P15, DOI 10.1139/f74-003; Miller MP, 2008, EVOL APPL, V1, P336, DOI 10.1111/j.1752-4571.2008.00018.x; Nehring R.B., 2003, MANAGING RISK, P31; Nehring R.B., 2001, 76 COL DIV WILDL AQ; Nehring RB, 2006, 79 COL DIV WILDL AQ; Nehring RB, 2011, FEDERAL AID FISH WIL; Nielsen EE, 2001, CONSERV GENET, V2, P219, DOI 10.1023/A:1012239029574; O'GRODNICK J J, 1975, Journal of Wildlife Diseases, V11, P54; Pritchard JK, 2000, GENETICS, V155, P945; Ryce EKN, 2005, DIS AQUAT ORGAN, V63, P69, DOI 10.3354/dao063069; Ryce EKN, 2001, J AQUAT ANIM HEALTH, V13, P63, DOI 10.1577/1548-8667(2001)013&lt;0063:LOSFRT&gt;2.0.CO;2; SAS Institute Inc, 2010, SAS SYST SOFTW REL 9; Schisler GJ, 2006, J AQUAT ANIM HEALTH, V18, P109, DOI 10.1577/H05-047.1; Schisler GJ, 2000, T AM FISH SOC, V129, P859, DOI 10.1577/1548-8659(2000)129&lt;0859:EOMSOM&gt;2.3.CO;2; Schisler GJ, 1999, N AM J AQUACULT, V61, P175, DOI 10.1577/1548-8454(1999)061<0175:EOCGSO>2.0.CO;2; Schisler GJ, 1999, J AQUAT ANIM HEALTH, V11, P170, DOI 10.1577/1548-8667(1999)011&lt;0170:GEOJRT&gt;2.0.CO;2; SEBER GAF, 1970, BIOMETRICS, V26, P393, DOI 10.2307/2529096; Temple Gabriel M., 2007, P95; Thompson KG, 2011, AQUAT ECOSYST HEALTH, V14, P305, DOI 10.1080/14634988.2011.602276; Thompson KG, 1999, J AQUAT ANIM HEALTH, V11, P312, DOI 10.1577/1548-8667(1999)011&lt;0312:FEOSSO&gt;2.0.CO;2; USGS, 2009, USGS REAL TIM WAT DA; Van Den Avyle M. J., 1999, INLAND FISHERIES MAN, P127; von Bertalanffy L, 1938, HUM BIOL, V10, P181, DOI DOI 10.2307/41447359; Walker P. G., 1995, INVESTIGATION DETERM; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Williams JE, 2009, N AM J FISH MANAGE, V29, P533, DOI 10.1577/M08-072.1	50	11	11	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96954	10.1371/journal.pone.0096954	http://dx.doi.org/10.1371/journal.pone.0096954			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24811066	Green Published, gold			2022-12-27	WOS:000338213300098
J	Ouyang, ZM; Zhou, JL; Norgard, MV				Ouyang, Zhiming; Zhou, Jianli; Norgard, Michael V.			Synthesis of RpoS Is Dependent on a Putative Enhancer Binding Protein Rrp2 in Borrelia burgdorferi	PLOS ONE			English	Article							LYME-DISEASE SPIROCHETE; OUTER-SURFACE PROTEIN; RESPONSE REGULATOR RRP2; STRESS-RESPONSE; LIFE-CYCLE; EXPRESSION; OSPC; INFECTION; VIRULENCE; RNA	The RpoN-RpoS regulatory pathway plays a central role in governing adaptive changes by B. burgdorferi when the pathogen shuttles between its tick vector and mammalian hosts. In general, transcriptional activation of bacterial RpoN (sigma(54))dependent genes requires an enhancer binding protein. B. burgdorferi encodes the putative enhancer binding protein Rrp2. Previous studies have revealed that the expression of sigma(54)-dependent rpoS was abolished in an rrp2 point mutant. However, direct evidence linking the production of Rrp2 in B. burgdorferi and the expression of rpoS has been lacking, primarily due to the inability to inactivate rrp2 via deletion or insertion mutagenesis. Herein we introduced a regulatable (IPTG-inducible) rrp2 expression shuttle plasmid into B. burgdorferi, and found that the controlled up-regulation of Rrp2 resulted in the induction of sigma(54)-dependent rpoS expression. Moreover, we created an rrp2 conditional lethal mutant in virulent B. burgdorferi. By exploiting this conditional mutant, we were able to experimentally manipulate the temporal level of Rrp2 expression in B. burgdorferi, and examine its direct impact on activation of the RpoN-RpoS regulatory pathway. Our data revealed that the synthesis of RpoS was coincident with the IPTG-induced Rrp2 levels in B. burgdorferi. In addition, the synthesis of OspC, a lipoprotein required by B. burgdorferi to establish mammalian infection, was rescued in the rrp2 point mutant when RpoS production was restored, suggesting that Rrp2 influences ospC expression indirectly via its control over RpoS. These data demonstrate that Rrp2 is required for the synthesis of RpoS, presumably via its action as an enhancer binding protein for the activation of RpoN and subsequent transcription of rpoS in B. burgdorferi.	[Ouyang, Zhiming; Zhou, Jianli; Norgard, Michael V.] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Norgard, MV (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA.	michael.norgard@utsouthwestern.edu	zhou, jianli/I-8911-2014		NIAID-NIH [AI-059062]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI059062, R01AI059062] Funding Source: NIH RePORTER	NIAID-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by grant NIAID-NIH AI-059062. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alverson J, 2003, MOL MICROBIOL, V48, P1665, DOI 10.1046/j.1365-2958.2003.03537.x; Blevins JS, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-82; Blevins JS, 2007, APPL ENVIRON MICROB, V73, P1501, DOI 10.1128/AEM.02454-06; Boardman BK, 2008, INFECT IMMUN, V76, P3844, DOI 10.1128/IAI.00467-08; Boylan JA, 2003, P NATL ACAD SCI USA, V100, P11684, DOI 10.1073/pnas.2032956100; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; Burtnick MN, 2007, MOL MICROBIOL, V65, P277, DOI 10.1111/j.1365-2958.2007.05813.x; Bush M, 2012, MICROBIOL MOL BIOL R, V76, P497, DOI 10.1128/MMBR.00006-12; Caimano MJ, 2005, J BACTERIOL, V187, P7845, DOI 10.1128/JB.187.22.7845-7852.2005; Caimano MJ, 2004, INFECT IMMUN, V72, P6433, DOI 10.1128/IAI.72.11.6433-6445.2004; Calmano MJ, 2007, MOL MICROBIOL, V65, P1193, DOI 10.1111/j.1365-2958.2007.05860.x; Crother TR, 2004, INFECT IMMUN, V72, P5063, DOI 10.1128/IAI.72.9.5063-5072.2004; deSilva AM, 1996, J EXP MED, V183, P271, DOI 10.1084/jem.183.1.271; Dunham-Ems SM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002532; Fisher MA, 2005, P NATL ACAD SCI USA, V102, P5162, DOI 10.1073/pnas.0408536102; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Freedman JC, 2010, FEMS IMMUNOL MED MIC, V58, P285, DOI 10.1111/j.1574-695X.2009.00635.x; Ghosh T, 2010, FEMS MICROBIOL REV, V34, P611, DOI 10.1111/j.1574-6976.2010.00239.x; Gilbert MA, 2007, MOL MICROBIOL, V63, P1259, DOI 10.1111/j.1365-2958.2007.05593.x; Grimm D, 2004, P NATL ACAD SCI USA, V101, P3142, DOI 10.1073/pnas.0306845101; Groshong AM, 2012, J BACTERIOL, V194, P3336, DOI 10.1128/JB.00253-12; He M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002133; He M, 2008, MOL MICROBIOL, V70, P1453, DOI 10.1111/j.1365-2958.2008.06491.x; Hubner A, 2001, P NATL ACAD SCI USA, V98, P12724, DOI 10.1073/pnas.231442498; HUGHES CAN, 1992, J CLIN MICROBIOL, V30, P698, DOI 10.1128/JCM.30.3.698-703.1992; Hyde JA, 2009, MOL MICROBIOL, V74, P1344, DOI 10.1111/j.1365-2958.2009.06951.x; Jutras BL, 2013, J BIOL CHEM, V288, P26220, DOI 10.1074/jbc.M113.491357; Jutras BL, 2012, J BACTERIOL, V194, P778, DOI 10.1128/JB.06394-11; Karna SLR, 2011, INFECT IMMUN, V79, P732, DOI 10.1128/IAI.00882-10; Katona LI, 2004, J BACTERIOL, V186, P6443, DOI 10.1128/JB.186.19.6443-6456.2004; Kostick JL, 2011, MOL MICROBIOL, V81, P219, DOI 10.1111/j.1365-2958.2011.07687.x; Lenhart TR, 2010, MOL MICROBIOL, V75, P692, DOI 10.1111/j.1365-2958.2009.07015.x; Liang FT, 2002, J EXP MED, V196, P275, DOI 10.1084/jem.20020770; Lybecker MC, 2007, MOL MICROBIOL, V64, P1075, DOI 10.1111/j.1365-2958.2007.05716.x; Lybecker MC, 2010, MOL MICROBIOL, V78, P622, DOI 10.1111/j.1365-2958.2010.07374.x; Medrano MS, 2010, NUCLEIC ACIDS RES, V38, P414, DOI 10.1093/nar/gkp1027; Miller CL, 2013, MOL MICROBIOL, V88, P105, DOI 10.1111/mmi.12171; Montgomery RR, 1996, J EXP MED, V183, P261, DOI 10.1084/jem.183.1.261; MORETT E, 1993, J BACTERIOL, V175, P6067, DOI 10.1128/JB.175.19.6067-6074.1993; Ohnishi J, 2001, P NATL ACAD SCI USA, V98, P670, DOI 10.1073/pnas.98.2.670; Ouyang ZM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-44; Ouyang ZM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001272; Ouyang ZM, 2010, J BACTERIOL, V192, P1965, DOI 10.1128/JB.01616-09; Ouyang ZM, 2009, MOL MICROBIOL, V74, P1331, DOI 10.1111/j.1365-2958.2009.06945.x; Ouyang ZM, 2009, P NATL ACAD SCI USA, V106, P3449, DOI 10.1073/pnas.0812999106; Pal U, 2000, J CLIN INVEST, V106, P561, DOI 10.1172/JCI9427; Pal U, 2004, J CLIN INVEST, V113, P220, DOI 10.1172/JCI200419894; POLLACK RJ, 1993, J CLIN MICROBIOL, V31, P1251, DOI 10.1128/JCM.31.5.1251-1255.1993; Prelich G, 2012, GENETICS, V190, P841, DOI 10.1534/genetics.111.136911; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Rappas M, 2007, CURR OPIN STRUC BIOL, V17, P110, DOI 10.1016/j.sbi.2006.11.002; Rogers EA, 2009, MOL MICROBIOL, V71, P1551, DOI 10.1111/j.1365-2958.2009.06621.x; Salman-Dilgimen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022168; Samuels D S, 1995, Methods Mol Biol, V47, P253; Samuels D.S., 2010, BORRELIA MOL BIOL HO; Samuels DS, 2011, ANNU REV MICROBIOL, V65, P479, DOI 10.1146/annurev.micro.112408.134040; Samuels DS, 2009, MOL MICROBIOL, V74, P1295, DOI 10.1111/j.1365-2958.2009.06971.x; Sanjuan E, 2009, INFECT IMMUN, V77, P5149, DOI 10.1128/IAI.00673-09; Scheckelhoff MR, 2007, P NATL ACAD SCI USA, V104, P7247, DOI 10.1073/pnas.0607263104; SCHWAN TG, 1995, P NATL ACAD SCI USA, V92, P2909, DOI 10.1073/pnas.92.7.2909; Schwan TG, 2000, J CLIN MICROBIOL, V38, P382; Shi YL, 2008, INFECT IMMUN, V76, P1239, DOI 10.1128/IAI.00897-07; Smith AH, 2007, J BACTERIOL, V189, P2139, DOI 10.1128/JB.01653-06; STEERE AC, 1993, HOSP PRACT, V28, P37, DOI 10.1080/21548331.1993.11442776; Studholme DJ, 2003, J BACTERIOL, V185, P1757, DOI 10.1128/JB.185.6.1757-1767.2003; Sultan SZ, 2010, MOL MICROBIOL, V77, P128, DOI 10.1111/j.1365-2958.2010.07191.x; Sze CW, 2013, INFECT IMMUN, V81, P1775, DOI 10.1128/IAI.00050-13; Sze CW, 2011, INFECT IMMUN, V79, P1270, DOI 10.1128/IAI.00871-10; Tilly K, 2006, INFECT IMMUN, V74, P3554, DOI 10.1128/IAI.01950-05; Weening EH, 2008, INFECT IMMUN, V76, P5694, DOI 10.1128/IAI.00690-08; Wigneshweraraj S, 2008, MOL MICROBIOL, V68, P538, DOI 10.1111/j.1365-2958.2008.06181.x; Xu QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053212; Yang XFF, 2005, J BACTERIOL, V187, P4822, DOI 10.1128/JB.187.14.4822-4829.2005; Yang XFF, 2004, J EXP MED, V199, P641, DOI 10.1084/jem.20031960; Yang XFF, 2003, P NATL ACAD SCI USA, V100, P11001, DOI 10.1073/pnas.1834315100; Zhiming OY, 2008, MICROBIOL-SGM, V154, P2641, DOI 10.1099/mic.0.2008/019992-0	76	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96917	10.1371/journal.pone.0096917	http://dx.doi.org/10.1371/journal.pone.0096917			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810170	Green Published, Green Submitted, gold			2022-12-27	WOS:000338213300089
J	Rezende, RS; Petrucio, MM; Goncalves, JF				Rezende, Renan S.; Petrucio, Mauricio M.; Goncalves, Jose F., Jr.			The Effects of Spatial Scale on Breakdown of Leaves in a Tropical Watershed	PLOS ONE			English	Article							LEAF-LITTER BREAKDOWN; LAND-USE; STREAM; FUNGI; DECOMPOSITION; ECOSYSTEM; DETRITUS; BACTERIA; LANDSCAPES; INDICATORS	The objective was to assess the effects of natural variation in the physical structure of the environment on biological communities and on the processing of Eucalyptus cloeziana and Inga laurina and to identify the controlling factors at different scales along stream order gradients. The study area consisted of 14 sampling sites distributed within a tropical watershed (1st, 2nd, 3rd and 4th order streams replicated in 4 sub-basins). Our samples consisted of 3 g of leaves of E. cloeziana (high-quality) and I. laurina (low-quality) placed in 252 bags with 10mm mesh (measured by the chemical composition of the detritus). Four samples of each leaf type were collected periodically (three times) over a period of 75125 days and washed on a sieve to separate the invertebrates. A series of leaf disks were cut to determine ash-free dry mass, polyphenol, lignin, cellulose, total microbial biomass and fungal biomass, and the remaining material was oven-dried to determine the dry weight. We performed analyses within and between spatial scales (regional and local) to assess which watershed scale was the more import determinant of the leaf breakdown rate (k). The microbial and shredder were most influenced at the local scale (stream order). Shredders were influenced by microorganisms, with stronger interactions between them than were found to drive the k at the local scale. Moreover, differences in the overall k and abiotic variables were more strongly influenced at the regional scale (sub-basin), showing that the study scale alters the response of the studied variables. We found higher k values at higher values of water velocity, dissolved oxygen and temperature, all of which accelerate biological metabolism in response to variations on the regional scale. Watersheds with warmer microclimates and streams with higher nutrient levels and oxygen could be accelerating the ecosystem metabolism, independent of the detritus quality.	[Rezende, Renan S.; Petrucio, Mauricio M.] Univ Fed Santa Catarina, Inst Biol Sci, Grad Program Ecol, Dept Ecol & Zool, Florianopolis, SC, Brazil; [Rezende, Renan S.; Goncalves, Jose F., Jr.] Univ Brasilia, Inst Biol, Dept Ecol, Brasilia, DF, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade de Brasilia	Rezende, RS (corresponding author), Univ Fed Santa Catarina, Inst Biol Sci, Grad Program Ecol, Dept Ecol & Zool, Florianopolis, SC, Brazil.	renanrezende30@gmail.com	Petrucio, Mauricio/AAC-6232-2019; Rezende, Renan de Souza/I-5165-2014; Petrucio, Mauricio/E-2590-2013; Gonçalves Júnior, José/G-3910-2012	Petrucio, Mauricio/0000-0002-7242-9426; Rezende, Renan de Souza/0000-0002-4129-0863; Gonçalves Júnior, José/0000-0001-8191-2113	PROCAD-NF/CAPES [173/2010]; PNADB/Edital/CAPES [1098/2010]; PELD/CNPq [558233/2009-0]; FAPEMIG [APQ-00274-12]; Federal University of Santa Catarina (UFSC); University of Brasilia (UnB - DPP) [121366/2011]	PROCAD-NF/CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PNADB/Edital/CAPES; PELD/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Federal University of Santa Catarina (UFSC); University of Brasilia (UnB - DPP)	The sources of funding that have supported the work were PROCAD-NF/CAPES (No. 173/2010), PNADB/Edital 17/2009/CAPES (No. 1098/2010), PELD/CNPq (No. 558233/2009-0), FAPEMIG (No. APQ-00274-12), Federal University of Santa Catarina (UFSC) and funds of University of Brasilia (UnB - DPP; No. 121366/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelho M, 2001, ScientificWorldJournal, V1, P656; Abelho Manuela, 2005, P223, DOI 10.1007/1-4020-3466-0_30; Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; Allen T. F. H., 1982, HIERARCHY PERSPECTIV; Ardon M, 2006, FRESHWATER BIOL, V51, P618, DOI 10.1111/j.1365-2427.2006.01515.x; Ardon M, 2008, OECOLOGIA, V155, P311, DOI 10.1007/s00442-007-0913-x; Bae MJ, 2011, ANN LIMNOL-INT J LIM, V47, pS91, DOI 10.1051/limn/2011022; Barlocher Felix, 2005, P97, DOI 10.1007/1-4020-3466-0_14; Benda L, 2004, BIOSCIENCE, V54, P413, DOI 10.1641/0006-3568(2004)054[0413:TNDHHC]2.0.CO;2; Boyero L, 2012, GLOBAL ECOL BIOGEOGR, V21, P134, DOI 10.1111/j.1466-8238.2011.00673.x; Bruder A, 2013, FRESHWATER BIOL; Carvalho FMV, 2009, BIOL CONSERV, V142, P1392, DOI 10.1016/j.biocon.2009.01.031; Crawley M.J., 2007, R BOOK; Cummins KW, 2005, STUD NEOTROP FAUNA E, V40, P69, DOI 10.1080/01650520400025720; Cummins KW, 1974, PRODUCTIVITY WORLD E, P166; Cummins KW, 1996, INTRO AQUATIC INSECT; Fonseca ALD, 2013, HYDROBIOLOGIA, V703, P59, DOI 10.1007/s10750-012-1342-3; Fabre E, 1998, ARCH HYDROBIOL, V141, P167; Frauendorf TC, 2013, FRESHWATER BIOL, V58, P1340, DOI 10.1111/fwb.12131; FRISSELL CA, 1986, ENVIRON MANAGE, V10, P199, DOI 10.1007/BF01867358; Gessner Mark O., 2005, P115, DOI 10.1007/1-4020-3466-0_17; Gessner Mark O., 2005, P189, DOI 10.1007/1-4020-3466-0_25; Gessner MO, 1999, OIKOS, V85, P377, DOI 10.2307/3546505; Golterman H. L., 1978, METHODS CHEM ANAL FR; Goncalves JFJ, 2007, FRESHWATER BIOL, V52, P1440, DOI 10.1111/j.1365-2427.2007.01769.x; Goncalves JF, 2012, AUSTRAL ECOL, V37, P807, DOI 10.1111/j.1442-9993.2011.02341.x; Goncalves JF, 2012, MAR FRESHWATER RES, V63, P428, DOI 10.1071/MF11172; GONCALVES JR J. F., 2013, INSETOS AQUATICOS BI; GRACA M. A. S., 2005, METHODS STUDY LITTER; Graca MAS, 2001, FRESHWATER BIOL, V46, P947, DOI 10.1046/j.1365-2427.2001.00729.x; Gulis V, 2003, AQUAT MICROB ECOL, V30, P149, DOI 10.3354/ame030149; Hagen EM, 2006, J N AM BENTHOL SOC, V25, P330, DOI 10.1899/0887-3593(2006)25[330:ALBRAU]2.0.CO;2; Hansen H.P., 2007, METHODS SEAWATER ANA, P159, DOI [10.1002/9783527613984.ch10, DOI 10.1002/9783527613984, DOI 10.1002/9783527613984.CH10]; Hieber M, 2002, ECOLOGY, V83, P1026, DOI 10.1890/0012-9658(2002)083[1026:COSDFA]2.0.CO;2; IRONS JG, 1994, FRESHWATER BIOL, V32, P401, DOI 10.1111/j.1365-2427.1994.tb01135.x; Del Arco AI, 2012, LIMNETICA, V31, P141; Larned ST, 2010, FRESHWATER BIOL, V55, P717, DOI 10.1111/j.1365-2427.2009.02322.x; Larned ST, 2000, J N AM BENTHOL SOC, V19, P215, DOI 10.2307/1468066; Li AOY, 2009, AQUAT SCI, V71, P80, DOI 10.1007/s00027-008-8117-y; Ligeiro R, 2010, HYDROBIOLOGIA, V654, P125, DOI 10.1007/s10750-010-0375-8; Lowe WH, 2006, BIOSCIENCE, V56, P591, DOI 10.1641/0006-3568(2006)56[591:LSISE]2.0.CO;2; Mathuriau C, 2002, J N AM BENTHOL SOC, V21, P384, DOI 10.2307/1468477; Medeiros AO, 2009, FRESHWATER BIOL, V54, P142, DOI 10.1111/j.1365-2427.2008.02101.x; MINSHALL GW, 1983, ECOL MONOGR, V53, P1, DOI 10.2307/1942585; Moretti M, 2007, LIMNOLOGICA, V37, P250, DOI 10.1016/j.limno.2007.01.003; Moulton TP, 2010, HYDROBIOLOGIA, V638, P55, DOI 10.1007/s10750-009-0009-1; Naiman RJ, 1997, ANNU REV ECOL SYST, V28, P621, DOI 10.1146/annurev.ecolsys.28.1.621; Oliveira-Filho AT, 1994, J BOT, V52, P141; Perez G.P., 1988, GUIA STUDIO MACROINV; PETERSEN RC, 1974, FRESHWATER BIOL, V4, P343, DOI 10.1111/j.1365-2427.1974.tb00103.x; POMPEO MLM, 1999, PERSPECTIVAS LIMNOLO, P21; Royer TV, 2003, J N AM BENTHOL SOC, V22, P352, DOI 10.2307/1468266; Rueda-Delgado G, 2006, J N AM BENTHOL SOC, V25, P233, DOI 10.1899/0887-3593(2006)25[233:LDIAAF]2.0.CO;2; Schneider DC, 2001, BIOSCIENCE, V51, P545, DOI 10.1641/0006-3568(2001)051[0545:TROTCO]2.0.CO;2; Sponseller RA, 2001, J N AM BENTHOL SOC, V20, P44, DOI 10.2307/1468187; STATZNER B, 1985, CAN J FISH AQUAT SCI, V42, P1038, DOI 10.1139/f85-129; STRAHLER AN, 1952, GEOL SOC AM BULL, V63, P1117, DOI 10.1130/0016-7606(1952)63[1117:HAAOET]2.0.CO;2; Strickland JDH, 1960, MANUAL SEAWATER ANAL; SUBERKROPP K, 1995, ECOLOGY, V76, P1433, DOI 10.2307/1938146; Sutherland WJ, 2013, J ECOL, V101, P58, DOI 10.1111/1365-2745.12025; Tiegs SD, 2009, OECOLOGIA, V161, P343, DOI 10.1007/s00442-009-1386-x; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Wantzen KM, 2006, J N AM BENTHOL SOC, V25, P216, DOI 10.1899/0887-3593(2006)25[216:DPBISA]2.0.CO;2; Weyers HS, 1996, J N AM BENTHOL SOC, V15, P408, DOI 10.2307/1467795; Wiens JA, 2002, FRESHWATER BIOL, V47, P501, DOI 10.1046/j.1365-2427.2002.00887.x; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Wright MS, 2005, MICROB ECOL, V49, P536, DOI 10.1007/s00248-004-0052-4; Young RG, 2009, FRESHWATER BIOL, V54, P2155, DOI 10.1111/j.1365-2427.2009.02239.x	68	28	31	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e97072	10.1371/journal.pone.0097072	http://dx.doi.org/10.1371/journal.pone.0097072			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810918	Green Published, Green Submitted, gold			2022-12-27	WOS:000338213300116
J	Shahi, MH; Holt, R; Rebhun, RB				Shahi, Mehdi Hayat; Holt, Roseline; Rebhun, Robert B.			Blocking Signaling at the Level of GLI Regulates Downstream Gene Expression and Inhibits Proliferation of Canine Osteosarcoma Cells	PLOS ONE			English	Article							SONIC HEDGEHOG; IN-VIVO; PATHWAY; MEDULLOBLASTOMA; GROWTH; TARGET; CANCER; IDENTIFICATION; NEUROBLASTOMA; TRANSCRIPTION	The Hedgehog-GLI signaling pathway is active in a variety of human malignancies and is known to contribute to the growth and survival of human osteosarcoma cells. In this study, we examined the expression and regulation of GLI transcription factors in multiple canine osteosarcoma cell lines and analyzed the effects of inhibiting GLI with GANT61, a GLI-specific inhibitor. Compared with normal canine osteoblasts, real-time PCR showed that GLI1 and GLI2 were highly expressed in two out of three cell lines and correlated with downstream target gene expression of PTCH1and PAX6. Treatment of canine osteosarcoma cells with GANT61 resulted in decreased expression of GLI1, GLI2, PTCH1, and PAX6. Furthermore, GANT61 inhibited proliferation and colony formation in all three canine osteosarcoma cell lines. The finding that GLI signaling activity is present and active in canine osteosarcoma cells suggests that spontaneously arising osteosarcoma in dogs might serve as a good model for future preclinical testing of GLI inhibitors.	[Shahi, Mehdi Hayat; Holt, Roseline; Rebhun, Robert B.] Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Rebhun, RB (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA.	rbrebhun@ucdavis.edu		Rebhun, Robert/0000-0002-8047-3494	Bernice Barbour Foundation; Center for Companion Animal Health-School of Veterinary Medicine; NCRR [K01 RR031272]; Office of Research Infrastructure Programs [8K01OD011111-02]; NATIONAL CENTER FOR RESEARCH RESOURCES [K01RR031272] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD011111] Funding Source: NIH RePORTER	Bernice Barbour Foundation; Center for Companion Animal Health-School of Veterinary Medicine; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the Bernice Barbour Foundation, the Center for Companion Animal Health-School of Veterinary Medicine, and NCRR K01 RR031272 (currently supported by the Office of Research Infrastructure Programs 8K01OD011111-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angstadt AY, 2012, CANCER GENET-NY, V205, P572, DOI 10.1016/j.cancergen.2012.09.005; Bai CYB, 2001, DEVELOPMENT, V128, P5161; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Dahmane N, 1997, NATURE, V389, P876, DOI 10.1038/39918; Drenkhahn SK, 2013, CURR CANCER DRUG TAR, V13, P580; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hirotsu M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-5; Jami A, 2013, MOL CELLS, V35, P305, DOI 10.1007/s10059-013-2310-0; Jenkins D, 2009, CELL SIGNAL, V21, P1023, DOI 10.1016/j.cellsig.2009.01.033; KOZMIK Z, 1995, P NATL ACAD SCI USA, V92, P5709, DOI 10.1073/pnas.92.12.5709; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Lee J, 1997, DEVELOPMENT, V124, P2537; Legare ME, 2011, J CANCER, V2, P262, DOI 10.7150/jca.2.262; Maeda J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043355; McMillan R, 2012, CLIN CANCER RES, V18, P4883, DOI 10.1158/1078-0432.CCR-11-2509; Mohseny AB, 2012, EUR J CANCER, V48, P3429, DOI 10.1016/j.ejca.2012.06.018; Nagao H, 2011, J PATHOL, V224, P169, DOI 10.1002/path.2880; Nakamura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069466; O'Donoghue LE, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-506; Paoloni M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-625; Pawlowski KM, 2011, POL J VET SCI, V14, P11, DOI 10.2478/v10181-011-0002-2; Pfaffl MW, 2001, APMIS, V109, P345, DOI 10.1034/j.1600-0463.2001.090503.x; PREAT T, 1990, NATURE, V347, P87, DOI 10.1038/347087a0; Queiroz KCS, 2012, DRUG RESIST UPDATE, V15, P211, DOI 10.1016/j.drup.2012.05.002; Rankin KS, 2012, PEDIATR BLOOD CANCER, V58, P327, DOI 10.1002/pbc.23341; Regl G, 2002, ONCOGENE, V21, P5529, DOI 10.1038/sj.onc.1205748; Shahi MH, 2008, ONCOL REP, V19, P681; Shahi MH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-614; Sisson JC, 1997, CELL, V90, P235, DOI 10.1016/S0092-8674(00)80332-3; Smith MA, 2012, PEDIATR BLOOD CANCER, V59, P753, DOI 10.1002/pbc.23391; Stecca B, 2005, TRENDS MOL MED, V11, P199, DOI 10.1016/j.molmed.2005.03.004; STRACHAN T, 1994, CURR OPIN GENET DEV, V4, P427, DOI 10.1016/0959-437X(94)90032-9; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Warzecha J, 2012, INT J MOL MED, V29, P423, DOI 10.3892/ijmm.2011.851; Wetmore C, 2003, CURR OPIN GENET DEV, V13, P34, DOI 10.1016/S0959-437X(03)00002-9; Wickstrom M, 2013, INT J CANCER, V132, P1516, DOI 10.1002/ijc.27820; Yang W, 2013, J ORTHOP RES, V31, P502, DOI 10.1002/jor.22230; Yun JI, 2012, ARCH PHARM RES, V35, P1317, DOI 10.1007/s12272-012-0801-8; Zhang J, 2009, MOL CANCER RES, V7, P67, DOI 10.1158/1541-7786.MCR-08-0347	41	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96593	10.1371/journal.pone.0096593	http://dx.doi.org/10.1371/journal.pone.0096593			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24810746	Green Published, Green Submitted, gold			2022-12-27	WOS:000338213300055
J	Tomonaga, Y; Brennwald, MS; Livingstone, DM; Tomonaga, G; Kipfer, R				Tomonaga, Yama; Brennwald, Matthias S.; Livingstone, David M.; Tomonaga, Genevieve; Kipfer, Rolf			Determination of Natural In Vivo Noble-Gas Concentrations in Human Blood	PLOS ONE			English	Article							SOLUBILITY; XENON; POREWATER; WATER; PARTITION; PROXIES; HELIUM; XE-133	Although the naturally occurring atmospheric noble gases He, Ne, Ar, Kr, and Xe possess great potential as tracers for studying gas exchange in living beings, no direct analytical technique exists for simultaneously determining the absolute concentrations of these noble gases in body fluids in vivo. In this study, using human blood as an example, the absolute concentrations of all stable atmospheric noble gases were measured simultaneously by combining and adapting two analytical methods recently developed for geochemical research purposes. The partition coefficients determined between blood and air, and between blood plasma and red blood cells, agree with values from the literature. While the noble-gas concentrations in the plasma agree rather well with the expected solubility equilibrium concentrations for air-saturated water, the red blood cells are characterized by a distinct supersaturation pattern, in which the gas excess increases in proportion to the atomic mass of the noble-gas species, indicating adsorption on to the red blood cells. This study shows that the absolute concentrations of noble gases in body fluids can be easily measured using geochemical techniques that rely only on standard materials and equipment, and for which the underlying concepts are already well established in the field of noble-gas geochemistry.	[Tomonaga, Yama; Brennwald, Matthias S.; Livingstone, David M.; Kipfer, Rolf] Swiss Fed Inst Aquat Sci & Technol, Eawag, Dept Water Resources & Drinking Water, Dubendorf, Switzerland; [Tomonaga, Yama; Kipfer, Rolf] Swiss Fed Inst Technol, Inst Biogeochem & Pollutant Dynam, Zurich, Switzerland; [Tomonaga, Genevieve] Ergomotion, Losone, Switzerland; [Kipfer, Rolf] Swiss Fed Inst Technol, Inst Geochem & Petr, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Tomonaga, Y (corresponding author), Swiss Fed Inst Aquat Sci & Technol, Eawag, Dept Water Resources & Drinking Water, Dubendorf, Switzerland.	tomonaga@eawag.ch	Tomonaga, Yama/ABG-9540-2020	Tomonaga, Yama/0000-0003-2871-8826	Swiss Federal Institute of Aquatic Science and Technology (Eawag); Swiss National Science Foundation (SNF) [20FI21_124972, 200021_124981]	Swiss Federal Institute of Aquatic Science and Technology (Eawag); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	This work was funded by the Swiss Federal Institute of Aquatic Science and Technology (Eawag) and the Swiss National Science Foundation (SNF Grants 20FI21_124972 and 200021_124981). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT MS, 1994, NATURE, V370, P199, DOI 10.1038/370199a0; Beyerle U, 2000, ENVIRON SCI TECHNOL, V34, P2042, DOI 10.1021/es990840h; Brennwald MS, 2013, EARTH PLANET SC LETT, V366, P27, DOI 10.1016/j.epsl.2013.01.039; Brennwald MS, 2005, EARTH PLANET SC LETT, V235, P31, DOI 10.1016/j.epsl.2005.03.004; Brennwald MS, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019153; Brennwald MS, 2003, LIMNOL OCEANOGR-METH, V1, P51, DOI 10.4319/lom.2003.1.51; Burney P, 2014, THORAX, V69, DOI 10.1136/thoraxjnl-2013-204460; Damgaard M, 2005, CLIN PHYSIOL FUNCT I, V25, P142, DOI 10.1111/j.1475-097X.2005.00602.x; EDWARDS AWT, 1963, J APPL PHYSIOL, V18, P107; Goto T, 1998, BRIT J ANAESTH, V80, P255, DOI 10.1093/bja/80.2.255; HARDEWIG A, 1960, J APPL PHYSIOL, V15, P723, DOI 10.1152/jappl.1960.15.4.723; HLASTALA MP, 1980, UNDERSEA BIOMED RES, V7, P297; ISBISTER WH, 1965, PHYS MED BIOL, V10, P243, DOI 10.1088/0031-9155/10/2/308; Jordan Bryan D, 2010, AANA J, V78, P387; Kipfer R, 2002, REV MINERAL GEOCHEM, V47, P615, DOI 10.2138/rmg.2002.47.14; Kitani K, 1972, SCAND J CLIN LAB INV, V29, P176; LADEFOGED J, 1967, PHYS MED BIOL, V12, P353, DOI 10.1088/0031-9155/12/3/307; Macher L, 2012, ENVIRON SCI TECHNOL, V46, P8288, DOI 10.1021/es3004409; MUEHLBAECHER CA, 1966, MOL PHARMACOL, V2, P86; Osbak PS, 2011, SCAND J CLIN LAB INV, V71, P304, DOI 10.3109/00365513.2011.563790; Ozima M., 2022, NOBLE GAS GEOCHEMIST; Pavlovskaya GE, 2005, P NATL ACAD SCI USA, V102, P18275, DOI 10.1073/pnas.0509419102; Purves W. K., 2004, LIFE SCI BIOL; ROCHESTER DF, 1967, J APPL PHYSIOL, V22, P423, DOI 10.1152/jappl.1967.22.3.423; Schlosser P, 2002, REV MINERAL GEOCHEM, V47, P701, DOI 10.2138/rmg.2002.47.15; Strassmann KM, 2005, GEOCHIM COSMOCHIM AC, V69, P1665, DOI 10.1016/j.gca.2004.07.037; Tomonaga Y, 2012, J ASIAN EARTH SCI, V59, P99, DOI 10.1016/j.jseaes.2012.05.011; Tomonaga Y, 2011, LIMNOL OCEANOGR-METH, V9, P42, DOI 10.4319/lom.2011.9.42; Tomonaga Y, 2011, GEOCHIM COSMOCHIM AC, V75, P2848, DOI 10.1016/j.gca.2011.02.038; VEALL N, 1965, PHYS MED BIOL, V10, P375, DOI 10.1088/0031-9155/10/3/306; Wieler R., 2014, TREATISE GEOCHEMISTR, V15, P355, DOI [10.1016/B978-0-08-095975-7.01428-5, DOI 10.1016/B978-0-08-095975-7.01428-5]; YEH SY, 1965, J APPL PHYSIOL, V20, P1041, DOI 10.1152/jappl.1965.20.5.1041	32	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e96972	10.1371/journal.pone.0096972	http://dx.doi.org/10.1371/journal.pone.0096972			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24811123	Green Published, gold			2022-12-27	WOS:000338213300099
J	Lopez-Lopez, A; Gamez, J; Syriani, E; Morales, M; Salvado, M; Rodriguez, MJ; Mahy, N; Vidal-Taboada, JM				Lopez-Lopez, Alan; Gamez, Josep; Syriani, Emilio; Morales, Miguel; Salvado, Maria; Rodriguez, Manuel J.; Mahy, Nicole; Vidal-Taboada, Jose M.			CX3CR1 Is a Modifying Gene of Survival and Progression in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							FRACTALKINE RECEPTOR; SUPEROXIDE-DISMUTASE; SPORADIC ALS; DISEASE PROGRESSION; RISK-FACTOR; POLYMORPHISM; ASSOCIATION; ACTIVATION; EXPRESSION; MUTATIONS	The objective of this study was to investigate the association of functional variants of the human CX3CR1 gene (Fractalkine receptor) with the risk of Amyotrophic Lateral Sclerosis (ALS), the survival and the progression rate of the disease symptoms in a Spanish ALS cohort. 187 ALS patients (142 sporadic [sALS] and 45 familial) and 378 controls were recruited. We investigated CX3CR1 V249I (rs3732379) and T280M (rs3732378) genotypes and their haplotypes as predictors of survival, the progression rate of the symptoms (as measured by ALSFRS-R and FVC decline) and the risk of suffering ALS disease. The results indicated that sALS patients with CX3CR1 249(I/I) or 249(V/I) genotypes presented a shorter survival time (42.27 +/- 4.90) than patients with 249(V/V) genotype (67.65 +/- 7.42; diff -25.49 months 95% CI [-42.79,-8.18]; p = 0.004; adj-p = 0.018). The survival time was shorter in sALS patients with spinal topography and CX3CR1 249 I alleles (diff = -29.78 months; 95% CI [-49.42,-10.14]; p = 0.003). The same effects were also observed in the spinal sALS patients with 249(I) -280 M haplotype (diff = -27.02 months; 95% CI [-49.57, -4.48]; p = 0.019). In the sALS group, the CX3CR1 249 I variant was associated with a faster progression of the disease symptoms (OR = 2.58; 95IC% [1.32, 5.07]; p = 0.006; adj-p = 0.027). There was no evidence for association of these two CX3CR1 variants with ALS disease risk. The association evidenced herein is clinically relevant and indicates that CX3CR1 could be a disease-modifying gene in sALS. The progression rate of the disease's symptoms and the survival time is affected in patients with one or two copies of the CX3CR1 249I allele. The CX3CR1 is the most potent ALS survival genetic factor reported to date. These results reinforce the role of the immune system in ALS pathogenesis.	[Lopez-Lopez, Alan; Rodriguez, Manuel J.; Mahy, Nicole; Vidal-Taboada, Jose M.] Univ Barcelona, Fac Med, IDIBAPS, Biochem & Mol Biol Unit,Dept Physiol Sci 1, Barcelona 7, Spain; [Gamez, Josep; Syriani, Emilio; Salvado, Maria] Autonomous Univ Barcelona, Hosp Univ Vall dHebron, VHIR, ALS Unit,Neurol Dept, Barcelona, Spain; [Syriani, Emilio; Morales, Miguel] CIBIR, Synapt Struct Plast Lab, Logrono, Spain; [Rodriguez, Manuel J.; Mahy, Nicole; Vidal-Taboada, Jose M.] ISCIII, CIBERNED, Ctr Invest Biomed Red Enfermedades Neurogenerat, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBERNED; Instituto de Salud Carlos III	Gamez, J (corresponding author), Autonomous Univ Barcelona, Hosp Univ Vall dHebron, VHIR, ALS Unit,Neurol Dept, Barcelona, Spain.	josepgamez.bcn@gmail.com; josevidal@ub.edu	Morales, Miguel/G-8995-2014; Rodriguez, Manuel J/L-2212-2014; Vidal-Taboada, Jose Manuel/L-4777-2014	Morales, Miguel/0000-0002-8885-2333; Rodriguez, Manuel J/0000-0002-4476-004X; Vidal-Taboada, Jose Manuel/0000-0001-5667-4133; Gamez, Josep/0000-0003-3127-7486	Spanish Ministerio de Ciencia e Innovacion (Micinn) [SAF2008-01902, IPT-010000-2010-35]; Generalitat de Catalunya [2009SGR1380]; Micinn [BFU2010-17537]; Spanish Fondo de Investigaciones Sanitarias [PI10-01070-FEDER, FIS PI13-01272]	Spanish Ministerio de Ciencia e Innovacion (Micinn)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Micinn(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Spanish Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III)	The research of JVT, NM and MJR was supported by grants SAF2008-01902 and IPT-010000-2010-35 from the Spanish Ministerio de Ciencia e Innovacion (Micinn), and by a 2009SGR1380 grant from the Generalitat de Catalunya. MM and ES were supported by grant BFU2010-17537 from Micinn. ALL holds a fellowship from the Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS). JG was supported by Spanish Fondo de Investigaciones Sanitarias grants (PI10-01070-FEDER and FIS PI13-01272). This work was supported by a Marato' de TV3 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen PM, 1997, BRAIN, V120, P1723, DOI 10.1093/brain/120.10.1723; Apostolakis S, 2009, ATHEROSCLEROSIS, V207, P8, DOI 10.1016/j.atherosclerosis.2009.03.044; Appel SH, 2010, TRENDS IMMUNOL, V31, P7, DOI 10.1016/j.it.2009.09.003; Arli B, 2013, INT J NEUROSCI, V123, P31, DOI 10.3109/00207454.2012.723079; Ballana E, 2010, CLIN INFECT DIS, V50, P1022, DOI 10.1086/651114; Beers DR, 2011, BRAIN, V134, P1293, DOI 10.1093/brain/awr074; Blasco H, 2011, J NEUROL SCI, V303, P124, DOI 10.1016/j.jns.2010.12.018; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Brand S, 2006, AM J GASTROENTEROL, V101, P99, DOI 10.1111/j.1572-0241.2005.00361.x; Brettschneider J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039216; Brettschneider J, 2012, ACTA NEUROPATHOL, V123, P395, DOI 10.1007/s00401-011-0932-x; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Cockwell P, 2002, NEPHROL DIAL TRANSPL, V17, P734, DOI 10.1093/ndt/17.5.734; Corcia P, 2006, NEUROLOGY, V67, P1147, DOI 10.1212/01.wnl.0000233830.85206.1e; Corcia P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052941; Cudkowicz ME, 1997, ANN NEUROL, V41, P210, DOI 10.1002/ana.410410212; D'Haese JG, 2012, EXPERT OPIN THER TAR, V16, P613, DOI 10.1517/14728222.2012.682574; Daoudi M, 2004, J BIOL CHEM, V279, P19649, DOI 10.1074/jbc.M313457200; Diekstra FP, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.029; Evans MC, 2013, MOL CELL NEUROSCI, V53, P34, DOI 10.1016/j.mcn.2012.10.008; Faure S, 2000, SCIENCE, V287, P2274, DOI 10.1126/science.287.5461.2274; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Forbes RB, 2001, AMYOTROPH LATERAL SC, V2, P135, DOI 10.1080/146608201753275472; Gamez J, 2002, NEUROLOGY, V59, P1456, DOI 10.1212/01.WNL.0000032496.64510.4E; Gamez J, 2006, J NEUROL SCI, V247, P21, DOI 10.1016/j.jns.2006.03.006; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Henkel JS, 2009, J NEUROIMMUNE PHARM, V4, P389, DOI 10.1007/s11481-009-9171-5; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Ince PG, 2011, ACTA NEUROPATHOL, V122, P657, DOI 10.1007/s00401-011-0913-0; Landers JE, 2009, P NATL ACAD SCI USA, V106, P9004, DOI 10.1073/pnas.0812937106; Langefeld CD, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.07.017; McCombe PA, 2011, CURR MOL MED, V11, P246; McDermott DH, 2003, J CLIN INVEST, V111, P1241, DOI 10.1172/JCI200316790; Moatti D, 2001, BLOOD, V97, P1925, DOI 10.1182/blood.V97.7.1925; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; Nardo G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025545; Niessner A, 2005, THROMB HAEMOSTASIS, V93, P949, DOI 10.1160/TH04-11-0735; Orrell RW, 2007, NEW ENGL J MED, V357, P822, DOI 10.1056/NEJMe078146; Pratt AJ, 2012, DEGENER NEUROL NEURO, V2, P1, DOI 10.2147/DNND.S19803; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Steinacker P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023600; Tou JS, 2004, FASEB J, V18, P1297, DOI 10.1096/fj.04-1862fje; Van Hoecke A, 2012, NAT MED, V18, P1418, DOI 10.1038/nm.2901; Veldink JH, 2001, NEUROLOGY, V56, P749, DOI 10.1212/WNL.56.6.749; Wijesekera LC, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-3; Wolf Y, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00026; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160	50	42	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96528	10.1371/journal.pone.0096528	http://dx.doi.org/10.1371/journal.pone.0096528			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806473	gold, Green Published, Green Submitted			2022-12-27	WOS:000335728900068
J	Sizmur, T; Lind, KR; Benomar, S; VanEvery, H; Cademartiri, L				Sizmur, Tom; Lind, Kara R.; Benomar, Saida; VanEvery, Hannah; Cademartiri, Ludovico			A Simple and Versatile 2-Dimensional Platform to Study Plant Germination and Growth under Controlled Humidity	PLOS ONE			English	Article							ROOT ARCHITECTURE; ARABIDOPSIS; PAPER; SOIL; TOMOGRAPHY; BIOASSAYS; SYMBIOSIS; SYSTEM; YIELD; VIGOR	We describe a simple, inexpensive, but remarkably versatile and controlled growth environment for the observation of plant germination and seedling root growth on a flat, horizontal surface over periods of weeks. The setup provides to each plant a controlled humidity (between 56% and 91% RH), and contact with both nutrients and atmosphere. The flat and horizontal geometry of the surface supporting the roots eliminates the gravitropic bias on their development and facilitates the imaging of the entire root system. Experiments can be setup under sterile conditions and then transferred to a non-sterile environment. The system can be assembled in 1-2 minutes, costs approximately 8.78$ per plant, is almost entirely reusable (0.43$ per experiment in disposables), and is easily scalable to a variety of plants. We demonstrate the performance of the system by germinating, growing, and imaging Wheat (Triticum aestivum), Corn (Zea mays), and Wisconsin Fast Plants (Brassica rapa). Germination rates were close to those expected for optimal conditions.	[Sizmur, Tom; Lind, Kara R.; Benomar, Saida; VanEvery, Hannah; Cademartiri, Ludovico] Iowa State Univ, Dept Mat Sci & Engn, Ames, IA 50011 USA; [Sizmur, Tom; Benomar, Saida; Cademartiri, Ludovico] Iowa State Univ, Ames Lab, US DOE, Ames, IA USA; [VanEvery, Hannah; Cademartiri, Ludovico] Iowa State Univ, Dept Chem & Biol Engn, Ames, IA USA	Iowa State University; Iowa State University; United States Department of Energy (DOE); Ames National Laboratory; Iowa State University	Cademartiri, L (corresponding author), Iowa State Univ, Dept Mat Sci & Engn, Ames, IA 50011 USA.	lcademar@iastate.edu	Sizmur, Tom/F-4532-2018; Cademartiri, Ludovico/A-4142-2008	Sizmur, Tom/0000-0001-9835-7195; Cademartiri, Ludovico/0000-0001-8805-9434; VanEvery, Hannah/0000-0002-0778-0607	Iowa State University	Iowa State University	This work was funded by Iowa State University through startup funds to LC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright L, 2001, CONTROLLING GREENHOU, P47; Asseng S, 2000, COMPUTER ASSISTED TO, P343; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Burgess SSO, 2004, PLANT CELL ENVIRON, V27, P1023, DOI 10.1111/j.1365-3040.2004.01207.x; Carrilho E, 2009, ANAL CHEM, V81, P7091, DOI 10.1021/ac901071p; Clark LJ, 1999, PLANT SOIL, V207, P37, DOI 10.1023/A:1004489501678; de Dorlodot S, 2007, TRENDS PLANT SCI, V12, P474, DOI 10.1016/j.tplants.2007.08.012; Derda R, 2009, P NATL ACAD SCI USA, V106, P18457, DOI 10.1073/pnas.0910666106; Driss-Ecole D, 2008, PHYSIOL PLANTARUM, V134, P191, DOI 10.1111/j.1399-3054.2008.01121.x; Ehrhardt DW, 2012, PLANT CELL ONLINE; ELLIS RH, 1992, PLANT GROWTH REGUL, V11, P249, DOI 10.1007/BF00024563; Ennos AR, 2000, ADV BOT RES, V33, P133, DOI 10.1016/S0065-2296(00)33042-7; Food and Agriculture Organization, 2009, FOOD BAL SHEETS; Granier C, 2006, NEW PHYTOL, V169, P623, DOI 10.1111/j.1469-8137.2005.01609.x; GREENSPAN L, 1977, J RES NBS A PHYS CH, V81, P89, DOI 10.6028/jres.081A.011; Harris E, 2004, EMBO REP, V5, P7, DOI 10.1038/sj.embor.7400058; Harrison MJ, 1997, TRENDS PLANT SCI, V2, P54, DOI 10.1016/S1360-1385(97)82563-0; HERDER GD, 2010, TRENDS PLANT SCI, V0015, P00600, DOI DOI 10.1016/J.TPLANTS.2010.08.009; Hoson T, 1997, PLANTA, V203, pS187, DOI 10.1007/PL00008108; Iyer-Pascuzzi AS, 2010, PLANT PHYSIOL, V152, P1148, DOI 10.1104/pp.109.150748; Jaggard KW, 2010, PHILOS T R SOC B, V365, P2835, DOI 10.1098/rstb.2010.0153; JAMES BR, 1985, PLANT SOIL, V85, P291, DOI 10.1007/BF02139633; Kamra SK, 1968, SEED STUDIA FORESTAL, V65; Lind KR, 2014, LEGO BRICKS BU UNPUB; LYNCH J, 1995, PLANT PHYSIOL, V109, P7, DOI 10.1104/pp.109.1.7; Mairhofer S, 2012, PLANT PHYSIOL, V158, P561, DOI 10.1104/pp.111.186221; Martinez AW, 2007, ANGEW CHEM INT EDIT, V46, P1318, DOI 10.1002/anie.200603817; McCourt P, 1998, METH MOL B, V82, P13; Monshausen GB, 2011, PLANT J, V65, P309, DOI 10.1111/j.1365-313X.2010.04423.x; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Nagel KA, 2012, FUNCT PLANT BIOL, V39, P891, DOI 10.1071/FP12023; Pierret A, 2003, AGRONOMIE, V23, P471, DOI 10.1051/agro:2003019; Subramanian R, 2013, MACH VISION APPL, V24, P619, DOI 10.1007/s00138-012-0434-4; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Swarup R, 2005, NAT CELL BIOL, V7, P1057, DOI 10.1038/ncb1316; TEKRONY DM, 1991, CROP SCI, V31, P816, DOI 10.2135/cropsci1991.0011183X003100030054x; The LEGO Group, 2013, LEG GROUP CO PROF; TOMKINS SP, 1990, J BIOL EDUC, V24, P239, DOI 10.1080/00219266.1990.9655152; Tracy SR, 2010, J EXP BOT, V61, P311, DOI 10.1093/jxb/erp386; VANRHIJN P, 1995, MICROBIOL REV, V59, P124, DOI 10.1128/MMBR.59.1.124-142.1995; Whitesides G.M., 2011, EC WORLD, V2012, P154; Wiengweera A, 1997, ANN BOT-LONDON, V80, P115, DOI 10.1006/anbo.1996.0405; Willan R.L., 1985, GUIDE FOREST SEED HA	43	4	4	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96730	10.1371/journal.pone.0096730	http://dx.doi.org/10.1371/journal.pone.0096730			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806462	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000335728900086
J	Tsutsumi, M; Fujiwara, R; Nishizawa, H; Ito, M; Kogo, H; Inagaki, H; Ohye, T; Kato, T; Fujii, T; Kurahashi, H				Tsutsumi, Makiko; Fujiwara, Reiko; Nishizawa, Haruki; Ito, Mayuko; Kogo, Hiroshi; Inagaki, Hidehito; Ohye, Tamae; Kato, Takema; Fujii, Takuma; Kurahashi, Hiroki			Age-Related Decrease of Meiotic Cohesins in Human Oocytes	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; ADVANCED MATERNAL AGE; HUMAN ANEUPLOIDY; CHROMOSOME COHESION; GENE-EXPRESSION; MOUSE OOCYTES; ASSOCIATION; MEIOSIS; SMC1-BETA; PROTEINS	Aneuploidy in fetal chromosomes is one of the causes of pregnancy loss and of congenital birth defects. It is known that the frequency of oocyte aneuploidy increases with the human maternal age. Recent data have highlighted the contribution of cohesin complexes in the correct segregation of meiotic chromosomes. In mammalian oocytes, cohesion is established during the fetal stages and meiosis-specific cohesin subunits are not replenished after birth, raising the possibility that the long meiotic arrest of oocytes facilitates a deterioration of cohesion that leads to age-related increases in aneuploidy. We here examined the cohesin levels in dictyate oocytes from different age groups of humans and mice by immunofluorescence analyses of ovarian sections. The meiosis-specific cohesin subunits, REC8 and SMC1B, were found to be decreased in women aged 40 and over compared with those aged around 20 years (P < 0.01). Age-related decreases in meiotic cohesins were also evident in mice. Interestingly, SMC1A, the mitotic counterpart of SMC1B, was substantially detectable in human oocytes, but little expressed in mice. Further, the amount of mitotic cohesins of mice slightly increased with age. These results suggest that, mitotic and meiotic cohesins may operate in a coordinated way to maintain cohesions over a sustained period in humans and that age-related decreases in meiotic cohesin subunits impair sister chromatid cohesion leading to increased segregation errors.	[Tsutsumi, Makiko; Fujiwara, Reiko; Ito, Mayuko; Inagaki, Hidehito; Ohye, Tamae; Kato, Takema; Kurahashi, Hiroki] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Mol Genet, Toyoake, Aichi, Japan; [Nishizawa, Haruki; Ito, Mayuko; Fujii, Takuma] Fujita Hlth Univ, Dept Obstet & Gynecol, Toyoake, Aichi, Japan; [Kogo, Hiroshi] Gunma Univ, Grad Sch Med, Dept Anat & Cell Biol, Maebashi, Gunma, Japan	Fujita Health University; Fujita Health University; Gunma University	Kurahashi, H (corresponding author), Fujita Hlth Univ, Inst Comprehens Med Sci, Div Mol Genet, Toyoake, Aichi, Japan.	kura@fujita-hu.ac.jp	Kogo, Hiroshi/AAB-8467-2019	Kogo, Hiroshi/0000-0003-0584-7158	JSPS KAKENHI [22790334, 25860255, 21028020, 23013019]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from JSPS KAKENHI (22790334 and 25860255 to MT and 21028020 and 23013019 to HK, URL: http://www.jsps.go.jp/j-grantsinaid/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen AMN, 2000, BRIT MED J, V320, P1708, DOI 10.1136/bmj.320.7251.1708; Bickel SE, 2005, NAT GENET, V37, P1303, DOI 10.1038/ng1205-1303; Chiang T, 2011, BIOL REPROD, V85, P1279, DOI 10.1095/biolreprod.111.094094; Chiang T, 2010, CURR BIOL, V20, P1522, DOI 10.1016/j.cub.2010.06.069; Duncan FE, 2012, AGING CELL, V11, P1121, DOI 10.1111/j.1474-9726.2012.00866.x; Eijpe M, 2000, J CELL SCI, V113, P673; Fragouli E, 2010, MOL HUM REPROD, V16, P570, DOI 10.1093/molehr/gaq033; Garcia-Cruz R, 2010, HUM REPROD, V25, P2316, DOI 10.1093/humrep/deq180; Grande M, 2012, HUM REPROD, V27, P3109, DOI 10.1093/humrep/des251; Grondahl ML, 2010, HUM REPROD, V25, P957, DOI 10.1093/humrep/deq014; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hassold T, 2007, HUM MOL GENET, V16, pR203, DOI 10.1093/hmg/ddm243; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Jessberger R, 2012, EMBO REP, V13, P539, DOI 10.1038/embor.2012.54; Koehler KE, 2006, CURR BIOL, V16, pR579, DOI 10.1016/j.cub.2006.07.018; Kouznetsova A, 2005, J CELL SCI, V118, P2271, DOI 10.1242/jcs.02362; Kurahashi H, 2012, CONGENIT ANOM, V52, P8, DOI 10.1111/j.1741-4520.2011.00350.x; Lee J, 2006, CELL CYCLE, V5, P1448, DOI 10.4161/cc.5.13.2903; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; Lister LM, 2010, CURR BIOL, V20, P1511, DOI 10.1016/j.cub.2010.08.023; Markholt S, 2012, MOL HUM REPROD, V18, P96, DOI 10.1093/molehr/gar083; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Revenkova E, 2004, NAT CELL BIOL, V6, P555, DOI 10.1038/ncb1135; Revenkova E, 2010, CURR BIOL, V20, P1529, DOI 10.1016/j.cub.2010.08.024; Rudra S, 2013, J CELL SCI, V126, P31, DOI 10.1242/jcs.116566; Selesniemi K, 2011, P NATL ACAD SCI USA, V108, P12319, DOI 10.1073/pnas.1018793108; Skibbens RV, 2000, GENOME RES, V10, P1664, DOI 10.1101/gr.153600; Steuerwald N, 2001, MOL HUM REPROD, V7, P49, DOI 10.1093/molehr/7.1.49; Tachibana-Konwalski K, 2010, GENE DEV, V24, P2505, DOI 10.1101/gad.605910; Titus S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004925; Tsutsumi M, 2012, J HUM GENET, V57, P515, DOI 10.1038/jhg.2012.61; Wood AJ, 2010, NAT REV GENET, V11, P391, DOI 10.1038/nrg2794; Yoon PW, 1996, AM J HUM GENET, V58, P628	33	87	96	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96710	10.1371/journal.pone.0096710	http://dx.doi.org/10.1371/journal.pone.0096710			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806359	gold, Green Submitted, Green Published			2022-12-27	WOS:000335728900083
J	van Leeuwen, J; Berg, DK; Smith, CS; Wells, DN; Pfeffer, PL				van Leeuwen, Jessica; Berg, Debra K.; Smith, Craig S.; Wells, David N.; Pfeffer, Peter L.			Specific Epiblast Loss and Hypoblast Impairment in Cattle Embryos Sensitized to Survival Signalling by Ubiquitous Overexpression of the Proapoptotic Gene BAD	PLOS ONE			English	Article							IN-VITRO; TROPHOBLASTIC VESICLES; MOUSE EMBRYOS; BOVINE; PHOSPHORYLATION; BLASTOCYSTS; EXPRESSION; APOPTOSIS; DEFECTS; CULTURE	Early embryonic lethality is common, particularly in dairy cattle. We made cattle embryos more sensitive to environmental stressors by raising the threshold of embryo survival signaling required to overcome the deleterious effects of overexpressing the proapoptotic protein BAD. Two primary fibroblast cell lines expressing BAD and exhibiting increased sensitivity to stress-induced apoptosis were used to generate transgenic Day13/14 BAD embryos. Transgenic embryos were normal in terms of retrieval rates, average embryo length or expression levels of the trophectoderm marker ASCL2. However both lines of BAD-tg embryos lost the embryonic disc and thus the entire epiblast lineage at significantly greater frequencies than either co-transferrred IVP controls or LacZ-tg embryos. Embryos without epiblast still contained the second ICM-derived lineage, the hypopblast, albeit frequently in an impaired state, as shown by reduced expression of the hypoblast markers GATA4 and FIBRONECTIN. This indicates a gradient of sensitivity (epiblast. hypoblast. TE) to BAD overexpression. We postulate that the greater sensitivity of specifically the epiblast lineage that we have seen in our transgenic model, reflects an inherent greater susceptibility of this lineage to environmental stress and may underlie the epiblast-specific death seen in phantom pregnancies.	[van Leeuwen, Jessica; Berg, Debra K.; Smith, Craig S.; Wells, David N.; Pfeffer, Peter L.] AgResearch, Anim Prod, Hamilton, Waikato, New Zealand; [van Leeuwen, Jessica] Univ Waikato, Dept Biol Sci, Hamilton, Waikato, New Zealand; [Smith, Craig S.] Univ Notre Dame, Sch Med, Sydney, NSW, Australia	AgResearch - New Zealand; University of Waikato; University of Notre Dame Australia	Pfeffer, PL (corresponding author), AgResearch, Anim Prod, Hamilton, Waikato, New Zealand.	drplpepper@gmail.com	Pfeffer, Peter/J-7675-2017; Berg, Debbie/GYJ-3287-2022	Pfeffer, Peter/0000-0001-5933-9728; Berg, Debbie/0000-0002-3287-0356; Wells, David/0000-0002-8729-4958	Ministry of Science and Innovation grant [C10X1001]; Royal Society of New Zealand Marsden Grant [07-AGR-004]	Ministry of Science and Innovation grant; Royal Society of New Zealand Marsden Grant(Royal Society of New ZealandMarsden Fund (NZ))	This work was supported by Ministry of Science and Innovation grant C10X1001 and Royal Society of New Zealand Marsden Grant 07-AGR-004 awarded to P.L.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedzhov I, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002609; Berg DK, 2010, THERIOGENOLOGY, V73, P250, DOI 10.1016/j.theriogenology.2009.09.005; Berg DK, 2011, DEV CELL, V20, P244, DOI 10.1016/j.devcel.2011.01.003; BETTERIDGE KJ, 1988, THERIOGENOLOGY, V29, P155, DOI 10.1016/0093-691X(88)90038-6; Brandao DO, 2004, BIOL REPROD; Byrne AT, 2002, MOL REPROD DEV, V62, P489, DOI 10.1002/mrd.10153; Cavalieri J, 2003, P AUSTR NZ COMB DAIR, P365; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Danial NN, 2008, ONCOGENE, V27, pS53, DOI 10.1038/onc.2009.44; Datta SR, 2002, DEV CELL, V3, P631, DOI 10.1016/S1534-5807(02)00326-X; Diskin MG, 2012, REPROD FERT DEVELOP, V24, P244, DOI 10.1071/RD11914; Donnison M, 2005, DEVELOPMENT, V132, P2299, DOI 10.1242/dev.01819; Fischer-Brown AE, 2004, REPROD FERT DEVELOP, V16, P787, DOI 10.1071/RD04026; Ganeshan L, 2010, BIOL REPROD, V83, P958, DOI 10.1095/biolreprod.109.083162; Gopichandran N, 2006, REPRODUCTION, V131, P269, DOI 10.1530/rep.1.00677; Gray CA, 2001, BIOL REPROD, V64, P1608, DOI 10.1095/biolreprod64.6.1608; HEYMAN Y, 1984, J REPROD FERTIL, V70, P533, DOI 10.1530/jrf.0.0700533; Kuijk EW, 2012, DEVELOPMENT, V139, P871, DOI 10.1242/dev.071688; LANE M, 1992, HUM REPROD, V7, P558, DOI 10.1093/oxfordjournals.humrep.a137690; Leidenfrost S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022121; Li A, 2007, BIOL REPROD, V76, P362, DOI 10.1095/biolreprod.106.056838; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Loureiro B, 2011, AM J REPROD IMMUNOL, V65, P578, DOI 10.1111/j.1600-0897.2010.00953.x; Loureiro B, 2009, ENDOCRINOLOGY, V150, P5046, DOI 10.1210/en.2009-0481; Lu DP, 2004, J CELL SCI, V117, P1567, DOI 10.1242/jcs.00991; Maddox-Hyttel P, 2003, REPRODUCTION, V125, P607, DOI 10.1530/rep.0.1250607; Makarevich AV, 2002, BIOL REPROD, V66, P386, DOI 10.1095/biolreprod66.2.386; Nagai K, 2009, J REPROD DEVELOP, V55, P454, DOI 10.1262/jrd.20222; Narita N, 1997, DEV BIOL, V189, P270, DOI 10.1006/dbio.1997.8684; Nichols J, 2011, DEVELOPMENT, V138, P3, DOI 10.1242/dev.050831; O'Neill C, 2012, THERIOGENOLOGY, V77, P773, DOI 10.1016/j.theriogenology.2011.12.016; Oback B, 2003, CLONING STEM CELLS, V5, P243, DOI 10.1089/153623003772032763; Ranger AM, 2003, P NATL ACAD SCI USA, V100, P9324, DOI 10.1073/pnas.1533446100; Robertson I., 1998, MANUAL INT EMBRYO TR, P103; ROCHE JF, 1981, VET REC, V109, P401, DOI 10.1136/vr.109.18.401; Smith C, 2007, REPRODUCTION, V133, P231, DOI 10.1530/rep.1.0966; Smith CS, 2010, CELL REPROGRAM, V12, P699, DOI 10.1089/cell.2010.0040; Spencer Thomas E, 2004, Reprod Biol Endocrinol, V2, P49, DOI 10.1186/1477-7827-2-49; Takahashi M, 2005, J REPROD DEVELOP, V51, P47, DOI 10.1262/jrd.51.47; Thompson JG, 2000, J REPROD FERTIL, V118, P47, DOI 10.1530/reprod/118.1.47; Vajta G, 2004, THERIOGENOLOGY, V62, P1253, DOI 10.1016/j.theriogenology.2004.01.007; VanSoom A, 1997, BIOL REPROD, V57, P1041, DOI 10.1095/biolreprod57.5.1041; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3	45	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96843	10.1371/journal.pone.0096843	http://dx.doi.org/10.1371/journal.pone.0096843			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806443	Green Submitted, Green Published, gold			2022-12-27	WOS:000335728900105
J	Li, SS; Fan, H; An, XP; Fan, HH; Jiang, HH; Chen, YB; Tong, YG				Li, Shasha; Fan, Hang; An, Xiaoping; Fan, Huahao; Jiang, Huanhuan; Chen, Yubao; Tong, Yigang			Scrutinizing Virus Genome Termini by High-Throughput Sequencing	PLOS ONE			English	Article							BACILLUS-SUBTILIS; DNA-REPLICATION; HOST-TAKEOVER; PHAGE; COMPONENT; REVEAL; GENE	Analysis of genomic terminal sequences has been a major step in studies on viral DNA replication and packaging mechanisms. However, traditional methods to study genome termini are challenging due to the time-consuming protocols and their inefficiency where critical details are lost easily. Recent advances in next generation sequencing (NGS) have enabled it to be a powerful tool to study genome termini. In this study, using NGS we sequenced one iridovirus genome and twenty phage genomes and confirmed for the first time that the high frequency sequences (HFSs) found in the NGS reads are indeed the terminal sequences of viral genomes. Further, we established a criterion to distinguish the type of termini and the viral packaging mode. We also obtained additional terminal details such as terminal repeats, multi-termini, asymmetric termini. With this approach, we were able to simultaneously detect details of the genome termini as well as obtain the complete sequence of bacteriophage genomes. Theoretically, this application can be further extended to analyze larger and more complicated genomes of plant and animal viruses. This study proposed a novel and efficient method for research on viral replication, packaging, terminase activity, transcription regulation, and metabolism of the host cell.	[Li, Shasha; Fan, Hang; An, Xiaoping; Fan, Huahao; Jiang, Huanhuan; Tong, Yigang] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Chen, Yubao] Beijing Comp Ctr, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Chen, YB (corresponding author), Beijing Comp Ctr, Beijing, Peoples R China.	allexchen@126.com; tong.yigang@gmail.com	Fan, Huahao/AAR-8062-2021; Fan, Hang/AAA-8489-2022	Fan, Huahao/0000-0001-5007-2158; Fan, Hang/0000-0002-7927-1684; Tong, Yigang/0000-0002-8503-8045	National Natural Science Foundation of China [30872223]; National Hi-Tech Research and Development (863) Program of China [2012AA022-003]; China Mega-Project on Infectious Disease Prevention [2013ZX10004-605]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Hi-Tech Research and Development (863) Program of China(National High Technology Research and Development Program of China); China Mega-Project on Infectious Disease Prevention	This research was supported by grants from the National Natural Science Foundation of China (NO. 30872223), the National Hi-Tech Research and Development (863) Program of China (No. 2012AA022-003), and the China Mega-Project on Infectious Disease Prevention (No. 2013ZX10004-605). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MH, 1959, BACTERIOPHAGES; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; BHATTACHARYYA SP, 1994, GENE, V146, P67, DOI 10.1016/0378-1119(94)90834-6; BHATTACHARYYA SP, 1993, VIROLOGY, V196, P34, DOI 10.1006/viro.1993.1452; Born Y, 2011, APPL ENVIRON MICROB, V77, P5945, DOI 10.1128/AEM.03022-10; Braid MD, 2004, J BACTERIOL, V186, P6560, DOI 10.1128/JB.186.19.6560-6574.2004; Casjens SR, 2005, J BACTERIOL, V187, P1091, DOI 10.1128/JB.187.3.1091-1104.2005; CATALANO CE, 1995, MOL MICROBIOL, V16, P1075, DOI 10.1111/j.1365-2958.1995.tb02333.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; ESCARMIS C, 1981, P NATL ACAD SCI-BIOL, V78, P1446, DOI 10.1073/pnas.78.3.1446; Fan HH, 2012, J VIROL, V86, P13861, DOI 10.1128/JVI.02684-12; Fouts DE, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-165; Fujisawa H, 1997, GENES CELLS, V2, P537, DOI 10.1046/j.1365-2443.1997.1450343.x; GOORHA R, 1982, P NATL ACAD SCI-BIOL, V79, P248, DOI 10.1073/pnas.79.2.248; GORDON A., 2011, FASTX TOOLKIT COMPUT; Jiang XF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-194; Kreuzer KN, 2000, TRENDS BIOCHEM SCI, V25, P165, DOI 10.1016/S0968-0004(00)01559-0; Kutter E., 2005, BACTERIOPHAGES BIOL; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lobocka M, 2012, ADV VIRUS RES, V83, P143, DOI 10.1016/B978-0-12-394438-2.00005-0; MONTAG D, 1989, J BACTERIOL, V171, P4378, DOI 10.1128/JB.171.8.4378-4384.1989; OHMORI H, 1988, J MOL BIOL, V202, P1, DOI 10.1016/0022-2836(88)90512-8; Oliveira L, 2005, J MOL BIOL, V353, P529, DOI 10.1016/j.jmb.2005.08.063; Pennisi E, 2010, SCIENCE, V327, P1190, DOI 10.1126/science.327.5970.1190; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Rao Venigalla B., 2005, P40; Sambrook J., 2001, MOL CLONING LAB MANU; Sampath A, 2004, J BACTERIOL, V186, P1785, DOI 10.1128/JB.186.6.1785-1792.2004; Sheng W, 2010, J MED COLL PLA, V25, P331; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Stewart CR, 2009, VIROLOGY, V392, P271, DOI 10.1016/j.virol.2009.06.046; Stewart CR, 2009, J MOL BIOL, V388, P48, DOI 10.1016/j.jmb.2009.03.009; Stewart CR, 1998, VIROLOGY, V246, P329, DOI 10.1006/viro.1998.9197; Sun S, 2012, P NATL ACAD SCI USA, V109, P817, DOI 10.1073/pnas.1110224109; WEI P, 1993, J BACTERIOL, V175, P7887, DOI 10.1128/JB.175.24.7887-7900.1993; ZABALLOS A, 1986, GENE, V43, P103, DOI 10.1016/0378-1119(86)90013-2; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang J, 2011, J GENETICS GENOMICS	39	179	185	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85806	10.1371/journal.pone.0085806	http://dx.doi.org/10.1371/journal.pone.0085806			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465717	Green Published, Green Submitted, gold			2022-12-27	WOS:000330240500075
J	Choi, BY; Kim, J; Chung, J; Kim, AR; Mun, SJ; Kang, SI; Lee, SH; Kim, N; Oh, SH				Choi, Byung Yoon; Kim, Jiwoong; Chung, Juyong; Kim, Ah Reum; Mun, Sue Jean; Kang, Seong Il; Lee, Sang-Heon; Kim, Namshin; Oh, Seung-Ha			Whole-Exome Sequencing Identifies a Novel Genotype-Phenotype Correlation in the Entactin Domain of the Known Deafness Gene TECTA	PLOS ONE			English	Article							NONSYNDROMIC HEARING IMPAIRMENT; TECTORIAL MEMBRANE; MUTATIONS; PROTEIN; EXPRESSION; CONFIRMS; DELETION; FAMILIES; OTOGELIN; DFNA12	Postlingual progressive hearing loss, affecting primarily the high frequencies, is the clinical finding in most cases of autosomal dominant nonsyndromic hearing loss (ADNSHL). The molecular genetic etiology of ADNSHL is extremely heterogeneous. We applied whole-exome sequencing to reveal the genetic etiology of high-frequency hearing loss in a mid-sized Korean family without any prior linkage data. Whole-exome sequencing of four family members (two affected and two unaffected), together with our filtering strategy based on comprehensive bioinformatics analyses, identified 21 potential pathogenic candidates. Sanger validation of an additional five family members excluded 20 variants, leaving only one novel variant, TECTA c.710C>T (p.T237I), as the strongest candidate. This variant resides in the entactin (ENT) domain and co-segregated perfectly with non-progressive high-frequency hearing loss in the family. It was absent among 700 ethnically matched control chromosomes, and the T237 residue is conserved among species, which supports its pathogenicity. Interestingly, this finding contrasted with a previously proposed genotype-phenotype correlation in which variants of the ENT domain of TECTA were associated with mid-frequency hearing loss. Based upon what we observed, we propose a novel "genotype to phenotype'' correlation in the ENT domain of TECTA. Our results shed light on another important application of whole-exome sequencing: the establishment of a novel genotype-phenotype in the molecular genetic diagnosis of autosomal dominant hearing loss.	[Choi, Byung Yoon] Seoul Natl Univ, Dept Otorhinolaryngol, Bundang Hosp, Songnam, South Korea; [Kim, Jiwoong; Lee, Sang-Heon; Kim, Namshin] KRIBB, Korean Bioinformat Ctr, Taejon, South Korea; [Chung, Juyong] Ajou Univ, Dept Otolaryngol, Sch Med, Suwon 441749, South Korea; [Kim, Ah Reum; Mun, Sue Jean; Kang, Seong Il; Oh, Seung-Ha] Seoul Natl Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea; [Lee, Sang-Heon; Kim, Namshin] Univ Sci & Technol, Dept Bioinformat, Taejon, South Korea	Seoul National University (SNU); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Ajou University; Seoul National University (SNU)	Kim, N (corresponding author), KRIBB, Korean Bioinformat Ctr, Taejon, South Korea.	n@rna.kr; shaoh@snu.ac.kr	Kim, Namshin/Q-6491-2017	Kim, Namshin/0000-0001-6361-274X	Ministry for Health, Welfare and Family Affairs, Republic of Korea [A080588, A111377]; National Research Foundation of Korea - Korean government (Ministry of Education, Science, and Technology) [20120009215]	Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation of Korea - Korean government (Ministry of Education, Science, and Technology)	This study was supported by the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (Nos. A080588 and A111377), and the National Research Foundation of Korea grant funded by the Korean government (Ministry of Education, Science, and Technology; No. 20120009215). The funding bodies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alasti F, 2008, INT J PEDIATR OTORHI, V72, P249, DOI 10.1016/j.ijporl.2007.09.023; Alloisio N, 1999, EUR J HUM GENET, V7, P255, DOI 10.1038/sj.ejhg.5200273; Balciuniene J, 1999, HUM GENET, V105, P211, DOI 10.1007/s004390051091; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; CHUNG AE, 1993, KIDNEY INT, V43, P13, DOI 10.1038/ki.1993.4; Collin RWJ, 2008, EUR J HUM GENET, V16, P1430, DOI 10.1038/ejhg.2008.110; Delmaghani S, 2012, HUM MOL GENET, V21, P3835, DOI 10.1093/hmg/dds212; DURKIN ME, 1988, J CELL BIOL, V107, P2749, DOI 10.1083/jcb.107.6.2749; DZIADEK M, 1985, EMBO J, V4, P2513, DOI 10.1002/j.1460-2075.1985.tb03964.x; Govaerts PJ, 1998, AM J OTOL, V19, P718; Hildebrand MS, 2011, HUM MUTAT, V32, P825, DOI 10.1002/humu.21512; Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002; Huygen PL, 2007, GENES HEARING DEAFNE, P185; Iwasaki S, 2002, ARCH OTOLARYNGOL, V128, P913, DOI 10.1001/archotol.128.8.913; King KA, 2010, LARYNGOSCOPE, V120, P384, DOI 10.1002/lary.20722; Knipper M, 2001, J BIOL CHEM, V276, P39046, DOI 10.1074/jbc.M103385200; Legan PK, 2000, NEURON, V28, P273, DOI 10.1016/S0896-6273(00)00102-1; Legan PK, 2005, NAT NEUROSCI, V8, P1035, DOI 10.1038/nn1496; Legan PK, 1997, J BIOL CHEM, V272, P8791, DOI 10.1074/jbc.272.13.8791; Lezirovitz K, 2012, GENE, V511, P280, DOI 10.1016/j.gene.2012.09.023; Maeda Y, 2001, NEUROREPORT, V12, P3223, DOI 10.1097/00001756-200110290-00016; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer NC, 2007, CLIN GENET, V72, P130, DOI 10.1111/j.1399-0004.2007.00828.x; Meyer NC, 2007, AM J MED GENET A, V143A, P1623, DOI 10.1002/ajmg.a.31718; Moreno-Pelayo M A, 2001, J Med Genet, V38, pE13, DOI 10.1136/jmg.38.5.e13; Mustapha M, 1999, HUM MOL GENET, V8, P409, DOI 10.1093/hmg/8.3.409; Naz S, 2003, J MED GENET, V40, P360, DOI 10.1136/jmg.40.5.360; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Pfister M, 2004, CELL PHYSIOL BIOCHEM, V14, P369, DOI 10.1159/000080347; Plantinga RF, 2006, JARO-J ASSOC RES OTO, V7, P173, DOI 10.1007/s10162-006-0033-z; Rau A, 1999, J COMP NEUROL, V405, P271; Rehman AU, 2014, AM J HUM GENET, V94, P144, DOI 10.1016/j.ajhg.2013.12.004; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Sagong B, 2012, GENE, V492, P239, DOI 10.1016/j.gene.2011.10.022; Sagong B, 2010, ANN CLIN LAB SCI, V40, P380; Santos-Cortez RLP, 2013, AM J HUM GENET, V93, P132, DOI 10.1016/j.ajhg.2013.05.018; Schraders M, 2012, AM J HUM GENET, V91, P883, DOI 10.1016/j.ajhg.2012.09.012; Schraders M, 2011, AM J HUM GENET, V88, P628, DOI 10.1016/j.ajhg.2011.04.012; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Tekin M, 2013, J CLIN INVEST, V123, P2094, DOI 10.1172/JCI65853; Verhoeven K, 1997, AM J HUM GENET, V60, P1168; Verhoeven K, 1998, NAT GENET, V19, P60, DOI 10.1038/ng0598-60; Walsh T, 2010, AM J HUM GENET, V87, P90, DOI 10.1016/j.ajhg.2010.05.010; Yariz KO, 2012, AM J HUM GENET, V91, P872, DOI 10.1016/j.ajhg.2012.09.011	46	37	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97040	10.1371/journal.pone.0097040	http://dx.doi.org/10.1371/journal.pone.0097040			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	25226504	gold, Green Published, Green Submitted			2022-12-27	WOS:000336838000097
J	Xu, MY; Xie, F; Wang, K				Xu, Min-Yun; Xie, Fan; Wang, Kun			Response of Vegetation and Soil Carbon and Nitrogen Storage to Grazing Intensity in Semi-Arid Grasslands in the Agro-Pastoral Zone of Northern China	PLOS ONE			English	Article							INNER-MONGOLIA; SPATIAL VARIABILITY; PHYSICAL-PROPERTIES; SHORTGRASS STEPPE; ORGANIC-CARBON; ROOT BIOMASS; BULK-DENSITY; MIXED-GRASS; LAND-USE; MANAGEMENT	Overgrazing has been the primary cause of grassland degradation in the semi-arid grasslands of the agro-pastoral transition zone in northern China. However, there has been little evidence regarding grazing intensity impacts on vegetation change and soil C and N dynamics in this region. This paper reports the effects of four grazing intensities namely un-grazed (UG), lightly grazed (LG), moderately grazed (MG) and heavily grazed (HG) on vegetation characteristics and soil properties of grasslands in the Guyuan county in the agro-pastoral transition region, Hebei province, northern China. Our study showed that the vegetation height, canopy cover, plant species abundance and aboveground biomass decreased significantly with increased grazing intensity. Similarly, soil organic carbon (SOC) and total nitrogen (STN) in the 0-50 cm were highest under UG (13.3 kg C m(-2) and 1.69 kg N m(-2)) and lowest under HG (9.8 kg C m(-2) and 1.22 kg N m(-2)). Soil available nitrogen (SAN) was significantly lower under HG (644 kg N hm(-2)) than under other treatments (725-731 kg N hm(-2)) in the 0-50 cm. Our results indicate that the pasture management of ''take half-leave half'' has potential benefits for primary production and livestock grazing in this region. However, grazing exclusion was perhaps the most effective choice for restoring degraded grasslands in this region. Therefore, flexible rangeland management should be adopted in this region.	[Xu, Min-Yun] Peking Univ, Coll Urban & Environm Sci, Dept Ecol, Beijing 100871, Peoples R China; [Xu, Min-Yun] Hebei Agr Univ, Coll Anim Sci & Technol, Baoding, Hebei Province, Peoples R China; [Xie, Fan] China Natl Light Ind Council, Dept Party Affairs, Beijing, Peoples R China; [Wang, Kun] China Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China	Peking University; Hebei Agricultural University; China Agricultural University	Xu, MY (corresponding author), Peking Univ, Coll Urban & Environm Sci, Dept Ecol, Beijing 100871, Peoples R China.	xuminyun@pku.edu.cn			Baoding Science and Technology Development Project [13zf063]	Baoding Science and Technology Development Project	This research was funded by Baoding Science and Technology Development Project (Grant No. 13zf063). The funder (URL: http://www. bdskjj.gov.cn/) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao S.D, 2000, SOIL AGRO CHEM ANAL, P49; BAUER A, 1987, SOIL SCI SOC AM J, V51, P176, DOI 10.2136/sssaj1987.03615995005100010037x; Chen Z., 2000, TYPICAL STEPPE ECOSY; Chen ZQ, 2001, J GEOGR SCI, V11, P433, DOI DOI 10.1007/BF02837971; Christensen L, 2004, CLIMATIC CHANGE, V63, P351, DOI 10.1023/B:CLIM.0000018513.60904.fe; Derner JD, 2007, J SOIL WATER CONSERV, V62, P77; Ding HA, 2007, INT J SUST DEV WORLD, V14, P391; FRANK AB, 1995, J RANGE MANAGE, V48, P470, DOI 10.2307/4002255; Gan L, 2012, PEDOSPHERE, V22, P165, DOI 10.1016/S1002-0160(12)60003-4; Gao YZ, 2008, PLANT SOIL, V307, P41, DOI 10.1007/s11104-008-9579-3; Gao YH, 2007, POL J ECOL, V55, P469; Gill R, 1999, ECOSYSTEMS, V2, P226; Gong DY, 2004, J ARID ENVIRON, V59, P771, DOI 10.1016/j.jaridenv.2004.02.006; Haynes RJ, 1999, BIOL FERT SOILS, V28, P253, DOI 10.1007/s003740050490; He NP, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00017.1; He NP, 2008, SOIL BIOL BIOCHEM, V40, P2952, DOI 10.1016/j.soilbio.2008.08.018; Hiernaux P, 1998, PLANT ECOL, V138, P191, DOI 10.1023/A:1009752606688; HOLLAND EA, 1992, AM NAT, V140, P685, DOI 10.1086/285435; HOLLAND EA, 1990, ECOLOGY, V71, P1040, DOI 10.2307/1937372; Huang D, 2007, J ARID ENVIRON, V70, P120, DOI 10.1016/j.jaridenv.2006.12.009; Institute of Soil Science Chinese Academy of Sciences, 1978, SOIL PHYS CHEM AN; LEHOUEROU HN, 1988, J ARID ENVIRON, V15, P1, DOI 10.1016/S0140-1963(18)31001-2; LEIBOLD MA, 1989, AM NAT, V134, P922, DOI 10.1086/285022; Li Yong-Hong, 1993, Acta Botanica Sinica, V35, P877; [刘全友 Liu Quanyou], 2003, [生态学报, Acta Ecologica Sinica], V23, P1025; Liu TZ, 2011, NUTR CYCL AGROECOSYS, V91, P67, DOI 10.1007/s10705-011-9445-1; Liu Yingru, 2004, Yingyong Shengtai Xuebao, V15, P1604; McNaughton SJ, 1997, SCIENCE, V278, P1798, DOI 10.1126/science.278.5344.1798; McNaughton SJ, 1998, ECOLOGY, V79, P587, DOI 10.1890/0012-9658(1998)079[0587:RBAPIA]2.0.CO;2; MILCHUNAS DG, 1993, ECOL MONOGR, V63, P327, DOI 10.2307/2937150; Milchunas DG, 1998, OIKOS, V83, P65, DOI 10.2307/3546547; NAETH MA, 1991, CAN J SOIL SCI, V71, P313, DOI 10.4141/cjss91-031; NAETH MA, 1995, J RANGE MANAGE, V48, P528, DOI 10.2307/4003065; Neff JC, 2005, ECOL APPL, V15, P87, DOI 10.1890/04-0268; Page A.L., 1983, METHODS SOIL ANAL 2; Reeder JD, 2002, ENVIRON POLLUT, V116, P457, DOI 10.1016/S0269-7491(01)00223-8; Ren JZ, 1985, GRASSLAND SURVEY PLA; Schuman GE, 1999, ECOL APPL, V9, P65, DOI 10.1890/1051-0761(1999)009[0065:IOGMOT]2.0.CO;2; Stavi I, 2008, CATENA, V75, P288, DOI 10.1016/j.catena.2008.07.007; Steffens M, 2008, GEODERMA, V143, P63, DOI 10.1016/j.geoderma.2007.09.004; Su YZ, 2004, SOIL TILL RES, V75, P27, DOI 10.1016/S0167-1987(03)00157-0; Tracy BF, 1998, OECOLOGIA, V114, P556, DOI 10.1007/s004420050480; VANHAVEREN BP, 1983, J RANGE MANAGE, V36, P586; Wen L, 2013, PLANT SOIL, V368, P329, DOI 10.1007/s11104-012-1500-4; WILLMS WD, 1993, J RANGE MANAGE, V46, P320, DOI 10.2307/4002466; Wu L, 2008, J ENVIRON QUAL, V37, P663, DOI 10.2134/jeq2007.0196; Xu MY, 2011, AFR J BIOTECHNOL, V10, P4844; Zhao Y, 2007, ECOL MODEL, V205, P241, DOI 10.1016/j.ecolmodel.2007.02.019; Zhou ZC, 2010, CATENA, V82, P87, DOI 10.1016/j.catena.2010.05.005; Zhou ZY, 2007, BIOGEOCHEMISTRY, V82, P127, DOI 10.1007/s10533-006-9058-y	50	24	28	8	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96604	10.1371/journal.pone.0096604	http://dx.doi.org/10.1371/journal.pone.0096604			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	25003849	Green Published, Green Submitted, gold			2022-12-27	WOS:000336653300023
J	Lee, MD; Steyvers, M; Miller, B				Lee, Michael D.; Steyvers, Mark; Miller, Brent			A Cognitive Model for Aggregating People's Rankings	PLOS ONE			English	Article								We develop a cognitive modeling approach, motivated by classic theories of knowledge representation and judgment from psychology, for combining people's rankings of items. The model makes simple assumptions about how individual differences in knowledge lead to observed ranking data in behavioral tasks. We implement the cognitive model as a Bayesian graphical model, and use computational sampling to infer an aggregate ranking and measures of the individual expertise. Applications of the model to 23 data sets, dealing with general knowledge and prediction tasks, show that the model performs well in producing an aggregate ranking that is often close to the ground truth and, as in the "wisdom of the crowd'' effect, usually performs better than most of individuals. We also present some evidence that the model outperforms the traditional statistical Borda count method, and that the model is able to infer people's relative expertise surprisingly well without knowing the ground truth. We discuss the advantages of the cognitive modeling approach to combining ranking data, and in wisdom of the crowd research generally, as well as highlighting a number of potential directions for future model development.	[Lee, Michael D.; Steyvers, Mark; Miller, Brent] Univ Calif Irvine, Dept Cognit Sci, Irvine, CA 92717 USA	University of California System; University of California Irvine	Lee, MD (corresponding author), Univ Calif Irvine, Dept Cognit Sci, Irvine, CA 92717 USA.	mdlee@uci.edu	; , Chris/A-5366-2009	Komar, John/0000-0002-2063-4065; Steyvers, mark/0000-0003-1466-5647; , Chris/0000-0003-1158-8244	University California Irvine [85299]; Department of Interior National Business Center (DoI/NBC) [D11PC20059]	University California Irvine; Department of Interior National Business Center (DoI/NBC)	This research was supported by SURP Award 85299 (http://www.urop.uci.edu/SURP.html) from the University California Irvine, and by the Intelligence Advanced Research Projects Activity (IARPA: http://www.iarpa.gov/) via Department of Interior National Business Center (DoI/NBC) contract number D11PC20059. The U.S. Government is authorized to reproduce and distribute reprints for Governmental purposes notwithstanding any copyright annotation thereon. Disclaimer: The views and conclusions contained herein are those of the authors and should not be interpreted as necessarily representing the official policies or endorsements, either expressed or implied, of IARPA, DoI/NBC, or the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bockenholt U., 1993, PROBABILITY MODELS S, P157; Borg I., 1997, MODERN MULTIDIMENSIO; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; DeBoeck P., 2004, FRAMEWORK ITEM RESPO; Gordon K, 1924, J EXP PSYCHOL, V7, P398, DOI 10.1037/h0074666; Henson R, 2001, PSYCHOLOGIST, V14, P70; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; Huang J, 2009, J MACH LEARN RES, V10, P997; Johnson TR, 2013, BEHAV RES METHODS; Karabatsos G, 2003, PSYCHOMETRIKA, V68, P373, DOI 10.1007/BF02294733; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Klementiev A, 2009, INT JOINT C ART INT; KONDOR R., 2007, P 11 INT C ART INT S; Lebanon G, 2002, P 19 INT C MACH LEAR; Lebanon G, 2008, J MACH LEARN RES, V9, P2401; Lee M., 2011, P 33 ANN C COGN SCI, P1304; Lee MD, 2012, TOP COGN SCI, V4, P151, DOI 10.1111/j.1756-8765.2011.01175.x; Lee MD, 2011, MEM COGNITION, V39, P914, DOI 10.3758/s13421-010-0059-7; LUCE RD, 1994, PSYCHOL REV, V101, P271, DOI 10.1037/0033-295X.101.2.271; Marden JI, 1995, ANAL MODELING RANK D; Oravecz Z, 2013, PSYCHOMETRIKA; Plummer M., 2003, P 3 INT WORKSH DISTR; ROMNEY AK, 1987, AM BEHAV SCI, V31, P163, DOI 10.1177/000276487031002003; Steyvers M., 2009, ADV NEURAL INFORM PR, V22, P1785; Surowiecki James, 2004, WISDOM CROWDS; Thompson B, 2004, EXPLORATORY CONFIRMA; Thurstone LL, 1927, PSYCHOL REV, V34, P273, DOI 10.1037/h0070288; Weiss DJ, 2014, APPL COGNITIVE PSYCH; Zhang SN, 2010, COGNITION IN FLUX, P1118	29	83	85	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96431	10.1371/journal.pone.0096431	http://dx.doi.org/10.1371/journal.pone.0096431			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	25140822	gold, Green Published			2022-12-27	WOS:000336838000037
J	Xu, XY; Li, F; Zhang, X; Li, PC; Zhang, X; Wu, ZX; Li, DP				Xu, Xiaoyan; Li, Feng; Zhang, Xin; Li, Pengcheng; Zhang, Xing; Wu, Zhaoxi; Li, Dapeng			In Vitro Synergistic Antioxidant Activity and Identification of Antioxidant Components from Astragalus membranaceus and Paeonia lactiflora	PLOS ONE			English	Article							RADIX-ASTRAGALI; HPLC; MECHANISMS; CONSTITUENTS; PERSPECTIVE; ANTICANCER; FLAVONOIDS; APOPTOSIS; EXTRACT; ASSAY	Many traditionally used herbs demonstrate significantly better pharmacological effects when used in combination than when used alone. However, the mechanism underlying this synergism is still poorly understood. This study aimed to investigate the synergistic antioxidant activity of Astragalus membranaceus (AME) and Paeonia Lactiflora (PL), and identify the potential antioxidant components by 1,1-diphenyl-2-picrylhydrazine (DPPH) radical spiking test followed by a high performance liquid chromatography separation combined with diode array detection and tandem mass spectrometry analysis (DPPH-HPLC-DAD-MS/MS). Eight AME-PL combined extracts (E-1-E-8) were prepared based on bioactivity-guided fractionation. Among them, E-1 exhibited the strongest synergistic effect in scavenging DPPH radicals and reducing ferric ions (P<0.05). Moreover, E-1 presented strong cytoprotection against H2O2-induced oxidative damage in MRC-5 cells by suppressing the decrease of the superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and catalase (CAT) activities. A strong correlation between the increment of total phenolic/flavonoid and synergistic antioxidant activity, especially between the increment of total flavonoid and the increase in ferric reducing power was observed. Finally, seven antioxidant substances were identified in E-1 as oxypaeoniflora, catechin, calycosin-7-O-beta-D-glucopyranoside, fomononetin-7-O-beta-D-glucopyranoside, 9,10-dimethoxy-pterocarpan-3-O-beta-D-glucopyranoside, quercetin and 2'-dihydroxy-3',4'-dimethyl-isoflavan- 7-O-beta-D-glucopyranoside.	[Xu, Xiaoyan; Li, Feng; Zhang, Xin; Zhang, Xing; Wu, Zhaoxi; Li, Dapeng] Shandong Agr Univ, Dept Food Sci, Tai An, Shandong, Peoples R China; [Li, Pengcheng] Shandong Agr Univ, Coll Life Sci, Tai An, Shandong, Peoples R China; [Li, Dapeng] Natl Res Ctr Apple Engn & Technol, Tai An, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University	Li, DP (corresponding author), Shandong Agr Univ, Dept Food Sci, Tai An, Shandong, Peoples R China.	dpli73@sdau.edu.cn	DaPeng, Li/G-4164-2010; li, dapeng/G-4166-2010	DaPeng, Li/0000-0002-1816-3217; li, dapeng/0000-0002-1816-3217; Ross, Kathryn/0000-0002-3628-766X; Demos, Kathryn/0000-0002-8578-4312; Xu, Xiaomeng/0000-0003-3695-4845	National Key Technology R&D Program of China [2012BAK17B05]; Shandong Provincial Natural Science Foundation of China [ZR2009DM046]; Foundation of National Natural Science Foundation of China [31201417]	National Key Technology R&D Program of China(National Key Technology R&D Program); Shandong Provincial Natural Science Foundation of China(Natural Science Foundation of Shandong Province); Foundation of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Technology R&D Program of China (2012BAK17B05), Shandong Provincial Natural Science Foundation of China (ZR2009DM046), and the Foundation of National Natural Science Foundation of China (31201417). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atangwho IJ, 2012, J ETHNOPHARMACOL, V141, P878, DOI 10.1016/j.jep.2012.03.041; Bandoniene D, 2002, J BIOCHEM BIOPH METH, V53, P45, DOI 10.1016/S0165-022X(02)00091-X; Barbouti A, 2002, FREE RADICAL BIO MED, V33, P691, DOI 10.1016/S0891-5849(02)00967-X; Bendaoud H, 2010, J FOOD SCI, V75, pC466, DOI 10.1111/j.1750-3841.2010.01711.x; Benzie IFF, 1999, METHOD ENZYMOL, V299, P15; Cai YZ, 2004, LIFE SCI, V74, P2157, DOI 10.1016/j.lfs.2003.09.047; CHOU TC, 1994, JNCI-J NATL CANCER I, V86, P1517, DOI 10.1093/jnci/86.20.1517; Chu C, 2010, J SEP SCI, V33, P570, DOI 10.1002/jssc.200900687; Fattahi M, 2013, FOOD CHEM, V141, P139, DOI 10.1016/j.foodchem.2013.03.019; GRECO WR, 1995, PHARMACOL REV, V47, P331; Huang DJ, 2005, J AGR FOOD CHEM, V53, P1841, DOI 10.1021/jf030723c; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Kim SH, 2009, J ENZYM INHIB MED CH, V24, P1138, DOI 10.1080/14756360802667977; Leung HWC, 2006, EUR J PHARMACOL, V534, P12, DOI 10.1016/j.ejphar.2006.01.021; Ma XH, 2009, DRUG DISCOV TODAY, V14, P579, DOI 10.1016/j.drudis.2009.03.012; MAK IT, 1983, J BIOL CHEM, V258, P3733; Misbah H, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-118; Nagata Hidetaka, 1999, Tokai Journal of Experimental and Clinical Medicine, V24, P1; Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418; Rathee JS, 2006, J AGR FOOD CHEM, V54, P9046, DOI 10.1021/jf061679e; Rodea-Palomares I, 2010, WATER RES, V44, P427, DOI 10.1016/j.watres.2009.07.026; SIMIC MG, 1988, MUTAT RES, V202, P377, DOI 10.1016/0027-5107(88)90199-6; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Stermitz FR, 2000, P NATL ACAD SCI USA, V97, P1433, DOI 10.1073/pnas.030540597; Tang D, 2008, J SEP SCI, V31, P3519, DOI 10.1002/jssc.200800173; Verma AR, 2010, FOOD CHEM TOXICOL, V48, P704, DOI 10.1016/j.fct.2009.11.052; Wang L.S., 2012, NUTR WELL BEING HLTH, V7, P201, DOI DOI 10.5772/25862; Wang PC, 2003, MECH AGEING DEV, V124, P1025, DOI 10.1016/j.mad.2003.08.005; Wijesekara I, 2011, FOOD RES INT, V44, P703, DOI 10.1016/j.foodres.2010.12.022; Xiao HB, 2004, J CHROMATOGR A, V1032, P117, DOI 10.1016/j.chroma.2003.09.032; Yang WJ, 2009, BIOL PHARM BULL, V32, P1021, DOI 10.1248/bpb.32.1021; Yao H, 2012, FOOD CHEM, V135, P2802, DOI 10.1016/j.foodchem.2012.07.076; Zhu YZ, 2004, NAT PROD REP, V21, P478, DOI 10.1039/b304821g	33	85	91	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96780	10.1371/journal.pone.0096780	http://dx.doi.org/10.1371/journal.pone.0096780			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816851	Green Published, gold, Green Submitted			2022-12-27	WOS:000336838000064
J	Li, SF; Gao, WJ; Zhao, XP; Dong, TY; Deng, CL; Lu, LD				Li, Shu-Fen; Gao, Wu-Jun; Zhao, Xin-Peng; Dong, Tian-Yu; Deng, Chuan-Liang; Lu, Long-Dou			Analysis of Transposable Elements in the Genome of Asparagus officinalis from High Coverage Sequence Data	PLOS ONE			English	Article							REPETITIVE SEQUENCES; SEX-CHROMOSOMES; SIZE VARIATION; RETROTRANSPOSONS	Asparagus officinalis is an economically and nutritionally important vegetable crop that is widely cultivated and is used as a model dioecious species to study plant sex determination and sex chromosome evolution. To improve our understanding of its genome composition, especially with respect to transposable elements (TEs), which make up the majority of the genome, we performed Illumina HiSeq2000 sequencing of both male and female asparagus genomes followed by bioinformatics analysis. We generated 17 Gb of sequence (126coverage) and assembled them into 163,406 scaffolds with a total cumulated length of 400 Mbp, which represent about 30% of asparagus genome. Overall, TEs masked about 53% of the A. officinalis assembly. Majority of the identified TEs belonged to LTR retrotransposons, which constitute about 28% of genomic DNA, with Ty1/copia elements being more diverse and accumulated to higher copy numbers than Ty3/gypsy. Compared with LTR retrotransposons, non-LTR retrotransposons and DNA transposons were relatively rare. In addition, comparison of the abundance of the TE groups between male and female genomes showed that the overall TE composition was highly similar, with only slight differences in the abundance of several TE groups, which is consistent with the relatively recent origin of asparagus sex chromosomes. This study greatly improves our knowledge of the repetitive sequence construction of asparagus, which facilitates the identification of TEs responsible for the early evolution of plant sex chromosomes and is helpful for further studies on this dioecious plant.	[Li, Shu-Fen; Gao, Wu-Jun; Zhao, Xin-Peng; Dong, Tian-Yu; Deng, Chuan-Liang; Lu, Long-Dou] Henan Normal Univ, Coll Life Sci, Xinxiang, Henan, Peoples R China; [Li, Shu-Fen; Gao, Wu-Jun; Deng, Chuan-Liang; Lu, Long-Dou] Univ Henan Prov, Key Lab Microorganisms & Funct Mol, Xinxiang, Peoples R China	Henan Normal University	Gao, WJ (corresponding author), Henan Normal Univ, Coll Life Sci, Xinxiang, Henan, Peoples R China.	gaowujun1@163.com	Fan, Huahao/AAR-8062-2021; Fan, Hang/AAA-8489-2022	Fan, Huahao/0000-0001-5007-2158; Fan, Hang/0000-0002-7927-1684; Tong, Yigang/0000-0002-8503-8045	National Natural Science Foundation of China [30970211, 31300202, 31000165]; Key Science and Technology Research Project of Henan Province [132102110195]; Program for Innovative Research Team (in Science and Technology) in University of Henan Province [13IRTSTHN009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Science and Technology Research Project of Henan Province; Program for Innovative Research Team (in Science and Technology) in University of Henan Province	This work was supported by grants from the National Natural Science Foundation of China (30970211, 31300202 and 31000165), the Key Science and Technology Research Project of Henan Province (No. 132102110195) and the Program for Innovative Research Team (in Science and Technology) in University of Henan Province (13IRTSTHN009). The founders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Bergero R, 2009, TRENDS ECOL EVOL, V24, P94, DOI 10.1016/j.tree.2008.09.010; Cermak T, 2008, CHROMOSOME RES, V16, P961, DOI 10.1007/s10577-008-1254-2; Charlesworth D, 2005, HEREDITY, V95, P118, DOI 10.1038/sj.hdy.6800697; Charlesworth D, 2013, J EXP BOT, V64, P405, DOI 10.1093/jxb/ers322; Dassanayake M, 2011, NAT GENET, V43, P913, DOI 10.1038/ng.889; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Du JC, 2012, PLANT CELL, V24, P21, DOI [10.1105/tpc.111.092759, 10.1105/tpc.112.103630]; Ellision JH, 1986, BREEDING VEGETABLE C, P521; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Gao LH, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-18; Gregory TR, 2005, NAT REV GENET, V6, P699, DOI 10.1038/nrg1674; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Hertweck KL, 2013, GENOME, V56, P487, DOI 10.1139/gen-2013-0042; Hill P, 2005, MOL GENET GENOMICS, V273, P371, DOI 10.1007/s00438-005-1141-x; Hribova E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-204; Huang CRL, 2012, ANNU REV GENET, V46, P651, DOI 10.1146/annurev-genet-110711-155616; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Kumar Amar, 2000, Trends in Plant Science, V5, P509, DOI 10.1016/S1360-1385(00)01760-X; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lepesant JMJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r14; Liu Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-180; Macas J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-427; Macas J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027335; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Mende DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031386; Ming R, 2011, ANNU REV PLANT BIOL, V62, P485, DOI 10.1146/annurev-arplant-042110-103914; Negrutiu I, 2001, PLANT PHYSIOL, V127, P1418, DOI 10.1104/pp.010711; Ouyang S, 2004, NUCLEIC ACIDS RES, V32, pD360, DOI 10.1093/nar/gkh099; Reamon-Buttner SM, 1998, MOL BREEDING, V4, P91, DOI 10.1023/A:1009650221460; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; Rick CM, 1943, AM J BOT, V30, P711, DOI 10.2307/2437718; Tenaillon MI, 2011, GENOME BIOL EVOL, V3, P219, DOI 10.1093/gbe/evr008; Vitte C, 2013, ANN BOT-LONDON, V112, P881, DOI 10.1093/aob/mct155; Vyskot B, 2004, TRENDS GENET, V20, P432, DOI 10.1016/j.tig.2004.06.006; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Williams-Carrier R, 2010, PLANT J, V63, P167, DOI 10.1111/j.1365-313X.2010.04231.x; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Zuccolo A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-152	42	179	185	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e97189	10.1371/journal.pone.0097189	http://dx.doi.org/10.1371/journal.pone.0097189			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24465717	Green Published, Green Submitted, gold			2022-12-27	WOS:000338213300131
J	Wang, H; Liu, B; Liu, X; Li, ZL; Yu, XF; Zhang, WY				Wang, Hong; Liu, Bin; Liu, Xin; Li, Zhaolong; Yu, Xiao-Fang; Zhang, Wenyan			Identification of HIV-1 Vif Regions Required for CBF-beta Interaction and APOBEC3 Suppression	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 VIF; LIGASE COMPLEX; HCCH MOTIF; SOCS-BOX; BINDING; DEGRADATION; INFECTION; DETERMINANTS; RESTRICTION	Human immunodeficiency virus type 1 (HIV-1) Vif requires core binding factor beta (CBF-beta) to degrade the host APOBEC3 restriction factors. Although a minimum domain and certain amino acids of HIV-1 Vif, including hydrophobic residues at the N-terminal, have been identified as critical sites for binding with CBF-beta, other regions that potentially mediate this interaction need to be further investigated. Here, we mapped two new regions of HIV-1 Vif that are required for interaction with CBF-beta by generating a series of single-site or multiple-site Vif mutants and testing their effect on the suppression of APOBEC3G (A3G) and APOBEC3F (A3F). A number of the mutants, including G84A/SIEW86-89AAAA (84/86-89), E88A/W89A (88/89), G84A, W89A, L106S and I107S in the (84)GxSIEW(89) and L(102)ADQLI(107) regions, affected Vif function by disrupting CBF-beta binding. These Vif mutants also had altered interactions with CUL5, since CBF-beta is known to facilitate the binding of Vif to CUL5. We further showed that this effect was not due to misfolding or conformational changes in Vif, as the mutants still maintained their interactions with other factors such as ElonginB, A3G and A3F. Notably, G84D and D104A had stronger effects on the Vif-CUL5 interaction than on the Vif-CBF-beta interaction, indicating that they mainly influenced the CUL5 interaction and implying that the interaction of Vif with CUL5 contributes to the binding of Vif to CBF-beta. These new binding interfaces with CBF-beta in HIV-1 Vif provide novel targets for the development of HIV-1 inhibitors.	[Wang, Hong; Liu, Bin; Liu, Xin; Li, Zhaolong; Yu, Xiao-Fang; Zhang, Wenyan] Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun 130023, Jilin Province, Peoples R China; [Liu, Bin] Jilin Univ, Hosp 1, Dept Hand Surg, Changchun 130023, Jilin Province, Peoples R China; [Yu, Xiao-Fang] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA	Jilin University; Jilin University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Zhang, WY (corresponding author), Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun 130023, Jilin Province, Peoples R China.	zhangwenyan@jlu.edu.cn			National Natural Science Foundation of China [31270202]; Chinese Ministry of Science and Technology [2012CB911102, 2013ZX10001-005]; Chinese Ministry of Education [IRT1016]; Key Laboratory of Molecular Virology, Jilin Province [20102209]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Ministry of Education(Ministry of Education, China); Key Laboratory of Molecular Virology, Jilin Province	This work was supported in part by funding from National Natural Science Foundation of China (No. 31270202), the Chinese Ministry of Science and Technology (2012CB911102 and No. 2013ZX10001-005), the Chinese Ministry of Education (IRT1016), and the Key Laboratory of Molecular Virology, Jilin Province (20102209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chackerian B, 1997, J VIROL, V71, P3932, DOI 10.1128/JVI.71.5.3932-3939.1997; Chen GY, 2009, J VIROL, V83, P8674, DOI 10.1128/JVI.00653-09; Dang Y, 2010, J VIROL, V84, P5741, DOI 10.1128/JVI.00079-10; Dang Y, 2009, J VIROL, V83, P8544, DOI 10.1128/JVI.00651-09; de Bruijn MFTR, 2004, ONCOGENE, V23, P4238, DOI 10.1038/sj.onc.1207763; Du J, 2013, J VIROL, V87, P1906, DOI 10.1128/JVI.02199-12; Fribourgh JL, 2014, J VIROL; Guo YY, 2014, NATURE, V505, P229, DOI 10.1038/nature12884; He ZW, 2008, J MOL BIOL, V381, P1000, DOI 10.1016/j.jmb.2008.06.061; Hultquist JF, 2012, J VIROL, V86, P2874, DOI 10.1128/JVI.06950-11; Jager S, 2012, NATURE, V481, P371, DOI 10.1038/nature10693; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Kim DY, 2013, MOL CELL, V49, P632, DOI 10.1016/j.molcel.2012.12.012; Luo K, 2005, P NATL ACAD SCI USA, V102, P11444, DOI 10.1073/pnas.0502440102; Matsui Y, 2014, VIROLOGY, V449, P82, DOI 10.1016/j.virol.2013.11.004; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Paul I, 2006, P NATL ACAD SCI USA, V103, P18475, DOI 10.1073/pnas.0604150103; Pery E, 2009, J VIROL, V83, P2374, DOI 10.1128/JVI.01898-08; Russell RA, 2007, J VIROL, V81, P8201, DOI 10.1128/JVI.00395-07; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Tian CJ, 2006, J VIROL, V80, P3112, DOI 10.1128/JVI.80.6.3112-3115.2006; Wang XD, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-94; Wissing S, 2011, J BIOL CHEM, V286, P36427, DOI 10.1074/jbc.M111.251058; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Yu YK, 2004, GENE DEV, V18, P2867, DOI 10.1101/gad.1250204; Zhang WY, 2012, NATURE, V481, P376, DOI 10.1038/nature10718; Zhang WY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003963; Zhen AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038771; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004; Zhou XH, 2014, J VIROL, V88, P2555, DOI 10.1128/JVI.03604-13; Zhou XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033495	31	50	51	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e95738	10.1371/journal.pone.0095738	http://dx.doi.org/10.1371/journal.pone.0095738			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24595218	gold, Green Published, Green Submitted			2022-12-27	WOS:000338213300014
J	Li, X; Wu, LH; Liu, W; Jin, YC; Chen, Q; Wang, LL; Fan, XH; Li, Z; Cheng, YY				Li, Xiang; Wu, Leihong; Liu, Wei; Jin, Yecheng; Chen, Qian; Wang, Linli; Fan, Xiaohui; Li, Zheng; Cheng, Yiyu			A Network Pharmacology Study of Chinese Medicine QiShenYiQi to Reveal Its Underlying Multi-Compound, Multi-Target, Multi-Pathway Mode of Action	PLOS ONE			English	Article							PPAR-GAMMA AGONISTS; SIGNALING PATHWAYS; HEME OXYGENASE-1; RAW264.7; EXPRESSION; MECHANISMS; PROTEIN; LIPOPOLYSACCHARIDE; INFLAMMATION; THERAPEUTICS	Chinese medicine is a complex system guided by traditional Chinese medicine (TCM) theories, which has proven to be especially effective in treating chronic and complex diseases. However, the underlying modes of action (MOA) are not always systematically investigated. Herein, a systematic study was designed to elucidate the multi-compound, multi-target and multi-pathway MOA of a Chinese medicine, QiShenYiQi (QSYQ), on myocardial infarction. QSYQ is composed of Astragalus membranaceus (Huangqi), Salvia miltiorrhiza (Danshen), Panax notoginseng (Sanqi), and Dalbergia odorifera (Jiangxiang). Male Sprague Dawley rat model of myocardial infarction were administered QSYQ intragastrically for 7 days while the control group was not treated. The differentially expressed genes (DEGs) were identified from myocardial infarction rat model treated with QSYQ, followed by constructing a cardiovascular disease (CVD)-related multilevel compound-target-pathway network connecting main compounds to those DEGs supported by literature evidences and the pathways that are functionally enriched in ArrayTrack. 55 potential targets of QSYQ were identified, of which 14 were confirmed in CVD-related literatures with experimental supporting evidences. Furthermore, three sesquiterpene components of QSYQ, Trans-nerolidol, (3S, 6S, 7R)-3,7,11-trimethyl-3,6-epoxy-1,10-dodecadien-7-ol and (3S, 6R, 7R)-3,7,11-trimethyl- 3,6-epoxy-1,10-dodecadien-7-ol from Dalbergia odorifera T. Chen, were validated experimentally in this study. Their anti-inflammatory effects and potential targets including extracellular signal-regulated kinase-1/2, peroxisome proliferator-activated receptor-gamma and heme oxygenase-1 were identified. Finally, through a three-level compound-target-pathway network with experimental analysis, our study depicts a complex MOA of QSYQ on myocardial infarction.	[Li, Xiang; Wu, Leihong; Liu, Wei; Jin, Yecheng; Chen, Qian; Wang, Linli; Fan, Xiaohui; Cheng, Yiyu] Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Zheng] Tianjin Univ Tradit Chinese Med, State Key Lab Modern Chinese Med, Tianjin, Peoples R China	Zhejiang University; Tianjin University of Traditional Chinese Medicine	Fan, XH (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310003, Zhejiang, Peoples R China.	fanxh@zju.edu.cn; lizheng1@gmail.com	Wu, Leihong/AAM-9483-2020; FAN, Xiaohui/F-6458-2010; Bligh, S W Annie/AAI-9786-2020	Wu, Leihong/0000-0002-4093-3708; FAN, Xiaohui/0000-0002-6336-3007; Bligh, S W Annie/0000-0002-4757-2159; LI, Xiaojun/0000-0003-0336-8081	National Basic Research Program of China [2012CB518405]; National Natural Science Foundation of China [81373893]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Basic Research Program of China (no. 2012CB518405) and the National Natural Science Foundation of China (no. 81373893). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Microarray test was performed by National Engineering Center for Biochip at Shanghai by Dr. Huasheng Xiao's team.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Amara U, 2008, ADV EXP MED BIOL, V632, P71, DOI 10.1007/978-0-387-78952-1_6; Aramoto H, 2004, AM J PHYSIOL-HEART C, V287, pH1590, DOI 10.1152/ajpheart.00767.2003; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barber GN, 2011, CURR OPIN IMMUNOL, V23, P10, DOI 10.1016/j.coi.2010.12.015; Berger SI, 2009, BIOINFORMATICS, V25, P2466, DOI 10.1093/bioinformatics/btp465; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Campbell IW, 2005, CURR MOL MED, V5, P349, DOI 10.2174/1566524053766068; Chao W, 2009, AM J PHYSIOL-HEART C, V296, pH1, DOI 10.1152/ajpheart.00995.2008; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Chen T, 2011, JIANGXI MED J, V46, P3; Cheung F, 2011, NATURE, V480, pS82, DOI 10.1038/480S82a; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Diez D, 2010, MOL BIOSYST, V6, P289, DOI 10.1039/b912078e; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Finck BN, 2007, CARDIOVASC RES, V73, P269, DOI 10.1016/j.cardiores.2006.08.023; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hirota SA, 2009, RECENT PATENTS INFLA, V3, P1, DOI 10.2174/187221309787158434; Hong SeChul, 2012, Journal of Medicinal Plants Research, V6, P4494; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hopkins AL, 2007, NAT BIOTECHNOL, V25, P1110, DOI 10.1038/nbt1007-1110; Humar R, 2002, FASEB J, V16, DOI 10.1096/fj.01-0658com; Jeong JB, 2013, FOOD CHEM TOXICOL, V55, P229, DOI 10.1016/j.fct.2012.12.062; Ji HY, 2010, INFLAMM RES, V59, P921, DOI 10.1007/s00011-010-0203-7; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Jiang WY, 2005, TRENDS PHARMACOL SCI, V26, P558, DOI 10.1016/j.tips.2005.09.006; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Kim BC, 2006, J ETHNOPHARMACOL, V106, P364, DOI 10.1016/j.jep.2006.01.009; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kronke G, 2007, ARTERIOSCL THROM VAS, V27, P1276, DOI 10.1161/ATVBAHA.107.142638; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lee M, 2012, STRAD, V123, P7; Li YF, 2008, J PHARMACEUT BIOMED, V47, P407, DOI 10.1016/j.jpba.2007.12.037; Li YF, 2008, CHROMATOGRAPHIA, V67, P293, DOI 10.1365/s10337-007-0479-0; Lin HY, 2003, BIOCHEM PHARMACOL, V66, P1821, DOI 10.1016/S0006-2952(03)00422-2; Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006; Martin H, 2009, MUTAT RES-FUND MOL M, V669, P1, DOI 10.1016/j.mrfmmm.2009.06.009; Miksa M, 2007, J IMMUNOL, V179, P6263, DOI 10.4049/jimmunol.179.9.6263; Murphy GJ, 2000, TRENDS PHARMACOL SCI, V21, P469, DOI 10.1016/S0165-6147(00)01559-5; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Palojoki E, 2001, AM J PHYSIOL-HEART C, V280, pH2726, DOI 10.1152/ajpheart.2001.280.6.H2726; Petit V, 2000, BIOL CELL, V92, P477, DOI 10.1016/S0248-4900(00)01101-1; PFEFFER MA, 1979, CIRC RES, V44, P503, DOI 10.1161/01.RES.44.4.503; Robinson ES, 2010, SEMIN NEPHROL, V30, P591, DOI 10.1016/j.semnephrol.2010.09.007; Sawle P, 2005, BRIT J PHARMACOL, V145, P800, DOI 10.1038/sj.bjp.0706241; Suefuji H, 1997, AM HEART J, V134, P253, DOI 10.1016/S0002-8703(97)70132-7; Suh SJ, 2006, ARCH BIOCHEM BIOPHYS, V447, P136, DOI 10.1016/j.abb.2006.01.016; Tang S, 2011, INFLAMMATION, V34, P111, DOI 10.1007/s10753-010-9214-3; Tao Y, 2010, FITOTERAPIA, V81, P393, DOI 10.1016/j.fitote.2009.11.012; Terzic A, 2011, CTS-CLIN TRANSL SCI, V4, P225, DOI 10.1111/j.1752-8062.2011.00295.x; Timmers L, 2008, CIRC RES, V102, P257, DOI 10.1161/CIRCRESAHA.107.158220; Tong WD, 2003, ENVIRON HEALTH PERSP, V111, P1819, DOI 10.1289/ehp.6497; von Knethen A, 2011, FREE RADICAL BIO MED, V51, P396, DOI 10.1016/j.freeradbiomed.2011.04.033; Wahli W, 2012, TRENDS ENDOCRIN MET, V23, P351, DOI 10.1016/j.tem.2012.05.001; Waldman SA, 2011, CLIN PHARMACOL THER, V90, P483, DOI 10.1038/clpt.2011.213; Wang Linli, 2013, Evid Based Complement Alternat Med, V2013, P652373, DOI 10.1155/2013/652373; [魏万林 WEI Wan-lin], 2009, [中国循环杂志, Chinese Circulation Journal], V24, P182; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Wu Leihong, 2013, Database (Oxford), V2013, pbat047, DOI 10.1093/database/bat047; Xing B, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-4; Yamaguchi F, 1997, J MOL CELL CARDIOL, V29, P753, DOI 10.1006/jmcc.1996.0319; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yan F. F., 2007, SHANGHAI J TRADITION, V41, P59; Yaoita H, 2000, CARDIOVASC RES, V45, P630, DOI 10.1016/S0008-6363(99)00349-1; Zaytseva YY, 2011, ANTICANCER RES, V31, P813; Zhang L, 2010, INT J CARDIOL, V143, P105, DOI 10.1016/j.ijcard.2008.11.210; Zhang YF, 2012, CURR DRUG METAB, V13, P510, DOI 10.2174/1389200211209050510; Zhao S, 2012, ANNU REV PHARMACOL, V52, P505, DOI 10.1146/annurev-pharmtox-010611-134520; Zheng XH, 2007, AM J CHINESE MED, V35, P831, DOI 10.1142/S0192415X07005302; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008; 朱明丹, 2013, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V24, P22; 刘梅, 2009, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V20, P829	80	220	235	12	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e95004	10.1371/journal.pone.0095004	http://dx.doi.org/10.1371/journal.pone.0095004			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24587076	Green Published, Green Submitted, gold			2022-12-27	WOS:000336838000010
